ID	Catalog Number	Plate	Well	Platenew	FDAplate1536w	FDAplate1536worder	FDAplate1536wq	Well1536w	FDAplate384w	Wellnew384w	cas	compound_name	Synonyms	MWt	Target	PathWay	Biological Activity	Saltdata	Formula	Batch No	Solubility	Solvent_x	Quantity	Research Area	smiles	URL	Clinical Information	Field21	Source Plate Barcode	Source Well	well_location	Transfer Volume	Unit [nL]	plate_id	Source Plate Type	Source Plate Name	Destination Plate Name	SAMPLEIDDISPLAY	Stock concentration	Unit[mM]	VESSELPOSITION	Solvent_y	MW	WellNumber	WellLetter	unique_sample_id
136	HY-A0119	HYCPK40902	N07	HYCPK40902	91z	1261.0	1.0	AA13	902.0	N07	13755-38-9	Nitroprusside (disodium dihydrate)	Sodium nitroprusside dihydrate; Sodium Nitroferricyanide(III) Dihydrate	297.95	Autophagy	Autophagy	Nitroprusside disodium dehydrate (Sodium nitroprusside dihydrate) is a vasodilator that available for the research of acute hypertension, heart failure. Nitroprusside disodium dehydrate induces autophagy in glutathione-depleted osteoblasts. Nitroprusside disodium dehydrate acts as a nitric oxide (NO) donor in a rat intestinal ischemia reperfusion model[1][2][3][4].	Sodium	C5H4FeN6Na2O3	18025.0	DMSO : 50 mg/mL (167.81 mM; Need ultrasonic); H2O : 100 mg/mL (335.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	[Na2[Fe(CN)5NO].2H2O]	https://www.medchemexpress.com/Nitroprusside-disodium-dihydrate.html	Launched		91.0	AA13	A3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0119	10.0	mM	3.0	DMSO	27.010899	3	A	pluskal_fda_drugs_5005_A3_id
231	HY-A0077	HYCPK40902	E14	HYCPK40902	91z	411.0	1.0	I27	902.0	E14	58-39-9	Perphenazine		403.97	5-HT Receptor; Adrenergic Receptor; Apoptosis; Autophagy; Dopamine Receptor; Histamine Receptor	Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Perphenazine is an orally active dopamine receptor and histamine-1 receptor antagonist, with Ki values of 0.56 nM (D2), 0.43 nM (D3), 6 nM (5-HT2A), respectively. Perphenazine also binds to Alpha-1A adrenergic receptor. Perphenazine inhibits cancer cell proliferation, and induces apoptosis. Perphenazine can be used in the research of mental disease, cancer, inflammation[1][3][5].	Free Base	C21H26ClN3OS	87485.0	DMSO : 100 mg/mL (247.54 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Inflammation/Immunology; Neurological Disease	OCCN1CCN(CCCN2C3=C(C=CC=C3)SC4=CC=C(Cl)C=C24)CC1	https://www.medchemexpress.com/Perphenazine.html	Launched		91.0	I27	A3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0077	10.0	mM	3.0	DMSO	403.148511	3	A	pluskal_fda_drugs_5005_A3_id
555	HY-14397	HYCPK40903	L12	HYCPK40903	91z	1080.0	2.0	W24	903.0	L12	53-86-1	Indomethacin	Indometacin	357.79	Antibiotic; Bacterial; COX; Influenza Virus	Anti-infection; Immunology/Inflammation	Indomethacin (Indometacin) is a potent, orally active COX1/2  inhibitor with IC50 values of 18 nM and 26 nM for COX-1 and COX-2, respectively. Indomethacin has anticancer activity and anti-infective activity. Indomethacin can be used for cancer, inflammation and viral infection research[1][2][3].	Free Acid	C19H16ClNO4	84227.0	H2O : < 0.1 mg/mL (insoluble); Ethanol : 12.5 mg/mL (34.94 mM; Need ultrasonic); DMSO : 100 mg/mL (279.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	COC1=CC=C(N(C(C2=CC=C(Cl)C=C2)=O)C(C)=C3CC(O)=O)C3=C1	https://www.medchemexpress.com/Indomethacin.html	Launched		91.0	W24	A3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14397	10.0	mM	3.0	DMSO	357.076786	3	A	pluskal_fda_drugs_5005_A3_id
727	HY-B0369A	HYCPK40903	G22	HYCPK40903	91z	620.0	2.0	M44	903.0	G22	4682-36-4	Orphenadrine (citrate)		461.50	iGluR	Membrane Transporter/Ion Channel; Neuronal Signaling	Orphenadrine citrate is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM. Orphenadrine citrate relieves stiffness, pain and discomfort due to muscle strains, sprains or other injuries. Orphenadrine citrate is also used to relieve tremors associated with parkinson's disease. Orphenadrine citrate has good neuroprotective properties, can be used in studies of neurodegenerative diseases[1][2].	Citrate	C24H31NO8	16754.0	H2O : 10 mg/mL (21.67 mM; Need ultrasonic); DMSO : 100 mg/mL (216.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/orphenadrine-citrate.html	Launched		91.0	M44	A3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0369A	10.0	mM	3.0	DMSO	269.177964	3	A	pluskal_fda_drugs_5005_A3_id
1096	HY-B0124	HYCPK40905	A06	HYCPK40905	91z	60.0	4.0	B12	905.0	A06	68291-97-4	Zonisamide	AD 810; CI 912	212.23	Apoptosis; Carbonic Anhydrase	Apoptosis; Metabolic Enzyme/Protease	Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy[1][2][3][4].	Free Base	C8H8N2O3S	125452.0	DMSO : 250 mg/mL (1177.97 mM; Need ultrasonic); H2O : 0.67 mg/mL (3.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=S(CC1=NOC2=C1C=CC=C2)(N)=O	https://www.medchemexpress.com/zonisamide.html	Launched		91.0	B12	A3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0124	10.0	mM	3.0	DMSO	212.025563	3	A	pluskal_fda_drugs_5005_A3_id
1097	HY-B0157A	HYCPK40905	B06	HYCPK40905	91z	156.0	4.0	D12	905.0	B06	34580-14-8	Ketotifen (fumarate)	HC 20511 fumarate	425.50	Endogenous Metabolite; Histamine Receptor; Influenza Virus; SARS-CoV	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Ketotifen (HC 20-511) fumarate is an orally active second-generation noncompetitive histamine 1 (H1) receptor blocker and mast cell stabilizer. Ketotifen fumarate can block 6-phosphogluconate dehydrogenase (PGD) in vitro. Ketotifen fumarate also has antiviral activity against SARS-CoV-2 and Influenza virus. Ketotifen fumarate can be used to the research of autoimmune encephalomyelitis (EAE) and asthma attack prevention[1][2][3][4].	Fumarate	C23H23NO5S	15876.0	DMSO : ≥ 100 mg/mL (235.02 mM); H2O : 16.67 mg/mL (39.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	O=C(C1=C/2C=CS1)CC3=CC=CC=C3C2=C4CCN(C)CC/4.O=C(O)/C=C/C(O)=O	https://www.medchemexpress.com/Ketotifen-fumarate.html	Launched		91.0	D12	A3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0157A	10.0	mM	3.0	DMSO	309.118735	3	A	pluskal_fda_drugs_5005_A3_id
1114	HY-10264A	HYCPK40905	C07	HYCPK40905	91z	254.0	4.0	F14	905.0	C07	480449-71-6	Edoxaban (tosylate)	DU-176b	720.26	Factor Xa; Thrombin	Metabolic Enzyme/Protease	Edoxaban (DU-176b) tosylate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Kis of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban tosylate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban tosylate can be used for preventing thromboembolic disease research[1].	Tosylate	C31H38ClN7O7S2	58705.0	DMSO : 100 mg/mL (138.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(N(C)C)[C@@H](CC1)C[C@H]([C@H]1NC(C(NC(C=C2)=NC=C2Cl)=O)=O)NC(C3=NC(CC4)=C(CN4C)S3)=O.O=S(C5=CC=C(C)C=C5)(O)=O	https://www.medchemexpress.com/edoxaban-tosylate.html	Launched		91.0	F14	A3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10264A	10.0	mM	3.0	DMSO	547.176851	3	A	pluskal_fda_drugs_5005_A3_id
1117	HY-14914	HYCPK40905	F07	HYCPK40905	91z	542.0	4.0	L14	905.0	F07	147403-03-0	Azilsartan	TAK-536	456.45	Angiotensin Receptor; Apoptosis; Reactive Oxygen Species	Apoptosis; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Azilsartan (TAK-536) is an orally active, potent, selective and specific angiotensin II type 1 receptor (AT1) antagonist. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity. Azilsartan can be used for hypertension and stroke research[1][2][3][4][5].	Free Acid	C25H20N4O5	8956.0	DMSO : 25 mg/mL (54.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Neurological Disease; Cardiovascular Disease	O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C(N5)=NOC5=O)C=C3)=CC=C1)O	https://www.medchemexpress.com/Azilsartan.html	Launched		91.0	L14	A3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14914	10.0	mM	3.0	DMSO	456.14337	3	A	pluskal_fda_drugs_5005_A3_id
228	HY-B1493	HYCPK40902	B14	HYCPK40902	91z	123.0	1.0	C27	902.0	B14	37106-97-1	Bentiromide		404.42	Others	Others	Bentiromide is a peptide that is broken down in the pancreas by chymotrypsin. The bentiromide test is an excellent means of confirming the diagnosis of pancreatic exocrine insufficiency by outpatient test of chymotrypsin function[1].	Free Acid	C23H20N2O5	64390.0	DMSO : ≥ 250 mg/mL (618.17 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(O)C1=CC=C(NC([C@@H](NC(C2=CC=CC=C2)=O)CC3=CC=C(O)C=C3)=O)C=C1	https://www.medchemexpress.com/bentiromide.html	Launched		91.0	C27	A4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1493	10.0	mM	4.0	DMSO	404.137222	4	A	pluskal_fda_drugs_5005_A4_id
279	HY-15781	HYCPK40902	E17	HYCPK40902	91z	417.0	1.0	I33	902.0	E17	92478-27-8	Morinidazole		270.29	Bacterial	Anti-infection	Morinidazole is an orally active and 5-nitroimidazole antimicrobial agent that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation. Morinidazole can be used for bacterial infections research including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria[1].	Free Base	C11H18N4O4	17810.0	DMSO : ≥ 100 mg/mL (369.97 mM)	DMSO Solution	10mM  * 100uL	Infection	OC(CN1C([N+]([O-])=O)=CN=C1C)CN2CCOCC2	https://www.medchemexpress.com/Morinidazole.html	Launched		91.0	I33	A4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15781	10.0	mM	4.0	DMSO	270.132805	4	A	pluskal_fda_drugs_5005_A4_id
328	HY-B0804	HYCPK40902	P20	HYCPK40902	91z	1479.0	1.0	AE39	902.0	P20	42200-33-9	Nadolol	SQ-11725	309.40	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Nadolol (SQ-11725) is a non-selective and orally active β-adrenergic receptors blocker and is a substrate of organic anion transporting polypeptide 1A2 (OATP1A2). Nadolol has the the potential for high blood pressure, angina pectoris and vascular headaches research[1][2][3].	Free Base	C17H27NO4	109720.0	DMSO : 50 mg/mL (161.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	OC1CC2=C(C(OCC(O)CNC(C)(C)C)=CC=C2)CC1O	https://www.medchemexpress.com/nadolol.html	Launched		91.0	AE39	A4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0804	10.0	mM	4.0	DMSO	309.194008	4	A	pluskal_fda_drugs_5005_A4_id
608	HY-B0564	HYCPK40903	F14	HYCPK40903	91z	508.0	2.0	K28	903.0	F14	14402-89-2	Sodium nitroprusside	Ro 21-2498	261.92	Others	Others	Sodium nitroprusside (Ro 21-2498) is a potent vasodilator working through releasing NO spontaneously in blood.	Sodium	C5FeN6Na2O	118417.0	DMSO : 33.33 mg/mL (127.25 mM; Need ultrasonic); H2O : 100 mg/mL (381.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	N#C[Fe-2](C#N)(C#N)(C#N)(N=O)C#N.[Na+].[Na+]	https://www.medchemexpress.com/Nitroprusside-Sodium.html	Launched		91.0	K28	A4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0564	10.0	mM	4.0	DMSO	27.010899	4	A	pluskal_fda_drugs_5005_A4_id
950	HY-B0667	HYCPK40904	O16	HYCPK40904	91z	1423.0	3.0	AD31	904.0	O16	80573-04-2	Balsalazide		357.32	Interleukin Related; STAT	Immunology/Inflammation; JAK/STAT Signaling; Stem Cell/Wnt	Balsalazide could suppress colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway.	Free Acid	C17H15N3O6	36024.0	DMSO : 100 mg/mL (279.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(O)C1=CC(/N=N/C2=CC=C(C(NCCC(O)=O)=O)C=C2)=CC=C1O	https://www.medchemexpress.com/Balsalazide.html	Launched		91.0	AD31	A4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0667	10.0	mM	4.0	DMSO	357.096085	4	A	pluskal_fda_drugs_5005_A4_id
1062	HY-B1550	HYCPK40905	O03	HYCPK40905	91z	1398.0	4.0	AD6	905.0	O03	119-53-9	Benzoin	DL-Benzoin; Desyl alcohol; (±)-2-Hydroxy-2-phenylacetophenone	212.24	Others	Others	Benzoin is a kind of alsamic resin isolated from the styracaceae family. Benzoin can be used as a colour additive used for marking plants[1].		C14H12O2	115799.0	DMSO : 50 mg/mL (235.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	OC(C1=CC=CC=C1)C(C2=CC=CC=C2)=O	https://www.medchemexpress.com/benzoin.html	Launched		91.0	AD6	A4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1550	10.0	mM	4.0	DMSO	212.08373	4	A	pluskal_fda_drugs_5005_A4_id
1243	HY-10264	HYCPK40905	D15	HYCPK40905	91z	366.0	4.0	H30	905.0	D15	480449-70-5	Edoxaban	DU-176	548.06	Factor Xa; Thrombin	Metabolic Enzyme/Protease	Edoxaban (DU-176b) is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Ki values of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban can be used in preventing thromboembolic disease research[1].	Free Base	C24H30ClN7O4S	41922.0	DMSO : 10 mg/mL (18.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(N(C)C)[C@@H](CC1)C[C@H]([C@H]1NC(C(NC(C=C2)=NC=C2Cl)=O)=O)NC(C3=NC(CC4)=C(CN4C)S3)=O	https://www.medchemexpress.com/edoxaban.html	Launched		91.0	H30	A4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10264	10.0	mM	4.0	DMSO	547.176851	4	A	pluskal_fda_drugs_5005_A4_id
1304	HY-10571A	HYCPK40905	A19	HYCPK40905	91z	86.0	4.0	B38	905.0	A19	147221-93-0	Delavirdine (mesylate)	U 90152 (mesylate); BHAP-U 90152 (mesylate)	552.67	HIV; Reverse Transcriptase	Anti-infection	Delavirdine (U 90152) mesylate is a potent, highly specific and orally active non-nucleoside reverse transcriptase inhibitor (NNRTI). Delavirdine mesylate selectively inhibits HIV-1 reverse transcriptase (RT) (IC50=0.26?μM) over DNA polymerase?α?(IC50=440 μM) and polymerase?δ (IC50>550?μM). Delavirdine mesylate is an inhibitor of HIV-1 replication and can can be used for the study of AIDs[1].	Mesylate	C23H32N6O6S2	14767.0	DMSO : ≥ 40.3 mg/mL (72.92 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(NC1=CC=C(NC(C(N2CCN(C3=C(NC(C)C)C=CC=N3)CC2)=O)=C4)C4=C1)(C)=O.O=S(O)(C)=O	https://www.medchemexpress.com/Delavirdine-mesylate.html	Launched		91.0	B38	A4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10571A	10.0	mM	4.0	DMSO	456.19436	4	A	pluskal_fda_drugs_5005_A4_id
442	HY-B0178A	HYCPK40903	O04	HYCPK40903	91z	1352.0	2.0	AC8	903.0	O04	50-01-1	Guanidine (hydrochloride)	Guanidinium (chloride); Aminoformamidine (hydrochloride)	95.53	Endogenous Metabolite	Metabolic Enzyme/Protease	Guanidine hydrochloride (Guanidinium chloride) a strong chaotrope, is also a strong denaturant of proteins[1][2].	Hydrochloride	CH6ClN3	16552.0	H2O : ≥ 50 mg/mL (523.40 mM); DMSO : ≥ 100 mg/mL (1046.79 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	NC(N)=N.Cl	https://www.medchemexpress.com/guanidine-hydrochloride.html	Launched		91.0	AC8	A5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0178A	10.0	mM	5.0	DMSO	59.048347	5	A	pluskal_fda_drugs_5005_A5_id
543	HY-B0935	HYCPK40903	P11	HYCPK40903	91z	1462.0	2.0	AE22	903.0	P11	120-51-4	Benzyl benzoate	Benzoic acid benzyl ester	212.24	Endogenous Metabolite; Parasite	Anti-infection; Metabolic Enzyme/Protease	Benzyl benzoate (Benzoic acid benzyl ester) is a fragrance ingredient in cosmetic products. Benzyl benzoate can be used for the research of Scabies and Demodex-associated inflammatory skin conditions[1][2][3].	Free Base	C14H12O2	17700.0	DMSO : ≥ 50 mg/mL (235.58 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(OCC1=CC=CC=C1)C2=CC=CC=C2	https://www.medchemexpress.com/Benzyl-benzoate.html	Launched		91.0	AE22	A5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0935	10.0	mM	5.0	DMSO	212.08373	5	A	pluskal_fda_drugs_5005_A5_id
676	HY-10821	HYCPK40903	J18	HYCPK40903	91z	900.0	2.0	S36	903.0	J18	112887-68-0	Raltitrexed	ZD1694; D1694; ICI-D1694	458.49	Nucleoside Antimetabolite/Analog; Thymidylate Synthase	Apoptosis; Cell Cycle/DNA Damage	Raltitrexed is an antimetabolite drug used in chemotherapy, acting by inhibiting thymidylate synthase.	Free Acid	C21H22N4O6S	98871.0	DMSO : ≥ 29 mg/mL (63.25 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC(NC1=O)=NC2=C1C=C(CN(C)C3=CC=C(C(N[C@H](C(O)=O)CCC(O)=O)=O)S3)C=C2	https://www.medchemexpress.com/Raltitrexed.html	Launched		91.0	S36	A5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10821	10.0	mM	5.0	DMSO	458.126005	5	A	pluskal_fda_drugs_5005_A5_id
797	HY-17041	HYCPK40904	B07	HYCPK40904	91z	157.0	3.0	D13	904.0	B07	635728-49-3	Darunavir (Ethanolate)	TMC114 (Ethanolate)	593.73	HIV; HIV Protease	Anti-infection; Metabolic Enzyme/Protease	Darunavir ethanolate (TMC114 Ethanolate) is a potent HIV protease inhibitor used to treat and prevent HIV/AIDS. Darunavir has a Ki of 1 nM for wild type HIV-1 protease.	Free Base	C29H43N3O8S	68109.0	DMSO : ≥ 50 mg/mL (84.21 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(O[C@@H]1[C@@]2([H])[C@@](OCC2)([H])OC1)N[C@@H](CC3=CC=CC=C3)[C@H](O)CN(S(=O)(C4=CC=C(N)C=C4)=O)CC(C)C.CCO	https://www.medchemexpress.com/Darunavir-Ethanolate.html	Launched		91.0	D13	A5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17041	10.0	mM	5.0	DMSO	547.235222	5	A	pluskal_fda_drugs_5005_A5_id
828	HY-114657A	HYCPK40904	A09	HYCPK40904	91z	65.0	3.0	B17	904.0	A09	19428-14-9	Benproperine (phosphate)		407.44	Arp2/3 Complex	Cytoskeleton	Benproperine phosphate is an orally active, potent actin-related protein 2/3 complex subunit 2 (ARPC2) inhibitor. Benproperine phosphate attenuates the actin polymerization rate of action polymerization nucleation by impairing Arp2/3 function. Benproperine phosphate has the potential for a cough suppressant and suppresses cancer cell migration and tumor metastasis[1].	Phosphate	C21H30NO5P	103809.0	H2O : ≥ 100 mg/mL (245.43 mM); DMSO : 250 mg/mL (613.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	CC(N1CCCCC1)COC2=CC=CC=C2CC3=CC=CC=C3.O=P(O)(O)O	https://www.medchemexpress.com/benproperine-phosphate.html	Launched		91.0	B17	A5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-114657A	10.0	mM	5.0	DMSO	309.209264	5	A	pluskal_fda_drugs_5005_A5_id
849	HY-B0077	HYCPK40904	F10	HYCPK40904	91z	547.0	3.0	L19	904.0	F10	3543-75-7	Bendamustine (hydrochloride)	SDX-105	394.72378	Apoptosis; DNA Alkylator/Crosslinker	Apoptosis; Cell Cycle/DNA Damage	Bendamustine hydrochloride (SDX-105), a purine analogue, is a DNA cross-linking agent. Bendamustine hydrochloride activats DNA-damage stress response and apoptosis. Bendamustine hydrochloride has potent alkylating, anticancer and antimetabolite properties[1].	Hydrochloride	C16H22Cl3N3O2	98611.0	DMSO : 100 mg/mL (253.34 mM; Need ultrasonic); H2O : 12.5 mg/mL (31.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CN1C(C=CC(N(CCCl)CCCl)=C2)=C2N=C1CCCC(O)=O.Cl	https://www.medchemexpress.com/bendamustine-hydrochloride.html	Launched		91.0	L19	A5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0077	10.0	mM	5.0	DMSO	357.101082	5	A	pluskal_fda_drugs_5005_A5_id
959	HY-B0234	HYCPK40904	H17	HYCPK40904	91z	753.0	3.0	P33	904.0	H17	53-16-7	Estrone	E1; Oestrone	270.37	Endogenous Metabolite; Estrogen Receptor/ERR	Metabolic Enzyme/Protease; Others	Estrone (E1) is a natural estrogenic hormone. Estrone is the main representative of the endogenous estrogens and is produced by several tissues, especially adipose tissue. Estrone is the result of the process of aromatization of androstenedione that occurs in fat cells[1][2].	Free Base	C18H22O2	65792.0	H2O : 0.1 mg/mL (0.37 mM; Need ultrasonic); DMSO : 25 mg/mL (92.47 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@]1([C@](CC2)([H])[C@]3([H])CCC4=C(C=CC(O)=C4)[C@@]3([H])CC1)C2=O	https://www.medchemexpress.com/Estrone.html	Launched		91.0	P33	A5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0234	10.0	mM	5.0	DMSO	270.16198	5	A	pluskal_fda_drugs_5005_A5_id
1089	HY-B1095	HYCPK40905	J05	HYCPK40905	91z	922.0	4.0	T10	905.0	J05	302-22-7	Chlormadinone acetate		404.93	Progesterone Receptor	Others	Chlormadinone acetate is a steroidal progestin, with antiandrogen and antiestrogenic effects.	Free Base	C23H29ClO4	17602.0	DMSO : 10 mg/mL (24.70 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Endocrinology	CC([C@@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])C=C(Cl)C4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O	https://www.medchemexpress.com/Chlormadinone-acetate.html	Launched		91.0	T10	A5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1095	10.0	mM	5.0	DMSO	404.175437	5	A	pluskal_fda_drugs_5005_A5_id
121	HY-B0337	HYCPK40902	O06	HYCPK40902	91z	1355.0	1.0	AC11	902.0	O06	122-11-2	Sulfadimethoxine	Sulphadimethoxine	310.33	Antibiotic; Bacterial	Anti-infection	Sulfadimethoxine (Sulphadimethoxine) is a sulfonamide antibiotic used to treat many infections[1][2].	Free Base	C12H14N4O4S	16769.0	DMSO : ≥ 100 mg/mL (322.24 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC(OC)=NC(OC)=C2)=O	https://www.medchemexpress.com/sulfadimethoxine.html	Launched		91.0	AC11	A6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0337	10.0	mM	6.0	DMSO	310.073576	6	A	pluskal_fda_drugs_5005_A6_id
141	HY-N0504	HYCPK40902	C08	HYCPK40902	91z	207.0	1.0	E15	902.0	C08	75330-75-5	Lovastatin	Mevinolin	404.54	Autophagy; Ferroptosis; HMG-CoA Reductase (HMGCR)	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Lovastatin is a cell-permeable HMG-CoA reductase inhibitor used to lower cholesterol.	Free Base	C24H36O5	27139.0	DMSO : ≥ 100 mg/mL (247.19 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C([C@@H](C)CC)O[C@@H]1[C@@]([C@H]2CC[C@@H](OC3=O)C[C@H](C3)O)([H])C(C=C[C@@H]2C)=C[C@H](C)C1	https://www.medchemexpress.com/Lovastatin.html	Launched		91.0	E15	A6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0504	10.0	mM	6.0	DMSO	404.256274	6	A	pluskal_fda_drugs_5005_A6_id
241	HY-12176	HYCPK40902	O14	HYCPK40902	91z	1371.0	1.0	AC27	902.0	O14	173334-57-1	Aliskiren	CGP 60536; CGP60536B; SPP 100	551.76	Autophagy; Renin	Autophagy; Metabolic Enzyme/Protease	Aliskiren is an orally active, highly potent and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren can be used for the research of hypertension, cardiovascular diseases and cancer cachexia[1][2][3].	Free Base	C30H53N3O6	23468.0	Ethanol : 100 mg/mL (181.24 mM; Need ultrasonic); DMSO : 100 mg/mL (181.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	COCCCOC1=CC(C[C@@H](C[C@@H]([C@H](C[C@H](C(NCC(C)(C(N)=O)C)=O)C(C)C)O)N)C(C)C)=CC=C1OC	https://www.medchemexpress.com/Aliskiren.html	Launched		91.0	AC27	A6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12176	10.0	mM	6.0	DMSO	551.393436	6	A	pluskal_fda_drugs_5005_A6_id
414	HY-12532	HYCPK40902	F22	HYCPK40902	91z	523.0	1.0	K43	902.0	F22	68844-77-9	Astemizole	R 43512	458.57	Histamine Receptor; Potassium Channel	GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling	Astemizole (R 43512), a second-generation antihistamine drug to diminish allergic symptoms with a long duration of action, is a histamine H1-receptor antagonist, with an IC50 of 4 nM. Astemizole also shows potent hERG K+ channel blocking activity with an IC50 of 0.9 nM. Astemizole has antipruritic effects[1][2].	Free Base	C28H31FN4O	63213.0	DMSO : 125 mg/mL (272.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	COC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)CC2)C=C1	https://www.medchemexpress.com/astemizole.html	Launched		91.0	K43	A6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12532	10.0	mM	6.0	DMSO	458.24819	6	A	pluskal_fda_drugs_5005_A6_id
459	HY-Y0319G	HYCPK40903	P05	HYCPK40903	91z	1450.0	2.0	AE10	903.0	P05	16674-78-5	Magnesium acetate tetrahydrate		214.45	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Magnesium acetate tetrahydrate is a hydrated form of anhydrous magnesium acetate salt. As a salt form of Magnesium, Magnesium acetate is one of the bioavailable forms of magnesium and forms a very water soluble compound. Magnesium acetate tetrahydrate can be used as an electrolyte supplementation or a reagent in molecular biology experiments[1].	hydrate	C4H14MgO8	151851.0	DMSO : 100 mg/mL (466.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	[Mg].O=C(O)C.O	https://www.medchemexpress.com/magnesium-acetate-tetrahydrate.html	Launched		91.0	AE10	A6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0319G	10.0	mM	6.0	DMSO	60.021129	6	A	pluskal_fda_drugs_5005_A6_id
645	HY-13567	HYCPK40903	K16	HYCPK40903	91z	992.0	2.0	U32	903.0	K16	16506-27-7	Bendamustine	SDX-105 (free base)	358.26	Apoptosis; DNA Alkylator/Crosslinker	Apoptosis; Cell Cycle/DNA Damage	Bendamustine (SDX-105 free base), a purine analogue, is a DNA cross-linking agent. Bendamustine activates DNA-damage stress response and apoptosis. Bendamustine has potent alkylating, anticancer and antimetabolite properties[1].		C16H21Cl2N3O2	139181.0	DMSO : 100 mg/mL (279.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CCCC1=NC2=CC(N(CCCl)CCCl)=CC=C2N1C	https://www.medchemexpress.com/Bendamustine.html	Launched		91.0	U32	A6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13567	10.0	mM	6.0	DMSO	357.101082	6	A	pluskal_fda_drugs_5005_A6_id
963	HY-A0069	HYCPK40904	L17	HYCPK40904	91z	1137.0	3.0	X33	904.0	L17	562-10-7	Doxylamine (succinate)		388.46	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Doxylamine (succinate), a first generation antihistamine, is a histamine (H1) receptor antagonist. Doxylamine is also a local analgesic agent and effective hypnotic agent[1][2][3].	Succinate	C21H28N2O5	18547.0	DMSO : ≥ 100 mg/mL (257.43 mM); H2O : 50 mg/mL (128.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(O)CCC(O)=O.CC(C1=NC=CC=C1)(C2=CC=CC=C2)OCCN(C)C	https://www.medchemexpress.com/Doxylamine-succinate.html	Launched		91.0	X33	A6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0069	10.0	mM	6.0	DMSO	270.173213	6	A	pluskal_fda_drugs_5005_A6_id
1354	HY-B0641	HYCPK40905	C22	HYCPK40905	91z	284.0	4.0	F44	905.0	C22	5728-52-9	Felbinac	4-Biphenylacetic acid	212.24	Others	Others	Felbinac is a potent non-steroidal anti-inflammatory agent, used to treat muscle inflammation and arthritis.	Free Acid	C14H12O2	27099.0	DMSO : 100 mg/mL (471.16 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)CC1=CC=C(C2=CC=CC=C2)C=C1	https://www.medchemexpress.com/Felbinac.html	Launched		91.0	F44	A6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0641	10.0	mM	6.0	DMSO	212.08373	6	A	pluskal_fda_drugs_5005_A6_id
808	HY-12177	HYCPK40904	M07	HYCPK40904	91z	1213.0	3.0	Z13	904.0	M07	173334-58-2	Aliskiren (hemifumarate)	CGP 60536 (hemifumarate); CGP60536B (hemifumarate); SPP 100 (hemifumarate)	1219.59	Autophagy; Renin	Autophagy; Metabolic Enzyme/Protease	Aliskiren (CGP 60536; CGP60536B; SPP 100) hemifumarate is an orally active and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren hemifumarate can be used for the research of hypertension, cardiovascular diseases and cancer cachexia[1][2][3].	Fumarate	C64H110N6O16	4478.0	H2O : ≥ 50 mg/mL (41.00 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(O)/C=C/C(O)=O.O=C(NCC(C)(C(N)=O)C)[C@@H](C[C@@H]([C@H](C[C@@H](C(C)C)CC1=CC=C(OC)C(OCCCOC)=C1)N)O)C(C)C.O=C(NCC(C)(C(N)=O)C)[C@H](C(C)C)C[C@H](O)[C@@H](N)C[C@@H](C(C)C)CC2=CC=C(OC)C(OCCCOC)=C2	https://www.medchemexpress.com/Aliskiren-hemifumarate.html	Launched		91.0	Z13	A7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12177	10.0	mM	7.0	DMSO	551.393436	7	A	pluskal_fda_drugs_5005_A7_id
816	HY-14885A	HYCPK40904	E08	HYCPK40904	91z	447.0	3.0	J15	904.0	E08	928659-70-5	Eliglustat (hemitartrate)	Genz-112638; Eliglustat tartrate	959.17	Others	Others	Eliglustat hemitartrate is an specific, potent and orally active glucocerebroside synthase inhibitor with an IC50 of 24 nM.	Tartrate	C50H78N4O14	24886.0	H2O : ≥ 50 mg/mL (52.13 mM); DMSO : 110 mg/mL (114.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	CCCCCCCC(N[C@H](CN1CCCC1)[C@@H](C2=CC=C(OCCO3)C3=C2)O)=O.CCCCCCCC(N[C@H](CN4CCCC4)[C@@H](C5=CC=C(OCCO6)C6=C5)O)=O.O=C(O)[C@H](O)[C@@H](O)C(O)=O	https://www.medchemexpress.com/Eliglustat-hemitartrate.html	Launched		91.0	J15	A7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14885A	10.0	mM	7.0	DMSO	404.267508	7	A	pluskal_fda_drugs_5005_A7_id
923	HY-Y0319B	HYCPK40904	P14	HYCPK40904	91z	1515.0	3.0	AF27	904.0	P14	127-08-2	Potassium acetate		98.14	Endogenous Metabolite	Metabolic Enzyme/Protease	Potassium acetate is a potassium salt employed to replenish electrolytes, for restoration of water-electrolyte balance. Potassium acetate can employ in DNA and protein purification. Potassium acetate has been used to prepare neutralizing solution for alkaline lysis of bacteria[1][2].		C2H3KO2	145039.0	DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)	DMSO Solution	10mM  * 100uL	Infection	CC(O[K])=O	https://www.medchemexpress.com/potassium-acetate.html	Launched		91.0	AF27	A7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0319B	10.0	mM	7.0	DMSO	60.021129	7	A	pluskal_fda_drugs_5005_A7_id
1059	HY-50667	HYCPK40905	L03	HYCPK40905	91z	1110.0	4.0	X6	905.0	L03	503612-47-3	Apixaban	BMS-562247-01	459.50	Factor Xa	Metabolic Enzyme/Protease	Apixaban (BMS-562247-01) is a highly selective, reversible and orally active inhibitor of Factor Xa with Ki of 0.08 nM and 0.17 nM in human and rabbit, respectively[1]. Apixaban is in development for the prevention and treatment of various thromboembolic diseases[2].	Free Base	C25H25N5O4	41718.0	DMSO : 50 mg/mL (108.81 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	NC(C1=NN(C2=C1CCN(C2=O)C3=CC=C(C=C3)N4CCCCC4=O)C5=CC=C(C=C5)OC)=O	https://www.medchemexpress.com/Apixaban.html	Launched		91.0	X6	A7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50667	10.0	mM	7.0	DMSO	459.190654	7	A	pluskal_fda_drugs_5005_A7_id
1100	HY-B0295	HYCPK40905	E06	HYCPK40905	91z	444.0	4.0	J12	905.0	E06	773-76-2	Chloroxine		214.05	Antibiotic; Bacterial	Anti-infection	Chloroxine is one of the important 8-hydroxyquinoline derivative. Chloroxine has effective antibacterial, antifungal, antiprotozoal and antiamoebic activities, especially used in treating the intestinal amebiasis. Chloroxine is also used in the treatment of dandruff and seborrheic dermatitis of the scalp[1][2].	Free Base	C9H5Cl2NO	16031.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 33.33 mg/mL (155.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC1=C2N=CC=CC2=C(Cl)C=C1Cl	https://www.medchemexpress.com/Chloroxine.html	Launched		91.0	J12	A7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0295	10.0	mM	7.0	DMSO	212.974819	7	A	pluskal_fda_drugs_5005_A7_id
1249	HY-B0141A	HYCPK40905	J15	HYCPK40905	91z	942.0	4.0	T30	905.0	J15	57-91-0	Alpha-Estradiol	Alfatradiol; Epiestradiol; Epiestrol	272.38	5 alpha Reductase; Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Alpha-Estradiol is a weak estrogen and a 5α-reductase inhibitor which is used as a topical medication in the treatment of androgenic alopecia.	Free Base	C18H24O2	28694.0	DMSO : 62.5 mg/mL (229.46 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@H](O)CC[C@@]1([H])[C@]3([H])CCC4=C(C=CC(O)=C4)[C@@]3([H])CC2	https://www.medchemexpress.com/Alpha-Estradiol.html	Launched		91.0	T30	A7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0141A	10.0	mM	7.0	DMSO	272.17763	7	A	pluskal_fda_drugs_5005_A7_id
1278	HY-B0337A	HYCPK40905	G17	HYCPK40905	91z	658.0	4.0	N34	905.0	G17	1037-50-9	Sulfadimethoxine (sodium)	Sulphadimethoxine (sodium)	332.31	Antibiotic; Bacterial	Anti-infection	Sulfadimethoxine sodium (Sulphadimethoxine sodium) is a sulfonamide antibiotic used to treat many infections[1][2].	Sodium	C12H13N4NaO4S	80703.0	DMSO : 250 mg/mL (752.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(N([Na])C2=NC(OC)=NC(OC)=C2)=O	https://www.medchemexpress.com/sulfadimethoxine-sodium.html	Launched		91.0	N34	A7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0337A	10.0	mM	7.0	DMSO	310.073576	7	A	pluskal_fda_drugs_5005_A7_id
1353	HY-17386	HYCPK40905	B22	HYCPK40905	91z	188.0	4.0	D44	905.0	B22	122320-73-4	Rosiglitazone	BRL 49653	357.43	Apoptosis; Autophagy; Ferroptosis; PPAR; TRP Channel	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel; Neuronal Signaling	Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].	Free Base	C18H19N3O3S	113160.0	H2O : < 0.1 mg/mL (ultrasonic) (insoluble); DMSO : 250 mg/mL (699.44 mM; Need ultrasonic); Ethanol : 2 mg/mL (5.60 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology; Neurological Disease	O=C(N1)SC(CC2=CC=C(OCCN(C)C3=NC=CC=C3)C=C2)C1=O	https://www.medchemexpress.com/Rosiglitazone.html	Launched		91.0	D44	A7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17386	10.0	mM	7.0	DMSO	357.114712	7	A	pluskal_fda_drugs_5005_A7_id
97	HY-15592	HYCPK40902	G05	HYCPK40902	91z	585.0	1.0	M9	902.0	G05	1051375-10-0	Cabotegravir	GSK-1265744; S/GSK1265744	405.35	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	Cabotegravir (GSK-1265744) is a orally active and long-acting HIV integrase inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 μM and 0.81 μM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral drugs (ARVs). Cabotegravir can be used to research AIDS[1][2].	Free Base	C19H17F2N3O5	18032.0	DMSO : 16.67 mg/mL (41.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	FC1=C(CNC(C2=CN3C(C(N([C@@H](C)CO4)[C@@]4([H])C3)=O)=C(O)C2=O)=O)C=CC(F)=C1	https://www.medchemexpress.com/Cabotegravir.html	Launched		91.0	M9	A8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15592	10.0	mM	8.0	DMSO	405.113627	8	A	pluskal_fda_drugs_5005_A8_id
130	HY-100256	HYCPK40902	H07	HYCPK40902	91z	685.0	1.0	O13	902.0	H07	895542-09-3	Trifarotene	CD5789	459.58	Autophagy; RAR/RXR	Autophagy; Metabolic Enzyme/Protease	Trifarotene (CD5789) is a potent and selective RARγ agonist. Trifarotene (CD5789) shows ～65-fold and ～16-fold selectivitiy for the RARγ (EC50=7.7 nM) over RARα (EC50=500 nM) and RARβ (EC50=125 nM), respectively[1].	Free Acid	C29H33NO4	61544.0	DMSO : 250 mg/mL (543.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=C(C2=CC=C(OCCO)C(C3=CC=C(N4CCCC4)C(C(C)(C)C)=C3)=C2)C=C1)O	https://www.medchemexpress.com/Trifarotene.html	Launched		91.0	O13	A8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100256	10.0	mM	8.0	DMSO	459.240959	8	A	pluskal_fda_drugs_5005_A8_id
225	HY-B1235	HYCPK40902	O13	HYCPK40902	91z	1369.0	1.0	AC25	902.0	O13	546-88-3	Acetohydroxamic acid	AHA	75.07	Bacterial	Anti-infection	"Acetohydroxamic acid is a potent and irreversible inhibitor of bacterial and plant urease and also used as adjunctive therapy in chronic urinary infection.
Target: Urease
Acetohydroxamic acid selectively inhibits arachidonate 5-lipoxygenase and thus has potential use in the treatment of asthma."	Free Base	C2H5NO2	80132.0	H2O : 100 mg/mL (1332.09 mM; Need ultrasonic); DMSO : 250 mg/mL (3330.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC(NO)=O	https://www.medchemexpress.com/Acetohydroxamic-acid.html	Launched		91.0	AC25	A8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1235	10.0	mM	8.0	DMSO	75.032028	8	A	pluskal_fda_drugs_5005_A8_id
448	HY-B0353	HYCPK40903	E05	HYCPK40903	91z	394.0	2.0	I10	903.0	E05	80-77-3	Chlormezanone		273.74	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Chlormezanone resembles benzodiazepine. The action of Chlormezanone is similar to benzodiazepine-type agents. Chlormezanone is used as an anxiolytic and a muscle relaxant.	Free Base	C11H12ClNO3S	17006.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (365.31 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(CC1)N(C)C(C2=CC=C(Cl)C=C2)S1(=O)=O	https://www.medchemexpress.com/chlormezanone.html	Launched		91.0	I10	A8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0353	10.0	mM	8.0	DMSO	273.022642	8	A	pluskal_fda_drugs_5005_A8_id
614	HY-B0439	HYCPK40903	L14	HYCPK40903	91z	1084.0	2.0	W28	903.0	L14	2447-57-6	Sulfadoxine	Sulphadoxine	310.33	Antibiotic; Endogenous Metabolite; HIV; Parasite	Anti-infection; Metabolic Enzyme/Protease	Sulfadoxine(Sulphadoxine) is a long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract and malarial infections. Sulfadoxine inhibits HIV replication in peripheral blood mononuclear cells.	Free Base	C12H14N4O4S	15059.0	DMSO : ≥ 100 mg/mL (322.24 mM); H2O : 0.1 mg/mL (0.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(NC1=NC=NC(OC)=C1OC)(C2=CC=C(N)C=C2)=O	https://www.medchemexpress.com/Sulfadoxine.html	Launched		91.0	W28	A8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0439	10.0	mM	8.0	DMSO	310.073576	8	A	pluskal_fda_drugs_5005_A8_id
826	HY-15408	HYCPK40904	O08	HYCPK40904	91z	1407.0	3.0	AD15	904.0	O08	865759-25-7	Trelagliptin	SYR-472	357.3821032	Dipeptidyl Peptidase	Metabolic Enzyme/Protease	Trelagliptin (SYR-472) is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM)[1].	Free Base	C18H20FN5O2	9105.0	DMSO : ≥ 50 mg/mL (139.91 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	N#CC1=CC=C(F)C=C1CN(C(N2C)=O)C(N3C[C@H](N)CCC3)=CC2=O	https://www.medchemexpress.com/trelagliptin.html	Launched		91.0	AD15	A8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15408	10.0	mM	8.0	DMSO	357.160103	8	A	pluskal_fda_drugs_5005_A8_id
1244	HY-13585	HYCPK40905	E15	HYCPK40905	91z	462.0	4.0	J30	905.0	E15	154-93-8	Carmustine		214.05	DNA Alkylator/Crosslinker	Cell Cycle/DNA Damage	Carmustine is an antitumor chemotherapeutic agent, which works by akylating DNA and RNA.	Free Base	C5H9Cl2N3O2	112844.0	DMSO : ≥ 35 mg/mL (163.51 mM); H2O : 100 mg/mL (467.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NCCCl)N(CCCl)N=O	https://www.medchemexpress.com/Carmustine.html	Launched		91.0	J30	A8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13585	10.0	mM	8.0	DMSO	213.007182	8	A	pluskal_fda_drugs_5005_A8_id
1265	HY-14881A	HYCPK40905	J16	HYCPK40905	91z	944.0	4.0	T32	905.0	J16	845533-86-0	Bedaquiline (fumarate)	R403323; TMC207 fumarate; R207910 fumarate	671.58	Antibiotic; Bacterial	Anti-infection	Bedaquiline fumarate, a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections.	Fumarate	C36H35BrN2O6	13087.0	DMSO : 100 mg/mL (148.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC(/C=C/C(O)=O)=O.BrC1=CC=C(N=C(OC)C([C@H]([C@@](C2=CC=CC3=C2C=CC=C3)(O)CCN(C)C)C4=CC=CC=C4)=C5)C5=C1	https://www.medchemexpress.com/Bedaquiline-fumarate.html	Launched		91.0	T32	A8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14881A	10.0	mM	8.0	DMSO	554.15689	8	A	pluskal_fda_drugs_5005_A8_id
157	HY-15408A	HYCPK40902	G09	HYCPK40902	91z	593.0	1.0	M17	902.0	G09	1029877-94-8	Trelagliptin (succinate)	SYR-472 succinate	475.47	Dipeptidyl Peptidase	Metabolic Enzyme/Protease	Trelagliptin (SYR-472) succinate is a potent, orally active and highly selective DPP-4 inhibitor with an IC50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM)[1].	Succinate	C22H26FN5O6	9028.0	DMSO : ≥ 50 mg/mL (105.16 mM); H2O : 100 mg/mL (210.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(C=C(N1C[C@H](N)CCC1)N2CC3=C(C#N)C=CC(F)=C3)N(C)C2=O.O=C(O)CCC(O)=O	https://www.medchemexpress.com/Trelagliptin-succinate.html	Launched		91.0	M17	A9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15408A	10.0	mM	9.0	DMSO	357.160103	9	A	pluskal_fda_drugs_5005_A9_id
240	HY-N7123	HYCPK40902	N14	HYCPK40902	91z	1275.0	1.0	AA27	902.0	N14	144-80-9	Sulfacetamide	Sulphacetamide	214.24	Antibiotic; Bacterial	Anti-infection	Sulfacetamide (Sulphacetamide), a bacteriostatic sulphonamide, is a popular antibiotic prescribed for treating ocular infections[1][2].	Free Base	C8H10N2O3S	45955.0	DMSO : 100 mg/mL (466.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC(NS(=O)(C1=CC=C(N)C=C1)=O)=O	https://www.medchemexpress.com/sulfacetamide.html	Launched		91.0	AA27	A9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7123	10.0	mM	9.0	DMSO	214.041213	9	A	pluskal_fda_drugs_5005_A9_id
271	HY-B0203A	HYCPK40902	M16	HYCPK40902	91z	1183.0	1.0	Y31	902.0	M16	152520-56-4	Nebivolol (hydrochloride)	R 065824 hydrochloride	441.90	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Nebivolol (R 065824) hydrochloride is an orally active beta receptor blocker and has the high beta(1)-receptor affinity.Nebivolol hydrochloride has direct vasodilator properties and adrenergic blocking characteristics. Nebivolol hydrochloride can be used for the research of kinds of diseases such as hypertension, coronary artery disease, congestive heart failure and ischemic heart disease[1][2].	Hydrochloride	C22H26ClF2NO4	81736.0	H2O : 1.79 mg/mL (4.05 mM; ultrasonic and warming and heat to 60°C); DMSO : 100 mg/mL (226.30 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	FC1=CC=C2C(CC[C@]([C@@H](O)CNC[C@H](O)[C@@]3([H])CCC(C=C(F)C=C4)=C4O3)([H])O2)=C1.Cl	https://www.medchemexpress.com/nebivolol-hydrochloride.html	Launched		91.0	Y31	A9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0203A	10.0	mM	9.0	DMSO	405.175165	9	A	pluskal_fda_drugs_5005_A9_id
289	HY-17406	HYCPK40902	O17	HYCPK40902	91z	1377.0	1.0	AC33	902.0	O17	134308-13-7	Tolcapone	Ro 40-7592	273.24	Amyloid-β; Apoptosis; COMT	Apoptosis; Metabolic Enzyme/Protease; Neuronal Signaling	Tolcapone (Ro 40-7592) is a selective, orally active and powerful mixed (peripheral and central) COMT inhibitor with an IC50 of 773?nM in the liver[1]. Tolcapone is also a potent inhibitor of α-syn and Aβ42 oligomerization and fibrillogenesis[2]. Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in neuroblastoma[3].	Free Base	C14H11NO5	8611.0	DMSO : 100 mg/mL (365.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C(C1=CC(O)=C(O)C([N+]([O-])=O)=C1)C2=CC=C(C)C=C2	https://www.medchemexpress.com/tolcapone.html	Launched		91.0	AC33	A9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17406	10.0	mM	9.0	DMSO	273.063722	9	A	pluskal_fda_drugs_5005_A9_id
383	HY-B0313	HYCPK40902	P04	HYCPK40902	91z	1447.0	1.0	AE7	902.0	P04	127-07-1	Hydroxyurea	Hydroxycarbamide	76.05	Apoptosis; Autophagy; DNA/RNA Synthesis; HIV; Orthopoxvirus	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage	Hydroxyurea is a cell apoptosis inducer that inhibit DNA synthesis through inhibition of ribonucleotide reductase. Hydroxyurea shows anti-orthopoxvirus activity.	Free Base	CH4N2O2	90624.0	H2O : 50 mg/mL (657.46 mM; Need ultrasonic); DMSO : 100 mg/mL (1314.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N)NO	https://www.medchemexpress.com/hydroxyurea.html	Launched		91.0	AE7	A9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0313	10.0	mM	9.0	DMSO	76.027277	9	A	pluskal_fda_drugs_5005_A9_id
691	HY-109061	HYCPK40903	C20	HYCPK40903	91z	232.0	2.0	E40	903.0	C20	1903008-80-9	Lazertinib	YH25448; GNS-1480	554.64	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Lazertinib (YH25448) is a potent, highly mutant-selective, blood-brain barrier permeable, orally available and irreversible third-generation EGFR tyrosine kinase inhibitor, and can be used in the research of non-small cell lung cancer[1].	Free Base	C30H34N8O3	36758.0	DMSO : 9 mg/mL (16.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C=CC(NC1=CC(NC2=NC=CC(N3N=C(C4=CC=CC=C4)C(CN(C)C)=C3)=N2)=C(OC)C=C1N5CCOCC5)=O	https://www.medchemexpress.com/Lazertinib.html	Launched		91.0	E40	A9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109061	10.0	mM	9.0	DMSO	554.275387	9	A	pluskal_fda_drugs_5005_A9_id
1101	HY-B0539	HYCPK40905	F06	HYCPK40905	91z	540.0	4.0	L12	905.0	F06	100643-71-8	Desloratadine	Sch34117	310.82	Endogenous Metabolite; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Desloratadine (Sch34117) is the orally active major metabolite of the nonsedating H1-antihistamine Loratadine. Desloratadine is a selective H1-receptor antagonist that has anti-allergic and anti-inflammatory activities[1][2].	Free Base	C19H19ClN2	16362.0	DMSO : 25 mg/mL (80.43 mM; Need ultrasonic); H2O : 0.67 mg/mL (2.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	ClC1=CC=C2C(CCC3=CC=CN=C3/C2=C4CCNCC/4)=C1	https://www.medchemexpress.com/Desloratadine.html	Launched		91.0	L12	A9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0539	10.0	mM	9.0	DMSO	310.123676	9	A	pluskal_fda_drugs_5005_A9_id
1251	HY-109523	HYCPK40905	L15	HYCPK40905	91z	1134.0	4.0	X30	905.0	L15	143201-11-0	Cerivastatin (sodium)		481.53	Ferroptosis; HMG-CoA Reductase (HMGCR)	Apoptosis; Metabolic Enzyme/Protease	Cerivastatin sodium is a synthetic lipid-lowering agent and a highly potent, well-tolerated and orally active HMG-CoA reductase inhibitor, with a Ki of 1.3 nM/L. Cerivastatin sodium reduces low-density lipoprotein cholesterol levels. Cerivastatin sodium also inhibits proliferation and invasiveness of MDA-MB-231 cells, mainly by RhoA inhibition, and has anti-cancer effect[1][2].	Sodium	C26H33FNNaO5	121829.0	H2O : 100 mg/mL (207.67 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C([O-])C[C@H](O)C[C@H](O)/C=C/C1=C(C2=CC=C(F)C=C2)C(COC)=C(C(C)C)N=C1C(C)C.[Na+]	https://www.medchemexpress.com/cerivastatin-sodium.html	Launched		91.0	X30	A9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109523	10.0	mM	9.0	DMSO	459.242101	9	A	pluskal_fda_drugs_5005_A9_id
192	HY-70037	HYCPK40902	N11	HYCPK40902	91z	1269.0	1.0	AA21	902.0	N11	226256-56-0	Cinacalcet	AMG 073	357.41	CaSR; Endogenous Metabolite	GPCR/G Protein; Metabolic Enzyme/Protease	Cinacalcet (AMG 073) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease treatment.	Free Base	C22H22F3N	11065.0	DMSO : ≥ 100 mg/mL (279.79 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	FC(F)(C1=CC(CCCN[C@@H](C2=C3C=CC=CC3=CC=C2)C)=CC=C1)F	https://www.medchemexpress.com/Cinacalcet.html	Launched		91.0	AA21	A10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-70037	10.0	mM	10.0	DMSO	357.170434	10	A	pluskal_fda_drugs_5005_A10_id
587	HY-B0576	HYCPK40904	A16	HYCPK40904	91z	79.0	3.0	B31	904.0	A16	127-56-0	Sulfacetamide (Sodium)		236.22	Antibiotic; Bacterial	Anti-infection	"Sulfacetamide Sodium is an anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections.
Target: Antibacterial
Sulfacetamide is a sulfonamide antibiotic. Sulfacetamide is able to inhibit the growth of all isolated strains. Depending on the type of bacteria concentrations of 0.006 up to 6.4% sodium sulfacetamide proved to be effective. Simultaneously, all patients were treated with sulfacetamide containing ointment and/or eye drops 4 times daily for maximum of 14 days. With swabs taken at intervals of 7 and 14 days no bacterial growth was detected. Sulfacetamide 10% topical lotion, sold under the brand name Klaron or Ovace, is approved for the treatment of acne and seborrheic dermatitis. Sulfacetamide has been investigated for use in the treatment of pityriasis versicolor and rosacea. It may also have anti-inflammatory properties when used to treat blepharitis or conjunctivitis. It is believed to work by limiting the presence of folic acid which bacteria need to survive. It has been suggested that sulfacetamide may also serve as a treatment for mild forms of hidradenitis suppurativa. Sulfacetamide has antibacterial activity and is used to control acne. Some research indicates that sulfacetamide derivatives may act as antifungals by an CYP51A1-independent mechanism [1-4]."	Sodium	C8H9N2NaO3S	13418.0	H2O : ≥ 50 mg/mL (211.67 mM); DMSO : 33.33 mg/mL (141.10 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(N([Na])C(C)=O)=O	https://www.medchemexpress.com/Sulfacetamide-Sodium.html	Launched		91.0	B31	A10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0576	10.0	mM	10.0	DMSO	214.041213	10	A	pluskal_fda_drugs_5005_A10_id
777	HY-B0301	HYCPK40904	N05	HYCPK40904	91z	1305.0	3.0	AB9	904.0	N05	60628-96-8	Bifonazole	Bay H-4502	310.39	Antibiotic; Fungal	Anti-infection	Bifonazole (Bay H-4502) is an imidazole antifungal drug.	Free Base	C22H18N2	15206.0	H2O : 0.67 mg/mL (2.16 mM; Need ultrasonic); DMSO : 33.33 mg/mL (107.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	N1(C(C2=CC=C(C3=CC=CC=C3)C=C2)C4=CC=CC=C4)C=CN=C1	https://www.medchemexpress.com/Bifonazole.html	Launched		91.0	AB9	A10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0301	10.0	mM	10.0	DMSO	310.146999	10	A	pluskal_fda_drugs_5005_A10_id
827	HY-118861A	HYCPK40904	P08	HYCPK40904	91z	1503.0	3.0	AF15	904.0	P08	7599-79-3	Enclomiphene (citrate)	(E)-Clomiphene (citrate); trans-Clomiphene (citrate); Enclomifene (citrate)	598.08	Estrogen Receptor/ERR	Others	Enclomiphene ((E)-Clomiphene) citrate is a potent and orally active non-steroidal estrogen receptor antagonist, with antioestrogenic property. Enclomiphene citrate can be used for the research of ovarian dysfunction, testosterone deficiency, male hypogonadism and type 2 diabetes[1].	Citrate	C32H36ClNO8	42747.0	DMSO : ≥ 50 mg/mL (83.60 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Metabolic Disease	Cl/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(CC)CC)C=C2)\C3=CC=CC=C3.O=C(CC(C(O)=O)(O)CC(O)=O)O.[(E)]	https://www.medchemexpress.com/enclomiphene-citrate.html	Launched		91.0	AF15	A10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-118861A	10.0	mM	10.0	DMSO	405.185942	10	A	pluskal_fda_drugs_5005_A10_id
885	HY-10984	HYCPK40904	J12	HYCPK40904	91z	935.0	3.0	T23	904.0	J12	19171-19-8	Pomalidomide	CC-4047	273.24	Apoptosis; Ligands for E3 Ligase; Molecular Glues	Apoptosis; PROTAC	Pomalidomide, the third-generation immunomodulatory agent, acts as molecular glue. Pomalidomide interacts with the E3 ligase cereblon and induces degradation of essential Ikaros transcription factors.	Free Base	C13H11N3O4	116229.0	DMSO : 50 mg/mL (182.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1N(C(C2=C1C=CC=C2N)=O)C(C(N3)=O)CCC3=O	https://www.medchemexpress.com/Pomalidomide.html	Launched		91.0	T23	A10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10984	10.0	mM	10.0	DMSO	273.074956	10	A	pluskal_fda_drugs_5005_A10_id
934	HY-12085	HYCPK40904	K15	HYCPK40904	91z	1037.0	3.0	V29	904.0	K15	608141-41-9	Apremilast	CC-10004	460.50	Apoptosis; Phosphodiesterase (PDE); TNF Receptor	Apoptosis; Metabolic Enzyme/Protease	Apremilast (CC-10004) is an orally available inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM. Apremilast inhibits TNF-α release by lipopolysaccharide (LPS) with an IC50 of 104 nM[1].	Free Base	C22H24N2O7S	6838.0	DMSO : 44 mg/mL (95.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(NC1=CC=CC(C(N2[C@@H](C3=CC=C(OC)C(OCC)=C3)CS(=O)(C)=O)=O)=C1C2=O)=O	https://www.medchemexpress.com/Apremilast.html	Launched		91.0	V29	A10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12085	10.0	mM	10.0	DMSO	460.130422	10	A	pluskal_fda_drugs_5005_A10_id
954	HY-B1626A	HYCPK40904	C17	HYCPK40904	91z	273.0	3.0	F33	904.0	C17	56-94-0	Demecarium Bromide	BC-48	716.59	Cholinesterase (ChE)	Neuronal Signaling	Demecarium Bromide (BC-48) is a potent cholinesterase inhibitor, with an apparent affinity (Kiapp) of 0.15 μM[1]. Demecarium Bromide (BC-48) is used as a glaucoma agent[2].	Bromide	C32H52Br2N4O4	38582.0	DMSO : 160 mg/mL (223.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N(CCCCCCCCCCN(C(OC1=CC([N+](C)(C)C)=CC=C1)=O)C)C)OC2=CC([N+](C)(C)C)=CC=C2.[Br-].[Br-]	https://www.medchemexpress.com/Demecarium_Bromide.html	Launched		91.0	F33	A10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1626A	10.0	mM	10.0	DMSO	556.397759	10	A	pluskal_fda_drugs_5005_A10_id
1110	HY-B0314	HYCPK40905	O06	HYCPK40905	91z	1404.0	4.0	AD12	905.0	O06	14807-96-6	Talc		78.10	Others	Others	Talc, a naturally occurring mineral composed primarily of magnesium, silicon and oxygen, is used in many cosmetics, from baby powder to blush[1][2].		H2O3Si	27483.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble or slightly soluble)	DMSO Solution	10mM  * 100uL	Cancer	O[Si](O)=O.[0.75 Mg]	https://www.medchemexpress.com/talc.html	Launched		91.0	AD12	A10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0314	10.0	mM	10.0	DMSO	77.97732	10	A	pluskal_fda_drugs_5005_A10_id
158	HY-B2227B	HYCPK40902	H09	HYCPK40902	91z	689.0	1.0	O17	902.0	H09	72-17-3	Lactate (sodium)	Lactic acid (sodium)	112.06	Others	Others	Lactate (Lactic acid) sodium is the product of glycogenolysis and glycolysis. Lactate (Lactic acid) sodium functions in a variety of biochemical processes[1].	Sodium	C3H5NaO3	236443.0	DMSO : ≥ 100 mg/mL (892.38 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	[Na].O=C(O)C(O)C	https://www.medchemexpress.com/lactate-sodium.html	Launched		91.0	O17	A11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2227B	10.0	mM	11.0	DMSO	90.031694	11	A	pluskal_fda_drugs_5005_A11_id
352	HY-B0639	HYCPK40903	I03	HYCPK40903	91z	774.0	2.0	Q6	903.0	I03	20537-88-6	Amifostine	WR2721	214.22	HIF/HIF Prolyl-Hydroxylase; MDM-2/p53	Apoptosis; Metabolic Enzyme/Protease	Amifostine (WR2721) is a broad-spectrum cytoprotective agent and a radioprotector. Amifostine selectively protects normal tissues from damage caused by radiation and chemotherapy. Amifostine is potent hypoxia-inducible factor-α1 (HIF-α1) and p53 inducer. Amifostine protects cells from damage by scavenging oxygen-derived free radicals. Amifostine reduces renal toxicity and has antiangiogenic action[1][2][3][4].	Free Acid	C5H15N2O3PS	16836.0	DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble); H2O : 100 mg/mL (466.81 mM; Need ultrasonic); DMF : 1 mg/mL (4.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OP(SCCNCCCN)(O)=O	https://www.medchemexpress.com/Amifostine.html	Launched		91.0	Q6	A11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0639	10.0	mM	11.0	DMSO	214.0541	11	A	pluskal_fda_drugs_5005_A11_id
639	HY-B0118A	HYCPK40903	E16	HYCPK40903	91z	416.0	2.0	I32	903.0	E16	50700-72-6	Vecuronium (bromide)	ORG NC 45	637.73	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Vecuronium (ORG NC 45) bromide is a non-depolarizing neuromuscular blocking agent that also acts as a nicotinic acetylcholine receptor (nAChR) inhibitor, a muscle relaxant, and can be used for pre-surgical anesthesia[1][2].	Bromide	C34H57BrN2O4	11707.0	DMSO : ≥ 46 mg/mL (72.13 mM); H2O : ≥ 100 mg/mL (156.81 mM)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	C[C@@]1([C@H]2OC(C)=O)[C@](C[C@@H]2[N+]3(CCCCC3)C)([H])[C@@](CC[C@]4([H])[C@@]5(C[C@H](N6CCCCC6)[C@@H](OC(C)=O)C4)C)([H])[C@]5([H])CC1.[Br-]	https://www.medchemexpress.com/vecuronium-bromide.html	Launched		91.0	I32	A11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0118A	10.0	mM	11.0	DMSO	557.431285	11	A	pluskal_fda_drugs_5005_A11_id
729	HY-B0275A	HYCPK40903	I22	HYCPK40903	91z	812.0	2.0	Q44	903.0	I22	2058-46-0	Oxytetracycline (hydrochloride)		496.89	Antibiotic; Bacterial; Endogenous Metabolite; HSV	Anti-infection; Metabolic Enzyme/Protease	Oxytetracycline hydrochloride is an antibiotic belonging to the tetracycline class. Oxytetracycline hydrochloride potent inhibits Gram-negative and Gram-positive bacteria. Oxytetracycline hydrochloride is a protein synthesis inhibitor and prevents the binding from aminoacil-tRNA to the complex m-ribosomal RNA. Oxytetracycline hydrochloride also possesses anti-HSV-1 activity[1][2][3].	Hydrochloride	C22H25ClN2O9	80767.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 500 mg/mL (1006.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O[C@@](C(O)=C(C1=O)[C@@]2([H])[C@](O)(C3=CC=CC(O)=C13)C)(C4=O)[C@@]([C@@H](C(O)=C4C(N)=O)N(C)C)([H])[C@H]2O.Cl	https://www.medchemexpress.com/oxytetracycline-hydrochloride.html	Launched		91.0	Q44	A11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0275A	10.0	mM	11.0	DMSO	460.14818	11	A	pluskal_fda_drugs_5005_A11_id
879	HY-B0110	HYCPK40904	D12	HYCPK40904	91z	359.0	3.0	H23	904.0	D12	60282-87-3	Gestodene	SHB 331; WL 70	310.43	Progesterone Receptor	Others	"Gestodene(SHB 331;WL 70) is a progestogen hormonal contraceptive.
Target: Estrogen Receptor/ERR
Gestodene is androgenically neutral, meaning that contraceptive pills containing gestodene do not exhibit the androgenic side effects (e.g. acne, hirsutism, weight gain) often associated with second-generation contraceptive pills, such as those containing levonorgestrel. When 40 micrograms of gestodene was taken, six out of seven women did not ovulate, and one out of seven had a cycle with luteal insufficiency. These data indicate that 40 micrograms of gestodene is the borderline dose for inhibition of ovulation. A combination of 75 micrograms gestodene with 30 micrograms ethinyl estradiol was found to inhibit ovulation in ten subjects, and no follicular maturation was noted [1]. gestodene bound with high affinity to the progesterone receptor, as did other synthetic and natural progestogens. However, gestodene did not bind to the estradiol receptor. The relative binding affinities of all tested synthetic and natural ligands showed no organ-specific differences and no differences between neoplastically transformed and normal tissues [2].
Clinical indications: Female contraception"	Free Base	C21H26O2	15666.0	DMSO : ≥ 100 mg/mL (322.13 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	CC[C@@]1([C@]2(O)C#C)[C@](C=C2)([H])[C@@](CCC3=CC4=O)([H])[C@]([C@@]3([H])CC4)([H])CC1	https://www.medchemexpress.com/Gestodene.html	Launched		91.0	H23	A11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0110	10.0	mM	11.0	DMSO	310.19328	11	A	pluskal_fda_drugs_5005_A11_id
900	HY-70037A	HYCPK40904	I13	HYCPK40904	91z	841.0	3.0	R25	904.0	I13	364782-34-3	Cinacalcet (hydrochloride)	AMG-073 (hydrochloride)	393.87	CaSR; Endogenous Metabolite	GPCR/G Protein; Metabolic Enzyme/Protease	Cinacalcet hydrochloride (AMG-073 hydrochloride) is an orally active, allosteric agonist of Ca receptor (CaR), used for cardiovascular disease treatment.	Hydrochloride	C22H23ClF3N	7579.0	DMSO : ≥ 50 mg/mL (126.95 mM); H2O : 1 mg/mL (2.54 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	FC(F)(C1=CC(CCCN[C@@H](C2=C3C=CC=CC3=CC=C2)C)=CC=C1)F.Cl	https://www.medchemexpress.com/Cinacalcet-hydrochloride.html	Launched		91.0	R25	A11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-70037A	10.0	mM	11.0	DMSO	357.170434	11	A	pluskal_fda_drugs_5005_A11_id
1144	HY-B0286A	HYCPK40905	A09	HYCPK40905	91z	66.0	4.0	B18	905.0	A09	113-92-8	Chlorpheniramine (maleate)	Chlorphenamine maleate	390.86	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	"Chlorpheniramine maleate is an histamine H1 receptor antagonist with IC50 of 12 nM.
Target: Histamine H1 Receptor
Chlorpheniramine inhibits the proliferation of MCF-7, MDA-MB 231, and Ehrlich cells in a dose-response manner, and significantly reduces the ornithine decarboxylase mRNA translation by 50%-70% at the 250 μM [1]. Chlorpheniramine displaces of [3H]pyrilamine from human histamine receptor subtype 1 expressed in CHO cells with IC50 of 66 nM. Chlorpheniramine displays antimalarial activity against CQS strain (D6) and MDR strain (Dd2) of P. falciparum with IC50 of 61.2 uM and 3.9 uM, respectively. Chlorpheniramine displays cytotoxicity against the proliferation of concanavalin A-induced murine splenic lymphocytes with IC50 of 33.4 μM [2].
Oral administration of Chlorpheniramine inhibits histamine-induced mortality in guinea pigs with an ED50 of 0.17 mg/kg [3]. Oral administration of Chlorpheniramine (10 mg/kg) significantly inhibits short-duration scratching in BALB/c mice stimulated by ovalbumin active cutaneous anaphylaxis and in ICR mice subcutaneously injected with histamine, but not long-duration scratching seen in NC/Nga mice, in contrast to that of dexamethasone or tacrolimus [4]."	Maleate	C20H23ClN2O4	15398.0	DMSO : ≥ 100 mg/mL (255.85 mM); H2O : 33.33 mg/mL (85.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	CN(C)CCC(C1=CC=C(Cl)C=C1)C2=CC=CC=N2.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Chlorpheniramine-maleate.html	Launched		91.0	B18	A11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0286A	10.0	mM	11.0	DMSO	274.123676	11	A	pluskal_fda_drugs_5005_A11_id
1266	HY-B0463	HYCPK40905	K16	HYCPK40905	91z	1040.0	4.0	V32	905.0	K16	50-41-9	Clomiphene (citrate)	Clomifene citrate	598.08	Estrogen Receptor/ERR	Others	"Clomiphene citrate (Clomifene citrate) is a selective estrogen receptor modulator.
Target: Estrogen Receptor/ERR
Clomifene citrate (CC) acted as an estrogen antagonist regardless of the concentration of E2 added together. In conclusion, CC acts as an estrogen agonist/antagonist via ER alpha in a coexisting estrogen concentration-dependent way whereas it acts as an estrogen antagonist via ER beta whether or not estrogen is present [1]. Clomiphene was effective in increasing pregnancy rate compared to placebo (OR 5.8, 95% CI 1.6 to 21.5) as was clomiphene plus dexamethasone treatment (OR 9.46, 95% CI 5.1 to 17.7) compared to clomiphene alone. A significant improvement in the pregnancy rate was reported for clomiphene plus combined oral contraceptives versus clomiphene alone. No evidence of a difference in effect on pregnancy rate was found with any of the other comparisons [2]."	Citrate	C32H36ClNO8	12851.0	H2O : 1 mg/mL (1.67 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (83.60 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	Cl/C(C1=CC=CC=C1)=C(C2=CC=CC=C2)/C3=CC=C(OCCN(CC)CC)C=C3.OC(CC(O)=O)(C(O)=O)CC(O)=O	https://www.medchemexpress.com/clomiphene-citrate.html	Launched		91.0	V32	A11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0463	10.0	mM	11.0	DMSO	405.185942	11	A	pluskal_fda_drugs_5005_A11_id
82	HY-B0275	HYCPK40902	K03	HYCPK40902	91z	965.0	1.0	U5	902.0	K03	79-57-2	Oxytetracycline		460.43	Antibiotic; Bacterial; Endogenous Metabolite; HSV	Anti-infection; Metabolic Enzyme/Protease	Oxytetracycline is an antibiotic belonging to the tetracycline class. Oxytetracycline potent inhibits Gram-negative and Gram-positive bacteria. Oxytetracycline is a protein synthesis inhibitor and prevents the binding from aminoacil-tRNA to the complex m-ribosomal RNA. Oxytetracycline also possesses anti-HSV-1 activity[1][2][3].	Free Base	C22H24N2O9	16364.0	DMSO : ≥ 50 mg/mL (108.59 mM); H2O : 0.67 mg/mL (1.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])[C@@H](O)[C@]3([H])[C@](C)(O)C4=C(C(C3=C(O)[C@@]21O)=O)C(O)=CC=C4)N	https://www.medchemexpress.com/Oxytetracycline.html	Launched		91.0	U5	A12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0275	10.0	mM	12.0	DMSO	460.14818	12	A	pluskal_fda_drugs_5005_A12_id
323	HY-B2227A	HYCPK40902	K20	HYCPK40902	91z	999.0	1.0	U39	902.0	K20	814-80-2	Lactate (calcium)	Lactic acid (calcium)	109.11	Others	Others	Lactate (Lactic acid) calcium is used by the beverage industry as a source of calcium to fortify fruit juice. Lactate calcium facilitates the growth and phytic acid degradation of soybean sprouts[1][2].	Calcium	C3H5O3.1/2Ca	26181.0	H2O : ≥ 50 mg/mL (458.25 mM); DMSO : 100 mg/mL (916.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC(O)C([O-])=O.CC(O)C([O-])=O.[Ca+2]	https://www.medchemexpress.com/calcium-lactate.html	Launched		91.0	U39	A12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2227A	10.0	mM	12.0	DMSO	90.031694	12	A	pluskal_fda_drugs_5005_A12_id
615	HY-B0005	HYCPK40903	M14	HYCPK40903	91z	1180.0	2.0	Y28	903.0	M14	89778-27-8	Toremifene (citrate)	Z-Toremifene (citrate); NK 622; FC-1157a	598.08	Apoptosis; Estrogen Receptor/ERR	Apoptosis; Others	Toremifene citrate (Z-Toremifene citrate) is a second-generation selective estrogen-receptor modulator (SERM) in development for the prevention of osteoporosis. Toremifene citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.07 μM and 2.6 μM, respectively[1][2].	Citrate	C32H36ClNO8	16814.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (167.20 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	ClCC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(C)C)C=C2)\C3=CC=CC=C3.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/toremifene-citrate.html	Launched		91.0	Y28	A12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0005	10.0	mM	12.0	DMSO	405.185942	12	A	pluskal_fda_drugs_5005_A12_id
664	HY-B0563A	HYCPK40903	N17	HYCPK40903	91z	1282.0	2.0	AA34	903.0	N17	132112-35-7	Ropivacaine (hydrochloride monohydrate)		328.88	Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel	Ropivacaine hydrochloride monohydrate is a potent?sodium channel?blocker and blocks impulse conduction via reversible inhibition of?sodium ion influx?in nerve fibrese[1][2]. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane[3]. Ropivacaine is widely used for regional anesthesia and neuropathic pain?management in vivo[1].	Hydrochloride	C17H29ClN2O2	14568.0	H2O : 50 mg/mL (152.03 mM; Need ultrasonic); DMSO : 100 mg/mL (304.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease; Cancer	O=C([C@H]1N(CCC)CCCC1)NC2=C(C)C=CC=C2C.O.Cl	https://www.medchemexpress.com/Ropivacaine-hydrochloride-monohydrate.html	Launched		91.0	AA34	A12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0563A	10.0	mM	12.0	DMSO	274.204513	12	A	pluskal_fda_drugs_5005_A12_id
673	HY-B1236	HYCPK40903	G18	HYCPK40903	91z	612.0	2.0	M36	903.0	G18	547-44-4	Sulfacarbamide		215.23	Others	Others	Sulfacarbamide is a blood sugar-lowering drug, also acting on the vegetative nervous system.	Free Base	C7H9N3O3S	23862.0	DMSO : ≥ 28 mg/mL (130.09 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(C1=CC=C(N)C=C1)(NC(N)=O)=O	https://www.medchemexpress.com/Sulfacarbamide.html	Launched		91.0	M36	A12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1236	10.0	mM	12.0	DMSO	215.036462	12	A	pluskal_fda_drugs_5005_A12_id
686	HY-B0267A	HYCPK40903	N19	HYCPK40903	91z	1286.0	2.0	AA38	903.0	N19	1508-65-2	Oxybutynin (chloride)		393.95	mAChR; Potassium Channel	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Oxybutynin chloride is an oral active and competitive mAChR antagonist with Kis of 14.3 and 5.55 nM for specific [3H]NMS binding in the mouse bladder and cerebral cortex, respectively. Oxybutynin chloride inhibits vascular Kv channels in a manner independent of anticholinergic effect, with an IC50 value of 11.51 μM. Oxybutynin chloride reduces muscle spasm in the bladder and urinary tract, can be used in study of overactive bladder syndrome (OAB)[1][2].	Hydrochloride	C22H32ClNO3	16335.0	H2O : 33.33 mg/mL (84.60 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (253.84 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C(O)(C1=CC=CC=C1)C2CCCCC2)OCC#CCN(CC)CC.[H]Cl	https://www.medchemexpress.com/Oxybutynin-chloride.html	Launched		91.0	AA38	A12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0267A	10.0	mM	12.0	DMSO	357.230394	12	A	pluskal_fda_drugs_5005_A12_id
1033	HY-B0589	HYCPK40904	B22	HYCPK40904	91z	187.0	3.0	D43	904.0	B22	134523-00-5	Atorvastatin		558.64	Autophagy; HMG-CoA Reductase (HMGCR)	Autophagy; Metabolic Enzyme/Protease	Atorvastatin is an orally active HMG-CoA reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively[1][2][3].	Free Acid	C33H35FN2O5	79961.0	DMSO : 50 mg/mL (89.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Inflammation/Immunology; Cancer	O=C(C(C(C1=CC=CC=C1)=C(C2=CC=C(F)C=C2)N3CC[C@@H](O)C[C@@H](O)CC(O)=O)=C3C(C)C)NC4=CC=CC=C4	https://www.medchemexpress.com/atorvastatin.html	Launched		91.0	D43	A12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0589	10.0	mM	12.0	DMSO	558.253	12	A	pluskal_fda_drugs_5005_A12_id
1276	HY-B0390	HYCPK40905	E17	HYCPK40905	91z	466.0	4.0	J34	905.0	E17	72-33-3	Mestranol		310.42994	Estrogen Receptor/ERR	Others	Mestranol is an inactive prodrug and becomes biologically active on conversion to ethinyl estradiol (EE). Mestranol acts as an estrogen receptor agonist. Mestranol combines with a?progestin in vivo?and can be used for?the research of menopausal hormone or?menstrual disorders[1][2].	Free Base	C21H26O2	17005.0	DMSO : 33.33 mg/mL (107.37 mM; Need ultrasonic); H2O : 0.67 mg/mL (2.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	C[C@@]1([C@]2(O)C#C)[C@](CC2)([H])[C@@](CCC3=C4C=CC(OC)=C3)([H])[C@]4([H])CC1	https://www.medchemexpress.com/mestranol.html	Launched		91.0	J34	A12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0390	10.0	mM	12.0	DMSO	310.19328	12	A	pluskal_fda_drugs_5005_A12_id
358	HY-B1087	HYCPK40903	O03	HYCPK40903	91z	1350.0	2.0	AC6	903.0	O03	2920-86-7	Prednisolone (hemisuccinate)	Prednisolone 21-hemisuccinate	460.52	Glucocorticoid Receptor	Immunology/Inflammation	Prednisolone hemisuccinate is a synthetic glucocorticoid, a derivative of cortisol, which is used to treat a variety of inflammatory and auto-immune conditions.	Free Acid	C25H32O8	63801.0	DMSO : 250 mg/mL (542.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(COC(CCC(O)=O)=O)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/Prednisolone-hemisuccinate.html	Launched		91.0	AC6	A13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1087	10.0	mM	13.0	DMSO	460.209718	13	A	pluskal_fda_drugs_5005_A13_id
477	HY-16289	HYCPK40903	B07	HYCPK40903	91z	110.0	2.0	C14	903.0	B07	63610-09-3	Lodoxamide (tromethamine)	U-42585E	553.90	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Lodoxamide tromethamine (U-42585E) is a medication for the treatment of prophylaxis of mast cell-mediated allergic disease.	Tris	C19H28ClN5O12	45427.0	DMSO : 20 mg/mL (36.11 mM; Need ultrasonic and warming); H2O : ≥ 100 mg/mL (180.54 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	N#CC1=CC(NC(C(O)=O)=O)=C(Cl)C(NC(C(O)=O)=O)=C1.OCC(CO)(N)CO.OCC(CO)(N)CO	https://www.medchemexpress.com/Lodoxamide_tromethamine.html	Launched		91.0	C14	A13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16289	10.0	mM	13.0	DMSO	310.994513	13	A	pluskal_fda_drugs_5005_A13_id
573	HY-B0563	HYCPK40903	E19	HYCPK40903	91z	422.0	2.0	I38	903.0	E19	84057-95-4	Ropivacaine		274.40	Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel	Ropivacain is a potent?sodium channel?blocker. Ropivacain blocks impulse conduction via reversible inhibition of?sodium ion influx?in nerve fibrese[1][2]. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane[3]. Ropivacaine is used for the research of neuropathic pain?management[1].		C17H26N2O	78889.0	DMSO : 12.5 mg/mL (45.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease; Cancer	O=C([C@H]1N(CCC)CCCC1)NC2=C(C)C=CC=C2C	https://www.medchemexpress.com/ropivacaine.html	Launched		91.0	I38	A13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0563	10.0	mM	13.0	DMSO	274.204513	13	A	pluskal_fda_drugs_5005_A13_id
938	HY-13311	HYCPK40904	C16	HYCPK40904	91z	271.0	3.0	F31	904.0	C16	872511-34-7	Infigratinib	BGJ-398; NVP-BGJ398	560.48	Apoptosis; FGFR	Apoptosis; Protein Tyrosine Kinase/RTK	Infigratinib (BGJ-398; NVP-BGJ398) is a potent inhibitor of the FGFR family with IC50s of 0.9 nM, 1.4 nM, 1 nM, and 60 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively.	Free Base	C26H31Cl2N7O3	83492.0	DMSO : 12 mg/mL (21.41 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	ClC1=C(C(Cl)=C(C=C1OC)OC)NC(N(C2=CC(NC3=CC=C(C=C3)N4CCN(CC4)CC)=NC=N2)C)=O	https://www.medchemexpress.com/NVP-BGJ398.html	Launched		91.0	F31	A13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13311	10.0	mM	13.0	DMSO	559.186543	13	A	pluskal_fda_drugs_5005_A13_id
1057	HY-N3025	HYCPK40905	J03	HYCPK40905	91z	918.0	4.0	T6	905.0	J03	7446-20-0	Zinc sulfate (heptahydrate)		287.55	Others	Others	Zinc sulfate heptahydrate is a hydrate that is the heptahydrate form of zinc sulfate. Zinc sulfate heptahydrate is a dietary supplement used for zinc deficiency and to prevent the condition in those at high risk[1][2].	Zinc	H14O11SZn	62380.0	DMSO : 100 mg/mL (347.77 mM; Need ultrasonic); H2O : 100 mg/mL (347.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	[ZnSO4. 7H2O]	https://www.medchemexpress.com/zinc-sulfate-heptahydrate.html	Launched		91.0	T6	A13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N3025	10.0	mM	13.0	DMSO	97.96738	13	A	pluskal_fda_drugs_5005_A13_id
1194	HY-B0772A	HYCPK40905	C12	HYCPK40905	91z	264.0	4.0	F24	905.0	C12	130656-51-8	Nifekalant (hydrochloride)	MS-551	441.91	Potassium Channel	Membrane Transporter/Ion Channel	Nifekalant hydrochloride (MS-551), a class III antiarrhythmic agent, is a IKr potassium channel blocker with an IC50 of 10 μM. Nifekalant hydrochloride can be used for refractory ventricular tachyarrhythmias research[1][2].	Hydrochloride	C19H28ClN5O5	152118.0	DMSO : 125 mg/mL (282.86 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	[H]Cl.O=C1N(C)C(C=C(NCCN(CCO)CCCC2=CC=C([N+]([O-])=O)C=C2)N1C)=O	https://www.medchemexpress.com/nifekalant-hydrochloride.html	Launched		91.0	F24	A13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0772A	10.0	mM	13.0	DMSO	405.201219	13	A	pluskal_fda_drugs_5005_A13_id
1240	HY-B0267	HYCPK40905	A15	HYCPK40905	91z	78.0	4.0	B30	905.0	A15	5633-20-5	Oxybutynin		357.49	mAChR; Potassium Channel	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Oxybutynin is an anticholinergic agent, which inhibits vascular Kv channels in a concentration-dependent manner, with an IC50 of 11.51 μM[1].	Free Base	C22H31NO3	43327.0	H2O : ≥ 50 mg/mL (139.86 mM); DMSO : 100 mg/mL (279.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C(O)(C1=CC=CC=C1)C2CCCCC2)OCC#CCN(CC)CC	https://www.medchemexpress.com/Oxybutynin.html	Launched		91.0	B30	A13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0267	10.0	mM	13.0	DMSO	357.230394	13	A	pluskal_fda_drugs_5005_A13_id
1350	HY-16045	HYCPK40905	O21	HYCPK40905	91z	1434.0	4.0	AD42	905.0	O21	140898-91-5	Hexaminolevulinate (hydrochloride)	Hexyl 5-aminolevulinate hydrochloride; P-1206; 5-Aminolevulinic acid hexyl ester hydrochloride	251.75	Others	Others	Hexaminolevulinate hydrochloride is a fluorescent agent, and can be used with a light test to check for bladder cancer[1][2].	Hydrochloride	C11H22ClNO3	18730.0	DMSO : ≥ 100 mg/mL (397.22 mM); H2O : 100 mg/mL (397.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(OCCCCCC)CCC(CN)=O.[H]Cl	https://www.medchemexpress.com/Hexaminolevulinate-hydrochloride.html	Launched		91.0	AD42	A13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16045	10.0	mM	13.0	DMSO	215.152144	13	A	pluskal_fda_drugs_5005_A13_id
90	HY-B0368	HYCPK40902	C04	HYCPK40902	91z	199.0	1.0	E7	902.0	C04	62571-86-2	Captopril	SQ 14225	217.29	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Captopril (SQ 14225), antihypertensive agent, is a thiol-containing competitive, orally active angiotensin-converting enzyme (ACE) inhibitor (IC50=0.025 μM) and has been widely used for research of hypertension and congestive heart failure. Captopril is also a New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor with an IC50 of 7.9 μM[1][2][3].	Free Acid	C9H15NO3S	13195.0	DMSO : ≥ 50 mg/mL (230.11 mM); H2O : ≥ 50 mg/mL (230.11 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(O)[C@H]1N(C([C@H](C)CS)=O)CCC1	https://www.medchemexpress.com/Captopril.html	Launched		91.0	E7	A14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0368	10.0	mM	14.0	DMSO	217.077264	14	A	pluskal_fda_drugs_5005_A14_id
208	HY-B0006	HYCPK40902	N12	HYCPK40902	91z	1271.0	1.0	AA23	902.0	N12	72956-09-3	Carvedilol	BM 14190	406.47	Adrenergic Receptor; Autophagy; Bacterial	Anti-infection; Autophagy; GPCR/G Protein; Neuronal Signaling	Carvedilol (BM 14190) is a non-selective β/α-1 blocker[1]. Carvedilol inhibits lipid peroxidation in a dose-dependent manner with an IC50 of 5 μM. Carvedilol is a multiple action antihypertensive agent with potential use in angina and congestive heart failure[2]. Carvedilol is an autophagy inducer that inhibits the NLRP3 inflammasome[3].	Free Base	C24H26N2O4	8081.0	DMSO : 100 mg/mL (246.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Cardiovascular Disease	OC(CNCCOC1=CC=CC=C1OC)COC2=CC=CC(N3)=C2C4=C3C=CC=C4	https://www.medchemexpress.com/carvedilol.html	Launched		91.0	AA23	A14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0006	10.0	mM	14.0	DMSO	406.189257	14	A	pluskal_fda_drugs_5005_A14_id
545	HY-B1337	HYCPK40903	B12	HYCPK40903	91z	120.0	2.0	C24	903.0	B12	67-48-1	Choline (chloride)		139.62	Endogenous Metabolite; nAChR	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Choline chloride is an essential nutrient that activates alpha7 nicotinic receptors and has analgesic and anti-inflammatory activity. Glycerophosphoinositol choline can affect diseases such as liver disease, atherosclerosis and neurological disorders[1][2].	Chloride	C5H14ClNO	17524.0	H2O : ≥ 100 mg/mL (716.23 mM); DMSO : ≥ 140 mg/mL (1002.72 mM)	DMSO Solution	10mM  * 100uL	Cancer	OCC[N+](C)(C)C.[Cl-]	https://www.medchemexpress.com/Choline-chloride.html	Launched		91.0	C24	A14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1337	10.0	mM	14.0	DMSO	104.10699	14	A	pluskal_fda_drugs_5005_A14_id
770	HY-B0024	HYCPK40904	B05	HYCPK40904	91z	153.0	3.0	D9	904.0	B05	123447-62-1	Prulifloxacin	NM441	461.46	Antibiotic; Bacterial	Anti-infection	Prulifloxacin (NM441) is an orally active fluoroquinolone antibiotic with a broad spectrum of activity against Gram-positive and -negative bacteria. Prulifloxacin is a prodrug of a thiazeto-quinoline carboxylic acid derivative Ulifloxacin (NM394). Prulifloxacin has the potential for lower urinary tract infections and exacerbations of chronic bronchitis[1][2].	Free Acid	C21H20FN3O6S	122182.0	DMSO : 12.5 mg/mL (27.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=C(SC2C)N2C3=C(C=C(F)C(N4CCN(CC5=C(C)OC(O5)=O)CC4)=C3)C1=O)O	https://www.medchemexpress.com/Prulifloxacin.html	Launched		91.0	D9	A14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0024	10.0	mM	14.0	DMSO	461.105685	14	A	pluskal_fda_drugs_5005_A14_id
880	HY-B0563C	HYCPK40904	E12	HYCPK40904	91z	455.0	3.0	J23	904.0	E12	854056-07-8	Ropivacaine (mesylate)		370.51	Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel	Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of?sodium ion influx?in nerve fibressup>[1][2]. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel)?TREK-1?with an IC50?of 402.7 μM in COS-7 cell's membrane[3].	Mesylate	C18H30N2O4S	64297.0	H2O : 250 mg/mL (674.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease; Cancer	O=C([C@H]1N(CCC)CCCC1)NC2=C(C)C=CC=C2C.CS(=O)(O)=O	https://www.medchemexpress.com/ropivacaine-mesylate.html	Launched		91.0	J23	A14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0563C	10.0	mM	14.0	DMSO	274.204513	14	A	pluskal_fda_drugs_5005_A14_id
1052	HY-14270	HYCPK40905	E03	HYCPK40905	91z	438.0	4.0	J6	905.0	E03	53882-12-5	Lodoxamide	U-42585E (free acid)	311.63	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Lodoxamide (U-42585E free acid) is an antiallergic compound acting as a mast-cell stabilizer for the treatment of asthma and allergic conjunctivitis.	Free Acid	C11H6ClN3O6	32764.0	DMSO : 50 mg/mL (160.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	OC(C(NC1=C(Cl)C(NC(C(O)=O)=O)=CC(C#N)=C1)=O)=O	https://www.medchemexpress.com/Lodoxamide.html	Launched		91.0	J6	A14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14270	10.0	mM	14.0	DMSO	310.994513	14	A	pluskal_fda_drugs_5005_A14_id
1135	HY-103714A	HYCPK40905	H08	HYCPK40905	91z	736.0	4.0	P16	905.0	H08	2137030-98-7	Ensartinib (dihydrochloride)	X-396 (dihydrochloride)	634.36	Anaplastic lymphoma kinase (ALK); c-Met/HGFR	Protein Tyrosine Kinase/RTK	Ensartinib dihydrochloride (X-396 dihydrochloride) is a potent and dual ALK/MET inhibitor with IC50s of <0.4 nM and 0.74 nM, respectively.	Hydrochloride	C26H29Cl4FN6O3	31300.0	H2O : 33.33 mg/mL (52.54 mM; Need ultrasonic); DMSO : 35.71 mg/mL (56.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=NN=C(N)C(O[C@@H](C2=C(Cl)C=CC(F)=C2Cl)C)=C1)NC3=CC=C(C(N4C[C@@H](C)N[C@@H](C)C4)=O)C=C3.Cl.Cl	https://www.medchemexpress.com/X-396_hydrochloride.html	Launched		91.0	P16	A14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-103714A	10.0	mM	14.0	DMSO	560.150572	14	A	pluskal_fda_drugs_5005_A14_id
1336	HY-A0166	HYCPK40905	A21	HYCPK40905	91z	90.0	4.0	B42	905.0	A21	82009-34-5	Cilastatin	MK0791	358.45	Antibiotic; Bacterial	Anti-infection	Cilastatin (MK0791) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin is an antibacterial adjunct[1][2][3].	Free Acid	C16H26N2O5S	27577.0	H2O : 12.5 mg/mL (34.87 mM; ultrasonic and warming and heat to 60°C); DMSO : 100 mg/mL (278.98 mM; Need ultrasonic); 1M NaOH : 100 mg/mL (278.98 mM; ultrasonic and adjust pH to 12 with NaOH)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)/C(NC([C@@H]1C(C)(C)C1)=O)=C/CCCCSC[C@H](N)C(O)=O	https://www.medchemexpress.com/Cilastatin.html	Launched		91.0	B42	A14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0166	10.0	mM	14.0	DMSO	358.156243	14	A	pluskal_fda_drugs_5005_A14_id
334	HY-B0214	HYCPK40902	O21	HYCPK40902	91z	1385.0	1.0	AC41	902.0	O21	53-03-2	Prednisone	Dehydrocortisone	358.43	Apoptosis; Glucocorticoid Receptor	Apoptosis; Immunology/Inflammation	"Prednisone (Adasone) is a synthetic corticosteroid agent that is particularly effective as an immunosuppressant compound.
Target: Others
Prednisone is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant drug. It is used to treat certain inflammatory diseases (such as moderate allergic reactions) and (at higher doses) some types of cancer, but has significant adverse effects. Because it suppresses the immune system, it leaves patients more susceptible to infections.
Prednisone can also be used in the treatment of decompensated heart failure to potentiate renal responsiveness to diuretics, especially in heart failure patients with refractory diuretic resistance with large dose of loop diuretics. The mechanism is prednisone, as a glucocorticoid, can improve renal responsiveness to atrial natriuretic peptide by increasing the density of natriuretic peptide receptor type A in the renal inner medullary collecting duct, inducing a potent diuresis."	Free Base	C21H26O5	91442.0	DMSO : 125 mg/mL (348.74 mM; ultrasonic and warming and heat to 80°C); H2O : 1 mg/mL (2.79 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]1(C2)[C@](C(CO)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])C2=O)=O	https://www.medchemexpress.com/prednisone.html	Launched		91.0	AC41	A15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0214	10.0	mM	15.0	DMSO	358.178024	15	A	pluskal_fda_drugs_5005_A15_id
372	HY-B1436	HYCPK40902	E04	HYCPK40902	91z	391.0	1.0	I7	902.0	E04	965-52-6	Nifuroxazide		275.22	Antibiotic; Bacterial; STAT	Anti-infection; JAK/STAT Signaling; Stem Cell/Wnt	Nifuroxazide is an effective inhibitor of STAT3, also exerts potent anti-tumor and anti-metastasis activity.	Free Base	C12H9N3O5	17561.0	DMSO : ≥ 155 mg/mL (563.19 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(N/N=C/C1=CC=C([N+]([O-])=O)O1)C2=CC=C(O)C=C2	https://www.medchemexpress.com/Nifuroxazide.html	Launched		91.0	I7	A15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1436	10.0	mM	15.0	DMSO	275.05422	15	A	pluskal_fda_drugs_5005_A15_id
874	HY-B0529A	HYCPK40904	O11	HYCPK40904	91z	1413.0	3.0	AD21	904.0	O11	37091-65-9	Azlocillin (sodium salt)	Sodium azlocillin	483.47	Antibiotic; Bacterial; Parasite	Anti-infection	Azlocillin sodium salt (Sodium azlocillin), a semisynthetic penicillin, is a broad spectrum β-lactam antibiotic. Azlocillin sodium salt shows antipseudomonal activity, and also potent against the malarial parasite Plasmodium falciparum[1][2][3].	Sodium	C20H22N5NaO6S	13587.0	DMSO : 100 mg/mL (206.84 mM; Need ultrasonic); H2O : 6.67 mg/mL (13.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC([C@H](NC(N3CCNC3=O)=O)C4=CC=CC=C4)=O)N1C2=O)O[Na]	https://www.medchemexpress.com/Azlocillin-sodium-salt.html	Launched		91.0	AD21	A15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0529A	10.0	mM	15.0	DMSO	461.136904	15	A	pluskal_fda_drugs_5005_A15_id
952	HY-N0650	HYCPK40904	A17	HYCPK40904	91z	81.0	3.0	B33	904.0	A17	56-45-1	L-Serine	(-)-Serine; (S)-Serine	105.09	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	L-Serine ((-)-Serine; (S)-Serine), one of the so-called non-essential amino acids, plays a central role in cellular proliferation.	Free Acid	C3H7NO3	36669.0	H2O : 50 mg/mL (475.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	N[C@@H](CO)C(O)=O	https://www.medchemexpress.com/L-Serine.html	Launched		91.0	B33	A15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0650	10.0	mM	15.0	DMSO	105.042593	15	A	pluskal_fda_drugs_5005_A15_id
966	HY-B1184	HYCPK40904	O17	HYCPK40904	91z	1425.0	3.0	AD33	904.0	O17	50-12-4	Mephenytoin		218.25	Cytochrome P450	Metabolic Enzyme/Protease	Mephenytoin, an anticonvulsant, is the CYP2C19 and CYP2B6 substrate[1].	Free Base	C12H14N2O2	124145.0	DMSO : 50 mg/mL (229.10 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1N(C)C(C(C2=CC=CC=C2)(CC)N1)=O	https://www.medchemexpress.com/mephenytoin.html	Launched		91.0	AD33	A15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1184	10.0	mM	15.0	DMSO	218.105528	15	A	pluskal_fda_drugs_5005_A15_id
988	HY-B0920	HYCPK40904	E19	HYCPK40904	91z	469.0	3.0	J37	904.0	E19	1156-19-0	Tolazamide	U-17835	311.40	Others	Others	Tolazamide is an oral blood glucose lowering drug used for people with Type 2 diabetes.	Free Base	C14H21N3O3S	28699.0	DMSO : ≥ 39 mg/mL (125.24 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=S(C1=CC=C(C)C=C1)(NC(NN2CCCCCC2)=O)=O	https://www.medchemexpress.com/Tolazamide.html	Launched		91.0	J37	A15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0920	10.0	mM	15.0	DMSO	311.130363	15	A	pluskal_fda_drugs_5005_A15_id
1037	HY-B1358	HYCPK40904	F22	HYCPK40904	91z	571.0	3.0	L43	904.0	F22	7179-49-9	Lincomycin (hydrochloride monohydrate)		461.01	Antibiotic; Bacterial	Anti-infection	Lincomycin hydrochloride monohydrate is a narrow-spectrum antibiotic, has similar effects to erythromycin, which has a good effect on gram-positive coccus, mainly used to inhibit the synthesis of bacterial cell protein[1][2].	Hydrochloride	C18H37ClN2O7S	17652.0	DMSO : ≥ 100 mg/mL (216.92 mM); H2O : 50 mg/mL (108.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	C[C@@H](O)[C@](NC([C@H]1N(C)C[C@H](CCC)C1)=O)([H])[C@@]2([H])O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O.Cl.O	https://www.medchemexpress.com/Lincomycin-hydrochloride-hydrate.html	Launched		91.0	L43	A15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1358	10.0	mM	15.0	DMSO	406.213758	15	A	pluskal_fda_drugs_5005_A15_id
1098	HY-12678	HYCPK40905	C06	HYCPK40905	91z	252.0	4.0	F12	905.0	C06	1108743-60-7	Entrectinib	NMS-E628; RXDX-101	560.64	Anaplastic lymphoma kinase (ALK); Autophagy; ROS Kinase; Trk Receptor	Autophagy; Neuronal Signaling; Protein Tyrosine Kinase/RTK	Entrectinib (NMS-E628) is a potent, orally available, and CNS-active pan-Trk, ROS1, and ALK inhibitor. Entrectinib inhibits TrkA, TrkB, TrkC, ROS1 and ALK with IC50 values of 1, 3, 5, 12 and 7 nM, respectively. Antitumor activity.	Free Base	C31H34F2N6O2	79323.0	DMSO : ≥ 31 mg/mL (55.29 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=NNC2=C1C=C(CC3=CC(F)=CC(F)=C3)C=C2)C4=C(NC5CCOCC5)C=C(N6CCN(C)CC6)C=C4	https://www.medchemexpress.com/Entrectinib.html	Launched		91.0	F12	A15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12678	10.0	mM	15.0	DMSO	560.271131	15	A	pluskal_fda_drugs_5005_A15_id
539	HY-B1128A	HYCPK40903	L11	HYCPK40903	91z	1078.0	2.0	W22	903.0	L11	30034-03-8	Cefamandole (sodium)	Cephamandole sodium	484.48	Antibiotic; Bacterial	Anti-infection	Cefamandole Sodium Salt is a second-generation broad-spectrum cephalosporin antibiotic.	Sodium	C18H17N6NaO5S2	153062.0	H2O : 33.33 mg/mL (68.80 mM; Need ultrasonic); DMSO : 50 mg/mL (103.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@H](NC([C@H](O)C4=CC=CC=C4)=O)C1=O)O[Na]	https://www.medchemexpress.com/Cefamandole-sodium.html	Launched		91.0	W22	A16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1128A	10.0	mM	16.0	DMSO	462.07801	16	A	pluskal_fda_drugs_5005_A16_id
819	HY-10450	HYCPK40904	H08	HYCPK40904	91z	735.0	3.0	P15	904.0	H08	461432-26-8	Dapagliflozin	BMS-512148	408.87	SGLT	Membrane Transporter/Ion Channel	"Dapagliflozin (BMS-512148), a new type of drug used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine[1].
Dapagliflozin induces HIF1 expression and attenuates renal IR injury[2]."	Free Base	C21H25ClO6	105855.0	DMSO : ≥ 100 mg/mL (244.58 mM); H2O : 50 mg/mL (122.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O	https://www.medchemexpress.com/Dapagliflozin.html	Launched		91.0	P15	A16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10450	10.0	mM	16.0	DMSO	408.133966	16	A	pluskal_fda_drugs_5005_A16_id
974	HY-B0339	HYCPK40904	G18	HYCPK40904	91z	659.0	3.0	N35	904.0	G18	125-33-7	Primidone		218.25	Sodium Channel	Membrane Transporter/Ion Channel	Primidone is a potent anticonvulsant agent of the barbiturate class. Primidone is a?neuronal?voltage-gated sodium channel (VGSC) blocker and can be used for the study of epilepsy, essential tremor, and Psychiatric disorders[1].	Free Base	C12H14N2O2	17125.0	DMSO : 50 mg/mL (229.10 mM; Need ultrasonic); H2O : ≥ 0.67 mg/mL (3.07 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1(CC)C2=CC=CC=C2)NCNC1=O	https://www.medchemexpress.com/primidone.html	Launched		91.0	N35	A16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0339	10.0	mM	16.0	DMSO	218.105528	16	A	pluskal_fda_drugs_5005_A16_id
1050	HY-B0892	HYCPK40905	C03	HYCPK40905	91z	246.0	4.0	F6	905.0	C03	100-51-6	Benzyl alcohol	Benzenemethanol	108.14	Endogenous Metabolite	Metabolic Enzyme/Protease	Benzyl alcohol is an aromatic alcohol; a colorless liquid with a mild pleasant aromatic odor.	Free Base	C7H8O	17436.0	DMSO : ≥ 1.8 mg/mL (16.65 mM); H2O : 20 mg/mL (184.95 mM; Need ultrasonic); Ethanol : ≥ 100 mg/mL (924.73 mM)	DMSO Solution	10mM  * 100uL	Others	OCC1=CC=CC=C1	https://www.medchemexpress.com/Benzyl-alcohol.html	Launched		91.0	F6	A16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0892	10.0	mM	16.0	DMSO	108.057515	16	A	pluskal_fda_drugs_5005_A16_id
1084	HY-13204A	HYCPK40905	E05	HYCPK40905	91z	442.0	4.0	J10	905.0	E05	514-65-8	Biperiden	KL 373	311.46	mAChR	GPCR/G Protein; Neuronal Signaling	Biperiden (KL 373) is a non-selective muscarinic receptor antagonist that competitively binds to M1 muscarinic receptors, thereby inhibiting acetylcholine and enhancing dopamine signaling in the central nervous system. Biperiden has the potential for the research of Parkinson's disease and other related psychiatric disorders[1][2].	Free Base	C21H29NO	156635.0	DMSO : 50 mg/mL (160.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC([C@H]1C[C@@H]2C=C[C@H]1C2)(CCN3CCCCC3)C4=CC=CC=C4	https://www.medchemexpress.com/Biperiden.html	Launched		91.0	J10	A16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13204A	10.0	mM	16.0	DMSO	311.224915	16	A	pluskal_fda_drugs_5005_A16_id
1180	HY-122975	HYCPK40905	E11	HYCPK40905	91z	454.0	4.0	J22	905.0	E11	13182-89-3	Metronidazole Benzoate	Benzoyl metronidazole	275.26	Bacterial; Parasite	Anti-infection	Metronidazole Benzoate, derives from a metronidazole and a benzoic acid, has a role as an antibacterial, antimicrobial, antiparasitic, and antitrichomonal agent[1].		C13H13N3O4	63992.0	DMSO : 250 mg/mL (908.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=[N+](C1=CN=C(C)N1CCOC(C2=CC=CC=C2)=O)[O-]	https://www.medchemexpress.com/metronidazole-benzoate.html	Launched		91.0	J22	A16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-122975	10.0	mM	16.0	DMSO	275.090606	16	A	pluskal_fda_drugs_5005_A16_id
1227	HY-B2224	HYCPK40905	D14	HYCPK40905	91z	364.0	4.0	H28	905.0	D14	67-16-3	Thiamine disulfide		562.71	Endogenous Metabolite; HIV	Anti-infection; Metabolic Enzyme/Protease	Thiamine disulfide, a vitamin B1 derivative, is an oxidized dimer of Thiamine. Thiamine disulfide is a potent HIV-1 inhibitor. Thiamine disulfide significantly depresses HIV-1 transactivator (Tat) activity[1][2].		C24H34N8O4S2	103601.0	DMSO : 250 mg/mL (444.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Metabolic Disease	C/C(N(CC1=CN=C(C)N=C1N)C=O)=C(SS/C(CCO)=C(N(CC2=CN=C(C)N=C2N)C=O)\C)/CCO	https://www.medchemexpress.com/thiamine-disulfide.html	Launched		91.0	H28	A16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2224	10.0	mM	16.0	DMSO	562.214444	16	A	pluskal_fda_drugs_5005_A16_id
1317	HY-B0732	HYCPK40905	N19	HYCPK40905	91z	1334.0	4.0	AB38	905.0	N19	122892-31-3	Itopride (hydrochloride)	HSR803	394.89	Bacterial; Cholinesterase (ChE); Dopamine Receptor	Anti-infection; GPCR/G Protein; Neuronal Signaling	Itopride (HSR803) hydrochloride is a potent dopamine-2 antagonist and an acetylcholine esterase (AChE) inhibitor. Itopride hydrochloride enhances gastric motility through both antidopaminergic and anti-acetylcholinesterasic actions, can be used as a gastrointestinal prokinetic agent. Itopride can be used for researching gastro-esophageal reflux disease (GERD)[1][2].	Hydrochloride	C20H27ClN2O4	16839.0	DMSO : 100 mg/mL (253.24 mM; Need ultrasonic); H2O : 50 mg/mL (126.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NCC1=CC=C(OCCN(C)C)C=C1)C2=CC=C(OC)C(OC)=C2.Cl	https://www.medchemexpress.com/itopride-hydrochloride.html	Launched		91.0	AB38	A16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0732	10.0	mM	16.0	DMSO	358.189257	16	A	pluskal_fda_drugs_5005_A16_id
195	HY-N0420	HYCPK40902	A12	HYCPK40902	91z	23.0	1.0	A23	902.0	A12	110-15-6	Succinic acid	Wormwood acid	118.09	Endogenous Metabolite	Metabolic Enzyme/Protease	Succinic acid is a potent and orally active anxiolytic agent. Succinic acid is an intermediate product of the tricarboxylic acid cycle. Succinic acid can be used as a precursor of many industrially important chemicals in food, chemical and pharmaceutical industries[1][2].	Free Acid	C4H6O4	14595.0	H2O : 30 mg/mL (254.04 mM; Need ultrasonic); DMSO : 100 mg/mL (846.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(O)CCC(O)=O	https://www.medchemexpress.com/Succinic_acid.html	Launched		91.0	A23	A17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0420	10.0	mM	17.0	DMSO	118.026609	17	A	pluskal_fda_drugs_5005_A17_id
245	HY-13322	HYCPK40902	C15	HYCPK40902	91z	221.0	1.0	E29	902.0	C15	929016-96-6	Pracinostat	SB939	358.48	Apoptosis; HDAC	Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Pracinostat is a potent histone deacetylase (HDAC) inhibitor, with IC50s of 40-140 nM, used for cancer research. Pracinostat also inhibits metallo-β-lactamase domain-containing protein?2 (MBLAC2) hydrolase activity with an EC50 below 10 nM[1][4].	Free Base	C20H30N4O2	114387.0	DMSO : 250 mg/mL (697.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	ONC(/C=C/C1=CC=C2N(C(CCCC)=NC2=C1)CCN(CC)CC)=O	https://www.medchemexpress.com/pracinostat.html	Launched		91.0	E29	A17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13322	10.0	mM	17.0	DMSO	358.236876	17	A	pluskal_fda_drugs_5005_A17_id
337	HY-B0661	HYCPK40902	B22	HYCPK40902	91z	139.0	1.0	C43	902.0	B22	106133-20-4	Tamsulosin	(R)-(-)-YM12617 (free base); LY253351 (free base)	408.51	Adrenergic Receptor; Endogenous Metabolite	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Tamsulosin ((R)-(-)-YM12617 free base) is an inhibitor of α1-adrenergic receptor. Tamsulosin is used for the research of prostatic hyperplasia. Tamsulosin attenuates abdominal aortic aneurysm growth in animal models[1].	Free Base	C20H28N2O5S	13388.0	DMSO : 100 mg/mL (244.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Neurological Disease	O=S(C1=CC(C[C@H](NCCOC2=CC=CC=C2OCC)C)=CC=C1OC)(N)=O	https://www.medchemexpress.com/Tamsulosin.html	Launched		91.0	C43	A17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0661	10.0	mM	17.0	DMSO	408.171893	17	A	pluskal_fda_drugs_5005_A17_id
452	HY-B0547A	HYCPK40903	I05	HYCPK40903	91z	778.0	2.0	Q10	903.0	I05	51-56-9	Homatropine (Bromide)		356.25	mAChR	GPCR/G Protein; Neuronal Signaling	Homatropine Bromide is an orally active muscarinic acetylcholine receptor antagonist and can be used as an anticholinergic agent[1].	Hydrobromide	C16H22BrNO3	16753.0	DMSO : 100 mg/mL (280.70 mM; Need ultrasonic); H2O : 100 mg/mL (280.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C(C1=CC=CC=C1)O)O[C@H]2C[C@@H](CC3)N(C)[C@@H]3C2.Br	https://www.medchemexpress.com/homatropine-bromide.html	Launched		91.0	Q10	A17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0547A	10.0	mM	17.0	DMSO	275.152144	17	A	pluskal_fda_drugs_5005_A17_id
467	HY-14137	HYCPK40903	H06	HYCPK40903	91z	684.0	2.0	O12	903.0	H06	158681-13-1	Rimonabant (Hydrochloride)	SR 141716A (Hydrochloride)	500.25	Bacterial; Cannabinoid Receptor	Anti-infection; GPCR/G Protein; Neuronal Signaling	Rimonabant Hydrochloride (SR 141716A Hydrochloride) is a highly potent and selective central cannabinoid receptor (CB1) antagonist with an Ki of 1.8 nM. Rimonabant Hydrochloride (SR 141716A Hydrochloride) also inhibits Mycobacterial membrane protein Large 3 (MMPL3).	Hydrochloride	C22H22Cl4N4O	8612.0	DMSO : 33.33 mg/mL (66.63 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease	ClC1=CC=C(C2=C(C)C(C(NN3CCCCC3)=O)=NN2C4=CC=C(Cl)C=C4Cl)C=C1.Cl	https://www.medchemexpress.com/Rimonabant-Hydrochloride.html	Launched		91.0	O12	A17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14137	10.0	mM	17.0	DMSO	462.078094	17	A	pluskal_fda_drugs_5005_A17_id
585	HY-135221	HYCPK40904	O15	HYCPK40904	91z	1421.0	3.0	AD29	904.0	O15	147816-23-7	Cefcapene pivoxil (hydrochloride)		604.10	Antibiotic; Bacterial	Anti-infection	Cefcapene pivoxil hydrochloride, an antibiotic, is an orally active and potent 3rd-generation cephalosporin  with a wide spectrum of anti-bacterial activity[1].Cefcapene pivoxil hydrochloride  has the potential for the  palmoplantar pustulosis (PPP) treatment[2].	Hydrochloride	C23H30ClN5O8S2	58056.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 125 mg/mL (206.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[H]Cl.CC(C)(C)C(OCOC(C1=C(COC(N)=O)CS[C@@]([C@@H]2NC(/C(C3=CSC(N)=N3)=C\CC)=O)([H])N1C2=O)=O)=O	https://www.medchemexpress.com/cefcapene-pivoxil-hydrochloride.html	Launched		91.0	AD29	A17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-135221	10.0	mM	17.0	DMSO	567.145755	17	A	pluskal_fda_drugs_5005_A17_id
681	HY-B0932	HYCPK40903	O18	HYCPK40903	91z	1380.0	2.0	AC36	903.0	O18	119793-66-7	Levocarnitine propionate (hydrochloride)	L-Propionylcarnitine (chloride); ST-261	253.72	Others	Others	Levocarnitine propionate hydrochloride (L-Propionylcarnitine chloride; ST-261) is used to treat the deterioration of renal function, congestive heart failure, intermittent claudication, and other diseases.	Chloride	C10H20ClNO4	116264.0	H2O : 60 mg/mL (236.48 mM; Need ultrasonic); DMSO : 250 mg/mL (985.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CCC(O[C@H](CC(O)=O)C[N+](C)(C)C)=O.[Cl-]	https://www.medchemexpress.com/Levocarnitine-propionate-hydrochloride.html	Launched		91.0	AC36	A17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0932	10.0	mM	17.0	DMSO	218.138685	17	A	pluskal_fda_drugs_5005_A17_id
1272	HY-106372A	HYCPK40905	A17	HYCPK40905	91z	82.0	4.0	B34	905.0	A17	1042-42-8	Carcainium (chloride)	QX 572; RSD 931	347.84	Others	Others	Carcainium chloride (QX 572) is a quaternary derivative of Lidocaine. Antitussive effect[1][2].	Chloride	C18H22ClN3O2	125456.0	DMSO : 33.33 mg/mL (95.82 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	O=C(NC1=CC=CC=C1)C[N+](C)(C)CC(NC2=CC=CC=C2)=O.[Cl-]	https://www.medchemexpress.com/carcainium-chloride.html	Launched		91.0	B34	A17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-106372A	10.0	mM	17.0	DMSO	312.170653	17	A	pluskal_fda_drugs_5005_A17_id
256	HY-W016715	HYCPK40902	N15	HYCPK40902	91z	1277.0	1.0	AA29	902.0	N15	7048-04-6	L-Cysteine (hydrochloride hydrate)		175.63	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Cysteine hydrochloride hydrate is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride hydrate suppresses ghrelin and reduces appetite in rodents and humans[1].	Hydrochloride	C3H10ClNO3S	124091.0	DMSO : 100 mg/mL (569.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	N[C@@H](CS)C(O)=O.[H]Cl.[H]O[H]	https://www.medchemexpress.com/l-cysteine-hydrochloride-hydrate.html	Launched		91.0	AA29	A18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W016715	10.0	mM	18.0	DMSO	121.019749	18	A	pluskal_fda_drugs_5005_A18_id
443	HY-B1429	HYCPK40903	P04	HYCPK40903	91z	1448.0	2.0	AE8	903.0	P04	94-20-2	Chlorpropamide		276.74	Na+/K+ ATPase	Membrane Transporter/Ion Channel	"Chlorpropamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).
Target:
Chlorpropamide belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating β cells of the pancreas to release insulin.Chlorpropamide is not recommended for the treatment of NIDDM as it increases blood pressure and the risk of retinopathy. Up to 80% of the single oral dose of chlorpropramide is metabolized, likely in the liver; 80-90% of the dose is excreted in urine as unchanged drug and metabolites."	Free Base	C10H13ClN2O3S	17636.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (361.35 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=S(C1=CC=C(Cl)C=C1)(NC(NCCC)=O)=O	https://www.medchemexpress.com/Chlorpropamide.html	Launched		91.0	AE8	A18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1429	10.0	mM	18.0	DMSO	276.033541	18	A	pluskal_fda_drugs_5005_A18_id
541	HY-B0244	HYCPK40903	N11	HYCPK40903	91z	1270.0	2.0	AA22	903.0	N11	55268-74-1	Praziquantel		312.41	Antibiotic; Parasite	Anti-infection	Praziquantel is a racemic mixture, which is composed of (R)-Praziquantel and (S)- Praziquantel. Praziquantel is safe and has been used for the research of schistosomiasis[1].	Free Base	C19H24N2O2	13643.0	H2O : 0.1 mg/mL (0.32 mM; Need ultrasonic); DMSO : 50 mg/mL (160.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1CN(C(C2CCCCC2)=O)CC3N1CCC4=C3C=CC=C4	https://www.medchemexpress.com/Praziquantel.html	Launched		91.0	AA22	A18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0244	10.0	mM	18.0	DMSO	312.183778	18	A	pluskal_fda_drugs_5005_A18_id
831	HY-B0562	HYCPK40904	D09	HYCPK40904	91z	353.0	3.0	H17	904.0	D09	135-07-9	Methyclothiazide		360.24	Carbonic Anhydrase	Metabolic Enzyme/Protease	Methyclothiazide is an orally active antihypertensive agent and a diuretic agent.?Methyclothiazide leads to a reduction of the vascular response to the action of endogenous vasoconstricting stimuli, such as Norepinephrine (HY-13715).?Methyclothiazide is against voltage-dependent Ca-channel (VDCC) activity in vitro[1][2][3].	Free Base	C9H11Cl2N3O4S2	64658.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 72 mg/mL (199.87 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=S(C1=C(Cl)C=C(C2=C1)NC(CCl)N(C)S2(=O)=O)(N)=O	https://www.medchemexpress.com/methyclothiazide.html	Launched		91.0	H17	A18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0562	10.0	mM	18.0	DMSO	358.956803	18	A	pluskal_fda_drugs_5005_A18_id
872	HY-N0324A	HYCPK40904	M11	HYCPK40904	91z	1221.0	3.0	Z21	904.0	M11	361-09-1	Cholic acid (sodium)		430.55	Endogenous Metabolite	Metabolic Enzyme/Protease	Cholic acid sodium is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid sodium is orally active[1][2].	Sodium	C24H39NaO5	65592.0	H2O : ≥ 250 mg/mL (580.65 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	C[C@H](CCC(O[Na])=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@@]21C	https://www.medchemexpress.com/cholic-acid-sodium.html	Launched		91.0	Z21	A18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0324A	10.0	mM	18.0	DMSO	408.287574	18	A	pluskal_fda_drugs_5005_A18_id
912	HY-B0508	HYCPK40904	E14	HYCPK40904	91z	459.0	3.0	J27	904.0	E14	16773-42-5	Ornidazole	Ro 7-0207	219.63	Antibiotic; Bacterial; Parasite	Anti-infection	"Ornidazole(Ro 7-0207) is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria. 
Target: Antibacterial; Antiparasitic
Ornidazole is a drug that cures some protozoan infections. Ornidazole 1 g/day is effective for the prevention of recurrence of Crohn's disease after ileocolonic resection [1]. Ornidazole is converted to reduction products that interact with DNA to cause destruction of helical DNA structure and strand leading to a protein synthesis inhibition and cell death in susceptible organisms [2]."	Free Base	C7H10ClN3O3	16735.0	H2O : 10 mg/mL (45.53 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (455.31 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	CC1=NC=C([N+]([O-])=O)N1CC(CCl)O	https://www.medchemexpress.com/ornidazole.html	Launched		91.0	J27	A18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0508	10.0	mM	18.0	DMSO	219.041069	18	A	pluskal_fda_drugs_5005_A18_id
1189	HY-124290	HYCPK40905	N11	HYCPK40905	91z	1318.0	4.0	AB22	905.0	N11	401905-67-7	Carotegrast methyl	AJM300	569.44	Integrin	Cytoskeleton	Carotegrast methyl (AJM300) is an orally active and selective α4 integrin antagonist. HCA2969, an active metabolite of Carotegrast methyl, is a specific and dual α4β1/α4β7 integrin antagonist. Carotegrast methyl prevents the development of colitis in mice[1]. <br/>	Free Base	C28H26Cl2N4O5	101245.0	DMSO : 100 mg/mL (175.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C([C@@H](NC(C1=C(C=CC=C1Cl)Cl)=O)CC2=CC=C(C=C2)N3C(N(C4=C(C3=O)C=C(C=C4)N(C)C)C)=O)OC	https://www.medchemexpress.com/carotegrast-methyl.html	Launched		91.0	AB22	A18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-124290	10.0	mM	18.0	DMSO	568.128025	18	A	pluskal_fda_drugs_5005_A18_id
1193	HY-111529A	HYCPK40905	B12	HYCPK40905	91z	168.0	4.0	D24	905.0	B12	106635-81-8	Tafenoquine (Succinate)	WR 238605 (Succinate)	581.58	Parasite	Anti-infection	Tafenoquine Succinate (WR 238605 Succinate) is an 8-aminoquinoline. Tafenoquine is an anti-malarial prophylactic agent[1].	Succinate	C28H34F3N3O7	64014.0	DMSO : 125 mg/mL (214.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)CCC(O)=O.CC(NC1=C2N=C(OC)C=C(C)C2=C(OC3=CC=CC(C(F)(F)F)=C3)C(OC)=C1)CCCN	https://www.medchemexpress.com/Tafenoquine_Succinate.html	Launched		91.0	D24	A18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-111529A	10.0	mM	18.0	DMSO	463.208276	18	A	pluskal_fda_drugs_5005_A18_id
210	HY-10201A	HYCPK40902	P12	HYCPK40902	91z	1463.0	1.0	AE23	902.0	P12	475207-59-1	Sorafenib (Tosylate)	Bay 43-9006 (Tosylate)	637.03	Apoptosis; Autophagy; Ferroptosis; FLT3; Raf; VEGFR	Apoptosis; Autophagy; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK	Sorafenib Tosylate (Bay 43-9006 Tosylate) is a potent and orally active Raf inhibitor with IC50s of 6 nM and 20 nM for Raf-1 and B-Raf, respectively. SorafenibTosylate is a multikinase inhibitor with IC50s of 90 nM, 15 nM, 20 nM, 57 nM and 58 nM for VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit, respectively. Sorafenib Tosylate induces autophagy and apoptosis. Sorafenib Tosylate has anti-tumor activity. Sorafenib Tosylate is a ferroptosis activator[1].	Tosylate	C28H24ClF3N4O6S	21053.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 31 mg/mL (48.66 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=S(C1=CC=C(C=C1)C)(O)=O.O=C(NC2=CC=C(C(C(F)(F)F)=C2)Cl)NC3=CC=C(OC4=CC(C(NC)=O)=NC=C4)C=C3	https://www.medchemexpress.com/Sorafenib-Tosylate.html	Launched		91.0	AE23	A19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10201A	10.0	mM	19.0	DMSO	464.086303	19	A	pluskal_fda_drugs_5005_A19_id
497	HY-B0430A	HYCPK40903	F08	HYCPK40903	91z	496.0	2.0	K16	903.0	F08	867-81-2	D-Pantothenic acid (sodium)	Sodium pantothenate; Vitamin B5 (sodium)	241.22	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	D-Pantothenic acid sodium (Sodium pantothenate) is an essential trace nutrient that functions as the obligate precursor of coenzyme A (CoA). D-Pantothenic acid sodium plays key roles in myriad biological processes, including many that regulate carbohydrate, lipid, protein, and nucleic acid metabolism[1].	Sodium	C9H16NNaO5	18632.0	H2O : 100 mg/mL (414.56 mM; Need ultrasonic); DMSO : 5 mg/mL (20.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	OCC(C)(C)[C@@H](O)C(NCCC(O[Na])=O)=O	https://www.medchemexpress.com/D-Pantothenic-acid-sodium.html	Launched		91.0	K16	A19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0430A	10.0	mM	19.0	DMSO	219.110673	19	A	pluskal_fda_drugs_5005_A19_id
567	HY-10844	HYCPK40903	H13	HYCPK40903	91z	698.0	2.0	O26	903.0	H13	187235-37-6	Pretomanid	PA-824; (S)-PA 824	359.26	Antibiotic; Bacterial	Anti-infection	Pretomanid (PA-824) is an antibiotic used for the research of multi-drug-resistant tuberculosis affecting the lungs. Pretomanid exhibits a sub-micromolar MIC against M. tuberculosis (MTB). The MIC values of PA-824 against a panel of MTB pan-sensitive and Rifampin mono-resistant clinical isolates range from 0.015 to 0.25?μg/mL[1].	Free Base	C14H12F3N3O5	64733.0	DMSO : 125 mg/mL (347.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	FC(F)(F)OC(C=C1)=CC=C1CO[C@@H]2COC3=NC([N+]([O-])=O)=CN3C2	https://www.medchemexpress.com/PA-824.html	Launched		91.0	O26	A19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10844	10.0	mM	19.0	DMSO	359.072905	19	A	pluskal_fda_drugs_5005_A19_id
636	HY-13680	HYCPK40903	B16	HYCPK40903	91z	128.0	2.0	C32	903.0	B16	97207-47-1	Meisoindigo	Dian III; N-Methylisoindigotin; Natura-α	276.29	Apoptosis	Apoptosis	Meisoindigo (Dian III), a derivative of Indirubin (HY-N0117), halts the cell cycle at the G0/G1 phase and induces apoptosis in primary acute myeloid leukemia (AML) cells. Meisoindigo exhibits high antitumor activity[1][2].	Free Base	C17H12N2O2	11353.0	DMSO : ≥ 51 mg/mL (184.59 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1N(C)C2=C(C=CC=C2)/C1=C3C(NC4=C\3C=CC=C4)=O	https://www.medchemexpress.com/Meisoindigo.html	Launched		91.0	C32	A19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13680	10.0	mM	19.0	DMSO	276.089878	19	A	pluskal_fda_drugs_5005_A19_id
666	HY-B0770	HYCPK40903	P17	HYCPK40903	91z	1474.0	2.0	AE34	903.0	P17	75887-54-6	Artemotil	β-Arteether; (+)-Arteether; Arteether	312.40	Parasite	Anti-infection	Artemotil (β-Arteether) has antimalarial activity for the treatment of chloroquine-resistant Plasmodium falciparum malaria with an IC50 of 1.61 nM. Artemotil also has central nervous system (CNS) neurotoxicity and anorectic toxicity  in rats, dogs and monkeys[1][2].	Free Base	C17H28O5	20367.0	DMSO : 50 mg/mL (160.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@@H]1[C@@](CC[C@@H](C)[C@]2([H])CC[C@]3(C)O4)([H])[C@@]2(OO3)[C@]4([H])O[C@@H]1OCC	https://www.medchemexpress.com/Artemotil.html	Launched		91.0	AE34	A19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0770	10.0	mM	19.0	DMSO	312.193674	19	A	pluskal_fda_drugs_5005_A19_id
767	HY-13685	HYCPK40904	O04	HYCPK40904	91z	1399.0	3.0	AD7	904.0	O04	58066-85-6	Miltefosine	HePC; Hexadecyl phosphocholine	407.57	Akt; HIV; Parasite	Anti-infection; PI3K/Akt/mTOR	Miltefosine is a broad spectrum antimicrobial, anti-leishmanial, phospholipid agent acting by inhibiting the PI3K/Akt activity[1][2][3][4]. Miltefosine is an inhibitor of CTP-phosphocholine cytidyltransferase (CCT)[5].	Free Base	C21H46NO4P	12122.0	H2O : 50 mg/mL (122.68 mM; Need ultrasonic); DMSO : 5 mg/mL (12.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=P(OCC[N+](C)(C)C)(OCCCCCCCCCCCCCCCC)[O-]	https://www.medchemexpress.com/Miltefosine.html	Launched		91.0	AD7	A19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13685	10.0	mM	19.0	DMSO	408.323722	19	A	pluskal_fda_drugs_5005_A19_id
1063	HY-D0227	HYCPK40905	P03	HYCPK40905	91z	1494.0	4.0	AF6	905.0	P03	77-86-1	Trometamol	Tromethamine	121.14	Others	Others	Trometamol (Tromethamine) is a biologically inert amino alcohol of low toxicity, which buffers carbon dioxide and acids in vitro and in vivo. Trometamol is an effective amine compound for pH control in the physiological range[1].	Free Base	C4H11NO3	25466.0	DMSO : ≥ 50 mg/mL (412.75 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	OCC(CO)(N)CO	https://www.medchemexpress.com/Tris.html	Launched		91.0	AF6	A19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0227	10.0	mM	19.0	DMSO	121.073893	19	A	pluskal_fda_drugs_5005_A19_id
1252	HY-14736	HYCPK40905	M15	HYCPK40905	91z	1230.0	4.0	Z30	905.0	M15	863031-21-4	Azilsartan medoxomil	TAK-491	568.53	Angiotensin Receptor	GPCR/G Protein	"Azilsartan medoxomil(TAK 491) is an orally administered angiotensin II receptor type 1 antagonist with IC50 of  0.62 nM, which used in the treatment of adults with essential hypertension. 
IC50 Value: 0.62 nM [2]
Target: AT1 receptor
in vitro: In aortic endothelial cells, azilsartan inhibited cell proliferation at concentrations as low as 1 μmol/l, whereas valsartan showed little or no antiproliferative effects at concentrations below 10 μmol/l. Antiproliferative effects of azilsartan were also observed in cells lacking AT1 receptors[1].
in vivo: Oral administration of 0.1-3 mg/kg olmesartan medoxomil reduced blood pressure; however, only the two highest doses significantly reduced blood pressure 24h after dosing. ED(25) values were 0.41 and 1.3 mg/kg for azilsartan medoxomil and olmesartan medoxomil, respectively [2]. Over a longer treatment period of 24 weeks, azilsartan medoxomil showed sustained BP-lowering efficacy, with the reduction in 24-hour mean SBP at week 24 significantly greater with azilsartan medoxomil 40 or 80 mg once daily than with valsartan 320 mg once daily. Mean reductions from baseline in mean clinic SBP and DBP as well as DBP by ABPM were also significantly greater with azilsartan medoxomil 40 or 80 mg once daily than with valsartan[3].  In 4 randomized controlled trials (3 published to date), azilsartan medoxomil/chlorthalidone 40 mg/12.5 mg and 40 mg/25 mg reduced blood pressure (BP) significantly more than comparators did, including an approximately 5-mm Hg greater BP reduction than olmesartan medoxomil/hydrochlorothiazide 40 mg/25 mg and azilsartan medoxomil/hydrochlorothiazide [4].
Clinical trial: Effect of Azilsartan on Aldosterone in Post-menopausal Females . Phase not specified"	Free Base	C30H24N4O8	43115.0	DMSO : 125 mg/mL (219.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C5=NC(ON5)=O)C=C3)=CC=C1)OCC6=C(C)OC(O6)=O	https://www.medchemexpress.com/azilsartan-medoxomil.html	Launched		91.0	Z30	A19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14736	10.0	mM	19.0	DMSO	568.159414	19	A	pluskal_fda_drugs_5005_A19_id
303	HY-W011602	HYCPK40902	G19	HYCPK40902	91z	613.0	1.0	M37	902.0	G19	77-93-0	Triethyl citrate		276.29	Others	Others	Triethyl citrate is an?ester?of?citric acid. Triethyl citrate can be?used as a?plasticizer?for cellulosic plastic-based nanocomposites[1].		C12H20O7	122584.0	DMSO : 100 mg/mL (361.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	OC(C(OCC)=O)(CC(OCC)=O)CC(OCC)=O	https://www.medchemexpress.com/triethyl-citrate.html	Launched		91.0	M37	A20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W011602	10.0	mM	20.0	DMSO	276.120903	20	A	pluskal_fda_drugs_5005_A20_id
486	HY-D0227A	HYCPK40903	K07	HYCPK40903	91z	974.0	2.0	U14	903.0	K07	1185-53-1	Trometamol (hydrochloride)	Tromethamine (hydrochloride)	157.60	Others	Others	Trometamol hydrochloride (Tromethamine hydrochloride) is a biologically inert amino alcohol of low toxicity, which buffers carbon dioxide and acids in vitro and in vivo. Trometamol hydrochloride is an effective amine compound for pH control in the physiological range[1].	Hydrochloride	C4H12ClNO3	67940.0	DMSO : 250 mg/mL (1586.29 mM; Need ultrasonic); H2O : 50 mg/mL (317.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	OCC(CO)(N)CO.[H]Cl	https://www.medchemexpress.com/trometamol-hydrochloride.html	Launched		91.0	U14	A20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0227A	10.0	mM	20.0	DMSO	121.073893	20	A	pluskal_fda_drugs_5005_A20_id
705	HY-B1664	HYCPK40903	A21	HYCPK40903	91z	42.0	2.0	A42	903.0	A21	96-83-3	Iopanoic acid		570.93	Others	Others	Iopanoic acid is an inhibitor of 5'-Deiodinase and also an iodinated contrast medium.	Free Acid	C11H12I3NO2	27399.0	DMSO : 100 mg/mL (175.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(O)C(CC)CC1=C(I)C=C(I)C(N)=C1I	https://www.medchemexpress.com/Iopanoic_acid.html	Launched		91.0	A42	A20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1664	10.0	mM	20.0	DMSO	570.800223	20	A	pluskal_fda_drugs_5005_A20_id
708	HY-17356	HYCPK40903	D21	HYCPK40903	91z	330.0	2.0	G42	903.0	D21	49562-28-9	Fenofibrate		360.83	Autophagy; Cytochrome P450; PPAR	Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Fenofibrate is a selective PPARα agonist with an EC50 of 30 μM. Fenofibrate also inhibits human cytochrome P450 isoforms, with IC50s of 0.2, 0.7, 9.7, 4.8 and 142.1 μM for CYP2C19, CYP2B6, CYP2C9, CYP2C8, and CYP3A4, respectively.	Free Base	C20H21ClO4	130985.0	DMSO : 250 mg/mL (692.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	CC(C)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C(OC(C)C)=O	https://www.medchemexpress.com/Fenofibrate.html	Launched		91.0	G42	A20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17356	10.0	mM	20.0	DMSO	360.112837	20	A	pluskal_fda_drugs_5005_A20_id
1042	HY-B0430	HYCPK40904	K22	HYCPK40904	91z	1051.0	3.0	V43	904.0	K22	79-83-4	D-Pantothenic acid	Pantothenate; Vitamin B5	219.23	Endogenous Metabolite	Metabolic Enzyme/Protease	D-Pantothenic acid (Pantothenate) is an essential trace nutrient that functions as the obligate precursor of coenzyme A (CoA). D-Pantothenic acid plays key roles in myriad biological processes, including many that regulate carbohydrate, lipid, protein, and nucleic acid metabolism[1].	Free Acid	C9H17NO5	233464.0	DMSO : 50 mg/mL (228.07 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Others	OCC(C)(C)[C@@H](O)C(NCCC(O)=O)=O	https://www.medchemexpress.com/d-pantothenic-acid.html	Launched		91.0	V43	A20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0430	10.0	mM	20.0	DMSO	219.110673	20	A	pluskal_fda_drugs_5005_A20_id
1056	HY-16725	HYCPK40905	I03	HYCPK40905	91z	822.0	4.0	R6	905.0	I03	1369764-02-2	Lemborexant	E-2006	410.42	Orexin Receptor (OX Receptor)	GPCR/G Protein; Neuronal Signaling	Lemborexant (E-2006) is a reversible, competitive and orally active dual antagonist of the orexin OX1 and OX2 receptors with IC50 values of 6.1 nM and 2.6 nM, respectively. Lemborexant can be treated insomnia[1].	Free Base	C22H20F2N4O2	16649.0	DMSO : 100 mg/mL (243.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C([C@H]1[C@@](C2=CC=CC(F)=C2)(COC3=CN=C(C)N=C3C)C1)NC4=NC=C(F)C=C4	https://www.medchemexpress.com/Lemborexant.html	Launched		91.0	R6	A20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16725	10.0	mM	20.0	DMSO	410.155432	20	A	pluskal_fda_drugs_5005_A20_id
1203	HY-B0071A	HYCPK40905	L12	HYCPK40905	91z	1128.0	4.0	X24	905.0	L12	107007-99-8	Granisetron (Hydrochloride)	BRL 43694A	348.87	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Granisetron (Hydrochloride) (BRL 43694A) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.	Hydrochloride	C18H25ClN4O	11792.0	H2O : 100 mg/mL (286.64 mM; Need ultrasonic); DMSO : 7.69 mg/mL (22.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CN1N=C(C(N[C@H]2C[C@H](N3C)CCC[C@H]3C2)=O)C4=CC=CC=C41.[H]Cl	https://www.medchemexpress.com/Granisetron-Hydrochloride.html	Launched		91.0	X24	A20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0071A	10.0	mM	20.0	DMSO	312.195011	20	A	pluskal_fda_drugs_5005_A20_id
1308	HY-70002	HYCPK40905	E19	HYCPK40905	91z	470.0	4.0	J38	905.0	E19	915087-33-1	Enzalutamide	MDV3100	464.44	Androgen Receptor; Autophagy	Autophagy; Others	Enzalutamide (MDV3100) is an androgen receptor (AR) antagonist with an IC50 of 36 nM in LNCaP prostate cells. Enzalutamide is an autophagy activator[1][2].	Free Base	C21H16F4N4O2S	87114.0	DMSO : ≥ 50 mg/mL (107.66 mM); H2O : ≥ 0.1 mg/mL (0.22 mM)	DMSO Solution	10mM  * 100uL	Cancer	S=C(N(C(C1(C)C)=O)C2=CC=C(C#N)C(C(F)(F)F)=C2)N1C3=CC(F)=C(C(NC)=O)C=C3	https://www.medchemexpress.com/Enzalutamide.html	Launched		91.0	J38	A20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-70002	10.0	mM	20.0	DMSO	464.09301	20	A	pluskal_fda_drugs_5005_A20_id
93	HY-17560	HYCPK40902	C05	HYCPK40902	91z	201.0	1.0	E9	902.0	C05	64-73-3	Demeclocycline (hydrochloride)		501.31	Antibiotic; Bacterial	Anti-infection	Demeclocycline hydrochloride is a tetracycline antibiotic; is an antibiotic in the treatment of Lyme disease, acne, and bronchitis.	Hydrochloride	C21H22Cl2N2O8	146810.0	H2O : 20 mg/mL (39.90 mM; Need ultrasonic and warming); DMSO : 100 mg/mL (199.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])[C@H](O)C4=C(C(C3=C(O)[C@@]21O)=O)C(O)=CC=C4Cl)N.Cl	https://www.medchemexpress.com/demeclocycline-hydrochloride.html	Launched		91.0	E9	A21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17560	10.0	mM	21.0	DMSO	464.098643	21	A	pluskal_fda_drugs_5005_A21_id
95	HY-17020A	HYCPK40902	E05	HYCPK40902	91z	393.0	1.0	I9	902.0	E05	210110-90-0	Miglustat (hydrochloride)	N-Butyldeoxynojirimycin (hydrochloride); NB-DNJ (hydrochloride); OGT 918 (hydrochloride)	255.74	Glucosylceramide Synthase (GCS)	Neuronal Signaling	Miglustat (N-Butyldeoxynojirimycin) hydrochloride is an orally active ceramide glucosyltransferase inhibitor. Miglustat hydrochloride can be used for the research of type I gaucher disease[1][2].	Hydrochloride	C10H22ClNO4	109622.0	H2O : ≥ 34 mg/mL (132.95 mM); DMSO : 65 mg/mL (254.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O[C@H]1[C@H](O)[C@@H](CO)N(CCCC)C[C@@H]1O.[H]Cl	https://www.medchemexpress.com/Miglustat-hydrochloride.html	Launched		91.0	I9	A21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17020A	10.0	mM	21.0	DMSO	219.147058	21	A	pluskal_fda_drugs_5005_A21_id
108	HY-109025	HYCPK40902	B06	HYCPK40902	91z	107.0	1.0	C11	902.0	B06	1985606-14-1	Baloxavir marboxil	S-033188	571.55	Influenza Virus	Anti-infection	Baloxavir marboxil (S-033188) is a selective inhibitor of influenza cap-dependent endonuclease. Baloxavir marboxil, a potent antiviral agent, shows activity against influenza A and B virus[1].	Free Base	C27H23F2N3O7S	45866.0	DMSO : 33.33 mg/mL (58.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C=C1)C(OCOC(OC)=O)=C2N1N([C@H]3C4=CC=C(F)C(F)=C4CSC5=CC=CC=C35)[C@@]6([H])N(CCOC6)C2=O	https://www.medchemexpress.com/Baloxavir_marboxil.html	Launched		91.0	C11	A21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109025	10.0	mM	21.0	DMSO	571.122478	21	A	pluskal_fda_drugs_5005_A21_id
267	HY-B0424	HYCPK40902	I16	HYCPK40902	91z	799.0	1.0	Q31	902.0	I16	39562-70-4	Nitrendipine	BAY-E-5009	360.36	Autophagy; Calcium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Nitrendipine (BAY-E-5009), an analogue of Nifedipine (HY-B0284), is a dihydropyridine calcium channel blocker with vasodilator action. Nitrendipine has antihypertensive effect[1][2][3][4].	Free Base	C18H20N2O6	16660.0	DMSO : 50 mg/mL (138.75 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OCC	https://www.medchemexpress.com/Nitrendipine.html	Launched		91.0	Q31	A21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0424	10.0	mM	21.0	DMSO	360.132136	21	A	pluskal_fda_drugs_5005_A21_id
550	HY-B0256	HYCPK40903	G12	HYCPK40903	91z	600.0	2.0	M24	903.0	G12	446-86-6	Azathioprine	BW 57-322	277.26	Apoptosis	Apoptosis	Azathioprine (BW 57-322) is an orally active immunosuppressive agent. Azathioprine can be converted in vivo to the active metabolite 6-mercaptopurine (6-MP). Azathioprine has myelosuppressive effects and induces apoptosis[1][3].	Free Base	C9H7N7O2S	15432.0	DMSO : 50 mg/mL (180.34 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.36 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CN1C(SC2=C3N=CNC3=NC=N2)=C([N+]([O-])=O)N=C1	https://www.medchemexpress.com/Azathioprine.html	Launched		91.0	M24	A21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0256	10.0	mM	21.0	DMSO	277.038193	21	A	pluskal_fda_drugs_5005_A21_id
785	HY-B0271	HYCPK40904	F06	HYCPK40904	91z	539.0	3.0	L11	904.0	F06	98-96-4	Pyrazinamide	Pyrazinecarboxamide; Pyrazinoic acid amide	123.11	Antibiotic; Autophagy; Bacterial	Anti-infection; Autophagy	Pyrazinamide?(Pyrazinecarboxamide; Pyrazinoic acid amide) is a potent and orally active antitubercular antibiotic. Pyrazinamide is a prodrug that is converted to the active form pyrazinoic acid (POA) by PZase/nicotinamidase encoded by the?pncA?gene in?M. tuberculosis[1][2].	Free Base	C5H5N3O	11969.0	DMSO : ≥ 50 mg/mL (406.14 mM); H2O : 6.67 mg/mL (54.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=NC=CN=C1)N	https://www.medchemexpress.com/pyrazinamide.html	Launched		91.0	L11	A21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0271	10.0	mM	21.0	DMSO	123.043262	21	A	pluskal_fda_drugs_5005_A21_id
1003	HY-17016	HYCPK40904	D20	HYCPK40904	91z	375.0	3.0	H39	904.0	D20	204255-11-8	Oseltamivir (phosphate)	GS 4104	410.40	Influenza Virus	Anti-infection	Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B.	Phosphate	C16H31N2O8P	85146.0	H2O : 100 mg/mL (243.66 mM; Need ultrasonic); DMSO : 100 mg/mL (243.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(OCC)C1=C[C@H]([C@@H]([C@H](C1)N)NC(C)=O)OC(CC)CC.OP(O)(O)=O	https://www.medchemexpress.com/Oseltamivir-phosphate.html	Launched		91.0	H39	A21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17016	10.0	mM	21.0	DMSO	312.204907	21	A	pluskal_fda_drugs_5005_A21_id
1333	HY-B1051	HYCPK40905	N20	HYCPK40905	91z	1336.0	4.0	AB40	905.0	N20	2135-17-3	Flumethasone	Flumetasone	410.45	Fungal	Anti-infection	Flumethasone is a corticosteroid for topical use, in combination with Clioquinol for the treatment of otitis externa and otomycosis. Flumethasone shows fully 420 times the potency of cortisone in an animal model for anti-inflammatory activity.	Free Base	C22H28F2O5	17616.0	DMSO : 100 mg/mL (243.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(CO)=O)(O)[C@H](C)C[C@@]1([H])[C@]3([H])C[C@H](F)C4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/Flumethasone.html	Launched		91.0	AB40	A21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1051	10.0	mM	21.0	DMSO	410.19048	21	A	pluskal_fda_drugs_5005_A21_id
77	HY-12279	HYCPK40902	F03	HYCPK40902	91z	485.0	1.0	K5	902.0	F03	1532533-67-7	Umbralisib	TGR-1202; RP5264	571.55	Casein Kinase; PI3K	Cell Cycle/DNA Damage; PI3K/Akt/mTOR; Stem Cell/Wnt	Umbralisib (TGR-1202) is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. Umbralisib exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib can be used for haematological malignancies reseach[1][2][3][4].	Free Base	C31H24F3N5O3	22812.0	DMSO : 100 mg/mL (174.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C(C2=CC=CC(F)=C2)=C([C@@H](N3N=C(C4=CC=C(OC(C)C)C(F)=C4)C5=C(N)N=CN=C53)C)OC6=CC=C(F)C=C16	https://www.medchemexpress.com/TGR-1202.html	Launched		91.0	K5	A22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12279	10.0	mM	22.0	DMSO	571.183124	22	A	pluskal_fda_drugs_5005_A22_id
343	HY-B1716	HYCPK40902	P22	HYCPK40902	91z	1483.0	1.0	AE43	902.0	P22	4350-09-8	L-5-Hydroxytryptophan	L-5-HTP; Oxitriptan	220.22	Endogenous Metabolite	Metabolic Enzyme/Protease	L-5-Hydroxytryptophan (L-5-HTP), a naturally occurring amino acid and a dietary supplement for use as an antidepressant, appetite suppressant, and sleep aid, is the immediate precursor of the neurotransmitter serotonin and a reserpine antagonist[1]. L-5-Hydroxytryptophan (L-5-HTP) is used to treat fibromyalgia, myoclonus, migraine, and cerebellar ataxia[2][3][4][5].	Free Acid	C11H12N2O3	27061.0	DMSO : 12.5 mg/mL (56.76 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	N[C@@H](CC1=CNC2=CC=C(O)C=C12)C(O)=O	https://www.medchemexpress.com/L-5-Hydroxytryptophan.html	Launched		91.0	AE43	A22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1716	10.0	mM	22.0	DMSO	220.084792	22	A	pluskal_fda_drugs_5005_A22_id
420	HY-B0257A	HYCPK40903	E09	HYCPK40903	91z	402.0	2.0	I18	903.0	E09	152-62-5	Dydrogesterone		312.45	Progesterone Receptor	Others	Dydrogesterone is a potent, orally active progestogen indicated in a wide variety of gynaecological conditions related to progesterone deficiency.	Free Base	C21H28O2	41968.0	DMSO : 33.33 mg/mL (106.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	CC([C@H]1CC[C@@]2([H])[C@]3([H])C=CC4=CC(CC[C@@]4(C)[C@]3([H])CC[C@]12C)=O)=O	https://www.medchemexpress.com/dydrogesterone.html	Launched		91.0	I18	A22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0257A	10.0	mM	22.0	DMSO	312.20893	22	A	pluskal_fda_drugs_5005_A22_id
441	HY-B1149A	HYCPK40903	N04	HYCPK40903	91z	1256.0	2.0	AA8	903.0	N04	37661-08-8	Bacampicillin (hydrochloride)		501.98	Antibiotic; Bacterial	Anti-infection	Bacampicillin hydrochloride is a penicillin antibiotic, is a prodrug of ampicillin with improved oral bioavailability.	Hydrochloride	C21H28ClN3O7S	155716.0	DMSO : 125 mg/mL (249.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC([C@H](N)C3=CC=CC=C3)=O)N1C2=O)OC(OC(OCC)=O)C.[H]Cl	https://www.medchemexpress.com/Bacampicillin-hydrochloride.html	Launched		91.0	AA8	A22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1149A	10.0	mM	22.0	DMSO	465.156971	22	A	pluskal_fda_drugs_5005_A22_id
508	HY-N1380	HYCPK40903	A09	HYCPK40903	91z	18.0	2.0	A18	903.0	A09	90-05-1	Guaiacol	2-Methoxyphenol	124.14	COX; Endogenous Metabolite; NF-κB	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Guaiacol, a phenolic compound, inhibits LPS-stimulated COX-2 expression and NF-κB activation[1]. Anti-inflammatory activity[1].	Free Base	C7H8O2	38554.0	DMSO : ≥ 100 mg/mL (805.54 mM); H2O : 37.5 mg/mL (302.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC1=CC=CC=C1OC	https://www.medchemexpress.com/Guaiacol.html	Launched		91.0	A18	A22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1380	10.0	mM	22.0	DMSO	124.052429	22	A	pluskal_fda_drugs_5005_A22_id
616	HY-B0506	HYCPK40903	N14	HYCPK40903	91z	1276.0	2.0	AA28	903.0	N14	124858-35-1	Nadifloxacin	OPC7251	360.38	Antibiotic; Bacterial	Anti-infection	"Nadifloxacin(OPC7251) is a topical fluoroquinolone antibiotic for the treatment of acne vulgaris. 
Target: Antibacterial
Nadifloxacin is a potent, broad-spectrum, quinolone agent approved for topical use in acne vulgaris and skin infections. Nadifloxacin inhibits the enzyme DNA gyrase that is involved in bacterial DNA synthesis and replication, thus inhibiting the bacterial multiplication. In vitro studies of nadifloxacin show potent and broad-spectrum antibacterial activity against aerobic Gram-positive, Gram-negative and anaerobic bacteria. Additionally, studies also suggest that the effectiveness of nadifloxacin in inflammatory acne lesions may be attributed to its inhibitory effect on pro-inflammatory cytokines like interleukin (IL)-1α, IL-6, and IL-8 which also play an important role in acne pathogenesis [1, 2]."	Free Acid	C19H21FN2O4	16866.0	H2O : 0.67 mg/mL (1.86 mM; Need ultrasonic); DMSO : 25 mg/mL (69.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN2C(C)CCC3=C2C(C1=O)=CC(F)=C3N4CCC(O)CC4)O	https://www.medchemexpress.com/nadifloxacin.html	Launched		91.0	AA28	A22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0506	10.0	mM	22.0	DMSO	360.148535	22	A	pluskal_fda_drugs_5005_A22_id
910	HY-B1152	HYCPK40904	C14	HYCPK40904	91z	267.0	3.0	F27	904.0	C14	3819-00-9	Piperacetazine		410.57	Others	Others	Piperacetazine is an antipsychotic prodrug, used forschizophrenia.	Free Base	C24H30N2O2S	26130.0	DMSO : ≥ 6 mg/mL (14.61 mM); Ethanol : 50 mg/mL (121.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(C(C=C1N2CCCN3CCC(CCO)CC3)=CC=C1SC4=C2C=CC=C4)=O	https://www.medchemexpress.com/Piperacetazine.html	Launched		91.0	F27	A22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1152	10.0	mM	22.0	DMSO	410.202799	22	A	pluskal_fda_drugs_5005_A22_id
965	HY-B1109	HYCPK40904	N17	HYCPK40904	91z	1329.0	3.0	AB33	904.0	N17	32795-44-1	N-Acetylprocainamide	Acecainide; NAPA	277.36	Drug Metabolite; Potassium Channel	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	N-Acetylprocainamide is a class III antiarrhythmic, which blocks K+ channels.	Free Base	C15H23N3O2	25897.0	DMSO : ≥ 100 mg/mL (360.54 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(NCCN(CC)CC)C1=CC=C(NC(C)=O)C=C1	https://www.medchemexpress.com/N-Acetylprocainamide.html	Launched		91.0	AB33	A22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1109	10.0	mM	22.0	DMSO	277.179027	22	A	pluskal_fda_drugs_5005_A22_id
132	HY-12279C	HYCPK40902	J07	HYCPK40902	91z	877.0	1.0	S13	902.0	J07	1532533-78-0	Umbralisib (hydrochloride)	TGR-1202 hydrochloride; RP5264 hydrochloride	608.01	Casein Kinase; PI3K	Cell Cycle/DNA Damage; PI3K/Akt/mTOR; Stem Cell/Wnt	Umbralisib (TGR-1202) hydrochloride is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. Umbralisib hydrochloride exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib hydrochloride can be used for haematological malignancies reseach[1][2][3][4].	Hydrochloride	C31H25ClF3N5O3	39614.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : ≥ 150 mg/mL (246.71 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C(C2=CC=CC(F)=C2)=C([C@@H](N3N=C(C4=CC=C(OC(C)C)C(F)=C4)C5=C(N)N=CN=C53)C)OC6=CC=C(F)C=C16.[H]Cl	https://www.medchemexpress.com/TGR-1202-hydrochloride.html	Launched		91.0	S13	B3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12279C	10.0	mM	27.0	DMSO	571.183124	3	B	pluskal_fda_drugs_5005_B3_id
353	HY-32735	HYCPK40903	J03	HYCPK40903	91z	870.0	2.0	S6	903.0	J03	38748-32-2	Triptolide	PG490	360.40	Apoptosis; NF-κB	Apoptosis; NF-κB	Triptolide is a diterpenoid triepoxide extracted from the root of Tripterygium wilfordii with immunosuppressive, anti-inflammatory, antiproliferative and antitumour effects. Triptolide is a NF-κB activation inhibitor[1][2][3][4][5][6].	Free Base	C20H24O6	217852.0	DMSO : ≥ 33 mg/mL (91.56 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	C[C@@]12[C@@]34[C@](O5)([C@@H]([C@](O6)(C(C)C)[C@@H]6[C@@H]3O4)O)[C@@H]5C[C@@]1([H])C7=C(C(OC7)=O)CC2	https://www.medchemexpress.com/Triptolide.html	Launched		91.0	S6	B3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-32735	10.0	mM	27.0	DMSO	360.157288	3	B	pluskal_fda_drugs_5005_B3_id
431	HY-B0527A	HYCPK40903	D04	HYCPK40903	91z	296.0	2.0	G8	903.0	D04	549-18-8	Amitriptyline (hydrochloride)		313.86	5-HT Receptor; Adrenergic Receptor; Histamine Receptor; mAChR; Serotonin Transporter; Sodium Channel; Trk Receptor	GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling; Protein Tyrosine Kinase/RTK	Amitriptyline hydrochloride is an inhibitor of serotonin reuptake transporter (SERT) and noradrenaline reuptake transporter (NET), with Kis of 3.45 nM and 13.3 nM for human SERT and NET, respectively. Amitriptyline hydrochloride also weakly binds to dopamine reuptake transporter (DAT) with a Ki of 2.58 μM. Amitriptyline hydrochloride also inhibits adrenergic, muscarinic, histamine and 5-HT receptors. Amitriptyline hydrochloride is a TrkA and TrkB receptors agonist with potent neurotrophic activity. Amitriptyline hydrochloride has antidepressant activity[1][2][3].	Hydrochloride	C20H24ClN	16279.0	H2O : ≥ 50 mg/mL (159.31 mM); DMSO : ≥ 100 mg/mL (318.61 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CN(C)CC/C=C1C2=CC=CC=C2CCC3=C\1C=CC=C3.Cl	https://www.medchemexpress.com/amitriptyline-hydrochloride.html	Launched		91.0	G8	B3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0527A	10.0	mM	27.0	DMSO	277.18305	3	B	pluskal_fda_drugs_5005_B3_id
455	HY-B0137	HYCPK40903	L05	HYCPK40903	91z	1066.0	2.0	W10	903.0	L05	721-50-6	Prilocaine		220.31	Na+/K+ ATPase	Membrane Transporter/Ion Channel	Prilocaine, an amino amide, is a Na, K-ATPase inhibitor. Prilocaine has neurotoxic effects[1][2].	Free Base	C13H20N2O	11685.0	H2O : 2.5 mg/mL (11.35 mM; Need ultrasonic); DMSO : 100 mg/mL (453.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(NCCC)C(NC1=CC=CC=C1C)=O	https://www.medchemexpress.com/prilocaine.html	Launched		91.0	W10	B3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0137	10.0	mM	27.0	DMSO	220.157563	3	B	pluskal_fda_drugs_5005_B3_id
802	HY-11018	HYCPK40904	G07	HYCPK40904	91z	637.0	3.0	N13	904.0	G07	106266-06-2	Risperidone	R 64 766	410.48	5-HT Receptor; Dopamine Receptor; P-glycoprotein	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Risperidone is a serotonin 5-HT2 receptor blocker, P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist, with Kis of 4.8, 5.9 nM for 5-HT2A and dopamine D2 receptor, respectively.	Free Base	C23H27FN4O2	17053.0	DMSO : 10 mg/mL (24.36 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1C(CCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)=C(C)N=C5N1CCCC5	https://www.medchemexpress.com/Risperidone.html	Launched		91.0	N13	B3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-11018	10.0	mM	27.0	DMSO	410.211804	3	B	pluskal_fda_drugs_5005_B3_id
1005	HY-14149	HYCPK40904	F20	HYCPK40904	91z	567.0	3.0	L39	904.0	F20	81098-60-4	Cisapride	R 51619; (±)-Cisaprid	465.95	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Cisapride is an orally and potent 5-HT4 receptor agonist and hERG inhibitor. Cisapride is an prokinetic agent which facilitates or restores motility throughout the length of the gastrointestinal tract. Cisapride stimulates gastrointestinal motor activity through an indirect mechanism involving the release of acetylcholine mediated by postganglionic nerve endings in the myenteric plexus of the gut[1][2].	Free Base	C23H29ClFN3O4	16680.0	DMSO : 100 mg/mL (214.62 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.21 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease	ClC1=C(N)C=C(OC)C(C(N[C@H]2[C@@H](OC)CN(CCCOC3=CC=C(F)C=C3)CC2)=O)=C1	https://www.medchemexpress.com/Cisapride.html	Launched		91.0	L39	B3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14149	10.0	mM	27.0	DMSO	465.183062	3	B	pluskal_fda_drugs_5005_B3_id
1228	HY-30270	HYCPK40905	E14	HYCPK40905	91z	460.0	4.0	J28	905.0	E14	150-76-5	Mequinol	4-Methoxyphenol	124.14	Others	Others	Mequinol (4-Methoxyphenol) is one of bioactive components in Mercurialis. Mequinol is used for skin depigmentation[1]	Free Base	C7H8O2	27069.0	H2O : ≥ 100 mg/mL (805.54 mM); DMSO : ≥ 100 mg/mL (805.54 mM)	DMSO Solution	10mM  * 100uL	Others	OC(C=C1)=CC=C1OC	https://www.medchemexpress.com/mequinol.html	Launched		91.0	J28	B3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-30270	10.0	mM	27.0	DMSO	124.052429	3	B	pluskal_fda_drugs_5005_B3_id
1260	HY-B0294	HYCPK40905	E16	HYCPK40905	91z	464.0	4.0	J32	905.0	E16	31430-15-6	Flubendazole		313.28	Apoptosis; Microtubule/Tubulin; Parasite	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Flubendazole is a safe and efficacious anthelmintic drug, which is widely used for anthelmintic to human, rodents and ruminants. Flubendazole exerts anticancer activities by mechanisms including inhibition of microtubule function. Flubendazole induces p53-mediated apoptosis and arrests G2/M cell cycle[1][2].	Free Base	C16H12FN3O3	16710.0	DMSO : 4.17 mg/mL (13.31 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(OC)NC1=NC2=CC=C(C(C3=CC=C(F)C=C3)=O)C=C2N1	https://www.medchemexpress.com/flubendazole.html	Launched		91.0	J32	B3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0294	10.0	mM	27.0	DMSO	313.086269	3	B	pluskal_fda_drugs_5005_B3_id
145	HY-N1214	HYCPK40902	K08	HYCPK40902	91z	975.0	1.0	U15	902.0	K08	111-02-4	Squalene	Super Squalene; trans-Squalene; AddaVax	410.72	Endogenous Metabolite; Fungal; Reactive Oxygen Species	Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Squalene is an intermediate product in the synthesis of cholesterol, and shows several pharmacological properties such as hypolipidemic, hepatoprotective, cardioprotective, antioxidant, and antitoxicant activity. Squalene also has anti-fungal activity and can be used for the research of Trichophyton mentagrophytes treatment[2].	Free Base	C30H50	36653.0	DMSO : 16.67 mg/mL (40.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cardiovascular Disease	C/C(C)=C\CC/C(C)=C/CC/C(C)=C/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)\C	https://www.medchemexpress.com/Squalene.html	Launched		91.0	U15	B4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1214	10.0	mM	28.0	DMSO	410.391252	4	B	pluskal_fda_drugs_5005_B4_id
388	HY-13803C	HYCPK40902	I09	HYCPK40902	91z	785.0	1.0	Q17	902.0	I09	1467052-75-0	Tazemetostat (hydrobromide)	EPZ-6438 (hydrobromide); E-7438 (hydrobromide)	653.65	Histone Methyltransferase	Epigenetics	Tazemetostat hydrobromide (EPZ-6438 hydrobromide) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat hydrobromide inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat hydrobromide inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat hydrobromide inhibits Rat EZH2 with an IC50 of 4 nM. Tazemetostat hydrobromide also inhibits EZH1 with an IC50 of 392 nM.	Hydrobromide	C34H45BrN4O4	158250.0	DMSO : 83.33 mg/mL (127.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC(C2=CC=C(CN3CCOCC3)C=C2)=CC(N(CC)C4CCOCC4)=C1C)NCC5=C(C)C=C(C)NC5=O.[H]Br	https://www.medchemexpress.com/tazemetostat-hydrobromide.html	Launched		91.0	Q17	B4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13803C	10.0	mM	28.0	DMSO	572.336256	4	B	pluskal_fda_drugs_5005_B4_id
721	HY-13733	HYCPK40903	A22	HYCPK40903	91z	44.0	2.0	A44	903.0	A22	366-70-1	Procarbazine (Hydrochloride)		257.76	DNA Alkylator/Crosslinker	Cell Cycle/DNA Damage	Procarbazine Hydrochloride is an orally active alkylating agent, with anticancer activity. Procarbazine Hydrochloride can be used in Hodgkin's disease research[1][2].	Hydrochloride	C12H20ClN3O	15404.0	DMSO : 16.67 mg/mL (64.67 mM; Need ultrasonic); H2O : 100 mg/mL (387.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC(C)C)C1=CC=C(CNNC)C=C1.Cl	https://www.medchemexpress.com/Procarbazine-Hydrochloride.html	Launched		91.0	A44	B4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13733	10.0	mM	28.0	DMSO	221.152812	4	B	pluskal_fda_drugs_5005_B4_id
841	HY-17461	HYCPK40904	N09	HYCPK40904	91z	1313.0	3.0	AB17	904.0	N09	53-06-5	Cortisone	17-Hydroxy-11-dehydrocorticosterone; Kendall's compound E	360.44	Endogenous Metabolite; Glucocorticoid Receptor	Immunology/Inflammation; Metabolic Enzyme/Protease	Cortisone (17-Hydroxy-11-dehydrocorticosterone), an oxidized metabolite of Cortisol (a Glucocorticoid). Cortisone acts as an immunosuppressant and anti-inflammatory agent. Cortisone can partially intervene in binding of Glucocorticoid to Glucocorticoid-receptor at high concentrations[1][3][4].	Free Base	C21H28O5	95676.0	DMSO : 100 mg/mL (277.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	C[C@@]1(C2)[C@](C(CO)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])C2=O)=O	https://www.medchemexpress.com/Cortisone.html	Launched		91.0	AB17	B4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17461	10.0	mM	28.0	DMSO	360.193674	4	B	pluskal_fda_drugs_5005_B4_id
1019	HY-17374	HYCPK40904	D21	HYCPK40904	91z	377.0	3.0	H41	904.0	D21	22457-89-2	Benfotiamine	S-Benzoylthiamine O-monophosphate	466.45	Others	Others	Benfotiamine (S-Benzoylthiamine O-monophosphate) is an analog of vitamin B1 with higher absorption and bioavailability than vitamin B1, and is commonly used as a food supplement for diabetic complications. Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage[1][2].	Free Acid	C19H23N4O6PS	7340.0	H2O : 0.67 mg/mL (1.44 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (107.19 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC1=NC=C(CN(/C(C)=C(CCOP(O)(O)=O)/SC(C2=CC=CC=C2)=O)C=O)C(N)=N1	https://www.medchemexpress.com/benfotiamine.html	Launched		91.0	H41	B4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17374	10.0	mM	28.0	DMSO	466.107592	4	B	pluskal_fda_drugs_5005_B4_id
1134	HY-B0196A	HYCPK40905	G08	HYCPK40905	91z	640.0	4.0	N16	905.0	G08	99300-78-4	Venlafaxine (hydrochloride)	Wy 45030 hydrochloride	313.86	Serotonin Transporter	Neuronal Signaling	Venlafaxine hydrochloride (Wy 45030 hydrochloride) is an orally active, potent serotonin (5-HT)/norepinephrine (NE) reuptake dual inhibitor. Venlafaxine is an antidepressant[1].	Hydrochloride	C17H28ClNO2	15321.0	H2O : ≥ 100 mg/mL (318.61 mM); DMSO : 50 mg/mL (159.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	OC1(C(C2=CC=C(OC)C=C2)CN(C)C)CCCCC1.Cl	https://www.medchemexpress.com/Venlafaxine-hydrochloride.html	Launched		91.0	N16	B4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0196A	10.0	mM	28.0	DMSO	277.204179	4	B	pluskal_fda_drugs_5005_B4_id
1165	HY-107795	HYCPK40905	F10	HYCPK40905	91z	548.0	4.0	L20	905.0	F10	5003-48-5	Benorilate	Salipran	313.30	Prostaglandin Receptor	GPCR/G Protein	Benorylate (Salipran) is the esterification product of paracetamol and acetylsalicylic acid. Benorylate has anti-inflammatory, analgesic and antipyretic properties. Benorylate could also inhibit prostaglandin (PG) synthesis[1][2][3][4].	Free Base	C17H15NO5	37142.0	DMSO : 125 mg/mL (398.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(OC1=CC=C(NC(C)=O)C=C1)C2=CC=CC=C2OC(C)=O	https://www.medchemexpress.com/Benorilate.html	Launched		91.0	L20	B4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107795	10.0	mM	28.0	DMSO	313.095023	4	B	pluskal_fda_drugs_5005_B4_id
1328	HY-B2115	HYCPK40905	I20	HYCPK40905	91z	856.0	4.0	R40	905.0	I20	1321-14-8	Sulfogaiacol		242.29	Bacterial	Anti-infection	Sulfogaiacol is a antitussive agent. Sulfogaiacol is used for acute respiratory tract infections, cough and other conditions.	Potassium	C7H7O5S.K	26079.0	H2O : ≥ 50 mg/mL (206.36 mM); DMSO : 50 mg/mL (206.36 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC1=CC=CC=C1OC.O=S(C)(O[K])=O	https://www.medchemexpress.com/Sulfogaiacol.html	Launched		91.0	R40	B4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2115	10.0	mM	28.0	DMSO	124.052429	4	B	pluskal_fda_drugs_5005_B4_id
317	HY-A0096	HYCPK40902	E20	HYCPK40902	91z	423.0	1.0	I39	902.0	E20	78919-13-8	Iloprost	Ciloprost; ZK 36374	360.49	Endogenous Metabolite; Prostaglandin Receptor	GPCR/G Protein; Metabolic Enzyme/Protease	Iloprost (ZK 36374; Ciloprost) is a prostacyclin (PGI2) analogue, involves in embryo development and inflammation improvement, and inhibits tumor metastasis. Iloprost can be used for peripheral vascular research[1][2][3][4].	Free Acid	C22H32O4	20557.0	DMSO : 100 mg/mL (277.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C(O)CCC/C=C1C[C@@]2([H])C[C@@H](O)[C@H](/C=C/[C@@H](O)C(C)CC#CC)[C@@]2([H])C\1	https://www.medchemexpress.com/Iloprost.html	Launched		91.0	I39	B5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0096	10.0	mM	29.0	DMSO	360.23006	5	B	pluskal_fda_drugs_5005_B5_id
348	HY-B0429	HYCPK40903	E03	HYCPK40903	91z	390.0	2.0	I6	903.0	E03	15500-66-0	Pancuronium (dibromide)		732.67	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Pancuronium dibromide, a bis-quaternary steroid, is a neuromuscular relaxant. Pancuronium dibromide inhibits neuromuscular transmission by competing with acetylcholine for binding sites on nACh receptors. Pancuronium dibromide also inhibits cardiac muscarinic receptors and has a sympathomimetic action[1][2][3].	Bromide	C35H60Br2N2O4	15897.0	H2O : 100 mg/mL (136.49 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (136.49 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+]1([C@@H]2[C@@H](OC(C)=O)C[C@@](CC[C@]3([H])[C@]4([H])CC[C@@]5(C)[C@@]3([H])C[C@H]([N+]6(C)CCCCC6)[C@@H]5OC(C)=O)([H])[C@]4(C)C2)CCCCC1.[Br-].[Br-]	https://www.medchemexpress.com/Pancuronium-dibromide.html	Launched		91.0	I6	B5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0429	10.0	mM	29.0	DMSO	572.454211	5	B	pluskal_fda_drugs_5005_B5_id
650	HY-B0782	HYCPK40903	P16	HYCPK40903	91z	1472.0	2.0	AE32	903.0	P16	59-66-5	Acetazolamide		222.25	Autophagy; Bacterial; Carbonic Anhydrase	Anti-infection; Autophagy; Metabolic Enzyme/Protease	Acetazolamide is a carbonic anhydrase (CA) IX inhibitor with an IC50 of 30 nM for hCA IX. Acetazolamide has diuretic, antihypertensive and anti-gonococcal activities[1][4][5][6].	Free Base	C4H6N4O3S2	14423.0	DMSO : 50 mg/mL (224.97 mM; Need ultrasonic); H2O : 1 mg/mL (4.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	CC(NC1=NN=C(S(=O)(N)=O)S1)=O	https://www.medchemexpress.com/Acetazolamide.html	Launched		91.0	AE32	B5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0782	10.0	mM	29.0	DMSO	221.988132	5	B	pluskal_fda_drugs_5005_B5_id
796	HY-14560C	HYCPK40904	A07	HYCPK40904	91z	61.0	3.0	B13	904.0	A07	98769-84-7	Reboxetine (mesylate)	FCE20124 mesylate; PNU155950E mesylate	409.50	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Reboxetine mesylate (FCE20124 mesylate) is a potent, selective, and specific noradrenaline reuptake inhibitor (NARI) for the research of depression. Reboxetine mesylate inhibits the uptake of norepinephrine, with a Ki of 8 nM[1].	Mesylate	C20H27NO6S	60030.0	H2O : 50 mg/mL (122.10 mM; Need ultrasonic); DMSO : 125 mg/mL (305.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CS(=O)(O)=O.CCOC1=C(C=CC=C1)O[C@]([C@@]2([H])CNCCO2)([H])C3=CC=CC=C3.[relative stereochemistry]	https://www.medchemexpress.com/reboxetine-mesylate.html	Launched		91.0	B13	B5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14560C	10.0	mM	29.0	DMSO	313.167794	5	B	pluskal_fda_drugs_5005_B5_id
972	HY-13600	HYCPK40904	E18	HYCPK40904	91z	467.0	3.0	J35	904.0	E18	25122-46-7	Clobetasol propionate		466.97	Cytochrome P450	Metabolic Enzyme/Protease	Clobetasol propionate is a potent and selective CYP3A5 inhibitor with an IC50 of 0.206 μM. Clobetasol propionate has no inhibiting on CYP3A4 or other major CYPs. Clobetasol propionate is a corticosteroid and has the potential for psoriasis and other dermatoses research[1][2][3].	Free Base	C25H32ClFO5	15251.0	DMSO : ≥ 100 mg/mL (214.15 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]12[C@](C(CCl)=O)(OC(CC)=O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/Clobetasol-propionate.html	Launched		91.0	J35	B5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13600	10.0	mM	29.0	DMSO	466.19223	5	B	pluskal_fda_drugs_5005_B5_id
1121	HY-B1262	HYCPK40905	J07	HYCPK40905	91z	926.0	4.0	T14	905.0	J07	5714-00-1	Acetophenazine (dimaleate)		643.70	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Acetophenazine dimaleate, a phenothiazine derivative, is an antipsychotic agent. Acetophenazine dimaleate primarily blocks dopamine D2 receptors in the brain. Acetophenazine dimaleate can be used for researching psychotic disorders such as schizophrenia and anxious depression[1][2].	Maleate	C31H37N3O10S	109710.0	DMSO : 125 mg/mL (194.19 mM; Need ultrasonic); H2O : 8.33 mg/mL (12.94 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(C(C=C1N2CCCN3CCN(CCO)CC3)=CC=C1SC4=C2C=CC=C4)=O.O=C(O)/C=C\C(O)=O.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Acetophenazine_dimaleate.html	Launched		91.0	T14	B5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1262	10.0	mM	29.0	DMSO	411.198048	5	B	pluskal_fda_drugs_5005_B5_id
1288	HY-108017	HYCPK40905	A18	HYCPK40905	91z	84.0	4.0	B36	905.0	A18	33725-54-1	Ferric maltol		431.15	Others	Others	Ferric maltol is an orally active complex of a single ferric ion (Fe3+). Ferric maltol has tha potential for iron deficiency anemia treatment in inflammatory bowel disease[1].		C18H15FeO9	98940.0	DMSO : 12.5 mg/mL (28.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	CC1=C2[O-][Fe+3]([O-]C3=C4C)([O-]C5=C6C)(O=C5C=CO6)(O=C3C=CO4)O=C2C=CO1	https://www.medchemexpress.com/ferric-maltol.html	Launched		91.0	B36	B5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108017	10.0	mM	29.0	DMSO	126.031694	5	B	pluskal_fda_drugs_5005_B5_id
1297	HY-B1784	HYCPK40905	J18	HYCPK40905	91z	948.0	4.0	T36	905.0	J18	515-64-0	Sulfisomidin	Sulfaisodimidine	278.33	Antibiotic; Bacterial	Anti-infection	Sulfisomidin (Sulfaisodimidine) is an orally active short-acting sulfonamide antibacterial. Sulfisomidin can be used for the research of lower urinary tract infections[1][2].	Free Base	C12H14N4O2S	26146.0	DMSO : ≥ 30 mg/mL (107.79 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC(C)=NC(C)=C2)=O	https://www.medchemexpress.com/Sulfisomidin.html	Launched		91.0	T36	B5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1784	10.0	mM	29.0	DMSO	278.083747	5	B	pluskal_fda_drugs_5005_B5_id
540	HY-13055	HYCPK40903	M11	HYCPK40903	91z	1174.0	2.0	Y22	903.0	M11	1137608-69-5	Telotristat etiprate	LX1606 (Hippurate)	754.15	Tryptophan Hydroxylase	Metabolic Enzyme/Protease	Telotristat etiprate (LX1606 Hippurate) is a novel, orally-delivered inhibitor of tryptophan hydroxylase that reduces serotonin production.	Hippurate	C36H35ClF3N7O6	15042.0	DMSO : ≥ 28 mg/mL (37.13 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C([C@H](CC1=CC=C(C=C1)C2=CC(O[C@H](C3=C(C=C(C=C3)Cl)N4C=CC(C)=N4)C(F)(F)F)=NC(N)=N2)N)OCC.O=C(C5=CC=CC=C5)NCC(O)=O	https://www.medchemexpress.com/LX1606-Hippurate.html	Launched		91.0	Y22	B6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13055	10.0	mM	30.0	DMSO	574.170701	6	B	pluskal_fda_drugs_5005_B6_id
574	HY-B0782A	HYCPK40903	F19	HYCPK40903	91z	518.0	2.0	K38	903.0	F19	1424-27-7	Acetazolamide (sodium)		245.24	Autophagy; Bacterial; Carbonic Anhydrase	Anti-infection; Autophagy; Metabolic Enzyme/Protease	Acetazolamide sodium is a carbonic anhydrase (CA) IX inhibitor with an IC50 of 30 nM for hCA IX. Acetazolamide sodium has diuretic, antihypertensive and anti-gonococcal activities[1][4][5][6].	Sodium	C4H6N4NaO3S2	217715.0	DMSO : 100 mg/mL (407.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Metabolic Disease	CC(NC1=NN=C(S(=O)(N)=O)S1)=O.[Na]	https://www.medchemexpress.com/acetazolamide-sodium.html	Launched		91.0	K38	B6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0782A	10.0	mM	30.0	DMSO	221.988132	6	B	pluskal_fda_drugs_5005_B6_id
629	HY-B0955	HYCPK40903	K15	HYCPK40903	91z	990.0	2.0	U30	903.0	K15	126-27-2	Oxethazaine	Oxetacaine	467.64	HBV	Anti-infection	Oxethazaine (Oxetacaine), a precursor of phentermine?acidic,  is an acid-resistent and orally active analgesic agent. Oxethazaine (Oxetacaine) has the potential for the relief of pain associated with?peptic ulcer disease?or?esophagitis[1].	Free Base	C28H41N3O3	26818.0	DMSO : ≥ 50 mg/mL (106.92 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	OCCN(CC(N(C(C)(C)CC1=CC=CC=C1)C)=O)CC(N(C(C)(C)CC2=CC=CC=C2)C)=O	https://www.medchemexpress.com/Oxethazaine.html	Launched		91.0	U30	B6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0955	10.0	mM	30.0	DMSO	467.314792	6	B	pluskal_fda_drugs_5005_B6_id
753	HY-B1805	HYCPK40904	A04	HYCPK40904	91z	55.0	3.0	B7	904.0	A04	101-20-2	Triclocarban	3,4,4′-Trichlorocarbanilide	315.58	Bacterial	Anti-infection	Triclocarban (3,4,4′-Trichlorocarbanilide), a broad spectrum antibacterial compound, is widely used in a broad range of applications such as the production of soaps, skin creams, toothpastes and deodorants. Triclocarban is a potential endocrine-disrupting chemical with the capacity to modulate androgen and estrogen activities as well as other hormone-mediated biological processes[1][2][3].	Free Base	C13H9Cl3N2O	26352.0	DMSO : 100 mg/mL (316.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	ClC1=CC=C(C=C1)NC(NC2=CC=C(C(Cl)=C2)Cl)=O	https://www.medchemexpress.com/Triclocarban.html	Launched		91.0	B7	B6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1805	10.0	mM	30.0	DMSO	313.978046	6	B	pluskal_fda_drugs_5005_B6_id
926	HY-B0572	HYCPK40904	C15	HYCPK40904	91z	269.0	3.0	F29	904.0	C15	13463-41-7	Zinc Pyrithione		317.69	Bacterial; Fungal; Proton Pump	Anti-infection; Membrane Transporter/Ion Channel	Zinc Pyrithione is an antifungal and antibacterial agent disrupting membrane transport by blocking the proton pump[1]. Zinc Pyrithione is also a copper ionophore that delivers copper into cells and is a useful tool for studying cuproptosis[2].	Free Base	C10H8N2O2S2Zn	16659.0	H2O : 0.1 mg/mL (0.31 mM; Need ultrasonic); DMSO : 33.33 mg/mL (104.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Metabolic Disease	N12[O-][Zn+2]3([S]=C1C=CC=C2)[O-]N(C=CC=C4)C4=[S]3	https://www.medchemexpress.com/zinc-pyrithione.html	Launched		91.0	F29	B6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0572	10.0	mM	30.0	DMSO	127.009185	6	B	pluskal_fda_drugs_5005_B6_id
1099	HY-B2191	HYCPK40905	D06	HYCPK40905	91z	348.0	4.0	H12	905.0	D06	6223-35-4	Sodium gualenate	Guaiazulenesulfonate sodium	300.35	Others	Others	Sodium gualenate (Guaiazulenesulfonate sodium) is a hydrophilic derivative of guaiazulene with excellent anti-inflammatory and wound-healing effects mainly used for the treatment of duodenal ulcer, gastric ulcer and gastritis.	Sodium	C15H17NaO3S	26787.0	DMSO : 30 mg/mL (99.88 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=S(C1=C2C(C)=CC=C(C(C)C)C=C2C(C)=C1)(O[Na])=O	https://www.medchemexpress.com/Sodium_gualenate.html	Launched		91.0	H12	B6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2191	10.0	mM	30.0	DMSO	278.097665	6	B	pluskal_fda_drugs_5005_B6_id
1153	HY-15407A	HYCPK40905	J09	HYCPK40905	91z	930.0	4.0	T18	905.0	J09	1369773-39-6	Sacubitril hemicalcium salt	AHU-377 (hemicalcium salt)	430.52	Neprilysin	Metabolic Enzyme/Protease	Sacubitril hemicalcium salt (AHU-377 hemicalcium salt) is a potent NEP inhibitor with an IC50 of 5 nM. Sacubitril hemicalcium salt is a component of the heart failure medicine LCZ696.	Calcium	C24H28Ca0.5NO5	45796.0	DMSO : 125 mg/mL (290.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(CCC([O-])=O)N[C@H](CC1=CC=C(C2=CC=CC=C2)C=C1)C[C@@H](C)C(OCC)=O.[0.5Ca2+]	https://www.medchemexpress.com/AHU-377-hemicalcium-salt.html	Launched		91.0	T18	B6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15407A	10.0	mM	30.0	DMSO	411.204573	6	B	pluskal_fda_drugs_5005_B6_id
1237	HY-16726	HYCPK40905	N14	HYCPK40905	91z	1324.0	4.0	AB28	905.0	N14	301692-76-2	Polmacoxib	CG100649	361.39	Carbonic Anhydrase; COX	Immunology/Inflammation; Metabolic Enzyme/Protease	Polmacoxib (CG100649) is a first-in-class, orally active nonsteroidal anti-inflammatory drug (NSAID) which is a dual inhibitor of COX-2 (IC50 around 0.1 μg/ml) and carbonic anhydrase[1]. Polmacoxib inhibits colorectal adenoma and tumor growth in mouse models[2].		C18H16FNO4S	117485.0	DMSO : 250 mg/mL (691.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=S(C1=CC=C(C(OC2(C)C)=C(C3=CC=CC(F)=C3)C2=O)C=C1)(N)=O	https://www.medchemexpress.com/polmacoxib.html	Launched		91.0	AB28	B6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16726	10.0	mM	30.0	DMSO	361.078407	6	B	pluskal_fda_drugs_5005_B6_id
72	HY-12542	HYCPK40902	A03	HYCPK40902	91z	5.0	1.0	A5	902.0	A03	7261-97-4	Dantrolene	F 368	314.25	Others	Others	Dantrolene (F368), a muscle relaxant, non-competitively inhibits human erythrocyte glutathione reductase. Ki and IC50 values are 111.6 μM and 52.3 μM, respectively. Dantrolene is a ryanodine receptor antagonist and Ca2+ signaling stabilizer. Dantrolene can be used for the research of muscle spasticity, malignant hyperthermia, Huntington's disease and other neuroleptic malignant syndrome[1][2][3][4][5].		C14H10N4O5	178727.0	DMSO : ≥ 20 mg/mL (63.64 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	O=C1NC(CN1/N=C/C2=CC=C(C3=CC=C([N+]([O-])=O)C=C3)O2)=O	https://www.medchemexpress.com/dantrolene.html	Launched		91.0	A5	B7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12542	10.0	mM	31.0	DMSO	314.065119	7	B	pluskal_fda_drugs_5005_B7_id
162	HY-B0139	HYCPK40902	P09	HYCPK40902	91z	1457.0	1.0	AE17	902.0	P09	2022-85-7	Flucytosine	5-Fluorocytosine; NSC 103805; Ro 2-9915	129.09	Antibiotic; Fungal	Anti-infection	"Flucytosine (5-Fluorocytosine, 5-FC, Ancobon), a fluorinated pyrimidine analogue, is an antifungal drug.
Target: antifungal
Flucytosine, or 5-fluorocytosine, a fluorinated pyrimidine analogue, is a synthetic antimycotic drug. It is structurally related to the cytostatic fluorouracil and to floxuridine. It is available in oral and in some countries also in injectable form. A common brand name is Ancobon. Flucytosine was first synthesized in 1957 but its antifungal properties were discovered in 1964. The drug is dispensed in capsules of 250 mg and 500 mg strength. The injectable form is diluted in 250 mL saline solution to contain 2.5 g total (10 mg/mL). The solution is physically incompatible with other drugs including amphotericin B.
Flucytosine is well absorbed (75 to 90%) from the gastrointestinal tract. Intake with meals slows the absorption, but does not decrease the amount absorbed. Following an oral dose of 2 grams peak serum levels are reached after approximately 6 hours. The time to peak level decreases with continued therapy. After 4 days peak levels are measured after 2 hours. The drug is eliminated renally. In normal patients flucytosine has reportedly a half-life of 2.5 to 6 hours. In patients with impaired renal function higher serum levels are seen and the drug tends to cumulate in these patients. The drug is mainly excreted unchanged in the urine (90% of an oral dose) and only traces are metabolized and excreted in the feces. Therapeutic serum levels range from 25 to 100  g/ml. Serum levels in excess of 100 ug are associated with a higher incidence of side effects. Periodic measurements of serum levels are recommended for all patients and are a must in patients with renal damage."	Free Base	C4H4FN3O	15279.0	DMSO : 16.67 mg/mL (129.13 mM; Need ultrasonic); H2O : 6.67 mg/mL (51.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1NC=C(F)C(N)=N1	https://www.medchemexpress.com/Flucytosine.html	Launched		91.0	AE17	B7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0139	10.0	mM	31.0	DMSO	129.03384	7	B	pluskal_fda_drugs_5005_B7_id
253	HY-B0768A	HYCPK40902	K15	HYCPK40902	91z	989.0	1.0	U29	902.0	K15	101477-54-7	Lomerizine dihydrochloride	KB-2796	541.46	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Lomerizine dihydrochloride is an antagonist of L- and T-type voltagegated calcium channels.	Hydrochloride	C27H32Cl2F2N2O3	29691.0	DMSO : 125 mg/mL (230.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	COC1=CC=C(CN2CCN(C(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)CC2)C(OC)=C1OC.[H]Cl.[H]Cl	https://www.medchemexpress.com/Lomerizine_dihydrochloride.html	Launched		91.0	U29	B7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0768A	10.0	mM	31.0	DMSO	468.222449	7	B	pluskal_fda_drugs_5005_B7_id
278	HY-B0717	HYCPK40902	D17	HYCPK40902	91z	321.0	1.0	G33	902.0	D17	9002-96-4	Tocofersolan	TPGS; D-α-Tocopherol polyethylene glycol 1000 succinate; Vitamin E-TPGS	1513.00	Others	Others	Tocofersolan is synthetic polyethylene glycol derivative of α-tocopherol. Tocofersolan is an orally active and water-soluble analog of vitamin E. Tocofersolan can reduce neurobehavioral deficits in zebrafish embryos exposed to moderate and high concentrations of BaP during early development. Tocofersolan shows antioxidant activity. Tocofersolan can be used to provide an orally bioavailable source of vitamin E[1][2][3].	Free Base		19575.0	DMSO : 100 mg/mL (66.09 mM; Need ultrasonic); Ethanol : 50 mg/mL (33.05 mM; Need ultrasonic); H2O : 100 mg/mL (66.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	CC1=C(CCC(CCCC(C)CCCC(C)CCCC(C)C)(C)O2)C2=C(C)C(C)=C1OC(CCC(OCCO)=O)=O.[n]	https://www.medchemexpress.com/Tocofersolan.html	Launched		91.0	G33	B7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0717	10.0	mM	31.0	DMSO	574.42334	7	B	pluskal_fda_drugs_5005_B7_id
306	HY-B2113	HYCPK40902	J19	HYCPK40902	91z	901.0	1.0	S37	902.0	J19	496-67-3	Bromisoval	Bromovalerylurea	223.07	Others	Others	Bromisoval has anti-inflammatory effects.	Free Base	C6H11BrN2O2	26355.0	DMSO : 300 mg/mL (1344.87 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	CC(C)C(Br)C(NC(N)=O)=O	https://www.medchemexpress.com/Bromisoval.html	Launched		91.0	S37	B7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2113	10.0	mM	31.0	DMSO	222.00039	7	B	pluskal_fda_drugs_5005_B7_id
407	HY-13801	HYCPK40902	G21	HYCPK40902	91z	617.0	1.0	M41	902.0	G21	59729-37-2	Fexinidazole	HOE 239	279.31	Parasite	Anti-infection	Fexinidazole (HOE 239) is an orally active, potent nitroimidazole antitrypanosomal drug. Fexinidazole shows  trypanocidal activity against T. brucei subspecies and strains with IC50s of 0.7-3.3 μM (0.2-0.9 μg/ml). Fexinidazol has the potential for human sleeping sickness (HAT) caused by infection with T. brucei[1].	Free Base	C12H13N3O3S	20279.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 50 mg/mL (179.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=[N+](C1=CN=C(COC2=CC=C(SC)C=C2)N1C)[O-]	https://www.medchemexpress.com/Fexinidazole.html	Launched		91.0	M41	B7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13801	10.0	mM	31.0	DMSO	279.067762	7	B	pluskal_fda_drugs_5005_B7_id
554	HY-B0637	HYCPK40903	K12	HYCPK40903	91z	984.0	2.0	U24	903.0	K12	41859-67-0	Bezafibrate	BM15075	361.82	PPAR	Cell Cycle/DNA Damage	Bezafibrate is an agonist of PPAR, with EC50s of 50 μM, 60 μM, 20 μM for human PPARα, PPARγ and PPARδ, and 90 μM, 55 μM, 110 μM for murine PPARα, PPARγ and PPARδ, respectively; Bezafibrate is used as an hypolipidemic agent.	Free Acid	C19H20ClNO4	56902.0	DMSO : ≥ 50 mg/mL (138.19 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	CC(C)(OC1=CC=C(CCNC(C2=CC=C(Cl)C=C2)=O)C=C1)C(O)=O	https://www.medchemexpress.com/Bezafibrate.html	Launched		91.0	U24	B7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0637	10.0	mM	31.0	DMSO	361.108086	7	B	pluskal_fda_drugs_5005_B7_id
890	HY-14896	HYCPK40904	O12	HYCPK40904	91z	1415.0	3.0	AD23	904.0	O12	923287-50-7	Opicapone	BIA 9-1067	413.17	COMT	Metabolic Enzyme/Protease; Neuronal Signaling	Opicapone (BIA 9-1067) is a potent third-generation catechol-O-methyltransferase (COMT) inhibitor for the research of Parkinson's disease and motor fluctuations. Opicapone decreases the ATP content of the cells with an IC50 of 98 μM[1].	Free Base	C15H10Cl2N4O6	12642.0	DMSO : 100 mg/mL (242.03 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC1=[N+]([O-])C(Cl)=C(C2=NOC(C3=CC([N+]([O-])=O)=C(O)C(O)=C3)=N2)C(C)=C1Cl	https://www.medchemexpress.com/opicapone.html	Launched		91.0	AD23	B7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14896	10.0	mM	31.0	DMSO	411.997739	7	B	pluskal_fda_drugs_5005_B7_id
79	HY-B0330	HYCPK40902	H03	HYCPK40902	91z	677.0	1.0	O5	902.0	H03	100986-85-4	Levofloxacin	(-)-Ofloxacin	361.37	Antibiotic; Bacterial; DNA/RNA Synthesis; Orthopoxvirus; Topoisomerase	Anti-infection; Cell Cycle/DNA Damage	Levofloxacin ((-)-Ofloxacin) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin inhibits the DNA gyrase and topoisomerase IV.  Levofloxacin can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin shows anti-orthopoxvirus activity[1][2][3][4][5].	Free Acid	C18H20FN3O4	64276.0	DMSO : 10 mg/mL (27.67 mM; Need ultrasonic); H2O : ≥ 5 mg/mL (13.84 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(C1=O)=CN2[C@@H](C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O	https://www.medchemexpress.com/Levofloxacin.html	Launched		91.0	O5	B8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0330	10.0	mM	32.0	DMSO	361.143784	8	B	pluskal_fda_drugs_5005_B8_id
109	HY-B0457	HYCPK40902	C06	HYCPK40902	91z	203.0	1.0	E11	902.0	C06	17321-77-6	Clomipramine (hydrochloride)	Chlorimipramine (hydrochloride); G-34586 (hydrochloride); NSC-169865 (hydrochloride)	351.31	Serotonin Transporter	Neuronal Signaling	Clomipramine (Chlorimipramine) hydrochloride is a potent 5-HT reuptake blocker with the IC50 value of 1.5 nM. Clomipramine hydrochloride is a tricyclic antidepressant that can be used for the research of depression and obsessive compulsive disorder (OCD)[1].	Hydrochloride	C19H24Cl2N2	16622.0	H2O : ≥ 50 mg/mL (142.32 mM); DMSO : 50 mg/mL (142.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN(C)CCCN1C2=CC(Cl)=CC=C2CCC3=C1C=CC=C3.Cl	https://www.medchemexpress.com/clomipramine-hydrochloride.html	Launched		91.0	E11	B8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0457	10.0	mM	32.0	DMSO	314.154976	8	B	pluskal_fda_drugs_5005_B8_id
193	HY-N6670	HYCPK40902	O11	HYCPK40902	91z	1365.0	1.0	AC21	902.0	O11	69712-56-7	Cefotetan		575.62	Antibiotic; Bacterial	Anti-infection	Cefotetan is a semisynthetic cephamycin antibiotic that exerts its bactericidal effects by inhibition of cell-wall synthesis[1].		C17H17N7O8S4	63587.0	DMSO : 250 mg/mL (434.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@](OC)(NC(C(S/4)SC4=C(C(O)=O)/C(N)=O)=O)C1=O)O	https://www.medchemexpress.com/cefotetan.html	Launched		91.0	AC21	B8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N6670	10.0	mM	32.0	DMSO	575.002145	8	B	pluskal_fda_drugs_5005_B8_id
274	HY-B0033	HYCPK40902	P16	HYCPK40902	91z	1471.0	1.0	AE31	902.0	P16	1391054-02-6	Vigabatrin (hydrochloride)	γ-Vinyl-GABA (hydrochloride)	165.62	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Vigabatrin hydrochloride (γ-Vinyl-GABA hydrochloride), a inhibitory neurotransmitter GABA vinyl-derivative, is an orally active and irreversible GABA transaminase inhibitor. Vigabatrin hydrochloride is an antiepileptic agent, which acts by increasing GABA levels in the brain by inhibiting the catabolism of GABA by GABA transaminase[1][2][3].	Hydrochloride	C6H12ClNO2	17806.0	DMSO : 27.5 mg/mL (166.04 mM; Need ultrasonic and warming); H2O : 33.33 mg/mL (201.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C=CC(N)CCC(O)=O.Cl	https://www.medchemexpress.com/Vigabatrin-Hydrochloride.html	Launched		91.0	AE31	B8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0033	10.0	mM	32.0	DMSO	129.078979	8	B	pluskal_fda_drugs_5005_B8_id
300	HY-B1435	HYCPK40902	D19	HYCPK40902	91z	325.0	1.0	G37	902.0	D19	964-52-3	Moxisylyte (hydrochloride)	Thymoxamine hydrochloride	315.84	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Moxisylyte (hydrochloride) is (alpha 1-blocker) antagonist, it can vasodilates cerebral vessels without reducing blood pressure. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. [1][2]	Hydrochloride	C16H26ClNO3	20787.0	DMSO : 20 mg/mL (63.32 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (158.31 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	CC(C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1)C.[H]Cl	https://www.medchemexpress.com/Moxisylyte-hydrochloride.html	Launched		91.0	G37	B8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1435	10.0	mM	32.0	DMSO	279.183444	8	B	pluskal_fda_drugs_5005_B8_id
672	HY-14542	HYCPK40903	F18	HYCPK40903	91z	516.0	2.0	K36	903.0	F18	146939-27-7	Ziprasidone	CP-88059	412.94	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Ziprasidone (CP-88059), an orally active antipsychotic agent, is a combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].	Free Base	C21H21ClN4OS	36704.0	DMSO : 13.5 mg/mL (32.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	ClC1=CC2=C(CC(N2)=O)C=C1CCN(CC3)CCN3C4=NSC5=C4C=CC=C5	https://www.medchemexpress.com/ziprasidone.html	Launched		91.0	K36	B8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14542	10.0	mM	32.0	DMSO	412.11246	8	B	pluskal_fda_drugs_5005_B8_id
803	HY-B1096	HYCPK40904	H07	HYCPK40904	91z	733.0	3.0	P13	904.0	H07	304-84-7	Etamivan	Ethamivan; N,N-Diethylvanillamide	223.27	Others	Others	Etamivan (Ethamivan), an orally active respiratory stimulant, is mainly used in the research of barbiturate overdose and chronic obstructive pulmonary disease[1][2].	Free Base	C12H17NO3	21243.0	DMSO : ≥ 36 mg/mL (161.24 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N(CC)CC)C1=CC=C(O)C(OC)=C1	https://www.medchemexpress.com/Etamivan.html	Launched		91.0	P13	B8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1096	10.0	mM	32.0	DMSO	223.120843	8	B	pluskal_fda_drugs_5005_B8_id
1351	HY-13528	HYCPK40905	P21	HYCPK40905	91z	1530.0	4.0	AF42	905.0	P21	30299-08-2	Clinofibrate	S-8527	468.58	Autophagy; HMG-CoA Reductase (HMGCR)	Autophagy; Metabolic Enzyme/Protease	Clinofibrate (S-8527) is a hypelipidemic agent and a HMG-CoA reductase inhibitor.	Free Acid	C28H36O6	24539.0	DMSO : 100 mg/mL (213.41 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CCC(OC1=CC=C(C2(C3=CC=C(OC(CC)(C)C(O)=O)C=C3)CCCCC2)C=C1)(C)C(O)=O	https://www.medchemexpress.com/Clinofibrate.html	Launched		91.0	AF42	B8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13528	10.0	mM	32.0	DMSO	468.251189	8	B	pluskal_fda_drugs_5005_B8_id
177	HY-17492	HYCPK40902	O10	HYCPK40902	91z	1363.0	1.0	AC19	902.0	O10	107753-78-6	Zafirlukast	ICI 204219	575.68	Leukotriene Receptor	GPCR/G Protein	Zafirlukast (ICI 204219) is a potent orally active leukotriene D4 (LTD4) receptor antagonist. Zafirlukast shows anti-asthmatic, anti-inflammatory and anti-bacterial effects.	Free Base	C31H33N3O6S	25341.0	DMSO : 100 mg/mL (173.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(OC1CCCC1)NC2=CC3=C(N(C)C=C3CC4=CC=C(C(NS(=O)(C5=CC=CC=C5C)=O)=O)C=C4OC)C=C2	https://www.medchemexpress.com/Zafirlukast.html	Launched		91.0	AC19	B9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17492	10.0	mM	33.0	DMSO	575.209007	9	B	pluskal_fda_drugs_5005_B9_id
378	HY-B0125	HYCPK40902	K04	HYCPK40902	91z	967.0	1.0	U7	902.0	K04	82419-36-1	Ofloxacin	Hoe-280	361.37	Antibiotic; Bacterial; Endogenous Metabolite; Orthopoxvirus	Anti-infection; Metabolic Enzyme/Protease	Ofloxacin (Hoe-280) is a fluoroquinolone whose primary mechanism of action is inhibition of bacterial DNA gyrase. Ofloxacin shows inhibitory activity against vaccinia virus (VV).	Free Acid	C18H20FN3O4	86357.0	DMSO : ≥ 4 mg/mL (11.07 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(C1=O)=CN2C(C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O	https://www.medchemexpress.com/Ofloxacin.html	Launched		91.0	U7	B9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0125	10.0	mM	33.0	DMSO	361.143784	9	B	pluskal_fda_drugs_5005_B9_id
761	HY-B0162A	HYCPK40904	I04	HYCPK40904	91z	823.0	3.0	R7	904.0	I04	148849-67-6	Ivabradine (hydrochloride)		505.05	HCN Channel	Membrane Transporter/Ion Channel	Ivabradine hydrochloride is a potent and orally active HCN (hyperpolarization-activated cyclic nucleotide-gated) channel blocker that inhibits the cardiac pacemaker current (If). Ivabradine hydrochloride reduces dose-dependently heart rate without modification of blood pressure. Ivabradine hydrochloride shows anticonvulsant, anti-ischaemic and anti-anginal activity[1][2][3][4].	Hydrochloride	C27H37ClN2O5	11537.0	DMSO : 25 mg/mL (49.50 mM; Need ultrasonic); H2O : 50 mg/mL (99.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=C1N(CCCN(C[C@@H]2C3=CC(OC)=C(OC)C=C3C2)C)CCC4=CC(OC)=C(OC)C=C4C1.Cl	https://www.medchemexpress.com/ivabradine-hydrochloride.html	Launched		91.0	R7	B9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0162A	10.0	mM	33.0	DMSO	468.262422	9	B	pluskal_fda_drugs_5005_B9_id
859	HY-17471A	HYCPK40904	P10	HYCPK40904	91z	1507.0	3.0	AF19	904.0	P10	1115-70-4	Metformin (hydrochloride)	1,1-Dimethylbiguanide (hydrochloride)	165.62	AMPK; Autophagy; Mitophagy	Autophagy; Epigenetics; PI3K/Akt/mTOR	Metformin hydrochloride (1,1-Dimethylbiguanide hydrochloride) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research. Metformin hydrochloride triggers autophagy[1].	Hydrochloride	C4H12ClN5	21245.0	DMSO : ≥ 1.7 mg/mL (10.26 mM); H2O : ≥ 100 mg/mL (603.79 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease; Cancer	NC(NC(N(C)C)=N)=N.Cl	https://www.medchemexpress.com/Metformin-hydrochloride.html	Launched		91.0	AF19	B9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17471A	10.0	mM	33.0	DMSO	129.101445	9	B	pluskal_fda_drugs_5005_B9_id
918	HY-17407	HYCPK40904	K14	HYCPK40904	91z	1035.0	3.0	V27	904.0	K14	138982-67-9	Ziprasidone (hydrochloride monohydrate)	CP 88059 (hydrochloride monohydrate)	467.41	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Ziprasidone (CP-88059) hydrochloride monohydrate is an orally active combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone hydrochloride monohydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].	Hydrochloride	C21H24Cl2N4O2S	11212.0	H2O : 1 mg/mL (2.14 mM; Need ultrasonic and warming); DMSO : 25 mg/mL (53.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1CC2=CC(CCN3CCN(C4=NSC5=C4C=CC=C5)CC3)=C(Cl)C=C2N1.[H]Cl.O	https://www.medchemexpress.com/ziprasidone-hydrochloride-monohydrate.html	Launched		91.0	V27	B9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17407	10.0	mM	33.0	DMSO	412.11246	9	B	pluskal_fda_drugs_5005_B9_id
1115	HY-N0437	HYCPK40905	D07	HYCPK40905	91z	350.0	4.0	H14	905.0	D07	57-83-0	Progesterone	Pregn-4-ene-3,20-dione	314.46	Endogenous Metabolite; Progesterone Receptor	Metabolic Enzyme/Protease; Others	Progesterone is a steroid hormone that regulates the menstrual cycle and is crucial for pregnancy.	Free Base	C21H30O2	84205.0	DMSO : 25 mg/mL (79.50 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	CC([C@H]1CC[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O	https://www.medchemexpress.com/Progesterone.html	Launched		91.0	H14	B9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0437	10.0	mM	33.0	DMSO	314.22458	9	B	pluskal_fda_drugs_5005_B9_id
1177	HY-B0946	HYCPK40905	B11	HYCPK40905	91z	166.0	4.0	D22	905.0	B11	1220-83-3	Sulfamonomethoxine		280.30	Antibiotic; Bacterial	Anti-infection	Sulfamonomethoxine is a long acting sulfonamide antibacterial agent, used in blood kinetic studies,and blocks the synthesis of folic acid by inhibiting synthetase of dihydropteroate.	Free Base	C11H12N4O3S	17099.0	DMSO : 100 mg/mL (356.76 mM; Need ultrasonic); H2O : 1 mg/mL (3.57 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC=NC(OC)=C2)=O	https://www.medchemexpress.com/Sulfamonomethoxine.html	Launched		91.0	D22	B9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0946	10.0	mM	33.0	DMSO	280.063011	9	B	pluskal_fda_drugs_5005_B9_id
1296	HY-B0423	HYCPK40905	I18	HYCPK40905	91z	852.0	4.0	R36	905.0	I18	114-80-7	Neostigmine (Bromide)	Eustigmin bromide; Neoserine bromide	303.20	Cholinesterase (ChE)	Neuronal Signaling	"Neostigmine Bromide is a cholinesterase inhibitor used in the treatment of myasthenia gravis.
Target: Cholinesterase
Neostigmine is a parasympathomimetic that acts as a reversible acetylcholinesterase inhibitor. Neostigmine enhances excitatory parasympathetic activity by competing with acetylcholine for attachment to acetylcholinesterase at sites of cholinergic transmission and enhancing cholinergic action. Neostigmine is a safe and effective treatment for acute colonic pseudo-obstruction [1]."	Bromide	C12H19BrN2O2	17024.0	DMSO : 100 mg/mL (329.82 mM; Need ultrasonic); H2O : 100 mg/mL (329.82 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	C[N+](C)(C)C1=CC=CC(OC(N(C)C)=O)=C1.[Br-]	https://www.medchemexpress.com/neostigmine-bromide.html	Launched		91.0	R36	B9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0423	10.0	mM	33.0	DMSO	223.144104	9	B	pluskal_fda_drugs_5005_B9_id
395	HY-A0130	HYCPK40902	D18	HYCPK40902	91z	323.0	1.0	G35	902.0	D18	152-47-6	Sulfalene	Sulfametopyrazine; AS-18908	280.30	Antibiotic; Bacterial; Parasite	Anti-infection	Sulfalene (Sulfametopyrazine) is an antimalarial agent. Sulfalene is also a long-acting sulfonamide antibacterial.	Free Base	C11H12N4O3S	27526.0	DMSO : 100 mg/mL (356.76 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC=CN=C2OC)=O	https://www.medchemexpress.com/Sulfalene.html	Launched		91.0	G35	B10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0130	10.0	mM	34.0	DMSO	280.063011	10	B	pluskal_fda_drugs_5005_B10_id
456	HY-90006	HYCPK40903	M05	HYCPK40903	91z	1162.0	2.0	Y10	903.0	M05	51-21-8	5-Fluorouracil	5-FU	130.08	Apoptosis; Endogenous Metabolite; HIV; Nucleoside Antimetabolite/Analog	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	5-Fluorouracil (5-FU) is an analogue of uracil and a potent antitumor agent. 5-Fluorouracil affects pyrimidine synthesis by inhibiting thymidylate synthetase thus depleting intracellular dTTP pools. 5-Fluorouracil induces apoptosis and can be used as a chemical sensitizer[1][2]. 5-Fluorouracil also inhibits HIV[3].	Free Base	C4H3FN2O2	22009.0	DMSO : 50 mg/mL (384.38 mM; Need ultrasonic); H2O : 20 mg/mL (153.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N1)NC=C(F)C1=O	https://www.medchemexpress.com/5-Fluorouracil.html	Launched		91.0	Y10	B10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-90006	10.0	mM	34.0	DMSO	130.017856	10	B	pluskal_fda_drugs_5005_B10_id
465	HY-N0093	HYCPK40903	F06	HYCPK40903	91z	492.0	2.0	K12	903.0	F06	10212-25-6	Ancitabine (hydrochloride)	Cyclocytidine hydrochloride; Cyclo-CMP hydrochloride; Cyclo-C	261.66	Autophagy; CMV	Anti-infection; Autophagy	Ancitabine (hydrochloride) is an important antileukemia drugs.	Hydrochloride	C9H12ClN3O4	19198.0	DMSO : 25 mg/mL (95.54 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (191.09 mM)	DMSO Solution	10mM  * 100uL	Cancer	"OC[C@@H]1[C@@H](O)[C@@](O2)([H])[C@@](N(C2=N3)C=CC3=N)([H])O1.[H]Cl
JjbwQ0byOjHpJ4gXWRYObRsaR41DaP=="	https://www.medchemexpress.com/Ancitabine-hydrochloride.html	Launched		91.0	K12	B10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0093	10.0	mM	34.0	DMSO	225.074956	10	B	pluskal_fda_drugs_5005_B10_id
625	HY-B0967	HYCPK40903	G15	HYCPK40903	91z	606.0	2.0	M30	903.0	G15	131-69-1	Phthalylsulfacetamide		362.36	Bacterial	Anti-infection	Phthalylsulfacetamide is a sulfa drug, after oral administration, slowly decompose in the intestine,and release sulfacetamide ,generating antibacterial effect.	Free Acid	C16H14N2O6S	25817.0	DMSO : 25 mg/mL (68.99 mM; Need ultrasonic); H2O : 1 mg/mL (2.76 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)C1=CC=CC=C1C(NC2=CC=C(S(=O)(NC(C)=O)=O)C=C2)=O	https://www.medchemexpress.com/Phthalylsulfacetamide.html	Launched		91.0	M30	B10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0967	10.0	mM	34.0	DMSO	362.057257	10	B	pluskal_fda_drugs_5005_B10_id
703	HY-107339	HYCPK40903	O20	HYCPK40903	91z	1384.0	2.0	AC40	903.0	O20	131-01-1	Deserpidine	Harmonyl	578.65	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Deserpidine (Harmonyl) is an alkaloid isolated from the root of Rauwolfia canescens related to Reserpine. Deserpidine is used as an antihypertensive agent and a tranquilizer. Deserpidine is a competitive angiotensin converting enzyme (ACE) inhibitor. Deserpidine also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex[1][2][3].	Free Base	C32H38N2O8	65466.0	DMSO : 100 mg/mL (172.82 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	COC([C@H]1[C@@]2([H])C[C@]3([H])C4=C(CCN3C[C@@]2([H])C[C@@H](OC(C5=CC(OC)=C(OC)C(OC)=C5)=O)[C@@H]1OC)C6=CC=CC=C6N4)=O	https://www.medchemexpress.com/deserpidine.html	Launched		91.0	AC40	B10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107339	10.0	mM	34.0	DMSO	578.262816	10	B	pluskal_fda_drugs_5005_B10_id
773	HY-75502	HYCPK40904	J05	HYCPK40904	91z	921.0	3.0	T9	904.0	J05	99755-59-6	Rotigotine	N-0437; N-0923	315.47	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Rotigotine is a potent dopamine receptor agonist with Ki values of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors and dopamine D1 receptor. Rotigotine a partial agonist of the 5-HT1A receptor, and an antagonist of the α2B-adrenergic receptor. Rotigotine  can be used for parkinson's disease (PD) research[1][2][3][4].	Free Base	C19H25NOS	7257.0	DMSO : ≥ 50 mg/mL (158.49 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C=CC=C3O)C2	https://www.medchemexpress.com/rotigotine.html	Launched		91.0	T9	B10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-75502	10.0	mM	34.0	DMSO	315.165685	10	B	pluskal_fda_drugs_5005_B10_id
906	HY-B0977	HYCPK40904	O13	HYCPK40904	91z	1417.0	3.0	AD25	904.0	O13	13412-64-1	Dicloxacillin (Sodium hydrate)	Dicloxacillin sodium salt monohydrate	510.32	Antibiotic; Bacterial	Anti-infection	Dicloxacillin Sodium hydrate (Dicloxacillin sodium salt monohydrate) is a narrow-spectrum β-Lactam antibiotic of the penicillin class, is used to treat infections caused by susceptible Gram-positive bacteria, active against beta-lactamase-producing organisms such as Staphylococcus aureus[1][2][3].	Sodium	C19H18Cl2N3NaO6S	61541.0	H2O : 25 mg/mL (48.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(O[Na])[C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C3=C(C)ON=C3C4=C(Cl)C=CC=C4Cl)=O)N1C2=O.O	https://www.medchemexpress.com/Dicloxacillin-Sodium-hydrate.html	Launched		91.0	AD25	B10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0977	10.0	mM	34.0	DMSO	469.026597	10	B	pluskal_fda_drugs_5005_B10_id
1030	HY-13404	HYCPK40904	O21	HYCPK40904	91z	1433.0	3.0	AD41	904.0	O21	1029712-80-8	Capmatinib	INC280; INCB28060	412.42	Apoptosis; c-Met/HGFR	Apoptosis; Protein Tyrosine Kinase/RTK	Capmatinib (INC280; INCB28060) is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor (IC50=0.13 nM). Capmatinib can inhibit phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Capmatinib potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis. Antitumor activity. Capmatinib is largely metabolized by CYP3A4 and aldehyde oxidase[1][2][3].	Free Base	C23H17FN6O	19894.0	DMSO : 25 mg/mL (60.62 mM; Need ultrasonic); H2O : 10 mg/mL (24.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC)C1=CC=C(C2=NN3C(N=C2)=NC=C3CC4=CC=C5N=CC=CC5=C4)C=C1F	https://www.medchemexpress.com/INCB28060.html	Launched		91.0	AD41	B10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13404	10.0	mM	34.0	DMSO	412.144787	10	B	pluskal_fda_drugs_5005_B10_id
219	HY-B0682A	HYCPK40902	I13	HYCPK40902	91z	793.0	1.0	Q25	902.0	I13	207844-01-7	Mitiglinide (calcium hydrate)	KAD-1229; S-21403	352.46	Potassium Channel	Membrane Transporter/Ion Channel	Mitiglinide calcium hydrate (KAD-1229), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide calcium hydrate is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium hydrate can be used for the research of type 2 diabetes[1][2].	Calcium	C19H24NO3.1/2Ca.H2O	119331.0	DMSO : 25 mg/mL (70.93 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(N1C[C@@](CCCC2)([H])[C@@]2([H])C1)C[C@@H](C([O-])=O)CC3=CC=CC=C3.[0.5Ca2+].O	https://www.medchemexpress.com/Mitiglinide-calcium-hydrate.html	Launched		91.0	Q25	B11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0682A	10.0	mM	35.0	DMSO	315.183444	11	B	pluskal_fda_drugs_5005_B11_id
361	HY-50898B	HYCPK40903	B04	HYCPK40903	91z	104.0	2.0	C8	903.0	B04	388082-78-8	Lapatinib (ditosylate monohydrate)	GW572016 (ditosylate monohydrate); GW2016 (ditosylate monohydrate)	943.48	Autophagy; EGFR; Ferroptosis	Apoptosis; Autophagy; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Lapatinib ditosylate monohydrate (GW572016 ditosylate monohydrate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1].	Tosylate	C43H44ClFN4O11S3	115711.0	DMSO : 50 mg/mL (53.00 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=S(CCNCC1=CC=C(C2=CC3=C(NC4=CC=C(OCC5=CC=CC(F)=C5)C(Cl)=C4)N=CN=C3C=C2)O1)(C)=O.O=S(C6=CC=C(C)C=C6)(O)=O.O=S(C7=CC=C(C)C=C7)(O)=O.O	https://www.medchemexpress.com/lapatinib-ditosylate-monohydrate.html	Launched		91.0	C8	B11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50898B	10.0	mM	35.0	DMSO	580.134732	11	B	pluskal_fda_drugs_5005_B11_id
417	HY-B0802	HYCPK40902	I22	HYCPK40902	91z	811.0	1.0	Q43	902.0	I22	23031-32-5	Terbutaline (sulfate)	Terbutaline hemisulfate	274.32	Adrenergic Receptor; Antibiotic	Anti-infection; GPCR/G Protein; Neuronal Signaling	Terbutaline sulfate is an orally active β2-adrenergic receptor agonist and an active metabolite of bambuterol[1]. Terbutaline sulfate can be used in asthma symptom research[2].	Sulfate	C12H19NO3.1/2H2SO4	31127.0	H2O : 250 mg/mL (911.34 mM; Need ultrasonic); DMSO : 5 mg/mL (18.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	OC1=CC(C(O)CNC(C)(C)C)=CC(O)=C1.[0.5H2SO4]	https://www.medchemexpress.com/Terbutaline-sulfate.html	Launched		91.0	Q43	B11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0802	10.0	mM	35.0	DMSO	225.136493	11	B	pluskal_fda_drugs_5005_B11_id
619	HY-N0305	HYCPK40903	A15	HYCPK40903	91z	30.0	2.0	A30	903.0	A15	5451-09-2	5-Aminolevulinic acid (hydrochloride)	5-ALA (hydrochloride); δ-Aminolevulinic acid (hydrochloride); 5-Amino-4-oxopentanoic acid (hydrochloride)	167.59	Apoptosis; Autophagy; Endogenous Metabolite; Mitophagy	Apoptosis; Autophagy; Metabolic Enzyme/Protease	5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride) is an intermediate in heme biosynthesis in the body and the universal precursor of tetrapyrroles.	Hydrochloride	C5H10ClNO3	65790.0	DMSO : 100 mg/mL (596.69 mM; Need ultrasonic); H2O : 16.67 mg/mL (99.47 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(O)CCC(CN)=O.[H]Cl	https://www.medchemexpress.com/5-aminolevulinic-acid-hydrochloride.html	Launched		91.0	A30	B11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0305	10.0	mM	35.0	DMSO	131.058243	11	B	pluskal_fda_drugs_5005_B11_id
792	HY-B0213	HYCPK40904	M06	HYCPK40904	91z	1211.0	3.0	Z11	904.0	M06	651-06-9	Sulfameter	Sulfametoxydiazine; 5-Methoxysulfadiazine	280.30	Antibiotic; Bacterial	Anti-infection	Sulfameter (Sulfametoxydiazine; 5-Methoxysulfadiazine) is an effective long-acting sulfonamide antibiotic with antibacterial activities. Sulfameter can be used for the research of urinary tract infections and lepriasis[1].	Free Base	C11H12N4O3S	16534.0	DMSO : ≥ 100 mg/mL (356.76 mM); H2O : 0.67 mg/mL (2.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC=C(OC)C=N2)=O	https://www.medchemexpress.com/sulfameter.html	Launched		91.0	Z11	B11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0213	10.0	mM	35.0	DMSO	280.063011	11	B	pluskal_fda_drugs_5005_B11_id
1011	HY-B1396	HYCPK40904	L20	HYCPK40904	91z	1143.0	3.0	X39	904.0	L20	82752-99-6	Nefazodone (hydrochloride)	BMY-13754; MJ-13754-1	506.47	5-HT Receptor; Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Nefazodone hydrochloride (BMY-13754) is a potent and selective 5HT2A (Ki=5.8 nM) antagonist with moderate inhibition of 5-HT and noradrenaline uptake (IC50 of 290 and 300 nM, respectively). Nefazodone hydrochloride is a phenylpiperazine antidepressant with less alpha-adrenergic blocking activity[1][2].	Hydrochloride	C25H33Cl2N5O2	17538.0	DMSO : 50 mg/mL (98.72 mM; Need ultrasonic); H2O : 2 mg/mL (3.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C(CC)N1CCOC4=CC=CC=C4.[H]Cl	https://www.medchemexpress.com/Nefazodone-hydrochloride.html	Launched		91.0	X39	B11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1396	10.0	mM	35.0	DMSO	469.224453	11	B	pluskal_fda_drugs_5005_B11_id
1206	HY-N7067	HYCPK40905	O12	HYCPK40905	91z	1416.0	4.0	AD24	905.0	O12	178307-42-1	Revaprazan (hydrochloride)		398.90	Bacterial; COX	Anti-infection; Immunology/Inflammation	Revaprazan hydrochloride is a novel acid pump antagonist (APA). Revaprazan hydrochloride reduces COX-2 expression and has significant anti-inflammatory actions activities in H. pylori infection[1].	Hydrochloride	C22H24ClFN4	144887.0	DMSO : 8.33 mg/mL (20.88 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Infection	CC1=C(C)C(N2C(C)C3=C(C=CC=C3)CC2)=NC(NC4=CC=C(F)C=C4)=N1.[H]Cl	https://www.medchemexpress.com/revaprazan-hydrochloride.html	Launched		91.0	AD24	B11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7067	10.0	mM	35.0	DMSO	362.190675	11	B	pluskal_fda_drugs_5005_B11_id
1339	HY-B1444	HYCPK40905	D21	HYCPK40905	91z	378.0	4.0	H42	905.0	D21	24168-96-5	Isoconazole (nitrate)		479.14	Antibiotic; Bacterial; Fungal	Anti-infection	Isoconazole nitrate is a broad-spectrum antimicrobial agent with a highly effective antimycotic and gram-positive antibacterial activity, exhibiting a rapid rate of absorption and low systemic exposure potential[1].	Nitrate	C18H15Cl4N3O4	18560.0	DMSO : 100 mg/mL (208.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	ClC1=C(COC(C2=CC=C(Cl)C=C2Cl)CN3C=CN=C3)C(Cl)=CC=C1.O[N+]([O-])=O	https://www.medchemexpress.com/Isoconazole-nitrate.html	Launched		91.0	H42	B11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1444	10.0	mM	35.0	DMSO	413.986024	11	B	pluskal_fda_drugs_5005_B11_id
384	HY-B0454	HYCPK40902	E08	HYCPK40902	91z	399.0	1.0	I15	902.0	E08	22916-47-8	Miconazole	R18134	416.13	Antibiotic; Bacterial; Fungal	Anti-infection	Miconazole (R18134) is an imidazole antifungal agent. Miconazole also has antibacterial effects[2].	Free Base	C18H14Cl4N2O	149760.0	DMSO : 100 mg/mL (240.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	ClC1=C(C=CC(Cl)=C1)C(OCC(C=CC(Cl)=C2)=C2Cl)CN3C=CN=C3	https://www.medchemexpress.com/miconazole.html	Launched		91.0	I15	B12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0454	10.0	mM	36.0	DMSO	413.986024	12	B	pluskal_fda_drugs_5005_B12_id
415	HY-B0674	HYCPK40902	G22	HYCPK40902	91z	619.0	1.0	M43	902.0	G22	90729-43-4	Ebastine	LAS-W 090; RP64305	469.66	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Ebastine (LAS-W 090) is an orally active, second-generation histamine H1 receptor antagonist. Ebastine can be used for the symptoms of allergic rhinitis and chronic idiopathic urticaria research[1].	Free Base	C32H39NO2	16159.0	Ethanol : 58.75 mg/mL (125.09 mM; Need ultrasonic); DMSO : 8.33 mg/mL (17.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(C1=CC=C(C(C)(C)C)C=C1)CCCN2CCC(OC(C3=CC=CC=C3)C4=CC=CC=C4)CC2	https://www.medchemexpress.com/Ebastine.html	Launched		91.0	M43	B12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0674	10.0	mM	36.0	DMSO	469.298079	12	B	pluskal_fda_drugs_5005_B12_id
742	HY-B1476	HYCPK40904	F03	HYCPK40904	91z	533.0	3.0	L5	904.0	F03	17140-60-2	NSC 42196		490.42	Endogenous Metabolite	Metabolic Enzyme/Protease	NSC 42196 is an endogenous metabolite.		C14H26CaO16	146445.0	H2O : 100 mg/mL (203.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O[C@H]([C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)C([O-])=O.O[C@H]([C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)C([O-])=O.[Ca+2]	https://www.medchemexpress.com/nsc-42196.html	Launched		91.0	L5	B12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1476	10.0	mM	36.0	DMSO	226.068867	12	B	pluskal_fda_drugs_5005_B12_id
875	HY-14286	HYCPK40904	P11	HYCPK40904	91z	1509.0	3.0	AF21	904.0	P11	141505-33-1	Levosimendan	Simsndan; OR-1259	280.28	Autophagy; Phosphodiesterase (PDE); Potassium Channel	Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Levosimendan (Simsndan; OR-1259) is a calcium sensitiser used in the management of acutely decompensated congestive heart failure.	Free Base	C14H12N6O	57985.0	DMSO : ≥ 50 mg/mL (178.39 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C1C[C@@H](C)C(C2=CC=C(N/N=C(C#N)/C#N)C=C2)=NN1	https://www.medchemexpress.com/Levosimendan.html	Launched		91.0	AF21	B12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14286	10.0	mM	36.0	DMSO	280.107259	12	B	pluskal_fda_drugs_5005_B12_id
977	HY-B0152	HYCPK40904	J18	HYCPK40904	91z	947.0	3.0	T35	904.0	J18	73-24-5	Adenine	6-Aminopurine; Vitamin B4	135.13	DNA/RNA Synthesis; Endogenous Metabolite	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	"Adenine (6-Aminopurine), a purine, is one of the four nucleobases in the nucleic acid of DNA. 
Adenine acts as a chemical component of DNA and RNA. Adenine also plays an important role in biochemistry involved in cellular respiration, the form of both ATP and the cofactors (NAD and FAD), and protein synthesis[1][2][3]."	Free Base	C5H5N5	15877.0	DMSO : ≥ 10 mg/mL (74.00 mM); H2O : 2 mg/mL (14.80 mM; ultrasonic and warming and heat to 60°C); 1M HCl : 20 mg/mL (148.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	NC1=C2N=CNC2=NC=N1	https://www.medchemexpress.com/Adenine.html	Launched		91.0	T35	B12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0152	10.0	mM	36.0	DMSO	135.054495	12	B	pluskal_fda_drugs_5005_B12_id
986	HY-10285	HYCPK40904	C19	HYCPK40904	91z	277.0	3.0	F37	904.0	C19	361442-04-8	Saxagliptin	BMS-477118	315.41	Dipeptidyl Peptidase	Metabolic Enzyme/Protease	Saxagliptin (BMS-477118) is a potent, selective, reversible, competitive and orally active dipeptidyl peptidase-4 (DPP-4) (Ki = 0.6-1.3 nM) inhibitor. Saxagliptin has the peotential for type 2 diabetes mellitus research[1][2][3].	Free Base	C18H25N3O2	4684.0	DMSO : ≥ 34 mg/mL (107.80 mM); H2O : 10 mg/mL (31.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	N[C@@H]([C@](C[C@H](C1)C2)(C[C@@H]1C3)C[C@]23O)C(N([C@@H](C4)C#N)[C@@H]5[C@H]4C5)=O	https://www.medchemexpress.com/Saxagliptin.html	Launched		91.0	F37	B12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10285	10.0	mM	36.0	DMSO	315.194677	12	B	pluskal_fda_drugs_5005_B12_id
1080	HY-A0002	HYCPK40905	A05	HYCPK40905	91z	58.0	4.0	B10	905.0	A05	242478-38-2	Solifenacin (Succinate)	YM905	480.55	mAChR	GPCR/G Protein; Neuronal Signaling	Solifenacin Succinate (YM905) is a novel muscarinic receptor antagonist with pKis of 7.6, 6.9 and 8.0 for M1, M2 and M3 receptors, respectively.	Succinate	C27H32N2O6	3375.0	H2O : 100 mg/mL (208.09 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (208.09 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(O[C@H]1CN2CCC1CC2)N3[C@H](C4=C(CC3)C=CC=C4)C5=CC=CC=C5.O=C(CCC(O)=O)O	https://www.medchemexpress.com/Solifenacin-Succinate.html	Launched		91.0	B10	B12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0002	10.0	mM	36.0	DMSO	362.199428	12	B	pluskal_fda_drugs_5005_B12_id
1216	HY-13038	HYCPK40905	I13	HYCPK40905	91z	842.0	4.0	R26	905.0	I13	1025687-58-4	Fostamatinib Disodium	R788(Disodium)	624.42	FLT3; Syk	Protein Tyrosine Kinase/RTK	Fostamatinib Disodium (R788 Disodium) is the oral prodrug of the active compound R406[1]. R406 is an orally available and competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM[2]. R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM)[3].	Sodium	C23H24FN6Na2O9P	160014.0	DMSO : 50 mg/mL (80.07 mM; Need ultrasonic); H2O : ≥ 1 mg/mL (1.60 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	COC1=CC(NC2=NC=C(C(NC3=NC(N4COP(O[Na])(O[Na])=O)=C(C=C3)OC(C)(C)C4=O)=N2)F)=CC(OC)=C1OC	https://www.medchemexpress.com/r788_prodrug-of-r406_.html	Launched		91.0	R26	B12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13038	10.0	mM	36.0	DMSO	580.148291	12	B	pluskal_fda_drugs_5005_B12_id
81	HY-13038B	HYCPK40902	J03	HYCPK40902	91z	869.0	1.0	S5	902.0	J03	914295-16-2	Fostamatinib (disodium hexahydrate)	R788 (disodium hexahydrate)	732.51	FLT3; Syk	Protein Tyrosine Kinase/RTK	Fostamatinib (R788) disodium hexahydrate is the oral prodrug of the active compound R406[1]. R406 is an orally available and competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM[2]. R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM)[3].	Sodium	C23H36FN6Na2O15P	57596.0	H2O : 2 mg/mL (2.73 mM; ultrasonic and warming and heat to 60°C); DMSO : 31.81 mg/mL (43.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	COC1=CC(NC2=NC=C(C(NC3=NC(N4COP(O[Na])(O[Na])=O)=C(C=C3)OC(C)(C)C4=O)=N2)F)=CC(OC)=C1OC.O.O.O.O.O.O	https://www.medchemexpress.com/R788-disodium-hexahydrate.html	Launched		91.0	S5	B13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13038B	10.0	mM	37.0	DMSO	580.148291	13	B	pluskal_fda_drugs_5005_B13_id
269	HY-B0152B	HYCPK40902	K16	HYCPK40902	91z	991.0	1.0	U31	902.0	K16	321-30-2	Adenine (hemisulfate)	6-Aminopurine (hemisulfate); Vitamin B4 (hemisulfate)	233.21	DNA/RNA Synthesis; Endogenous Metabolite	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Adenine hemisulfate (6-Aminopurine hemisulfate), a purine, is one of the four nucleobases in the nucleic acid of DNA. Adenine hemisulfate acts as a chemical component of DNA and RNA. Adenine hemisulfate also plays an important role in biochemistry involved in cellular respiration, the form of both ATP and the cofactors (NAD and FAD), and protein synthesis[1][2].	Sulfate	C5H7N5O4S	112360.0	DMSO : 100 mg/mL (428.80 mM; Need ultrasonic); H2O : 5 mg/mL (21.44 mM; ultrasonic and heat to 50°C)	DMSO Solution	10mM  * 100uL	Cancer	NC1=C2N=CNC2=NC=N1.O=S(O)(O)=O.[1/2]	https://www.medchemexpress.com/adenine-hemisulfate.html	Launched		91.0	U31	B13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0152B	10.0	mM	37.0	DMSO	135.054495	13	B	pluskal_fda_drugs_5005_B13_id
460	HY-N0583	HYCPK40903	A06	HYCPK40903	91z	12.0	2.0	A12	903.0	A06	50-23-7	Hydrocortisone	Cortisol	362.46	Endogenous Metabolite; Glucocorticoid Receptor	Immunology/Inflammation; Metabolic Enzyme/Protease	Hydrocortisone (Cortisol) is a steroid hormone or glucocorticoid secreted by the adrenal cortex[1].	Free Base	C21H30O5	45506.0	DMSO : ≥ 31 mg/mL (85.53 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]1([C@@]2(O)C(CO)=O)[C@](CC2)([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(CC4)C)([H])[C@@H](O)C1	https://www.medchemexpress.com/Hydrocortisone.html	Launched		91.0	A12	B13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0583	10.0	mM	37.0	DMSO	362.209324	13	B	pluskal_fda_drugs_5005_B13_id
725	HY-A0145	HYCPK40903	E22	HYCPK40903	91z	428.0	2.0	I44	903.0	E22	435-97-2	Phenprocoumon		280.32	Others	Others	Phenprocoumon is a coumarin derivative that acts as a long acting oral anticoagulant and an antagonist of vitamin K.	Free Base	C18H16O3	34963.0	DMSO : ≥ 125 mg/mL (445.92 mM)	DMSO Solution	10mM  * 100uL	Others	O=C1C(C(C2=CC=CC=C2)CC)=C(O)C3=CC=CC=C3O1	https://www.medchemexpress.com/Phenprocoumon.html	Launched		91.0	I44	B13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0145	10.0	mM	37.0	DMSO	280.109944	13	B	pluskal_fda_drugs_5005_B13_id
839	HY-B0555A	HYCPK40904	L09	HYCPK40904	91z	1121.0	3.0	X17	904.0	L09	7177-50-6	Nafcillin (sodium monohydrate)		454.47	Antibiotic; Bacterial	Anti-infection	Nafcillin sodium monohydrate, an antibiotic, is a reversible inhibitor of β-lactamase. Nafcillin sodium monohydrate can be used for the research of staphylococcal infections[1][2].	Sodium	C21H23N2NaO6S	31485.0	H2O : 1 mg/mL (2.20 mM; Need ultrasonic); DMSO : 100 mg/mL (220.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H]1N(C2=O)[C@]([C@@H]2NC(C(C3=CC=CC=C3C=C4)=C4OCC)=O)([H])SC1(C)C)O[Na].O	https://www.medchemexpress.com/Nafcillin-sodium-monohydrate.html	Launched		91.0	X17	B13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0555A	10.0	mM	37.0	DMSO	414.124943	13	B	pluskal_fda_drugs_5005_B13_id
1043	HY-N0180	HYCPK40904	L22	HYCPK40904	91z	1147.0	3.0	X43	904.0	L22	471-53-4	18β-Glycyrrhetinic acid		470.68	Endogenous Metabolite	Metabolic Enzyme/Protease	18β-Glycyrrhetinic acid is the major bioactive component of Glycyrrhiza uralensis and possesses anti-ulcerative, anti-inflammatory and antiproliferative properties.	Free Acid	C30H46O4	129786.0	DMSO : ≥ 250 mg/mL (531.15 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	CC1(C)[C@@H](O)CC[C@]([C@@]1([H])CC[C@@]([C@@]2(CC[C@]3(CC[C@](C(O)=O)(C[C@]3(C2=C4)[H])C)C)C)5C)(C)[C@@]5([H])C4=O	https://www.medchemexpress.com/18_beta_-Glycyrrhetinic_acid.html	Launched		91.0	X43	B13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0180	10.0	mM	37.0	DMSO	470.33961	13	B	pluskal_fda_drugs_5005_B13_id
1127	HY-14268	HYCPK40905	P07	HYCPK40905	91z	1502.0	4.0	AF14	905.0	P07	144060-53-7	Febuxostat	TEI 6720; TMX 67	316.37	Xanthine Oxidase	Metabolic Enzyme/Protease	Febuxostat (TEI 6720) is a potent, selective and non-purine xanthine oxidase (XO) inhibitor with a Ki value of 0.6 nM. Febuxostat has the potential for the research of hyperuricemia and gout[1][2][3].	Free Acid	C16H16N2O3S	10754.0	DMSO : 50 mg/mL (158.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	CC(COC1=CC=C(C=C1C#N)C2=NC(C)=C(S2)C(O)=O)C	https://www.medchemexpress.com/Febuxostat.html	Launched		91.0	AF14	B13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14268	10.0	mM	37.0	DMSO	316.088163	13	B	pluskal_fda_drugs_5005_B13_id
1151	HY-16349	HYCPK40905	H09	HYCPK40905	91z	738.0	4.0	P18	905.0	H09	6506-37-2	Nimorazole	K-1900	226.23246	Antibiotic; Parasite	Anti-infection	Nimorazole (K-1900), a 2-nitroimidazole, is a hypoxic cell-radiation sensitizer. Nimorazole has anti-infective and anti-protozoal against trichomoniasis. Nimorazole has the potential for head and neck cancer[1][2].	Free Base	C9H14N4O3	13709.0	DMSO : 33.33 mg/mL (147.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=[N+](C1=CN=CN1CCN2CCOCC2)[O-]	https://www.medchemexpress.com/Nimorazole.html	Launched		91.0	P18	B13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16349	10.0	mM	37.0	DMSO	226.10659	13	B	pluskal_fda_drugs_5005_B13_id
212	HY-18767	HYCPK40902	B13	HYCPK40902	91z	121.0	1.0	C25	902.0	B13	1448347-49-6	Ivosidenib	AG-120	582.96	Isocitrate Dehydrogenase (IDH)	Metabolic Enzyme/Protease	Ivosidenib (AG-120) is an orally active inhibitor of isocitrate dehydrogenase 1 mutant (mIDH1) enzyme, it exhibits profound d-2-hydroxyglutatrate (2-HG) lowering in vivo. Ivosidenib (AG-120) has the potential for AML therapy due to its acceptable safety profile and clinical activity[1].	Free Base	C28H22ClF3N6O3	20567.0	DMSO : ≥ 39 mg/mL (66.90 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	ClC1=C([C@H](N(C2=CC(F)=CN=C2)C([C@H]3N(C4=NC=CC(C#N)=C4)C(CC3)=O)=O)C(NC5CC(F)(F)C5)=O)C=CC=C1	https://www.medchemexpress.com/Ivosidenib.html	Launched		91.0	C25	B14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18767	10.0	mM	38.0	DMSO	582.139401	14	B	pluskal_fda_drugs_5005_B14_id
563	HY-B1810	HYCPK40903	D13	HYCPK40903	91z	314.0	2.0	G26	903.0	D13	41570-61-0	Tulobuterol	C-78 (free base)	227.73	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Tulobuterol (C-78 free base) is a long-acting β2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol is also a sympathomimetic agent used as a transdermal patch, and increases normal diaphragm muscle strength[1].	Free Base	C12H18ClNO	115797.0	DMSO : 100 mg/mL (439.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	CC(C)(NCC(O)C1=CC=CC=C1Cl)C	https://www.medchemexpress.com/tulobuterol.html	Launched		91.0	G26	B14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1810	10.0	mM	38.0	DMSO	227.107692	14	B	pluskal_fda_drugs_5005_B14_id
632	HY-13702	HYCPK40903	N15	HYCPK40903	91z	1278.0	2.0	AA30	903.0	N15	63612-50-0	Nilutamide	Nilandron; RU 23908	317.22	Androgen Receptor; Parasite	Anti-infection; Others	Nilutamide (Nilandron) is an orally active nonsteroidal androgen receptor antagonist with affinity for androgen receptors but not for progestogen, estrogen or glucocorticoid receptors. Nilutamide can be used to research prostate cancer. Nilutamide also has antischistosomal properties[1][4].	Free Base	C12H10F3N3O4	43830.0	DMSO : ≥ 250 mg/mL (788.10 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Endocrinology	O=C1N(C2=CC=C([N+]([O-])=O)C(C(F)(F)F)=C2)C(C(C)(C)N1)=O	https://www.medchemexpress.com/nilutamide.html	Launched		91.0	AA30	B14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13702	10.0	mM	38.0	DMSO	317.06234	14	B	pluskal_fda_drugs_5005_B14_id
701	HY-14957	HYCPK40903	M20	HYCPK40903	91z	1192.0	2.0	Y40	903.0	M20	245765-41-7	Ozenoxacin	T-3912	363.41	Bacterial	Anti-infection	Ozenoxacin is a nonfluorinated quinolone antibacterial, which shows potent activities against the main microorganisms isolated from skin and soft tissue infections.	Free Acid	C21H21N3O3	28607.0	DMSO : 4.17 mg/mL (11.47 mM; ultrasonic and warming and heat to 70°C)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2CC2)C3=C(C=CC(C4=CC(C)=C(NC)N=C4)=C3C)C1=O)O	https://www.medchemexpress.com/Ozenoxacin.html	Launched		91.0	Y40	B14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14957	10.0	mM	38.0	DMSO	363.158292	14	B	pluskal_fda_drugs_5005_B14_id
752	HY-B1804	HYCPK40904	P03	HYCPK40904	91z	1493.0	3.0	AF5	904.0	P03	538-23-8	Tricaprilin	Trioctanoin; Glyceryl trioctanoate	470.68	Endogenous Metabolite	Metabolic Enzyme/Protease	Tricaprilin (Trioctanoin) is used in study for patients with mild to moderate Alzheimer's disease and has a role as an anticonvulsant and a plant metabolite[1][2].	Free Base	C27H50O6	42897.0	DMSO : 41.67 mg/mL (88.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCCCCCCC(OCC(OC(CCCCCCC)=O)COC(CCCCCCC)=O)=O	https://www.medchemexpress.com/tricaprilin.html	Launched		91.0	AF5	B14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1804	10.0	mM	38.0	DMSO	470.360739	14	B	pluskal_fda_drugs_5005_B14_id
800	HY-B1490	HYCPK40904	E07	HYCPK40904	91z	445.0	3.0	J13	904.0	E07	113-52-0	Imipramine (hydrochloride)		316.87	Apoptosis; Autophagy; Serotonin Transporter	Apoptosis; Autophagy; Neuronal Signaling	Imipramine hydrochloride is an orally active tertiary amine tricyclic antidepressant. Imipramine hydrochloride is a Fascin1 inhibitor with antitumor activities. Imipramine hydrochloride also inhibits serotonin transporter with an IC50 value of 32 nM. Imipramine hydrochloride stimulates U-87MG glioma cells autophagy and induces HL-60 cell apoptosis. Imipramine hydrochloride shows neuroprotective and immunomodulatory effects[1][2][3][4][5].	Hydrochloride	C19H25ClN2	23298.0	H2O : 62.5 mg/mL (197.24 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (315.59 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31.[H]Cl	https://www.medchemexpress.com/Imipramine-hydrochloride.html	Launched		91.0	J13	B14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1490	10.0	mM	38.0	DMSO	280.193949	14	B	pluskal_fda_drugs_5005_B14_id
1065	HY-15552	HYCPK40905	B04	HYCPK40905	91z	152.0	4.0	D8	905.0	B04	518-28-5	Podofilox	Podophyllotoxin	414.41	Microtubule/Tubulin	Cell Cycle/DNA Damage; Cytoskeleton	Podofilox (Podophyllotoxin) is a potent inhibitor of microtubule assembly and DNA topoisomerase II.	Free Base	C22H22O8	17027.0	DMSO : 100 mg/mL (241.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1OC[C@]2([H])[C@@H](O)C3=C(C=C4OCOC4=C3)[C@@H](C5=CC(OC)=C(OC)C(OC)=C5)[C@]21[H]	https://www.medchemexpress.com/Podophyllotoxin.html	Launched		91.0	D8	B14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15552	10.0	mM	38.0	DMSO	414.131468	14	B	pluskal_fda_drugs_5005_B14_id
1337	HY-B0524	HYCPK40905	B21	HYCPK40905	91z	186.0	4.0	D42	905.0	B21	5638-76-6	Betahistine		136.19	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Betahistine is an orally active histamine H1 receptor agonist and a H3 receptor antagonist[1]. Betahistine is used for the study of rheumatoid arthritis (RA)[3].		C8H12N2	68184.0	DMSO : 100 mg/mL (734.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	CNCCC1=NC=CC=C1	https://www.medchemexpress.com/betahistine.html	Launched		91.0	D42	B14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0524	10.0	mM	38.0	DMSO	136.100048	14	B	pluskal_fda_drugs_5005_B14_id
258	HY-B0023	HYCPK40902	P15	HYCPK40902	91z	1469.0	1.0	AE29	902.0	P15	123524-52-7	Azelnidipine	CS 905	582.65	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	"Azelnidipine(CS 905; Calblock) is a novel dihydropyridine derivative, a L-type calcium channel blocker, and an antihypertensive.
IC50 value:
Target: L-type calcium channel
Acute administration of azelnidipine prevents a sudden drop of cardiac function after acute stress. Azelnidipine may have a protective role in inflammation associated with atherosclerosis."	Free Base	C33H34N4O6	7190.0	DMSO : ≥ 100 mg/mL (171.63 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(N)NC(C)=C(C(OC(C)C)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OC3CN(C(C4=CC=CC=C4)C5=CC=CC=C5)C3	https://www.medchemexpress.com/Azelnidipine.html	Launched		91.0	AE29	B15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0023	10.0	mM	39.0	DMSO	582.247835	15	B	pluskal_fda_drugs_5005_B15_id
375	HY-B0590	HYCPK40902	H04	HYCPK40902	91z	679.0	1.0	O7	902.0	H04	58-46-8	Tetrabenazine	Ro 1-9569	317.42	Monoamine Transporter	Membrane Transporter/Ion Channel	Tetrabenazine (Ro 1-9569) is a reversible inhibitor of the vesicular monoamine transporter VMAT2 with the Kd value of 1.34 nM. Tetrabenazine can be used for research on diseases related to hyperactive movement disorders such as Huntington's disease[1][2][3].	Free Base	C19H27NO3	13370.0	DMSO : 33.33 mg/mL (105.00 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1[C@@H](CC(C)C)CN2CCC3=CC(OC)=C(OC)C=C3[C@]2([H])C1.[relative stereochemistry]	https://www.medchemexpress.com/Tetrabenazine.html	Launched		91.0	O7	B15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0590	10.0	mM	39.0	DMSO	317.199094	15	B	pluskal_fda_drugs_5005_B15_id
556	HY-N0264	HYCPK40903	M12	HYCPK40903	91z	1176.0	2.0	Y24	903.0	M12	1124-11-4	Ligustrazine	Chuanxiongzine; Tetramethylpyrazine	136.19	Apoptosis	Apoptosis	Ligustrazine (Chuanxiongzine), an alkylpyrazine isolated from  Ligusticum chuanxiong Hort. (Chuan Xiong)[1], is present in french fries, bread, cooked meats, tea, cocoa, coffee, beer, spirits, peanuts, filberts, dairy products and soy products as fragrance and flavouring ingredienexhibits. Ligustrazine also has potential nootropic and anti-inflammatory activities in rats[2][3].	Free Base	C8H12N2	39933.0	DMSO : 50 mg/mL (367.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease	CC1=C(C)N=C(C)C(C)=N1	https://www.medchemexpress.com/Tetramethylpyrazine.html	Launched		91.0	Y24	B15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0264	10.0	mM	39.0	DMSO	136.100048	15	B	pluskal_fda_drugs_5005_B15_id
640	HY-101474A	HYCPK40903	F16	HYCPK40903	91z	512.0	2.0	K32	903.0	F16	1691249-45-2	Zanubrutinib	BGB-3111	471.55	Btk	Protein Tyrosine Kinase/RTK	Zanubrutinib (BGB-3111) is a selective Bruton tyrosine kinase (Btk) inhibitor[1].	Free Base	C27H29N5O3	79640.0	DMSO : 200 mg/mL (424.13 mM; Need ultrasonic); Ethanol : < 1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	NC(C1=C2N(N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)[C@H](C5CCN(C(C=C)=O)CC5)CCN2)=O	https://www.medchemexpress.com/Zanubrutinib.html	Launched		91.0	K32	B15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101474A	10.0	mM	39.0	DMSO	471.22704	15	B	pluskal_fda_drugs_5005_B15_id
904	HY-U00124B	HYCPK40904	M13	HYCPK40904	91z	1225.0	3.0	Z25	904.0	M13	41544-24-5	Tromantadine (hydrochloride)		316.87	HSV	Anti-infection	Tromantadine hydrochloride, an Amantadine derivative with antiherpetic activity, inhibits herpes simplex virus type 1 (HSV-1) and HSV-2 replication[1].	Hydrochloride	C16H29ClN2O2	78882.0	DMSO : 62.5 mg/mL (197.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[H]Cl.O=C(COCCN(C)C)NC1(C[C@H](C2)C3)C[C@H]3C[C@H]2C1	https://www.medchemexpress.com/tromantadine-hydrochloride.html	Launched		91.0	Z25	B15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-U00124B	10.0	mM	39.0	DMSO	280.215078	15	B	pluskal_fda_drugs_5005_B15_id
1088	HY-W010950	HYCPK40905	I05	HYCPK40905	91z	826.0	4.0	R10	905.0	I05	54143-55-4	Flecainide		414.34	Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel	Flecainide is a potent and orally active antiarrhythmic agent. Flecainide blocks the cardiac fast inward Na+ current (INa) and the rapid component of the delayed rectifier K+ current. Flecainide prolongs the action potential duration (APD) in ventricular and atrial muscle fibres. Flecainide has the potential for the research of fetal tachycardias[1][2][3].		C17H20F6N2O3	190340.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F)NCC2NCCCC2	https://www.medchemexpress.com/flecainide.html	Launched		91.0	R10	B15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W010950	10.0	mM	39.0	DMSO	414.137812	15	B	pluskal_fda_drugs_5005_B15_id
1303	HY-W011100	HYCPK40905	P18	HYCPK40905	91z	1524.0	4.0	AF36	905.0	P18	2624-43-3	Cyclofenil		364.44	Estrogen Receptor/ERR; Influenza Virus	Anti-infection; Others	Cyclofenil is a selective estrogen receptor modulator and an ovulation-inducing agent. Cyclofenil shows an inhibitory effect on dengue virus replication in Vero cells with an EC50 of 1.62 μM. Cyclofenil has anti-dengue-virus activity[1][2].		C23H24O4	91167.0	DMSO : 100 mg/mL (274.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Endocrinology	CC(OC1=CC=C(/C(C2=CC=C(OC(C)=O)C=C2)=C3CCCCC\3)C=C1)=O	https://www.medchemexpress.com/cyclofenil.html	Launched		91.0	AF36	B15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W011100	10.0	mM	39.0	DMSO	364.167459	15	B	pluskal_fda_drugs_5005_B15_id
1342	HY-W011733	HYCPK40905	G21	HYCPK40905	91z	666.0	4.0	N42	905.0	G21	56776-01-3	Tulobuterol (hydrochloride)	C-78	264.19	Adrenergic Receptor; Antibiotic; Influenza Virus	Anti-infection; GPCR/G Protein; Neuronal Signaling	Tulobuterol hydrochloride (C-78) is a long-acting β2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol hydrochloride is also a sympathomimetic agent used as a transdermal patch, increases normal diaphragm muscle strength[1]. Tulobuterol hydrochloride inhibit rhinovirus replication and modulate airway inflammation[2].	Hydrochloride	C12H19Cl2NO	27104.0	DMSO : 50 mg/mL (189.26 mM; Need ultrasonic); H2O : 100 mg/mL (378.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Endocrinology; Inflammation/Immunology	CC(C)(NCC(O)C1=CC=CC=C1Cl)C.Cl	https://www.medchemexpress.com/Tulobuterol_hydrochloride.html	Launched		91.0	N42	B15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W011733	10.0	mM	39.0	DMSO	227.107692	15	B	pluskal_fda_drugs_5005_B15_id
80	HY-B1193	HYCPK40902	I03	HYCPK40902	91z	773.0	1.0	Q5	902.0	I03	50679-08-8	Terfenadine	(±)-Terfenadine; MDL-991	471.67	Apoptosis; Caspase; Histamine Receptor; Na+/Ca2+ Exchanger; Potassium Channel	Apoptosis; GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling	Terfenadine ((±)-Terfenadine) is a potent open-channel blocker of hERG with an IC50 of 204 nM[1]. Terfenadine, an H1 histamine receptor antagonist, acts as a potent apoptosis inducer in melanoma cells through modulation of Ca2+ homeostasis. Terfenadine induces ROS-dependent apoptosis, simultaneously activates Caspase-4, -2, -9[2].	Free Base	C32H41NO2	24050.0	DMSO : ≥ 50 mg/mL (106.01 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Endocrinology	OC(C1=CC=C(C(C)(C)C)C=C1)CCCN2CCC(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)CC2	https://www.medchemexpress.com/Terfenadine.html	Launched		91.0	Q5	B16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1193	10.0	mM	40.0	DMSO	471.31373	16	B	pluskal_fda_drugs_5005_B16_id
530	HY-B1221	HYCPK40903	C11	HYCPK40903	91z	214.0	2.0	E22	903.0	C11	530-78-9	Flufenamic acid		281.23	AMPK; Calcium Channel; Chloride Channel; COX; Parasite; Potassium Channel	Anti-infection; Epigenetics; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling; PI3K/Akt/mTOR	Flufenamic acid is a non-steroidal anti-inflammatory agent, inhibits cyclooxygenase (COX), activates AMPK, and also modulates ion channels, blocking chloride channels and L-type Ca2+ channels, modulating non-selective cation channels (NSC), activating K+ channels. Flufenamic acid binds to the central pocket of TEAD2 YBD and inhibits both TEAD function and TEAD-YAP-dependent processes, such as cell migration and proliferation.	Free Acid	C14H10F3NO2	17479.0	DMSO : 100 mg/mL (355.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C1=CC=CC=C1NC2=CC=CC(C(F)(F)F)=C2	https://www.medchemexpress.com/Flufenamic-acid.html	Launched		91.0	E22	B16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1221	10.0	mM	40.0	DMSO	281.066363	16	B	pluskal_fda_drugs_5005_B16_id
565	HY-A0067	HYCPK40903	F13	HYCPK40903	91z	506.0	2.0	K26	903.0	F13	131-57-7	Oxybenzone	Benzophenone 3	228.24	Apoptosis; Autophagy; RAR/RXR	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Oxybenzone (Benzophenone 3) is a commonly used UV filter in sun tans and skin protectants. Oxybenzone act as endocrine disrupting chemicals (EDCs) and can pass through the placental and blood-brain barriers. Benzophenone-3 impairs autophagy, alters epigenetic status, and disrupts retinoid X receptor signaling in apoptotic neuronal cells[1][2][3].	Free Base	C14H12O3	16651.0	DMSO : 100 mg/mL (438.14 mM; Need ultrasonic); H2O : 1 mg/mL (4.38 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=C(OC)C=C1O)C2=CC=CC=C2	https://www.medchemexpress.com/Oxybenzone.html	Launched		91.0	K26	B16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0067	10.0	mM	40.0	DMSO	228.078644	16	B	pluskal_fda_drugs_5005_B16_id
570	HY-15440A	HYCPK40903	B19	HYCPK40903	91z	134.0	2.0	C38	903.0	B19	864953-29-7	Fostemsavir	BMS-663068	583.49	HIV	Anti-infection	Fostemsavir (BMS-663068) is the phosphonooxymethyl prodrug of BMS-626529.  Fostemsavir (BMS-663068) is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells.	Free Acid	C25H26N7O8P	23236.0	H2O : 20 mg/mL (34.28 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (171.38 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(N1CCN(C(C2=CC=CC=C2)=O)CC1)C(C3=CN(COP(O)(O)=O)C4=C3C(OC)=CN=C4N5N=C(C)N=C5)=O	https://www.medchemexpress.com/BMS-663068.html	Launched		91.0	C38	B16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15440A	10.0	mM	40.0	DMSO	583.158047	16	B	pluskal_fda_drugs_5005_B16_id
936	HY-B1012	HYCPK40904	M15	HYCPK40904	91z	1229.0	3.0	Z29	904.0	M15	152-43-2	Quinestrol	W-3566	364.52	Estrogen Receptor/ERR	Others	Quinestrol  is a synthetic estrogen, used in hormone replacement therapy, and occasionally to treat breast cancer and prostate cancer	Free Base	C25H32O2	217977.0	DMSO : 250 mg/mL (685.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C#C[C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=C(C=CC(OC5CCCC5)=C4)[C@@]3([H])CC[C@]12C	https://www.medchemexpress.com/Quinestrol.html	Launched		91.0	Z29	B16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1012	10.0	mM	40.0	DMSO	364.24023	16	B	pluskal_fda_drugs_5005_B16_id
976	HY-B0590A	HYCPK40904	I18	HYCPK40904	91z	851.0	3.0	R35	904.0	I18	718635-93-9	Tetrabenazine (Racemate)	Ro 1-9569 (Racemate)	317.42	Monoamine Transporter	Membrane Transporter/Ion Channel	"Tetrabenazine Racemate (Ro 1-9569 Racemate)  is a selective and reversible inhibitor of vesicular monoamine transporter-2 (VMAT-2).
(1) The reference for administration is 0.25-0.75 mg/kg IP
(2) Injections of tetrabenazine into accumbens core also reduced FR5 lever pressing and increased chow intake. 
(3) Tetrabenazine (Racemate) reduced extracellular DA and altered DARPP-32 signaling in both substance-P- and enkephalin-containing accumbens neurons. 
(4) Tetrabenazine (Racemate) inhibits locomotor activity and produces hypothermia upon systemic administration in rats and mice."	Free Base	C19H27NO3	21090.0	DMSO : 50 mg/mL (157.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1C(CC(C)C)CN2CCC3=CC(OC)=C(OC)C=C3C2C1	https://www.medchemexpress.com/Tetrabenazine-Racemate.html	Launched		91.0	R35	B16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0590A	10.0	mM	40.0	DMSO	317.199094	16	B	pluskal_fda_drugs_5005_B16_id
1027	HY-17429	HYCPK40904	L21	HYCPK40904	91z	1145.0	3.0	X41	904.0	L21	54143-56-5	Flecainide (acetate)	R-818	474.39	Sodium Channel	Membrane Transporter/Ion Channel	Flecainide acetate (R-818) is a class 1C antiarrhythmic drug especially used for the management of supraventricular arrhythmia; works by blocking the Nav1.5 sodium channel in the heart, causing prolongation of the cardiac action potential.	Acetate	C19H24F6N2O5	16833.0	H2O : 20 mg/mL (42.16 mM; Need ultrasonic); DMSO : 50 mg/mL (105.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(NCC1NCCCC1)C2=CC(OCC(F)(F)F)=CC=C2OCC(F)(F)F.CC(O)=O	https://www.medchemexpress.com/flecainide-acetate.html	Launched		91.0	X41	B16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17429	10.0	mM	40.0	DMSO	414.137812	16	B	pluskal_fda_drugs_5005_B16_id
1281	HY-N0550	HYCPK40905	J17	HYCPK40905	91z	946.0	4.0	T34	905.0	J17	18172-67-3	β-Pinene	(-)-β-Pinene	136.23	Bacterial	Anti-infection	β-Pinene ((-)-β-Pinene), a major component of turpentine, inhibit infectious bronchitis virus (IBV) with an IC50 of 1.32 mM. β-Pinene presents antimicrobial activity[1][2].		C10H16	64130.0	DMSO : ≥ 250 mg/mL (1835.13 mM)	DMSO Solution	10mM  * 100uL	Infection	C=C1[C@@](C2)([H])C(C)(C)[C@@]2([H])CC1	https://www.medchemexpress.com/β-pinene.html	Launched		91.0	T34	B16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0550	10.0	mM	40.0	DMSO	136.125201	16	B	pluskal_fda_drugs_5005_B16_id
139	HY-B0811	HYCPK40902	A08	HYCPK40902	91z	15.0	1.0	A15	902.0	A08	65-45-2	Salicylamide	2-Hydroxybenzamide	137.14	Others	Others	Salicylamide is an inhibitor of microsomal UDP-glucuronosyltransferase. Salicylamide is an analgesic and anti-pyretic agent.	Free Base	C7H7NO2	26080.0	DMSO : ≥ 100 mg/mL (729.18 mM); H2O : 0.1 mg/mL (0.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(N)C1=CC=CC=C1O	https://www.medchemexpress.com/Salicylamide.html	Launched		91.0	A15	B17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0811	10.0	mM	41.0	DMSO	137.047678	17	B	pluskal_fda_drugs_5005_B17_id
270	HY-16561	HYCPK40902	L16	HYCPK40902	91z	1087.0	1.0	W31	902.0	L16	501-36-0	Resveratrol	trans-Resveratrol; SRT501	228.24	Antibiotic; Apoptosis; Autophagy; Bacterial; Fungal; IKK; Keap1-Nrf2; Mitophagy; Sirtuin	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; NF-κB	Resveratrol (trans-Resveratrol; SRT501), a natural polyphenolic phytoalexin that possesses anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. Resveratrol (SRT 501) has a wide spectrum of targets including mTOR, JAK, β-amyloid, Adenylyl cyclase, IKKβ, DNA polymerase. Resveratrol also is a specific SIRT1 activator[1][2][3][4]. Resveratrol is a potent pregnane X receptor (PXR) inhibitor[5]. Resveratrol is an Nrf2 activator, ameliorates aging-related progressive renal injury in mice model[6]. Resveratrol increases production of NO in endothelial cells[7].	Free Base	C14H12O3	58706.0	DMSO : 100 mg/mL (438.14 mM; Need ultrasonic); Ethanol : 50 mg/mL (219.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	OC1=CC=C(/C=C/C2=CC(O)=CC(O)=C2)C=C1	https://www.medchemexpress.com/Resveratrol.html	Launched		91.0	W31	B17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16561	10.0	mM	41.0	DMSO	228.078644	17	B	pluskal_fda_drugs_5005_B17_id
429	HY-B0467B	HYCPK40903	N09	HYCPK40903	91z	1266.0	2.0	AA18	903.0	N09	61336-70-7	Amoxicillin (trihydrate)	Amoxycillin (trihydrate)	419.45	Antibiotic; Bacterial	Anti-infection	Amoxicillin (Amoxycillin) trihydrateis an antibiotic with good oral absorption and broad spectrum antimicrobial activity. Amoxicillin trihydrateis inhibits the biosynthesis of polypeptides in the cell wall, thereby inhibiting cell growth[1][2][3].	Free Acid	C16H25N3O8S	13340.0	DMSO : 10 mg/mL (23.84 mM; Need ultrasonic); H2O : 2 mg/mL (4.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC([C@@H]1N(C2=O)[C@]([C@@H]2NC([C@@H](C3=CC=C(O)C=C3)N)=O)([H])SC1(C)C)=O.[3H2O]	https://www.medchemexpress.com/Amoxicillin-trihydrate.html	Launched		91.0	AA18	B17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0467B	10.0	mM	41.0	DMSO	365.104542	17	B	pluskal_fda_drugs_5005_B17_id
739	HY-B0542	HYCPK40904	C03	HYCPK40904	91z	245.0	3.0	F5	904.0	C03	11018-89-6	Ouabain (Octahydrate)	Acocantherine; G-Strophanthin	728.77	Autophagy; Na+/K+ ATPase	Autophagy; Membrane Transporter/Ion Channel	Ouabain Octahydrate is an inhibitor of Na+/K+-ATPase, used for the treatment of congestive heart failure.	Free Base	C29H60O20	133935.0	DMSO : ≥ 125 mg/mL (171.52 mM); H2O : 10 mg/mL (13.72 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	OC[C@@]([C@](CC1)(C[C@@H](O[C@@](O[C@@H](C)[C@H](O)[C@H]2O)([H])[C@@H]2O)C3)O)([C@@H]3O)[C@]([C@@H](C[C@@]45C)O)([H])[C@]1([H])[C@]4(CC[C@@H]5C(CO6)=CC6=O)O.[8 H2O]	https://www.medchemexpress.com/Ouabain-Octahydrate.html	Launched		91.0	F5	B17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0542	10.0	mM	41.0	DMSO	584.283277	17	B	pluskal_fda_drugs_5005_B17_id
776	HY-B1046	HYCPK40904	M05	HYCPK40904	91z	1209.0	3.0	Z9	904.0	M05	2030-63-9	Clofazimine		473.40	Antibiotic; Bacterial	Anti-infection	Clofazimine is an iminophenazine dye, has a marked anti-inflammatory effect, has been used in combination with other antimycobacterial drugs to treat AIDS and Crohn's disease.	Free Base	C27H22Cl2N4	122478.0	DMSO : 8.93 mg/mL (18.86 mM; ultrasonic and warming and heat to 60°C); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(/N=C1C(NC2=CC=C(Cl)C=C2)=CC3=NC4=C(C=CC=C4)N(C5=CC=C(Cl)C=C5)C3=C/1)C	https://www.medchemexpress.com/Clofazimine.html	Launched		91.0	Z9	B17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1046	10.0	mM	41.0	DMSO	472.122152	17	B	pluskal_fda_drugs_5005_B17_id
1020	HY-B0251	HYCPK40904	E21	HYCPK40904	91z	473.0	3.0	J41	904.0	E21	107724-20-9	Eplerenone	Epoxymexrenone	414.49	Endogenous Metabolite; Mineralocorticoid Receptor	Metabolic Enzyme/Protease	Eplerenone (Epoxymexrenone) is a selective, highly specific and orally active aldosterone blocker (SAB). Eplerenone also is a selective mineralocorticoid receptor antagonist (MRA) with IC50 value of 0.081 μM.  Eplerenone can be used for the research of hypertension, atherosclerosis, chronic systolic heart failure (HF) and cardiovascular (CV)[1][2].	Free Base	C24H30O6	16488.0	DMSO : 25 mg/mL (60.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C(CC1)O[C@@]21CC[C@@]3([H])[C@]4([H])[C@H](C(OC)=O)CC5=CC(CC[C@]5(C)[C@@]46[C@H](O6)C[C@@]32C)=O	https://www.medchemexpress.com/eplerenone.html	Launched		91.0	J41	B17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0251	10.0	mM	41.0	DMSO	414.204239	17	B	pluskal_fda_drugs_5005_B17_id
1113	HY-B1239	HYCPK40905	B07	HYCPK40905	91z	158.0	4.0	D14	905.0	B07	548-66-3	Drofenine (hydrochloride)	Hexahydroadiphenine hydrochloride	353.93	Cholinesterase (ChE)	Neuronal Signaling	"Drofenine hydrochloride is a potent competitive inhibitor of BChE, and the ki values of Drofenine is calculated to be 3 uM.
IC50 value: 3 uM (ki)
Target: BChE
Benactyzine is widely used anticholinergic drugs, acts on smooth muscle to stop muscle spasms."	Hydrochloride	C20H32ClNO2	33446.0	H2O : ≥ 33.3 mg/mL (94.09 mM); DMSO : ≥ 75 mg/mL (211.91 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCN(CC)CC)C(C1CCCCC1)C2=CC=CC=C2.[H]Cl	https://www.medchemexpress.com/Drofenine-hydrochloride.html	Launched		91.0	D14	B17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1239	10.0	mM	41.0	DMSO	317.235479	17	B	pluskal_fda_drugs_5005_B17_id
1191	HY-12785	HYCPK40905	P11	HYCPK40905	91z	1510.0	4.0	AF22	905.0	P11	54029-12-8	Albendazole sulfoxide	Ricobendazole; Albendazole oxide	281.33	Parasite	Anti-infection	Albendazole sulfoxide (Ricobendazole), the main active metabolite of Albendazole, exhibits anti-parasite effect against Echinococcus multilocularis Metacestodes[1].		C12H15N3O3S	63984.0	DMSO : 25 mg/mL (88.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(OC)NC1=NC2=CC=C(S(CCC)=O)C=C2N1	https://www.medchemexpress.com/albendazole-sulfoxide.html	Launched		91.0	AF22	B17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12785	10.0	mM	41.0	DMSO	281.083412	17	B	pluskal_fda_drugs_5005_B17_id
213	HY-B0467A	HYCPK40902	C13	HYCPK40902	91z	217.0	1.0	E25	902.0	C13	26787-78-0	Amoxicillin	Amoxycillin	365.40	Antibiotic; Bacterial	Anti-infection	Amoxicillin (Amoxycillin) is an antibiotic with good oral absorption and broad spectrum antimicrobial activity. Amoxicillin inhibits the biosynthesis of polypeptides in the cell wall, thereby inhibiting cell growth[1][2][3].	Free Acid	C16H19N3O5S	90331.0	DMSO : 83.33 mg/mL (228.05 mM; Need ultrasonic); H2O : 2 mg/mL (5.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	OC([C@@H]1N(C2=O)[C@]([C@@H]2NC([C@@H](C3=CC=C(O)C=C3)N)=O)([H])SC1(C)C)=O	https://www.medchemexpress.com/amoxicillin.html	Launched		91.0	E25	B18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0467A	10.0	mM	42.0	DMSO	365.104542	18	B	pluskal_fda_drugs_5005_B18_id
925	HY-13511A	HYCPK40904	B15	HYCPK40904	91z	173.0	3.0	D29	904.0	B15	182349-12-8	Rupatadine (Fumarate)	UR-12592 (Fumarate)	532.03	Autophagy; Histamine Receptor	Autophagy; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Rupatadine (UR-12592) Fumarate is a potent, orally active and long-lasting dual PAF/H1 antagonist, with Kis of 0.55 μM and 0.1 μM, respectively. Rupatadine Fumarate can be used for the research of allergic rhinitis and urticaria[1][2][3].	Fumarate	C30H30ClN3O4	13892.0	DMSO : 30 mg/mL (56.39 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC1=CN=CC(CN2CC/C(CC2)=C3C4=CC=C(Cl)C=C4CCC5=CC=CN=C5\3)=C1.O=C(O)/C=C/C(O)=O	https://www.medchemexpress.com/Rupatadine-Fumarate.html	Launched		91.0	D29	B18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13511A	10.0	mM	42.0	DMSO	415.181526	18	B	pluskal_fda_drugs_5005_B18_id
989	HY-B0238	HYCPK40904	F19	HYCPK40904	91z	565.0	3.0	L37	904.0	F19	78613-38-4	Amorolfine (hydrochloride)	Ro 14-4767/002	353.97	Antibiotic; Fungal	Anti-infection	Amorolfine (Ro 14-4767/002) hydrochloride is a potent anti-fungal agent. Amorolfine hydrochloride inhibits ergosterol biosynthesis. Amorolfine hydrochloride has the potential for the research of Neoscytalidium dimidiatum onychomycosis[1][2].	Hydrochloride	C21H36ClNO	66276.0	DMSO : 12.5 mg/mL (35.31 mM; Need ultrasonic); H2O : 3.33 mg/mL (9.41 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	C[C@@H]1O[C@H](C)CN(CC(C)CC2=CC=C(C(C)(C)CC)C=C2)C1.Cl	https://www.medchemexpress.com/Amorolfine-hydrochloride.html	Launched		91.0	L37	B18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0238	10.0	mM	42.0	DMSO	317.271865	18	B	pluskal_fda_drugs_5005_B18_id
1070	HY-12404	HYCPK40905	G04	HYCPK40905	91z	632.0	4.0	N8	905.0	G04	908-54-3	Diminazene (aceturate)	Diminazene (diaceturate)	515.52	Angiotensin-converting Enzyme (ACE); Parasite	Anti-infection; Metabolic Enzyme/Protease	Diminazene aceturate (Diminazene diaceturate) is an anti-trypanosome agent for livestock. The main biochemical mechanism of the trypanocidal actions of Diminazene aceturate is by binding to trypanosomal kinetoplast DNA (kDNA) in a non-intercalative manner through specific interaction with sites rich in adenine-thymine base pairs. Diminazene aceturate is also an angiotensin-converting enzyme 2 (ACE2) activator and has strong and potent anti-inflammatory properties[1][2][3].	Aceturate	C22H29N9O6	108944.0	H2O : 50 mg/mL (96.99 mM; Need ultrasonic); DMSO : 25 mg/mL (48.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(O)CNC(C)=O.N=C(C1=CC=C(/N=N/NC2=CC=C(C(N)=N)C=C2)C=C1)N.O=C(O)CNC(C)=O	https://www.medchemexpress.com/diminazene-aceturate.html	Launched		91.0	N8	B18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12404	10.0	mM	42.0	DMSO	281.138893	18	B	pluskal_fda_drugs_5005_B18_id
1095	HY-10284	HYCPK40905	P05	HYCPK40905	91z	1498.0	4.0	AF10	905.0	P05	668270-12-0	Linagliptin	BI 1356	472.54	Autophagy; Dipeptidyl Peptidase; Ferroptosis	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.	Free Base	C25H28N8O2	10993.0	DMSO : 25 mg/mL (52.91 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C1N(C2=C(C(N1CC3=NC(C)=C4C=CC=CC4=N3)=O)N(CC#CC)C(N5CCC[C@@H](N)C5)=N2)C	https://www.medchemexpress.com/Linagliptin.html	Launched		91.0	AF10	B18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10284	10.0	mM	42.0	DMSO	472.233522	18	B	pluskal_fda_drugs_5005_B18_id
1190	HY-78726	HYCPK40905	O11	HYCPK40905	91z	1414.0	4.0	AD22	905.0	O11	226700-79-4	Fosamprenavir	Amprenavir phosphate; GW 433908	585.61	Endogenous Metabolite; HIV	Anti-infection; Metabolic Enzyme/Protease	Fosamprenavir (Amprenavir phosphate;GW 433908) is a phosphate ester prodrug of the antiretroviral protease inhibitor Amprenavir, with improved solubility[1]. Anti-HIV infection[1].	Free Acid	C25H36N3O9PS	10321.0	DMSO : ≥ 100 mg/mL (170.76 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(O[C@@H]1COCC1)N[C@@H](CC2=CC=CC=C2)[C@H](OP(O)(O)=O)CN(S(=O)(C3=CC=C(N)C=C3)=O)CC(C)C	https://www.medchemexpress.com/Fosamprenavir.html	Launched		91.0	AD22	B18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-78726	10.0	mM	42.0	DMSO	585.190987	18	B	pluskal_fda_drugs_5005_B18_id
1214	HY-B0167A	HYCPK40905	G13	HYCPK40905	91z	650.0	4.0	N26	905.0	G13	54-21-7	Sodium Salicylate	Salicylic acid (sodium salt); 2-Hydroxybenzoic acid (sodium salt)	160.10	Apoptosis; Autophagy; COX; Endogenous Metabolite; NF-κB; Ribosomal S6 Kinase (RSK)	Apoptosis; Autophagy; Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB	Sodium Salicylate (Salicylic acid sodium salt) inhibits cyclo-oxygenase-2 (COX-2) activity independently of transcription factor (NF-κB) activation[1]. Sodium Salicylate is also a S6K inhibitor.Sodium Salicylate is a NF-κB inhibitor that decreases inflammatory gene expression and improves repair in aged muscle[4].	Sodium	C7H5NaO3	47075.0	H2O : ≥ 100 mg/mL (624.61 mM); DMSO : 100 mg/mL (624.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(O[Na])C1=CC=CC=C1O	https://www.medchemexpress.com/Sodium-Salicylate.html	Launched		91.0	N26	B18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0167A	10.0	mM	42.0	DMSO	138.031694	18	B	pluskal_fda_drugs_5005_B18_id
1270	HY-B0428	HYCPK40905	O16	HYCPK40905	91z	1424.0	4.0	AD32	905.0	O16	82571-53-7	Ozagrel	OKY-046	228.25	Prostaglandin Receptor	GPCR/G Protein	Ozagrel (OKY-046)is an anti-asthmatic agent and a thromboxane A2 (TXA2) synthase inhibitor. Ozagrel is an antiplatelet agent, which selectively inhibits human platelet aggregation with an IC50 of 53.12 μM[1].	Free Acid	C13H12N2O2	14984.0	DMSO : 50 mg/mL (219.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O)/C=C/C1=CC=C(CN2C=CN=C2)C=C1	https://www.medchemexpress.com/Ozagrel.html	Launched		91.0	AD32	B18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0428	10.0	mM	42.0	DMSO	228.089878	18	B	pluskal_fda_drugs_5005_B18_id
94	HY-B1729	HYCPK40902	D05	HYCPK40902	91z	297.0	1.0	G9	902.0	D05	122-99-6	Phenoxyethanol		138.16	Bacterial	Anti-infection	Phenoxyethanol has a broad spectrum of antimicrobial activity against various gram-negative and gram-positive bacteria. Phenoxyethanol is an uncouple agent in  oxidative phosphorylation from respiration and competitively inhibits malate dehydrogenase. Phenoxyethanol is used as a preservative in cosmetic, vaccine, and textile, et al[1].		C8H10O2	105783.0	DMSO : 100 mg/mL (723.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OCCOC1=CC=CC=C1	https://www.medchemexpress.com/phenoxyethanol.html	Launched		91.0	G9	B19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1729	10.0	mM	43.0	DMSO	138.06808	19	B	pluskal_fda_drugs_5005_B19_id
393	HY-14302	HYCPK40902	B18	HYCPK40902	91z	131.0	1.0	C35	902.0	B18	89365-50-4	Salmeterol	GR33343X	415.57	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Salmeterol (GR33343X) is a potent and selective human β2 adrenoceptor agonist. Salmeterol shows potent stimulation of cAMP accumulation in CHO cells expressing human β2, β1 and β3 adrenoceptors with pEC50s of 9.6, 6.1, and 5.9, respectively[1].	Free Base	C25H37NO4	105533.0	DMSO : ≥ 100 mg/mL (240.63 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	OC1=CC=C(C(O)CNCCCCCCOCCCCC2=CC=CC=C2)C=C1CO	https://www.medchemexpress.com/Salmeterol.html	Launched		91.0	C35	B19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14302	10.0	mM	43.0	DMSO	415.272259	19	B	pluskal_fda_drugs_5005_B19_id
428	HY-14739	HYCPK40903	M09	HYCPK40903	91z	1170.0	2.0	Y18	903.0	M09	856676-23-8	Choline Fenofibrate	ABT-335	421.91	COX; PPAR	Cell Cycle/DNA Damage; Immunology/Inflammation	Choline Fenofibrate (ABT-335), a choline salt of Fenofibric acid (HY-B0760), releases free Fenofibric acid in the gastrointestinal tract. Fenofibric acid is a PPAR activator with antihyperlipidemic effect[1].	Choline	C22H28ClNO5	22604.0	Ethanol : 33.33 mg/mL (79.00 mM; Need ultrasonic); DMSO : 20 mg/mL (47.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CC=C(OC(C)(C([O-])=O)C)C=C1)C2=CC=C(Cl)C=C2.C[N+](C)(CCO)C	https://www.medchemexpress.com/Choline-Fenofibrate.html	Launched		91.0	Y18	B19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14739	10.0	mM	43.0	DMSO	318.065887	19	B	pluskal_fda_drugs_5005_B19_id
476	HY-B0500	HYCPK40903	A07	HYCPK40903	91z	14.0	2.0	A14	903.0	A07	5560-59-8	Alverine (citrate)	NSC 35459	473.56	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Alverine citrate is a 5-HT1A receptor antagonist, with an IC50 of 101 nM.	Citrate	C26H35NO7	14900.0	DMSO : 100 mg/mL (211.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Alverine-citrate.html	Launched		91.0	A14	B19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0500	10.0	mM	43.0	DMSO	281.21435	19	B	pluskal_fda_drugs_5005_B19_id
596	HY-17431	HYCPK40903	J13	HYCPK40903	91z	890.0	2.0	S26	903.0	J13	226700-81-8	Fosamprenavir (Calcium Salt)	GW433908G	623.67	Endogenous Metabolite; HIV	Anti-infection; Metabolic Enzyme/Protease	Fosamprenavir Calcium Salt (GW433908G) is a phosphate ester prodrug of the antiretroviral protease inhibitor Amprenavir, with improved solubility[1]. Anti-HIV infection[1].	Calcium	C25H34CaN3O9PS	10302.0	DMSO : 50 mg/mL (80.17 mM; Need ultrasonic); H2O : 0.25 mg/mL (0.40 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	O=C(O[C@@H]1COCC1)N[C@@H](CC2=CC=CC=C2)[C@H](OP([O-])([O-])=O)CN(S(=O)(C3=CC=C(N)C=C3)=O)CC(C)C.[Ca+2]	https://www.medchemexpress.com/fosamprenavir-calcium-salt.html	Launched		91.0	S26	B19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17431	10.0	mM	43.0	DMSO	585.190987	19	B	pluskal_fda_drugs_5005_B19_id
940	HY-B0428A	HYCPK40904	E16	HYCPK40904	91z	463.0	3.0	J31	904.0	E16	189224-26-8	Ozagrel (sodium)	OKY-046 (sodium)	250.23	Prostaglandin Receptor	GPCR/G Protein	Ozagrel sodium (OKY-046 sodium) is a thromboxane A2 (TXA2) synthase inhibitor. Ozagrel sodium is an antiplatelet agent, which selectively inhibits human platelet aggregation with an IC50 of 53.12 μM[1].	Sodium	C13H11N2NaO2	14983.0	H2O : 50 mg/mL (199.82 mM; Need ultrasonic); DMSO : 6.25 mg/mL (24.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O[Na])/C=C/C1=CC=C(CN2C=CN=C2)C=C1	https://www.medchemexpress.com/Ozagrel-sodium.html	Launched		91.0	J31	B19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0428A	10.0	mM	43.0	DMSO	228.089878	19	B	pluskal_fda_drugs_5005_B19_id
1195	HY-14818A	HYCPK40905	D12	HYCPK40905	91z	360.0	4.0	H24	905.0	D12	203120-46-1	Laninamivir octanoate	CS-8958	472.53	Influenza Virus	Anti-infection	Laninamivir octanoate (CS-8958), a prodrug of Laninamivir, is a long-acting neuraminidase (NA) inhibitor with anti-influenza virus activity. Laninamivir octanoate shows anti-influenza activity against Oseltamivir-resistant viruses, and also against the pandemic influenza viruses[1][2].		C21H36N4O8	96517.0	DMSO : 100 mg/mL (211.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC(N[C@H]1[C@](OC(C(O)=O)=C[C@@H]1NC(N)=N)([H])[C@H](OC)[C@H](O)COC(CCCCCCC)=O)=O	https://www.medchemexpress.com/laninamivir-octanoate.html	Launched		91.0	H24	B19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14818A	10.0	mM	43.0	DMSO	472.253314	19	B	pluskal_fda_drugs_5005_B19_id
1325	HY-B0467	HYCPK40905	F20	HYCPK40905	91z	568.0	4.0	L40	905.0	F20	34642-77-8	Amoxicillin (sodium)	Amoxycillin (sodium)	387.39	Antibiotic; Bacterial	Anti-infection	Amoxicillin (Amoxycillin) sodium is an antibiotic with good oral absorption and broad spectrum antimicrobial activity. Amoxicillin sodium inhibits the biosynthesis of polypeptides in the cell wall, thereby inhibiting cell growth[1][2][3].	Sodium	C16H18N3NaO5S	83973.0	DMSO : 10 mg/mL (25.81 mM; Need ultrasonic); H2O : 100 mg/mL (258.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H]1N(C2=O)[C@]([C@@H]2NC([C@@H](C3=CC=C(O)C=C3)N)=O)([H])SC1(C)C)O[Na]	https://www.medchemexpress.com/Amoxicillin-sodium.html	Launched		91.0	L40	B19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0467	10.0	mM	43.0	DMSO	365.104542	19	B	pluskal_fda_drugs_5005_B19_id
226	HY-106467B	HYCPK40902	P13	HYCPK40902	91z	1465.0	1.0	AE25	902.0	P13	55750-05-5	Caroverine (hydrochloride)	Tinnex (hydrochloride)	401.93	iGluR	Membrane Transporter/Ion Channel; Neuronal Signaling	Caroverine (Tinnex) hydrochloride is a potent, competitive and reversible antagonist of NMDA and AMPA glutamate receptor. Caroverine hydrochloride is also an antioxidant and calcium-blocking agent that exhibits vasorelaxant action. Caroverine hydrochloride can be used for the research of inner ear tinnitus[1][2][3].	Hydrochloride	C22H28ClN3O2	102299.0	DMSO : 100 mg/mL (248.80 mM; Need ultrasonic); H2O : 20 mg/mL (49.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1N(CCN(CC)CC)C2=C(C=CC=C2)N=C1CC3=CC=C(OC)C=C3.[H]Cl	https://www.medchemexpress.com/caroverine-hydrochloride.html	Launched		91.0	AE25	B20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-106467B	10.0	mM	44.0	DMSO	365.210327	20	B	pluskal_fda_drugs_5005_B20_id
259	HY-W009326	HYCPK40902	A16	HYCPK40902	91z	31.0	1.0	A31	902.0	A16	59227-89-3	Laurocapram		281.48	Others	Others	Laurocapram is a absorption enhancer and has been one of the most effective for substances of both lipophilic and hydrophilic nature[1].		C18H35NO	45494.0	DMSO : 100 mg/mL (355.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C1N(CCCCCCCCCCCC)CCCCC1	https://www.medchemexpress.com/laurocapram.html	Launched		91.0	A31	B20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W009326	10.0	mM	44.0	DMSO	281.271865	20	B	pluskal_fda_drugs_5005_B20_id
621	HY-18690A	HYCPK40903	C15	HYCPK40903	91z	222.0	2.0	E30	903.0	C15	1650550-25-6	Enasidenib (mesylate)	AG-221 mesylate	569.48	Isocitrate Dehydrogenase (IDH)	Metabolic Enzyme/Protease	Enasidenib mesylate is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes.	Mesylate	C20H21F6N7O4S	29394.0	DMSO : ≥ 100 mg/mL (175.60 mM)	DMSO Solution	10mM  * 100uL	Cancer	CS(=O)(O)=O.CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1	https://www.medchemexpress.com/Enasidenib_mesylate.html	Launched		91.0	E30	B20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18690A	10.0	mM	44.0	DMSO	473.139877	20	B	pluskal_fda_drugs_5005_B20_id
861	HY-B0191	HYCPK40904	B11	HYCPK40904	91z	165.0	3.0	D21	904.0	B11	155206-00-1	Bimatoprost	AGN 192024	415.57	Prostaglandin Receptor	GPCR/G Protein	"Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension.
Target: Prostaglandin Receptor
Bimatoprost is a prostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. In December 2008, the indication to lengthen eyelashes was approved by the U.S. Food and Drug Administration (FDA); the cosmetic formulation of bimatoprost is sold as Latisse. In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.
Bimatoprost activates prostamide alpha F2 receptors found in the hair follicle to stimulate its growth rate. Research led by Professor Randall and the University of Bradford found that it may also offer a treatment for scalp hair regrowth in trials conducted on samples taken from men undergoing hair transplants. According to Allergan's package labeling, users of its Latisse cosmetic product didn't develop darker irises in clinical studies; however, ""patients should be advised about the potential for increased brown iris pigmentation which is likely to be permanent."""	Free Base	C25H37NO4	97452.0	DMSO : ≥ 100 mg/mL (240.63 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C(NCC)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCC2=CC=CC=C2)[C@H](O)C[C@@H]1O	https://www.medchemexpress.com/Bimatoprost.html	Launched		91.0	D21	B20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0191	10.0	mM	44.0	DMSO	415.272259	20	B	pluskal_fda_drugs_5005_B20_id
999	HY-13315	HYCPK40904	P19	HYCPK40904	91z	1525.0	3.0	AF37	904.0	P19	151767-02-1	Montelukast (sodium)	MK0476	608.17	Leukotriene Receptor	GPCR/G Protein	Montelukast sodium (MK0476) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast sodium decreases eosinophil infiltration into the asthmatic airways. Montelukast sodium can also be used for COVID-19 research[1][2][3][4].	Sodium	C35H35ClNNaO3S	26447.0	DMSO : 50 mg/mL (82.21 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (82.21 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	ClC1=CC2=C(C=C1)C=CC(/C=C/C3=CC([C@H](SCC4(CC(O[Na])=O)CC4)CCC5=CC=CC=C5C(C)(O)C)=CC=C3)=N2	https://www.medchemexpress.com/Montelukast-sodium.html	Launched		91.0	AF37	B20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13315	10.0	mM	44.0	DMSO	585.210443	20	B	pluskal_fda_drugs_5005_B20_id
1031	HY-B0568	HYCPK40904	P21	HYCPK40904	91z	1529.0	3.0	AF41	904.0	P21	30652-11-0	Deferiprone		139.15	Ferroptosis; HCV	Anti-infection; Apoptosis	"Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload. 
Target：
Deferiprone is an orphan drug designed and developed primarily by academic initiatives for the treatment of iron overload in thalassaemia. Deferiprone has been used in several other iron or other metal imbalance conditions and has prospects of wider clinical applications. Deferiprone has high affinity for iron and interacts with almost all the iron pools at the molecular, cellular, tissue and organ levels. Doses of 50-120 mg/kg/day appear to be effective in bringing patients to negative iron balance. Deferiprone increases urinary iron excretion, which mainly depends on the iron load of patients and the dose of the drug."	Free Base	C7H9NO2	58361.0	DMSO : 7.14 mg/mL (51.31 mM; Need ultrasonic); H2O : 3.33 mg/mL (23.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C1C(O)=C(C)N(C)C=C1	https://www.medchemexpress.com/Deferiprone.html	Launched		91.0	AF41	B20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0568	10.0	mM	44.0	DMSO	139.063329	20	B	pluskal_fda_drugs_5005_B20_id
1058	HY-B0428B	HYCPK40905	K03	HYCPK40905	91z	1014.0	4.0	V6	905.0	K03	78712-43-3	Ozagrel (hydrochloride)	OKY-046 (hydrochloride)	264.71	Prostaglandin Receptor	GPCR/G Protein	Ozagrel hydrochloride (OKY-046 hydrochloride) is a thromboxane A2 (TXA2) synthase inhibitor. Ozagrel hydrochloride is an antiplatelet agent, which selectively inhibits human platelet aggregationwith an IC50 of 53.12 μM[1].	Hydrochloride	C13H13ClN2O2	79087.0	H2O : 100 mg/mL (377.77 mM; Need ultrasonic); DMSO : 250 mg/mL (944.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	[H]Cl.O=C(O)/C=C/C1=CC=C(CN2C=CN=C2)C=C1	https://www.medchemexpress.com/ozagrel-hydrochloride.html	Launched		91.0	V6	B20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0428B	10.0	mM	44.0	DMSO	228.089878	20	B	pluskal_fda_drugs_5005_B20_id
1217	HY-10225	HYCPK40905	J13	HYCPK40905	91z	938.0	4.0	T26	905.0	J13	866323-14-0	Belinostat	PXD101; PX105684	318.35	Autophagy; HDAC	Autophagy; Cell Cycle/DNA Damage; Epigenetics	Belinostat (PXD101; PX105684) is a potent HDAC inhibitor with an IC50 of 27 nM in HeLa cell extracts.	Free Base	C15H14N2O4S	28508.0	DMSO : 100 mg/mL (314.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=S(NC1=CC=CC=C1)(C2=CC(/C=C/C(NO)=O)=CC=C2)=O.[(E)]	https://www.medchemexpress.com/Belinostat.html	Launched		91.0	T26	B20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10225	10.0	mM	44.0	DMSO	318.067428	20	B	pluskal_fda_drugs_5005_B20_id
235	HY-B0480	HYCPK40902	I14	HYCPK40902	91z	795.0	1.0	Q27	902.0	I14	980-71-2	Brompheniramine (maleate)	(±)-Brompheniramine (maleate)	435.31	Calcium Channel; Histamine Receptor; mAChR; Potassium Channel; Sodium Channel	GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling	Brompheniramine ((±)-Brompheniramine) maleate is a potent and orally active antihistamine of the alkylamine class. Brompheniramine maleate is a selective histamine H1 receptor antagonist with a Kd of 6.06 nM. Brompheniramine maleate can block the hERG channels, calcium channels, and sodium channels with IC50s of 0.90 μM, 16.12 μM and 21.26 μM, respectively. Brompheniramine maleate has anticholinergic, antidepressant and anesthetic properties and can be used for allergic rhinitis research[1][2][3][4].	Maleate	C20H23BrN2O4	16767.0	DMSO : 100 mg/mL (229.72 mM; Need ultrasonic); H2O : 100 mg/mL (229.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology; Neurological Disease	O=C(O)/C=C\C(O)=O.CN(C)CCC(C1=CC=CC=N1)C2=CC=C(Br)C=C2	https://www.medchemexpress.com/Brompheniramine-maleate.html	Launched		91.0	Q27	B21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0480	10.0	mM	45.0	DMSO	318.073161	21	B	pluskal_fda_drugs_5005_B21_id
264	HY-103399	HYCPK40902	F16	HYCPK40902	91z	511.0	1.0	K31	902.0	F16	147059-75-4	Trovafloxacin (mesylate)		512.46	Antibiotic; Bacterial; Topoisomerase	Anti-infection; Cell Cycle/DNA Damage	Trovafloxacin mesylate is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive, Gram-negative and anaerobic organisms. Trovafloxacin mesylate blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin mesylate is also a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 μM for PANX1 inward current. Trovafloxacin mesylate does not inhibit connexin 43 gap junction or PANX2. Trovafloxacin mesylate leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1[1][2][3].	Mesylate	C21H19F3N4O6S	156977.0	DMSO : 125 mg/mL (243.92 mM; ultrasonic and warming and heat to 60°C); H2O : 20 mg/mL (39.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2=CC=C(F)C=C2F)C3=NC(N4C[C@@]5([H])[C@H](N)[C@@]5([H])C4)=C(F)C=C3C1=O)O.CS(=O)(O)=O	https://www.medchemexpress.com/trovafloxacin-mesylate.html	Launched		91.0	K31	B21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-103399	10.0	mM	45.0	DMSO	416.109625	21	B	pluskal_fda_drugs_5005_B21_id
301	HY-B0559	HYCPK40902	E19	HYCPK40902	91z	421.0	1.0	I37	902.0	E19	42924-53-8	Nabumetone	BRL14777	228.29	COX	Immunology/Inflammation	Nabumetone is an orally active non-acidic anti-inflammatory agent, acts as a potent and selective COX-2 inhibitor, and is the prodrug of the active metabolite 6MNA.	Free Base	C15H16O2	15944.0	DMSO : ≥ 100 mg/mL (438.04 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CC(CCC1=CC=C2C=C(OC)C=CC2=C1)=O	https://www.medchemexpress.com/Nabumetone.html	Launched		91.0	I37	B21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0559	10.0	mM	45.0	DMSO	228.11503	21	B	pluskal_fda_drugs_5005_B21_id
362	HY-B0493	HYCPK40903	C04	HYCPK40903	91z	200.0	2.0	E8	903.0	C04	4394-00-7	Niflumic acid		282.22	Chloride Channel	Membrane Transporter/Ion Channel	"Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Target: Others
niflumic acid, an inhibitor of calcium-activated chloride currents. Niflumic acid does not block directly calcium channels or activate potassium channels. Niflumic acid selectively reduces a component of noradrenaline- and 5-HT-induced pressor responses by inhibiting a mechanism which leads to the opening of voltage-gated calcium channels [1]. Niflumic acid molecule is completely buried in the substrate-binding hydrophobic channel. The conformations of the binding site in PLA(2) as well as that of niflumic acid are not altered upon binding [2]. Niflumic acid (NFA) produces biphasic behavior on human CLC-K channels that suggests the presence of two functionally different binding sites: an activating site and a blocking site [3]."	Free Acid	C13H9F3N2O2	16711.0	DMSO : ≥ 100 mg/mL (354.33 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=CN=C1NC2=CC=CC(C(F)(F)F)=C2)O	https://www.medchemexpress.com/niflumic-acid.html	Launched		91.0	E8	B21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0493	10.0	mM	45.0	DMSO	282.061612	21	B	pluskal_fda_drugs_5005_B21_id
447	HY-13832	HYCPK40903	D05	HYCPK40903	91z	298.0	2.0	G10	903.0	D05	95233-18-4	Atovaquone	Atavaquone	366.84	Antibiotic; Bacterial; Cytochrome P450; Parasite	Anti-infection; Metabolic Enzyme/Protease	Atovaquone (Atavaquone) is a potent, selective and orally active inhibitor of the parasite’s mitochondrial cytochrome?bc1?complex. Atovaquone is against human and ?P. falciparum?cytochrome?bc1?activity with IC50 values of 460 nM and 2.0 nM, respectively. Atovaquone is an antimalarial agent and has the potential for the investigation of neumocystis pneumonia, toxoplasmosis, malaria, and babesia[1][2].	Free Base	C22H19ClO3	13059.0	DMSO : 8.33 mg/mL (22.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1C([C@H]2CC[C@H](C3=CC=C(Cl)C=C3)CC2)=C(O)C(C4=C1C=CC=C4)=O	https://www.medchemexpress.com/atovaquone.html	Launched		91.0	G10	B21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13832	10.0	mM	45.0	DMSO	366.102272	21	B	pluskal_fda_drugs_5005_B21_id
516	HY-B0117C	HYCPK40903	E10	HYCPK40903	91z	404.0	2.0	I20	903.0	E10		Tigecycline (tetramesylate)	GAR-936 tetramesylate	970.07	Antibiotic; Autophagy; Bacterial	Anti-infection; Autophagy	Tigecycline tetramesylate (GAR-936 tetramesylate) is a broad-spectrum glycylcycline antibiotic. The mean inhibitory concentration (MIC) of Tigecycline for E. coli (MG1655 strain) is approximately 125 ng/mL[1]. MIC50 and MIC90 are 1 and 2 mg/L for Acinetobacter baumannii (A. baumannii), respectively[2].	Mesylate	C33H55N5O20S4	37300.0	DMSO : 100 mg/mL (103.09 mM; Need ultrasonic); H2O : 50 mg/mL (51.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=S(C)(O)=O.O=S(C)(O)=O.O=S(C)(O)=O.O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])CC4=C(C(C3=C(O)[C@@]21O)=O)C(O)=C(NC(CNC(C)(C)C)=O)C=C4N(C)C)N.O=S(C)(O)=O	https://www.medchemexpress.com/Tigecycline_tetramesylate.html	Launched		91.0	I20	B21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0117C	10.0	mM	45.0	DMSO	585.279863	21	B	pluskal_fda_drugs_5005_B21_id
728	HY-B1378	HYCPK40903	H22	HYCPK40903	91z	716.0	2.0	O44	903.0	H22	77-67-8	Ethosuximide		141.17	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Ethosuximide, a widely prescribed anti-epileptic drug, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel.	Free Base	C7H11NO2	83698.0	DMSO : 100 mg/mL (708.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C(C)(CC)C1)NC1=O	https://www.medchemexpress.com/Ethosuximide.html	Launched		91.0	O44	B21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1378	10.0	mM	45.0	DMSO	141.078979	21	B	pluskal_fda_drugs_5005_B21_id
1013	HY-17556	HYCPK40904	N20	HYCPK40904	91z	1335.0	3.0	AB39	904.0	N20	58-05-9	Folinic acid	leucovorin	473.44	Antifolate; Endogenous Metabolite	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	"Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with <a href=""/Methotrexate.html"" class=""link-product"" target=""_blank"">Methotrexate (MTX)</a> (HY-14519) as a rescue agent to decrease MTX-induced toxicity[1]."	Free Acid	C20H23N7O7	109362.0	DMSO : 250 mg/mL (528.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(NCC2N(C=O)C3=C(N=C(N)NC3=O)NC2)C=C1)=O	https://www.medchemexpress.com/folinic-acid.html	Launched		91.0	AB39	B21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17556	10.0	mM	45.0	DMSO	473.165896	21	B	pluskal_fda_drugs_5005_B21_id
128	HY-B0513	HYCPK40902	F07	HYCPK40902	91z	493.0	1.0	K13	902.0	F07	56-04-2	Methylthiouracil	MTU	142.18	ERK; Interleukin Related; NF-κB; TNF Receptor	Apoptosis; Immunology/Inflammation; MAPK/ERK Pathway; NF-κB; Stem Cell/Wnt	Methylthiouracil is an antithyroid agent. Methylthiouracil suppresses the production TNF-α and IL-6, and the activation of NF-κB and ERK1/2.	Free Base	C5H6N2OS	16712.0	DMSO : ≥ 50 mg/mL (351.67 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(C=C(C)N1)NC1=S	https://www.medchemexpress.com/methylthiouracil.html	Launched		91.0	K13	B22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0513	10.0	mM	46.0	DMSO	142.020084	22	B	pluskal_fda_drugs_5005_B22_id
171	HY-B0409A	HYCPK40902	I10	HYCPK40902	91z	787.0	1.0	Q19	902.0	I10	4205-91-8	Clonidine (hydrochloride)		266.55	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Clonidine hydrochloride is an agonist of α2-adrenoceptor and potent antihypertensive agent.	Hydrochloride	C9H10Cl3N3	16803.0	DMSO : 7.6 mg/mL (28.51 mM; Need ultrasonic and warming); H2O : 33.33 mg/mL (125.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	ClC1=C(NC2=NCCN2)C(Cl)=CC=C1.Cl	https://www.medchemexpress.com/Clonidine-hydrochloride.html	Launched		91.0	Q19	B22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0409A	10.0	mM	46.0	DMSO	229.017353	22	B	pluskal_fda_drugs_5005_B22_id
535	HY-13738A	HYCPK40903	H11	HYCPK40903	91z	694.0	2.0	O22	903.0	H11	82640-04-8	Raloxifene (hydrochloride)	Keoxifene (hydrochloride); LY156758; LY139481 (hydrochloride)	510.04	Autophagy; Estrogen Receptor/ERR	Autophagy; Others	Raloxifene hydrochloride (Keoxifene hydrochloride) is a  second generation?selective and orally active estrogen receptor modulator. Raloxifene hydrochloride produces estrogen-agonistic effects on bone and lipid metabolism and  estrogen-antagonistic effects on uterine endometrium and breast tissue[1].	Hydrochloride	C28H28ClNO4S	12906.0	DMSO : 33.33 mg/mL (65.35 mM; Need ultrasonic); H2O : 1 mg/mL (1.96 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C(C1=C(C2=CC=C(O)C=C2)SC3=CC(O)=CC=C31)C4=CC=C(OCCN5CCCCC5)C=C4.Cl	https://www.medchemexpress.com/raloxifene-hydrochloride.html	Launched		91.0	O22	B22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13738A	10.0	mM	46.0	DMSO	473.166079	22	B	pluskal_fda_drugs_5005_B22_id
769	HY-B0094	HYCPK40904	A05	HYCPK40904	91z	57.0	3.0	B9	904.0	A05	63968-64-9	Artemisinin	Qinghaosu; NSC 369397	282.33	Akt; Ferroptosis; HCV; Parasite	Anti-infection; Apoptosis; PI3K/Akt/mTOR	Artemisinin (Qinghaosu), a sesquiterpene lactone,  is an anti-malarial drug isolated from the aerial parts of Artemisia annua L. plants[1]. Artemisinin inhibits AKT signaling pathway by decreasing pAKT in a dose-dependent manner. Artemisinin reduces cancer cell proliferation, migration, invasion, tumorigenesis and metastasis and has neuroprotective effects[2].	Free Base	C15H22O5	12872.0	DMSO : 50 mg/mL (177.10 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Neurological Disease	O=C1[C@H](C)[C@]2([H])CC[C@@H](C)[C@]3([H])CC[C@@](O4)(C)OO[C@]32[C@]4([H])O1	https://www.medchemexpress.com/artemisinin.html	Launched		91.0	B9	B22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0094	10.0	mM	46.0	DMSO	282.146724	22	B	pluskal_fda_drugs_5005_B22_id
790	HY-66009	HYCPK40904	K06	HYCPK40904	91z	1019.0	3.0	V11	904.0	K06	82159-09-9	Epalrestat	ONO2235	319.40	Aldose Reductase	Metabolic Enzyme/Protease	"Epalrestat is an aldose reductase inhibitor for the treatment of diabetic neuropathy.
Target: Aldose Reductase
Epalrestat may affect or delay progression of the underlying disease process. Data from six clinical trials were evaluated, and it was determined that epalrestat 50 mg 3 times/day may improve motor and sensory nerve conduction velocity and subjective neuropathy symptoms as compared with baseline and placebo. Epalrestat may serve as a new therapeutic option to prevent or slow the progression of diabetic neuropathy [1]. Epalrestat significantly increased the amplitude of 3 cpm waves on EGG and improved the spectral analytical parameters of heart rate variability. These findings suggest that epalrestat is useful for the treatment of diabetic gastroparesis [2]. Epalrestat is a highly effective and safe agent for the treatment of diabetic neuropathy [3]."	Free Acid	C15H13NO3S2	15664.0	DMSO : 20 mg/mL (62.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(O)CN(C/1=O)C(SC1=C/C(C)=C/C2=CC=CC=C2)=S	https://www.medchemexpress.com/Epalrestat.html	Launched		91.0	V11	B22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-66009	10.0	mM	46.0	DMSO	319.033685	22	B	pluskal_fda_drugs_5005_B22_id
953	HY-B0248	HYCPK40904	B17	HYCPK40904	91z	177.0	3.0	D33	904.0	B17	638-94-8	Desonide		416.51	Glucocorticoid Receptor	Immunology/Inflammation	"Desonide is a nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses.
Target: Glucocorticoid Receptor
Desonide is a low-potency topical corticosteroid that has been used for decades in the treatment of steroid-responsive dermatoses [1]. Desonide induced significant colorimetric improvement compared with placebo. A good to excellent response was achieved in 30% for desonide, and 6% for placebo. Decreased pigmentation in the desonide-treated axillae was associated with recovery of disruption at the basal membrane. Desonide showed depigmenting properties in women with axillary hyperpigmentation [2]. Given the favorable safety profile of all other desonide preparations and their utility as a low potency corticosteroid, desonide foam promises to be a useful addition to the armamentarium, when other desonide vehicles might be less acceptable [3]."	Free Base	C24H32O6	16538.0	DMSO : ≥ 100 mg/mL (240.09 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]12[C@@]3(C(CO)=O)[C@@](OC(C)(O3)C)([H])C[C@@]1([H])[C@]4([H])CCC5=CC(C=C[C@]5(C)[C@@]4([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/desonide.html	Launched		91.0	D33	B22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0248	10.0	mM	46.0	DMSO	416.219889	22	B	pluskal_fda_drugs_5005_B22_id
1041	HY-B2145	HYCPK40904	J22	HYCPK40904	91z	955.0	3.0	T43	904.0	J22	172152-50-0	Ilaprazole (sodium)	IY-81149 (sodium)	388.42	Proton Pump; TOPK	Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel	Ilaprazole (IY-81149) sodium is an orally active proton pump inhibitor. Ilaprazole sodium irreversibly inhibits H+/K+-ATPase in a dose-dependent manner with an IC50 of 6 μM in rabbit parietal cell preparation. Ilaprazole sodium is used for the research of gastric ulcers. Ilaprazole sodium is also a potent TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor[1][2].	Sodium	C19H17N4NaO2S	79263.0	DMSO : 41.67 mg/mL (107.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=S(C1=NC2=CC=C(N3C=CC=C3)C=C2[N-]1)CC4=NC=CC(OC)=C4C.[Na+]	https://www.medchemexpress.com/ilaprazole-sodium.html	Launched		91.0	T43	B22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2145	10.0	mM	46.0	DMSO	366.115047	22	B	pluskal_fda_drugs_5005_B22_id
1102	HY-B0117	HYCPK40905	G06	HYCPK40905	91z	636.0	4.0	N12	905.0	G06	220620-09-7	Tigecycline	GAR-936	585.65	Antibiotic; Autophagy; Bacterial	Anti-infection; Autophagy	Tigecycline (GAR-936) is a broad-spectrum glycylcycline antibiotic. The mean inhibitory concentration (MIC) of Tigecycline for E. coli (MG1655 strain) is approximately 125 ng/mL[1]. MIC50 and MIC90 are 1 and 2 mg/L for Acinetobacter baumannii (A. baumannii), respectively[2].	Free Base	C29H39N5O8	36199.0	DMSO : 150 mg/mL (256.13 mM; Need ultrasonic); H2O : 8.33 mg/mL (14.22 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])CC4=C(C(C3=C(O)[C@@]21O)=O)C(O)=C(NC(CNC(C)(C)C)=O)C=C4N(C)C)N	https://www.medchemexpress.com/Tigecycline.html	Launched		91.0	N12	B22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0117	10.0	mM	46.0	DMSO	585.279863	22	B	pluskal_fda_drugs_5005_B22_id
261	HY-B2117	HYCPK40902	C16	HYCPK40902	91z	223.0	1.0	E31	902.0	C16	2430-27-5	Valpromide		143.23	Epoxide Hydrolase; HSV	Anti-infection; Metabolic Enzyme/Protease	Valpromide is an amide derivative of valproic acid and inhibits human epoxide hydrolase.	Free Base	C8H17NO	27575.0	DMSO : ≥ 50 mg/mL (349.09 mM)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease	CCCC(CCC)C(N)=O	https://www.medchemexpress.com/Valpromide.html	Launched		91.0	E31	C3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2117	10.0	mM	51.0	DMSO	143.131014	3	C	pluskal_fda_drugs_5005_C3_id
451	HY-B0111	HYCPK40903	H05	HYCPK40903	91z	682.0	2.0	O10	903.0	H05	67392-87-4	Drospirenone	Dihydrospirorenone	366.49	Progesterone Receptor	Others	"Drospirenone(Dihydrospirorenone) is a synthetic progestin that is an analog to spironolactone.
Target: Progesterone Receptor
Drospirenone is a novel progestin under clinical development that is similar to the natural hormone progesterone, combining potent progestogenic with antimineralocorticoid and antiandrogenic activities. drospirenone was devoid of glucocorticoid activity. Both progestins did not show any antiglucocorticoid action. Furthermore, drospirenone and progesterone both showed considerable antimineralocorticoid activity and weak mineralocorticoid activity [1]. the pharmacological profile of drospirenone is more closely related to that of the natural hormone progesterone than is that of any other synthetic progestogen in use today. Therefore, drospirenone is anticipated to give rise to a number of additional health benefits both for users of oral contraceptives and hormone replacement therapy recipients [2]. The combination of 17beta-estradiol and drospirenone has a positive effect on BMD and a potentially beneficial effect on lipids. Although endometrial thickness increased slightly, the safety of the endometrium was assured, as no cases of hyperplasia or cancer occurred [3].
Clinical indications: Acne; Dysmenorrhea; Endometriosis; Female contraception; Folic acid deficiency; Premenstrual syndrome"	Free Base	C24H30O3	41729.0	DMSO : 50 mg/mL (136.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	C[C@@]12[C@](OC3=O)(CC3)[C@@H](C4)[C@@H]4[C@@]1([H])[C@@]([C@@H]5[C@H]6C5)([H])[C@]([C@](C6=CC7=O)(CC7)C)([H])CC2	https://www.medchemexpress.com/drospirenone.html	Launched		91.0	O10	C3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0111	10.0	mM	51.0	DMSO	366.219495	3	C	pluskal_fda_drugs_5005_C3_id
546	HY-B2116	HYCPK40903	C12	HYCPK40903	91z	216.0	2.0	E24	903.0	C12	526-18-1	Osalmid	Oxaphenamide; 4'-Hydroxysalicylanilide	229.23	HBV	Anti-infection	Osalmid is a ribonucleotide reductase small subunit M2 (RRM2) targeting compound; suppresses ribonucleotide reductase activity with an IC50 of 8.23 μM.	Free Base	C13H11NO3	23624.0	DMSO : ≥ 100 mg/mL (436.24 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(NC1=CC=C(O)C=C1)C2=CC=CC=C2O	https://www.medchemexpress.com/Osalmid.html	Launched		91.0	E24	C3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2116	10.0	mM	51.0	DMSO	229.073893	3	C	pluskal_fda_drugs_5005_C3_id
675	HY-B0279	HYCPK40903	I18	HYCPK40903	91z	804.0	2.0	Q36	903.0	I18	87333-19-5	Ramipril	HOE-498	416.51	Angiotensin-converting Enzyme (ACE); Apoptosis	Apoptosis; Metabolic Enzyme/Protease	Ramipril (HOE-498) is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 5 nM.	Free Acid	C23H32N2O5	16577.0	DMSO : ≥ 100 mg/mL (240.09 mM); H2O : 1 mg/mL (2.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C([C@@H]1C[C@@](CCC2)([H])[C@@]2([H])N1C([C@@H](N[C@H](C(OCC)=O)CCC3=CC=CC=C3)C)=O)O	https://www.medchemexpress.com/ramipril.html	Launched		91.0	Q36	C3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0279	10.0	mM	51.0	DMSO	416.231122	3	C	pluskal_fda_drugs_5005_C3_id
992	HY-135815A	HYCPK40904	I19	HYCPK40904	91z	853.0	3.0	R37	904.0	I19	2389149-74-8	Mobocertinib (succinate)	TAK-788 (succinate); AP32788 (succinate)	703.78	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Mobocertinib (TAK-788) succinate is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib succinate potently inhibits oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib succinate can be used in NSCLC research[1][2].	Succinate	C36H45N7O8	63489.0	DMSO : 125 mg/mL (177.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CN=C(NC2=CC(NC(C=C)=O)=C(N(CCN(C)C)C)C=C2OC)N=C1C3=CN(C)C4=C3C=CC=C4)OC(C)C.O=C(O)CCC(O)=O	https://www.medchemexpress.com/mobocertinib-succinate.html	Launched		91.0	R37	C3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-135815A	10.0	mM	51.0	DMSO	585.306353	3	C	pluskal_fda_drugs_5005_C3_id
1014	HY-10787	HYCPK40904	O20	HYCPK40904	91z	1431.0	3.0	AD39	904.0	O20	192939-46-1	Ximelagatran	H 376/95	473.57	Thrombin	Metabolic Enzyme/Protease	Ximelagatran (H 376/95) is an orally active thrombin inhibitor that selectively and competitively inhibits both free and clot-bound thrombin. Ximelagatran is an anticoagulant agent with a rapid onset of anticoagulant effect, predictable, dose-dependent pharmcokinetics and pharmacodynamics[1][2].	Free Base	C24H35N5O5	51796.0	DMSO : 250 mg/mL (527.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C([C@@H]1CCN1C([C@@H](C2CCCCC2)NCC(OCC)=O)=O)NCC3=CC=C(C=C3)/C(N)=N/O	https://www.medchemexpress.com/ximelagatran.html	Launched		91.0	AD39	C3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10787	10.0	mM	51.0	DMSO	473.263819	3	C	pluskal_fda_drugs_5005_C3_id
1157	HY-B1833	HYCPK40905	N09	HYCPK40905	91z	1314.0	4.0	AB18	905.0	N09	56287-74-2	Afloqualone	HQ-495	283.30	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Afloqualone (HQ-495) is a GABAergic agent and has agonist activity at the β subtype of the?GABAα receptor. Afloqualone has antivertiginous effects thought to be attributable to the increased sensitivity of GABA receptors of the LVN neuron site[1].	Free Base	C16H14FN3O	18417.0	DMSO : ≥ 33 mg/mL (116.48 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1N(C2=CC=CC=C2C)C(CF)=NC3=C1C=C(N)C=C3	https://www.medchemexpress.com/Afloqualone.html	Launched		91.0	AB18	C3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1833	10.0	mM	51.0	DMSO	283.11209	3	C	pluskal_fda_drugs_5005_C3_id
1324	HY-B1546A	HYCPK40905	E20	HYCPK40905	91z	472.0	4.0	J40	905.0	E20	161804-20-2	Benzamil (hydrochloride)	Benzylamiloride (hydrochloride)	356.21	Na+/Ca2+ Exchanger; Sodium Channel	Membrane Transporter/Ion Channel	Benzamil hydrochloride (Benzylamiloride hydrochloride), an Amiloride analogue, is a Na+/Ca2+ exchanger (NCX) inhibitor (IC50~100 nM). Benzamil hydrochloride also is a non-selective Deg/epithelial sodium channels (ENaC) blocker, and can potentiate myogenic vasoconstriction. Benzamil hydrochloride inhibits TRPP3-mediated Ca2+-activated currents, with an IC50 of 1.1 μM[1][2][3].	Hydrochloride	C13H15Cl2N7O	26259.0	DMSO : ≥ 100 mg/mL (280.73 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=NC(Cl)=C(N)N=C1N)NC(NCC2=CC=CC=C2)=N.[H]Cl	https://www.medchemexpress.com/Benzamil_hydrochloride.html	Launched		91.0	J40	C3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1546A	10.0	mM	51.0	DMSO	319.094836	3	C	pluskal_fda_drugs_5005_C3_id
173	HY-14537	HYCPK40902	K10	HYCPK40902	91z	979.0	1.0	U19	902.0	K10	97657-92-6	Latrepirdine (dihydrochloride)	Dimebolin dihydrochloride	392.37	5-HT Receptor; Adrenergic Receptor; Amyloid-β; Autophagy; Histamine Receptor	Autophagy; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Latrepirdine dihydrochloride is a neuroactive compound with antagonist activity at histaminergic, α-adrenergic, and serotonergic receptors. Latrepirdine stimulates amyloid precursor protein (APP) catabolism and amyloid-β (Aβ) secretion.	Hydrochloride	C21H27Cl2N3	22214.0	DMSO : 6.4 mg/mL (16.31 mM; Need warming); H2O : 100 mg/mL (254.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CN(C1)CCC2=C1C3=CC(C)=CC=C3N2CCC4=CN=C(C)C=C4.Cl.Cl	https://www.medchemexpress.com/Latrepirdine-dihydrochloride.html	Launched		91.0	U19	C4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14537	10.0	mM	52.0	DMSO	319.204848	4	C	pluskal_fda_drugs_5005_C4_id
179	HY-15025A	HYCPK40902	A11	HYCPK40902	91z	21.0	1.0	A21	902.0	A11	171599-83-0	Sildenafil (citrate)	UK-92480 (citrate)	666.70	Apoptosis; Autophagy; Bacterial; Phosphodiesterase (PDE)	Anti-infection; Apoptosis; Autophagy; Metabolic Enzyme/Protease	Sildenafil citrate is a potent phosphodiesterase type 5 (PDE5) inhibitor with IC50 of 5.22 nM.	Citrate	C28H38N6O11S	10183.0	DMSO : 50 mg/mL (75.00 mM; Need ultrasonic); H2O : 2 mg/mL (3.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C1C(N(C)N=C2CCC)=C2N=C(C3=CC(S(=O)(N4CCN(C)CC4)=O)=CC=C3OCC)N1.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Sildenafil-citrate.html	Launched		91.0	A21	C4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15025A	10.0	mM	52.0	DMSO	474.204924	4	C	pluskal_fda_drugs_5005_C4_id
282	HY-B0763	HYCPK40902	H17	HYCPK40902	91z	705.0	1.0	O33	902.0	H17	50847-11-5	Ibudilast	KC-404; AV-411; MN-166	230.31	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Ibudilast (KC-404; AV-411; MN-166) is a cyclic AMP phosphodiesterase (PDE) inhibitor. Ibudilast has platelet anti-aggregatory effects. Ibudilast can be used for the research of asthma for its inhibitory effects on tracheal smooth muscle contractility. Ibudilast may be a useful neuroprotective and anti-dementia agent counteracting neurotoxicity in activated microglia[1].	Free Base	C14H18N2O	33846.0	DMSO : ≥ 140 mg/mL (607.88 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CC(C)C(C1=C2C=CC=CN2N=C1C(C)C)=O	https://www.medchemexpress.com/Ibudilast.html	Launched		91.0	O33	C4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0763	10.0	mM	52.0	DMSO	230.141913	4	C	pluskal_fda_drugs_5005_C4_id
506	HY-16562	HYCPK40903	O08	HYCPK40903	91z	1360.0	2.0	AC16	903.0	O08	97682-44-5	Irinotecan	(+)-Irinotecan; CPT-11	586.68	Autophagy; Topoisomerase	Autophagy; Cell Cycle/DNA Damage	Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex[1].	Free Base	C33H38N4O6	146099.0	DMSO : 25 mg/mL (42.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N1CCC(N2CCCCC2)CC1)OC3=CC=C4N=C5C(CN6C(C(COC([C@@]7(CC)O)=O)=C7C=C65)=O)=C(CC)C4=C3	https://www.medchemexpress.com/Irinotecan.html	Launched		91.0	AC16	C4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16562	10.0	mM	52.0	DMSO	586.279135	4	C	pluskal_fda_drugs_5005_C4_id
763	HY-16749A	HYCPK40904	K04	HYCPK40904	91z	1015.0	3.0	V7	904.0	K04	2040295-03-0	Pexidartinib (hydrochloride)	PLX-3397 (hydrochloride)	454.28	Apoptosis; c-Fms; c-Kit	Apoptosis; Protein Tyrosine Kinase/RTK	Pexidartinib hydrochloride (PLX-3397 hydrochloride) is a potent, orally active, selective, and ATP-competitive colony stimulating factor 1 receptor (CSF1R or M-CSFR) and c-Kit inhibitor, with IC50s of 20 and 10 nM, respectively. Pexidartinib hydrochloride exhibits 10- to 100-fold selectivity for c-Kit and CSF1R over other related kinases. Pexidartinib hydrochloride induces cell apoptosis and has anti-cancer activity[1].	Hydrochloride	C20H16Cl2F3N5	40773.0	H2O : < 0.1 mg/mL (ultrasonic) (insoluble); DMSO : 60 mg/mL (132.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	FC(C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C43)C=C2)C=N1)(F)F.Cl	https://www.medchemexpress.com/pexidartinib-hydrochloride.html	Launched		91.0	V7	C4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16749A	10.0	mM	52.0	DMSO	417.096808	4	C	pluskal_fda_drugs_5005_C4_id
820	HY-103315	HYCPK40904	I08	HYCPK40904	91z	831.0	3.0	R15	904.0	I08	68099-86-5	Bepridil hydrochloride	CERM 1978	403.00	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Bepridil hydrochloride (CERM 1978) is a calcium channel blocker, with antianginal activity.	Hydrochloride	C24H35ClN2O	32129.0	DMSO : ≥ 150 mg/mL (372.21 mM); H2O : 12.5 mg/mL (31.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	[H]Cl.CC(C)COCC(N1CCCC1)CN(C2=CC=CC=C2)CC3=CC=CC=C3	https://www.medchemexpress.com/Bepridil_hydrochloride.html	Launched		91.0	R15	C4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-103315	10.0	mM	52.0	DMSO	366.267114	4	C	pluskal_fda_drugs_5005_C4_id
1301	HY-B1781	HYCPK40905	N18	HYCPK40905	91z	1332.0	4.0	AB36	905.0	N18	80-32-0	Sulfachloropyridazine	Sulfachlorpyridazine	284.72	Antibiotic; Bacterial	Anti-infection	Sulfachloropyridazine is a broad spectrum sulfonamide used against both Gram-positive and Gram-negative aerobic bacteria.	Free Base	C10H9ClN4O2S	26960.0	DMSO : 160 mg/mL (561.96 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NN=C(Cl)C=C2)=O	https://www.medchemexpress.com/Sulfachloropyridazine.html	Launched		91.0	AB36	C4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1781	10.0	mM	52.0	DMSO	284.013474	4	C	pluskal_fda_drugs_5005_C4_id
1302	HY-17363	HYCPK40905	O18	HYCPK40905	91z	1428.0	4.0	AD36	905.0	O18	624-49-7	Dimethyl fumarate		144.13	Autophagy; Endogenous Metabolite; HIV; Keap1-Nrf2; Reactive Oxygen Species	Anti-infection; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Dimethyl fumarate (DMF) is an orally active and brain-penetrant Nrf2 activator and induces upregulation of antioxidant gene expression. Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway, and also induces cell autophagy. Dimethyl fumarate can be used for multiple sclerosis research[1][2].	Free Base	C6H8O4	61626.0	DMSO : 62.5 mg/mL (433.64 mM; Need ultrasonic); H2O : 8.33 mg/mL (57.80 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology; Neurological Disease	O=C(OC)/C=C/C(OC)=O	https://www.medchemexpress.com/Dimethyl-fumarate.html	Launched		91.0	AD36	C4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17363	10.0	mM	52.0	DMSO	144.042259	4	C	pluskal_fda_drugs_5005_C4_id
242	HY-B1900	HYCPK40902	P14	HYCPK40902	91z	1467.0	1.0	AE27	902.0	P14	2921-57-5	Methylprednisolone succinate	Methylprednisolone hydrogen succinate	474.54	Bacterial; Glucocorticoid Receptor	Anti-infection; Immunology/Inflammation	Methylprednisolone succinate is a synthetic glucocorticoid and widely used as an anti-inflammatory agent.	Free Acid	C26H34O8	27755.0	DMSO : ≥ 100 mg/mL (210.73 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Endocrinology	C[C@@]12[C@](C(COC(CCC(O)=O)=O)=O)(O)CC[C@@]1([H])[C@]3([H])C[C@H](C)C4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/Methylprednisolone_succinate.html	Launched		91.0	AE27	C5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1900	10.0	mM	53.0	DMSO	474.225368	5	C	pluskal_fda_drugs_5005_C5_id
628	HY-16952A	HYCPK40903	J15	HYCPK40903	91z	894.0	2.0	S30	903.0	J15	74764-40-2	Bepridil (hydrochloride hydrate)	(±)-Bepridil (hydrochloride hydrate); Org 5730 (hydrochloride hydrate)	421.02	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Bepridil hydrochloride hydrate ((±)-Bepridil hydrochloride hydrate) is a non-selective, long-acting Ca+ channel antagonist and Na+, K+ channel inhibitor, with antianginal and type I antiarrhythmic effects. Bepridil hydrochloride hydrate also acts as a cardiac Na+/Ca2+ exchange (NCX1) inhibitor. Bepridil hydrochloride hydrate can be used for the research of cardiovascular disorders[1][2][3][4][5].	Hydrochloride	C24H37ClN2O2	102269.0	DMSO : 125 mg/mL (296.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC(C)COCC(N1CCCC1)CN(C2=CC=CC=C2)CC3=CC=CC=C3.[H]Cl.[H]O[H]	https://www.medchemexpress.com/bepridil-hydrochloride-hydrate.html	Launched		91.0	S30	C5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16952A	10.0	mM	53.0	DMSO	366.267114	5	C	pluskal_fda_drugs_5005_C5_id
856	HY-16749	HYCPK40904	M10	HYCPK40904	91z	1219.0	3.0	Z19	904.0	M10	1029044-16-3	Pexidartinib	PLX-3397	417.81	Apoptosis; c-Fms; c-Kit	Apoptosis; Protein Tyrosine Kinase/RTK	Pexidartinib (PLX-3397) is a potent, orally active, selective, and ATP-competitive colony stimulating factor 1 receptor (CSF1R or M-CSFR) and c-Kit inhibitor, with IC50s of 20 and 10 nM, respectively. Pexidartinib (PLX-3397) exhibits 10- to 100-fold selectivity for c-Kit and CSF1R over other related kinases. Pexidartinib (PLX-3397) induces cell apoptosis and has anti-tumor activity[1].	Free Base	C20H15ClF3N5	111524.0	DMSO : 100 mg/mL (239.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	FC(C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C43)C=C2)C=N1)(F)F	https://www.medchemexpress.com/Pexidartinib.html	Launched		91.0	Z19	C5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16749	10.0	mM	53.0	DMSO	417.096808	5	C	pluskal_fda_drugs_5005_C5_id
881	HY-14832	HYCPK40904	F12	HYCPK40904	91z	551.0	3.0	L23	904.0	F12	775304-57-9	Ataluren	PTC124	284.24	Autophagy; CFTR	Autophagy; Membrane Transporter/Ion Channel	Ataluren (PTC124) is an orally available CFTR-G542X nonsense allele inhibitor.	Free Acid	C15H9FN2O3	27382.0	DMSO : ≥ 52 mg/mL (182.94 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(C1=CC=CC(C2=NOC(C3=CC=CC=C3F)=N2)=C1)O	https://www.medchemexpress.com/PTC124.html	Launched		91.0	L23	C5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14832	10.0	mM	53.0	DMSO	284.05972	5	C	pluskal_fda_drugs_5005_C5_id
896	HY-B0334A	HYCPK40904	E13	HYCPK40904	91z	457.0	3.0	J25	904.0	E13	69388-84-7	Sulbactam (sodium)	CP45899 (sodium)	255.22	Antibiotic; Bacterial	Anti-infection	Sulbactam (CP45899) sodium is a competitive, irreversible beta-lactamase inhibitor. Sulbactam sodium shows antimicrobial activity against multidrug-resistant (MDR) acinetobacter calcoaceticus--Acinetobacter baumannii (Acb) complex[1][2].	Sodium	C8H10NNaO5S	99636.0	H2O : ≥ 100 mg/mL (391.82 mM); DMSO : 50 mg/mL (195.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S([C@]1([H])C2)(=O)=O)N1C2=O)O[Na]	https://www.medchemexpress.com/sulbactam-sodium.html	Launched		91.0	J25	C5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0334A	10.0	mM	53.0	DMSO	233.035793	5	C	pluskal_fda_drugs_5005_C5_id
931	HY-19883	HYCPK40904	H15	HYCPK40904	91z	749.0	3.0	P29	904.0	H15	1110766-97-6	Lusutrombopag	S-888711	591.55	Thrombopoietin Receptor	Immunology/Inflammation	Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, used for treatment of chronic liver disease.	Free Acid	C29H32Cl2N2O5S	22971.0	DMSO : ≥ 33 mg/mL (55.79 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)/C(C)=C/C1=C(Cl)C=C(C(NC2=NC(C3=CC=CC([C@@H](OCCCCCC)C)=C3OC)=CS2)=O)C=C1Cl	https://www.medchemexpress.com/Lusutrombopag.html	Launched		91.0	P29	C5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19883	10.0	mM	53.0	DMSO	590.140898	5	C	pluskal_fda_drugs_5005_C5_id
1029	HY-17469	HYCPK40904	N21	HYCPK40904	91z	1337.0	3.0	AB41	904.0	N21	103766-25-2	Gimeracil	Gimestat	145.54	Others	Others	Gimeracil, a component of an oral fluoropyrimidine derivative S-1, inhibits DNA DSB repair and is a potent inhibitor of DPYD (dihydropyrimidine dehydrogenase, DPD)[1][2].	Free Base	C5H4ClNO2	11965.0	DMSO : 100 mg/mL (687.10 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C=C(O)C(Cl)=CN1	https://www.medchemexpress.com/gimeracil.html	Launched		91.0	AB41	C5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17469	10.0	mM	53.0	DMSO	144.993056	5	C	pluskal_fda_drugs_5005_C5_id
1305	HY-B0421	HYCPK40905	B19	HYCPK40905	91z	182.0	4.0	D38	905.0	B19	24280-93-1	Mycophenolic acid	Mycophenolate	320.34	Antibiotic; Apoptosis; Bacterial; Endogenous Metabolite; Fungal	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Mycophenolic acid is a potent uncompetitive inosine monophosphate dehydrogenase (IMPDH) inhibitor with an EC50 of 0.24 μM.?Mycophenolic acid demonstrates antiviral effects against a wide range of RNA viruses including influenza. Mycophenolic acid is an immunosuppressive agent. Antiangiogenic and antitumor effects[1][2].	Free Acid	C17H20O6	15395.0	DMSO : ≥ 100 mg/mL (312.17 mM); H2O : 0.1 mg/mL (0.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=C(O)CC/C(C)=C/CC1=C(O)C2=C(COC2=O)C(C)=C1OC	https://www.medchemexpress.com/Mycophenolic-acid.html	Launched		91.0	D38	C5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0421	10.0	mM	53.0	DMSO	320.125988	5	C	pluskal_fda_drugs_5005_C5_id
295	HY-W018791	HYCPK40902	O18	HYCPK40902	91z	1379.0	1.0	AC35	902.0	O18	73536-69-3	Bifendate	DDB	418.35	HBV	Anti-infection	Bifendate (DDB) is a synthetic intermediate of Schisandrin C with anti-HBV efficacy in research of chronic hepatitis B[1].	Free Base	C20H18O10	27708.0	DMSO : 50 mg/mL (119.52 mM; Need ultrasonic); H2O : 1 mg/mL (2.39 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	C2=C(OC)C1=C(OCO1)C(=C2C(OC)=O)C3=C(C=C(OC)C4=C3OCO4)C(OC)=O	https://www.medchemexpress.com/bifendate.html	Launched		91.0	AC35	C6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W018791	10.0	mM	54.0	DMSO	418.089997	6	C	pluskal_fda_drugs_5005_C6_id
327	HY-116408A	HYCPK40902	O20	HYCPK40902	91z	1383.0	1.0	AC39	902.0	O20	54556-98-8	Propiverine (hydrochloride)		403.94	Calcium Channel; mAChR	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Propiverine hydrochloride is a bladder spasmolytic with calcium antagonistic and anticholinergic properties. Propiverine hydrochloride can be used for the research of overactive blaqdder and urinary incontinence[1][2].	Hydrochloride	C23H30ClNO3	104002.0	H2O : 50 mg/mL (123.78 mM; Need ultrasonic); DMSO : 50 mg/mL (123.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C(C1=CC=CC=C1)(C2=CC=CC=C2)OCCC)OC3CCN(CC3)C.[H]Cl	https://www.medchemexpress.com/propiverine-hydrochloride.html	Launched		91.0	AC39	C6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-116408A	10.0	mM	54.0	DMSO	367.214744	6	C	pluskal_fda_drugs_5005_C6_id
599	HY-10619B	HYCPK40903	M13	HYCPK40903	91z	1178.0	2.0	Y26	903.0	M13	1038915-73-9	Niraparib (tosylate)	MK-4827 (tosylate)	492.59	Apoptosis; PARP	Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Niraparib tosylate (MK-4827 tosylate) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with an IC50 of 3.8 and 2.1 nM, respectively. Niraparib tosylate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity[1][2][3].	Tosylate	C26H28N4O4S	25385.0	DMSO : 100 mg/mL (203.01 mM; ultrasonic and warming and heat to 60°C); H2O : 1 mg/mL (2.03 mM; heat to 50°C)	DMSO Solution	10mM  * 100uL	Cancer	NC(C1=CC=CC2=CN(C3=CC=C([C@H]4CNCCC4)C=C3)N=C21)=O.O=S(C5=CC=C(C)C=C5)(O)=O	https://www.medchemexpress.com/MK-4827-tosylate.html	Launched		91.0	Y26	C6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10619B	10.0	mM	54.0	DMSO	320.163711	6	C	pluskal_fda_drugs_5005_C6_id
669	HY-B1655	HYCPK40903	C18	HYCPK40903	91z	228.0	2.0	E36	903.0	C18	1841-19-6	Fluspirilene	R 6218; Redeptin	475.57	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Fluspirilene is a non-competitive antagonist of L-type calcium channels with an IC50 of 0.03 μM. Fluspirileneis a long-acting injectable depot antipsychotic drug used for schizophrenia.	Free Base	C29H31F2N3O	150996.0	DMSO : 25 mg/mL (52.57 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1NCN(C2=CC=CC=C2)C13CCN(CCCC(C4=CC=C(F)C=C4)C5=CC=C(F)C=C5)CC3	https://www.medchemexpress.com/Fluspirilene.html	Launched		91.0	E36	C6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1655	10.0	mM	54.0	DMSO	475.243519	6	C	pluskal_fda_drugs_5005_C6_id
868	HY-A0169A	HYCPK40904	I11	HYCPK40904	91z	837.0	3.0	R21	904.0	I11	79416-27-6	Methyl aminolevulinate (hydrochloride)		181.62	Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Methyl aminolevulinate hydrochloride is an agent used as a sensitizer in photodynamic therapy (PDT). Methyl aminolevulinate is a prodrug that can be metabolized to Protoporphyrin IX[1].	Hydrochloride	C6H12ClNO3	145221.0	DMSO : 100 mg/mL (550.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(OC)CCC(CN)=O.[H]Cl	https://www.medchemexpress.com/methyl-aminolevulinate-hydrochloride.html	Launched		91.0	R21	C6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0169A	10.0	mM	54.0	DMSO	145.073893	6	C	pluskal_fda_drugs_5005_C6_id
891	HY-B1904	HYCPK40904	P12	HYCPK40904	91z	1511.0	3.0	AF23	904.0	P12	5002-47-1	Fluphenazine decanoate		591.77	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Fluphenazine decanoate is a dopamine D2 receptor inhibitor, is a long-acting phenothiazine neuroleptic. Fluphenazine can be used for schizophrenia research[1][2][3].		C32H44F3N3O2S	59125.0	Ethanol : 50 mg/mL (84.49 mM; Need ultrasonic); DMSO : 125 mg/mL (211.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCCCCCCCCC(OCCN1CCN(CCCN2C3=C(C=CC=C3)SC4=CC=C(C(F)(F)F)C=C24)CC1)=O	https://www.medchemexpress.com/fluphenazine-decanoate.html	Launched		91.0	AF23	C6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1904	10.0	mM	54.0	DMSO	591.310633	6	C	pluskal_fda_drugs_5005_C6_id
1148	HY-N0343	HYCPK40905	E09	HYCPK40905	91z	450.0	4.0	J18	905.0	E09	80154-34-3	Helicid	Helicide; Helicidum; 4-Formylphenyl-β-D-allopyranoside	284.26	Others	Others	Helicid (Helicide) is a major constituent of Helicia nilgirica Bedd. Helicid has been used to treat psychoneurosis for its analgesic properties[1].	Free Base	C13H16O7	40779.0	H2O : 4.58 mg/mL (16.11 mM; Need ultrasonic); DMSO : 110 mg/mL (386.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O[C@@H]1[C@@H](CO)O[C@@H](OC2=CC=C(C=O)C=C2)[C@H](O)[C@@H]1O	https://www.medchemexpress.com/helicid.html	Launched		91.0	J18	C6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0343	10.0	mM	54.0	DMSO	284.089603	6	C	pluskal_fda_drugs_5005_C6_id
1187	HY-B0334	HYCPK40905	L11	HYCPK40905	91z	1126.0	4.0	X22	905.0	L11	68373-14-8	Sulbactam	CP45899	233.24	Antibiotic; Bacterial	Anti-infection	Sulbactam (CP45899) is a competitive, irreversible beta-lactamase inhibitor. Sulbactam shows antimicrobial activity against multidrug-resistant (MDR) acinetobacter calcoaceticus--Acinetobacter baumannii (Acb) complex[1][2].	Free Acid	C8H11NO5S	13457.0	H2O : 20 mg/mL (85.75 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (428.74 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S([C@]1([H])C2)(=O)=O)N1C2=O)O	https://www.medchemexpress.com/Sulbactam.html	Launched		91.0	X22	C6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0334	10.0	mM	54.0	DMSO	233.035793	6	C	pluskal_fda_drugs_5005_C6_id
319	HY-13575	HYCPK40902	G20	HYCPK40902	91z	615.0	1.0	M39	902.0	G20	132810-10-7	Blonanserin	AD-5423	367.50	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor; Sigma Receptor	GPCR/G Protein; Neuronal Signaling	Blonanserin (AD-5423) is a potent?and orally active 5-HT2A?(Ki=0.812 nM) and?dopamine D2?receptor?(Ki =0.142?nM)?antagonist. Blonanserin is usually acts as an atypical antipsychotic?agent and can be used for the research of extrapyramidal symptoms, excessive?sedation, or?hypotension[1].	Free Base	C23H30FN3	15452.0	DMSO : 14.29 mg/mL (38.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	FC1=CC=C(C2=C(CCCCCC3)C3=NC(N4CCN(CC)CC4)=C2)C=C1	https://www.medchemexpress.com/Blonanserin.html	Launched		91.0	M39	C7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13575	10.0	mM	55.0	DMSO	367.242376	7	C	pluskal_fda_drugs_5005_C7_id
449	HY-B0265	HYCPK40903	F05	HYCPK40903	91z	490.0	2.0	K10	903.0	F05	66085-59-4	Nimodipine	BAY-e 9736	418.44	Autophagy; Calcium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Nimodipine (BAY-e 9736) is an orally active, well-tolerated and light-sensitive dihydropyridine calcium antagonist. Nimodipine can be used for the research of cerebrovascular disorders[1].	Free Base	C21H26N2O7	25686.0	DMSO : 100 mg/mL (238.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(C1=C(C)NC(C)=C(C(OC(C)C)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OCCOC	https://www.medchemexpress.com/Nimodipine.html	Launched		91.0	K10	C7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0265	10.0	mM	55.0	DMSO	418.174001	7	C	pluskal_fda_drugs_5005_C7_id
635	HY-B0211A	HYCPK40903	A16	HYCPK40903	91z	32.0	2.0	A32	903.0	A16	850608-87-6	Riluzole hydrochloride	PK 26124 hydrochloride	270.66	GABA Receptor; Sodium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Riluzole hydrochloride is an anticonvulsant drug and belongs to the family of use-dependent Na+ channel blocker which can also inhibit GABA uptake with an IC50 of 43 μM.	Hydrochloride	C8H6ClF3N2OS	28876.0	H2O : 4.17 mg/mL (15.41 mM; Need ultrasonic); DMSO : 100 mg/mL (369.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	NC1=NC2=CC=C(OC(F)(F)F)C=C2S1.Cl	https://www.medchemexpress.com/Riluzole_hydrochloride.html	Launched		91.0	A32	C7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0211A	10.0	mM	55.0	DMSO	234.007468	7	C	pluskal_fda_drugs_5005_C7_id
654	HY-14904A	HYCPK40903	D17	HYCPK40903	91z	322.0	2.0	G34	903.0	D17	131707-23-8	Umifenovir (hydrochloride)		513.88	Influenza Virus; SARS-CoV	Anti-infection	Umifenovir hydrochloride is a potent, orally active broad-spectrum antiviral with activity against a number of enveloped and non-enveloped viruses. Umifenovir hydrochloride is used as an anti-influenza virus agent. Umifenovir hydrochloride could effectively inhibit the fusion of virus with host cells[1][2]. Umifenovir hydrochloride is an efficient inhibitor of SARS-CoV-2 in vitro. Anti-inflammatory activity[3].	Hydrochloride	C22H26BrClN2O3S	14415.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 25 mg/mL (48.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=C(CSC2=CC=CC=C2)N(C)C3=C1C(CN(C)C)=C(O)C(Br)=C3)OCC.[H]Cl	https://www.medchemexpress.com/Arbidol-hydrochloride.html	Launched		91.0	G34	C7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14904A	10.0	mM	55.0	DMSO	476.076926	7	C	pluskal_fda_drugs_5005_C7_id
723	HY-N7115	HYCPK40903	C22	HYCPK40903	91z	236.0	2.0	E44	903.0	C22	76497-13-7	Sultamicillin		594.66	Antibiotic; Bacterial	Anti-infection	Sultamicillin is an orally active double prodrug of Ampicillin/Sulbactan. Sulbactam is a semisynthetic beta-lactamase inhibitor which, in combination with Ampicillin, extends the antibacterial activity of the latter to include some beta-lactamase-producing strains of bacteria that would otherwise be resistant[1].	Free Base	C25H30N4O9S2	150080.0	DMSO : 100 mg/mL (168.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(OCOC([C@H](N1C2=O)C(C)(S[C@@]1([C@@H]2NC([C@@H](C3=CC=CC=C3)N)=O)[H])C)=O)[C@H](N45)C(C)(S([C@@]4(CC5=O)[H])(=O)=O)C	https://www.medchemexpress.com/sultamicillin.html	Launched		91.0	E44	C7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7115	10.0	mM	55.0	DMSO	594.145421	7	C	pluskal_fda_drugs_5005_C7_id
793	HY-B0020	HYCPK40904	N06	HYCPK40904	91z	1307.0	3.0	AB11	904.0	N06	105826-92-4	Tropisetron (Hydrochloride)	SDZ-ICS-930	320.81	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Tropisetron Hydrochloride (SDZ-ICS-930) is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor.
IC50 value: 70.1 ± 0.9 nM
Target: 5-HT3 receptor; α7-nicotinic receptor
in vitro: Retinal ganglion cells(RGCs) pretreated with 100 nM tropisetron before glutamate increased cell survival to an average of 105% compared to controls. Inhibition studies using the alpha7 nAChR antagonist, MLA (10 nM), support the hypothesis that tropisetron is an effective neuroprotective agent against glutamate-induced excitotoxicity; mediated by α7 nAChR activation. Tropisetron had no discernible effects on pAkt levels but significantly decreased p38 MAPK levels associated with excitotoxicity from an average of 15 ng/ml to 6 ng/ml [2]. Tropisetron, but not granisetron, significantly inhibits the phosphatase activity of calcineurin, over-expresses the CB(1) receptors at both transcriptional and protein levels, and reduces cAMP content in cerebellar granule neurons (CGNs) [4].
in vivo: Animals were treated intracerebroventricularly with tropisetron, mCPBG (selective 5-HT3 receptor agonist) or mCPBG plus tropisetron on days 1, 3, 5 and 7. Tropisetron significantly diminished the elevated levels of these markers and reversed the cognitive deficit. Interestingly, tropisetron was also found to be a potent inhibitor of calcineurin phosphatase activity [1]. tropisetron (5mg/kg/day) plus mCPBG (10mg/kg/day), and granisetron (5mg/kg/day) intraperitoneally on days 3-35 post-immunization. Treatment with tropisetron and granisetron markedly suppressed the clinical symptoms of EAE (p<0.001) and reduced leukocyte infiltration as well as demyelination in the spinal cord (p<0.05) [3]."	Hydrochloride	C17H21ClN2O2	5127.0	H2O : ≥ 50 mg/mL (155.86 mM); DMSO : 33.33 mg/mL (103.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C1=CNC2=C1C=CC=C2)O[C@H]3C[C@H]4CC[C@H](N4C)C3.[H]Cl	https://www.medchemexpress.com/Tropisetron-Hydrochloride.html	Launched		91.0	AB11	C7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0020	10.0	mM	55.0	DMSO	284.152478	7	C	pluskal_fda_drugs_5005_C7_id
1094	HY-17426	HYCPK40905	O05	HYCPK40905	91z	1402.0	4.0	AD10	905.0	O05	104227-87-4	Famciclovir	BRL 42810	321.33	HBV; HSV	Anti-infection	Famciclovir (BRL 42810) is an orally active nucleoside analogue. Famciclovir is an antiviral agent with potent activities against HBV, HSV and VZV. Famciclovir can be used for the research of herpesvirus infection[1].	Free Base	C14H19N5O4	13705.0	H2O : 50 mg/mL (155.60 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (311.21 mM)	DMSO Solution	10mM  * 100uL	Infection	NC1=NC=C2N=CN(CCC(COC(C)=O)COC(C)=O)C2=N1	https://www.medchemexpress.com/Famciclovir.html	Launched		91.0	AD10	C7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17426	10.0	mM	55.0	DMSO	321.143704	7	C	pluskal_fda_drugs_5005_C7_id
1125	HY-N0709	HYCPK40905	N07	HYCPK40905	91z	1310.0	4.0	AB14	905.0	N07	91-64-5	Coumarin		146.14	Influenza Virus	Anti-infection	Coumarin is the primary bioactive ingredient in Radix Glehniae, named Beishashen in China, which possesses many pharmacological activities, including anticancer, anti-inflammation and antivirus activities.	Free Base	C9H6O2	27478.0	H2O : 4 mg/mL (27.37 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (684.28 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=C1C=CC2=CC=CC=C2O1	https://www.medchemexpress.com/Coumarin.html	Launched		91.0	AB14	C7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0709	10.0	mM	55.0	DMSO	146.036779	7	C	pluskal_fda_drugs_5005_C7_id
118	HY-100818	HYCPK40902	L06	HYCPK40902	91z	1067.0	1.0	W11	902.0	L06	1448169-71-8	Futibatinib	TAS-120	418.45	FGFR	Protein Tyrosine Kinase/RTK	Futibatinib (TAS-120) is an orally bioavailable, highly selective, and irreversible FGFR inhibitor, with IC50s of 3.9, 1.3, 1.6, and 8.3 nM for FGFR 1-4, respectively. Futibatinib inhibits mutant and wild-type FGFR2 with similar IC50s (wild-type FGFR2=0.9?nM; V5651=1-3?nM; N550H=3.6?nM; E566G=2.4?nM)[1][2][3].	Free Base	C22H22N6O3	87520.0	DMSO : ≥ 29 mg/mL (69.30 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C=C)N(C1)CC[C@@H]1N(N=C2C#CC3=CC(OC)=CC(OC)=C3)C4=C2C(N)=NC=N4	https://www.medchemexpress.com/FGFR-IN-1.html	Launched		91.0	W11	C8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100818	10.0	mM	56.0	DMSO	418.175339	8	C	pluskal_fda_drugs_5005_C8_id
150	HY-B2168	HYCPK40902	P08	HYCPK40902	91z	1455.0	1.0	AE15	902.0	P08	29216-28-2	Mequitazine	LM-209	322.47	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Mequitazine is a potent, and long-acting histamine H1 antagonist.	Free Base	C20H22N2S	41113.0	DMSO : 16 mg/mL (49.62 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C12=CC=CC=C1N(CC3CN4CCC3CC4)C5=C(C=CC=C5)S2	https://www.medchemexpress.com/Mequitazine.html	Launched		91.0	AE15	C8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2168	10.0	mM	56.0	DMSO	322.15037	8	C	pluskal_fda_drugs_5005_C8_id
495	HY-B0384	HYCPK40903	D08	HYCPK40903	91z	304.0	2.0	G16	903.0	D08	110221-44-8	Temocapril (hydrochloride)		513.07	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Temocapril hydrochloride is an orally active angiotensin-converting enzyme (ACE) inhibitor. Temocapril hydrochloride can be used for the research of hypertension, congestive heart failure, acute myocardial infarction, insulin resistance, and renal diseases[1][2].	Hydrochloride	C23H29ClN2O5S2	15807.0	DMSO : 62.5 mg/mL (121.82 mM; ultrasonic and warming and heat to 60°C); H2O : 2.27 mg/mL (4.42 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O)CN1C[C@@H](C2=CC=CS2)SC[C@H](N[C@H](C(OCC)=O)CCC3=CC=CC=C3)C1=O.Cl	https://www.medchemexpress.com/Temocapril-hydrochloride.html	Launched		91.0	G16	C8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0384	10.0	mM	56.0	DMSO	476.143964	8	C	pluskal_fda_drugs_5005_C8_id
503	HY-B0072	HYCPK40903	L08	HYCPK40903	91z	1072.0	2.0	W16	903.0	L08	89565-68-4	Tropisetron	SDZ-ICS-930 (free base)	284.35	5-HT Receptor; nAChR	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	"Tropisetron (SDZ-ICS-930 free base) is a selective 5-HT3 receptor antagonist and α7-nicotinic receptor agonist with an IC50 of 70.1 ± 0.9 nM for 5-HT3 receptor. 
IC50 value: 70.1 ± 0.9 nM [1]
Target: 5-HT3 receptor
in vitro: Tropisetron specifically inhibited both IL-2 gene transcription and IL-2 synthesis in stimulated T cells. tropisetron inhibited both the binding to DNA and the transcriptional activity of NFAT and AP-1. We also observed that tropisetron is a potent inhibitor of PMA plus ionomycin-induced NF-(kappa)B activation but in contrast TNF(alpha)-mediated NF-(kappa)B activation was not affected by this antagonist [2]. Tropisetron prevents the phosphorylation and thus activation of the p38 MAPK, which is involved in post-transcriptional regulation of various cytokines [3].
in vivo: Two different doses of tropisetron (5 and 10 mg/kg) or vehicle were administered intraperitoneally 30 min before pMCAO. Neurological deficit scores, mortality rate and infarct volume were determined 24 h after permanent focal cerebral ischemia [4]."	Free Base	C17H20N2O2	7755.0	H2O : ≥ 55 mg/mL (193.42 mM); DMSO : ≥ 100 mg/mL (351.68 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C1=CNC2=C1C=CC=C2)O[C@H]3C[C@H]4CC[C@H](N4C)C3	https://www.medchemexpress.com/tropisetron.html	Launched		91.0	W16	C8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0072	10.0	mM	56.0	DMSO	284.152478	8	C	pluskal_fda_drugs_5005_C8_id
726	HY-N0283	HYCPK40903	F22	HYCPK40903	91z	524.0	2.0	K44	903.0	F22	13739-02-1	Diacerein	Diacerhein; Diacetylrhein	368.29	Interleukin Related	Immunology/Inflammation	Diacerein (Diacerhein), a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases.	Free Acid	C19H12O8	40927.0	DMSO : 12.5 mg/mL (33.94 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C(C=C1C2=O)=CC(OC(C)=O)=C1C(C3=C2C=CC=C3OC(C)=O)=O)O	https://www.medchemexpress.com/diacerein.html	Launched		91.0	K44	C8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0283	10.0	mM	56.0	DMSO	368.053217	8	C	pluskal_fda_drugs_5005_C8_id
1223	HY-B0211	HYCPK40905	P13	HYCPK40905	91z	1514.0	4.0	AF26	905.0	P13	1744-22-5	Riluzole	PK 26124	234.20	GABA Receptor; Sodium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Riluzole is an anticonvulsant drug and belongs to the family of use-dependent Na+ channel blocker which can also inhibit GABA uptake with an IC50 of 43 μM.	Free Base	C8H5F3N2OS	16556.0	H2O : 1 mg/mL (4.27 mM; ultrasonic and adjust pH to 3 with HCl); DMSO : 100 mg/mL (426.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	NC1=NC2=CC=C(OC(F)(F)F)C=C2S1	https://www.medchemexpress.com/riluzole.html	Launched		91.0	AF26	C8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0211	10.0	mM	56.0	DMSO	234.007468	8	C	pluskal_fda_drugs_5005_C8_id
1268	HY-N7111	HYCPK40905	M16	HYCPK40905	91z	1232.0	4.0	Z32	905.0	M16	83105-70-8	Sultamicillin (tosylate)		766.86	Antibiotic; Bacterial	Anti-infection	Sultamicillin (tosylate) is a potent and orally active beta-lactamase inhibitor, an antibiotic with antibacterial activity. Sultamicillin (tosylate) is the tosylate salt of the double ester of sulbactam plus ampicillin[1].</br>	Tosylate	C32H38N4O12S3	149208.0	DMSO : 125 mg/mL (163.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC([C@H](N)C3=CC=CC=C3)=O)N1C2=O)OCOC([C@@H](C(C)(C)S(C4C5)(=O)=O)N4C5=O)=O.O=S(C6=CC=C(C)C=C6)(O)=O	https://www.medchemexpress.com/sultamicillin-tosylate.html	Launched		91.0	Z32	C8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7111	10.0	mM	56.0	DMSO	594.145421	8	C	pluskal_fda_drugs_5005_C8_id
1357	HY-B1469	HYCPK40905	J22	HYCPK40905	91z	956.0	4.0	T44	905.0	J22	652-67-5	Isosorbide	D-Isosorbide; Dianhydro-D-glucitol	146.14	Others	Others	Isosorbide (D-Isosorbide), an orally active vasodilating agent that can be used for the research of heart failure and angina (chest pain). Isosorbide is also an oral hyperosmotic diuretic[1][2].	Free Base	C6H10O4	18548.0	H2O : ≥ 100 mg/mL (684.28 mM); DMSO : ≥ 100 mg/mL (684.28 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O[C@H]1[C@]2([H])[C@]([C@@H](O)CO2)([H])OC1	https://www.medchemexpress.com/Isosorbide.html	Launched		91.0	T44	C8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1469	10.0	mM	56.0	DMSO	146.057909	8	C	pluskal_fda_drugs_5005_C8_id
190	HY-14545	HYCPK40902	L11	HYCPK40902	91z	1077.0	1.0	W21	902.0	L11	71675-85-9	Amisulpride	DAN 2163	369.48	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Amisulpride is a dopamine D2/D3 receptor antagonist with Kis of 2.8 and 3.2 nM for human dopamine D2 and D3, respectively.	Free Base	C17H27N3O4S	118181.0	H2O : 0.2 mg/mL (0.54 mM; Need ultrasonic); DMSO : 50 mg/mL (135.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	CCN1C(CNC(C2=CC(S(=O)(CC)=O)=C(N)C=C2OC)=O)CCC1	https://www.medchemexpress.com/Amisulpride.html	Launched		91.0	W21	C9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14545	10.0	mM	57.0	DMSO	369.172227	9	C	pluskal_fda_drugs_5005_C9_id
496	HY-N0176	HYCPK40903	E08	HYCPK40903	91z	400.0	2.0	I16	903.0	E08	71939-50-9	Dihydroartemisinin	Dihydroqinghaosu; β-Dihydroartemisinin; Artenimol	284.35	Apoptosis; Autophagy; NF-κB; Parasite	Anti-infection; Apoptosis; Autophagy; NF-κB	Dihydroartemisinin is a potent anti-malaria agent.	Free Base	C15H24O5	46195.0	Ethanol : 10 mg/mL (35.17 mM; Need ultrasonic); DMSO : 25 mg/mL (87.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O[C@@H]1[C@H](C)[C@]2([H])CC[C@@H](C)[C@]3([H])CC[C@@](O4)(C)OO[C@]32[C@]4([H])O1	https://www.medchemexpress.com/Dihydroartemisinin.html	Launched		91.0	I16	C9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0176	10.0	mM	57.0	DMSO	284.162374	9	C	pluskal_fda_drugs_5005_C9_id
509	HY-B0727	HYCPK40903	B09	HYCPK40903	91z	114.0	2.0	C18	903.0	B09	2152-44-5	Betamethasone valerate	Betamethasone 17-valerate	476.58	Glucocorticoid Receptor	Immunology/Inflammation	Betamethasone valerate (Betamethasone 17-valerate), the 17-valerate ester of Betamethasone, is a topical corticosteroid with anti-inflammatory activity. Betamethasone valerate is used in the treatment of recurrent aphthous stomatitis. Betamethasone valerate inhibits the binding of the radiolabeled glucocorticoid dexamethasone (3H dexamethasone) to human epidermis and mouse skin with IC50s of 5 and 6 nM, respectively[1][2][3].		C27H37FO6	100398.0	DMSO : 100 mg/mL (209.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(CO)=O)(OC(CCCC)=O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/betamethasone-valerate.html	Launched		91.0	C18	C9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0727	10.0	mM	57.0	DMSO	476.257417	9	C	pluskal_fda_drugs_5005_C9_id
788	HY-108013	HYCPK40904	I06	HYCPK40904	91z	827.0	3.0	R11	904.0	I06	53696-74-5	Armillarisin A		234.20	Interleukin Related	Immunology/Inflammation	Armillarisin A has the potential for the ulcerative colitis (UC) study. Armillarisin A increases IL-4 and lower IL-1β[1].		C12H10O5	100719.0	DMSO : 100 mg/mL (426.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OCC1=C2C(OC(C(C(C)=O)=C2)=O)=CC(O)=C1	https://www.medchemexpress.com/armillarisin-a.html	Launched		91.0	R11	C9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108013	10.0	mM	57.0	DMSO	234.052823	9	C	pluskal_fda_drugs_5005_C9_id
853	HY-16423	HYCPK40904	J10	HYCPK40904	91z	931.0	3.0	T19	904.0	J10	156137-99-4	Rapacuronium bromide	Org 9487	677.80	mAChR	GPCR/G Protein; Neuronal Signaling	Rapacuronium bromide (Org 9487), a non-depolarizing neuromuscular blocker, is an allosteric modulator of muscarinic acetylcholine receptor (mAChR)[1].	Bromide	C37H61BrN2O4	39940.0	DMSO : ≥ 125 mg/mL (184.42 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[C@@]12[C@](CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])C[C@H]([N+]5(CC=C)CCCCC5)[C@@H]4OC(CC)=O)([H])C[C@H](OC(C)=O)[C@@H](N6CCCCC6)C1.[Br-]	https://www.medchemexpress.com/RAPACURONIUM_BROMIDE.html	Launched		91.0	T19	C9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16423	10.0	mM	57.0	DMSO	597.462585	9	C	pluskal_fda_drugs_5005_C9_id
932	HY-101086	HYCPK40904	I15	HYCPK40904	91z	845.0	3.0	R29	904.0	I15	2260-50-6	Acetylcholine (iodide)	ACh (iodide)	273.11	Endogenous Metabolite	Metabolic Enzyme/Protease	Acetylcholine iodide (ACh iodide) is a common neurotransmitter found in the central and peripheral nerve system[1].	Iodide	C7H16INO2	45482.0	H2O : ≥ 100 mg/mL (366.15 mM); DMSO : 100 mg/mL (366.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C(OCC[N+](C)(C)C)C.[I-]	https://www.medchemexpress.com/acetylcholine-iodide.html	Launched		91.0	R29	C9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101086	10.0	mM	57.0	DMSO	146.117555	9	C	pluskal_fda_drugs_5005_C9_id
1170	HY-B0753	HYCPK40905	K10	HYCPK40905	91z	1028.0	4.0	V20	905.0	K10	21187-98-4	Gliclazide	S1702; SE1702	323.41	Potassium Channel	Membrane Transporter/Ion Channel	Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Gliclazide is used as an antidiabetic[1].	Free Base	C15H21N3O3S	16579.0	DMSO : ≥ 100 mg/mL (309.21 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(C1=CC=C(C)C=C1)(NC(NN2CC3C(CCC3)C2)=O)=O	https://www.medchemexpress.com/gliclazide.html	Launched		91.0	V20	C9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0753	10.0	mM	57.0	DMSO	323.130363	9	C	pluskal_fda_drugs_5005_C9_id
1179	HY-B1471	HYCPK40905	D11	HYCPK40905	91z	358.0	4.0	H22	905.0	D11	3801-06-7	Fluorometholone acetate		418.50	Carbonic Anhydrase	Metabolic Enzyme/Protease	Fluorometholone acetate is a synthetic glucocorticoid corticosteroid and a corticosteroid ester. Fluorometholone acetate potently inhibits carbonic anhydrase (CA) with IC50s of 2.18 μM and 17.5 μM for hCA-I and hCA-II, respectively. Fluorometholone acetate has anti-inflammatory effect and has the potential for external ocular inflammation research[1][2][3].		C24H31FO5	68308.0	DMSO : 250 mg/mL (597.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC([C@@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])C[C@H](C)C4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)=O)=O	https://www.medchemexpress.com/fluorometholone-acetate.html	Launched		91.0	H22	C9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1471	10.0	mM	57.0	DMSO	418.215552	9	C	pluskal_fda_drugs_5005_C9_id
263	HY-16771	HYCPK40902	E16	HYCPK40902	91z	415.0	1.0	I31	902.0	E16	1025504-45-3	Valbenazine	NBI-98854	418.57	Monoamine Transporter	Membrane Transporter/Ion Channel	Valbenazine (NBI-98854) is a vesicular monoamine transporter 2 (VMAT2) inhibitor with the Ki of 110-190 nM[1].	Free Base	C24H38N2O4	22015.0	DMSO : 50 mg/mL (119.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C([C@@H](N)C(C)C)O[C@@H]1C[C@]2([H])C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC(C)C	https://www.medchemexpress.com/Valbenazine.html	Launched		91.0	I31	C10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16771	10.0	mM	58.0	DMSO	418.283158	10	C	pluskal_fda_drugs_5005_C10_id
518	HY-N0597	HYCPK40903	G10	HYCPK40903	91z	596.0	2.0	M20	903.0	G10	32791-84-7	Panaxatriol		476.73	Others	Others	Panaxatriol is a natural product that can relieve myelosuppression induced by radiation injury.	Free Base	C30H52O4	22716.0	DMSO : 25 mg/mL (52.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	C[C@@]1(CC[C@@H]2O)[C@](C[C@H]3O)([H])[C@](C[C@@H](O)[C@@]1([H])C2(C)C)(C)[C@@]4(C)[C@@]3([H])[C@]([C@](CCC5)(C)OC5(C)C)([H])CC4	https://www.medchemexpress.com/Panaxatriol.html	Launched		91.0	M20	C10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0597	10.0	mM	58.0	DMSO	476.38656	10	C	pluskal_fda_drugs_5005_C10_id
648	HY-12641	HYCPK40903	N16	HYCPK40903	91z	1280.0	2.0	AA32	903.0	N16	33401-94-4	Pyrantel (tartrate)		356.39	Antibiotic; nAChR; Parasite	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Pyrantel tartrate is an orally active anthelmintic and an agonist of the nicotinic acetylcholine receptor (nAChR). Pyrantel tartrate can cause spasmodic muscle paralysis in parasites. Pyrantel tartrate can be used in the study of parasitic infections such as ascariasis, hookworm infections, intestinal worms (pinworm infections), trichinosis and trichinosis[1][2].	Tartrate	C15H20N2O6S	15050.0	DMSO : ≥ 34 mg/mL (95.40 mM)	DMSO Solution	10mM  * 100uL	Infection	CN1CCCN=C1/C=C/C2=CC=CS2.O=C(O)[C@H](O)[C@@H](O)C(O)=O	https://www.medchemexpress.com/Pyrantel-tartrate.html	Launched		91.0	AA32	C10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12641	10.0	mM	58.0	DMSO	150.016438	10	C	pluskal_fda_drugs_5005_C10_id
706	HY-102003	HYCPK40903	B21	HYCPK40903	91z	138.0	2.0	C42	903.0	B21	1859053-21-6	Rucaparib (monocamsylate)	AG014699 (monocamsylate); PF-01367338 (monocamsylate)	555.66	PARP	Cell Cycle/DNA Damage; Epigenetics	Rucaparib (AG014699) monocamsylate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib monocamsylate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib monocamsylate has the potential for castration-resistant prostate cancer (CRPC) research[1][2][3][4].	Camsylate	C29H34FN3O5S	43418.0	DMSO : 83.33 mg/mL (149.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1.O=S(C[C@@]5(C6(C)C)C(C[C@@]6([H])CC5)=O)(O)=O	https://www.medchemexpress.com/Rucaparib_Camsylate.html	Launched		91.0	C42	C10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-102003	10.0	mM	58.0	DMSO	323.14339	10	C	pluskal_fda_drugs_5005_C10_id
801	HY-B0185A	HYCPK40904	F07	HYCPK40904	91z	541.0	3.0	L13	904.0	F07	73-78-9	Lidocaine (hydrochloride)	Lignocaine hydrochloride	270.80	Apoptosis; ERK; MEK; NF-κB; Sodium Channel	Apoptosis; MAPK/ERK Pathway; Membrane Transporter/Ion Channel; NF-κB; Stem Cell/Wnt	Lidocaine hydrochloride (Lignocaine hydrochloride) inhibits sodium channels involving complex voltage and using dependence[1]. Lidocaine hydrochloride decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine hydrochloride is an amide derivative and a drug to treat ventricular arrhythmia and an effective tumor-inhibitor[2].	Hydrochloride	C14H23ClN2O	15187.0	H2O : ≥ 100 mg/mL (369.28 mM); DMSO : ≥ 100 mg/mL (369.28 mM)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C(NC1=C(C)C=CC=C1C)CN(CC)CC.[H]Cl	https://www.medchemexpress.com/Lidocaine-hydrochloride.html	Launched		91.0	L13	C10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0185A	10.0	mM	58.0	DMSO	234.173213	10	C	pluskal_fda_drugs_5005_C10_id
967	HY-W013172	HYCPK40904	P17	HYCPK40904	91z	1521.0	3.0	AF33	904.0	P17	35189-28-7	Norgestimate		369.50	Progesterone Receptor	Others	Norgestimate, a synthetic progesterone analog, is an orally active progestin with highly selective progestational activity and minimal androgenicity. Norgestimate is used for an oral contraceptive[1][2].	Free Base	C23H31NO3	155978.0	DMSO : 125 mg/mL (338.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	C#C[C@@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])CCC4=C/C(CC[C@]4([H])[C@@]3([H])CC[C@]12CC)=N/O	https://www.medchemexpress.com/norgestimate.html	Launched		91.0	AF33	C10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W013172	10.0	mM	58.0	DMSO	369.230394	10	C	pluskal_fda_drugs_5005_C10_id
1163	HY-13318	HYCPK40905	D10	HYCPK40905	91z	356.0	4.0	H20	905.0	D10	187227-45-8	Oseltamivir acid	GS 4071; Ro 64-0802; Oseltamivir carboxylate	284.35	Drug Metabolite; Influenza Virus	Anti-infection; Metabolic Enzyme/Protease	Oseltamivir acid (GS 4071), the active metabolite of Oseltamivir phosphate, is an orally bioavailable, potent and selective inhibitor of influenza virus neuraminidase (IC50=2 nM) with activity against both influenza A and B viruses[1][2].	Free Acid	C14H24N2O4	112376.0	H2O : 125 mg/mL (439.60 mM; Need ultrasonic); DMSO : ≥ 230 mg/mL (808.86 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)C1=C[C@H]([C@@H]([C@H](C1)N)NC(C)=O)OC(CC)CC	https://www.medchemexpress.com/Oseltamivir-acid.html	Launched		91.0	H20	C10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13318	10.0	mM	58.0	DMSO	284.173607	10	C	pluskal_fda_drugs_5005_C10_id
1322	HY-104077	HYCPK40905	C20	HYCPK40905	91z	280.0	4.0	F40	905.0	C20	1809249-37-3	Remdesivir	GS-5734	602.58	DNA/RNA Synthesis; SARS-CoV	Anti-infection; Cell Cycle/DNA Damage	Remdesivir (GS-5734), a nucleoside analogue with effective antiviral activity, has EC50s of 3.3 μM, 4.7 μM, 32 μM, 3.7 μM and 9.2 μM for SARS-CoV-2 and its variants alpha, beta, gamma and delta, respectively. Remdesivir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro[1][2][3].	Free Base	C27H35N6O8P	96213.0	DMSO : 100 mg/mL (165.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	C[C@H](N[P@@](OC1=CC=CC=C1)(OC[C@H]2O[C@@](C#N)(C3=CC=C4C(N)=NC=NN43)[C@H](O)[C@@H]2O)=O)C(OCC(CC)CC)=O	https://www.medchemexpress.com/Remdesivir.html	Launched		91.0	F40	C10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-104077	10.0	mM	58.0	DMSO	602.225399	10	C	pluskal_fda_drugs_5005_C10_id
152	HY-10446	HYCPK40902	B09	HYCPK40902	91z	113.0	1.0	C17	902.0	B09	146464-95-1	Pralatrexate		477.47	Antifolate; Apoptosis	Apoptosis; Cell Cycle/DNA Damage	Pralatrexate is an antifolate and is a potent dihydrofolate reductasean (DHFR) inhibitor with a Ki of 13.4 pM. Pralatrexate is a substrate for folylpolyglutamate synthetase with improved cellular uptake and retention. Pralatrexate has antitumor activities and has the potential for relapsed/refractory T-cell lymphoma treatment[1][2][3][4].	Free Acid	C23H23N7O5	44082.0	DMSO : ≥ 50 mg/mL (104.72 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(CC[C@H](NC(C1=CC=C(C=C1)C(CC#C)CC2=NC3=C(N=C(N=C3N=C2)N)N)=O)C(O)=O)O	https://www.medchemexpress.com/Pralatrexate.html	Launched		91.0	C17	C11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10446	10.0	mM	59.0	DMSO	477.176067	11	C	pluskal_fda_drugs_5005_C11_id
238	HY-B0069	HYCPK40902	L14	HYCPK40902	91z	1083.0	1.0	W27	902.0	L14	21679-14-1	Fludarabine	F-ara-A; NSC 118218	285.23	Apoptosis; DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog; STAT	Apoptosis; Cell Cycle/DNA Damage; JAK/STAT Signaling; Stem Cell/Wnt	Fludarabine (NSC 118218) is a DNA synthesis inhibitor and a fluorinated purine analogue with antineoplastic activity in lymphoproliferative malignancies. Fludarabine inhibits the cytokine-induced activation of STAT1 and STAT1-dependent gene transcription in normal resting or activated lymphocytes[1][2][3][4].	Free Base	C10H12FN5O4	29013.0	DMSO : 25 mg/mL (87.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	NC1=NC(F)=NC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O	https://www.medchemexpress.com/fludarabine.html	Launched		91.0	W27	C11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0069	10.0	mM	59.0	DMSO	285.087332	11	C	pluskal_fda_drugs_5005_C11_id
502	HY-101036	HYCPK40903	K08	HYCPK40903	91z	976.0	2.0	U16	903.0	K08	87-67-2	Choline (bitartrate)		253.25	Endogenous Metabolite; mAChR	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Choline bitartrate is a vitamin-like essential nutrient, can affect diseases such as liver disease, atherosclerosis and neurological disorders[1][2]. Choline bitartrate is a precursor for the neurotransmitter acetylcholine, as a methyl donor in various metabolic processes, and in lipid metabolism[3].	Tartrate	C9H19NO7	45492.0	H2O : 120 mg/mL (473.84 mM; Need ultrasonic); DMSO : 55 mg/mL (217.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	OCC[N+](C)(C)C.O=C(O)[C@H](O)[C@@H](O)C([O-])=O	https://www.medchemexpress.com/choline-bitartrate.html	Launched		91.0	U16	C11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101036	10.0	mM	59.0	DMSO	150.016438	11	C	pluskal_fda_drugs_5005_C11_id
876	HY-13238	HYCPK40904	A12	HYCPK40904	91z	71.0	3.0	B23	904.0	A12	1051375-16-6	Dolutegravir	S/GSK1349572	419.38	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir (S/GSK1349572) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50=3.6-5.8 nM)[1][2].	Free Base	C20H19F2N3O5	23055.0	DMSO : 10 mg/mL (23.84 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	FC1=CC(F)=C(C=C1)CNC(C2=CN(C3=C(C2=O)O)C[C@@]([H])(N4C3=O)OCC[C@H]4C)=O	https://www.medchemexpress.com/Dolutegravir.html	Launched		91.0	B23	C11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13238	10.0	mM	59.0	DMSO	419.129277	11	C	pluskal_fda_drugs_5005_C11_id
990	HY-10617A	HYCPK40904	G19	HYCPK40904	91z	661.0	3.0	N37	904.0	G19	283173-50-2	Rucaparib	AG014699; PF-01367338	323.36	PARP	Cell Cycle/DNA Damage; Epigenetics	Rucaparib (AG014699) is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib has the potential for castration-resistant prostate cancer (CRPC) research[1][2][3][4].	Free Base	C19H18FN3O	141264.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 25 mg/mL (77.31 mM; ultrasonic and adjust pH to 4 with HCl)	DMSO Solution	10mM  * 100uL	Cancer	FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1	https://www.medchemexpress.com/rucaparib.html	Launched		91.0	N37	C11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10617A	10.0	mM	59.0	DMSO	323.14339	11	C	pluskal_fda_drugs_5005_C11_id
1006	HY-B0360	HYCPK40904	G20	HYCPK40904	91z	663.0	3.0	N39	904.0	G20	90098-04-7	Rebamipide	OPC12759; Proamipide	370.79	COX	Immunology/Inflammation	Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer[1][2].	Free Acid	C19H15ClN2O4	14711.0	H2O : 0.1 mg/mL (0.27 mM; Need ultrasonic); DMSO : 50 mg/mL (134.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	OC(C(NC(C1=CC=C(Cl)C=C1)=O)CC(C2=CC=CC=C2N3)=CC3=O)=O	https://www.medchemexpress.com/rebamipide.html	Launched		91.0	N39	C11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0360	10.0	mM	59.0	DMSO	370.072035	11	C	pluskal_fda_drugs_5005_C11_id
1039	HY-N0480	HYCPK40904	H22	HYCPK40904	91z	763.0	3.0	P43	904.0	H22	50-55-5	Reserpine		608.68	Autophagy; Monoamine Transporter	Autophagy; Membrane Transporter/Ion Channel	Reserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).	Free Base	C33H40N2O9	27769.0	DMSO : 25 mg/mL (41.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C([C@H]([C@@H](OC)[C@H](OC(C1=CC(OC)=C(OC)C(OC)=C1)=O)C[C@]2([H])CN3CC4)[C@@]2([H])C[C@]3([H])C5=C4C(C=CC(OC)=C6)=C6N5)OC	https://www.medchemexpress.com/Reserpine.html	Launched		91.0	P43	C11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0480	10.0	mM	59.0	DMSO	608.273381	11	C	pluskal_fda_drugs_5005_C11_id
1053	HY-B0553	HYCPK40905	F03	HYCPK40905	91z	534.0	4.0	L6	905.0	F03	554-57-4	Methazolamide	L584601	236.27	Carbonic Anhydrase	Metabolic Enzyme/Protease	Methazolamide (L584601) is a sulfonamide derivative used as a carbonic anhydrase inhibitor with a Ki of 14 nM for human carbonic anhydrase II. Methazolamide, an intraocular pressure-lowering agent, reduces intraocular pressure elevations associated with glaucoma and other ocular disorders[1][2].	Free Base	C5H8N4O3S2	13322.0	DMSO : ≥ 50 mg/mL (211.62 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CC(/N=C1SC(S(=O)(N)=O)=NN/1C)=O	https://www.medchemexpress.com/methazolamide.html	Launched		91.0	L6	C11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0553	10.0	mM	59.0	DMSO	236.003782	11	C	pluskal_fda_drugs_5005_C11_id
174	HY-B0109A	HYCPK40902	L10	HYCPK40902	91z	1075.0	1.0	W19	902.0	L10	130693-82-2	Dorzolamide (hydrochloride)	L671152 hydrochloride; MK507 hydrochloride	360.90	Carbonic Anhydrase	Metabolic Enzyme/Protease	Dorzolamide (L671152) hydrochloride is a potent carbonic anhydrase II  inhibitor, with IC50 values of 0.18 nM and 600 nM for red blood cell CA-II and CA-I respectively. Dorzolamide possesses anti-tumor activity[1].<br/>	Hydrochloride	C10H17ClN2O4S3	14418.0	H2O : 12.5 mg/mL (34.64 mM; Need ultrasonic); DMSO : 100 mg/mL (277.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	others	O=S(C(S1)=CC2=C1S([C@@H](C)C[C@@H]2NCC)(=O)=O)(N)=O.Cl	https://www.medchemexpress.com/Dorzolamide-hydrochloride.html	Launched		91.0	W19	C12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0109A	10.0	mM	60.0	DMSO	324.02722	12	C	pluskal_fda_drugs_5005_C12_id
341	HY-B1070	HYCPK40902	N22	HYCPK40902	91z	1291.0	1.0	AA43	902.0	N22	25990-60-7	DL-Xylose	(±)-Xylos	150.13	Others	Others	DL-Xylose is an intermediate of organic synthesis.	Free Base	C5H10O5	45386.0	H2O : 125 mg/mL (832.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C[C@@H]([C@H]([C@@H](CO)O)O)O	https://www.medchemexpress.com/DL-Xylose.html	Launched		91.0	AA43	C12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1070	10.0	mM	60.0	DMSO	150.052823	12	C	pluskal_fda_drugs_5005_C12_id
457	HY-17474A	HYCPK40903	N05	HYCPK40903	91z	1258.0	2.0	AA10	903.0	N05	198470-85-8	Parecoxib (Sodium)	SC 69124A	392.40	COX	Immunology/Inflammation	Parecoxib Sodium (SC 69124A) is a highly selective?and orally active COX-2 inhibitor, the prodrug of Valdecoxib (HY-15762). Parecoxib Sodium is a nonsteroidal anti-inflammatory agent (NSAID) and inhibits prostaglandin (PG) synthesis. Parecoxib Sodium can be used for the relief of acute postoperative pain and symptoms of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis in vivo[1][2].	Sodium	C19H17N2NaO4S	20917.0	DMSO : ≥ 100 mg/mL (254.84 mM); H2O : ≥ 100 mg/mL (254.84 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CCC(N([Na])S(=O)(C1=CC=C(C2=C(C)ON=C2C3=CC=CC=C3)C=C1)=O)=O	https://www.medchemexpress.com/Parecoxib-Sodium.html	Launched		91.0	AA10	C12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17474A	10.0	mM	60.0	DMSO	370.098728	12	C	pluskal_fda_drugs_5005_C12_id
489	HY-11100	HYCPK40903	N07	HYCPK40903	91z	1262.0	2.0	AA14	903.0	N07	85650-56-2	Asenapine (maleate)	Org 5222 maleate	401.84	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Asenapine maleate is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and D2 antagonist with Ki values of 0.03-4.0 nM, 1.3nM, respectively, and an antipsychotic.	Maleate	C21H20ClNO5	6445.0	DMSO : 25 mg/mL (62.21 mM; Need ultrasonic); H2O : 6.25 mg/mL (15.55 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1C[C@]2([H])C3=CC=CC=C3OC4=CC=C(Cl)C=C4[C@]2(C1)[H].O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Asenapine-maleate.html	Launched		91.0	AA14	C12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-11100	10.0	mM	60.0	DMSO	285.092042	12	C	pluskal_fda_drugs_5005_C12_id
646	HY-B0266	HYCPK40903	L16	HYCPK40903	91z	1088.0	2.0	W32	903.0	L16	122795-43-1	Gadodiamide (hydrate)		591.67	Others	Others	"Gadodiamide hydrate is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. 
Target: Others
Gadodiamide hydrate is a gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. 
Gadodiamide hydrate is a contrast medium for cranial and spinal magnetic resonance imaging (MRI) and for general MRI of the body after intravenous administration. 
The product provides contrast enhancement and facilitates visualisation of abnormal structures or lesions in various parts of the body including the central nervous system (CNS). 
A recent review takes the question of toxicity caused by loss of gadolinium from the complex. ""The challenge for nephrologists includes (a) evidence of transmetallation, such as gadolinium deposits in bone, increased urinary zinc excretion, iron-transferrin dissociation or 'spurious hypocalcemia' in exposed people"" [1]."	Free Base	C16H28GdN5O9	25182.0	DMSO : 16 mg/mL (27.04 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Others	CNC1=O[Gd+3]([N]2(C3)CC4)([N]5(C6)CC2)(O=C(NC)C5)([O-]C7=O)([O-]C6=O)([O-]C3=O)[N]4(C7)C1.O	https://www.medchemexpress.com/Gadodiamide-hydrate.html	Launched		91.0	W32	C12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0266	10.0	mM	60.0	DMSO	419.201613	12	C	pluskal_fda_drugs_5005_C12_id
717	HY-107319	HYCPK40903	M21	HYCPK40903	91z	1194.0	2.0	Y42	903.0	M21	29608-49-9	Almitrine mesylate	Almitrine bismesylate; Almitrine bismethanesulfonate; Almitrine dimesylate	669.76	Potassium Channel	Membrane Transporter/Ion Channel	Almitrine mesylate, a peripheral chemoreceptor agonist, inhibits selectively the Ca2+-dependent K+ channel.	Mesylate	C28H37F2N7O6S2	30542.0	DMSO : 100 mg/mL (149.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease	C=CCNC1=NC(N(CC2)CCN2C(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)=NC(NCC=C)=N1.O=S(O)(C)=O.O=S(O)(C)=O	https://www.medchemexpress.com/Almitrine_mesylate.html	Launched		91.0	Y42	C12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107319	10.0	mM	60.0	DMSO	477.24525	12	C	pluskal_fda_drugs_5005_C12_id
855	HY-B1409	HYCPK40904	L10	HYCPK40904	91z	1123.0	3.0	X19	904.0	L10	87-33-2	Isosorbide dinitrate	ISDN	236.14	NO Synthase	Immunology/Inflammation	Isosorbide dinitrate (ISDN) is an NO donor that prevents LV remodeling and degradation of cardiac function following myocardial infarction (MI)[1].	Free Base	C6H8N2O8	60816.0	DMSO : ≥ 250 mg/mL (1058.69 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	[H][C@]12OC[C@H](O[N+]([O-])=O)[C@]1(OC[C@H]2O[N+]([O-])=O)[H]	https://www.medchemexpress.com/isosorbide-dinitrate.html	Launched		91.0	X19	C12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1409	10.0	mM	60.0	DMSO	236.028065	12	C	pluskal_fda_drugs_5005_C12_id
945	HY-N0714A	HYCPK40904	J16	HYCPK40904	91z	943.0	3.0	T31	904.0	J16	6078-17-7	Berbamine (dihydrochloride)		681.65	Apoptosis; Autophagy; NF-κB	Apoptosis; Autophagy; NF-κB	Berbamine dihydrochloride is an inhibitor of NF-κB activity with remarkable anti-myeloma efficacy.	Hydrochloride	C37H42Cl2N2O6	45605.0	DMSO : ≥ 100 mg/mL (146.70 mM)	DMSO Solution	10mM  * 100uL	Cancer	COC1=C(OC2=CC([C@]3([H])CC(C=C4)=CC=C4O5)=C(CCN3C)C=C2OC)C([C@@]6([H])CC7=CC=C(O)C5=C7)=C(CCN6C)C=C1OC.Cl.Cl	https://www.medchemexpress.com/Berbamine-dihydrochloride.html	Launched		91.0	T31	C12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0714A	10.0	mM	60.0	DMSO	608.288637	12	C	pluskal_fda_drugs_5005_C12_id
281	HY-10121	HYCPK40902	G17	HYCPK40902	91z	609.0	1.0	M33	902.0	G17	65576-45-6	Asenapine	Org 5222	285.77	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Asenapine (Org 5222), an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine can be used in the research of schizophrenia and bipolar disorder[1][2].	Free Base	C17H16ClNO	43713.0	DMSO : 200 mg/mL (699.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	ClC1=CC=C2OC3=CC=CC=C3[C@@](C4)([H])[C@](CN4C)([H])C2=C1	https://www.medchemexpress.com/Asenapine.html	Launched		91.0	M33	C13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10121	10.0	mM	61.0	DMSO	285.092042	13	C	pluskal_fda_drugs_5005_C13_id
332	HY-B0187A	HYCPK40902	M21	HYCPK40902	91z	1193.0	1.0	Y41	902.0	M21	364622-82-2	Doripenem (monohydrate)	S 4661 monohydrate	438.52	Antibiotic; Bacterial	Anti-infection	"Doripenem monohydrate is a new member of the carbapenem class of beta-lactam antibiotics with broad-spectrum coverage of Gram-positive, Gram-negative and anaerobic pathogens.
Target: Antibacterial
Doripenem is an ultra-broad-spectrum injectable antibiotic. It is a beta-lactam and belongs to the subgroup of carbapenems. It was launched by Shionogi Co. of Japan under the brand name Finibax in 2005 and is being marketed outside Japan by Johnson & Johnson. It is particularly active against Pseudomonas aeruginosa. It is recommended that those allergic to doripenem or to any type of beta-lactam antibiotics such as cephalosporin or other Carbapenems not receive doripenem.
Doripenem appears as crystalline powder anywhere from a white to somewhat yellowish colour.Doripenem is moderately soluble in water, slightly soluble in methanol, and virtually insoluble in ethanol. Doripenem is also solution in N,N-dimethylformamide. Doripenem's chemical configuration has 6 asymmetrical carbon atoms (6 stereocentres) and is most commonly supplied as one pure isomer. In terms of doripenem for injection, the crystallized powered drug can form a monohydrate when mixed with water. However, Doripenem has not been proven to possess polymorphism."	Free Acid	C15H26N4O7S2	13642.0	DMSO : 50 mg/mL (114.02 mM; Need ultrasonic); H2O : 10 mg/mL (22.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(S[C@@H]3CN[C@H](CNS(=O)(N)=O)C3)[C@H](C)[C@]2([H])[C@@H]([C@H](O)C)C1=O)O.O	https://www.medchemexpress.com/Doripenem-monohydrate.html	Launched		91.0	Y41	C13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0187A	10.0	mM	61.0	DMSO	420.113726	13	C	pluskal_fda_drugs_5005_C13_id
576	HY-14164	HYCPK40903	H19	HYCPK40903	91z	710.0	2.0	O38	903.0	H19	111406-87-2	Zileuton	A 64077; Abbott 64077	236.29	Ferroptosis; Lipoxygenase	Apoptosis; Metabolic Enzyme/Protease	Zileuton is a potent and selective inhibitor of 5-lipoxygenase with antiasthmatic properties.	Free Base	C11H12N2O2S	15663.0	DMSO : ≥ 100 mg/mL (423.21 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CC(N(O)C(N)=O)C1=CC2=CC=CC=C2S1	https://www.medchemexpress.com/Zileuton.html	Launched		91.0	O38	C13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14164	10.0	mM	61.0	DMSO	236.061949	13	C	pluskal_fda_drugs_5005_C13_id
591	HY-W013075	HYCPK40905	H22	HYCPK40905	91z	764.0	4.0	P44	905.0	H22	250249-75-3	Rutin (trihydrate)	Rutoside (trihydrate); Quercetin 3-O-rutinoside (trihydrate)	664.56	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	Rutin (Rutoside) trihydrate is a multifunctional natural flavonoid glycoside. Rutin trihydrate has been demonstrating excellent antioxidant, anti-inflammatory, anti-diabetic, and anti-carcinogenic properties. Cardioprotective and neuroprotective activities [1][2][3].		C27H36O19	129837.0	DMSO : 50 mg/mL (75.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(O)C(O)=C4)OC5=CC(O)=CC(O)=C15.O.O.O	https://www.medchemexpress.com/rutin-trihydrate.html	Launched		91.0	P44	C13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W013075	10.0	mM	61.0	DMSO	610.153385	13	C	pluskal_fda_drugs_5005_C13_id
716	HY-B0750B	HYCPK40903	L21	HYCPK40903	91z	1098.0	2.0	W42	903.0	L21	878143-33-0	Dolasetron (Mesylate hydrate)	MDL-73147EF (hydrate)	438.49	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Dolasetron Mesylate hydrate (MDL-73147EF hydrate) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.	Mesylate	C20H26N2O7S	14869.0	DMSO : 250 mg/mL (570.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CNC2=C1C=CC=C2)O[C@@H]3C[C@@](CC4C5)([H])[N@](CC4=O)[C@@]5([H])C3.O=S(C)(O)=O.O	https://www.medchemexpress.com/Dalasetron-Mesylate-hydrate.html	Launched		91.0	W42	C13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0750B	10.0	mM	61.0	DMSO	324.147393	13	C	pluskal_fda_drugs_5005_C13_id
732	HY-N6810	HYCPK40903	L22	HYCPK40903	91z	1100.0	2.0	W44	903.0	L22	89-83-8	Thymol		150.22	Bacterial	Anti-infection	Thymol is the main monoterpene phenol occurring in essential oils isolated from plants belonging to the Lamiaceae family, and other plants such as those belonging to the Verbenaceae, Scrophulariaceae, Ranunculaceae and Apiaceae families. Thymol has antioxidant, anti-inflammatory, antibacterial and antifungal effects[1].	Free Base	C10H14O	45384.0	DMSO : 125 mg/mL (832.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	OC1=CC(C)=CC=C1C(C)C	https://www.medchemexpress.com/thymol.html	Launched		91.0	W44	C13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N6810	10.0	mM	61.0	DMSO	150.104465	13	C	pluskal_fda_drugs_5005_C13_id
1234	HY-14905	HYCPK40905	K14	HYCPK40905	91z	1036.0	4.0	V28	905.0	K14	4105-38-8	Uridine triacetate	Tri-O-acetyl uridine	370.31	Others	Others	"Uridine triacetate (Tri-O-acetyl uridine) is an orally active prodrug of <a href=""/Uridine.html"" class=""link-product"" target=""_blank"">Uridine</a> (HY-B1449). Uridine triacetate is quickly absorbed in the gut, and is rapidly deacetylated in the circulation to yield free uridine. Uridine triacetate is used for the research of 5-fluorouracil (5-FU) and capecitabine toxicity, or early-onset cardiac or central nervous system (CNS)[1][2]."	Free Base	C15H18N2O9	64038.0	DMSO : ≥ 100 mg/mL (270.04 mM); H2O : 10 mg/mL (27.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NC(C=C1)=O)N1[C@H](O2)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]2COC(C)=O	https://www.medchemexpress.com/uridine-triacetate.html	Launched		91.0	V28	C13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14905	10.0	mM	61.0	DMSO	370.10123	13	C	pluskal_fda_drugs_5005_C13_id
1264	HY-16082	HYCPK40905	I16	HYCPK40905	91z	848.0	4.0	R32	905.0	I16	252017-04-2	AZD7545		478.87	PDHK	Metabolic Enzyme/Protease	AZD7545 is a potent, competitive, selective PDHK2 (pyruvate dehydrogenase kinase 2) inhibitor with IC50s of 36.8 nM, 6.4 nM for PDHK1 and PDHK2, respectively[1].	Free Base	C19H18ClF3N2O5S	11419.0	DMSO : ≥ 46 mg/mL (96.06 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(N(C)C)C1=CC=C(S(=O)(C2=CC=C(NC([C@@](C)(O)C(F)(F)F)=O)C(Cl)=C2)=O)C=C1	https://www.medchemexpress.com/AZD7545.html	Launched		91.0	R32	C13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16082	10.0	mM	61.0	DMSO	478.057705	13	C	pluskal_fda_drugs_5005_C13_id
335	HY-17425A	HYCPK40902	P21	HYCPK40902	91z	1481.0	1.0	AE41	902.0	P21	124832-27-5	Valacyclovir (hydrochloride)	Valaciclovir hydrochloride	360.80	Antibiotic; Bacterial; HSV	Anti-infection	Valacyclovir hydrochloride (Valaciclovir hydrochloride) is an orally active antiviral drug for herpes simplex, herpes zoster, and herpes B. Valacyclovir hydrochloride inhibits HSV-1 W (50=2.9 μg/ml). Valacyclovir hydrochloride is a prodrug of Aciclovir (HY-17422) [1][2][3][4][5].	Hydrochloride	C13H21ClN6O4	59591.0	H2O : 100 mg/mL (277.16 mM; Need ultrasonic); DMSO : 43.33 mg/mL (120.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	N[C@@H](C(C)C)C(OCCOCN1C=NC2=C1N=C(N)NC2=O)=O.Cl	https://www.medchemexpress.com/valacyclovir-hydrochloride.html	Launched		91.0	AE41	C14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17425A	10.0	mM	62.0	DMSO	324.154603	14	C	pluskal_fda_drugs_5005_C14_id
437	HY-N0148A	HYCPK40903	J04	HYCPK40903	91z	872.0	2.0	S8	903.0	J04	207671-50-9	Rutin (hydrate)	Rutoside (hydrate); Quercetin 3-O-rutinoside (hydrate)	740.26	Amyloid-β; Apoptosis; Autophagy; Endogenous Metabolite	Apoptosis; Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling	Rutin (Rutoside) hydrate is a flavonoid found in many plants and shows a wide range of biological activities including anti-inflammatory, antidiabetic, antioxidant, neuroprotective, nephroprotective, hepatoprotective and reducing Aβ oligomer activities. Rutin hydrate can cross the blood brain barrier. Rutin hydrate attenuates vancomycin-induced renal tubular cell apoptosis via suppression of apoptosis, mitochondrial dysfunction, and oxidative stress[1][2][3].	Free Base	C27H3O16.36/5 H2O	68252.0	DMSO : 50 mg/mL (67.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(O)C(O)=C4)OC5=CC(O)=CC(O)=C15.O.[36/5]	https://www.medchemexpress.com/Rutin_hydrate.html	Launched		91.0	S8	C14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0148A	10.0	mM	62.0	DMSO	610.153385	14	C	pluskal_fda_drugs_5005_C14_id
634	HY-13071	HYCPK40903	P15	HYCPK40903	91z	1470.0	2.0	AE30	903.0	P15	7759-35-5	Nestoron	ST-1435; Elcometrine	370.48	Progesterone Receptor	Others	Nestoron (ST-1435) is a 19-norprogesterone derivative with high affinity and selectivity for progesterone receptors. Nestoron is a highly selective and potent progestogen that can be used as a hormonal contraceptive[1][2].	Free Base	C23H30O4	27663.0	DMSO : 33.33 mg/mL (89.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	CC([C@]1(OC(C)=O)[C@@]2([C@]([H])([C@@]3(CCC4=CC(CC[C@@]4([C@]3(CC2)[H])[H])=O)[H])CC1=C)C)=O	https://www.medchemexpress.com/nestoron.html	Launched		91.0	AE30	C14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13071	10.0	mM	62.0	DMSO	370.214409	14	C	pluskal_fda_drugs_5005_C14_id
668	HY-13677	HYCPK40903	B18	HYCPK40903	91z	132.0	2.0	C36	903.0	B18	50-44-2	6-Mercaptopurine	Mercaptopurine; 6-MP	152.18	Autophagy; Endogenous Metabolite; Nucleoside Antimetabolite/Analog	Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	6-Mercaptopurine is a purine analogue which acts as an antagonist of the endogenous purines and has been widely used as antileukemic agent and immunosuppressive drug.	Free Base	C5H4N4S	9348.0	DMSO : 35.71 mg/mL (234.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	S=C1NC=NC2=C1NC=N2	https://www.medchemexpress.com/6-Mercaptopurine.html	Launched		91.0	C36	C14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13677	10.0	mM	62.0	DMSO	152.015667	14	C	pluskal_fda_drugs_5005_C14_id
718	HY-B1616	HYCPK40903	N21	HYCPK40903	91z	1290.0	2.0	AA42	903.0	N21	25122-57-0	Clobetasone butyrate		478.98	Glucocorticoid Receptor	Immunology/Inflammation	Clobetasone butyrate is a synthetic glucocorticoid and has topical anti-inflammatory activity especially in skin. Clobetasone butyrate can be used to relieve corticosteroid-responsive dermatoses, including atopic?dermatitis and psoriasis[1].	Free Base	C26H32ClFO5	63249.0	DMSO : ≥ 250 mg/mL (521.94 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]1(C2)[C@](C(CCl)=O)(OC(CCC)=O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)C2=O)=O	https://www.medchemexpress.com/clobetasone-butyrate.html	Launched		91.0	AA42	C14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1616	10.0	mM	62.0	DMSO	478.19223	14	C	pluskal_fda_drugs_5005_C14_id
870	HY-12222	HYCPK40904	K11	HYCPK40904	91z	1029.0	3.0	V21	904.0	K11	459789-99-2	Obeticholic acid	INT-747; 6-ECDCA; 6-Ethylchenodeoxycholic acid	420.63	Autophagy; FXR	Autophagy; Metabolic Enzyme/Protease	Obeticholic acid (INT-747) is a potent, selective and orally active FXR agonist with an EC50 of 99 nM. Obeticholic acid has anticholeretic and anti-inflammation effect. Obeticholic acid also induces autophagy[1][2][3].	Free Acid	C26H44O4	61353.0	DMSO : ≥ 100 mg/mL (237.74 mM); Ethanol : ≥ 50 mg/mL (118.87 mM)	DMSO Solution	10mM  * 100uL	Others	C[C@@]([C@]1([H])[C@@H](CC)[C@H]2O)(CC[C@@H](O)C1)[C@]3([H])[C@]2([H])[C@@](CC[C@]4([H])[C@H](C)CCC(O)=O)([H])[C@]4(C)CC3	https://www.medchemexpress.com/INT-747.html	Launched		91.0	V21	C14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12222	10.0	mM	62.0	DMSO	420.32396	14	C	pluskal_fda_drugs_5005_C14_id
1106	HY-16567	HYCPK40905	K06	HYCPK40905	91z	1020.0	4.0	V12	905.0	K06	1412458-61-7	Asenapine (hydrochloride)		322.23	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Asenapine hydrochloride, an antipsychotic,  is a 5-HT (1A, 1B, 2A, 2B, 2C, 5A, 6, 7) and  Dopamine (D2, D3, D4) receptor antagonist with Ki values of 0.03-4.0 nM for 5-HT and 1.3, 0.42, 1.1 nM for Dopamine receptor, respectively.	Hydrochloride	C17H17Cl2NO	3590.0	DMSO : 50 mg/mL (155.17 mM; Need ultrasonic); H2O : 100 mg/mL (310.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	[H]Cl.ClC1=CC2=C(C=C1)OC3=C(C=CC=C3)[C@](C4)([H])[C@]2([H])CN4C	https://www.medchemexpress.com/Asenapine-hydrochloride.html	Launched		91.0	V12	C14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16567	10.0	mM	62.0	DMSO	285.092042	14	C	pluskal_fda_drugs_5005_C14_id
1155	HY-B0246	HYCPK40905	L09	HYCPK40905	91z	1122.0	4.0	X18	905.0	L09	298-46-4	Carbamazepine	CBZ; NSC 169864	236.26858	Autophagy; Mitophagy; Sodium Channel	Autophagy; Membrane Transporter/Ion Channel	"Carbamazepine, a sodium channel blocker, is an anticonvulsant drug.
Target: Sodium channel
Carbamazepine inhibits the binding of [3H]batrachotoxinin A 20-α-benzoate (BTX-B) to a receptor site of voltage-sensitive sodium channel with IC50 of 131 μM, to decrease the activation of sodium channel ion flux in rat brain synaptosomes. Carbamazepine does not alter basal 125I-labeled scorpion toxin binding to synaptosomes in the absence of batrachotoxin, but when batrachotoxin (1.25 μM) added, Carbamazepine inhibits the batrachotoxin-dependent increase in scorpion toxin binding in a concentration-dependent manner with IC50 of 260 μM mediated at the alkaloid toxin binding site, none of which affects [3H]saxitoxin binding [1]. Carbamazepine at 25 mg/kg significantly increases extracellular levels of striatal and hippocampal dopamine (DA), 3,4-dihydroxyphenylalanine (DOPA), 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in a dose dependent manner, while Carbamazepine at 50 mg/kg significantly decreases total levels of striatal DA and DOPA as well as hippocampal HVA, but has no effect on total levels of striatal DOPAC and HVA nor on hippocampal DA, DOPA and DOPAC [2]."	Free Base	C15H12N2O	85273.0	DMSO : 100 mg/mL (423.24 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(N1C2=CC=CC=C2C=CC3=CC=CC=C31)N	https://www.medchemexpress.com/Carbamazepine.html	Launched		91.0	X18	C14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0246	10.0	mM	62.0	DMSO	236.094963	14	C	pluskal_fda_drugs_5005_C14_id
85	HY-17403	HYCPK40902	N03	HYCPK40902	91z	1253.0	1.0	AA5	902.0	N03	89226-75-5	Manidipine (dihydrochloride)	CV-4093	683.62	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	"Manidipine dihydrochloride (CV-4093) is a dihydropyridine compound and a calcium channel blocker for Ca2+ current with IC50 of 2.6 nM. 
IC50 value: 2.6 nM
Target: calcium channel
Manidipine dihydrochloride is described to block T-type Ca2+ channels specifically and is also described to have a high selectivity for the vasculature, presenting negligible cardiodepression as compared to other Ca2+ channel antagonists. Manidipine is also described to not significantly affect norepinephrine levels, suggesting a lack of sympathetic activation with this compound. Manidipine reduces pro-inflammatory cytokines secretion in human endothelial cells and macrophages. Manidipine, unlike other third-generation dihydropyridine derived drugs, blocks T-type calcium channels present in the efferent glomerular arterioles, reducing intraglomerular pressure and microalbuminuria."	Hydrochloride	C35H40Cl2N4O6	11968.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 50 mg/mL (73.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OCCN3CCN(C(C4=CC=CC=C4)C5=CC=CC=C5)CC3.[H]Cl.[H]Cl	https://www.medchemexpress.com/manidipine-dihydrochloride.html	Launched		91.0	AA5	C15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17403	10.0	mM	63.0	DMSO	610.279135	15	C	pluskal_fda_drugs_5005_C15_id
439	HY-U00058	HYCPK40903	L04	HYCPK40903	91z	1064.0	2.0	W8	903.0	L04	59198-70-8	Diflucortolone valerate		478.57	Bacterial; Fungal	Anti-infection	Diflucortolone valerate is a powerful corticosteroid used topically for the research of various skin diseases[1].	Free Base	C27H36F2O5	91032.0	DMSO : 100 mg/mL (208.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	C[C@@]12[C@@H](C(COC(CCCC)=O)=O)[C@H](C)C[C@@]1([H])[C@]3([H])C[C@H](F)C4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/diflucortolone-valerate.html	Launched		91.0	W8	C15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-U00058	10.0	mM	63.0	DMSO	478.253081	15	C	pluskal_fda_drugs_5005_C15_id
765	HY-B1287	HYCPK40904	M04	HYCPK40904	91z	1207.0	3.0	Z7	904.0	M04	59729-32-7	Citalopram (hydrobromide)	(±)-Citalopram hydrobromide; Lu 10-171	405.30	Autophagy; Serotonin Transporter	Autophagy; Neuronal Signaling	Citalopram hydrobromide is a selective serotonin reuptake inhibitor (SSRI). Citalopram hydrobromide inhibits 5-HT uptake into synaptosomes with an IC50 of 1.8 nM. Citalopram hydrobromideinhibits the 5-HT uptake in rabbit blood platelets with an IC50 of 14 nM. Antidepressant effect[1].	Hydrobromide	C20H22BrFN2O	17632.0	DMSO : ≥ 38 mg/mL (93.76 mM); H2O : 10 mg/mL (24.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	N#CC1=CC2=C(C(C3=CC=C(F)C=C3)(CCCN(C)C)OC2)C=C1.[H]Br	https://www.medchemexpress.com/Citalopram-hydrobromide.html	Launched		91.0	Z7	C15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1287	10.0	mM	63.0	DMSO	324.163792	15	C	pluskal_fda_drugs_5005_C15_id
846	HY-B1363	HYCPK40904	C10	HYCPK40904	91z	259.0	3.0	F19	904.0	C10	73-48-3	Bendroflumethiazide	Bendrofluazide	421.41	Others	Others	Bendroflumethiazide is an orally active diuretic. Bendroflumethiazide is an antihypertensive agent. Bendroflumethiazide has the potential for the research of arterial hypertensive disease[1].		C15H14F3N3O4S2	159084.0	DMSO : 250 mg/mL (593.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(C1=C(C(F)(F)F)C=C(C2=C1)NC(CC3=CC=CC=C3)NS2(=O)=O)(N)=O	https://www.medchemexpress.com/bendroflumethiazide.html	Launched		91.0	F19	C15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1363	10.0	mM	63.0	DMSO	421.037783	15	C	pluskal_fda_drugs_5005_C15_id
915	HY-10980	HYCPK40904	H14	HYCPK40904	91z	747.0	3.0	P27	904.0	H14	174671-46-6	Tavaborole	AN-2690	151.93	Antibiotic; Fungal	Anti-infection	Tavaborole (AN-2690)  is an antifungal agent with activity against Trichophyton species, in a topical solution formulation for the potential treatment of onychomycosis.	Free Base	C7H6BFO2	7710.0	DMSO : ≥ 100 mg/mL (658.20 mM)	DMSO Solution	10mM  * 100uL	Infection	OB1OCC2=CC(F)=CC=C21	https://www.medchemexpress.com/AN-2690.html	Launched		91.0	P27	C15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10980	10.0	mM	63.0	DMSO	152.044488	15	C	pluskal_fda_drugs_5005_C15_id
1159	HY-14248	HYCPK40905	P09	HYCPK40905	91z	1506.0	4.0	AF18	905.0	P09	112809-51-5	Letrozole	CGS 20267	285.30	Aromatase; Autophagy	Autophagy; Others	Letrozole (CGS 20267) is a potent, selective, reversible and orally active non-steroidal inhibitor of aromatase, with an IC50 of 11.5 nM. Letrozole selective inhibits estrogen biosynthesis, and can be used for the research of breast cancer[1][2][3].	Free Base	C17H11N5	42975.0	DMSO : 50 mg/mL (175.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	N#CC1=CC=C(C(N2C=NC=N2)C3=CC=C(C#N)C=C3)C=C1	https://www.medchemexpress.com/Letrozole.html	Launched		91.0	AF18	C15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14248	10.0	mM	63.0	DMSO	285.101445	15	C	pluskal_fda_drugs_5005_C15_id
1245	HY-105634A	HYCPK40905	F15	HYCPK40905	91z	558.0	4.0	L30	905.0	F15	58652-20-3	Nomegestrol acetate		370.48	Progesterone Receptor	Others	Nomegestrol acetate is an orally active, highly selective progestogen and a progesterone receptor complete agonist. Nomegestrol acetate inhibits ovulation. Nomegestrol acetate is also effective in inhibiting the proliferation of human endometrial cancer RL95-2 cells in vitro and in vivo. Nomegestrol acetate can be used in cancer (especially endometrial cancer) and contraceptive studies[1][2][3].		C23H30O4	56236.0	DMSO : 62.5 mg/mL (168.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	CC([C@@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])C=C(C)C4=CC(CC[C@]4([H])[C@@]3([H])CC[C@]12C)=O)=O	https://www.medchemexpress.com/nomegestrol-acetate.html	Launched		91.0	L30	C15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-105634A	10.0	mM	63.0	DMSO	370.214409	15	C	pluskal_fda_drugs_5005_C15_id
1280	HY-B1895	HYCPK40905	I17	HYCPK40905	91z	850.0	4.0	R34	905.0	I17	99291-25-5	Levodropropizine	(S)-(-)-Dropropizine; DF-526	236.31	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Levodropropizine (DF-526) is a histamine receptor inhibitor, Levodropropizine is an effective and very well tolerated peripheral antitussive drug.	Free Base	C13H20N2O2	18791.0	H2O : 10 mg/mL (42.32 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (211.59 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	OC[C@@H](O)CN1CCN(C2=CC=CC=C2)CC1	https://www.medchemexpress.com/Levodropropizine.html	Launched		91.0	R34	C15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1895	10.0	mM	63.0	DMSO	236.152478	15	C	pluskal_fda_drugs_5005_C15_id
223	HY-N2319	HYCPK40902	M13	HYCPK40902	91z	1177.0	1.0	Y25	902.0	M13	24730-10-7	Dihydroergocristine (mesylate)	DHEC (mesylate)	707.84	Amyloid-β	Neuronal Signaling	Dihydroergocristine mesylate (DHEC mesylate) is a inhibitor of γ-secretase (GSI), reduces the production of the Alzheimer's disease amyloid-β peptides, binds directly to γ-secretase and Nicastrin with equilibrium dissociation constants (Kd) of 25.7 nM and 9.8 μM, respectively[1].	Mesylate	C36H45N5O8S	123320.0	H2O : 1 mg/mL (1.41 mM; Need ultrasonic); DMSO : 50 mg/mL (70.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O[C@@]([C@@](CCC1)([H])N1C2=O)(O[C@](NC([C@@H](CN(C)[C@]3([H])C4)C[C@]3([H])C5=C6C4=CNC6=CC=C5)=O)(C(C)C)C7=O)N7[C@H]2CC8=CC=CC=C8.CS(=O)(O)=O	https://www.medchemexpress.com/dihydroergocristine-mesylate.html	Launched		91.0	Y25	C16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N2319	10.0	mM	64.0	DMSO	611.310769	16	C	pluskal_fda_drugs_5005_C16_id
294	HY-B0189A	HYCPK40902	N18	HYCPK40902	91z	1283.0	1.0	AA35	902.0	N18	112885-42-4	Mosapride (citrate)	TAK-370 citrate; AS-4370 citrate	614.02	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Mosapride citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist.
Target:  5HT4 
Mosapride is a gastroprokinetic agent that acts as a selective 5HT4 agonist. The major active metabolite of mosapride, known as M1, additionally acts as a 5HT3 antagonist, which accelerates gastric emptying throughout the whole of the gastrointestinal tract in humans, and is used for the treatment of gastritis, gastro-oesophageal reflux disease, functional dyspepsia and irritable bowel syndrome. It is recommended to be taken on an empty stomach (i.e. at least one hour before food or two hours after food).
In addition to its prokinetic properties, mosapride also exerts anti-inflammatory effects on the gastrointestinal tract which may contribute to some of its therapeutic effects. Mosapride also promotes neurogenesis in the gastrointestinal tract which may prove useful in certain bowel disorders. The neurogenesis is due to mosapride's effect on the 5-HT4 receptor where it acts as an agonist.Its common side effects include dry mouth, abdominal pain, dizziness, headache, insomnia, malaise, nausea, diarrhoea and sometimes constipation. Unlike some other prokinetic agents, mosapride has little effect on potassium channels, no effect on hERG transfected cells, and no effect on cardiovascular function that could be detected in tests on humans. Due to the pharmacokinetics of mosapride, it would take 1,000 - 3,000 times the therapeutic dose to elicit cardiovascular effects."	Citrate	C27H33ClFN3O10	16413.0	DMSO : 100 mg/mL (162.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(NCC1CN(CC2=CC=C(F)C=C2)CCO1)C3=CC(Cl)=C(N)C=C3OCC.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Mosapride-citrate.html	Launched		91.0	AA35	C16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0189A	10.0	mM	64.0	DMSO	421.156848	16	C	pluskal_fda_drugs_5005_C16_id
507	HY-B1751	HYCPK40903	P08	HYCPK40903	91z	1456.0	2.0	AE16	903.0	P08	56-54-2	Quinidine		324.42	Apoptosis; Cytochrome P450; Parasite; Potassium Channel	Anti-infection; Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Quinidine is an antiarrhythmic agent. Quinidine is a potent, orally active, selective cytochrome P450db inhibitor. Quinidine is also a K+ channel blocker with an IC50 of 19.9 μM, and can induce apoptosis. Quinidine can be used for malaria research[1][2][3][4].	Free Base	C20H24N2O2	62278.0	DMSO : ≥ 50 mg/mL (154.12 mM); Ethanol : 14.29 mg/mL (44.05 mM; ultrasonic and warming and heat to 60°C); H2O : 0.67 mg/mL (2.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Cardiovascular Disease	C=C[C@H]1C[N@](CC[C@H]1C2)[C@@]2([H])[C@@H](O)C3=CC=NC4=CC=C(OC)C=C34	https://www.medchemexpress.com/Quinidine.html	Launched		91.0	AE16	C16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1751	10.0	mM	64.0	DMSO	324.183778	16	C	pluskal_fda_drugs_5005_C16_id
560	HY-12297	HYCPK40903	A13	HYCPK40903	91z	26.0	2.0	A26	903.0	A13	1308672-74-3	Sulfatinib	HMPL-012	480.58	FGFR; VEGFR	Protein Tyrosine Kinase/RTK	Sulfatinib (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 and CSF1R with IC50s of in a range of 1 to 24 nM.	Free Base	C24H28N6O3S	22179.0	DMSO : ≥ 100 mg/mL (208.08 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=S(CC1=CC=CC(NC2=NC=CC(OC3=CC4=C(NC(C)=C4)C=C3)=N2)=C1)(NCCN(C)C)=O	https://www.medchemexpress.com/KDR-IN-1.html	Launched		91.0	A26	C16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12297	10.0	mM	64.0	DMSO	480.19436	16	C	pluskal_fda_drugs_5005_C16_id
583	HY-122537A	HYCPK40904	G05	HYCPK40904	91z	633.0	3.0	N9	904.0	G05	68377-92-4	Arotinolol		371.54	5-HT Receptor; Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Arotinolol is a nonselective α/β-adrenergic receptor blocker and a vasodilating β-blocker[1]. Arotinolol also shows potency for  inhibiting the binding of the radioligand 125I-ICYP to 5HT1B-serotonergic receptor sites[2]. Arotinolol is an antihypertensive agent for the treatment of a variety of cardiovascular pathologies as well as non-cardiovascular diseases[1].	Free Base	C15H21N3O2S3	89026.0	DMSO : 125 mg/mL (336.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CC=C(C2=CSC(SCC(O)CNC(C)(C)C)=N2)S1)N	https://www.medchemexpress.com/arotinolol.html	Launched		91.0	N9	C16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-122537A	10.0	mM	64.0	DMSO	371.07959	16	C	pluskal_fda_drugs_5005_C16_id
911	HY-B0545	HYCPK40904	D14	HYCPK40904	91z	363.0	3.0	H27	904.0	D14	57-66-9	Probenecid		285.36	Bacterial; HIV; TRP Channel	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Probenecid is a potent and selective agonist of transient receptor potential vanilloid 2 (TRPV2) channels. Probenecid also inhibits pannexin 1 channels.	Free Acid	C13H19NO4S	27261.0	DMSO : ≥ 100 mg/mL (350.43 mM); 0.5 M NaOH : 100 mg/mL (350.43 mM; ultrasonic and adjust pH to 12 with NaOH)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(O)C1=CC=C(S(=O)(N(CCC)CCC)=O)C=C1	https://www.medchemexpress.com/Probenecid.html	Launched		91.0	H27	C16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0545	10.0	mM	64.0	DMSO	285.103479	16	C	pluskal_fda_drugs_5005_C16_id
1083	HY-I0447	HYCPK40905	D05	HYCPK40905	91z	346.0	4.0	H10	905.0	D05	65-49-6	4-Aminosalicylic acid		153.14	Antibiotic; Bacterial	Anti-infection	4-Aminosalicylic acid (ASA) is an orally active antibiotic and has the potential to treat tuberculosis[1].	Free Acid	C7H7NO3	111220.0	DMSO : 100 mg/mL (653.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(O)C1=CC=C(N)C=C1O	https://www.medchemexpress.com/4-aminosalicylic-acid.html	Launched		91.0	H10	C16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-I0447	10.0	mM	64.0	DMSO	153.042593	16	C	pluskal_fda_drugs_5005_C16_id
1263	HY-B1345	HYCPK40905	H16	HYCPK40905	91z	752.0	4.0	P32	905.0	H16	68890-66-4	Piroctone olamine	Piroctone ethanolamine	298.42	Fungal	Anti-infection	Piroctone olamine is a pyridine derivate. It is known to have a fungicidal effect.	Olamine	C16H30N2O3	26147.0	DMSO : 11.11 mg/mL (37.23 mM; Need ultrasonic); H2O : 50 mg/mL (167.55 mM; ultrasonic and adjust pH to 9 with NaOH)	DMSO Solution	10mM  * 100uL	Infection	O=C1C=C(C)C=C(CC(C)CC(C)(C)C)N1O.NCCO	https://www.medchemexpress.com/Piroctone_olamine.html	Launched		91.0	P32	C16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1345	10.0	mM	64.0	DMSO	237.172879	16	C	pluskal_fda_drugs_5005_C16_id
181	HY-D0143	HYCPK40902	C11	HYCPK40902	91z	213.0	1.0	E21	902.0	C11	130-95-0	Quinine		324.42	Parasite; Potassium Channel	Anti-infection; Membrane Transporter/Ion Channel	Quinine is an alkaloid derived from the bark of the cinchona tree, acts as an anti-malaria agent. Quinine is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2].	Free Base	C20H24N2O2	27672.0	H2O : 0.1 mg/mL (0.31 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (308.24 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@H](C1=CC=NC2=C1C=C(OC)C=C2)[C@@]3([H])[N@](C[C@@H]4C=C)CC[C@H]4C3	https://www.medchemexpress.com/Quinine.html	Launched		91.0	E21	C17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0143	10.0	mM	65.0	DMSO	324.183778	17	C	pluskal_fda_drugs_5005_C17_id
247	HY-15027	HYCPK40902	E15	HYCPK40902	91z	413.0	1.0	I29	902.0	E15	89-57-6	5-Aminosalicylic Acid	Mesalamine; 5-ASA; Mesalazine	153.14	Endogenous Metabolite; NF-κB; PAK; PPAR	Cell Cycle/DNA Damage; Cytoskeleton; Metabolic Enzyme/Protease; NF-κB	5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.	Free Acid	C7H7NO3	14055.0	DMSO : ≥ 6 mg/mL (39.18 mM); H2O : 2 mg/mL (13.06 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	OC1=C(C(O)=O)C=C(N)C=C1	https://www.medchemexpress.com/5-Aminosalicylic-acid.html	Launched		91.0	I29	C17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15027	10.0	mM	65.0	DMSO	153.042593	17	C	pluskal_fda_drugs_5005_C17_id
381	HY-13448	HYCPK40902	N04	HYCPK40902	91z	1255.0	1.0	AA7	902.0	N04	69049-73-6	Nedocromil	FPL 59002	371.34	Histamine Receptor; Leukotriene Receptor; Prostaglandin Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Nedocromil suppresses the action or formation of multiple mediators, including histamine, leukotriene C4 (LTC4), and prostaglandin D2 (PGD2).	Free Acid	C19H17NO7	11108.0	DMSO : 16.67 mg/mL (44.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(C1=CC(C2=CC3=C(N(CC)C(C(O)=O)=CC3=O)C(CCC)=C2O1)=O)O	https://www.medchemexpress.com/Nedocromil.html	Launched		91.0	AA7	C17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13448	10.0	mM	65.0	DMSO	371.100502	17	C	pluskal_fda_drugs_5005_C17_id
624	HY-A0090	HYCPK40903	F15	HYCPK40903	91z	510.0	2.0	K30	903.0	F15	67-20-9	Nitrofurantoin		238.16	Antibiotic; Bacterial	Anti-infection	Nitrofurantoin is a potent and orally active broad-spectrum beta-lactamase antimicrobial agent. Nitrofurantoin acts as an antibiotic and can be used for the study of urinary tract infections (UTIs), including cystitis and kidney infections[1].	Free Base	C8H6N4O5	68417.0	DMSO : 100 mg/mL (419.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1NC(CN1/N=C/C2=CC=C([N+]([O-])=O)O2)=O	https://www.medchemexpress.com/Nitrofurantoin.html	Launched		91.0	K30	C17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0090	10.0	mM	65.0	DMSO	238.033819	17	C	pluskal_fda_drugs_5005_C17_id
696	HY-16069A	HYCPK40903	H20	HYCPK40903	91z	712.0	2.0	O40	903.0	H20	1429755-56-5	Tucatinib (hemiethanolate)	Irbinitinib (hemiethanolate); ARRY-380 (hemiethanolate); ONT-380 (hemiethanolate)	503.57	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Tucatinib (Irbinitinib) hemiethanolate is a potent, orally active and selective HER2 inhibitor with an IC50 of 8 nM.	Ethanolate	C26H24N8O2.1/2C2H6O	110854.0	DMSO : 125 mg/mL (248.23 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	CC1=CC(NC2=C3C=C(NC4=NC(C)(C)CO4)C=CC3=NC=N2)=CC=C1OC5=CC6=NC=NN6C=C5.CCO.[1/2]	https://www.medchemexpress.com/tucatinib-hemiethanolate.html	Launched		91.0	O40	C17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16069A	10.0	mM	65.0	DMSO	480.202222	17	C	pluskal_fda_drugs_5005_C17_id
1081	HY-B1281	HYCPK40905	B05	HYCPK40905	91z	154.0	4.0	D10	905.0	B05	59-33-6	Mepyramine maleate	Pyrilamine maleate	401.46	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Mepyramine maleate, a first generation antihistamine, is an antagonist of histamine H1 receptor, with Kds of 0.8 nM, 5200 nM and >3000 nM for H1, H2, and H3 receptor, respectively, and a pKd of 9.4 for H1 receptor.	Maleate	C21H27N3O5	30509.0	DMSO : ≥ 100 mg/mL (249.09 mM); H2O : 50 mg/mL (124.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CN(C)CCN(CC1=CC=C(OC)C=C1)C2=NC=CC=C2.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Mepyramine_maleate.html	Launched		91.0	D10	C17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1281	10.0	mM	65.0	DMSO	285.184112	17	C	pluskal_fda_drugs_5005_C17_id
1087	HY-B0144	HYCPK40905	H05	HYCPK40905	91z	730.0	4.0	P10	905.0	H05	147526-32-7	Pitavastatin (Calcium)	NK-104 (hemicalcium); Pitavastatin (hemicalcium)	440.49	Apoptosis; Autophagy; HMG-CoA Reductase (HMGCR); Mitophagy	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Pitavastatin Calcium (NK-104 hemicalcium) is a potent hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitor. Pitavastatin Calcium (NK-104 hemicalcium) inhibits cholesterol synthesis from acetic acid with an IC50 of 5.8 nM in HepG2 cells. Pitavastatin Calcium is an efficient hepatocyte low-density lipoprotein-cholesterol (LDL-C) receptor inducer. Pitavastatin Calcium also possesses anti-atherosclerotic, anti-asthmatic, anti-osteoarthritis, antineoplastic, neuroprotective, hepatoprotective and reno-protective effects[1][2][3][8].	Calcium	C25H23FNO4.1/2Ca	10944.0	DMSO : ≥ 50 mg/mL (113.51 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Neurological Disease; Cardiovascular Disease	O=C([O-])C[C@H](O)C[C@H](O)/C=C/C1=C(C2=CC=C(F)C=C2)C3=CC=CC=C3N=C1C4CC4.[0.5Ca2+]	https://www.medchemexpress.com/pitavastatin-calcium.html	Launched		91.0	P10	C17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0144	10.0	mM	65.0	DMSO	421.168936	17	C	pluskal_fda_drugs_5005_C17_id
1360	HY-B0425A	HYCPK40905	M22	HYCPK40905	91z	1244.0	4.0	Z44	905.0	M22	1476-53-5	Novobiocin (sodium)	Albamycin (sodium); Cathomycin (sodium)	634.61	Antibiotic; Apoptosis; Bacterial; DNA/RNA Synthesis; HSP; Orthopoxvirus	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Novobiocin (Albamycin) sodium is a potent and orally active antibiotic. Novobiocin sodium also is a DNA gyrase inhibitor and a heat shock protein 90 (Hsp90) antagonist. Novobiocin sodium has the potential for the research of highly beta-lactam-resistant pneumococcal infections. Novobiocin sodium shows anti-orthopoxvirus activity[1][2][3][4].	Sodium	C31H35N2NaO11	18944.0	DMSO : ≥ 30 mg/mL (47.27 mM); H2O : 50 mg/mL (78.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	CC1=C(OC2=O)C(C(O)=C2NC(C3=CC(C/C=C(C)/C)=C(O[Na])C=C3)=O)=CC=C1O[C@H](OC(C)(C)[C@H](OC)[C@H]4OC(N)=O)[C@@H]4O	https://www.medchemexpress.com/novobiocin-sodium.html	Launched		91.0	Z44	C17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0425A	10.0	mM	65.0	DMSO	612.23191	17	C	pluskal_fda_drugs_5005_C17_id
168	HY-15315A	HYCPK40902	F10	HYCPK40902	91z	499.0	1.0	K19	902.0	F10	1187595-84-1	Baricitinib (phosphate)	LY3009104 (phosphate); INCB028050 (phosphate)	469.41	JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Baricitinib phosphate (LY3009104 phosphate; INCB028050 phosphate) is a selective orally bioavailable JAK1/JAK2 inhibitor with IC50 of 5.9 nM and 5.7 nM, respectively.	Phosphate	C16H20N7O6PS	8874.0	DMSO : ≥ 4.7 mg/mL (10.01 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(S(=O)(CC)=O)C1.O=P(O)(O)O	https://www.medchemexpress.com/Baricitinib-phosphate.html	Launched		91.0	K19	C18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15315A	10.0	mM	66.0	DMSO	371.116444	18	C	pluskal_fda_drugs_5005_C18_id
472	HY-15346A	HYCPK40903	M06	HYCPK40903	91z	1164.0	2.0	Y12	903.0	M06	1402152-13-9	Copanlisib (dihydrochloride)	BAY 80-6946 (dihydrochloride)	553.44	Apoptosis; PI3K	Apoptosis; PI3K/Akt/mTOR	Copanlisib dihydrochloride (BAY 80-6946 dihydrochloride) is a potent, selective and ATP-competitive pan-class I PI3K inhibitor, with IC50s of 0.5 nM, 0.7 nM, 3.7 nM and 6.4 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ, respectively. Copanlisib dihydrochloride has more than 2,000-fold selectivity against other lipid and protein kinases, except for mTOR. Copanlisib dihydrochloride has superior antitumor activity[1].	Hydrochloride	C23H30Cl2N8O4	116704.0	DMSO : 5 mg/mL (9.03 mM; ultrasonic and warming and heat to 60°C); H2O : 20 mg/mL (36.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CN=C(N)N=C1)NC2=NC3=C(OC)C(OCCCN4CCOCC4)=CC=C3C5=NCCN25.[H]Cl.[H]Cl	https://www.medchemexpress.com/copanlisib-dihydrochloride.html	Launched		91.0	Y12	C18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15346A	10.0	mM	66.0	DMSO	480.223351	18	C	pluskal_fda_drugs_5005_C18_id
491	HY-N7114A	HYCPK40903	P07	HYCPK40903	91z	1454.0	2.0	AE14	903.0	P07	982-57-0	Chloramphenicol succinate (sodium)		445.18	Antibiotic; Bacterial	Anti-infection	Chloramphenicol succinate sodium is a prodrug of Chloramphenicol, with Haemotoxicity. Chloramphenicol succinate is a competitive substrate and inhibitor of succinate dehydrogenase (SDH) that is the possible reason for its toxicity[1][2][3].	Sodium	C15H15Cl2N2NaO8	64985.0	DMSO : 125 mg/mL (280.79 mM; Need ultrasonic); H2O : 50 mg/mL (112.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Infection	O=C(CCC(O[Na])=O)OC[C@H]([C@@H](C1=CC=C(C=C1)[N+]([O-])=O)O)NC(C(Cl)Cl)=O	https://www.medchemexpress.com/chloramphenicol-succinate-sodium.html	Launched		91.0	AE14	C18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7114A	10.0	mM	66.0	DMSO	422.028371	18	C	pluskal_fda_drugs_5005_C18_id
604	HY-19314A	HYCPK40903	B14	HYCPK40903	91z	124.0	2.0	C28	903.0	B14	1333126-31-0	Azvudine (hydrochloride)	RO-0622 (hydrochloride); FNC (hydrochloride)	322.68	HBV; HCV; HIV; Reverse Transcriptase	Anti-infection	Azvudine (RO-0622) hydrochloride is a potent nucleoside reverse transcriptase inhibitor (NRTI), with antiviral activity on HIV, HBV and HCV. Azvudine hydrochloride exerts highly potent inhibition on HIV-1 (EC50s ranging from 0.03 to 6.92 nM) and HIV-2 (EC50s ranging from 0.018 to 0.025 nM). Azvudine hydrochloride inhibits NRTI-resistant viral strains[1].	Hydrochloride	C9H12ClFN6O4	66286.0	H2O : 125 mg/mL (387.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	NC(C=CN1[C@@H]2O[C@@](N=[N+]=[N-])([C@H]([C@@H]2F)O)CO)=NC1=O.[H]Cl	https://www.medchemexpress.com/azvudine-hydrochloride.html	Launched		91.0	C28	C18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19314A	10.0	mM	66.0	DMSO	286.082581	18	C	pluskal_fda_drugs_5005_C18_id
865	HY-B0689A	HYCPK40904	F11	HYCPK40904	91z	549.0	3.0	L21	904.0	F11	157810-81-6	Indinavir (sulfate)	MK-639; L735524	711.87	Apoptosis; HIV; HIV Protease; MMP; SARS-CoV	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Indinavir sulfate (MK-639) is an orally active and selective HIV-1 protease inhibitor with a Ki of 0.54 nM for PR. Indinavir sulfate exhibits anticancer activity by inhibiting the activation of MMPs-2 hydrolysis, anti-angiogenesis and inducing apoptosis. Indinavir sulfate is also a SARS-CoV 3CLpro inhibitor[1][2][3][4].	Sulfate	C36H49N5O8S	21869.0	H2O : 50 mg/mL (70.24 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (140.48 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C([C@@H](C[C@H](O)CN(CCN(CC1=CN=CC=C1)C2)[C@@H]2C(NC(C)(C)C)=O)CC3=CC=CC=C3)N[C@H]4C(C=CC=C5)=C5C[C@H]4O.O=S(O)(O)=O	https://www.medchemexpress.com/indinavir-sulfate.html	Launched		91.0	L21	C18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0689A	10.0	mM	66.0	DMSO	613.362805	18	C	pluskal_fda_drugs_5005_C18_id
1054	HY-I0447A	HYCPK40905	G03	HYCPK40905	91z	630.0	4.0	N6	905.0	G03	6018-19-5	Sodium 4-aminosalicylate (dihydrate)	4-Aminosalicylic acid (sodium salt dihydrate)	211.15	Antibiotic; Bacterial	Anti-infection	Sodium 4-aminosalicylate dihydrate (4-Aminosalicylic acid sodium salt dihydrate) is one of the antimycobacterial drugs currently used for multidrug-resistant tuberculosis.	Sodium	C7H10NNaO5	16366.0	H2O : 100 mg/mL (473.60 mM; Need ultrasonic); DMSO : 100 mg/mL (473.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(O[Na])C1=C(O)C=C(N)C=C1.O.O	https://www.medchemexpress.com/p-Aminosalicylic-acid-sodium-salt-dihydrate.html	Launched		91.0	N6	C18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-I0447A	10.0	mM	66.0	DMSO	153.042593	18	C	pluskal_fda_drugs_5005_C18_id
1197	HY-B1302	HYCPK40905	F12	HYCPK40905	91z	552.0	4.0	L24	905.0	F12	6151-40-2	Quinidine hydrochloride monohydrate		378.89	Parasite; Potassium Channel	Anti-infection; Membrane Transporter/Ion Channel	Quinidine hydrochloride monohydrate is an anti-arrythmic agent which is also a potent blocker of K+ channel with an IC50 of 19.9 μM.	Hydrochloride	C20H27ClN2O3	27696.0	DMSO : 100 mg/mL (263.93 mM; Need ultrasonic); H2O : 2.5 mg/mL (6.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cardiovascular Disease	C=C[C@H]1C[N@](CC[C@H]1C2)[C@@]2([H])[C@@H](O)C3=CC=NC4=CC=C(OC)C=C34.[H]Cl.[H]O[H]	https://www.medchemexpress.com/Quinidine_hydrochloride_monohydrate.html	Launched		91.0	L24	C18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1302	10.0	mM	66.0	DMSO	324.183778	18	C	pluskal_fda_drugs_5005_C18_id
1277	HY-A0042	HYCPK40905	F17	HYCPK40905	91z	562.0	4.0	L34	905.0	F17	106308-44-5	Rufinamide	CGP 33101; E 2080; RUF 331	238.19	Others	Others	"Rufinamide(E 2080; CGP 33101; RUF 331) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS).
IC50 Value:
Target: 
in vitro:
in vivo: Rufinamide and amitriptyline alleviated injury-induced mechanical allodynia for 4 h (maximal effect: 0.10 ± 0.03 g (mean ± SD) to 1.99 ± 0.26 g for rufinamide and 0.25 ± 0.22 g to 1.92 ± 0.85 g for amitriptyline) in mice [1]. Oral rufinamide suppressed pentylenetetrazol-induced seizures in mice (ED(50) 45.8 mg/kg) but not rats, and was active against MES-induced tonic seizures in mice (ED(50) 23.9 mg/kg) and rats (ED(50) 6.1 mg/kg) [2].  Intraperitoneal rufinamide suppressed pentylenetetrazol-, bicuculline-, and picrotoxin-induced clonus in mice (ED(50) 54.0, 50.5, and 76.3 mg/kg, respectively).
Clinical trial: Exploratory Study to Evaluate the Effect of SYN-111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD). Phase 2"	Free Base	C10H8F2N4O	9172.0	DMSO : 50 mg/mL (209.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CN(CC2=C(F)C=CC=C2F)N=N1)N	https://www.medchemexpress.com/rufinamide.html	Launched		91.0	L34	C18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0042	10.0	mM	66.0	DMSO	238.066617	18	C	pluskal_fda_drugs_5005_C18_id
153	HY-17477	HYCPK40902	C09	HYCPK40902	91z	209.0	1.0	E17	902.0	C09	55482-89-8	Guacetisal		286.28	Others	Others	Guacetisal is obtained from the esterification of acetylsalicylic acid with guaiacol which has the potential for chronic bronchitis  treatment extracted from patent CN 106866420 A.	Free Base	C16H14O5	26674.0	DMSO : 100 mg/mL (349.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OC1=CC=CC=C1OC)C2=CC=CC=C2OC(C)=O	https://www.medchemexpress.com/Guacetisal.html	Launched		91.0	E17	C19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17477	10.0	mM	67.0	DMSO	286.084124	19	C	pluskal_fda_drugs_5005_C19_id
398	HY-B0233	HYCPK40902	G18	HYCPK40902	91z	611.0	1.0	M35	902.0	G18	75695-93-1	Isradipine	PN 200-110	371.39	Autophagy; Calcium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Isradipine (PN 200-110) is an orally active L-type calcium channel blocker. Isradipine, as a powerful peripheral vasodilator, is a dihydropyridine calcium antagonist with selective actions on the heart as well as the peripheral circulation. Isradipine is a potentially viable neuroprotective agent for Parkinson's disease[1][2][3].	Free Base	C19H21N3O5	12978.0	DMSO : ≥ 100 mg/mL (269.26 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(OC(C)C)=O)C1C2=CC=CC3=NON=C23)OC	https://www.medchemexpress.com/isradipine.html	Launched		91.0	M35	C19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0233	10.0	mM	67.0	DMSO	371.148121	19	C	pluskal_fda_drugs_5005_C19_id
427	HY-14779	HYCPK40903	L09	HYCPK40903	91z	1074.0	2.0	W18	903.0	L09	625115-55-1	Riociguat	BAY 632521	422.42	Guanylate Cyclase	GPCR/G Protein	Riociguat is an oral stimulator of soluble guanylate cyclase (sGC) used in the treatment of pulmonary hypertension.	Free Base	C20H19FN8O2	10445.0	DMSO : 20 mg/mL (47.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	FC1=CC=CC=C1CN2C3=NC=CC=C3C(C4=NC(N)=C(C(N)=N4)N(C)C(OC)=O)=N2	https://www.medchemexpress.com/Riociguat.html	Launched		91.0	W18	C19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14779	10.0	mM	67.0	DMSO	422.1615	19	C	pluskal_fda_drugs_5005_C19_id
485	HY-107346	HYCPK40903	J07	HYCPK40903	91z	878.0	2.0	S14	903.0	J07	6606-65-1	Enbucrilate	Butyl cyanoacrylate	153.18	Others	Others	Enbucrilate (Butyl cyanoacrylate) is a cyanoacrylate ester that has been used as surgical tissue adhesive.	Free Base	C8H11NO2	123012.0	DMSO : 100 mg/mL (652.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CCCCOC(C(C#N)=C)=O	https://www.medchemexpress.com/Enbucrilate.html	Launched		91.0	S14	C19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107346	10.0	mM	67.0	DMSO	153.078979	19	C	pluskal_fda_drugs_5005_C19_id
707	HY-B0926A	HYCPK40903	C21	HYCPK40903	91z	234.0	2.0	E42	903.0	C21	737-31-5	Sodium diatrizoate	Diatrizoic acid (sodium salt); Sodium amidotrizoate	635.90	Apoptosis	Apoptosis	Sodium diatrizoate (Diatrizoic acid sodium salt) is an iodinated radiocontrast agent and has the potential for radiographic imaging of the airways. Sodium diatrizoate induces mitochondrial turnover and oxidative stress, and activating apoptosis by dysregulating calcium[1][2].	Sodium	C11H8I3N2NaO4	28536.0	DMSO : 100 mg/mL (157.26 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (78.63 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O[Na])C1=C(I)C(NC(C)=O)=C(I)C(NC(C)=O)=C1I	https://www.medchemexpress.com/Sodium_diatrizoate.html	Launched		91.0	E42	C19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0926A	10.0	mM	67.0	DMSO	613.769651	19	C	pluskal_fda_drugs_5005_C19_id
997	HY-30234A	HYCPK40904	N19	HYCPK40904	91z	1333.0	3.0	AB37	904.0	N19	1163-36-6	Clemizole (hydrochloride)		362.30	HCV; HCV Protease; Histamine Receptor; TRP Channel	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Clemizole hydrochloride is an H1 histamine receptor antagonist, is found to substantially inhibit HCV replication. Clemizole hydrochloride is an inhibitor of TRPC5 channel. The IC50 of Clemizole hydrochloride for RNA binding by NS4B is 24 nM, whereas its EC50 for viral replication is 8 μM.	Hydrochloride	C19H21Cl2N3	9260.0	H2O : 20 mg/mL (55.20 mM; Need ultrasonic); DMSO : 33.33 mg/mL (92.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Endocrinology	ClC1=CC=C(C=C1)CN2C(CN3CCCC3)=NC4=CC=CC=C24.[H]Cl	https://www.medchemexpress.com/Clemizole-hydrochloride.html	Launched		91.0	AB37	C19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-30234A	10.0	mM	67.0	DMSO	325.134575	19	C	pluskal_fda_drugs_5005_C19_id
1124	HY-B0616	HYCPK40905	M07	HYCPK40905	91z	1214.0	4.0	Z14	905.0	M07	123171-59-5	Cefepime (Dihydrochloride Monohydrate)		571.50	Antibiotic; Bacterial	Anti-infection	Cefepime Dihydrochloride Monohydrate is a broad-spectrum cephalosporin with enhanced coverage against Gram-positive and Gram-negative bacteria[1].	Hydrochloride	C19H28Cl2N6O6S2	87262.0	H2O : 10 mg/mL (17.50 mM; Need ultrasonic); DMSO : 6 mg/mL (10.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[N+]1(CC(CS[C@]2([H])[C@@H]3NC(/C(C4=CSC(N)=N4)=N\OC)=O)=C(C(O)=O)N2C3=O)CCCC1.[Cl-].Cl.O	https://www.medchemexpress.com/Cefepime-Dihydrochloride-Monohydrate.html	Launched		91.0	Z14	C19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0616	10.0	mM	67.0	DMSO	481.132236	19	C	pluskal_fda_drugs_5005_C19_id
1312	HY-B1505	HYCPK40905	I19	HYCPK40905	91z	854.0	4.0	R38	905.0	I19	652-37-9	Acefylline	Theophyllineacetic acid; Theophylline-7-acetic acid	238.20	Adenosine Receptor; Phosphodiesterase (PDE); Protein Arginine Deiminase	Epigenetics; GPCR/G Protein; Metabolic Enzyme/Protease	Acefylline (Theophyllineacetic acid), a xanthine derivative, is an adenosine receptor antagonist. Acefylline is a peptidylarginine deiminase (PAD) activator. Acefylline is also a bronchodilator, which inhibits rat lung cAMP phosphodiesterase isoenzymes[1][2].	Free Acid	C9H10N4O4	26920.0	DMSO : 33.33 mg/mL (139.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CN1C=NC(N(C)C(N2C)=O)=C1C2=O	https://www.medchemexpress.com/Acefylline.html	Launched		91.0	R38	C19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1505	10.0	mM	67.0	DMSO	238.070205	19	C	pluskal_fda_drugs_5005_C19_id
99	HY-17512	HYCPK40902	I05	HYCPK40902	91z	777.0	1.0	Q9	902.0	I05	114798-26-4	Losartan	DuP-753	422.91	Angiotensin Receptor	GPCR/G Protein	Losartan is an angiotensin II receptor antagonist, competing with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM.	Free Base	C22H23ClN6O	27304.0	DMSO : ≥ 100 mg/mL (236.46 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	OCC1=C(Cl)N=C(CCCC)N1CC2=CC=C(C3=CC=CC=C3C4=NNN=N4)C=C2	https://www.medchemexpress.com/Losartan.html	Launched		91.0	Q9	C20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17512	10.0	mM	68.0	DMSO	422.162187	20	C	pluskal_fda_drugs_5005_C20_id
249	HY-17504	HYCPK40902	G15	HYCPK40902	91z	605.0	1.0	M29	902.0	G15	147098-20-2	Rosuvastatin (Calcium)	Rosuvastatin hemicalcium; ZD 4522 Calcium	500.57	Autophagy; Bacterial; HMG-CoA Reductase (HMGCR); Potassium Channel	Anti-infection; Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Rosuvastatin Calcium is a competitive HMG-CoA reductase (HMGCR) inhibitor, with an IC50 of 11 nM. Rosuvastatin Calcium potently blocks hERG current with an IC50 of 195 nM[2]. Rosuvastatin Calcium reduces the expression of the mature hERG and the interaction of heat shock protein 70 (Hsp70) with the hERG protein. Rosuvastatin Calcium effectively lowers low-density lipoprotein (LDL) cholesterol, triglycerides, and C-reactive protein levels[1][2][3].	Calcium	C22H27Ca0.5FN3O6S	85547.0	H2O : 1 mg/mL (2.00 mM; Need ultrasonic); DMSO : 25 mg/mL (49.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease; Cancer	O=C([O-])C[C@H](O)C[C@H](O)/C=C/C1=C(C(C)C)N=C(N(C)S(=O)(C)=O)N=C1C2=CC=C(F)C=C2.[0.5Ca2+]	https://www.medchemexpress.com/Rosuvastatin-Calcium.html	Launched		91.0	M29	C20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17504	10.0	mM	68.0	DMSO	481.168285	20	C	pluskal_fda_drugs_5005_C20_id
293	HY-17423	HYCPK40902	M18	HYCPK40902	91z	1187.0	1.0	Y35	902.0	M18	136470-78-5	Abacavir		286.33	Apoptosis; HIV; Reverse Transcriptase; Telomerase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Abacavir is an orally active and competitive nucleoside reverse transcriptase inhibitor. Abacavir can inhibits the replication of HIV. Abacavir shows anticancer activity in prostate cancer cell lines. Abacavir can trespass the blood-brain-barrier and suppresses telomerase activity[1][2][3].	Free Base	C14H18N6O	11778.0	DMSO : 100 mg/mL (349.25 mM; Need ultrasonic); H2O : 2 mg/mL (6.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	NC1=NC(NC2CC2)=C3N=CN([C@H]4C=C[C@@H](CO)C4)C3=N1	https://www.medchemexpress.com/Abacavir.html	Launched		91.0	Y35	C20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17423	10.0	mM	68.0	DMSO	286.154209	20	C	pluskal_fda_drugs_5005_C20_id
445	HY-19344	HYCPK40903	B05	HYCPK40903	91z	106.0	2.0	C10	903.0	B05	1025967-78-5	Lifitegrast	SAR 1118; SHP-606	615.48	Integrin	Cytoskeleton	Lifitegrast (SAR 1118) is a potent integrin antagonist. Lifitegrast blocks the binding of intercellular adhesion molecule 1 (ICAM-1) to lymphocyte function-associated antigen 1 (LFA-1), interrupting the T cell-mediated inflammatory cycle. Lifitegrast inhibits Jurkat T cell attachment to ICAM-1 with an IC50 of 2.98 nM. Lifitegrast can be used for researching dry eye disease[1].	Free Acid	C29H24Cl2N2O7S	23729.0	DMSO : ≥ 29 mg/mL (47.12 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)[C@H](CC1=CC=CC(S(=O)(C)=O)=C1)NC(C2=C(Cl)C3=C(CN(C(C4=CC=C5C=COC5=C4)=O)CC3)C=C2Cl)=O	https://www.medchemexpress.com/Lifitegrast.html	Launched		91.0	C10	C20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19344	10.0	mM	68.0	DMSO	614.068127	20	C	pluskal_fda_drugs_5005_C20_id
622	HY-B1326	HYCPK40903	D15	HYCPK40903	91z	318.0	2.0	G30	903.0	D15	64-65-3	Bemegride	3-Ethyl-3-methylglutarimide; Bemegrid	155.19	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Bemegride (3-Ethyl-3-methylglutarimide) is a central nervous system stimulant and antidote for barbiturate poisoning[1][2].	Free Base	C8H13NO2	17635.0	DMSO : ≥ 32 mg/mL (206.20 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(CC(C)(CC)C1)NC1=O	https://www.medchemexpress.com/Bemegride.html	Launched		91.0	G30	C20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1326	10.0	mM	68.0	DMSO	155.094629	20	C	pluskal_fda_drugs_5005_C20_id
867	HY-B0478	HYCPK40904	H11	HYCPK40904	91z	741.0	3.0	P21	904.0	H11	25332-39-2	Trazodone (hydrochloride)	AF-1161	408.32	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Trazodone (hydrochloride) (AF-1161) is an antidepressant belonging to the class of serotonin receptor antagonists and reuptake inhibitors for treatment of anxiety disorders.	Hydrochloride	C19H23Cl2N5O	16947.0	DMSO : 16.67 mg/mL (40.83 mM; Need ultrasonic); H2O : 16.67 mg/mL (40.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C4C=CC=CN41.Cl	https://www.medchemexpress.com/Trazodone-hydrochloride.html	Launched		91.0	P21	C20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0478	10.0	mM	68.0	DMSO	371.151288	20	C	pluskal_fda_drugs_5005_C20_id
1021	HY-B0184	HYCPK40904	F21	HYCPK40904	91z	569.0	3.0	L41	904.0	F21	25451-15-4	Felbamate	W-554; ADD-03055	238.24	iGluR	Membrane Transporter/Ion Channel; Neuronal Signaling	Felbamate (W-554) is a potent nonsedative anticonvulsant whose clinical effect may be related to the inhibition of N-methyl-D-aspartate (NMDA).	Free Base	C11H14N2O4	158967.0	DMSO : ≥ 100 mg/mL (419.74 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC(OCC(C1=CC=CC=C1)COC(N)=O)=O	https://www.medchemexpress.com/felbamate.html	Launched		91.0	L41	C20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0184	10.0	mM	68.0	DMSO	238.095357	20	C	pluskal_fda_drugs_5005_C20_id
1246	HY-A0269	HYCPK40905	G15	HYCPK40905	91z	654.0	4.0	N30	905.0	G15	32887-01-7	Mecillinam	Amdinocillin; FL 1060	325.43	Antibiotic; Bacterial	Anti-infection	Mecillinam (Amdinocillin), the β-lactam antibiotic, has a broad spectrum of activity against gram-negative organisms[1].		C15H23N3O3S	78853.0	H2O : 100 mg/mL (307.29 mM; Need ultrasonic); DMSO : 250 mg/mL (768.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2/N=C/N3CCCCCC3)N1C2=O)O	https://www.medchemexpress.com/mecillinam.html	Launched		91.0	N30	C20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0269	10.0	mM	68.0	DMSO	325.146013	20	C	pluskal_fda_drugs_5005_C20_id
305	HY-14771A	HYCPK40902	I19	HYCPK40902	91z	805.0	1.0	Q37	902.0	I19	775351-61-6	Imeglimin (hydrochloride)	EMD 387008 hydrochloride	191.66186	Mitochondrial Metabolism; Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Imeglimin hydrochloride (EMD 387008) is an oral glucose-lowering agent. Imeglimin also reduces reactive oxygen species (ROS) production, increases mitochondrial DNA and improves mitochondrial function[1].	Hydrochloride	C6H14ClN5	211952.0	H2O : ≥ 50 mg/mL (260.88 mM); DMSO : 25 mg/mL (130.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	[H]Cl.NC1=N[C@@H](C)N=C(N(C)C)N1	https://www.medchemexpress.com/imeglimin-hydrochloride.html	Launched		91.0	Q37	C21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14771A	10.0	mM	69.0	DMSO	155.117095	21	C	pluskal_fda_drugs_5005_C21_id
325	HY-13910A	HYCPK40902	M20	HYCPK40902	91z	1191.0	1.0	Y39	902.0	M20	206184-49-8	Tenofovir (hydrate)	GS 1278 (hydrate); PMPA (hydrate)	305.23	HIV; Reverse Transcriptase	Anti-infection	Tenofovir hydrate is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.	Free Acid	C9H16N5O5P	32804.0	DMSO : ≥ 6 mg/mL (19.66 mM)	DMSO Solution	10mM  * 100uL	Infection	C[C@@H](OCP(O)(O)=O)CN1C=NC2=C(N)N=CN=C12.O	https://www.medchemexpress.com/tenofovir-hydrate.html	Launched		91.0	Y39	C21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13910A	10.0	mM	69.0	DMSO	287.078341	21	C	pluskal_fda_drugs_5005_C21_id
373	HY-N0750	HYCPK40902	F04	HYCPK40902	91z	487.0	1.0	K7	902.0	F04	315-22-0	Monocrotaline	Crotaline	325.36	Others	Others	Monocrotaline is an pyrrolizidine alkaloid extracted from the seeds of the Crotalaria pallida plant to induce pulmonary hypertension in rodents.	Free Base	C16H23NO6	67175.0	DMSO : 25 mg/mL (76.84 mM; ultrasonic and warming and heat to 60°C); H2O : 2 mg/mL (6.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(O[C@]1([H])CCN2[C@]1([H])C(CO3)=CC2)[C@H](C)[C@@](C)(O)[C@@](C)(O)C3=O	https://www.medchemexpress.com/Monocrotaline.html	Launched		91.0	K7	C21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0750	10.0	mM	69.0	DMSO	325.152537	21	C	pluskal_fda_drugs_5005_C21_id
571	HY-B1153A	HYCPK40903	C19	HYCPK40903	91z	230.0	2.0	E38	903.0	C19	65513-72-6	Glafenine (hydrochloride)	Glafenin hydrochloride	409.26	Others	Others	Glafenine hydrochloride is a non-narcotic analgesic and non-steroidal anti-inflammatory drug. It is an ABCG2 inhibitor with an IC50 of 3.2 μM.	Hydrochloride	C19H18Cl2N2O4	63589.0	DMSO : 41.67 mg/mL (101.82 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	[H]Cl.O=C(OCC(O)CO)C1=CC=CC=C1NC2=CC=NC3=CC(Cl)=CC=C23	https://www.medchemexpress.com/Glafenine_hydrochloride.html	Launched		91.0	E38	C21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1153A	10.0	mM	69.0	DMSO	372.087685	21	C	pluskal_fda_drugs_5005_C21_id
620	HY-B1110A	HYCPK40903	B15	HYCPK40903	91z	126.0	2.0	C30	903.0	B15	32795-47-4	Nomifensine (maleate)	(±)-Nomifensine maleat	354.40	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Nomifensine maleate is a selective inhibitor of dopamine uptake, used in adult attention deficit disorder.	Maleate	C20H22N2O4	24719.0	DMSO : ≥ 80 mg/mL (225.73 mM); H2O : 2.2 mg/mL (6.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC1=CC=CC2=C1CN(C)CC2C3=CC=CC=C3.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Nomifensine-maleate.html	Launched		91.0	C30	C21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1110A	10.0	mM	69.0	DMSO	238.146999	21	C	pluskal_fda_drugs_5005_C21_id
760	HY-10999A	HYCPK40904	H04	HYCPK40904	91z	727.0	3.0	P7	904.0	H04	1187431-43-1	Trametinib (DMSO solvate)	GSK-1120212 (DMSO solvate); JTP-74057 (DMSO solvate)	693.53	Apoptosis; MEK	Apoptosis; MAPK/ERK Pathway	Trametinib (DMSO solvate) (GSK-1120212 (DMSO solvate);JTP-74057 (DMSO solvate)) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib (DMSO solvate) activates autophagy and induces apoptosis[1][2].	Free Base	C28H29FIN5O5S	7379.0	DMSO : 69 mg/mL (99.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CN1C(C(C)=C(N(C(N(C2=O)C3CC3)=O)C4=CC=CC(NC(C)=O)=C4)C2=C1NC5=CC=C(C=C5F)I)=O.CS(C)=O	https://www.medchemexpress.com/Trametinib-DMSO-solvate.html	Launched		91.0	P7	C21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10999A	10.0	mM	69.0	DMSO	615.07788	21	C	pluskal_fda_drugs_5005_C21_id
897	HY-B1203A	HYCPK40904	F13	HYCPK40904	91z	553.0	3.0	L25	904.0	F13	514-36-3	Fludrocortisone acetate	9α-Fludrocortisone acetate; 9α-Fluorcortisol acetate	422.49	Autophagy; Mineralocorticoid Receptor	Autophagy; Metabolic Enzyme/Protease	Fludrocortisone acetate (9α-Fludrocortisone acetate) is a synthetic mineralocorticoid, used to control the amount of sodium and fluids in your body. It is used to treat Addison's disease by decreasing the amount of sodium that is lost (excreted) in your urine, also used to increase blood pressure.	Free Base	C23H31FO6	17626.0	DMSO : 50 mg/mL (118.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(COC(C)=O)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/Fludrocortisone-acetate.html	Launched		91.0	L25	C21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1203A	10.0	mM	69.0	DMSO	422.210467	21	C	pluskal_fda_drugs_5005_C21_id
1183	HY-B0290A	HYCPK40905	H11	HYCPK40905	91z	742.0	4.0	P22	905.0	H11	150821-03-7	Pranlukast (hemihydrate)	ONO-1078 (hemihydrate)	490.51	Endogenous Metabolite; Leukotriene Receptor	GPCR/G Protein; Metabolic Enzyme/Protease	Pranlukast hemihydrate is a highly potent, selective and competitive antagonist of peptide leukotrienes. Pranlukast inhibits [3H]LTE4, [3H]LTD4, and [3H]LTC4 bindings to lung membranes with Kis of 0.63±0.11, 0.99±0.19, and 5640±680 nM, respectively.	Free Base	C27H23N5O4.1/2H2O	22422.0	DMSO : 25 mg/mL (50.97 mM; Need ultrasonic); H2O : 1 mg/mL (2.04 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=C(OCCCCC2=CC=CC=C2)C=C1)NC3=C4C(C(C=C(C5=NN=NN5)O4)=O)=CC=C3.[1/2].O	https://www.medchemexpress.com/Pranlukast-hemihydrate.html	Launched		91.0	P22	C21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0290A	10.0	mM	69.0	DMSO	481.175004	21	C	pluskal_fda_drugs_5005_C21_id
86	HY-12882A	HYCPK40902	O03	HYCPK40902	91z	1349.0	1.0	AC5	902.0	O03	23210-58-4	Ifenprodil (tartrate)		400.49	iGluR; Potassium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Ifenprodil tartrate is a typical noncompetitive NMDA receptor antagonist. Ifenprodil tartrate exerts high affinity at NR1A/NR2B receptors (IC50=0.34 μM) over 400-fold than at NR1A/NR2A receptors (IC50=146 μM)[1]. Ifenprodil tartrate inhibits GIRK (Kir3), reduces inward currents through the basal GIRK activity. Ifenprodil tartrate has the potential to be a cerebral vasodilator[2].	Tartrate	C21H27NO2.1/2C4H6O6	16062.0	DMSO : ≥ 500 mg/mL (1248.47 mM); H2O : 5 mg/mL (12.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC(C1=CC=C(O)C=C1)C(C)N(CC2)CCC2CC3=CC=CC=C3.O=C(O)[C@H](O)[C@@H](O)C(O)=O.[1/2]	https://www.medchemexpress.com/Ifenprodil-tartrate.html	Launched		91.0	AC5	C22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12882A	10.0	mM	70.0	DMSO	325.204179	22	C	pluskal_fda_drugs_5005_C22_id
88	HY-76299	HYCPK40902	A04	HYCPK40902	91z	7.0	1.0	A7	902.0	A04	357-70-0	Galanthamine	Galantamine	287.35	Apoptosis; Cholinesterase (ChE)	Apoptosis; Neuronal Signaling	Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM.	Free Base	C17H21NO3	20877.0	DMSO : ≥ 59 mg/mL (205.32 mM); 1M HCl : 50 mg/mL (174.00 mM; ultrasonic and adjust pH to 1 with HCl)	DMSO Solution	10mM  * 100uL	Neurological Disease	O[C@@H]1C[C@@H]2OC3=C4C(CN(C)CC[C@]42C=C1)=CC=C3OC	https://www.medchemexpress.com/Galanthamine.html	Launched		91.0	A7	C22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-76299	10.0	mM	70.0	DMSO	287.152144	22	C	pluskal_fda_drugs_5005_C22_id
412	HY-B1110	HYCPK40902	D22	HYCPK40902	91z	331.0	1.0	G43	902.0	D22	24526-64-5	Nomifensine	(±)-Nomifensin	238.33	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Nomifensine is a norepinephrine-dopamine reuptake inhibitor, increases the amount of synaptic norepinephrine and dopamine available to receptors by blocking the dopamine and norepinephrine reuptake transporters.	Free Base	C16H18N2	29173.0	DMSO : ≥ 100 mg/mL (419.59 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC1=CC=CC2=C1CN(C)CC2C3=CC=CC=C3	https://www.medchemexpress.com/Nomifensine.html	Launched		91.0	G43	C22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1110	10.0	mM	70.0	DMSO	238.146999	22	C	pluskal_fda_drugs_5005_C22_id
521	HY-B0408A	HYCPK40903	J10	HYCPK40903	91z	884.0	2.0	S20	903.0	J10	21462-39-5	Clindamycin (hydrochloride)		461.44	Antibiotic; Bacterial	Anti-infection	Clindamycin (hydrochloride) is a semisynthetic lincosamide antibiotic, which inhibits protein synthesis by acting on the 50S ribosomal.	Hydrochloride	C18H34Cl2N2O5S	11828.0	DMSO : ≥ 100 mg/mL (216.71 mM); H2O : ≥ 100 mg/mL (216.71 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@H](Cl)[C@@]([C@@]([C@@H]([C@H](O)[C@H]1O)O)([H])O[C@@H]1SC)([H])NC([C@@H]2C[C@@H](CCC)CN2C)=O.Cl	https://www.medchemexpress.com/clindamycin-hydrochloride.html	Launched		91.0	S20	C22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0408A	10.0	mM	70.0	DMSO	424.179871	22	C	pluskal_fda_drugs_5005_C22_id
994	HY-10999	HYCPK40904	K19	HYCPK40904	91z	1045.0	3.0	V37	904.0	K19	871700-17-3	Trametinib	GSK1120212; JTP-74057	615.39	Apoptosis; Autophagy; MEK	Apoptosis; Autophagy; MAPK/ERK Pathway	Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].	Free Base	C26H23FIN5O4	30987.0	DMSO : 25 mg/mL (40.62 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	CC(NC1=CC=CC(N(C2=O)C(C(C(N2C3CC3)=O)=C(N4C)NC5=CC=C(C=C5F)I)=C(C4=O)C)=C1)=O	https://www.medchemexpress.com/Trametinib.html	Launched		91.0	V37	C22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10999	10.0	mM	70.0	DMSO	615.07788	22	C	pluskal_fda_drugs_5005_C22_id
1169	HY-N0157	HYCPK40905	J10	HYCPK40905	91z	932.0	4.0	T20	905.0	J10	65-86-1	Orotic acid	6-Carboxyuracil; Vitamin B13	156.10	Endogenous Metabolite; Nucleoside Antimetabolite/Analog	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Orotic acid (6-Carboxyuracil), a precursor in biosynthesis of pyrimidine nucleotides and RNA, is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme. Orotic acid is a marker for measurement in routine newborn screening for urea cycle disorders. Orotic acid can induce hepatic steatosis and hepatomegaly in rats[1][2][3].	Free Acid	C5H4N2O4	9719.0	DMSO : 55 mg/mL (352.34 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(C(NC1=O)=CC(N1)=O)O	https://www.medchemexpress.com/Orotic-acid.html	Launched		91.0	T20	C22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0157	10.0	mM	70.0	DMSO	156.017107	22	C	pluskal_fda_drugs_5005_C22_id
1176	HY-B0243	HYCPK40905	A11	HYCPK40905	91z	70.0	4.0	B22	905.0	A11	1247-42-3	Meprednisone		372.45	Autophagy; Glucocorticoid Receptor	Autophagy; Immunology/Inflammation	"Meprednisone is a glucocorticoid and a methylated derivative of prednisone.
Target: Glucocorticoid Receptor
Meprednisone is a glucocorticoid and a methylated derivative of prednisone. The methylprednisone to MPL area under the curve ratio decreased from 0.19 +/- 0.04 in control to 0.14 +/- 0.03 in ketoconazole-treated rats (P less than .05) due to altered interconversion between these steroids. An improved pharmacokinetic/dynamic receptor/gene-mediated model characterized the steroid receptor binding and induction of tyrosine aminotransferase activity after i.v. MPL sodium succinate (10 mg/kg). In contrast to previous in vitro studies, ketoconazole at maximally tolerated doses failed to antagonize the steroid receptor-mediated activity of MPL [1]."	Free Base	C22H28O5	16489.0	DMSO : ≥ 100 mg/mL (268.49 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Endocrinology; Cancer	C[C@@]1(C2)[C@](C(CO)=O)(O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])C2=O)=O	https://www.medchemexpress.com/meprednisone.html	Launched		91.0	B22	C22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0243	10.0	mM	70.0	DMSO	372.193674	22	C	pluskal_fda_drugs_5005_C22_id
1235	HY-14809	HYCPK40905	L14	HYCPK40905	91z	1132.0	4.0	X28	905.0	L14	841301-32-4	Amenamevir	ASP2151	482.55	HSV	Anti-infection	Amenamevir is a helicase-primase inhibitor which has potent antiviral activity against HSVs with an EC50 of 14 ng/mL.	Free Base	C24H26N4O5S	41995.0	DMSO : ≥ 50 mg/mL (103.62 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(CC1)CCS1(=O)=O)N(C2=C(C)C=CC=C2C)CC(NC3=CC=C(C4=NOC=N4)C=C3)=O	https://www.medchemexpress.com/Amenamevir.html	Launched		91.0	X28	C22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14809	10.0	mM	70.0	DMSO	482.162391	22	C	pluskal_fda_drugs_5005_C22_id
244	HY-B1675A	HYCPK40902	B15	HYCPK40902	91z	125.0	1.0	C29	902.0	B15	50293-90-8	Levalbuterol (hydrochloride)	(R)-Albuterol (hydrochloride); (R)-Salbutamol (hydrochloride); Levosalbutamol (hydrochloride)	275.77	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Levalbuterol ((R)-Albuterol) hydrochloride is a short-acting β2-adrenergic receptor agonist and the active (R)-enantiomer of Salbutamol. Levalbuterol hydrochloride is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD[1].	Hydrochloride	C13H22ClNO3	155068.0	H2O : 100 mg/mL (362.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(C)(NC[C@@H](C1=CC=C(C(CO)=C1)O)O)C.[H]Cl	https://www.medchemexpress.com/levalbuterol-hydrochloride.html	Launched		91.0	C29	D3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1675A	10.0	mM	75.0	DMSO	239.152144	3	D	pluskal_fda_drugs_5005_D3_id
276	HY-109025A	HYCPK40902	B17	HYCPK40902	91z	129.0	1.0	C33	902.0	B17	1985605-59-1	Baloxavir	Baloxavir acid; S-033447	483.49	Influenza Virus	Anti-infection	Baloxavir (Baloxavir acid), derived from the prodrug Baloxavir marboxil, is a first-in-class, potent and selective cap-dependent endonuclease (CEN) inhibitor within the polymerase PA subunit of influenza A and B viruses. Baloxavir inhibits viral RNA transcription and replication and has potently antiviral activity[1][2].	Free Base	C24H19F2N3O4S	103197.0	DMSO : 41.67 mg/mL (86.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1N2[C@](COCC2)([H])N([C@@H]3C4=CC=CC=C4SCC5=C(F)C(F)=CC=C35)N6C1=C(O)C(C=C6)=O	https://www.medchemexpress.com/Baloxavir.html	Launched		91.0	C33	D3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109025A	10.0	mM	75.0	DMSO	483.106434	3	D	pluskal_fda_drugs_5005_D3_id
345	HY-B0076	HYCPK40903	B03	HYCPK40903	91z	102.0	2.0	C6	903.0	B03	104344-23-2	Bisoprolol (hemifumarate)		766.96	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Bisoprolol hemifumarate is a potent, selective and orally active β1-adrenergic receptor blocker with little activity on β2-receptor. Bisoprolol hemifumarate has the potential for hypertension, coronary artery disease and stable ventricular dysfunction research[1][2].	Fumarate	C18H31NO4.1/2C4H4O4	11823.0	H2O : 20 mg/mL (26.08 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (65.19 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Inflammation/Immunology; Cardiovascular Disease	OC(CNC(C)C)COC1=CC=C(COCCOC(C)C)C=C1.OC(/C=C/C(O)=O)=O.[1/2]	https://www.medchemexpress.com/__plusmn__-bisoprolol-hemifumarate.html	Launched		91.0	C6	D3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0076	10.0	mM	75.0	DMSO	325.225308	3	D	pluskal_fda_drugs_5005_D3_id
418	HY-B0093A	HYCPK40902	J22	HYCPK40902	91z	907.0	1.0	S43	902.0	J22	86541-74-4	Benazepril (hydrochloride)	CGS14824A	460.95	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	"Benazepril hydrochloride, an angiotensin converting enzyme inhibitor, which is a medication used to treat high blood pressure.
Target: angiotensin converting enzyme (ACE)
Benazepril hydrochloride is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril hydrochloride is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor [1].
Animals were randomly divided into 4 groups: sham STNx group (control), STNx group, morning benazepril hydrochloride group (MB) and evening benazepril hydrochloride group (EB).Benazepril hydrochloride was intragastrically administered at a dose of 10 mg/kg/day at 07:00 and 19:00 in the MB group and EB group respectively for 12 weeks. All the animals were synchronized to the light:dark cycle of 12:12 for 12 weeks. Systolic blood pressure (SBP), 24-h urinary protein excretion and renal function were measured at 11 weeks. Blood samples and kidneys were collected every 4 h throughout a day to detect the expression pattern of renin activity (RA), angiotensin II (AngII) and aldosterone (Ald) by radioimmunoassay (RIA) and the mRNA expression profile of clock genes (bmal1, dbp and per2) by real-time PCR at 12 weeks. Our results showed that no significant differences were noted in the SBP, 24-h urine protein excretion and renal function between the MB and EB groups. There were no significant differences in average Ald and RA content of a day between the MB group and EB group. The expression peak of bmal1 mRNA was phase-delayed by 4 to 8 h, and the diurnal variation of per2 and dbp mRNA diminished in the MB and EB groups compared with the control and STNx groups. It was concluded when the similar SBP reduction, RAAS inhibition and clock gene profile were achieved with optimal dose of benazepril hydrochloride, morning versus evening dosing of benazepril hydrochloride has the same renoprotection effects [2].
Clinical indications: Congestive heart failure; End stage renal disease; Hypertension
FDA Approved Date:  
Toxicity: headaches; cough;  Anaphylaxis; angioedema;  hyperkalemia"	Hydrochloride	C24H29ClN2O5	15639.0	H2O : 10 mg/mL (21.69 mM; Need ultrasonic); DMSO : 100 mg/mL (216.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C1N(CC(O)=O)C2=CC=CC=C2CC[C@@H]1N[C@@H](CCC3=CC=CC=C3)C(OCC)=O.Cl	https://www.medchemexpress.com/Benazepril-hydrochloride.html	Launched		91.0	S43	D3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0093A	10.0	mM	75.0	DMSO	424.199822	3	D	pluskal_fda_drugs_5005_D3_id
493	HY-B1414	HYCPK40903	B08	HYCPK40903	91z	112.0	2.0	C16	903.0	B08	88-04-0	Chloroxylenol	4-Chloro-3,5-dimethylphenol; PCMX	156.61	Bacterial; Influenza Virus; Parasite	Anti-infection	"Chloroxylenol is a broad spectrum antimicrobial chemical compound used to control bacteria, algae, fungi and virus.
Target: Antibacterial
Chloroxylenol is used in hospitals and households for disinfection and sanitation. Chloroxylenol is also commonly used in antibacterial soaps, wound-cleansing applications and household antiseptics such as Dettol liquid, cream and ointments."	Free Base	C8H9ClO	17585.0	DMSO : ≥ 100 mg/mL (638.53 mM)	DMSO Solution	10mM  * 100uL	Infection	OC1=CC(C)=C(Cl)C(C)=C1	https://www.medchemexpress.com/Chloroxylenol.html	Launched		91.0	C16	D3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1414	10.0	mM	75.0	DMSO	156.034193	3	D	pluskal_fda_drugs_5005_D3_id
791	HY-B1201	HYCPK40904	L06	HYCPK40904	91z	1115.0	3.0	X11	904.0	L06	51-24-1	Tiratricol	3,3',5-Triiodothyroacetic acid	621.93	Thyroid Hormone Receptor	Others	Tiratricol is a thyroid hormone analog with hepatic, has been used to suppress pituitary TSH secretion,  with attenuation of extrapituitary thyromimetic effects.	Free Acid	C14H9I3O4	36652.0	DMSO : ≥ 42 mg/mL (67.53 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1	https://www.medchemexpress.com/Tiratricol.html	Launched		91.0	X11	D3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1201	10.0	mM	75.0	DMSO	621.763503	3	D	pluskal_fda_drugs_5005_D3_id
817	HY-A0009	HYCPK40904	F08	HYCPK40904	91z	543.0	3.0	L15	904.0	F08	1953-04-4	Galanthamine (hydrobromide)	Galantamine (hydrobromide)	368.27	Cholinesterase (ChE); nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Galanthamine hydrobromide (Galantamine hydrobromide) is a selective, reversible, competitive, alkaloid AChE inhibitor, with an IC50 of 0.35 μM. Galanthamine hydrobromide is a potent allosteric potentiating ligand (APL) of human α3β4, α4β2, α6β4 nicotinic receptors ( nAChRs). Galanthamine hydrobromide is developed for the research of Alzheimer's disease (AD)[1][2][3].	Hydrobromide	C17H22BrNO3	17545.0	DMSO : ≥ 3.7 mg/mL (10.05 mM); H2O : 16.67 mg/mL (45.27 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O[C@@H]1C[C@@H]2OC3=C4C(CN(C)CC[C@]42C=C1)=CC=C3OC.Br	https://www.medchemexpress.com/Galanthamine-hydrobromide.html	Launched		91.0	L15	D3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0009	10.0	mM	75.0	DMSO	287.152144	3	D	pluskal_fda_drugs_5005_D3_id
917	HY-B1472	HYCPK40904	J14	HYCPK40904	91z	939.0	3.0	T27	904.0	J14	56-47-3	Deoxycorticosterone acetate	11-Deoxycorticosterone acetate; DOC acetate; Cortexone acetate	372.50	Endogenous Metabolite; Mineralocorticoid Receptor	Metabolic Enzyme/Protease	Deoxycorticosterone acetate (DOCA) is an adrenocortin, acts as a precursor to aldosterone. Deoxycorticosterone acetate is a mineralocorticoid receptor agonist. Deoxycorticosterone acetate can cause severe renal injury, including inflammation, fibrosis, glomerular damage, and proteinuria[1][2].	Free Base	C23H32O4	65207.0	DMSO : 41.67 mg/mL (111.87 mM; ultrasonic and warming and heat to 80°C); H2O : 1 mg/mL (2.68 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Endocrinology	C[C@@]12[C@@H](C(COC(C)=O)=O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC2)=O	https://www.medchemexpress.com/Deoxycorticosterone-acetate.html	Launched		91.0	T27	D3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1472	10.0	mM	75.0	DMSO	372.23006	3	D	pluskal_fda_drugs_5005_D3_id
76	HY-13635	HYCPK40902	E03	HYCPK40902	91z	389.0	1.0	I5	902.0	E03	98319-26-7	Finasteride	MK-906	372.54	5 alpha Reductase	Metabolic Enzyme/Protease	Finasteride (MK-906) is a potent and competitive 5α-reductase inhibitor, with an IC50 of 4.2 nM for type II 5α-reductase. Finasteride has approximately a 100-fold greater affinity for type II 5α-reductase enzyme than for the type I enzyme. Finasteride can be used for the research of benign prostatic hyperplasia (BPH) and androgenic alopecia[1][2][3].	Free Base	C23H36N2O2	11681.0	DMSO : 150 mg/mL (402.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)C=CC(N[C@]4([H])CC[C@]32[H])=O)NC(C)(C)C	https://www.medchemexpress.com/finasteride.html	Launched		91.0	I5	D4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13635	10.0	mM	76.0	DMSO	372.277678	4	D	pluskal_fda_drugs_5005_D4_id
307	HY-B0452	HYCPK40902	K19	HYCPK40902	91z	997.0	1.0	U37	902.0	K19	23239-51-2	Ritodrine (hydrochloride)	DU21220 (hydrochloride)	323.81	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Ritodrine (DU21220) hydrochloride is a β-adrenergic agonist, also an effective smooth muscle and uterine relaxant. Ritodrine hydrochloride prolongs contraction interval, can be used for researching arrest premature labor[1][2][3].	Hydrochloride	C17H22ClNO3	16820.0	H2O : ≥ 100 mg/mL (308.82 mM); DMSO : 120 mg/mL (370.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	OC1=CC=C(CCN[C@H](C)[C@@H](O)C2=CC=C(O)C=C2)C=C1.Cl	https://www.medchemexpress.com/ritodrine-hydrochloride.html	Launched		91.0	U37	D4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0452	10.0	mM	76.0	DMSO	287.152144	4	D	pluskal_fda_drugs_5005_D4_id
547	HY-B0497	HYCPK40903	D12	HYCPK40903	91z	312.0	2.0	G24	903.0	D12	50-65-7	Niclosamide	BAY2353	327.12	Antibiotic; Parasite; STAT	Anti-infection; JAK/STAT Signaling; Stem Cell/Wnt	Niclosamide (BAY2353) is an orally active antihelminthic agent used in parasitic infection research[1]. Niclosamide is a STAT3 inhibitor with an IC50 of 0.25 μM in HeLa cells[4]. Niclosamide has biological activities against cancer, inhibits DNA replication in Vero E6 cells[2][3][5].	Free Base	C13H8Cl2N2O4	15718.0	DMSO : 4.55 mg/mL (13.91 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMF : 5 mg/mL (15.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(NC1=CC=C([N+]([O-])=O)C=C1Cl)C2=CC(Cl)=CC=C2O	https://www.medchemexpress.com/Niclosamide.html	Launched		91.0	G24	D4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0497	10.0	mM	76.0	DMSO	325.986112	4	D	pluskal_fda_drugs_5005_D4_id
789	HY-B1037	HYCPK40904	J06	HYCPK40904	91z	923.0	3.0	T11	904.0	J06	18559-94-9	Salbutamol	Albuterol; AH-3365	239.31	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).	Free Base	C13H21NO3	145195.0	DMSO : 100 mg/mL (417.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	OC(CNC(C)(C)C)C1=CC=C(O)C(CO)=C1	https://www.medchemexpress.com/Salbutamol.html	Launched		91.0	T11	D4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1037	10.0	mM	76.0	DMSO	239.152144	4	D	pluskal_fda_drugs_5005_D4_id
862	HY-B0499A	HYCPK40904	C11	HYCPK40904	91z	261.0	3.0	F21	904.0	C11	26095-59-0	Otilonium (bromide)	Octylonium bromide; SP63	563.57	mAChR	GPCR/G Protein; Neuronal Signaling	"Octylonium bromide (SP63) is an antimuscarinic used as a spasmolytic agent.
Target: mAChR
Octylonium bromide (SP63) inhibited the generation of ACh-induced calcium signals in a dose dependent manner (IC50=880 nM) [1]. 
Octylonium bromide (SP63), a clinically useful spasmolytic, behaves as a potent blocker of neuronal nicotinic acetylcholine receptors (AChR). Whole-cell Ba2+ currents (IBa) through Ca2+ channels of voltage-clamped chromaffin cells were blocked by otilonium with an IC50 of 6.4 microM. 
Octylonium bromide (SP63) inhibited the secretory responses induced by 10 s pulses of 50 microM DMPP with an IC50 of 7.4 nM [2]. 
Octylonium bromide (SP63) may represent an effective treatment for irritable bowel syndrome because it reduces its predominant symptom (abdominal pain/ discomfort) more than placebo does [3]. 
Octylonium bromide (SP63) is a spasmolytic agent that blocks L-Type Calcium channels in human colonic smooth muscle. 
Octylonium bromide (SP63) is safe, well tolerated and superior to placebo in reducing the frequency of abdominal pain, severity of abdominal bloating and protecting from symptom relapse in IBS. These results further confirm that patients with IBS can improve during and following treatment with otilonium bromide [4]."	Bromide	C29H43BrN2O4	15960.0	DMSO : 50 mg/mL (88.72 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (177.44 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCC[N+](CC)(CC)C)C1=CC=C(NC(C2=CC=CC=C2OCCCCCCCC)=O)C=C1.[Br-]	https://www.medchemexpress.com/Otilonium-bromide.html	Launched		91.0	F21	D4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0499A	10.0	mM	76.0	DMSO	483.321734	4	D	pluskal_fda_drugs_5005_D4_id
957	HY-75161	HYCPK40904	F17	HYCPK40904	91z	561.0	3.0	L33	904.0	F17	2216-51-5	(-)-Menthol		156.27	Endogenous Metabolite; TRP Channel	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	(-)-Menthol is a key component of peppermint oil that binds and activates transient receptor potential melastatin 8 (TRPM8), a Ca2+-permeable nonselective cation channel, to increase [Ca2+]i[1].  Antitumor activity[1].	Free Base	C10H20O	27180.0	H2O : 1.89 mg/mL (12.09 mM; ultrasonic and warming and heat to 60°C); DMSO : 100 mg/mL (639.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O[C@H]1[C@H](C(C)C)CC[C@@H](C)C1	https://www.medchemexpress.com/_-_-Menthol.html	Launched		91.0	L33	D4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-75161	10.0	mM	76.0	DMSO	156.151415	4	D	pluskal_fda_drugs_5005_D4_id
1255	HY-16474	HYCPK40905	P15	HYCPK40905	91z	1518.0	4.0	AF30	905.0	P15	737789-87-6	Relugolix	TAK-385	623.63	GnRH Receptor	GPCR/G Protein	Relugolix (TAK-385)?is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209)[1]. Relugolix is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al[2].	Free Base	C29H27F2N7O5S	22071.0	DMSO : 100 mg/mL (160.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	O=C(NOC)NC1=CC=C(C(S2)=C(CN(C)C)C(C(N3C4=NN=C(OC)C=C4)=O)=C2N(CC5=C(F)C=CC=C5F)C3=O)C=C1	https://www.medchemexpress.com/Relugolix.html	Launched		91.0	AF30	D4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16474	10.0	mM	76.0	DMSO	623.176244	4	D	pluskal_fda_drugs_5005_D4_id
1340	HY-B0165A	HYCPK40905	E21	HYCPK40905	91z	474.0	4.0	J42	905.0	E21	81131-70-6	Pravastatin (sodium)	CS-514 (sodium)	446.51	Autophagy; Ferroptosis; HMG-CoA Reductase (HMGCR)	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.	Sodium	C23H35NaO7	29645.0	DMSO : 100 mg/mL (223.96 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (111.98 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O[C@@H](C[C@@H](O)CC(O[Na])=O)CC[C@@H]([C@H](C=C1)C)[C@@](C1=C[C@@H](O)C2)([H])[C@H]2OC([C@@H](C)CC)=O	https://www.medchemexpress.com/pravastatin-sodium.html	Launched		91.0	J42	D4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0165A	10.0	mM	76.0	DMSO	424.246103	4	D	pluskal_fda_drugs_5005_D4_id
187	HY-10261	HYCPK40902	I11	HYCPK40902	91z	789.0	1.0	Q21	902.0	I11	850140-72-6	Afatinib	BIBW 2992	485.94	Akt; Apoptosis; Autophagy; c-Met/HGFR; EGFR; p38 MAPK	Apoptosis; Autophagy; JAK/STAT Signaling; MAPK/ERK Pathway; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK	Afatinib (BIBW 2992) is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer[1][2][3][4].	Free Base	C24H25ClFN5O3	66910.0	DMSO : 100 mg/mL (205.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=C(C=C2C(C(NC3=CC(Cl)=C(C=C3)F)=NC=N2)=C1)O[C@H]4CCOC4)/C=C/CN(C)C.[(E)]	https://www.medchemexpress.com/Afatinib.html	Launched		91.0	Q21	D5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10261	10.0	mM	77.0	DMSO	485.162996	5	D	pluskal_fda_drugs_5005_D5_id
315	HY-16974	HYCPK40902	C20	HYCPK40902	91z	231.0	1.0	E39	902.0	C20	1093861-60-9	Afoxolaner		625.87	Chloride Channel; GABA Receptor; Parasite	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Afoxolaner is an orally active isoxazoline insecticide/acaricide against Ixodes scapularis in dogs. Afoxolaner acts on the insect γ-aminobutyric acid receptor (GABA) and glutamate receptors, inhibiting GABA & glutamate-regulated uptake of chloride ions, resulting in excess neuronal stimulation and death of the arthropod[1][2].		C26H17ClF9N3O3	59944.0	DMSO : ≥ 250 mg/mL (399.44 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=C2C=CC=CC2=C(C3=NOC(C(F)(F)F)(C4=CC(C(F)(F)F)=CC(Cl)=C4)C3)C=C1)NCC(NCC(F)(F)F)=O	https://www.medchemexpress.com/afoxolaner.html	Launched		91.0	E39	D5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16974	10.0	mM	77.0	DMSO	625.081473	5	D	pluskal_fda_drugs_5005_D5_id
380	HY-76251	HYCPK40902	M04	HYCPK40902	91z	1159.0	1.0	Y7	902.0	M04	41340-25-4	Etodolac	AY-24236	287.35	COX	Immunology/Inflammation	Etodolac (AY-24236) is a non-steroidal anti-inflammatory compound that is a non-selective inhibitor of COX (IC50=53.5 nM)	Free Acid	C17H21NO3	1830.0	DMSO : ≥ 100 mg/mL (348.01 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O)CC(OCC1)(CC)C2=C1C3=CC=CC(CC)=C3N2	https://www.medchemexpress.com/etodolac.html	Launched		91.0	Y7	D5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-76251	10.0	mM	77.0	DMSO	287.152144	5	D	pluskal_fda_drugs_5005_D5_id
748	HY-B1223	HYCPK40904	L03	HYCPK40904	91z	1109.0	3.0	X5	904.0	L03	532-11-6	Anethole trithione		240.36	mAChR	GPCR/G Protein; Neuronal Signaling	Anethole trithione, a sulfur heterocyclic choleretic, is a bile secretion-stimulating agent. Anethole trithione enhances salivary secretion and increases mAChRs, and can be used for dry mouth research[1][2].	Free Base	C10H8OS3	17456.0	DMSO : 12.5 mg/mL (52.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	S=C1SSC(C2=CC=C(OC)C=C2)=C1	https://www.medchemexpress.com/Anethole-trithione.html	Launched		91.0	X5	D5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1223	10.0	mM	77.0	DMSO	239.973728	5	D	pluskal_fda_drugs_5005_D5_id
919	HY-N1369	HYCPK40904	L14	HYCPK40904	91z	1131.0	3.0	X27	904.0	L14	1490-04-6	Menthol		156.27	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Menthol is a natural analgesic compound. Menthol could cause a feeling of coolness due to stimulation of ‘cold’ receptors by inhibiting Ca++ currents of neuronal membranes[1].		C10H20O	81187.0	DMSO : 250 mg/mL (1599.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	OC1C(C(C)C)CCC(C)C1	https://www.medchemexpress.com/menthol.html	Launched		91.0	X27	D5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1369	10.0	mM	77.0	DMSO	156.151415	5	D	pluskal_fda_drugs_5005_D5_id
1004	HY-B0175	HYCPK40904	E20	HYCPK40904	91z	471.0	3.0	J39	904.0	E20	69004-03-1	Toltrazuril	BAY-i 9142	425.38	Antibiotic; Parasite	Anti-infection	Toltrazuril (BAY-i 9142) is an antiprotozoal agent that acts upon Coccidia parasites.	Free Base	C18H14F3N3O4S	26833.0	DMSO : 130 mg/mL (305.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N(C1=CC=C(OC2=CC=C(SC(F)(F)F)C=C2)C(C)=C1)C(N3)=O)N(C)C3=O	https://www.medchemexpress.com/toltrazuril.html	Launched		91.0	J39	D5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0175	10.0	mM	77.0	DMSO	425.065712	5	D	pluskal_fda_drugs_5005_D5_id
1082	HY-14539	HYCPK40905	C05	HYCPK40905	91z	250.0	4.0	F10	905.0	C05	5786-21-0	Clozapine	HF 1854	326.82	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor; mAChR	GPCR/G Protein; Neuronal Signaling	Clozapine (HF 1854) is an antipsychotic used for the research of schizophrenia. Clozapine has high affinity for a number of neuroreceptors. Clozapine is a potent antagonist of dopamine D2 with a Ki of 75 nM. Clozapine inhibits the muscarinic M1 receptor and serotonin 5HT2A receptor with Kis of 9.5 nM and 4 nM, respectively[1][2][3]. Clozapine is also a potent and selective agonist at the muscarinic M4 receptor (EC50=11 nM)[4].	Free Base	C18H19ClN4	15729.0	DMSO : 50 mg/mL (152.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1CCN(CC1)C2=NC3=CC(Cl)=CC=C3NC4=CC=CC=C42	https://www.medchemexpress.com/Clozapine.html	Launched		91.0	F10	D5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14539	10.0	mM	77.0	DMSO	326.129824	5	D	pluskal_fda_drugs_5005_D5_id
1334	HY-16564	HYCPK40905	O20	HYCPK40905	91z	1432.0	4.0	AD40	905.0	O20	554435-83-5	Deferasirox (Fe3+ chelate)		426.18	Bacterial; Ferroptosis	Anti-infection; Apoptosis	Deferasirox Fe3+ Chelate is an iron chelating agent extracted from patent WO2003053986[1].	Free Base	C21H12FeN3O4	7845.0	DMSO : 50 mg/mL (117.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C([O-])C1=CC=C(N2N=C3[N]4=C2C5=CC=CC=C5[O-][Fe+3]4[O-]C6=CC=CC=C63)C=C1	https://www.medchemexpress.com/Deferasirox-Fe3_addition_-chelate.html	Launched		91.0	AD40	D5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16564	10.0	mM	77.0	DMSO	373.106256	5	D	pluskal_fda_drugs_5005_D5_id
277	HY-109056	HYCPK40902	C17	HYCPK40902	91z	225.0	1.0	E33	902.0	C17	868046-19-9	Elsulfavirine		629.28	HIV	Anti-infection	Elsulfavirine is a reverse transcriptase inhibitors for HIV-1 infection and is a new anti-HIV drug[1].	Free Base	C24H17BrCl2FN3O5S	115265.0	DMSO : 62.5 mg/mL (99.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(NC1=CC=C(S(=O)(NC(CC)=O)=O)C=C1Cl)CC2=CC=C(Br)C(OC3=CC(C#N)=CC(Cl)=C3)=C2F	https://www.medchemexpress.com/elsulfavirine.html	Launched		91.0	E33	D6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109056	10.0	mM	78.0	DMSO	626.943337	6	D	pluskal_fda_drugs_5005_D6_id
288	HY-B0923	HYCPK40902	N17	HYCPK40902	91z	1281.0	1.0	AA33	902.0	N17	117-10-2	Danthron	Dantron; Chrysazin; 1,8-Dihydroxyanthraquinone	240.21	AMPK; Autophagy; Bacterial; Virus Protease	Anti-infection; Autophagy; Epigenetics; PI3K/Akt/mTOR	Danthron is a natural product extracted from the traditional Chinese medicine Salvia miltiorrhiza Bunge. Danthron functions in regulating glucose and lipid metabolism by activating AMPK.	Free Base	C14H8O4	17256.0	DMSO : 5 mg/mL (20.82 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C2=C(C=CC=C2O)C(C3=CC=CC(O)=C13)=O	https://www.medchemexpress.com/Danthron.html	Launched		91.0	AA33	D6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0923	10.0	mM	78.0	DMSO	240.042259	6	D	pluskal_fda_drugs_5005_D6_id
422	HY-19568	HYCPK40903	G09	HYCPK40903	91z	594.0	2.0	M18	903.0	G09	944118-01-8	Peficitinib	ASP015K; JNJ-54781532	326.39	JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Peficitinib (ASP015K) is an orally active JAK inhibitor, with IC50s of 3.9, 5.0, 0.7 and 4.8 nM for JAK1, JAK2, JAK3 and Tyk2, respectively[1].	Free Base	C18H22N4O2	30961.0	DMSO : ≥ 60 mg/mL (183.83 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O[C@](C[C@@H]1C[C@H]2C3)(C2)C[C@@H]3[C@H]1NC4=C5C(NC=C5)=NC=C4C(N)=O	https://www.medchemexpress.com/Peficitinib.html	Launched		91.0	M18	D6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19568	10.0	mM	78.0	DMSO	326.174276	6	D	pluskal_fda_drugs_5005_D6_id
659	HY-B0366A	HYCPK40903	I17	HYCPK40903	91z	802.0	2.0	Q34	903.0	I17	969-33-5	Cyproheptadine (hydrochloride)		323.86	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Cyproheptadine hydrochloride is a potent and orally active 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders[1][2].	Hydrochloride	C21H22ClN	16122.0	DMSO : 50 mg/mL (154.39 mM; Need ultrasonic); H2O : 0.67 mg/mL (2.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease; Cancer	CN1CC/C(CC1)=C2C3=CC=CC=C3C=CC4=CC=CC=C/24.Cl	https://www.medchemexpress.com/Cyproheptadine-hydrochloride.html	Launched		91.0	Q34	D6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0366A	10.0	mM	78.0	DMSO	287.1674	6	D	pluskal_fda_drugs_5005_D6_id
993	HY-17359	HYCPK40904	J19	HYCPK40904	91z	949.0	3.0	T37	904.0	J19	201530-41-8	Deferasirox	ICL 670	373.36	Bacterial; Ferroptosis	Anti-infection; Apoptosis	Deferasirox (ICL 670) is an orally available iron chelator used for the management of transfusional iron overload[1][2][3].	Free Acid	C21H15N3O4	7890.0	DMSO : ≥ 100 mg/mL (267.84 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)C1=CC=C(N2N=C(C3=CC=CC=C3O)N=C2C4=CC=CC=C4O)C=C1	https://www.medchemexpress.com/Deferasirox.html	Launched		91.0	T37	D6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17359	10.0	mM	78.0	DMSO	373.106256	6	D	pluskal_fda_drugs_5005_D6_id
1023	HY-10981	HYCPK40904	H21	HYCPK40904	91z	761.0	3.0	P41	904.0	H21	417716-92-8	Lenvatinib	E7080	426.85	c-Kit; FGFR; PDGFR; RET; VEGFR	Protein Tyrosine Kinase/RTK	Lenvatinib (E7080) is an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows  potent antitumor activities[1][2].	Free Base	C21H19ClN4O4	87432.0	DMSO : ≥ 12.78 mg/mL (29.94 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N)C1=C(C=C2N=CC=C(C2=C1)OC3=CC=C(C(Cl)=C3)NC(NC4CC4)=O)OC	https://www.medchemexpress.com/lenvatinib.html	Launched		91.0	P41	D6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10981	10.0	mM	78.0	DMSO	426.109483	6	D	pluskal_fda_drugs_5005_D6_id
1209	HY-14300A	HYCPK40905	B13	HYCPK40905	91z	170.0	4.0	D26	905.0	B13	503070-58-4	Vilanterol (trifenatate)	GW642444 (trifenatate)	774.77	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Vilanterol trifenatate (GW642444 trifenatate) is a long-acting β2-adrenoceptor (β2-AR) agonist with inherent 24-hour activity. The pEC50s for β2-AR, β1-AR and β3-AR are 10.37, 6.98 and 7.36, respectively.	Trifenatate	C44H49Cl2NO7	10379.0	DMSO : 100 mg/mL (129.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	OC1=CC=C([C@@H](O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl)C=C1CO.O=C(O)C(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5	https://www.medchemexpress.com/Vilanterol-trifenatate.html	Launched		91.0	D26	D6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14300A	10.0	mM	78.0	DMSO	485.173579	6	D	pluskal_fda_drugs_5005_D6_id
1320	HY-14768	HYCPK40905	A20	HYCPK40905	91z	88.0	4.0	B40	905.0	A20	259793-96-9	Favipiravir	T-705	157.10	Bacterial; DNA/RNA Synthesis; Influenza Virus; SARS-CoV	Anti-infection; Cell Cycle/DNA Damage	Favipiravir (T-705) is a potent viral RNA polymerase inhibitor, it is phosphoribosylated by cellular enzymes to its active form, Favipiravir-ribofuranosyl-5′-triphosphate (RTP). Favipiravir-RTP inhibits the influenza viral RNA-dependent RNA polymerase (RdRP) activity with an IC50 of 341 nM.	Free Base	C5H4FN3O2	63584.0	H2O : 6.25 mg/mL (39.78 mM; Need ultrasonic); DMSO : 100 mg/mL (636.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N)C1=NC(F)=CNC1=O	https://www.medchemexpress.com/T_705.html	Launched		91.0	B40	D6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14768	10.0	mM	78.0	DMSO	157.028755	6	D	pluskal_fda_drugs_5005_D6_id
211	HY-15284A	HYCPK40902	A13	HYCPK40902	91z	25.0	1.0	A25	902.0	A13	389574-19-0	Prasugrel (hydrochloride)	PCR 4099 (hydrochloride)	409.90	P2Y Receptor	GPCR/G Protein	Prasugrel hydrochloride (PCR 4099 hydrochloride), a thienopyridine and prodrug, inhibits platelet function. Prasugrel hydrochloride is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation[1].	Hydrochloride	C20H21ClFNO3S	41898.0	DMSO : 41.67 mg/mL (101.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	FC1=CC=CC=C1C(C(C2CC2)=O)N3CCC4=C(C3)C=C(S4)OC(C)=O.Cl	https://www.medchemexpress.com/prasugrel-hydrochloride.html	Launched		91.0	A25	D7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15284A	10.0	mM	79.0	DMSO	373.114793	7	D	pluskal_fda_drugs_5005_D7_id
313	HY-B1715	HYCPK40902	A20	HYCPK40902	91z	39.0	1.0	A39	902.0	A20	62613-82-5	Oxiracetam	ISF2522	158.16	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Oxiracetam is a cyclic derivative of γ-aminobutyric acid (GABA) which has been commonly used as nootropic drug to treat cognitive impairments.	Free Base	C6H10N2O3	27068.0	DMSO : 10 mg/mL (63.23 mM; Need ultrasonic and warming); H2O : ≥ 100 mg/mL (632.27 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N)CN1C(CC(O)C1)=O	https://www.medchemexpress.com/Oxiracetam.html	Launched		91.0	A39	D7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1715	10.0	mM	79.0	DMSO	158.069142	7	D	pluskal_fda_drugs_5005_D7_id
698	HY-16774	HYCPK40903	J20	HYCPK40903	91z	904.0	2.0	S40	903.0	J20	1350653-20-1	Vericiguat	BAY1021189	426.38	Guanylate Cyclase	GPCR/G Protein	Vericiguat (BAY1021189) is a potent, orally available and soluble guanylate cyclase stimulator.	Free Base	C19H16F2N8O2	40402.0	DMSO : 60 mg/mL (140.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(OC)NC1=C(N)N=C(C2=NN(CC3=CC=CC=C3F)C4=NC=C(F)C=C42)N=C1N	https://www.medchemexpress.com/Vericiguat.html	Launched		91.0	S40	D7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16774	10.0	mM	79.0	DMSO	426.136428	7	D	pluskal_fda_drugs_5005_D7_id
715	HY-14300	HYCPK40903	K21	HYCPK40903	91z	1002.0	2.0	U42	903.0	K21	503068-34-6	Vilanterol	GW642444	486.43	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Vilanterol (GW642444) is a long-acting β2-adrenoceptor (β2-AR) agonist with 24 h activity. The pEC50s for β2-AR,β1-AR and β3-AR is 10.37±0.05, 6.98±0.03 and 7.36±0.03, respectively.	Free Base	C24H33Cl2NO5	89088.0	DMSO : ≥ 100 mg/mL (205.58 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	OC1=CC=C([C@@H](O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl)C=C1CO	https://www.medchemexpress.com/Vilanterol.html	Launched		91.0	U42	D7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14300	10.0	mM	79.0	DMSO	485.173579	7	D	pluskal_fda_drugs_5005_D7_id
943	HY-B1487	HYCPK40904	H16	HYCPK40904	91z	751.0	3.0	P31	904.0	H16	1508-76-5	Procyclidine (hydrochloride)	Tricyclamol (hydrochloride); (±)-Procyclidine (hydrochloride)	323.90	iGluR; mAChR	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Procyclidine (Tricyclamol, (±)-Procyclidine) hydrochloride , an anticholinergic agent, is a muscarinic receptor antagonist that also has the properties of an N-methyl-D-aspartate (NMDA) antagonist. Procyclidine hydrochloride can be used in studies of Parkinson's disease and related psychiatric disorders such as Soman-induced epilepsy[1][2].	Hydrochloride	C19H30ClNO	63591.0	DMSO : 10.66 mg/mL (32.91 mM; Need ultrasonic and warming); H2O : 5.56 mg/mL (17.17 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC(C1=CC=CC=C1)(C2CCCCC2)CCN3CCCC3.[H]Cl	https://www.medchemexpress.com/Procyclidine-hydrochloride.html	Launched		91.0	P31	D7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1487	10.0	mM	79.0	DMSO	287.224915	7	D	pluskal_fda_drugs_5005_D7_id
948	HY-B0107	HYCPK40904	M16	HYCPK40904	91z	1231.0	3.0	Z31	904.0	M16	55079-83-9	Acitretin	Ro 10-1670	326.43	Apoptosis; Autophagy; RAR/RXR	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Acitretin (Ro 10-1670) is a second-generation, systemic retinoid that has been used in the treatment of psoriasis. Acitretin also can be used for the research of Alzheimer’s disease[1][2][3].	Free Acid	C21H26O3	11791.0	H2O : 0.67 mg/mL (2.05 mM; Need ultrasonic); DMSO : 20 mg/mL (61.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CC(/C=C/C(C(C)=CC(OC)=C1C)=C1C)=C\C=C\C(C)=C\C(O)=O	https://www.medchemexpress.com/acitretin.html	Launched		91.0	Z31	D7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0107	10.0	mM	79.0	DMSO	326.188195	7	D	pluskal_fda_drugs_5005_D7_id
1128	HY-13725A	HYCPK40905	A08	HYCPK40905	91z	64.0	4.0	B16	905.0	A08	95343-20-7	Pirarubicin (Hydrochloride)	THP Hydrochloride	664.10	Antibiotic; Autophagy; Bacterial; Topoisomerase	Anti-infection; Autophagy; Cell Cycle/DNA Damage	Pirarubicin Hydrochloride is an anthracycline antibiotics, acts as a topoisomerase II inhibitor, and is a widely used for treatment of various cancers, in particular, solid tumors.	Hydrochloride	C32H38ClNO12	45897.0	DMSO : 20.83 mg/mL (31.37 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C1C2=C(C=CC=C2OC)C(C3=C(O)C4=C([C@@H](O[C@@]5([H])C[C@H](N)[C@H](O[C@@]6([H])OCCCC6)[C@H](C)O5)C[C@@](C(CO)=O)(O)C4)C(O)=C31)=O.Cl	https://www.medchemexpress.com/pirarubicin-hydrochloride.html	Launched		91.0	B16	D7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13725A	10.0	mM	79.0	DMSO	627.231576	7	D	pluskal_fda_drugs_5005_D7_id
1318	HY-B0374	HYCPK40905	O19	HYCPK40905	91z	1430.0	4.0	AD38	905.0	O19	75438-57-2	Moxonidine	BDF5895	241.68	Imidazoline Receptor	Neuronal Signaling	"Moxonidine(BDF5895) is a selective agonist at the imidazoline receptor subtype 1, used as antihypertensive agent.
Target: I1-R
Moxonidine is a centrally acting antihypertensive agent. Mixed Nischarin (I1 imidazoline receptor) and α2-AR (adrenergic) agonist; displays 40-fold higher affinity for I1 receptors versus α2-adrenoceptors. Moxonidine reduced stimulated NE overflow (log EC50: -6.15 +/- 0.14). AGN192403, a selective ligand at I1-R, had no influence on the dose-response curve of moxonidine (log EC50: -6.01 +/- 0.25) [1]. The hypotensive and bradycardic actions of moxonidine but not clonidine are mediated through imidazoline receptors and are dependent on intact noradrenergic pathways within the RVLM. Furthermore, the noradrenergic innervation may be associated with a 42 kDa imidazoline receptor protein [2]."	Free Base	C9H12ClN5O	16826.0	DMSO : 20 mg/mL (82.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC1=NC(OC)=C(NC2=NCCN2)C(Cl)=N1	https://www.medchemexpress.com/moxonidine.html	Launched		91.0	AD38	D7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0374	10.0	mM	79.0	DMSO	241.073038	7	D	pluskal_fda_drugs_5005_D7_id
175	HY-B1119	HYCPK40902	M10	HYCPK40902	91z	1171.0	1.0	Y19	902.0	M10	3380-34-5	Triclosan		289.54	Antibiotic; Autophagy; Bacterial; Fungal	Anti-infection; Autophagy	Triclosan is an antibacterial and antifungal agent found in consumer products, including soaps, detergents, toys, and surgical cleaning treatments.	Free Base	C12H7Cl3O2	17541.0	DMSO : ≥ 100 mg/mL (345.38 mM); H2O : 1 mg/mL (3.45 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	OC1=CC(Cl)=CC=C1OC2=CC=C(Cl)C=C2Cl	https://www.medchemexpress.com/Triclosan.html	Launched		91.0	Y19	D8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1119	10.0	mM	80.0	DMSO	287.951163	8	D	pluskal_fda_drugs_5005_D8_id
191	HY-B0222	HYCPK40902	M11	HYCPK40902	91z	1173.0	1.0	Y21	902.0	M11	661-19-8	1-Docosanol	Behenyl alcohol	326.60	HSV	Anti-infection	1-Docosanol is a saturated fatty alcohol used traditionally as an emollient, emulsifier, and thickener in cosmetics, and nutritional supplement; inhibitor of lipid-enveloped viruses including herpes simplex.	Free Base	C22H46O	16384.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : < 0.1 mg/mL (insoluble); Ethanol : 50 mg/mL (153.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CCCCCCCCCCCCCCCCCCCCCCO	https://www.medchemexpress.com/1-Docosanol.html	Launched		91.0	Y21	D8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0222	10.0	mM	80.0	DMSO	326.354866	8	D	pluskal_fda_drugs_5005_D8_id
302	HY-17460A	HYCPK40902	F19	HYCPK40902	91z	517.0	1.0	K37	902.0	F19	223652-90-2	Garenoxacin (Mesylate hydrate)	BMS284756 (Mesylate hydrate)	540.53	Antibiotic; Bacterial; DNA/RNA Synthesis; Topoisomerase	Anti-infection; Cell Cycle/DNA Damage	Garenoxacin (BMS284756) Mesylate hydrate is an orally active quinolone antibiotic and has a broad spectrum of activity against a wide array of gram-positive and gram-negative bacteria, anaerobes, and fastidious organisms[1].	Mesylate	C24H26F2N2O8S	179268.0	DMSO : 100 mg/mL (185.00 mM; Need ultrasonic); H2O : 12.5 mg/mL (23.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2CC2)C3=C(C=CC(C4=CC5=C([C@@H](C)NC5)C=C4)=C3OC(F)F)C1=O)O.CS(=O)(O)=O.O	https://www.medchemexpress.com/Garenoxacin-Mesylate-hydrate.html	Launched		91.0	K37	D8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17460A	10.0	mM	80.0	DMSO	426.139114	8	D	pluskal_fda_drugs_5005_D8_id
575	HY-B1613A	HYCPK40903	G19	HYCPK40903	91z	614.0	2.0	M38	903.0	G19	57645-91-7	Clebopride (malate)		507.96	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	"Clebopride malate is a dopamine antagonist drug with antiemetic and prokinetic properties used to treat functional gastrointestinal disorders. 
Target: dopamine
Clebopride is a substituted benzamide, closely related to metoclopramide."	Malate	C24H30ClN3O7	19200.0	DMSO : 60 mg/mL (118.12 mM; Need ultrasonic); H2O : 8.33 mg/mL (16.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)C(O)CC(O)=O.O=C(NC1CCN(CC2=CC=CC=C2)CC1)C3=CC(Cl)=C(N)C=C3OC	https://www.medchemexpress.com/Clebopride-malate.html	Launched		91.0	M38	D8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1613A	10.0	mM	80.0	DMSO	373.155705	8	D	pluskal_fda_drugs_5005_D8_id
581	HY-10274	HYCPK40904	E05	HYCPK40904	91z	441.0	3.0	J9	904.0	E05	211915-06-9	Dabigatran etexilate	BIBR 1048	627.73	Thrombin	Metabolic Enzyme/Protease	Dabigatran etexilate (BIBR 1048) is an orally active prodrug of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation[1].	Free Base	C34H41N7O5	7402.0	DMSO : ≥ 100 mg/mL (159.30 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(N(C1=NC=CC=C1)CCC(OCC)=O)C2=CC=C3C(N=C(N3C)CNC4=CC=C(C(NC(OCCCCCC)=O)=N)C=C4)=C2	https://www.medchemexpress.com/Dabigatran-etexilate.html	Launched		91.0	J9	D8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10274	10.0	mM	80.0	DMSO	627.316917	8	D	pluskal_fda_drugs_5005_D8_id
832	HY-A0091A	HYCPK40904	E09	HYCPK40904	91z	449.0	3.0	J17	904.0	E09	555-57-7	Pargyline		159.23	Monoamine Oxidase	Neuronal Signaling	Pargyline is an irreversible monoamine oxidase (MAO) inhibitor with Kis of 13 μM and 0.5 μM for MAO-A and MAO-B, respectively. Pargyline has antihypertensive and anticancer activities[1][2][3].	Free Base	C11H13N	136017.0	DMSO : 100 mg/mL (628.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	C#CCN(C)CC1=CC=CC=C1	https://www.medchemexpress.com/Pargyline.html	Launched		91.0	J17	D8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0091A	10.0	mM	80.0	DMSO	159.104799	8	D	pluskal_fda_drugs_5005_D8_id
1073	HY-16582	HYCPK40905	J04	HYCPK40905	91z	920.0	4.0	T8	905.0	J04	1218778-77-8	Sonidegib (diphosphate)	Erismodegib (diphosphate); LDE225 (diphosphate); NVP-LDE225 (diphosphate)	681.49	Smo	Stem Cell/Wnt	Sonidegib diphosphate (Erismodegib diphosphate) is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively[1].	Phosphate	C26H32F3N3O11P2	7961.0	DMSO : 100 mg/mL (146.74 mM; Need ultrasonic); H2O : 0.25 mg/mL (0.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(C)C(C(C=C2)=CC=C2OC(F)(F)F)=CC=C1)NC3=CC=C(N=C3)N4C[C@@H](C)O[C@@H](C)C4.O=P(O)(O)O.O=P(O)(O)O	https://www.medchemexpress.com/LDE225-Diphosphate.html	Launched		91.0	T8	D8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16582	10.0	mM	80.0	DMSO	485.192626	8	D	pluskal_fda_drugs_5005_D8_id
1212	HY-107383	HYCPK40905	E13	HYCPK40905	91z	458.0	4.0	J26	905.0	E13	17528-72-2	Tetrahydrobiopterin	(Rac)-Sapropterin	241.25	Endogenous Metabolite; NO Synthase	Immunology/Inflammation; Metabolic Enzyme/Protease	Tetrahydrobiopterin ((Rac)-Sapropterin) is a cofactor of the aromatic amino acid hydroxylases enzymes and also acts as an essential cofactor for all nitric oxide synthase (NOS) isoforms.	Free Base	C9H15N5O3	26503.0	DMSO : 50 mg/mL (207.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1C2=C(NC(N)=N1)NCC(C(O)C(O)C)N2	https://www.medchemexpress.com/Tetrahydrobiopterin.html	Launched		91.0	J26	D8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107383	10.0	mM	80.0	DMSO	241.117489	8	D	pluskal_fda_drugs_5005_D8_id
342	HY-B0664	HYCPK40902	O22	HYCPK40902	91z	1387.0	1.0	AC43	902.0	O22	52214-84-3	Ciprofibrate	Win35833	289.15	PPAR	Cell Cycle/DNA Damage	Ciprofibrate (Win35833) is a potent peroxisome proliferator and increases the phosphorylation level of the PPARalpha[1]. Ciprofibrate acts as an orally active hypolipidaemic agent and can be used for the research of primary hyperlipidaemias[2].	Free Acid	C13H14Cl2O3	14155.0	DMSO : ≥ 100 mg/mL (345.84 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC(C)(OC1=CC=C(C2C(Cl)(Cl)C2)C=C1)C(O)=O	https://www.medchemexpress.com/Ciprofibrate.html	Launched		91.0	AC43	D9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0664	10.0	mM	81.0	DMSO	288.032	9	D	pluskal_fda_drugs_5005_D9_id
360	HY-B0287	HYCPK40903	A04	HYCPK40903	91z	8.0	2.0	A8	903.0	A04	637-07-0	Clofibrate		242.70	PPAR	Cell Cycle/DNA Damage	Clofibrate is an agonist of PPAR, with EC50s of 50 μM, ～500 μM for murine PPARα and PPARγ, and 55 μM, ～500 μM for human PPARα and PPARγ, respectively.	Free Base	C12H15ClO3	25407.0	DMSO : ≥ 100 mg/mL (412.03 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC(C)(OC1=CC=C(Cl)C=C1)C(OCC)=O	https://www.medchemexpress.com/Clofibrate.html	Launched		91.0	A8	D9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0287	10.0	mM	81.0	DMSO	242.070972	9	D	pluskal_fda_drugs_5005_D9_id
430	HY-U00089	HYCPK40903	O09	HYCPK40903	91z	1362.0	2.0	AC18	903.0	O09	508-99-6	Hydrocortisone cypionate		486.64	Glucocorticoid Receptor	Immunology/Inflammation	Hydrocortisone cypionate is a synthetic glucocorticoid corticosteroid and a corticosteroid ester.	Free Base	C29H42O6	37454.0	DMSO : 125 mg/mL (256.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]1([C@@]2(O)C(COC(CCC3CCCC3)=O)=O)[C@](CC2)([H])[C@@](CCC4=CC5=O)([H])[C@]([C@]4(CC5)C)([H])[C@@H](O)C1	https://www.medchemexpress.com/Hydrocortisone_cypionate.html	Launched		91.0	AC18	D9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-U00089	10.0	mM	81.0	DMSO	486.298139	9	D	pluskal_fda_drugs_5005_D9_id
662	HY-10274A	HYCPK40903	L17	HYCPK40903	91z	1090.0	2.0	W34	903.0	L17	872728-81-9	Dabigatran etexilate (mesylate)	BIBR 1048MS; Dabigatran etexilate methanesulfonate	723.84	Thrombin	Metabolic Enzyme/Protease	Dabigatran etexilate mesylate (BIBR 1048MS) is an orally active prodrug of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate mesylate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation[1].	Mesylate	C35H45N7O8S	10862.0	DMSO : 25 mg/mL (34.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(N(C1=NC=CC=C1)CCC(OCC)=O)C2=CC=C3C(N=C(N3C)CNC4=CC=C(C(NC(OCCCCCC)=O)=N)C=C4)=C2.CS(=O)(O)=O	https://www.medchemexpress.com/Dabigatran-etexilate-mesylate.html	Launched		91.0	W34	D9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10274A	10.0	mM	81.0	DMSO	627.316917	9	D	pluskal_fda_drugs_5005_D9_id
695	HY-B1147	HYCPK40903	G20	HYCPK40903	91z	616.0	2.0	M40	903.0	G20	3736-81-0	Diloxanide furoate		328.15	Parasite	Anti-infection	Diloxanide furoate is the prodrug of Diloxanide. Diloxanide furoate is a potent and orally active anti-protozoal agent and can be used for the research of amebiasis, mild intestinal amebiasis or asymptomatic cyst carriers[1].	Free Base	C14H11Cl2NO4	113971.0	Ethanol : 20 mg/mL (60.95 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (152.37 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CC=CO1)OC2=CC=C(N(C(C(Cl)Cl)=O)C)C=C2	https://www.medchemexpress.com/Diloxanide-furoate.html	Launched		91.0	M40	D9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1147	10.0	mM	81.0	DMSO	327.006513	9	D	pluskal_fda_drugs_5005_D9_id
780	HY-A0083	HYCPK40904	A06	HYCPK40904	91z	59.0	3.0	B11	904.0	A06	62-51-1	Methacholine (chloride)	Acetyl-β-methylcholine chloride	195.69	mAChR	GPCR/G Protein; Neuronal Signaling	Methacholine (Acetyl-β-methylcholine) choride is a potent muscarinic-3 (M3) agonist. Methacholine choride acts directly on acetylcholine receptors on smooth muscle causing bronchoconstriction and airway narrowing. Methacholine choride shows a high sensitivity to identify bronchial hyperresponsiveness (BHR). Methacholine choride can be used to measure airway hyperresponsiveness (AHR) as a diagnostic aid in the assessment of individuals with asthma-like symptoms and normal resting expiratory flow rates[1][2][3][4].	Chloride	C8H18ClNO2	150629.0	DMSO : ≥ 42 mg/mL (214.63 mM); H2O : ≥ 100 mg/mL (511.01 mM)	DMSO Solution	10mM  * 100uL	Others	CC(OC(C)=O)C[N+](C)(C)C.[Cl-]	https://www.medchemexpress.com/Methacholine-chloride.html	Launched		91.0	B11	D9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0083	10.0	mM	81.0	DMSO	160.133205	9	D	pluskal_fda_drugs_5005_D9_id
916	HY-14763A	HYCPK40904	I14	HYCPK40904	91z	843.0	3.0	R27	904.0	I14	1083076-69-0	Cariprazine (hydrochloride)	RGH188 hydrochloride	463.87	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Cariprazine hydrochloride is a novel antipsychotic drug candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).	Hydrochloride	C21H33Cl3N4O	16398.0	H2O : 2.86 mg/mL (6.17 mM; ultrasonic and warming and heat to 60°C); DMSO : 6.67 mg/mL (14.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N[C@H]1CC[C@H](CCN2CCN(C3=CC=CC(Cl)=C3Cl)CC2)CC1)N(C)C.[H]Cl	https://www.medchemexpress.com/Cariprazine-hydrochloride.html	Launched		91.0	R27	D9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14763A	10.0	mM	81.0	DMSO	426.195317	9	D	pluskal_fda_drugs_5005_D9_id
1048	HY-17009	HYCPK40905	A03	HYCPK40905	91z	54.0	4.0	B6	905.0	A03	123663-49-0	Iguratimod	T614	374.37	COX	Immunology/Inflammation	Iguratimod is an antirheumatic agent, acts as an inhibitor of COX-2, with an IC50 of 20 μM (7.7 μg/mL), but shows no effect on COX-1. Iguratimod also inhibits macrophage migration inhibitory factor (MIF) with an IC50 of 6.81 μM.	Free Base	C17H14N2O6S	5422.0	DMSO : 33.33 mg/mL (89.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1C2=CC(OC3=CC=CC=C3)=C(C=C2OC=C1NC([H])=O)NS(=O)(C)=O	https://www.medchemexpress.com/iguratimod.html	Launched		91.0	B6	D9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17009	10.0	mM	81.0	DMSO	374.057257	9	D	pluskal_fda_drugs_5005_D9_id
137	HY-B0373	HYCPK40902	O07	HYCPK40902	91z	1357.0	1.0	AC13	902.0	O07	1953-02-2	Tiopronin		163.19	Others	Others	Tiopronin is a diffusible antioxidant, an antidote to heavy metal poisoning and a radioprotective agent. Tiopronin can control the rate of cystine precipitation and excretion and has the potential for cystinuria, rheumatoid arthritis and hepatic disorders[1][2].	Free Acid	C5H9NO3S	13588.0	H2O : 100 mg/mL (612.78 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (612.78 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)CNC(C(S)C)=O	https://www.medchemexpress.com/Tiopronin.html	Launched		91.0	AC13	D10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0373	10.0	mM	82.0	DMSO	163.030314	10	D	pluskal_fda_drugs_5005_D10_id
566	HY-B0260	HYCPK40903	G13	HYCPK40903	91z	602.0	2.0	M26	903.0	G13	83-43-2	Methylprednisolone	U 7532	374.47	Autophagy; Bacterial; Glucocorticoid Receptor; SARS-CoV	Anti-infection; Autophagy; Immunology/Inflammation	Methylprednisolone is a synthetic corticosteroid with anti-inflammatory and immunomodulating properties. Methylprednisolone improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels[3].	Free Base	C22H30O5	87118.0	H2O : < 0.1 mg/mL (ultrasonic) (insoluble); DMSO : 125 mg/mL (333.81 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Endocrinology; Inflammation/Immunology	O=C1C=C[C@]2(C)[C@@]3([H])[C@@H](O)C[C@]4(C)[C@@](O)(C(CO)=O)CC[C@@]4([H])[C@]3([H])C[C@H](C)C2=C1	https://www.medchemexpress.com/methylprednisolone.html	Launched		91.0	M26	D10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0260	10.0	mM	82.0	DMSO	374.209324	10	D	pluskal_fda_drugs_5005_D10_id
731	HY-17410	HYCPK40903	K22	HYCPK40903	91z	1004.0	2.0	U44	903.0	K22	133454-47-4	Iloperidone	HP 873	426.48	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Iloperidone (HP 873) is a D2/5-HT2 receptor antagonist. Iloperidone is an atypical antipsychotic for the schizophrenia symptoms[1][2].	Free Base	C24H27FN2O4	11795.0	DMSO : 50 mg/mL (117.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(C1=CC=C(OCCCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C(OC)=C1)=O	https://www.medchemexpress.com/iloperidone.html	Launched		91.0	U44	D10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17410	10.0	mM	82.0	DMSO	426.195486	10	D	pluskal_fda_drugs_5005_D10_id
778	HY-10181	HYCPK40904	O05	HYCPK40904	91z	1401.0	3.0	AD9	904.0	O05	302962-49-8	Dasatinib	BMS-354825	488.01	Apoptosis; Autophagy; Bcr-Abl; Src	Apoptosis; Autophagy; Protein Tyrosine Kinase/RTK	Dasatinib (BMS-354825) is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively. Dasatinib inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively[1]. Dasatinib also induces apoptosis and autophagy.	Free Base	C22H26ClN7O2S	97871.0	DMSO : 250 mg/mL (512.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CN=C(S1)NC2=NC(C)=NC(N3CCN(CC3)CCO)=C2)NC4=C(C=CC=C4Cl)C	https://www.medchemexpress.com/Dasatinib.html	Launched		91.0	AD9	D10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10181	10.0	mM	82.0	DMSO	487.155722	10	D	pluskal_fda_drugs_5005_D10_id
903	HY-N0239	HYCPK40904	L13	HYCPK40904	91z	1129.0	3.0	X25	904.0	L13	107668-79-1	Bulleyaconitine A		627.76	Sodium Channel	Membrane Transporter/Ion Channel	Bulleyaconitine A is an analgesic and antiinflammatory drug isolated from Aconitum plants; has several potential targets, including voltage-gated Na+ channels.	Free Base	C35H49NO9	64415.0	DMSO : 20.83 mg/mL (33.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=C(OC)C=C1)C2C3(O)C(OC)CC4(OC(C)=O)C2C(C3)C56C(C(OC)C4C6N(CC)C7)C7(COC)CCC5OC	https://www.medchemexpress.com/Bulleyaconitine-A.html	Launched		91.0	X25	D10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0239	10.0	mM	82.0	DMSO	627.340732	10	D	pluskal_fda_drugs_5005_D10_id
937	HY-B0412	HYCPK40904	B16	HYCPK40904	91z	175.0	3.0	D31	904.0	B16	50-27-1	Estriol	Oestriol	288.38	Endogenous Metabolite; Estrogen Receptor/ERR	Metabolic Enzyme/Protease; Others	"Estriol is an antagonist of the G-protein coupled estrogen receptor in estrogen receptor-negative breast cancer cells.
Target: Estrogen Receptor/ERR
A recent study shows that estrogen (estrone, estradiol, and estriol) inhibits Alzheimer's disease-associated low-order Aβ oligomer formation, and among them, estriol shows the strongest in vitro activity [1]. In mPTEN+/- mice, estriol treatments resulted in a 187.54% gain in the relative ratio of uterine wet weight to body weight; estriol also increases the ratio to 176.88% in wild-type mice [2]. Estriol treatment (20 mg/kg ip), in vivo, sensitizes Kupffer cells to LPS via mechanisms dependent on an increase in CD14 by elevated portal blood endotoxin caused by increased gut permeability in rats; while one-half of the rats given estriol intraperitoneally 24 hours before an injection of a sublethal dose of LPS (5 mg/kg) died within 24 hours [3]."	Free Base	C18H24O3	17936.0	DMSO : 250 mg/mL (866.91 mM; Need ultrasonic); H2O : 1 mg/mL (3.47 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	C[C@@]1([C@H]2O)[C@](C[C@H]2O)([H])[C@@](CCC3=C4C=CC(O)=C3)([H])[C@]4([H])CC1	https://www.medchemexpress.com/Estriol.html	Launched		91.0	D31	D10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0412	10.0	mM	82.0	DMSO	288.172545	10	D	pluskal_fda_drugs_5005_D10_id
1045	HY-18706	HYCPK40904	N22	HYCPK40904	91z	1339.0	3.0	AB43	904.0	N22	70806-55-2	trans-Tranilast	trans-MK-341; trans-SB 252218	327.33	Angiotensin Receptor	GPCR/G Protein	"trans-Tranilast (trans-MK-341) is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.
Target: Angiotensin Receptor
Tranilast has been approved in Japan and South Korea, since 1982, for the treatment of bronchial asthma, with indications for keloids and hypertrophic scar added in 1993. Tranilast is also used to treat asthma, autoimmune diseases, atopic and fibrotic pathologies, and can also inhibit angiogenesis. The antiproliferative properties of tranilast were found that tranilast elicited an inhibitory effect on fibroblast proliferation in vitro and also suppressed collagen production both in vitro and in vivo . Tranilast also reduced the release of chemical mediators from mast cells and suppressed hypersensitivity reactions. [1]
Three-week-old C57Bl/10 and mdx mice received tranilast (~300 mg/kg) in their food for 9 weeks, after which fibrosis was assessed through histological analyses, and functional properties of tibialis anterior muscles were assessed in situ and diaphragm muscle strips in vitro. Tranilast administration did not significantly alter the mass of any muscles in control or mdx mice, but it decreased fibrosis in the severely affected diaphragm muscle by 31% compared with untreated mdx mice (P< 0.05) [2]."	Free Acid	C18H17NO5	17754.0	DMSO : 100 mg/mL (305.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC(OC)=C(OC)C=C2)=O.[(E)]	https://www.medchemexpress.com/Tranilast-trans-.html	Launched		91.0	AB43	D10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18706	10.0	mM	82.0	DMSO	327.110673	10	D	pluskal_fda_drugs_5005_D10_id
1346	HY-B0288B	HYCPK40905	K21	HYCPK40905	91z	1050.0	4.0	V42	905.0	K21	71720-56-4	Fenoprofen (Calcium hydrate)	Fenoprofen calcium salt dihydrate	279.32	Apoptosis; COX	Apoptosis; Immunology/Inflammation	"Fenoprofen Calcium hydrate is a nonsteroidal, anti-inflammatory antiarthritic agent.
Target: Prostaglandin G/H synthase 1
Fenoprofen is a non-steroidal anti-inflammatory, antipyretic, analgesic agent advocated for use in rheumatoid arthritis, degenerative joint disease, ankylosing spondylitis and gout. Fenoprofen has a serum half-life of about 150 to 180 minutes and is at least 99% bound to plasma proteins. It is extensively metabolised after oral administration, the main metabolites being fenoprofen glucuronide and 4-hydroxy-fenoprofen glucuronide [1]. Fenoprofen calcium is revealed for relief of mild to moderate pain in adults and for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.  In patients with osteoarthritis, the anti-inflammatory and analgesic effects of fenoprofen calcium have been demonstrated by decrease in tenderness as a response to pressure and reduction in night pain, stiffness, swelling, and overall disease activity. These effects have also been demonstrated by attenuation of pain with motion and at rest and increased range of motion in involved joints [2]."	Calcium	C15H15Ca0.5O4	15978.0	H2O : 1 mg/mL (3.58 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (358.01 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(C([O-])=O)C1=CC(OC2=CC=CC=C2)=CC=C1.O.[0.5Ca2+]	https://www.medchemexpress.com/Fenoprofen-Calcium-hydrate.html	Launched		91.0	V42	D10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0288B	10.0	mM	82.0	DMSO	242.094294	10	D	pluskal_fda_drugs_5005_D10_id
453	HY-128922	HYCPK40903	J05	HYCPK40903	91z	874.0	2.0	S10	903.0	J05	14899-36-6	Dexamethasone palmitate	DXP	630.87	Others	Others	"Dexamethasone palmitate (DXP) is a prodrug of <a href=""/Rapamycin.html"" class=""link-product"" target=""_blank"">Dexamethasone</a> (HY-14648). Dexamethasone palmitate can be used for the research of inflammation[1][2]."	Free Base	C38H59FO6	99026.0	DMSO : 50 mg/mL (79.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]12[C@](C[C@@H](C)[C@]2(O)C(COC(CCCCCCCCCCCCCCC)=O)=O)([H])[C@@]3([H])[C@@](F)([C@@]4(C(CC3)=CC(C=C4)=O)C)[C@@H](O)C1	https://www.medchemexpress.com/dexamethasone-palmitate.html	Launched		91.0	S10	D11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-128922	10.0	mM	83.0	DMSO	630.429568	11	D	pluskal_fda_drugs_5005_D11_id
468	HY-14806A	HYCPK40903	I06	HYCPK40903	91z	780.0	2.0	Q12	903.0	I06	906093-29-6	Teneligliptin (hydrobromide)	MP-513 (hydrobromide)	628.86	Dipeptidyl Peptidase	Metabolic Enzyme/Protease	Teneligliptin (MP-513) hydrobromide is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM.	Hydrobromide	C22H30N6OS.5/2HBr	11367.0	H2O : ≥ 200 mg/mL (318.04 mM); DMSO : ≥ 100 mg/mL (159.02 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(N1CSCC1)[C@H]2NC[C@@H](N3CCN(C4=CC(C)=NN4C5=CC=CC=C5)CC3)C2.[2.5 HBr]	https://www.medchemexpress.com/Teneligliptin-hydrobromide.html	Launched		91.0	Q12	D11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14806A	10.0	mM	83.0	DMSO	426.220181	11	D	pluskal_fda_drugs_5005_D11_id
557	HY-N0337	HYCPK40903	N12	HYCPK40903	91z	1272.0	2.0	AA24	903.0	N12	97-53-0	Eugenol		164.20	Apoptosis; Bacterial; Ferroptosis; Parasite; Reactive Oxygen Species	Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Eugenol is an essential oil found in cloves with antibacterial, anthelmintic and antioxidant activity. Eugenol is shown to inhibit lipid peroxidation.	Free Base	C10H12O2	26497.0	DMSO : ≥ 100 mg/mL (609.01 mM)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Cancer	OC1=CC=C(CC=C)C=C1OC	https://www.medchemexpress.com/Eugenol.html	Launched		91.0	AA24	D11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0337	10.0	mM	83.0	DMSO	164.08373	11	D	pluskal_fda_drugs_5005_D11_id
588	HY-16305	HYCPK40905	E22	HYCPK40905	91z	476.0	4.0	J44	905.0	E22	176161-24-3	Maribavir	1263W94; BW1263W94; GW257406X	376.24	CMV	Anti-infection	Maribavir is a potent inhibitor of histone phosphorylation catalyzed by wild-type pUL97 in vitro, with an IC50 of 3 nM. Maribavir has potent antiviral activity against HCMV and Epstein-Barr virus (EBV).	Free Base	C15H19Cl2N3O4	17044.0	DMSO : 200 mg/mL (531.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	ClC1=C(Cl)C=C2C(N=C(NC(C)C)N2[C@@H]3[C@@H](O)[C@@H](O)[C@H](CO)O3)=C1	https://www.medchemexpress.com/Maribavir.html	Launched		91.0	J44	D11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16305	10.0	mM	83.0	DMSO	375.075261	11	D	pluskal_fda_drugs_5005_D11_id
978	HY-109108	HYCPK40904	K18	HYCPK40904	91z	1043.0	3.0	V35	904.0	K18	1809336-39-7	Valemetostat	DS-3201	488.02	Histone Methyltransferase	Epigenetics	Valemetostat (DS-3201) is a first-in-class EZH1/2 dual inhibitor, used in the research of relapsed/refractory peripheral T-cell lymphoma[1].	Free Base	C26H34ClN3O4	212593.0	DMSO : 70 mg/mL (143.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC1=C(O[C@@](C)([C@]2([H])CC[C@@H](N(C)C)CC2)O3)C3=C(Cl)C=C1C(NCC(C4=O)=C(C=C(C)N4)C)=O	https://www.medchemexpress.com/Valemetostat.html	Launched		91.0	V35	D11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109108	10.0	mM	83.0	DMSO	487.223784	11	D	pluskal_fda_drugs_5005_D11_id
985	HY-B0195	HYCPK40904	B19	HYCPK40904	91z	181.0	3.0	D37	904.0	B19	53902-12-8	Tranilast	MK-341; SB 252218	327.33	Angiotensin Receptor; Prostaglandin Receptor	GPCR/G Protein	Tranilast (MK-341) acts as an anti-atopic agent. Tranilast suppresses production of prostaglandin D2 (PGD2, IC50= 0.1 mM). Tranilast sodium exhibits anti-inflammatory and immunomodulatory effects[1]. Tranilast sodium antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells[2].	Free Acid	C18H17NO5	15697.0	DMSO : 50 mg/mL (152.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC=C(OC)C(OC)=C2)=O	https://www.medchemexpress.com/Tranilast.html	Launched		91.0	D37	D11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0195	10.0	mM	83.0	DMSO	327.110673	11	D	pluskal_fda_drugs_5005_D11_id
1047	HY-B0653A	HYCPK40904	P22	HYCPK40904	91z	1531.0	3.0	AF43	904.0	P22	27262-48-2	Levobupivacaine (hydrochloride)	(S)-(-)-Bupivacaine monohydrochloride	324.89	Ferroptosis; Sodium Channel	Apoptosis; Membrane Transporter/Ion Channel	Levobupivacaine hydrochloride ((S)-(-)-Bupivacaine monohydrochloride) is a long-acting amide local anaesthetic. Levobupivacaine hydrochloride exerts anaesthetic and analgesic effects through reversible blockade of neuronal sodium channel. Levobupivacaine hydrochloride can inhibit impulse transmission and conduction in cardiovascular and other tissues, possessing certain cardiac and CNS toxicity. Levobupivacaine hydrochloride is metabolized by hepatic cytochrome P450 (CYP450) enzymes in vivo. Levobupivacaine hydrochloride can also induce ferroptosis by miR-489-3p/SLC7A11 signaling in gastric cancer[1][2][3].	Hydrochloride	C18H29ClN2O	16423.0	H2O : ≥ 50 mg/mL (153.90 mM); DMSO : 100 mg/mL (307.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C([C@H]1N(CCCC)CCCC1)NC2=C(C)C=CC=C2C.[H]Cl	https://www.medchemexpress.com/Levobupivacaine-hydrochloride.html	Launched		91.0	AF43	D11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0653A	10.0	mM	83.0	DMSO	288.220164	11	D	pluskal_fda_drugs_5005_D11_id
1198	HY-17387	HYCPK40905	G12	HYCPK40905	91z	648.0	4.0	N24	905.0	G12	102518-79-6	(-)-Huperzine A	Huperzine A	242.32	Apoptosis; Cholinesterase (ChE); iGluR	Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling	(-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity. (-)-Huperzine A is a potent, highly specific, reversible and blood-brain barrier penetrant inhibitor of acetylcholinesterase (AChE), with an IC50 of 82 nM. (-)-Huperzine A also is non-competitive antagonist of N-methyl-D-aspartate glutamate (NMDA) receptor. (-)-Huperzine A is developed for the research of neurodegenerative diseases, including Alzheimer’s disease[1][2][3][4][5].	Free Base	C15H18N2O	19940.0	DMSO : ≥ 100 mg/mL (412.68 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1NC2=C([C@@](/C3=C\C)(N)CC(C)=C[C@@]3([H])C2)C=C1	https://www.medchemexpress.com/_-_-Huperzine-A.html	Launched		91.0	N24	D11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17387	10.0	mM	83.0	DMSO	242.141913	11	D	pluskal_fda_drugs_5005_D11_id
312	HY-17390	HYCPK40902	P19	HYCPK40902	91z	1477.0	1.0	AE37	902.0	P19	1977-10-2	Loxapine		327.81	5-HT Receptor; Bacterial; Dopamine Receptor	Anti-infection; GPCR/G Protein; Neuronal Signaling	Loxapine is an orally active dopamine inhibitor, 5-HT receptor antagonist and also a dibenzoxazepine anti-psychotic agent[1][4].	Free Base	C18H18ClN3O	7892.0	DMSO : ≥ 33.33 mg/mL (101.67 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1CCN(C2=NC3=CC=CC=C3OC4=CC=C(Cl)C=C24)CC1	https://www.medchemexpress.com/Loxapine.html	Launched		91.0	AE37	D12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17390	10.0	mM	84.0	DMSO	327.11384	12	D	pluskal_fda_drugs_5005_D12_id
542	HY-17038B	HYCPK40903	O11	HYCPK40903	91z	1366.0	2.0	AC22	903.0	O11	824393-18-2	Agomelatine (L(+)-Tartaric acid)	S-20098 L(+)-Tartaric acid	393.39	5-HT Receptor; Endogenous Metabolite; Melatonin Receptor	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].	Tartrate	C19H23NO8	42447.0	DMSO : 100 mg/mL (254.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(NCCC1=C2C=C(OC)C=CC2=CC=C1)=O.O=C(O)[C@H](O)[C@@H](O)C(O)=O	https://www.medchemexpress.com/agomelatine-l__addition__-tartaric-acid.html	Launched		91.0	AC22	D12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17038B	10.0	mM	84.0	DMSO	243.125929	12	D	pluskal_fda_drugs_5005_D12_id
644	HY-10581A	HYCPK40903	J16	HYCPK40903	91z	896.0	2.0	S32	903.0	J16	121577-32-0	Gatifloxacin (hydrochloride)	AM-1155 (hydrochloride); BMS-206584 (hydrochloride); PD135432 (hydrochloride)	411.86	Antibiotic; Bacterial; Topoisomerase	Anti-infection; Cell Cycle/DNA Damage	Gatifloxacin hydrochloride (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin hydrochloride inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml)[1]. Gatifloxacin hydrochloride can be used to treat bacterial conjunctivitis?in vivo.	Hydrochloride	C19H23ClFN3O4	58765.0	DMSO : 4 mg/mL (9.71 mM; ultrasonic and warming and heat to 60°C); H2O : 10 mg/mL (24.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC1NCCN(C2=C(F)C=C3C(N(C4CC4)C=C(C(O)=O)C3=O)=C2OC)C1.Cl	https://www.medchemexpress.com/gatifloxacin-hydrochloride.html	Launched		91.0	S32	D12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10581A	10.0	mM	84.0	DMSO	375.159434	12	D	pluskal_fda_drugs_5005_D12_id
740	HY-106673	HYCPK40904	D03	HYCPK40904	91z	341.0	3.0	H5	904.0	D03	72590-77-3	Hydrocortisone buteprate	Hydrocortisone probutate; HBP	488.61	Others	Others	Hydrocortisone buteprate (Hydrocortisone probutate) is a medium potent, non-halogenated double-ester of hydrocortisone with a favorable benefit/risk ratio for the treatment of inflammatory skin disorders. Hydrocortisone buteprate (Hydrocortisone probutate) is available as a 0.1% cream or ointment formulation[1].	Free Base	C28H40O7	44866.0	DMSO : 250 mg/mL (511.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CCC(OCC([C@@]1([C@@]2([C@@]([C@@]3([H])[C@]([C@@]4(C(CC3)=CC(CC4)=O)C)([H])[C@@H](O)C2)([H])CC1)C)OC(CCC)=O)=O)=O	https://www.medchemexpress.com/hydrocortisone-buteprate.html	Launched		91.0	H5	D12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-106673	10.0	mM	84.0	DMSO	488.277404	12	D	pluskal_fda_drugs_5005_D12_id
750	HY-Y0258	HYCPK40904	N03	HYCPK40904	91z	1301.0	3.0	AB5	904.0	N03	94-09-7	Benzocaine		165.19	Bacterial; Sodium Channel	Anti-infection; Membrane Transporter/Ion Channel	Benzocaine shares a common receptor with all othe rLAs in the voltage-gated Na+ channel, with an IC50 of 0.8 mM tested with a potential of +30 mV.	Free Base	C9H11NO2	17269.0	DMSO : ≥ 100 mg/mL (605.36 mM); H2O : 2 mg/mL (12.11 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCC)C1=CC=C(N)C=C1	https://www.medchemexpress.com/Benzocaine.html	Launched		91.0	AB5	D12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0258	10.0	mM	84.0	DMSO	165.078979	12	D	pluskal_fda_drugs_5005_D12_id
908	HY-B0405A	HYCPK40904	A14	HYCPK40904	91z	75.0	3.0	B27	904.0	A14	18010-40-7	Bupivacaine (hydrochloride)		324.89	Calcium Channel; iGluR; Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Bupivacaine hydrochloride is a NMDA receptor inhibitor.Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine hydrochloride can be used for the research of chronic pain[1][2][3].	Hydrochloride	C18H29ClN2O	16108.0	H2O : 12.5 mg/mL (38.47 mM; Need ultrasonic); DMSO : 25 mg/mL (76.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C(C1N(CCCC)CCCC1)NC2=C(C)C=CC=C2C.Cl	https://www.medchemexpress.com/Bupivacaine-hydrochloride.html	Launched		91.0	B27	D12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0405A	10.0	mM	84.0	DMSO	288.220164	12	D	pluskal_fda_drugs_5005_D12_id
1267	HY-14806	HYCPK40905	L16	HYCPK40905	91z	1136.0	4.0	X32	905.0	L16	760937-92-6	Teneligliptin	MP-513	426.58	Dipeptidyl Peptidase	Metabolic Enzyme/Protease	Teneligliptin (MP-513) is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor. Teneligliptin competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM[1].	Free Base	C22H30N6OS	227861.0	DMSO : 33.33 mg/mL (78.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C([C@H]1NC[C@@H](N2CCN(C3=CC(C)=NN3C4=CC=CC=C4)CC2)C1)N5CSCC5	https://www.medchemexpress.com/teneligliptin.html	Launched		91.0	X32	D12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14806	10.0	mM	84.0	DMSO	426.220181	12	D	pluskal_fda_drugs_5005_D12_id
1319	HY-14789	HYCPK40905	P19	HYCPK40905	91z	1526.0	4.0	AF38	905.0	P19	834153-87-6	(R)-Elagolix	NBI-56418	631.59	GnRH Receptor	GPCR/G Protein	"Elagolix is a highly potent, selective, orally-active, short-duration, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR) (KD = 54 pM).
Target: GnRH
in vitro: Elagolix is a short-acting, nonpeptide, GnRH antagonist, administered orally, that unlike injectable depot GnRH agonists and antagonists, produces a dose-dependent suppression of ovarian estrogen production, that is, from partial suppression at lower doses to full suppression at higher doses. Elagolix is regarded as the frontrunner of a new class of GnRH inhibitors that have been denoted as second-generation, due to their non-peptide nature and oral bioavailability."	Free Acid	C32H30F5N3O5	19377.0	DMSO : ≥ 100 mg/mL (158.33 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	FC1=C(C2=C(C)N(CC3=C(C(F)(F)F)C=CC=C3F)C(N(C[C@](C4=CC=CC=C4)([H])NCCCC(O)=O)C2=O)=O)C=CC=C1OC	https://www.medchemexpress.com/Elagolix.html	Launched		91.0	AF38	D12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14789	10.0	mM	84.0	DMSO	631.210562	12	D	pluskal_fda_drugs_5005_D12_id
391	HY-A0012	HYCPK40902	L09	HYCPK40902	91z	1073.0	1.0	W17	902.0	L09	133099-07-7	Darifenacin (hydrobromide)	UK-88525 (hydrobromide)	507.46	mAChR	GPCR/G Protein; Neuronal Signaling	"Darifenacin hydrobromide (UK-88525 hydrobromide) is a selective M3 muscarinic receptor antagonist with pKi of 8.9.
IC50 value: 8.9 (pKi) [1]
Target: M3 receptor
in vitro: Darifenacin exerts non-parallel rightward displacement of the agonist curve and also significant depression of the maximum response (+)-cis-Dioxolane produced concentration-dependent contraction of the isolated bladder of rat [1]. Darifenacin produces a concentration dependent increase in R123 (P-gp probe) accumulation in MDCK cells. Darifenacin stimulates ATPase activity in P-gp membrane in a clear concentration dependent response manner with an estimated ED50 value of 1.6 μM. Darifenacin (100 nM) shows a significantly greater permeability for darifenacin in the basolateral to apical direction resulting in an efflux ratio in BBMEC monolayers of approximately 2.6 [2].
in vivo: Darifenacin produces dose-dependent inhibition of amplitude of volume-induced bladder contractions(VIBCAMP), producing 35% inhibition at dose of 283.3 nmol/kg and maximal inhibition of approximately 50–55% [1]. Darifenacin (0.1 mg/kg i.v.) reduces bladder afferent activity in both Aδ and C fibers in female Sprague-Dawley rats, the decrease in afferent spikes in C fibers may be more pronounced than that in Aδ fibers [3]."	Hydrobromide	C28H31BrN2O2	10.0	DMSO : 33.33 mg/mL (65.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C(C1=CC=CC=C1)([C@@H]2CCN(CCC3=CC4=C(OCC4)C=C3)C2)C5=CC=CC=C5)N.Br	https://www.medchemexpress.com/Darifenacin-hydrobromide.html	Launched		91.0	W17	D13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0012	10.0	mM	85.0	DMSO	426.230728	13	D	pluskal_fda_drugs_5005_D13_id
552	HY-B1470	HYCPK40903	I12	HYCPK40903	91z	792.0	2.0	Q24	903.0	I12	1649-18-9	Azaperone	R-1929	327.40	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Azaperone (R-1929) acts as a dopamine antagonist but also has some antihistaminic and anticholinergic properties. Azaperone is a pyridinylpiperazine and butyrophenone neuroleptic drug with antiemetic effects, which is used mainly as a tranquilizer in veterinary medicine.	Free Base	C19H22FN3O	18582.0	H2O : 0.67 mg/mL (2.05 mM; Need ultrasonic); DMSO : 50 mg/mL (152.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=C(F)C=C1)CCCN2CCN(C3=NC=CC=C3)CC2	https://www.medchemexpress.com/Azaperone.html	Launched		91.0	Q24	D13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1470	10.0	mM	85.0	DMSO	327.174691	13	D	pluskal_fda_drugs_5005_D13_id
605	HY-B1039	HYCPK40903	C14	HYCPK40903	91z	220.0	2.0	E28	903.0	C14	18683-91-5	Ambroxol	NA-872	378.10	Autophagy; Glucosidase	Autophagy; Metabolic Enzyme/Protease	Ambroxol (NA-872), an active metabolite of the prodrug Bromhexine, has potent expectorant effects. Ambroxol is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research[1][2].	Free Base	C13H18Br2N2O	17159.0	DMSO : ≥ 200 mg/mL (528.96 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	O[C@H]1CC[C@H](NCC2=CC(Br)=CC(Br)=C2N)CC1	https://www.medchemexpress.com/Ambroxol.html	Launched		91.0	E28	D13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1039	10.0	mM	85.0	DMSO	375.978587	13	D	pluskal_fda_drugs_5005_D13_id
1123	HY-B1445	HYCPK40905	L07	HYCPK40905	91z	1118.0	4.0	X14	905.0	L07	83701-22-8	Minoxidil sulfate		289.31	Potassium Channel	Membrane Transporter/Ion Channel	Minoxidil sulfate, a potent and ATP-sensitive K+ channel opener, is the sulfated metabolite of minoxidil. Minoxidil sulfate is considered as a vasodilator to promote hair growth in vivo[1][3].		C9H15N5O4S	79604.0	DMSO : 250 mg/mL (864.12 mM; Need ultrasonic); H2O : 50 mg/mL (172.82 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	NC1=NC(N2CCCCC2)=CC(N1OS(=O)(O)=O)=N	https://www.medchemexpress.com/minoxidil-sulfate.html	Launched		91.0	X14	D13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1445	10.0	mM	85.0	DMSO	289.084475	13	D	pluskal_fda_drugs_5005_D13_id
1178	HY-B1428	HYCPK40905	C11	HYCPK40905	91z	262.0	4.0	F22	905.0	C11	938-73-8	2-Ethoxybenzamide	Ethenzamide	165.19	Others	Others	2-Ethoxybenzamide is widely used as an antipyretic anodyne.	Free Base	C9H11NO2	17717.0	DMSO : ≥ 47 mg/mL (284.52 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(N)C1=CC=CC=C1OCC	https://www.medchemexpress.com/2-Ethoxybenzamide.html	Launched		91.0	F22	D13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1428	10.0	mM	85.0	DMSO	165.078979	13	D	pluskal_fda_drugs_5005_D13_id
1257	HY-10119A	HYCPK40905	B16	HYCPK40905	91z	176.0	4.0	D32	905.0	B16	705260-08-8	Vorapaxar (sulfate)	SCH 530348 (sulfate)	590.66	Protease Activated Receptor (PAR)	GPCR/G Protein	Vorapaxar sulfate (SCH 530348 sulfate), an antiplatelet agent, is a selective, orally active, and competitive thrombin receptor protease-activated receptor (PAR-1) antagonist (Ki=8.1 nM). Vorapaxar sulfate inhibits thrombin receptor-activating peptide (TRAP)-induced platelet aggregation in a dose-dependent manner[1].	Sulfate	C29H35FN2O8S	137396.0	DMSO : 125 mg/mL (211.63 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O[C@@H]1C)[C@@]2([H])[C@]1([H])[C@@H](/C=C/C3=NC=C(C=C3)C4=CC=CC(F)=C4)[C@]([C@](C5)([H])C2)([H])CC[C@H]5NC(OCC)=O.O=S(O)(O)=O	https://www.medchemexpress.com/vorapaxar-sulfate.html	Launched		91.0	D32	D13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10119A	10.0	mM	85.0	DMSO	492.242436	13	D	pluskal_fda_drugs_5005_D13_id
1275	HY-17038A	HYCPK40905	D17	HYCPK40905	91z	370.0	4.0	H34	905.0	D17	1176316-99-6	Agomelatine (hydrochloride)	S-20098 hydrochloride	279.76	5-HT Receptor; Endogenous Metabolite; Melatonin Receptor	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Agomelatine hydrochloride (S-20098 hydrochloride) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine hydrochloride is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].	Hydrochloride	C15H18ClNO2	32072.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (357.45 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(NCCC1=C2C=C(OC)C=CC2=CC=C1)=O.Cl	https://www.medchemexpress.com/agomelatine-hydrochloride.html	Launched		91.0	H34	D13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17038A	10.0	mM	85.0	DMSO	243.125929	13	D	pluskal_fda_drugs_5005_D13_id
1326	HY-14369	HYCPK40905	G20	HYCPK40905	91z	664.0	4.0	N40	905.0	G20	832720-36-2	Elagolix sodium	NBI-56418 sodium	653.57	GnRH Receptor	GPCR/G Protein	Elagolix sodium is a human GnRH receptor (GnRHR) antagonist with an IC50 and Ki of 0.25 and 3.7 nM, respectively.	Sodium	C32H29F5N3NaO5	28896.0	DMSO : 50 mg/mL (76.50 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (76.50 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C(CCCN[C@@H](CN(C1=O)C(N(C(C)=C1C2=CC=CC(OC)=C2F)CC3=C(C=CC=C3F)C(F)(F)F)=O)C4=CC=CC=C4)O[Na]	https://www.medchemexpress.com/Elagolix_sodium.html	Launched		91.0	N40	D13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14369	10.0	mM	85.0	DMSO	631.210562	13	D	pluskal_fda_drugs_5005_D13_id
401	HY-17038	HYCPK40902	J18	HYCPK40902	91z	899.0	1.0	S35	902.0	J18	138112-76-2	Agomelatine	S-20098	243.30	5-HT Receptor; Endogenous Metabolite; Melatonin Receptor	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively[1]. Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively[2].	Free Base	C15H17NO2	15325.0	DMSO : ≥ 100 mg/mL (411.02 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(NCCC1=C2C=C(OC)C=CC2=CC=C1)=O	https://www.medchemexpress.com/Agomelatine.html	Launched		91.0	S35	D14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17038	10.0	mM	86.0	DMSO	243.125929	14	D	pluskal_fda_drugs_5005_D14_id
454	HY-10119	HYCPK40903	K05	HYCPK40903	91z	970.0	2.0	U10	903.0	K05	618385-01-6	Vorapaxar	SCH 530348	492.58	Protease Activated Receptor (PAR)	GPCR/G Protein	Vorapaxar (SCH 530348), an antiplatelet agent, is a selective, orally active, and competitive thrombin receptor protease-activated receptor (PAR-1) antagonist (Ki=8.1 nM). Vorapaxar (SCH 530348) inhibits thrombin receptor-activating peptide (TRAP)-induced platelet aggregation in a dose-dependent manner[1].	Free Base	C29H33FN2O4	32674.0	DMSO : 25 mg/mL (50.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O[C@@H]1C)[C@@]2([H])[C@]1([H])[C@@H](/C=C/C3=NC=C(C=C3)C4=CC=CC(F)=C4)[C@]([C@](C5)([H])C2)([H])CC[C@H]5NC(OCC)=O	https://www.medchemexpress.com/Vorapaxar.html	Launched		91.0	U10	D14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10119	10.0	mM	86.0	DMSO	492.242436	14	D	pluskal_fda_drugs_5005_D14_id
569	HY-B1192	HYCPK40903	A19	HYCPK40903	91z	38.0	2.0	A38	903.0	A19	50-50-0	Estradiol benzoate	β-Estradiol 3-benzoate; 17β-Estradiol 3-benzoate	376.49	Estrogen Receptor/ERR	Others	Estradiol Benzoate (β-Estradiol 3-benzoate), a prodrug of estradiol, acts as a steroid sex hormone. It exhibits mild anabolic and metabolic properties, and increases blood coagulability[1][2][3].	Free Base	C25H28O3	17482.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 100 mg/mL (265.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@@]12[C@@H](O)CC[C@@]1([H])[C@]3([H])CCC4=C(C=CC(OC(C5=CC=CC=C5)=O)=C4)[C@@]3([H])CC2	https://www.medchemexpress.com/Estradiol-benzoate.html	Launched		91.0	A38	D14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1192	10.0	mM	86.0	DMSO	376.203845	14	D	pluskal_fda_drugs_5005_D14_id
758	HY-15136	HYCPK40904	F04	HYCPK40904	91z	535.0	3.0	L7	904.0	F04	193275-84-2	Lonafarnib	Sch66336	638.82	Autophagy; Farnesyl Transferase; Ras	Autophagy; GPCR/G Protein; Metabolic Enzyme/Protease	Lonafarnib (Sch66336) is a potent and orally active farnesyl transferase (FTase) inhibitor. Lonafarnib inhibits the activities of H-ras, K-ras and N-ras with IC50 values of 1.9 nM, 5.2 nM and 2.8 nM, respectively. Lonafarnib also has anti-hepatitis delta virus (HDV) activities.	Free Base	C27H31Br2ClN4O2	58210.0	DMSO : 50 mg/mL (78.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(N1CCC(CC(N2CCC([C@@H]3C4=C(Br)C=C(Cl)C=C4CCC5=CC(Br)=CN=C53)CC2)=O)CC1)N	https://www.medchemexpress.com/Lonafarnib.html	Launched		91.0	L7	D14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15136	10.0	mM	86.0	DMSO	636.050228	14	D	pluskal_fda_drugs_5005_D14_id
871	HY-B1542A	HYCPK40904	L11	HYCPK40904	91z	1125.0	3.0	X21	904.0	L11	57-37-4	Benactyzine hydrochloride		363.88	Cholinesterase (ChE)	Neuronal Signaling	Benactyzine hydrochloride is a butyrylcholinesterase (BChE) inhibitor with a Ki of 0.010 mM.	Hydrochloride	C20H26ClNO3	27242.0	DMSO : 150 mg/mL (412.22 mM; Need ultrasonic and warming); H2O : 50 mg/mL (137.41 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCN(CC)CC)C(C1=CC=CC=C1)(O)C2=CC=CC=C2.[H]Cl	https://www.medchemexpress.com/Benactyzine_hydrochloride.html	Launched		91.0	X21	D14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1542A	10.0	mM	86.0	DMSO	327.183444	14	D	pluskal_fda_drugs_5005_D14_id
1160	HY-B1324	HYCPK40905	A10	HYCPK40905	91z	68.0	4.0	B20	905.0	A10	64211-46-7	Oxiconazole nitrate	Ro 13-8996	492.14	Antibiotic; Cytochrome P450; Fungal	Anti-infection; Metabolic Enzyme/Protease	"Oxiconazole (Ro 13-8996) nitrate is a broad spectrum anti-fungal agent which can inhibit the growth of Candida, Aspergillus and Trichophyton. Oxiconazole nitrate is also a highly efficacious activator of CYP3A4 transactivation, which could be antagonized by <a href=""/Rifampicin.html"" class=""link-product"" target=""_blank"">Rifampicin</a> (HY-B0272) in a competitive manner. Oxiconazole nitrate exhibits inhibitory effect against colorectal cancer (CRC) via peroxiredoxin-2 (PRDX2)-mediated autophagy arrest[1][2][3]."	Nitrate	C18H14Cl4N4O4	26712.0	DMSO : ≥ 100 mg/mL (203.19 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	[O-][N+](O)=O.ClC1=CC=C(/C(CN2C=CN=C2)=N/OCC3=CC=C(Cl)C=C3Cl)C(Cl)=C1	https://www.medchemexpress.com/Oxiconazole_nitrate.html	Launched		91.0	B20	D14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1324	10.0	mM	86.0	DMSO	426.981273	14	D	pluskal_fda_drugs_5005_D14_id
1186	HY-108316	HYCPK40905	K11	HYCPK40905	91z	1030.0	4.0	V22	905.0	K11	61-56-3	Sultiame		290.36	Carbonic Anhydrase	Metabolic Enzyme/Protease	Sultiame is a carbonic anhydrase inhibitor, widely used as an antiepileptic drug.	Free Base	C10H14N2O4S2	125285.0	DMSO : 50 mg/mL (172.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=S(C1=CC=C(N(CCCC2)S2(=O)=O)C=C1)(N)=O	https://www.medchemexpress.com/Sultiame.html	Launched		91.0	V22	D14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108316	10.0	mM	86.0	DMSO	290.039499	14	D	pluskal_fda_drugs_5005_D14_id
1233	HY-B0934	HYCPK40905	J14	HYCPK40905	91z	940.0	4.0	T28	905.0	J14	120-47-8	Ethylparaben	Ethyl parahydroxybenzoate; Ethyl 4-hydroxybenzoate	166.17	Bacterial	Anti-infection	Ethylparaben  is the ethyl ester of p-hydroxybenzoic acid, used as an antifungal preservative. and food additive	Free Base	C9H10O3	17334.0	DMSO : 100 mg/mL (601.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(OCC)C1=CC=C(O)C=C1	https://www.medchemexpress.com/Ethylparaben.html	Launched		91.0	T28	D14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0934	10.0	mM	86.0	DMSO	166.062994	14	D	pluskal_fda_drugs_5005_D14_id
189	HY-N0017	HYCPK40902	K11	HYCPK40902	91z	981.0	1.0	U21	902.0	K11	477-90-7	Bergenin	Cuscutin	328.27	Apoptosis; Autophagy; Bacterial; Fungal; Virus Protease	Anti-infection; Apoptosis; Autophagy	Bergenin is a cytoprotective and antioxidative polyphenol found in many medicinal plants. Bergenin has a wide spectrum activities such as hepatoprotective, antiinflammatory, immunomodulatory, antitumor, antiviral, and antifungal properties[1][2].	Free Base	C14H16O9	26507.0	DMSO : ≥ 100 mg/mL (304.63 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	OC1=C(OC)C(O)=C([C@@]2([H])[C@@](OC3=O)([H])[C@@H](O)[C@H](O)[C@@H](CO)O2)C3=C1	https://www.medchemexpress.com/Bergenin.html	Launched		91.0	U21	D15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0017	10.0	mM	87.0	DMSO	328.079432	15	D	pluskal_fda_drugs_5005_D15_id
413	HY-B1825	HYCPK40902	E22	HYCPK40902	91z	427.0	1.0	I43	902.0	E22	35607-66-0	Cefoxitin		427.45	Antibiotic; Bacterial	Anti-infection	Cefoxitin, a β-lactam antibiotic, is a broad-spectrum, second-generation cephalosporin. Cefoxitin has a broad spectrum antibacterial activity which includes anaerobic as well as Gram-positive and Gram-negative aerobic bacteria[1][2].		C16H17N3O7S2	68239.0	DMSO : 100 mg/mL (233.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@@](NC(CC3=CC=CS3)=O)(OC)C1=O)O	https://www.medchemexpress.com/cefoxitin.html	Launched		91.0	I43	D15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1825	10.0	mM	87.0	DMSO	427.050792	15	D	pluskal_fda_drugs_5005_D15_id
492	HY-17437A	HYCPK40903	A08	HYCPK40903	91z	16.0	2.0	A16	903.0	A08	51773-92-3	Mefloquine (hydrochloride)	Mefloquin hydrochloride	414.77	Autophagy; Parasite; Potassium Channel; ROS Kinase; SARS-CoV	Anti-infection; Autophagy; Membrane Transporter/Ion Channel; Protein Tyrosine Kinase/RTK	Mefloquine hydrochloride (Mefloquin hydrochloride), a quinoline antimalarial agent, is an anti-SARS-CoV-2 entry inhibitor. Mefloquine hydrochloride is also a K+ channel (KvQT1/minK) antagonist with an IC50 of ~1 μM. Mefloquine hydrochloride can be used for malaria, systemic lupus erythematosus and cancer research[1][2][3].	Hydrochloride	C17H17ClF6N2O	8961.0	H2O : 2.86 mg/mL (6.90 mM; ultrasonic and warming and heat to 60°C); DMSO : ≥ 100 mg/mL (241.10 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease; Inflammation/Immunology	O[C@H]([C@]1([H])NCCCC1)C2=CC(C(F)(F)F)=NC3=C(C(F)(F)F)C=CC=C32.[H]Cl	https://www.medchemexpress.com/mefloquine-hydrochloride.html	Launched		91.0	A16	D15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17437A	10.0	mM	87.0	DMSO	378.116682	15	D	pluskal_fda_drugs_5005_D15_id
532	HY-13765	HYCPK40903	E11	HYCPK40903	91z	406.0	2.0	I22	903.0	E11	154-42-7	6-Thioguanine	Thioguanine; 2-Amino-6-purinethiol	167.19	Apoptosis; Autophagy; Deubiquitinase; DNA Methyltransferase; Endogenous Metabolite; SARS-CoV	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease	6-Thioguanine (Thioguanine; 2-Amino-6-purinethiol) is an anti-leukemia and immunosuppressant agent, acts as an inhibitor of SARS and MERS coronavirus papain-like proteases (PLpros) and also potently inhibits USP2 activity, with IC50s of 25 μM and 40 μM for Plpros and recombinant human USP2, respectively.	Free Base	C5H5N5S	16655.0	DMSO : 10 mg/mL (59.81 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	SC1=NC(N)=NC2=C1N=CN2	https://www.medchemexpress.com/6-Thioguanine.html	Launched		91.0	I22	D15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13765	10.0	mM	87.0	DMSO	167.026566	15	D	pluskal_fda_drugs_5005_D15_id
572	HY-B0210	HYCPK40903	D19	HYCPK40903	91z	326.0	2.0	G38	903.0	D19	62893-19-0	Cefoperazone		645.67	Antibiotic; Bacterial	Anti-infection	Cefoperazone, a semisynthetic cephalosporin, has a broad spectrum of antibacterial activity[1].	Free Acid	C25H27N9O8S2	16551.0	H2O : 0.1 mg/mL (0.15 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (154.88 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@H](NC([C@H](NC(N4C(C(N(CC)CC4)=O)=O)=O)C5=CC=C(O)C=C5)=O)C1=O)O	https://www.medchemexpress.com/cefoperazone.html	Launched		91.0	G38	D15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0210	10.0	mM	87.0	DMSO	645.142401	15	D	pluskal_fda_drugs_5005_D15_id
756	HY-B0510C	HYCPK40904	D04	HYCPK40904	91z	343.0	3.0	H7	904.0	D04	23256-42-0	Trimethoprim (lactate)		380.40	Antibiotic; Antifolate; Bacterial	Anti-infection; Cell Cycle/DNA Damage	Trimethoprim lactate is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim lactate is active against a wide range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim lactate has the potential for the research of urinary tract infections, Shigellosis and Pneumocystis pneumonia. Trimethoprim lactate can inhibit infection of Influenza A virus in chick embryo when combinated with zinc[1][2][3][4].	Lactic acid	C17H24N4O6	105963.0	H2O : 16.67 mg/mL (43.82 mM; Need ultrasonic); DMSO : 250 mg/mL (657.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC(O)C(O)=O.NC1=NC=C(CC2=CC(OC)=C(OC)C(OC)=C2)C(N)=N1	https://www.medchemexpress.com/trimethoprim-lactate.html	Launched		91.0	H7	D15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0510C	10.0	mM	87.0	DMSO	290.13789	15	D	pluskal_fda_drugs_5005_D15_id
947	HY-B0944	HYCPK40904	L16	HYCPK40904	91z	1135.0	3.0	X31	904.0	L16	121808-62-6	Pidotimod		244.27	Bacterial	Anti-infection	Pidotimod is an orally active dipeptide immunostimulant with immunomodulatory properties on the adaptive and the innate immune responses. Pidotimod increases macrophage activity and humoral immune functions. Pidotimod can be used for the research of chronic bronchitis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and chronic idiopathic urticaria,et al[1][2].	Free Acid	C9H12N2O4S	17660.0	DMSO : 100 mg/mL (409.38 mM; Need ultrasonic); H2O : 25 mg/mL (102.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C([C@H]1N(C([C@H](CC2)NC2=O)=O)CSC1)O	https://www.medchemexpress.com/Pidotimod.html	Launched		91.0	X31	D15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0944	10.0	mM	87.0	DMSO	244.051778	15	D	pluskal_fda_drugs_5005_D15_id
1035	HY-13998	HYCPK40904	D22	HYCPK40904	91z	379.0	3.0	H43	904.0	D22	1132935-63-7	Dasabuvir	ABT-333	493.57	DNA/RNA Synthesis; HCV	Anti-infection; Cell Cycle/DNA Damage	Dasabuvir (ABT-333) is a nonnucleoside hepatitis C virus (HCV) polymerase inhibitor. Dasabuvir inhibits RNA-dependent RNA polymerase encoded by the HCV NS5B gene. Dasabuvir inhibits genotype 1a (strain H77) and 1b (strain Con1) replicons, with EC50 values of 7.7 and 1.8 nM, respectively[1].	Free Base	C26H27N3O5S	11509.0	DMSO : ≥ 46 mg/mL (93.20 mM)	DMSO Solution	10mM  * 100uL	Infection	CS(=O)(NC1=CC=C2C=C(C3=CC(N(C(N4)=O)C=CC4=O)=CC(C(C)(C)C)=C3OC)C=CC2=C1)=O	https://www.medchemexpress.com/ABT-333.html	Launched		91.0	H43	D15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13998	10.0	mM	87.0	DMSO	493.167142	15	D	pluskal_fda_drugs_5005_D15_id
105	HY-15463	HYCPK40902	O05	HYCPK40902	91z	1353.0	1.0	AC9	902.0	O05	152459-95-5	Imatinib	STI571; CGP-57148B	493.60	Autophagy; Bcr-Abl; c-Kit; PDGFR; SARS-CoV	Anti-infection; Autophagy; Protein Tyrosine Kinase/RTK	Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively[1][2][3][4]. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV[5].	Free Base	C29H31N7O	58028.0	DMSO : 12.5 mg/mL (25.32 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	CN(CC1)CCN1CC2=CC=C(C(NC3=CC=C(C)C(NC4=NC(C5=CC=CN=C5)=CC=N4)=C3)=O)C=C2	https://www.medchemexpress.com/Imatinib.html	Launched		91.0	AC9	D16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15463	10.0	mM	88.0	DMSO	493.259009	16	D	pluskal_fda_drugs_5005_D16_id
297	HY-10820A	HYCPK40902	A19	HYCPK40902	91z	37.0	1.0	A37	902.0	A19	150399-23-8	Pemetrexed (disodium)	LY231514 (disodium)	471.37	Antifolate; Apoptosis; Autophagy	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Pemetrexed disodium (LY231514 disodium) is an antifolate, the Kis of the pentaglutamate of Pemetrexed disodium are 1.3, 7.2, and 65 nM for inhibits thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), respectively[1].	Sodium	C20H19N5Na2O6	117827.0	H2O : ≥ 100 mg/mL (212.15 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NC(N)=NC2=C1C(CCC3=CC=C(C=C3)C(N[C@@H](CCC(O[Na])=O)C(O[Na])=O)=O)=CN2	https://www.medchemexpress.com/Pemetrexed-disodium.html	Launched		91.0	A37	D16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10820A	10.0	mM	88.0	DMSO	427.149183	16	D	pluskal_fda_drugs_5005_D16_id
333	HY-B1196	HYCPK40902	N21	HYCPK40902	91z	1289.0	1.0	AA41	902.0	N21	51012-33-0	Tiapride (hydrochloride)		364.89	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Tiapride hydrochloride is a selective and orally active D2 and D3 dopamine receptors antagonist with IC50 values of 110-320 nM and 180 nM, respectively. Tiapride hydrochloride shows anti-dyskinetic activity and anxiolytic activity. Tiapride hydrochloride is a neuroleptic agent[1][2].	Hydrochloride	C15H25ClN2O4S	105070.0	H2O : ≥ 200 mg/mL (548.11 mM); DMSO : 31.25 mg/mL (85.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NCCN(CC)CC)C1=CC(S(=O)(C)=O)=CC=C1OC.[H]Cl	https://www.medchemexpress.com/Tiapride-hydrochloride.html	Launched		91.0	AA41	D16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1196	10.0	mM	88.0	DMSO	328.145678	16	D	pluskal_fda_drugs_5005_D16_id
438	HY-B1388	HYCPK40903	K04	HYCPK40903	91z	968.0	2.0	U8	903.0	K04	80-49-9	Homatropine (methylbromide)	Homatropine methobromide	370.28	mAChR	GPCR/G Protein; Neuronal Signaling	Homatropine methylbromide (Homatropine methobromide) is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively.	Bromide	C17H24BrNO3	21132.0	DMSO : ≥ 31 mg/mL (83.72 mM); H2O : ≥ 100 mg/mL (270.07 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+]1([C@@H]2C[C@@H](OC(C(O)C3=CC=CC=C3)=O)C[C@H]1CC2)C.[Br-]	https://www.medchemexpress.com/Homatropine-methylbromide.html	Launched		91.0	U8	D16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1388	10.0	mM	88.0	DMSO	290.17507	16	D	pluskal_fda_drugs_5005_D16_id
504	HY-B0723	HYCPK40903	M08	HYCPK40903	91z	1168.0	2.0	Y16	903.0	M08	128607-22-7	Ospemifene	FC-1271a	378.89	Estrogen Receptor/ERR	Others	Ospemifene is a non-estrogen selective estrogen receptor modulator (SERM), with Kis of 380 and 410 nM for estrogen receptor α (ERα) and ERβ, respectively. Ospemifene can be used for the research of vaginal atrophy and breast cancer[1][2].	Free Base	C24H23ClO2	22335.0	DMSO : ≥ 100 mg/mL (263.93 mM)	DMSO Solution	10mM  * 100uL	Cancer	ClCC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCO)C=C2)\C3=CC=CC=C3	https://www.medchemexpress.com/Ospemifene.html	Launched		91.0	Y16	D16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0723	10.0	mM	88.0	DMSO	378.138658	16	D	pluskal_fda_drugs_5005_D16_id
510	HY-B0471	HYCPK40903	C09	HYCPK40903	91z	210.0	2.0	E18	903.0	C09	61-76-7	Phenylephrine (hydrochloride)	(R)-(-)-Phenylephrine (hydrochloride); L-Phenylephrine (hydrochloride)	203.67	Adrenergic Receptor; Endogenous Metabolite	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	(R)-(-)-Phenylephrine hydrochloride is a selective α1-adrenoceptor agonist with pKis of 5.86, 4.87 and 4.70 for α1D, α1B and α1A receptors respectively.	Hydrochloride	C9H14ClNO2	24964.0	DMSO : ≥ 150 mg/mL (736.49 mM); H2O : 100 mg/mL (490.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	OC1=CC([C@@H](O)CNC)=CC=C1.Cl	https://www.medchemexpress.com/_r_-_-_-phenylephrine-hydrochloride.html	Launched		91.0	E18	D16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0471	10.0	mM	88.0	DMSO	167.094629	16	D	pluskal_fda_drugs_5005_D16_id
713	HY-13463	HYCPK40903	I21	HYCPK40903	91z	810.0	2.0	Q42	903.0	I21	570406-98-3	Avatrombopag	AKR-501; E5501; YM477	649.65	Thrombopoietin Receptor	Immunology/Inflammation	Avatrombopag (AKR-501) is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag mimics the biological activities of TPO. Avatrombopag increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A[1][2][3].	Free Acid	C29H34Cl2N6O3S2	229643.0	DMSO : 8.33 mg/mL (12.82 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(C1CCN(C2=NC=C(C(NC3=NC(C4=CC(Cl)=CS4)=C(N5CCN(C6CCCCC6)CC5)S3)=O)C=C2Cl)CC1)O	https://www.medchemexpress.com/avatrombopag.html	Launched		91.0	Q42	D16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13463	10.0	mM	88.0	DMSO	648.151086	16	D	pluskal_fda_drugs_5005_D16_id
1143	HY-B1449	HYCPK40905	P08	HYCPK40905	91z	1504.0	4.0	AF16	905.0	P08	58-96-8	Uridine	β-Uridine	244.20	Endogenous Metabolite; Nucleoside Antimetabolite/Analog	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Uridine (β-Uridine) is a glycosylated pyrimidine-analog containing uracil attached to a ribose ring (or more specifically, aribofuranose) via a β-N1-glycosidic bond.	Free Base	C9H12N2O6	93367.0	H2O : ≥ 100 mg/mL (409.50 mM); DMSO : 50 mg/mL (204.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(C=C2)=O)=O)O1	https://www.medchemexpress.com/Uridin.html	Launched		91.0	AF16	D16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1449	10.0	mM	88.0	DMSO	244.069536	16	D	pluskal_fda_drugs_5005_D16_id
600	HY-A0070A	HYCPK40903	N13	HYCPK40903	91z	1274.0	2.0	AA26	903.0	N13	6893-02-3	Liothyronine	Triiodothyronine; 3,3',5-Triiodo-L-thyronine; T3	650.97	Endogenous Metabolite; Thyroid Hormone Receptor	Metabolic Enzyme/Protease; Others	Liothyronine is an active form of thyroid hormone.  Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[1][2][3].	Free Acid	C15H12I3NO4	62097.0	0.1 M NaOH : 16.67 mg/mL (25.61 mM; ultrasonic and warming and adjust pH to 11 with NaOH and heat to 60°C); DMSO : 50 mg/mL (76.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	OC1=C(I)C=C(OC2=C(I)C=C(C[C@H](N)C(O)=O)C=C2I)C=C1	https://www.medchemexpress.com/3,3_acute_,5-Triiodo-L-thyronine.html	Launched		91.0	AA26	D17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0070A	10.0	mM	89.0	DMSO	650.790052	17	D	pluskal_fda_drugs_5005_D17_id
613	HY-B0769	HYCPK40903	K14	HYCPK40903	91z	988.0	2.0	U28	903.0	K14	59-42-7	Phenylephrine	(R)-(-)-Phenylephrine; L-Phenylephrine	167.21	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	(R)-(-)-Phenylephrine is a selective α1-adrenoceptor agonist primarily used as a decongestant.		C9H13NO2	84614.0	H2O : 5 mg/mL (29.90 mM; Need ultrasonic); DMSO : 50 mg/mL (299.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O[C@H](C1=CC(O)=CC=C1)CNC	https://www.medchemexpress.com/_R_-_-_-Phenylephrine.html	Launched		91.0	U28	D17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0769	10.0	mM	89.0	DMSO	167.094629	17	D	pluskal_fda_drugs_5005_D17_id
627	HY-129390	HYCPK40903	I15	HYCPK40903	91z	798.0	2.0	Q30	903.0	I15	1655504-04-3	Orelabrutinib	ICP-022	427.50	Btk	Protein Tyrosine Kinase/RTK	Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor with potential antineoplastic activity. Orelabrutinib prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, inhibiting the growth of malignant B-cells that overexpress BTK[1][2].		C26H25N3O3	67525.0	DMSO : 100 mg/mL (233.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=C(C2CCN(C(C=C)=O)CC2)N=C1C3=CC=C(OC4=CC=CC=C4)C=C3)N	https://www.medchemexpress.com/orelabrutinib.html	Launched		91.0	Q30	D17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-129390	10.0	mM	89.0	DMSO	427.189592	17	D	pluskal_fda_drugs_5005_D17_id
941	HY-B0170A	HYCPK40904	F16	HYCPK40904	91z	559.0	3.0	L31	904.0	F16	3978-86-7	Azatadine (dimaleate)	Azatadine maleate	522.55	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	"Azatadine dimaleate is an histamine and cholinergic inhibitor with IC50 of 6.5 nM and 10 nM, respectively.
Target: Histamine Receptor
Azatadine, a new antihistamine, was evaluated for its efficacy in 20 patients with chronic allergic rhinitis. Eighty percent of patients had symptomatic relief with a twice daily dosage of 2 mg. Sedation was volunteered as a side effect by six of the patients and was admitted by two further patients after specific questioning. A choice reaction time test gave slowing of motor function in these sedated patients. Four of the previously sedated patients experienced good symptomatic control with minimal sedation when the azatadine dose was reduced to 1 mg twice daily; slowing of motor function was not observed at this, the normal recommended dose.
Azatadine delays the onset of dyspnea-induced by aerosolized histamine, acetylcholine and serotonin in the conscious guinea-pig with PD50 of 0.01 mg/kg, 0.739 mg/kg and 0.86 mg/kg. Azatadine protects conscious guinea-pigs against death induced by the intravenous injection of histamine with oral PD50 of 0.009 mg/kg in guinea-pig and 0.22 mg/kg in mice."	Maleate	C28H30N2O8	15899.0	H2O : ≥ 100 mg/mL (191.37 mM); DMSO : ≥ 100 mg/mL (191.37 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(O)/C=C\C(O)=O.O=C(O)/C=C\C(O)=O.CN1CC/C(CC1)=C2C3=CC=CC=C3CCC4=CC=CN=C4\2	https://www.medchemexpress.com/Azatadine-dimaleate.html	Launched		91.0	L31	D17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0170A	10.0	mM	89.0	DMSO	290.178299	17	D	pluskal_fda_drugs_5005_D17_id
987	HY-15123	HYCPK40904	D19	HYCPK40904	91z	373.0	3.0	H37	904.0	D19	51543-39-6	(S)-Flurbiprofen	Esflurbiprofen	244.26	COX; PGE synthase	Immunology/Inflammation	(S)-Flurbiprofen is an active enantiomer of Flurbiprofen, with IC50 values of 0.48 μM and 0.47 μM for COX-1 and COX-2, respectively[1].	Free Acid	C15H13FO2	67434.0	DMSO : 100 mg/mL (409.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)[C@@H](C)C1=CC=C(C2=CC=CC=C2)C(F)=C1	https://www.medchemexpress.com/s-flurbiprofen.html	Launched		91.0	H37	D17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15123	10.0	mM	89.0	DMSO	244.089958	17	D	pluskal_fda_drugs_5005_D17_id
1274	HY-13209	HYCPK40905	C17	HYCPK40905	91z	274.0	4.0	F34	905.0	C17	177036-94-1	Ambrisentan	BSF 208075; LU 208075	378.42	Endothelin Receptor	GPCR/G Protein	Ambrisentan is a selective ET type A receptor (ETAR) antagonist.	Free Acid	C22H22N2O4	10517.0	DMSO : 100 mg/mL (264.26 mM; Need ultrasonic); Ethanol : 7.14 mg/mL (18.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C([C@H](C(OC)(C1=CC=CC=C1)C2=CC=CC=C2)OC3=NC(C)=CC(C)=N3)O	https://www.medchemexpress.com/Ambrisentan.html	Launched		91.0	F34	D17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13209	10.0	mM	89.0	DMSO	378.157957	17	D	pluskal_fda_drugs_5005_D17_id
1289	HY-10122	HYCPK40905	B18	HYCPK40905	91z	180.0	4.0	D36	905.0	B18	160970-54-7	Silodosin	KAD 3213; KMD 3213	495.53	Adrenergic Receptor; Bacterial	Anti-infection; GPCR/G Protein; Neuronal Signaling	Silodosin (KAD 3213; KMD 3213) is a potent, selective and orally active α1A-adrenergic receptor  (α1A-AR) blocker. Silodosin exhibits high affinity for α1A-AR (Ki=0.036 nM), over 162-fold and 50-fold than for α1B-AR and α1D-AR with Ki values of 21 nM and 2.0 nM, respectively. Silodosin is an  effective and well-tolerated agent, it can be used for the investigation of LUTS/BPH[1][3].	Free Base	C25H32F3N3O4	4097.0	DMSO : ≥ 50 mg/mL (100.90 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	O=C(N)C1=CC(C[C@@H](C)NCCOC2=CC=CC=C2OCC(F)(F)F)=CC3=C1N(CC3)CCCO	https://www.medchemexpress.com/Silodosin.html	Launched		91.0	D36	D17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10122	10.0	mM	89.0	DMSO	495.234491	17	D	pluskal_fda_drugs_5005_D17_id
1361	HY-19489	HYCPK40905	N22	HYCPK40905	91z	1340.0	4.0	AB44	905.0	N22	851-68-3	(±)-Levomepromazine	(±)-Methotrimeprazine; dl-Methotrimeprazine	328.47	Others	Others	(±)-Levomepromazine is the racemate of Levomepromazine. Levomepromazine is an orally active and potent antipsychotic agent[1].		C19H24N2OS	231369.0	DMSO : 50 mg/mL (152.22 mM; ultrasonic and warming and heat to 70°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(CN(C)C)CN1C2=CC=CC=C2SC3=CC=C(OC)C=C13	https://www.medchemexpress.com/racemic-levomepromazine.html	Launched		91.0	AB44	D17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19489	10.0	mM	89.0	DMSO	328.160934	17	D	pluskal_fda_drugs_5005_D17_id
96	HY-14870	HYCPK40902	F05	HYCPK40902	91z	489.0	1.0	K9	902.0	F05	475086-01-2	Selexipag	NS-304; ACT-293987	496.62	Prostaglandin Receptor	GPCR/G Protein	Selexipag (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor).	Free Base	C26H32N4O4S	15571.0	DMSO : ≥ 50 mg/mL (100.68 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(NS(=O)(C)=O)COCCCCN(C1=NC(C2=CC=CC=C2)=C(C3=CC=CC=C3)N=C1)C(C)C	https://www.medchemexpress.com/NS-304.html	Launched		91.0	K9	D18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14870	10.0	mM	90.0	DMSO	496.214427	18	D	pluskal_fda_drugs_5005_D18_id
424	HY-B1234	HYCPK40903	I09	HYCPK40903	91z	786.0	2.0	Q18	903.0	I09	5466-77-3	Octinoxate	Octyl methoxycinnamate	290.40	Others	Others	Octinoxate is an organic compound that is an ingredient in some sunscreens and lip balms, primarily used is in sunscreens and other cosmetics to absorb UV-B rays from the sun, protecting the skin from damage. It is also used to reduce the appearance of scars.	Free Base	C18H26O3	17418.0	DMSO : 1 mg/mL (3.44 mM; Need ultrasonic); Ethanol : 140 mg/mL (482.09 mM; Need ultrasonic); H2O : 0.67 mg/mL (2.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(OCC(CC)CCCC)/C=C/C1=CC=C(OC)C=C1	https://www.medchemexpress.com/Octinoxate.html	Launched		91.0	Q18	D18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1234	10.0	mM	90.0	DMSO	290.188195	18	D	pluskal_fda_drugs_5005_D18_id
818	HY-B1108	HYCPK40904	G08	HYCPK40904	91z	639.0	3.0	N15	904.0	G08	32780-64-6	Labetalol (hydrochloride)	AH-5158 hydrochloride; Sch-15719W	364.87	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Labetalol hydrochloride is a mixed alpha/beta adrenergic antagonist that is used to treat high blood pressure.	Hydrochloride	C19H25ClN2O3	17650.0	DMSO : ≥ 100 mg/mL (274.07 mM); H2O : 20 mg/mL (54.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(N)C1=CC(C(O)CNC(C)CCC2=CC=CC=C2)=CC=C1O.[H]Cl	https://www.medchemexpress.com/Labetalol-hydrochloride.html	Launched		91.0	N15	D18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1108	10.0	mM	90.0	DMSO	328.178693	18	D	pluskal_fda_drugs_5005_D18_id
858	HY-111372	HYCPK40904	O10	HYCPK40904	91z	1411.0	3.0	AD19	904.0	O10	1050477-31-0	Finerenone	BAY 94-8862	378.42	Mineralocorticoid Receptor	Metabolic Enzyme/Protease	Finerenone (BAY 94-8862) is a third-generation, selective, and orally available nonsteroidal mineralocorticoid receptor (MR) antagonist (IC50=18 nM). Finerenone displays excellent selectivity versus glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (>500-fold). Finerenone has the potential for cardiorenal diseases research, such as type 2 diabetes mellitus and chronic kidney disease[1][2].	Free Base	C21H22N4O3	113995.0	DMSO : 200 mg/mL (528.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC2=C(C(OCC)=NC=C2C)[C@@H]1C3=CC=C(C#N)C=C3OC)N	https://www.medchemexpress.com/finerenone.html	Launched		91.0	AD19	D18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-111372	10.0	mM	90.0	DMSO	378.169191	18	D	pluskal_fda_drugs_5005_D18_id
922	HY-17566	HYCPK40904	O14	HYCPK40904	91z	1419.0	3.0	AD27	904.0	O14	1405-37-4	Capreomycin (sulfate)		750.78	Antibiotic; Bacterial	Anti-infection	"Capreomycin sulfate is a peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for MDR-tuberculosis.
IC50 value:
Target: 
The drug should not be given with streptomycin or other drugs that may damage the auditory vestibular nerve. Patients on this drug will often require audiology tests. It is a cyclic peptide.Capreomycin is administered intramuscularly and shows bacteriostatic activity."	Sulfate	C25H46N14O11S	66234.0	H2O : ≥ 37 mg/mL (49.28 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(CC(N)CCCN)NCC(C(N/C(C(NC(C1NC(NCC1)=N)C2=O)=O)=C/NC(N)=O)=O)NC(C(NC(C(CN2)N)=O)C)=O.O=S(O)(O)=O	https://www.medchemexpress.com/Capreomycin-sulfate.html	Launched		91.0	AD27	D18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17566	10.0	mM	90.0	DMSO	652.35174	18	D	pluskal_fda_drugs_5005_D18_id
968	HY-18346	HYCPK40904	A18	HYCPK40904	91z	83.0	3.0	B35	904.0	A18	137975-06-5	Mozavaptan	OPC-31260	427.54	Vasopressin Receptor	GPCR/G Protein	Mozavaptan (OPC-31260) is a benzazepine derivative and a potent, selective, competitive and orally active vasopressin V2 receptor antagonist with an IC50 of 14 nM. Mozavaptan shows ~85-fold selectivity for V2 receptor over V1 receptor (IC50 of 1.2 μM), and can antagonize the antidiuretic action of arginine vasopressin (AVP) in vivo. Mozavaptan has the potential for hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), and congestive heart failure treatment[1][2].	Free Base	C27H29N3O2	23864.0	DMSO : 6.2 mg/mL (14.50 mM; Need warming)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Metabolic Disease	CC1=CC=CC=C1C(NC2=CC=C(C(N3C(C=CC=C4)=C4C(N(C)C)CCC3)=O)C=C2)=O	https://www.medchemexpress.com/Mozavaptan.html	Launched		91.0	B35	D18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18346	10.0	mM	90.0	DMSO	427.225977	18	D	pluskal_fda_drugs_5005_D18_id
1016	HY-B1395	HYCPK40904	A21	HYCPK40904	91z	89.0	3.0	B41	904.0	A21	826-39-1	Mecamylamine (hydrochloride)		203.75	Histamine Receptor; nAChR	GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling	Mecamylamine hydrochloride is an orally active, nonselective, noncompetitive nAChR antagonist. Mecamylamine hydrochloride is also a ganglionic blocker. Mecamylamine hydrochloride can across the blood-brain barrier. Mecamylamine hydrochloride can be used in the research of neuropsychiatric disorders, hypertension, antidepressant area[1][2][5].	Hydrochloride	C11H22ClN	112116.0	DMSO : 31.25 mg/mL (153.37 mM; Need ultrasonic); H2O : 100 mg/mL (490.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease	CC1(C)C(NC)(C)C2CCC1C2.[H]Cl	https://www.medchemexpress.com/mecamylamine-hydrochloride.html	Launched		91.0	B41	D18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1395	10.0	mM	90.0	DMSO	167.1674	18	D	pluskal_fda_drugs_5005_D18_id
1146	HY-B0100A	HYCPK40905	C09	HYCPK40905	91z	258.0	4.0	F18	905.0	C09	53188-20-8	Etomidate (hydrochloride)	R16659 hydrochloride	280.75	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Etomidate hydrochloride (R 16659 hydrochloride) is a potent GABAA receptor agonist. Etomidate hydrochlorideis a neurological drug and effective parenteral medication and has the potential for management of endogenous hypercortisolaemia[1][2].	Hydrochloride	C14H17ClN2O2	26539.0	H2O : ≥ 50 mg/mL (178.09 mM); DMSO : ≥ 100 mg/mL (356.19 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C1=CN=CN1[C@@H](C2=CC=CC=C2)C)OCC.Cl	https://www.medchemexpress.com/etomidate-hydrochloride.html	Launched		91.0	F18	D18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0100A	10.0	mM	90.0	DMSO	244.121178	18	D	pluskal_fda_drugs_5005_D18_id
318	HY-17381	HYCPK40902	F20	HYCPK40902	91z	519.0	1.0	K39	902.0	F20	57852-57-0	Idarubicin (hydrochloride)	4-Demethoxydaunorubicin hydrochloride	533.95	Antibiotic; Autophagy; Bacterial; c-Myc; DNA/RNA Synthesis; Fungal; Topoisomerase	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage	Idarubicin hydrochloride is an anthracycline antileukemic drug. It inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription. Idarubicin hydrochloride inhibits the growth of bacteria and yeasts.	Hydrochloride	C26H28ClNO9	79198.0	DMSO : 83.33 mg/mL (156.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	OC(C(C(C1=CC=CC=C21)=O)=C3C2=O)=C4[C@H](C[C@@](C(C)=O)(O)CC4=C3O)O[C@@](O[C@@H](C)[C@H]5O)([H])C[C@@H]5N.Cl	https://www.medchemexpress.com/Idarubicin-hydrochloride.html	Launched		91.0	K39	D19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17381	10.0	mM	91.0	DMSO	497.168581	19	D	pluskal_fda_drugs_5005_D19_id
423	HY-17401	HYCPK40903	H09	HYCPK40903	91z	690.0	2.0	O18	903.0	H09	95635-56-6	Ranolazine (dihydrochloride)	CVT 303 (dihydrochloride); RS 43285	500.46	Autophagy; Calcium Channel; Sodium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Ranolazine dihydrochloride (CVT 303 dihydrochloride) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50  values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP)[1][2]. Ranolazine dihydrochloride is also a partial fatty acid oxidation inhibitor[3].	Hydrochloride	C24H35Cl2N3O4	19517.0	DMSO : ≥ 50 mg/mL (99.91 mM); H2O : ≥ 50 mg/mL (99.91 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(NC1=C(C)C=CC=C1C)CN2CCN(CC(O)COC3=CC=CC=C3OC)CC2.[H]Cl.[H]Cl	https://www.medchemexpress.com/ranolazine-dihydrochloride.html	Launched		91.0	O18	D19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17401	10.0	mM	91.0	DMSO	427.247107	19	D	pluskal_fda_drugs_5005_D19_id
471	HY-B2239	HYCPK40903	L06	HYCPK40903	91z	1068.0	2.0	W12	903.0	L06	752-56-7	Riboflavin Tetrabutyrate		656.72	Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Riboflavin Tetrabutyrate is a lipophilic flavin derivative with antioxidative and lipid peroxide-removing activity.	Free Base	C33H44N4O10	26353.0	DMSO : ≥ 100 mg/mL (152.27 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(CCC)O[C@H]([C@H](OC(CCC)=O)[C@H](OC(CCC)=O)COC(CCC)=O)CN1C(C=C(C)C(C)=C2)=C2N=C(C(N3)=O)C1=NC3=O	https://www.medchemexpress.com/Riboflavin_Tetrabutyrate.html	Launched		91.0	W12	D19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2239	10.0	mM	91.0	DMSO	656.305744	19	D	pluskal_fda_drugs_5005_D19_id
641	HY-B0100	HYCPK40903	G16	HYCPK40903	91z	608.0	2.0	M32	903.0	G16	33125-97-2	Etomidate	R 16659	244.29	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Etomidate (R 16659) is a potent GABAA receptor agonist. Etomidate is a neurological drug and effective parenteral medication and has the potential for management of endogenous hypercortisolaemia[1][2].	Free Base	C14H16N2O2	15399.0	DMSO : ≥ 100 mg/mL (409.35 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C1=CN=CN1[C@@H](C2=CC=CC=C2)C)OCC	https://www.medchemexpress.com/Etomidate.html	Launched		91.0	M32	D19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0100	10.0	mM	91.0	DMSO	244.121178	19	D	pluskal_fda_drugs_5005_D19_id
944	HY-121383	HYCPK40904	I16	HYCPK40904	91z	847.0	3.0	R31	904.0	I16	36894-69-6	Labetalol	AH5158; Sch-15719W (free base)	328.41	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Labetalol (AH5158) is an orally active selective α1- and non-selective β-adrenergic receptors competitive antagonist. Labetalol, an anti-hypertensive agent, can be used for the research of cardiovascular disease, such as hypertension in pregnancy[1][2][3].		C19H24N2O3	146349.0	DMSO : 125 mg/mL (380.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	O=C(C1=CC(C(CNC(CCC2=CC=CC=C2)C)O)=CC=C1O)N	https://www.medchemexpress.com/labetalol.html	Launched		91.0	R31	D19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-121383	10.0	mM	91.0	DMSO	328.178693	19	D	pluskal_fda_drugs_5005_D19_id
1090	HY-W011053	HYCPK40905	K05	HYCPK40905	91z	1018.0	4.0	V10	905.0	K05	165450-17-9	Neotame		378.46	Others	Others	Neotame is a derivative of Aspartame and is a low-caloric and high-intensity artificial sweetener that is 7000-13,000 times sweeter than sugar. Neotame is a non-nutritive sweetener and flavor enhancer that can be used in a variety of foods[1][2].		C20H30N2O5	129606.0	DMSO : 100 mg/mL (264.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	COC([C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NCCC(C)(C)C)=O)=O	https://www.medchemexpress.com/neotame.html	Launched		91.0	V10	D19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W011053	10.0	mM	91.0	DMSO	378.215472	19	D	pluskal_fda_drugs_5005_D19_id
1103	HY-B0659	HYCPK40905	H06	HYCPK40905	91z	732.0	4.0	P12	905.0	H06	59803-98-4	Brimonidine	UK 14304; AGN190342	292.13	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Brimonidine (UK 14304) is a full α2-adrenergic receptor (α2-AR) agonist.	Free Base	C11H10BrN5	33738.0	DMSO : 50 mg/mL (171.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	BrC1=C2N=CC=NC2=CC=C1NC3=NCCN3	https://www.medchemexpress.com/uk-14,304.html	Launched		91.0	P12	D19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0659	10.0	mM	91.0	DMSO	291.011957	19	D	pluskal_fda_drugs_5005_D19_id
1271	HY-N0523A	HYCPK40905	P16	HYCPK40905	91z	1520.0	4.0	AF32	905.0	P16	5995-86-8	Gallic acid (hydrate)	3,4,5-Trihydroxybenzoic acid (hydrate)	188.13	Apoptosis; COX; Endogenous Metabolite; Ferroptosis; Reactive Oxygen Species	Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Gallic acid (3,4,5-Trihydroxybenzoic acid) hydrate is a natural polyhydroxyphenolic compound and an free radical scavenger to inhibit cyclooxygenase-2 (COX-2)[1]. Gallic acid hydrate has various activities, such as antimicrobial, antioxidant, antimicrobial, anti-inflammatory, and anticance activities[2].	hydrate	C7H8O6	96627.0	DMSO : 50 mg/mL (265.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(O)C1=CC(O)=C(O)C(O)=C1.O	https://www.medchemexpress.com/gallic-acid-hydrate.html	Launched		91.0	AF32	D19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0523A	10.0	mM	91.0	DMSO	170.021523	19	D	pluskal_fda_drugs_5005_D19_id
98	HY-N0523	HYCPK40902	H05	HYCPK40902	91z	681.0	1.0	O9	902.0	H05	149-91-7	Gallic acid	3,4,5-Trihydroxybenzoic acid	170.12	Apoptosis; COX; Endogenous Metabolite; Ferroptosis; Reactive Oxygen Species	Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Gallic acid (3,4,5-Trihydroxybenzoic acid) is a natural polyhydroxyphenolic compound and an free radical scavenger to inhibit cyclooxygenase-2 (COX-2)[1]. Gallic acid has various activities, such as antimicrobial, antioxidant, antimicrobial, anti-inflammatory, and anticance activities[2].	Free Acid	C7H6O5	27626.0	DMSO : ≥ 100 mg/mL (587.82 mM); H2O : 8.33 mg/mL (48.97 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	O=C(O)C1=CC(O)=C(O)C(O)=C1	https://www.medchemexpress.com/Gallic_acid.html	Launched		91.0	O9	D20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0523	10.0	mM	92.0	DMSO	170.021523	20	D	pluskal_fda_drugs_5005_D20_id
135	HY-B0607	HYCPK40902	M07	HYCPK40902	91z	1165.0	1.0	Y13	902.0	M07	104206-65-7	Nitisinone	NTBC; Nitisone; SC0735	329.23	Others	Others	Nitisinone is an orally active, competitive and reversible 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) inhibitor with an IC50 of 173 nM. Nitisinone promotes tyrosine accumulation in a dose-dependent manner. nitisinone can be used in studies of hereditary tyrosinemia type 1 (HT-1) (a rare genetic disorder) and albinism[1][2][3][4].	Free Base	C14H10F3NO5	14558.0	DMSO : 41.67 mg/mL (126.57 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C1C(C(C2=CC=C(C(F)(F)F)C=C2[N+]([O-])=O)=O)C(CCC1)=O	https://www.medchemexpress.com/Nitisinone.html	Launched		91.0	Y13	D20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0607	10.0	mM	92.0	DMSO	329.051107	20	D	pluskal_fda_drugs_5005_D20_id
215	HY-17416	HYCPK40902	E13	HYCPK40902	91z	409.0	1.0	I25	902.0	E13	29110-48-3	Guanfacine (hydrochloride)		282.55	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Guanfacine (hydrochloride) is an orally active noradrenergic α2A agonist and has high selective for the α2A receptor subtype. Guanfacine has effects in producing hypotension and sedation. Guanfacine can be used for the research of a variety of prefrontal cortex (PFC) cognitive disorders, including tourette's syndrome and attention deficit hyperactivity disorder (ADHD)[1][2][3].	Hydrochloride	C9H10Cl3N3O	34239.0	DMSO : ≥ 30 mg/mL (106.18 mM); H2O : 20 mg/mL (70.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(NC(N)=N)CC1=C(Cl)C=CC=C1Cl.[H]Cl	https://www.medchemexpress.com/Guanfacine-hydrochloride.html	Launched		91.0	I25	D20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17416	10.0	mM	92.0	DMSO	245.012267	20	D	pluskal_fda_drugs_5005_D20_id
433	HY-B0551A	HYCPK40903	F04	HYCPK40903	91z	488.0	2.0	K8	903.0	F04	7081-53-0	Doxapram (hydrochloride hydrate)		432.98	Potassium Channel	Membrane Transporter/Ion Channel	"Doxapram hydrochloride hydrate inhibits TASK-1, TASK-3, TASK-1/TASK-3 heterodimeric channel function with EC50 of 410 nM, 37 μM, 9 μM, respectively.
Target: Potassium Channel
Doxapram is a respiratory stimulant. Doxapram (15-150 microM) also evoked 3H overflow in a concentration dependent manner, and doxapram-evoked release was inhibited by the Ca2+ channel blocker nifedipine (5 microM). Analysis of released tritiated compounds suggested that doxapram preferentially stimulated the release of dopamine. Our results indicate that the mechanism of action of doxapram shares similarities with that of hypoxia in the carotid body [1]. Doxapram (1-100 microM) caused rapid, reversible and dose-dependent inhibitions of K+ currents recorded in type I cells (IC50 approximately 13 microM). doxapram was also seen to directly inhibit Ca(2+)-independent K+ currents. Doxapram was a more potent inhibitor of the Ca(2+)-activated K+ currents recorded under control conditions. Doxapram (10 microM) was without effect on L-type Ca2+ channel currents recorded under conditions where K+ channel activity was minimized and was also without significant effect on K+ currents recorded in the neuronal cell line NG-108 15, suggesting a selective effect on carotid body type I cells. The effects of doxapram on type I cells show similarities to those of the physiological stimuli of the carotid body, suggesting that doxapram may share a similar mechanism of action in stimulating the intact organ [2]."	Hydrochloride	C24H33ClN2O3	12591.0	DMSO : ≥ 55 mg/mL (127.03 mM); H2O : 25 mg/mL (57.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1N(CC)CC(CCN2CCOCC2)C1(C3=CC=CC=C3)C4=CC=CC=C4.Cl.O	https://www.medchemexpress.com/doxapram-hydrochloride-hydrate.html	Launched		91.0	K8	D20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0551A	10.0	mM	92.0	DMSO	378.230728	20	D	pluskal_fda_drugs_5005_D20_id
444	HY-B1454	HYCPK40903	A05	HYCPK40903	91z	10.0	2.0	A10	903.0	A05	25507-04-4	Clindamycin palmitate (hydrochloride)		699.85	Antibiotic; Bacterial	Anti-infection	Clindamycin palmitate hydrochloride is a hydrochloride salt of the ester of clindamycin and palmitic acid and it is an antibacterial drug. Clindamycin palmitate hydrochloride is inactive in vitro, rapid in vivo hydrolysis converts this compound to the antibacterially active clindamycin[1].	Hydrochloride	C34H64Cl2N2O6S	64159.0	DMSO : ≥ 250 mg/mL (357.22 mM)	DMSO Solution	10mM  * 100uL	Infection	C[C@H](Cl)[C@@]([C@@]([C@@H]([C@H](O)[C@H]1OC(CCCCCCCCCCCCCCC)=O)O)([H])O[C@@H]1SC)([H])NC([C@@H]2C[C@@H](CCC)CN2C)=O.Cl[H]	https://www.medchemexpress.com/clindamycin-palmitate-hydrochloride.html	Launched		91.0	A10	D20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1454	10.0	mM	92.0	DMSO	662.409536	20	D	pluskal_fda_drugs_5005_D20_id
810	HY-124411	HYCPK40904	O07	HYCPK40904	91z	1405.0	3.0	AD13	904.0	O07	63329-53-3	Lobenzarit		291.69	Others	Others	Lobenzarit, an immunomodulator, possesses anti-oxidative[1].		C14H10ClNO4	180463.0	DMSO : 100 mg/mL (342.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=C(C=C1NC2=CC=CC=C2C(O)=O)Cl)O	https://www.medchemexpress.com/lobenzarit.html	Launched		91.0	AD13	D20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-124411	10.0	mM	92.0	DMSO	291.029835	20	D	pluskal_fda_drugs_5005_D20_id
844	HY-14557	HYCPK40904	A10	HYCPK40904	91z	67.0	3.0	B19	904.0	A10	706779-91-1	Pimavanserin	ACP-103	427.55	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Pimavanserin is a selective inverse agonist of the 5-HT2A receptor with pIC50 and pKd of 8.73 and 9.3, respectively.	Free Base	C25H34FN3O2	25278.0	DMSO : 50 mg/mL (116.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(C)COC1=CC=C(CNC(N(CC2=CC=C(F)C=C2)C3CCN(C)CC3)=O)C=C1	https://www.medchemexpress.com/pimavanserin.html	Launched		91.0	B19	D20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14557	10.0	mM	92.0	DMSO	427.263506	20	D	pluskal_fda_drugs_5005_D20_id
1307	HY-18347A	HYCPK40905	D19	HYCPK40905	91z	374.0	4.0	H38	905.0	D19	168626-94-6	Conivaptan (hydrochloride)	YM 087	535.03538	Vasopressin Receptor	GPCR/G Protein	Conivaptan (hydrochloride) is a non-peptide antagonist of vasopressin receptor, with Ki values of 0.48 and 3.04 nM for rat liver V1A receptor and rat kidney V2 receptor respectively.	Hydrochloride	C32H27ClN4O2	12196.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : ≥ 100 mg/mL (186.90 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(C1=CC=CC=C1C2=CC=CC=C2)NC3=CC=C(C(N4CCC(N=C(C)N5)=C5C6=CC=CC=C64)=O)C=C3.Cl	https://www.medchemexpress.com/Conivaptan-hydrochloride.html	Launched		91.0	H38	D20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18347A	10.0	mM	92.0	DMSO	498.205576	20	D	pluskal_fda_drugs_5005_D20_id
127	HY-B0133	HYCPK40902	E07	HYCPK40902	91z	397.0	1.0	I13	902.0	E07	7681-93-8	Natamycin	Pimaricin	665.72518	Antibiotic; Bacterial; Endogenous Metabolite; Fungal	Anti-infection; Metabolic Enzyme/Protease	Natamycin (Pimaricin) is a macrolide antibiotic agent produced by several Streptomyces strains. Natamycin inhibits the growth of fungi via inhibition of amino acid and glucose transport across the plasma membrane. Natamycin is a food preservative, an antifungal agent in agriculture, and is widely used for fungal keratitis research[1][2].	Free Acid	C33H47NO13	13893.0	DMSO : 16.67 mg/mL (25.04 mM; ultrasonic and adjust pH to 6 with HCl); H2O : 1 mg/mL (1.50 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	OC([C@H]1[C@@](C[C@H](/C=C/C=C/C=C/C=C/C[C@@H](C)OC2=O)O[C@@](O[C@H](C)[C@@H](O)[C@@H]3N)([H])[C@H]3O)([H])O[C@](O)(C[C@H](C[C@]4([H])[C@@H](/C=C/2)O4)O)C[C@@H]1O)=O	https://www.medchemexpress.com/Natamycin.html	Launched		91.0	I13	D21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0133	10.0	mM	93.0	DMSO	665.304741	21	D	pluskal_fda_drugs_5005_D21_id
643	HY-12866	HYCPK40903	I16	HYCPK40903	91z	800.0	2.0	Q32	903.0	I16	1223403-58-4	Larotrectinib	LOXO-101; ARRY-470	428.44	Apoptosis; Trk Receptor	Apoptosis; Neuronal Signaling; Protein Tyrosine Kinase/RTK	Larotrectinib (LOXO-101) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).	Free Base	C21H22F2N6O2	44020.0	DMSO : ≥ 4.6 mg/mL (10.74 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N1C[C@@H](O)CC1)NC2=C3N=C(N4[C@@H](C5=CC(F)=CC=C5F)CCC4)C=CN3N=C2	https://www.medchemexpress.com/LOXO-101.html	Launched		91.0	Q32	D21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12866	10.0	mM	93.0	DMSO	428.17723	21	D	pluskal_fda_drugs_5005_D21_id
746	HY-B1240	HYCPK40904	J03	HYCPK40904	91z	917.0	3.0	T5	904.0	J03	548-73-2	Droperidol	Dehydrobenzperidol	379.43	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	"Droperidol is a Dopamine-2 Receptor Antagonist. 
Target: D2DR
Droperidol is a butyrophenone, with anti-emetic, sedative and anti-anxiety properties."	Free Base	C22H22FN3O2	91759.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (263.55 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1NC2=CC=CC=C2N1C3=CCN(CCCC(C4=CC=C(F)C=C4)=O)CC3	https://www.medchemexpress.com/Droperidol.html	Launched		91.0	T5	D21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1240	10.0	mM	93.0	DMSO	379.169605	21	D	pluskal_fda_drugs_5005_D21_id
907	HY-B2133	HYCPK40904	P13	HYCPK40904	91z	1513.0	3.0	AF25	904.0	P13	14984-68-0	Cloperastine (hydrochloride)		366.32	Potassium Channel	Membrane Transporter/Ion Channel	Cloperastine hydrochloride inhibits the hERG K+ currents in a concentration-dependent manner with an IC50 value of 27 nM[1].	Hydrochloride	C20H25Cl2NO	122201.0	H2O : 100 mg/mL (272.99 mM; Need ultrasonic); DMSO : 250 mg/mL (682.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	ClC1=CC=C(C(C2=CC=CC=C2)OCCN3CCCCC3)C=C1.[H]Cl	https://www.medchemexpress.com/cloperastine-hydrochloride.html	Launched		91.0	AF25	D21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2133	10.0	mM	93.0	DMSO	329.154642	21	D	pluskal_fda_drugs_5005_D21_id
921	HY-B0318	HYCPK40904	N14	HYCPK40904	91z	1323.0	3.0	AB27	904.0	N14	443-48-1	Metronidazole		171.15	Antibiotic; Apoptosis; Bacterial; Parasite	Anti-infection; Apoptosis	Metronidazole is an orally active nitroimidazole antibiotic. Metronidazole can cross blood brain barrier. Metronidazole can be used for the research of anaerobic infections[1][2][3][4].	Free Base	C6H9N3O3	16013.0	H2O : 16.67 mg/mL (97.40 mM; Need ultrasonic); DMSO : 35 mg/mL (204.50 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	OCCN1C([N+]([O-])=O)=CN=C1C	https://www.medchemexpress.com/Metronidazole.html	Launched		91.0	AB27	D21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0318	10.0	mM	93.0	DMSO	171.064391	21	D	pluskal_fda_drugs_5005_D21_id
979	HY-101561	HYCPK40904	L18	HYCPK40904	91z	1139.0	3.0	X35	904.0	L18	1703793-34-3	Avapritinib	BLU-285	498.56	c-Kit; PDGFR	Protein Tyrosine Kinase/RTK	Avapritinib (BLU-285) is a highly potent, selective, and orally active KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. Avapritinib (BLU-285) binds the active conformation of the kinase and shows antitumor activity. Avapritinib (BLU-285) attenuates the transport function of both ABCB1 and ABCG2[1][2].	Free Base	C26H27FN10	66072.0	DMSO : ≥ 83.33 mg/mL (167.14 mM)	DMSO Solution	10mM  * 100uL	Cancer	CN1N=CC(C2=CN3C(C(N4CCN(C5=NC=C([C@@](C)(N)C6=CC=C(F)C=C6)C=N5)CC4)=NC=N3)=C2)=C1	https://www.medchemexpress.com/BLU-285.html	Launched		91.0	X35	D21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101561	10.0	mM	93.0	DMSO	498.240419	21	D	pluskal_fda_drugs_5005_D21_id
1075	HY-14803	HYCPK40905	L04	HYCPK40905	91z	1112.0	4.0	X8	905.0	L04	609799-22-6	Tasimelteon	BMS-214778; VEC-162	245.32	Melatonin Receptor	GPCR/G Protein; Neuronal Signaling	Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a  circadian regulator and has the potential for Non-24-Hour  Sleep-Wake  Disorder  (Non-24)[1][2].	Free Base	C15H19NO2	20202.0	DMSO : ≥ 33 mg/mL (134.52 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	[H][C@]1(C2=C3C(OCC3)=CC=C2)[C@@](CNC(CC)=O)([H])C1	https://www.medchemexpress.com/Tasimelteon.html	Launched		91.0	X8	D21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14803	10.0	mM	93.0	DMSO	245.141579	21	D	pluskal_fda_drugs_5005_D21_id
1086	HY-10341	HYCPK40905	G05	HYCPK40905	91z	634.0	4.0	N10	905.0	G05	105628-07-7	Fasudil (Hydrochloride)	HA-1077 (Hydrochloride); AT-877 (Hydrochloride)	327.83	Autophagy; Calcium Channel; HIV; PKA; PKC; ROCK	Anti-infection; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; Membrane Transporter/Ion Channel; Neuronal Signaling; Stem Cell/Wnt; TGF-beta/Smad	Fasudil (HA-1077; AT877) Hydrochloride is a nonspecific RhoA/ROCK inhibitor and also has inhibitory effect on protein kinases, with an Ki of 0.33 μM for ROCK1, IC50s of 0.158 μM and 4.58 μM, 12.30 μM, 1.650 μM for ROCK2 and PKA, PKC, PKG, respectively. Fasudil Hydrochloride is also a potent Ca2+ channel antagonist and vasodilator[1][2][3].	Hydrochloride	C14H18ClN3O2S	62099.0	DMSO : ≥ 31 mg/mL (94.56 mM); H2O : 55 mg/mL (167.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=S(C1=CC=CC2=C1C=CN=C2)(N3CCNCCC3)=O.Cl[H]	https://www.medchemexpress.com/Fasudil-Hydrochloride.html	Launched		91.0	N10	D21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10341	10.0	mM	93.0	DMSO	291.104148	21	D	pluskal_fda_drugs_5005_D21_id
140	HY-14566	HYCPK40902	B08	HYCPK40902	91z	111.0	1.0	C15	902.0	B08	120014-06-4	Donepezil	E2020 (free base)	379.49	Cholinesterase (ChE)	Neuronal Signaling	Donepezil (E2020 free base) is a specific and potent AChE inhibitor with IC50s of 8.12 nM and 11.6 nM for bovine AChE and human AChE, respectively[1].	Free Base	C24H29NO3	56295.0	DMSO : 33.33 mg/mL (87.83 mM; Need ultrasonic); H2O : 2 mg/mL (5.27 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C(C=C(OC)C(OC)=C1)=C1C2)C2CC(CC3)CCN3CC4=CC=CC=C4	https://www.medchemexpress.com/donepezil.html	Launched		91.0	C15	D22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14566	10.0	mM	94.0	DMSO	379.214744	22	D	pluskal_fda_drugs_5005_D22_id
160	HY-15772	HYCPK40902	N09	HYCPK40902	91z	1265.0	1.0	AA17	902.0	N09	1421373-65-0	Osimertinib	AZD-9291; Mereletinib	499.61	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].	Free Base	C28H33N7O2	25959.0	DMSO : 62.5 mg/mL (125.10 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O	https://www.medchemexpress.com/AZD-9291.html	Launched		91.0	AA17	D22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15772	10.0	mM	94.0	DMSO	499.269573	22	D	pluskal_fda_drugs_5005_D22_id
166	HY-B1035	HYCPK40902	D10	HYCPK40902	91z	307.0	1.0	G19	902.0	D10	27912-14-7	Levobunolol (hydrochloride)	l-Bunolol hydrochloride	327.85	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Levobunolol (l-Bunolol) hydrochloride is a potent and nonselective β-adrenergic receptor antagonist. Levobunolol hydrochloride is an ocular hypotensive agent and lowers mean intraocular pressure (IOP). Levobunolol hydrochloride can be used for glaucoma and superior oblique myokymia (SOM) research[1][2][3].	Hydrochloride	C17H26ClNO3	64305.0	DMSO : ≥ 62.5 mg/mL (190.64 mM); H2O : 50 mg/mL (152.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C1CCCC2=C1C=CC=C2OC[C@@H](O)CNC(C)(C)C.[H]Cl	https://www.medchemexpress.com/Levobunolol-hydrochloride.html	Launched		91.0	G19	D22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1035	10.0	mM	94.0	DMSO	291.183444	22	D	pluskal_fda_drugs_5005_D22_id
222	HY-14200	HYCPK40902	L13	HYCPK40902	91z	1081.0	1.0	W25	902.0	L13	185517-74-2	(S)-Rasagiline	TVP1022; S-PAI	171.24	Monoamine Oxidase	Neuronal Signaling	(S)-Rasagiline (TVP1022) is the relatively inactive S-enantiomer form of Rasagiline. Rasagiline is a highly potent selective irreversible MAO inhibitor with IC50s of 4.43?nM and 412?nM for rat brain MAO B and A activity, respectively[1].	Free Base	C12H13N	16496.0	DMSO : 100 mg/mL (583.98 mM; Need ultrasonic); Ethanol : 100 mg/mL (583.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C#CCN[C@H]1CCC2=CC=CC=C21	https://www.medchemexpress.com/TVP1022.html	Launched		91.0	W25	D22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14200	10.0	mM	94.0	DMSO	171.104799	22	D	pluskal_fda_drugs_5005_D22_id
237	HY-16216	HYCPK40902	K14	HYCPK40902	91z	987.0	1.0	U27	902.0	K14	478296-72-9	Gabapentin enacarbil	XP-13512	329.39	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	"Gabapentin enacarbil (XP-13512) is a prodrug for the anticonvulsant and analgesic drug gabapentin.
IC50 Value:  
Target: Calcium Channel
Gabapentin enacarbil is an actively transported prodrug of gabapentin that provides sustained dose-proportional exposure to gabapentin and predictable bioavailability.
in vitro: The prodrug (XP-13512) demonstrated active apical to basolateral transport across Caco-2 cell monolayers and pH-dependent passive permeability across artificial membranes. XP13512 inhibited uptake of (14)C-lactate by human embryonic kidney cells expressing monocarboxylate transporter type-1, and direct uptake of prodrug by these cells was confirmed using liquid chromatography-tandem mass spectrometry. XP13512 inhibited uptake of (3)H-biotin into Chinese hamster ovary cells overexpressing human sodium-dependent multivitamin transporter (SMVT) [1].
in vivo:  In 4 studies of healthy volunteers (136 subjects total), the pharmacokinetics of XP13512 immediate- and extended-release formulations were compared with those of oral gabapentin. XP13512 immediate-release (up to 2800 mg single dose and 2100 mg twice daily) was well absorbed (>68%, based on urinary recovery of gabapentin), converted rapidly to gabapentin, and provided dose-proportional exposure, whereas absorption of oral gabapentin declined with increasing doses to <27% at 1200 mg. Compared with 600 mg gabapentin, an equimolar XP13512 extended-release dose provided extended gabapentin exposure (time to maximum concentration, 8.4 vs 2.7 hours) and superior bioavailability (74.5% vs 36.6%) [2].
Toxicity: Gabapentin's most common side effects in adult patients include dizziness, fatigue, weight gain, drowsiness, and peripheral edema (swelling of extremities)."	Free Acid	C16H27NO6	111624.0	H2O : 0.67 mg/mL (2.03 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (303.59 mM); Ethanol : 100 mg/mL (303.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(O)CC1(CNC(OC(OC(C(C)C)=O)C)=O)CCCCC1	https://www.medchemexpress.com/Gabapentin-enacarbil.html	Launched		91.0	U27	D22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16216	10.0	mM	94.0	DMSO	329.183838	22	D	pluskal_fda_drugs_5005_D22_id
564	HY-B1042	HYCPK40903	E13	HYCPK40903	91z	410.0	2.0	I26	903.0	E13	1949-20-8	Oxolamine (citrate)	SKF-9976 citrate; AF-438 citrate	437.44	Others	Others	Oxolamine citrate (SKF-9976 citrate) is a cough suppressant that can be used for the research of respiratory tract diseases. Oxolamine citrate also exhibits anti-inflammatory effect[1][2].	Citrate	C20H27N3O8	22775.0	DMSO : ≥ 100 mg/mL (228.60 mM); H2O : 14.29 mg/mL (32.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CCN(CC)CCC1=NC(C2=CC=CC=C2)=NO1.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Oxolamine-citrate.html	Launched		91.0	I26	D22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1042	10.0	mM	94.0	DMSO	245.152812	22	D	pluskal_fda_drugs_5005_D22_id
757	HY-B0202	HYCPK40904	E04	HYCPK40904	91z	439.0	3.0	J7	904.0	E04	138402-11-6	Irbesartan	SR-47436; BMS-186295	428.53	Angiotensin Receptor; Apoptosis	Apoptosis; GPCR/G Protein	Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].	Free Base	C25H28N6O	14030.0	DMSO : 100 mg/mL (233.36 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C1N(CC2=CC=C(C3=C(C4=NN=NN4)C=CC=C3)C=C2)C(CCCC)=NC15CCCC5	https://www.medchemexpress.com/Irbesartan.html	Launched		91.0	J7	D22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0202	10.0	mM	94.0	DMSO	428.23246	22	D	pluskal_fda_drugs_5005_D22_id
1164	HY-17003	HYCPK40905	E10	HYCPK40905	91z	452.0	4.0	J20	905.0	E10	149845-06-7	Saquinavir (Mesylate)	Ro 31-8959/003	766.95	Autophagy; HIV; HIV Protease	Anti-infection; Autophagy; Metabolic Enzyme/Protease	"Saquinavir mesylate is an HIV Protease Inhibitor used in antiretroviral therapy. 
IC50 Value:
Target: HIV Protease
Saquinavir is a protease inhibitor. Proteases are enzymes that cleave protein molecules into smaller fragments. HIV protease is vital for both viral replication within the cell and release of mature viral particles from an infected cell. Saquinavir binds to the active site of the viral protease and prevents cleavage of viral polyproteins, preventing maturation of the virus. Saquinavir inhibits both HIV-1 and HIV-2 proteases.Studies have also looked at Saquinavir as a possible anti-cancer agent."	Mesylate	C39H54N6O8S	5410.0	DMSO : 20 mg/mL (26.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	NC(C[C@H](C(N[C@@H](CC1=CC=CC=C1)C(CN2C[C@@]3([H])CCCC[C@]3(C[C@H]2C(NC(C)(C)C)=O)[H])O)=O)NC(C4=NC5=CC=CC=C5C=C4)=O)=O.CS(O)(=O)=O	https://www.medchemexpress.com/saquinavir-mesylate.html	Launched		91.0	J20	D22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17003	10.0	mM	94.0	DMSO	670.384269	22	D	pluskal_fda_drugs_5005_D22_id
286	HY-B1621A	HYCPK40902	L17	HYCPK40902	91z	1089.0	1.0	W33	902.0	L17	5870-29-1	Cyclopentolate (hydrochloride)	DL-Cyclopentolate (hydrochloride)	327.85	mAChR	GPCR/G Protein; Neuronal Signaling	Cyclopentolate (DL-Cyclopentolate) hydrochloride is an Atropine-like muscarinic receptors antagonist with a pKB value of 7.8 (on the circular ciliary muscle). Cyclopentolate hydrochloride is an anti-muscarinic agent commonly used in the ophthalmologic practice[1][2].	Hydrochloride	C17H26ClNO3	64270.0	H2O : 100 mg/mL (305.02 mM; Need ultrasonic); DMSO : 250 mg/mL (762.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCN(C)C)C(C1(O)CCCC1)C2=CC=CC=C2.[H]Cl	https://www.medchemexpress.com/cyclopentolate-hydrochloride.html	Launched		91.0	W33	E3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1621A	10.0	mM	99.0	DMSO	291.183444	3	E	pluskal_fda_drugs_5005_E3_id
586	HY-14290	HYCPK40904	P15	HYCPK40904	91z	1517.0	3.0	AF29	904.0	P15	60560-33-0	Pinacidil	P-1134	245.32	Potassium Channel	Membrane Transporter/Ion Channel	Pinacidil is a potent activator of potassium channel. Pinacidil is an antihypertensive agent which hyperpolarises vascular smooth muscle by opening K+-channels. Pinacidil significantly improves the reperfusion function and cardiac compliance. Pinacidil has direct cardioprotective efficacy[1].		C13H19N5	143255.0	DMSO : 100 mg/mL (407.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC(C(C)(C)C)N/C(NC1=CC=NC=C1)=N\C#N	https://www.medchemexpress.com/pinacidil.html	Launched		91.0	AF29	E3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14290	10.0	mM	99.0	DMSO	245.164046	3	E	pluskal_fda_drugs_5005_E3_id
649	HY-B0135	HYCPK40903	O16	HYCPK40903	91z	1376.0	2.0	AC32	903.0	O16	54-31-9	Furosemide		330.74	GABA Receptor; NKCC	Membrane Transporter/Ion Channel; Neuronal Signaling	Furosemide is a potent and orally active inhibitor of Na+/K+/2Cl-?(NKCC) cotransporter, NKCC1 and NKCC2[1].?Furosemide is also a GABAA?receptors antagonist and displays 100-fold selectivity for?α6-containing receptors than?α1-containing receptors. Furosemide acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema[2].	Free Acid	C12H11ClN2O5S	41168.0	DMSO : ≥ 100 mg/mL (302.35 mM); H2O : 0.1 mg/mL (0.30 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(O)C1=CC(S(=O)(N)=O)=C(Cl)C=C1NCC2=CC=CO2	https://www.medchemexpress.com/furosemide.html	Launched		91.0	AC32	E3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0135	10.0	mM	99.0	DMSO	330.00772	3	E	pluskal_fda_drugs_5005_E3_id
651	HY-B0885	HYCPK40903	A17	HYCPK40903	91z	34.0	2.0	A34	903.0	A17	27220-47-9	Econazole	(±)-Econazol	381.68	Antibiotic; Fungal	Anti-infection	Econazole is an antifungal compound of the imidazole class.	Free Base	C18H15Cl3N2O	100402.0	DMSO : 100 mg/mL (262.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	ClC1=CC=C(C(OCC2=CC=C(Cl)C=C2)CN3C=CN=C3)C(Cl)=C1	https://www.medchemexpress.com/Econazole.html	Launched		91.0	A34	E3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0885	10.0	mM	99.0	DMSO	380.024996	3	E	pluskal_fda_drugs_5005_E3_id
811	HY-B0420A	HYCPK40904	P07	HYCPK40904	91z	1501.0	3.0	AF13	904.0	P07	3160-91-6	Moroxydine (hydrochloride)	ABOB hydrochloride	207.66	Influenza Virus	Anti-infection	"Moroxydine hydrochloride (ABOB hydrochloride) is a synthetic antiviral compound chemically belonging to the series of the heterocyclic biguanidines.
Target: Influenza Virus
Moroxydine hydrochloride (ABOB hydrochloride) is an antiviral drug that was originally developed in the 1950s as an influenza treatment. It has potential applications against a number of RNA and DNA viruses [1]. 
Structurally moroxydine is a heterocyclic biguanidine. Moroxydine was reported in March 2014 that three kindergartens in two provinces of China had been found to be secretly dosing their students with moroxydine hydrochloride to try to prevent them from becoming ill. The kindergartens are paid only for the days that pupils attend and wanted to ensure that they maximised their earnings [2]."	Hydrochloride	C6H14ClN5O	17038.0	H2O : ≥ 100 mg/mL (481.56 mM); DMSO : 50 mg/mL (240.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	N=C(N1CCOCC1)NC(N)=N.Cl	https://www.medchemexpress.com/moroxydine-hydrochloride.html	Launched		91.0	AF13	E3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0420A	10.0	mM	99.0	DMSO	171.11201	3	E	pluskal_fda_drugs_5005_E3_id
860	HY-12100	HYCPK40904	A11	HYCPK40904	91z	69.0	3.0	B21	904.0	A11	869113-09-7	Umeclidinium (bromide)	GSK573719A	508.49	mAChR	GPCR/G Protein; Neuronal Signaling	Umeclidinium bromide is a novel mAChR antagonist. The affinity (Ki) of Umeclidinium bromide for the cloned human M1-M5 mAChRs ranges from 0.05 to 0.16 nM.	Bromide	C29H34BrNO2	24584.0	DMSO : ≥ 25 mg/mL (49.17 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	OC(C12CC[N+](CC2)(CCOCC3=CC=CC=C3)CC1)(C4=CC=CC=C4)C5=CC=CC=C5.[Br-]	https://www.medchemexpress.com/Umeclidinium-bromide.html	Launched		91.0	B21	E3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12100	10.0	mM	99.0	DMSO	428.258406	3	E	pluskal_fda_drugs_5005_E3_id
1147	HY-N7122	HYCPK40905	D09	HYCPK40905	91z	354.0	4.0	H18	905.0	D09	69558-55-0	Thymopentin		679.77	Endogenous Metabolite	Metabolic Enzyme/Protease	Thymopentin is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs)[1][2].	Free Acid	C30H49N9O9	147902.0	DMSO : 20.83 mg/mL (30.64 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(N[C@@H](C(C)C)C(N[C@H](C(O)=O)CC1=CC=C(O)C=C1)=O)[C@H](CC(O)=O)NC([C@H](CCCCN)NC([C@@H](N)CCCNC(N)=N)=O)=O	https://www.medchemexpress.com/thymopentin-1.html	Launched		91.0	H18	E3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7122	10.0	mM	99.0	DMSO	679.365324	3	E	pluskal_fda_drugs_5005_E3_id
1152	HY-15772A	HYCPK40905	I09	HYCPK40905	91z	834.0	4.0	R18	905.0	I09	1421373-66-1	Osimertinib mesylate	AZD-9291 mesylate; Mereletinib mesylate	595.71	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Osimertinib mesylate (AZD9291 mesylate) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].	Mesylate	C29H37N7O5S	110591.0	DMSO : 13.89 mg/mL (23.32 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O.CS(=O)(O)=O	https://www.medchemexpress.com/AZD-9291-mesylate.html	Launched		91.0	R18	E3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15772A	10.0	mM	99.0	DMSO	499.269573	3	E	pluskal_fda_drugs_5005_E3_id
180	HY-19696B	HYCPK40902	B11	HYCPK40902	91z	117.0	1.0	C21	902.0	B11	117609-50-4	Tauroursodeoxycholate (dihydrate)	Tauroursodeoxycholic acid (dihydrate); TUDCA (dihydrate); UR 906 (dihydrate)	535.73	Apoptosis; Caspase; Endogenous Metabolite; ERK	Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Stem Cell/Wnt	Tauroursodeoxycholate (Tauroursodeoxycholic acid; TDUCA) dihydrate is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK[1][2].	Free Acid	C26H49NO8S	119891.0	DMSO : 83.33 mg/mL (155.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@H](CCC(NCCS(=O)(O)=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C.O.O	https://www.medchemexpress.com/tauroursodeoxycholate-dihydrate.html	Launched		91.0	C21	E4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19696B	10.0	mM	100.0	DMSO	499.296759	4	E	pluskal_fda_drugs_5005_E4_id
199	HY-N7122A	HYCPK40902	E12	HYCPK40902	91z	407.0	1.0	I23	902.0	E12	89318-88-7	Thymopentin (acetate)		739.82	Endogenous Metabolite	Metabolic Enzyme/Protease	Thymopentin acetate is a biologically active peptide secreted mainly by the epithelial cells of thymic cortex and medulla. Thymopentin acetate is an effective immunomodulatory agent with a short plasma half-life of 30 seconds. Thymopentin acetate enhances the generation of T-cell lineage derived from human embryonic stem cells (hESCs)[1][2].	Acetate	C32H53N9O11	60725.0	DMSO : 16.67 mg/mL (22.53 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(N[C@@H](C(C)C)C(N[C@H](C(O)=O)CC1=CC=C(O)C=C1)=O)[C@H](CC(O)=O)NC([C@H](CCCCN)NC([C@@H](N)CCCNC(N)=N)=O)=O.CC(O)=O	https://www.medchemexpress.com/thymopentin-acetate.html	Launched		91.0	I23	E4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7122A	10.0	mM	100.0	DMSO	679.365324	4	E	pluskal_fda_drugs_5005_E4_id
266	HY-A0057	HYCPK40902	H16	HYCPK40902	91z	703.0	1.0	O31	902.0	H16	60142-96-3	Gabapentin		171.24	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Gabapentin is a potent, orally active P/Q type Ca2+ channel blocker. Gabapentin inhibits neuronal Ca2+ influx and reduction of neurotransmitter release. Gabapentin is a GABA analog that can be used to relieve neuropathic pain[1][2][3].	Free Acid	C9H17NO2	126088.0	H2O : 50 mg/mL (291.99 mM; Need ultrasonic); DMSO : 1 mg/mL (5.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(O)CC1(CN)CCCCC1	https://www.medchemexpress.com/Gabapentin.html	Launched		91.0	O31	E4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0057	10.0	mM	100.0	DMSO	171.125929	4	E	pluskal_fda_drugs_5005_E4_id
284	HY-19569	HYCPK40902	J17	HYCPK40902	91z	897.0	1.0	S33	902.0	J17	1310726-60-3	Upadacitinib	ABT-494	380.37	JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Upadacitinib (ABT-494) is a potent, orally active and selective Janus kinase 1 (JAK1) inhibitor (IC50=43 nM). Upadacitinib (ABT-494) displays approximately 74 fold selective for JAK1 over JAK2 (200 nM) in cellular assays dependent on specific, relevant cytokines. Upadacitinib (ABT-494) can be used for several autoimmune disorders research[1][2].	Free Base	C17H19F3N6O	83693.0	DMSO : ≥ 22 mg/mL (57.84 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(N1C[C@@H](CC)[C@@H](C2=CN=C3C=NC(NC=C4)=C4N32)C1)NCC(F)(F)F	https://www.medchemexpress.com/Upadacitinib.html	Launched		91.0	S33	E4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19569	10.0	mM	100.0	DMSO	380.157244	4	E	pluskal_fda_drugs_5005_E4_id
584	HY-17395	HYCPK40904	N15	HYCPK40904	91z	1325.0	3.0	AB29	904.0	N15	78628-80-5	Terbinafine hydrochloride	TDT 067 hydrochloride	327.89	Antibiotic; Bacterial; Fungal	Anti-infection	Terbinafine hydrochloride (TDT 067 hydrochloride) is an orally active and potent antifungal agent. Terbinafine hydrochloride is a potent non-competitive inhibitor of squalene epoxidase from Candida, with a Ki of 30 nM. Terbinafine hydrochloride also shows antibacterial activity against certain Gram-positive and Gram-negative bacteria[1][2][3].	Hydrochloride	C21H26ClN	41201.0	DMSO : 60 mg/mL (182.99 mM; Need ultrasonic); H2O : 1 mg/mL (3.05 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	CN(C/C([H])=C([H])/C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C21.[H]Cl	https://www.medchemexpress.com/terbinafine-hydrochloride.html	Launched		91.0	AB29	E4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17395	10.0	mM	100.0	DMSO	291.1987	4	E	pluskal_fda_drugs_5005_E4_id
674	HY-101481	HYCPK40903	H18	HYCPK40903	91z	708.0	2.0	O36	903.0	H18	91503-79-6	Flurbiprofen axetil		330.35	COX	Immunology/Inflammation	Flurbiprofen axetil is a non-selective cyclooxygenase (COX) inhibitor. Flurbiprofen axetil has anti-inflammatory effect[1].		C19H19FO4	158974.0	DMSO : 250 mg/mL (756.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OC(OC(C)=O)C)C(C)C1=CC=C(C2=CC=CC=C2)C(F)=C1	https://www.medchemexpress.com/flurbiprofen-axetil.html	Launched		91.0	O36	E4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101481	10.0	mM	100.0	DMSO	330.126737	4	E	pluskal_fda_drugs_5005_E4_id
813	HY-14290A	HYCPK40904	B08	HYCPK40904	91z	159.0	3.0	D15	904.0	B08	85371-64-8	Pinacidil (monohydrate)	P-1134 (monohydrate)	263.34	Potassium Channel	Membrane Transporter/Ion Channel	Pinacidil (P-1134) monohydrate, an antihypertensive drug, is a potassium channel activator.	hydrate	C13H21N5O	133926.0	Ethanol : 50 mg/mL (189.87 mM; Need ultrasonic); DMSO : 100 mg/mL (379.74 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Others	[H]O[H].CC(C)(C)C(N/C(NC#N)=N/C1=CC=NC=C1)C	https://www.medchemexpress.com/Pinacidil_monohydrate.html	Launched		91.0	D15	E4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14290A	10.0	mM	100.0	DMSO	245.164046	4	E	pluskal_fda_drugs_5005_E4_id
969	HY-B0742	HYCPK40904	B18	HYCPK40904	91z	179.0	3.0	D35	904.0	B18	630-56-8	Hydroxyprogesterone caproate	17α-Hydroxyprogesterone hexanoate; 17α-Hydroxyprogesterone caproate	428.60	Others	Others	Hydroxyprogesterone caproate is a synthetic, steroidal progestin; an ester derivative of 17α-hydroxyprogesterone formed from caproic acid.	Free Base	C27H40O4	16466.0	H2O : 0.1 mg/mL (0.23 mM; Need ultrasonic); DMSO : 50 mg/mL (116.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CC([C@@]1(OC(CCCCC)=O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O	https://www.medchemexpress.com/Hydroxyprogesterone-caproate.html	Launched		91.0	D35	E4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0742	10.0	mM	100.0	DMSO	428.29266	4	E	pluskal_fda_drugs_5005_E4_id
436	HY-B0691A	HYCPK40903	I04	HYCPK40903	91z	776.0	2.0	Q8	903.0	I04	86408-72-2	Ecabet (sodium)	TA-2711	402.48	Apoptosis; Bacterial; Reactive Oxygen Species	Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Ecabet sodium  (TA-2711) is currently applied to some gastrointestinal disease by inhibiting the ROS production and improving Helicobacter pylori eradication[1]. Ecabet sodium reduces apoptosis[2].	Sodium	C20H27NaO5S	46048.0	DMSO : 100 mg/mL (248.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@]1(C)CCC[C@]2(C)C3=C(CC[C@@]12[H])C=C(C(C)C)C(S(=O)(O)=O)=C3)O[Na]	https://www.medchemexpress.com/ecabet-sodium.html	Launched		91.0	Q8	E5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0691A	10.0	mM	101.0	DMSO	380.165745	5	E	pluskal_fda_drugs_5005_E5_id
481	HY-B1123	HYCPK40903	F07	HYCPK40903	91z	494.0	2.0	K14	903.0	F07	34031-32-8	Auranofin	SKF-39162	680.50	Bacterial; SARS-CoV	Anti-infection	Auranofin (SKF-39162) is a thioredoxin reductase (TrxR) inhibitor with an IC50 of 0.2 μM. Auranofin exhibits antiviral activity against SARS-CoV21, with a CC50 of 4.2?μM for monkey kidney Vero E6 cells.	Free Base	C20H36AuO9PS	118341.0	DMSO : 50 mg/mL (73.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	CC(O[C@@H]1[C@@H](OC(C)=O)[C@H]([SH-][Au+]P(CC)(CC)CC)O[C@H](COC(C)=O)[C@H]1OC(C)=O)=O	https://www.medchemexpress.com/Auranofin.html	Launched		91.0	K14	E5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1123	10.0	mM	101.0	DMSO	680.148334	5	E	pluskal_fda_drugs_5005_E5_id
737	HY-B0097	HYCPK40904	A03	HYCPK40904	91z	53.0	3.0	B5	904.0	A03	50-91-9	Floxuridine	5-Fluorouracil 2'-deoxyriboside	246.19	Apoptosis; Bacterial; CMV; DNA/RNA Synthesis; HSV; Nucleoside Antimetabolite/Analog	Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Floxuridine (5-Fluorouracil 2'-deoxyriboside) is a?pyrimidine?analog?and known as an?oncology antimetabolite. Floxuridine inhibits Poly(ADP-Ribose) polymerase and induces DNA damage by activating the ATM and ATR checkpoint signaling pathways in vitro. Floxuridine is a extreamly potent inhibitor for S. aureus infection and induces cell apoptosis[1][2]. Floxuridine has antiviral effects against HSV and CMV[3].	Free Base	C9H11FN2O5	27264.0	DMSO : 250 mg/mL (1015.48 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (203.10 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	OC[C@@H]1[C@H](C[C@H](N2C(NC(C(F)=C2)=O)=O)O1)O	https://www.medchemexpress.com/floxuridine.html	Launched		91.0	B5	E5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0097	10.0	mM	101.0	DMSO	246.0652	5	E	pluskal_fda_drugs_5005_E5_id
834	HY-B0891	HYCPK40904	G09	HYCPK40904	91z	641.0	3.0	N17	904.0	G09	68-96-2	17α-Hydroxyprogesterone	17-Hydroxyprogesterone; 17-OHP	330.46	Endogenous Metabolite; Progesterone Receptor	Metabolic Enzyme/Protease; Others	17α-Hydroxyprogesterone (17-Hydroxyprogesterone) is an endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones, including the corticosteroids and the androgens and the estrogens.	Free Base	C21H30O3	17150.0	DMSO : 50 mg/mL (151.30 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Others	CC([C@@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O	https://www.medchemexpress.com/17-Hydroxyprogesterone.html	Launched		91.0	N17	E5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0891	10.0	mM	101.0	DMSO	330.219495	5	E	pluskal_fda_drugs_5005_E5_id
836	HY-17395A	HYCPK40904	I09	HYCPK40904	91z	833.0	3.0	R17	904.0	I09	91161-71-6	Terbinafine	TDT 067	291.43	Antibiotic; Bacterial; Fungal	Anti-infection	Terbinafine (TDT 067) is an orally active and potent antifungal agent. Terbinafine is a potent non-competitive inhibitor of squalene epoxidase from Candida, with a Ki of 30 nM. Terbinafine also shows antibacterial activity against certain Gram-positive and Gram-negative bacteria[1][2][3].	Free Base	C21H25N	11682.0	DMSO : ≥ 100 mg/mL (343.14 mM)	DMSO Solution	10mM  * 100uL	Infection	CN(C/C=C/C#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1	https://www.medchemexpress.com/Terbinafine.html	Launched		91.0	R17	E5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17395A	10.0	mM	101.0	DMSO	291.1987	5	E	pluskal_fda_drugs_5005_E5_id
854	HY-W013136	HYCPK40904	K10	HYCPK40904	91z	1027.0	3.0	V19	904.0	K10	620-67-7	Triheptanoin		428.61	Others	Others	Triheptanoin (Propane-1,2,3-triyl triheptanoate) is a synthetic medium-chain triglyceride (MCT) consisting of three odd-chain 7-carbon (heptanoate) fatty acids on a glycerol backbone. Triheptanoin can be used for the research of inherited metabolic disorders[1].		C24H44O6	98994.0	DMSO : 100 mg/mL (233.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCCCCCC(OCC(OC(CCCCCC)=O)COC(CCCCCC)=O)=O	https://www.medchemexpress.com/triheptanoin.html	Launched		91.0	V19	E5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W013136	10.0	mM	101.0	DMSO	428.313789	5	E	pluskal_fda_drugs_5005_E5_id
1002	HY-N1429	HYCPK40904	C20	HYCPK40904	91z	279.0	3.0	F39	904.0	C20	6009-98-9	Taurochenodeoxycholic acid (sodium)	12-Deoxycholyltaurine (sodium)	521.69	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	Taurochenodeoxycholic acid (12-Deoxycholyltaurine) sodium is one of the main bioactive substances of animals' bile acid. Taurochenodeoxycholic acid sodium induces apoptosis and shows obvious anti-inflammatory and immune regulation properties[1][2].	Sodium	C26H44NNaO6S	85652.0	DMSO : 100 mg/mL (191.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@H](CCC(NCCS(=O)(O[Na])=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C	https://www.medchemexpress.com/taurochenodeoxycholic-acid-sodium-salt.html	Launched		91.0	F39	E5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1429	10.0	mM	101.0	DMSO	499.296759	5	E	pluskal_fda_drugs_5005_E5_id
1343	HY-12961A	HYCPK40905	H21	HYCPK40905	91z	762.0	4.0	P42	905.0	H21	61-75-6	Bretylium (tosylate)		414.36	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	"Bretylium (tosylate) is an inhibitor of the presynaptic release of vasoconstrictor neurotransmitters. It is the sympathetic nerve and adrenergic ganglion blocking agent .
(1) Bretylium tosylate inhibits adrenergic function presynaptically only after an initial release in neurotransmitter substance.
(2) The reference for administration dose is 15 mg/kg (I.P)."	Tosylate	C18H24BrNO3S	21194.0	DMSO : ≥ 30 mg/mL (72.40 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+](C)(CC)CC1=CC=CC=C1Br.O=S(C2=CC=C(C)C=C2)([O-])=O	https://www.medchemexpress.com/Bretylium-tosylate.html	Launched		91.0	P42	E5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12961A	10.0	mM	101.0	DMSO	172.019415	5	E	pluskal_fda_drugs_5005_E5_id
146	HY-10564	HYCPK40902	L08	HYCPK40902	91z	1071.0	1.0	W15	902.0	L08	135159-51-2	Sarpogrelate (hydrochloride)	MCI-9042	465.97	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Sarpogrelate hydrochloride (MCI-9042) is a selective 5-HT2R antagonist, with pKis of 8.52, 6.57, and 7.43 for 5-HT2A, 5-HT2B, and 5-HT2C receptors, respectively. Sarpogrelate hydrochloride displays selectivity over 5-HT1, 5-HT3, 5-HT4, α1-, α2- and β-adrenoreceptor, histamine H1, H2 and muscarinic M3 receptors. Sarpogrelate hydrochloride can be used for the research of vascular disease associated with thrombosis[1][2][3].	Hydrochloride	C24H32ClNO6	13640.0	DMSO : ≥ 62 mg/mL (133.06 mM); H2O : 33.33 mg/mL (71.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	COC1=CC=CC(CCC2=CC=CC=C2OCC(CN(C)C)OC(CCC(O)=O)=O)=C1.Cl	https://www.medchemexpress.com/Sarpogrelate-hydrochloride.html	Launched		91.0	W15	E6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10564	10.0	mM	102.0	DMSO	429.215138	6	E	pluskal_fda_drugs_5005_E6_id
204	HY-108256	HYCPK40902	J12	HYCPK40902	91z	887.0	1.0	S23	902.0	J12	10563-70-9	Melitracen (hydrochloride)		327.89	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Melitracen hydrochloride is an orally active biphasic antidepressant and antianxiety agent. Melitracen hydrochloride can inhibit the uptake of Norepinephrine and 5-HT (serotonin) through the presynaptic membrane inducing the increase of monoamine transmitters in synaptic space[1][2].	Hydrochloride	C21H26ClN	64121.0	H2O : 100 mg/mL (304.98 mM; Need ultrasonic); DMSO : 100 mg/mL (304.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN(C)CC/C=C1C2=C(C=CC=C2)C(C)(C)C3=CC=CC=C/13.Cl	https://www.medchemexpress.com/melitracen-hydrochloride.html	Launched		91.0	S23	E6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108256	10.0	mM	102.0	DMSO	291.1987	6	E	pluskal_fda_drugs_5005_E6_id
410	HY-B0747	HYCPK40902	J21	HYCPK40902	91z	905.0	1.0	S41	902.0	J21	86227-47-6	Eicosapentaenoic acid ethyl ester	EPA ethyl ester; Ethyl eicosapentaenoate	330.50	Endogenous Metabolite	Metabolic Enzyme/Protease	Eicosapentaenoic acid ethyl ester is an omega-3 fatty acid agent.	Free Base	C22H34O2	39125.0	Ethanol : 50 mg/mL (151.29 mM; Need ultrasonic); DMSO : 33.33 mg/mL (100.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(OCC)=O	https://www.medchemexpress.com/Eicosapentaenoic-acid-ethyl-ester.html	Launched		91.0	S41	E6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0747	10.0	mM	102.0	DMSO	330.25588	6	E	pluskal_fda_drugs_5005_E6_id
416	HY-B0242	HYCPK40902	H22	HYCPK40902	91z	715.0	1.0	O43	902.0	H22	63-74-1	Sulfanilamide	Sulphanilamide	172.20	Antibiotic; Bacterial	Anti-infection	ulfanilamide (Sulphanilamide) is a potent and orally active sulfonamide antibiotic and can be a major intermediate of sulfamethoxazole biodegradation. Sulfanilamide also is a carbonic anhydrase inhibitor. Sulfanilamide shows inhibition on virus of lymphogranuloma venereum[1][2][3][4].	Free Base	C6H8N2O2S	15986.0	DMSO : 100 mg/mL (580.72 mM; Need ultrasonic); H2O : 10 mg/mL (58.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(N)=O	https://www.medchemexpress.com/Sulfanilamide.html	Launched		91.0	O43	E6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0242	10.0	mM	102.0	DMSO	172.030648	6	E	pluskal_fda_drugs_5005_E6_id
536	HY-16488	HYCPK40903	I11	HYCPK40903	91z	790.0	2.0	Q22	903.0	I11	122341-38-2	Temoporfin	m-THPC; KW2345	680.75	Others	Others	"Temoporfin(KW 2345) used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck.
Target: Others
Temoporfin used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck. Patients can remain photosensitive for several weeks after treatment."	Free Base	C44H32N4O4	221988.0	DMSO : 10 mg/mL (14.69 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	OC1=CC=CC(/C2=C3CCC(/C(C4=CC(O)=CC=C4)=C5C=C/C(N/5)=C(C6=CC(O)=CC=C6)/C(C=C/7)=NC7=C(C8=CC(O)=CC=C8)/C9=CC=C2N9)=N\3)=C1	https://www.medchemexpress.com/Temoporfin.html	Launched		91.0	Q22	E6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16488	10.0	mM	102.0	DMSO	680.242356	6	E	pluskal_fda_drugs_5005_E6_id
1036	HY-N2027	HYCPK40904	E22	HYCPK40904	91z	475.0	3.0	J43	904.0	E22	516-35-8	Taurochenodeoxycholic acid	12-Deoxycholyltaurine	499.70	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	Taurochenodeoxycholic acid (12-Deoxycholyltaurine) is one of the main bioactive substances of animals' bile acid. Taurochenodeoxycholic acid induces apoptosis and shows obvious anti-inflammatory and immune regulation properties[1][2].	Free Acid	C26H45NO6S	147059.0	DMSO : ≥ 25 mg/mL (50.03 mM); H2O : 100 mg/mL (200.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]1([C@@]2([H])[C@H](C)CCC(NCCS(=O)(O)=O)=O)[C@](CC2)([H])[C@@]([C@@H](C[C@]3([H])C[C@H](O)CC4)O)([H])[C@]([C@]34C)([H])CC1	https://www.medchemexpress.com/Taurochenodeoxycholic_acid.html	Launched		91.0	J43	E6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N2027	10.0	mM	102.0	DMSO	499.296759	6	E	pluskal_fda_drugs_5005_E6_id
1079	HY-14398	HYCPK40905	P04	HYCPK40905	91z	1496.0	4.0	AF8	905.0	P04	169590-42-5	Celecoxib	SC 58635	381.37	COX	Immunology/Inflammation	Celecoxib,a selective non-steroidal anti-inflammatory drug (NSAID), is a selective COX-2 inhibitor with an IC50 of 40 nM.	Free Base	C17H14F3N3O2S	19552.0	DMSO : ≥ 50 mg/mL (131.11 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CC1=CC=C(C=C1)C2=CC(C(F)(F)F)=NN2C3=CC=C(C=C3)S(=O)(N)=O	https://www.medchemexpress.com/Celecoxib.html	Launched		91.0	AF8	E6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14398	10.0	mM	102.0	DMSO	381.075882	6	E	pluskal_fda_drugs_5005_E6_id
1145	HY-B0021	HYCPK40905	B09	HYCPK40905	91z	162.0	4.0	D18	905.0	B09	3094-09-5	Doxifluridine	Ro 21-9738; 5-Fluoro-5'-deoxyuridine; 5'-DFUR	246.19	Nucleoside Antimetabolite/Analog	Cell Cycle/DNA Damage	"Doxifluridine(Ro 21-9738; 5'-DFUR) is a thymidine phosphorylase activator for PC9-DPE2 cells with IC50 of 0.62 μM. 
IC50 value: 0.62 μM(PC9-DPE2 cell).
Target: Nucleoside antimetabolite/analog
Doxifluridine is a fluoropyrimidine derivative and oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU) with antitumor activity. Doxifluridine, designed to circumvent the rapid degradation of 5-FU by dihydropyrimidine dehydrogenase in the gut wall, is converted into 5-FU in the presence of pyrimidine nucleoside phosphorylase. 5-FU interferes with DNA synthesis and subsequent cell division by reducing normal thymidine production and interferes with RNA transcription by competing with uridine triphosphate for incorporation into the RNA strand.
in vitro: 5'-DFUR's metabolic product(N3-Me-5'-dFUR) was found to be non-toxic in all the cell growth experiments performed. The absence of cytotoxicity could be explained by the observation that the metabolite was not recognized as a substrate by thymidine phosphorilase, the enzyme responsible for 5-fluorouracil (5-FU) release from doxifluridine, as ascertained by high-performance liquid chromatography/ultraviolet (HPLC-UV) analysis of the incubation mixture[1].
in vivo: Administration of 200 mg of Furtulon to 23 beagle dogs, the plasma concentrations of doxifluridine, 5-FU, and 5-FUrd were measured simultaneously, using LC-MS/MS. The parent-metabolite compartment model with first-order absorption and Michaelis-Menten kinetics described the pharmacokinetics of doxifluridine, 5-FU, and 5-FUrd. Michaelis-Menten kinetics sufficiently explained the generation and elimination processes of 5-FU and 5-FUrd[2].
Clinical trial: A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer was reported in 2009[3]."	Free Base	C9H11FN2O5	15614.0	DMSO : ≥ 100 mg/mL (406.19 mM); DMF : 100 mg/mL (406.19 mM; Need ultrasonic); H2O : 20 mg/mL (81.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@@H]1[C@H]([C@H]([C@H](N2C(NC(C(F)=C2)=O)=O)O1)O)O	https://www.medchemexpress.com/Doxifluridine.html	Launched		91.0	D18	E6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0021	10.0	mM	102.0	DMSO	246.0652	6	E	pluskal_fda_drugs_5005_E6_id
110	HY-N0683	HYCPK40902	D06	HYCPK40902	91z	299.0	1.0	G11	902.0	D06	59-02-9	α-Vitamin E	(+)-α-Tocopherol; D-α-Tocopherol	430.71	Bacterial; Endogenous Metabolite; Ferroptosis; Influenza Virus; Reactive Oxygen Species	Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	α-Vitamin E ((+)-α-Tocopherol), a naturally occurring vitamin E form, is a potent antioxidant[1][2].	Free Base	C29H50O2	118241.0	H2O : < 0.1 mg/mL (ultrasonic) (insoluble); DMSO : 50 mg/mL (116.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	OC1=C(C)C(C)=C2C(CC[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)O2)=C1C	https://www.medchemexpress.com/__addition__-_alpha_-Tocopherol.html	Launched		91.0	G11	E7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0683	10.0	mM	103.0	DMSO	430.381081	7	E	pluskal_fda_drugs_5005_E7_id
528	HY-B1154	HYCPK40903	A11	HYCPK40903	91z	22.0	2.0	A22	903.0	A11	38363-32-5	Penbutolol (sulfate)	(-)-Terbuclomine	340.47	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Penbutolol sulfate is able to bind to both beta-1 adrenergic receptors and beta-2 adrenergic receptors (the two subtypes), thus making it a non-selective β blocker. Penbutolol is a sympathomimetic drug，used in the treatment of high blood pressure.	Sulfate	C18H29NO2.1/2H2SO4	36496.0	H2O : 5 mg/mL (14.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O[C@@H](CNC(C)(C)C)COC1=CC=CC=C1C2CCCC2.[0.5H2SO4]	https://www.medchemexpress.com/Penbutolol-sulfate.html	Launched		91.0	A22	E7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1154	10.0	mM	103.0	DMSO	291.219829	7	E	pluskal_fda_drugs_5005_E7_id
799	HY-B0462	HYCPK40904	D07	HYCPK40904	91z	349.0	3.0	H13	904.0	D07	79307-93-0	Azelastine (hydrochloride)		418.36	Histamine Receptor; SARS-CoV	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Azelastine hydrochloridem, an antihistamine, is a potent and selective histamine 1 (H1) antagonist. Azelastine hydrochloride can be used for the research of allergic rhinitis, asthma, diabetic hyperlipidemic and SARS-CoV-2[1][2][3][4].	Hydrochloride	C22H25Cl2N3O	15671.0	H2O : 6.67 mg/mL (15.94 mM; Need ultrasonic); DMSO : 50 mg/mL (119.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Endocrinology; Metabolic Disease; Inflammation/Immunology	O=C1N(C2CCN(C)CCC2)N=C(CC3=CC=C(Cl)C=C3)C4=C1C=CC=C4.Cl	https://www.medchemexpress.com/Azelastine-hydrochloride.html	Launched		91.0	H13	E7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0462	10.0	mM	103.0	DMSO	381.16079	7	E	pluskal_fda_drugs_5005_E7_id
928	HY-B0578A	HYCPK40904	E15	HYCPK40904	91z	461.0	3.0	J29	904.0	E15	80382-23-6	Loxoprofen (sodium)		268.28	COX	Immunology/Inflammation	Loxoprofen sodium is a non-steroidal, orally active anti-inflammatory agent with analgesic and anti-pyretic properties. Loxoprofen sodium is a nonselective COX inhibitor with IC50s of 6.5 and 13.5 μM for COX-1 and COX-2, respectively. Loxoprofen sodium can reduce atherosclerosis and shows antitumor activity[1][2][3][4].	Sodium	C15H17NaO3	78630.0	DMSO : 19.23 mg/mL (71.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Cardiovascular Disease	O=C1C(CCC1)CC2=CC=C(C(C)C(O[Na])=O)C=C2	https://www.medchemexpress.com/loxoprofen-sodium.html	Launched		91.0	J29	E7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0578A	10.0	mM	103.0	DMSO	246.125594	7	E	pluskal_fda_drugs_5005_E7_id
1001	HY-N0276	HYCPK40904	B20	HYCPK40904	91z	183.0	3.0	D39	904.0	B20	77181-26-1	Flaconitine	Acetylaconitine; 3-Acetylaconitine	687.77	NF-κB	NF-κB	Flaconitine is considered to be a NF-κB inhibitor.	Free Base	C36H49NO12	112281.0	DMSO : 50 mg/mL (72.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CO[C@@H]1C2([C@@](C[C@@]3(O)[C@@H]4OC(C5=CC=CC=C5)=O)([H])[C@@]4([H])[C@](OC(C)=O)([C@@H](O)[C@@H]3OC)C6C2N(CC)C7)[C@@]([C@H]6OC)([H])[C@@]7(COC)[C@H](OC(C)=O)C1	https://www.medchemexpress.com/Flaconitine.html	Launched		91.0	D39	E7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0276	10.0	mM	103.0	DMSO	687.325476	7	E	pluskal_fda_drugs_5005_E7_id
1051	HY-B0779	HYCPK40905	D03	HYCPK40905	91z	342.0	4.0	H6	905.0	D03	6809-52-5	Teprenone	Geranylgeranylacetone	330.55	HSP	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Teprenone is an anti-ulcer drug, and works as an inducer of heat shock proteins (HSPs).	Free Base	C23H38O	85825.0	DMSO : 100 mg/mL (302.53 mM; Need ultrasonic); Ethanol : 50 mg/mL (151.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC(CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)\C)=O	https://www.medchemexpress.com/Teprenone.html	Launched		91.0	H6	E7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0779	10.0	mM	103.0	DMSO	330.292266	7	E	pluskal_fda_drugs_5005_E7_id
1078	HY-B0332	HYCPK40905	O04	HYCPK40905	91z	1400.0	4.0	AD8	905.0	O04	58-27-5	Menadione	Vitamin K3	172.18	Endogenous Metabolite	Metabolic Enzyme/Protease	"Menadione, a naphthoquinone, can be converted to active vitamin K2 in vivo.
Target: Others
Menadione (Vitamin K3) is a synthetic analogue of of 1,4-naphthoquinone with a methyl group in the 2-position. Menadione is used as a phosphatase inhibitor and an inhibitor of mitochondrial DNA polymerase γ (pol γ). Menadione can be used as an oxidative injury (free radical generator) inducing agent [1]."	Free Base	C11H8O2	15374.0	DMSO : 50 mg/mL (290.39 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C1C(C)=CC(C2=C1C=CC=C2)=O	https://www.medchemexpress.com/Menadione.html	Launched		91.0	AD8	E7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0332	10.0	mM	103.0	DMSO	172.052429	7	E	pluskal_fda_drugs_5005_E7_id
1230	HY-19594	HYCPK40905	G14	HYCPK40905	91z	652.0	4.0	N28	905.0	G14	5560-78-1	Teclozan	WIN 13146	502.26	Parasite	Anti-infection	Teclozan (WIN 13146) is an antiprotozoal agent, class in benzylamine derivatives. Teclozan intervenes in the phospholipid metabolism preventes the formation of arachidonic acid. Teclozan acts in the intestinal lumen being effective in Anti-G. intestinalis. Teclozan can be used for the research of protozoan infections[1][2].		C20H28Cl4N2O4	124550.0	DMSO : 62.5 mg/mL (124.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N(CC1=CC=C(CN(CCOCC)C(C(Cl)Cl)=O)C=C1)CCOCC)C(Cl)Cl	https://www.medchemexpress.com/teclozan.html	Launched		91.0	N28	E7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19594	10.0	mM	103.0	DMSO	500.080318	7	E	pluskal_fda_drugs_5005_E7_id
185	HY-B1424	HYCPK40902	G11	HYCPK40902	91z	597.0	1.0	M21	902.0	G11	91-33-8	Benzthiazide		431.94	Carbonic Anhydrase	Metabolic Enzyme/Protease	Benzthiazide is a long-acting diuretic[1] and a hypertension agent. Benzthiazide is an inhibitor of carbonic anhydrase 9 (CA9), with Kis of 8.0, 8.8 and 10 nM for CA9, CA2 and CA1, respectively. Benzthiazide also suppresses proliferation of cancer cells[2].	Free Base	C15H14ClN3O4S3	36754.0	DMSO : 50 mg/mL (115.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=S(C1=C(Cl)C=C(C2=C1)NC(CSCC3=CC=CC=C3)=NS2(=O)=O)(N)=O	https://www.medchemexpress.com/Benzthiazide.html	Launched		91.0	M21	E8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1424	10.0	mM	104.0	DMSO	430.983497	8	E	pluskal_fda_drugs_5005_E8_id
580	HY-101820	HYCPK40904	D05	HYCPK40904	91z	345.0	3.0	H9	904.0	D05	944258-89-3	Simotinib		500.95	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Simotinib is a selective, specific, and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 19.9 nM. Antineoplastic activities[1].		C25H26ClFN4O4	153174.0	DMSO : 125 mg/mL (249.53 mM; ultrasonic and adjust pH to 3 with HCl)	DMSO Solution	10mM  * 100uL	Cancer	COC1=CC2=C(C(NC(C=C3)=CC(Cl)=C3F)=NC=N2)C=C1OCCN4CC5(CC5)C6(OCCO6)C4	https://www.medchemexpress.com/simotinib.html	Launched		91.0	H9	E8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101820	10.0	mM	104.0	DMSO	500.162661	8	E	pluskal_fda_drugs_5005_E8_id
598	HY-B1063	HYCPK40903	L13	HYCPK40903	91z	1082.0	2.0	W26	903.0	L13	2451-01-6	Terpin (hydrate)	Terpin monohydrate; cis-Terpin hydrate	190.28	Others	Others	Terpin hydrate is an expectorant, commonly used to loosen mucus in patients presenting with acute or chronic bronchitis, and related conditions.	Free Base	C10H22O3	17676.0	H2O : 1 mg/mL (5.26 mM; ultrasonic and warming and heat to 60°C); DMSO : ≥ 100 mg/mL (525.54 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O[C@]1(C)CC[C@H](C(C)(C)O)CC1.O	https://www.medchemexpress.com/Terpin-hydrate.html	Launched		91.0	W26	E8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1063	10.0	mM	104.0	DMSO	172.14633	8	E	pluskal_fda_drugs_5005_E8_id
852	HY-121276	HYCPK40904	I10	HYCPK40904	91z	835.0	3.0	R19	904.0	I10	2062-84-2	Benperidol		381.44	Others	Others	Benperidol is a relatively old antipsychotic drug. Benperidol is a butyrophenone antipsychotic, with the highest neuroleptic potency in terms of D2 receptor blockade[1].		C22H24FN3O2	152234.0	DMSO : 100 mg/mL (262.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1NC2=CC=CC=C2N1C3CCN(CC3)CCCC(C4=CC=C(C=C4)F)=O	https://www.medchemexpress.com/benperidol.html	Launched		91.0	R19	E8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-121276	10.0	mM	104.0	DMSO	381.185255	8	E	pluskal_fda_drugs_5005_E8_id
869	HY-116790A	HYCPK40904	J11	HYCPK40904	91z	933.0	3.0	T21	904.0	J11	38363-41-6	(+)-Penbutolol	(R)-Penbutolol; (+)-Isopenbutolol	291.43	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	(+)-Penbutolol is a β-adrenoceptor antagonist, with an IC50 of 0.74 μM[1]. (+)-Penbutolol is an optical isomer of l-penbutolol with Na+ channel-blocking action[2].	Free Base	C18H29NO2	36495.0	DMSO : 100 mg/mL (343.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Endocrinology	O[C@@H](COC1=C(C=CC=C1)C2CCCC2)CNC(C)(C)C	https://www.medchemexpress.com/__addition__-Penbutolol.html	Launched		91.0	T21	E8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-116790A	10.0	mM	104.0	DMSO	291.219829	8	E	pluskal_fda_drugs_5005_E8_id
964	HY-16059	HYCPK40904	M17	HYCPK40904	91z	1233.0	3.0	Z33	904.0	M17	84692-91-1	Arglabin	(+)-Arglabin	246.30	Autophagy; Farnesyl Transferase; NOD-like Receptor (NLR)	Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease	Arglabin ((+)-Arglabin), a natural product isolated from Artemisia glabella, is a NLRP3 inflammasome inhibitor. Arglabin shows anti-inflammatory and antitumor activities[1]. The antitumor activity of Arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene[2].	Free Base	C15H18O3	18774.0	DMSO : ≥ 100 mg/mL (406.01 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	C[C@]1(CC[C@](C2=C)([H])[C@@](OC2=O)([H])[C@@]3([H])C(C)=CC4)[C@]34O1	https://www.medchemexpress.com/Arglabin.html	Launched		91.0	Z33	E8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16059	10.0	mM	104.0	DMSO	246.125594	8	E	pluskal_fda_drugs_5005_E8_id
1071	HY-13578	HYCPK40905	H04	HYCPK40905	91z	728.0	4.0	P8	905.0	H04	69304-47-8	Brivudine	Bromovinyldeoxyuridine; BVDU	333.14	CMV	Anti-infection	Brivudine is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster.	Free Base	C11H13BrN2O5	23884.0	DMSO : 200 mg/mL (600.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	OC[C@@H]1[C@H](C[C@H](N2C(NC(C(/C=C/Br)=C2)=O)=O)O1)O	https://www.medchemexpress.com/Brivudine.html	Launched		91.0	P8	E8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13578	10.0	mM	104.0	DMSO	332.000784	8	E	pluskal_fda_drugs_5005_E8_id
1126	HY-13674	HYCPK40905	O07	HYCPK40905	91z	1406.0	4.0	AD14	905.0	O07	35846-53-8	Maytansine	NSC 153858	692.20	Microtubule/Tubulin	Cell Cycle/DNA Damage; Cytoskeleton	Maytansine is a highly potent microtubule-targeted compound that induces mitotic arrest and kills tumor cells at subnanomolar concentrations[1].		C34H46ClN3O10	113137.0	DMSO : 100 mg/mL (144.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@]12[C@@]([C@@H]([C@]3([H])C[C@]([C@@H](/C=C/C=C(CC4=CC(N(C(C[C@@H]2OC([C@H](C)N(C)C(C)=O)=O)=O)C)=C(C(OC)=C4)Cl)\C)OC)(NC(O3)=O)O)C)([H])O1	https://www.medchemexpress.com/maytansine.html	Launched		91.0	AD14	E8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13674	10.0	mM	104.0	DMSO	691.287172	8	E	pluskal_fda_drugs_5005_E8_id
101	HY-B0160	HYCPK40902	K05	HYCPK40902	91z	969.0	1.0	U9	902.0	K05	118288-08-7	Lafutidine	FRG-8813	431.55	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Lafutidine (FRG-8813) is a histamine H2-receptor  antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].	Free Base	C22H29N3O4S	11964.0	DMSO : ≥ 50 mg/mL (115.86 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Endocrinology	O=C(NC/C=C\COC1=NC=CC(CN2CCCCC2)=C1)CS(CC3=CC=CO3)=O	https://www.medchemexpress.com/lafutidine.html	Launched		91.0	U9	E9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0160	10.0	mM	105.0	DMSO	431.187877	9	E	pluskal_fda_drugs_5005_E9_id
151	HY-14751	HYCPK40902	A09	HYCPK40902	91z	17.0	1.0	A17	902.0	A09	552292-08-7	Rolapitant	SCH619734	500.48	Neurokinin Receptor	GPCR/G Protein; Neuronal Signaling	Rolapitant (SCH619734) is a potent, selective, long-acting and orally active neurokinin 1 (NK1) receptor antagonist with a Ki of 0.66 nM. Rolapitant does not interact with CYP3A4. Rolapitant shows potent anti-emetic activity in a ferret emesis model[1][2].	Free Base	C25H26F6N2O2	24224.0	DMSO : ≥ 30 mg/mL (59.94 mM)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	C[C@@](C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1)([H])OC[C@@]2(C3=CC=CC=C3)CC[C@@](CCC4=O)(N4)CN2	https://www.medchemexpress.com/Rolapitant.html	Launched		91.0	A17	E9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14751	10.0	mM	105.0	DMSO	500.189847	9	E	pluskal_fda_drugs_5005_E9_id
227	HY-B1442	HYCPK40902	A14	HYCPK40902	91z	27.0	1.0	A27	902.0	A14	99-15-0	Acetylleucine	N-Acetyl-DL-leucine	173.21	Others	Others	Acetylleucine (N-Acetyl-DL-leucine), orally active compound, can be used for the research of acute vestibular vertigo, cerebellar ataxia and nystagmus[1][2].	Free Acid	C8H15NO3	17259.0	H2O : 6.67 mg/mL (38.51 mM; Need ultrasonic); DMSO : 120 mg/mL (692.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CC(C)CC(C(O)=O)NC(C)=O	https://www.medchemexpress.com/Acetylleucine.html	Launched		91.0	A27	E9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1442	10.0	mM	105.0	DMSO	173.105193	9	E	pluskal_fda_drugs_5005_E9_id
260	HY-D0251	HYCPK40902	B16	HYCPK40902	91z	127.0	1.0	C31	902.0	B16	2321-07-5	Fluorescein	Uranine	332.31	Others	Others	Fluorescein (Uranine) is widely used as a fluorescent tracer in medicinal and biological applications and tumor infected tissues tracer. Fluorescein (Uranine) is a representative green fluorophore that has been widely used as a scaffold of practically useful green fluorescent probes[1][2].	Free Acid	C20H12O5	25763.0	DMSO : 250 mg/mL (752.31 mM; Need ultrasonic); H2O : 1 mg/mL (3.01 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C1OC2(C3=C(OC4=C2C=CC(O)=C4)C=C(O)C=C3)C5=C1C=CC=C5	https://www.medchemexpress.com/Fluorescein.html	Launched		91.0	C31	E9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0251	10.0	mM	105.0	DMSO	332.068473	9	E	pluskal_fda_drugs_5005_E9_id
287	HY-W013272	HYCPK40902	M17	HYCPK40902	91z	1185.0	1.0	Y33	902.0	M17	52806-53-8	Hydroxyflutamide	HFT	292.21	Androgen Receptor	Others	Hydroxyflutamide (HF), an active metabolite of Flutamide, is a potent androgen receptor antagonist (IC50=700 nM). Hydroxyflutamide can be used for the research of prostate cancer[1][2].		C11H11F3N2O4	154419.0	DMSO : 100 mg/mL (342.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC(C)(O)C(NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1)=O	https://www.medchemexpress.com/hydroxyflutamide.html	Launched		91.0	Y33	E9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W013272	10.0	mM	105.0	DMSO	292.067091	9	E	pluskal_fda_drugs_5005_E9_id
321	HY-125840	HYCPK40902	I20	HYCPK40902	91z	807.0	1.0	Q39	902.0	I20	1672668-24-4	Belzutifan	PT2977; MK-6482	383.34	HIF/HIF Prolyl-Hydroxylase	Metabolic Enzyme/Protease	Belzutifan (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of  9 nM. Belzutifan, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. Belzutifan is a potential treatment for clear cell renal cell carcinoma (ccRCC)[1].	Free Base	C17H12F3NO4S	67639.0	DMSO : 50 mg/mL (130.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	N#CC1=CC(F)=CC(OC2=CC=C(S(=O)(C)=O)C3=C2[C@@H](F)[C@@H](F)[C@H]3O)=C1	https://www.medchemexpress.com/pt2977.html	Launched		91.0	Q39	E9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-125840	10.0	mM	105.0	DMSO	383.043914	9	E	pluskal_fda_drugs_5005_E9_id
512	HY-B0168A	HYCPK40903	A10	HYCPK40903	91z	20.0	2.0	A20	903.0	A10	101152-94-7	Milnacipran (hydrochloride)		282.81	Serotonin Transporter	Neuronal Signaling	"Milnacipran hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia.
Target: SNRI
Milnacipran (Ixel, Savella, Dalcipran, Toledomin) is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia. It is not approved for the clinical treatment of major depressive disorder in the USA, but it is in other countries.
Milnacipran inhibits the reuptake of serotonin and norepinephrine in an approximately 1:3 ratio, respectively; in practical use this means a relatively balanced action upon bothneurotransmitters. Increasing both neurotransmitters concentration simultaneously works synergistically to treat both depression and fibromyalgia. Milnacipran exerts no significant actions onH1, α1, D1, D2, and mACh receptors, as well as on benzodiazepine and opioid binding sites. Milnacipran is well absorbed after oral dosing and has a bioavailability of 85%. Meals do not have an influence on the rapidity and extent of absorption. Peak plasma concentrations are reached 2 hours after oral dosing. The elimination half-life of 8 hours is not increased by liver impairment and old age, but by significant renal disease. Milnacipran is conjugated to the inactive glucuronide and excreted in the urine as unchanged drug and conjugate. Only traces of active metabolites are found."	Hydrochloride	C15H23ClN2O	11706.0	H2O : ≥ 100 mg/mL (353.59 mM); DMSO : ≥ 48 mg/mL (169.73 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C([C@@]1(C2=CC=CC=C2)[C@@H](CN)C1)N(CC)CC.Cl	https://www.medchemexpress.com/milnacipran-hydrochloride.html	Launched		91.0	A20	E9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0168A	10.0	mM	105.0	DMSO	246.173213	9	E	pluskal_fda_drugs_5005_E9_id
905	HY-B1907	HYCPK40904	N13	HYCPK40904	91z	1321.0	3.0	AB25	904.0	N13	14897-39-3	Rifamycin (sodium)	Rifamycin SV (sodium)	719.75	Antibiotic; Bacterial	Anti-infection	Rifamycin sodium (Rifamycin SV monosodium) belongs to the family of ansamycin antibiotics and has been isolated from the fermentation of A. mediterranei or its mutants. Rifamycin sodium displays a broad spectrum of antibiotic activity against Gram-positive and, to a lesser extent, Gram-negative bacteria[1].	Sodium	C37H46NNaO12	46698.0	DMSO : 250 mg/mL (347.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1C2=C(C([O-])=CC(NC(/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@H]3C)=O)=C4O)C4=C(O)C(C)=C2O[C@@]1(O/C=C/[C@@H]([C@H]([C@@]3([H])OC(C)=O)C)OC)C.[Na+]	https://www.medchemexpress.com/rifamycin-sodium.html	Launched		91.0	AB25	E9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1907	10.0	mM	105.0	DMSO	697.309826	9	E	pluskal_fda_drugs_5005_E9_id
133	HY-B1259	HYCPK40902	K07	HYCPK40902	91z	973.0	1.0	U13	902.0	K07	57-08-9	6-Acetamidohexanoic acid	Acexamic Acid; 6-Acetamidocaproic acid	173.21	Others	Others	6-Acetamidohexanoic acid is a pharmaceutical intermediate	Free Acid	C8H15NO3	17452.0	DMSO : 100 mg/mL (577.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(O)CCCCCNC(C)=O	https://www.medchemexpress.com/6-Acetamidohexanoic-acid.html	Launched		91.0	U13	E10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1259	10.0	mM	106.0	DMSO	173.105193	10	E	pluskal_fda_drugs_5005_E10_id
275	HY-10340	HYCPK40902	A17	HYCPK40902	91z	33.0	1.0	A33	902.0	A17	897016-82-9	Tirbanibulin	KX2-391; KX-01	431.53	Microtubule/Tubulin; Src	Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK	Tirbanibulin (KX2-391) is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.	Free Base	C26H29N3O3	62277.0	DMSO : 41.67 mg/mL (96.56 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(CC1=NC=C(C2=CC=C(OCCN3CCOCC3)C=C2)C=C1)NCC4=CC=CC=C4	https://www.medchemexpress.com/kx2-391.html	Launched		91.0	A33	E10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10340	10.0	mM	106.0	DMSO	431.220892	10	E	pluskal_fda_drugs_5005_E10_id
290	HY-Y0682	HYCPK40902	P17	HYCPK40902	91z	1473.0	1.0	AE33	902.0	P17	60-00-4	Ethylenediaminetetraacetic acid	EDTA	292.24	Others	Others	Ethylenediaminetetraacetic acid (EDTA) is a metal chelators (binds to metal divalent and trivalent cations including calcium), which shows activities of anticoagulant and anti-hypercalcemic. Ethylenediaminetetraacetic acid decreases the metal ion-catalyzed oxidative damage to proteins, and allows maintenance of reducing environment during protein purification. Ethylenediaminetetraacetic acid can also decrease the formation of disulfide bonds[1][2][3].		C10H16N2O8	26668.0	0.1 M NaOH : 6.67 mg/mL (22.82 mM; ultrasonic and warming and adjust pH to 7 with NaOH and heat to 60°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=C(O)CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O	https://www.medchemexpress.com/ethylenediaminetetraacetic-acid.html	Launched		91.0	AE33	E10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0682	10.0	mM	106.0	DMSO	292.090665	10	E	pluskal_fda_drugs_5005_E10_id
522	HY-B0588	HYCPK40903	K10	HYCPK40903	91z	980.0	2.0	U20	903.0	K10	138890-62-7	Brinzolamide	AL-4862	383.51	Carbonic Anhydrase	Metabolic Enzyme/Protease	Brinzolamide (AL-4862) is a selective carbonic anhydrase II inhibitor with anIC50 value of 3.2 nM. Brinzolamide hydrochloride reduces intraocular pressure (IOP) by inhibiting ciliary CA-II and decreasing atrial fluid secretion. Brinzolamide can be used in glaucoma disease research[1][2].	Free Base	C12H21N3O5S3	14349.0	DMSO : 100 mg/mL (260.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Others	O=S(C(S1)=CC2=C1S(N(CCCOC)C[C@@H]2NCC)(=O)=O)(N)=O	https://www.medchemexpress.com/Brinzolamide.html	Launched		91.0	U20	E10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0588	10.0	mM	106.0	DMSO	383.064334	10	E	pluskal_fda_drugs_5005_E10_id
1000	HY-13016	HYCPK40904	A20	HYCPK40904	91z	87.0	3.0	B39	904.0	A20	849217-68-1	Cabozantinib	XL184; BMS-907351	501.51	Apoptosis; c-Kit; c-Met/HGFR; FLT3; TAM Receptor; VEGFR	Apoptosis; Protein Tyrosine Kinase/RTK	Cabozantinib is a potent and orally active inhibitor of VEGFR2 and MET, with IC50 values of 0.035, and 1.3 nM, respectively. Cabozantinib displays strong inhibition of KIT, RET, AXL, TIE2, and FLT3 (IC50=4.6, 5.2, 7, 14.3, and 11.3 nM, respectively). Cabozantinib shows antiangiogenic activity. Cabozantinib disrupts tumor vasculature and promotes tumor and endothelial cell apoptosis[1][2].	Free Base	C28H24FN3O5	79158.0	DMSO : ≥ 30 mg/mL (59.82 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1(CC1)C(NC2=CC=C(F)C=C2)=O)NC3=CC=C(C=C3)OC4=C5C=C(OC)C(OC)=CC5=NC=C4	https://www.medchemexpress.com/Cabozantinib.html	Launched		91.0	B39	E10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13016	10.0	mM	106.0	DMSO	501.169999	10	E	pluskal_fda_drugs_5005_E10_id
1093	HY-B1332	HYCPK40905	N05	HYCPK40905	91z	1306.0	4.0	AB10	905.0	N05	66985-17-9	Ipratropium (bromide hydrate)	Sch 1000 (bromide hydrate)	430.38	mAChR	GPCR/G Protein; Neuronal Signaling	Ipratropium bromide (Sch 1000) hydrate is a muscarinic receptor antagonist, with IC50s of 2.9 nM, 2 nM, and 1.7 nM for M1, M2, and M3 receptors, respectively. Ipratropium bromide hydrate relaxes smooth muscle, can be used in the research for COPD (chronic obstructive pulmonary disease) and asthma[1][2][3][4][5].	Bromide	C20H32BrNO4	119888.0	H2O : 62.5 mg/mL (145.22 mM; Need ultrasonic); 10 mM in DMSO	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	C[N+]1([C@H]2CC[C@H]1CC(OC(C(CO)C3=CC=CC=C3)=O)C2)C(C)C.O.[Br-]	https://www.medchemexpress.com/ipratropium-bromide-hydrate.html	Launched		91.0	AB10	E10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1332	10.0	mM	106.0	DMSO	332.22202	10	E	pluskal_fda_drugs_5005_E10_id
1142	HY-17373	HYCPK40905	O08	HYCPK40905	91z	1408.0	4.0	AD16	905.0	O08	171228-49-2	Posaconazole	SCH 56592	700.78	Fungal; Parasite	Anti-infection	Posaconazole is a broad-spectrum, second generation, triazole compound with antifungal activity.	Free Base	C37H42F2N8O4	97134.0	DMSO : 50 mg/mL (71.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	FC1=CC=C([C@@]2(CN3C=NC=N3)C[C@H](COC4=CC=C(N5CCN(C6=CC=C(N7C=NN([C@@H](CC)[C@H](C)O)C7=O)C=C6)CC5)C=C4)CO2)C(F)=C1	https://www.medchemexpress.com/Posaconazole.html	Launched		91.0	AD16	E10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17373	10.0	mM	106.0	DMSO	700.329708	10	E	pluskal_fda_drugs_5005_E10_id
1211	HY-17427	HYCPK40905	D13	HYCPK40905	91z	362.0	4.0	H26	905.0	D13	143491-57-0	Emtricitabine	BW1592	247.25	Endogenous Metabolite; HIV; Reverse Transcriptase	Anti-infection; Metabolic Enzyme/Protease	Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) with an EC50 of 0.01 μM in PBMC cell. It is an antiviral drug for the treatment of HIV infection.	Free Base	C8H10FN3O3S	10819.0	DMSO : ≥ 100 mg/mL (404.45 mM); H2O : ≥ 25 mg/mL (101.11 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C1N=C(N)C(F)=CN1[C@@H]2CS[C@H](CO)O2	https://www.medchemexpress.com/Emtricitabine.html	Launched		91.0	H26	E10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17427	10.0	mM	106.0	DMSO	247.04269	10	E	pluskal_fda_drugs_5005_E10_id
198	HY-12044	HYCPK40902	D12	HYCPK40902	91z	311.0	1.0	G23	902.0	D12	1140909-48-3	Cabozantinib (S-malate)	XL184 (S-malate); BMS-907351 (S-malate)	635.59	Apoptosis; VEGFR	Apoptosis; Protein Tyrosine Kinase/RTK	Cabozantinib S-malate (XL184 S-malate) is a potent multiple receptor tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively.	S-Malate	C32H30FN3O10	17715.0	DMSO : ≥ 23 mg/mL (36.19 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@H](CC(O)=O)O)O.O=C(NC1=CC=C(C=C1)OC2=CC=NC3=CC(OC)=C(C=C23)OC)C4(CC4)C(NC5=CC=C(C=C5)F)=O	https://www.medchemexpress.com/Cabozantinib-S-malate.html	Launched		91.0	G23	E11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12044	10.0	mM	107.0	DMSO	501.169999	11	E	pluskal_fda_drugs_5005_E11_id
272	HY-B1888B	HYCPK40902	N16	HYCPK40902	91z	1279.0	1.0	AA31	902.0	N16	120638-55-3	Bromfenac (sodium hydrate)	Bromfenac (monosodium salt sesquihydrate)	383.17	COX	Immunology/Inflammation	Bromfenac sodium hydrate (Bromfenac monosodium salt sesquihydrate) is a potent and orally active inhibitor of COX, with IC50s of 5.56 and 7.45 nM for COX-1 and COX-2, respectively. Bromfenac sodium hydrate can be used in ocular inflammation research[1].	Sodium	C15H14BrNNaO4.5	21231.0	DMSO : ≥ 100 mg/mL (260.98 mM); H2O : ≥ 100 mg/mL (260.98 mM)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(O[Na])CC1=CC=CC(C(C2=CC=C(Br)C=C2)=O)=C1N.[1.5H2O]	https://www.medchemexpress.com/Bromfenac-sodium-hydrate.html	Launched		91.0	AA31	E11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1888B	10.0	mM	107.0	DMSO	333.000055	11	E	pluskal_fda_drugs_5005_E11_id
399	HY-B0531	HYCPK40902	H18	HYCPK40902	91z	707.0	1.0	O35	902.0	H18	322-79-2	Triflusal		248.16	COX	Immunology/Inflammation	"Triflusal irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1.
Target: COX
Triflusal at 10 mM, 100 mM and 1 M decreases LDH efflux in rat brain slices after anoxia/reoxygenation by 24%, 35% and 49% respectively. Triflusal also reduces inducible NO synthase activity by 18%, 21% and 30% [1].
Triflusal (10 mg/kg i.v.) reduces platelet deposition on subendothelium-induced primary thrombus by about 68% in rabbits. Triflusal (10 mg/kg i.v.) reduces platelet deposition on a fresh thrombus formed over tunica media by about 48% in rabbits. Triflusal (40 mg/kg p.o.) reduces platelet deposition on a primary thrombus triggered by subendothelium and tunica media by 53% in rabbits. Triflusal (40 mg/kg p.o.) significantly reduces Cox-2 mRNA levels and protein levels without influence Cox-1 mRNA levels on the vascular wall in rabbits [2]. Triflusal (600 mg/day for 5 days) results in an increase in NO production by neutrophils and an increase in endothelial nitric oxide synthase (eNOS) protein expression in neutrophils in healthy volunteers [3]."	Free Acid	C10H7F3O4	16707.0	DMSO : 100 mg/mL (402.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C1=CC=C(C(F)(F)F)C=C1OC(C)=O	https://www.medchemexpress.com/triflusal.html	Launched		91.0	O35	E11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0531	10.0	mM	107.0	DMSO	248.029643	11	E	pluskal_fda_drugs_5005_E11_id
446	HY-100373	HYCPK40903	C05	HYCPK40903	91z	202.0	2.0	E10	903.0	C05	946075-13-4	Isavuconazonium (sulfate)	BAL8557-002	814.84	Fungal	Anti-infection	Isavuconazonium sulfate (BAL8557-002), the prodrug of the active triazole Isavuconazole, is an orally active antifungal agent. Isavuconazonium sulfate is used for invasive aspergillosis and mucormycosis[1][2].	Sulfate	C35H36F2N8O9S2	112846.0	DMSO : 166.67 mg/mL (204.54 mM; Need ultrasonic); H2O : 0.5 mg/mL (0.61 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	O[C@@](CN(N=C1)C=[N+]1C(C)OC(N(C(N=CC=C2)=C2COC(CNC)=O)C)=O)(C(C=C3F)=C(C=C3)F)[C@H](C4=NC(C(C=C5)=CC=C5C#N)=CS4)C.O=[S]([O-])(O)=O	https://www.medchemexpress.com/isavuconazonium-sulfate.html	Launched		91.0	E10	E11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100373	10.0	mM	107.0	DMSO	717.24137	11	E	pluskal_fda_drugs_5005_E11_id
483	HY-B0099	HYCPK40903	H07	HYCPK40903	91z	686.0	2.0	O14	903.0	H07	89-25-8	Edaravone	MCI-186	174.20	Apoptosis; MMP	Apoptosis; Metabolic Enzyme/Protease	Edaravone is a strong novel free radical scavenger, and inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.	Free Base	C10H10N2O	16686.0	DMSO : 100 mg/mL (574.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1N(C2=CC=CC=C2)N=C(C)C1	https://www.medchemexpress.com/Edaravone.html	Launched		91.0	O14	E11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0099	10.0	mM	107.0	DMSO	174.079313	11	E	pluskal_fda_drugs_5005_E11_id
602	HY-B0309	HYCPK40903	P13	HYCPK40903	91z	1466.0	2.0	AE26	903.0	P13	72509-76-3	Felodipine		384.25	Autophagy; Calcium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Felodipine, a dihydropyridine, is a potent, vasoselective calcium channel antagonist. Felodipine lowers blood pressure (BP) by selective action on vascular smooth muscle, especially in the resistance vessels. Felodipine, an anti-hypertensive agent, induces autophagy. Felodipine can cross the blood-brain barrier[1][2][3].	Free Base	C18H19Cl2NO4	14820.0	DMSO : 100 mg/mL (260.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC(Cl)=C2Cl)OCC	https://www.medchemexpress.com/felodipine.html	Launched		91.0	AE26	E11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0309	10.0	mM	107.0	DMSO	383.069113	11	E	pluskal_fda_drugs_5005_E11_id
784	HY-10340B	HYCPK40904	E06	HYCPK40904	91z	443.0	3.0	J11	904.0	E06	1080645-95-9	Tirbanibulin (Mesylate)	KX2-391 (Mesylate); KX01 (Mesylate)	527.63	Microtubule/Tubulin; Src	Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK	Tirbanibulin Mesylate (KX2-391 Mesylate) is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.	Mesylate	C27H33N3O6S	22460.0	DMSO : 100 mg/mL (189.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NCC1=CC=CC=C1)CC2=NC=C(C3=CC=C(OCCN4CCOCC4)C=C3)C=C2.CS(=O)(O)=O	https://www.medchemexpress.com/KX2-391-Mesylate.html	Launched		91.0	J11	E11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10340B	10.0	mM	107.0	DMSO	431.220892	11	E	pluskal_fda_drugs_5005_E11_id
1355	HY-17495A	HYCPK40905	D22	HYCPK40905	91z	380.0	4.0	H44	905.0	D22	51781-21-6	Carteolol hydrochloride	OPC-1085 hydrochloride	328.8343	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Carteolol hydrochloride (OPC-1085 hydrochloride) is a non-selective beta blocker used to treat glaucoma.	Hydrochloride	C16H25ClN2O3	147469.0	DMSO : 50 mg/mL (152.05 mM; ultrasonic and warming and heat to 60°C); H2O : ≥ 25 mg/mL (76.03 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C1NC2=C(C(OCC(O)CNC(C)(C)C)=CC=C2)CC1.Cl	https://www.medchemexpress.com/Carteolol-hydrochloride.html	Launched		91.0	H44	E11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17495A	10.0	mM	107.0	DMSO	292.178693	11	E	pluskal_fda_drugs_5005_E11_id
464	HY-13507	HYCPK40903	E06	HYCPK40903	91z	396.0	2.0	I12	903.0	E06	220991-20-8	Lumiracoxib	COX-189	293.72	COX	Immunology/Inflammation	Lumiracoxib is a potent,selective and orally active COX-2 inhibitor with a Ki value of 0.06?μM[1]. Lumiracoxib acts as a nonselective NSAID with?anti-inflammatory, analgesic and antipyretic activities. Lumiracoxib can be used for osteoarthritis and bone cancer research[1][2].		C15H13ClFNO2	145945.0	DMSO : 125 mg/mL (425.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology	O=C(O)CC1=CC(C)=CC=C1NC2=C(F)C=CC=C2Cl	https://www.medchemexpress.com/lumiracoxib.html	Launched		91.0	I12	E12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13507	10.0	mM	108.0	DMSO	293.061885	12	E	pluskal_fda_drugs_5005_E12_id
484	HY-90001	HYCPK40903	I07	HYCPK40903	91z	782.0	2.0	Q14	903.0	I07	155213-67-5	Ritonavir	ABT 538; RTV	720.94	Apoptosis; HIV; HIV Protease; SARS-CoV	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.	Free Base	C37H48N6O5S2	64195.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 25 mg/mL (34.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(N[C@@H](CC1=CC=CC=C1)[C@H](C[C@H](CC2=CC=CC=C2)NC([C@H](C(C)C)NC(N(CC3=CSC(C(C)C)=N3)C)=O)=O)O)OCC4=CN=CS4	https://www.medchemexpress.com/Ritonavir.html	Launched		91.0	Q14	E12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-90001	10.0	mM	108.0	DMSO	720.312761	12	E	pluskal_fda_drugs_5005_E12_id
561	HY-B0688	HYCPK40903	B13	HYCPK40903	91z	122.0	2.0	C26	903.0	B13	80-08-0	Dapsone	4,4′-Diaminodiphenyl sulfone; DDS	248.30	Antibiotic; Bacterial; Parasite; Reactive Oxygen Species	Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Dapsone (4,4′-Diaminodiphenyl sulfone) is an orally active and blood-brain penetrant sulfonamide antibiotic with bacteriostatic, antimycobacterial and antiprotozoal activities[1]. Dapsone?exerts effective antileprosy activity?and inhibits folate synthesis in cell extracts of?M. leprae. Dapsone is used for dermatologic disorder research, including leprosy, dermatitis herpetiformis, acne vulgaris et al[2][3].	Free Base	C12H12N2O2S	16760.0	DMSO : 50 mg/mL (201.37 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=S(C1=CC=C(N)C=C1)(C2=CC=C(N)C=C2)=O	https://www.medchemexpress.com/dapsone.html	Launched		91.0	C26	E12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0688	10.0	mM	108.0	DMSO	248.061949	12	E	pluskal_fda_drugs_5005_E12_id
638	HY-B0147A	HYCPK40903	D16	HYCPK40903	91z	320.0	2.0	G32	903.0	D16	70458-95-6	Pefloxacin (mesylate)	Pefloxacinium mesylate	429.46	Antibiotic; Bacterial	Anti-infection	"Pefloxacin mesylate is a an antibacterial agent and prevents bacterial DNA replication by inhibiting DNA gyrase (topoisomerse)
Target: DNA gyrase
Pefloxacin is a synthetic chemotherapeutic agent used to treat severe and life-threatening bacterial infections. Pefloxacin is commonly referred to as afluoroquinolone (or quinolone) drug and is a member of the fluoroquinolone class of antibacterials. It is an analog of norfloxacin. It is a synthetic fluoroquinolone, belonging to the 3rd generation of quinolones. Pefloxacin is extensively prescribed in France. Pefloxacin has not been approved for use in the United States.
The bactericidal action of pefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited."	Mesylate	C18H24FN3O6S	16541.0	DMSO : 12.5 mg/mL (29.11 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (232.85 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCN(C)CC3)=C2)C1=O)O.CS(=O)(O)=O	https://www.medchemexpress.com/pefloxacin-mesylate.html	Launched		91.0	G32	E12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0147A	10.0	mM	108.0	DMSO	333.14887	12	E	pluskal_fda_drugs_5005_E12_id
735	HY-B1263	HYCPK40903	O22	HYCPK40903	91z	1388.0	2.0	AC44	903.0	O22	57-15-8	Chlorobutanol		177.46	Bacterial; Fungal	Anti-infection	Chlorobutanol is a pharmaceutical preservative. Chlorobutanol is active against a wide variety of Gram-positive and Gram-negative bacteria, and several mold spores and fungi. Chlorobutanol is widely used in food and cosmetic industry[1][2].		C4H7Cl3O	26383.0	DMSO : 100 mg/mL (563.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease	CC(O)(C)C(Cl)(Cl)Cl	https://www.medchemexpress.com/chlorobutanol.html	Launched		91.0	AC44	E12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1263	10.0	mM	108.0	DMSO	175.956248	12	E	pluskal_fda_drugs_5005_E12_id
837	HY-13678A	HYCPK40904	J09	HYCPK40904	91z	929.0	3.0	T17	904.0	J09	119478-56-7	Meropenem (trihydrate)	SM 7338 trihydrate	437.51	Antibiotic; Bacterial	Anti-infection	Meropenem trihydrate (SM 7338 trihydrate) is a carbapenem antibiotic with broad-spectrum antibacterial activity. Meropenem trihydrate has activity against susceptible and resistant N. gonorrhoeae (MIC value of 0.02-0.06 mg/mL), H. influenzae (MIC value of 0.03-0.12 mg/mL), and H. ducreyi (MIC value of 0.015-0.12 mg/mL)[1][2].	Free Acid	C17H31N3O8S	97656.0	DMSO : 100 mg/mL (228.57 mM; Need ultrasonic); H2O : 12.5 mg/mL (28.57 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(N12)=C(S[C@@H]3CN[C@H](C(N(C)C)=O)C3)[C@H](C)[C@]2([H])[C@@H]([C@H](O)C)C1=O)O.O.O.O	https://www.medchemexpress.com/meropenem-trihydrate.html	Launched		91.0	T17	E12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13678A	10.0	mM	108.0	DMSO	383.151492	12	E	pluskal_fda_drugs_5005_E12_id
961	HY-B0164	HYCPK40904	J17	HYCPK40904	91z	945.0	3.0	T33	904.0	J17	108612-45-9	Mizolastine		432.49	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Mizolastine is an orally active, high affinity and specific peripheral histamine H1 receptor antagonist (second generation antihistamine). Mizolastine effectively inhibits mRNA expression of VEGF165, VEGF120, TNF-α and KC. Mizolastine can be used in studies of allergic rhinitis and chronic idiopathic urticarial[1][2][3].	Free Base	C24H25FN6O	15957.0	DMSO : 25 mg/mL (57.80 mM; Need ultrasonic); H2O : 1 mg/mL (2.31 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1NC(N(C2CCN(C3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)CC2)C)=NC=C1	https://www.medchemexpress.com/Mizolastine.html	Launched		91.0	T33	E12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0164	10.0	mM	108.0	DMSO	432.207388	12	E	pluskal_fda_drugs_5005_E12_id
1129	HY-B0780	HYCPK40905	B08	HYCPK40905	91z	160.0	4.0	D16	905.0	B08	247257-48-3	Fimasartan	BR-A-657	501.65	Angiotensin Receptor; Apoptosis	Apoptosis; GPCR/G Protein	"Fimasartan(BR-A-657) is a non-peptide angiotensin II receptor antagonist used for the treatment of hypertension and heart failure.
IC50 value:
Target: AT1 receptor antagonist
in vitro: Fimasartan suppressed the expressions of inducible nitric oxide synthase (iNOS) by down-regulating its transcription, and subsequently inhibited the productions of nitric oxide (NO). In addition, fimasartan attenuated LPS-induced transcriptional and DNA-binding activities of nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) [1]. BR-A-657 displaced [125I][Sar1
-Ile8]angiotensin II (Ang II) from its specific binding sites to AT1 subtype receptors in membrane fractions of HEK-293 cells with an IC50 of 0.16 nM [2]. 
in vivo: After oral administration of 240 mg fimasartan, the mean area under the plasma concentration-time curve from time zero to infinity was 2899.0 ng/ml/h in the older, which was significantly greater than in young subjects (1767.4 ng/ml/h; p = 0.03) [3]. Compared with atorvastatin alone, coadministration of fimasartan and atorvastatin increased the atorvastatin acid mean (95% confidence interval) maximum concentration (Cmax,ss) by 1.89-fold (1.49-2.39) and the area under the concentration curve (AUCτ,ss) by 1.19-fold (0.96-1.48). Fimasartan also increased the mean 2-hydroxy atorvastatin acid Cmax,ss and AUCτ,ss by 2.45-fold (1.80-3.35) and 1.42-fold (1.09-1.85), respectively [4]."	Free Base	C27H31N7OS	16507.0	DMSO : ≥ 49 mg/mL (97.68 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C1N(C(CCCC)=NC(C)=C1CC(N(C)C)=S)CC2=CC=C(C3=C(C4=NN=NN4)C=CC=C3)C=C2	https://www.medchemexpress.com/Fimasartan.html	Launched		91.0	D16	E12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0780	10.0	mM	108.0	DMSO	501.23108	12	E	pluskal_fda_drugs_5005_E12_id
184	HY-B0002B	HYCPK40902	F11	HYCPK40902	91z	501.0	1.0	K21	902.0	F11	99614-02-5	Ondansetron	GR 38032; SN 307	293.36	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Ondansetron(GR 38032; SN 307) is a serotonin 5-HT3 receptor antagonist used mainly as anantiemetic (to treat nausea and vomiting), often following chemotherapy.
IC50 Value: 
Target: 5- HT3 Receptor
in vitro: 5-HT evoked transient inward currents (EC50 = 3.4 microM; Hill coefficient = 1.8) that were blocked by the 5-HT3 receptor antagonist ondansetron (IC50 = 103 pM) [1]. The 5-HT3A receptor antagonist ondansetron (0.3 nM) reversibly inhibited the 5-HT (30 microM) signal by 70% and at 3 nM it abolished the response [2].
in vivo: Acute ondansetron administration at the lowest dose (0.1 mg/kg, IP) tested had no effect, while other doses (0.33 and 1 mg/kg, IP) produced improvements in auditory gating [3]. Different doses of ondansetron were injected intraperitoneally (i.p.) at fixed times during the day to determine both the sublethal (TD50) and lethal (LD50) doses, which were, respectively, 3.7 +/- 0.6 mg/kg and 4.6 +/- 0.5 mg/kg [4]. ondansetron (0.25-1.0 mg/kg, subcutaneously) given before the challenge dose of ethanol (2.4 g/kg, intraperitoneally) injection, significantly and dose dependently attenuated the expression of sensitization. In addition, ondansetron (1.0 mg/kg, subcutaneously) given before ethanol injection on days 1, 4, 7, and 10 significantly blocked the development (days 1, 4, 7, and 10), and expression (day 15) of sensitization to the locomotor stimulant effect of ethanol injection [5]. 
Toxicity: Ondansetron may be safe in lower doses used to prevent nausea and vomiting in radiation treatment or postoperatively. However, as there is a report that a lower dose of ondansetron prolonged the QT interval in healthy volunteers, this needs to be clarified by the FDA [6]."	Free Base	C18H19N3O	16985.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 10 mg/mL (34.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C1C(CN2C=CN=C2C)CCC(N3C)=C1C4=C3C=CC=C4	https://www.medchemexpress.com/Ondansetron.html	Launched		91.0	K21	E13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0002B	10.0	mM	109.0	DMSO	293.152812	13	E	pluskal_fda_drugs_5005_E13_id
515	HY-B0801A	HYCPK40903	D10	HYCPK40903	91z	308.0	2.0	G20	903.0	D10	153439-40-8	Fexofenadine (hydrochloride)	MDL-16455 (hydrochloride); Terfenadine carboxylate (hydrochloride)	538.12	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Fexofenadine (MDL-16455) hydrochloride is an orally active and nonsedative H1 receptor antagonist. Fexofenadine hydrochloride can be used in allergic rhinitis and chronic idiopathic urticarial research[1][2][3].	Hydrochloride	C32H40ClNO4	18708.0	DMSO : ≥ 100 mg/mL (185.83 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C(C)(C)C1=CC=C(C(O)CCCN2CCC(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)CC2)C=C1.[H]Cl	https://www.medchemexpress.com/Fexofenadine-hydrochloride.html	Launched		91.0	G20	E13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0801A	10.0	mM	109.0	DMSO	501.287909	13	E	pluskal_fda_drugs_5005_E13_id
520	HY-B0577	HYCPK40903	I10	HYCPK40903	91z	788.0	2.0	Q20	903.0	I10	130209-82-4	Latanoprost	PHXA41	432.59	Prostaglandin Receptor	GPCR/G Protein	Latanoprost (PHXA41) is a prostaglandin F2α analogue and an agonist for the FP prostanoid receptor, and lowers intraocular-pressure (IOP).	Free Base	C26H40O5	90610.0	H2O : 100 mg/mL (231.17 mM; Need ultrasonic); Ethanol : 100 mg/mL (231.17 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (231.17 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(OC(C)C)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCC2=CC=CC=C2)[C@H](O)C[C@@H]1O	https://www.medchemexpress.com/Latanoprost.html	Launched		91.0	Q20	E13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0577	10.0	mM	109.0	DMSO	432.287574	13	E	pluskal_fda_drugs_5005_E13_id
787	HY-10238	HYCPK40904	H06	HYCPK40904	91z	731.0	3.0	P11	904.0	H06	850876-88-9	Danoprevir	ITMN-191; R7227; RO5190591; RG7227	731.83	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Danoprevir (ITMN-191) is an orally active NS3/4A protease inhibitor for hepatitis C virus (HCV) with an IC50 of 0.29 nM and is selective for NS3/4A over a panel of 53 proteases (IC50 higher than 10 μM). Danoprevir (ITMN-191) inhibits HCV genotypes 1a, 1b, 4, 5, and 6 (IC50s=0.2-0.4 nM) as well as 2b and 3a (IC50s=1.6, 3.5 nM)[1][2]. Danoprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 0.05 μM[3].	Free Base	C35H46FN5O9S	3959.0	DMSO : ≥ 100 mg/mL (136.64 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(NC([C@@]1(NC([C@]2([H])C[C@@H](OC(N3CC4=C(C3)C=CC=C4F)=O)CN2C5=O)=O)C[C@]1(/C=C/CCCCC[C@@H]5NC(OC(C)(C)C)=O)[H])=O)(C6CC6)=O	https://www.medchemexpress.com/Danoprevir.html	Launched		91.0	P11	E13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10238	10.0	mM	109.0	DMSO	731.300027	13	E	pluskal_fda_drugs_5005_E13_id
829	HY-B1055	HYCPK40904	B09	HYCPK40904	91z	161.0	3.0	D17	904.0	B09	23142-01-0	Carbetapentane (citrate)	Pentoxyverine citrate	525.59	Others	Others	Carbetapentane citrate is a selective inhibitor of the cough, with mild atropine-like effect and local anesthesia effect.	Citrate	C26H39NO10	154080.0	DMSO : ≥ 36 mg/mL (68.49 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1(C2=CC=CC=C2)CCCC1)OCCOCCN(CC)CC.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Carbetapentane-citrate.html	Launched		91.0	D17	E13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1055	10.0	mM	109.0	DMSO	333.230394	13	E	pluskal_fda_drugs_5005_E13_id
888	HY-18062	HYCPK40904	M12	HYCPK40904	91z	1223.0	3.0	Z23	904.0	M12	58-14-0	Pyrimethamine	Pirimecidan; Pirimetamin; RP 4753	248.71	Antifolate; Parasite	Anti-infection; Cell Cycle/DNA Damage	Pyrimethamine (Pirimecidan) is a potent, orally active dihydrofolate reductase (DHFR) inhibitor. Pyrimethamine is an antimalarial agent. Pyrimethamine affects the nucleoprotein metabolism of malarial parasites by interference in the folic–folinic acid systems and affects cell division by inhibiting the conversion of dihydrofolate to tetrahydrofolate[1][2].	Free Base	C12H13ClN4	61625.0	DMSO : 20 mg/mL (80.41 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	NC1=NC(N)=C(C2=CC=C(Cl)C=C2)C(CC)=N1	https://www.medchemexpress.com/pyrimethamine.html	Launched		91.0	Z23	E13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18062	10.0	mM	109.0	DMSO	248.082874	13	E	pluskal_fda_drugs_5005_E13_id
1028	HY-B0193A	HYCPK40904	M21	HYCPK40904	91z	1241.0	3.0	Z41	904.0	M21	19237-84-4	Prazosin (hydrochloride)		419.86	Adrenergic Receptor; Autophagy	Autophagy; GPCR/G Protein; Neuronal Signaling	Prazosin hydrochloride is a well-tolerated, CNS-active α1-adrenergic receptor antagonist for the research of high blood pressure and alcohol use disorders[1]. Prazosin hydrochloride potently inhibits Norepinephrine (NE)-stimulated 45Ca efflux with an IC50 of 0.15 nM[2].Prazosin hydrochloride inhibits organic cation transporters OCT-1 and OCT-3 with IC50s of 1.8, and 13 μM, respectively[3].	Hydrochloride	C19H22ClN5O4	15874.0	H2O : 0.59 mg/mL (1.41 mM; Need ultrasonic); DMSO : 14.29 mg/mL (34.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4=CC=CO4.Cl	https://www.medchemexpress.com/Prazosin-hydrochloride.html	Launched		91.0	Z41	E13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0193A	10.0	mM	109.0	DMSO	383.159354	13	E	pluskal_fda_drugs_5005_E13_id
1315	HY-W039454	HYCPK40905	L19	HYCPK40905	91z	1142.0	4.0	X38	905.0	L19	1777-82-8	2,4-Dichlorobenzyl alcohol		177.03	Bacterial	Anti-infection	2,4-Dichlorobenzyl alcohol is a mild antiseptic, with a broad spectrum for bacterial and virus associated with mouth and throat infections[1].		C7H6Cl2O	145078.0	DMSO : 100 mg/mL (564.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OCC1=CC=C(Cl)C=C1Cl	https://www.medchemexpress.com/2-4-dichlorobenzyl-alcohol.html	Launched		91.0	X38	E13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W039454	10.0	mM	109.0	DMSO	175.97957	13	E	pluskal_fda_drugs_5005_E13_id
142	HY-13566A	HYCPK40902	D08	HYCPK40902	91z	303.0	1.0	G15	902.0	D08	213819-48-8	Belotecan (hydrochloride)	CKD-602	469.96	Topoisomerase	Cell Cycle/DNA Damage	Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic camptothecin derivative.	Hydrochloride	C25H28ClN3O4	25321.0	DMSO : 25 mg/mL (53.20 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C(CCNC(C)C)C5=CC=CC=C5N=C4C3=C2)=O.[H]Cl	https://www.medchemexpress.com/Belotecan_hydrochloride.html	Launched		91.0	G15	E14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13566A	10.0	mM	110.0	DMSO	433.200156	14	E	pluskal_fda_drugs_5005_E14_id
202	HY-N1373	HYCPK40902	H12	HYCPK40902	91z	695.0	1.0	O23	902.0	H12	6882-68-4	Sophoridine		248.36	Apoptosis	Apoptosis	Sophoridine is a quinolizidine alkaloid isolated from leafs of Leguminous plant Sophora alopecuroides.L. Sophoridine induces apoptosis. Sophoridine has the potential to be a novel, potent and selective antitumor drug candidate for pancreatic cancer with well-tolerated toxicity[1].	Free Base	C15H24N2O	58053.0	DMSO : 50 mg/mL (201.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1CCC[C@]2([H])[C@@]3([H])CCCN4[C@@]3([H])[C@@](CCC4)([H])CN21	https://www.medchemexpress.com/sophoridine.html	Launched		91.0	O23	E14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1373	10.0	mM	110.0	DMSO	248.188863	14	E	pluskal_fda_drugs_5005_E14_id
514	HY-50912	HYCPK40903	C10	HYCPK40903	91z	212.0	2.0	E20	903.0	C10	155148-31-5	Plerixafor (octahydrochloride)	AMD3100 (octahydrochloride); JM3100 (octahydrochloride); SID791 (octahydrochloride)	794.47	CXCR; HIV; Virus Protease	Anti-infection; GPCR/G Protein; Immunology/Inflammation	Plerixafor octahydrochloride (AMD3100 octahydrochloride) is a selective CXCR4 antagonist with an IC50 of 44 nM.	Hydrochloride	C28H62Cl8N8	18689.0	H2O : 100 mg/mL (125.87 mM; Need ultrasonic); DMSO : < 1 mg/mL (insoluble or slightly soluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.N1(CCCNCCNCCCNCC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3	https://www.medchemexpress.com/Plerixafor-octahydrochloride.html	Launched		91.0	E20	E14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50912	10.0	mM	110.0	DMSO	502.447144	14	E	pluskal_fda_drugs_5005_E14_id
525	HY-B0166A	HYCPK40903	N10	HYCPK40903	91z	1268.0	2.0	AA20	903.0	N10	134-03-2	L-Ascorbic acid (sodium salt)	Sodium ascorbate; Sodium L-ascorbate; Vitamin C (sodium salt)	198.11	Apoptosis; Calcium Channel; Endogenous Metabolite; Reactive Oxygen Species	Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB	L-Ascorbic acid sodium salt (Sodium ascorbate), an electron donor, is an endogenous antioxidant agent. L-Ascorbic acid sodium salt selectively inhibits Cav3.2 channels with an IC50 of 6.5 μM. L-Ascorbic acid sodium salt is also a collagen deposition enhancer and an elastogenesis inhibitor[1][2][3].	Sodium	C6H7NaO6	22693.0	H2O : 100 mg/mL (504.77 mM; Need ultrasonic); DMSO : 1 mg/mL (5.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O[C@@H](CO)[C@]1([H])C(O[Na])=C(O)C(O1)=O	https://www.medchemexpress.com/L-Ascorbic-acid-sodium.html	Launched		91.0	AA20	E14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0166A	10.0	mM	110.0	DMSO	176.032088	14	E	pluskal_fda_drugs_5005_E14_id
864	HY-14544	HYCPK40904	E11	HYCPK40904	91z	453.0	3.0	J21	904.0	E11	111974-69-7	Quetiapine	ICI204636	383.51	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Quetiapine (ICI204636) is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor. Quetiapine is a dopamine receptor antagonist with a pIC50 of 6.33 for human D2 receptor. Quetiapine has moderate to high affinity for the human D2, HT1A, 5-HT2A, 5-HT2C receptor with pKis of 7.25, 5.74, 7.54, 5.55. Antidepressant and anxiolytic effects[1].	Free Base	C21H25N3O2S	8076.0	Ethanol : 100 mg/mL (260.75 mM; Need ultrasonic); DMSO : 100 mg/mL (260.75 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.26 mM; ultrasonic and warming and heat to 50°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	OCCOCCN(CC1)CCN1C2=NC3=CC=CC=C3SC4=C2C=CC=C4	https://www.medchemexpress.com/Quetiapine.html	Launched		91.0	J21	E14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14544	10.0	mM	110.0	DMSO	383.166748	14	E	pluskal_fda_drugs_5005_E14_id
927	HY-B1180	HYCPK40904	D15	HYCPK40904	91z	365.0	3.0	H29	904.0	D15	4880-88-0	Vinburnine	(-)-Eburnamonine; (-)-Vincamone	294.39	Drug Metabolite	Metabolic Enzyme/Protease	Vincamone is a vinca alkaloid and a metabolite of vincamine, is a vasodilator.	Free Base	C19H22N2O	79384.0	DMSO : 8.33 mg/mL (28.30 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C1C[C@@]2(CC)[C@@]3([H])C(N1C4=CC=CC=C54)=C5CCN3CCC2	https://www.medchemexpress.com/Vinburnine.html	Launched		91.0	H29	E14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1180	10.0	mM	110.0	DMSO	294.173213	14	E	pluskal_fda_drugs_5005_E14_id
1116	HY-134004	HYCPK40905	E07	HYCPK40905	91z	446.0	4.0	J14	905.0	E07	77-23-6	Pentoxyverine	Carbetapentane	333.47	Sigma Receptor	Neuronal Signaling	Pentoxyverine (Carbetapentane) is a sigma-1 receptor agonist, with a Ki of 75 nM on guinea-pig brain membranes. Pentoxyverine is a centrally-acting cough suppressant with antimuscarinic and anticonvulsant properties. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].		C20H31NO3	101687.0	DMSO : 250 mg/mL (749.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1(C2=CC=CC=C2)CCCC1)OCCOCCN(CC)CC	https://www.medchemexpress.com/pentoxyverine.html	Launched		91.0	J14	E14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-134004	10.0	mM	110.0	DMSO	333.230394	14	E	pluskal_fda_drugs_5005_E14_id
1349	HY-B0220	HYCPK40905	N21	HYCPK40905	91z	1338.0	4.0	AB42	905.0	N21	114-07-8	Erythromycin		733.93	Antibiotic; Bacterial; DNA/RNA Synthesis	Anti-infection; Cell Cycle/DNA Damage	Erythromycin is a macrolide antibiotic produced by actinomycete?Streptomyces erythreus?with a broad spectrum of antimicrobial activity. Erythromycin binds to bacterial 50S ribosomal subunits and inhibits?RNA-dependent protein synthesis?by blockage of transpeptidation and/or translocation reactions, without affecting synthesis of nucleic acid[1][2]. Erythromycin also exhibits antitumor and neuroprotective effect in different fields of research[3][4].	Free Base	C37H67NO13	15945.0	DMSO : ≥ 100 mg/mL (136.25 mM); H2O : 1 mg/mL (1.36 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@@H]([C@@H]([C@H](C(O[C@@H]1CC)=O)C)O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@@]2(C)OC)[C@H]([C@](O)(C[C@H](C([C@@H]([C@@H](O)[C@@]1(O)C)C)=O)C)C)O[C@@](O[C@H](C)C[C@@H]3N(C)C)([H])[C@@H]3O	https://www.medchemexpress.com/Erythromycin.html	Launched		91.0	AB42	E14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0220	10.0	mM	110.0	DMSO	733.461241	14	E	pluskal_fda_drugs_5005_E14_id
392	HY-N0187	HYCPK40902	A18	HYCPK40902	91z	35.0	1.0	A35	902.0	A18	90-33-5	4-Methylumbelliferone	Hymecromone; 4-MU	176.17	Others	Others	4-Methylumbelliferone is a hyaluronic acid biosynthesis inhibitor with antitumoral and antimetastatic effects.	Free Base	C10H8O3	25636.0	DMSO : 100 mg/mL (567.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C1C=C(C)C2=CC=C(O)C=C2O1	https://www.medchemexpress.com/4-Methylumbelliferone.html	Launched		91.0	A35	E15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0187	10.0	mM	111.0	DMSO	176.047344	15	E	pluskal_fda_drugs_5005_E15_id
440	HY-14877	HYCPK40903	M04	HYCPK40903	91z	1160.0	2.0	Y8	903.0	M04	739366-20-2	Anagliptin	SK-0403	383.45	Dipeptidyl Peptidase	Metabolic Enzyme/Protease	Anagliptin (SK-0403) is a highly selective, potent, orally active inhibitor of dipeptidyl peptidase 4 (DPP-4), with an IC50 of 3.8 nM, and less selective at DPP-8 and DDP-9 with IC50s of 68 nM and 60 nM, respectively[1].	Free Base	C19H25N7O2	17588.0	DMSO : 100 mg/mL (260.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=C(C1=CN2C(N=C1)=CC(C)=N2)NCC(C)(NCC(N3[C@H](C#N)CCC3)=O)C	https://www.medchemexpress.com/Anagliptin.html	Launched		91.0	Y8	E15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14877	10.0	mM	111.0	DMSO	383.206973	15	E	pluskal_fda_drugs_5005_E15_id
909	HY-14872	HYCPK40904	B14	HYCPK40904	91z	171.0	3.0	D27	904.0	B14	865854-05-3	Tideglusib	NP031112	334.39	GSK-3	PI3K/Akt/mTOR; Stem Cell/Wnt	Tideglusib (NP031112) is an irreversible GSK-3 inhibitor with IC50s of 5 nM and 60 nM for GSK-3βWT (1 h preincubation) and GSK-3βC199A (1 h preincubation), respectively.	Free Base	C19H14N2O2S	14379.0	DMSO : 33.33 mg/mL (99.67 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N(SC1=O)C2=C3C=CC=CC3=CC=C2)N1CC4=CC=CC=C4	https://www.medchemexpress.com/Tideglusib.html	Launched		91.0	D27	E15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14872	10.0	mM	111.0	DMSO	334.077599	15	E	pluskal_fda_drugs_5005_E15_id
914	HY-B0289	HYCPK40904	G14	HYCPK40904	91z	651.0	3.0	N27	904.0	G14	84611-23-4	Erdosteine	RV 144	249.31	Bacterial; NF-κB	Anti-infection; NF-κB	Erdosteine inhibits lipopolysaccharide (LPS)-induced NF-κB activation[1][2]. Erdosteine has muco-modulatory, anti-bacterial, anti-inflammatory and anti-oxidant effects[3].	Free Acid	C8H11NO4S2	16011.0	H2O : 6.67 mg/mL (26.75 mM; Need ultrasonic); DMSO : 50 mg/mL (200.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Metabolic Disease; Inflammation/Immunology	O=C(O)CSCC(NC(CCS1)C1=O)=O	https://www.medchemexpress.com/Erdosteine.html	Launched		91.0	N27	E15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0289	10.0	mM	111.0	DMSO	249.01295	15	E	pluskal_fda_drugs_5005_E15_id
1015	HY-W195048	HYCPK40904	P20	HYCPK40904	91z	1527.0	3.0	AF39	904.0	P20	1191-50-0	Tetradecyl sulfate (sodium)		316.43	Others	Others	Tetradecyl sulfate sodium, a detergent sclerosant, is widely used agent for esophageal varices and varicose veins[1].	Sodium	C14H29NaO4S	150218.0		DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(OCCCCCCCCCCCCCC)(O[Na])=O	https://www.medchemexpress.com/tetradecyl-sulfate-sodium.html	Launched		91.0	AF39	E15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W195048	10.0	mM	111.0	DMSO	294.18648	15	E	pluskal_fda_drugs_5005_E15_id
1167	HY-B1248	HYCPK40905	H10	HYCPK40905	91z	740.0	4.0	P20	905.0	H10	55-56-1	Chlorhexidine		505.45	Antibiotic; Bacterial	Anti-infection	Chlorhexidine is an antibacterial used as an antiseptic and for other applications. Chlorhexidine is used to clean the skin after an injury, before surgery, or before an injection. Chlorhexidine is also used to clean the hands before a procedure[1].	Free Base	C22H30Cl2N10	22839.0	DMSO : 25 mg/mL (49.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	N=C(NC1=CC=C(Cl)C=C1)NC(NCCCCCCNC(NC(NC2=CC=C(Cl)C=C2)=N)=N)=N	https://www.medchemexpress.com/Chlorhexidine.html	Launched		91.0	P20	E15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1248	10.0	mM	111.0	DMSO	504.203196	15	E	pluskal_fda_drugs_5005_E15_id
1208	HY-10466	HYCPK40905	A13	HYCPK40905	91z	74.0	4.0	B26	905.0	A13	1009119-64-5	Daclatasvir	BMS-790052; EBP 883	738.88	HCV	Anti-infection	Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 μM and 3.27 μM, respectively[1][2][3].	Free Base	C40H50N8O6	13883.0	DMSO : ≥ 40 mg/mL (54.14 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](NC(OC)=O)C(C)C)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C5=CN=C([C@@H]6CCCN6C([C@@H](NC(OC)=O)C(C)C)=O)N5)C=C4	https://www.medchemexpress.com/Daclatasvir.html	Launched		91.0	B26	E15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10466	10.0	mM	111.0	DMSO	738.385331	15	E	pluskal_fda_drugs_5005_E15_id
1241	HY-B0199	HYCPK40905	B15	HYCPK40905	91z	174.0	4.0	D30	905.0	B15	128794-94-5	Mycophenolate Mofetil	RS 61443; TM-MMF	433.49474	Apoptosis; Bacterial; Drug Metabolite; Endogenous Metabolite	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Mycophenolate mofetil (RS 61443) is the morpholinoethylester prodrug of Mycophenolic acid. Mycophenolate mofetil inhibits de novo purine synthesis via the inhibition of inosine monophosphate dehydrogenase (IMPDH). Mycophenolate mofetil shows selective lymphocyte antiproliferative effects involve both T and B cells, preventing antibody formation[1].	Free Base	C23H31NO7	26036.0	DMSO : 100 mg/mL (230.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(OCCN1CCOCC1)CC/C(C)=C/CC2=C(O)C3=C(COC3=O)C(C)=C2OC	https://www.medchemexpress.com/mycophenolate-mofetil.html	Launched		91.0	D30	E15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0199	10.0	mM	111.0	DMSO	433.210052	15	E	pluskal_fda_drugs_5005_E15_id
163	HY-B0212	HYCPK40902	A10	HYCPK40902	91z	19.0	1.0	A19	902.0	A10	144-83-2	Sulfapyridine		249.29	Antibiotic; Bacterial	Anti-infection	Sulfapyridine, a major metabolite of Sulfasalazine, is a sulfonamide antibiotic agent. Sulfapyridine inhibits recombinant P. carinii dihydropteroate synthetase (DHPS) with an IC50 of 0.18 μM. Sulfapyridine has antibacterial, anti-inflammatory and anti-rheumatic activities[1][2][3].	Free Base	C11H11N3O2S	16513.0	DMSO : 60 mg/mL (240.68 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=S(C1=CC=C(N)C=C1)(NC2=NC=CC=C2)=O	https://www.medchemexpress.com/sulfapyridine.html	Launched		91.0	A19	E16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0212	10.0	mM	112.0	DMSO	249.057198	16	E	pluskal_fda_drugs_5005_E16_id
176	HY-B1280	HYCPK40902	N10	HYCPK40902	91z	1267.0	1.0	AA19	902.0	N10	59-26-7	Nikethamide	N,N-Diethylnicotinamide	178.23	Others	Others	Nikethamide, one of the respiratory central stimulants, has the potential for respiratory failure research[1].	Free Base	C10H14N2O	27055.0	H2O : ≥ 50 mg/mL (280.54 mM); DMSO : ≥ 1 mg/mL (5.61 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(C1=CC=CN=C1)N(CC)CC	https://www.medchemexpress.com/Nikethamide.html	Launched		91.0	AA19	E16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1280	10.0	mM	112.0	DMSO	178.110613	16	E	pluskal_fda_drugs_5005_E16_id
350	HY-N7120	HYCPK40903	G03	HYCPK40903	91z	582.0	2.0	M6	903.0	G03	6130-64-9	Penicillin G procaine (hydrate)	PGP (hydrate)	588.72	Antibiotic; Bacterial	Anti-infection	Penicillin G Procaine hydrate (PGP hydrate), a β-lactam antibiotic, is a crystalline complex produced by chemically combining penicillin G with procaine[1][2].		C29H40N4O7S	64787.0	DMSO : 250 mg/mL (424.65 mM; Need ultrasonic); H2O : 3.14 mg/mL (5.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(CC3=CC=CC=C3)=O)N1C2=O)O.O=C(OCCN(CC)CC)C4=CC=C(N)C=C4.[H]O[H]	https://www.medchemexpress.com/penicillin-g-procaine.html	Launched		91.0	M6	E16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7120	10.0	mM	112.0	DMSO	334.098728	16	E	pluskal_fda_drugs_5005_E16_id
356	HY-109120	HYCPK40903	M03	HYCPK40903	91z	1158.0	2.0	Y6	903.0	M03	501692-44-0	Odevixibat	A4250	740.93	Apical Sodium-Dependent Bile Acid Transporter	Membrane Transporter/Ion Channel	Odevixibat (A4250) is a potent, selective and orally active inhibitor of the ileal bile acid transporter (IBAT). Odevixibat (A4250)decreases cholestatic liver and bile duct injury in mice model. Odevixibat (A4250) has the potential for the treatment of primary biliary cirrhosis[1].		C37H48N4O8S2	108961.0	DMSO : 166.67 mg/mL (224.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC[C@H](NC([C@H](NC(COC1=C(SC)C=C(C2=C1)N(C3=CC=CC=C3)CC(CCCC)(CCCC)NS2(=O)=O)=O)C4=CC=C(O)C=C4)=O)C(O)=O	https://www.medchemexpress.com/odevixibat.html	Launched		91.0	Y6	E16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109120	10.0	mM	112.0	DMSO	740.291356	16	E	pluskal_fda_drugs_5005_E16_id
692	HY-14959	HYCPK40903	D20	HYCPK40903	91z	328.0	2.0	G40	903.0	D20	159811-51-5	Ulipristal	CDB-3236; Deacetyl CDB-2914	433.58	Progesterone Receptor	Others	Ulipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM). Ulipristal binds to the progesteron receptor, thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system[1].	Free Base	C28H35NO3	63391.0	DMSO : ≥ 250 mg/mL (576.59 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	CN(C)C1=CC=C([C@]2([H])C([C@]3([H])[C@@](CC[C@]4(O)C(C)=O)([H])[C@]4(C)C2)=C(CC5)C(CC3)=CC5=O)C=C1	https://www.medchemexpress.com/ulipristal.html	Launched		91.0	G40	E16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14959	10.0	mM	112.0	DMSO	433.261694	16	E	pluskal_fda_drugs_5005_E16_id
825	HY-B1243	HYCPK40904	N08	HYCPK40904	91z	1311.0	3.0	AB15	904.0	N08	550-83-4	Propoxycaine (hydrochloride)		330.85	Sodium Channel	Membrane Transporter/Ion Channel	Propoxycaine hydrochloride inhibits voltage-gated sodium channels, and thereby inhibits the ionic flux required for the initiation and conduction of impulses. Propoxycaine hydrochloride application can lead to a loss of sensation.	Hydrochloride	C16H27ClN2O3	145116.0	DMSO : 50 mg/mL (151.13 mM; Need ultrasonic); H2O : 100 mg/mL (302.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCN(CC)CC)C1=CC=C(N)C=C1OCCC.[H]Cl	https://www.medchemexpress.com/Propoxycaine-hydrochloride.html	Launched		91.0	AB15	E16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1243	10.0	mM	112.0	DMSO	294.194343	16	E	pluskal_fda_drugs_5005_E16_id
1231	HY-10457	HYCPK40905	H14	HYCPK40905	91z	748.0	4.0	P28	905.0	H14	866933-46-2	Velusetrag	TD-5108	504.64	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Velusetrag (TD-5108) is an orally active, potent and selective agonist of serotonin 5-HT4 receptor (5-HT4R), with a pKi of 7.7. Velusetrag exhibits no affinity (Ki>10 μM) for 5-HT2A and 5-HT2B receptors. Velusetrag can be used for the research of gastrointestinal diseases and Parkinson's disease[1][2][3][4][5].		C25H36N4O5S	114655.0	DMSO : 100 mg/mL (198.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	O=C(C1=CC2=C(N(C(C)C)C1=O)C=CC=C2)N[C@@H]3C[C@@H](N4C[C@@H](O)CN(C)S(=O)(C)=O)CC[C@@H]4C3	https://www.medchemexpress.com/velusetrag.html	Launched		91.0	P28	E16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10457	10.0	mM	112.0	DMSO	504.240641	16	E	pluskal_fda_drugs_5005_E16_id
1347	HY-14558	HYCPK40905	L21	HYCPK40905	91z	1146.0	4.0	X42	905.0	L21	87760-53-0	Tandospirone	SM-3997	383.49	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Tandospirone (SM-3997) is a potent and selective 5-HT1A receptor partial agonist, with a Ki of 27 nM. Tandospirone has anxiolytic and antidepressant activities. Tandospirone can be used for the research of the central nervous system disorders and the underlying mechanisms[1][2][3].	Free Base	C21H29N5O2	86642.0	DMSO : 16.67 mg/mL (43.47 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1[C@]2([H])[C@]([C@H]3CC[C@@H]2C3)([H])C(N1CCCCN(CC4)CCN4C5=NC=CC=N5)=O	https://www.medchemexpress.com/Tandospirone.html	Launched		91.0	X42	E16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14558	10.0	mM	112.0	DMSO	383.232125	16	E	pluskal_fda_drugs_5005_E16_id
114	HY-B0204	HYCPK40902	H06	HYCPK40902	91z	683.0	1.0	O11	902.0	H06	74150-27-9	Pimobendan	UD-CG115	334.37	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Pimobendan (UD-CG115) is a selective inhibitor of PDE3 with IC50 of 0.32 μM.	Free Base	C19H18N4O2	14153.0	DMSO : 50 mg/mL (149.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C1CC(C)C(C2=CC=C3N=C(C4=CC=C(OC)C=C4)NC3=C2)=NN1	https://www.medchemexpress.com/Pimobendan.html	Launched		91.0	O11	E17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0204	10.0	mM	113.0	DMSO	334.142976	17	E	pluskal_fda_drugs_5005_E17_id
129	HY-B0273A	HYCPK40902	G07	HYCPK40902	91z	589.0	1.0	M13	902.0	G07	547-32-0	Sulfadiazine (sodium)		272.26	Antibiotic; Bacterial; Parasite	Anti-infection	Sulfadiazine sodium is a sulfonamide?antibiotic with antimalarial activity. Sulfadiazine can be used for toxoplasmosis research[1][2].	Sodium	C10H9N4NaO2S	78648.0	DMSO : 125 mg/mL (459.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(N([Na])C2=NC=CC=N2)=O	https://www.medchemexpress.com/sulfadiazine-sodium.html	Launched		91.0	M13	E17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0273A	10.0	mM	113.0	DMSO	250.052447	17	E	pluskal_fda_drugs_5005_E17_id
309	HY-N0139	HYCPK40902	M19	HYCPK40902	91z	1189.0	1.0	Y37	902.0	M19	7085-55-4	Troxerutin	Trihydroxyethylrutin	742.68	NOD-like Receptor (NLR)	Immunology/Inflammation	Troxerutin, also known as vitamin P4, is a tri-hydroxyethylated derivative of natural bioflavonoid rutins which can inhibit the production of reactive oxygen species (ROS) and depress ER stress-mediated NOD activation.	Free Base	C33H42O19	27664.0	DMSO : 100 mg/mL (134.65 mM; Need ultrasonic and warming); H2O : ≥ 50 mg/mL (67.32 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology; Neurological Disease	O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(OCCO)C(OCCO)=C4)OC5=CC(OCCO)=CC(O)=C15	https://www.medchemexpress.com/Troxerutin.html	Launched		91.0	Y37	E17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0139	10.0	mM	113.0	DMSO	742.232029	17	E	pluskal_fda_drugs_5005_E17_id
376	HY-10162	HYCPK40902	I04	HYCPK40902	91z	775.0	1.0	Q7	902.0	I04	763113-22-0	Olaparib	AZD2281; KU0059436	434.46	Autophagy; Mitophagy; PARP	Autophagy; Cell Cycle/DNA Damage; Epigenetics	Olaparib (AZD2281; KU0059436) is a potent and orally active PARP inhibitor with IC50s of 5 and 1 nM for PARP1 and PARP2, respectively. Olaparib is an autophagy and mitophagy activator[1][2][3][4].	Free Base	C24H23FN4O3	149190.0	DMSO : 100 mg/mL (230.17 mM; Need ultrasonic); DMF : 50 mg/mL (115.09 mM; Need ultrasonic); Ethanol : 3.12 mg/mL (7.18 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC(CC(C2=C3C=CC=C2)=NNC3=O)=CC=C1F)N4CCN(C(C5CC5)=O)CC4	https://www.medchemexpress.com/Olaparib.html	Launched		91.0	Q7	E17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10162	10.0	mM	113.0	DMSO	434.175419	17	E	pluskal_fda_drugs_5005_E17_id
425	HY-B0649	HYCPK40903	J09	HYCPK40903	91z	882.0	2.0	S18	903.0	J09	2078-54-8	Propofol	2,6-Diisopropylphenol	178.27	Endogenous Metabolite; GABA Receptor	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Propofol potently and directly activates GABAA receptor and inhibits glutamate receptor mediated excitatory synaptic transmission. Propofol has antinociceptive properties and is used for sedation and hypnotic[1].	Free Base	C12H18O	27056.0	H2O : 0.5 mg/mL (2.80 mM; Need ultrasonic); DMSO : 100 mg/mL (560.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	OC1=C(C(C)C)C=CC=C1C(C)C	https://www.medchemexpress.com/propofol.html	Launched		91.0	S18	E17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0649	10.0	mM	113.0	DMSO	178.135765	17	E	pluskal_fda_drugs_5005_E17_id
597	HY-B1448	HYCPK40903	K13	HYCPK40903	91z	986.0	2.0	U26	903.0	K13	91599-74-5	Benidipine (hydrochloride)	KW-3049	542.02	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Benidipine hydrochloride is a dihydropyridine calcium channel blocker for the treatment of high blood pressure (hypertension).	Hydrochloride	C28H32ClN3O6	94857.0	DMSO : 33.33 mg/mL (61.49 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(O[C@H]2CN(CC3=CC=CC=C3)CCC2)=O)[C@@H]1C4=CC=CC([N+]([O-])=O)=C4)OC.[H]Cl	https://www.medchemexpress.com/Benidipine-hydrochloride.html	Launched		91.0	U26	E17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1448	10.0	mM	113.0	DMSO	505.221286	17	E	pluskal_fda_drugs_5005_E17_id
617	HY-B1107	HYCPK40903	O14	HYCPK40903	91z	1372.0	2.0	AC28	903.0	O14	3200-06-4	Naftidrofuryl (oxalate)	Nafronyl oxalate salt	473.56	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Naftidrofuryl oxalate (Nafronyl oxalate salt) is a drug used in the management of peripheral and cerebral vascular disorders as a vasodilator, enhance cellular oxidative capacity, and may also be a 5-HT2 receptor antagonist.	Oxalate	C26H35NO7	17613.0	DMSO : ≥ 100 mg/mL (211.17 mM); H2O : 100 mg/mL (211.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(OCCN(CC)CC)C(CC1=C2C=CC=CC2=CC=C1)CC3OCCC3.O=C(O)C(O)=O	https://www.medchemexpress.com/Naftidrofuryl-oxalate.html	Launched		91.0	AC28	E17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1107	10.0	mM	113.0	DMSO	383.246044	17	E	pluskal_fda_drugs_5005_E17_id
736	HY-B1213	HYCPK40903	P22	HYCPK40903	91z	1484.0	2.0	AE44	903.0	P22	521-78-8	Trimipramine (maleate)		410.51	5-HT Receptor; Bacterial	Anti-infection; GPCR/G Protein; Neuronal Signaling	Trimipramine maleate is a 5-HT receptor antagonist, with pKi binding values of 6.39, 8.10, 4.66 for 5-HT1C, 5-HT2 and 5-HT1A, respectively[1]. Trimipramine maleate is also a potent and selective inhibitor targeting human noradrenaline (hNAT), serotonin (hSERT) and organic cation transporters (hOCT1, hOCT2) with IC50 values of 4.99 μM, 2.11 μM, 3.72 μM, 8.00 μM, respectively[2]. Trimipramine maleate has vascular activity and anxiolytic efficacy[3].	Maleate	C24H30N2O4	23687.0	DMSO : ≥ 100 mg/mL (243.60 mM); H2O : 14.29 mg/mL (34.81 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(CN(C)C)CN1C2=C(C=CC=C2)CCC3=C1C=CC=C3.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Trimipramine-maleate.html	Launched		91.0	AE44	E17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1213	10.0	mM	113.0	DMSO	294.209599	17	E	pluskal_fda_drugs_5005_E17_id
124	HY-B0258	HYCPK40902	B07	HYCPK40902	91z	109.0	1.0	C13	902.0	B07	25812-30-0	Gemfibrozil	CI-719	250.33	Cytochrome P450; PPAR	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Gemfibrozil is an activator of PPAR-α, used as a lipid-lowering drug; Gemfibrozil is also a nonselective inhibitor of several P450 isoforms, with Ki values for CYP2C9, 2C19, 2C8, and 1A2 of 5.8, 24, 69, and 82 μM, respectively.	Free Acid	C15H22O3	24575.0	DMSO : 100 mg/mL (399.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease; Cancer	O=C(O)C(C)(C)CCCOC1=CC(C)=CC=C1C	https://www.medchemexpress.com/Gemfibrozil.html	Launched		91.0	C13	E18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0258	10.0	mM	114.0	DMSO	250.156895	18	E	pluskal_fda_drugs_5005_E18_id
148	HY-14434	HYCPK40902	N08	HYCPK40902	91z	1263.0	1.0	AA15	902.0	N08	630420-16-5	Asunaprevir	BMS-650032	748.29	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Asunaprevir (BMS-650032) is a potent and orally bioavailable hepatitis C virus (HCV) NS3 protease inhibitor, with IC50 of 0.2 nM-3.5 nM[1]. Asunaprevir inhibits SARS-CoV-2 3CLpro activity[5].	Free Base	C35H46ClN5O9S	51625.0	DMSO : ≥ 100 mg/mL (133.64 mM); Ethanol : 20 mg/mL (26.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	ClC1=CC=C2C(C(O[C@H]3CN(C([C@@H](NC(OC(C)(C)C)=O)C(C)(C)C)=O)[C@H](C(N[C@@]4(C(NS(C5CC5)(=O)=O)=O)[C@H](C=C)C4)=O)C3)=NC=C2OC)=C1	https://www.medchemexpress.com/Asunaprevir.html	Launched		91.0	AA15	E18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14434	10.0	mM	114.0	DMSO	747.270477	18	E	pluskal_fda_drugs_5005_E18_id
209	HY-B1175	HYCPK40902	O12	HYCPK40902	91z	1367.0	1.0	AC23	902.0	O12	4697-14-7	(2S,5R,6R)-Ticarcillin (disodium)		428.39	Antibiotic; Bacterial	Anti-infection	(2S,5R,6R)-Ticarcillin disodium is an injectable antibiotic for the treatment of Gram-negative bacteria, particularly Pseudomonas aeruginosa. It is also one of the few antibiotics capable of treating Stenotrophomonas maltophilia infections.	Sodium	C15H14N2Na2O6S2	63604.0	DMSO : 125 mg/mL (291.79 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (233.43 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C(C(O[Na])=O)C3=CSC=C3)=O)N1C2=O)O[Na]	https://www.medchemexpress.com/Ticarcillin-disodium.html	Launched		91.0	AC23	E18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1175	10.0	mM	114.0	DMSO	384.044978	18	E	pluskal_fda_drugs_5005_E18_id
304	HY-D0205A	HYCPK40902	H19	HYCPK40902	91z	709.0	1.0	O37	902.0	H19	638-23-3	Carbocisteine	S-(Carboxymethyl)-L-cysteine	179.19	Enterovirus	Anti-infection	Carbocisteine, a mucolytic agent, can be used for the research of chronic obstructive pulmonary disease (COPD)[1].		C5H9NO4S	26623.0	H2O : 6 mg/mL (33.48 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	N[C@@H](CSCC(O)=O)C(O)=O	https://www.medchemexpress.com/carbocisteine.html	Launched		91.0	O37	E18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0205A	10.0	mM	114.0	DMSO	179.025229	18	E	pluskal_fda_drugs_5005_E18_id
524	HY-B0224	HYCPK40903	M10	HYCPK40903	91z	1172.0	2.0	Y20	903.0	M10	58-94-6	Chlorothiazide		295.72	Others	Others	Chlorothiazide is an orally active diuretic and anti-hypertensive agent[1].	Free Base	C7H6ClN3O4S2	15327.0	DMSO : 100 mg/mL (338.16 mM; Need ultrasonic); H2O : 0.67 mg/mL (2.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(C1=C(Cl)C=C(C2=C1)N=CNS2(=O)=O)(N)=O	https://www.medchemexpress.com/Chlorothiazide.html	Launched		91.0	Y20	E18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0224	10.0	mM	114.0	DMSO	294.948825	18	E	pluskal_fda_drugs_5005_E18_id
667	HY-B1121	HYCPK40903	A18	HYCPK40903	91z	36.0	2.0	A36	903.0	A18	3385-03-3	Flunisolide		434.50	Apoptosis; Glucocorticoid Receptor	Apoptosis; Immunology/Inflammation	Flunisolide is a corticosteroid, which is an orally active glucocorticoid receptor activator with anti-inflammatory activity. Flunisolide can induce eosinophil apoptosis, and is used for the research of asthma or rhinitis, and inflammation[1][2].	Free Base	C24H31FO6	105231.0	DMSO : 125 mg/mL (287.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	C[C@@]12[C@@]3(C(CO)=O)[C@@](OC(C)(O3)C)([H])C[C@@]1([H])[C@]4([H])C[C@H](F)C5=CC(C=C[C@]5(C)[C@@]4([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/Flunisolide.html	Launched		91.0	A36	E18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1121	10.0	mM	114.0	DMSO	434.210467	18	E	pluskal_fda_drugs_5005_E18_id
1156	HY-17430	HYCPK40905	M09	HYCPK40905	91z	1218.0	4.0	Z18	905.0	M09	161814-49-9	Amprenavir	VX-478	505.63	HIV; HIV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Amprenavir (VX-478) is a HIV protease inhibitor (Ki=0.6 nM) used to treat HIV infection. Amprenavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.09 μM.	Free Base	C25H35N3O6S	18119.0	DMSO : ≥ 100 mg/mL (197.77 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(O[C@@H]1COCC1)N[C@@H](CC2=CC=CC=C2)[C@H](O)CN(S(=O)(C3=CC=C(N)C=C3)=O)CC(C)C	https://www.medchemexpress.com/Amprenavir.html	Launched		91.0	Z18	E18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17430	10.0	mM	114.0	DMSO	505.224657	18	E	pluskal_fda_drugs_5005_E18_id
1310	HY-B1467	HYCPK40905	G19	HYCPK40905	91z	662.0	4.0	N38	905.0	G19	538-71-6	Domiphen (bromide)		414.46	Potassium Channel	Membrane Transporter/Ion Channel	Domiphen bromide is a chemical antiseptic and a quaternary ammonium compound, used as a cationic surfactant.	Bromide	C22H40BrNO	18557.0	DMSO : 100 mg/mL (241.28 mM; Need ultrasonic); H2O : 100 mg/mL (241.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1.[Br-]	https://www.medchemexpress.com/Domiphen-bromide.html	Launched		91.0	N38	E18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1467	10.0	mM	114.0	DMSO	334.310441	18	E	pluskal_fda_drugs_5005_E18_id
268	HY-14648A	HYCPK40902	J16	HYCPK40902	91z	895.0	1.0	S31	902.0	J16	1177-87-3	Dexamethasone acetate	Dexamethasone 21-acetate; Hexadecadrol acetate	434.50	Antibiotic; Autophagy; Bacterial; Complement System; Glucocorticoid Receptor; Mitophagy; SARS-CoV	Anti-infection; Autophagy; Immunology/Inflammation	Dexamethasone acetate (Dexamethasone 21-acetate) is a glucocorticoid receptor agonist. Dexamethasone also significantly decreases CD11b, CD18, and CD62L expression on neutrophils, and CD11b and CD18 expression on monocytes. Dexamethasone is highly effective in the control of COVID-19 infection. Dexamethasone inhibits production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.	Free Base	C24H31FO6	101330.0	DMSO : 50 mg/mL (115.07 mM; Need ultrasonic); H2O : ≥ 1 mg/mL (2.30 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]1([C@@]2(O)C(COC(C)=O)=O)[C@](C[C@H]2C)([H])[C@@](CCC3=CC4=O)([H])[C@@](F)([C@]3(C=C4)C)[C@@H](O)C1	https://www.medchemexpress.com/Dexamethasone-acetate.html	Launched		91.0	S31	E19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14648A	10.0	mM	115.0	DMSO	434.210467	19	E	pluskal_fda_drugs_5005_E19_id
394	HY-B0197A	HYCPK40902	C18	HYCPK40902	91z	227.0	1.0	E35	902.0	C18	143388-64-1	Naratriptan (hydrochloride)	GR-85548A hydrochloride	371.93	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Naratriptan hydrochloride is a selective 5-HT1 receptor subtype agonist and  is a triptan drug that is used for the treatment of migraine headaches.
Target: 5-HT1 Receptor
Naratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-HT1 receptor subtype agonist. Naratriptan is used for the treatment of the acute migraine attacks and the symptoms of migraine, including severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound or light.
The causes of migraine are not clearly understood; however, the efficacy of naratriptans and other triptans is believed to be due to their activity as 5HT (serotonin) agonists.A meta-analysis of 53 clinical trials has shown that all triptans are effective for treating migraine at marketed doses and that naratriptan, although less effective than sumatriptan and rizatriptan was more effective than placebo in reducing migraine symptoms at two hours and efficacy was demonstrated in almost two thirds of subjects after four hours of treatment."	Hydrochloride	C17H26ClN3O2S	20788.0	DMSO : ≥ 35 mg/mL (94.10 mM); H2O : 6.67 mg/mL (17.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=S(CCC1=CC2=C(NC=C2C3CCN(C)CC3)C=C1)(NC)=O.Cl	https://www.medchemexpress.com/naratriptan-hydrochloride.html	Launched		91.0	E35	E19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0197A	10.0	mM	115.0	DMSO	335.166748	19	E	pluskal_fda_drugs_5005_E19_id
734	HY-B1320	HYCPK40903	N22	HYCPK40903	91z	1292.0	2.0	AA44	903.0	N22	6385-02-0	Meclofenamic acid (sodium)	Meclofenamate (sodium)	318.13	Endogenous Metabolite; Gap Junction Protein	Cytoskeleton; Metabolic Enzyme/Protease	Meclofenamic acid (Meclofenamate) sodium is a nonsteroidal anti-inflammatory drug (NSAID) approved for use in arthritis (osteo and rheumatoid), analgesia (mild to moderate pain), dysmenorrhea, and heavy menstrual blood loss (menorrhagia). Meclofenamic acid sodium is a non-selective gap-junction blocker and a highly selective inhibitor of fat mass and obesity-associated (FTO) enzyme inhibitor[1][2][3].	Sodium	C14H10Cl2NNaO2	48289.0	DMSO : 125 mg/mL (392.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O[Na])C1=CC=CC=C1NC2=C(Cl)C=CC(C)=C2Cl	https://www.medchemexpress.com/meclofenamate-sodium.html	Launched		91.0	AA44	E19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1320	10.0	mM	115.0	DMSO	295.016684	19	E	pluskal_fda_drugs_5005_E19_id
771	HY-B0929	HYCPK40904	H05	HYCPK40904	91z	729.0	3.0	P9	904.0	H05	118-60-5	Octisalate	Octyl salicylate; 2-Ethylhexyl salicylate	250.33	Others	Others	Octisalate is an organic compound used as an ingredient in sunscreens and cosmetics to absorb the full range of UVB rays from the sun.	Free Base	C15H22O3	17214.0	DMSO : 100 mg/mL (399.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(OCC(CC)CCCC)C1=CC=CC=C1O	https://www.medchemexpress.com/Octisalate.html	Launched		91.0	P9	E19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0929	10.0	mM	115.0	DMSO	250.156895	19	E	pluskal_fda_drugs_5005_E19_id
991	HY-17452	HYCPK40904	H19	HYCPK40904	91z	757.0	3.0	P37	904.0	H19	104146-53-4	Cefditoren (sodium)	ME 1206	528.56024928	Bacterial	Anti-infection	Cefditoren sodium (ME 1206) is a broad-spectrum, third-generation, oral cephalosporin antibacterial with enhanced stability against many common β lactamases. Cefditoren  sodium has activity against Gram-negative organisms and Gram-positive organisms. Cefditoren  sodium can be used in the research of infection diseases such as acute exacerbations of chronic bronchitis, community-acquired pneumonia (CAP), streptococcal pharyngitis/tonsillitis, or uncomplicated skin and skin structure infections[1][2].	Sodium	C19H17N6NaO5S3	119330.0	DMSO : 31.25 mg/mL (59.12 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(C1=C(/C=C\C2=C(N=CS2)C)CS[C@@]([C@@H]3NC(/C(C4=CSC(N)=N4)=N\OC)=O)([H])N1C3=O)O[Na]	https://www.medchemexpress.com/cefditoren-sodium.html	Launched		91.0	P37	E19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17452	10.0	mM	115.0	DMSO	506.050081	19	E	pluskal_fda_drugs_5005_E19_id
1111	HY-B1691	HYCPK40905	P06	HYCPK40905	91z	1500.0	4.0	AF12	905.0	P06	5714-73-8	Methenamine (hippurate)	Hexamine (hippurate)	319.36	Bacterial	Anti-infection	Methenamine hippurate (Hexamine hippurate) is an orally active urinary antiseptic agent with a wide antibacterial spectrum. Methenamine hippurate is effective against most common urinary tract pathogens[1][2].	Hippurate	C15H21N5O3	64104.0	DMSO : 25 mg/mL (78.28 mM; Need ultrasonic); H2O : 100 mg/mL (313.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CNC(C1=CC=CC=C1)=O.N2(C3)CN4CN3CN(C4)C2	https://www.medchemexpress.com/methenamine-hippurate.html	Launched		91.0	AF12	E19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1691	10.0	mM	115.0	DMSO	179.058243	19	E	pluskal_fda_drugs_5005_E19_id
1120	HY-B1089	HYCPK40905	I07	HYCPK40905	91z	830.0	4.0	R14	905.0	I07	297-76-7	Ethynodiol diacetate	Ethynodiol acetate	384.51	Progesterone Receptor	Others	Ethynodiol diacetate (Ethynodiol acetate) is a steroidal progestin which is used as a hormonal contraceptive, it has relatively little or no potency as an androgen,has significant estrogenic effects.	Free Base	C24H32O4	17177.0	DMSO : 150 mg/mL (390.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	C#C[C@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])CCC4=C[C@@H](OC(C)=O)CC[C@]4([H])[C@@]3([H])CC[C@]12C	https://www.medchemexpress.com/Ethynodiol-diacetate.html	Launched		91.0	R14	E19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1089	10.0	mM	115.0	DMSO	384.23006	19	E	pluskal_fda_drugs_5005_E19_id
1290	HY-17508	HYCPK40905	C18	HYCPK40905	91z	276.0	4.0	F36	905.0	C18	81103-11-9	Clarithromycin		747.95336	Antibiotic; Autophagy; Bacterial; Cytochrome P450	Anti-infection; Autophagy; Metabolic Enzyme/Protease	Clarithromycin has a broad spectrum of antimicrobial activity. Clarithromycin inhibits the CYP3A4-catalyzed triazolam alpha-hydroxylation with the IC50 (Ki) value of 56 (43) μM[2]. Clarithromycin significantly inhibits the HERG potassium current[3].Clarithromycin affects the autophagic flux by impairing the signaling pathway linking hERG1 and PI3K[4].	Free Base	C38H69NO13	16542.0	DMSO : 33.33 mg/mL (44.56 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@@](OC)(C[C@H](C([C@@H]1C)=O)C)[C@@H]([C@H]([C@@H]([C@H](C(O[C@H](CC)[C@@](C)(O)[C@@H]1O)=O)C)O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@@]2(C)OC)C)O[C@@](O[C@H](C)C[C@@H]3N(C)C)([H])[C@@H]3O	https://www.medchemexpress.com/Clarithromycin.html	Launched		91.0	F36	E19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17508	10.0	mM	115.0	DMSO	747.476891	19	E	pluskal_fda_drugs_5005_E19_id
330	HY-17506	HYCPK40902	K21	HYCPK40902	91z	1001.0	1.0	U41	902.0	K21	83905-01-5	Azithromycin	CP 62993	748.98	Antibiotic; Autophagy; Bacterial; Parasite	Anti-infection; Autophagy	Azithromycin is a macrolide antibiotic useful for the treatment of a number of bacterial infections.	Free Base	C38H72N2O12	14276.0	DMSO : ≥ 100 mg/mL (133.51 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@@H]([C@@H]([C@@](C(O[C@@H]([C@@](C)(O)[C@@H]1O)CC)=O)([H])C)O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@@]2(C)OC)[C@H]([C@](O)(C[C@H](CN([C@@H]1C)C)C)C)O[C@@](O[C@H](C)C[C@@H]3N(C)C)([H])[C@@H]3O	https://www.medchemexpress.com/Azithromycin.html	Launched		91.0	U41	E20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17506	10.0	mM	116.0	DMSO	748.508526	20	E	pluskal_fda_drugs_5005_E20_id
351	HY-B0383	HYCPK40903	H03	HYCPK40903	91z	678.0	2.0	O6	903.0	H03	181183-52-8	Almotriptan (malate)	PNU180638	469.55174	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Almotriptan Malate is a 5-HT1B/1D-receptor agonist used to treat migraine.
IC50:
Target: 5-hydroxytryptamine1B/1D (5-HT1B/1D) Receptor
Almotriptan Malate is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, used for the treatment of Migraine attacks in adults. Almotriptan showed low nanomolar affinity for the 5-HT(1B) and 5-HT(1D) receptors in several species, including the human, while affinity for 5-HT receptors other than 5-HT(1B/1D) was clearly less. Almotriptan did not exhibit significant affinity for several non-5-HT receptors studied up to 100 microM. Almotriptan inhibited forskolin-stimulated cyclic AMP accumulation in HeLa cells transfected with 5-HT(1B) or 5-HT(1D) human receptors [1]. Almotriptan had a mild antiemetic effect and a slight, transient diuretic effect in dogs, although the latter effect is probably of no clinical relevance. In addition, no effect on the respiratory system of conscious guinea pigs was observed following almotriptan treatment. These results indicate that almotriptan has a favourable safety profile with respect to the central nervous, renal and respiratory systems [2]."	Malate	C21H31N3O7S	16381.0	H2O : 33.33 mg/mL (70.98 mM; Need ultrasonic); DMSO : 100 mg/mL (212.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(O)C(O)CC(O)=O.O=S(CC1=CC2=C(NC=C2CCN(C)C)C=C1)(N3CCCC3)=O	https://www.medchemexpress.com/Almotriptan-malate.html	Launched		91.0	O6	E20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0383	10.0	mM	116.0	DMSO	335.166748	20	E	pluskal_fda_drugs_5005_E20_id
463	HY-15777	HYCPK40903	D06	HYCPK40903	91z	300.0	2.0	G12	903.0	D06	1211441-98-3	Ribociclib	LEE011	434.54	CDK	Cell Cycle/DNA Damage	Ribociclib (LEE01) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex[1].	Free Base	C23H30N8O	139086.0	DMSO : 20 mg/mL (46.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N(C)C)C(N1C2CCCC2)=CC(C1=N3)=CN=C3NC(N=C4)=CC=C4N5CCNCC5	https://www.medchemexpress.com/LEE011.html	Launched		91.0	G12	E20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15777	10.0	mM	116.0	DMSO	434.254258	20	E	pluskal_fda_drugs_5005_E20_id
603	HY-B1125	HYCPK40903	A14	HYCPK40903	91z	28.0	2.0	A28	903.0	A14	3416-24-8	Glucosamine	D-Glucosamine; Chitosamine	179.17	Autophagy; Endogenous Metabolite; HIF/HIF Prolyl-Hydroxylase; Reactive Oxygen Species	Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Glucosamine (D-Glucosamine) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement. Glucosamine also is a natural constituent of glycosaminoglycans in the cartilage matrix and synovial fluid, which when administered exogenously, exerts pharmacological effects on osteoarthritic cartilage and chondrocytes[1].	Free Base	C6H13NO5	205073.0	DMSO : 3.33 mg/mL (18.59 mM; Need ultrasonic); H2O : 100 mg/mL (558.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C[C@H](N)[C@H]([C@@H]([C@@H](CO)O)O)O	https://www.medchemexpress.com/Glucosamine.html	Launched		91.0	A28	E20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1125	10.0	mM	116.0	DMSO	179.079373	20	E	pluskal_fda_drugs_5005_E20_id
670	HY-B0343A	HYCPK40903	D18	HYCPK40903	91z	324.0	2.0	G36	903.0	D18	91296-87-6	Sarafloxacin (hydrochloride)	A-56620 (hydrochloride)	421.83	Antibiotic; Bacterial	Anti-infection	Sarafloxacin (hydrochloride) (A-56620 (hydrochloride)) is a quinolone antibiotic drug.	Hydrochloride	C20H18ClF2N3O3	18061.0	DMSO : 8.33 mg/mL (19.75 mM; Need ultrasonic); H2O : 1 mg/mL (2.37 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2=CC=C(F)C=C2)C3=C(C=C(F)C(N4CCNCC4)=C3)C1=O)O.Cl	https://www.medchemexpress.com/Sarafloxacin-hydrochloride.html	Launched		91.0	G36	E20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0343A	10.0	mM	116.0	DMSO	385.123798	20	E	pluskal_fda_drugs_5005_E20_id
883	HY-15036	HYCPK40904	H12	HYCPK40904	91z	743.0	3.0	P23	904.0	H12	15307-86-5	Diclofenac		296.15	Apoptosis; COX	Apoptosis; Immunology/Inflammation	Diclofenac is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells[1], and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively[2]. Diclofenac induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade[3].	Free Acid	C14H11Cl2NO2	42379.0	DMSO : 125 mg/mL (422.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl	https://www.medchemexpress.com/Diclofenac.html	Launched		91.0	P23	E20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15036	10.0	mM	116.0	DMSO	295.016684	20	E	pluskal_fda_drugs_5005_E20_id
1104	HY-16297	HYCPK40905	I06	HYCPK40905	91z	828.0	4.0	R12	905.0	I06	1231930-82-7	Abemaciclib (methanesulfonate)	LY2835219 (methanesulfonate)	602.70	CDK	Cell Cycle/DNA Damage	Abemaciclib methanesulfonate (LY2835219 methanesulfonate) is a selective CDK4/6 inhibitor with IC50s of 2 nM and 10 nM for CDK4 and CDK6, respectively[1][2][3].	Methanesulfonate	C28H36F2N8O3S	101243.0	H2O : 125 mg/mL (207.40 mM; Need ultrasonic); DMSO : 10 mg/mL (16.59 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	CC(N1C2=CC(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)=CC(F)=C2N=C1C)C.CS(=O)(O)=O	https://www.medchemexpress.com/LY2835219.html	Launched		91.0	R12	E20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16297	10.0	mM	116.0	DMSO	506.271799	20	E	pluskal_fda_drugs_5005_E20_id
1174	HY-10978	HYCPK40905	O10	HYCPK40905	91z	1412.0	4.0	AD20	905.0	O10	906673-24-3	Crisaborole	AN-2728; PF-06930164	251.05	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Crisaborole (AN-2728) is a potent inhibitor of  PDE4 and cytokine release; inhibit PDE4 with an IC50 of 0.49 μM.	Free Base	C14H10BNO3	19132.0	DMSO : ≥ 100 mg/mL (398.33 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	N#CC1=CC=C(OC2=CC=C(B(O)OC3)C3=C2)C=C1	https://www.medchemexpress.com/AN-2728.html	Launched		91.0	AD20	E20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10978	10.0	mM	116.0	DMSO	251.075374	20	E	pluskal_fda_drugs_5005_E20_id
154	HY-10241	HYCPK40902	D09	HYCPK40902	91z	305.0	1.0	G17	902.0	D09	923604-59-5	Simeprevir	TMC435; TMC435350	749.94	DNA/RNA Synthesis; HCV; HCV Protease; SARS-CoV	Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Simeprevir (TMC435; TMC435350) is an oral, potent and highly specific hepatitis C virus (HCV) NS3/4A protease inhibitor with a Ki of 0.36 nM. Simeprevir inhibits HCV replication with an EC50 of 7.8 nM. Simeprevir also potently suppresses SARS-CoV-2 replication and synergizes with Remdesivir. Simeprevir inhibits the main protease (Mpro) and the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2, and also modulates host immune responses[1][4].	Free Base	C38H47N5O7S2	8216.0	DMSO : 14.29 mg/mL (19.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	COC1=C(C)C2=C(C(O[C@H]3C[C@@H](C(N(C)CCCC/C=C\[C@H](C4)[C@]4(C(NS(=O)(C5CC5)=O)=O)N6)=O)[C@H](C6=O)C3)=CC(C7=NC(C(C)C)=CS7)=N2)C=C1	https://www.medchemexpress.com/Simeprevir.html	Launched		91.0	G17	E21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10241	10.0	mM	117.0	DMSO	749.291691	21	E	pluskal_fda_drugs_5005_E21_id
201	HY-16908A	HYCPK40902	G12	HYCPK40902	91z	599.0	1.0	M23	902.0	G12	1350636-82-6	Lefamulin (acetate)	BC-3781 (acetate)	567.78	Antibiotic; Bacterial	Anti-infection	Lefamulin (BC-3781) acetate is an orally active antibiotic. Lefamulin acetate inhibits protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome. Lefamulin acetate has anti-inflammatory activity. Lefamulin acetate can be used in the research of bacterial infections, such as bacterial pneumonia[1].	Acetate	C30H49NO7S	63241.0	H2O : 1 mg/mL (1.76 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (176.12 mM)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	CC(O)=O.C[C@@H]1[C@]23[C@](C(CC3)=O)([H])[C@]([C@@H](C[C@](C)([C@H]1O)C=C)OC(CS[C@H]4[C@@H](C[C@@H](CC4)N)O)=O)([C@@H](CC2)C)C	https://www.medchemexpress.com/lefamulin-acetate.html	Launched		91.0	M23	E21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16908A	10.0	mM	117.0	DMSO	507.301845	21	E	pluskal_fda_drugs_5005_E21_id
229	HY-B0326	HYCPK40902	C14	HYCPK40902	91z	219.0	1.0	E27	902.0	C14	26750-81-2	Alibendol		251.28	Others	Others	"Alibendol is an antispasmodic,choleretic, and cholekinetic. 
Target: Others
administration of alibendol in beagle dogs, observed retention times were approximately 5.0 min for alibendol. The within-run precision showed RSD values between 5.83 and 16.96 %. The between-run RSD values varied from 6.73 to 17.99 % at the LLOQ [1]."	Free Base	C13H17NO4	16027.0	DMSO : ≥ 100 mg/mL (397.96 mM); H2O : 0.91 mg/mL (3.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(NCCO)C1=CC(CC=C)=CC(OC)=C1O	https://www.medchemexpress.com/Alibendol.html	Launched		91.0	E27	E21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0326	10.0	mM	117.0	DMSO	251.115758	21	E	pluskal_fda_drugs_5005_E21_id
316	HY-17399	HYCPK40902	D20	HYCPK40902	91z	327.0	1.0	G39	902.0	D20	81110-73-8	Racecadotril	Acetorphan	385.48	Neprilysin	Metabolic Enzyme/Protease	Racecadotril (Acetorphan) is a neutral endopeptidase (NEP) inhibitor. Racecadotril and its active metabolite Thiorphan inhibits purified NEP activity from mouse brain with Kis of 4500 and 6.1 nM, , respectively. Antidiarrheal agent[1].	Free Base	C21H23NO4S	14560.0	DMSO : ≥ 100 mg/mL (259.42 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(OCC1=CC=CC=C1)CNC(C(CSC(C)=O)CC2=CC=CC=C2)=O	https://www.medchemexpress.com/Racecadotril.html	Launched		91.0	G39	E21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17399	10.0	mM	117.0	DMSO	385.134779	21	E	pluskal_fda_drugs_5005_E21_id
498	HY-17577	HYCPK40903	G08	HYCPK40903	91z	592.0	2.0	M16	903.0	G08	68030-18-2	Berberine (chloride hydrate)	Natural Yellow 18 (chloride hydrate)	389.83	Antibiotic; Autophagy; Bacterial; Endogenous Metabolite; Parasite; Reactive Oxygen Species; Topoisomerase	Anti-infection; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Berberine chloride hydrate (Natural Yellow 18 chloride hydrate) is an alkaloid that acts as an antibiotic. Berberine chloride hydrate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].	Chloride	C20H20ClNO5	27049.0	DMSO : ≥ 3.9 mg/mL (10.00 mM); H2O : 1 mg/mL (2.57 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	COC1=C(OC)C2=C[N+]3=C(C(C(CC3)=C4)=CC5=C4OCO5)C=C2C=C1.[Cl-].O	https://www.medchemexpress.com/Berberine-chloride-hydrate.html	Launched		91.0	M16	E21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17577	10.0	mM	117.0	DMSO	336.123034	21	E	pluskal_fda_drugs_5005_E21_id
1009	HY-50903	HYCPK40904	J20	HYCPK40904	91z	951.0	3.0	T39	904.0	J20	366789-02-8	Rivaroxaban	BAY 59-7939	435.88	Factor Xa	Metabolic Enzyme/Protease	Rivaroxaban (BAY 59-7939) is a highly potent, selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM)[1][2].	Free Base	C19H18ClN3O5S	9480.0	DMSO : 50 mg/mL (114.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(N(C1=CC=C(N2C(COCC2)=O)C=C1)C3)O[C@H]3CNC(C4=CC=C(S4)Cl)=O	https://www.medchemexpress.com/Rivaroxaban.html	Launched		91.0	T39	E21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50903	10.0	mM	117.0	DMSO	435.065569	21	E	pluskal_fda_drugs_5005_E21_id
1107	HY-17595	HYCPK40905	L06	HYCPK40905	91z	1116.0	4.0	X12	905.0	L06	31431-39-7	Mebendazole		295.29	Apoptosis; Microtubule/Tubulin; Parasite	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Mebendazole is a highly effective, broad-spectrum antihelmintic against nematode infestations. Mebendazole also exhibits inhibitory effect against glioblastoma multiforme (GBM), inhibits Hedgehog pathway and tubulin polymerization. Mebendazole is orally active and can cross CNS penetration[1][2][3].	Free Base	C16H13N3O3	25171.0	DMSO : 4.17 mg/mL (14.12 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(OC)NC1=NC2=CC=C(C(C3=CC=CC=C3)=O)C=C2N1	https://www.medchemexpress.com/Mebendazole.html	Launched		91.0	X12	E21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17595	10.0	mM	117.0	DMSO	295.095691	21	E	pluskal_fda_drugs_5005_E21_id
1329	HY-N0733	HYCPK40905	J20	HYCPK40905	91z	952.0	4.0	T40	905.0	J20	66-84-2	Glucosamine (hydrochloride)	D-(+)-Glucosamine hydrochloride; Chitosamine hydrochloride	215.63	Autophagy; Endogenous Metabolite; HIF/HIF Prolyl-Hydroxylase; Reactive Oxygen Species	Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Glucosamine hydrochloride (D-Glucosamine hydrochloride) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement. Glucosamine hydrochloride also is a natural constituent of glycosaminoglycans in the cartilage matrix and synovial fluid, which when administered exogenously, exerts pharmacological effects on osteoarthritic cartilage and chondrocytes[1].	Hydrochloride	C6H14ClNO5	17584.0	DMSO : 100 mg/mL (463.76 mM; Need ultrasonic); H2O : 50 mg/mL (231.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C[C@H](N)[C@H]([C@@H]([C@@H](CO)O)O)O.Cl	https://www.medchemexpress.com/Glucosamine-hydrochloride.html	Launched		91.0	T40	E21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0733	10.0	mM	117.0	DMSO	179.079373	21	E	pluskal_fda_drugs_5005_E21_id
104	HY-B0375A	HYCPK40902	N05	HYCPK40902	91z	1257.0	1.0	AA9	902.0	N05	141396-28-3	Argatroban (monohydrate)	MD-805 (monohydrate); MCI-9038 (monohydrate); Argipidine (monohydrate)	526.65	Thrombin	Metabolic Enzyme/Protease	Argatroban (monohydrate) (MD-805 (monohydrate)) is a direct, selective thrombin inhibitor.	Free Acid	C23H38N6O6S	16336.0	DMSO : ≥ 100 mg/mL (189.88 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C([C@@H]1N(C([C@@H](NS(=O)(C2=CC=CC3=C2NCC(C)C3)=O)CCCNC(N)=N)=O)CC[C@@H](C)C1)O.O	https://www.medchemexpress.com/Argatroban-monohydrate.html	Launched		91.0	AA9	E22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0375A	10.0	mM	118.0	DMSO	508.246789	22	E	pluskal_fda_drugs_5005_E22_id
117	HY-18763	HYCPK40902	K06	HYCPK40902	91z	971.0	1.0	U11	902.0	K06	63610-08-2	Indobufen	Ibustrin	295.33	COX	Immunology/Inflammation	Indobufen is a platelet aggregation inhibitor. Indobufen is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes[1].	Free Acid	C18H17NO3	112091.0	DMSO : 250 mg/mL (846.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O)C(CC)C1=CC=C(N(CC2=C3C=CC=C2)C3=O)C=C1	https://www.medchemexpress.com/indobufen.html	Launched		91.0	U11	E22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18763	10.0	mM	118.0	DMSO	295.120843	22	E	pluskal_fda_drugs_5005_E22_id
220	HY-B0448	HYCPK40902	J13	HYCPK40902	91z	889.0	1.0	S25	902.0	J13	57-41-0	Phenytoin	5,5-Diphenylhydantoin	252.27	Sodium Channel; Virus Protease	Anti-infection; Membrane Transporter/Ion Channel	Phenytoin (5,5-Diphenylhydantoin) is a potent Voltage-gated Na+ channels (VGSCs) blocker. Phenytoin has antiepileptic activity and reduces breast tumour growth and metastasis in mice[1][2].	Free Base	C15H12N2O2	120885.0	DMSO : 50 mg/mL (198.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C1NC(C(C2=CC=CC=C2)(C3=CC=CC=C3)N1)=O	https://www.medchemexpress.com/phenytoin.html	Launched		91.0	S25	E22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0448	10.0	mM	118.0	DMSO	252.089878	22	E	pluskal_fda_drugs_5005_E22_id
409	HY-B1115	HYCPK40902	I21	HYCPK40902	91z	809.0	1.0	Q41	902.0	I21	33386-08-2	Buspirone (hydrochloride)		421.96	5-HT Receptor; Reactive Oxygen Species	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB	Buspirone hydrochloride is a 5-HT1A receptor agonist. Buspirone hydrochloride can be used for anxiety and depression research[1][2].	Hydrochloride	C21H32ClN5O2	100901.0	DMSO : 50 mg/mL (118.49 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (236.99 mM)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C(N(CCCCN1CCN(C2=NC=CC=N2)CC1)C(C3)=O)CC43CCCC4.[H]Cl	https://www.medchemexpress.com/Buspirone-hydrochloride.html	Launched		91.0	Q41	E22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1115	10.0	mM	118.0	DMSO	385.247775	22	E	pluskal_fda_drugs_5005_E22_id
458	HY-50175	HYCPK40903	O05	HYCPK40903	91z	1354.0	2.0	AC10	903.0	O05	571170-77-9	Laropiprant	MK-0524	435.90	Prostaglandin Receptor	GPCR/G Protein	Laropiprant is a potent and selective DP receptor antagonist with Ki values of 0.57 nM and 2.95 nM for DP receptor and TP Receptor, respectively[1][2][3].	Free Acid	C21H19ClFNO4S	4492.0	DMSO : ≥ 100 mg/mL (229.41 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=S(C1=CC(F)=CC2=C1N(C3=C2CC[C@@H]3CC(O)=O)CC4=CC=C(Cl)C=C4)(C)=O	https://www.medchemexpress.com/laropiprant.html	Launched		91.0	AC10	E22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50175	10.0	mM	118.0	DMSO	435.070735	22	E	pluskal_fda_drugs_5005_E22_id
702	HY-A0093	HYCPK40903	N20	HYCPK40903	91z	1288.0	2.0	AA40	903.0	N20	5370-01-4	Mexiletine (hydrochloride)	KOE-1173 (hydrochloride)	215.72	Sodium Channel	Membrane Transporter/Ion Channel	Mexiletine hydrochloride (KOE-1173 hydrochloride), a Class IB antianhythmic, is a non-selective voltage-gated sodium channel blocker[1][2].	Hydrochloride	C11H18ClNO	16770.0	DMSO : ≥ 41 mg/mL (190.06 mM); H2O : 100 mg/mL (463.56 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC(N)COC1=C(C)C=CC=C1C.[H]Cl	https://www.medchemexpress.com/Mexiletine-hydrochloride.html	Launched		91.0	AA40	E22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0093	10.0	mM	118.0	DMSO	179.131014	22	E	pluskal_fda_drugs_5005_E22_id
805	HY-100584	HYCPK40904	J07	HYCPK40904	91z	925.0	3.0	T13	904.0	J07	55224-05-0	Davercin	Erythromycin Cyclocarbonate	759.92	Antibiotic; Bacterial	Anti-infection	Davercin (Erythromycin Cyclocarbonate), derivative of Erythromycin, which is active against Gram-positive and some Gram-negative microorganisms.	Free Base	C38H65NO14	190150.0	DMSO : ≥ 50 mg/mL (65.80 mM)	DMSO Solution	10mM  * 100uL	Infection	C[C@]([C@H](OC([C@@H]([C@H]([C@H](C)[C@H]1O[C@@](O[C@H](C)C[C@@H]2N(C)C)([H])[C@@H]2O)O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC)C)=O)CC)(O4)[C@]([C@H](C([C@@H](C[C@]1(O)C)C)=O)C)([H])OC4=O	https://www.medchemexpress.com/Erythromycin-Cyclocarbonate.html	Launched		91.0	T13	E22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100584	10.0	mM	118.0	DMSO	759.440506	22	E	pluskal_fda_drugs_5005_E22_id
1182	HY-B0440	HYCPK40905	G11	HYCPK40905	91z	646.0	4.0	N22	905.0	G11	59804-37-4	Tenoxicam	Ro-12-0068	337.37	COX	Immunology/Inflammation	Tenoxicam (Ro-12-0068), an antiinflammatory agent with analgesic and antipyretic properties.	Free Base	C13H11N3O4S2	16490.0	DMSO : 50 mg/mL (148.21 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC(C(SC=C1)=C1S2(=O)=O)=C(N2C)C(NC3=CC=CC=N3)=O	https://www.medchemexpress.com/tenoxicam.html	Launched		91.0	N22	E22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0440	10.0	mM	118.0	DMSO	337.019098	22	E	pluskal_fda_drugs_5005_E22_id
299	HY-B1684	HYCPK40902	C19	HYCPK40902	91z	229.0	1.0	E37	902.0	C19	78266-06-5	Mebrofenin	SQ 26962	387.23	Others	Others	Mebrofenin (SQ 26962) is a type of iminodiacetic acid (IDA). Mebrofenin is available as a ready to use the kit for radio-labeling with Tc-99m. Tc-99m Mebrofenin, a diagnostic agent, is used for hepatobiliary imaging. Tc-99m Mebrofenin is the radiopharmaceutical of choice for the evaluation of hepatic function[1][2].	Free Acid	C15H19BrN2O5	58120.0	DMSO : 250 mg/mL (645.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(O)CN(CC(NC1=C(C)C=C(C)C(Br)=C1C)=O)CC(O)=O	https://www.medchemexpress.com/mebrofenin.html	Launched		91.0	E37	F3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1684	10.0	mM	123.0	DMSO	386.047734	3	F	pluskal_fda_drugs_5005_F3_id
385	HY-12199	HYCPK40902	F08	HYCPK40902	91z	495.0	1.0	K15	902.0	F08	362665-56-3	Pitolisant	Tiprolisant	295.85	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Pitolisant is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM).	Free Base	C17H26ClNO	104896.0	DMSO : 100 mg/mL (338.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1	https://www.medchemexpress.com/pitolisant.html	Launched		91.0	K15	F3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12199	10.0	mM	123.0	DMSO	295.170292	3	F	pluskal_fda_drugs_5005_F3_id
783	HY-B1357	HYCPK40904	D06	HYCPK40904	91z	347.0	3.0	H11	904.0	D06	71-63-6	Digitoxin		764.94	Na+/K+ ATPase	Membrane Transporter/Ion Channel	"Digitoxin is an effective Na+/K+-ATPase inhibitor, the EC50 value of Digitoxin is 0.78 μM.
IC50 value: 0.78 μM (EC50)
Target: Na+/K+-ATPase
in vitro: Digitoxin shows a significantly cytotoxic effect in H1975 cells by causing G2 phase arrest, also remarkably activates 5' adenosine monophosphate-activated protein kinase (AMPK). Moreover, Digitoxin suppresses microtubule formation through decreasing α-tubulin. Digitoxin effectively depresses the growth of TKI-resistance NSCLC H1975 cells by inhibiting microtubule polymerization and inducing cell cycle arrest. Digitoxin has the highest cytotoxicity in H1975 cells, whose CC50 value was 0.19 ± 0.06 μM. Digitoxin-induced inhibition mechanism is likely due to causing G2/M cell cycle arrest in H1975 cells in dose dependent manners."	Free Base	C41H64O13	63498.0	DMSO : 100 mg/mL (130.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	C[C@H]1O[C@](O[C@@H]2[C@@H](C)O[C@](O[C@H]3[C@@H](O)C[C@@](O[C@@H]4C[C@](CC[C@]5([H])[C@]6([H])CC[C@@]7(C)[C@]5(O)CC[C@@H]7C(CO8)=CC8=O)([H])[C@]6(C)CC4)([H])O[C@@H]3C)([H])C[C@@H]2O)([H])C[C@H](O)[C@@H]1O	https://www.medchemexpress.com/Digitoxin.html	Launched		91.0	H11	F3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1357	10.0	mM	123.0	DMSO	764.434692	3	F	pluskal_fda_drugs_5005_F3_id
886	HY-B0377	HYCPK40904	K12	HYCPK40904	91z	1031.0	3.0	V23	904.0	K12	76824-35-6	Famotidine	MK-208	337.45	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.	Free Base	C8H15N7O2S3	16067.0	H2O : 0.1 mg/mL (0.30 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (296.34 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Endocrinology; Cancer	N=C(NS(=O)(N)=O)CCSCC1=CSC(NC(N)=N)=N1	https://www.medchemexpress.com/Famotidine.html	Launched		91.0	V23	F3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0377	10.0	mM	123.0	DMSO	337.044936	3	F	pluskal_fda_drugs_5005_F3_id
1076	HY-100607A	HYCPK40905	M04	HYCPK40905	91z	1208.0	4.0	Z8	905.0	M04	144481-98-1	Landiolol (hydrochloride)	ONO1101 (hydrochloride)	546.05	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Landiolol hydrochloride (ONO1101 hydrochloride) is a highly beta1 selective ultra-short acting beta-blocker (β1/β2 selectivity?=?255:1, a half-life of 4?min)， acts as an adrenoceptor antagonist[1].	Hydrochloride	C25H40ClN3O8	84771.0	DMSO : 250 mg/mL (457.83 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (183.13 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(OC[C@H]1OC(C)(C)OC1)CCC2=CC=C(OC[C@@H](O)CNCCNC(N3CCOCC3)=O)C=C2.[H]Cl	https://www.medchemexpress.com/landiolol-hydrochloride.html	Launched		91.0	Z8	F3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100607A	10.0	mM	123.0	DMSO	509.273715	3	F	pluskal_fda_drugs_5005_F3_id
1185	HY-B0338A	HYCPK40905	J11	HYCPK40905	91z	934.0	4.0	T22	905.0	J11	1501-84-4	Rimantadine (hydrochloride)		215.76	Influenza Virus	Anti-infection	"Rimantadine hydrochloride is an anti-influenza virus drug.
Target: Influenza Virus
Rimantadine hydrochloride are oral antiviral drugs useful in the prophylaxis and treatment of influenza A virus infections. rimantadine has prophylactic efficacy comparable to amantadine but lower potential for causing adverse effects [1]. double-blind study of children with influenza-like illness. 37 received rimantadine for five days. Of the total 37 children in the rimantadine group, 27% were found to have resistant isolated compared with 6% in the total group receiving acetaminophen (P < .04). Furthermore, the mean inhibitory concentration of rimantadine increased with time in the rimantadine group (r = .4, P = .002) [2]."	Hydrochloride	C12H22ClN	11798.0	DMSO : 50 mg/mL (231.74 mM; Need ultrasonic); H2O : 33.33 mg/mL (154.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC(C1(C[C@H](C2)C3)C[C@H]3C[C@H]2C1)N.Cl	https://www.medchemexpress.com/Rimantadine-hydrochloride.html	Launched		91.0	T22	F3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0338A	10.0	mM	123.0	DMSO	179.1674	3	F	pluskal_fda_drugs_5005_F3_id
1356	HY-B0822	HYCPK40905	I22	HYCPK40905	91z	860.0	4.0	R44	905.0	I22	120068-37-3	Fipronil		437.15	Cytochrome P450; GABA Receptor	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Fipronil is an insecticide that acts as a selective antagonist of insect GABA receptors (IC50s = 30 nM and 1,600 nM for cockroach and rat receptors, respectively). Fipronil also inhibits desensitizing and non-desensitizing glutamate-induced chloride currents in cockroach neurons (IC500s = 800 nM and 10 nM, respectively). Fipronil induces activity of the cytochrome P450 (CYP) isoforms CYP1A1/2, CYP2B1/2, and CYP3A1/2 in isolated rat liver microsomes.		C12H4Cl2F6N4OS	68311.0	DMSO : 250 mg/mL (571.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	N#CC1=NN(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)C(N)=C1S(C(F)(F)F)=O	https://www.medchemexpress.com/fipronil.html	Launched		91.0	R44	F3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0822	10.0	mM	123.0	DMSO	435.938706	3	F	pluskal_fda_drugs_5005_F3_id
1358	HY-B0322	HYCPK40905	K22	HYCPK40905	91z	1052.0	4.0	V44	905.0	K22	723-46-6	Sulfamethoxazole	Ro 4-2130	253.28	Antibiotic; Bacterial	Anti-infection	Sulfamethoxazole (Ro 4-2130) is a sulfonamide bacteriostatic antibiotic, used for bacterial infections. Sulfonamides is a competitive antagonists of para-aminobenzoic acid (PABA)[1].	Free Base	C10H11N3O3S	16197.0	H2O : 0.1 mg/mL (0.39 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (394.82 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NOC(C)=C2)=O	https://www.medchemexpress.com/Sulfamethoxazole.html	Launched		91.0	V44	F3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0322	10.0	mM	123.0	DMSO	253.052112	3	F	pluskal_fda_drugs_5005_F3_id
207	HY-10065	HYCPK40902	M12	HYCPK40902	91z	1175.0	1.0	Y23	902.0	M12	319460-85-0	Axitinib	AG-013736	386.47	PDGFR; VEGFR	Protein Tyrosine Kinase/RTK	Axitinib is a multi-targeted tyrosine kinase inhibitor with IC50s of 0.1, 0.2, 0.1-0.3, 1.6 nM for VEGFR1, VEGFR2, VEGFR3 and  PDGFRβ, respectively.	Free Base	C22H18N4OS	81748.0	DMSO : 20.83 mg/mL (53.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(SC2=CC3=C(C(/C=C/C4=CC=CC=N4)=NN3)C=C2)C=CC=C1)NC	https://www.medchemexpress.com/Axitinib.html	Launched		91.0	Y23	F4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10065	10.0	mM	124.0	DMSO	386.120132	4	F	pluskal_fda_drugs_5005_F4_id
389	HY-100009	HYCPK40902	J09	HYCPK40902	91z	881.0	1.0	S17	902.0	J09	67330-25-0	Ufenamate	Flufenamic acid butyl ester; Butyl flufenamate	337.34	Others	Others	Ufenamate (Flufenamic acid butyl ester) is an anthranilic acid-based anti-inflammatory agent. Ufenamate can be used for the research of skin diseases, such as acute and chronic eczema, contact dermatitis, diaper dermatitis, miliaria and atopic dermatitis[1][2].	Free Base	C18H18F3NO2	20267.0	DMSO : ≥ 44 mg/mL (130.43 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCCCC)C1=CC=CC=C1NC2=CC=CC(C(F)(F)F)=C2	https://www.medchemexpress.com/Ufenamate.html	Launched		91.0	S17	F4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100009	10.0	mM	124.0	DMSO	337.128963	4	F	pluskal_fda_drugs_5005_F4_id
609	HY-B0575	HYCPK40903	G14	HYCPK40903	91z	604.0	2.0	M28	903.0	G14	396-01-0	Triamterene		253.26	G protein-coupled Bile Acid Receptor 1; Sodium Channel	GPCR/G Protein; Membrane Transporter/Ion Channel	Triamterene blocks epithelial Na+ channel (ENaC) in a voltage-dependent manner, which used as a mild diuretic. Triamterene as an inhibitor of the TGR5 receptor.	Free Base	C12H11N7	16873.0	DMSO : 16.67 mg/mL (65.82 mM; ultrasonic and adjust pH to 5 with HCl); H2O : 0.1 mg/mL (0.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	NC1=NC(N)=C2N=C(C3=CC=CC=C3)C(N)=NC2=N1	https://www.medchemexpress.com/triamterene.html	Launched		91.0	M28	F4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0575	10.0	mM	124.0	DMSO	253.107593	4	F	pluskal_fda_drugs_5005_F4_id
682	HY-B1392	HYCPK40903	P18	HYCPK40903	91z	1476.0	2.0	AE36	903.0	P18	81161-17-3	Esmolol (hydrochloride)		331.83	Adrenergic Receptor; Autophagy; Mitophagy	Autophagy; GPCR/G Protein; Neuronal Signaling	Esmolol hydrochloride is a beta adrenergic receptor blocker.	Hydrochloride	C16H26ClNO4	17681.0	H2O : ≥ 50 mg/mL (150.68 mM); DMSO : ≥ 100 mg/mL (301.36 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=C(OC)CCC1=CC=C(OCC(O)CNC(C)C)C=C1.[H]Cl	https://www.medchemexpress.com/Esmolol-hydrochloride.html	Launched		91.0	AE36	F4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1392	10.0	mM	124.0	DMSO	295.178358	4	F	pluskal_fda_drugs_5005_F4_id
878	HY-12594	HYCPK40904	C12	HYCPK40904	91z	263.0	3.0	F23	904.0	C12	1216941-48-8	Paritaprevir	ABT-450; Veruprevir	765.88	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Paritaprevir (ABT-450) is a potent, orally active and antiviral non-structural protein 3/4A (NS3/4A) protease inhibitor with EC50s of 1 and 0.21 nM against HCV 1a and 1b, respectively. Paritaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.31 μM. Paritaprevir is metabolized primarily by cytochrome P450 (CYP) 3A. The plasma concentration and half-life of Paritaprevir can be enhanced by Ritonavir (a CYP450 inhibitor)[1][2][3][4].	Free Base	C40H43N7O7S	18265.0	DMSO : ≥ 125 mg/mL (163.21 mM); H2O : ≥ 0.1 mg/mL (0.13 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@]1(NC([C@@]2([H])N3C[C@H](OC4=C(C=CC=C5)C5=C6C(C=CC=C6)=N4)C2)=O)[C@H](/C=C\CCCCC[C@H](NC(C7=NC=C(C)N=C7)=O)C3=O)C1)NS(=O)(C8CC8)=O	https://www.medchemexpress.com/Paritaprevir.html	Launched		91.0	F23	F4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12594	10.0	mM	124.0	DMSO	765.294468	4	F	pluskal_fda_drugs_5005_F4_id
995	HY-B1325	HYCPK40904	L19	HYCPK40904	91z	1141.0	3.0	X37	904.0	L19	64544-07-6	Cefuroxime axetil		510.47	Antibiotic; Bacterial	Anti-infection	Cefuroxime Axetil, a prodrug of the cephalosporin cefuroxime and an oarl broad spectrum antibiotic, inhibits several gram-positive and gram-negative organisms, including those most frequently associated with various common community-acquired infections[1].		C20H22N4O10S	64271.0	DMSO : 250 mg/mL (489.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@H](NC(/C(C3=CC=CO3)=N\OC)=O)C1=O)OC(OC(C)=O)C	https://www.medchemexpress.com/cefuroxime-axetil.html	Launched		91.0	X37	F4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1325	10.0	mM	124.0	DMSO	510.105664	4	F	pluskal_fda_drugs_5005_F4_id
1313	HY-107831	HYCPK40905	J19	HYCPK40905	91z	950.0	4.0	T38	905.0	J19	13110-96-8	5-Acetylsalicylic acid		180.16	Others	Others	5-Acetylsalicylic acid has anti-inflammatory and is considered to be the active agent in inflammatory bowel disease (IBD)[1].	Free Acid	C9H8O4	45555.0	DMSO : 100 mg/mL (555.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C1=CC(C(C)=O)=CC=C1O	https://www.medchemexpress.com/5-acetylsalicylic-acid.html	Launched		91.0	T38	F4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107831	10.0	mM	124.0	DMSO	180.042259	4	F	pluskal_fda_drugs_5005_F4_id
1327	HY-B0736A	HYCPK40905	H20	HYCPK40905	91z	760.0	4.0	P40	905.0	H20	99592-39-9	Sertaconazole (nitrate)	FI7056	500.78	Apoptosis; Autophagy; Fungal; Microtubule/Tubulin; p38 MAPK	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; MAPK/ERK Pathway	Sertaconazole nitrate (FI7056) is a broad-spectrum topical antifungal agent, exhibits anti-inflammatory activity via activation of a p38-COX-2-PGE2 pathway. Sertaconazole nitrate is also a microtubule inhibitor, shows antiproliferative effect, induces apoptosis and autophagy, and can also inhibit the migration of cells[1][2][3][4].	Nitrate	C20H16Cl3N3O4S	12269.0	DMSO : ≥ 100 mg/mL (199.69 mM)	DMSO Solution	10mM  * 100uL	Infection	ClC1=CC=C(C(OCC2=CSC3=C(Cl)C=CC=C32)CN4C=CN=C4)C(Cl)=C1.O[N+]([O-])=O	https://www.medchemexpress.com/sertaconazole-nitrate.html	Launched		91.0	P40	F4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0736A	10.0	mM	124.0	DMSO	435.997067	4	F	pluskal_fda_drugs_5005_F4_id
125	HY-15298B	HYCPK40902	C07	HYCPK40902	91z	205.0	1.0	E13	902.0	C07	1350462-55-3	Grazoprevir hydrate	MK-5172 (hydrate)	784.92	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Grazoprevir hydrate (MK-5172 hydrate) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively[1][2]. Grazoprevir hydrate inhibits SARS-CoV-2 3CLpro activity[3].	Free Base	C38H52N6O10S	179727.0	DMSO : 50 mg/mL (63.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	COC1=CC2=C(N=C(CCCCC[C@@H]3C[C@H]3OC4=O)C(O[C@H]5CN(C([C@H](C(C)(C)C)N4)=O)[C@H](C(N[C@@]([C@@H]6C=C)(C6)C(NS(C7CC7)(=O)=O)=O)=O)C5)=N2)C=C1.O	https://www.medchemexpress.com/MK-5172-hydrate.html	Launched		91.0	E13	F5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15298B	10.0	mM	125.0	DMSO	766.335998	5	F	pluskal_fda_drugs_5005_F5_id
138	HY-B1411	HYCPK40902	P07	HYCPK40902	91z	1453.0	1.0	AE13	902.0	P07	87-89-8	i-Inositol	myo-Inositol; meso-Inositol	180.16	Endogenous Metabolite	Metabolic Enzyme/Protease	i-Inositol is a chemical compound, associated lipids are found in many foods, in particular fruit, especially cantaloupe and oranges.	Free Base	C6H12O6	82088.0	H2O : ≥ 100 mg/mL (555.06 mM); DMSO : 10 mg/mL (55.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O[C@H]1[C@H]([C@H]([C@@H]([C@H]([C@@H]1O)O)O)O)O	https://www.medchemexpress.com/i-Inositol.html	Launched		91.0	AE13	F5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1411	10.0	mM	125.0	DMSO	180.063388	5	F	pluskal_fda_drugs_5005_F5_id
178	HY-13413	HYCPK40902	P10	HYCPK40902	91z	1459.0	1.0	AE19	902.0	P10	1201913-82-7	Tofogliflozin (hydrate)	CSG-452 hydrate	404.45	Reactive Oxygen Species; SGLT	Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; NF-κB	Tofogliflozin hydrate (CSG-452 hydrate) is a potent and highly specific sodium/glucose cotransporter 2 (SGLT2) inhibitor with an IC50 of 2.9 nM and Ki values of 2.9 nM, 14.9 nM, and 6.4 nM for human, rat, and mouse SGLT2[1]. Tofogliflozin partially inhibits high glucose-induced reactive oxyen species (ROS) generation in tubular cells[2].	Free Base	C22H28O7	15616.0	DMSO : ≥ 100 mg/mL (247.25 mM); H2O : 0.33 mg/mL (0.82 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@]21OCC3=C2C=C(CC4=CC=C(CC)C=C4)C=C3.O	https://www.medchemexpress.com/Tofogliflozin-hydrate.html	Launched		91.0	AE19	F5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13413	10.0	mM	125.0	DMSO	386.172939	5	F	pluskal_fda_drugs_5005_F5_id
408	HY-B0416	HYCPK40902	H21	HYCPK40902	91z	713.0	1.0	O41	902.0	H21	65-29-2	Gallamine Triethiodide		891.53	mAChR	GPCR/G Protein; Neuronal Signaling	"Gallamine Triethiodide is a synthetic nondepolarizing blocking drug.
Target: mAChR
Gallamine triethiodide is a non-depolarising muscle relaxant. It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine. Gallamine triethiodide has a parasympatholytic effect on the cardiac vagus nerve which causes tachycardia and occasionally hypertension. Very high doses cause histamine release. Gallamine triethiodide is commonly used to stabilize muscle contractions during surgical procedures."	Iodide	C30H60I3N3O3	39797.0	H2O : ≥ 30 mg/mL (33.65 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC[N+](CC)(CC)CCOC(C(OCC[N+](CC)(CC)CC)=CC=C1)=C1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]	https://www.medchemexpress.com/Gallamine-Triethiodide.html	Launched		91.0	O41	F5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0416	10.0	mM	125.0	DMSO	510.461822	5	F	pluskal_fda_drugs_5005_F5_id
633	HY-10394	HYCPK40903	O15	HYCPK40903	91z	1374.0	2.0	AC30	903.0	O15	165800-03-3	Linezolid	PNU-100766	337.35	Antibiotic; Bacterial	Anti-infection	Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis. Linezolid is used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics[1][2][3].	Free Base	C16H20FN3O4	43931.0	DMSO : ≥ 100 mg/mL (296.43 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(O[C@H]1CNC(C)=O)N(C1)C2=CC(F)=C(N3CCOCC3)C=C2	https://www.medchemexpress.com/Linezolid.html	Launched		91.0	AC30	F5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10394	10.0	mM	125.0	DMSO	337.143784	5	F	pluskal_fda_drugs_5005_F5_id
1034	HY-15461A	HYCPK40904	C22	HYCPK40904	91z	283.0	3.0	F43	904.0	C22	1210344-83-4	Ertugliflozin L-pyroglutamic acid	PF-04971729 L-pyroglutamic acid	566.00	SGLT	Membrane Transporter/Ion Channel	Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2[1]. Has the potential for the treatment of type 2 diabetes mellitus[2].		C27H32ClNO10	37713.0	DMSO : ≥ 125 mg/mL (220.85 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	ClC1=CC=C([C@]23O[C@@](CO)(CO3)[C@@H](O)[C@H](O)[C@H]2O)C=C1CC4=CC=C(OCC)C=C4.O=C5CC[C@@H](C(O)=O)N5	https://www.medchemexpress.com/Ertugliflozin_L-pyroglutamic_acid.html	Launched		91.0	F43	F5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15461A	10.0	mM	125.0	DMSO	436.128881	5	F	pluskal_fda_drugs_5005_F5_id
1204	HY-B0240	HYCPK40905	M12	HYCPK40905	91z	1224.0	4.0	Z24	905.0	M12	97-77-8	Disulfiram	Tetraethylthiuram disulfide; TETD	296.54	Aldehyde Dehydrogenase (ALDH); Apoptosis; Interleukin Related; Pyroptosis	Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease	Disulfiram (Tetraethylthiuram disulfide) is a specific inhibitor of?aldehyde-dehydrogenase (ALDH1), used for the treatment of chronic alcoholism by producing an acute sensitivity to alcohol. Disulfiram inhibits gasdermin D (GSDMD) pore formation in liposomes and inflammasome-mediated pyroptosis and IL-1β secretion in human and mouse cells. Disulfiram?+?Cu2+ increases intracellular ROS levels triggering apoptosis of ovarian cancer stem cells[1-6].	Free Base	C10H20N2S4	97170.0	DMSO : 75 mg/mL (252.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	S=C(SSC(N(CC)CC)=S)N(CC)CC	https://www.medchemexpress.com/disulfiram.html	Launched		91.0	Z24	F5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0240	10.0	mM	125.0	DMSO	296.050933	5	F	pluskal_fda_drugs_5005_F5_id
1359	HY-17424	HYCPK40905	L22	HYCPK40905	91z	1148.0	4.0	X44	905.0	L22	39809-25-1	Penciclovir	BRL 39123; VSA 671	253.26	HSV	Anti-infection	Penciclovir (VSA 671) is a potent and selective anti-herpesvirus agent with EC50 values of 0.5, 0.8 μg/ml for HSV-1 (HFEM), HSV-2 (MS), respectively. Penciclovir shows anti-herpesvirus activity with no-toxic. Penciclovir preventes mortality in mouse[1][2].	Free Base	C10H15N5O3	13704.0	DMSO : 25 mg/mL (98.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1NC(N)=NC2=C1N=CN2CCC(CO)CO	https://www.medchemexpress.com/Penciclovir.html	Launched		91.0	X44	F5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17424	10.0	mM	125.0	DMSO	253.117489	5	F	pluskal_fda_drugs_5005_F5_id
183	HY-B0216	HYCPK40902	E11	HYCPK40902	91z	405.0	1.0	I21	902.0	E11	57-63-6	Ethynyl Estradiol	17α-Ethynylestradiol; Ethynylestradiol	296.40	Endogenous Metabolite; Estrogen Receptor/ERR	Metabolic Enzyme/Protease; Others	"Ethynyl Estradiol (17α-Ethynylestradiol;Ethynylestradiol) is an orally bio-active estrogen used in almost all modern formulations of combined oral contraceptive pills.
Target: Estrogen Receptor
Ethynyl Estradiol (17α-Ethynylestradiol;Ethynylestradiol), also sometimes written as ethinylestradiol, ethynyl estradiol, or ethinyl estradiol, is a derivative of 17β-estradiol (E2), the major endogenous estrogen in humans. 
Ethynyl Estradiol (17α-Ethynylestradiol;Ethynylestradiol) is an orally bioactive estrogen used in many formulations of combined oral contraceptive pills. It is one of the most commonly used medications for this purpose. 
Transdermal ethinyl estradiol carries a greater risk of clot formation and venous thromboembolism than 17 beta estradiol, which some have theorized to be related to different amounts of hepatic metabolism after absorption. 
The same contraindications and precautions apply for EE as with other estrogen medications.
Ethynyl Estradiol was a preparation of Ethynyl Estradiol alone that was used for the management of menopausal symptoms and female hypogonadism. 
Ethynyl Estradiol (17α-Ethynylestradiol;Ethynylestradiol) is released into the environment as a xenoestrogen from the urine and feces of people who take it as a medication. 
The major concern with unopposed estrogen is of endometrial cancer. As such, the medication is generally prescribed with progesterone in the setting of birth control. 
The first orally active semisynthetic steroidal estrogen, Ethynyl Estradiol, the 17α-ethynyl analog of E2, was synthesized in 1938 by Hans Herloff Inhoffen and Walter Hohlweg at Schering AG in Berlin."	Free Base	C20H24O2	20742.0	DMSO : 250 mg/mL (843.45 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	OC1=CC=C2C(CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@]4(C#C)O)=C1	https://www.medchemexpress.com/Ethynyl-Estradiol.html	Launched		91.0	I21	F6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0216	10.0	mM	126.0	DMSO	296.17763	6	F	pluskal_fda_drugs_5005_F6_id
298	HY-B0469	HYCPK40902	B19	HYCPK40902	91z	133.0	1.0	C37	902.0	B19	71-58-9	Medroxyprogesterone acetate	Medroxyprogesterone 17-acetate; Farlutin	386.52	Androgen Receptor; Endogenous Metabolite; Glucocorticoid Receptor; Progesterone Receptor	Immunology/Inflammation; Metabolic Enzyme/Protease; Others	Medroxyprogesterone acetate is a widely used synthetic steroid by its interaction with progesterone, androgen and glucocorticoid receptors[1].	Free Base	C24H34O4	152339.0	DMSO : 10 mg/mL (25.87 mM; Need ultrasonic); H2O : 1 mg/mL (2.59 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	CC(O[C@@]([C@]12C)(CC[C@@]1([H])[C@@](C[C@H](C)C3=CC4=O)([H])[C@]([C@]3(CC4)C)([H])CC2)C(C)=O)=O	https://www.medchemexpress.com/Medroxyprogesterone-acetate.html	Launched		91.0	C37	F6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0469	10.0	mM	126.0	DMSO	386.24571	6	F	pluskal_fda_drugs_5005_F6_id
590	HY-B0875	HYCPK40905	G22	HYCPK40905	91z	668.0	4.0	N44	905.0	G22	75738-58-8	Cefmenoxime (hydrochloride)	SCE-1365 (hydrochloride)	529.79	Antibiotic; Bacterial	Anti-infection	Cefmenoxime (SCE-1365) hydrochloride is a new semisynthetic cephalosporin antibiotic. Cefmenoxime has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria[1][2].	Hydrochloride	C16H17N9O5S3.1/2 HCl	16385.0	DMSO : 65 mg/mL (122.69 mM; Need ultrasonic and warming); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)O.[0.5HCl]	https://www.medchemexpress.com/Cefmenoxime-hydrochloride.html	Launched		91.0	N44	F6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0875	10.0	mM	126.0	DMSO	511.051478	6	F	pluskal_fda_drugs_5005_F6_id
743	HY-B0889	HYCPK40904	G03	HYCPK40904	91z	629.0	3.0	N5	904.0	G03	6402-23-9	Ethacridine (lactate monohydrate)	Acrinol (monohydrate)	361.39	Bacterial	Anti-infection	Ethacridine lactate (Acrinol) monohydrate is a widely used antiseptic and abortifacient. Ethacridine lactate monohydrate is effective against Staphylococcus aureus and other gram-positive cocci. Ethacridine lactate monohydrate is also a poly(ADP-ribose) glycohydrolase (PARG) inhibitor[1][2][3].	Lactic acid	C18H23N3O5	17633.0	DMSO : ≥ 100 mg/mL (276.71 mM); H2O : 2 mg/mL (5.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC(O)C(O)=O.NC1=CC2=NC3=CC=C(OCC)C=C3C(N)=C2C=C1.O	https://www.medchemexpress.com/Ethacridine-lactate-monohydrate.html	Launched		91.0	N5	F6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0889	10.0	mM	126.0	DMSO	253.121512	6	F	pluskal_fda_drugs_5005_F6_id
807	HY-15298	HYCPK40904	L07	HYCPK40904	91z	1117.0	3.0	X13	904.0	L07	1350514-68-9	Grazoprevir	MK-5172	766.90	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Grazoprevir (MK-5172) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively[1][2]. Grazoprevir inhibits SARS-CoV-2 3CLpro activity[3].	Free Base	C38H50N6O9S	9948.0	DMSO : 50 mg/mL (65.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	COC1=CC2=C(N=C(CCCCC[C@@H]3C[C@H]3OC4=O)C(O[C@H]5CN(C([C@H](C(C)(C)C)N4)=O)[C@H](C(N[C@@]([C@@H]6C=C)(C6)C(NS(C7CC7)(=O)=O)=O)=O)C5)=N2)C=C1	https://www.medchemexpress.com/MK-5172.html	Launched		91.0	X13	F6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15298	10.0	mM	126.0	DMSO	766.335998	6	F	pluskal_fda_drugs_5005_F6_id
1215	HY-N7092	HYCPK40905	H13	HYCPK40905	91z	746.0	4.0	P26	905.0	H13	57-48-7	D-Fructose	D(-​)​-​Fructose	180.16	Endogenous Metabolite	Metabolic Enzyme/Protease	D-Fructose (D(-)-Fructose) is a naturally occurring monosaccharide found in many plants.		C6H12O6	64013.0	H2O : 125 mg/mL (693.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	OC[C@@H](O)[C@@H](O)[C@H](O)C(CO)=O	https://www.medchemexpress.com/d-fructose.html	Launched		91.0	P26	F6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7092	10.0	mM	126.0	DMSO	180.063388	6	F	pluskal_fda_drugs_5005_F6_id
1220	HY-15461	HYCPK40905	M13	HYCPK40905	91z	1226.0	4.0	Z26	905.0	M13	1210344-57-2	Ertugliflozin	PF-04971729	436.88	SGLT	Membrane Transporter/Ion Channel	Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2[1]. Has the potential for the treatment of type 2 diabetes mellitus[2].	Free Base	C22H25ClO7	29402.0	DMSO : 250 mg/mL (572.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	ClC1=CC=C([C@]23O[C@@](CO)(CO3)[C@@H](O)[C@H](O)[C@H]2O)C=C1CC4=CC=C(OCC)C=C4	https://www.medchemexpress.com/PF-04971729.html	Launched		91.0	Z26	F6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15461	10.0	mM	126.0	DMSO	436.128881	6	F	pluskal_fda_drugs_5005_F6_id
1286	HY-13577A	HYCPK40905	O17	HYCPK40905	91z	1426.0	4.0	AD34	905.0	O17	1640292-55-2	Oclacitinib (maleate)	PF-03394197 maleate	453.51	JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Oclacitinib maleate (PF-03394197 maleate) is a novel JAK inhibitor. Oclacitinib maleate (PF-03394197 maleate) is most potent at inhibiting JAK1 (IC50=10 nM).	Maleate	C19H27N5O6S	116242.0	DMSO : 250 mg/mL (551.26 mM; Need ultrasonic); H2O : 5 mg/mL (11.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=S(C[C@H]1CC[C@H](N(C)C2=C3C(NC=C3)=NC=N2)CC1)(NC)=O.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Oclacitinib_maleate.html	Launched		91.0	AD34	F6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13577A	10.0	mM	126.0	DMSO	337.157246	6	F	pluskal_fda_drugs_5005_F6_id
326	HY-17030	HYCPK40902	N20	HYCPK40902	91z	1287.0	1.0	AA39	902.0	N20	77337-73-6	Acamprosate (calcium)	Calcium N-acetylhomotaurinate	200.24	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	"Acamprosate calcium(Campral EC) is a GABA receptor agonist and modulator of glutamatergic systems; reduces alcohol consumption in animal models of alcohol addiction.
IC50 value:
Target: GABA receptor
Acamprosate, or N-acetyl homotaurine, is an N-methyl-D-aspartate receptor modulator approved by the Food and Drug Administration (FDA) as a pharmacological treatment for alcohol dependence.Acamprosate has low bioavailability, but also has an excellent tolerability and safety profile. In comparison with naltrexone and disulfiram, which are the other FDA-approved treatments for alcohol dependence, acamprosate is unique in that it is not metabolized by the liver and is also not impacted by alcohol use, so can be administered to patients with hepatitis or liver disease (a common comorbid condition among individuals with alcohol dependence) and to patients who continue drinking alcohol."	Calcium	C5H10NO4S.1/2Ca	21254.0	H2O : 100 mg/mL (499.40 mM; Need ultrasonic); DMSO : < 1 mg/mL (insoluble or slightly soluble)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(NCCCS([O-])(=O)=O)=O.[0.5Ca2+]	https://www.medchemexpress.com/Acamprosate-calcium.html	Launched		91.0	AA39	F7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17030	10.0	mM	127.0	DMSO	181.040879	7	F	pluskal_fda_drugs_5005_F7_id
331	HY-A0261	HYCPK40902	L21	HYCPK40902	91z	1097.0	1.0	W41	902.0	L21	5534-95-2	Pentagastrin	ICI-50123	767.89	Cholecystokinin Receptor	GPCR/G Protein; Neuronal Signaling	Pentagastrin (ICI-50123) is a potent, selective Cholecystokinin B (CCKB) receptor antagonists with IC50 values of 11 nM and 1100 nM for CCKB and CCKA, respectively. Pentagastrin enhances gastric mucosal defense mechanisms against acid and protects the gastric mucosa from experimental injury[1].[2].	Free Acid	C37H49N7O9S	158243.0	DMSO : ≥ 34 mg/mL (44.28 mM); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	O=C(N[C@@H](CCSC)C(N[C@@H](CC(O)=O)C(N[C@H](C(N)=O)CC1=CC=CC=C1)=O)=O)[C@@H](NC(CCNC(OC(C)(C)C)=O)=O)CC2=CNC3=C2C=CC=C3	https://www.medchemexpress.com/Pentagastrin.html	Launched		91.0	W41	F7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0261	10.0	mM	127.0	DMSO	767.331247	7	F	pluskal_fda_drugs_5005_F7_id
405	HY-B1894A	HYCPK40902	E21	HYCPK40902	91z	425.0	1.0	I41	902.0	E21	111696-23-2	Cefetamet pivoxil (hydrochloride)	Ro 15-8075	548.03	Antibiotic; Bacterial	Anti-infection	Cefetamet pivoxil hydrochloride is an oral third generation cephalosporin antibiotic.	Hydrochloride	C20H26ClN5O7S2	18780.0	H2O : 0.67 mg/mL (1.22 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (182.47 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)OCOC(C(C)(C)C)=O.[H]Cl	https://www.medchemexpress.com/Cefetamet-pivoxil-hydrochloride.html	Launched		91.0	I41	F7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1894A	10.0	mM	127.0	DMSO	511.11954	7	F	pluskal_fda_drugs_5005_F7_id
850	HY-17623	HYCPK40904	G10	HYCPK40904	91z	643.0	3.0	N19	904.0	G10	942195-55-3	Tegoprazan		387.38	Proton Pump	Membrane Transporter/Ion Channel	Tegoprazan, a potassium-competitive acid blocker, is a potent, oral active and highly selective inhibitor of gastric H+/K+-ATPase that could control gastric acid secretion and motility, with IC50 values ranging from 0.29-0.52 μM for porcine, canine, and human H+/K+-ATPases in vitro[1].	Free Base	C20H19F2N3O3	96372.0	DMSO : 100 mg/mL (258.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	FC1=CC(F)=C2[C@@H](OC3=CC(C(N(C)C)=O)=CC4=C3N=C(C)N4)CCOC2=C1	https://www.medchemexpress.com/Tegoprazan.html	Launched		91.0	N19	F7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17623	10.0	mM	127.0	DMSO	387.139448	7	F	pluskal_fda_drugs_5005_F7_id
1025	HY-13632	HYCPK40904	J21	HYCPK40904	91z	953.0	3.0	T41	904.0	J21	107868-30-4	Exemestane	FCE 24304; EXE	296.40	Aromatase	Others	Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research[1][2].	Free Base	C20H24O2	11302.0	DMSO : ≥ 54 mg/mL (182.19 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	C[C@]1([C@](CC2)([H])[C@]3([H])CC(C4=CC(C=C[C@]4(C)[C@@]3([H])CC1)=O)=C)C2=O	https://www.medchemexpress.com/Exemestane.html	Launched		91.0	T41	F7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13632	10.0	mM	127.0	DMSO	296.17763	7	F	pluskal_fda_drugs_5005_F7_id
1055	HY-B1897A	HYCPK40905	H03	HYCPK40905	91z	726.0	4.0	P6	905.0	H03	130-37-0	Menadione bisulfite (sodium)	Menadione sodium bisulfite; Vitamin K3 sodium bisulfite	276.24	Others	Others	Menadione bisulfite (sodium) is used as an agent to induce acute oxidative stress, and to function as a plant-defense activator against several pathogens.	Sodium	C11H9NaO5S	22683.0	DMSO : 100 mg/mL (362.00 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (362.00 mM)	DMSO Solution	10mM  * 100uL	Others	O=S(C(CC(C1=C2C=CC=C1)=O)(C)C2=O)(O[Na])=O	https://www.medchemexpress.com/Menadione-bisulfite-sodium.html	Launched		91.0	P6	F7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1897A	10.0	mM	127.0	DMSO	254.024894	7	F	pluskal_fda_drugs_5005_F7_id
1205	HY-B1013	HYCPK40905	N12	HYCPK40905	91z	1320.0	4.0	AB24	905.0	N12	1524-88-5	Flurandrenolide	Fludroxycortide; Flurandrenolone	436.51	Others	Others	Fludroxycortide is a synthetic topical steroid and is used as an anti-inflammatory treatment for use on skin irritations.	Free Base	C24H33FO6	179927.0	DMSO : 100 mg/mL (229.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@@]3(C(CO)=O)[C@@](OC(C)(O3)C)([H])C[C@@]1([H])[C@]4([H])C[C@H](F)C5=CC(CC[C@]5(C)[C@@]4([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/Flurandrenolide.html	Launched		91.0	AB24	F7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1013	10.0	mM	127.0	DMSO	436.226117	7	F	pluskal_fda_drugs_5005_F7_id
1247	HY-B1029	HYCPK40905	H15	HYCPK40905	91z	750.0	4.0	P30	905.0	H15	17230-88-5	Danazol		337.46	Androgen Receptor	Others	Danazol is a derivative of the synthetic steroid ethisterone, that suppresses the production of gonadotrophins, and has some weak androgenic effects.	Free Base	C22H27NO2	22976.0	DMSO : 6.67 mg/mL (19.77 mM; Need ultrasonic); Ethanol : 20 mg/mL (59.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C#C[C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC5=C(C=NO5)C[C@]4(C)[C@@]3([H])CC[C@@]21C	https://www.medchemexpress.com/Danazol.html	Launched		91.0	P30	F7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1029	10.0	mM	127.0	DMSO	337.204179	7	F	pluskal_fda_drugs_5005_F7_id
75	HY-13004	HYCPK40902	D03	HYCPK40902	91z	293.0	1.0	G5	902.0	D03	376348-65-1	Maraviroc	UK-427857	513.67	CCR; HIV	Anti-infection; GPCR/G Protein; Immunology/Inflammation	Maraviroc (UK-427857) is a selective CCR5 antagonist with activity against human HIV.	Free Base	C29H41F2N5O	61687.0	Ethanol : 6.5 mg/mL (12.65 mM; Need ultrasonic); DMSO : 50 mg/mL (97.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer; Endocrinology	O=C(C1CCC(F)(F)CC1)N[C@H](C2=CC=CC=C2)CCN3[C@H]4C[C@@H](N5C(C)=NN=C5C(C)C)C[C@@H]3CC4	https://www.medchemexpress.com/Maraviroc.html	Launched		91.0	G5	F8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13004	10.0	mM	128.0	DMSO	513.327917	8	F	pluskal_fda_drugs_5005_F8_id
103	HY-15833	HYCPK40902	M05	HYCPK40902	91z	1161.0	1.0	Y9	902.0	M05	77-36-1	Chlorthalidone		338.77	Others	Others	Chlorthalidone is a thiazide-like diuretic used to treat hypertension.	Free Base	C14H11ClN2O4S	10960.0	DMSO : ≥ 41 mg/mL (121.03 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(C1=CC(C2(O)NC(C3=C2C=CC=C3)=O)=CC=C1Cl)(N)=O	https://www.medchemexpress.com/Chlorthalidone.html	Launched		91.0	Y9	F8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15833	10.0	mM	128.0	DMSO	338.012806	8	F	pluskal_fda_drugs_5005_F8_id
113	HY-13701	HYCPK40902	G06	HYCPK40902	91z	587.0	1.0	M11	902.0	G06	121032-29-9	Nelarabine	506U78; GW 506U78; Nelzarabine	297.27	Apoptosis; Nucleoside Antimetabolite/Analog	Apoptosis; Cell Cycle/DNA Damage	Nelarabine (506U78) is a nucleoside analogue and can be used for the research of T cell acute lymphoblastic leukemia (T-ALL)[1].	Free Base	C11H15N5O5	11453.0	DMSO : 100 mg/mL (336.39 mM; Need ultrasonic); H2O : 10 mg/mL (33.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC[C@@H]1[C@@H](O)[C@H](O)[C@H](N2C=NC3=C(OC)N=C(N)N=C23)O1	https://www.medchemexpress.com/Nelarabine.html	Launched		91.0	M11	F8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13701	10.0	mM	128.0	DMSO	297.107319	8	F	pluskal_fda_drugs_5005_F8_id
741	HY-10493	HYCPK40904	E03	HYCPK40904	91z	437.0	3.0	J5	904.0	E03	1004316-88-4	Cobicistat	GS-9350	776.02	Cytochrome P450; HIV	Anti-infection; Metabolic Enzyme/Protease	Cobicistat is a potent and selective inhibitor of cytochrome P450 3A (CYP3A) enzymes with IC50s of 30-285 nM. Cobicistat is a pharmacokinetic enhancer?which increases the overall absorption of several HIV medications.	Free Base	C40H53N7O5S2	96790.0	DMSO : 250 mg/mL (322.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	CN(C(N[C@@H](CCN1CCOCC1)C(N[C@@H](CC2=CC=CC=C2)CC[C@@H](NC(OCC3=CN=CS3)=O)CC4=CC=CC=C4)=O)=O)CC5=CSC(C(C)C)=N5	https://www.medchemexpress.com/Cobicistat.html	Launched		91.0	J5	F8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10493	10.0	mM	128.0	DMSO	775.35496	8	F	pluskal_fda_drugs_5005_F8_id
889	HY-B0227	HYCPK40904	N12	HYCPK40904	91z	1319.0	3.0	AB23	904.0	N12	22071-15-4	Ketoprofen	RP-19583	254.28	COX	Immunology/Inflammation	Ketoprofen (RP-19583) is a non-steroidal anti-inflammatory agent. Ketoprofen can inhibits the activity of cyclooxygenase with IC50 values of 2 nM (COX-1) and 26 nM (COX-2). which is potential in the research of inflammation, immunology, and metabolic disease such as obesity[1][2][3].	Free Acid	C16H14O3	43970.0	H2O : < 0.1 mg/mL (ultrasonic) (insoluble); DMSO : ≥ 100 mg/mL (393.27 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Inflammation/Immunology; Cancer	O=C(C1=CC=CC=C1)C2=CC=CC(C(C(O)=O)C)=C2	https://www.medchemexpress.com/Ketoprofen.html	Launched		91.0	AB23	F8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0227	10.0	mM	128.0	DMSO	254.094294	8	F	pluskal_fda_drugs_5005_F8_id
1119	HY-10208	HYCPK40905	H07	HYCPK40905	91z	734.0	4.0	P14	905.0	H07	444731-52-6	Pazopanib	GW786034	437.52	Autophagy; c-Kit; FGFR; PDGFR; VEGFR	Autophagy; Protein Tyrosine Kinase/RTK	Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.	Free Base	C21H23N7O2S	7292.0	DMSO : 62.5 mg/mL (142.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=S(C1=CC(NC2=NC=CC(N(C3=CC4=NN(C(C)=C4C=C3)C)C)=N2)=CC=C1C)(N)=O	https://www.medchemexpress.com/Pazopanib.html	Launched		91.0	P14	F8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10208	10.0	mM	128.0	DMSO	437.163394	8	F	pluskal_fda_drugs_5005_F8_id
1130	HY-B0371A	HYCPK40905	C08	HYCPK40905	91z	256.0	4.0	F16	905.0	C08	70024-40-7	Terazosin (hydrochloride dihydrate)		459.92	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Terazosin hydrochloride dihydrate is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin hydrochloride dihydrate works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride dihydrate has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3].	Hydrochloride	C19H30ClN5O6	15959.0	DMSO : 31.25 mg/mL (67.95 mM; Need ultrasonic); H2O : 12.5 mg/mL (27.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Metabolic Disease	O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OCCC4.O.Cl.O	https://www.medchemexpress.com/Terazosin-hydrochloride-dihydrate.html	Launched		91.0	F16	F8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0371A	10.0	mM	128.0	DMSO	387.190654	8	F	pluskal_fda_drugs_5005_F8_id
1229	HY-B0207A	HYCPK40905	F14	HYCPK40905	91z	556.0	4.0	L28	905.0	F14	101-26-8	Pyridostigmine (bromide)		261.12	Cholinesterase (ChE)	Neuronal Signaling	"Pyridostigmine bromide is a parasympathomimetic and a reversible cholinesterase inhibitor.
Target: AChE
Pyridostigmine bromide is a parasympathomimetic and a reversible cholinesterase inhibitor. Since it is a quaternary amine, it is poorly absorbed in the gut and does not cross the blood–brain barrier, except possibly in stressful conditions. 
Pyridostigmine bromide inhibits acetylcholinesterase in the synaptic cleft, thus slowing down the hydrolysis of acetylcholine. 
It is a quaternary carbamate inhibitor of cholinesterase that does not cross the blood–brain barrier which carbamylates about 30% of peripheral cholinesterase enzyme. The carbamylated enzyme eventually regenerates by natural hydrolysis and excess ACh levels revert to normal.
Pyridostigmine bromide is used to treat muscle weakness in people with myasthenia gravis and to combat the effects of curariform drug toxicity. 
Pyridostigmine bromide has been FDA approved for military use during combat situations as an agent to be given prior to exposure to the nerve agent Soman in order to increase survival. 
Used in particular during the first Gulf War, pyridostigmine bromide has been implicated as a causal factor in Gulf War syndrome. Pyridostigmine bromide sometimes is used to treat orthostatic hypotension. It may also be of benefit in chronic axonal polyneuropathy."	Bromide	C9H13BrN2O2	105419.0	H2O : 8.8 mg/mL (33.70 mM; Need ultrasonic and warming); DMSO : 50 mg/mL (191.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+]1=CC=CC(OC(N(C)C)=O)=C1.[Br-]	https://www.medchemexpress.com/pyridostigmine-bromide.html	Launched		91.0	L28	F8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0207A	10.0	mM	128.0	DMSO	181.097154	8	F	pluskal_fda_drugs_5005_F8_id
296	HY-B1283	HYCPK40902	P18	HYCPK40902	91z	1475.0	1.0	AE35	902.0	P18	59-47-2	Mephenesin		182.22	iGluR	Membrane Transporter/Ion Channel; Neuronal Signaling	"Mephenesin is an NMDA receptor antagonist, is a centrally acting muscle relaxant.
Target: NMDA receptor"	Free Base	C10H14O3	19207.0	DMSO : ≥ 100 mg/mL (548.79 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	OCC(O)COC1=CC=CC=C1C	https://www.medchemexpress.com/Mephenesin.html	Launched		91.0	AE35	F9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1283	10.0	mM	129.0	DMSO	182.094294	9	F	pluskal_fda_drugs_5005_F9_id
314	HY-18341A	HYCPK40902	B20	HYCPK40902	91z	135.0	1.0	C39	902.0	B20	6106-07-6	L-Thyroxine (sodium salt pentahydrate)	Sodium levothyroxine pentahydrate	888.93	Endogenous Metabolite; Thyroid Hormone Receptor	Metabolic Enzyme/Protease; Others	L-Thyroxine sodium salt pentahydrate (Levothyroxine; T4) is a synthetic hormone for the research of hypothyroidism. DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4)[1].	Sodium	C15H20I4NNaO9	13901.0	DMSO : ≥ 28 mg/mL (31.50 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	N[C@@H](CC1=CC(I)=C(C(I)=C1)OC2=CC(I)=C(O)C(I)=C2)C(O[Na])=O.O.O.O.O.O	https://www.medchemexpress.com/L-Thyroxine-sodium-salt-pentahydrate.html	Launched		91.0	C39	F9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18341A	10.0	mM	129.0	DMSO	776.6867	9	F	pluskal_fda_drugs_5005_F9_id
531	HY-B0371B	HYCPK40903	D11	HYCPK40903	91z	310.0	2.0	G22	903.0	D11	109351-34-0	(R)-Terazosin		387.43	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	(R)-Terazosin is an active R-enantiomer of Terazosin. (R)-Terazosin is a potent α1-adrenoceptor antagonist with Ki values of 6.51 nM, 1.01 nM and 1.97 nM for α1a, α1b and α1d-adrenoceptor, respectively[1].	Free Base	C19H25N5O4	61525.0	DMSO : 75 mg/mL (193.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)[C@@H]4OCCC4	https://www.medchemexpress.com/r-terazosin.html	Launched		91.0	G22	F9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0371B	10.0	mM	129.0	DMSO	387.190654	9	F	pluskal_fda_drugs_5005_F9_id
601	HY-13955	HYCPK40903	O13	HYCPK40903	91z	1370.0	2.0	AC26	903.0	O13	144701-48-4	Telmisartan	BIBR 277	514.62	Angiotensin Receptor; Autophagy	Autophagy; GPCR/G Protein	Telmisartan is a potent, long lasting antagonist of angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with IC50 of 9.2 nM.	Free Acid	C33H30N4O2	41590.0	DMSO : 6.67 mg/mL (12.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(C1=CC=CC=C1C2=CC=C(CN3C4=CC(C5=NC6=CC=CC=C6N5C)=CC(C)=C4N=C3CCC)C=C2)O	https://www.medchemexpress.com/telmisartan.html	Launched		91.0	AC26	F9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13955	10.0	mM	129.0	DMSO	514.236876	9	F	pluskal_fda_drugs_5005_F9_id
623	HY-B0477	HYCPK40903	E15	HYCPK40903	91z	414.0	2.0	I30	903.0	E15	82586-55-8	Quinapril (hydrochloride)	CI-906	474.98	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Quinapril (hydrochloride) (CI-906) is a prodrug that belongs to the angiotensin-converting enzyme (ACE) inhibitor class of medications.	Hydrochloride	C25H31ClN2O5	17171.0	DMSO : ≥ 100 mg/mL (210.54 mM); H2O : ≥ 50 mg/mL (105.27 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C([C@H]1N(C([C@@H](N[C@H](C(OCC)=O)CCC2=CC=CC=C2)C)=O)CC3=C(C=CC=C3)C1)O.Cl	https://www.medchemexpress.com/quinapril-hydrochloride.html	Launched		91.0	I30	F9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0477	10.0	mM	129.0	DMSO	438.215472	9	F	pluskal_fda_drugs_5005_F9_id
866	HY-101482	HYCPK40904	G11	HYCPK40904	91z	645.0	3.0	N21	904.0	G11	64622-45-3	Ibuprofen piconol	U75630	297.39	Others	Others	Ibuprofen piconol is a non-steroidal, anti-inflammatory (NSAID) agent for the topical relief of primary thermal burns and sunburns.	Free Base	C19H23NO2	34419.0	DMSO : ≥ 50 mg/mL (168.13 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCC1=NC=CC=C1)C(C)C2=CC=C(CC(C)C)C=C2	https://www.medchemexpress.com/Ibuprofen_piconol.html	Launched		91.0	N21	F9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101482	10.0	mM	129.0	DMSO	297.172879	9	F	pluskal_fda_drugs_5005_F9_id
884	HY-B2137	HYCPK40904	I12	HYCPK40904	91z	839.0	3.0	R23	904.0	I12	22161-81-5	S-(+)-Ketoprofen	(S)-Ketoprofen; Dexketoprofen	254.28	COX	Immunology/Inflammation	S-(+)-Ketoprofen is a potent inhibitor of both COX-1 and COX-2 with IC50s of 1.9 and 27 nM, respectively.	Free Acid	C16H14O3	104492.0	DMSO : 100 mg/mL (393.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=CC([C@@H](C(O)=O)C)=C1)C2=CC=CC=C2	https://www.medchemexpress.com/S-__addition__-Ketoprofen.html	Launched		91.0	R23	F9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2137	10.0	mM	129.0	DMSO	254.094294	9	F	pluskal_fda_drugs_5005_F9_id
975	HY-B1198	HYCPK40904	H18	HYCPK40904	91z	755.0	3.0	P35	904.0	H18	51-03-6	Piperonyl butoxide	ENT-14250	338.44	Parasite	Anti-infection	Piperonyl butoxide is a semisynthetic derivative of safrole，used as a component of pesticide formulations. It is a synergist, despite having no pesticidal activity of its own, it enhances the potency of certain pesticides such as Carbamates, Pyrethrins, Pyrethroids, and Rotenone.	Free Base	C19H30O5	38710.0	H2O : < 0.1 mg/mL (insoluble); Ethanol : 100 mg/mL (295.47 mM; Need ultrasonic); DMSO : 100 mg/mL (295.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CCCC1=C(COCCOCCOCCCC)C=C2OCOC2=C1	https://www.medchemexpress.com/Piperonyl-butoxide.html	Launched		91.0	P35	F9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1198	10.0	mM	129.0	DMSO	338.209324	9	F	pluskal_fda_drugs_5005_F9_id
490	HY-B0810A	HYCPK40903	O07	HYCPK40903	91z	1358.0	2.0	AC14	903.0	O07	32887-03-9	Pivmecillinam (hydrochloride)	FL-1039 hydrochloride	476.03	Antibiotic; Bacterial	Anti-infection	Pivmecillinam hydrochloride (FL-1039 hydrochloride) is an orally active prodrug of mecillinam, an extended-spectrum penicillin antibiotic.	Hydrochloride	C21H34ClN3O5S	15965.0	DMSO : ≥ 34 mg/mL (71.42 mM); H2O : 100 mg/mL (210.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2/N=C/N3CCCCCC3)N1C2=O)OCOC(C(C)(C)C)=O.[H]Cl	https://www.medchemexpress.com/Pivmecillinam-hydrochloride.html	Launched		91.0	AC14	F10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0810A	10.0	mM	130.0	DMSO	439.214092	10	F	pluskal_fda_drugs_5005_F10_id
501	HY-B0380A	HYCPK40903	J08	HYCPK40903	91z	880.0	2.0	S16	903.0	J08	34140-59-5	Trimebutine (maleate)		503.54	Opioid Receptor	GPCR/G Protein; Neuronal Signaling	"Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects.
Target: Opioid Receptor
Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain [1]. The major product from drug metabolism of trimebutine in human beings is nor-trimebutine, which comes from removal of one of the methyl groups attached to nitrogen. Trimebutine exerts its effects in part due to causing a premature activation of phase III of the migrating motor complex in the digestive tract [2, 3]."	Maleate	C26H33NO9	16245.0	DMSO : 100 mg/mL (198.59 mM; Need ultrasonic); H2O : 25 mg/mL (49.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)/C=C\C(O)=O.O=C(OCC(C1=CC=CC=C1)(N(C)C)CC)C2=CC(OC)=C(OC)C(OC)=C2	https://www.medchemexpress.com/Trimebutine-maleate.html	Launched		91.0	S16	F10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0380A	10.0	mM	130.0	DMSO	387.204573	10	F	pluskal_fda_drugs_5005_F10_id
652	HY-10342	HYCPK40903	B17	HYCPK40903	91z	130.0	2.0	C34	903.0	B17	170364-57-5	Enzastaurin	LY317615	515.61	Apoptosis; Autophagy; PKC	Apoptosis; Autophagy; Epigenetics; TGF-beta/Smad	Enzastaurin (LY317615) is a potent and selective PKCβ inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKCα, PKCγ and PKCε[1].	Free Base	C32H29N5O2	8635.0	DMSO : 8.33 mg/mL (16.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C(C1=CN(C)C2=C1C=CC=C2)=C3C4=CN(C5CCN(CC6=NC=CC=C6)CC5)C7=C4C=CC=C7)NC3=O	https://www.medchemexpress.com/Enzastaurin.html	Launched		91.0	C34	F10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10342	10.0	mM	130.0	DMSO	515.232125	10	F	pluskal_fda_drugs_5005_F10_id
655	HY-100795A	HYCPK40903	E17	HYCPK40903	91z	418.0	2.0	I34	903.0	E17	61477-94-9	Pirmenol (hydrochloride)	Cl-845; (±)-Pirmenol hydrochlorid	374.95	mAChR; Potassium Channel	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Pirmenol hydrochloride is an orally active antiarrhythmic agent. Pirmenol hydrochloride inhibits IK.ACh (IC50: 0.1 μM) by blocking mAchR. Pirmenol hydrochloride can be used in the research of cardiovascular disease, such as atrial fibrillation[1][2][4].	Hydrochloride	C22H31ClN2O	146056.0	DMSO : 125 mg/mL (333.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	OC(C1=CC=CC=C1)(CCCN2[C@@H](C)CCC[C@H]2C)C3=CC=CC=N3.Cl[H]	https://www.medchemexpress.com/Pirmenol-hydrochloride.html	Launched		91.0	I34	F10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100795A	10.0	mM	130.0	DMSO	338.235814	10	F	pluskal_fda_drugs_5005_F10_id
774	HY-B1138	HYCPK40904	K05	HYCPK40904	91z	1017.0	3.0	V9	904.0	K05	36330-85-5	Fenbufen	CL-82204	254.28	Caspase; COX	Apoptosis; Immunology/Inflammation	Fenbufen (CL-82204) is an orally active non-steroidal anti-inflammatory drug (NSAID), with analgetic and antipyretic effects. Fenbufen has potent activity in a variety of animal model, including carageenin edema, UV erythema and adjuvant arthritis. Fenbufen has inhibitory activities against COX-1 and COX-2 with IC50s of 3.9 μM and 8.1 μM, respectively. Fenbufen is a caspases (caspase-1, 3, 4, 5, 9) inhibitor[1][2][3][4][5].	Free Acid	C16H14O3	17525.0	H2O : 0.67 mg/mL (2.63 mM; Need ultrasonic); DMSO : 50 mg/mL (196.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)CCC(C1=CC=C(C2=CC=CC=C2)C=C1)=O	https://www.medchemexpress.com/Fenbufen.html	Launched		91.0	V9	F10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1138	10.0	mM	130.0	DMSO	254.094294	10	F	pluskal_fda_drugs_5005_F10_id
781	HY-B0619	HYCPK40904	B06	HYCPK40904	91z	155.0	3.0	D11	904.0	B06	74711-43-6	Zaltoprofen	CN100	298.36	COX	Immunology/Inflammation	Zaltoprofen (CN100), a non-steroidal anti-inflammatory drug (NSAID), is a preferential and orally active COX-2 inhibitor, with IC50s of 1.3 and 0.34 μM for COX-1 and COX-2, respectively. Zaltoprofen exhibits powerful anti-inflammatory effects as well as an analgesic action on inflammatory pain[1][2][3].	Free Acid	C17H14O3S	17003.0	DMSO : ≥ 100 mg/mL (335.17 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(C1=CC=C(SC2=C3C=CC=C2)C(CC3=O)=C1)C(O)=O	https://www.medchemexpress.com/zaltoprofen.html	Launched		91.0	D11	F10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0619	10.0	mM	130.0	DMSO	298.066365	10	F	pluskal_fda_drugs_5005_F10_id
1283	HY-W004546	HYCPK40905	L17	HYCPK40905	91z	1138.0	4.0	X34	905.0	L17	1762-34-1	Abametapir		184.24	MMP; Parasite	Anti-infection; Metabolic Enzyme/Protease	Abametapir is a metalloproteinase (MMP) inhibitor which is able to target metalloproteinases critical to egg hatching and louse development. Abametapir can inhibit hatching of both head and body louse[1][2].		C12H12N2	111437.0	DMSO : 25 mg/mL (135.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC1=CN=C(C2=NC=C(C)C=C2)C=C1	https://www.medchemexpress.com/abametapir.html	Launched		91.0	X34	F10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W004546	10.0	mM	130.0	DMSO	184.100048	10	F	pluskal_fda_drugs_5005_F10_id
1293	HY-18341B	HYCPK40905	F18	HYCPK40905	91z	564.0	4.0	L36	905.0	F18	55-03-8	L-Thyroxine (sodium)	Levothyroxine (sodium); T4 (sodium)	798.85	Endogenous Metabolite; Thyroid Hormone Receptor	Metabolic Enzyme/Protease; Others	L-Thyroxine sodium (Levothyroxine sodium) is a synthetic hormone for the research of hypothyroidism. DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4)[1].	Sodium	C15H10I4NNaO4	120024.0	H2O : 14 mg/mL (17.53 mM; ultrasonic and adjust pH to 12 with NaOH); DMSO : 62.5 mg/mL (78.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O[Na])=O	https://www.medchemexpress.com/l-thyroxine-sodium.html	Launched		91.0	L36	F10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18341B	10.0	mM	130.0	DMSO	776.6867	10	F	pluskal_fda_drugs_5005_F10_id
100	HY-18341	HYCPK40902	J05	HYCPK40902	91z	873.0	1.0	S9	902.0	J05	51-48-9	L-Thyroxine	Levothyroxine; T4	776.87	Endogenous Metabolite; Thyroid Hormone Receptor	Metabolic Enzyme/Protease; Others	L-Thyroxine (Levothyroxine; T4) is a synthetic hormone for the research of hypothyroidism. DIO enzymes convert biologically active thyroid hormone (Triiodothyronine,T3) from L-Thyroxine (T4)[1].	Free Acid	C15H11I4NO4	114361.0	DMSO : 250 mg/mL (321.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	N[C@@H](CC1=CC(I)=C(C(I)=C1)OC2=CC(I)=C(O)C(I)=C2)C(O)=O	https://www.medchemexpress.com/l-thyroxine.html	Launched		91.0	S9	F11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18341	10.0	mM	131.0	DMSO	776.6867	11	F	pluskal_fda_drugs_5005_F11_id
123	HY-B0354A	HYCPK40902	A07	HYCPK40902	91z	13.0	1.0	A13	902.0	A07	64887-14-5	Urapidil (hydrochloride)		423.94	5-HT Receptor; Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Urapidil hydrochloride is an orally active α1-adrenoceptor antagonist and 5-HT1A receptor agonist with a pIC50 of 6.13 and 4.38 against α1- and α2-adrenoceptor, respectively. Urapidil hydrochloride shows antihypertensive effect[1][2].	Hydrochloride	C20H30ClN5O3	139191.0	DMSO : 14.29 mg/mL (33.71 mM; ultrasonic and warming and heat to 60°C); H2O : 100 mg/mL (235.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C1N(C)C(C=C(NCCCN2CCN(C3=CC=CC=C3OC)CC2)N1C)=O.Cl	https://www.medchemexpress.com/urapidil-hydrochloride.html	Launched		91.0	A13	F11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0354A	10.0	mM	131.0	DMSO	387.22704	11	F	pluskal_fda_drugs_5005_F11_id
144	HY-14543	HYCPK40902	J08	HYCPK40902	91z	879.0	1.0	S15	902.0	J08	106516-24-9	Sertindole	Lu 23-174	440.94	5-HT Receptor; Adrenergic Receptor; Autophagy; Dopamine Receptor	Autophagy; GPCR/G Protein; Neuronal Signaling	Sertindole (Lu 23-174) is an orally active 5-HT2A, 5-HT2C, dopamine D2, and αl-adrenergic receptors antagonist. Sertindole shows antipsychotic activity and anti-proliferative activity to multiple cancer cells[1][2][3].	Free Base	C24H26ClFN4O	16635.0	DMSO : 25 mg/mL (56.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	FC1=CC=C(N2C3=CC=C(Cl)C=C3C(C4CCN(CCN5CCNC5=O)CC4)=C2)C=C1	https://www.medchemexpress.com/Sertindole.html	Launched		91.0	S15	F11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14543	10.0	mM	131.0	DMSO	440.177917	11	F	pluskal_fda_drugs_5005_F11_id
671	HY-B0122	HYCPK40903	E18	HYCPK40903	91z	420.0	2.0	I36	903.0	E18	97240-79-4	Topiramate	McN 4853; RWJ 17021	339.36	Calcium Channel; Carbonic Anhydrase; GABA Receptor; iGluR; Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Topiramate (McN 4853) is a broad-spectrum antiepileptic agent. Topiramate is a GluR5 receptor antagonist. Topiramate produces its antiepileptic effects through enhancement of GABAergic activity, inhibition of  kainate/AMPA receptors, inhibition of voltage-sensitive sodium and calcium channels, increases in potassium conductance, and inhibition of carbonic anhydrase[1][2][3].	Free Base	C12H21NO8S	14419.0	H2O : 4 mg/mL (11.79 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (294.67 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	NS(OC[C@]1(OC(C)(C)O2)[C@@H]2[C@H](OC(C)(C)O3)[C@H]3CO1)(=O)=O	https://www.medchemexpress.com/Topiramate.html	Launched		91.0	I36	F11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0122	10.0	mM	131.0	DMSO	339.098788	11	F	pluskal_fda_drugs_5005_F11_id
873	HY-B0914A	HYCPK40904	N11	HYCPK40904	91z	1317.0	3.0	AB21	904.0	N11	557-08-4	10-Undecenoic acid (zinc salt)	Zinc undecylenate	431.91	Antibiotic; Endogenous Metabolite; Fungal	Anti-infection; Metabolic Enzyme/Protease	10-Undecenoic acid zinc salt is a natural or synthetic fungistatic fatty acid, is used topically in creams against fungal infections, eczemas, ringworm, and other cutaneous conditions. The zinc provides an astringent action.	Zinc	C22H38O4Zn	17528.0	DMSO : < 1 mg/mL (insoluble or slightly soluble)	DMSO Solution	10mM  * 100uL	Infection	C=CCCCCCCCCC([O-])=O.C=CCCCCCCCCC([O-])=O.[Zn+2]	https://www.medchemexpress.com/10-Undecenoic-acid-zinc-salt.html	Launched		91.0	AB21	F11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0914A	10.0	mM	131.0	DMSO	184.14633	11	F	pluskal_fda_drugs_5005_F11_id
930	HY-B0128	HYCPK40904	G15	HYCPK40904	91z	653.0	3.0	N29	904.0	G15	479-18-5	Diphylline	Diprophylline	254.24	Adenosine Receptor; Phosphodiesterase (PDE)	GPCR/G Protein; Metabolic Enzyme/Protease	Diphylline (Diprophylline) is a potent A1/A2 adenosine receptor antagonist and cyclic nucleotide phosphodiesterase inhibitor. Diphylline, a xanthine derivative, is a bronchodilator and vasodilator drug and has the potential for chronic bronchitis and emphysema[1][2].	Free Base	C10H14N4O4	14034.0	H2O : 20 mg/mL (78.67 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (196.66 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	O=C(N1C)N(C)C2=C(N(CC(O)CO)C=N2)C1=O	https://www.medchemexpress.com/Diphylline.html	Launched		91.0	N29	F11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0128	10.0	mM	131.0	DMSO	254.101505	11	F	pluskal_fda_drugs_5005_F11_id
1060	HY-B0713	HYCPK40905	M03	HYCPK40905	91z	1206.0	4.0	Z6	905.0	M03	68302-57-8	Amlexanox	AA673; Amoxanox; CHX3673	298.29	IKK	NF-κB	Amlexanox (AA673; Amoxanox; CHX3673) is a specific inhibitor of IKKε and TBK1, and inhibits the IKKε and TBK1 activity determined by MBP phosphorylation with an IC50 of approximately 1-2 μM.	Free Acid	C16H14N2O4	15060.0	DMSO : 100 mg/mL (335.24 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(C1=C(N)N=C2C(C(C3=CC(C(C)C)=CC=C3O2)=O)=C1)O	https://www.medchemexpress.com/Amlexanox.html	Launched		91.0	Z6	F11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0713	10.0	mM	131.0	DMSO	298.095357	11	F	pluskal_fda_drugs_5005_F11_id
1232	HY-B0771A	HYCPK40905	I14	HYCPK40905	91z	844.0	4.0	R28	905.0	I14	113981-44-5	Cefozopran (hydrochloride)	SCE-2787 hydrochloride	551.99	Antibiotic; Bacterial	Anti-infection	Cefozopran (SCE-2787) hydrochloride is a semi-synthetic, parenteral, fourth-generation cephalosporin. Cefozopran hydrochloride, an antibiotic, has a broad spectrum of antibacterial activity, inhibiting most of the gram-negative and gram-positive organisms[1][2].	Hydrochloride	C19H18ClN9O5S2	85293.0	H2O : ≥ 52 mg/mL (94.20 mM); DMSO : 100 mg/mL (181.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[H]Cl.[O-]C(C(N1[C@@]2([H])[C@H](NC(/C(C3=NSC(N)=N3)=N\OC)=O)C1=O)=C(CS2)C[N+]4=C(C=CC=N5)N5C=C4)=O	https://www.medchemexpress.com/Cefozopran-hydrochloride.html	Launched		91.0	R28	F11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0771A	10.0	mM	131.0	DMSO	516.086683	11	F	pluskal_fda_drugs_5005_F11_id
78	HY-18253	HYCPK40902	G03	HYCPK40902	91z	581.0	1.0	M5	902.0	G03	268203-93-6	Udenafil	DA8159	516.66	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Udenafil (DA8159) is a potent, selective and orally active phosphodiesterase type 5 (PDE5) inhibitor. Udenafil also inhibits cGMP hydrolysis and can be used for erectile dysfunction research[1][2].	Free Base	C25H36N6O4S	21775.0	DMSO : ≥ 33 mg/mL (63.87 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=S(C1=CC=C(OCCC)C(C2=NC3=C(N(C)N=C3CCC)C(N2)=O)=C1)(NCCC4N(C)CCC4)=O	https://www.medchemexpress.com/Udenafil.html	Launched		91.0	M5	F12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18253	10.0	mM	132.0	DMSO	516.251875	12	F	pluskal_fda_drugs_5005_F12_id
216	HY-17357	HYCPK40902	F13	HYCPK40902	91z	505.0	1.0	K25	902.0	F13	78281-72-8	Nepafenac	AHR 9434; AL 6515	254.28	Bacterial; COX	Anti-infection; Immunology/Inflammation	"Nepafenac(AHR 9434; AL 6515; Nevanac) is a selective COX-2 inhibitor; is prodrug of Amfenac.
IC50 value:
Target: COX-2
Nepafenac is a NSAID (nonsteroidal anti inflammatory drug) that is routinely used in opthamology to control pain following cataract surgery."	Free Base	C15H14N2O2	16164.0	DMSO : 100 mg/mL (393.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(N)CC1=CC=CC(C(C2=CC=CC=C2)=O)=C1N	https://www.medchemexpress.com/Nepafenac.html	Launched		91.0	K25	F12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17357	10.0	mM	132.0	DMSO	254.105528	12	F	pluskal_fda_drugs_5005_F12_id
273	HY-N0603	HYCPK40902	O16	HYCPK40902	91z	1375.0	1.0	AC31	902.0	O16	14197-60-5	20(S)-Ginsenoside Rg3	20(S)-Propanaxadiol; S-ginsenoside Rg3	785.01	Amyloid-β; COX; Endogenous Metabolite; NF-κB; Potassium Channel; Sodium Channel	Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB	20(S)-Ginsenoside Rg3 is the main component of  Panax ginseng C. A. Meyer. Ginsenoside Rg3 inhibits Na+ and hKv1.4 channel with IC50s of 32.2±4.5 and 32.6±2.2 μM, respectively. 20(S)-Ginsenoside Rg3 also inhibits Aβ levels, NF-κB activity, and COX-2 expression.	Free Base	C42H72O13	83553.0	DMSO : 100 mg/mL (127.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	O[C@@H]([C@@H]([C@@H](CO)O1)O)[C@@H](O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O)[C@@H]1O[C@H]3CC[C@]4(C)[C@@]5([H])C[C@@H](O)[C@]6([H])[C@@H](C(C)(O)CC/C=C(C)\C)CC[C@](C)6[C@@](C)5CCC4C3(C)C	https://www.medchemexpress.com/Ginsenoside-Rg3.html	Launched		91.0	AC31	F12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0603	10.0	mM	132.0	DMSO	784.497292	12	F	pluskal_fda_drugs_5005_F12_id
470	HY-120824	HYCPK40903	K06	HYCPK40903	91z	972.0	2.0	U12	903.0	K06	78967-07-4	Mofezolac		339.34	COX	Immunology/Inflammation	Mofezolac, a non-steroidal anti-inflammatory drug (NSAID), is a selective, reversible and orally active COX-1 inhibitor with an IC50 of 1.44 nM. Mofezolac shows weak inhibitory activity on COX-2 (IC50 of 447 nM). Mofezolac can relieve pain and has anti-inflammatory activities[1].		C19H17NO5	104066.0	DMSO : 100 mg/mL (294.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)CC1=C(C2=CC=C(OC)C=C2)C(C3=CC=C(OC)C=C3)=NO1	https://www.medchemexpress.com/mofezolac.html	Launched		91.0	U12	F12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-120824	10.0	mM	132.0	DMSO	339.110673	12	F	pluskal_fda_drugs_5005_F12_id
505	HY-B1344	HYCPK40903	N08	HYCPK40903	91z	1264.0	2.0	AA16	903.0	N08	68813-55-8	Oxantel (pamoate)	Oxantel embonate	604.65	Parasite	Anti-infection	Oxantel pamoate is a widely available dewormer, potently against Trichuris muris and Hookworms.	Pamoate	C36H32N2O7	21866.0	DMSO : ≥ 50 mg/mL (82.69 mM); H2O : 0.67 mg/mL (1.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=C(O)C(CC2=C3C=CC=CC3=CC(C(O)=O)=C2O)=C4C=CC=CC4=C1)O.OC5=CC=CC(/C=C/C6=NCCCN6C)=C5	https://www.medchemexpress.com/Oxantel-pamoate.html	Launched		91.0	AA16	F12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1344	10.0	mM	132.0	DMSO	388.094688	12	F	pluskal_fda_drugs_5005_F12_id
960	HY-B1118	HYCPK40904	I17	HYCPK40904	91z	849.0	3.0	R33	904.0	I17	3366-95-8	Secnidazole	RP-14539; PM-185184	185.18	Antibiotic; Bacterial; Parasite	Anti-infection	Secnidazole (RP-14539) is an orally active azole antibiotic and a imidazole mitigator of Serratia  marcescens virulence. Secnidazole, as an analog of acylhomoserine lactones, effectively inhibits QS resulting in the attenuation of Pseudomonas aeruginosa pathogenesis. Secnidazole has antimicrobial activity against many anaerobic Gram-negative and Gram-positive bacterial species in vitro. Secnidazole can be used for the research of various diseases, such as amoebiasis and giardiasis, and bacterial vaginitis[1][2][3].	Free Base	C7H11N3O3	17161.0	DMSO : ≥ 30 mg/mL (162.00 mM); H2O : 25 mg/mL (135.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC(C)CN1C([N+]([O-])=O)=CN=C1C	https://www.medchemexpress.com/Secnidazole.html	Launched		91.0	R33	F12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1118	10.0	mM	132.0	DMSO	185.080041	12	F	pluskal_fda_drugs_5005_F12_id
1181	HY-104044	HYCPK40905	F11	HYCPK40905	91z	550.0	4.0	L22	905.0	F11	1446261-44-4	Pamiparib	BGB-290	298.31	PARP	Cell Cycle/DNA Damage; Epigenetics	Pamiparib (BGB-290) is an orally active, potent, highly selective PARP inhibitor, with IC50 values of 0.9 nM and 0.5 nM for PARP1 and PARP2, respectively. Pamiparib has potent PARP trapping, and capability to penetrate the brain, and can be used for the research of various cancers including the solid tumor[1][2].	Free Base	C16H15FN4O	55988.0	DMSO : 62.5 mg/mL (209.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NN=C2CN(CCC3)[C@@]3(C)C(N4)=C2C5=C4C=C(F)C=C51	https://www.medchemexpress.com/Pamiparib.html	Launched		91.0	L22	F12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-104044	10.0	mM	132.0	DMSO	298.122989	12	F	pluskal_fda_drugs_5005_F12_id
1335	HY-10997A	HYCPK40905	P20	HYCPK40905	91z	1528.0	4.0	AF40	905.0	P20	936563-87-0	Ibrutinib (Racemate)	PCI-32765 (Racemate)	440.50	Btk	Protein Tyrosine Kinase/RTK	Ibrutinib Racemate (PCI-32765 Racemate) is the racemate of Ibrutinib. Ibrutinib is a selective, irreversible Btk inhibitor with IC50 value of 0.5 nM.	Free Base	C25H24N6O2	11158.0	DMSO : 25 mg/mL (56.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C=CC(N1CC(N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)=O	https://www.medchemexpress.com/PCI-32765-Racemate.html	Launched		91.0	AF40	F12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10997A	10.0	mM	132.0	DMSO	440.196074	12	F	pluskal_fda_drugs_5005_F12_id
84	HY-B1654A	HYCPK40902	M03	HYCPK40902	91z	1157.0	1.0	Y5	902.0	M03	84366-81-4	Flavin adenine dinucleotide (disodium salt)	FAD (disodium salt); FAD-Na2	829.51	Endogenous Metabolite	Metabolic Enzyme/Protease	Flavin adenine dinucleotide (FAD) disodium salt is a redox cofactor, more specifically a prosthetic group of a protein, involved in several important enzymatic reactions in metabolism.	Sodium	C27H31N9Na2O15P2	158454.0	H2O : 33.33 mg/mL (40.18 mM; Need ultrasonic); DMSO : 5 mg/mL (6.03 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(N)=C3N=C2)O[C@@H]1COP(OP(OC[C@H]([C@H]([C@H](CN4C(C=C5C)=C(C=C5C)N=C6C4=NC(NC6=O)=O)O)O)O)(O[Na])=O)(O[Na])=O	https://www.medchemexpress.com/Flavin_Adenine_Dinucleotide_Disodium.html	Launched		91.0	Y5	F13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1654A	10.0	mM	133.0	DMSO	785.157135	13	F	pluskal_fda_drugs_5005_F13_id
283	HY-114703	HYCPK40902	I17	HYCPK40902	91z	801.0	1.0	Q33	902.0	I17	104746-04-5	Eslicarbazepine	BIA 2-194	254.28	Others	Others	Eslicarbazepine is an oral anticonvulsant indicated for the adjunctive treatment of partial seizures.	Free Base	C15H14N2O2	58016.0	DMSO : 250 mg/mL (983.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N)N1C2=CC=CC=C2C[C@@H](C3=CC=CC=C31)O	https://www.medchemexpress.com/Eslicarbazepine.html	Launched		91.0	Q33	F13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-114703	10.0	mM	133.0	DMSO	254.105528	13	F	pluskal_fda_drugs_5005_F13_id
320	HY-B0558	HYCPK40902	H20	HYCPK40902	91z	711.0	1.0	O39	902.0	H20	22232-54-8	Carbimazole		186.23	Others	Others	Carbimazole is an imidazole antithyroid agent and can be used for the research of Graves' disease. Carbimazole plays its role due to its rapid conversion to methylmercapto imidazole (MMI) in vivo and can be converted to methimazole in vitro[1].	Free Base	C7H10N2O2S	16837.0	DMSO : 100 mg/mL (536.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(N1C=CN(C)C1=S)OCC	https://www.medchemexpress.com/carbimazole.html	Launched		91.0	O39	F13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0558	10.0	mM	133.0	DMSO	186.046299	13	F	pluskal_fda_drugs_5005_F13_id
689	HY-12707	HYCPK40903	A20	HYCPK40903	91z	40.0	2.0	A40	903.0	A20	3605-01-4	Piribedil		298.34	Adrenergic Receptor; Dopamine Receptor; Histone Methyltransferase	Epigenetics; GPCR/G Protein; Neuronal Signaling	Piribedil is a potent and orally active dopamine D2 and dopamine D3 agonist. Piribedil is also a α2-adrenoceptors antagonist. Piribedil can inhibit MLL1 methyltransferase activity (EC50: 0.18 μM). Piribedil has the potential for the research of parkinson's disease, circulatory disorders, cancers[1][2][3][4].	Free Base	C16H18N4O2	27071.0	DMSO : 33.33 mg/mL (111.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Neurological Disease	C1(N2CCN(CC3=CC=C(OCO4)C4=C3)CC2)=NC=CC=N1	https://www.medchemexpress.com/Piribedil.html	Launched		91.0	A40	F13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12707	10.0	mM	133.0	DMSO	298.142976	13	F	pluskal_fda_drugs_5005_F13_id
699	HY-12355	HYCPK40903	K20	HYCPK40903	91z	1000.0	2.0	U40	903.0	K20	1230487-00-9	Siponimod	BAF-312	516.60	LPL Receptor	GPCR/G Protein	Siponimod (BAF-312) is an orally active and selective sphingosine-1-phosphate (S1P) receptor modulator. Siponimod is selective for S1P1 and S1P5 over S1P2, S1P3, and S1P4, with EC50s of 0.4, 0.98, >10000, >1000, and 750 nM, respectively. Siponimod can be used for multiple sclerosis (MS) research[1]-[4].	Free Acid	C29H35F3N2O3	31081.0	DMSO : ≥ 30 mg/mL (58.07 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	O=C(C1CN(CC2=CC=C(/C(C)=N/OCC3=CC=C(C4CCCCC4)C(C(F)(F)F)=C3)C=C2CC)C1)O	https://www.medchemexpress.com/Siponimod.html	Launched		91.0	U40	F13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12355	10.0	mM	133.0	DMSO	516.259978	13	F	pluskal_fda_drugs_5005_F13_id
1166	HY-B0895	HYCPK40905	G10	HYCPK40905	91z	644.0	4.0	N20	905.0	G10	10246-75-0	Hydroxyzine (pamoate)		763.27	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	"Hydroxyzine pamoate is a histamine H1-receptor antagonist.
Target: Histamine H1-Receptor
Hydroxyzine inhibits carbachol (10 μM)-induced serotonin release by 34% at 10 μM, by 25% 1 μM and by 17% 0.1 μM in pretreated bladder slices for 60 min [1]. Hydroxyzine (0.1 mM) treatment inhibits the progression and severity of EAE by 50% and the extent of mast cell degranulation by 70% in Lewis rats with allergic encephalomyelitis (EAE) [2]. Hydroxyzine (500  M) significantly increases transport of etoposide to the serosal site in the jejunal everted sacs. Hydroxyzine significantly reduces the efflux and approximately 2.4 ug/mL of etoposide in the jejunum and ileum. Hydroxyzine (0.2 μg/mL) significantly enhances the efflux of RH123 to the lumen [3].
Hydroxyzine (500 μM) significantly decreases the steady-state etoposide concentration 2-fold, where the steady-state concentration reached about 0.055 μM/mL in Sprague-Dawley rats [3]. Hydroxyzine (12.5 mg/kg, 25 mg/kg and 50 mg/kg i.p.) shows little direct analgesic activity but markedly potentiates only the effect of morphine on the vocalization after-discharge which represents the affective component of pain in rats. Hydroxyzine (50 mg/kg i.p.) potentiates morphine on the tail-flick test, while Hydroxyzine (12.5 mg/kg i.p.) decreases morphine antinociception in rats [4]."	Pamoate	C44H43ClN2O8	80713.0	DMSO : 250 mg/mL (327.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(C1=C(O)C(CC2=C3C=CC=CC3=CC(C(O)=O)=C2O)=C4C=CC=CC4=C1)O.ClC5=CC=C(C(N6CCN(CCOCCO)CC6)C7=CC=CC=C7)C=C5	https://www.medchemexpress.com/Hydroxyzine-pamoate.html	Launched		91.0	N20	F13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0895	10.0	mM	133.0	DMSO	388.094688	13	F	pluskal_fda_drugs_5005_F13_id
1201	HY-A0023	HYCPK40905	J12	HYCPK40905	91z	936.0	4.0	T24	905.0	J12	850649-62-6	Alogliptin (Benzoate)	SYR 322	461.51	Dipeptidyl Peptidase; Ferroptosis	Apoptosis; Metabolic Enzyme/Protease	Alogliptin Benzoate (SYR-322) is a potent, selective and orally active inhibitor of DPP-4 with an IC50 of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Alogliptin Benzoate can be used for the research of type 2 diabetes[1][2][3].	Benzoate	C25H27N5O4	23117.0	DMSO : 50 mg/mL (108.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease	O=C(C=C(N1C[C@H](N)CCC1)N(C2=O)CC3=C(C#N)C=CC=C3)N2C.O=C(O)C4=CC=CC=C4	https://www.medchemexpress.com/alogliptin-benzoate.html	Launched		91.0	T24	F13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0023	10.0	mM	133.0	DMSO	339.169525	13	F	pluskal_fda_drugs_5005_F13_id
1321	HY-10997	HYCPK40905	B20	HYCPK40905	91z	184.0	4.0	D40	905.0	B20	936563-96-1	Ibrutinib	PCI-32765	440.50	Btk; Ligands for Target Protein for PROTAC	PROTAC; Protein Tyrosine Kinase/RTK	Ibrutinib (PCI-32765) is a selective, irreversible Btk inhibitor with an IC50 of 0.5 nM[1].	Free Base	C25H24N6O2	61547.0	DMSO : 100 mg/mL (227.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C=CC(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)=O	https://www.medchemexpress.com/PCI-32765.html	Launched		91.0	D40	F13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10997	10.0	mM	133.0	DMSO	440.196074	13	F	pluskal_fda_drugs_5005_F13_id
234	HY-12752A	HYCPK40902	H14	HYCPK40902	91z	699.0	1.0	O27	902.0	H14	4330-99-8	Alimemazine hemitartrate	Trimeprazine hemitartrate	373.49	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Alimemazine hemitartrate is a phenothiazine derivative that is generally used as an antipruritic agent and also a hemagglutinin (HA)-receptor antagonist.	Tartrate	C18H22N2S.1/2C4H6O6	27580.0	DMSO : 30 mg/mL (80.32 mM; Need ultrasonic and warming); H2O : 100 mg/mL (267.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease; Cancer	CC(CN(C)C)CN1C2=CC=CC=C2SC3=CC=CC=C13.O=C(O)[C@H](O)[C@@H](O)C(O)=O.[0.5]	https://www.medchemexpress.com/Alimemazine_hemitartrate.html	Launched		91.0	O27	F14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12752A	10.0	mM	134.0	DMSO	298.15037	14	F	pluskal_fda_drugs_5005_F14_id
324	HY-N7121	HYCPK40902	L20	HYCPK40902	91z	1095.0	1.0	W39	902.0	L20	3521-62-8	Erythromycin estolate		1056.39	Bacterial	Anti-infection	Erythromycin estolate, erythromycin derivative[1], is a macrolide antibiotic used in the treatment of a wide variety of bacterial infections. Erythromycin estolate causes several cases of liver injury which mostly include cholestatic hepatitis. Erythromycin estolate toxicity is related to its inhibitory effect on bile acid transport[2].	Sulfate	C52H97NO18S	64122.0	DMSO : 100 mg/mL (94.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CCCCCCCCCCCCOS(=O)(O)=O.CCC(O[C@H]([C@H](C[C@@H](C)O1)N(C)C)[C@]1([H])O[C@@H]2[C@H]([C@@H]([C@H](C(O[C@@H]([C@@](C)(O)[C@H](O)[C@@H](C)C([C@H](C)C[C@]2(O)C)=O)CC)=O)C)O[C@@]3([H])C[C@](C)([C@@H](O)[C@H](C)O3)OC)C)=O	https://www.medchemexpress.com/erythromycin-estolate.html	Launched		91.0	W39	F14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7121	10.0	mM	134.0	DMSO	789.487456	14	F	pluskal_fda_drugs_5005_F14_id
377	HY-109044	HYCPK40902	J04	HYCPK40902	91z	871.0	1.0	S7	902.0	J04	79338-84-4	Tapinarof	WBI-1001; Benvitimod; GSK2894512	254.32	Aryl Hydrocarbon Receptor	Immunology/Inflammation	Tapinarof (WBI-1001) is a natural aryl hydrocarbon receptor (AhR) agonist with an EC50 of 13 nM. Tapinarof resolves skin inflammation in mice[1].	Free Base	C17H18O2	32879.0	DMSO : 100 mg/mL (393.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC1=C(C(C)C)C(O)=CC(/C=C/C2=CC=CC=C2)=C1	https://www.medchemexpress.com/Tapinarof.html	Launched		91.0	S7	F14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109044	10.0	mM	134.0	DMSO	254.13068	14	F	pluskal_fda_drugs_5005_F14_id
396	HY-W010841	HYCPK40902	E18	HYCPK40902	91z	419.0	1.0	I35	902.0	E18	130018-87-0	Levocetirizine (dihydrochloride)	(R)-Cetirizine (dihydrochloride)	461.81	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Levocetirizine dihydrochloride ((R)-Cetirizine dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Levocetirizine dihydrochloride is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine dihydrochloride has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[1].	Hydrochloride	C21H27Cl3N2O3	57233.0	DMSO : 100 mg/mL (216.54 mM; Need ultrasonic); H2O : 100 mg/mL (216.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	O=C(O)COCCN1CCN([C@@H](C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1.[H]Cl.[H]Cl	https://www.medchemexpress.com/levocetirizine-dihydrochloride.html	Launched		91.0	I35	F14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W010841	10.0	mM	134.0	DMSO	388.15537	14	F	pluskal_fda_drugs_5005_F14_id
559	HY-16637	HYCPK40903	P12	HYCPK40903	91z	1464.0	2.0	AE24	903.0	P12	59-30-3	Folic acid	Vitamin B9; Vitamin M	441.40	DNA/RNA Synthesis; Endogenous Metabolite	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Folic acid (Vitamin B9) is a orally active essential nutrient from the B complex group of vitamins. Folic acid shows antidepressant-like effect. Folic acid sodium reduces the risk of neonatal neural tube defects. Folic acid can be used to the treatment of megaloblastic and macrocytic anemias due to folic deficiency[1][2][3][4].	Free Acid	C19H19N7O6	25470.0	1M NaOH : 100 mg/mL (226.55 mM; Need ultrasonic); DMSO : 33.33 mg/mL (75.51 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(NCC2=CN=C3N=C(N)NC(C3=N2)=O)C=C1)=O	https://www.medchemexpress.com/Folic-acid.html	Launched		91.0	AE24	F14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16637	10.0	mM	134.0	DMSO	441.139681	14	F	pluskal_fda_drugs_5005_F14_id
755	HY-14749A	HYCPK40904	C04	HYCPK40904	91z	247.0	3.0	F7	904.0	C04	76748-86-2	Pyronaridine (tetraphosphate)		910.03	Parasite	Anti-infection	Pyronaridine tetraphosphate is an orally active Mannich base anti-malarial agent. Pyronaridine tetraphosphate is active against P. falciparum and Echinococcus granulosus infection[1][2].	Phosphate	C29H44ClN5O18P4	33681.0	DMSO : 12.5 mg/mL (13.74 mM; ultrasonic and warming and heat to 60°C); H2O : 25 mg/mL (27.47 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	OC1=C(CN2CCCC2)C=C(NC3=C4N=C(OC)C=CC4=NC5=CC(Cl)=CC=C53)C=C1CN6CCCC6.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O	https://www.medchemexpress.com/Pyronaridine_tetraphosphate.html	Launched		91.0	F7	F14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14749A	10.0	mM	134.0	DMSO	517.224453	14	F	pluskal_fda_drugs_5005_F14_id
1118	HY-A0075	HYCPK40905	G07	HYCPK40905	91z	638.0	4.0	N14	905.0	G07	13073-96-6	Decloxizine (dihydrochloride)	UCB 1402 dihydrochloride	413.38	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Decloxizine dihydrochloride(UCB-1402; NSC289116) is a histamine 1 receptor antagonist.	Hydrochloride	C21H30Cl2N2O2	13604.0	H2O : ≥ 100 mg/mL (241.91 mM); DMSO : ≥ 50 mg/mL (120.95 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	OCCOCCN1CCN(C(C2=CC=CC=C2)C3=CC=CC=C3)CC1.[H]Cl.[H]Cl	https://www.medchemexpress.com/Decloxizine-dihydrochloride.html	Launched		91.0	N14	F14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0075	10.0	mM	134.0	DMSO	340.215078	14	F	pluskal_fda_drugs_5005_F14_id
1344	HY-B0163A	HYCPK40905	I21	HYCPK40905	91z	858.0	4.0	R42	905.0	I21	90038-01-0	Detomidine (hydrochloride)		222.71	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Detomidine hydrochloride, an imidazole derivative, is a potent α2-adrenergic agonist. Detomidine hydrochloride produces dose-dependent analgesic effects[1][2].	Hydrochloride	C12H15ClN2	11943.0	H2O : 20 mg/mL (89.80 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (449.01 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CC1=C(C)C(CC2=CN=CN2)=CC=C1.Cl	https://www.medchemexpress.com/detomidine-hydrochloride.html	Launched		91.0	R42	F14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0163A	10.0	mM	134.0	DMSO	186.115698	14	F	pluskal_fda_drugs_5005_F14_id
357	HY-B1065	HYCPK40903	N03	HYCPK40903	91z	1254.0	2.0	AA6	903.0	N03	2490-97-3	Aceglutamide	α-N-Acetyl-L-glutamine; N2-Acetylglutamine	188.18	Autophagy; Endogenous Metabolite	Autophagy; Metabolic Enzyme/Protease	Aceglutamide (α-N-Acetyl-L-glutamine) is a psychostimulant and nootropic, used to improve memory and concentration[1].	Free Acid	C7H12N2O4	17302.0	DMSO : 16.67 mg/mL (88.59 mM; Need ultrasonic); H2O : 33.33 mg/mL (177.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N)CC[C@@H](C(O)=O)NC(C)=O	https://www.medchemexpress.com/Aceglutamide.html	Launched		91.0	AA6	F15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1065	10.0	mM	135.0	DMSO	188.079707	15	F	pluskal_fda_drugs_5005_F15_id
499	HY-B0884A	HYCPK40903	H08	HYCPK40903	91z	688.0	2.0	O16	903.0	H08	25953-17-7	Minaprine (dihydrochloride)		371.30	Monoamine Oxidase	Neuronal Signaling	Minaprine dihydrochloride is a reversible inhibitor of MAO-A; weakly inhibit acetylcholinesterase; an antidepressant for treatment of depression.	Hydrochloride	C17H24Cl2N4O	68235.0	H2O : 100 mg/mL (269.32 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (269.32 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	[H]Cl.CC1=CC(C2=CC=CC=C2)=NN=C1NCCN3CCOCC3.[H]Cl	https://www.medchemexpress.com/Minaprine-dihydrochloride.html	Launched		91.0	O16	F15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0884A	10.0	mM	135.0	DMSO	298.179361	15	F	pluskal_fda_drugs_5005_F15_id
782	HY-17010	HYCPK40904	C06	HYCPK40904	91z	251.0	3.0	F11	904.0	C06	224452-66-8	Retapamulin	SB-275833	517.76	Antibiotic; Bacterial	Anti-infection	"Retapamulin(SB-275833)  is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM.
IC50 Value: 3 nM(Kd, E.coli)
Target: Antibacterial
Retapamulin is a topical antibiotic developed by GlaxoSmithKline. Retapamulin(SB-275833) is the first drug in the new class of pleuromutilin antibiotics to be approved for human use.Retapamulin(SB-275833) is marketed as an ointment under the brand names Altabax and Altargo.  Retapamulin(SB-275833) is useful for Antibiotics."	Free Base	C30H47NO4S	29893.0	DMSO : 110 mg/mL (212.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	C[C@@H]1[C@]23[C@](C(CC3)=O)([H])[C@]([C@H](OC(CS[C@@H]4C[C@@H]5N(C)[C@@H](CC5)C4)=O)C[C@](C=C)(C)[C@H]1O)([C@H](C)CC2)C	https://www.medchemexpress.com/Retapamulin.html	Launched		91.0	F11	F15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17010	10.0	mM	135.0	DMSO	517.32258	15	F	pluskal_fda_drugs_5005_F15_id
804	HY-13609	HYCPK40904	I07	HYCPK40904	91z	829.0	3.0	R13	904.0	I07	14484-47-0	Deflazacort		441.52	Glucocorticoid Receptor	Immunology/Inflammation	Deflazacort, a glucocorticoid, is an inactive prodrug and is converted rapidly to the active metabolite 21-desacetyldeflazacort. Deflazacort is used as an anti-inflammatory and immunosuppressant[1].	Free Base	C25H31NO6	15252.0	DMSO : ≥ 100 mg/mL (226.49 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@]5([H])[C@@]4(C(COC(C)=O)=O)N=C(C)O5)=C1	https://www.medchemexpress.com/Deflazacort.html	Launched		91.0	R13	F15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13609	10.0	mM	135.0	DMSO	441.215138	15	F	pluskal_fda_drugs_5005_F15_id
983	HY-B0523A	HYCPK40904	P18	HYCPK40904	91z	1523.0	3.0	AF35	904.0	P18	58579-51-4	Anagrelide (hydrochloride)	BL4162A	292.55	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	"Anagrelide hydrochloride (BL4162A) is a drug used for the treatment of essential thrombocytosis.
Target: PDE
Anagrelide hydrochloride is an oral imidazoquinazoline agent that has been shown to reduce elevated platelet counts and the risk of thrombosis in patients with thrombocythaemia in various myeloproliferative disorders (MPD). It is currently approved by the FDA as oral treatment for essential thrombocythaemia (ET) and thrombocythaemia associated with polycythaemia vera (PV). Anagrelide is known to inhibit platelet cyclic adenosine monophosphate (cAMP) phosphodiesterase at concentrations that exceed those achieved at doses used to treat ET. Anagrelide is extensively metabolised in the liver and its metabolites are primarily excreted in the urine [1]. Anagrelide is an established platelet-reducing drug. Studies have also investigated the effects of anagrelide on platelets, indicating that platelet function is as important as platelet counts in ET [2]."	Hydrochloride	C10H8Cl3N3O	14567.0	DMSO : 7.69 mg/mL (26.29 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	ClC1=C(CN(C2)C3=NC2=O)C(N3)=CC=C1Cl.Cl	https://www.medchemexpress.com/Anagrelide-hydrochloride.html	Launched		91.0	AF35	F15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0523A	10.0	mM	135.0	DMSO	254.996617	15	F	pluskal_fda_drugs_5005_F15_id
1207	HY-B1059	HYCPK40905	P12	HYCPK40905	91z	1512.0	4.0	AF24	905.0	P12	23672-07-3	Levosulpiride	RV-12309; S-(-)-Sulpiride	341.43	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Levosulpiride (RV-12309) is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic drug of the benzamide class.	Free Base	C15H23N3O4S	17567.0	DMSO : 50 mg/mL (146.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NC[C@H]1N(CC)CCC1)C2=CC(S(=O)(N)=O)=CC=C2OC	https://www.medchemexpress.com/Levosulpiride.html	Launched		91.0	AF24	F15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1059	10.0	mM	135.0	DMSO	341.140927	15	F	pluskal_fda_drugs_5005_F15_id
1262	HY-17042A	HYCPK40905	G16	HYCPK40905	91z	656.0	4.0	N32	905.0	G16	83881-52-1	Cetirizine (dihydrochloride)	P071	461.81	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Cetirizine dihydrochloride, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist. Cetirizine dihydrochloride marks antiallergic properties and inhibits eosinophil chemotaxis during the allergic response[1][2][3].	Hydrochloride	C21H27Cl3N2O3	14746.0	DMSO : 100 mg/mL (216.54 mM; Need ultrasonic); H2O : 100 mg/mL (216.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	O=C(O)COCCN1CCN(C(C2=CC=C(Cl)C=C2)C3=CC=CC=C3)CC1.Cl.Cl	https://www.medchemexpress.com/cetirizine-dihydrochloride.html	Launched		91.0	N32	F15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17042A	10.0	mM	135.0	DMSO	388.15537	15	F	pluskal_fda_drugs_5005_F15_id
1331	HY-B0606	HYCPK40905	L20	HYCPK40905	91z	1144.0	4.0	X40	905.0	L20	211427-08-6	Diquafosol (tetrasodium)	INS365	878.23	P2Y Receptor	GPCR/G Protein	Diquafosol tetrasodium is a P2Y2 receptor agonist that stimulates fluid and mucin secretion on the ocular surface, as a topical treatment of dry eye disease.	Sodium	C18H22N4Na4O23P4	28674.0	H2O : 100 mg/mL (113.87 mM; Need ultrasonic); DMSO : 1 mg/mL (1.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O[C@H]1[C@@H](O)[C@H](N(C(N2)=O)C=CC2=O)O[C@@H]1COP(OP(OP(OP(OC[C@@H]3[C@@H](O)[C@@H](O)[C@H](N4C(NC(C=C4)=O)=O)O3)(O[Na])=O)(O[Na])=O)(O[Na])=O)(O[Na])=O	https://www.medchemexpress.com/Diquafosol__tetrasodium_.html	Launched		91.0	X40	F15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0606	10.0	mM	135.0	DMSO	789.99383	15	F	pluskal_fda_drugs_5005_F15_id
169	HY-13407	HYCPK40902	G10	HYCPK40902	91z	595.0	1.0	M19	902.0	G10	303-45-7	Gossypol	BL 193	518.55	Bcl-2 Family	Apoptosis	Gossypol binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively.	Free Base	C30H30O8	99218.0	DMSO : 33.33 mg/mL (64.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=CC1=C(O)C(O)=C(C(C)C)C2=CC(C)=C(C3=C(C)C=C4C(C(C)C)=C(O)C(O)=C(C=O)C4=C3O)C(O)=C12	https://www.medchemexpress.com/Gossypol.html	Launched		91.0	M19	F16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13407	10.0	mM	136.0	DMSO	518.194068	16	F	pluskal_fda_drugs_5005_F16_id
218	HY-A0015	HYCPK40902	H13	HYCPK40902	91z	697.0	1.0	O25	902.0	H13	190786-44-8	Bepotastine (besilate)		547.06	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Bepotastine besilate is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF). Bepotastine besilate has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research[1][2][3][4].	Benzenesulfonate	C27H31ClN2O6S	5012.0	DMSO : ≥ 100 mg/mL (182.80 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(CCCN1CCC(CC1)O[C@H](C2=NC=CC=C2)C3=CC=C(C=C3)Cl)O.O=S(C4=CC=CC=C4)(O)=O	https://www.medchemexpress.com/Bepotastine-Beslilate.html	Launched		91.0	O25	F16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0015	10.0	mM	136.0	DMSO	388.15537	16	F	pluskal_fda_drugs_5005_F16_id
513	HY-109513	HYCPK40903	B10	HYCPK40903	91z	116.0	2.0	C20	903.0	B10	107793-72-6	Ioxilan		791.11	Others	Others	Ioxilan is a low-osmolar, nonionic and tri-iodinated diagnostic contrast agent. Ioxilan is also an X-ray contrast agent for excretory urography and contrast enhanced computed tomographic (CECT) imaging of the head and body. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs[1][2][3].		C18H24I3N3O8	63919.0	DMSO : ≥ 250 mg/mL (316.01 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(C1=C(I)C(N(C(C)=O)CC(O)CO)=C(I)C(C(NCCO)=O)=C1I)NCC(O)CO	https://www.medchemexpress.com/ioxilan.html	Launched		91.0	C20	F16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109513	10.0	mM	136.0	DMSO	790.869759	16	F	pluskal_fda_drugs_5005_F16_id
618	HY-14262	HYCPK40903	P14	HYCPK40903	91z	1468.0	2.0	AE28	903.0	P14	163521-12-8	Vilazodone	EMD 68843; SB659746A	441.52	5-HT Receptor; Serotonin Transporter	GPCR/G Protein; Neuronal Signaling	Vilazodone (EMD 68843; SB 659746A) is a potent, selective and orally active?serotonin?reuptake inhibitor (SSRI) and partial?5-HT1A receptor agonist. Vilazodone exhibits antidepressant efficacy in vivo can be used for the research of major depressive disorder (MDD) and affective disorders[1][2].	Free Base	C26H27N5O2	4953.0	DMSO : ≥ 100 mg/mL (226.49 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC(C1=CC2=C(C=CC(N3CCN(CCCCC4=CNC5=CC=C(C=C54)C#N)CC3)=C2)O1)=O	https://www.medchemexpress.com/vilazodone.html	Launched		91.0	AE28	F16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14262	10.0	mM	136.0	DMSO	441.216475	16	F	pluskal_fda_drugs_5005_F16_id
935	HY-B0554	HYCPK40904	L15	HYCPK40904	91z	1133.0	3.0	X29	904.0	L15	68-22-4	Norethindrone	Norethisterone	298.42	Bacterial; Progesterone Receptor	Anti-infection; Others	Norethindrone is a female progestin approved by FDA for the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels, and secondary amenorrhea.	Free Base	C20H26O2	25328.0	DMSO : 110 mg/mL (368.61 mM; Need ultrasonic); H2O : 2.7 mg/mL (9.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@@]1([C@]2(O)C#C)[C@](CC2)([H])[C@@](CCC3=CC4=O)([H])[C@]([C@@]3([H])CC4)([H])CC1	https://www.medchemexpress.com/norethindrone.html	Launched		91.0	X29	F16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0554	10.0	mM	136.0	DMSO	298.19328	16	F	pluskal_fda_drugs_5005_F16_id
1196	HY-B1019	HYCPK40905	E12	HYCPK40905	91z	456.0	4.0	J24	905.0	E12	15676-16-1	Sulpiride		341.43	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Sulpiride is a D2 receptor a antagonist, an atypical antipsychotic drug of the benzamide class, used mainly in the treatment of psychosis associated with schizophrenia and major depressive disorder, and sometimes used in low dosage to treat anxiety and mild depression.	Free Base	C15H23N3O4S	17274.0	DMSO : 100 mg/mL (292.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NCC1N(CC)CCC1)C2=CC(S(=O)(N)=O)=CC=C2OC	https://www.medchemexpress.com/Sulpiride.html	Launched		91.0	J24	F16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1019	10.0	mM	136.0	DMSO	341.140927	16	F	pluskal_fda_drugs_5005_F16_id
1210	HY-B0495	HYCPK40905	C13	HYCPK40905	91z	266.0	4.0	F26	905.0	C13	84057-84-1	Lamotrigine	LTG; BW430C	256.09	Autophagy; Sodium Channel	Autophagy; Membrane Transporter/Ion Channel	Lamotrigine (BW430C) is a potent and orally active anticonvulsant or antiepileptic agent. Lamotrigine selectively blocks voltage-gated Na+ channels, stabilizing presynaptic neuronal membranes and inhibiting glutamate release. Lamotrigine can be used for the research of epilepsy,?focal seizure, et al[1][2].	Free Base	C9H7Cl2N5	15879.0	H2O : 0.1 mg/mL (0.39 mM; Need ultrasonic); DMSO : 25 mg/mL (97.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	NC1=NC(N)=C(C2=CC=CC(Cl)=C2Cl)N=N1	https://www.medchemexpress.com/Lamotrigine.html	Launched		91.0	F26	F16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0495	10.0	mM	136.0	DMSO	255.007851	16	F	pluskal_fda_drugs_5005_F16_id
1258	HY-B0171	HYCPK40905	C16	HYCPK40905	91z	272.0	4.0	F32	905.0	C16	60-80-0	Antipyrine	Phenazone; Phenazon	188.23	Others	Others	Antipyrine (Phenazone) is an antipyretic and analgesic. Antipyrine can be used as a probe drug for oxidative drug metabolism. Antipyrine has been widely used in assessment of hepatic oxidative capacity[1][2].	Free Base	C11H12N2O	15875.0	H2O : ≥ 100 mg/mL (531.26 mM); DMSO : 100 mg/mL (531.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1N(C2=CC=CC=C2)N(C)C(C)=C1	https://www.medchemexpress.com/Antipyrine.html	Launched		91.0	F32	F16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0171	10.0	mM	136.0	DMSO	188.094963	16	F	pluskal_fda_drugs_5005_F16_id
243	HY-B0449	HYCPK40902	A15	HYCPK40902	91z	29.0	1.0	A29	902.0	A15	3963-95-9	Methacycline (hydrochloride)		478.88	Antibiotic; Bacterial	Anti-infection	Methacycline hydrochloride is a tetracycline antibiotic and can inhibits bacterial protein synthesis. Methacycline hydrochloride is a potent epithelial-mesenchymal transition (EMT) inhibitor. Methacycline hydrochloride blocks EMT in vitro and fibrogenesis in vivo without directly affecting TGF-β1 Smad signaling. Methacycline hydrochloride is an antimicrobial and has the potential for pulmonary fibrosis[1].	Hydrochloride	C22H23ClN2O8	16104.0	DMSO : 50 mg/mL (104.41 mM; Need ultrasonic); H2O : 6.67 mg/mL (13.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O[C@@](C(O)=C(C(C1=C2C=CC=C1O)=O)[C@](C2=C)([H])[C@@H]3O)(C(C(C(N)=O)=C4O)=O)[C@]3([H])[C@@H]4N(C)C.Cl	https://www.medchemexpress.com/Methacycline-hydrochloride.html	Launched		91.0	A29	F17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0449	10.0	mM	137.0	DMSO	442.137616	17	F	pluskal_fda_drugs_5005_F17_id
397	HY-17574	HYCPK40902	F18	HYCPK40902	91z	515.0	1.0	K35	902.0	F18	52-24-4	Thio-TEPA		189.22	Antibiotic; Bacterial; DNA Alkylator/Crosslinker	Anti-infection; Cell Cycle/DNA Damage	Thio-TEPA is a DNA alkylating agent, with antitumor activity.	Free Base	C6H12N3PS	57814.0	DMSO : ≥ 50 mg/mL (264.24 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Infection	S=P(N1CC1)(N2CC2)N3CC3	https://www.medchemexpress.com/Thio-TEPA.html	Launched		91.0	K35	F17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17574	10.0	mM	137.0	DMSO	189.048955	17	F	pluskal_fda_drugs_5005_F17_id
579	HY-N2591	HYCPK40904	C05	HYCPK40904	91z	249.0	3.0	F9	904.0	C05	475-67-2	Isocorydine		341.40	Endogenous Metabolite	Metabolic Enzyme/Protease	Isocorydine is isolated from Dicranostigma leptopodum (Maxim.) Fedde (DLF). Isocorydine combines with Doxorubicin (DOX) has a promising potential to eradicate hepatocellular carcinoma (HCC)[1].	Free Base	C20H23NO4	117250.0	DMSO : 20 mg/mL (58.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	COC1=C2C3=C(C=C1OC)CCN(C)[C@@]3([H])CC4=CC=C(OC)C(O)=C24	https://www.medchemexpress.com/isocorydine.html	Launched		91.0	F9	F17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N2591	10.0	mM	137.0	DMSO	341.162708	17	F	pluskal_fda_drugs_5005_F17_id
657	HY-B1410	HYCPK40903	G17	HYCPK40903	91z	610.0	2.0	M34	903.0	G17	87771-40-2	Ioversol	MP-328	807.11	Others	Others	Ioversol (MP-328) is a nonionic iodinated contrast medium (CM) that is used during a CT scan or x-ray in animal experiment. Ioversol does not damage the blood-brain barrier (BBB) in animal[1][2][3][4].	Free Base	C18H24I3N3O9	25941.0	DMSO : ≥ 100 mg/mL (123.90 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(C1=C(I)C(N(C(CO)=O)CCO)=C(I)C(C(NCC(O)CO)=O)=C1I)NCC(O)CO	https://www.medchemexpress.com/Ioversol.html	Launched		91.0	M34	F17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1410	10.0	mM	137.0	DMSO	806.864673	17	F	pluskal_fda_drugs_5005_F17_id
899	HY-B0327	HYCPK40904	H13	HYCPK40904	91z	745.0	3.0	P25	904.0	H13	57381-26-7	Irsogladine	Dicloguamine	256.09	mAChR; Phosphodiesterase (PDE)	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	"Irsogladine is a PDE4 inhibitor and muscarinic acetylcholine receptor binder.
Target: PDE4; mACHR
Irsogladine treatment (300 and 500 mg/kg/day) resulted in a dose-dependent reduction of angiogenesis in wild-type mice by 21 and 45.3% (P < 0.02, P < 0.001), in tPA-deficient mice by 42.6 and 46% (P < 0.001, P < 0.001), and in uPA-deficient mice by 27.2 and 46% (P < 0.05, p < 0.001), respectively. Irsogladine inhibits bFGF-induced angiogenesis in wild-type, tPA-knockout, and uPA-knockout mice [1]. Irsogladine up-regulates GJIC between PC cells via regulation of the PKA pathway. It also suggests a useful adjuvant of Irsogladine to pancreatic cancer therapy [2]. irsogladine produces the increase of intracellular cAMP content via non-selective inhibition of PDE isozymes, which may be a key mechanism involved in its gastroprotective actions [3]."	Free Base	C9H7Cl2N5	16018.0	DMSO : 120 mg/mL (468.59 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	NC1=NC(N)=NC(C2=CC(Cl)=CC=C2Cl)=N1	https://www.medchemexpress.com/Irsogladine.html	Launched		91.0	P25	F17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0327	10.0	mM	137.0	DMSO	255.007851	17	F	pluskal_fda_drugs_5005_F17_id
920	HY-17510	HYCPK40904	M14	HYCPK40904	91z	1227.0	3.0	Z27	904.0	M14	12542-36-8	Gossypol (acetic acid)	(±)-Gossypol-acetic acid; BL-193 (acetic acid)	578.61	Bcl-2 Family	Apoptosis	Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively.	Acetate	C32H34O10	10817.0	DMSO : 25 mg/mL (43.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC1=C(C2=C(O)C(C(C=O)=C(O)C(O)=C3C(C)C)=C3C=C2C)C(C)=CC4=C(C(C)C)C(O)=C(O)C(C=O)=C41.O=C(O)C	https://www.medchemexpress.com/Gossypol-acetic-acid.html	Launched		91.0	Z27	F17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17510	10.0	mM	137.0	DMSO	518.194068	17	F	pluskal_fda_drugs_5005_F17_id
1044	HY-I0021	HYCPK40904	M22	HYCPK40904	91z	1243.0	3.0	Z43	904.0	M22	125602-71-3	Bepotastine		388.89	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Bepotastine is a selective and orally active second-generation histamine H1 receptor antagonist, can suppress the expression of nerve growth factor (NGF). Bepotastine has the potential for allergic rhinitis, allergic conjunctivitis and urticaria/pruritus research[1][2][3][4].	Free Acid	C21H25ClN2O3	4654.0	DMSO : 100 mg/mL (257.14 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (257.14 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	O=C(O)CCCN1CCC(O[C@@H](C2=CC=C(Cl)C=C2)C3=CC=CC=N3)CC1	https://www.medchemexpress.com/bepotastine.html	Launched		91.0	Z43	F17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-I0021	10.0	mM	137.0	DMSO	388.15537	17	F	pluskal_fda_drugs_5005_F17_id
1242	HY-B1404	HYCPK40905	C15	HYCPK40905	91z	270.0	4.0	F30	905.0	C15	849-55-8	Nylidrin (hydrochloride)	Buphenine hydrochloride	335.87	Others	Others	Nylidrin hydrochloride was an effective inhibitor of IgE-mediated release of histamine from passively sensitized rat peritoneal mast cells and human basophils, and of IgG1-mediated release of histamine from passively sensitized guinea pig lung slices.	Hydrochloride	C19H26ClNO2	18393.0	DMSO : ≥ 41 mg/mL (122.07 mM); H2O : 5 mg/mL (14.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC(C(NC(C)CCC1=CC=CC=C1)C)C2=CC=C(O)C=C2.[H]Cl	https://www.medchemexpress.com/Nylidrin-hydrochloride.html	Launched		91.0	F30	F17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1404	10.0	mM	137.0	DMSO	299.188529	17	F	pluskal_fda_drugs_5005_F17_id
607	HY-15306	HYCPK40903	E14	HYCPK40903	91z	412.0	2.0	I28	903.0	E14	496775-61-2	Eltrombopag	SB-497115	442.47	Apoptosis; Bacterial; Thrombopoietin Receptor	Anti-infection; Apoptosis; Immunology/Inflammation	Eltrombopag (SB-497115) is an orally active thrombopoietin receptor nonpeptide agonist. Eltrombopag owns thrombopoietic activity, and has been used to research low blood platelet counts with chronic immune thrombocytopenia. Eltrombopag can be used for the research of cardiovascular. Eltrombopag also has highly inhibitory effects against multidrug resistant Staphylococcus aureus. Eltrombopag can induce apoptosis in hepatocellular carcinomab (HCC) as well[1][2][3][4][5].	Free Acid	C25H22N4O4	147328.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 8.33 mg/mL (18.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Cardiovascular Disease	O=C(C1=CC(C2=CC=CC(N/N=C3C(C)=NN(C4=CC=C(C)C(C)=C4)C/3=O)=C2O)=CC=C1)O	https://www.medchemexpress.com/Eltrombopag.html	Launched		91.0	I28	F18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15306	10.0	mM	138.0	DMSO	442.164105	18	F	pluskal_fda_drugs_5005_F18_id
693	HY-128932	HYCPK40903	E20	HYCPK40903	91z	424.0	2.0	I40	903.0	E20	75498-96-3	Cefminox (sodium)	MT-141	541.56	Antibiotic; Bacterial; PPAR; Prostaglandin Receptor	Anti-infection; Cell Cycle/DNA Damage; GPCR/G Protein	Cefminox sodium (MT-141) is a semisynthetic cephamycin, which exhibits a broad spectrum of antibacterial activity[1]. Cefminox sodium (MT-141) also acts as a dual agonist of prostacyclin receptor (IP) and PPARγ, upregulates cAMP production and PTEN expression and inhibits Akt/mTOR signaling. Cefminox sodium (MT-141) also prevents pulmonary arterial hypertension[2].	Sodium	C16H20N7NaO7S3	89638.0	H2O : 83.33 mg/mL (153.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cardiovascular Disease; Endocrinology	O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@](OC)(NC(CSC[C@@H](N)C(O)=O)=O)C1=O)O[Na]	https://www.medchemexpress.com/cefminox-sodium.html	Launched		91.0	I40	F18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-128932	10.0	mM	138.0	DMSO	519.066459	18	F	pluskal_fda_drugs_5005_F18_id
709	HY-B0507	HYCPK40903	E21	HYCPK40903	91z	426.0	2.0	I42	903.0	E21	72-14-0	Sulfathiazole		255.32	Antibiotic; Bacterial	Anti-infection	Sulfathiazole, an organosulfur compound, is used as a short-acting sulfonamide antibiotic[1][2][3].	Free Base	C9H9N3O2S2	213074.0	DMSO : 250 mg/mL (979.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC=CS2)=O	https://www.medchemexpress.com/sulfathiazole.html	Launched		91.0	I42	F18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0507	10.0	mM	138.0	DMSO	255.013619	18	F	pluskal_fda_drugs_5005_F18_id
747	HY-12751A	HYCPK40904	K03	HYCPK40904	91z	1013.0	3.0	V5	904.0	K03	554-92-7	Trimethobenzamide (hydrochloride)	Ro 2-9578	424.92	Dopamine Receptor; Influenza Virus	Anti-infection; GPCR/G Protein; Neuronal Signaling	Trimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.	Hydrochloride	C21H29ClN2O5	26261.0	DMSO : ≥ 100 mg/mL (235.34 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(NCC1=CC=C(OCCN(C)C)C=C1)C2=CC(OC)=C(OC)C(OC)=C2.Cl	https://www.medchemexpress.com/Trimethobenzamide_hydrochloride.html	Launched		91.0	V5	F18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12751A	10.0	mM	138.0	DMSO	388.199822	18	F	pluskal_fda_drugs_5005_F18_id
798	HY-B1418	HYCPK40904	C07	HYCPK40904	91z	253.0	3.0	F13	904.0	C07	89786-04-9	Tazobactam	CL-298741; YTR-830H	300.29	Antibiotic; Bacterial	Anti-infection	Tazobactam (CL-298741) is a potent β-lactamases inhibitor and penicillin antibiotic. Tazobactam has antibacterial activity. Tazobactam can be used for pneumonia research[1][2].	Free Acid	C10H12N4O5S	19620.0	DMSO : 50 mg/mL (166.51 mM; Need ultrasonic); H2O : 1 mg/mL (3.33 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H]([C@@](CN1N=NC=C1)(C)S([C@]2([H])C3)(=O)=O)N2C3=O)O	https://www.medchemexpress.com/Tazobactam.html	Launched		91.0	F13	F18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1418	10.0	mM	138.0	DMSO	300.05284	18	F	pluskal_fda_drugs_5005_F18_id
1032	HY-B0011	HYCPK40904	A22	HYCPK40904	91z	91.0	3.0	B43	904.0	A22	114977-28-5	Docetaxel	RP-56976	807.88	Apoptosis; Endogenous Metabolite; Microtubule/Tubulin	Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; Metabolic Enzyme/Protease	Docetaxel (RP-56976) is a microtubule?depolymerization inhibitor, with an IC50 of 0.2 μM. Docetaxel attenuates the effects of?bcl-2 and bcl-xL gene expression. Docetaxel arrests the cell cycle at G2/M and leads to cell apoptosis. Docetaxel has anti-cancer activity[1][3].	Free Base	C43H53NO14	111613.0	DMSO : ≥ 35 mg/mL (43.32 mM); Ethanol : 50 mg/mL (61.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(OC(C)(C)C)N[C@@H](C1=CC=CC=C1)[C@H](C(O[C@@H]2C(C)=C([C@@H](O)C([C@@]3(C)[C@]([C@@](CO4)(OC(C)=O)[C@@]4([H])C[C@@H]3O)([H])[C@@H]5OC(C6=CC=CC=C6)=O)=O)C(C)(C)[C@@]5(O)C2)=O)O	https://www.medchemexpress.com/Docetaxel.html	Launched		91.0	B43	F18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0011	10.0	mM	138.0	DMSO	807.346605	18	F	pluskal_fda_drugs_5005_F18_id
1077	HY-B0432A	HYCPK40905	N04	HYCPK40905	91z	1304.0	4.0	AB8	905.0	N04	34183-22-7	Propafenone (hydrochloride)	SA-79 (hydrochloride)	377.90	Sodium Channel	Membrane Transporter/Ion Channel	Propafenone (hydrochloride) (SA-79 (hydrochloride)) is a class of anti-arrhythmic medication, which treats illnesses associated with rapid heart beats such as atrial and ventricular arrhythmias.	Hydrochloride	C21H28ClNO3	14617.0	H2O : 0.67 mg/mL (1.77 mM; Need ultrasonic); DMSO : 33.33 mg/mL (88.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CC=CC=C1OCC(O)CNCCC)CCC2=CC=CC=C2.[H]Cl	https://www.medchemexpress.com/Propafenone-hydrochloride.html	Launched		91.0	AB8	F18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0432A	10.0	mM	138.0	DMSO	341.199094	18	F	pluskal_fda_drugs_5005_F18_id
1309	HY-B1730	HYCPK40905	F19	HYCPK40905	91z	566.0	4.0	L38	905.0	F19	86-34-0	Phensuximide		189.21	Others	Others	Phensuximide is an orally active succinimide antiepileptic and anticonvulsant  agent. Phensuximide inhibits cyclic AMP and cyclic GMP accumulation in depolarized brain tissue. Phensuximide can be used for the study of seizure and petit mal[1][3].	Free Base	C11H11NO2	64393.0	DMSO : 250 mg/mL (1321.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	O=C(C(C1=CC=CC=C1)C2)N(C)C2=O	https://www.medchemexpress.com/phensuximide.html	Launched		91.0	L38	F18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1730	10.0	mM	138.0	DMSO	189.078979	18	F	pluskal_fda_drugs_5005_F18_id
214	HY-13782A	HYCPK40902	D13	HYCPK40902	91z	313.0	1.0	G25	902.0	D13	201341-05-1	Tenofovir Disoproxil	Bis(POC)-PMPA; GS 4331	519.44	HBV; HIV; Reverse Transcriptase	Anti-infection	Tenofovir Disoproxil (Bis(POC)-PMPA) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B.	Free Base	C19H30N5O10P	43113.0	DMSO : ≥ 38 mg/mL (73.16 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(OC(C)C)OCOP(OCOC(OC(C)C)=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)=O	https://www.medchemexpress.com/Tenofovir-Disoproxil.html	Launched		91.0	G25	F19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13782A	10.0	mM	139.0	DMSO	519.173029	19	F	pluskal_fda_drugs_5005_F19_id
684	HY-101165	HYCPK40903	L19	HYCPK40903	91z	1094.0	2.0	W38	903.0	L19	2259-96-3	Cyclothiazide		389.88	iGluR	Membrane Transporter/Ion Channel; Neuronal Signaling	Cyclothiazide, a positive allosteric modulator of AMPA receptors, is used frequently to block the desensitization of both native and heterologously expressed AMPA receptors. Cyclothiazide is known to produce a fast inhibition of AMPA receptor desensitization and a much slower potentiation of the AMPA current[1].		C14H16ClN3O4S2	158833.0	DMSO : 125 mg/mL (320.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=S(C1=C(Cl)C=C(C2=C1)NC(C3C(C4)C=CC4C3)NS2(=O)=O)(N)=O	https://www.medchemexpress.com/cyclothiazide.html	Launched		91.0	W38	F19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101165	10.0	mM	139.0	DMSO	389.027076	19	F	pluskal_fda_drugs_5005_F19_id
973	HY-B0011A	HYCPK40904	F18	HYCPK40904	91z	563.0	3.0	L35	904.0	F18	148408-66-6	Docetaxel (Trihydrate)	RP-56976 (Trihydrate)	861.93	Apoptosis; Microtubule/Tubulin	Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Docetaxel Trihydrate (RP-56976 Trihydrate) is an antineoplastic agent and inhibits microtubule?depolymerization with an IC50 value of 0.2 μM[1]. Docetaxel Trihydrate is a semisynthetic analog of taxol and attenuates the effects of?bcl-2?and?bcl-xL?gene expression. Docetaxel Trihydrate arrests the cell cycle at G2/M and leads to cell apoptosis[1][3].	Free Base	C43H59NO17	125414.0	Ethanol : 50 mg/mL (58.01 mM; Need ultrasonic); DMSO : 250 mg/mL (290.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(OC(C)(C)C)N[C@H]([C@H](C(O[C@@H]1C(C)=C([C@@H](O)C([C@@]2(C)[C@]([C@@](CO3)(OC(C)=O)[C@@]3([H])C[C@@H]2O)([H])[C@@H]4OC(C5=CC=CC=C5)=O)=O)C(C)(C)[C@@]4(O)C1)=O)O)C6=CC=CC=C6.O.O.O	https://www.medchemexpress.com/docetaxel-trihydrate.html	Launched		91.0	L35	F19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0011A	10.0	mM	139.0	DMSO	807.346605	19	F	pluskal_fda_drugs_5005_F19_id
1018	HY-B1074	HYCPK40904	C21	HYCPK40904	91z	281.0	3.0	F41	904.0	C21	2624-44-4	Ethamsylate	Etamsylate	263.31	Prostaglandin Receptor	GPCR/G Protein	Ethamsylate is a haemostatic drug, also inhibits biosynthesis and action of those prostaglandins.	Free Acid	C10H17NO5S	17301.0	DMSO : 120 mg/mL (455.74 mM; Need ultrasonic); H2O : 50 mg/mL (189.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=S(C1=CC(O)=CC=C1O)(O)=O.CCNCC	https://www.medchemexpress.com/Ethamsylate.html	Launched		91.0	F41	F19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1074	10.0	mM	139.0	DMSO	189.993594	19	F	pluskal_fda_drugs_5005_F19_id
1064	HY-100375	HYCPK40905	A04	HYCPK40905	91z	56.0	4.0	B8	905.0	A04	1577222-14-0	Diroximel fumarate	ALKS 8700; BIIB098	255.22	Others	Others	Diroximel fumarate (ALKS 8700) is an orally-active and well-tolerated monomethyl fumarate (MMF) prodrug in a controlled-release formulation. Diroximel fumarate is considered as active equivalent to its active metabolite dimethyl fumarate (DMF). Diroximel fumarate has a favorable safety and efficacy profile, has the potential for the study of multiple sclerosis (MS)[1].	Free Base	C11H13NO6	42553.0	H2O : ≥ 10 mg/mL (39.18 mM); DMSO : 125 mg/mL (489.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(OCCN1C(CCC1=O)=O)/C=C/C(OC)=O	https://www.medchemexpress.com/diroximel-fumarate.html	Launched		91.0	B8	F19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100375	10.0	mM	139.0	DMSO	255.074287	19	F	pluskal_fda_drugs_5005_F19_id
1173	HY-76569	HYCPK40905	N10	HYCPK40905	91z	1316.0	4.0	AB20	905.0	N10	207679-81-0	Desfesoterodine	PNU-200577; 5-Hydroxymethyl Tolterodine	341.49	mAChR	GPCR/G Protein; Neuronal Signaling	Desfesoterodine (PNU-200577) is a potent and selective muscarinic receptor (mAChR) antagonist with a KB and a pA2 of 0.84 nM and 9.14, respectively[1]. Desfesoterodine is a major pharmacologically active metabolite of Tolterodine (PNU-200583; HY-A0024) and Fesoterodine (HY-70053)[2][3]. Desfesoterodine improves cerebral infarction induced detrusor overactivity in rats[4].	Free Base	C22H31NO2	7198.0	DMSO : 50 mg/mL (146.42 mM; Need ultrasonic); H2O : 100 mg/mL (292.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC1=C(C=C(CO)C=C1)[C@@H](C2=CC=CC=C2)CCN(C(C)C)C(C)C	https://www.medchemexpress.com/_R_-5-Hydroxymethyl-Tolterodine.html	Launched		91.0	AB20	F19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-76569	10.0	mM	139.0	DMSO	341.235479	19	F	pluskal_fda_drugs_5005_F19_id
1202	HY-B0491A	HYCPK40905	K12	HYCPK40905	91z	1032.0	4.0	V24	905.0	K12	51460-26-5	Carbazochrome (sodium sulfonate)	AC-17	322.27	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Carbazochrome sodium sulfonate (AC-17) is a capillary stabiliser and used for the research of haemorrhage. Carbazochrome sodium sulfonate is an antihemorrhagic agent[1].	Sodium	C10H11N4NaO5S	16842.0	DMSO : ≥ 49 mg/mL (152.05 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(C(CC1=C/C2=N/NC(N)=O)N(C)C1=CC2=O)(O[Na])=O	https://www.medchemexpress.com/carbazochrome-sodium-sulfonate.html	Launched		91.0	V24	F19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0491A	10.0	mM	139.0	DMSO	300.05284	19	F	pluskal_fda_drugs_5005_F19_id
1239	HY-I0383	HYCPK40905	P14	HYCPK40905	91z	1516.0	4.0	AF28	905.0	P14	928672-86-0	Canagliflozin (hemihydrate)	JNJ 28431754 (hemihydrate)	453.52	SGLT	Membrane Transporter/Ion Channel	Canagliflozin hemihydrate (JNJ28431754 hemihydrate) is a selective SGLT2 inhibitor with IC50s of 2 nM, 3.7 nM, and 4.4 nM for mSGLT2, rSGLT2, and hSGLT2 in CHOK cells, respectively[1].	Free Base	C24H26FO5.5S	10921.0	DMSO : ≥ 100 mg/mL (220.50 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	CC1=CC=C([C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)C=C1CC3=CC=C(C4=CC=C(F)C=C4)S3.[0.5H2O]	https://www.medchemexpress.com/Canagliflozin-hemihydrate.html	Launched		91.0	AF28	F19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-I0383	10.0	mM	139.0	DMSO	444.140673	19	F	pluskal_fda_drugs_5005_F19_id
111	HY-90009A	HYCPK40902	E06	HYCPK40902	91z	395.0	1.0	I11	902.0	E06	171596-29-5	Tadalafil	IC-351	389.40	Apoptosis; Phosphodiesterase (PDE)	Apoptosis; Metabolic Enzyme/Protease	Tadalafil (IC-351) is a PDE5 inhibitor with an IC50 value of 1.8 nM.	Free Base	C22H19N3O4	11536.0	DMSO : ≥ 52 mg/mL (133.54 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C([C@@]1([H])CC2=C([C@@H](C3=CC=C(OCO4)C4=C3)N15)NC6=C2C=CC=C6)N(C)CC5=O	https://www.medchemexpress.com/Tadalafil.html	Launched		91.0	I11	F20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-90009A	10.0	mM	140.0	DMSO	389.137556	20	F	pluskal_fda_drugs_5005_F20_id
122	HY-14649	HYCPK40902	P06	HYCPK40902	91z	1451.0	1.0	AE11	902.0	P06	302-79-4	Retinoic acid	Vitamin A acid; all-trans-Retinoic acid; ATRA	300.44	Autophagy; Endogenous Metabolite; PPAR; RAR/RXR	Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Retinoic acid is a metabolite of vitamin A that plays important roles in cell growth, differentiation, and organogenesis. Retinoic acid is a natural agonist of RAR nuclear receptors, with IC50s of 14 nM for RARα/β/γ. Retinoic acid bind to PPARβ/δ with Kd of 17 nM. Retinoic acid acts as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha.	Free Acid	C20H28O2	86070.0	DMSO : 50 mg/mL (166.42 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	CC1(C)C(/C=C/C(C)=C/C=C/C(C)=C/C(O)=O)=C(C)CCC1	https://www.medchemexpress.com/Retinoic-acid.html	Launched		91.0	AE11	F20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14649	10.0	mM	140.0	DMSO	300.20893	20	F	pluskal_fda_drugs_5005_F20_id
322	HY-B2123	HYCPK40902	J20	HYCPK40902	91z	903.0	1.0	S39	902.0	J20	63-42-3	Lactose		342.30	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Lactose, a major sugar in the milk of most species, could regulate human’s intestinal microflora.		C12H22O11	27572.0	DMSO : 50 mg/mL (146.07 mM; Need ultrasonic); H2O : 100 mg/mL (292.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H]([C@H](O)[C@@H](O)C=O)[C@H](O)CO)O1	https://www.medchemexpress.com/Lactose.html	Launched		91.0	S39	F20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2123	10.0	mM	140.0	DMSO	342.116212	20	F	pluskal_fda_drugs_5005_F20_id
421	HY-B0138	HYCPK40903	F09	HYCPK40903	91z	498.0	2.0	K18	903.0	F09	74103-07-4	Ketorolac (tromethamine salt)	Ketorolac Tromethamine; Ketorolac tris salt; RS37619 tromethamine salt	376.40	COX	Immunology/Inflammation	Ketorolac tromethamine salt (RS37619 tromethamine salt) is a non-steroidal anti-inflammatory agent, acting as a nonselective COX inhibitor, with IC50s of 20 nM for COX-1 and 120 nM for COX-2.	Tris	C19H24N2O6	12092.0	DMSO : ≥ 30 mg/mL (79.70 mM); H2O : 100 mg/mL (265.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(C1C2=CC=C(C(C3=CC=CC=C3)=O)N2CC1)O.OCC(CO)(N)CO	https://www.medchemexpress.com/Ketorolac-tromethamine-salt.html	Launched		91.0	K18	F20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0138	10.0	mM	140.0	DMSO	255.089543	20	F	pluskal_fda_drugs_5005_F20_id
553	HY-13723	HYCPK40903	J12	HYCPK40903	91z	888.0	2.0	S24	903.0	J12	137071-32-0	Pimecrolimus	SDZ-ASM 981	810.45	Phosphatase	Metabolic Enzyme/Protease	Pimecrolimus (SDZ-ASM 981) is a potent, nonsteroid and orally active calcineurin inhibitor with a Ki of 117 nM. Pimecrolimus shows anti-inflammatory activity[1][2].	Free Base	C43H68ClNO11	23420.0	DMSO : ≥ 32 mg/mL (39.48 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C([C@@](CCCC1)([H])N1C(C([C@@]2(O)[C@H](C)C[C@H](OC)[C@@](O2)([H])[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H]3CC)=O)=O)O[C@H](/C(C)=C/[C@H]4C[C@@H](OC)[C@@H](Cl)CC4)[C@H](C)[C@@H](O)CC3=O	https://www.medchemexpress.com/Pimecrolimus.html	Launched		91.0	S24	F20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13723	10.0	mM	140.0	DMSO	809.44809	20	F	pluskal_fda_drugs_5005_F20_id
582	HY-13782	HYCPK40904	F05	HYCPK40904	91z	537.0	3.0	L9	904.0	F05	202138-50-9	Tenofovir Disoproxil (fumarate)	Tenofovir DF; Bis(POC)-PMPA (fumarate); GS 4331 (fumarate)	635.51	HBV; HIV; Reverse Transcriptase	Anti-infection	Tenofovir Disoproxil fumarate is a nucleotide reverse transcriptase inhibitor used to treat HIV and chronic Hepatitis B.	Fumarate	C23H34N5O14P	8608.0	DMSO : ≥ 50 mg/mL (78.68 mM); H2O : 16.67 mg/mL (26.23 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	O=C(OC(C)C)OCOP(OCOC(OC(C)C)=O)(CO[C@H](C)CN1C=NC2=C(N)N=CN=C12)=O.O=C(O)/C=C/C(O)=O	https://www.medchemexpress.com/tenofovir-disoproxil-fumarate.html	Launched		91.0	L9	F20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13782	10.0	mM	140.0	DMSO	519.173029	20	F	pluskal_fda_drugs_5005_F20_id
998	HY-B1182	HYCPK40904	O19	HYCPK40904	91z	1429.0	3.0	AD37	904.0	O19	4940-39-0	Chromocarb	Chromone-2-carboxylic acid	190.15	Others	Others	Chromocarb is a synthetic vasoprotectant.	Free Acid	C10H6O4	17586.0	DMSO : 100 mg/mL (525.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CC(C2=CC=CC=C2O1)=O)O	https://www.medchemexpress.com/Chromocarb.html	Launched		91.0	AD37	F20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1182	10.0	mM	140.0	DMSO	190.026609	20	F	pluskal_fda_drugs_5005_F20_id
1105	HY-B0474	HYCPK40905	J06	HYCPK40905	91z	924.0	4.0	T12	905.0	J06	64-75-5	Tetracycline (hydrochloride)		480.90	Antibiotic; Bacterial	Anti-infection	Tetracycline (hydrochloride) is a broad-spectrum antibiotic, exhibiting activity against a wide range of gram-positive and gram-negative bacteria.	Hydrochloride	C22H25ClN2O8	14508.0	DMSO : 62.5 mg/mL (129.96 mM; Need ultrasonic); H2O : 50 mg/mL (103.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O[C@@]1(C(C(C(N)=O)=C2O)=O)[C@@]([C@@H]2N(C)C)([H])C[C@@]([C@](O)(C3=CC=C4)C)([H])C(C(C3=C4O)=O)=C1O.Cl	https://www.medchemexpress.com/Tetracycline-hydrochloride.html	Launched		91.0	T12	F20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0474	10.0	mM	140.0	DMSO	444.153266	20	F	pluskal_fda_drugs_5005_F20_id
236	HY-B1050	HYCPK40902	J14	HYCPK40902	91z	891.0	1.0	S27	902.0	J14	210353-53-0	Gemifloxacin (mesylate)	SB-265805S; LB-20304a	485.49	Bacterial	Anti-infection	Gemifloxacin mesylate is an oral broad-spectrum quinolone antibacterial agent, used in the treatment of acute bacterial exacerbation of chronic bronchitis, and mild-to-moderate pneumonia.	Mesylate	C19H24FN5O7S	29054.0	H2O : 50 mg/mL (102.99 mM; Need ultrasonic); DMSO : 100 mg/mL (205.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CC(CN)/C(C4)=N/OC)=N3)C1=O)O.CS(=O)(O)=O	https://www.medchemexpress.com/Gemifloxacin-mesylate.html	Launched		91.0	S27	F21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1050	10.0	mM	141.0	DMSO	389.149932	21	F	pluskal_fda_drugs_5005_F21_id
406	HY-B2070	HYCPK40902	F21	HYCPK40902	91z	521.0	1.0	K41	902.0	F21	3166-62-9	Methylbenactyzium Bromide		422.36	mAChR	GPCR/G Protein; Neuronal Signaling	Methylbenactyzium Bromide is a muscarinic acetylcholine receptor (mAChR) inhibitor.	Bromide	C21H28BrNO3	26713.0	DMSO : 6 mg/mL (14.21 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCC[N+](CC)(CC)C)C(C1=CC=CC=C1)(O)C2=CC=CC=C2.[Br-]	https://www.medchemexpress.com/Methylbenactyzium_Bromide.html	Launched		91.0	K41	F21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2070	10.0	mM	141.0	DMSO	342.20637	21	F	pluskal_fda_drugs_5005_F21_id
631	HY-13780	HYCPK40903	M15	HYCPK40903	91z	1182.0	2.0	Y30	903.0	M15	143-67-9	Vinblastine (sulfate)	Vincaleukoblastine sulfate salt	909.0526	Autophagy; Microtubule/Tubulin	Autophagy; Cell Cycle/DNA Damage; Cytoskeleton	Vinblastine sulfate is a cytotoxic alkaloid used against various cancer types. Vinblastine sulfate inhibits the formation of microtubule and suppresses nAChR with an IC50 of 8.9 μM.	Sulfate	C46H60N4O13S	13003.0	DMSO : ≥ 44 mg/mL (48.40 mM); H2O : 50 mg/mL (55.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	[H][C@@]12C[C@@](C3=C(OC)C=C(N([C@]4([H])[C@@]56[C@]7([H])[C@](C=CCN7CC6)(CC)[C@@H](OC(C)=O)[C@@]4(C(OC)=O)O)C)C5=C3)(C(OC)=O)C(NC8=C9C=CC=C8)=C9CC[N@](C2)C[C@](O)(CC)C1.OS(=O)(O)=O	https://www.medchemexpress.com/Vinblastine-sulfate.html	Launched		91.0	Y30	F21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13780	10.0	mM	141.0	DMSO	810.420379	21	F	pluskal_fda_drugs_5005_F21_id
700	HY-N0565B	HYCPK40903	L20	HYCPK40903	91z	1096.0	2.0	W40	903.0	L20	24390-14-5	Doxycycline (hyclate)	Doxycycline (hydrochloride hemiethanolate hemihydrate); WC2031	512.94	Antibiotic; Bacterial; MMP; Parasite	Anti-infection; Metabolic Enzyme/Protease	Doxycycline hyclate, an antibiotic, is an orally active and broad-spectrum metalloproteinase (MMP) inhibitor[1]. Doxycycline hyclate shows antibacterial activity and anti-cancer cell proliferation activity[1][2][3][4][5].	Hydrochloride	C22H24N2O8.1/2C2H6O.ClH.1/2H2O	32780.0	H2O : 125 mg/mL (243.69 mM; Need ultrasonic); DMSO : 240 mg/mL (467.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])[C@@H](O)[C@]3([H])[C@@H](C)C4=C(C(C3=C(O)[C@@]21O)=O)C(O)=CC=C4)N.Cl.[0.5H2O].[0.5C2H6O]	https://www.medchemexpress.com/Doxycycline-hyclate.html	Launched		91.0	W40	F21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0565B	10.0	mM	141.0	DMSO	444.153266	21	F	pluskal_fda_drugs_5005_F21_id
762	HY-10237	HYCPK40904	J04	HYCPK40904	91z	919.0	3.0	T7	904.0	J04	394730-60-0	Boceprevir	EBP 520; SCH 503034	519.68	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay[1][2][3][4][5]. Boceprevir inhibits SARS-CoV-2 3CLpro activity[6].	Free Base	C27H45N5O5	61643.0	DMSO : 16.67 mg/mL (32.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N1[C@@H]([C@@]2([H])C(C)([C@]2(C1)[H])C)C(NC(C(C(N)=O)=O)CC3CCC3)=O)[C@@H](NC(NC(C)(C)C)=O)C(C)(C)C	https://www.medchemexpress.com/Boceprevir.html	Launched		91.0	T7	F21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10237	10.0	mM	141.0	DMSO	519.34207	21	F	pluskal_fda_drugs_5005_F21_id
764	HY-13637A	HYCPK40904	L04	HYCPK40904	91z	1111.0	3.0	X7	904.0	L04	107910-75-8	Ganciclovir (sodium)	BW 759 (sodium); 2'-Nor-2'-deoxyguanosine (sodium)	277.21	Antibiotic; CMV; HSV; Nucleoside Antimetabolite/Analog	Anti-infection; Cell Cycle/DNA Damage	Ganciclovir (BW 759) sodium, a nucleoside analogue, is an orally active antiviral agent with activity against CMV. Ganciclovir sodium also has activity in vitro against members of the herpes group and some other DNA viruses. Ganciclovir sodium inhibits the in vitro replication of human herpes viruses (HSV 1 and 2, CMV) and adenovirus serotypes 1, 2, 4, 6, 8, 10, 19, 22 and 28. Ganciclovir sodium has an IC50 of 5.2 μM for feline herpesvirus type-1 (FHV-1) and can diffuse into the brain[1][2][3].	Sodium	C9H12N5NaO4	78957.0	H2O : 50 mg/mL (180.37 mM; Need ultrasonic); DMSO : 5 mg/mL (18.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	OCC(OCN1C=NC2=C1N=C(N)N=C2O[Na])CO	https://www.medchemexpress.com/ganciclovir-sodium.html	Launched		91.0	X7	F21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13637A	10.0	mM	141.0	DMSO	255.096754	21	F	pluskal_fda_drugs_5005_F21_id
814	HY-15128	HYCPK40904	C08	HYCPK40904	91z	255.0	3.0	F15	904.0	C08	5300-03-8	9-cis-Retinoic acid	ALRT1057	300.44	Apoptosis; Endogenous Metabolite; RAR/RXR	Apoptosis; Metabolic Enzyme/Protease	9-cis-Retinoic acid (ALRT1057), a vitamin A derivative, is a potent RAR/RXR agonist. 9-cis-Retinoic acid induces apoptosis, regulates cell cycle and has  anticancer, anti-inflammatory and neuroprotection activities[1][2][3][4][5].		C20H28O2	232064.0	DMSO : 25 mg/mL (83.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	CC(/C=C/C(C(C)(CCC1)C)=C1C)=C/C=C/C(C)=C/C(O)=O	https://www.medchemexpress.com/9-cis-retinoic-acid.html	Launched		91.0	F15	F21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15128	10.0	mM	141.0	DMSO	300.20893	21	F	pluskal_fda_drugs_5005_F21_id
955	HY-B1159	HYCPK40904	D17	HYCPK40904	91z	369.0	3.0	H33	904.0	D17	4008-48-4	Nitroxoline	8-Hydroxy-5-nitroquinoline; 5-Nitro-8-quinolinol	190.16	Antibiotic; Autophagy; Bacterial	Anti-infection; Autophagy	Nitroxoline is an antibiotic that has proven to be very effective at combating biofilm infections. Nitroxoline functions by chelating Fe2+ and Zn2+ ions from the biofilm matrix.	Free Base	C9H6N2O3	17677.0	DMSO : 125 mg/mL (657.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	OC1=C2N=CC=CC2=C([N+]([O-])=O)C=C1	https://www.medchemexpress.com/Nitroxoline.html	Launched		91.0	H33	F21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1159	10.0	mM	141.0	DMSO	190.037842	21	F	pluskal_fda_drugs_5005_F21_id
480	HY-B1484	HYCPK40903	E07	HYCPK40903	91z	398.0	2.0	I14	903.0	E07	64953-12-4	Moxalactam (sodium salt)	Latamoxef (sodium); Lamoxactam (sodium); LY-127935 (sodium)	564.44	Antibiotic; Bacterial	Anti-infection	Moxalactam (Latamoxef) sodium salt is a synthetic oxa-β-lactam antibiotic. Moxalactam sodium salt has a broad spectrum of activity against Gram-positive and Gram-negative aerobic and anaerobic bacteria. Moxalactam sodium salt inhibits production of β-lactamases[1].	Sodium	C20H18N6Na2O9S	101656.0	DMSO : 62.5 mg/mL (110.73 mM; Need ultrasonic); H2O : 100 mg/mL (177.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3C)CO[C@]2([H])[C@](OC)(NC([C@H](C(O[Na])=O)C4=CC=C(O)C=C4)=O)C1=O)O[Na]	https://www.medchemexpress.com/Moxalactam-sodium-salt.html	Launched		91.0	I14	F22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1484	10.0	mM	142.0	DMSO	520.101247	22	F	pluskal_fda_drugs_5005_F22_id
568	HY-B0711	HYCPK40903	I13	HYCPK40903	91z	794.0	2.0	Q26	903.0	I13	1188-38-1	Carglumic Acid	N-Carbamyl-L-glutamic acid	190.15	Others	Others	Carglumic acid (N-Carbamyl-L-glutamic acid), a functional analogue of N-acetylglutamate (NAG) and a carbamoyl phosphate synthetase 1 (CPS1) activator, is used to treat acute and chronic hyperammonemia associated with NAG synthase (NAGS) deficiency.	Free Acid	C6H10N2O5	27668.0	H2O : 8.33 mg/mL (43.81 mM; Need ultrasonic); DMSO : 100 mg/mL (525.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CC[C@@H](C(O)=O)NC(N)=O	https://www.medchemexpress.com/Carglumic_Acid.html	Launched		91.0	Q26	F22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0711	10.0	mM	142.0	DMSO	190.058971	22	F	pluskal_fda_drugs_5005_F22_id
759	HY-B0192	HYCPK40904	G04	HYCPK40904	91z	631.0	3.0	N7	904.0	G04	81403-80-7	Alfuzosin	SL 77499	389.44878	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Alfuzosin (SL 77499-10) is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin can be used in study of benign prostatic hyperplasia (BPH)[1][2].	Free Base	C19H27N5O4	16596.0	DMSO : ≥ 50 mg/mL (128.39 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(C1OCCC1)NCCCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C	https://www.medchemexpress.com/Alfuzosin.html	Launched		91.0	N7	F22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0192	10.0	mM	142.0	DMSO	389.206304	22	F	pluskal_fda_drugs_5005_F22_id
823	HY-N0565	HYCPK40904	L08	HYCPK40904	91z	1119.0	3.0	X15	904.0	L08	564-25-0	Doxycycline		444.43	Antibiotic; Bacterial; MMP; Parasite	Anti-infection; Metabolic Enzyme/Protease	Doxycycline, an antibiotic, is an orally active and broad-spectrum metalloproteinase (MMP) inhibitor[1]. Doxycycline shows antibacterial activity and anti-cancer cell proliferation activity[1][2][3][4][5].		C22H24N2O8	126248.0	DMSO : 125 mg/mL (281.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])[C@@H](O)[C@]3([H])[C@@H](C)C4=C(C(C3=C(O)[C@@]21O)=O)C(O)=CC=C4)N	https://www.medchemexpress.com/doxycycline.html	Launched		91.0	X15	F22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0565	10.0	mM	142.0	DMSO	444.153266	22	F	pluskal_fda_drugs_5005_F22_id
851	HY-17375	HYCPK40904	H10	HYCPK40904	91z	739.0	3.0	P19	904.0	H10	432-60-0	Allylestrenol		300.48	Others	Others	Allylestrenol, a synthetic sexualsteroid, is used worldwide in case of endangered pregnancies.	Free Base	C21H32O	28486.0	DMSO : ≥ 50 mg/mL (166.40 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	C[C@@]12[C@](O)(CC=C)CC[C@@]1([H])[C@]3([H])CCC4=CCCC[C@]4([H])[C@@]3([H])CC2	https://www.medchemexpress.com/Allylestrenol.html	Launched		91.0	P19	F22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17375	10.0	mM	142.0	DMSO	300.245316	22	F	pluskal_fda_drugs_5005_F22_id
1158	HY-B0303A	HYCPK40905	O09	HYCPK40905	91z	1410.0	4.0	AD18	905.0	O09	147-24-0	Diphenhydramine (hydrochloride)		291.82	Bacterial; Endogenous Metabolite; Histamine Receptor	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Diphenhydramine hydrochloride is a first-generation histamine H1-receptor antagonist with anti-cholinergic effect. Diphenhydramine hydrochloride can across the ovine blood-brain barrier (BBB)[1][2].	Hydrochloride	C17H22ClNO	15205.0	DMSO : 100 mg/mL (342.68 mM; Need ultrasonic); H2O : 100 mg/mL (342.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl	https://www.medchemexpress.com/Diphenhydramine-hydrochloride.html	Launched		91.0	AD18	F22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0303A	10.0	mM	142.0	DMSO	255.162314	22	F	pluskal_fda_drugs_5005_F22_id
1287	HY-A0062	HYCPK40905	P17	HYCPK40905	91z	1522.0	4.0	AF34	905.0	P17	191114-48-4	Telithromycin	HMR3647; RU66647	812.00	Antibiotic; Bacterial	Anti-infection	Telithromycin (HMR3647) is a novel ketolide antibiotic that structurally resembles macrolides. Telithromycin belongs to the ketolide family that is characterized by a keto group at position 3 of the macrolide ring and is active against bacteria causing community-acquired pneumonia, acute exacerbation of chronic bronchitis, and acute sinusitis. Telithromycin also has similar immunomodulatory effects as macrolides. Telithromycin can be used for the research of respiratory infections including bronchial asthma[1][2].	Free Base	C43H65N5O10	84425.0	DMSO : 100 mg/mL (123.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O[C@H]1[C@]([H])(O[C@@H]([C@](C)(OC)C[C@@H](C)C2=O)[C@@H](C)C([C@@H](C)C(O[C@H](CC)[C@](OC(N3CCCCN4C=C(C5=CC=CN=C5)N=C4)=O)(C)[C@@]3([H])[C@H]2C)=O)=O)O[C@H](C)C[C@@H]1N(C)C	https://www.medchemexpress.com/telithromycin.html	Launched		91.0	AF34	F22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0062	10.0	mM	142.0	DMSO	811.473143	22	F	pluskal_fda_drugs_5005_F22_id
1291	HY-B1834	HYCPK40905	D18	HYCPK40905	91z	372.0	4.0	H36	905.0	D18	3562-63-8	Megestrol		342.47	Drug Metabolite	Metabolic Enzyme/Protease	Megestrol is a synthetic progestin and used for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with an acquired immunodeficiency syndrome diagnosis[1].	Free Base	C22H30O3	47123.0	DMSO : 70 mg/mL (204.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CC([C@@]1(O)CC[C@@]2([H])[C@]3([H])C=C(C)C4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O	https://www.medchemexpress.com/megestrol.html	Launched		91.0	H36	F22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1834	10.0	mM	142.0	DMSO	342.219495	22	F	pluskal_fda_drugs_5005_F22_id
161	HY-B1164	HYCPK40902	O09	HYCPK40902	91z	1361.0	1.0	AC17	902.0	O09	4093-35-0	Bromopride		344.25	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Bromopride is a dopamine antagonist with prokinetic properties, widely used as an antiemetic.	Free Base	C14H22BrN3O2	229939.0	DMSO : 170 mg/mL (493.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NCCN(CC)CC)C1=CC(Br)=C(N)C=C1OC	https://www.medchemexpress.com/Bromopride.html	Launched		91.0	AC17	G3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1164	10.0	mM	147.0	DMSO	343.089539	3	G	pluskal_fda_drugs_5005_G3_id
165	HY-B1908	HYCPK40902	C10	HYCPK40902	91z	211.0	1.0	E19	902.0	C10	35457-80-8	Midecamycin	SF-837; Antibiotic SF-837	813.97	Antibiotic; Bacterial	Anti-infection	Midecamycin, an acetoxy-substituted macrolide antibiotic, is tested against gram-positive and gram-negative bacteria.	Free Base	C41H67NO15	60920.0	DMSO : ≥ 36 mg/mL (44.23 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@H]1[C@](O[C@H](C)[C@@H](O[C@@](O[C@@H](C)[C@@H]2OC(CC)=O)([H])C[C@]2(O)C)[C@@H]1N(C)C)([H])O[C@@H]([C@H](C[C@H]([C@H](/C=C/C=C/C3)O)C)CC=O)[C@H]([C@](CC(O[C@@H]3C)=O)([H])OC(CC)=O)OC	https://www.medchemexpress.com/Midecamycin.html	Launched		91.0	E19	G3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1908	10.0	mM	147.0	DMSO	813.45107	3	G	pluskal_fda_drugs_5005_G3_id
494	HY-13693	HYCPK40903	C08	HYCPK40903	91z	208.0	2.0	E16	903.0	C08	83919-23-7	Mometasone furoate	Sch32088	521.43	Glucocorticoid Receptor	Immunology/Inflammation	Mometasone furoate (Sch32088) is a?glucocorticoid receptor?agonist with anti-inflammatory and anti-allergic activity. Mometasone furoate acts as a corticosteroid agent and used for topical applications in chronic skin eczema and airway inflammation management of asthma in vivo[1]	Free Base	C27H30Cl2O6	15476.0	DMSO : 50 mg/mL (95.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]12[C@](C(CCl)=O)(OC(C3=CC=CO3)=O)[C@H](C)C[C@@]1([H])[C@]4([H])CCC5=CC(C=C[C@]5(C)[C@@]4(Cl)[C@@H](O)C2)=O	https://www.medchemexpress.com/Mometasone-furoate.html	Launched		91.0	E16	G3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13693	10.0	mM	147.0	DMSO	520.141944	3	G	pluskal_fda_drugs_5005_G3_id
738	HY-B1215	HYCPK40904	B03	HYCPK40904	91z	149.0	3.0	D5	904.0	B03	523-87-5	Dimenhydrinate		469.96	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Dimenhydrinate is an anti-emetic and anti-histamine commonly available over-the-counter as a motion sickness remedy.	Free Base	C24H28ClN5O3	64007.0	DMSO : ≥ 37 mg/mL (78.73 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	O=C(N1C)N(C)C2=C(NC(Cl)=N2)C1=O.CN(C)CCOC(C3=CC=CC=C3)C4=CC=CC=C4	https://www.medchemexpress.com/Dimenhydrinate.html	Launched		91.0	D5	G3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1215	10.0	mM	147.0	DMSO	255.162314	3	G	pluskal_fda_drugs_5005_G3_id
815	HY-15746	HYCPK40904	D08	HYCPK40904	91z	351.0	3.0	H15	904.0	D08	49745-95-1	Dobutamine (hydrochloride)		337.84	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Dobutamine hydrochloride is a synthetic catecholamine that acts on α1-AR, β1-AR, β2-AR (α-1, β-1 andβ-2 adrenoceptors). Dobutamine hydrochloride is a selective β1-AR agonist, relatively weak activity at α1-AR and β2-AR. Dobutamine hydrochloride can increase cardiac output and correct hypoperfusion[1][2][3][4].	Hydrochloride	C18H24ClNO3	32591.0	DMSO : ≥ 33 mg/mL (97.68 mM); H2O : 20 mg/mL (59.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	OC1=CC=C(CCNC(C)CCC2=CC=C(O)C=C2)C=C1O.[H]Cl	https://www.medchemexpress.com/Dobutamine-hydrochloride.html	Launched		91.0	H15	G3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15746	10.0	mM	147.0	DMSO	301.167794	3	G	pluskal_fda_drugs_5005_G3_id
882	HY-B0766	HYCPK40904	G12	HYCPK40904	91z	647.0	3.0	N23	904.0	G12	118159-48-1	Bicyclol	SY801	390.34	Autophagy; HBV	Anti-infection; Autophagy	"Bicyclol(SY 801) is a anti-hepatitis drug.
Target: HBV
Oral administration of bicyclol normalized the elevated serum transaminases (ALT, AST) by approximately 50% in chronic viral hepatitis B and C, and also showed certain level of inhibiting HBV and HCV replication. No noticeable adverse reaction has been observed. In combination therapy of bicyclol with interferon alpha, lamivudine and adefovir dipivoxil in HBV or HCV, bicyclol may potentiate the anti-viral efficacy and reduce YMDD mutant and side effects. In 2004 China FDA issued license to manufacture bicyclol. Since then bicyclol has been widely used to treat chronic HBV and HCV in China [1]."	Free Base	C19H18O9	21457.0	DMSO : 100 mg/mL (256.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C1=CC(OC)=C(OCO2)C2=C1C3=C4OCOC4=C(OC)C=C3CO)OC	https://www.medchemexpress.com/Bicyclol.html	Launched		91.0	N23	G3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0766	10.0	mM	147.0	DMSO	390.095082	3	G	pluskal_fda_drugs_5005_G3_id
1295	HY-B0978	HYCPK40905	H18	HYCPK40905	91z	756.0	4.0	P36	905.0	H18	134-62-3	Diethyltoluamide	DEET; N,N-Diethyl-m-toluamide	191.27	Parasite	Anti-infection	Diethyltoluamide is the most common active ingredient in insect repellents. It is intended to provide protection against mosquitoes, ticks, fleas, chiggers, leeches, and many other biting insects.	Free Base	C12H17NO	17164.0	H2O : 2 mg/mL (10.46 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (522.82 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(N(CC)CC)C1=CC=CC(C)=C1	https://www.medchemexpress.com/DEET.html	Launched		91.0	P36	G3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0978	10.0	mM	147.0	DMSO	191.131014	3	G	pluskal_fda_drugs_5005_G3_id
1338	HY-10353A	HYCPK40905	C21	HYCPK40905	91z	282.0	4.0	F42	905.0	C21	871038-72-1	Raltegravir (potassium)	MK 0518 (potassium)	482.51	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	Raltegravir (MK 0518) potassium is a potent integrase (IN) inhibitor, used to treat HIV infection.	Potassium	C20H20FKN6O5	37711.0	DMSO : 20.83 mg/mL (43.17 mM; ultrasonic and warming and heat to 60°C); H2O : 25 mg/mL (51.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(N=C(C(NC(C1=NN=C(C)O1)=O)(C)C)N2C)=C(O[K])C2=O)NCC3=CC=C(F)C=C3	https://www.medchemexpress.com/Raltegravir-potassium-salt.html	Launched		91.0	F42	G3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10353A	10.0	mM	147.0	DMSO	444.155746	3	G	pluskal_fda_drugs_5005_G3_id
143	HY-N0184	HYCPK40902	I08	HYCPK40902	91z	783.0	1.0	Q15	902.0	I08	1405-86-3	Glycyrrhizic acid	Glycyrrhizin	822.93	Virus Protease	Anti-infection	Glycyrrhizic acid is a triterpenoid saponinl, acting as a direct HMGB1 antagonist, with anti-tumor, anti-diabetic activities.	Free Acid	C42H62O16	26252.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 500 mg/mL (607.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	C[C@]12[C@@](C(C=C3[C@]2(CC[C@]4(C)[C@@]3([H])C[C@](C(O)=O)(C)CC4)C)=O)([H])[C@@]5([C@@](C(C)([C@@H](O[C@]6([H])[C@@H]([C@H]([C@H](O)[C@@H](C(O)=O)O6)O)O[C@]7([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O)=O)CC5)C)([H])CC1)C	https://www.medchemexpress.com/Glycyrrhizic_acid.html	Launched		91.0	Q15	G4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0184	10.0	mM	148.0	DMSO	822.403786	4	G	pluskal_fda_drugs_5005_G4_id
200	HY-A0168	HYCPK40902	F12	HYCPK40902	91z	503.0	1.0	K23	902.0	F12	313348-27-5	Regadenoson	CVT-3146	390.35	Adenosine Receptor	GPCR/G Protein	Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow, can be used in study of myocardial perfusion imaging. Regadenoson also increases the permeability of the blood-brain barrier (BBB) in rodents, can be used to study increased delivery of drugs to the human CNS[1][2].	Free Base	C15H18N8O5	58642.0	DMSO : 50 mg/mL (128.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=C(N=C2)C(N)=NC(N4C=C(C=N4)C(NC)=O)=N3)O1	https://www.medchemexpress.com/Regadenoson.html	Launched		91.0	K23	G4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0168	10.0	mM	148.0	DMSO	390.140016	4	G	pluskal_fda_drugs_5005_G4_id
404	HY-14153A	HYCPK40902	D21	HYCPK40902	91z	329.0	1.0	G41	902.0	D21	189188-57-6	Tegaserod (maleate)	SDZ-HTF-919; HTF-919	417.46	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Tegaserod maleate is a selective 5-HT4 receptor partial agonist and a 5-HT2B receptor antagonist. Tegaserod maleate exhibits a promotile effect throughout the gastrointestinal (GI) tract[1][2][5].	Maleate	C20H27N5O5	16287.0	H2O : 1 mg/mL (2.40 mM; Need ultrasonic); DMSO : ≥ 35 mg/mL (83.84 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	O=C(O)/C=C\C(O)=O.COC1=CC=C(NC=C2/C=N/NC(NCCCCC)=N)C2=C1	https://www.medchemexpress.com/Tegaserod-maleate.html	Launched		91.0	G41	G4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14153A	10.0	mM	148.0	DMSO	301.19026	4	G	pluskal_fda_drugs_5005_G4_id
469	HY-10353	HYCPK40903	J06	HYCPK40903	91z	876.0	2.0	S12	903.0	J06	518048-05-0	Raltegravir	MK-0518	444.42	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection.	Free Base	C20H21FN6O5	32013.0	DMSO : ≥ 100 mg/mL (225.01 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(O)=C(C(NCC1=CC=C(C=C1)F)=O)N=C2C(C)(C)NC(C3=NN=C(C)O3)=O)N2C	https://www.medchemexpress.com/raltegravir.html	Launched		91.0	S12	G4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10353	10.0	mM	148.0	DMSO	444.155746	4	G	pluskal_fda_drugs_5005_G4_id
685	HY-B0298A	HYCPK40903	M19	HYCPK40903	91z	1190.0	2.0	Y38	903.0	M19	14976-57-9	Clemastine (fumarate)	HS-592 (fumarate); Meclastine (fumarate)	459.96	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Clemastine (HS-592) fumarate is a selective histamine H1 receptor antagonist. Clemastine fumarate is an antihistamine mainly used for relieving symptoms of allergic reactions primarily by competing with histamine to bind H1 receptors. Anti-inflammatory effects[1][2].	Fumarate	C25H30ClNO5	85486.0	DMSO : 14.29 mg/mL (31.07 mM; Need ultrasonic); H2O : 0.67 mg/mL (1.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CN1[C@@H](CCO[C@](C2=CC=CC=C2)(C3=CC=C(Cl)C=C3)C)CCC1.O=C(O)/C=C/C(O)=O	https://www.medchemexpress.com/Clemastine-fumarate.html	Launched		91.0	Y38	G4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0298A	10.0	mM	148.0	DMSO	343.170292	4	G	pluskal_fda_drugs_5005_G4_id
958	HY-15448	HYCPK40904	G17	HYCPK40904	91z	657.0	3.0	N33	904.0	G17	1152311-62-0	Tezacaftor	VX-661	520.50	Autophagy; CFTR	Autophagy; Membrane Transporter/Ion Channel	Tezacaftor (VX-661) is a second F508del CFTR corrector and help CFTR protein reach the cell surface.	Free Base	C26H27F3N2O6	9722.0	DMSO : ≥ 100 mg/mL (192.12 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1(C2=CC=C(OC(F)(F)O3)C3=C2)CC1)NC4=CC5=C(N(C[C@@H](O)CO)C(C(C)(C)CO)=C5)C=C4F	https://www.medchemexpress.com/VX-661.html	Launched		91.0	N33	G4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15448	10.0	mM	148.0	DMSO	520.182121	4	G	pluskal_fda_drugs_5005_G4_id
1112	HY-12642	HYCPK40905	A07	HYCPK40905	91z	62.0	4.0	B14	905.0	A07	1642-54-2	Diethylcarbamazine (citrate)		391.42	Parasite	Anti-infection	Diethylcarbamazine citrate is an inhibitor of arachidonic acid metabolism in filarial microfilaria; is highly specific for several parasites and does not contain any toxic metallic elements.	Citrate	C16H29N3O8	15039.0	DMSO : ≥ 39 mg/mL (99.64 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(N1CCN(C)CC1)N(CC)CC.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Diethylcarbamazine-citrate.html	Launched		91.0	B14	G4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12642	10.0	mM	148.0	DMSO	192.027003	4	G	pluskal_fda_drugs_5005_G4_id
1161	HY-17428	HYCPK40905	B10	HYCPK40905	91z	164.0	4.0	D20	905.0	B10	154-69-8	Tripelennamine (hydrochloride)		291.82	Endogenous Metabolite; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Tripelennamine hydrochloride, an ethylenediamine derivative, is a potent histamine H1-receptor antagonist. Tripelennamine hydrochloride lessens the allergic response of the organism caused by histamine. Tripelennamine hydrochloride can be used for the research of rhinitis, conjunctivitis, and allergic and anaphylactic reactions[1][2][3].	Hydrochloride	C16H22ClN3	18832.0	DMSO : 25 mg/mL (85.67 mM; Need ultrasonic); H2O : 100 mg/mL (342.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	CN(C)CCN(CC1=CC=CC=C1)C2=NC=CC=C2.[H]Cl	https://www.medchemexpress.com/Tripelennamine-hydrochloride.html	Launched		91.0	D20	G4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17428	10.0	mM	148.0	DMSO	255.173548	4	G	pluskal_fda_drugs_5005_G4_id
126	HY-B0679	HYCPK40902	D07	HYCPK40902	91z	301.0	1.0	G13	902.0	D07	136790-76-6	Lubiprostone	RU-0211; SPI-0211	390.46	Chloride Channel	Membrane Transporter/Ion Channel	"Lubiprostone(SPI-0211;RU0211) is a gastrointestinal agent used for the treatment of idiopathic chronic constipation.
Target: Others
Lubiprostone is a bicyclic fatty acid derived from prostaglandin E1 that acts by specifically activating ClC-2 chloride channels on the apical aspect of gastrointestinal epithelial cells, producing a chloride-rich fluid secretion. These secretions soften the stool, increase motility, and promote spontaneous bowel movements (SBM). From Wikipedia."	Free Acid	C20H32F2O5	12620.0	DMSO : 100 mg/mL (256.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(C(F)(F)CCCC)CC[C@@H]([C@@H](C1)O)[C@H](C1=O)CCCCCCC(O)=O	https://www.medchemexpress.com/lubiprostone.html	Launched		91.0	G13	G5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0679	10.0	mM	149.0	DMSO	390.221781	5	G	pluskal_fda_drugs_5005_G5_id
488	HY-B0272	HYCPK40903	M07	HYCPK40903	91z	1166.0	2.0	Y14	903.0	M07	13292-46-1	Rifampicin	Rifampin; Rifamycin AMP	822.94	Antibiotic; Bacterial; Influenza Virus; Orthopoxvirus	Anti-infection	Rifampicin is a potent and broad spectrum antibiotic against bacterial pathogens. Rifampicin has anti-influenza virus activities. Rifampicin shows anti-orthopoxvirus activity.	Free Base	C43H58N4O12	96905.0	DMSO : 25 mg/mL (30.38 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	OC(C(/C=N/N1CCN(C)CC1)=C(NC(/C(C)=C\C=C\[C@@H]([C@@H]([C@@H](C)[C@H]2O)O)C)=O)C(O)=C3C(O)=C4C)=C3C5=C4O[C@](C)(O/C=C/[C@@H]([C@H]([C@@]([C@@H]2C)([H])OC(C)=O)C)OC)C5=O	https://www.medchemexpress.com/rifampicin.html	Launched		91.0	Y14	G5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0272	10.0	mM	149.0	DMSO	822.405123	5	G	pluskal_fda_drugs_5005_G5_id
863	HY-B0552A	HYCPK40904	D11	HYCPK40904	91z	357.0	3.0	H21	904.0	D11	61-12-1	Dibucaine (hydrochloride)	Cinchocaine hydrochloride	379.92	Sodium Channel	Membrane Transporter/Ion Channel	Dibucaine hydrochloride (Cinchocaine hydrochloride) is a sodium channel inhibitor. Dibucaine hydrochloride is a potent SChE inhibitor[1][2].	Hydrochloride	C20H30ClN3O2	16109.0	H2O : 100 mg/mL (263.21 mM; Need ultrasonic); DMSO : 110 mg/mL (289.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC(OCCCC)=NC2=CC=CC=C12)NCCN(CC)CC.Cl	https://www.medchemexpress.com/Dibucaine-hydrochloride.html	Launched		91.0	H21	G5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0552A	10.0	mM	149.0	DMSO	343.225977	5	G	pluskal_fda_drugs_5005_G5_id
1038	HY-13502A	HYCPK40904	G22	HYCPK40904	91z	667.0	3.0	N43	904.0	G22	70476-82-3	Mitoxantrone (dihydrochloride)	Mitozantrone (dihydrochloride); NSC 301739 (dihydrochloride)	517.40	Apoptosis; Endogenous Metabolite; Orthopoxvirus; PKC; Topoisomerase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease; TGF-beta/Smad	Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. Mitoxantrone dihydrochloride also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone dihydrochloride induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone dihydrochloride shows antitumor activity[1][2][3][4]. Mitoxantrone dihydrochloride also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively[5].	Hydrochloride	C22H30Cl2N4O6	15228.0	DMSO : ≥ 43 mg/mL (83.11 mM); H2O : 100 mg/mL (193.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C1C2=C(C(NCCNCCO)=CC=C2NCCNCCO)C(C3=C(O)C=CC(O)=C13)=O.[H]Cl.[H]Cl	https://www.medchemexpress.com/Mitoxantrone-dihydrochloride.html	Launched		91.0	N43	G5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13502A	10.0	mM	149.0	DMSO	444.200885	5	G	pluskal_fda_drugs_5005_G5_id
1069	HY-12639A	HYCPK40905	F04	HYCPK40905	91z	536.0	4.0	L8	905.0	F04	3818-50-6	Bephenium (hydroxynaphthoate)		443.53	Parasite	Anti-infection	Bephenium hydroxynaphthoate is an anthelmintic agent formerly used in the treatment of hookworm infections and ascariasis; B-type AChR activator.	Free Base	C28H29NO4	15047.0	DMSO : 60 mg/mL (135.28 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	C[N+](CCOC1=CC=CC=C1)(C)CC2=CC=CC=C2.O=C(C3=C(O)C=C4C=CC=CC4=C3)[O-]	https://www.medchemexpress.com/Bephenium-hydroxynaphthoate.html	Launched		91.0	L8	G5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12639A	10.0	mM	149.0	DMSO	256.169591	5	G	pluskal_fda_drugs_5005_G5_id
1122	HY-111406	HYCPK40905	K07	HYCPK40905	91z	1022.0	4.0	V14	905.0	K07	1187451-19-9	Omidenepag isopropyl	DE-117	520.60	Prostaglandin Receptor	GPCR/G Protein	Omidenepag isopropyl is a selective EP2 receptor agonist. Omidenepag isopropyl is converted to the active product Omidenepag during corneal penetration, and Omidenepag is a highly selective EP2 receptor agonist.?Omidenepag isopropyl shows only weak affinity for EP1, EP2, and FP receptors. Omidenepag isopropyl is under development for the treatment of glaucoma as an intraocular pressure (IOP)-lowering drug[1][2].		C26H28N6O4S	85478.0	DMSO : 50 mg/mL (96.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OC(C)C)CNC1=NC(CN(CC2=CC=C(N3N=CC=C3)C=C2)S(=O)(C4=CC=CN=C4)=O)=CC=C1	https://www.medchemexpress.com/omidenepag-isopropyl.html	Launched		91.0	V14	G5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-111406	10.0	mM	149.0	DMSO	520.189274	5	G	pluskal_fda_drugs_5005_G5_id
1131	HY-B1610	HYCPK40905	D08	HYCPK40905	91z	352.0	4.0	H16	905.0	D08	6132-04-3	Sodium citrate (dihydrate)	Trisodium citrate (dihydrate); Citric acid (trisodium salt dihydrate)	294.10	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Sodium citrate dehydrate is an anticoagulant and also used as a buffer and food preservatives.	Sodium	C6H9Na3O9	39619.0	H2O : 125 mg/mL (425.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cardiovascular Disease	O=C(CC(C(O[Na])=O)(O)CC(O[Na])=O)O[Na].O.O	https://www.medchemexpress.com/Sodium_citrate_dihydrate.html	Launched		91.0	H16	G5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1610	10.0	mM	149.0	DMSO	192.027003	5	G	pluskal_fda_drugs_5005_G5_id
1238	HY-B0174	HYCPK40905	O14	HYCPK40905	91z	1420.0	4.0	AD28	905.0	O14	6054-98-4	Olsalazine (Disodium)		346.20	Antibiotic; Leukotriene Receptor	Anti-infection; GPCR/G Protein	"Olsalazine Disodium is an anti-inflammatory drug used in the treatment of Inflammatory Bowel Disease and Ulcerative Colitis.
Target: Antibacterial
Olsalazine Disodium is a derivative of salicylic acid. Inactive by itself (it is a prodrug), it is converted by the bacteria in the colon to mesalamine. 
Olsalazine Disodium is potent inhibitors of human intestinal macrophages chemotaxis to LTB4 with IC50 of 0.39 mM. 
Olsalazine Disodium (0.4 mM) inhibits the superoxide radical production generated by phorbol myristate acetate (PMA)-activated neutrophils or by xanthine-xanthine oxidase reaction by reduction of 31% and 73%, respectively. 
Olsalazine Disodium inhibits tumor growth in a rodent model of colorectal cancer. In 1,2-dimethylhydrazine-treated rats, Olsalazine (25 mg/kg/day) decreases number and volume of tumors by 58.17% and 62.67%, respectively. 
Administration of Olsalazine (Disodium) induces a 1.7-fold times increase in the number of apoptotic cells, companied with a reduction of 42.4% in cell proliferation rate."	Sodium	C14H8N2Na2O6	15806.0	DMSO : 20 mg/mL (57.77 mM; Need ultrasonic); H2O : 50 mg/mL (144.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O[Na])C1=C(O)C=CC(/N=N/C2=CC(C(O[Na])=O)=C(O)C=C2)=C1	https://www.medchemexpress.com/Olsalazine-Disodium.html	Launched		91.0	AD28	G5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0174	10.0	mM	149.0	DMSO	302.053886	5	G	pluskal_fda_drugs_5005_G5_id
221	HY-B1920	HYCPK40902	K13	HYCPK40902	91z	985.0	1.0	U25	902.0	K13	16846-24-5	Josamycin	EN-141	827.99	Antibiotic; Bacterial	Anti-infection	Josamycin (EN-141) is a macrolide antibiotic exhibiting antimicrobial activity against a wide spectrum of pathogens, such as bacteria. The dissociation constant Kd from ribosome for Josamycin is 5.5 nM.	Free Base	C42H69NO15	115254.0	H2O : 8.33 mg/mL (10.06 mM; ultrasonic and adjust pH to 6 with HCl); DMSO : ≥ 41.67 mg/mL (50.33 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@H]1[C@](O[C@H](C)[C@@H](O[C@@](O[C@@H](C)[C@@H]2OC(CC(C)C)=O)([H])C[C@]2(O)C)[C@@H]1N(C)C)([H])O[C@@H]([C@H](C[C@H]([C@H](/C=C/C=C/C3)O)C)CC=O)[C@H]([C@](CC(O[C@@H]3C)=O)([H])OC(C)=O)OC	https://www.medchemexpress.com/Josamycin.html	Launched		91.0	U25	G6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1920	10.0	mM	150.0	DMSO	827.466721	6	G	pluskal_fda_drugs_5005_G6_id
246	HY-17555	HYCPK40902	D15	HYCPK40902	91z	317.0	1.0	G29	902.0	D15	3685-84-5	Meclofenoxate (hydrochloride)		294.17	iGluR; nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	"Meclofenoxate hydrochloride, an ester of dimethylethanolamine (DMAE) and 4-chlorophenoxyacetic acid (pCPA), has been shown to improve memory, have a mentally stimulating effect, and improve general cognition.
IC50 value: 
Target: nootropic
Meclofenoxate, administered in a dose of 50 mg/kg twice daily for 7 days using the maze-training method, increased the number of responses to the conditioned stimulus, when retention tests were made 24 hours and 7 days after training, whereas citicholine, applied in the same way in a dose of 10 mg/kg, shortened the latency of the responses with reinforcement during the training and increased the number of correct responses to the conditioned stimulus in retention tests 7 days after the training [1]. Meclofenoxate appears to increase the consolidation of new information into long-term memory, but does not affect other aspects of remembering [2]."	Hydrochloride	C12H17Cl2NO3	11015.0	H2O : 33.33 mg/mL (113.30 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (169.97 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	ClC1=CC=C(OCC(OCCN(C)C)=O)C=C1.Cl	https://www.medchemexpress.com/meclofenoxate-hydrochloride.html	Launched		91.0	G29	G6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17555	10.0	mM	150.0	DMSO	257.081871	6	G	pluskal_fda_drugs_5005_G6_id
336	HY-B0648	HYCPK40902	A22	HYCPK40902	91z	43.0	1.0	A43	902.0	A22	520-85-4	Medroxyprogesterone	17α-Hydroxy-6α-methylprogesterone; U8840	344.49	Progesterone Receptor	Others	"Medroxyprogesterone is a progestin, a synthetic variant of the human hormone progesterone and a potent progesterone receptor agonist.
Target: Progesterone Receptor
Medroxyprogesterone (MP), is a steroidal progestin drug which was never marketed for use in humans. An acylated derivative, medroxyprogesterone acetate (MPA), is clinically used as a pharmaceutical medicine. Compared to MPA, MP is over two orders of magnitude less potent as a progestogen. As such, MP itself is not used clinically, though it has seen limited use in veterinary medicine under the trade name Controlestril in France. In addition, it is an metabolite of MPA [1]."	Free Base	C22H32O3	23175.0	DMSO : 50 mg/mL (145.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@@]1([C@@]2(O)C(C)=O)[C@](CC2)([H])[C@@](C[C@H](C)C3=CC4=O)([H])[C@]([C@]3(CC4)C)([H])CC1	https://www.medchemexpress.com/Medroxyprogesterone.html	Launched		91.0	A43	G6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0648	10.0	mM	150.0	DMSO	344.235145	6	G	pluskal_fda_drugs_5005_G6_id
354	HY-B0186B	HYCPK40903	K03	HYCPK40903	91z	966.0	2.0	U6	903.0	K03	122841-12-7	Cefoselis (sulfate)	FK-037	620.64	Antibiotic; Bacterial	Anti-infection	Cefoselis sulfate (FK-037), the fourth gen-eration of cephalosporin, is a β-lactam antibiotic. Cefoselis sulfate exhibits good activity against a wide range of Gram-positive and Gram-negative organisms. Cefoselis sulfate penetrates the blood-brain barrier[1][2][3].	Sulfate	C19H24N8O10S3	13419.0	DMSO : 100 mg/mL (161.12 mM; Need ultrasonic); H2O : 14.29 mg/mL (23.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CN3N(CCO)C(C=C3)=N)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)O.O=S(O)(O)=O	https://www.medchemexpress.com/Cefoselis-sulfate.html	Launched		91.0	U6	G6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0186B	10.0	mM	150.0	DMSO	522.110372	6	G	pluskal_fda_drugs_5005_G6_id
548	HY-109013	HYCPK40903	E12	HYCPK40903	91z	408.0	2.0	I24	903.0	E12	1628106-94-4	Sofpironium (bromide)	BBI 4000	470.40	mAChR	GPCR/G Protein; Neuronal Signaling	Sofpironium bromide (BBI 4000) is an anticholinergic agent used in the study of primary axillary hyperhidrosis (PAH). Sofpironium bromide reduces sweating by inhibiting M3 muscarinic receptors in eccrine glands at the application site. Sofpironium bromide also has a high afnity for the M1, M2, M4 and M5 subtypes[1].	Bromide	C22H32BrNO5	111886.0	DMSO : 100 mg/mL (212.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCOC(C[N+](C)(CC1)C[C@@H]1OC([C@@](C2CCCC2)(C3=CC=CC=C3)O)=O)=O.[Br-]	https://www.medchemexpress.com/sofpironium-bromide.html	Launched		91.0	I24	G6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109013	10.0	mM	150.0	DMSO	390.2275	6	G	pluskal_fda_drugs_5005_G6_id
710	HY-B0254	HYCPK40903	F21	HYCPK40903	91z	522.0	2.0	K42	903.0	F21	29094-61-9	Glipizide	CP 28720; K 4024	445.54	Potassium Channel	Membrane Transporter/Ion Channel	Glipizide (CP 2872; K 4024)?a potent, orally active and sulfonylurea class anti-diabetic agent and can be used for type 2?diabetes mellitus research but not type 1. Glipizide acts by partially blocking ATP-sensitive potassium?(KATP) channels among β cells of pancreatic islets of Langerhans[1][2].	Free Base	C21H27N5O4S	16733.0	DMSO : 50 mg/mL (112.22 mM; Need ultrasonic); H2O : 0.67 mg/mL (1.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(C1=NC=C(C)N=C1)NCCC2=CC=C(S(=O)(NC(NC3CCCCC3)=O)=O)C=C2	https://www.medchemexpress.com/glipizide.html	Launched		91.0	K42	G6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0254	10.0	mM	150.0	DMSO	445.178375	6	G	pluskal_fda_drugs_5005_G6_id
895	HY-N1428	HYCPK40904	D13	HYCPK40904	91z	361.0	3.0	H25	904.0	D13	77-92-9	Citric acid		192.12	Antibiotic; Apoptosis; Endogenous Metabolite	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Citric acid is a natural preservative and food tartness enhancer. Citric acid induces apoptosis and cell cycle arrest at G2/M phase and S phase in HaCaT cells. Citric acid cause oxidative damage of the liver by means of the decrease of antioxidative enzyme activities. Citric acid causes renal toxicity in mice[1][2][3].	Free Acid	C6H8O7	115493.0	H2O : 100 mg/mL (520.51 mM; Need ultrasonic); DMSO : 100 mg/mL (520.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease	OC(CC(CC(O)=O)(C(O)=O)O)=O	https://www.medchemexpress.com/Citric_acid.html	Launched		91.0	H25	G6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1428	10.0	mM	150.0	DMSO	192.027003	6	G	pluskal_fda_drugs_5005_G6_id
1362	HY-106541	HYCPK40905	O22	HYCPK40905	91z	1436.0	4.0	AD44	905.0	O22	130726-68-0	Neticonazole		302.43	Fungal	Anti-infection	Neticonazole is an imidazole derivative and a potent and long-acting antifungal agent. Neticonazole has anti-infection and anti-cancer effects[1][2][3].		C17H22N2OS	62984.0	DMSO : 250 mg/mL (826.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	CCCCCOC1=CC=CC=C1/C(N2C=CN=C2)=C\SC	https://www.medchemexpress.com/neticonazole.html	Launched		91.0	AD44	G6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-106541	10.0	mM	150.0	DMSO	302.145284	6	G	pluskal_fda_drugs_5005_G6_id
432	HY-B2201	HYCPK40903	E04	HYCPK40903	91z	392.0	2.0	I8	903.0	E04	68-04-2	Citric acid (trisodium)		258.07	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	Citric acid trisodium is a natural preservative and food tartness enhancer. Citric acid trisodium induces apoptosis and cell cycle arrest at G2/M phase and S phase. Citric acid trisodium cause oxidative damage of the liver by means of the decrease of antioxidative enzyme activities. Citric acid trisodium causes renal toxicity in mice[1][2][3].	Sodium	C6H5Na3O7	26378.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Metabolic Disease	[Na].O=C(O)CC(O)(C(=O)O)CC(=O)O	https://www.medchemexpress.com/citric-acid-trisodium.html	Launched		91.0	I8	G7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2201	10.0	mM	151.0	DMSO	192.027003	7	G	pluskal_fda_drugs_5005_G7_id
511	HY-12357	HYCPK40903	P09	HYCPK40903	91z	1458.0	2.0	AE18	903.0	P09	738606-46-7	Bempedoic acid	ETC-1002; ESP-55016	344.49	AMPK; ATP Citrate Lyase	Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR	Bempedoic acid (ETC-1002) is an ATP-citrate lyase (ACL) inhibitor[1]. Bempedoic acid (ETC-1002) activates AMPK[2].	Free Acid	C19H36O5	25403.0	DMSO : 100 mg/mL (290.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O	https://www.medchemexpress.com/ETC-1002.html	Launched		91.0	AE18	G7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12357	10.0	mM	151.0	DMSO	344.256274	7	G	pluskal_fda_drugs_5005_G7_id
519	HY-15164A	HYCPK40903	H10	HYCPK40903	91z	692.0	2.0	O20	903.0	H10	610798-31-7	Icotinib	BPI-2009	391.42	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Icotinib (BPI-2009) is a potent and specific EGFR inhibitor with an IC50 of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790M and EGFRL861Q.	Free Base	C22H21N3O4	153452.0	DMSO : ≥ 155 mg/mL (395.99 mM)	DMSO Solution	10mM  * 100uL	Cancer	C#CC1=CC(NC2=C(C=C(OCCOCCOCCO3)C3=C4)C4=NC=N2)=CC=C1	https://www.medchemexpress.com/icotinib.html	Launched		91.0	O20	G7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15164A	10.0	mM	151.0	DMSO	391.153206	7	G	pluskal_fda_drugs_5005_G7_id
537	HY-B1489	HYCPK40903	J11	HYCPK40903	91z	886.0	2.0	S22	903.0	J11	64490-92-2	Tolmetin (sodium dihydrate)		315.30	COX	Immunology/Inflammation	Tolmetin sodium dihydrate is an orally active and potent COX inhibitor with IC50s of 0.35 μM and 0.82 μM human COX-1 and COX-2, respectively. Tolmetin sodium dihydrate is a non-steroidal anti-inflammatory drug (NSAID)[1][2].	Sodium	C15H18NNaO5	18546.0	H2O : ≥ 100 mg/mL (317.16 mM); DMSO : 12.5 mg/mL (39.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(O[Na])CC1=CC=C(C(C2=CC=C(C)C=C2)=O)N1C.O.O	https://www.medchemexpress.com/Tolmetin-sodium-dihydrate.html	Launched		91.0	S22	G7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1489	10.0	mM	151.0	DMSO	257.105193	7	G	pluskal_fda_drugs_5005_G7_id
665	HY-B0898	HYCPK40903	O17	HYCPK40903	91z	1378.0	2.0	AC34	903.0	O17	104010-37-9	Ceftiofur (sodium)	sodium ceftiofur	545.54	Antibiotic; Bacterial	Anti-infection	Ceftiofur sodium is an antibiotic of the cephalosporin type (third generation), licensed for use in veterinary medicine.	Sodium	C19H16N5NaO7S3	17768.0	DMSO : ≥ 40 mg/mL (73.32 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(O[Na])C(N12)=C(CSC(C3=CC=CO3)=O)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O	https://www.medchemexpress.com/Ceftiofur-sodium.html	Launched		91.0	AC34	G7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0898	10.0	mM	151.0	DMSO	523.029011	7	G	pluskal_fda_drugs_5005_G7_id
845	HY-B0686	HYCPK40904	B10	HYCPK40904	91z	163.0	3.0	D19	904.0	B10	188627-80-7	Eptifibatide		831.96	Integrin	Cytoskeleton	Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1].	Free Acid	C35H49N11O9S2	80269.0	DMSO : 250 mg/mL (300.50 mM; Need ultrasonic); H2O : 50 mg/mL (60.10 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(N(CCC1)[C@]1([H])C(N[C@@H](CSSCCC2=O)C(N)=O)=O)[C@](NC([C@@H](NC(CNC([C@@H](N2)CCCCNC(N)=N)=O)=O)CC(O)=O)=O)([H])CC3=CNC4=CC=CC=C34	https://www.medchemexpress.com/Eptifibatide.html	Launched		91.0	D19	G7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0686	10.0	mM	151.0	DMSO	831.315614	7	G	pluskal_fda_drugs_5005_G7_id
1139	HY-N0197	HYCPK40905	L08	HYCPK40905	91z	1120.0	4.0	X16	905.0	L08	21967-41-9	Baicalin	Baicalein 7-O-β-D-glucuronide	446.36	Autophagy; HIV; NF-κB	Anti-infection; Autophagy; NF-κB	Baicalin, as a flavonoid glycoside, is an allosteric carnitine palmityl transferase 1 (CPT1) activator. Baicalin reduces the expression of NF-κB[1][2][3].	Free Acid	C21H18O11	25640.0	DMSO : ≥ 100 mg/mL (224.03 mM); H2O : 0.1 mg/mL (0.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O[C@H]([C@H]([C@@H]([C@@H](C(O)=O)O1)O)O)[C@@H]1OC2=C(O)C(O)=C3C(C=C(C4=CC=CC=C4)OC3=C2)=O	https://www.medchemexpress.com/Baicalin.html	Launched		91.0	X16	G7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0197	10.0	mM	151.0	DMSO	446.084911	7	G	pluskal_fda_drugs_5005_G7_id
1332	HY-128365	HYCPK40905	M20	HYCPK40905	91z	1240.0	4.0	Z40	905.0	M20	130773-02-3	Neticonazole (hydrochloride)		338.90	Fungal	Anti-infection	Neticonazole hydrochloride is an imidazole derivative and a potent and long-acting antifungal agent. Neticonazole hydrochloride has anti-infection and anti-cancer effects[1][2][3].	Hydrochloride	C17H23ClN2OS	62843.0	DMSO : 250 mg/mL (737.68 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (295.07 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	CCCCCOC1=CC=CC=C1/C(N2C=CN=C2)=C\SC.[H]Cl	https://www.medchemexpress.com/neticonazole-hydrochloride.html	Launched		91.0	Z40	G7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-128365	10.0	mM	151.0	DMSO	302.145284	7	G	pluskal_fda_drugs_5005_G7_id
120	HY-W011175	HYCPK40902	N06	HYCPK40902	91z	1259.0	1.0	AA11	902.0	N06	544-62-7	Batilol		344.58	Endogenous Metabolite	Metabolic Enzyme/Protease	3-(Octadecyloxy)propane-1,2-diol is an endogenous metabolite.		C21H44O3	45304.0	DMSO : 8.33 mg/mL (24.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	OCC(O)COCCCCCCCCCCCCCCCCCC	https://www.medchemexpress.com/3-octadecyloxy-propane-1-2-diol.html	Launched		91.0	AA11	G8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W011175	10.0	mM	152.0	DMSO	344.329045	8	G	pluskal_fda_drugs_5005_G8_id
338	HY-75054	HYCPK40902	K22	HYCPK40902	91z	1003.0	1.0	U43	902.0	K22	154229-18-2	Abiraterone acetate	CB7630	391.55	Cytochrome P450	Metabolic Enzyme/Protease	Abiraterone acetate (CB7630) is an oral, potent, selective, and irreversible inhibitor of CYP17A1 with antiandrogen activity. Abiraterone acetate is a prodrug form of Abiraterone (CB7598).	Free Base	C26H33NO2	8480.0	DMSO : 10 mg/mL (25.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O[C@@H]1CC2=CC[C@]3([H])[C@]([H])(CC[C@](C)(C(C4=CN=CC=C4)=CC5)[C@]35[H])[C@@]2(C)CC1)C	https://www.medchemexpress.com/Abiraterone-acetate.html	Launched		91.0	U43	G8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-75054	10.0	mM	152.0	DMSO	391.251129	8	G	pluskal_fda_drugs_5005_G8_id
344	HY-B1798A	HYCPK40903	A03	HYCPK40903	91z	6.0	2.0	A6	903.0	A03	71395-14-7	Tocainide (hydrochloride)		228.72	Sodium Channel	Membrane Transporter/Ion Channel	Tocainide hydrochloride is a sodium channel blocker, it blocks the sodium channels in the pain-producing foci in the nerve membranes. Tocainide hydrochloride is a primary amine analog of lidocaine, can be used for the treatment of tinnitus[1][2].	Hydrochloride	C11H17ClN2O	80109.0	H2O : 50 mg/mL (218.61 mM; Need ultrasonic); DMSO : 125 mg/mL (546.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(N)C(NC1=C(C)C=CC=C1C)=O.[H]Cl	https://www.medchemexpress.com/tocainide-hydrochloride.html	Launched		91.0	A6	G8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1798A	10.0	mM	152.0	DMSO	192.126263	8	G	pluskal_fda_drugs_5005_G8_id
382	HY-B1077	HYCPK40902	O04	HYCPK40902	91z	1351.0	1.0	AC7	902.0	O04	26864-56-2	Penfluridol	R-16341	523.97	Autophagy; Calcium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Penfluridol is a highly potent, first generation diphenylbutylpiperidine antipsychotic.	Free Base	C28H27ClF5NO	98285.0	DMSO : ≥ 100 mg/mL (190.85 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	OC1(C2=CC=C(Cl)C(C(F)(F)F)=C2)CCN(CCCC(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4)CC1	https://www.medchemexpress.com/Penfluridol.html	Launched		91.0	AC7	G8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1077	10.0	mM	152.0	DMSO	523.170133	8	G	pluskal_fda_drugs_5005_G8_id
461	HY-50895	HYCPK40903	B06	HYCPK40903	91z	108.0	2.0	C12	903.0	B06	184475-35-2	Gefitinib	ZD1839	446.90	Apoptosis; Autophagy; EGFR	Apoptosis; Autophagy; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy and cell apoptosis, which can be used for cancer related research, such as Lung cancer and breast cancer [1][2][5].	Free Base	C22H24ClFN4O3	65694.0	DMSO : 125 mg/mL (279.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	ClC1=C(C=CC(NC2=NC=NC3=C2C=C(C(OC)=C3)OCCCN4CCOCC4)=C1)F	https://www.medchemexpress.com/Gefitinib.html	Launched		91.0	C12	G8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50895	10.0	mM	152.0	DMSO	446.152097	8	G	pluskal_fda_drugs_5005_G8_id
534	HY-D0014	HYCPK40903	G11	HYCPK40903	91z	598.0	2.0	M22	903.0	G11	6104-58-1	Brilliant blue G-250		854.02	Others	Others	Brilliant Blue G-250 is a dye commonly used for the visualization of proteins separated by SDS-PAGE, offering a simple staining procedure and high quantitation. In the Bradford protein assay, protein concentrations are determined by the absorbance at 595 nm due to the binding of Brilliant Blue G-250 to proteins. Brilliant Blue G-250 is a safe highly selective P2×7R antagonist with promising consequent inactivation of NLRP3 inflammasome[1][2][3].	Sodium	C47H48N3NaO7S2	178623.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Others	O=S(C1=CC(CN(C2=CC(C)=C(/C(C3=CC=C(NC4=CC=C(OCC)C=C4)C=C3)=C5C(C)=C/C(C=C/5)=[N+](CC)/CC6=CC=CC(S(=O)([O-])=O)=C6)C=C2)CC)=CC=C1)(O[Na])=O	https://www.medchemexpress.com/brilliant-blue-g-250.html	Launched		91.0	M22	G8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0014	10.0	mM	152.0	DMSO	832.308469	8	G	pluskal_fda_drugs_5005_G8_id
1168	HY-108411	HYCPK40905	I10	HYCPK40905	91z	836.0	4.0	R20	905.0	I10	87233-61-2	Emedastine		302.41	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Emedastine is an orally active, selective and high affinity histamine H1 receptor antagonist with a Ki value of 1.3 nM. Emedastine is a benzimidazole derivative with potent antiallergic properties and used for allergic rhinitis, allergic skin diseases and allergic conjunctivitis[1][2][3].	Free Base	C17H26N4O	63123.0	DMSO : 125 mg/mL (413.35 mM; Need ultrasonic); Ethanol : 100 mg/mL (330.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CN1CCN(C2=NC3=CC=CC=C3N2CCOCC)CCC1	https://www.medchemexpress.com/emedastine.html	Launched		91.0	R20	G8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108411	10.0	mM	152.0	DMSO	302.210661	8	G	pluskal_fda_drugs_5005_G8_id
1261	HY-B0182	HYCPK40905	F16	HYCPK40905	91z	560.0	4.0	L32	905.0	F16	61422-45-5	Carmofur	HCFU	257.26	Nucleoside Antimetabolite/Analog; SARS-CoV; Virus Protease	Anti-infection; Cell Cycle/DNA Damage	Carmofur (HCFU), a derivative of 5-Fluorouracil, is an antineoplastic agent. Carmofur is an inhibitor of acid ceramidase with an IC50 of 79 nM for the rat enzyme. Carmofur inhibits the SARS-CoV-2 main protease (Mpro). Carmofur Inhibits SARS-CoV-2 in Vero E6 cell with an EC50 of ?24.3 ?μM[1][2].	Free Base	C11H16FN3O3	83696.0	DMSO : ≥ 100 mg/mL (388.71 mM); H2O : 0.67 mg/mL (2.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N(C(N1)=O)C=C(F)C1=O)NCCCCCC	https://www.medchemexpress.com/carmofur.html	Launched		91.0	L32	G8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0182	10.0	mM	152.0	DMSO	257.11757	8	G	pluskal_fda_drugs_5005_G8_id
194	HY-B1384	HYCPK40902	P11	HYCPK40902	91z	1461.0	1.0	AE21	902.0	P11	79-81-2	Retinyl palmitate	Vitamin A palmitate; Retinol palmitate	524.86	Endogenous Metabolite	Metabolic Enzyme/Protease	Retinyl palmitate is an ester of Retinol and is the major form of vitamin A found in the epidermis. Retinyl palmitate has been widely used in pharmaceutical and cosmetic formulations.	Free Base	C36H60O2	154769.0	Ethanol : 10 mg/mL (19.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CC(/C=C/C=C(/C=C/C1=C(CCCC(C)1C)C)C)=C\COC(CCCCCCCCCCCCCCC)=O	https://www.medchemexpress.com/Retinyl_palmitate.html	Launched		91.0	AE21	G9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1384	10.0	mM	153.0	DMSO	524.459331	9	G	pluskal_fda_drugs_5005_G9_id
426	HY-109085	HYCPK40903	K09	HYCPK40903	91z	978.0	2.0	U18	903.0	K09	937782-05-3	Difamilast	OPA-15406	446.44	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Difamilast (OPA-15406) is a topical, selective and nonsteroidal phosphodiesterase-4 (PDE4) inhibitor with particularly efficient inhibition of subtype B (IC50=11.2 nM). Difamilast can be used for the research of mild to moderate atopic dermatitis (AD)[1][2][3].		C23H24F2N2O5	90407.0	DMSO : 100 mg/mL (223.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(C)OC(C=C(C1=NC(CNC(C(C=CC=C2)=C2OCC)=O)=CO1)C=C3)=C3OC(F)F	https://www.medchemexpress.com/difamilast.html	Launched		91.0	U18	G9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109085	10.0	mM	153.0	DMSO	446.165328	9	G	pluskal_fda_drugs_5005_G9_id
578	HY-76938	HYCPK40903	J19	HYCPK40903	91z	902.0	2.0	S38	903.0	J19	18699-02-0	Actarit	4-Acetylaminophenylacetic acid; MS-932	193.20	Others	Others	Actarit, an orally active antirheumatic compound, has the potential to treat type II collagen-induced arthritis[1].	Free Acid	C10H11NO3	152572.0	DMSO : 100 mg/mL (517.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C)NC(C=C1)=CC=C1CC(O)=O	https://www.medchemexpress.com/actarit.html	Launched		91.0	S38	G9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-76938	10.0	mM	153.0	DMSO	193.073893	9	G	pluskal_fda_drugs_5005_G9_id
660	HY-17391	HYCPK40903	J17	HYCPK40903	91z	898.0	2.0	S34	903.0	J17	606-04-2	Pamabrom		348.20	Others	Others	Pamabron is a common over-the-counter diuretic used for relief of menstrual-associated symptoms. The active diuretic ingredient in pamabrom is 8-bromotheophylline. Pamabrom is available in combination with acetaminophen (paracetamol) for various conditions such as back pain and menstrual relief. The acetaminophen helps reduce menstrual pains and the pamabrom reduces associated bloating.	Free Base	C11H18BrN5O3	35608.0	DMSO : 150 mg/mL (430.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(N1C)N(C)C2=C(N=C(Br)N2)C1=O.CC(C)(N)CO	https://www.medchemexpress.com/pamabrom.html	Launched		91.0	S34	G9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17391	10.0	mM	153.0	DMSO	257.975238	9	G	pluskal_fda_drugs_5005_G9_id
719	HY-17360	HYCPK40903	O21	HYCPK40903	91z	1386.0	2.0	AC42	903.0	O21	136310-93-5	Tiotropium (Bromide)	BA679 BR	472.42	mAChR	GPCR/G Protein; Neuronal Signaling	Tiotropium Bromide (BA679 BR) is a muscarinic acetylcholine receptor (mAChR) antagonist that blocks the binding of the acetylcholine ligand and subsequent opening of the ligand-gated ion channel.	Bromide	C19H22BrNO4S2	99846.0	DMSO : ≥ 30 mg/mL (63.50 mM); H2O : 25 mg/mL (52.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C(C1=CC=CS1)(O)C2=CC=CS2)O[C@H]3C[C@H]([N+]4(C)C)[C@@H]5O[C@@H]5[C@H]4C3.[Br-]	https://www.medchemexpress.com/Tiotropium-Bromide.html	Launched		91.0	AC42	G9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17360	10.0	mM	153.0	DMSO	392.098477	9	G	pluskal_fda_drugs_5005_G9_id
779	HY-B0113A	HYCPK40904	P05	HYCPK40904	91z	1497.0	3.0	AF9	904.0	P05	95510-70-6	Omeprazole (sodium)	H 16868 (sodium)	367.40	Autophagy; Bacterial; Phospholipase; Proton Pump	Anti-infection; Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Omeprazole sodium (H 16868 sodium), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. Omeprazole sodium shows competitive inhibition of CYP2C19 activity with a Ki of 2 to 6 μM[1]. Omeprazole sodium also inhibits growth of Gram-positive and Gram-negative bacteria[2]. Omeprazole is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[3].	Sodium	C17H18N3NaO3S	79189.0	DMSO : 125 mg/mL (340.23 mM; Need ultrasonic); H2O : 5.56 mg/mL (15.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease	O=S(C1=NC2=CC=C(OC)C=C2N1[Na])CC3=NC=C(C)C(OC)=C3C	https://www.medchemexpress.com/omeprazole-sodium.html	Launched		91.0	AF9	G9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0113A	10.0	mM	153.0	DMSO	345.114712	9	G	pluskal_fda_drugs_5005_G9_id
786	HY-B0643	HYCPK40904	G06	HYCPK40904	91z	635.0	3.0	N11	904.0	G06	62013-04-1	Dirithromycin	LY237216	835.07	Antibiotic; Bacterial	Anti-infection	Dirithromycin (LY237216), a derivative of Erythromycin, is a potent and orally active semi-synthetic macrolide antibiotic. Dirithromycin is active against gram-positive bacteria, Legionella spp., Helicobacter pylori, and Chlamydia trachomatis[1][2].	Free Base	C42H78N2O14	16990.0	Ethanol : ≥ 50 mg/mL (59.88 mM); DMSO : 33.33 mg/mL (39.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC1[C@@]([C@](O)([C@H](OC([C@@H]2C)=O)CC)C)([H])O[C@H](COCCOC)N[C@@]1([H])[C@](C[C@@](O)([C@@H]([C@@H](C)[C@]2([H])O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC)O[C@@](O[C@H](C)C[C@@H]4N(C)C)([H])[C@@H]4O)C)([H])C	https://www.medchemexpress.com/dirithromycin.html	Launched		91.0	N11	G9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0643	10.0	mM	153.0	DMSO	834.545305	9	G	pluskal_fda_drugs_5005_G9_id
1259	HY-B0660	HYCPK40905	D16	HYCPK40905	91z	368.0	4.0	H32	905.0	D16	10417-94-4	Eicosapentaenoic Acid	EPA; Timnodonic acid	302.45	Endogenous Metabolite; Histone Demethylase	Epigenetics; Metabolic Enzyme/Protease	Eicosapentaenoic Acid (EPA) is an orally active Omega-3 long-chain polyunsaturated fatty acid (ω-3 LC-PUFA). Eicosapentaenoic Acid exhibits a DNA demethylating action that promotes the re-expression of the tumor suppressor gene CCAAT/enhancer-binding protein δ (C/EBPδ). Eicosapentaenoic Acid activates RAS/ERK/C/EBPβ pathway through H-Ras intron 1 CpG island demethylation in U937 leukemia cells. Eicosapentaenoic Acid can promote relaxation of vascular smooth muscle cells and vasodilation[1][2][3].	Free Acid	C20H30O2	101434.0	DMSO : ≥ 53 mg/mL (175.24 mM); Ethanol : ≥ 100 mg/mL (330.63 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(O)=O	https://www.medchemexpress.com/Eicosapentaenoic-Acid.html	Launched		91.0	H32	G9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0660	10.0	mM	153.0	DMSO	302.22458	9	G	pluskal_fda_drugs_5005_G9_id
107	HY-15459	HYCPK40902	A06	HYCPK40902	91z	11.0	1.0	A11	902.0	A06	183133-96-2	Cabazitaxel	XRP6258; RPR-116258A; taxoid XRP6258	835.93	Autophagy; Microtubule/Tubulin	Autophagy; Cell Cycle/DNA Damage; Cytoskeleton	Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity.	Free Base	C45H57NO14	39943.0	DMSO : ≥ 100 mg/mL (119.63 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC1=C([C@@H](OC)C([C@@]2(C)[C@@]3([H])[C@](OC(C)=O)(CO4)[C@H]4C[C@@H]2OC)=O)C(C)(C)[C@@]([C@H]3OC(C5=CC=CC=C5)=O)(O)C[C@@H]1OC([C@H](O)[C@H](C6=CC=CC=C6)NC(OC(C)(C)C)=O)=O	https://www.medchemexpress.com/Cabazitaxel.html	Launched		91.0	A11	G10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15459	10.0	mM	154.0	DMSO	835.377906	10	G	pluskal_fda_drugs_5005_G10_id
170	HY-14648	HYCPK40902	H10	HYCPK40902	91z	691.0	1.0	O19	902.0	H10	50-02-2	Dexamethasone	Hexadecadrol; Prednisolone F	392.46	Antibiotic; Autophagy; Bacterial; Complement System; Glucocorticoid Receptor; Mitophagy; SARS-CoV	Anti-infection; Autophagy; Immunology/Inflammation	Dexamethasone (Hexadecadrol) is a glucocorticoid receptor agonist. Dexamethasone also significantly decreases CD11b, CD18, and CD62L expression on neutrophils, and CD11b and CD18 expression on monocytes. Dexamethasone is highly effective in the control of COVID-19 infection. Dexamethasone inhibits production of exosomes containing inflammatory microRNA-155 in lipopolysaccharide-induced macrophage inflammatory responses.	Free Base	C22H29FO5	84637.0	Ethanol : 8.33 mg/mL (21.23 mM; Need ultrasonic); DMSO : 250 mg/mL (637.01 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Endocrinology; Inflammation/Immunology	O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(CO)=O)O)=C1	https://www.medchemexpress.com/Dexamethasone.html	Launched		91.0	O19	G10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14648	10.0	mM	154.0	DMSO	392.199902	10	G	pluskal_fda_drugs_5005_G10_id
252	HY-114370	HYCPK40902	J15	HYCPK40902	91z	893.0	1.0	S29	902.0	J15	2152628-33-4	Selpercatinib	LOXO-292	525.60	RET	Protein Tyrosine Kinase/RTK	Selpercatinib (LOXO-292) is a potent, selective RET kinase inhibitor with IC50 values of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M), and RET (G810R), respectively. Selpercatinib has anticancer activity[1][2].	Free Base	C29H31N7O3	47139.0	DMSO : 62.5 mg/mL (118.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	N#CC1=C2C(C3=CC=C(N4CC(C5)N(CC6=CC=C(OC)N=C6)C5C4)N=C3)=CC(OCC(C)(O)C)=CN2N=C1	https://www.medchemexpress.com/RET_kinase_inhibitor_1.html	Launched		91.0	S29	G10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-114370	10.0	mM	154.0	DMSO	525.248838	10	G	pluskal_fda_drugs_5005_G10_id
371	HY-18708	HYCPK40902	D04	HYCPK40902	91z	295.0	1.0	G7	902.0	D04	1346242-81-6	Erdafitinib	JNJ-42756493	446.54	Apoptosis; FGFR	Apoptosis; Protein Tyrosine Kinase/RTK	Erdafitinib (JNJ-42756493) is a potent and orally available FGFR family inhibitor; inhibits FGFR1/2/3/4 with IC50s of 1.2, 2.5, 3.0 and 5.7 nM, respectively.	Free Base	C25H30N6O2	109837.0	DMSO : 62.5 mg/mL (139.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CN1N=CC(C2=NC3=CC(N(C4=CC(OC)=CC(OC)=C4)CCNC(C)C)=CC=C3N=C2)=C1	https://www.medchemexpress.com/Erdafitinib.html	Launched		91.0	G7	G10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18708	10.0	mM	154.0	DMSO	446.243024	10	G	pluskal_fda_drugs_5005_G10_id
462	HY-B1430	HYCPK40903	C06	HYCPK40903	91z	204.0	2.0	E12	903.0	C06	94-25-7	Butamben	Butyl 4-aminobenzoate	193.24	Calcium Channel; Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Butamben (Butyl 4-aminobenzoate) results in long-lasting relief from pain, without impairing motor function or other sensory functions[1][2].	Free Base	C11H15NO2	17455.0	DMSO : ≥ 100 mg/mL (517.49 mM); H2O : 0.1 mg/mL (0.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCCC)C1=CC=C(N)C=C1	https://www.medchemexpress.com/Butamben.html	Launched		91.0	E12	G10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1430	10.0	mM	154.0	DMSO	193.110279	10	G	pluskal_fda_drugs_5005_G10_id
487	HY-100008	HYCPK40903	L07	HYCPK40903	91z	1070.0	2.0	W14	903.0	L07	81485-25-8	Peretinoin	NIK333	302.45	Autophagy; HCV; RAR/RXR; SphK	Anti-infection; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease	Peretinoin is an oral acyclic retinoid with a vitamin A-like structure that targets retinoid nuclear receptors such as retinoid X receptor (RXR) and retinoic acid receptor (RAR). Peretinoin reduces the mRNA level of sphingosine kinase 1 (SPHK1) in vitro by downregulating a transcription factor, Sp1[1]. Peretinoin prevents the progression of non-alcoholic steatohepatitis (NASH) and the development of hepatocellular carcinoma (HCC) through activating the autophagy pathway by increased Atg16L1 expression[2]. Peretinoin inhibits HCV RNA amplification and virus release by altering lipid metabolism with a EC50 of 9 μM[3].	Free Acid	C20H30O2	49783.0	DMSO : 50 mg/mL (165.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	C/C(C)=C/CC/C(C)=C/CC/C(C)=C/C=C/C(C)=C/C(O)=O	https://www.medchemexpress.com/Peretinoin.html	Launched		91.0	W14	G10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100008	10.0	mM	154.0	DMSO	302.22458	10	G	pluskal_fda_drugs_5005_G10_id
902	HY-B0113	HYCPK40904	K13	HYCPK40904	91z	1033.0	3.0	V25	904.0	K13	73590-58-6	Omeprazole	H 16868	345.42	Autophagy; Bacterial; Phospholipase; Proton Pump	Anti-infection; Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Omeprazole (H 16868), a proton pump inhibitor (PPI), is available for treatment of acid-related gastrointestinal disorders. Omeprazole shows competitive inhibition of CYP2C19 activity with a Ki of 2 to 6 μM[1]. Omeprazole also inhibits growth of Gram-positive and Gram-negative bacteria[2].Omeprazole is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[3].	Free Base	C17H19N3O3S	104384.0	DMSO : ≥ 100 mg/mL (289.50 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease	O=S(C1=NC2=CC=C(OC)C=C2N1)CC3=NC=C(C)C(OC)=C3C	https://www.medchemexpress.com/Omeprazole.html	Launched		91.0	V25	G10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0113	10.0	mM	154.0	DMSO	345.114712	10	G	pluskal_fda_drugs_5005_G10_id
1253	HY-B1480	HYCPK40905	N15	HYCPK40905	91z	1326.0	4.0	AB30	905.0	N15	452-35-7	Ethoxzolamide	Redupresin; L-643786; PNU-4191	258.32	Bacterial; Carbonic Anhydrase	Anti-infection; Metabolic Enzyme/Protease	Ethoxzolamide is a carbonic anhydrase inhibitor with Ki of 1 nM.	Free Base	C9H10N2O3S2	26531.0	DMSO : ≥ 100 mg/mL (387.12 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=S(C1=NC2=CC=C(OCC)C=C2S1)(N)=O	https://www.medchemexpress.com/Ethoxzolamide.html	Launched		91.0	AB30	G10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1480	10.0	mM	154.0	DMSO	258.013284	10	G	pluskal_fda_drugs_5005_G10_id
91	HY-17364	HYCPK40902	A05	HYCPK40902	91z	9.0	1.0	A9	902.0	A05	85622-93-1	Temozolomide	NSC 362856; CCRG 81045; TMZ	194.15	Apoptosis; Autophagy; DNA Alkylator/Crosslinker	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Temozolomide (NSC 362856) is an oral active DNA alkylating agent that crosses the blood-brain barrier. Temozolomide is also a proautophagic and proapoptotic agent. Temozolomide is effective against tumor cells that are characterized by low levels of O6-alkylguanine DNA alkyltransferase (OGAT) and a functional mismatch repair system. Temozolomide has antitumor and antiangiogenic effects[1][2].	Free Base	C6H6N6O2	158755.0	H2O : 2.86 mg/mL (14.73 mM; Need ultrasonic); DMSO : 20.83 mg/mL (107.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(N2C=N1)N=NN(C)C2=O)N	https://www.medchemexpress.com/Temozolomide.html	Launched		91.0	A9	G11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17364	10.0	mM	155.0	DMSO	194.055223	11	G	pluskal_fda_drugs_5005_G11_id
224	HY-14299A	HYCPK40902	N13	HYCPK40902	91z	1273.0	1.0	AA25	902.0	N13	753498-25-8	Indacaterol (maleate)	QAB149	508.56	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Indacaterol maleate (QAB149) is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol maleate inhibits NF-κB activity in a β-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD (chronic obstructive pulmonary disorder). Indacaterol maleate can also be used in cardiovascular disease research[1][2].	Maleate	C28H32N2O7	12907.0	DMSO : 100 mg/mL (196.63 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C1NC2=C(C([C@@H](O)CNC3CC4=C(C=C(CC)C(CC)=C4)C3)=CC=C2O)C=C1.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Indacaterol-maleate.html	Launched		91.0	AA25	G11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14299A	10.0	mM	155.0	DMSO	392.209993	11	G	pluskal_fda_drugs_5005_G11_id
280	HY-100593	HYCPK40902	F17	HYCPK40902	91z	513.0	1.0	K33	902.0	F17	8025-81-8	Spiramycin	Rovamycin	843.05	Antibiotic; Bacterial; Parasite	Anti-infection	Spiramycin (Rovamycin) is a macrolide antibiotic produced by Streptomyces ambofaciens with against bacteria and Toxoplasma gondii activities, and also has antiparasitic effect. Spiramycin is composed of a 16-member lactone ring, on which three sugars (mycaminose, forosamine, and mycarose) are attached[1][2].	Free Base	C43H74N2O14	58780.0	DMSO : ≥ 100 mg/mL (118.62 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@H](C1)[C@H](OC)[C@@H](O[C@H]2[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@](O)(C)C3)[C@@H](C)O2)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@@H]4O[C@H](C)[C@@H](N(C)C)CC4)/C=C/C=C/C[C@@H](C)OC1=O	https://www.medchemexpress.com/Spiramycin.html	Launched		91.0	K33	G11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100593	10.0	mM	155.0	DMSO	842.514005	11	G	pluskal_fda_drugs_5005_G11_id
285	HY-112823	HYCPK40902	K17	HYCPK40902	91z	993.0	1.0	U33	902.0	K17	1899921-05-1	Almonertinib	HS-10296	525.64	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Almonertinib (HS-10296) is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM). Almonertinib is used for the research of the non-small cell lung cancer[1][2].	Free Base	C30H35N7O2	65966.0	DMSO : ≥ 83.33 mg/mL (158.53 mM)	DMSO Solution	10mM  * 100uL	Cancer	COC(C=C(N(C)CCN(C)C)C(NC(C=C)=O)=C1)=C1NC2=NC(C3=CN(C4CC4)C5=C3C=CC=C5)=CC=N2	https://www.medchemexpress.com/hs-10296.html	Launched		91.0	U33	G11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-112823	10.0	mM	155.0	DMSO	525.285223	11	G	pluskal_fda_drugs_5005_G11_id
653	HY-101467	HYCPK40903	C17	HYCPK40903	91z	226.0	2.0	E34	903.0	C17	1374743-00-6	Trilaciclib	G1T28	446.55	CDK	Cell Cycle/DNA Damage	Trilaciclib is a CDK4/6 inhibitor with IC50s of 1 nM and 4 nM for CDK4 and CDK6, respectively.	Free Base	C24H30N8O	149332.0	DMSO : 6.82 mg/mL (15.27 mM; ultrasonic and adjust pH to 6 with HCl)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NCC2(N3C1=CC4=CN=C(NC5=NC=C(N6CCN(C)CC6)C=C5)N=C43)CCCCC2	https://www.medchemexpress.com/Trilaciclib.html	Launched		91.0	E34	G11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101467	10.0	mM	155.0	DMSO	446.254258	11	G	pluskal_fda_drugs_5005_G11_id
687	HY-13593	HYCPK40903	O19	HYCPK40903	91z	1382.0	2.0	AC38	903.0	O19	305-03-3	Chlorambucil	CB-1348; WR-139013	304.21	DNA Alkylator/Crosslinker	Cell Cycle/DNA Damage	Chlorambucil (CB-1348), an orally active antineoplastic agent, is a bifunctional alkylating agent belonging to the nitrogen mustard group. Chlorambucil can be used for the research of lymphocytic leukemia, ovarian and breast carcinomas, and Hodgkin’s disease[1][2][3][4].	Free Acid	C14H19Cl2NO2	103577.0	DMSO : ≥ 24 mg/mL (78.89 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CCCC1=CC=C(N(CCCl)CCCl)C=C1	https://www.medchemexpress.com/Chlorambucil.html	Launched		91.0	AC38	G11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13593	10.0	mM	155.0	DMSO	303.079284	11	G	pluskal_fda_drugs_5005_G11_id
1008	HY-121186	HYCPK40904	I20	HYCPK40904	91z	855.0	3.0	R39	904.0	I20	42864-78-8	Bevantolol (hydrochloride)		381.89	Adrenergic Receptor; Calcium Channel	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Bevantolol hydrochloride is a selective β1 and α1-adrenergic receptor antagonist with pKi values of 7.83, 6.9 in rat cerebral cortex, respectively. Bevantolol hydrochloride is a potent Ca2+ antagonist[1][2].	Hydrochloride	C20H28ClNO4	64008.0	H2O : 4.55 mg/mL (11.91 mM; ultrasonic and warming and heat to 60°C); DMSO : 62.5 mg/mL (163.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	OC(CNCCC1=CC=C(C(OC)=C1)OC)COC2=CC=CC(C)=C2.[H]Cl	https://www.medchemexpress.com/bevantolol-hydrochloride.html	Launched		91.0	R39	G11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-121186	10.0	mM	155.0	DMSO	345.194008	11	G	pluskal_fda_drugs_5005_G11_id
1213	HY-B1508	HYCPK40905	F13	HYCPK40905	91z	554.0	4.0	L26	905.0	F13	573-20-6	Vitamin K4	acetomenaphthone	258.27	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	Vitamin K4 is a chemically synthesized Vitamin K which plays an important role in the normal blood coagulation system.	Free Base	C15H14O4	27583.0	DMSO : 100 mg/mL (387.19 mM; Need ultrasonic); H2O : 0.67 mg/mL (2.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	CC1=CC(OC(C)=O)=C2C=CC=CC2=C1OC(C)=O	https://www.medchemexpress.com/Vitamin_K4.html	Launched		91.0	L26	G11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1508	10.0	mM	155.0	DMSO	258.089209	11	G	pluskal_fda_drugs_5005_G11_id
172	HY-N0060	HYCPK40902	J10	HYCPK40902	91z	883.0	1.0	S19	902.0	J10	1135-24-6	Ferulic acid	Coniferic acid	194.18	Endogenous Metabolite; FGFR	Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK	Ferulic acid is a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 μM for FGFR1 and FGFR2, respectively.	Free Acid	C10H10O4	99781.0	DMSO : 100 mg/mL (514.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)/C=C/C1=CC=C(O)C(OC)=C1	https://www.medchemexpress.com/Ferulic_acid.html	Launched		91.0	S19	G12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0060	10.0	mM	156.0	DMSO	194.057909	12	G	pluskal_fda_drugs_5005_G12_id
188	HY-B1210	HYCPK40902	J11	HYCPK40902	91z	885.0	1.0	S21	902.0	J11	51940-44-4	Pipemidic acid		303.32	Antibiotic; Bacterial	Anti-infection	Pipemidic acid, a derivative of Piromidic acid, is an antibacterial agent. Pipemidic acid is active against gram-negative bacteria including Pseudomonas aeruginosa as well as some gram-positive bacteria. Pipemidic acid can be used for the research of intestinal, urinary, and biliary tract infections[1].	Free Acid	C14H17N5O3	18945.0	DMSO : 5 mg/mL (16.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(CC)C2=NC(N3CCNCC3)=NC=C2C1=O)O	https://www.medchemexpress.com/Pipemidic-acid.html	Launched		91.0	S21	G12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1210	10.0	mM	156.0	DMSO	303.133139	12	G	pluskal_fda_drugs_5005_G12_id
482	HY-17025	HYCPK40903	G07	HYCPK40903	91z	590.0	2.0	M14	903.0	G07	72559-06-9	Rifabutin	Ansamycin; LM-427	847.00	Antibiotic; Bacterial	Anti-infection	Rifabutin (Ansamycin) is a semisynthetic ansamycin antibiotic with potent antimycobacterial properties. Rifabutin inhibits DNA-dependent RNA polymerase.	Free Base	C46H62N4O11	118508.0	DMSO : 50 mg/mL (59.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	C[C@@]1(O2)O/C=C/[C@@H]([C@H]([C@H]([C@H](C)[C@H](O)[C@H](C)[C@H]([C@H](/C=C/C=C(C(NC(C3=O)=C4NC5(CCN(CC(C)C)CC5)N=C4C6=C3C(O)=C(C)C2=C6C1=O)=O)\C)C)O)OC(C)=O)C)OC	https://www.medchemexpress.com/rifabutin.html	Launched		91.0	M14	G12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17025	10.0	mM	156.0	DMSO	846.441509	12	G	pluskal_fda_drugs_5005_G12_id
551	HY-B0391	HYCPK40903	H12	HYCPK40903	91z	696.0	2.0	O24	903.0	H12	57149-07-2	Naftopidil	KT-611; BM-15275	392.49072	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Naftopidil (KT-611) is is a selective alpha1-adrenoceptor antagonist, with Kis of 3.7 nM, 20 nM and 1.2 nM for the cloned human α1a-, α1b- and α1d-adrenoceptor subtypes, respectively. Naftopidil has antiproliferative effects. Naftopidil can be used for the research of prostate hyperplasia[1][2].	Free Base	C24H28N2O3	16555.0	H2O : 0.1 mg/mL (0.25 mM; Need ultrasonic); DMSO : 33.33 mg/mL (84.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	OC(CN1CCN(C(C=CC=C2)=C2OC)CC1)COC3=CC=CC4=CC=CC=C34	https://www.medchemexpress.com/naftopidil.html	Launched		91.0	O24	G12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0391	10.0	mM	156.0	DMSO	392.209993	12	G	pluskal_fda_drugs_5005_G12_id
589	HY-17484	HYCPK40905	F22	HYCPK40905	91z	572.0	4.0	L44	905.0	F22	99464-64-9	Ampiroxicam	CP 65703	447.46	COX	Immunology/Inflammation	"Ampiroxicam(CP65703) is a nonselective cyclooxygenase inhibitor uesd as anti-inflammatory drug.
Target: COX
Ampiroxicam is a non-steroidal anti-inflammatory drug. It is a prodrug of piroxicam. Ampiroxicam inhibits the stretching response in mice induced by phenylbenzoquinone (PBQ) with maximum protective effect (MPE) of 2 mg/kg. Ampiroxicam inhibits swelling in a dose-responsive manner in the rat foot edema (RFE) assay with ED50 of 28 mg/kg at single oral dose and 7.8 mg/kg at 5 daily oral dose. Ampiroxicam blocks primary and secondary lesion development in rat adjuvant arthritis with ED50 of 2.2 mg/kg and 0.5 mg/kg, respectively. Ampiroxicam (3.2 mg/kg) leads to a plasma concentration of 12 μg/mL at a Tmax of 2 hours for piroxicam derived from ampiroxicam in rats [1]. Ultraviolet-A (UVA)-irradiated 1% Ampiroxicam sensitized in guinea pigs shows positive reaction in the patch testing to UVA-irradiated 1% Ampiroxicam and 1% thiosalicylate (TOS). Concentration of Ampiroxicam is easily reduced by the increase in UVA irradiation doses, as compared with that of piroxicam [2]."	Free Base	C20H21N3O7S	15385.0	DMSO : 50 mg/mL (111.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OC(OC(C1=CC=CC=C12)=C(C(NC3=NC=CC=C3)=O)N(C)S2(=O)=O)C)OCC	https://www.medchemexpress.com/Ampiroxicam.html	Launched		91.0	L44	G12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17484	10.0	mM	156.0	DMSO	447.110021	12	G	pluskal_fda_drugs_5005_G12_id
806	HY-B0200B	HYCPK40904	K07	HYCPK40904	91z	1021.0	3.0	V13	904.0	K07	23325-78-2	Cephalexin (monohydrate)	Cefalexin hydrate; Cephacillin hydrate	365.40	Antibiotic; Bacterial	Anti-infection	Cephalexin (Cefalexin) monohydrate is a potent, orally active new semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin (Cefalexin) monohydrate has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin (Cefalexin) monohydrate targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin (Cefalexin) monohydrate is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al[1][2].	Free Acid	C16H19N3O5S	28257.0	H2O : 2 mg/mL (5.47 mM; Need ultrasonic); DMSO : 6.67 mg/mL (18.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=CC=C3)=O)C1=O)O.O	https://www.medchemexpress.com/cephalexin-monohydrate.html	Launched		91.0	V13	G12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0200B	10.0	mM	156.0	DMSO	347.093977	12	G	pluskal_fda_drugs_5005_G12_id
980	HY-17552	HYCPK40904	M18	HYCPK40904	91z	1235.0	3.0	Z35	904.0	M18	28319-77-9	sn-Glycero-3-phosphocholine	Choline Alfoscerate; Alpha-GPC; L-α-GPC	257.22	Cholinesterase (ChE); Endogenous Metabolite	Metabolic Enzyme/Protease; Neuronal Signaling	sn-Glycero-3-phosphocholine (Choline Alfoscerate) is a precursor in the biosynthesis of brain phospholipids and increases the bioavailability of choline in nervous tissue. sn-Glycero-3-phosphocholine (Choline Alfoscerate) has significant effects on cognitive function with a good safety profile and tolerability,  and is effective in the treatment of Alzheimer's disease and dementia[1][2].	Free Base	C8H20NO6P	43278.0	H2O : 500 mg/mL (1943.86 mM; Need ultrasonic); DMSO : 100 mg/mL (388.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=P(OCC[N+](C)(C)C)(OC[C@H](O)CO)[O-]	https://www.medchemexpress.com/sn-Glycero-3-phosphocholine.html	Launched		91.0	Z35	G12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17552	10.0	mM	156.0	DMSO	258.1101	12	G	pluskal_fda_drugs_5005_G12_id
1236	HY-112823B	HYCPK40905	M14	HYCPK40905	91z	1228.0	4.0	Z28	905.0	M14	2134096-03-8	Almonertinib (hydrochloride)	HS-10296 (hydrochloride)	562.11	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Almonertinib (HS-10296) hydrochloride is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib hydrochloride shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM). Almonertinib hydrochloride is used for the research of the non-small cell lung cancer[1][2].	Hydrochloride	C30H36ClN7O2	35912.0	DMSO : 83.33 mg/mL (148.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	COC(C=C(N(C)CCN(C)C)C(NC(C=C)=O)=C1)=C1NC2=NC(C3=CN(C4CC4)C5=C3C=CC=C5)=CC=N2.[H]Cl	https://www.medchemexpress.com/HS-10296_hydrochloride.html	Launched		91.0	Z28	G12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-112823B	10.0	mM	156.0	DMSO	525.285223	12	G	pluskal_fda_drugs_5005_G12_id
147	HY-17470	HYCPK40902	M08	HYCPK40902	91z	1167.0	1.0	Y15	902.0	M08	50924-49-7	Mizoribine	NSC 289637; HE 69	259.22	Antibiotic; HCV; Parasite; SARS-CoV	Anti-infection	Mizoribine (NSC 289637), an imidazole nucleoside, inhibits HCV RNA replication with IC50 of approximately 100 μM for anti-HCV activity. Immunosuppressant[1]. Mizoribine, an IMPDH inhibitor, inhibits replication of SARS-CoV with IC50s of 3.5 μg/mL and 16 μg/mL for SARS-CoV Frankfurt-1 and SARS-CoV HKU39849, respectively[2].	Free Base	C9H13N3O6	67180.0	DMSO : 125 mg/mL (482.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(O)=C(C(N)=O)N=C2)O1	https://www.medchemexpress.com/Mizoribine.html	Launched		91.0	Y15	G13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17470	10.0	mM	157.0	DMSO	259.080435	13	G	pluskal_fda_drugs_5005_G13_id
196	HY-B1422	HYCPK40902	B12	HYCPK40902	91z	119.0	1.0	C23	902.0	B12	90-45-9	9-Aminoacridine	Aminacrine	194.23	Bacterial; HIV	Anti-infection	9-Aminoacridine (Aminacrine) is a highly fluorescent dye used as a topical antiseptic and experimentally as a mutagen, an intracellular pH indicator. 9-Aminoacridine is an effective antibacterial agent with caries-disclosing features[1].	Free Base	C13H10N2	89232.0	DMSO : 27.5 mg/mL (141.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	NC1=C(C=CC=C2)C2=NC3=CC=CC=C31	https://www.medchemexpress.com/9-Aminoacridine.html	Launched		91.0	C23	G13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1422	10.0	mM	157.0	DMSO	194.084398	13	G	pluskal_fda_drugs_5005_G13_id
527	HY-B0461	HYCPK40903	P10	HYCPK40903	91z	1460.0	2.0	AE20	903.0	P10	10405-02-4	Trospium (chloride)		427.96	mAChR	GPCR/G Protein; Neuronal Signaling	Trospium chloride is an orally active, specific and competitive antagonist of muscarinic cholinergic receptors (mAChRs), with antimuscarinic activity. Trospium chloride binds to muscarinic receptors M1, M2 and M3 with high affinity, but not nicotinic, cholinergic receptors[1][2].	Chloride	C25H30ClNO3	13198.0	H2O : ≥ 100 mg/mL (233.67 mM); DMSO : 33.33 mg/mL (77.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	[H][C@@]12CC[C@@](C[C@@H](OC(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)=O)C2)([H])[N+]15CCCC5.[Cl-]	https://www.medchemexpress.com/Trospium-chloride.html	Launched		91.0	AE20	G13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0461	10.0	mM	157.0	DMSO	392.22202	13	G	pluskal_fda_drugs_5005_G13_id
562	HY-B0190A	HYCPK40903	C13	HYCPK40903	91z	218.0	2.0	E26	903.0	C13	82956-11-4	Nafamostat (mesylate)	FUT-175	539.58	Apoptosis; SARS-CoV; Ser/Thr Protease	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Nafamostat mesylate, a synthetic serine protease inhibitor, is an anticoagulant. Nafamostat mesylate supresses T cell auto-reactivity  by decreasing granzyme activity and CTL cytolysis. Nafamostat mesylate blocks activation of SARS-CoV-2.[1][2][3][4].	Mesylate	C21H25N5O8S2	39511.0	DMSO : 50 mg/mL (92.66 mM; Need ultrasonic); H2O : 33.33 mg/mL (61.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	CS(=O)(O)=O.O=C(OC1=CC=C2C=C(C(N)=N)C=CC2=C1)C3=CC=C(NC(N)=N)C=C3.CS(=O)(O)=O	https://www.medchemexpress.com/nafamostat-mesylate.html	Launched		91.0	E26	G13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0190A	10.0	mM	157.0	DMSO	347.138225	13	G	pluskal_fda_drugs_5005_G13_id
712	HY-14740	HYCPK40903	H21	HYCPK40903	91z	714.0	2.0	O42	903.0	H21	697761-98-1	Elvitegravir	GS-9137; JTK-303; D06677	447.88	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	Elvitegravir (GS-9137; JTK-303; D06677) is an HIV integrase inhibitor for HIV-1IIIB, HIV-2EHO and HIV-2ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively.	Free Acid	C23H23ClFNO5	114889.0	DMSO : 250 mg/mL (558.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)C1=CN(C2=C(C1=O)C=C(C(OC)=C2)CC3=CC=CC(Cl)=C3F)[C@@H](C(C)C)CO	https://www.medchemexpress.com/Elvitegravir.html	Launched		91.0	O42	G13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14740	10.0	mM	157.0	DMSO	447.124879	13	G	pluskal_fda_drugs_5005_G13_id
848	HY-B1607	HYCPK40904	E10	HYCPK40904	91z	451.0	3.0	J19	904.0	E10	77-38-3	Chlorphenoxamine		303.83	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	"Chlorphenoxamine is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent. 
Target: Histamine Receptor"	Free Base	C18H22ClNO	84628.0	DMSO : ≥ 48 mg/mL (157.98 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CN(CCOC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)C)C	https://www.medchemexpress.com/Chlorphenoxamine.html	Launched		91.0	J19	G13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1607	10.0	mM	157.0	DMSO	303.138992	13	G	pluskal_fda_drugs_5005_G13_id
933	HY-17643	HYCPK40904	J15	HYCPK40904	91z	941.0	3.0	T29	904.0	J15	1340593-59-0	Oteseconazole	VT-1161	527.39	Cytochrome P450; Fungal	Anti-infection; Metabolic Enzyme/Protease	Oteseconazole (VT-1161) is an orally active anti-fungal agent, potently binds to and inhibits Candida albicans CYP51 (Kd, <39 nM), shows no obvious effect on human CYP51[1][2].	Free Base	C23H16F7N5O2	108722.0	DMSO : 250 mg/mL (474.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O[C@@](CN1C=NN=N1)(C(C=CC(F)=C2)=C2F)C(F)(C3=CC=C(C4=CC=C(OCC(F)(F)F)C=C4)C=N3)F	https://www.medchemexpress.com/oteseconazole.html	Launched		91.0	T29	G13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17643	10.0	mM	157.0	DMSO	527.119222	13	G	pluskal_fda_drugs_5005_G13_id
1091	HY-B0957	HYCPK40905	L05	HYCPK40905	91z	1114.0	4.0	X10	905.0	L05	1264-62-6	Erythromycin Ethylsuccinate	Erythromycin ethyl succinate; EES	862.05	Antibiotic; Autophagy; Bacterial; HIV	Anti-infection; Autophagy	Erythromycin Ethylsuccinate is an antibiotic useful for the treatment of a number of bacterial infections, has an antimicrobial spectrum similar to or slightly wider than that of penicillin. Erythromycin Ethylsuccinate has antiviral activity against HIV-1.	Free Base	C43H75NO16	89127.0	Ethanol : ≥ 33.33 mg/mL (38.66 mM); DMSO : ≥ 50 mg/mL (58.00 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(CCC(OCC)=O)O[C@H]([C@H]1N(C)C)[C@](O[C@H](C)C1)([H])O[C@@H]([C@](O)(C[C@H](C([C@@H]([C@@H](O)[C@@]2(O)C)C)=O)C)C)[C@H]([C@@H]([C@H](C(O[C@@H]2CC)=O)C)O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC)C	https://www.medchemexpress.com/Erythromycin-Ethylsuccinate.html	Launched		91.0	X10	G13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0957	10.0	mM	157.0	DMSO	861.508585	13	G	pluskal_fda_drugs_5005_G13_id
74	HY-N0169	HYCPK40902	C03	HYCPK40902	91z	197.0	1.0	E5	902.0	C03	83-49-8	Hyodeoxycholic acid	HDCA	392.57	Endogenous Metabolite; G protein-coupled Bile Acid Receptor 1	GPCR/G Protein; Metabolic Enzyme/Protease	Hyodeoxycholic acid is a secondary bile acid formed in the small intestine by the gut flora, and acts as a TGR5 (GPCR19) agonist, with an EC50 of 31.6 μM in CHO cells.	Free Acid	C24H40O4	46046.0	DMSO : ≥ 100 mg/mL (254.73 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease	C[C@H](CCC(O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])C[C@H](O)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C	https://www.medchemexpress.com/Hyodeoxycholic_acid.html	Launched		91.0	E5	G14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0169	10.0	mM	158.0	DMSO	392.29266	14	G	pluskal_fda_drugs_5005_G14_id
102	HY-B0986	HYCPK40902	L05	HYCPK40902	91z	1065.0	1.0	W9	902.0	L05	136-77-6	Hexylresorcinol	4-Hexylresorcinol	194.27	Apoptosis; Bacterial; Endogenous Metabolite; Glucosidase; Parasite	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Hexylresorcinol (4-Hexylresorcinol) is a natural compound found in plants with antimicrobial, anthelmintic, antiseptic and antitumor activities. Hexylresorcinol can induce apoptosis in squamous carcinoma cells. Hexylresorcinol is a reversible and noncompetitive inhibitor of α-glucosidase. Hexylresorcinol has protective effects against oxidative DNA damage[1][2][3][4][5].	Free Base	C12H18O2	17475.0	DMSO : 250 mg/mL (1286.87 mM; Need ultrasonic); H2O : 1 mg/mL (5.15 mM; Need ultrasonic); Ethanol : 100 mg/mL (514.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease	OC1=CC=C(CCCCCC)C(O)=C1	https://www.medchemexpress.com/Hexylresorcinol.html	Launched		91.0	W9	G14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0986	10.0	mM	158.0	DMSO	194.13068	14	G	pluskal_fda_drugs_5005_G14_id
131	HY-B0431A	HYCPK40902	I07	HYCPK40902	91z	781.0	1.0	Q13	902.0	I07	63-92-3	Phenoxybenzamine (hydrochloride)		340.29	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Phenoxybenzamine hydrochloride is a nonselective, irreversible, orally active α-adrenoceptor antagonist that is commonly used for the research of hypertension, specifically caused by pheochromocytoma. Phenoxybenzamine hydrochloride also shows antitumor activity[1][2].	Hydrochloride	C18H23Cl2NO	16621.0	DMSO : 100 mg/mL (293.87 mM; Need ultrasonic); H2O : 0.67 mg/mL (1.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Cardiovascular Disease	CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl	https://www.medchemexpress.com/phenoxybenzamine-hydrochloride.html	Launched		91.0	Q13	G14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0431A	10.0	mM	158.0	DMSO	303.138992	14	G	pluskal_fda_drugs_5005_G14_id
149	HY-13062	HYCPK40902	O08	HYCPK40902	91z	1359.0	1.0	AC15	902.0	O08	23541-50-6	Daunorubicin (hydrochloride)	Daunomycin (hydrochloride); RP 13057 (hydrochloride); Rubidomycin (hydrochloride)	563.98	ADC Cytotoxin; Antibiotic; Apoptosis; Autophagy; Bacterial; DNA/RNA Synthesis; Topoisomerase	Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage	Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor[1][2][4][5].	Hydrochloride	C27H30ClNO10	45907.0	H2O : ≥ 34 mg/mL (60.29 mM); DMSO : 50 mg/mL (88.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Neurological Disease	O=C(C(C(OC)=CC=C1)=C1C2=O)C3=C2C(O)=C(C[C@@](O)(C(C)=O)C[C@@H]4O[C@@]5([H])C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O.[H]Cl	https://www.medchemexpress.com/Daunorubicin-Hydrochloride.html	Launched		91.0	AC15	G14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13062	10.0	mM	158.0	DMSO	527.179146	14	G	pluskal_fda_drugs_5005_G14_id
677	HY-B0269	HYCPK40903	K18	HYCPK40903	91z	996.0	2.0	U36	903.0	K18	61379-65-5	Rifapentine	DL 473; Cyclopentylrifampicin	877.03	Antibiotic; Bacterial	Anti-infection	"Rifapentine (DL 473) is an antibiotic compound used in the treatment of tuberculosis.
Target: Antibacterial
Rifapentine inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. A review of alternative regimens for prevention of active tuberculosis in HIV-negative individuals with latent TB found that a weekly, directly observed regimen of rifapentine with isoniazid for three months was as effective as a daily, self -administered regimen of isoniazid for nine months. But the rifapentine-isoniazid regimen had higher rates of treatment completion and lower rates of hepatotoxicity . However the rates of treatment-limiting adverse events were higher in the rifapentine-isoniazid regimen [1]."	Free Base	C47H64N4O12	16323.0	DMSO : ≥ 50 mg/mL (57.01 mM); H2O : 0.67 mg/mL (0.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC(C1=C(C2=O)C(O[C@@]2(O/C=C/[C@@H]([C@H]([C@@]([C@@H]3C)([H])OC(C)=O)C)OC)C)=C(C)C(O)=C1C(O)=C4NC(/C(C)=C\C=C\[C@@H]([C@@H]([C@@H](C)[C@H]3O)O)C)=O)=C4/C=N/N5CCN(C6CCCC6)CC5	https://www.medchemexpress.com/rifapentine.html	Launched		91.0	U36	G14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0269	10.0	mM	158.0	DMSO	876.452073	14	G	pluskal_fda_drugs_5005_G14_id
833	HY-B0231	HYCPK40904	F09	HYCPK40904	91z	545.0	3.0	L17	904.0	F09	84680-54-6	Enalaprilat (dihydrate)	MK-422	384.42	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Enalaprilat dihydrate (MK-422), the active metabolite of the oral prodrug Enalapril, is a potent, competitive and long-acting angiotensin-converting enzyme (ACE) inhibitor, with an IC50 of 1.94 nM. Enalaprilat dihydrate can be used for the research of hypertension[1][2][3].	Free Acid	C18H28N2O7	15470.0	DMSO : 100 mg/mL (260.13 mM; Need ultrasonic); H2O : 12.5 mg/mL (32.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O)[C@H]1N(C([C@H](C)N[C@H](C(O)=O)CCC2=CC=CC=C2)=O)CCC1.O.O	https://www.medchemexpress.com/Enalaprilat-dihydrate.html	Launched		91.0	L17	G14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0231	10.0	mM	158.0	DMSO	348.168522	14	G	pluskal_fda_drugs_5005_G14_id
1061	HY-B0573B	HYCPK40905	N03	HYCPK40905	91z	1302.0	4.0	AB6	905.0	N03	525-66-6	Propranolol		259.34	Adrenergic Receptor; Bacterial	Anti-infection; GPCR/G Protein; Neuronal Signaling	Propranolol is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol is used for the study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3].	Free Base	C16H21NO2	114522.0	DMSO : 100 mg/mL (385.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease; Endocrinology; Cancer	OC(COC1=C2C=CC=CC2=CC=C1)CNC(C)C	https://www.medchemexpress.com/propranolol.html	Launched		91.0	AB6	G14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0573B	10.0	mM	158.0	DMSO	259.157229	14	G	pluskal_fda_drugs_5005_G14_id
1132	HY-50767A	HYCPK40905	E08	HYCPK40905	91z	448.0	4.0	J16	905.0	E08	827022-32-2	Palbociclib (monohydrochloride)	PD 0332991 (monohydrochloride)	483.99	CDK	Cell Cycle/DNA Damage	Palbociclib (PD 0332991) monohydrochloride is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib monohydrochloride has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4].	Hydrochloride	C24H30ClN7O2	86840.0	DMSO : 4.63 mg/mL (9.57 mM; ultrasonic and warming and heat to 80°C); H2O : 7.14 mg/mL (14.75 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C(C(C)=O)=C(C)C2=CN=C(NC3=NC=C(N4CCNCC4)C=C3)N=C2N1C5CCCC5.Cl	https://www.medchemexpress.com/palbociclib-monohydrochloride.html	Launched		91.0	J16	G14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50767A	10.0	mM	158.0	DMSO	447.238273	14	G	pluskal_fda_drugs_5005_G14_id
87	HY-A0295	HYCPK40902	P03	HYCPK40902	91z	1445.0	1.0	AE5	902.0	P03	13071-11-9	(R)-Propranolol (hydrochloride)		295.80	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	(R)-Propranolol hydrochloride is a less active enantiomer of the?β-adrenoceptor antagonist?propranolol (HY-B0573). Propranolol is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1].	Hydrochloride	C16H22ClNO2	150833.0	DMSO : 250 mg/mL (845.17 mM; Need ultrasonic); H2O : 7.14 mg/mL (24.14 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Endocrinology; Neurological Disease; Cardiovascular Disease	O[C@@H](COC1=C2C=CC=CC2=CC=C1)CNC(C)C.[H]Cl	https://www.medchemexpress.com/r-propranolol-hydrochloride.html	Launched		91.0	AE5	G15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0295	10.0	mM	159.0	DMSO	259.157229	15	G	pluskal_fda_drugs_5005_G15_id
434	HY-W004520	HYCPK40903	G04	HYCPK40903	91z	584.0	2.0	M8	903.0	G04	299-11-6	Phenazine (methylsulfate)	5-Methylphenazinium (methylsulfate)	306.34	Antibiotic; Apoptosis; Bacterial	Anti-infection; Apoptosis	Phenazine methylsulfate is a free radical generator. Phenazine methylsulfate has been used as an electron transfer reactant in cell viability assays. Phenazine methylsulfate induces ssDNA break formation in the presence of the reducing agent NADPH. Phenazine methylsulfate induces oxidative DNA damage in an alkaline comet assay and apoptosis.	Methylsulfate	C14H14N2O4S	81448.0	DMSO : 62.5 mg/mL (204.02 mM; Need ultrasonic); H2O : 62.5 mg/mL (204.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	C[N+]1=C2C=CC=CC2=NC3=C1C=CC=C3.O=S(OC)([O-])=O	https://www.medchemexpress.com/phenazine-methylsulfate.html	Launched		91.0	M8	G15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W004520	10.0	mM	159.0	DMSO	195.091675	15	G	pluskal_fda_drugs_5005_G15_id
558	HY-15660	HYCPK40903	O12	HYCPK40903	91z	1368.0	2.0	AC24	903.0	O12	164650-44-6	Efinaconazole	KP-103	348.39	Fungal	Anti-infection	Efinaconazole (KP-103) is a triazole antifungal agent and againsts T. mentagrophytes SM-110 and C. albicans ATCC 10231 with MICs of 0.0039 μg/mL and 0.00098 μg/mL, respectively[1]. Efinaconazole has a potent in vitro activity against fungal pathogens including dermatophytes, Candida and Malassezia species[1].	Free Base	C18H22F2N4O	13946.0	DMSO : ≥ 100 mg/mL (287.03 mM)	DMSO Solution	10mM  * 100uL	Infection	C[C@@H](N1CCC(CC1)=C)[C@@](O)(C2=CC=C(F)C=C2F)CN3N=CN=C3	https://www.medchemexpress.com/Efinaconazole.html	Launched		91.0	AC24	G15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15660	10.0	mM	159.0	DMSO	348.176168	15	G	pluskal_fda_drugs_5005_G15_id
606	HY-12530	HYCPK40903	D14	HYCPK40903	91z	316.0	2.0	G28	903.0	D14	1377049-84-7	Velpatasvir	GS-5816	883.00	HCV; SARS-CoV	Anti-infection	Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.16 μM[2].	Free Base	C49H54N8O8	22477.0	H2O : 1 mg/mL (1.13 mM; Need ultrasonic and warming); DMSO : 146.66 mg/mL (166.09 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N([C@H]1C)[C@@H](CC1)C2=NC3=C(C(C=C(OCC4=CC(C5=CN=C([C@H](C[C@H](COC)C6)N6C([C@@H](C7=CC=CC=C7)NC(OC)=O)=O)N5)=CC=C84)C8=C9)=C9C=C3)N2)[C@H](C(C)C)NC(OC)=O	https://www.medchemexpress.com/Velpatasvir.html	Launched		91.0	G28	G15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12530	10.0	mM	159.0	DMSO	882.406461	15	G	pluskal_fda_drugs_5005_G15_id
642	HY-N0593A	HYCPK40903	H16	HYCPK40903	91z	704.0	2.0	O32	903.0	H16	302-95-4	Deoxycholic acid sodium salt	Sodium deoxycholate	414.55	Endogenous Metabolite; G protein-coupled Bile Acid Receptor 1	GPCR/G Protein; Metabolic Enzyme/Protease	Deoxycholic acid sodium salt (sodium deoxycholate), a bile acid, is a by-product of intestinal metabolism, that activates the G protein-coupled bile acid receptorTGR5[1][2].	Sodium	C24H39NaO4	27168.0	DMSO : 6.25 mg/mL (15.08 mM; Need ultrasonic); H2O : 333.33 mg/mL (804.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	C[C@@]1([C@@]2([H])[C@H](C)CCC(O[Na])=O)[C@](CC2)([H])[C@@](CC[C@@]3([H])[C@@]4(CC[C@@H](O)C3)C)([H])[C@]4([H])C[C@@H]1O	https://www.medchemexpress.com/Deoxycholic_acid_sodium_salt.html	Launched		91.0	O32	G15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0593A	10.0	mM	159.0	DMSO	392.29266	15	G	pluskal_fda_drugs_5005_G15_id
690	HY-16219	HYCPK40903	B20	HYCPK40903	91z	136.0	2.0	C40	903.0	B20	135326-22-6	Gadoxetate (Disodium)	Gd-EOB-DTPA (Disodium); ZK 139834	725.71	Others	Others	Gadoxetate Disodium (Gd-EOB-DTPA Disodium) is a contrast agent in magnetic resonance imaging (MRI) of the hepatobiliary system, which accumulates in normal, functioning hepatocytes. Gadoxetate Disodium (Gd-EOB-DTPA Disodium) is used to evaluate focal liver lesions, such as hepatocellular carcinoma or liver metastasis on T1-weighted imaging[1][2][3].	Sodium	C23H28GdN3Na2O11	43279.0	DMSO : 24 mg/mL (33.07 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (137.80 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1[O-][Gd+3]([N]2(C1)CC3=O)([O-]3)([O-]C4=O)([O-]C5=O)([N]6(C5)C7)([N](C4)(CC2)CC6CC8=CC=C(OCC)C=C8)[O-]C7=O.[Na+].[Na+]	https://www.medchemexpress.com/gadoxetate-disodium.html	Launched		91.0	C40	G15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16219	10.0	mM	159.0	DMSO	527.211509	15	G	pluskal_fda_drugs_5005_G15_id
766	HY-17000	HYCPK40904	N04	HYCPK40904	91z	1303.0	3.0	AB7	904.0	N04	150683-30-0	Tolvaptan	OPC-41061	448.94	Autophagy; Vasopressin Receptor	Autophagy; GPCR/G Protein	Tolvaptan is a selective, competitive and orally active vasopressin receptor 2 (V2R) antagonist with an IC50 of 1.28 μM for the inhibition of arginine vasopressin (AVP)-induced platelet aggregation. Tolvaptan induces cell apoposis and affects cell cycle. Tolvaptan can be used for the research of hyponatremia[1][2].	Free Base	C26H25ClN2O3	5105.0	DMSO : ≥ 100 mg/mL (222.75 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=C(C1=CC=CC=C1C)NC2=CC=C(C(C)=C2)C(N3CCCC(C4=CC(Cl)=CC=C43)O)=O	https://www.medchemexpress.com/Tolvaptan.html	Launched		91.0	AB7	G15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17000	10.0	mM	159.0	DMSO	448.15537	15	G	pluskal_fda_drugs_5005_G15_id
843	HY-B0397	HYCPK40904	P09	HYCPK40904	91z	1505.0	3.0	AF17	904.0	P09	120-97-8	Dichlorphenamide	Diclofenamide	305.16	Carbonic Anhydrase	Metabolic Enzyme/Protease	Dichlorphenamide (Diclofenamide) is an orally active, specific, carbonic anhydrase inhibitor. Dichlorphenamide can reduce intraocular pressure by inhibiting the secretion of water from the eye. Dichlorphenamide can be used for glaucoma research[1].	Free Base	C6H6Cl2N2O4S2	67670.0	DMSO : 100 mg/mL (327.70 mM; Need ultrasonic); H2O : 1 mg/mL (3.28 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=S(C1=CC(Cl)=C(Cl)C(S(=O)(N)=O)=C1)(N)=O	https://www.medchemexpress.com/Dichlorphenamide.html	Launched		91.0	AF17	G15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0397	10.0	mM	159.0	DMSO	303.914604	15	G	pluskal_fda_drugs_5005_G15_id
197	HY-N0865	HYCPK40902	C12	HYCPK40902	91z	215.0	1.0	E23	902.0	C12	30220-46-3	Ingenol	(-)-Ingenol	348.43	PKC	Epigenetics; TGF-beta/Smad	Ingenol is a PKC activator, with a Ki of 30 μM, with antitumor activity.	Free Base	C20H28O5	17906.0	DMSO : 100 mg/mL (287.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O[C@@]([C@@H](C(CO)=C[C@@]1([H])[C@H](C2(C)C)[C@H]2C3)O)([C@H]4O)[C@]([C@@H]3C)(C=C4C)C1=O	https://www.medchemexpress.com/Ingenol.html	Launched		91.0	E23	G16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0865	10.0	mM	160.0	DMSO	348.193674	16	G	pluskal_fda_drugs_5005_G16_id
265	HY-B1901	HYCPK40902	G16	HYCPK40902	91z	607.0	1.0	M31	902.0	G16	56839-43-1	Eperisone (hydrochloride)	(±)-Eperisone (hydrochloride)	295.85	Others	Others	Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is an antispastic agent used for treatment of diseases characterized by muscle stiffness and pain. It works by relaxing both skeletal muscles and vascularsmooth muscles, thus demonstrating avariety of effects such as reduction ofmyotonia, improvement of circulationand suppression of the pain reflex. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is a centrally acting muscle relaxant inhibiting the pain reflex pathway, having a vasodilator effect[1][2 [3].	Hydrochloride	C17H26ClNO	44708.0	DMSO : 31.25 mg/mL (105.63 mM; Need ultrasonic); H2O : 100 mg/mL (338.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=C(CC)C=C1)C(C)CN2CCCCC2.[H]Cl	https://www.medchemexpress.com/eperisone-hydrochloride.html	Launched		91.0	M31	G16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1901	10.0	mM	160.0	DMSO	259.193614	16	G	pluskal_fda_drugs_5005_G16_id
637	HY-B0226	HYCPK40903	C16	HYCPK40903	91z	224.0	2.0	E32	903.0	C16	59-87-0	Nitrofurazone	Nitrofural	198.14	Antibiotic; Bacterial	Anti-infection	Nitrofurazone (Nitrofural) is a bactericidal compound used as an antibiotic most commonly in the form of ointments.	Free Base	C6H6N4O4	16406.0	DMSO : ≥ 155 mg/mL (782.28 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(N/N=C/C1=CC=C([N+]([O-])=O)O1)N	https://www.medchemexpress.com/Nitrofurazone.html	Launched		91.0	E32	G16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0226	10.0	mM	160.0	DMSO	198.038905	16	G	pluskal_fda_drugs_5005_G16_id
683	HY-76847	HYCPK40903	K19	HYCPK40903	91z	998.0	2.0	U38	903.0	K19	474-25-9	Chenodeoxycholic Acid	CDCA	392.57	Autophagy; Endogenous Metabolite; FXR	Autophagy; Metabolic Enzyme/Protease	Chenodeoxycholic Acid is a hydrophobic primary bile acid that activates nuclear receptors (FXR) involved in cholesterol metabolism.	Free Acid	C24H40O4	39444.0	DMSO : ≥ 50 mg/mL (127.37 mM); 0.1 M NaOH : 50 mg/mL (127.37 mM; ultrasonic and adjust pH to 8 with NaOH)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(O)CC[C@@H](C)[C@]1([H])[C@]2(C)[C@](CC1)([H])[C@]3([H])[C@H](O)C[C@@](C4)([H])[C@@](CC[C@H]4O)(C)[C@]([H])3CC2	https://www.medchemexpress.com/Chenodeoxycholic-Acid.html	Launched		91.0	U38	G16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-76847	10.0	mM	160.0	DMSO	392.29266	16	G	pluskal_fda_drugs_5005_G16_id
842	HY-B1289	HYCPK40904	O09	HYCPK40904	91z	1409.0	3.0	AD17	904.0	O09	6004-24-6	Cetylpyridinium (chloride monohydrate)	Hexadecylpyridinium chloride monohydrate	358.00	Bacterial	Anti-infection	Cetylpyridinium chloride monohydrate is a cationic quaternary ammonium compound, used in some types of mouthwashes, toothpastes, throat and nasal sprays, is an antiseptic that kills bacteria and other microorganisms, effective in preventing dental plaque and reducing gingivitis.	Chloride	C21H40ClNO	17478.0	H2O : ≥ 100 mg/mL (279.33 mM); DMSO : 20 mg/mL (55.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.O.[Cl-]	https://www.medchemexpress.com/Cetylpyridinium-chloride-monohydrate.html	Launched		91.0	AD17	G16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1289	10.0	mM	160.0	DMSO	304.299877	16	G	pluskal_fda_drugs_5005_G16_id
893	HY-104010A	HYCPK40904	B13	HYCPK40904	91z	169.0	3.0	D25	904.0	B13	2119669-71-3	Asciminib (hydrochloride)	ABL001 (hydrochloride)	486.30	Bcr-Abl	Protein Tyrosine Kinase/RTK	Asciminib (ABL001) hydrochloride is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM[1].	Hydrochloride	C20H19Cl2F2N5O3	155870.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(C=C1)OC(Cl)(F)F)C2=CC(C3=NNC=C3)=C(N=C2)N4C[C@@H](CC4)O.[H]Cl	https://www.medchemexpress.com/asciminib-hydrochloride.html	Launched		91.0	D25	G16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-104010A	10.0	mM	160.0	DMSO	449.106624	16	G	pluskal_fda_drugs_5005_G16_id
981	HY-13613	HYCPK40904	N18	HYCPK40904	91z	1331.0	3.0	AB35	904.0	N18	164656-23-9	Dutasteride	GG 745; GI 198745	528.53	5 alpha Reductase; Apoptosis	Apoptosis; Metabolic Enzyme/Protease	Dutasteride (GG745) is a potent inhibitor of both 5α-reductase isozymes. Dutasteride may possess off-target effects on the androgen receptor (AR) due to its structural similarity to DHT[1].	Free Base	C27H30F6N2O2	15665.0	DMSO : 33.33 mg/mL (63.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@H]1CC[C@]2([H])[C@]1(C)CC[C@]3([H])[C@@]4(C)C=CC(N[C@]4([H])CC[C@]32[H])=O)NC5=CC(C(F)(F)F)=CC=C5C(F)(F)F	https://www.medchemexpress.com/Dutasteride.html	Launched		91.0	AB35	G16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13613	10.0	mM	160.0	DMSO	528.221148	16	G	pluskal_fda_drugs_5005_G16_id
1046	HY-15602B	HYCPK40904	O22	HYCPK40904	91z	1435.0	3.0	AD43	904.0	O22	1502654-87-6	Ledipasvir (D-tartrate)	GS-5885 D-tartrate	1039.09	HCV	Anti-infection	Ledipasvir D-tartrate is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.	D-Tartrate	C53H60F2N8O12	10898.0	DMSO : ≥ 28 mg/mL (26.95 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(C5=CC=C6N=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)[C@]8([H])CC[C@@]7([H])C8)NC6=C5)=C3)=C4C=C2)N1)C9)CC%109CC%10)=O)C(C)C.O[C@@H]([C@@H](C(O)=O)O)C(O)=O	https://www.medchemexpress.com/Ledipasvir-D-tartrate.html	Launched		91.0	AD43	G16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15602B	10.0	mM	160.0	DMSO	888.413438	16	G	pluskal_fda_drugs_5005_G16_id
478	HY-14171	HYCPK40903	C07	HYCPK40903	91z	206.0	2.0	E14	903.0	C07	153559-49-0	Bexarotene	LGD1069	348.48	Autophagy; RAR/RXR	Autophagy; Metabolic Enzyme/Protease	Bexarotene?(LGD1069) is a high-affinity and selective?retinoid X receptors (RXR)?agonist with EC50s?of 33, 24, 25 nM for RXRα, RXRβ, and RXRγ, respectively. Bexarotene shows limited affinity for RAR receptors (EC50?>10000 nM)[1][2][3]. Bexarotene can be used for the research of cutaneous T-cell lymphoma.	Free Acid	C24H28O2	112179.0	DMSO : 60 mg/mL (172.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC1(C2=C(C(C)(CC1)C)C=C(C(C(C3=CC=C(C=C3)C(O)=O)=C)=C2)C)C	https://www.medchemexpress.com/Bexarotene.html	Launched		91.0	E14	G17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14171	10.0	mM	161.0	DMSO	348.20893	17	G	pluskal_fda_drugs_5005_G17_id
663	HY-10158	HYCPK40903	M17	HYCPK40903	91z	1186.0	2.0	Y34	903.0	M17	380843-75-4	Bosutinib	SKI-606	530.45	Autophagy; Bcr-Abl; Src	Autophagy; Protein Tyrosine Kinase/RTK	Bosutinib is an oral Src/Abl tyrosine kinase inhibito with IC50 of 1.2 nM and 1 nM, respectively[1].	Free Base	C26H29Cl2N5O3	25402.0	DMSO : ≥ 46 mg/mL (86.72 mM)	DMSO Solution	10mM  * 100uL	Cancer	CN1CCN(CC1)CCCOC2=C(C=C3C(NC4=CC(OC)=C(C=C4Cl)Cl)=C(C=NC3=C2)C#N)OC	https://www.medchemexpress.com/Bosutinib.html	Launched		91.0	Y34	G17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10158	10.0	mM	161.0	DMSO	529.164745	17	G	pluskal_fda_drugs_5005_G17_id
679	HY-13551A	HYCPK40903	M18	HYCPK40903	91z	1188.0	2.0	Y36	903.0	M18	54301-15-4	Amsacrine (hydrochloride)	m-AMSA hydrochloride; acridinyl anisidide hydrochloride	429.92	Autophagy; Topoisomerase	Autophagy; Cell Cycle/DNA Damage	Amsacrine hydrochloride (m-AMSA hydrochloride; acridinyl anisidide hydrochloride) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.	Hydrochloride	C21H20ClN3O3S	62844.0	DMSO : 62.5 mg/mL (145.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CS(=O)(NC1=CC=C(NC2=C(C=CC=C3)C3=NC4=CC=CC=C42)C(OC)=C1)=O.[H]Cl	https://www.medchemexpress.com/amsacrine-hydrochloride.html	Launched		91.0	Y36	G17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13551A	10.0	mM	161.0	DMSO	393.114712	17	G	pluskal_fda_drugs_5005_G17_id
812	HY-B0270	HYCPK40904	A08	HYCPK40904	91z	63.0	3.0	B15	904.0	A08	40828-46-4	Suprofen	TN-762	260.31	PGE synthase	Immunology/Inflammation	Suprofen (TN-762) is a non-steroidal anti-inflammatory drug (NSAID).	Free Acid	C14H12O3S	15058.0	DMSO : ≥ 100 mg/mL (384.16 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C(C)C1=CC=C(C(C2=CC=CS2)=O)C=C1	https://www.medchemexpress.com/Suprofen.html	Launched		91.0	B15	G17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0270	10.0	mM	161.0	DMSO	260.050715	17	G	pluskal_fda_drugs_5005_G17_id
1012	HY-111338	HYCPK40904	M20	HYCPK40904	91z	1239.0	3.0	Z39	904.0	M20	321-64-2	Tacrine		198.26	Cholinesterase (ChE)	Neuronal Signaling	Tacrine is a potent acetylcholinesterse (AChE) inhibitor (IC50=109 nM), also acting as a CYP1A2 substrate drug. Tacrine exhibits certain hepatotoxicity in some individuals. Tacrine can be used for researching Alzheimer's disease (AD)[1][2][3].		C13H14N2	156765.0	DMSO : ≥ 100 mg/mL (504.39 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC1=C2CCCCC2=NC3=CC=CC=C31	https://www.medchemexpress.com/tacrine.html	Launched		91.0	Z39	G17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-111338	10.0	mM	161.0	DMSO	198.115698	17	G	pluskal_fda_drugs_5005_G17_id
1219	HY-104010	HYCPK40905	L13	HYCPK40905	91z	1130.0	4.0	X26	905.0	L13	1492952-76-7	Asciminib	ABL001	449.84	Bcr-Abl	Protein Tyrosine Kinase/RTK	Asciminib (ABL001) is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC50 of 0.25 nM[1].	Free Base	C20H18ClF2N5O3	26438.0	DMSO : ≥ 100 mg/mL (222.30 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC(C2=NNC=C2)=C(N3C[C@H](O)CC3)N=C1)NC4=CC=C(OC(F)(Cl)F)C=C4	https://www.medchemexpress.com/Asciminib.html	Launched		91.0	X26	G17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-104010	10.0	mM	161.0	DMSO	449.106624	17	G	pluskal_fda_drugs_5005_G17_id
1284	HY-15602	HYCPK40905	M17	HYCPK40905	91z	1234.0	4.0	Z34	905.0	M17	1256388-51-8	Ledipasvir	GS-5885	889.00	HCV; SARS-CoV	Anti-infection	Ledipasvir (GS-5885) is an inhibitor of the hepatitis C virus NS5A, with EC50s of 34 pM and 4 pM against genotype 1a and 1b replicon, respectively. Ledipasvir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.62 μM[3].	Free Base	C49H54F2N8O6	22433.0	DMSO : 50 mg/mL (56.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(C5=CC=C6N=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)[C@]8([H])CC[C@@]7([H])C8)NC6=C5)=C3)=C4C=C2)N1)C9)CC%109CC%10)=O)C(C)C	https://www.medchemexpress.com/Ledipasvir.html	Launched		91.0	Z34	G17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15602	10.0	mM	161.0	DMSO	888.413438	17	G	pluskal_fda_drugs_5005_G17_id
1298	HY-B1464	HYCPK40905	K18	HYCPK40905	91z	1044.0	4.0	V36	905.0	K18	123-03-5	Cetylpyridinium (chloride)		339.99	Bacterial; HBV	Anti-infection	Cetylpyridinium chloride, a cationic quaternary ammonium compound, is an anti-bacterial agent with broad-spectrum activity. Cetylpyridinium chloride is an effective anti-HBV capsid assembly inhibitor with an IC50 of 2.5 μM. Cetylpyridinium chloride is used in pesticides and various types of mouthwashes, and other personal care products[1][2].	Chloride	C21H38ClN	123686.0	DMSO : 100 mg/mL (294.13 mM; Need ultrasonic); H2O : 100 mg/mL (294.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Cl-]	https://www.medchemexpress.com/cetylpyridinium-chloride.html	Launched		91.0	V36	G17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1464	10.0	mM	161.0	DMSO	304.299877	17	G	pluskal_fda_drugs_5005_G17_id
186	HY-10159A	HYCPK40902	H11	HYCPK40902	91z	693.0	1.0	O21	902.0	H11	923288-90-8	Nilotinib (monohydrochloride monohydrate)	AMN107 (monohydrochloride monohydrate)	583.99	Autophagy; Bcr-Abl	Autophagy; Protein Tyrosine Kinase/RTK	Nilotinib monohydrochloride monohydrate is a second generation tyrosine kinase inhibitor (TKI), is significantly potent against BCR-ABL, and is active against many BCR-ABL mutants.	Hydrochloride	C28H25ClF3N7O2	20641.0	DMSO : ≥ 33 mg/mL (56.51 mM); H2O : 0.1 mg/mL (0.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC(C(F)(F)F)=CC(N2C=NC(C)=C2)=C1)C3=CC=C(C)C(NC4=NC=CC(C5=CC=CN=C5)=N4)=C3.[H]Cl.O	https://www.medchemexpress.com/Nilotinib-monohydrochloride-monohydrate.html	Launched		91.0	O21	G18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10159A	10.0	mM	162.0	DMSO	529.183793	18	G	pluskal_fda_drugs_5005_G18_id
656	HY-13997	HYCPK40903	F17	HYCPK40903	91z	514.0	2.0	K34	903.0	F17	1258226-87-7	Ombitasvir	ABT-267	894.11	HCV	Anti-infection	Ombitasvir is a potent inhibitor of the hepatitis C virus protein NS5A, with EC50s of 0.82 to 19.3 pM against HCV genotypes 1 to 5, and 366 pM against genotype 6a.	Free Base	C50H67N7O8	22272.0	DMSO : ≥ 33 mg/mL (36.91 mM)	DMSO Solution	10mM  * 100uL	Infection	CC(C)(C)C(C=C1)=CC=C1N2[C@H](C3=CC=C(NC([C@H]4N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC4)=O)C=C3)CC[C@H]2C5=CC=C(NC([C@@H]6CCCN6C([C@@H](NC(OC)=O)C(C)C)=O)=O)C=C5	https://www.medchemexpress.com/Ombitasvir.html	Launched		91.0	K34	G18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13997	10.0	mM	162.0	DMSO	893.505112	18	G	pluskal_fda_drugs_5005_G18_id
830	HY-B1335	HYCPK40904	C09	HYCPK40904	91z	257.0	3.0	F17	904.0	C09	67-43-6	Pentetic acid	Diethylenetriaminepentaacetic acid; DTPA	393.35	Others	Others	Pentetic acid is a compound used to construct magnetic adsorbent, which can simultaneously remove heavy metal and dye from complex wastewater[1].		C14H23N3O10	27562.0	DMSO : 5 mg/mL (12.71 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Others	O=C(O)CN(CCN(CC(O)=O)CC(O)=O)CCN(CC(O)=O)CC(O)=O	https://www.medchemexpress.com/pentetic-acid.html	Launched		91.0	F17	G18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1335	10.0	mM	162.0	DMSO	393.138344	18	G	pluskal_fda_drugs_5005_G18_id
970	HY-B1217	HYCPK40904	C18	HYCPK40904	91z	275.0	3.0	F35	904.0	C18	52-51-7	Bronopol	BNPD; BNPK	199.99	Bacterial	Anti-infection	Bronopol is an antimicrobial, with low mammalian toxicity (at in-use levels) and high activity against bacteria (especially the troublesome Gram-negative species).	Free Base	C3H6BrNO4	17417.0	H2O : 100 mg/mL (500.03 mM; Need ultrasonic); DMSO : 100 mg/mL (500.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OCC([N+]([O-])=O)(Br)CO	https://www.medchemexpress.com/Bronopol.html	Launched		91.0	F35	G18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1217	10.0	mM	162.0	DMSO	198.94802	18	G	pluskal_fda_drugs_5005_G18_id
1172	HY-106579	HYCPK40905	M10	HYCPK40905	91z	1220.0	4.0	Z20	905.0	M10	33005-95-7	Tiaprofenic acid		260.31	COX	Immunology/Inflammation	Tiaprofenic acid is an orally active nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory and analgesic potency. Tiaprofenic acid inhibits prostaglandin synthesis by suppressing cyclo-oxygenase (COX). Tiaprofenic acid can be used in the treatment of rheumatic diseases[1].		C14H12O3S	93918.0	DMSO : 100 mg/mL (384.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=CC=C1)C2=CC=C(C(C)C(O)=O)S2	https://www.medchemexpress.com/tiaprofenic-acid.html	Launched		91.0	Z20	G18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-106579	10.0	mM	162.0	DMSO	260.050715	18	G	pluskal_fda_drugs_5005_G18_id
1175	HY-14603	HYCPK40905	P10	HYCPK40905	91z	1508.0	4.0	AF20	905.0	P10	130-26-7	Clioquinol	Iodochlorhydroxyquin	305.50	Antibiotic; Autophagy; Fungal; Mitophagy; Parasite	Anti-infection; Autophagy	Clioquinol (Iodochlorhydroxyquin) is a topical antifungal agent with anticancer activity. Clioquinol acts as an oral antimicrobial agent for the research of diarrhea and skin infections. Antibiotic[1].	Free Base	C9H5ClINO	16514.0	DMSO : ≥ 50 mg/mL (163.67 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	ClC1=C(C=CC=N2)C2=C(O)C(I)=C1	https://www.medchemexpress.com/Clioquinol.html	Launched		91.0	AF20	G18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14603	10.0	mM	162.0	DMSO	304.910439	18	G	pluskal_fda_drugs_5005_G18_id
1199	HY-76200	HYCPK40905	H12	HYCPK40905	91z	744.0	4.0	P24	905.0	H12	137234-62-9	Voriconazole	UK-109496	349.31	Bacterial; Fungal	Anti-infection	Voriconazole (UK-109496) is a second-generation, broad-spectrum triazole antifungal agent that inhibits fungal ergosterol biosynthesis. Voriconazole exerts its antifungal activity by inhibition of 14-α-lanosterol demethylation, which is mediated by fungal cytochrome P450 enzymes[1][2].	Free Base	C16H14F3N5O	20322.0	DMSO : ≥ 50 mg/mL (143.14 mM); H2O : 0.17 mg/mL (0.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O[C@@]([C@@H](C)C1=NC=NC=C1F)(CN2N=CN=C2)C(C(F)=C3)=CC=C3F	https://www.medchemexpress.com/Voriconazole.html	Launched		91.0	P24	G18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-76200	10.0	mM	162.0	DMSO	349.115045	18	G	pluskal_fda_drugs_5005_G18_id
1248	HY-50878A	HYCPK40905	I15	HYCPK40905	91z	846.0	4.0	R30	905.0	I15	1415560-69-8	Crizotinib (hydrochloride)	PF-02341066 hydrochloride	486.80	Anaplastic lymphoma kinase (ALK); Autophagy; c-Met/HGFR; ROS Kinase	Autophagy; Protein Tyrosine Kinase/RTK	Crizotinib hydrochloride (PF-02341066 hydrochloride) is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib hydrochloride (PF-02341066 hydrochloride) inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. It is also a ROS proto-oncogene 1 (ROS1) inhibitor. Crizotinib hydrochloride (PF-02341066 hydrochloride) has effective tumor growth inhibition[1][2][3].	Hydrochloride	C21H23Cl3FN5O	10558.0	DMSO : ≥ 4.9 mg/mL (10.07 mM); H2O : 50 mg/mL (102.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	ClC1=C(F)C=CC(Cl)=C1[C@H](OC2=CC(C3=CN(N=C3)C4CCNCC4)=CN=C2N)C.[H]Cl	https://www.medchemexpress.com/Crizotinib-hydrochloride.html	Launched		91.0	R30	G18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50878A	10.0	mM	162.0	DMSO	449.118544	18	G	pluskal_fda_drugs_5005_G18_id
73	HY-50896	HYCPK40902	B03	HYCPK40902	91z	101.0	1.0	C5	902.0	B03	183321-74-6	Erlotinib	CP-358774; NSC 718781; OSI-774	393.44	Autophagy; EGFR	Autophagy; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Erlotinib (CP-358774) is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR. Erlotinib reduces EGFR autophosphorylation in intact tumor cells with an IC50 of 20 nM. Erlotinib is used for the treatment of non-small cell lung cancer[1].	Free Base	C22H23N3O4	19153.0	DMSO : 3.94 mg/mL (10.01 mM; ultrasonic and warming and heat to 40°C)	DMSO Solution	10mM  * 100uL	Cancer	C#CC1=CC=CC(NC2=NC=NC3=C2C=C(C(OCCOC)=C3)OCCOC)=C1	https://www.medchemexpress.com/erlotinib.html	Launched		91.0	C5	G19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50896	10.0	mM	163.0	DMSO	393.168856	19	G	pluskal_fda_drugs_5005_G19_id
164	HY-B0176A	HYCPK40902	B10	HYCPK40902	91z	115.0	1.0	C19	902.0	B10	79559-97-0	Sertraline (hydrochloride)		342.69	Serotonin Transporter	Neuronal Signaling	Sertraline hydrochloride is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Sertraline hydrochloride is researched for a number of diseases, such as major depressive disorder and obsessive[1][2].	Hydrochloride	C17H18Cl3N	83981.0	H2O : 2.86 mg/mL (8.35 mM; ultrasonic and warming and heat to 60°C); DMSO : 50 mg/mL (145.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CN[C@H]1CC[C@@H](C2=CC=C(Cl)C(Cl)=C2)C3=C1C=CC=C3.Cl	https://www.medchemexpress.com/sertraline-hydrochloride.html	Launched		91.0	C19	G19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0176A	10.0	mM	163.0	DMSO	305.073805	19	G	pluskal_fda_drugs_5005_G19_id
339	HY-100549	HYCPK40902	L22	HYCPK40902	91z	1099.0	1.0	W43	902.0	L22	1374356-45-2	(S)-Crizotinib		450.34	Apoptosis; DNA/RNA Synthesis	Apoptosis; Cell Cycle/DNA Damage	(S)-Crizotinib is a potent and selective MTH1 (mutT homologue) inhibitor with an IC50 of 330 nM. (S)-Crizotinib disrupts nucleotide pool homeostasis via MTH1 inhibition, induces an increase in DNA single strand breaks, activates DNA repair in human colon carcinoma cells, and effectively suppresses tumour growth in animal models[1].	Free Base	C21H22Cl2FN5O	49945.0	DMSO : 12.5 mg/mL (27.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	NC1=NC=C(C2=CN(C3CCNCC3)N=C2)C=C1O[C@H](C4=C(Cl)C=CC(F)=C4Cl)C	https://www.medchemexpress.com/_S_-Crizotinib.html	Launched		91.0	W43	G19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100549	10.0	mM	163.0	DMSO	449.118544	19	G	pluskal_fda_drugs_5005_G19_id
387	HY-A0256	HYCPK40902	H08	HYCPK40902	91z	687.0	1.0	O15	902.0	H08	58001-44-8	Clavulanic acid		199.16	Antibiotic; Bacterial	Anti-infection	Clavulanic acid is a naturally occurring powerful bacterial β-lactamases inhibitor for research of infections caused by bacteria, including infections of the ears. Clavulanic acid is active against a wide spectrum of gram-positive and gram-negative bacterias[1].		C8H9NO5	227900.0	H2O : 50 mg/mL (251.05 mM; Need ultrasonic); DMSO : 13.89 mg/mL (69.74 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C([C@@H](/C(O[C@]1([H])C2)=C/CO)N1C2=O)O	https://www.medchemexpress.com/clavulanic-acid.html	Launched		91.0	O15	G19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0256	10.0	mM	163.0	DMSO	199.048072	19	G	pluskal_fda_drugs_5005_G19_id
835	HY-B0105	HYCPK40904	H09	HYCPK40904	91z	737.0	3.0	P17	904.0	H09	65277-42-1	Ketoconazole	Ketoconazol; R 41400	531.43	Bacterial; Cytochrome P450; Fungal; Ras	Anti-infection; GPCR/G Protein; Metabolic Enzyme/Protease	Ketoconazole (R-41400) is an imidazole anti-fungal agent, a CYP3A4 and CYP24A1 inhibitor.	Free Base	C26H28Cl2N4O4	14239.0	DMSO : 25 mg/mL (47.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	CC(N1CCN(C2=CC=C(OC[C@@H]3O[C@@](CN4C=CN=C4)(C5=CC=C(Cl)C=C5Cl)OC3)C=C2)CC1)=O	https://www.medchemexpress.com/Ketoconazole.html	Launched		91.0	P17	G19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0105	10.0	mM	163.0	DMSO	530.148761	19	G	pluskal_fda_drugs_5005_G19_id
838	HY-10219	HYCPK40904	K09	HYCPK40904	91z	1025.0	3.0	V17	904.0	K09	53123-88-9	Rapamycin	Sirolimus; AY-22989	914.17	Antibiotic; Autophagy; Bacterial; Endogenous Metabolite; FKBP; Fungal; mTOR	Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; PI3K/Akt/mTOR	Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1[1]. Rapamycin is an autophagy activator, an immunosuppressant[2].	Free Base	C51H79NO13	61925.0	DMSO : 125 mg/mL (136.74 mM; Need ultrasonic); Ethanol : 50 mg/mL (54.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@@]1(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C([C@@H]([C@@H](/C(C)=C/[C@H]2C)O)OC)=O)C)OC)O1)C)C(N3CCCC[C@H]3C(O[C@@H](CC2=O)[C@@H](C[C@H]4C[C@H]([C@H](O)CC4)OC)C)=O)=O	https://www.medchemexpress.com/Rapamycin.html	Launched		91.0	V17	G19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10219	10.0	mM	163.0	DMSO	913.555142	19	G	pluskal_fda_drugs_5005_G19_id
1224	HY-B0335	HYCPK40905	A14	HYCPK40905	91z	76.0	4.0	B28	905.0	A14	13710-19-5	Tolfenamic Acid	GEA 6414	261.70	COX	Immunology/Inflammation	Tolfenamic Acid (GEA 6414) is a non-steroidal anti-inflammatory and anti-cancer agent, selectively inhibits COX-2, with an IC50 of 13.49 μM (3.53 μg/mL) in LPS-treated (COX-2) canine DH82 monocyte/macrophage cells, but shows no effect on COX-1.	Free Acid	C14H12ClNO2	90276.0	DMSO : ≥ 100 mg/mL (382.12 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O)C1=CC=CC=C1NC2=C(C)C(Cl)=CC=C2	https://www.medchemexpress.com/tolfenamic-acid.html	Launched		91.0	B28	G19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0335	10.0	mM	163.0	DMSO	261.055656	19	G	pluskal_fda_drugs_5005_G19_id
1311	HY-B1361	HYCPK40905	H19	HYCPK40905	91z	758.0	4.0	P38	905.0	H19	7280-37-7	Estropipate	Piperazine estrone sulfate; Estrone sulfate piperazine salt	436.56	Estrogen Receptor/ERR	Others	Estropipate is a form of estrogen, used to treat symptoms of menopause, also used to prevent osteoporosis.	Piperazine	C22H32N2O5S	17459.0	DMSO : 110 mg/mL (251.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	C[C@]1([C@](CC2)([H])[C@]3([H])CCC4=C(C=CC(OS(=O)(O)=O)=C4)[C@@]3([H])CC1)C2=O.N5CCNCC5	https://www.medchemexpress.com/Estropipate.html	Launched		91.0	P38	G19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1361	10.0	mM	163.0	DMSO	350.118795	19	G	pluskal_fda_drugs_5005_G19_id
248	HY-B0221	HYCPK40902	F15	HYCPK40902	91z	509.0	1.0	K29	902.0	F15	1397-89-3	Amphotericin B		924.08	Antibiotic; Bacterial; Fungal; Parasite	Anti-infection	Amphotericin B is a polyene antifungal agent against a wide variety of fungal pathogens. It binds irreversibly to ergosterol, resulting in disruption of membrane integrity and ultimately cell death.	Free Acid	C47H73NO17	62991.0	DMSO : 50 mg/mL (54.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@H]([C@@H](O)[C@@H](C)[C@H](C)OC1=O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](O[C@]2([H])O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@]3([H])[C@H](C(O)=O)[C@@H](O)C[C@](C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)C1)(O)O3	https://www.medchemexpress.com/amphotericin-b.html	Launched		91.0	K29	G20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0221	10.0	mM	164.0	DMSO	923.48785	20	G	pluskal_fda_drugs_5005_G20_id
308	HY-113293A	HYCPK40902	L19	HYCPK40902	91z	1093.0	1.0	W37	902.0	L19	1240-04-6	Estrone sulfate (potassium)		388.52	Endogenous Metabolite	Metabolic Enzyme/Protease	Estrone sulfate potassium is a natural endogenous steroid and is an estrogen ester and conjugate[1].	Potassium	C18H21KO5S	145055.0	DMSO : 100 mg/mL (257.39 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@]1([C@](CC2)([H])[C@]3([H])CCC4=C(C=CC(OS(=O)([O-])=O)=C4)[C@@]3([H])CC1)C2=O.[K+]	https://www.medchemexpress.com/estrone-sulfate-potassium.html	Launched		91.0	W37	G20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-113293A	10.0	mM	164.0	DMSO	350.118795	20	G	pluskal_fda_drugs_5005_G20_id
611	HY-14280	HYCPK40903	I14	HYCPK40903	91z	796.0	2.0	Q28	903.0	I14	130929-57-6	Entacapone		305.29	COMT	Metabolic Enzyme/Protease; Neuronal Signaling	Entacapone is a potent, reversible, peripherally acting and orally active catechol-O-methyltransferase (COMT) inhibitor. Entacapone inhibits COMT from rat brain, erythrocytes and liver with IC50 values of 10 nM, 20 nM, and 160 nM, respectively. Entacapone is selective for COMT over other catecholamine metabolizing enzymes, including MAO-A, MAO-B, phenolsulphotransferase M (PST-M) and PST-P (IC50s>50 μM). Entacapone can be used for the research of Parkinson's disease[1]. Entacapone serves as a inhibitor of FTO demethylation  with an IC50 of 3.5 μM, can be used for the research of metabolic disorders[2].	Free Base	C14H15N3O5	10600.0	H2O : 2 mg/mL (6.55 mM; ultrasonic and adjust pH to 10 with NaOH); DMSO : 33.33 mg/mL (109.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(N(CC)CC)/C(C#N)=C/C1=CC([N+]([O-])=O)=C(O)C(O)=C1	https://www.medchemexpress.com/entacapone.html	Launched		91.0	Q28	G20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14280	10.0	mM	164.0	DMSO	305.101171	20	G	pluskal_fda_drugs_5005_G20_id
612	HY-12008	HYCPK40903	J14	HYCPK40903	91z	892.0	2.0	S28	903.0	J14	183319-69-9	Erlotinib (Hydrochloride)	CP-358774 (hydrochloride); NSC 718781 (hydrochloride); OSI-774 (hydrochloride)	429.90	Autophagy; EGFR	Autophagy; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Erlotinib Hydrochloride (CP-358774 Hydrochloride) inhibits purified EGFR kinase with an IC50 of 2 nM.	Hydrochloride	C22H24ClN3O4	22932.0	DMSO : 6.2 mg/mL (14.42 mM; Need ultrasonic and warming); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	COCCOC1=CC2=NC=NC(NC3=CC=CC(C#C)=C3)=C2C=C1OCCOC.[H]Cl	https://www.medchemexpress.com/Erlotinib-Hydrochloride.html	Launched		91.0	S28	G20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12008	10.0	mM	164.0	DMSO	393.168856	20	G	pluskal_fda_drugs_5005_G20_id
733	HY-A0256A	HYCPK40903	M22	HYCPK40903	91z	1196.0	2.0	Y44	903.0	M22	61177-45-5	Clavulanate (potassium)		237.25	Antibiotic; Bacterial	Anti-infection	Clavulanate potassium is a potent β-lactamase inhibitor and acts as an antibiotic[1][2].	Potassium	C8H8KNO5	154357.0	H2O : 33.33 mg/mL (140.48 mM; ultrasonic and adjust pH to 2 with HCl)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](/C(O[C@]1([H])C2)=C/CO)N1C2=O)O[K]	https://www.medchemexpress.com/clavulanate-potassium.html	Launched		91.0	Y44	G20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0256A	10.0	mM	164.0	DMSO	199.048072	20	G	pluskal_fda_drugs_5005_G20_id
939	HY-17605	HYCPK40904	D16	HYCPK40904	91z	367.0	3.0	H31	904.0	D16	1611493-60-7	Bictegravir	GS-9883	449.38	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	Bictegravir (GS-9883) is a potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM.	Free Base	C21H18F3N3O5	27890.0	DMSO : 83.3 mg/mL (185.37 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	O=C1N([C@](CC2)([H])C[C@]2([H])O3)[C@@]3([H])CN(C=C(C(NCC(C(F)=CC(F)=C4)=C4F)=O)C5=O)C1=C5O	https://www.medchemexpress.com/Bictegravir.html	Launched		91.0	H31	G20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17605	10.0	mM	164.0	DMSO	449.119855	20	G	pluskal_fda_drugs_5005_G20_id
946	HY-B0105A	HYCPK40904	K16	HYCPK40904	91z	1039.0	3.0	V31	904.0	K16	142128-59-4	(+)-Ketoconazole	(+)-Ketoconazol; (+)-R 41400	531.43	Cytochrome P450; Fungal	Anti-infection; Metabolic Enzyme/Protease	"(+)-Ketoconazole ((+)-R 41400) is an imidazole anti-fungal agent, a CYP3A4 inhibitor.
Target: CYP3A4 
(+)-Ketoconazole, an imidazole anti-fungal agent, has often produced features of androgen deficiency including decreased libido, gynecomastia, impotence, oligospermia, and decreased testosterone levels, in men being treated for chronic mycotic infections [1]. (+)-Ketoconazole also is a cytochrome P450 inhibitor [2].
(+)-Ketoconazole (KTZ), on the antischistosomal potential of these quinolines against Schistosoma mansoni infection by evaluating parasitological, histopathological, and biochemical parameters. Mice were classified into 7 groups: uninfected untreated (I), infected untreated (II), infected treated orally with PZQ (1,000 mg/kg) (III), QN (400 mg/kg) (IV), KTZ (10 mg/kg)+QN as group IV (V), HF (400 mg/kg) (VI), and KTZ (as group V)+HF (as group VI) (VII). KTZ plus QN or HF produced more inhibition (P<0.05) in hepatic CYP450 (85.7% and 83.8%) and CYT b5 (75.5% and 73.5%) activities, respectively, than in groups treated with QN or HF alone. This was accompanied with more reduction in female (89.0% and 79.3%), total worms (81.4% and 70.3%), and eggs burden (hepatic; 83.8%, 66.0% and intestinal; 68%, 64.5%), respectively, and encountering the granulomatous reaction to parasite eggs trapped in the liver [3].
Clinical indications: Candida infection; Dermatophytosis; Folliculitis 
FDA Approved Date: 
Toxicity: teratogenesis; liver injuries; adrenal gland problems"	Free Base	C26H28Cl2N4O4	31883.0	DMSO : 33.33 mg/mL (62.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	ClC(C=C1)=CC(Cl)=C1[C@@]2(CN3C=CN=C3)OC[C@H](COC4=CC=C(N5CCN(C(C)=O)CC5)C=C4)O2	https://www.medchemexpress.com/__addition__-ketoconazole.html	Launched		91.0	V31	G20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0105A	10.0	mM	164.0	DMSO	530.148761	20	G	pluskal_fda_drugs_5005_G20_id
1184	HY-121235	HYCPK40905	I11	HYCPK40905	91z	838.0	4.0	R22	905.0	I11	17737-65-4	Clonixin	SCH-10304	262.69	Others	Others	Clonixin (SCH-10304) is an orally active non-steroidal anti-inflammatory agent in rodents[1].		C13H11ClN2O2	64129.0	DMSO : 100 mg/mL (380.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=CN=C1NC2=CC=CC(Cl)=C2C)O	https://www.medchemexpress.com/clonixin.html	Launched		91.0	R22	G20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-121235	10.0	mM	164.0	DMSO	262.050905	20	G	pluskal_fda_drugs_5005_G20_id
182	HY-B2087	HYCPK40902	D11	HYCPK40902	91z	309.0	1.0	G21	902.0	D11	611168-24-2	Glycerol phenylbutyrate	HPN-100	530.65	Sigma Receptor	Neuronal Signaling	Glycerol phenylbutyrate is a sigma-2 (σ2) receptor ligand, with a pKi of 8.02. Glycerol phenylbutyrate (GPB) is a new generation ammonia scavenger drug[1][2].	Free Base	C33H38O6	44190.0	Ethanol : 50 mg/mL (94.22 mM; Need ultrasonic); DMSO : ≥ 150 mg/mL (282.67 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(CCCC1=CC=CC=C1)OC(COC(CCCC2=CC=CC=C2)=O)COC(CCCC3=CC=CC=C3)=O	https://www.medchemexpress.com/Glycerol_phenylbutyrate.html	Launched		91.0	G21	G21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2087	10.0	mM	165.0	DMSO	530.266839	21	G	pluskal_fda_drugs_5005_G21_id
206	HY-B0328	HYCPK40902	L12	HYCPK40902	91z	1079.0	1.0	W23	902.0	L12	124-94-7	Triamcinolone		394.43	Bacterial; Glucocorticoid Receptor	Anti-infection; Immunology/Inflammation	"Triamcinolone is a long-acting corticosteroid. Triamcinolone is a corticosteroid hormone receptor agonist and an  anti-inflammatory agent.
Target: Glucocorticoid Receptor
Dimethyl fumarate is an anti-inflammatory. It is indicated for multiple sclerosis patients with relapsing forms and is also being investigated for the treatment of psoriasis. The mechanism of action of dimethyl fumarate in multiple sclerosis is not well understood. It is thought to involve dimethyl fumarate degradation to its active metabolite monomethyl fumarate (MMF) then MMF up-regulates the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway that is activated in response to oxidative stress [1]. 
The mean duration of follow-up was 40 months. The rate of decline in the FEV1 after bronchodilator use was similar in the 559 participants in the triamcinolone group and the 557 participants in the placebo group (44.2+/-2.9 vs. 47.0+/-3.0 ml per year, P= 0.50). Members of the triamcinolone group had fewer respiratory symptoms during the course of the study (21.1 per 100 person-years vs. 28.2 per 100 person-years, P=0.005) and had fewer visits to a physician because of a respiratory illness (1.2 per 100 person-years vs. 2.1 per 100 person-years, P=0.03). Those taking triamcinolone also had lower airway reactivity in response to methacholine challenge at 9 months and 33 months (P=0.02 for both comparisons) [2]."	Free Base	C21H27FO6	22273.0	H2O : 1 mg/mL (2.54 mM; ultrasonic and warming and heat to 80°C); DMSO : 100 mg/mL (253.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Endocrinology	F[C@@]1([C@]2(C=C3)C)[C@](CCC2=CC3=O)([H])[C@@](C[C@@H](O)[C@]4(O)C(CO)=O)([H])[C@]4(C)C[C@@H]1O	https://www.medchemexpress.com/Triamcinolone.html	Launched		91.0	W23	G21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0328	10.0	mM	165.0	DMSO	394.179167	21	G	pluskal_fda_drugs_5005_G21_id
355	HY-B0565	HYCPK40903	L03	HYCPK40903	91z	1062.0	2.0	W6	903.0	L03	7681-76-7	Ronidazole		200.15	Bacterial; Parasite	Anti-infection	Ronidazole is a potent and orally active antiprotozoal and anti-microbial agent. Ronidazole acts as a veterinary agent against Tritrichomonas foetus?in cats models. Ronidazole can be used the research of forhistomoniasis?and?swine?dysentery[1].	Free Base	C6H8N4O4	149330.0	DMSO : 100 mg/mL (499.63 mM; Need ultrasonic); H2O : 4 mg/mL (19.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	NC(OCC1=NC=C([N+]([O-])=O)N1C)=O	https://www.medchemexpress.com/Ronidazole.html	Launched		91.0	W6	G21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0565	10.0	mM	165.0	DMSO	200.054555	21	G	pluskal_fda_drugs_5005_G21_id
577	HY-14855B	HYCPK40903	I19	HYCPK40903	91z	806.0	2.0	Q38	903.0	I19	856867-55-5	Tedizolid (phosphate)	TR-701FA	450.32	Antibiotic; Bacterial	Anti-infection	Tedizolid phosphate (TR-701FA) is a novel oxazolidinone with activity against Gram-positive pathogens.	Free Acid	C17H16FN6O6P	18297.0	DMSO : ≥ 36 mg/mL (79.94 mM); H2O : 0.1 mg/mL (0.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1O[C@@H](COP(O)(O)=O)CN1C2=CC=C(C3=CC=C(C4=NN(C)N=N4)N=C3)C(F)=C2	https://www.medchemexpress.com/Tedizolid-phosphate.html	Launched		91.0	Q38	G21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14855B	10.0	mM	165.0	DMSO	450.085297	21	G	pluskal_fda_drugs_5005_G21_id
795	HY-13596	HYCPK40904	P06	HYCPK40904	91z	1499.0	3.0	AF11	904.0	P06	96946-42-8	Cisatracurium (besylate)	51W89	1243.48	Autophagy; nAChR	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Cisatracurium besylate (51W89) is a nondepolarizing neuromuscular blocking agent, antagonizing the action of acetylcholine by inhibiting neuromuscular transmission.	Benzenesulfonate	C65H82N2O18S2	15246.0	H2O : ≥ 50 mg/mL (40.21 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(OCCCCCOC(CC[N@+]1(C)[C@H](CC2=CC=C(OC)C(OC)=C2)C3=C(C=C(OC)C(OC)=C3)CC1)=O)CC[N@+]4(C)[C@H](CC5=CC=C(OC)C(OC)=C5)C6=C(C=C(OC)C(OC)=C6)CC4.O=S(C7=CC=CC=C7)([O-])=O.O=S(C8=CC=CC=C8)([O-])=O	https://www.medchemexpress.com/Cisatracurium-besylate.html	Launched		91.0	AF11	G21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13596	10.0	mM	165.0	DMSO	928.507429	21	G	pluskal_fda_drugs_5005_G21_id
824	HY-B1072	HYCPK40904	M08	HYCPK40904	91z	1215.0	3.0	Z15	904.0	M08	26002-80-2	Phenothrin		350.45	Parasite	Anti-infection	Phenothrin is a synthetic pyrethroid that kills adult fleas and ticks. It has also been used to kill head lice in humans.	Free Base	C23H26O3	152239.0	DMSO : 100 mg/mL (285.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1C(C)(C)C1/C=C(C)\C)OCC2=CC=CC(OC3=CC=CC=C3)=C2	https://www.medchemexpress.com/Phenothrin.html	Launched		91.0	Z15	G21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1072	10.0	mM	165.0	DMSO	350.188195	21	G	pluskal_fda_drugs_5005_G21_id
962	HY-B1085	HYCPK40904	K17	HYCPK40904	91z	1041.0	3.0	V33	904.0	K17	28657-80-9	Cinoxacin	Compound 64716	262.22	Antibiotic; Bacterial; DNA/RNA Synthesis	Anti-infection; Cell Cycle/DNA Damage	Cinoxacin (Compound 64716), a synthetic antimicrobial related to the quinolone class of orally active antibacterial agent. Cinoxacin has antibacterial activity against many gram-negative aerobic bacteria and inhibits bacterial DNA synthesis. Cinoxacin can be used for the research of urinary tract infections and bacterial prostatitis[1][2].	Free Acid	C12H10N2O5	61987.0	DMSO : 8.33 mg/mL (31.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=NN(CC)C2=C(C=C3C(OCO3)=C2)C1=O)O	https://www.medchemexpress.com/Cinoxacin.html	Launched		91.0	V33	G21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1085	10.0	mM	165.0	DMSO	262.058971	21	G	pluskal_fda_drugs_5005_G21_id
1049	HY-N0584	HYCPK40905	B03	HYCPK40905	91z	150.0	4.0	D6	905.0	B03	55869-99-3	Anisodamine	6-Hydroxyhyoscyamine	305.37	mAChR	GPCR/G Protein; Neuronal Signaling	Anisodamine (6-Hydroxyhyoscyamine), a belladonna alkaloid, is a non-subtype-selective muscarinic, and also a nicotinic cholinoceptor antagonist. Anisodamine employs in traditional Chinese medicine for many ailments, mainly to improve the microcirculation in states of shock, and also in organophosphate poisoning[1][2].	Free Base	C17H23NO4	139974.0	H2O : 20 mg/mL (65.49 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (327.47 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1[C@H]2[C@@H](O)C[C@@H]1C[C@H](OC([C@@H](C3=CC=CC=C3)CO)=O)C2	https://www.medchemexpress.com/Anisodamine.html	Launched		91.0	D6	G21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0584	10.0	mM	165.0	DMSO	305.162708	21	G	pluskal_fda_drugs_5005_G21_id
292	HY-30272	HYCPK40902	L18	HYCPK40902	91z	1091.0	1.0	W35	902.0	L18	103-16-2	Monobenzone		200.23	Others	Others	Monobenzone is a potent skin depigmenting agent. Monobenzone induces depigmentation and active human vitiligo and exhibits good potential for vitiligo research[1].	Free Base	C13H12O2	16465.0	DMSO : ≥ 100 mg/mL (499.43 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC1=CC=C(C=C1)OCC2=CC=CC=C2	https://www.medchemexpress.com/4-_Benzyloxy_phenol.html	Launched		91.0	W35	G22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-30272	10.0	mM	166.0	DMSO	200.08373	22	G	pluskal_fda_drugs_5005_G22_id
340	HY-B2155	HYCPK40902	M22	HYCPK40902	91z	1195.0	1.0	Y43	902.0	M22	773092-05-0	Acotiamide (monohydrochloride trihydrate)		541.06	Cholinesterase (ChE)	Neuronal Signaling	Acotiamide monohydrochloride trihydrate is an orally active, selective and reversible acetylcholinesterase (AChE) inhibitor, with IC50 of 1.79 μM. Acotiamide monohydrochloride trihydrate can enhance gastric contractility and accelerate delayed gastric emptying. Acotiamide monohydrochloride trihydrate has the potential for the research of functional dyspepsia involving gastric motility dysfunction and intestinal inflammatory [1][2][3].	Hydrochloride	C21H37ClN4O8S	57180.0	H2O : 3.03 mg/mL (5.60 mM; ultrasonic and warming and heat to 60°C); DMSO : 125 mg/mL (231.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Inflammation/Immunology	O=C(C1=CSC(NC(C2=CC(OC)=C(OC)C=C2O)=O)=N1)NCCN(C(C)C)C(C)C.[H]Cl.O.O.O	https://www.medchemexpress.com/acotiamide-monohydrochloride-trihydrate.html	Launched		91.0	Y43	G22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2155	10.0	mM	166.0	DMSO	450.193691	22	G	pluskal_fda_drugs_5005_G22_id
346	HY-13064	HYCPK40903	C03	HYCPK40903	91z	198.0	2.0	E6	903.0	C03	934660-93-2	Cobimetinib	GDC-0973; XL518	531.31	Apoptosis; MEK	Apoptosis; MAPK/ERK Pathway	Cobimetinib (GDC-0973, RG7420) is a potent, selective and oral MEK1 inhibitor with an IC50 of 4.2 nM for MEK1.	Free Base	C21H21F3IN3O2	7155.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : ≥ 100 mg/mL (188.21 mM)	DMSO Solution	10mM  * 100uL	Cancer	OC1([C@H]2NCCCC2)CN(C1)C(C3=C(C(F)=C(C=C3)F)NC4=C(C=C(C=C4)I)F)=O	https://www.medchemexpress.com/Cobimetinib.html	Launched		91.0	E6	G22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13064	10.0	mM	166.0	DMSO	531.06306	22	G	pluskal_fda_drugs_5005_G22_id
724	HY-B0136	HYCPK40903	D22	HYCPK40903	91z	332.0	2.0	G44	903.0	D22	91832-40-5	Cefdinir	FK-482; CI-983	395.41	Antibiotic; Bacterial	Anti-infection	Cefdinir (FK-482) is a semi-synthetic, broad-spectrum antibiotic in the third generation of the cephalosporin class, which is proved to be effective for infections caused by several Gram-negative and Gram-positive bacteria. Cefdinir can be used for the research of common bacterial infections of the ear, sinus, throat, and skin[1][2].	Free Acid	C14H13N5O5S2	15943.0	H2O : 0.67 mg/mL (1.69 mM; Need ultrasonic); DMSO : 33.33 mg/mL (84.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(C=C)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\O)=O)C1=O)O	https://www.medchemexpress.com/Cefdinir.html	Launched		91.0	G44	G22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0136	10.0	mM	166.0	DMSO	395.035811	22	G	pluskal_fda_drugs_5005_G22_id
924	HY-10218	HYCPK40904	A15	HYCPK40904	91z	77.0	3.0	B29	904.0	A15	159351-69-6	Everolimus	RAD001; SDZ-RAD	958.22	Apoptosis; Autophagy; Bacterial; FKBP; mTOR	Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation; PI3K/Akt/mTOR	"Everolimus (RAD001) is a <a href=""/Rapamycin.html"" class=""link-product"" target=""_blank"">Rapamycin</a> (HY-10219) derivative and a potent, selective and orally active mTOR1 inhibitor. Everolimus binds to FKBP-12 to generate an immunosuppressive complex. Everolimus inhibits tumor cells proliferation and induces cell apoptosis and autophagy. Everolimus has potent immunosuppressive and anticancer activities[1][2]."	Free Base	C53H83NO14	112991.0	DMSO : 50 mg/mL (52.18 mM; ultrasonic and warming and heat to 60°C); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@@]1(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C([C@@H]([C@@H](/C(C)=C/[C@H]2C)O)OC)=O)C)OC)O1)C)C(N3CCCC[C@H]3C(O[C@@H](CC2=O)[C@@H](C[C@H]4C[C@H]([C@H](OCCO)CC4)OC)C)=O)=O	https://www.medchemexpress.com/Everolimus.html	Launched		91.0	B29	G22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10218	10.0	mM	166.0	DMSO	957.581356	22	G	pluskal_fda_drugs_5005_G22_id
1109	HY-10448	HYCPK40905	N06	HYCPK40905	91z	1308.0	4.0	AB12	905.0	N06	404-86-4	Capsaicin	(E)-Capsaicin	305.41	Apoptosis; Autophagy; Endogenous Metabolite; TRP Channel	Apoptosis; Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Capsaicin ((E)-Capsaicin), an active component of chili peppers, is a TRPV1 agonist. Capsaicin has pain relief, antioxidant, anti-inflammatory, neuroprotection and anti-cancer effects[1][2].	Free Base	C18H27NO3	119780.0	DMSO : 100 mg/mL (327.43 mM; Need ultrasonic); Ethanol : 200 mg/mL (654.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC(C)/C=C/CCCCC(NCC1=CC=C(O)C(OC)=C1)=O	https://www.medchemexpress.com/Capsaicin.html	Launched		91.0	AB12	G22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10448	10.0	mM	166.0	DMSO	305.199094	22	G	pluskal_fda_drugs_5005_G22_id
1188	HY-N0191	HYCPK40905	M11	HYCPK40905	91z	1222.0	4.0	Z22	905.0	M11	5508-58-7	Andrographolide	Andrographis	350.45	Autophagy; Influenza Virus; NF-κB; Parasite; SARS-CoV	Anti-infection; Autophagy; NF-κB	Andrographolide is a NF-κB inhibitor, which inhibits NF-κB activation through covalent modification of a cysteine residue on p50 in endothelial cells without affecting IκBα degradation or p50/p65 nuclear translocation. Andrographolide has antiviral effects.	Free Base	C20H30O5	59592.0	H2O : 0.1 mg/mL (0.29 mM; Need ultrasonic); DMSO : 100 mg/mL (285.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=C1OC[C@@H](O)/C1=C\C[C@@H]2C(CC[C@]3([H])[C@](C)(CO)[C@H](O)CC[C@@]23C)=C	https://www.medchemexpress.com/andrographolide.html	Launched		91.0	Z22	G22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0191	10.0	mM	166.0	DMSO	350.209324	22	G	pluskal_fda_drugs_5005_G22_id
1345	HY-N0117	HYCPK40905	J21	HYCPK40905	91z	954.0	4.0	T42	905.0	J21	479-41-4	Indirubin	Couroupitine B; Indigo red; Indigopurpurin	262.26	Apoptosis	Apoptosis	Indirubin (Couroupitine B) is a bis-indole alkaloid and has emarkable anticancer activity against chronic myelocytic leukemia[1][2].	Free Base	C16H10N2O2	26340.0	DMSO : 5 mg/mL (19.07 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NC2=C(C=CC=C2)/C1=C3NC4=C(C=CC=C4)C\3=O	https://www.medchemexpress.com/Indirubin.html	Launched		91.0	T42	G22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0117	10.0	mM	166.0	DMSO	262.074228	22	G	pluskal_fda_drugs_5005_G22_id
89	HY-17034A	HYCPK40902	B04	HYCPK40902	91z	103.0	1.0	C7	902.0	B04	145108-58-3	Dexmedetomidine (hydrochloride)	(+)-Medetomidine (hydrochloride); (S)-Medetomidine (hydrochloride)	236.74	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Dexmedetomidine hydrochloride ((+)-Medetomidine hydrochloride) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine hydrochloride shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine hydrochloride exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3].	Hydrochloride	C13H17ClN2	15387.0	DMSO : 250 mg/mL (1056.01 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (211.20 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology; Cancer	C[C@H](C1=CN=CN1)C2=CC=CC(C)=C2C.Cl	https://www.medchemexpress.com/Dexmedetomidine-hydrochloride.html	Launched		91.0	C7	H3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17034A	10.0	mM	171.0	DMSO	200.131349	3	H	pluskal_fda_drugs_5005_H3_id
203	HY-B0261	HYCPK40902	I12	HYCPK40902	91z	791.0	1.0	Q23	902.0	I12	71125-38-7	Meloxicam		351.40	Apoptosis; Autophagy; COX; MMP	Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease	Meloxicam is a non-steroidal antiinflammatory agent, inhibits COX activity, with IC50s of 0.49 μM and 36.6 μM for COX-2 and COX-1, respectively.	Free Base	C14H13N3O4S2	16255.0	DMSO : 50 mg/mL (142.29 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(C1=C(O)C2=CC=CC=C2S(N1C)(=O)=O)NC3=NC=C(C)S3	https://www.medchemexpress.com/meloxicam.html	Launched		91.0	Q23	H3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0261	10.0	mM	171.0	DMSO	351.034748	3	H	pluskal_fda_drugs_5005_H3_id
526	HY-10562	HYCPK40903	O10	HYCPK40903	91z	1364.0	2.0	AC20	903.0	O10	74050-98-9	Ketanserin	R41468	395.43	5-HT Receptor; Autophagy; Potassium Channel	Autophagy; GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Ketanserin is a selective 5-HT2 receptor antagonist. Ketanserin also blocks hERG current (IhERG) in a concentration-dependent manner (IC50=0.11 μM).	Free Base	C22H22FN3O3	112489.0	DMSO : 16.67 mg/mL (42.16 mM; Need ultrasonic); DMF : 5 mg/mL (12.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=CC=C1N2)N(CCN3CCC(C(C4=CC=C(F)C=C4)=O)CC3)C2=O	https://www.medchemexpress.com/Ketanserin.html	Launched		91.0	AC20	H3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10562	10.0	mM	171.0	DMSO	395.16452	3	H	pluskal_fda_drugs_5005_H3_id
533	HY-B0153A	HYCPK40903	F11	HYCPK40903	91z	502.0	2.0	K22	903.0	F11	53885-35-1	Ticlopidine (hydrochloride)		300.25	Adenosine Receptor	GPCR/G Protein	"Ticlopidine hydrochloride is an adenosine diphosphate (ADP) receptor inhibitor against platelet aggregation with IC50 of ~2 μM.
Target: Adenosine diphosphate (ADP)
Ticlopidine (trade name Ticlid) is an antiplatelet drug in the thienopyridine family. Ticlopidine hydrochloride inhibits platelet aggregation with IC50 of ~2 μM in men. Like clopidogrel, it is an adenosine diphosphate (ADP) receptor inhibitor. It is used in patients in whom aspirin is not tolerated, or in whom dual antiplatelet therapy is desirable. Because it has been reported to increase the risk of thrombotic thrombocytopenic purpura (TTP) and neutropenia, its use has largely been supplanted by the newer drug, clopidogrel, which is felt to have a much lower hematologic risk. Its niche role as an alternative in those patients who do not tolerate Clopidogrel has now been superdeded by Ticagrelor and Prasugrel. The usual dose is 250 mg twice daily by the oral route.
Ticlopidine hydrochloride, when orally administered to rats, results in activation of basal and prostaglandin E1 (PGE1)-stimulated adenylate cylase activity through increase in affinity of the cyclase in platelet membrane to PGE1, although it failed to affect adenosine- or sodium fluoride-stimulated activity of the enzyme."	Hydrochloride	C14H15Cl2NS	16715.0	DMSO : 50 mg/mL (166.53 mM; Need ultrasonic); H2O : 50 mg/mL (166.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	ClC1=CC=CC=C1CN2CCC3=C(C=CS3)C2.Cl	https://www.medchemexpress.com/Ticlopidine-hydrochloride.html	Launched		91.0	K22	H3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0153A	10.0	mM	171.0	DMSO	263.053548	3	H	pluskal_fda_drugs_5005_H3_id
745	HY-B2184	HYCPK40904	I03	HYCPK40904	91z	821.0	3.0	R5	904.0	I03	64506-49-6	Sofalcone		450.52	Autophagy; Bacterial	Anti-infection; Autophagy	Sofalcone, a gastric antiulcer agent, is known to induce the expression of Heme oxygenase-1 (HO-1) in gastric epithelium.	Free Acid	C27H30O6	26655.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (221.97 mM)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(O)COC1=CC(OC/C=C(C)/C)=CC=C1C(/C=C/C2=CC=C(OC/C=C(C)/C)C=C2)=O	https://www.medchemexpress.com/Sofalcone.html	Launched		91.0	R5	H3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2184	10.0	mM	171.0	DMSO	450.204239	3	H	pluskal_fda_drugs_5005_H3_id
877	HY-B1583	HYCPK40904	B12	HYCPK40904	91z	167.0	3.0	D23	904.0	B12	25775-90-0	(Z)-Capsaicin	Zucapsaicin; Civamide; cis-Capsaicin	305.41	HSV; TRP Channel	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	(Z)-Capsaicin is the cis isomer of capsaicin, acts as an orally active TRPV1 agonist, and is used in the research of neuropathic pain.	Free Base	C18H27NO3	35607.0	DMSO : ≥ 125 mg/mL (409.29 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(C)/C=C\CCCCC(NCC1=CC=C(O)C(OC)=C1)=O	https://www.medchemexpress.com/_Z_-Capsaicin.html	Launched		91.0	D23	H3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1583	10.0	mM	171.0	DMSO	305.199094	3	H	pluskal_fda_drugs_5005_H3_id
1068	HY-13078	HYCPK40905	E04	HYCPK40905	91z	440.0	4.0	J8	905.0	E04	934662-91-6	Cobimetinib (racemate)	GDC-0973 (racemate); XL518 (racemate)	531.31	MEK	MAPK/ERK Pathway	Cobimetinib racemate (GDC-0973 racemate; XL518 racemate) is the racemate of Cobimetinib. Cobimetinib is a potent and selective MEK inhibitor.	Free Base	C21H21F3IN3O2	13725.0	DMSO : ≥ 40 mg/mL (75.29 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=C(F)C(F)=C1NC2=CC=C(I)C=C2F)N3CC(C4NCCCC4)(O)C3	https://www.medchemexpress.com/Cobimetinib-racemate.html	Launched		91.0	J8	H3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13078	10.0	mM	171.0	DMSO	531.06306	3	H	pluskal_fda_drugs_5005_H3_id
1140	HY-17573	HYCPK40905	M08	HYCPK40905	91z	1216.0	4.0	Z16	905.0	M08	37025-55-1	Carbetocin		988.16	Oxytocin Receptor	GPCR/G Protein	Carbetocin, an oxytocin (OT) analogue, is an oxytocin receptor agonist with a Ki of 7.1 nM. Carbetocin has high affinity to chimeric N-terminus (E1) of the oxytocin receptor (Ki=1.17 μM). Carbetocin has the potential for postpartum hemorrhage research. Carbetocin can crosse the blood-brain barrier and produces antidepressant-like activity via activation of oxytocin receptors in the CNS[1][2][3].	Free Base	C45H69N11O12S	160007.0	DMSO : ≥ 31 mg/mL (31.37 mM); H2O : ≥ 33.33 mg/mL (33.73 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Neurological Disease	O=C([C@H](CSCCCC(N[C@H](C1=O)CC2=CC=C(OC)C=C2)=O)NC([C@@H](NC([C@](NC([C@](N1)([H])[C@@H](C)CC)=O)([H])CCC(N)=O)=O)CC(N)=O)=O)N(CCC3)[C@@H]3C(N[C@@H](CC(C)C)C(NCC(N)=O)=O)=O	https://www.medchemexpress.com/Carbetocin.html	Launched		91.0	Z16	H3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17573	10.0	mM	171.0	DMSO	987.484788	3	H	pluskal_fda_drugs_5005_H3_id
83	HY-101277	HYCPK40902	L03	HYCPK40902	91z	1061.0	1.0	W5	902.0	L03	1000025-07-9	Vadadustat	PG-1016548; AKB-6548	306.70	HIF/HIF Prolyl-Hydroxylase	Metabolic Enzyme/Protease	Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor[1]. Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo[1][2].	Free Acid	C14H11ClN2O4	24169.0	DMSO : 100 mg/mL (326.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O)CNC(C1=NC=C(C2=CC=CC(Cl)=C2)C=C1O)=O	https://www.medchemexpress.com/Vadadustat.html	Launched		91.0	W5	H4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101277	10.0	mM	172.0	DMSO	306.040735	4	H	pluskal_fda_drugs_5005_H4_id
232	HY-B1275A	HYCPK40902	F14	HYCPK40902	91z	507.0	1.0	K27	902.0	F14	153-61-7	Cephalothin	Cephalotin	396.44	Antibiotic; Bacterial	Anti-infection	Cephalotin (Cephalotin) is a beta-lactam antibiotic, inhibits class C β-lactamase AmpC, with an Ki of 0.32 μM[1].	Free Acid	C16H16N2O6S2	149100.0	DMSO : 100 mg/mL (252.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(COC(C)=O)CS[C@]2([H])[C@H](NC(CC3=CC=CS3)=O)C1=O)O	https://www.medchemexpress.com/cephalothin.html	Launched		91.0	K27	H4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1275A	10.0	mM	172.0	DMSO	396.044978	4	H	pluskal_fda_drugs_5005_H4_id
523	HY-12719	HYCPK40903	L10	HYCPK40903	91z	1076.0	2.0	W20	903.0	L10	113775-47-6	Dexmedetomidine	(+)-Medetomidine; (S)-Medetomidine	200.28	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Dexmedetomidine ((+)-Medetomidine) is a potent, selective and orally active agonist of α2-adrenoceptor, with a Ki of 1.08 nM. Dexmedetomidine shows 1620-fold selectivity against α1-adrenoceptor. Dexmedetomidine exhibits anxiolysis, sedation, and modest analgesia effects[1][2][3].		C13H16N2	97817.0	DMSO : 125 mg/mL (624.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	C[C@H](C1=CN=CN1)C2=CC=CC(C)=C2C	https://www.medchemexpress.com/dexmedetomidine.html	Launched		91.0	W20	H4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12719	10.0	mM	172.0	DMSO	200.131349	4	H	pluskal_fda_drugs_5005_H4_id
538	HY-B1058	HYCPK40903	K11	HYCPK40903	91z	982.0	2.0	U22	903.0	K11	23642-66-2	Benfluorex (hydrochloride)	JP-992 (hydrochloride)	387.82	Others	Others	Benfluorex hydrochloride (JP-992 hydrochloride) is a hepatic nuclear factor 4 alpha (HNF4α) activator.	Hydrochloride	C19H21ClF3NO2	63036.0	DMSO : ≥ 100 mg/mL (257.85 mM); H2O : 2.27 mg/mL (5.85 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	FC(C1=CC(CC(NCCOC(C2=CC=CC=C2)=O)C)=CC=C1)(F)F.[H]Cl	https://www.medchemexpress.com/Benfluorex-hydrochloride.html	Launched		91.0	U22	H4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1058	10.0	mM	172.0	DMSO	351.144614	4	H	pluskal_fda_drugs_5005_H4_id
647	HY-17365	HYCPK40903	M16	HYCPK40903	91z	1184.0	2.0	Y32	903.0	M16	79517-01-4	Octreotide (acetate)	SMS 201-995 (acetate)	1079.29	Somatostatin Receptor	GPCR/G Protein; Neuronal Signaling	Octreotide acetate, a long-acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently.	Acetate	C51H70N10O12S2	100829.0	DMSO : ≥ 29 mg/mL (26.87 mM); H2O : 25 mg/mL (23.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease; Endocrinology; Cancer	O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@H](CO)[C@H](O)C)=O)NC([C@H](N)CC2=CC=CC=C2)=O)=O)CC3=CC=CC=C3)N[C@@H]1CC4=CNC5=CC=CC=C45.CC(O)=O	https://www.medchemexpress.com/Octreotide-acetate.html	Launched		91.0	Y32	H4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17365	10.0	mM	172.0	DMSO	1018.44048	4	H	pluskal_fda_drugs_5005_H4_id
1154	HY-B1417	HYCPK40905	K09	HYCPK40905	91z	1026.0	4.0	V18	905.0	K09	894-71-3	Nortriptyline (hydrochloride)	Desmethylamitriptyline (hydrochloride); Desitriptilina (hydrochloride)	299.84	Autophagy; Drug Metabolite	Autophagy; Metabolic Enzyme/Protease	Nortriptyline hydrochloride (Desmethylamitriptyline hydrochloride), the main active metabolite of Amitriptyline, is a tricyclic antidepressant used to relieve the symptoms of depression. Nortriptyline hydrochloride is a potent autophagy  inhibitor[1][2].	Hydrochloride	C19H22ClN	17680.0	DMSO : 83.33 mg/mL (277.91 mM; Need ultrasonic); H2O : 7.14 mg/mL (23.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	CNCC/C=C1C2=CC=CC=C2CCC3=CC=CC=C\13.[H]Cl	https://www.medchemexpress.com/Nortriptyline-hydrochloride.html	Launched		91.0	V18	H4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1417	10.0	mM	172.0	DMSO	263.1674	4	H	pluskal_fda_drugs_5005_H4_id
1171	HY-13064A	HYCPK40905	L10	HYCPK40905	91z	1124.0	4.0	X20	905.0	L10	1369665-02-0	Cobimetinib (hemifumarate)	GDC-0973 (hemifumarate); XL-518 (hemifumarate)	589.25	Apoptosis; MEK	Apoptosis; MAPK/ERK Pathway	Cobimetinib hemifumarate is a novel selective MEK1 inhibitor, and the IC50 value against MEK1 is 4.2 nM.	Fumarate	C21H21F3IN3O2.1/2C4H4O4	26068.0	H2O : 1 mg/mL (1.70 mM; ultrasonic and warming and heat to 60°C); DMSO : 50 mg/mL (84.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC1(CN(C(C2=C(NC3=C(F)C=C(I)C=C3)C(F)=C(F)C=C2)=O)C1)[C@H]4NCCCC4.O=C(/C=C/C(O)=O)O.[0.5]	https://www.medchemexpress.com/Cobimetinib_hemifumarate.html	Launched		91.0	X20	H4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13064A	10.0	mM	172.0	DMSO	531.06306	4	H	pluskal_fda_drugs_5005_H4_id
1294	HY-B0098A	HYCPK40905	G18	HYCPK40905	91z	660.0	4.0	N36	905.0	G18	77883-43-3	Doxazosin (mesylate)	UK 33274 mesylate	547.58	Adrenergic Receptor; Autophagy; Mitophagy	Autophagy; GPCR/G Protein; Neuronal Signaling	Doxazosin mesylate (UK 33274) is a quinazoline-derivative that selectively antagonizes postsynaptic α1-adrenergic receptors.	Mesylate	C24H29N5O8S	15705.0	H2O : 1 mg/mL (1.83 mM; Need ultrasonic); DMSO : 33.33 mg/mL (60.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4OC5=CC=CC=C5OC4.CS(=O)(O)=O	https://www.medchemexpress.com/Doxazosin-mesylate.html	Launched		91.0	N36	H4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0098A	10.0	mM	172.0	DMSO	451.185569	4	H	pluskal_fda_drugs_5005_H4_id
159	HY-B0263	HYCPK40902	M09	HYCPK40902	91z	1169.0	1.0	Y17	902.0	M09	148-79-8	Thiabendazole	2-(4-Thiazolyl)benzimidazole	201.25	Mitochondrial Metabolism; Parasite	Anti-infection; Metabolic Enzyme/Protease	"Thiabendazole inhibites the mitochondrial helminth-specific enzyme, fumarate reductase, with anthelminthic property. 
Target: Fumarate Reductase
Tiabendazole serves to block angiogenesis in both frog embryos and human cells. It has also been shown to serve as a vascular disrupting agent to reduce newly established blood vessels. Tiabendazole has been shown to effectively do this in certain cancer cells. Thiabendazole works by inhibition of the mitochondrial, helminth-specific enzyme, fumarate reductase, with possible interaction with endogenous quinone [1].
Thiabendazole inhibited B16F10 proliferation in vitro in a dose- and time-dependent manner with an IC50 of 532.4 +/- 32.6, 322.9 +/- 28.9, 238.5 +/- 19.8 microM at 24, 48, and 72 h, respectively. Moreover, thiabendazole inhibited the angiogenesis and the migration of B16F10 cells in vitro. Furthermore, thiabendazole restrained transcription and translation of the VEGF gene in B16F10 in vitro, and the apoptotic percentage of B16F10 cells was increased after exposure to thiabendazole [2]."	Free Base	C10H7N3S	15041.0	DMSO : 50 mg/mL (248.45 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	C1(C2=CSC=N2)=NC3=CC=CC=C3N1	https://www.medchemexpress.com/Thiabendazole.html	Launched		91.0	Y17	H5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0263	10.0	mM	173.0	DMSO	201.036068	5	H	pluskal_fda_drugs_5005_H5_id
233	HY-13262	HYCPK40902	G14	HYCPK40902	91z	603.0	1.0	M27	902.0	G14	936727-05-8	Lumacaftor	VX-809; VRT 826809	452.41	Autophagy; CFTR	Autophagy; Membrane Transporter/Ion Channel	Lumacaftor (VX-809; VRT 826809) is a CFTR modulator that corrects the folding and trafficking of CFTR protein.	Free Acid	C24H18F2N2O5	6855.0	DMSO : 50 mg/mL (110.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	FC1(F)OC(C=C(C=C2)C3(CC3)C(NC4=NC(C5=CC=CC(C(O)=O)=C5)=C(C=C4)C)=O)=C2O1	https://www.medchemexpress.com/VX-809.html	Launched		91.0	M27	H5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13262	10.0	mM	173.0	DMSO	452.118378	5	H	pluskal_fda_drugs_5005_H5_id
291	HY-B0101	HYCPK40902	K18	HYCPK40902	91z	995.0	1.0	U35	902.0	K18	86386-73-4	Fluconazole	UK-49858	306.27	Antibiotic; Bacterial; Fungal	Anti-infection	Fluconazole (UK-49858) is a triazole antifungal agent with excellent activities against a broad range of fungi, especially against Candida albicans. Fluconazole inhibits C. albicans and Candida kefyr with IC99s range from 0.20 μg/mL to 0.39 μg/mL[1].	Free Base	C13H12F2N6O	15618.0	H2O : 2 mg/mL (6.53 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (326.51 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	FC1=CC=C(C(O)(CN2C=NC=N2)CN3C=NC=N3)C(F)=C1	https://www.medchemexpress.com/Fluconazole.html	Launched		91.0	U35	H5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0101	10.0	mM	173.0	DMSO	306.104065	5	H	pluskal_fda_drugs_5005_H5_id
310	HY-110189	HYCPK40902	N19	HYCPK40902	91z	1285.0	1.0	AA37	902.0	N19	1852-38-6	Pregnenolone monosulfate (sodium)	3β-Hydroxy-5-pregnen-20-one monosulfate (sodium)	418.52	Autophagy; Cannabinoid Receptor; Endogenous Metabolite; TRP Channel	Autophagy; GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Pregnenolone monosulfate sodium (3β-Hydroxy-5-pregnen-20-one monosulfate sodium) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone monosulfate sodium acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of tetrahydrocannabinol (THC) that are mediated by the CB1 receptors. Pregnenolone monosulfate sodium can protect the brain from cannabis intoxication[1][2]. Pregnenolone monosulfate sodium is also a TRPM3 channel activator, and also can weakly activate TRPM1 channels[3].	Sodium	C21H31NaO5S	118650.0	DMSO : 100 mg/mL (238.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC([C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](OS(=O)(O[Na])=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O	https://www.medchemexpress.com/pregnenolone-monosulfate-sodium-salt.html	Launched		91.0	AA37	H5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-110189	10.0	mM	173.0	DMSO	396.197045	5	H	pluskal_fda_drugs_5005_H5_id
374	HY-17037	HYCPK40902	G04	HYCPK40902	91z	583.0	1.0	M7	902.0	G04	29868-97-1	Pirenzepine (dihydrochloride)	LS 519; Pirenzepin (dihydrochloride); Gastrozepin (dihydrochloride)	424.32	mAChR	GPCR/G Protein; Neuronal Signaling	Pirenzepine (LS 519) dihydrochloride is a selective M1 mAChR (muscarinic acetylcholine receptor) antagonist. Pirenzepine dihydrochloride reduces gastric acid secretion and reduces muscle spasm, can be used in peptic ulcers research. Pirenzepine dihydrochloride shows anti-proliferative activity to cancer cells[1][2].	Hydrochloride	C19H23Cl2N5O2	25525.0	H2O : 75 mg/mL (176.75 mM; Need ultrasonic); DMSO : 25 mg/mL (58.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	O=C1NC2=CC=CN=C2N(C(CN3CCN(C)CC3)=O)C4=CC=CC=C14.[H]Cl.[H]Cl	https://www.medchemexpress.com/Pirenzepine_dihydrochloride.html	Launched		91.0	M7	H5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17037	10.0	mM	173.0	DMSO	351.169525	5	H	pluskal_fda_drugs_5005_H5_id
751	HY-18678A	HYCPK40904	O03	HYCPK40904	91z	1397.0	3.0	AD5	904.0	O03	1607799-13-2	Bremelanotide (Acetate)	PT-141 Acetate	1085.22	Melanocortin Receptor	GPCR/G Protein; Neuronal Signaling	Bremelanotide Acetate (PT-141 Acetate), a synthetic peptide analogue of α-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R for the treatment of sexual dysfunction[1].	Acetate	C52H72N14O12	100918.0	DMSO : ≥ 36 mg/mL (33.17 mM); H2O : ≥ 50 mg/mL (46.07 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(N[C@](CCCCNC(C[C@@H]1NC([C@@H](NC(C)=O)CCCC)=O)=O)([H])C(O)=O)[C@@H](NC([C@@H](NC([C@@](NC([C@@H](NC1=O)CC2=CN=CN2)=O)([H])CC3=CC=CC=C3)=O)CCCNC(N)=N)=O)CC4=CNC5=CC=CC=C45.OC(C)=O	https://www.medchemexpress.com/Bremelanotide-Acetate.html	Launched		91.0	AD5	H5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18678A	10.0	mM	173.0	DMSO	1024.524284	5	H	pluskal_fda_drugs_5005_H5_id
768	HY-B1790	HYCPK40904	P04	HYCPK40904	91z	1495.0	3.0	AF7	904.0	P04	67915-31-5	Terconazole	R42470	532.46	Fungal	Anti-infection	Terconazole is a broad-spectrum antifungal medication for the treatment of vaginal yeast infection.	Free Base	C26H31Cl2N5O3	24487.0	DMSO : ≥ 30 mg/mL (56.34 mM)	DMSO Solution	10mM  * 100uL	Infection	CC(N1CCN(C2=CC=C(OC[C@@H]3O[C@@](CN4N=CN=C4)(C5=CC=C(Cl)C=C5Cl)OC3)C=C2)CC1)C	https://www.medchemexpress.com/Terconazole.html	Launched		91.0	AF7	H5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1790	10.0	mM	173.0	DMSO	531.180395	5	H	pluskal_fda_drugs_5005_H5_id
1108	HY-B0949	HYCPK40905	M06	HYCPK40905	91z	1212.0	4.0	Z12	905.0	M06	1225-55-4	Protriptyline (hydrochloride)		299.84	Cholinesterase (ChE)	Neuronal Signaling	Protriptyline hydrochloride is a tricyclic antidepressant (TCA), specifically a secondary amine, for the treatment of depression and ADHD. Unique among the TCAs, protriptyline tends to be energizing instead of sedating, used for narcolepsy to achieve a wakefulness-promoting effect.	Hydrochloride	C19H22ClN	26478.0	DMSO : 250 mg/mL (833.78 mM; Need ultrasonic); H2O : 100 mg/mL (333.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13.[H]Cl	https://www.medchemexpress.com/Protriptyline-hydrochloride.html	Launched		91.0	Z12	H5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0949	10.0	mM	173.0	DMSO	263.1674	5	H	pluskal_fda_drugs_5005_H5_id
155	HY-B1700A	HYCPK40902	E09	HYCPK40902	91z	401.0	1.0	I17	902.0	E09	106861-44-3	Mivacurium (dichloride)		1100.17	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Mivacurium dichloride is a benzylisoquinoline derivative and is a short-acting non-depolarizing neuromuscular blocking agent and skeletal muscle relaxant. Mivacurium dichloride couples with the nAChR to reduce or inhibit the depolarizing effect of acetylcholine on the terminal disc of the muscle cell[1][2][3].	Chloride	C58H80Cl2N2O14	65589.0	DMSO : 250 mg/mL (227.24 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (90.90 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCC[N+]1(C)[C@H](CC2=CC(OC)=C(OC)C(OC)=C2)C3=C(C=C(OC)C(OC)=C3)CC1)CC/C=C/CCC(OCCC[N+]4(C)[C@H](CC5=CC(OC)=C(OC)C(OC)=C5)C6=C(C=C(OC)C(OC)=C6)CC4)=O.[Cl-].[Cl-]	https://www.medchemexpress.com/mivacurium-dichloride.html	Launched		91.0	I17	H6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1700A	10.0	mM	174.0	DMSO	1028.559858	6	H	pluskal_fda_drugs_5005_H6_id
544	HY-12047	HYCPK40903	A12	HYCPK40903	91z	24.0	2.0	A24	903.0	A12	943319-70-8	Ponatinib	AP24534	532.56	Autophagy; Bcr-Abl; FGFR; PDGFR; Src; VEGFR	Autophagy; Protein Tyrosine Kinase/RTK	Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively[1].	Free Base	C29H27F3N6O	13771.0	DMSO : 50 mg/mL (93.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC1=C(C=C(C=C1)C(NC2=CC(C(F)(F)F)=C(C=C2)CN3CCN(CC3)C)=O)C#CC4=CN=C5N4N=CC=C5	https://www.medchemexpress.com/Ponatinib.html	Launched		91.0	A24	H6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12047	10.0	mM	174.0	DMSO	532.219844	6	H	pluskal_fda_drugs_5005_H6_id
744	HY-15307	HYCPK40904	H03	HYCPK40904	91z	725.0	3.0	P5	904.0	H03	911417-87-3	Belumosudil	KD025; SLx-2119	452.51	ROCK	Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad	Belumosudil (KD025) is a selective inhibitor of ROCK2 with IC50s of 105 nM and 24 μM for ROCK2 and ROCK1, respectively. Anti-fibrotic properties[1].	Free Base	C26H24N6O2	18202.0	DMSO : 250 mg/mL (552.47 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(NC(C)C)COC1=CC=CC(C2=NC(NC3=CC4=C(NN=C4)C=C3)=C5C=CC=CC5=N2)=C1	https://www.medchemexpress.com/SLx-2119.html	Launched		91.0	P5	H6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15307	10.0	mM	174.0	DMSO	452.196074	6	H	pluskal_fda_drugs_5005_H6_id
822	HY-B0188A	HYCPK40904	K08	HYCPK40904	91z	1023.0	3.0	V15	904.0	K08	21535-47-7	Mianserin (hydrochloride)	Org GB 94	300.83	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Mianserin hydrochloride (Org GB 94) is a H1 receptor inverse agonist and is a psychoactive agent of the tetracyclic antidepressant.	Hydrochloride	C18H21ClN2	26167.0	DMSO : 50 mg/mL (166.21 mM; Need ultrasonic); H2O : 25 mg/mL (83.10 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CN(CC1)CC2N1C3=CC=CC=C3CC4=CC=CC=C24.Cl	https://www.medchemexpress.com/mianserin-hydrochloride.html	Launched		91.0	V15	H6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0188A	10.0	mM	174.0	DMSO	264.162649	6	H	pluskal_fda_drugs_5005_H6_id
887	HY-107324	HYCPK40904	L12	HYCPK40904	91z	1127.0	3.0	X23	904.0	L12	515-13-9	β-Elemene	(-)-β-Elemene; Levo-β-elemene	204.35	Apoptosis	Apoptosis	β-Elemene ((-)-β-Elemene; Levo-β-elemene) is isolated from natural plant Curcuma aromatica with an  antitumor activity. β-Elemene can induce cell apoptosis.	Free Base	C15H24	113603.0	Ethanol : 50 mg/mL (244.68 mM; Need ultrasonic); DMSO : 50 mg/mL (244.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC([C@H]1[C@@](C)(CC[C@@H](C(C)=C)C1)C=C)=C	https://www.medchemexpress.com/β-elemene.html	Launched		91.0	X23	H6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107324	10.0	mM	174.0	DMSO	204.187801	6	H	pluskal_fda_drugs_5005_H6_id
1022	HY-14652	HYCPK40904	G21	HYCPK40904	91z	665.0	3.0	N41	904.0	G21	94497-51-5	Tamibarotene	Am 80	351.44	Apoptosis; Autophagy; RAR/RXR	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Tamibarotene is a retinoic acid receptor α/β (RARα/β) agonist, showing high selectivity over RARγ.	Free Acid	C22H25NO3	11307.0	DMSO : 25.5 mg/mL (72.56 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=C(C=C1)C(NC2=CC=C3C(C)(CCC(C)(C3=C2)C)C)=O)O	https://www.medchemexpress.com/Tamibarotene.html	Launched		91.0	N41	H6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14652	10.0	mM	174.0	DMSO	351.183444	6	H	pluskal_fda_drugs_5005_H6_id
1137	HY-10492	HYCPK40905	J08	HYCPK40905	91z	928.0	4.0	T16	905.0	J08	779353-01-4	Dinaciclib	SCH 727965	396.49	Apoptosis; CDK	Apoptosis; Cell Cycle/DNA Damage	Dinaciclib (SCH 727965) is a potent inhibitor of CDK, with IC50s of 1 nM, 1 nM, 3 nM, and 4 nM for CDK2, CDK5, CDK1, and CDK9, respectively[1].	Free Base	C21H28N6O2	120243.0	DMSO : 50 mg/mL (126.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OCC[C@H]1N(CCCC1)C2=NC3=C(C=NN3C(NCC4=C[N+]([O-])=CC=C4)=C2)CC	https://www.medchemexpress.com/Dinaciclib.html	Launched		91.0	T16	H6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10492	10.0	mM	174.0	DMSO	396.227374	6	H	pluskal_fda_drugs_5005_H6_id
1269	HY-50856A	HYCPK40905	N16	HYCPK40905	91z	1328.0	4.0	AB32	905.0	N16	941685-37-6	Ruxolitinib (S enantiomer)	S-Ruxolitinib; S-INCB18424	306.37	JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Ruxolitinib S enantiomer is the S-enantiomer of Ruxolitinib. Ruxolitinib S enantiomer is a JAK inhibitor[1]	Free Base	C17H18N6	11547.0	DMSO : ≥ 100 mg/mL (326.40 mM)	DMSO Solution	10mM  * 100uL	Cancer	N#CC[C@@H](C1CCCC1)N2N=CC(C3=NC=NC4=C3C=CN4)=C2	https://www.medchemexpress.com/ruxolitinib-s-enantiomer.html	Launched		91.0	AB32	H6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50856A	10.0	mM	174.0	DMSO	306.159295	6	H	pluskal_fda_drugs_5005_H6_id
479	HY-17583	HYCPK40903	D07	HYCPK40903	91z	302.0	2.0	G14	903.0	D07	126-07-8	Griseofulvin		352.77	Antibiotic; Apoptosis; Endogenous Metabolite; Fungal	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Griseofulvin(Gris-PEG; Grifulvin) is a spirocyclic fungal natural product used in treatment of fungal dermatophytes; Antifungal drug.	Free Base	C17H17ClO6	13495.0	DMSO : 33.33 mg/mL (94.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1[C@]2(C(OC)=CC(C[C@H]2C)=O)OC3=C(Cl)C(OC)=CC(OC)=C13	https://www.medchemexpress.com/Griseofulvin.html	Launched		91.0	G14	H7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17583	10.0	mM	175.0	DMSO	352.071366	7	H	pluskal_fda_drugs_5005_H7_id
661	HY-B1400	HYCPK40903	K17	HYCPK40903	91z	994.0	2.0	U34	903.0	K17	83-73-8	Diiodohydroxyquinoline	Iodoquinol; 5,7-Diiodo-8-hydroxyquinoline; 5,7-Diiodo-8-quinolinol	396.95	Antibiotic; Bacterial; Parasite	Anti-infection	Diiodohydroxyquinoline is a topical therapeutic agent, with satisfactory antibacterial properties.	Free Base	C9H5I2NO	17609.0	DMSO : 20.83 mg/mL (52.48 mM; ultrasonic and warming and heat to 60°C); H2O : 0.67 mg/mL (1.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC1=C2N=CC=CC2=C(I)C=C1I	https://www.medchemexpress.com/Diiodohydroxyquinoline.html	Launched		91.0	U34	H7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1400	10.0	mM	175.0	DMSO	396.84606	7	H	pluskal_fda_drugs_5005_H7_id
680	HY-107337	HYCPK40903	N18	HYCPK40903	91z	1284.0	2.0	AA36	903.0	N18	83435-67-0	Delapril (hydrochloride)		489.00	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Delapril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor for the treatment of cardiovascular diseases[1].	Hydrochloride	C26H33ClN2O5	58034.0	DMSO : 250 mg/mL (511.25 mM; Need ultrasonic); H2O : 1.72 mg/mL (3.52 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CCOC([C@H](CCC1=CC=CC=C1)N[C@@H](C)C(N(C2CC3=C(C=CC=C3)C2)CC(O)=O)=O)=O.[H]Cl	https://www.medchemexpress.com/delapril-hydrochloride.html	Launched		91.0	AA36	H7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107337	10.0	mM	175.0	DMSO	452.231122	7	H	pluskal_fda_drugs_5005_H7_id
772	HY-B1391	HYCPK40904	I05	HYCPK40904	91z	825.0	3.0	R9	904.0	I05	81-13-0	D-Panthenol	Dexpanthenol	205.25	Endogenous Metabolite	Metabolic Enzyme/Protease	D-Panthenol is the biologically-active alcohol of pantothenic acid, which leads to an elevation in the amount of coenzyme A in the cell.	Free Base	C9H19NO4	101441.0	DMSO : 33 mg/mL (160.78 mM; Need ultrasonic and warming); Ethanol : 110 mg/mL (535.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(NCCCO)[C@H](O)C(C)(C)CO	https://www.medchemexpress.com/D-Panthenol.html	Launched		91.0	R9	H7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1391	10.0	mM	175.0	DMSO	205.131408	7	H	pluskal_fda_drugs_5005_H7_id
1007	HY-50858	HYCPK40904	H20	HYCPK40904	91z	759.0	3.0	P39	904.0	H20	1092939-17-7	Ruxolitinib (phosphate)	INCB018424 phosphate	404.36	Autophagy; JAK; Mitophagy	Autophagy; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Ruxolitinib phosphate (INCB018424 phosphate) is a potent JAK1/2 inhibitor with IC50s of 3.3 nM/2.8 nM, respectively, showing more than 130-fold selectivity over JAK3.	Phosphate	C17H21N6O4P	108706.0	DMSO : ≥ 31 mg/mL (76.66 mM); H2O : 10 mg/mL (24.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	N#CC[C@H](C1CCCC1)N2N=CC(C3=C4C=CNC4=NC=N3)=C2.O=P(O)(O)O	https://www.medchemexpress.com/Ruxolitinib-phosphate.html	Launched		91.0	P39	H7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50858	10.0	mM	175.0	DMSO	306.159295	7	H	pluskal_fda_drugs_5005_H7_id
1026	HY-12687	HYCPK40904	K21	HYCPK40904	91z	1049.0	3.0	V41	904.0	K21	173903-47-4	Tizoxanide	TIZ	265.25	Autophagy; Bacterial; HIV; IKK; Influenza Virus; Parasite	Anti-infection; Autophagy; NF-κB	Tizoxanide (TIZ) is the active metabolite of Nitazoxanide, which is a thiazolide anti-infective compound against anaerobic bacteria, protozoa, and a range of viruses. Tizoxanide (TIZ) has anti-HIV-1 activities and potent inhibition of both HBV and HCV replication with values EC50 of 0.46μM and 0.15 μM, respectively. Tizoxanide also exerts anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines and suppressing of the activation of the NF-κB and the MAPK signaling pathways in LPS-treated macrophage cells[1][3][4][5].	Free Base	C10H7N3O4S	17718.0	DMSO : ≥ 38 mg/mL (143.26 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(NC1=NC=C([N+]([O-])=O)S1)C2=CC=CC=C2O	https://www.medchemexpress.com/Tizoxanide.html	Launched		91.0	V41	H7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12687	10.0	mM	175.0	DMSO	265.015727	7	H	pluskal_fda_drugs_5005_H7_id
1067	HY-15666	HYCPK40905	D04	HYCPK40905	91z	344.0	4.0	H8	905.0	D04	1257628-77-5	Olverembatinib	GZD824; HQP1351	532.56	Bcr-Abl	Protein Tyrosine Kinase/RTK	Olverembatinib (GZD824) is a potent and orally active pan-Bcr-Abl inhibitor. Olverembatinib potently inhibits a broad spectrum of Bcr-Abl mutants. Olverembatinib strongly inhibits native Bcr-Abl and Bcr-AblT315I with IC50s of 0.34 nM and 0.68 nM, respectively. Olverembatinib has antitumor activity[1].	Free Base	C29H27F3N6O	9150.0	DMSO : 50 mg/mL (93.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(CN2CCN(C)CC2)C(C(F)(F)F)=C1)C3=CC=C(C)C(C#CC4=CN=C(NN=C5)C5=C4)=C3	https://www.medchemexpress.com/gzd824.html	Launched		91.0	H8	H7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15666	10.0	mM	175.0	DMSO	532.219844	7	H	pluskal_fda_drugs_5005_H7_id
1218	HY-13948B	HYCPK40905	K13	HYCPK40905	91z	1034.0	4.0	V26	905.0	K13		Angiotensin II human (TFA)	Angiotensin II (TFA); Ang II (TFA); DRVYIHPF (TFA)	1160.20	Angiotensin Receptor; Apoptosis	Apoptosis; GPCR/G Protein	Angiotensin II human (Angiotensin II) TFA is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system. Angiotensin II human TFA plays a central role in regulating human blood pressure, which is mainly mediated by interactions between Angiotensin II and the G-protein-coupled receptors (GPCRs) Angiotensin II type 1 receptor (AT1R) and Angiotensin II type 2 receptor (AT2R). Angiotensin II human TFA stimulates sympathetic nervous stimulation, increases aldosterone biosynthesis and renal actions. Angiotensin II human TFA induces growth of vascular smooth muscle cells, increases collagen type I and III synthesis in fibroblasts, leading to thickening of the vascular wall and myocardium, and fibrosis. Angiotensin II human TFA also induces apoptosis. Angiotensin II human TFA induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway[1][2][3][4].	Trifluoroacetate	C52H72F3N13O14	118009.0	H2O : 10 mg/mL (8.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Cardiovascular Disease	O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC2=CNC=N2)C(N3[C@@H](CCC3)C(N[C@@H](CC4=CC=CC=C4)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(O)=O)N.O=C(O)C(F)(F)F	https://www.medchemexpress.com/angiotensin-ii-human-tfa.html	Launched		91.0	V26	H7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13948B	10.0	mM	175.0	DMSO	1045.534515	7	H	pluskal_fda_drugs_5005_H7_id
217	HY-B0352	HYCPK40902	G13	HYCPK40902	91z	601.0	1.0	M25	902.0	G13	85650-52-8	Mirtazapine	Org3770; 6-Azamianserin	265.35	5-HT Receptor; Adrenergic Receptor; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Mirtazapine (Org3770) is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent. Mirtazapine is also a 5-HT2, 5-HT3, histamine H1 receptor and α2-adrenoceptor antagonist with pKi values of 8.05, 8.1, 9.3 and 6.95, respectively[1][2].	Free Base	C17H19N3	16286.0	H2O : 0.67 mg/mL (2.52 mM; Need ultrasonic); DMSO : 50 mg/mL (188.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease; Cancer	CN1CC2C3=CC=CC=C3CC4=CC=CN=C4N2CC1	https://www.medchemexpress.com/mirtazapine.html	Launched		91.0	M25	H8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0352	10.0	mM	176.0	DMSO	265.157898	8	H	pluskal_fda_drugs_5005_H8_id
500	HY-10004	HYCPK40903	I08	HYCPK40903	91z	784.0	2.0	Q16	903.0	I08	141702-36-5	Faropenem daloxate	Faropenem medoxil	397.40	Antibiotic; Bacterial	Anti-infection	"Faropenem daloxate  is the first oral penem in a new class of beta-lactam antibiotics.
IC50 Value: 
Target: Antibacterial
Faropenem daloxate is useful for penem and antibiotics. Faropenem medoxomil has excellent in vitro activity against Streptococcus pneumoniae, Haemophilus influenzae and other key pathogens implicated in acute bacterial rhinosinusitis. Clinical studies have demonstrated that, in the treatment of acute bacterial rhinosinusitis in adults, 7 days of treatment with faropenem medoxomil is as clinically and bacteriologically effective as 10 days of treatment with cefuroxime axetil. One study showed faropenem medoxomil to be superior to cefuroxime axetil. Overall, the safety profile of faropenem medoxomil is similar to that of most comparators."	Free Base	C17H19NO8S	563.0	H2O : < 0.1 mg/mL (ultrasonic) (insoluble); DMSO : ≥ 100 mg/mL (251.64 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(N1[C@@]2(SC([C@@H]3OCCC3)=C1C(OCC4=C(OC(O4)=O)C)=O)[H])[C@]2([H])[C@H](O)C	https://www.medchemexpress.com/Faropenem-daloxate.html	Launched		91.0	Q16	H8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10004	10.0	mM	176.0	DMSO	397.083138	8	H	pluskal_fda_drugs_5005_H8_id
626	HY-13588	HYCPK40903	H15	HYCPK40903	91z	702.0	2.0	O30	903.0	H15	52152-93-9	Cefsulodin (sodium)	SCE-129 (sodium)	554.53	Antibiotic; Bacterial	Anti-infection	Cefsulodin (SCE-129) sodium is a third generation β lactam antibiotic and member of the cephems subgroup of antibiotics. Cefsulodin sodium inhibits cell wall synthesis by competitively inhibiting penicillin binding protein (PBP) cross-linking and transpeptidation of peptidogly. Cefsulodin sodium is a potent tyrosine phosphatase inhibitor against mPTPB, a virulent phosphatase from Mycobacterium tuberculosis, with an IC50 value of 16 μM[1][2][3][4].	Sodium	C22H19N4NaO8S2	46989.0	DMSO : 13.5 mg/mL (24.34 mM; Need ultrasonic); H2O : 55 mg/mL (99.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N[C@H]1[C@@]2([H])SCC(C[N+]3=CC=C(C(N)=O)C=C3)=C(C([O-])=O)N2C1=O)[C@@H](C4=CC=CC=C4)S(=O)(O[Na])=O	https://www.medchemexpress.com/Cefsulodin-sodium.html	Launched		91.0	O30	H8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13588	10.0	mM	176.0	DMSO	533.079532	8	H	pluskal_fda_drugs_5005_H8_id
722	HY-16397A	HYCPK40903	B22	HYCPK40903	91z	140.0	2.0	C44	903.0	B22	834-28-6	Phenformin (hydrochloride)	Phenethylbiguanide hydrochloride	241.72	AMPK; Autophagy	Autophagy; Epigenetics; PI3K/Akt/mTOR	Phenformin hydrochloride is an anti-diabetic drug from the biguanide class, can activate AMPK activity.	Hydrochloride	C10H16ClN5	85972.0	DMSO : 1 mg/mL (4.14 mM; ultrasonic and adjust pH to 2 with 1M HCl); DMF : < 1 mg/mL (insoluble); H2O : 12.5 mg/mL (51.71 mM; Need ultrasonic); Ethanol : < 1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	NC(NC(NCCC1=CC=CC=C1)=N)=N.Cl	https://www.medchemexpress.com/phenformin-hydrochloride.html	Launched		91.0	C44	H8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16397A	10.0	mM	176.0	DMSO	205.132745	8	H	pluskal_fda_drugs_5005_H8_id
749	HY-B1851	HYCPK40904	M03	HYCPK40904	91z	1205.0	3.0	Z5	904.0	M03	78587-05-0	Hexythiazox		352.88	Parasite	Anti-infection	Hexythiazox is a selective acaricide with ovicidal, larvicidal and nymphicidal activities. Hexythiazox is widely used for chemical control of mites on cotton, fruits and vegetables. Hexythiazox is harmless to mammals and has no effect on beneficial insects and predators of mites[1][2].	Free Base	C17H21ClN2O2S	64416.0	DMSO : 100 mg/mL (283.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N1C(S[C@H](C2=CC=C(Cl)C=C2)[C@H]1C)=O)NC3CCCCC3	https://www.medchemexpress.com/hexythiazox.html	Launched		91.0	Z5	H8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1851	10.0	mM	176.0	DMSO	352.101227	8	H	pluskal_fda_drugs_5005_H8_id
840	HY-16381A	HYCPK40904	M09	HYCPK40904	91z	1217.0	3.0	Z17	904.0	M09	396091-76-2	Pasireotide (acetate)	SOM230 (acetate)	1107.26	Somatostatin Receptor	GPCR/G Protein; Neuronal Signaling	Pasireotide (SOM230) acetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide acetate can suppress GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing's disease. Pasireotide acetate also exhibits antisecretory, antiproliferative, and proapoptotic activity[1][2][3].	Acetate	C60H70N10O11	116209.0	H2O : 1 mg/mL (0.90 mM; ultrasonic and warming and heat to 60°C); DMSO : 100 mg/mL (90.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	NCCCC[C@@H](C(N[C@H]1CC2=CC=C(C=C2)OCC3=CC=CC=C3)=O)NC([C@H](NC([C@H](C4=CC=CC=C4)NC([C@H]5N(C([C@H](CC6=CC=CC=C6)NC1=O)=O)C[C@H](OC(NCCN)=O)C5)=O)=O)CC7=CNC8=C7C=CC=C8)=O.CC(O)=O	https://www.medchemexpress.com/pasireotide-acetate.html	Launched		91.0	Z17	H8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16381A	10.0	mM	176.0	DMSO	1046.501424	8	H	pluskal_fda_drugs_5005_H8_id
1024	HY-14852	HYCPK40904	I21	HYCPK40904	91z	857.0	3.0	R41	904.0	I21	594839-88-0	Tafamidis		308.12	Transthyretin (TTR)	Neuronal Signaling	Tafamidis is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis inhibits amyloidogenesis[1].	Free Acid	C14H7Cl2NO3	37410.0	DMSO : 37.5 mg/mL (121.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O	https://www.medchemexpress.com/Tafamidis.html	Launched		91.0	R41	H8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14852	10.0	mM	176.0	DMSO	306.980298	8	H	pluskal_fda_drugs_5005_H8_id
1085	HY-15209	HYCPK40905	F05	HYCPK40905	91z	538.0	4.0	L10	905.0	F05	135062-02-1	Repaglinide	AG-EE 623ZW	452.59	Potassium Channel	Membrane Transporter/Ion Channel	Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].	Free Acid	C27H36N2O4	8958.0	DMSO : ≥ 50 mg/mL (110.48 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	CC(C)C[C@H](NC(CC1=CC(OCC)=C(C(O)=O)C=C1)=O)C2=CC=CC=C2N3CCCCC3	https://www.medchemexpress.com/Repaglinide.html	Launched		91.0	L10	H8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15209	10.0	mM	176.0	DMSO	452.267508	8	H	pluskal_fda_drugs_5005_H8_id
106	HY-B0302	HYCPK40902	P05	HYCPK40902	91z	1449.0	1.0	AE9	902.0	P05	2809-21-4	Etidronic acid	Etidronate; HEDPA; HEDP	206.03	Apoptosis	Apoptosis	Etidronic acid (Etidronate) is an orally and intravenously active bisphosphonate. Etidronic acid inhibits resorption of bone, reduces arterial calcification and can be used for osteoporosis research. Etidronic acid has anticancer activity. Etidronic acid is a chelating agent and can be used to remove heavy metal in water[1][2][3][4].	Free Acid	C2H8O7P2	15454.0	DMSO : 100 mg/mL (485.37 mM; Need ultrasonic); H2O : 100 mg/mL (485.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	OC(P(O)(O)=O)(P(O)(O)=O)C	https://www.medchemexpress.com/Etidronic-acid.html	Launched		91.0	AE9	H9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0302	10.0	mM	177.0	DMSO	205.974526	9	H	pluskal_fda_drugs_5005_H9_id
610	HY-N0482	HYCPK40903	H14	HYCPK40903	91z	700.0	2.0	O28	903.0	H14	487-41-2	Phillyrin		534.55	Bacterial; Cytochrome P450; Influenza Virus	Anti-infection; Metabolic Enzyme/Protease	Phillyrin is isolated from Forsythia suspensa Vahl (Oleaceae), has antibacterial and anti-inflammatory activities. Phillyrin has potential inductive effects on rat CYP1A2 and CYP2D1 activities, without affecting CYP2C11 and CYP3A1/2 activities[1]. Phillyrin has anti-influenza A virus activities[2].	Free Base	C27H34O11	57149.0	DMSO : 260 mg/mL (486.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	COC(C=C1[C@@H]2[C@](CO[C@H]3C4=CC(OC)=C(OC)C=C4)([H])[C@]3([H])CO2)=C(C=C1)O[C@@H]([C@@H]([C@@H](O)[C@@H]5O)O)O[C@@H]5CO	https://www.medchemexpress.com/phillyrin.html	Launched		91.0	O28	H9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0482	10.0	mM	177.0	DMSO	534.210112	9	H	pluskal_fda_drugs_5005_H9_id
697	HY-108974	HYCPK40903	I20	HYCPK40903	91z	808.0	2.0	Q40	903.0	I20	985-12-6	Drotaverine (hydrochloride)		433.97	Calcium Channel; Phosphodiesterase (PDE)	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Drotaverine (hydrochloride) is a type 4 cyclic nucleotide phosphodiesterase (PDE4) inhibitor and an L-type voltage-dependent calcium channel (L-VDCC) blocker, blocks the degradation of 3',5'-cyclic adenosine monophosphate. Drotaverine (hydrochloride) exhibits in vivo antispasmodic efficacy without anticholinergic effects.	Hydrochloride	C24H32ClNO4	137476.0	DMSO : 62.5 mg/mL (144.02 mM; ultrasonic and warming and heat to 60°C); H2O : 100 mg/mL (230.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL		CCOC1=CC2=C(C=C1OCC)CCN/C2=C\C3=CC=C(OCC)C(OCC)=C3.[H]Cl	https://www.medchemexpress.com/drotaverine-hydrochloride.html	Launched		91.0	Q40	H9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108974	10.0	mM	177.0	DMSO	397.225308	9	H	pluskal_fda_drugs_5005_H9_id
711	HY-B0217	HYCPK40903	G21	HYCPK40903	91z	618.0	2.0	M42	903.0	G21	55981-09-4	Nitazoxanide	NTZ; NSC 697855	307.28	Autophagy; Influenza Virus; Parasite	Anti-infection; Autophagy	Nitazoxanide (NTZ), an anthelmintic agent, exhibits a broad spectrum of activities against a wide variety of helminths, protozoa, and enteric bacteria infecting animals and humans. Nitazoxanide inhibits Giardia lamblia trophozoite proliferation in axenic culture with an IC50 of 2.4 μM[1]. Nitazoxanide can be used for the research of parasitic gastroenteritis. Nitazoxanide shows anti-Japanese encephalitis virus (JEV) activity in a mouse model[2].	Free Base	C12H9N3O5S	11310.0	DMSO : ≥ 100 mg/mL (325.44 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(NC1=NC=C([N+]([O-])=O)S1)C2=CC=CC=C2OC(C)=O	https://www.medchemexpress.com/nitazoxanide.html	Launched		91.0	M42	H9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0217	10.0	mM	177.0	DMSO	307.026291	9	H	pluskal_fda_drugs_5005_H9_id
942	HY-B1067	HYCPK40904	G16	HYCPK40904	91z	655.0	3.0	N31	904.0	G16	2508-72-7	Antazoline (hydrochloride)	Phenazoline (hydrochloride)	301.81	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Antazoline hydrochloride is a 1st generation antihistamine with also anticholinergic properties used to relieve nasal congestion and in eye drops.	Hydrochloride	C17H20ClN3	17370.0	DMSO : ≥ 53 mg/mL (175.61 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	[H]Cl.C1(CN(C2=CC=CC=C2)CC3=CC=CC=C3)=NCCN1	https://www.medchemexpress.com/Antazoline-hydrochloride.html	Launched		91.0	N31	H9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1067	10.0	mM	177.0	DMSO	265.157898	9	H	pluskal_fda_drugs_5005_H9_id
1136	HY-B1381	HYCPK40905	I08	HYCPK40905	91z	832.0	4.0	R16	905.0	I08	79350-37-1	Cefixime	FR-17027; FK-027; CL-284635	453.45	Antibiotic; Bacterial	Anti-infection	Cefixime is an antibiotic and a third generation cephalosporin antibiotic, useful for the treatment of a number of bacterial infections.	Free Acid	C16H15N5O7S2	17505.0	DMSO : 100 mg/mL (220.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(N12)=C(C=C)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OCC(O)=O)=O)C1=O)O	https://www.medchemexpress.com/Cefixime.html	Launched		91.0	R16	H9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1381	10.0	mM	177.0	DMSO	453.04129	9	H	pluskal_fda_drugs_5005_H9_id
1200	HY-N0110	HYCPK40905	I12	HYCPK40905	91z	840.0	4.0	R24	905.0	I12	10605-02-4	Palmatine (chloride)		387.86	Apoptosis; Aurora Kinase; Bacterial; Indoleamine 2,3-Dioxygenase (IDO); Parasite; Virus Protease	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease	Palmatine chloride is an orally active and irreversible indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor with IC50s of 3 μM and 157μM against HEK 293-hIDO-1 and rhIDO-1, respectively. Palmatine chloride can also inhibit West Nile virus (WNV) NS2B-NS3 protease in an uncompetitive manner with an IC50 of 96 μM. Palmatine chloride shows anti-cancer, anti-oxidation, anti-inflammatory, neuroprotection, antibacterial, anti-viral activities[1][2][3][4][5].	Chloride	C21H22ClNO4	18861.0	DMSO : ≥ 32 mg/mL (82.50 mM); H2O : 5 mg/mL (12.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Neurological Disease	COC1=C(OC)C2=C[N+]3=C(C4=CC(OC)=C(OC)C=C4CC3)C=C2C=C1.[Cl-]	https://www.medchemexpress.com/Palmatine-chloride.html	Launched		91.0	R24	H9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0110	10.0	mM	177.0	DMSO	352.154335	9	H	pluskal_fda_drugs_5005_H9_id
1363	HY-P0004A	HYCPK40905	P22	HYCPK40905	91z	1532.0	4.0	AF44	905.0	P22	83968-49-4	Lysipressin (acetate)	Lysine vasopressin (acetate); [Lys8]-Vasopressin (acetate)	1116.27	Adenylate Cyclase	GPCR/G Protein	Lysipressin (Lysine vasopressin) acetate is antidiuretic hormone that have been found in pigs and some marsupial families. Lysipressin acetate induces contraction of the rabbit urinary bladder smooth muscle, activate adenylate-cyclase[1][2].	Acetate	C48H69N13O14S2	159300.0	DMSO : ≥ 100 mg/mL (89.58 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(N1CCC[C@H]1C(N[C@H](C(NCC(N)=O)=O)CCCCN)=O)[C@@H](NC([C@H](CC(N)=O)NC([C@H](CCC(N)=O)NC([C@]([H])(CC2=CC=CC=C2)N3)=O)=O)=O)CSSC[C@H](N)C(N[C@@H](CC4=CC=C(C=C4)O)C3=O)=O.OC(C)=O	https://www.medchemexpress.com/Lysipressin_Acetat.html	Launched		91.0	AF44	H9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P0004A	10.0	mM	177.0	DMSO	1055.431707	9	H	pluskal_fda_drugs_5005_H9_id
134	HY-15498	HYCPK40902	L07	HYCPK40902	91z	1069.0	1.0	W13	902.0	L07	1289023-67-1	Rimegepant	BMS-927711	534.56	CGRP Receptor	GPCR/G Protein; Neuronal Signaling	Rimegepant (BMS-927711) is a highly potent, oral calcitonin gene-related peptide (CGRP) receptor antagonist with a Ki of 0.027 nM and an IC50 of 0.14 nM for hCGRP receptor[1].	Free Base	C28H28F2N6O3	13778.0	DMSO : 10 mg/mL (18.71 mM; Need ultrasonic and warming); Ethanol : 4.4 mg/mL (8.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	N[C@H]1[C@H](C2=C(F)C(F)=CC=C2)CC[C@@H](OC(N3CCC(N4C(C=CC=N5)=C5NC4=O)CC3)=O)C6=NC=CC=C61	https://www.medchemexpress.com/BMS-927711.html	Launched		91.0	W13	H10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15498	10.0	mM	178.0	DMSO	534.219095	10	H	pluskal_fda_drugs_5005_H10_id
379	HY-15981	HYCPK40902	L04	HYCPK40902	91z	1063.0	1.0	W7	902.0	L04	1226781-44-7	Omarigliptin	MK-3102	398.43	Dipeptidyl Peptidase	Metabolic Enzyme/Protease	Omarigliptin (MK-3102) is a potent, selective, orally active and cross the blood-brain barrier dipeptidyl peptidase 4 (DPP-4) inhibitor. Omarigliptin shows anti-parkinsonian activity. Omarigliptin  has the neuroprotective effect to improve diabetes-associated cognitive dysfunction[1][2][3].	Free Base	C17H20F2N4O3S	16071.0	DMSO : 50 mg/mL (125.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	N[C@@H]1[C@@H](C2=CC(F)=CC=C2F)OC[C@H](N3CC4=NN(S(=O)(C)=O)C=C4C3)C1	https://www.medchemexpress.com/Omarigliptin.html	Launched		91.0	W7	H10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15981	10.0	mM	178.0	DMSO	398.122418	10	H	pluskal_fda_drugs_5005_H10_id
386	HY-N1919	HYCPK40902	G08	HYCPK40902	91z	591.0	1.0	M15	902.0	G08	483-04-5	Ajmalicine	Raubasine	352.43	Adrenergic Receptor; Cholinesterase (ChE)	GPCR/G Protein; Neuronal Signaling	Ajmalicine (Raubasine) is a potent adrenolytic agent which preferentially blocks α1-adrenoceptor. Ajmalicine is an reversible but non-competitive nicotine receptor full inhibitor, with an IC50 of 72.3 μM. Ajmalicine also can be used as anti-hypertensive, and serpentine, with sedative activity[1][2].	Free Base	C21H24N2O3	153074.0	DMSO : 5.56 mg/mL (15.78 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Endocrinology; Neurological Disease	O=C(C1=CO[C@@H](C)[C@](CN2CC3)([H])[C@]1([H])C[C@@]2([H])C4=C3C5=CC=CC=C5N4)OC	https://www.medchemexpress.com/ajmalicine.html	Launched		91.0	M15	H10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1919	10.0	mM	178.0	DMSO	352.178693	10	H	pluskal_fda_drugs_5005_H10_id
466	HY-18733	HYCPK40903	G06	HYCPK40903	91z	588.0	2.0	M12	903.0	G06	1200-22-2	Lipoic acid	(R)-(+)-α-Lipoic acid; R-(+)-Thioctic acid	206.33	Endogenous Metabolite; Mitochondrial Metabolism; Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Lipoic acid ((R)-(+)-α-Lipoic acid) is an antioxidant, which is an essential cofactor of mitochondrial enzyme complexes. (R)-(+)-α-Lipoic acid is more effective than racemic Lipoic acid.	Free Acid	C8H14O2S2	46162.0	DMSO : ≥ 100 mg/mL (484.66 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O)CCCC[C@H]1SSCC1	https://www.medchemexpress.com/Lipoic-acid.html	Launched		91.0	M12	H10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18733	10.0	mM	178.0	DMSO	206.043522	10	H	pluskal_fda_drugs_5005_H10_id
982	HY-17580	HYCPK40904	O18	HYCPK40904	91z	1427.0	3.0	AD35	904.0	O18	873857-62-6	Fidaxomicin	OPT-80; PAR-101	1058.04	Antibiotic; Apoptosis; Bacterial; DNA/RNA Synthesis	Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Fidaxomicin (OPT-80), a macrocyclic antibiotic, is an orally active and potent RNA polymerase inhibitor. Fidaxomicin has a narrow spectrum of antibacterial activity and a good anti-Clostridium difficile activity (MIC90=0.12?μg/mL). Fidaxomicin can be used for Clostridium difficile infection (CDI) research[1][2][3].	Free Base	C52H74Cl2O18	23476.0	DMSO : ≥ 33 mg/mL (31.19 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(C(O)=C(Cl)C(O)=C1Cl)=C1CC)O[C@H]([C@H](O[C@H]2OC/C(C(O[C@](C/C=C3C)([H])[C@H](O)C)=O)=C\C=C\C[C@@H](/C(C)=C\[C@H](CC)[C@@H](O[C@@](OC(C)(C)[C@@H](OC(C(C)C)=O)[C@@H]4O)([H])[C@H]4O)\C(C)=C/3)O)C)[C@@H]([C@@H]2OC)O	https://www.medchemexpress.com/Fidaxomicin.html	Launched		91.0	AD35	H10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17580	10.0	mM	178.0	DMSO	1056.425221	10	H	pluskal_fda_drugs_5005_H10_id
1150	HY-16209	HYCPK40905	G09	HYCPK40905	91z	642.0	4.0	N18	905.0	G09	284490-13-7	Forodesine (hydrochloride)	BCX-1777 (hydrochloride); Immucillin-H (hydrochloride)	302.7142	Apoptosis; Nucleoside Antimetabolite/Analog	Apoptosis; Cell Cycle/DNA Damage	Forodesine hydrochloride (BCX-1777 hydrochloride) is a highly potent and orally active purine nucleoside phosphorylase (PNP) inhibitor with IC50 values ranging from 0.48 to 1.57 nM for human, mouse, rat, monkey and dog PNP. Forodesine hydrochloride is a potent human lymphocyte proliferation inhibitor. Forodesine hydrochloride could induce apoptosis in leukemic cells by increasing the dGTP levels[1][2].	Hydrochloride	C11H15ClN4O4	56727.0	H2O : 100 mg/mL (330.35 mM; Need ultrasonic); DMSO : 10 mg/mL (33.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C(NC=C2[C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)=C2NC=N1.Cl	https://www.medchemexpress.com/Forodesine-hydrochloride.html	Launched		91.0	N18	H10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16209	10.0	mM	178.0	DMSO	266.101505	10	H	pluskal_fda_drugs_5005_H10_id
1316	HY-B0359	HYCPK40905	M19	HYCPK40905	91z	1238.0	4.0	Z38	905.0	M19	73151-29-8	Fenticonazole (Nitrate)	REC 15-1476	518.41	Antibiotic; Fungal	Anti-infection	Fenticonazole Nitrate is an antifungal imidazole ring derivative. Fenticonazole Nitrate operates via hindering ergosterol integration, and sequentially destructing the cytoplasmatic outer membrane. Fenticonazole Nitrate is effective against Gram-positive bacteria, mycoses, and vaginal candidiasis[1][2].	Nitrate	C24H21Cl2N3O4S	16105.0	DMSO : ≥ 100 mg/mL (192.90 mM)	DMSO Solution	10mM  * 100uL	Infection	[O-][N+](O)=O.ClC1=CC=C(C(OCC2=CC=C(SC3=CC=CC=C3)C=C2)CN4C=CN=C4)C(Cl)=C1	https://www.medchemexpress.com/Fenticonazole-Nitrate.html	Launched		91.0	Z38	H10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0359	10.0	mM	178.0	DMSO	454.06734	10	H	pluskal_fda_drugs_5005_H10_id
1330	HY-13911A	HYCPK40905	K20	HYCPK40905	91z	1048.0	4.0	V40	905.0	K20	155558-32-0	Hydroxyfasudil (hydrochloride)	HA-1100 hydrochloride; HA 1100 hydrochloride; HA1100 hydrochloride	343.83	ROCK	Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad	Hydroxyfasudil hydrochloride is a ROCK inhibitor, with IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively.	Hydrochloride	C14H18ClN3O3S	30094.0	DMSO : 30 mg/mL (87.25 mM; Need ultrasonic); H2O : 3.33 mg/mL (9.69 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease; Cancer	O=C1NC=CC2=C1C=CC=C2S(=O)(N3CCNCCC3)=O.[H]Cl	https://www.medchemexpress.com/Hydroxyfasudil-hydrochloride.html	Launched		91.0	V40	H10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13911A	10.0	mM	178.0	DMSO	307.099062	10	H	pluskal_fda_drugs_5005_H10_id
167	HY-B0370	HYCPK40902	E10	HYCPK40902	91z	403.0	1.0	I19	902.0	E10	2398-96-1	Tolnaftate	NP-27	307.41	Fungal	Anti-infection	Tolnaftate (NP-27) is a synthetic thiocarbamate used as an anti-fungal agent. .	Free Base	C19H17NOS	16123.0	DMSO : 50 mg/mL (162.65 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	S=C(OC1=CC=C2C=CC=CC2=C1)N(C)C3=CC=CC(C)=C3	https://www.medchemexpress.com/Tolnaftate.html	Launched		91.0	I19	H11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0370	10.0	mM	179.0	DMSO	307.103085	11	H	pluskal_fda_drugs_5005_H11_id
251	HY-B0004	HYCPK40902	I15	HYCPK40902	91z	797.0	1.0	Q29	902.0	I15	69975-86-6	Doxofylline		266.25	Adenosine Receptor; Phosphodiesterase (PDE); Reactive Oxygen Species	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Doxofylline is an orally active PDE IV inhibitor and A1AR antagonist. Doxofylline reduces inflammation in epithelial cells via inhibiting mitochondrial ROS production and amelioration of multiple cellular pathways (NLRP3-TXNIP inflammasome activation). Doxophylline can be used in studies of asthma, chronic obstructive pulmonary disease, and bronchospasm[1][2][3].	Free Base	C11H14N4O4	27081.0	DMSO : 50 mg/mL (187.79 mM; Need ultrasonic); H2O : 25 mg/mL (93.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(N1C)N(C)C2=C(N(CC3OCCO3)C=N2)C1=O	https://www.medchemexpress.com/Doxofylline.html	Launched		91.0	Q29	H11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0004	10.0	mM	179.0	DMSO	266.101505	11	H	pluskal_fda_drugs_5005_H11_id
262	HY-13451	HYCPK40902	D16	HYCPK40902	91z	319.0	1.0	G31	902.0	D16	209342-40-5	Finafloxacin		398.39	Antibiotic; Bacterial	Anti-infection	"Finafloxacin is a fluoroquinolone antimicrobial agent that exhibits optimum efficacy in slightly acidic environments. 
Target: Antibacterial
Finafloxacin is a pH-activated fluoroquinolone (belonging to a new 8-cyano subclass) to treat serious bacterial infections associated with an acidic environment, including urinary tract infections (UTIs) and Helicobacter pylori infections. Finafloxacin exhibits optimal efficacy in slightly acidic environments (pH 5.0-6.0), under which other fluoroquinolones lose activity. Finafloxacin is highly selective for bacterial type II topoisomerases, including DNA gyrase and DNA topoisomerase IV. [1]"	Free Acid	C20H19FN4O4	20329.0	DMSO : 6.4 mg/mL (16.06 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4C[C@]5([H])OCCN[C@@]5([H])C4)=C3C#N)C1=O)O	https://www.medchemexpress.com/Finafloxacin.html	Launched		91.0	G31	H11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13451	10.0	mM	179.0	DMSO	398.139033	11	H	pluskal_fda_drugs_5005_H11_id
435	HY-10977A	HYCPK40903	H04	HYCPK40903	91z	680.0	2.0	O8	903.0	H04	682745-41-1	Tivozanib (hydrochloride hydrate)	AV-951 (hydrochloride hydrate); KRN951 (hydrochloride hydrate)	509.34	VEGFR	Protein Tyrosine Kinase/RTK	Tivozanib hydrochloride hydrate is a potent and selective and orally active  VEGFR tyrosine kinase inhibitor with IC50是of 0.21, 0.16, 0.24 nM for VEGFR-1, VEGFR-2, VEGFR-3, respectively. Tivozanib hydrochloride hydrate inhibits angiogenesis and vascular permeability in tumor tissues and shows antitumor activity. Tivozanib hydrochloride hydrate has the potential for the research of metastatic renal cell carcinoma (RCC) [1][2][3].	Hydrochloride	C22H22Cl2N4O6	159900.0	DMSO : 250 mg/mL (490.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(C=C1Cl)OC2=CC=NC3=CC(OC)=C(C=C23)OC)NC4=NOC(C)=C4.Cl.O	https://www.medchemexpress.com/tivozanib-hydrochloride-hydrate.html	Launched		91.0	O8	H11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10977A	10.0	mM	179.0	DMSO	454.104397	11	H	pluskal_fda_drugs_5005_H11_id
847	HY-78131A	HYCPK40904	D10	HYCPK40904	91z	355.0	3.0	H19	904.0	D10	51146-56-6	(S)-(+)-Ibuprofen	(S)-Ibuprofen	206.28	COX	Immunology/Inflammation	(S)-(+)-Ibuprofen ((S)-Ibuprofen), a S(+)-enantiomer of Ibuprofen, is a potent COX-1 and COX-2 inhibitor with IC50s of 2.1 μM and 1.6 μM, respectively. (S)-(+)-Ibuprofen has analgesic, anti-inflammatory, anticancer and antipyretic effects[1][2].	Free Acid	C13H18O2	11599.0	DMSO : 100 mg/mL (484.78 mM; Need ultrasonic); H2O : 1 mg/mL (4.85 mM; Need ultrasonic and warming); Ethanol : 100 mg/mL (484.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC([C@H](C1=CC=C(CC(C)C)C=C1)C)=O	https://www.medchemexpress.com/_S_-__addition__-Ibuprofen.html	Launched		91.0	H19	H11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-78131A	10.0	mM	179.0	DMSO	206.13068	11	H	pluskal_fda_drugs_5005_H11_id
898	HY-B1132	HYCPK40904	G13	HYCPK40904	91z	649.0	3.0	N25	904.0	G13	3485-62-9	Clidinium (bromide)	Ro 2-3773	432.35	mAChR	GPCR/G Protein; Neuronal Signaling	Clidinium bromide is a quaternary amine antimuscarinic agent. Clidinium bromide may help symptoms of cramping and abdominal/stomach pain by decreasing stomach acid, and slowing the intestines in vivo[1].	Bromide	C22H26BrNO3	46135.0	DMSO : 125 mg/mL (289.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+]1(CC2)CC(OC(C(C3=CC=CC=C3)(O)C4=CC=CC=C4)=O)C2CC1.[Br-]	https://www.medchemexpress.com/Clidinium-bromide.html	Launched		91.0	N25	H11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1132	10.0	mM	179.0	DMSO	352.19072	11	H	pluskal_fda_drugs_5005_H11_id
1074	HY-P1959A	HYCPK40905	K04	HYCPK40905	91z	1016.0	4.0	V8	905.0	K04	2378114-72-6	Lanreotide (acetate)	BIM 23014 (acetate)	1156.38	Others	Others	Lanreotide (BIM 23014) acetate is a somatostatin analogue with antineoplastic activity. Lanreotide acetate can be used for the research of carcinoid syndrome[1][2].	Acetate	C56H73N11O12S2	109963.0	H2O : 25 mg/mL (21.62 mM; Need ultrasonic); DMSO : 100 mg/mL (86.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	O=C([C@@H](NC([C@@](CSSC[C@@H](C(N[C@H](C(N)=O)[C@H](O)C)=O)NC([C@H](C(C)C)NC([C@@](CCCCN)([H])NC1=O)=O)=O)([H])NC([C@H](N)CC2=CC3=CC=CC=C3C=C2)=O)=O)CC4=CC=C(O)C=C4)N[C@@H]1CC5=CNC6=C5C=CC=C6.CC(O)=O	https://www.medchemexpress.com/lanreotide-acetate.html	Launched		91.0	V8	H11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P1959A	10.0	mM	179.0	DMSO	1095.467029	11	H	pluskal_fda_drugs_5005_H11_id
1133	HY-100474	HYCPK40905	F08	HYCPK40905	91z	544.0	4.0	L16	905.0	F08	934826-68-3	Visomitin	SKQ1	617.60	Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Visomitin (SKQ1) is a mitochondrial-targeted antioxidant with the high mitochondrion membrane penetrating ability and potent antioxidant capability[1].	Bromide	C36H42BrO2P	87525.0	DMSO : 100 mg/mL (161.92 mM; Need ultrasonic); Ethanol : 50 mg/mL (80.96 mM; Need ultrasonic); H2O : 3.33 mg/mL (5.39 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C(CCCCCCCCCC[P+](C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)=C4)C(C)=C(C)C4=O.[Br-]	https://www.medchemexpress.com/Visomitin.html	Launched		91.0	L16	H11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100474	10.0	mM	179.0	DMSO	537.291694	11	H	pluskal_fda_drugs_5005_H11_id
230	HY-B2082	HYCPK40902	D14	HYCPK40902	91z	315.0	1.0	G27	902.0	D14	804-30-8	Fursultiamine		398.54	Others	Others	Fursultiamine is a vitamin B1 derivative, has anti-nociceptive and antineoplastic activity. Fursultiamine can be used for vitamin B1?deficiency, osteoarthritis (OA) and cancer research[1][2].	Free Base	C17H26N4O3S2	27364.0	DMSO : 106.7 mg/mL (267.73 mM; Need ultrasonic and warming); H2O : ≥ 6.67 mg/mL (16.74 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease; Cancer	O=CN(CC1=CN=C(C)N=C1N)/C(C)=C(SSCC2OCCC2)\CCO	https://www.medchemexpress.com/Fursultiamine.html	Launched		91.0	G27	H12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2082	10.0	mM	180.0	DMSO	398.144633	12	H	pluskal_fda_drugs_5005_H12_id
239	HY-10977	HYCPK40902	M14	HYCPK40902	91z	1179.0	1.0	Y27	902.0	M14	475108-18-0	Tivozanib	AV-951; KRN951	454.86	VEGFR	Protein Tyrosine Kinase/RTK	Tivozanib (AV-951; KRN951) is a potent and selective and orally active  VEGFR tyrosine kinase inhibitor with IC50是of 0.21, 0.16, 0.24 nM for VEGFR-1, VEGFR-2, VEGFR-3, respectively. Tivozanib inhibits angiogenesis and vascular permeability in tumor tissues and shows antitumor activity. Tivozanib has the potential for the research of metastatic renal cell carcinoma (RCC) [1][2][3].		C22H19ClN4O5	7642.0	DMSO : 25 mg/mL (54.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(C=C1Cl)OC2=CC=NC3=CC(OC)=C(C=C23)OC)NC4=NOC(C)=C4	https://www.medchemexpress.com/Tivozanib.html	Launched		91.0	Y27	H12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10977	10.0	mM	180.0	DMSO	454.104397	12	H	pluskal_fda_drugs_5005_H12_id
704	HY-17498	HYCPK40903	P20	HYCPK40903	91z	1480.0	2.0	AE40	903.0	P20	29122-68-7	Atenolol	(RS)-Atenolol	266.34	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Atenolol ((RS)-Atenolol) is a cardioselective β1-adrenergic receptor blocker, with a Ki of 697 nM atβ1-adrenoceptor in guine pig left ventricle membrane. Atenolol can be used for the research of hypertension and angina pectoris[1][2].	Free Base	C14H22N2O3	16705.0	H2O : 8.33 mg/mL (31.28 mM; Need ultrasonic); DMSO : 100 mg/mL (375.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology; Cancer	O=C(N)CC1=CC=C(OCC(O)CNC(C)C)C=C1	https://www.medchemexpress.com/atenolol.html	Launched		91.0	AE40	H12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17498	10.0	mM	180.0	DMSO	266.163043	12	H	pluskal_fda_drugs_5005_H12_id
971	HY-78131B	HYCPK40904	D18	HYCPK40904	91z	371.0	3.0	H35	904.0	D18	51146-57-7	(R)-(-)-Ibuprofen	(R)-Ibuprofen	206.28	NF-κB	NF-κB	(R)-(-)-Ibuprofen is the R enantiomer of Ibuprofen, inactive on COX, inhibits NF-κB activation; (R)-(-)-Ibuprofen exhibits anti-inflammatory and antinociceptive effects.	Free Acid	C13H18O2	67841.0	H2O : 0.67 mg/mL (3.25 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (484.78 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	C[C@H](C1=CC=C(CC(C)C)C=C1)C(O)=O	https://www.medchemexpress.com/_R_-_-_-Ibuprofen.html	Launched		91.0	H35	H12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-78131B	10.0	mM	180.0	DMSO	206.13068	12	H	pluskal_fda_drugs_5005_H12_id
1141	HY-N1404	HYCPK40905	N08	HYCPK40905	91z	1312.0	4.0	AB16	905.0	N08	20977-05-3	Sodium aescinate		1123.21	NF-κB	NF-κB	Sodium aescinate is a triterpene saponin derived from Aesculus hippocastanum seeds, with anti-inflammatory and antioxidant activities[1]. Sodium aescinate inhibits hepatocellular carcinoma growth by targeting CARMA3/NF-κB pathway[2].	Sodium	C54H83NaO23	152900.0	DMSO : 100 mg/mL (89.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	CC(C(OC[C@@]12[C@H]3C[C@]4(C)C([C@]1([H])CC(C)(C)[C@H](O3)[C@@H]2O)=CC[C@@]5([H])[C@@]4(C)CC[C@]6([H])[C@]5(C)CC[C@H](O[C@@H]7O[C@H](C(O[Na])=O)[C@@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@]6(CO)C)=	https://www.medchemexpress.com/sodium-aescinate.html	Launched		91.0	AB16	H12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1404	10.0	mM	180.0	DMSO	1100.540339	12	H	pluskal_fda_drugs_5005_H12_id
1222	HY-15234	HYCPK40905	O13	HYCPK40905	91z	1418.0	4.0	AD26	905.0	O13	397864-44-7	Fluticasone furoate		538.58	Glucocorticoid Receptor	Immunology/Inflammation	Fluticasone furoate is a topical, intranasal, enhanced-affinity synthetic trifluorinated corticosteroid with a Kd of 0.3 nM. Fluticasone furoate has potent anti-inflamatory and anti-asthmatic activity, and low systemic exposure. Fluticasone furoate has the potential for allergic rhinitis treatment[1][2].		C27H29F3O6S	109514.0	DMSO : 100 mg/mL (185.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(SCF)=O)(OC(C3=CC=CO3)=O)[C@H](C)C[C@@]1([H])[C@]4([H])C[C@H](F)C5=CC(C=C[C@]5(C)[C@@]4(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/fluticasone-furoate.html	Launched		91.0	AD26	H12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15234	10.0	mM	180.0	DMSO	538.163694	12	H	pluskal_fda_drugs_5005_H12_id
1279	HY-14895A	HYCPK40905	H17	HYCPK40905	91z	754.0	4.0	P34	905.0	H17	173352-39-1	Fabomotizole (hydrochloride)	CM346 hydrochloride	343.87	Others	Others	Fabomotizole hydrochloride (CM346 hydrochloride) is an anxiolytic drug.  Fabomotizole hydrochloride  produces anxiolytic and neuroprotective effects without any muscle relaxant actions.	Hydrochloride	C15H22ClN3O2S	12546.0	DMSO : ≥ 44 mg/mL (127.96 mM); H2O : 100 mg/mL (290.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCOC1=CC=C2C(N=C(SCCN3CCOCC3)N2)=C1.Cl	https://www.medchemexpress.com/Fabomotizole-hydrochloride.html	Launched		91.0	P34	H12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14895A	10.0	mM	180.0	DMSO	307.135448	12	H	pluskal_fda_drugs_5005_H12_id
1282	HY-B0634	HYCPK40905	K17	HYCPK40905	91z	1042.0	4.0	V34	905.0	K17	89796-99-6	Aceclofenac		354.18	COX	Immunology/Inflammation	Aceclofenac is an orally active nonsteroidal anti-inflammatory drug (NSAID), with analgesic and anti-inflammatory properties. Aceclofenac is used for the research of osteoarthritis, ankylosing spondylitis, rheumatoid arthritis[1][2].	Free Acid	C16H13Cl2NO4	16160.0	H2O : 0.1 mg/mL (0.28 mM; Need ultrasonic and warming); DMSO : 100 mg/mL (282.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCC(O)=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl	https://www.medchemexpress.com/Aceclofenac.html	Launched		91.0	V34	H12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0634	10.0	mM	180.0	DMSO	353.022163	12	H	pluskal_fda_drugs_5005_H12_id
474	HY-13512	HYCPK40903	O06	HYCPK40903	91z	1356.0	2.0	AC12	903.0	O06	59721-29-8	Camostat (mesylate)	Camostat mesilate; FOY305; FOY-S980	494.52	SARS-CoV; Ser/Thr Protease	Anti-infection; Metabolic Enzyme/Protease	Camostat mesylate (Camostat mesilate) is an orally active, synthetic serine protease inhibitor for chronic pancreatitis. Camostat mesylate, an inhibitor of TMPRSS2, shows antiviral activity against SARS-CoV-2. Camostat mesylate also inhibits the activity of prostasin, trypsin, and matriptase[1][2][3].	Mesylate	C21H26N4O8S	80561.0	H2O : ≥ 50 mg/mL (101.11 mM); DMSO : 125 mg/mL (252.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(OCC(N(C)C)=O)CC1=CC=C(OC(C2=CC=C(NC(N)=N)C=C2)=O)C=C1.CS(=O)(O)=O	https://www.medchemexpress.com/Camostat-mesylate.html	Launched		91.0	AC12	H13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13512	10.0	mM	181.0	DMSO	398.15902	13	H	pluskal_fda_drugs_5005_H13_id
821	HY-B0484	HYCPK40904	J08	HYCPK40904	91z	927.0	3.0	T15	904.0	J08	35543-24-9	Buflomedil (hydrochloride)		343.85	Others	Others	"Buflomedil hydrochloride is a vasodilator used to treat claudication or the symptoms of peripheral arterial disease.
Target: Others
Buflomedil hydrochloride is a vasoactive drug used to treat claudication or the symptoms of peripheral arterial disease. In the EU, buflomedil, a vasoactive agent, was indicated for treatment of PAOD symptoms, specifically in patients with stage II PAOD who experience severe pain when walking even relatively short distances. Buflomedil is not currently approved by the US Food and Drug Administration for use in the United States."	Hydrochloride	C17H26ClNO4	16161.0	H2O : ≥ 55 mg/mL (159.95 mM); DMSO : 33.33 mg/mL (96.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(C1=C(OC)C=C(OC)C=C1OC)CCCN2CCCC2.Cl	https://www.medchemexpress.com/Buflomedil-hydrochloride.html	Launched		91.0	T15	H13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0484	10.0	mM	181.0	DMSO	307.178358	13	H	pluskal_fda_drugs_5005_H13_id
949	HY-P0053	HYCPK40904	N16	HYCPK40904	91z	1327.0	3.0	AB31	904.0	N16	38234-21-8	Fertirelin		1153.29	GnRH Receptor	GPCR/G Protein	Fertirelin is a GnRH and LH-RH analogue; it also becomes the treatment choice for reversing cow follicular cysts.	Free Base	C55H76N16O12	21683.0	DMSO : ≥ 100 mg/mL (86.71 mM); H2O : 100 mg/mL (86.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C([C@H]1NC(CC1)=O)N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@@H](CO)C(N[C@H](C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N3[C@@H](CCC3)C(NCC)=O)=O)=O)=O)=O)CC4=CC=C(C=C4)O)=O)=O)CC5=CNC6=CC=CC=C56)=O	https://www.medchemexpress.com/Fertirelin.html	Launched		91.0	AB31	H13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P0053	10.0	mM	181.0	DMSO	1152.582862	13	H	pluskal_fda_drugs_5005_H13_id
1149	HY-16398	HYCPK40905	F09	HYCPK40905	91z	546.0	4.0	L18	905.0	F09	54-91-1	Pipobroman		356.05	DNA Alkylator/Crosslinker	Cell Cycle/DNA Damage	Pipobroman is a bromide derivative of piperazine and acts as an alkylating agent. Pipobroman plays its role by inhibiting DNA and RNA polymerase or by reducing pyrimidine nucleotide incorporation into DNA. Pipobroman can be used for the cancer research, including polycythemia vera, myeloproliferative neoplasm, and AML et.al[1].	Free Base	C10H16Br2N2O2	84000.0	DMSO : ≥ 36 mg/mL (101.11 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N1CCN(C(CCBr)=O)CC1)CCBr	https://www.medchemexpress.com/Pipobroman.html	Launched		91.0	L18	H13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16398	10.0	mM	181.0	DMSO	353.957852	13	H	pluskal_fda_drugs_5005_H13_id
1162	HY-B0968	HYCPK40905	C10	HYCPK40905	91z	260.0	4.0	F20	905.0	C10	13171-25-0	Trimetazidine (dihydrochloride)		339.26	Autophagy	Autophagy	Trimetazidine dihydrochloride is a selective long chain 3-ketoyl coenzyme A thiolase inhibitor with an IC50 of 75 nM, which can inhibit β-oxidation of free fatty acid (FFA). Trimetazidine dihydrochloride is an effective antianginal agent and a cytoprotective drug, has anti-oxidant, anti-inflammatory, antinociceptive and gastroprotective properties. Trimetazidine dihydrochloride triggers autophagy. Trimetazidine dihydrochloride is also a 3-hydroxyacyl-CoA dehydrogenase (HADHA) inhibitor[1][2][3][4].	Hydrochloride	C14H24Cl2N2O3	17158.0	DMSO : 25 mg/mL (73.69 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (294.76 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	COC1=CC=C(CN2CCNCC2)C(OC)=C1OC.[H]Cl.[H]Cl	https://www.medchemexpress.com/Trimetazidine-dihydrochloride.html	Launched		91.0	F20	H13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0968	10.0	mM	181.0	DMSO	266.163043	13	H	pluskal_fda_drugs_5005_H13_id
1250	HY-11106	HYCPK40905	K15	HYCPK40905	91z	1038.0	4.0	V30	905.0	K15	656247-18-6	Nintedanib esylate	BIBF 1120 (esylate)	649.76	FGFR; PDGFR; VEGFR	Protein Tyrosine Kinase/RTK	Nintedanib esylate (BIBF 1120 esylate) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.	Esylate	C33H39N5O7S	13780.0	DMSO : 66.67 mg/mL (102.61 mM; Need ultrasonic); Ethanol : 3.08 mg/mL (4.74 mM; Need ultrasonic); H2O : 16.67 mg/mL (25.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC(NC/2=O)=C(C=C1)C2=C(NC3=CC=C(N(C)C(CN4CCN(C)CC4)=O)C=C3)/C5=CC=CC=C5)OC.CCS(=O)(O)=O	https://www.medchemexpress.com/BIBF-1120-esylate.html	Launched		91.0	V30	H13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-11106	10.0	mM	181.0	DMSO	539.253255	13	H	pluskal_fda_drugs_5005_H13_id
1299	HY-78131C	HYCPK40905	L18	HYCPK40905	91z	1140.0	4.0	X36	905.0	L18	31121-93-4	Ibuprofen (sodium)	(±)-Ibuprofen (sodium)	228.26	Apoptosis; COX; Parasite	Anti-infection; Apoptosis; Immunology/Inflammation	Ibuprofen ((±)-Ibuprofen) sodium is an orally active, selective COX-1 inhibitor with an IC50 value of 13 μM. Ibuprofen sodium inhibits cell proliferation, angiogenesis, and induces cell apoptosis. Ibuprofen sodium is a nonsteroidal anti-inflammatory agent and a nitric oxide (NO) donor. Ibuprofen sodium can be used in the research of pain, swelling, inflammation, infection, immunology, cancers[1][2][5][8].	Sodium	C13H17NaO2	227994.0	DMSO : 20.83 mg/mL (91.26 mM; ultrasonic and warming and heat to 60°C); H2O : ≥ 100 mg/mL (438.10 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology; Neurological Disease	O=C(O[Na])C(C)C1=CC=C(CC(C)C)C=C1	https://www.medchemexpress.com/ibuprofen-sodium.html	Launched		91.0	X36	H13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-78131C	10.0	mM	181.0	DMSO	206.13068	13	H	pluskal_fda_drugs_5005_H13_id
1323	HY-14519	HYCPK40905	D20	HYCPK40905	91z	376.0	4.0	H40	905.0	D20	59-05-2	Methotrexate	Amethopterin; CL14377; WR19039	454.44	ADC Cytotoxin; Antifolate; Apoptosis; Bacterial; DNA/RNA Synthesis	Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Methotrexate (Amethopterin), an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis. Methotrexate, also an immunosuppressant and antineoplastic agent, is used for the research of rheumatoid arthritis and a number of different cancers (such as acute lymphoblastic leukemia)[1][2][3].	Free Acid	C20H22N8O5	65795.0	DMSO : ≥ 50 mg/mL (110.03 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	NC1=NC(N)=C2C(N=CC(CN(C)C3=CC=C(C(N[C@@H](CCC(O)=O)C(O)=O)=O)C=C3)=N2)=N1	https://www.medchemexpress.com/Methotrexate.html	Launched		91.0	H40	H13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14519	10.0	mM	181.0	DMSO	454.171316	13	H	pluskal_fda_drugs_5005_H13_id
549	HY-15771	HYCPK40903	F12	HYCPK40903	91z	504.0	2.0	K24	903.0	F12	1351636-18-4	Tirabrutinib	ONO-4059; GS-4059	454.48	Apoptosis; Btk	Apoptosis; Protein Tyrosine Kinase/RTK	Tirabrutinib (ONO-4059) is an orally active Bruton’s Tyrosine Kinase (BTK) inhibitor (can cross the blood-brain barrier (BBB)), with an IC50 of 6.8 nM. Tirabrutinib irreversibly and covalently binds to BTK and inhibits aberrant B cell receptor signaling. Tirabrutinib can be used in studies of autoimmune diseases and hematological malignancies[1][2][3][4].	Free Base	C25H22N6O3	112546.0	DMSO : ≥ 100 mg/mL (220.03 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C1N(C2=CC=C(OC3=CC=CC=C3)C=C2)C4=C(N)N=CN=C4N1[C@H]5CN(C(C#CC)=O)CC5	https://www.medchemexpress.com/ONO-4059.html	Launched		91.0	K24	H14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15771	10.0	mM	182.0	DMSO	454.175339	14	H	pluskal_fda_drugs_5005_H14_id
951	HY-B0625	HYCPK40904	P16	HYCPK40904	91z	1519.0	3.0	AF31	904.0	P16	126544-47-6	Ciclesonide	RPR251526	540.69	Glucocorticoid Receptor	Immunology/Inflammation	Ciclesonide (RPR251526) is a glucocorticoid with an potent anti-inflammatory activity. Ciclesonide can be used for asthma research[1].	Free Base	C32H44O7	16624.0	DMSO : 50 mg/mL (92.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@@H](O)C5)(O[C@H](C6CCCCC6)O1)[C@]25C)COC(C(C)C)=O	https://www.medchemexpress.com/Ciclesonide.html	Launched		91.0	AF31	H14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0625	10.0	mM	182.0	DMSO	540.308704	14	H	pluskal_fda_drugs_5005_H14_id
1017	HY-B0323	HYCPK40904	B21	HYCPK40904	91z	185.0	3.0	D41	904.0	B21	127-69-5	Sulfisoxazole	Sulfafurazole	267.30	Antibiotic; Bacterial; Endothelin Receptor	Anti-infection; GPCR/G Protein	Sulfisoxazole (Sulfafurazole) is an endothelin receptor antagonist with IC50 values of 0.60 μM and 22 μM against endothelin receptor A and endothelin receptor B, respectively. Sulfisoxazole is a sulfonamide antibacterial with an oxazole substituent. Sulfisoxazole inhibits breast cancer exosome release by targeting endothelin receptor A[1][2].	Free Base	C11H13N3O3S	17004.0	DMSO : ≥ 150 mg/mL (561.17 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Endocrinology	O=S(C1=CC=C(N)C=C1)(NC2=C(C)C(C)=NO2)=O	https://www.medchemexpress.com/Sulfisoxazole.html	Launched		91.0	D41	H14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0323	10.0	mM	182.0	DMSO	267.067762	14	H	pluskal_fda_drugs_5005_H14_id
1092	HY-78131	HYCPK40905	M05	HYCPK40905	91z	1210.0	4.0	Z10	905.0	M05	15687-27-1	Ibuprofen	(±)-Ibuprofen	206.28	Apoptosis; COX; Parasite	Anti-infection; Apoptosis; Immunology/Inflammation	Ibuprofen ((±)-Ibuprofen) is a potent, orally active, selective COX-1 inhibitor with an IC50 value of 13 μM. Ibuprofen inhibits cell proliferation, angiogenesis, and induces cell apoptosis. Ibuprofen is a nonsteroidal anti-inflammatory agent and a nitric oxide (NO) donor. Ibuprofen ((±)-Ibuprofen) can be used in the research of pain, swelling, inflammation, infection, immunology, cancers[1][2][5][8].	Free Acid	C13H18O2	110093.0	H2O : 1 mg/mL (4.85 mM; Need ultrasonic); DMSO : 100 mg/mL (484.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology; Neurological Disease	OC(C(C1=CC=C(CC(C)C)C=C1)C)=O	https://www.medchemexpress.com/Ibuprofen.html	Launched		91.0	Z10	H14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-78131	10.0	mM	182.0	DMSO	206.13068	14	H	pluskal_fda_drugs_5005_H14_id
1192	HY-B0520A	HYCPK40905	A12	HYCPK40905	91z	72.0	4.0	B24	905.0	A12	132-17-2	Benztropine (mesylate)	Benzatropine mesylate; Benzotropine mesylate; Benztropine methanesulfonate	403.54	Dopamine Receptor; Histamine Receptor; mAChR	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Benztropine mesylate (Benzatropine mesylate) is an orally active centrally acting anticholinergic agent that can be used for Parkinson's disease research. Benztropine mesylate is an anti-histamine agent and a dopamine re-uptake inhibitor. Benztropine mesylate is also a human D2 dopamine receptor allosteric antagonist. Benztropine mesylate also has anti-CSCs (cancer stem cells) effects[1][2].	Mesylate	C22H29NO4S	13242.0	DMSO : 100 mg/mL (247.81 mM; Need ultrasonic); H2O : 100 mg/mL (247.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	CN1[C@H]2CC(OC(C3=CC=CC=C3)C4=CC=CC=C4)C[C@@H]1CC2.CS(=O)(O)=O	https://www.medchemexpress.com/Benztropine-mesylate.html	Launched		91.0	B24	H14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0520A	10.0	mM	182.0	DMSO	307.193614	14	H	pluskal_fda_drugs_5005_H14_id
1226	HY-13569A	HYCPK40905	C14	HYCPK40905	91z	268.0	4.0	F28	905.0	C14	496807-11-5	Beraprost (sodium)		420.47	Prostaglandin Receptor	GPCR/G Protein	Beraprost sodium, a prostacyclin analog, is a stable and orally active prodrug of PGI2. Beraprost sodium is a potent vasodilator, has the potential for pulmonary arterial hypertension treatment through expanding renal vessels, improving microcirculation[1].	Sodium	C24H29NaO5	157145.0	DMSO : 125 mg/mL (297.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@@]2([H])C3=CC=CC(CCCC(O[Na])=O)=C3O[C@@]2([H])C[C@H]1O.[Relative stereochemistry]	https://www.medchemexpress.com/rac-beraprost-sodium.html	Launched		91.0	F28	H14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13569A	10.0	mM	182.0	DMSO	398.209324	14	H	pluskal_fda_drugs_5005_H14_id
1300	HY-17405	HYCPK40905	M18	HYCPK40905	91z	1236.0	4.0	Z36	905.0	M18	79561-22-1	Alarelin (Acetate)	Alarelin	1287.42	GnRH Receptor	GPCR/G Protein	Alarelin acetate is a synthetic GnRH agonist.	Acetate	C60H86N16O16	79737.0	DMSO : 100 mg/mL (77.67 mM; Need ultrasonic); H2O : 100 mg/mL (77.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(N[C@@H](CO)C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N2CCC[C@H]2C(NCC)=O)=O)=O)=O)=O)=O)[C@@H](NC([C@@H](NC([C@@H](N3)CCC3=O)=O)CC4=CN=CN4)=O)CC5=CNC6=CC=CC=C65.CC(O)=O.CC(O)=O	https://www.medchemexpress.com/Alarelin-Acetate.html	Launched		91.0	Z36	H14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17405	10.0	mM	182.0	DMSO	1166.598512	14	H	pluskal_fda_drugs_5005_H14_id
1348	HY-12715	HYCPK40905	M21	HYCPK40905	91z	1242.0	4.0	Z42	905.0	M21	146-48-5	Yohimbine		354.44	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	"Yohimbine is a potent and relatively nonselective alpha 2-adrenergic
receptor (AR) antagonist, with IC50 of 0.6 μM. 
IC50 value: 0.6 uM [1]
Target: alpha 2-adrenergic receptor
in vitro: Yohimbine inhibits alpha2-receptor antagonist with Ki of 1.05 nM, 1.19 nM, and 1.19 nM for α2A, α2B, α2C, respectively. Yohimbine also inhibits 5-HT1B with Ki of 19.9 nM. Yohimbine acts to block the lowering of cAMP by alpha-2 adrenoceptor agonists. yohimbine actually causes a pronounced lowering of tyrosinase activity. [3]
in vivo: Yohimbine is an antagonist at alpha2-noradrenaline receptors with putative panicogenic effects in human subjects, was administered to Swiss-Webster mice at doses of 0.5, 1.0, and 2.0 mg/kg. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice.[2]"		C21H26N2O3	99037.0	DMSO : 5 mg/mL (14.11 mM; Need ultrasonic); H2O : 1 mg/mL (2.82 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	[H][C@]12C(NC3=C4C=CC=C3)=C4CCN1C[C@@]5(CC[C@H](O)[C@H](C(OC)=O)[C@]5(C2)[H])[H]	https://www.medchemexpress.com/Yohimbine.html	Launched		91.0	Z42	H14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12715	10.0	mM	182.0	DMSO	354.194343	14	H	pluskal_fda_drugs_5005_H14_id
112	HY-B0381A	HYCPK40902	F06	HYCPK40902	91z	491.0	1.0	K11	902.0	F06	63659-19-8	Betaxolol (hydrochloride)	SL75212	343.89	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Betaxolol Hydrochloride is a selective beta1 adrenergic receptor blocker that can be used for the research of hypertension and glaucoma.	Hydrochloride	C18H30ClNO3	15989.0	H2O : 10 mg/mL (29.08 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (290.79 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	OC(CNC(C)C)COC1=CC=C(CCOCC2CC2)C=C1.[H]Cl	https://www.medchemexpress.com/Betaxolol-hydrochloride.html	Launched		91.0	K11	H15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0381A	10.0	mM	183.0	DMSO	307.214744	15	H	pluskal_fda_drugs_5005_H15_id
156	HY-12956A	HYCPK40902	F09	HYCPK40902	91z	497.0	1.0	K17	902.0	F09	38562-01-5	Dinoprost (tromethamine salt)	Prostaglandin F2α (tromethamine salt); PGF2α THAM; Prostaglandin F2α THAM	475.62	Apoptosis; Autophagy; Endogenous Metabolite; Prostaglandin Receptor	Apoptosis; Autophagy; GPCR/G Protein; Metabolic Enzyme/Protease	Dinoprost tromethamine salt (Prostaglandin F2α tromethamine salt) is an orally active, potent prostaglandin F (PGF) receptor (FP receptor) agonist. Dinoprost tromethamine salt is a luteolytic hormone produced locally in the endometrial luminal epithelium and corpus luteum (CL). Dinoprost tromethamine salt plays a key role in the onset and progression of labour[1][2].	Tris	C24H45NO8	19027.0	H2O : ≥ 100 mg/mL (210.25 mM); DMSO : ≥ 100 mg/mL (210.25 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(O)=O.OCC(CO)(N)CO	https://www.medchemexpress.com/Dinoprost-tromethamine-salt.html	Launched		91.0	K17	H15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12956A	10.0	mM	183.0	DMSO	354.240624	15	H	pluskal_fda_drugs_5005_H15_id
250	HY-15771A	HYCPK40902	H15	HYCPK40902	91z	701.0	1.0	O29	902.0	H15	1439901-97-9	Tirabrutinib (hydrochloride)	ONO-4059 (hydrochloride); GS-4059 (hydrochloride)	490.94	Apoptosis; Btk	Apoptosis; Protein Tyrosine Kinase/RTK	Tirabrutinib (ONO-4059) hydrochloride is an orally active Bruton’s Tyrosine Kinase (BTK) inhibitor (can cross the blood-brain barrier (BBB)), with an IC50 of 6.8 nM. Tirabrutinib hydrochloride irreversibly and covalently binds to BTK and inhibits aberrant B cell receptor signaling. Tirabrutinib hydrochloride can be used in studies of autoimmune diseases and hematological malignancies[1][2][3][4].	Hydrochloride	C25H23ClN6O3	67503.0	DMSO : 100 mg/mL (203.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C1N(C2=CC=C(OC3=CC=CC=C3)C=C2)C4=C(N)N=CN=C4N1[C@H]5CN(C(C#CC)=O)CC5.[H]Cl	https://www.medchemexpress.com/ONO-4059-hydrochloride.html	Launched		91.0	O29	H15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15771A	10.0	mM	183.0	DMSO	454.175339	15	H	pluskal_fda_drugs_5005_H15_id
359	HY-B0450A	HYCPK40903	P03	HYCPK40903	91z	1446.0	2.0	AE6	903.0	P03	41621-49-2	Ciclopirox (olamine)	Ciclopirox (ethanolamine); HOE 296	268.35	Bacterial; Ferroptosis; Fungal	Anti-infection; Apoptosis	Ciclopirox olamine (Ciclopirox ethanolamine) is a synthetic antifungal agent that can be used for superficial mycoses reseaech. Ciclopirox olamine has a very broad spectrum of activity and inhibits dermatophytes, yeasts, molds, and many Gram-positive and Gram-negative species pathogenic[1].	Olamine	C14H24N2O3	33053.0	DMSO : 25 mg/mL (93.16 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1C=C(C)C=C(C2CCCCC2)N1O.NCCO	https://www.medchemexpress.com/Ciclopirox-olamine.html	Launched		91.0	AE6	H15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0450A	10.0	mM	183.0	DMSO	207.125929	15	H	pluskal_fda_drugs_5005_H15_id
473	HY-17413	HYCPK40903	N06	HYCPK40903	91z	1260.0	2.0	AA12	903.0	N06	30516-87-1	Zidovudine	Azidothymidine; AZT; ZDV	267.24	CRISPR/Cas9; HIV	Anti-infection; Cell Cycle/DNA Damage	Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. Zidovudine increases CRISPR/Cas9-mediated editing frequency.	Free Base	C10H13N5O4	25329.0	DMSO : ≥ 100 mg/mL (374.20 mM); H2O : 16.67 mg/mL (62.38 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(C)=CN1[C@@H](C2)O[C@@H]([C@H]2N=[N+]=[N-])CO)NC1=O	https://www.medchemexpress.com/Zidovudine.html	Launched		91.0	AA12	H15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17413	10.0	mM	183.0	DMSO	267.096754	15	H	pluskal_fda_drugs_5005_H15_id
1072	HY-13624A	HYCPK40905	I04	HYCPK40905	91z	824.0	4.0	R8	905.0	I04	56390-09-1	Epirubicin (hydrochloride)	4'-Epidoxorubicin (hydrochloride)	579.98	Antibiotic; Apoptosis; DNA/RNA Synthesis; Topoisomerase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Epirubicin hydrochloride (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase[1]. Epirubicin hydrochloride inhibits DNA and RNA synthesis. Epirubicin hydrochloride is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity[2].	Hydrochloride	C27H30ClNO11	84283.0	DMSO : 25 mg/mL (43.10 mM; Need ultrasonic); H2O : 50 mg/mL (86.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C2C(O)=C3[C@@H](O[C@@]4([H])C[C@H](N)[C@@H](O)[C@H](C)O4)C[C@@](C(CO)=O)(O)CC3=C1O)C5=CC=CC(OC)=C5C2=O.Cl	https://www.medchemexpress.com/epirubicin-hydrochloride.html	Launched		91.0	R8	H15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13624A	10.0	mM	183.0	DMSO	543.174061	15	H	pluskal_fda_drugs_5005_H15_id
1221	HY-10255	HYCPK40905	N13	HYCPK40905	91z	1322.0	4.0	AB26	905.0	N13	341031-54-7	Sunitinib (Malate)	SU 11248 (Malate)	532.56	Apoptosis; Autophagy; IRE1; Mitophagy; PDGFR; VEGFR	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK	Sunitinib Malate (SU 11248 Malate) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib Malate, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2].	Malate	C26H33FN4O7	4494.0	DMSO : ≥ 15 mg/mL (28.17 mM); H2O : 3.33 mg/mL (6.25 mM; ultrasonic and warming and heat to 60°C); H2O : 12.5 mg/mL (23.47 mM; ultrasonic and adjust pH to 3 with HCl)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NCCN(CC)CC)C1=C(NC(/C=C2C(NC3=C\2C=C(C=C3)F)=O)=C1C)C.O=C([C@H](CC(O)=O)O)O	https://www.medchemexpress.com/Sunitinib-Malate.html	Launched		91.0	AB26	H15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10255	10.0	mM	183.0	DMSO	398.211804	15	H	pluskal_fda_drugs_5005_H15_id
1306	HY-16321	HYCPK40905	C19	HYCPK40905	91z	278.0	4.0	F38	905.0	C19	208538-73-2	Micafungin (sodium)	FK 463 (sodium)	1292.26	Antibiotic; Fungal	Anti-infection	Micafungin sodium (FK 463 sodium) is an antifungal agent which inhibits 1, 3-beta-D-glucan synthesis.	Sodium	C56H70N9NaO23S	22367.0	DMSO : ≥ 32 mg/mL (24.76 mM); H2O : 100 mg/mL (77.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=S(OC1=CC([C@H](O)[C@@H](O)C(NC(C2N(C(C(NC([C@]([H])(C[C@@H](O)[C@@H](O)NC(C3N(C(C([C@H](O)CC(N)=O)N4)=O)C[C@H](C)[C@@H]3O)=O)NC(C5=CC=C(C6=NOC(C7=CC=C(OCCCCC)C=C7)=C6)C=C5)=O)=O)[C@H](O)C)=O)C[C@H](O)C2)=O)C4=O)=CC=C1O)(O[Na])=O	https://www.medchemexpress.com/Micafungin-sodium.html	Launched		91.0	F38	H15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16321	10.0	mM	183.0	DMSO	1269.438351	15	H	pluskal_fda_drugs_5005_H15_id
347	HY-B0921	HYCPK40903	D03	HYCPK40903	91z	294.0	2.0	G6	903.0	D03	116-43-8	Succinylsulfathiazole	Succinylsulphathiazole	355.39	Antibiotic; Bacterial	Anti-infection	Succinylsulfathiazole is a sulfonamide, it is an ultra long acting drug.	Free Acid	C13H13N3O5S2	17211.0	DMSO : 100 mg/mL (281.38 mM; Need ultrasonic); H2O : 1 mg/mL (2.81 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)CCC(NC1=CC=C(S(=O)(NC2=NC=CS2)=O)C=C1)=O	https://www.medchemexpress.com/Succinylsulfathiazole.html	Launched		91.0	G6	H16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0921	10.0	mM	184.0	DMSO	355.029663	16	H	pluskal_fda_drugs_5005_H16_id
517	HY-B0877	HYCPK40903	F10	HYCPK40903	91z	500.0	2.0	K20	903.0	F10	3093-35-4	Halcinonide	SQ-18566	454.96	Smo	Stem Cell/Wnt	Halcinonide (SQ-18566) is a high potency corticosteroid used topically in the treatment of certain skin conditions.	Free Base	C24H32ClFO5	16357.0	DMSO : ≥ 48 mg/mL (105.50 mM)	DMSO Solution	10mM  * 100uL	Others	C[C@@]12[C@@]3(C(CCl)=O)[C@@](OC(C)(O3)C)([H])C[C@@]1([H])[C@]4([H])CCC5=CC(CC[C@]5(C)[C@@]4(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/Halcinonide.html	Launched		91.0	K20	H16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0877	10.0	mM	184.0	DMSO	454.19223	16	H	pluskal_fda_drugs_5005_H16_id
913	HY-N0092	HYCPK40904	F14	HYCPK40904	91z	555.0	3.0	L27	904.0	F14	58-63-9	Inosine		268.23	Adenosine Receptor; Endogenous Metabolite	GPCR/G Protein; Metabolic Enzyme/Protease	Inosine is an endogenous purine nucleoside produced by catabolism of adenosine. Inosine has anti-inflammatory, antinociceptive, immunomodulatory and neuroprotective effects. Inosine is an agonist for adenosine A1 (A1R) and A2A (A2AR) receptors[1][2][3].	Free Base	C10H12N4O5	81425.0	DMSO : 25 mg/mL (93.20 mM; Need ultrasonic); H2O : 10 mg/mL (37.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3O)O1)O)O	https://www.medchemexpress.com/Inosine.html	Launched		91.0	L27	H16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0092	10.0	mM	184.0	DMSO	268.080769	16	H	pluskal_fda_drugs_5005_H16_id
1138	HY-11063	HYCPK40905	K08	HYCPK40905	91z	1024.0	4.0	V16	905.0	K08	162359-55-9	Fingolimod	FTY720 free base	307.47	LPL Receptor; PAK	Cell Cycle/DNA Damage; Cytoskeleton; GPCR/G Protein	Fingolimod (FTY720 free base) is a sphingosine 1-phosphate (S1P) antagonist with an IC50 of 0.033 nM in K562 and NK cells. Fingolimod also is a pak1 activator, a immunosuppressant[1].	Free Base	C19H33NO2	26715.0	DMSO : 2 mg/mL (6.50 mM; ultrasonic and heat to 60°C); Ethanol : 7.69 mg/mL (25.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	OCC(CCC1=CC=C(CCCCCCCC)C=C1)(N)CO	https://www.medchemexpress.com/fingolimod.html	Launched		91.0	V16	H16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-11063	10.0	mM	184.0	DMSO	307.251129	16	H	pluskal_fda_drugs_5005_H16_id
1225	HY-A0008	HYCPK40905	B14	HYCPK40905	91z	172.0	4.0	D28	905.0	B14	36085-73-1	Talipexole (dihydrochloride)	B-HT 920 (dihydrochloride)	282.23	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Talipexole dihydrochloride (B-HT 920 dihydrochloride) is a dopamine D2 receptor agonist, α2-adrenoceptor agonist and 5-HT3 receptor antagonist, which displays antiParkinsonian activity.	Hydrochloride	C10H17Cl2N3S	15161.0	DMSO : 28 mg/mL (99.21 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	NC1=NC2=C(CCN(CC2)CC=C)S1.Cl.Cl	https://www.medchemexpress.com/B-HT-920.html	Launched		91.0	D28	H16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0008	10.0	mM	184.0	DMSO	209.098668	16	H	pluskal_fda_drugs_5005_H16_id
1273	HY-14944	HYCPK40905	B17	HYCPK40905	91z	178.0	4.0	D34	905.0	B17	26833-87-4	Homoharringtonine	Omacetaxine mepesuccinate; HHT	545.62	STAT	JAK/STAT Signaling; Stem Cell/Wnt	Homoharringtonine (Omacetaxine mepesuccinate;HHT) is a cytotoxic alkaloid with antitumor properties which acts by inhibiting translation elongation.	Free Base	C29H39NO9	96907.0	H2O : 1.4 mg/mL (2.57 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (91.64 mM)	DMSO Solution	10mM  * 100uL	Cancer	[H][C@@]12[C@](CCC3)(C=C(OC)[C@]2(OC([C@](CCCC(O)(C)C)(O)CC(OC)=O)=O)[H])N3CCC4=CC5=C(OCO5)C=C14	https://www.medchemexpress.com/Homoharringtonine.html	Launched		91.0	D34	H16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14944	10.0	mM	184.0	DMSO	545.262482	16	H	pluskal_fda_drugs_5005_H16_id
1292	HY-B1924	HYCPK40905	E18	HYCPK40905	91z	468.0	4.0	J36	905.0	E18	213997-73-0	Norvancomycin (hydrochloride)	Desmethyl-vancomycin hydrochloride	1471.69	Bacterial	Anti-infection	"Norvancomycin hydrochloride is applicable for endocarditis, osteomyelitis, pneumonia, sepsis or soft tissue infections caused
by Staphylococcus (including Methicillin-resistant strains and multidrug-resistant microbial strains).
Target: Antibacterial"	Hydrochloride	C65H74Cl3N9O24	18170.0	H2O : ≥ 100 mg/mL (67.95 mM); DMSO : ≥ 100 mg/mL (67.95 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@H]2O)([H])C[C@@]2(N)C)[C@@H](O[C@H](CO)[C@H]1O)OC3=C(OC4=CC=C([C@H]([C@H]5NC([C@H](N)CC(C)C)=O)O)C=C4Cl)C=C([C@](NC([C@@H](NC5=O)CC(N)=O)=O)([H])C(N[C@](C6=O)([H])C7=CC8=C(O)C=C7)=O)C=C3OC9=CC=C([C@H]([C@](C(N[C@@](C(O)=	https://www.medchemexpress.com/Norvancomycin-hydrochloride.html	Launched		91.0	J36	H16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1924	10.0	mM	184.0	DMSO	1433.41455	16	H	pluskal_fda_drugs_5005_H16_id
1341	HY-10255A	HYCPK40905	F21	HYCPK40905	91z	570.0	4.0	L42	905.0	F21	557795-19-4	Sunitinib	SU 11248	398.47	Apoptosis; Autophagy; IRE1; Mitophagy; PDGFR; VEGFR	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK	Sunitinib (SU 11248) is a multi-targeted receptor tyrosine kinase inhibitor with IC50s of 80 nM and 2 nM for VEGFR2 and PDGFRβ, respectively[1]. Sunitinib, an ATP-competitive inhibitor, effectively inhibits autophosphorylation of Ire1α by inhibiting autophosphorylation and consequent RNase activation[2].	Free Base	C22H27FN4O2	103467.0	DMSO : 20.83 mg/mL (52.27 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NCCN(CC)CC)C1=C(NC(/C=C2C(NC3=C\2C=C(C=C3)F)=O)=C1C)C	https://www.medchemexpress.com/Sunitinib.html	Launched		91.0	L42	H16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10255A	10.0	mM	184.0	DMSO	398.211804	16	H	pluskal_fda_drugs_5005_H16_id
116	HY-B0112	HYCPK40902	J06	HYCPK40902	91z	875.0	1.0	S11	902.0	J06	38304-91-5	Minoxidil	U10858	209.25	Endogenous Metabolite; Potassium Channel	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Minoxidil (U10858) is an ATP-sensitive potassium (KATP) channel opener, a potent oral antihypertensive agent and a peripheral vasodilator that promotes vasodilation also affects hair growth. Minoxidil is also a potent inhibitor of soybean lipoxygenaseare with an IC50 of 20 μM[1][2][3].	Free Base	C9H15N5O	11680.0	Ethanol : 7.14 mg/mL (34.12 mM; Need ultrasonic); H2O : 1 mg/mL (4.78 mM; ultrasonic and warming and heat to 50°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	NC1=NC(N2CCCCC2)=CC(N)=[N+]1[O-]	https://www.medchemexpress.com/Minoxidil.html	Launched		91.0	S11	H17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0112	10.0	mM	185.0	DMSO	209.12766	17	H	pluskal_fda_drugs_5005_H17_id
257	HY-B1794	HYCPK40902	O15	HYCPK40902	91z	1373.0	1.0	AC29	902.0	O15	1420-55-9	Thiethylperazine		399.62	Amyloid-β; Bacterial; Dopamine Receptor; Histamine Receptor	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Thiethylperazine, a phenothiazine derivate, is an orally active and potent dopamine D2-receptor and histamine H1-receptor antagonist. Thiethylperazine is also a selective ABCC1activator that reduces amyloid-β (Aβ) load in mice. Thiethylperazine has anti-emetic, antipsychotic and antimicrobial effects[1][2][3].		C22H29N3S2	204820.0	DMSO : 100 mg/mL (250.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease	CN1CCN(CCCN2C3=C(C=CC=C3)SC4=CC=C(SCC)C=C24)CC1	https://www.medchemexpress.com/thiethylperazine.html	Launched		91.0	AC29	H17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1794	10.0	mM	185.0	DMSO	399.18029	17	H	pluskal_fda_drugs_5005_H17_id
658	HY-B0671	HYCPK40903	H17	HYCPK40903	91z	706.0	2.0	O34	903.0	H17	1404-90-6	Vancomycin		1449.25	Antibiotic; Autophagy; Bacterial	Anti-infection; Autophagy	Vancomycin is an antibiotic for the treatment of bacterial infections.	Free Base	C66H75Cl2N9O24	125716.0	DMSO : 125 mg/mL (86.25 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@H]2O)([H])C[C@@]2(N)C)[C@@H](O[C@H](CO)[C@H]1O)OC3=C(OC4=CC=C([C@H]([C@H]5NC([C@H](NC)CC(C)C)=O)O)C=C4Cl)C=C([C@](NC([C@@H](NC5=O)CC(N)=O)=O)([H])C(N[C@](C6=O)([H])C7=CC8=C(O)C=C7)=O)C=C3OC9=CC=C([C@H]([C@](C(N[C@@](C(O)	https://www.medchemexpress.com/vancomycin.html	Launched		91.0	O34	H17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0671	10.0	mM	185.0	DMSO	1447.4302	17	H	pluskal_fda_drugs_5005_H17_id
694	HY-135336	HYCPK40903	F20	HYCPK40903	91z	520.0	2.0	K40	903.0	F20	38176-02-2	(R)-Verapamil (hydrochloride)	(R)-(+)-Verapamil (hydrochloride)	491.06	Apoptosis; P-glycoprotein	Apoptosis; Membrane Transporter/Ion Channel	(R)-Verapamil hydrochloride ((R)-(+)-Verapamil hydrochloride) is a P-Glycoprotein inhibitor. (R)-Verapamil hydrochloride blocks MRP1 mediated transport, resulting in chemosensitization of MRP1-overexpressing cells to anticancer drugs[1][2].	Hydrochloride	C27H39ClN2O4	81503.0	DMSO : 100 mg/mL (203.64 mM; Need ultrasonic); H2O : 100 mg/mL (203.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	COC1=C(OC)C=CC(CCN(C)CCC[C@](C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)=C1.Cl	https://www.medchemexpress.com/r-verapamil-hydrochloride.html	Launched		91.0	K40	H17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-135336	10.0	mM	185.0	DMSO	454.283158	17	H	pluskal_fda_drugs_5005_H17_id
730	HY-101397	HYCPK40903	J22	HYCPK40903	91z	908.0	2.0	S44	903.0	J22	16220-07-8	Allopurinol riboside		268.23	Drug Metabolite; Endogenous Metabolite; Parasite	Anti-infection; Metabolic Enzyme/Protease	Allopurinol riboside, a metabolite of allopurinol, shows potent activities against parasites.	Free Base	C10H12N4O5	152183.0	DMSO : 100 mg/mL (372.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1C2=C(N([C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)N=C2)NC=N1	https://www.medchemexpress.com/Allopurinol_riboside.html	Launched		91.0	S44	H17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101397	10.0	mM	185.0	DMSO	268.080769	17	H	pluskal_fda_drugs_5005_H17_id
956	HY-106019	HYCPK40904	E17	HYCPK40904	91z	465.0	3.0	J33	904.0	E17	115575-11-6	Liarozole	R75251	308.76	Cytochrome P450; RAR/RXR	Metabolic Enzyme/Protease	Liarozole (R75251; R85246) is an imidazole derivative and orally active retinoic acid (RA) metabolism-blocking agent (RAMBA). Liarozole inhibits the cytochrome P450 (CYP26)-dependent 4-hydroxylation of retinoic acid (IC50=7 μM), resulting in increased tissue levels of retinoic acid. Liarozole shows antitumoral properties[1][2][3].		C17H13ClN4	105457.0	DMSO : 100 mg/mL (323.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology	ClC1=CC(C(C2=CC=C3N=CNC3=C2)N4C=CN=C4)=CC=C1	https://www.medchemexpress.com/liarozole.html	Launched		91.0	J33	H17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-106019	10.0	mM	185.0	DMSO	308.082874	17	H	pluskal_fda_drugs_5005_H17_id
1254	HY-B1322B	HYCPK40905	O15	HYCPK40905	91z	1422.0	4.0	AD30	905.0	O15	69-44-3	Amodiaquine (dihydrochloride)	Amodiaquin (dihydrochloride)	428.78	Histone Methyltransferase; Parasite	Anti-infection; Epigenetics	Amodiaquine dihydrochloride (Amodiaquin dihydrochloride), a 4-aminoquinoline class of antimalarial agent, is a potent and orally active histamine N-methyltransferase inhibitor with a Ki of 18.6 nM. Amodiaquine dihydrochloride is also a Nurr1 agonist and specifically binds to Nurr1-LBD (ligand binding domain) with an EC50 of ~20 μM. Anti-inflammatory effect[1][2][3][4][5].	Hydrochloride	C20H24Cl3N3O	78647.0	H2O : 50 mg/mL (116.61 mM; Need ultrasonic); DMSO : 125 mg/mL (291.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Neurological Disease	[H]Cl.[H]Cl.OC1=CC=C(NC2=CC=NC3=CC(Cl)=CC=C23)C=C1CN(CC)CC	https://www.medchemexpress.com/amodiaquine-dihydrochloride.html	Launched		91.0	AD30	H17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1322B	10.0	mM	185.0	DMSO	355.14514	17	H	pluskal_fda_drugs_5005_H17_id
1314	HY-13055B	HYCPK40905	K19	HYCPK40905	91z	1046.0	4.0	V38	905.0	K19	1033805-28-5	Telotristat	LP-778902	546.93	Tryptophan Hydroxylase	Metabolic Enzyme/Protease	Telotristat (LP-778902) is a potent tryptophan hydroxylase inhibitor with an in vivo IC50 of 0.028 μM.	Free Acid	C25H22ClF3N6O3	19607.0	DMSO : 33.33 mg/mL (60.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	N[C@@H](CC1=CC=C(C2=NC(N)=NC(O[C@H](C3=CC=C(Cl)C=C3N4N=C(C)C=C4)C(F)(F)F)=C2)C=C1)C(O)=O	https://www.medchemexpress.com/telotristat.html	Launched		91.0	V38	H17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13055B	10.0	mM	185.0	DMSO	546.139401	17	H	pluskal_fda_drugs_5005_H17_id
255	HY-B1794A	HYCPK40902	M15	HYCPK40902	91z	1181.0	1.0	Y29	902.0	M15	1179-69-7	Thiethylperazine (dimaleate)		631.76	Amyloid-β; Bacterial; Dopamine Receptor; Histamine Receptor	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Thiethylperazine dimaleate, a phenothiazine derivate, is an orally active and potent dopamine D2-receptor and histamine H1-receptor antagonist. Thiethylperazine dimaleate is also a selective ABCC1activator that reduces amyloid-β (Aβ) load in mice. Thiethylperazine dimaleate has anti-emetic, antipsychotic and antimicrobial effects[1][2][3].	Maleate	C30H37N3O8S2	204830.0	DMSO : 125 mg/mL (197.86 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease	CN1CCN(CCCN2C3=C(C=CC=C3)SC4=CC=C(SCC)C=C24)CC1.O=C(O)/C=C\C(O)=O.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/thiethylperazine-dimaleate.html	Launched		91.0	Y29	H18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1794A	10.0	mM	186.0	DMSO	399.18029	18	H	pluskal_fda_drugs_5005_H18_id
400	HY-B0534	HYCPK40902	I18	HYCPK40902	91z	803.0	1.0	Q35	902.0	I18	71320-77-9	Moclobemide	Ro111163	268.74	Monoamine Oxidase	Neuronal Signaling	Moclobemide (Ro111163) is a brain-penetrant and reversible monoamine oxidase (MAO-A) inhibitor with an IC50 of 6.061 μM for hMAO-A[1].Moclobemide up-regulates proliferation of hippocampal progenitor cells in chronically stressed mice.	Free Base	C13H17ClN2O2	16056.0	DMSO : 100 mg/mL (372.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NCCN1CCOCC1)C2=CC=C(Cl)C=C2	https://www.medchemexpress.com/Moclobemide.html	Launched		91.0	Q35	H18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0534	10.0	mM	186.0	DMSO	268.097855	18	H	pluskal_fda_drugs_5005_H18_id
402	HY-17475	HYCPK40902	B21	HYCPK40902	91z	137.0	1.0	C41	902.0	B21	2139-47-1	Nifenazone		308.33	Others	Others	Nifenazone is a pyrazole drug which can be used in the in the treatment of a variety of rheumatic disorders.	Free Base	C17H16N4O2	27856.0	DMSO : 16.67 mg/mL (54.07 mM; Need ultrasonic); H2O : 2 mg/mL (6.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=CN=C1)NC2=C(C)N(C)N(C3=CC=CC=C3)C2=O	https://www.medchemexpress.com/Nifenazone.html	Launched		91.0	C41	H18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17475	10.0	mM	186.0	DMSO	308.127326	18	H	pluskal_fda_drugs_5005_H18_id
411	HY-B0446	HYCPK40902	C22	HYCPK40902	91z	235.0	1.0	E43	902.0	C22	550-99-2	Naphazoline (hydrochloride)	Naphthazoline (hydrochloride)	246.74	Adrenergic Receptor; Interleukin Related; TNF Receptor; VEGFR	Apoptosis; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling; Protein Tyrosine Kinase/RTK	Naphazoline (Naphthazoline) hydrochloride is a potent α-adrenergic receptor agonist. Naphazoline hydrochloride reduces vascular hyperpermeability and promotes vasoconstriction. Naphazoline hydrochloride reduces the levels of inflammatory factors (TNF-α, IL-1β and IL-6), cytokines (IFN-γ and IL-4), IgE, GMCSF, and NGF。Naphazoline hydrochloride can be used for non-bacterial conjunctivitis research[1][2].	Hydrochloride	C14H15ClN2	11940.0	DMSO : ≥ 25 mg/mL (101.32 mM); H2O : 50 mg/mL (202.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	C1(CC2=NCCN2)=CC=CC3=CC=CC=C13.Cl	https://www.medchemexpress.com/naphazoline-hydrochloride.html	Launched		91.0	E43	H18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0446	10.0	mM	186.0	DMSO	210.115698	18	H	pluskal_fda_drugs_5005_H18_id
475	HY-14734	HYCPK40903	P06	HYCPK40903	91z	1452.0	2.0	AE12	903.0	P06	249921-19-5	Anamorelin	RC-1291; ONO-7643	546.70	GHSR	GPCR/G Protein	Anamorelin (RC-1291) is a potent ghrelin receptor agonist with EC50 value of 0.74 nM in the FLIPR assay.	Free Base	C31H42N6O3	8952.0	DMSO : ≥ 100 mg/mL (182.92 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	[H][C@](CC1=CNC2=CC=CC=C21)(NC(C(C)(C)N)=O)C(N3CCC[C@@](C(N(C)N(C)C)=O)(CC4=CC=CC=C4)C3)=O	https://www.medchemexpress.com/Anamorelin.html	Launched		91.0	AE12	H18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14734	10.0	mM	186.0	DMSO	546.331839	18	H	pluskal_fda_drugs_5005_H18_id
678	HY-A0088A	HYCPK40903	L18	HYCPK40903	91z	1092.0	2.0	W36	903.0	L18	63527-52-6	Cefotaxime	Cefotaxim; HR-756	455.47	Antibiotic; Bacterial	Anti-infection	Cefotaxime, a β-lactamase stable cephalosporin and a third-generation cephalosporin antibiotic, possesses broad-spectrum antibiotic activity against numerous Gram-positive and Gram-negative bacteria[1][2][3][4][2].		C16H17N5O7S2	83966.0	DMSO : 250 mg/mL (548.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(C(N12)=C(COC(C)=O)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)O	https://www.medchemexpress.com/cefotaxime.html	Launched		91.0	W36	H18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0088A	10.0	mM	186.0	DMSO	455.05694	18	H	pluskal_fda_drugs_5005_H18_id
688	HY-17584	HYCPK40903	P19	HYCPK40903	91z	1478.0	2.0	AE38	903.0	P19	851199-59-2	Linaclotide		1526.74	Guanylate Cyclase	GPCR/G Protein	Linaclotide is a potent and selective guanylate cyclase C agonist; developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation.	Free Acid	C59H79N15O21S6	221995.0	DMSO : 50 mg/mL (32.75 mM; Need ultrasonic); H2O : 16.67 mg/mL (10.92 mM; ultrasonic and adjust pH to 2 with HCl)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@@H](NC([C@@](CSSC[C@@H]1N)([H])NC([C@@](CSSC[C@H](N2)C(N[C@H](C(O)=O)CC3=CC=C(O)C=C3)=O)([H])NC([C@@H](NC([C@@H](N4)CCC(O)=O)=O)CC5=CC=C(O)C=C5)=O)=O)=O)CC(N)=O)N6[C@@](C(N[C@H](C(N[C@](CSSC[C@](C4=O)([H])NC1=O)([H])C(NC(C(NCC2=O)=O)[C@H](O)C)=O)=O	https://www.medchemexpress.com/Linaclotide.html	Launched		91.0	AE38	H18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17584	10.0	mM	186.0	DMSO	1525.389921	18	H	pluskal_fda_drugs_5005_H18_id
894	HY-13956	HYCPK40904	C13	HYCPK40904	91z	265.0	3.0	F25	904.0	C13	111025-46-8	Pioglitazone	U 72107	356.44	Ferroptosis; PPAR	Apoptosis; Cell Cycle/DNA Damage	Pioglitazone (U 72107) is an orally active and selective PPARγ (peroxisome proliferator-activated receptor) agonist with high affinity binding to the PPARγ ligand-binding domain with EC50 of 0.93 and 0.99 μM for human and mouse PPARγ, respectively. Pioglitazone can be used in diabetes research[2][3][4].	Free Base	C19H20N2O3S	33584.0	DMSO : 40 mg/mL (112.22 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(N1)SC(CC2=CC=C(OCCC3=NC=C(CC)C=C3)C=C2)C1=O	https://www.medchemexpress.com/pioglitazone.html	Launched		91.0	F25	H18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13956	10.0	mM	186.0	DMSO	356.119463	18	H	pluskal_fda_drugs_5005_H18_id
311	HY-14598	HYCPK40902	O19	HYCPK40902	91z	1381.0	1.0	AC37	902.0	O19	56-53-1	Diethylstilbestrol	Stilbestrol	268.35	Estrogen Receptor/ERR	Others	"Diethylstilbestrol (Stilbestrol), a synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders.
Target: Estrogen Receptor/ERR
Diethylstilbestrol (DES), a synthetic estrogen that was used in pregnancy, is a prototype endocrine-disrupting chemical. Although prenatal exposure to DES is known to increase risks of vaginal/cervical adenocarcinoma and adverse reproductive outcomes in women, and urogenital anomalies in men, data on nonreproductive medical conditions are lacking. Comparing persons exposed prenatally to DES with those who were not exposed, the hazard ratios were 1.21 (95% confidence interval = 0.96-1.54) for diabetes, 1.27 (1.00-1.62) for all cardiovascular disease, 1.18 (0.88-1.59) for coronary artery disease, 1.28 (0.88-1.86) for myocardial infarction, 1.12 (1.02-1.22) for high cholesterol, 1.14 (1.02-1.28) for hypertension, 1.24 (0.99-1.54) for osteoporosis, and 1.30 (0.95-1.79) for fractures. The associations did not differ by dose and timing of DES exposure, nor, in the women, by the presence or absence of vaginal epithelial changes (a marker of DES host susceptibility) [1]. The role of prenatal exposure to DES as an environmental risk factor for psychiatric disorders requires more evidence before any conclusions can be drawn [2]."	Free Base	C18H20O2	44041.0	DMSO : 50 mg/mL (186.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	OC1=CC=C(/C(CC)=C(CC)/C2=CC=C(O)C=C2)C=C1	https://www.medchemexpress.com/diethylstilbestrol.html	Launched		91.0	AC37	H19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14598	10.0	mM	187.0	DMSO	268.14633	19	H	pluskal_fda_drugs_5005_H19_id
419	HY-14601	HYCPK40903	D09	HYCPK40903	91z	306.0	2.0	G18	903.0	D09	112529-15-4	Pioglitazone (hydrochloride)	U 72107A; AD 4833	392.90	Ferroptosis; PPAR	Apoptosis; Cell Cycle/DNA Damage	Pioglitazone hydrochloride is a potent and selective PPARγ agonist with EC50s of 0.93 and 0.99 μM for human and mouse PPARγ, respectively.	Hydrochloride	C19H21ClN2O3S	10107.0	DMSO : 100 mg/mL (254.52 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	CCC1=CN=C(CCOC2=CC=C(CC3C(NC(S3)=O)=O)C=C2)C=C1.Cl	https://www.medchemexpress.com/pioglitazone-hydrochloride.html	Launched		91.0	G18	H19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14601	10.0	mM	187.0	DMSO	356.119463	19	H	pluskal_fda_drugs_5005_H19_id
450	HY-16779B	HYCPK40903	G05	HYCPK40903	91z	586.0	2.0	M10	903.0	G05	914361-45-8	Fosravuconazole (L-lysine ethanolate)	BMS-379224 (L-lysine ethanolate); E-1224 (L-lysine ethanolate)	739.73	Fungal; Parasite	Anti-infection	Fosravuconazole L-lysine ethanolate (BMS-379224 L-lysine ethanolate), a prodrug of Ravuconazole, is an orally active broad spectrum antifungal agent. Fosravuconazole L-lysine ethanolate can be used for candidiasis, onychomycosis and parasitemia research[1][2][3].	L-lysine	C31H40F2N7O8PS	147795.0	H2O : 50 mg/mL (67.59 mM; Need ultrasonic); DMSO : 50 mg/mL (67.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	N#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1.CCO.N[C@H](C(O)=O)CCCCN	https://www.medchemexpress.com/fosravuconazole-l-lysine-ethanolate.html	Launched		91.0	M10	H19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16779B	10.0	mM	187.0	DMSO	547.089083	19	H	pluskal_fda_drugs_5005_H19_id
775	HY-A0088	HYCPK40904	L05	HYCPK40904	91z	1113.0	3.0	X9	904.0	L05	64485-93-4	Cefotaxime (sodium)	Cefotaxim (sodium); HR-756 (sodium)	477.45	Antibiotic; Bacterial	Anti-infection	Cefotaxime (Cefotaxim) sodium, a β-lactamase stable cephalosporin and a third-generation cephalosporin antibiotic, possesses broad-spectrum antibiotic activity against numerous Gram-positive and Gram-negative bacteria[1][2][3][4][5].	Sodium	C16H16N5NaO7S2	16409.0	DMSO : 45 mg/mL (94.25 mM; Need ultrasonic); H2O : 50 mg/mL (104.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(COC(C)=O)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)O[Na]	https://www.medchemexpress.com/Cefotaxime-sodium-salt.html	Launched		91.0	X9	H19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0088	10.0	mM	187.0	DMSO	455.05694	19	H	pluskal_fda_drugs_5005_H19_id
901	HY-B0230	HYCPK40904	J13	HYCPK40904	91z	937.0	3.0	T25	904.0	J13	50-33-9	Phenylbutazone		308.3743	COX	Immunology/Inflammation	Phenylbutazone is an efficient reducing cofactor for the peroxidase activity of prostaglandin H synthase (PHS). Phenylbutazone, a hepatotoxin, is a nonsteroidal anti-inflammatory drug (NSAID). Phenylbutazone induces muscle blind-like protein 1 (MBNL1) expression and has the potential for ankylosing spondylitis research[1][2].	Free Base	C19H20N2O2	16420.0	H2O : 0.67 mg/mL (2.17 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (324.29 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1CCCC)N(C2=CC=CC=C2)N(C3=CC=CC=C3)C1=O	https://www.medchemexpress.com/phenylbutazone.html	Launched		91.0	T25	H19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0230	10.0	mM	187.0	DMSO	308.152478	19	H	pluskal_fda_drugs_5005_H19_id
984	HY-B0181	HYCPK40904	A19	HYCPK40904	91z	85.0	3.0	B37	904.0	A19	645-05-6	Altretamine	ENT-50852; RB-1515; WR-95704	210.28	DNA Alkylator/Crosslinker	Cell Cycle/DNA Damage	Altretamine is an alkylating antineoplastic agent.	Free Base	C9H18N6	16614.0	DMSO : 8.33 mg/mL (39.61 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	CN(C)C1=NC(N(C)C)=NC(N(C)C)=N1	https://www.medchemexpress.com/Altretamine.html	Launched		91.0	B37	H19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0181	10.0	mM	187.0	DMSO	210.159295	19	H	pluskal_fda_drugs_5005_H19_id
996	HY-B1426	HYCPK40904	M19	HYCPK40904	91z	1237.0	3.0	Z37	904.0	M19	92339-11-2	Iodixanol		1550.18	Others	Others	Iodixanol is an iodine-containing non-ionic radiocontrast agent[1].	Free Base	C35H44I6N6O15	230723.0	DMSO : 125 mg/mL (80.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC(CN(C1=C(I)C(C(NCC(O)CO)=O)=C(I)C(C(NCC(O)CO)=O)=C1I)C(C)=O)CN(C2=C(I)C(C(NCC(O)CO)=O)=C(I)C(C(NCC(O)CO)=O)=C2I)C(C)=O	https://www.medchemexpress.com/iodixanol.html	Launched		91.0	Z37	H19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1426	10.0	mM	187.0	DMSO	1549.713303	19	H	pluskal_fda_drugs_5005_H19_id
1010	HY-101714	HYCPK40904	K20	HYCPK40904	91z	1047.0	3.0	V39	904.0	K20	115-33-3	Oxyphenisatin acetate		401.41	Autophagy	Autophagy	Oxyphenisatin acetate, the pro-drug of oxyphenisatin, is used to be a laxative.	Free Base	C24H19NO5	24694.0	DMSO : 100 mg/mL (249.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NC2=C(C=CC=C2)C1(C3=CC=C(OC(C)=O)C=C3)C4=CC=C(OC(C)=O)C=C4	https://www.medchemexpress.com/Oxyphenisatin_acetate.html	Launched		91.0	V39	H19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101714	10.0	mM	187.0	DMSO	401.126323	19	H	pluskal_fda_drugs_5005_H19_id
115	HY-15455	HYCPK40902	I06	HYCPK40902	91z	779.0	1.0	Q11	902.0	I06	162401-32-3	Roflumilast		403.21	Phosphodiesterase (PDE); RSV	Anti-infection; Metabolic Enzyme/Protease	Roflumilast is a selective PDE4 inhibitor with IC50s of 0.7, 0.9, 0.7, and 0.2 nM for PDE4A1, PDEA4, PDEB1, and PDEB2, respectively, without affecting PDE1, PDE2, PDE3 or PDE5 isoenzymes from various cells.	Free Base	C17H14Cl2F2N2O3	9153.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 50 mg/mL (124.00 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(NC1=C(Cl)C=NC=C1Cl)C2=CC=C(OC(F)F)C(OCC3CC3)=C2	https://www.medchemexpress.com/Roflumilast.html	Launched		91.0	Q11	H20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15455	10.0	mM	188.0	DMSO	402.034954	20	H	pluskal_fda_drugs_5005_H20_id
329	HY-B0206	HYCPK40902	A21	HYCPK40902	91z	41.0	1.0	A41	902.0	A21	145202-66-0	Rizatriptan (benzoate)	MK 462	391.47	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Rizatriptan Benzoate(Maxalt) is a 5-HT1 agonist triptan drug for the treatment of migraine headaches.
Target: 5-HT1 agonist 
Rizatriptan Benzoate(Maxalt) is a 5-HT1 agonist triptan drug for the treatment of migraine headaches. It is believed to work by narrowing the blood vessels around the brain. Rizatriptan also reduces the substances in the body, which can also reduce headache pain, nausea, sensitivity to light and sound and other migraine symptoms.
Rizatriptan was rapidly absorbed with a median tmax of 1.3 h (range 1-3 h) vs a tmax for sumatriptan of 2.5 h (range 1-4 h, P < 0.001). Administration of either rizatriptan or sumatriptan produced maximal mean elevations of 5-10 mmHg in systolic and diastolic blood pressures without effect on heart rate; the changes occurred sooner following rizatriptan, consistent with more rapid absorption. Both rizatriptan and sumatriptan provoked mild increases in serum growth hormone without any effect on serum prolactin concentrations. The most commonly reported symptom following rizatriptan was drowsiness."	Benzoate	C22H25N5O2	16626.0	H2O : 100 mg/mL (255.45 mM; Need ultrasonic); DMSO : 50 mg/mL (127.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN(C)CCC1=CNC2=C1C=C(CN3N=CN=C3)C=C2.O=C(O)C4=CC=CC=C4	https://www.medchemexpress.com/rizatriptan-benzoate.html	Launched		91.0	A41	H20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0206	10.0	mM	188.0	DMSO	269.164046	20	H	pluskal_fda_drugs_5005_H20_id
349	HY-109532	HYCPK40903	F03	HYCPK40903	91z	486.0	2.0	K6	903.0	F03	129311-55-3	Ganirelix (acetate)	Ganirest	1690.42	GnRH Receptor	GPCR/G Protein	Ganirelix acetate (Ganirest) is an injectable competitive gonadotropin-releasing hormone (GnRH) antagonist. Ganirelix acetate directly competes against the endogenous molecule for receptor binding, and causes a rapid reduction in estradiol levels. Ganirelix acetate can be used for researching ovarian hyperstimulation syndrome (OHSS)[1].	Acetate	C84H121ClN18O17	180304.0	H2O : 50 mg/mL (29.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	OC(C=C1)=CC=C1C[C@H](NC([C@H](CO)NC([C@@H](CC2=CN=CC=C2)NC([C@H](NC([C@H](NC(C)=O)CC3=CC4=CC=CC=C4C=C3)=O)CC5=CC=C(Cl)C=C5)=O)=O)=O)C(N[C@H](CCCC/N=C(NCC)/NCC)C(N[C@@H](CC(C)C)C(N[C@@H](CCCC/N=C(NCC)/NCC)C(N6[C@@H](CCC6)C(N[C@H](C)C(N)=O)=O)=O)=O)=O)=O.CC	https://www.medchemexpress.com/ganirelix-acetate.html	Launched		91.0	K6	H20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109532	10.0	mM	188.0	DMSO	1568.842303	20	H	pluskal_fda_drugs_5005_H20_id
529	HY-B0672	HYCPK40903	B11	HYCPK40903	91z	118.0	2.0	C22	903.0	B11	979-32-8	Estradiol valerianate	β-Estradiol 17-valerate	356.50	Estrogen Receptor/ERR	Others	Estradiol valerianate (β-estradiol 17-valerate) is a synthetic estrogen widely used in combination with other steroid hormones in hormone replacement therapy drugs.	Free Base	C23H32O3	36237.0	DMSO : ≥ 50 mg/mL (140.25 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@@]1([C@H]2OC(CCCC)=O)[C@](CC2)([H])[C@@](CCC3=C4C=CC(O)=C3)([H])[C@]4([H])CC1	https://www.medchemexpress.com/_beta_-Estradiol-17-valerate.html	Launched		91.0	C22	H20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0672	10.0	mM	188.0	DMSO	356.235145	20	H	pluskal_fda_drugs_5005_H20_id
720	HY-B0593A	HYCPK40903	P21	HYCPK40903	91z	1482.0	2.0	AE42	903.0	P21	78439-06-2	Ceftazidime (pentahydrate)	GR20263 (pentahydrate)	636.65	Antibiotic; Bacterial	Anti-infection	Ceftazidime (GR20263) pentahydrate , an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime pentahydrate  is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases[1].	hydrate	C22H32N6O12S2	99136.0	DMSO : 100 mg/mL (157.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1[C@@H](NC(/C(C2=CSC(N)=N2)=N\OC(C)(C(O)=O)C)=O)[C@@]3([H])SCC(C[N+]4=CC=CC=C4)=C(C([O-])=O)N13.[5H2O]	https://www.medchemexpress.com/ceftazidime-pentahydrate.html	Launched		91.0	AE42	H20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0593A	10.0	mM	188.0	DMSO	547.106415	20	H	pluskal_fda_drugs_5005_H20_id
754	HY-B0341	HYCPK40904	B04	HYCPK40904	91z	151.0	3.0	D7	904.0	B04	65141-46-0	Nicorandil	SG-75	211.17	Potassium Channel	Membrane Transporter/Ion Channel	Nicorandil (SG-75) is a potent potassium channel activator and targets vascular nucleoside diphosphate-dependent K+ channels and cardiac ATP-sensitive K+ channels (KATP). Nicorandil is a nicotinamide ester with vasodilatory and cardioprotective effects and has the potential for angina and forischemic heart diseases[1][2][3].	Free Base	C8H9N3O4	19398.0	DMSO : ≥ 33 mg/mL (156.27 mM); H2O : ≥ 20 mg/mL (94.71 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CC=CN=C1)NCCO[N+]([O-])=O	https://www.medchemexpress.com/Nicorandil.html	Launched		91.0	D7	H20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0341	10.0	mM	188.0	DMSO	211.059306	20	H	pluskal_fda_drugs_5005_H20_id
1285	HY-17436	HYCPK40905	N17	HYCPK40905	91z	1330.0	4.0	AB34	905.0	N17	167221-71-8	Clevidipine		456.32	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	"Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension.
IC50 Value: 7.1 nM at V(H) = -40 mV [1]
Target: calcium channel
in vitro: Both clevidipine and nitroglycerin completely reversed U46619-induced contraction (clevidipine (50% effective concentration [EC50] = 3.88 +/- 0.84 x 10(-6) mol/L, nitroglycerin EC50 = 4.84 +/- 2.76 x 10(-8) mol/L) [2]. A decrease in temperature increased the half-life of clevidipine in blood, whereas dilution of the blood did not affect the in vitro half-life of clevidipine. The albumin concentration affected the hydrolysis rate of clevidipine in RBC suspended with saline [3].
in vivo: Clevidipine is a high-clearance drug with a relatively small volume of distribution, resulting in an extremely short half-life in all species studied. The median initial half-life of the individual value (Bayesian estimates) is 12, 20, and 22 s in the rabbit, rat, and dog, respectively [4]. The extremely high clearance value and the small volume of distribution resulted in short half-lives of clevidipine, 2.2 and 16.8 min, respectively. The blood concentration and dose rate producing half the maximal effect (i.e. EC50 and ED50) were approximately 25 nM and 1.5 microg/kg/min, respectively [5].
Clinical trial: CARVE: Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed. Phase 4"	Free Base	C21H23Cl2NO6	8955.0	DMSO : ≥ 50 mg/mL (109.57 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(C1=C(C)NC(C)=C(C(OCOC(CCC)=O)=O)C1C2=CC=CC(Cl)=C2Cl)OC	https://www.medchemexpress.com/Clevidipine.html	Launched		91.0	AB34	H20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17436	10.0	mM	188.0	DMSO	455.090243	20	H	pluskal_fda_drugs_5005_H20_id
1352	HY-B0134	HYCPK40905	A22	HYCPK40905	91z	92.0	4.0	B44	905.0	A22	58970-76-6	Bestatin	Ubenimex	308.37	Aminopeptidase; Antibiotic; Bacterial	Anti-infection; Metabolic Enzyme/Protease	Bestatin is a natural, broad-spectrum, and competitive CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase inhibitor. Bestatin has anticancer effects[1][2].	Free Acid	C16H24N2O4	84551.0	DMSO : 8.33 mg/mL (27.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	CC(C)C[C@@H](C(O)=O)NC([C@@H](O)[C@H](N)CC1=CC=CC=C1)=O	https://www.medchemexpress.com/Bestatin.html	Launched		91.0	B44	H20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0134	10.0	mM	188.0	DMSO	308.173607	20	H	pluskal_fda_drugs_5005_H20_id
119	HY-B0593	HYCPK40902	M06	HYCPK40902	91z	1163.0	1.0	Y11	902.0	M06	72558-82-8	Ceftazidime	GR20263	546.58	Antibiotic; Bacterial	Anti-infection	Ceftazidime (GR20263), an antibiotic, has a broad spectrum activity against Gram-positive and Gram-negative aerobic bacteria. Ceftazidime is also active against Enterobacteriaceae (including β-lactamase-positive strains) and is resistant to hydrolysis by most β-lactamases[1].	Free Acid	C22H22N6O7S2	118531.0	DMSO : 25 mg/mL (45.74 mM; ultrasonic and warming and heat to 80°C); H2O : 100 mg/mL (182.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1[C@@H](NC(/C(C2=CSC(N)=N2)=N\OC(C)(C(O)=O)C)=O)[C@@]3([H])SCC(C[N+]4=CC=CC=C4)=C(C([O-])=O)N13	https://www.medchemexpress.com/Ceftazidime.html	Launched		91.0	Y11	H21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0593	10.0	mM	189.0	DMSO	547.106415	21	H	pluskal_fda_drugs_5005_H21_id
205	HY-B0108	HYCPK40902	K12	HYCPK40902	91z	983.0	1.0	U23	902.0	K12	103060-53-3	Daptomycin	LY146032	1620.67	Antibiotic; Bacterial	Anti-infection	Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.	Free Acid	C72H101N17O26	86190.0	DMSO : ≥ 100 mg/mL (61.70 mM); H2O : 100 mg/mL (61.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(N[C@H](CC(N)=O)C(N[C@@H](CC(O)=O)C(N[C@H](C(NCC(N[C@H](C(N[C@@](C(N[C@@H](C(N[C@H]1CC(O)=O)=O)C)=O)([H])CC(O)=O)=O)CCCN)=O)=O)[C@H](OC([C@](NC([C@](NC([C@@](NC(CNC1=O)=O)([H])CO)=O)([H])[C@H](C)CC(O)=O)=O)([H])CC(C(C=CC=C2)=C2N)=O)=O)C)=O)=O)[C@@H](NC	https://www.medchemexpress.com/daptomycin.html	Launched		91.0	U23	H21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0108	10.0	mM	189.0	DMSO	1619.710366	21	H	pluskal_fda_drugs_5005_H21_id
630	HY-101405	HYCPK40903	L15	HYCPK40903	91z	1086.0	2.0	W30	903.0	L15	16320-04-0	Gestrinone	R 2323	308.41	Estrogen Receptor/ERR	Others	Gestrinone (R2323) is a synthetic steroid hormone used to treat endometriosis. It inhibits leiomyoma cells with an IC50 of 43.67 μM.	Free Base	C21H24O2	39753.0	H2O : 1 mg/mL (3.24 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (162.12 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C#C[C@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CCC4=C3C=C[C@]12CC)=O		Launched		91.0	W30	H21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101405	10.0	mM	189.0	DMSO	308.17763	21	H	pluskal_fda_drugs_5005_H21_id
714	HY-10019	HYCPK40903	J21	HYCPK40903	91z	906.0	2.0	S42	903.0	J21	249296-44-4	Varenicline	CP 526555	211.26	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Varenicline (CP 526555) is a potent partial agonist for α4β2 nicotinic acetylcholine receptor (nAChR) with an EC50 value of 2.3 μM. Varenicline is a full agonist for α3β4 and α7 nAChRs with EC50 values of 55 μM and 18 μM, respectively[2]. Varenicline is a nicotinic ligand based on the structure of cytosine, and has the potential for smoking cessation treatment[5].	Free Base	C13H13N3	8275.0	H2O : ≥ 20 mg/mL (94.67 mM); DMSO : 25 mg/mL (118.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease; Cancer	C12=C(C=C3N=CC=NC3=C2)C4CC1CNC4	https://www.medchemexpress.com/Varenicline.html	Launched		91.0	S42	H21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10019	10.0	mM	189.0	DMSO	211.110947	21	H	pluskal_fda_drugs_5005_H21_id
794	HY-14397A	HYCPK40904	O06	HYCPK40904	91z	1403.0	3.0	AD11	904.0	O06	74252-25-8	Indomethacin (sodium hydrate)	Indometacin (sodium hydrate)	433.82	Antibiotic; Bacterial; COX; Influenza Virus	Anti-infection; Immunology/Inflammation	Indomethacin (Indometacin) sodium hydrateis a potent, orally active COX1/2  inhibitor with IC50 values of 18 nM and 26 nM for COX-1 and COX-2, respectively. Indomethacin sodium hydrateis has anticancer activity and anti-infective activity. Indomethacin sodium hydrateis can be used for cancer, inflammation and viral infection research[1][2][3].	Sodium	C19H21ClNNaO7	78834.0	H2O : 25 mg/mL (57.63 mM; Need ultrasonic); DMSO : 12.5 mg/mL (28.81 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(O[Na])CC1=C(C)N(C(C2=CC=C(Cl)C=C2)=O)C3=C1C=C(OC)C=C3.O.O.O	https://www.medchemexpress.com/indomethacin-sodium-hydrate.html	Launched		91.0	AD11	H21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14397A	10.0	mM	189.0	DMSO	357.076786	21	H	pluskal_fda_drugs_5005_H21_id
892	HY-B1558A	HYCPK40904	A13	HYCPK40904	91z	73.0	3.0	B25	904.0	A13	62232-46-6	Bifemelane (hydrochloride)	MCI-2016	305.84	Monoamine Oxidase	Neuronal Signaling	Bifemelane hydrochloride (MCI-2016) is a potent, selective and competitive inhibitor of monoamine oxidase A (MAO-A), with a Ki of 4.20 μM. Bifemelane hydrochloride also inhibits MAO-B noncompetitively with a Ki of 46.0 μM. Bifemelane hydrochloride has a potent antidepressant activity and can be used for the research of cognitive and emotional disturbances related to cerebrovascular disease[1][2].	Hydrochloride	C18H24ClNO	100384.0	DMSO : 250 mg/mL (817.42 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CNCCCCOC1=CC=CC=C1CC2=CC=CC=C2.[H]Cl	https://www.medchemexpress.com/bifemelane-hydrochloride.html	Launched		91.0	B25	H21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1558A	10.0	mM	189.0	DMSO	269.177964	21	H	pluskal_fda_drugs_5005_H21_id
929	HY-50706A	HYCPK40904	F15	HYCPK40904	91z	557.0	3.0	L29	904.0	F15	943332-08-9	Selumetinib (sulfate)	AZD6244 (sulfate); ARRY-142886 (sulfate)	555.76	Apoptosis; MEK	Apoptosis; MAPK/ERK Pathway	Selumetinib (AZD6244) is selective, non-ATP-competitive oral?MEK1/2?inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.	Sulfate	C17H17BrClFN4O7S	56606.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 50 mg/mL (89.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OCCONC(C(C=C1C(N=CN1C)=C2F)=C2NC3=C(C=C(Br)C=C3)Cl)=O.O=S(O)(O)=O	https://www.medchemexpress.com/selumetinib-sulfate.html	Launched		91.0	L29	H21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50706A	10.0	mM	189.0	DMSO	456.000008	21	H	pluskal_fda_drugs_5005_H21_id
1256	HY-B1393	HYCPK40905	A16	HYCPK40905	91z	80.0	4.0	B32	905.0	A16	81-23-2	Dehydrocholic acid		402.52	Others	Others	Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. Dehydrocholic acid acts as a hydrocholeretic, increasing bile output to clear increased bile acid load.	Free Acid	C24H34O5	17597.0	DMSO : 25 mg/mL (62.11 mM; Need ultrasonic); H2O : 0.67 mg/mL (1.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	C[C@H](CCC(O)=O)[C@H]([C@]12C)CC[C@@]1([H])[C@]3([H])C(C[C@]4([H])CC(CC[C@]4(C)[C@@]3([H])CC2=O)=O)=O	https://www.medchemexpress.com/Dehydrocholic-acid.html	Launched		91.0	B32	H21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1393	10.0	mM	189.0	DMSO	402.240624	21	H	pluskal_fda_drugs_5005_H21_id
1397	HY-B0257	HYCPK40906	B05	HYCPK40906	92z	105.0	1.0	C9	906.0	B05	797-63-7	Levonorgestrel	D-Norgestrel	312.45	Progesterone Receptor	Others	"Levonorgestrel is a synthetic progestogen used as an active ingredient in some hormonal contraceptives.
Target: Progesterone Receptor
A synthetic progestational hormone with actions similar to those of progesterone and about twice as potent as its racemic or (+-)-isomer (norgestrel). It is used for contraception, control of menstrual disorders, and treatment of endometriosis. It is usually supplied in a racemic mixture (Norgestrel, 6533-00-2). Only the levonorgestrel isomer is active. Levonorgestrel is marketed mostly as a combination oral contraceptive under several brand names such as Alesse, Triphasil, and Min-Ovral [1]."	Free Base	C21H28O2	14149.0	DMSO : 100 mg/mL (320.05 mM; ultrasonic and warming and heat to 60°C); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C1CC[C@]2([H])[C@@]3([H])CC[C@]4(CC)[C@@](C#C)(O)CC[C@@]4([H])[C@]3([H])CCC2=C1	https://www.medchemexpress.com/Levonorgestrel.html	Launched		92.0	C9	H22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0257	10.0	mM	190.0	DMSO	312.20893	22	H	pluskal_fda_drugs_5005_H22_id
1581	HY-N6666	HYCPK40906	P14	HYCPK40906	92z	1467.0	1.0	AE27	906.0	P14	24356-66-9	Vidarabine (monohydrate)		285.26	Antibiotic; HSV	Anti-infection	Vidarabine monohydrate is an adenine arabinoside. Vidarabine monohydrate an antiviral drug which is active against herpes simplex viruses (HSV) and varicella zoster viruses[1].	hydrate	C10H15N5O5	89136.0	DMSO : 250 mg/mL (876.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[H]O[H].OC[C@@H]1[C@@H](O)[C@H](O)[C@H](N2C=NC3=C(N)N=CN=C23)O1	https://www.medchemexpress.com/vidarabine-monohydrate.html	Launched		92.0	AE27	H22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N6666	10.0	mM	190.0	DMSO	267.096754	22	H	pluskal_fda_drugs_5005_H22_id
1600	HY-107967	HYCPK40906	C16	HYCPK40906	92z	223.0	1.0	E31	906.0	C16	68238-36-8	Isosulfan blue		566.66	Others	Others	Isosulfan blue is a blue dye for the identification of lymph vessels during lymphangiography. Isosulfan blueis is used during sentinel lymph node biopsies in breast cancer. Isosulfan blue is possible to have an allergic reaction during breast cancer operations[1][2].	Sodium	C27H31N2NaO6S2	59879.0	H2O : ≥ 7.69 mg/mL (13.57 mM); DMSO : 83.33 mg/mL (147.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC/[N+](CC)=C1C=C/C(C=C/1)=C(C2=CC=C(N(CC)CC)C=C2)\C3=CC(S(=O)([O-])=O)=CC=C3S(=O)([O-])=O.[Na+]	https://www.medchemexpress.com/isosulfan-blue.html	Launched		92.0	E31	H22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107967	10.0	mM	190.0	DMSO	544.170179	22	H	pluskal_fda_drugs_5005_H22_id
1751	HY-Y1269	HYCPK40907	O05	HYCPK40907	92z	1354.0	2.0	AC10	907.0	O05	12125-02-9	Ammonium chloride		53.49	Autophagy	Autophagy	Ammonium chloride, as a heteropolar compound with pH value regulation, can cause intracellular alkalization and metabolic acidosis thus effecting enzymatic activity and influencing the process of biological system. Ammonium chloride is an autophagy inhibitor[1][2].		ClH4N	97210.0	DMSO : 50 mg/mL (934.75 mM; Need ultrasonic); H2O : 100 mg/mL (1869.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	[NH4].[Cl]	https://www.medchemexpress.com/ammonium-chloride.html	Launched		92.0	AC10	H22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y1269	10.0	mM	190.0	DMSO	17.026549	22	H	pluskal_fda_drugs_5005_H22_id
2089	HY-B0410	HYCPK40908	B08	HYCPK40908	92z	159.0	3.0	D15	908.0	B08	104632-26-0	Pramipexole		211.33	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Pramipexole is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].	Free Base	C10H17N3S	93833.0	DMSO : 100 mg/mL (473.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC1=NC(CC[C@H](NCCC)C2)=C2S1	https://www.medchemexpress.com/pramipexole.html	Launched		92.0	D15	H22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0410	10.0	mM	190.0	DMSO	211.114319	22	H	pluskal_fda_drugs_5005_H22_id
2190	HY-B1183	HYCPK40908	K14	HYCPK40908	92z	1035.0	3.0	V27	908.0	K14	50-03-3	Hydrocortisone acetate	Hydrocortisone 21-acetate; Cortisol 21-acetate	404.50	Endogenous Metabolite; Glucocorticoid Receptor	Immunology/Inflammation; Metabolic Enzyme/Protease	Hydrocortisone acetate is a corticosteroid, used to decrease swelling, itching, and pain that is caused by minor skin irritations or by hemorrhoids.	Free Base	C23H32O6	17617.0	DMSO : ≥ 38 mg/mL (93.94 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]12[C@](C(COC(C)=O)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/Hydrocortisone-acetate.html	Launched		92.0	V27	H22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1183	10.0	mM	190.0	DMSO	404.219889	22	H	pluskal_fda_drugs_5005_H22_id
2548	HY-14600	HYCPK40909	G11	HYCPK40909	92z	646.0	4.0	N22	909.0	G11	155141-29-0	Rosiglitazone (maleate)	BRL 49653C	473.50	Autophagy; Ferroptosis; PPAR; TRP Channel	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel; Neuronal Signaling	Rosiglitazone maleate (BRL 49653C) is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone maleate is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).	Maleate	C22H23N3O7S	10102.0	DMSO : 100 mg/mL (211.19 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology	O=C(O)/C=C\C(O)=O.CN(CCOC1=CC=C(CC2C(NC(S2)=O)=O)C=C1)C3=CC=CC=N3	https://www.medchemexpress.com/rosiglitazone-maleate.html	Launched		92.0	N22	H22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14600	10.0	mM	190.0	DMSO	357.114712	22	H	pluskal_fda_drugs_5005_H22_id
2549	HY-17412	HYCPK40909	H11	HYCPK40909	92z	742.0	4.0	P22	909.0	H11	13614-98-7	Minocycline (hydrochloride)		493.94	Antibiotic; Apoptosis; Bacterial; Calcium Channel; HIF/HIF Prolyl-Hydroxylase; MDM-2/p53; Potassium Channel	Anti-infection; Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Minocycline hydrochloride is an orally active, potent and BBB-penetrated semi-synthetic tetracycline antibiotic. Minocycline hydrochloride is a hypoxia-inducible factor (HIF)-1α inhibitor. Minocycline hydrochloride shows anti-cancer, anti-inflammatory, and glutamate antagonist effects. Minocycline hydrochloride reduces glutamate neurotransmission and shows neuroprotective properties and antidepressant effects. Minocycline hydrochloride inhibits bacterial protein synthesis through binding with the 30S subunit of the bacterial ribosome, resulting in a bacteriostatic effect[1][2][3][4][5][6][7].	Hydrochloride	C23H28ClN3O7	227983.0	DMSO : 19.23 mg/mL (38.93 mM; Need ultrasonic); H2O : 10 mg/mL (20.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease	OC1=C(C(N)=O)C([C@@]2(O)C(O)=C3C(C4=C(O)C=CC(N(C)C)=C4C[C@@]3([H])C[C@@]2([H])[C@@H]1N(C)C)=O)=O.Cl	https://www.medchemexpress.com/Minocycline-hydrochloride.html	Launched		92.0	P22	H22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17412	10.0	mM	190.0	DMSO	457.1849	22	H	pluskal_fda_drugs_5005_H22_id
1500	HY-Y0537	HYCPK40906	O09	HYCPK40906	92z	1361.0	1.0	AC17	906.0	O09	7447-40-7	Potassium chloride,AR,99.5%		74.55	Others	Others	Potassium chloride,AR,99.5% is extensively used as a potassium supplement. Potassium chloride,AR,99.5% is a readily available potassium fertilizer[1].		ClK	26234.0	DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble or slightly soluble)	DMSO Solution	10mM  * 100uL	Others	[K]Cl	https://www.medchemexpress.com/potassium-chloride-ar-99-5.html	Launched		92.0	AC17	I3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0537	10.0	mM	195.0	DMSO	35.976678	3	I	pluskal_fda_drugs_5005_I3_id
1537	HY-B0751	HYCPK40906	D12	HYCPK40906	92z	311.0	1.0	G23	906.0	D12	23110-15-8	Fumagillin	Amebacilin; NSC9168	458.54	Antibiotic; HIV; Parasite	Anti-infection	Fumagillin(NSC9168) is an antimicrobial compound first isolated in 1949 from the fungus Aspergillus fumigatu. Fumagillin can inhibits HIV‐1 infection through the inhibition of HIV-1 viral protein R (Vpr) activity.	Free Acid	C26H34O7	118442.0	DMSO : 50 mg/mL (109.04 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	C[C@]1([C@@H](C/C=C(C)/C)O1)[C@]([C@@H]2OC)([H])[C@]3(CC[C@H]2OC(/C=C/C=C/C=C/C=C/C(O)=O)=O)CO3	https://www.medchemexpress.com/fumagillin.html	Launched		92.0	G23	I3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0751	10.0	mM	195.0	DMSO	458.230453	3	I	pluskal_fda_drugs_5005_I3_id
1573	HY-14885	HYCPK40906	H14	HYCPK40906	92z	699.0	1.0	O27	906.0	H14	491833-29-5	Eliglustat	Genz 99067	404.54	Others	Others	Eliglustat is an specific, potent and orally active glucocerebroside synthase inhibitor with an IC50 of 24 nM.	Free Base	C23H36N2O4	26672.0	DMSO : 100 mg/mL (247.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	CCCCCCCC(N[C@H](CN1CCCC1)[C@@H](C2=CC=C(OCCO3)C3=C2)O)=O	https://www.medchemexpress.com/Eliglustat.html	Launched		92.0	O27	I3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14885	10.0	mM	195.0	DMSO	404.267508	3	I	pluskal_fda_drugs_5005_I3_id
1588	HY-B0277	HYCPK40906	G15	HYCPK40906	92z	605.0	1.0	M29	906.0	G15	5536-17-4	Vidarabine	Ara-A; Adenine Arabinoside; 9-β-D-Arabinofuranosyladenine	267.24	Antibiotic; HSV; Nucleoside Antimetabolite/Analog; Orthopoxvirus	Anti-infection; Cell Cycle/DNA Damage	Vidarabine (Ara-A) an antiviral agent which is active against herpes simplex and varicella zoster viruses[1][2]. Vidarabine has IC50s of 9.3 μg/ml for HSV-1 and 11.3 μg/ml for HSV-2[2]. Vidarabine also has anti-orthopoxvirus activity[3].	Free Base	C10H13N5O4	13894.0	H2O : 0.67 mg/mL (2.51 mM; Need ultrasonic); DMSO : 50 mg/mL (187.10 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O[C@@H]([C@@H]1O)[C@@H](O[C@@H]1CO)N2C(N=CN=C3N)=C3N=C2	https://www.medchemexpress.com/Vidarabine.html	Launched		92.0	M29	I3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0277	10.0	mM	195.0	DMSO	267.096754	3	I	pluskal_fda_drugs_5005_I3_id
1625	HY-14734A	HYCPK40906	L17	HYCPK40906	92z	1089.0	1.0	W33	906.0	L17	861998-00-7	Anamorelin (hydrochloride)	RC-1291 hydrochloride; ONO-7643 hydrochloride	583.16	GHSR	GPCR/G Protein	Anamorelin (RC-1291) hydrochloride is a potent ghrelin receptor agonist with EC50 value of 0.74 nM in the FLIPR assay.	Hydrochloride	C31H43ClN6O3	101973.0	DMSO : ≥ 28 mg/mL (48.01 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	[H][C@](CC1=CNC2=CC=CC=C21)(NC(C(C)(C)N)=O)C(N3CCC[C@@](C(N(C)N(C)C)=O)(CC4=CC=CC=C4)C3)=O.[H]Cl	https://www.medchemexpress.com/Anamorelin-hydrochloride.html	Launched		92.0	W33	I3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14734A	10.0	mM	195.0	DMSO	546.331839	3	I	pluskal_fda_drugs_5005_I3_id
1741	HY-17355A	HYCPK40907	E05	HYCPK40907	92z	394.0	2.0	I10	907.0	E05	104632-27-1	Dexpramipexole (dihydrochloride)	(R)-Pramipexole (dihydrochloride); R-(+)-Pramipexole (dihydrochloride); KNS-760704 (dihydrochloride)	284.25	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Dexpramipexole dihydrochloride ((R)-Pramipexole dihydrochloride) is a neuroprotective agent and weak non-ergoline dopamine agonist.	Hydrochloride	C10H19Cl2N3S	119100.0	H2O : 100 mg/mL (351.80 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (351.80 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC(S1)=NC2=C1C[C@H](NCCC)CC2.[H]Cl.[H]Cl	https://www.medchemexpress.com/Dexpramipexole-dihydrochloride.html	Launched		92.0	I10	I3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17355A	10.0	mM	195.0	DMSO	211.114319	3	I	pluskal_fda_drugs_5005_I3_id
1949	HY-B0501	HYCPK40907	M18	HYCPK40907	92z	1188.0	2.0	Y36	907.0	M18	119478-55-6	Danofloxacin (mesylate)	CP 76136-27	453.48	Antibiotic; Bacterial	Anti-infection	"Danofloxacin mesylate (CP 76136-27) is a fluoroquinolone antibacterial for veterinary use.
Target: Antibacterial
Danofloxacin mesylate (CP 76136-27) is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase, which is necessary for supercoiling of DNA to provide a suitable spatial arrangement of DNA within the bacterial cell. The minimum inhibitory concentration of danofloxacin against 90% (MIC90) of contemporary European and North American field isolates of Pasteurella haemolytica, Pasteurella multocida and Haemophilus somnus, the most important bacterial respiratory pathogens of cattle, is 0.125 μg/ml [1]. 
Danofloxacin mesylate (CP 76136-27) shows protective dose (PD50) of 0.38, 0.8, 2.42 mg/kg for P. multocida, E. coli and S. choleraesuis in in vivo mouse protection assay [2]."	Mesylate	C20H24FN3O6S	16816.0	DMSO : 20 mg/mL (44.10 mM; Need ultrasonic); H2O : 100 mg/mL (220.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4[C@](C5)([H])CN(C)[C@]5([H])C4)=C3)C1=O)O.CS(=O)(O)=O	https://www.medchemexpress.com/Danofloxacin-mesylate.html	Launched		92.0	Y36	I3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0501	10.0	mM	195.0	DMSO	357.14887	3	I	pluskal_fda_drugs_5005_I3_id
2301	HY-B0991	HYCPK40908	N21	HYCPK40908	92z	1337.0	3.0	AB41	908.0	N21	14028-44-5	Amoxapine	CL-67772	313.78	Others	Others	Amoxapine is a tetracyclic antidepressant of the dibenzoxazepine family, though it is often classified as a secondary amine tricyclic antidepressant.	Free Base	C17H16ClN3O	26675.0	DMSO : 8.33 mg/mL (26.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	ClC1=CC=C(OC2=CC=CC=C2N=C3N4CCNCC4)C3=C1	https://www.medchemexpress.com/Amoxapine.html	Launched		92.0	AB41	I3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0991	10.0	mM	195.0	DMSO	313.09819	3	I	pluskal_fda_drugs_5005_I3_id
1424	HY-B0410A	HYCPK40906	M06	HYCPK40906	92z	1163.0	1.0	Y11	906.0	M06	191217-81-9	Pramipexole (dihydrochloride hydrate)		302.26	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Pramipexole dihydrochloride hydrate is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole dihydrochloride hydrate can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].	Hydrochloride	C10H21Cl2N3OS	79161.0	H2O : 100 mg/mL (330.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	[H]Cl.NC1=NC(CC[C@H](NCCC)C2)=C2S1.[H]Cl.O	https://www.medchemexpress.com/pramipexole-dihydrochloride-hydrate.html	Launched		92.0	Y11	I4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0410A	10.0	mM	196.0	DMSO	211.114319	4	I	pluskal_fda_drugs_5005_I4_id
1529	HY-B0228	HYCPK40906	L11	HYCPK40906	92z	1077.0	1.0	W21	906.0	L11	58-61-7	Adenosine	Adenine riboside; D-Adenosine	267.24	Apoptosis; Autophagy; Endogenous Metabolite; Nucleoside Antimetabolite/Analog	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Adenosine (Adenine riboside), a ubiquitous endogenous autacoid, acts through the enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Adenosine affects almost all aspects of cellular physiology, including neuronal activity, vascular function, platelet aggregation, and blood cell regulation[1][2].	Free Base	C10H13N5O4	15969.0	DMSO : 33.33 mg/mL (124.72 mM; Need ultrasonic); H2O : ≥ 6.67 mg/mL (24.96 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	NC1=C2C(N([C@H]3[C@H](O)[C@H](O)[C@@H](CO)O3)C=N2)=NC=N1	https://www.medchemexpress.com/Adenosine.html	Launched		92.0	W21	I4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0228	10.0	mM	196.0	DMSO	267.096754	4	I	pluskal_fda_drugs_5005_I4_id
1594	HY-15592A	HYCPK40906	M15	HYCPK40906	92z	1181.0	1.0	Y29	906.0	M15	1051375-13-3	Cabotegravir (sodium)	GSK-1265744 (sodium); S/GSK1265744 (sodium)	427.33	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	Cabotegravir (GSK-1265744) sodium is a orally active and long-acting HIV integrase inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 μM and 0.81 μM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral drugs (ARVs). Cabotegravir sodium can be used to research AIDS[1][2].	Sodium	C19H16F2N3NaO5	231846.0	DMSO : 6.9 mg/mL (16.15 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	FC1=C(CNC(C2=CN3C(C(N([C@@H](C)CO4)[C@@]4([H])C3)=O)=C(O[Na])C2=O)=O)C=CC(F)=C1	https://www.medchemexpress.com/cabotegravir-sodium.html	Launched		92.0	Y29	I4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15592A	10.0	mM	196.0	DMSO	405.113627	4	I	pluskal_fda_drugs_5005_I4_id
1690	HY-121144	HYCPK40906	M21	HYCPK40906	92z	1193.0	1.0	Y41	906.0	M21	56187-47-4	Cefazedone	Refosporen	548.44	Antibiotic; Bacterial	Anti-infection	Cefazedone (Refosporen), a first-generation cephalosporin, is a time-dependent antibiotic with activity against Gram-positive and Gram-negative bacteria[1].		C18H15Cl2N5O5S3	64026.0	DMSO : 125 mg/mL (227.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)C(N1[C@@]([H])([C@@H](C1=O)NC(CN(C=C(C2=O)Cl)C=C2Cl)=O)SC3)=C3CSC4=NN=C(S4)C	https://www.medchemexpress.com/cefazedone.html	Launched		92.0	Y41	I4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-121144	10.0	mM	196.0	DMSO	546.961237	4	I	pluskal_fda_drugs_5005_I4_id
1805	HY-17372	HYCPK40907	E09	HYCPK40907	92z	402.0	2.0	I18	907.0	E09	162011-90-7	Rofecoxib	MK 966	314.36	COX	Immunology/Inflammation	Rofecoxib is a potent, specific and orally active COX-2 inhibitor, with IC50s of 26 and 18 nM for human COX-2 in human osteosarcoma cells and Chinese hamster ovary cells, with a 1000-fold selectivity for COX-2 over human COX-1 (IC50 > 50 μM in U937 cells and > 15 μM in Chinese hamster ovary cells).	Free Base	C17H14O4S	28805.0	DMSO : 33.33 mg/mL (106.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C1OCC(C2=CC=C(S(=O)(C)=O)C=C2)=C1C3=CC=CC=C3	https://www.medchemexpress.com/Rofecoxib.html	Launched		92.0	I18	I4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17372	10.0	mM	196.0	DMSO	314.06128	4	I	pluskal_fda_drugs_5005_I4_id
2412	HY-B0621	HYCPK40908	H22	HYCPK40908	92z	763.0	3.0	P43	908.0	H22	68786-66-3	Triclabendazole	CGA89317	359.66	Microtubule/Tubulin; Parasite	Anti-infection; Cell Cycle/DNA Damage; Cytoskeleton	"Triclabendazole(CGA89317) is a benzimidazole, it binds to tubulin impairing intracellular transport mechanisms and interferes with protein synthesis.
Target: Microtubule/Tubulin
Triclabendazole treatment produces percentage decreases of the fluke egg output by 15.3%, 4.3% and 36.6%, respectively, in sheep, dairy cows and heifers, these results indicate the presence of TCBZ-resistant Fasciola hepatica in sheep and cattle on this farm [1]. Triclabendazole sulphoxide (50 mg/mL) results in extensive damage to the tegument of triclabendazole-susceptible F. hepatica, whereas triclabendazole-resistant flukes shows only localized and relatively minor disruption of the tegument covering the spines [2].
Triclabendazole is metabolized into a number of compounds, depending on the route of administration, plasma levels peak at 18-24 hours (Triclabendazole sulphoxide) and 36-48 hours (Triclabendazole sulphone), neither Triclabendazole nor any toher metabolites can be detected in plasma. Triclabendazole sulphoxide blocks the transport of secretory bodies from the cell body to the tegumental surface, the block occurs at the site of their formation by the Golgi complex in the cell body, in their movement through the cytoplasmic connections to the syncytium, and in their movement from the base to the apex of the syncytium. Triclabendazole binds to the colchicine binding site on the β-tubulin molecule and this has been used at the basis for evaluating the relative acitvity of Triclabendazole [3]."	Free Base	C14H9Cl3N2OS	16782.0	DMSO : 100 mg/mL (278.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CSC1=NC2=CC(OC3=CC=CC(Cl)=C3Cl)=C(Cl)C=C2N1	https://www.medchemexpress.com/triclabendazole.html	Launched		92.0	P43	I4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0621	10.0	mM	196.0	DMSO	357.950117	4	I	pluskal_fda_drugs_5005_I4_id
2490	HY-Y0271	HYCPK40909	M07	HYCPK40909	92z	1214.0	4.0	Z14	909.0	M07	57-13-6	Urea	Carbamide; Carbonyldiamide	60.06	Endogenous Metabolite	Metabolic Enzyme/Protease	Urea is a powerful protein denaturant via both direct and indirect mechanisms[1]. A potent emollient and keratolytic agent[2]. Used as a diuretic agent. Blood urea nitrogen (BUN) has been utilized to evaluate renal function[3]. Widely used in fertilizers as a source of nitrogen and is an important raw material for the chemical industry.	Free Base	CH4N2O	26957.0	DMSO : 100 mg/mL (1665.00 mM; Need ultrasonic); H2O : 100 mg/mL (1665.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	NC(N)=O	https://www.medchemexpress.com/Urea.html	Launched		92.0	Z14	I4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0271	10.0	mM	196.0	DMSO	60.032363	4	I	pluskal_fda_drugs_5005_I4_id
2551	HY-N0880	HYCPK40909	J11	HYCPK40909	92z	934.0	4.0	T22	909.0	J11	1108-68-5	Cinobufotalin		458.54	Others	Others	Cinobufotalin is a cardiotonic steroids or bufadienolides, is extracted from the skin secretions of the giant toads. Cinobufotalin has been used as a cardiotonic, diuretic and a hemostatic agent, Cinobufotalin is also a potential anti-lung cancer agent[1].	Free Base	C26H34O7	151799.0	DMSO : 125 mg/mL (272.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@]([C@@H](C(C=C1)=COC1=O)[C@H]2OC(C)=O)(CC[C@@]3([H])[C@@]4([H])CC[C@@]5(O)[C@@]3(CC[C@H](O)C5)C)[C@@]64[C@@H]2O6	https://www.medchemexpress.com/Cinobufotalin.html	Launched		92.0	T22	I4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0880	10.0	mM	196.0	DMSO	458.230453	4	I	pluskal_fda_drugs_5005_I4_id
1401	HY-U00098	HYCPK40906	F05	HYCPK40906	92z	489.0	1.0	K9	906.0	F05	7681-14-3	Prednisolone Tebutate		458.59	Glucocorticoid Receptor	Immunology/Inflammation	Prednisolone tebutate is a synthetic glucocorticoid used as an antiinflammatory and immunosuppressant.	Free Base	C27H38O6	118660.0	DMSO : ≥ 100 mg/mL (218.06 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]1([C@@]2(O)C(COC(CC(C)(C)C)=O)=O)[C@](CC2)([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@@H](O)C1	https://www.medchemexpress.com/Prednisolone_Tebutate.html	Launched		92.0	K9	I5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-U00098	10.0	mM	197.0	DMSO	458.266839	5	I	pluskal_fda_drugs_5005_I5_id
1402	HY-15321	HYCPK40906	G05	HYCPK40906	92z	585.0	1.0	M9	906.0	G05	202409-33-4	Etoricoxib	MK-0663; L-791456	358.84	COX	Immunology/Inflammation	Etoricoxib (MK-0663) is a non steroidal anti-inflammatory agent, acting as a selective and orally active COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood.	Free Base	C18H15ClN2O2S	15036.0	DMSO : 100 mg/mL (278.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=S(C1=CC=C(C2=CC(Cl)=CN=C2C3=CC=C(C)N=C3)C=C1)(C)=O	https://www.medchemexpress.com/Etoricoxib.html	Launched		92.0	M9	I5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15321	10.0	mM	197.0	DMSO	358.054276	5	I	pluskal_fda_drugs_5005_I5_id
1694	HY-12542A	HYCPK40906	A22	HYCPK40906	92z	43.0	1.0	A43	906.0	A22	24868-20-0	Dantrolene (sodium hemiheptahydrate)	Dantrolene sodium hydrate	399.29	Autophagy; Calcium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Dantrolene sodium hemiheptahydrate is a skeletal muscle relaxant which acts by blocking muscle contraction beyond the neuromuscular junction. Dantrolene sodium hemiheptahydrate is a inhibitor of calcium channel proteins, inhibiting the release of Ca2+ from the sarcoplasm.	Sodium	C14H16N4NaO8.5	18806.0	DMSO : ≥ 33 mg/mL (82.65 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Others	O=C1N([Na])C(CN1/N=C/C2=CC=C(C3=CC=C([N+]([O-])=O)C=C3)O2)=O.[3.5H2O]	https://www.medchemexpress.com/Dantrolene-sodium-hemiheptahydrate.html	Launched		92.0	A43	I5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12542A	10.0	mM	197.0	DMSO	314.065119	5	I	pluskal_fda_drugs_5005_I5_id
1777	HY-16779	HYCPK40907	I07	HYCPK40907	92z	782.0	2.0	Q14	907.0	I07	351227-64-0	Fosravuconazole	BMS-379224; E-1224	547.47	Fungal; Parasite	Anti-infection	Fosravuconazole (BMS-379224), a prodrug of Ravuconazole, is an orally active broad spectrum antifungal agent. Fosravuconazole can be used for candidiasis, onychomycosis and parasitemia research[1][2][3].	Free Acid	C23H20F2N5O5PS	136843.0	DMSO : 100 mg/mL (182.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	N#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1	https://www.medchemexpress.com/Fosravuconazole.html	Launched		92.0	Q14	I5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16779	10.0	mM	197.0	DMSO	547.089083	5	I	pluskal_fda_drugs_5005_I5_id
1819	HY-B0025	HYCPK40907	C10	HYCPK40907	92z	212.0	2.0	E20	907.0	C10	83480-29-9	Voglibose		267.28	Glucosidase	Metabolic Enzyme/Protease	"Voglibose is an N-substituted derivative of valiolamine, excellent inhibitory activity against α-glucosidases and its action against hyperglycemia and various disorders caused by hyperglycemia.
Target: α-glucosidases
glibose can inhibit the intestinal α-glucosidases, which are responsible for the digestion of disaccharides such as maltose and sucrose, including maltase and sucrase. The Ki values of Voglibose for sucrase and maltase are about 106and 105 times smaller than the Km values for sucrose and maltose [1]. Voglibose (0.2 mg/kg) completely inhibits the insulin response to sucrose in rats. Voglibose (0.2 mg/kg) reduces the carbohydrate-induced increase in blood glucose in rats. Voglibose (0.2 mg/kg) reduces the carbohydrate-induced increase in blood glucose without causing sustained hypoglycemia in both normal and neonatal streptozotocin-induced diabetic rats [2]. Voglibose (0.001%) treatment increases GLP-1 secretion (Voglibose alone, 1.6-fold; Alogliptin plus Voglibose, 1.5-fold), while it decreases plasma glucose-dependent insulinotropic polypeptide (GIP) (Voglibose alone, 30%; Alogliptin plus voglibose, 29%) in prediabetic db/db mice after 3 weeks. Voglibose (0.001%) treatment decreases plasma DPP-4 activity by 15% in prediabetic db/db mice. Voglibose (0.001%) treatment increases plasma insulin by 1.8-fold and decreases plasma glucagon by 8% in prediabetic db/db mice [3]."	Free Base	C10H21NO7	15823.0	H2O : 250 mg/mL (935.35 mM; Need ultrasonic); DMSO : 100 mg/mL (374.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O[C@@H]1[C@@](O)(CO)C[C@H](NC(CO)CO)[C@H](O)[C@H]1O	https://www.medchemexpress.com/Voglibose.html	Launched		92.0	E20	I5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0025	10.0	mM	197.0	DMSO	267.131802	5	I	pluskal_fda_drugs_5005_I5_id
1853	HY-B0468	HYCPK40907	E12	HYCPK40907	92z	408.0	2.0	I24	907.0	E12	51-30-9	Isoprenaline (hydrochloride)	Isoproterenol (hydrochloride)	247.72	Adrenergic Receptor; Endogenous Metabolite	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Isoprenaline (Isoproterenol) hydrochloride is a non-selective, orally active β-adrenergic receptor agonist. Isoprenaline has potent peripheral vasodilator, bronchodilator, and cardiac stimulating activities. Isoprenaline can be used for the research of bradycardia and bronchial asthma[1][2][3][4][5][6].	Hydrochloride	C11H18ClNO3	79092.0	DMSO : 80 mg/mL (322.95 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (201.84 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	OC1=CC=C(C(O)CNC(C)C)C=C1O.Cl	https://www.medchemexpress.com/Isoprenaline-hydrochloride.html	Launched		92.0	I24	I5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0468	10.0	mM	197.0	DMSO	211.120843	5	I	pluskal_fda_drugs_5005_I5_id
2030	HY-77591	HYCPK40908	B04	HYCPK40908	92z	151.0	3.0	D7	908.0	B04	156-57-0	Cysteamine (hydrochloride)	2-Aminoethanethiol (hydrochloride); 2-Mercaptoethylamine (hydrochloride)	113.61	Apoptosis; Autophagy; Endogenous Metabolite; Reactive Oxygen Species	Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Cysteamine hydrochloride (2-Aminoethanethiol hydrochloride)  is an orally active agent for the treatment of nephropathic cystinosis and an antioxidant.	Hydrochloride	C2H8ClNS	14356.0	H2O : ≥ 50 mg/mL (440.10 mM); DMSO : 250 mg/mL (2200.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	SCCN.Cl	https://www.medchemexpress.com/Cysteamine-Hydrochloride.html	Launched		92.0	D7	I5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-77591	10.0	mM	197.0	DMSO	77.02992	5	I	pluskal_fda_drugs_5005_I5_id
2122	HY-B0596A	HYCPK40908	C10	HYCPK40908	92z	259.0	3.0	F19	908.0	C10	1549593-23-8	Taltirelin (acetate)	TA-0910 (acetate)	465.46	Thyroid Hormone Receptor	Others	Taltirelin acetate (TA-0910 acetate) is a superagonist at thyrotropin-releasing hormone receptor (TRH-R) with an IC50 of 910 nM and EC50 of 36 nM for stimulating an increase in cytosolic Ca2+ concentration (Ca2+ release)[1].	Acetate	C19H27N7O7	45841.0	DMSO : 125 mg/mL (268.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	O=C(N(CCC1)[C@@H]1C(N)=O)[C@@H](NC([C@@H](NC2=O)CC(N2C)=O)=O)CC3=CN=CN3.CC(O)=O	https://www.medchemexpress.com/taltirelin-acetate.html	Launched		92.0	F19	I5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0596A	10.0	mM	197.0	DMSO	405.176067	5	I	pluskal_fda_drugs_5005_I5_id
1453	HY-B0656A	HYCPK40907	O14	HYCPK40907	92z	1372.0	2.0	AC28	907.0	O14	117976-90-6	Rabeprazole (sodium)	LY307640 sodium	381.42	Apoptosis; Bacterial; Proton Pump	Anti-infection; Apoptosis; Membrane Transporter/Ion Channel	Rabeprazole sodium (LY307640 sodium) is a second-generation proton pump inhibitor (PPI) that irreversibly inactivates gastric H+/K+-ATPase. Rabeprazole sodium induces apoptosis. Rabeprazole sodium acts as an uridine nucleoside ribohydrolase (UNH) inhibitor with an IC50 of 0.3 μM. Rabeprazole sodium can be used for the research of gastric ulcerations and gastroesophageal reflux[1][2][3].	Sodium	C18H20N3NaO3S	81737.0	DMSO : ≥ 48 mg/mL (125.85 mM); H2O : ≥ 100 mg/mL (262.18 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=S(C1=NC2=CC=CC=C2N1[Na])CC3=NC=CC(OCCCOC)=C3C	https://www.medchemexpress.com/Rabeprazole-sodium.html	Launched		92.0	AC28	I6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0656A	10.0	mM	198.0	DMSO	359.130363	6	I	pluskal_fda_drugs_5005_I6_id
1497	HY-17503	HYCPK40906	L09	HYCPK40906	92z	1073.0	1.0	W17	906.0	L09	51384-51-1	Metoprolol		267.36	Adrenergic Receptor; Apoptosis	Apoptosis; GPCR/G Protein; Neuronal Signaling	Metoprolol is an orally active, selective β1-adrenoceptor antagonist. Metoprolol shows anti-inflammation, antitumor and anti-angiogenic properties[1][2][3].	Free Base	C15H25NO3	122513.0	DMSO : 100 mg/mL (374.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Endocrinology; Cardiovascular Disease	OC(CNC(C)C)COC1=CC=C(CCOC)C=C1	https://www.medchemexpress.com/Metoprolol.html	Launched		92.0	W17	I6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17503	10.0	mM	198.0	DMSO	267.183444	6	I	pluskal_fda_drugs_5005_I6_id
1618	HY-B0876	HYCPK40906	E17	HYCPK40906	92z	417.0	1.0	I33	906.0	E17	7554-65-6	Fomepizole	4-Methylpyrazole	82.10	Cytochrome P450	Metabolic Enzyme/Protease	Fomepizole (4-Methylpyrazole) is a potent cytochrome P450 (CYP2E1) inhibitor. Fomepizole is a competitive inhibitor of the enzyme alcohol dehydrogenase. Fomepizole blocks further conversion of methanol and ethylene glycol to toxic metabolites. Fomepizole has the potential for an antidote for ethylene glycol or methanol poisoning[1][2][3].	Free Base	C4H6N2	16370.0	DMSO : ≥ 100 mg/mL (1218.03 mM); H2O : 100 mg/mL (1218.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC1=CNN=C1	https://www.medchemexpress.com/Fomepizole.html	Launched		92.0	I33	I6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0876	10.0	mM	198.0	DMSO	82.053098	6	I	pluskal_fda_drugs_5005_I6_id
1681	HY-10569	HYCPK40906	D21	HYCPK40906	92z	329.0	1.0	G41	906.0	D21	854107-55-4	Ponesimod	ACT-128800	460.97	LPL Receptor	GPCR/G Protein	Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation[1][2][3].	Free Base	C23H25ClN2O4S	24876.0	DMSO : ≥ 100 mg/mL (216.93 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1N(C2=CC=CC=C2C)/C(S/C1=C\C3=CC=C(OC[C@H](O)CO)C(Cl)=C3)=N/CCC	https://www.medchemexpress.com/Ponesimod.html	Launched		92.0	G41	I6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10569	10.0	mM	198.0	DMSO	460.122356	6	I	pluskal_fda_drugs_5005_I6_id
1824	HY-10264B	HYCPK40907	H10	HYCPK40907	92z	692.0	2.0	O20	907.0	H10	1229194-11-9	Edoxaban (tosylate monohydrate)	DU-176b (monohydrate)	738.27	Factor Xa; Thrombin	Metabolic Enzyme/Protease	Edoxaban (DU-176b) monohydrate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Kis of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban monohydrate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban monohydrate can be used for preventing thromboembolic disease research[1].	Tosylate	C31H40ClN7O8S2	15962.0	H2O : 1 mg/mL (1.35 mM; Need ultrasonic); DMSO : 50 mg/mL (67.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(N(C)C)[C@@H](CC1)C[C@H]([C@H]1NC(C(NC(C=C2)=NC=C2Cl)=O)=O)NC(C3=NC(CC4)=C(CN4C)S3)=O.O=S(C5=CC=C(C)C=C5)(O)=O.O	https://www.medchemexpress.com/Edoxaban-tosylate-monohydrate.html	Launched		92.0	O20	I6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10264B	10.0	mM	198.0	DMSO	547.176851	6	I	pluskal_fda_drugs_5005_I6_id
2298	HY-15762	HYCPK40908	K21	HYCPK40908	92z	1049.0	3.0	V41	908.0	K21	181695-72-7	Valdecoxib	SC 65872	314.36	COX; Endogenous Metabolite	Immunology/Inflammation; Metabolic Enzyme/Protease	Valdecoxib is a highly potent and selective inhibitor of COX-2, with IC50s of 5 nM and 140 μM for COX-2 and COX-1, respeceively. Valdecoxib can be used in the research of arthritis and pain.	Free Base	C16H14N2O3S	10109.0	DMSO : ≥ 34 mg/mL (108.16 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=S(C1=CC=C(C2=C(C)ON=C2C3=CC=CC=C3)C=C1)(N)=O	https://www.medchemexpress.com/Valdecoxib.html	Launched		92.0	V41	I6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15762	10.0	mM	198.0	DMSO	314.072513	6	I	pluskal_fda_drugs_5005_I6_id
2307	HY-B0596	HYCPK40909	G07	HYCPK40909	92z	638.0	4.0	N14	909.0	G07	103300-74-9	Taltirelin	TA-0910	405.41	Thyroid Hormone Receptor	Others	Taltirelin (TA0910) is a superagonist at thyrotropin-releasing hormone receptor (TRH-R) with an IC50 of 910 nM and EC50 of 36 nM for stimulating an increase in cytosolic Ca2+ concentration (Ca2+ release)[1].	Free Base	C17H23N7O5	155513.0	DMSO : 100 mg/mL (246.66 mM; Need ultrasonic); H2O : 100 mg/mL (246.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	O=C(N(CCC1)[C@@H]1C(N)=O)[C@@H](NC([C@@H](NC2=O)CC(N2C)=O)=O)CC3=CN=CN3	https://www.medchemexpress.com/Taltirelin.html	Launched		92.0	N14	I6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0596	10.0	mM	198.0	DMSO	405.176067	6	I	pluskal_fda_drugs_5005_I6_id
2521	HY-B1276	HYCPK40909	L09	HYCPK40909	92z	1122.0	4.0	X18	909.0	L09	5874-97-5	Metaproterenol (hemisulfate)	Orciprenaline (hemisulfate)	260.30	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Metaproterenol hemisulfate (Orciprenaline hemisulfate) is a direct-acting sympathomimetic and a β2-adrenergic receptor (β2AR)  agonist with an IC50 of 68 nM. Metaproterenol hemisulfate also has anti-inflammatory activity[1][2].	Sulfate	C11H17NO3.1/2H2O4S	119380.0	DMSO : 62.5 mg/mL (240.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease; Endocrinology	O=S(O)(O)=O.OC1=CC(O)=CC(C(O)CNC(C)C)=C1.[1/2]	https://www.medchemexpress.com/metaproterenol-hemisulfate.html	Launched		92.0	X18	I6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1276	10.0	mM	198.0	DMSO	211.120843	6	I	pluskal_fda_drugs_5005_I6_id
1477	HY-N0524	HYCPK40906	H08	HYCPK40906	92z	687.0	1.0	O15	906.0	H08	121-79-9	Propyl gallate		212.20	Others	Others	Propyl gallate is a common food antioxidant. Propyl gallate can inhibit the production of acrolein, glyoxal and methylglyoxal[1][2].		C10H12O5	62869.0	DMSO : 250 mg/mL (1178.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(OCCC)C1=CC(O)=C(O)C(O)=C1	https://www.medchemexpress.com/propyl-gallate.html	Launched		92.0	O15	I7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0524	10.0	mM	199.0	DMSO	212.068473	7	I	pluskal_fda_drugs_5005_I7_id
1513	HY-17503A	HYCPK40906	L10	HYCPK40906	92z	1075.0	1.0	W19	906.0	L10	98418-47-4	Metoprolol (succinate)		652.82	Adrenergic Receptor; Apoptosis	Apoptosis; GPCR/G Protein; Neuronal Signaling	Metoprolol succinate is an orally active, selective β1-adrenoceptor antagonist. Metoprolol succinate shows anti-inflammation, antitumor and anti-angiogenic properties[1][2][3].	Succinate	C34H56N2O10	13192.0	H2O : ≥ 100 mg/mL (153.18 mM); DMSO : 16.67 mg/mL (25.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	OC(CNC(C)C)COC1=CC=C(CCOC)C=C1.OC(CNC(C)C)COC2=CC=C(CCOC)C=C2.OC(CCC(O)=O)=O	https://www.medchemexpress.com/Metoprolol-Succinate.html	Launched		92.0	W19	I7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17503A	10.0	mM	199.0	DMSO	267.183444	7	I	pluskal_fda_drugs_5005_I7_id
1615	HY-B1451	HYCPK40906	B17	HYCPK40906	92z	129.0	1.0	C33	906.0	B17	89396-94-1	Imidapril (hydrochloride)	TA-6366	441.91	Angiotensin-converting Enzyme (ACE); MMP	Metabolic Enzyme/Protease	Imidapril hydrochloride (TA-6366) is an orally active angiotensin-converting enzyme (ACE) and MMP-9 inhibitor. Imidapril hydrochloride suppresses the conversion of angiotensin I to angiotensin II and thereby reduces total peripheral resistance and systemic blood pressure. Imidapril hydrochloride can be used for hypertension, type 1 diabetic, nephropathy and chronic heart failure research[1][2].	Hydrochloride	C20H28ClN3O6	18296.0	H2O : 50 mg/mL (113.15 mM; Need ultrasonic); DMSO : 50 mg/mL (113.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=C([C@H](CN1C)N(C([C@@H](N[C@H](C(OCC)=O)CCC2=CC=CC=C2)C)=O)C1=O)O.[H]Cl	https://www.medchemexpress.com/Imidapril-hydrochloride.html	Launched		92.0	C33	I7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1451	10.0	mM	199.0	DMSO	405.189986	7	I	pluskal_fda_drugs_5005_I7_id
1932	HY-B1218	HYCPK40907	L17	HYCPK40907	92z	1090.0	2.0	W34	907.0	L17	526-08-9	Sulfaphenazole		314.36	Bacterial	Anti-infection	Sulfaphenazole is a specific inhibitor of CYP2C9 which blocks atherogenic and pro-inflammatory effects of linoleic acid (increase in oxidative stress and activation of AP-1) mediated by CYP2C9. Acts as an antibacterial and antimicrobial.	Free Base	C15H14N4O2S	57912.0	DMSO : ≥ 100 mg/mL (318.11 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=CC=NN2C3=CC=CC=C3)=O	https://www.medchemexpress.com/Sulfaphenazole.html	Launched		92.0	W34	I7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1218	10.0	mM	199.0	DMSO	314.083747	7	I	pluskal_fda_drugs_5005_I7_id
2062	HY-100500	HYCPK40908	G06	HYCPK40908	92z	635.0	3.0	N11	908.0	G06	80734-02-7	Lenampicillin (hydrochloride)	KBT 1585 hydrochloride	497.95	Bacterial	Anti-infection	Lenampicillin hydrochloride (KBT 1585 hydrochloride) is an orally active prodrug of Ampicillin and is an effective beta-lactam antibacterial agent that inhibits bacterial penicillin-binding proteins (transpeptidase). Lenampicillin hydrochloride has improved absorption and decreased side effects compares to Ampicillin and is applied in the investigation of the suppurative skin and soft tissue infection [1] [2] [3].	Hydrochloride	C21H24ClN3O7S	109709.0	DMSO : 100 mg/mL (200.82 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@@H]1N(C2=O)[C@]([C@@H]2NC([C@@H](C3=CC=CC=C3)N)=O)([H])SC1(C)C)OCC(OC4=O)=C(O4)C.Cl	https://www.medchemexpress.com/Lenampicillin-hydrochloride.html	Launched		92.0	N11	I7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100500	10.0	mM	199.0	DMSO	461.125671	7	I	pluskal_fda_drugs_5005_I7_id
2098	HY-17040	HYCPK40908	K08	HYCPK40908	92z	1023.0	3.0	V15	908.0	K08	206361-99-1	Darunavir	TMC114; UIC-94017	547.66	HIV; HIV Protease	Anti-infection; Metabolic Enzyme/Protease	Darunavir (TMC114), an orally active next generation HIV protease inhibitor, has a similar antiviral activity against the mutant and the wild-type viruses. Darunavir (TMC114) is potent against laboratory HIV-1 strains and primary clinical isolates (IC50 = 0.003 μM; IC90 = 0.009 μM) with minimal cytotoxicity[1][2].	Free Base	C27H37N3O7S	23728.0	DMSO : ≥ 100 mg/mL (182.60 mM)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(O[C@@H]1[C@@]2([H])[C@@](OCC2)([H])OC1)N[C@@H](CC3=CC=CC=C3)[C@H](O)CN(S(=O)(C4=CC=C(N)C=C4)=O)CC(C)C	https://www.medchemexpress.com/Darunavir.html	Launched		92.0	V15	I7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17040	10.0	mM	199.0	DMSO	547.235222	7	I	pluskal_fda_drugs_5005_I7_id
2129	HY-B0016	HYCPK40908	J10	HYCPK40908	92z	931.0	3.0	T19	908.0	J10	154361-50-9	Capecitabine		359.35	Apoptosis; DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog	Apoptosis; Cell Cycle/DNA Damage	Capecitabine is an oral prodrug that is converted to its active metabolite, 5-FU, by thymidine phosphorylase.	Free Base	C15H22FN3O6	5083.0	DMSO : 250 mg/mL (695.70 mM; Need ultrasonic); H2O : ≥ 33.33 mg/mL (92.75 mM)	DMSO Solution	10mM  * 100uL	Cancer	O[C@H]1[C@@H](O)[C@H](N2C=C(C(NC(OCCCCC)=O)=NC2=O)F)O[C@@H]1C	https://www.medchemexpress.com/Capecitabine.html	Launched		92.0	T19	I7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0016	10.0	mM	199.0	DMSO	359.149264	7	I	pluskal_fda_drugs_5005_I7_id
2515	HY-Y0479	HYCPK40909	F09	HYCPK40909	92z	546.0	4.0	L18	909.0	F09	79-33-4	L-Lactic acid	(S)-2-Hydroxypropanoic acid	90.08	Antibiotic; Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	L-Lactic acid is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid.	Free Acid	C3H6O3	97472.0	H2O : 100 mg/mL (1110.12 mM; Need ultrasonic); DMSO : 100 mg/mL (1110.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	C[C@H](O)C(O)=O	https://www.medchemexpress.com/L-Lactic_acid.html	Launched		92.0	L18	I7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0479	10.0	mM	199.0	DMSO	90.031694	7	I	pluskal_fda_drugs_5005_I7_id
52	HY-B0007	HYCPK40899	F05	HYCPK40909	92z	560.0	4.0	L32	909.0	F16	1134-47-0	Baclofen		213.66	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Baclofen, a lipophilic derivative of γ-aminobutyric acid (GABA), is an orally active, selective metabotropic GABAB receptor (GABABR) agonist. Baclofen mimics the action of GABA and produces slow presynaptic inhibition through the GABAB receptor. Baclofen has high blood brain barrier penetrance. Baclofen has the potential for muscle spasticity research[1][2][3].	Free Acid	C10H12ClNO2	15661.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 2 mg/mL (9.36 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Neurological Disease	O=C(O)CC(C1=CC=C(Cl)C=C1)CN	https://www.medchemexpress.com/Baclofen.html	Launched		92.0	L32	I8	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0007	2.0	mM	200.0	DMSO	213.055656	8	I	pluskal_fda_drugs_5005_I8_id
1421	HY-B0357	HYCPK40906	J06	HYCPK40906	92z	875.0	1.0	S11	906.0	J06	101831-37-2	Diclazuril	R-64433	407.64	Antibiotic; Parasite	Anti-infection	Diclazuril (R-64433), a benzeneacetonitrile derivative, is a potent and orally active anticoccidial agent. Diclazuril can be used for the research of certain infectious and parasitic diseases, including coccidiosis, acute toxoplasmosis, equine protozoal pyoencephalitis (EPM) et.al[1][2].	Free Base	C17H9Cl3N4O2	19357.0	DMSO : 25 mg/mL (61.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(NC1=O)N(N=C1)C2=CC(Cl)=C(C(C#N)C3=CC=C(Cl)C=C3)C(Cl)=C2	https://www.medchemexpress.com/diclazuril.html	Launched		92.0	S11	I8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0357	10.0	mM	200.0	DMSO	405.979109	8	I	pluskal_fda_drugs_5005_I8_id
1604	HY-10453	HYCPK40906	G16	HYCPK40906	92z	607.0	1.0	M31	906.0	G16	1072833-77-2	Ixazomib	MLN2238	361.03	Autophagy; Proteasome	Autophagy; Metabolic Enzyme/Protease	Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM).	Free Base	C14H19BCl2N2O4	150956.0	DMSO : 62.5 mg/mL (173.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OB([C@@H](NC(CNC(C1=CC(Cl)=CC=C1Cl)=O)=O)CC(C)C)O	https://www.medchemexpress.com/MLN2238.html	Launched		92.0	M31	I8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10453	10.0	mM	200.0	DMSO	360.081493	8	I	pluskal_fda_drugs_5005_I8_id
1623	HY-Y0332B	HYCPK40906	J17	HYCPK40906	92z	897.0	1.0	S33	906.0	J17	7778-77-0	Potassium phosphate monobasic		136.09	Others	Others	Potassium phosphate monobasic (DiA) is a commonly used in biological assay buffers. Potassium phosphate monobasic is moderate to highly concentrated aqueous solutions of potassium phosphate monobasic for the production of phosphate buffers and other laboratory applications.		H2KO4P	103428.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Others	O=P(O[O])=O.[KH2]	https://www.medchemexpress.com/potassium-phosphate-monobasic.html	Launched		92.0	S33	I8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0332B	10.0	mM	200.0	DMSO	97.976895	8	I	pluskal_fda_drugs_5005_I8_id
1774	HY-B0281A	HYCPK40907	F07	HYCPK40907	92z	494.0	2.0	K14	907.0	F07	66357-59-3	Ranitidine (hydrochloride)		350.86	Bacterial; Cytochrome P450; Histamine Receptor	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Ranitidine hydrochloride is a potent, selective and orally active histamine H2-receptor antagonist with an IC50 of 3.3 μM that inhibits gastric secretion. Ranitidine hydrochloride is a weak inhibitor of CYP2C19 and CYP2C9[1][2].	Hydrochloride	C13H23ClN4O3S	16550.0	H2O : ≥ 50 mg/mL (142.51 mM); DMSO : 50 mg/mL (142.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Endocrinology; Metabolic Disease; Cancer	CN/C(NCCSCC1=CC=C(CN(C)C)O1)=C\[N+]([O-])=O.Cl	https://www.medchemexpress.com/ranitidine-hydrochloride.html	Launched		92.0	K14	I8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0281A	10.0	mM	200.0	DMSO	314.141262	8	I	pluskal_fda_drugs_5005_I8_id
2198	HY-A0013	HYCPK40908	C15	HYCPK40908	92z	269.0	3.0	F29	908.0	C15	147536-97-8	Bosentan		551.61	Endothelin Receptor	GPCR/G Protein	Bosentan is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.	Free Base	C27H29N5O6S	13760.0	DMSO : ≥ 100 mg/mL (181.29 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=S(NC1=NC(C2=NC=CC=N2)=NC(OCCO)=C1OC3=CC=CC=C3OC)(C4=CC=C(C(C)(C)C)C=C4)=O	https://www.medchemexpress.com/Bosentan.html	Launched		92.0	F29	I8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0013	10.0	mM	200.0	DMSO	551.183855	8	I	pluskal_fda_drugs_5005_I8_id
2460	HY-107801	HYCPK40909	H05	HYCPK40909	92z	730.0	4.0	P10	909.0	H05	36703-88-5	Inosine pranobex	Imunovir; Delimmun; Groprinosin;	1115.23	HIV	Anti-infection	Inosine pranobex is a potent, broad-spectrum antiviral compound for HIV infection. Inosine pranobex is an immunopotentiator[1].		C52H78N10O17	44019.0	DMSO : 62.5 mg/mL (56.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC(NC1=CC=C(C(O)=O)C=C1)=O.CC(NC2=CC=C(C(O)=O)C=C2)=O.CC(O)CN(C)C.O[C@H]3[C@@H](O[C@H](CO)[C@H]3O)N4C5=C(C(N=CN5)=O)N=C4.CC(O)CN(C)C.CC(O)CN(C)C.CC(NC6=CC=C(C(O)=O)C=C6)=O	https://www.medchemexpress.com/inosine-pranobex.html	Launched		92.0	P10	I8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107801	10.0	mM	200.0	DMSO	268.080769	8	I	pluskal_fda_drugs_5005_I8_id
2462	HY-12987	HYCPK40909	J05	HYCPK40909	92z	922.0	4.0	T10	909.0	J05	2062-78-4	Pimozide	R6238	461.55	Adrenergic Receptor; Dopamine Receptor; Parasite; STAT	Anti-infection; GPCR/G Protein; JAK/STAT Signaling; Neuronal Signaling; Stem Cell/Wnt	Pimozide is a dopamine receptor antagonist, with Kis of 1.4 nM, 2.5 nM and 588 nM for dopamine D2, D3 and D1 receptors, respectively, and also has affinity at α1-adrenoceptor, with a Ki of 39 nM; Pimozide also inhibits STAT3 and STAT5.	Free Base	C28H29F2N3O	79523.0	DMSO : 16.67 mg/mL (36.12 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease; Endocrinology	O=C1NC2=CC=CC=C2N1C3CCN(CCCC(C4=CC=C(F)C=C4)C5=CC=C(F)C=C5)CC3	https://www.medchemexpress.com/Pimozide.html	Launched		92.0	T10	I8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12987	10.0	mM	200.0	DMSO	461.227869	8	I	pluskal_fda_drugs_5005_I8_id
364	HY-13458	HYCPK40899	G04	HYCPK40909	92z	654.0	4.0	N30	909.0	G15	23651-95-8	Droxidopa	L-DOPS; DOPS; SM5688	213.19	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Droxidopa(L-DOPS) is a potent, orally active norepinephrine precursor. Droxidopa increases standing blood pressure, ameliorates symptoms of orthostatic hypotension and improves standing ability. Droxidopa has the potential for the research of neurogenic orthostatic hypotension (nOH) and alternative ADHD (attention deficit hyperactivity disorder)[1][2][3][4].	Free Acid	C9H11NO5	25556.0	DMSO : 1.8 mg/mL (8.44 mM; Need ultrasonic and warming); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	2mM  * 100uL	Neurological Disease	OC1=C(O)C=CC([C@@H](O)[C@@H](C(O)=O)N)=C1	https://www.medchemexpress.com/droxidopa.html	Launched		92.0	N30	I9	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13458	2.0	mM	201.0	DMSO	213.063722	9	I	pluskal_fda_drugs_5005_I9_id
1379	HY-B0581	HYCPK40906	P03	HYCPK40906	92z	1445.0	1.0	AE5	906.0	P03	24584-09-6	Dexrazoxane	ICRF-187; ADR-529; NSC-169780	268.27	Others	Others	"Dexrazoxane (ICRF-187) is a cardioprotective agent.
Target: Others
Dexrazoxane is a cardioprotective agent. Dexrazoxane is a derivative of EDTA, dexrazoxane chelates iron and thus reduces the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals. The exact chelation mechanism is unknown, but it has be postulated that dexrazoxane can be converted into ring-opened form intracellularly and interfere with iron-mediated free radical generation that is in part thought to be responsible for anthryacycline induced cadiomyopathy. It was speculated that dexrazoxane could be used for further investigation to synthesize new antimalarial drugs [1, 2]."	Free Base	C11H16N4O4	124037.0	DMSO : 25 mg/mL (93.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	C[C@H](N(C1)CC(NC1=O)=O)CN(C2)CC(NC2=O)=O	https://www.medchemexpress.com/dexrazoxane.html	Launched		92.0	AE5	I9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0581	10.0	mM	201.0	DMSO	268.117155	9	I	pluskal_fda_drugs_5005_I9_id
1547	HY-10405	HYCPK40906	N12	HYCPK40906	92z	1271.0	1.0	AA23	906.0	N12	449811-01-2	Pamapimod	Ro4402257; R1503	406.38	Autophagy; p38 MAPK	Autophagy; MAPK/ERK Pathway	Pamapimod (Ro4402257) is a potent, selective and orally active p38 MAPK inhibitor with IC50s of 14 nM and 480 nM and Kis of 1.3 nM and 120 nM for p38α and p38β, respectively. Pamapimod has no activity against p38δ or p38γ isoforms. Pamapimod has the potential for rheumatoid arthritis and other autoimmune diseases treatment[1].	Free Base	C19H20F2N4O4	22269.0	DMSO : ≥ 34 mg/mL (83.67 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1C(OC2=CC=C(F)C=C2F)=CC3=CN=C(NC(CCO)CCO)N=C3N1C	https://www.medchemexpress.com/Pamapimod.html	Launched		92.0	AA23	I9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10405	10.0	mM	201.0	DMSO	406.145262	9	I	pluskal_fda_drugs_5005_I9_id
1756	HY-B1122	HYCPK40907	D06	HYCPK40907	92z	300.0	2.0	G12	907.0	D06	339-72-0	L-Cycloserine	(S)-Cycloserine; (S)-4-Amino-3-isoxazolidone	102.09	GABA Receptor; HIV	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	L-Cycloserine ((S)-4-Amino-3-isoxazolidone) irreversibly inhibits GABA pyridoxal 5′-phosphate-dependent aminitransferase in E. coli, as well in the brains of various animals in a time-dependent manner, results in increased levels of gamma-aminobutyric acid (GABA), which is an inhibitory neurotransmitter in vivo.	Free Base	C3H6N2O2	96648.0	H2O : 13.33 mg/mL (130.57 mM; Need ultrasonic); DMSO : 12.5 mg/mL (122.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C1NOC[C@@H]1N	https://www.medchemexpress.com/L-Cycloserine.html	Launched		92.0	G12	I9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1122	10.0	mM	201.0	DMSO	102.042927	9	I	pluskal_fda_drugs_5005_I9_id
1776	HY-B1402	HYCPK40907	H07	HYCPK40907	92z	686.0	2.0	O14	907.0	H07	2203-97-6	Hydrocortisone hemisuccinate	Hydrocortisone 21-hemisuccinate	462.53	Glucocorticoid Receptor; Interleukin Related	Immunology/Inflammation	Hydrocortisone hemisuccinate (Hydrocortisone 21-hemisuccinate), a physiological glucocorticoid, is an orally active steroidal anti-in?ammatory drug (SAID). Hydrocortisone hemisuccinate inhibits proinflammatory cytokine activity, with IC50s of 6.7 and 21.4 μM for IL-6 and IL-3, respectively. Hydrocortisone hemisuccinate can be used for the research of ulcerative colitis (UC)[1][2][3].		C25H34O8	123860.0	DMSO : 250 mg/mL (540.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Metabolic Disease; Inflammation/Immunology	C[C@@]12[C@](C(COC(CCC(O)=O)=O)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/hydrocortisone-hemisuccinate.html	Launched		92.0	O14	I9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1402	10.0	mM	201.0	DMSO	462.225368	9	I	pluskal_fda_drugs_5005_I9_id
1876	HY-13720A	HYCPK40907	L13	HYCPK40907	92z	1082.0	2.0	W26	907.0	L13	66104-23-2	Pergolide (mesylate)	Pergolide methanesulfonate; LY127809	410.59	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Pergolide mesylate (Pergolide methanesulfonate), an Ergoline derivative, is a potent and orally active dopamine D1 and D2 receptors agonist. Pergolide mesylate can be used for Parkinson's disease and hyperprolactinaemia research[1][2].	Mesylate	C20H30N2O3S2	33415.0	DMSO : ≥ 25 mg/mL (60.89 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	[H][C@@]1(N(CCC)C[C@H](CSC)C[C@@]12[H])CC3=CNC4=CC=CC2=C43.CS(=O)(O)=O	https://www.medchemexpress.com/pergolide-mesylate.html	Launched		92.0	W26	I9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13720A	10.0	mM	201.0	DMSO	314.18167	9	I	pluskal_fda_drugs_5005_I9_id
1937	HY-129650	HYCPK40907	A18	HYCPK40907	92z	36.0	2.0	A36	907.0	A18	938435-69-9	Flobetapir	AV-45	360.42	Others	Others	Flobetapir (AV-45) may be a well-tolerated imaging agent. Flobetapir synthesizes Florbetapir (18F) that is a PET scanning radiopharmaceutical compound containing the radionuclide fluorine-18[1].		C20H25FN2O3	113787.0	DMSO : 100 mg/mL (277.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CNC1=CC=C(/C=C/C2=CC=C(OCCOCCOCCF)N=C2)C=C1	https://www.medchemexpress.com/flobetapir.html	Launched		92.0	A36	I9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-129650	10.0	mM	201.0	DMSO	360.184921	9	I	pluskal_fda_drugs_5005_I9_id
2049	HY-A0013A	HYCPK40908	J05	HYCPK40908	92z	921.0	3.0	T9	908.0	J05	157212-55-0	Bosentan (hydrate)		569.63	Endothelin Receptor	GPCR/G Protein	Bosentan hydrate is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.	Free Base	C27H31N5O7S	8594.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (175.55 mM); Ethanol : 50 mg/mL (87.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=S(NC1=NC(C2=NC=CC=N2)=NC(OCCO)=C1OC3=CC=CC=C3OC)(C4=CC=C(C(C)(C)C)C=C4)=O.O	https://www.medchemexpress.com/Bosentan-hydrate.html	Launched		92.0	T9	I9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0013A	10.0	mM	201.0	DMSO	551.183855	9	I	pluskal_fda_drugs_5005_I9_id
23	HY-12432	HYCPK40899	A03	HYCPK40909	92z	76.0	4.0	B28	909.0	A14	1254053-43-4	Gilteritinib	ASP2215	552.71	FLT3; TAM Receptor	Protein Tyrosine Kinase/RTK	Gilteritinib (ASP2215) is a potent and ATP-competitive FLT3/AXL inhibitor with IC50s of 0.29 nM/0.73 nM, respectively.	Free Base	C29H44N8O3	18817.0	DMSO : 2 mg/mL (3.62 mM; Need ultrasonic); Ethanol : 100 mg/mL (180.93 mM; ultrasonic and adjust pH to 2 with HCl)	DMSO Solution	2mM  * 100uL	Cancer	NC(C1=NC(CC)=C(NC2CCOCC2)N=C1NC3=CC(OC)=C(N4CCC(N5CCN(C)CC5)CC4)C=C3)=O	https://www.medchemexpress.com/Gilteritinib.html	Launched		92.0	B28	I10	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12432	2.0	mM	202.0	DMSO	552.353637	10	I	pluskal_fda_drugs_5005_I10_id
1663	HY-B1408	HYCPK40906	B20	HYCPK40906	92z	135.0	1.0	C39	906.0	B20	87-17-2	Salicylanilide	2-Hydroxybenzanilide	213.23	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	"Salicylanilide demonstrates a wide range of biological activities including antiviral potency which can inhibit HIV virus
by targeting HIV-1 integrase or reverse transcriptase."	Free Base	C13H11NO2	26924.0	DMSO : 170 mg/mL (797.26 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	O=C(NC1=CC=CC=C1)C2=CC=CC=C2O	https://www.medchemexpress.com/Salicylanilide.html	Launched		92.0	C39	I10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1408	10.0	mM	202.0	DMSO	213.078979	10	I	pluskal_fda_drugs_5005_I10_id
1716	HY-14946	HYCPK40907	G03	HYCPK40907	92z	582.0	2.0	M6	907.0	G03	54-96-6	Amifampridine	3,4-Diaminopyridine	109.13	Potassium Channel	Membrane Transporter/Ion Channel	"Amifampridine (3,4-Diaminopyridine) is an orally active, potent and cell permeable voltage-gated potassium (Kv) channel blocker (PCB). Amifampridine is efficacy in the reversal of <a href=""/BoNT/A.html"" class=""link-product"" target=""_blank"">BoNT/A</a> (HY-P79153) intoxication. Amifampridine increases transmitter release from neuromuscular junctions (NMJs). Amifampridine can be used for Lambert-Eaton myasthenic syndrome (LEMS) research[1][2][3]."	Free Base	C5H7N3	14538.0	DMSO : ≥ 38 mg/mL (348.21 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC1=C(N)C=CN=C1	https://www.medchemexpress.com/Amifampridine.html	Launched		92.0	M6	I10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14946	10.0	mM	202.0	DMSO	109.063997	10	I	pluskal_fda_drugs_5005_I10_id
2159	HY-A0006	HYCPK40908	L12	HYCPK40908	92z	1127.0	3.0	X23	908.0	L12	53910-25-1	Pentostatin	CI-825; Deoxycoformycin	268.27	Adenosine Deaminase; Antibiotic	Anti-infection; Metabolic Enzyme/Protease	Pentostatin (CI-825; Deoxycoformycin) is an irreversible inhibitor of adenosine deaminase with Ki of 2.5 pM.	Free Base	C11H16N4O4	83523.0	H2O : 100 mg/mL (372.76 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (186.38 mM)	DMSO Solution	10mM  * 100uL	Cancer	O[C@H]1C(N=CN2[C@H](O[C@@H]3CO)C[C@@H]3O)=C2NC=NC1	https://www.medchemexpress.com/Pentostatin.html	Launched		92.0	X23	I10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0006	10.0	mM	202.0	DMSO	268.117155	10	I	pluskal_fda_drugs_5005_I10_id
2414	HY-17463	HYCPK40908	J22	HYCPK40908	92z	955.0	3.0	T43	908.0	J22	50-24-8	Prednisolone		360.44	Endogenous Metabolite; Glucocorticoid Receptor	Immunology/Inflammation; Metabolic Enzyme/Protease	Prednisolone is a potent, orally active corticosteroid and a glucocorticoid. Prednisolone possesses about four times the anti-inflammatory activity of hydrocortisone while causing less salt and water retention. Prednisolone can be used for ocular, anti-inflammatory research[1][2].	Free Base	C21H28O5	15184.0	H2O : 0.1 mg/mL (0.28 mM; Need ultrasonic); DMSO : 62.5 mg/mL (173.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	C[C@@]1([C@@]2(O)C(CO)=O)[C@](CC2)([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@@H](O)C1	https://www.medchemexpress.com/Prednisolone.html	Launched		92.0	T43	I10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17463	10.0	mM	202.0	DMSO	360.193674	10	I	pluskal_fda_drugs_5005_I10_id
2439	HY-12215	HYCPK40909	C04	HYCPK40909	92z	248.0	4.0	F8	909.0	C04	1454846-35-5	Lorlatinib	PF-06463922	406.41	Anaplastic lymphoma kinase (ALK); Apoptosis; ROS Kinase	Apoptosis; Protein Tyrosine Kinase/RTK	Lorlatinib (PF-06463922) is a selective, orally active, brain-penetrant and ATP-competitive ROS1/ALK inhibitor. Lorlatinib has Kis of <0.025 nM, <0.07 nM, and 0.7 nM for ROS1, wild type ALK, and ALKL1196M, respectively. Lorlatinib has anticancer activity[1][2].	Free Base	C21H19FN6O2	158457.0	DMSO : ≥ 28 mg/mL (68.90 mM)	DMSO Solution	10mM  * 100uL	Cancer	CN1C(C#N)=C2C(CN(C)C(C3=C([C@@H](C)OC4=C(N)N=CC2=C4)C=C(F)C=C3)=O)=N1	https://www.medchemexpress.com/PF-06463922.html	Launched		92.0	F8	I10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12215	10.0	mM	202.0	DMSO	406.155352	10	I	pluskal_fda_drugs_5005_I10_id
2446	HY-14447	HYCPK40909	J04	HYCPK40909	92z	920.0	4.0	T8	909.0	J04	202189-78-4	Bilastine		463.61	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	"Bilastine is a selective histamine H1 receptor antagonist used for treatment of allergic rhinoconjunctivitis and urticaria. 
Target: Histamine H1 Receptor
Bilastine binds to histamine H1-receptors as indicated by its displacement of [3H]-pyrilamine from H1-receptors expressed in guinea-pig cerebellum and human embryonic kidney (HEK) cell lines. The studies conducted on guinea-pig smooth muscle demonstrated the capability of bilastine to antagonise H1-receptors. Bilastine is selective for histamine H1-receptors as shown in receptor-binding screening conducted to determine the binding capacity of bilastine to 30 different receptors [1]. Bilastine distribution has an apparent volume of distribution of 1.29 L/kg, and has an elimination half-life of 14.5 h and plasma protein binding of 84-90% [2]."	Free Acid	C28H37N3O3	120225.0	DMSO : 10 mg/mL (21.57 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	CC(C)(C1=CC=C(CCN2CCC(C3=NC4=CC=CC=C4N3CCOCC)CC2)C=C1)C(O)=O	https://www.medchemexpress.com/Bilastine.html	Launched		92.0	T8	I10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14447	10.0	mM	202.0	DMSO	463.283492	10	I	pluskal_fda_drugs_5005_I10_id
2449	HY-10572	HYCPK40909	M04	HYCPK40909	92z	1208.0	4.0	Z8	909.0	M04	154598-52-4	Efavirenz	DMP 266; EFV; L-743726	315.68	Autophagy; Endogenous Metabolite; HIV; Parasite; Reverse Transcriptase	Anti-infection; Autophagy; Metabolic Enzyme/Protease	Efavirenz (DMP 266) is a potent inhibitor of the wild-type HIV-1 reverse transcriptase with a Ki of 2.93 nM and exhibits an IC95 of 1.5 nM for the inhibition of HIV-1 replicative spread in cell culture[1].	Free Base	C14H9ClF3NO2	141377.0	DMSO : ≥ 38 mg/mL (120.38 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	ClC1=CC=C(NC(O[C@]2(C#CC3CC3)C(F)(F)F)=O)C2=C1	https://www.medchemexpress.com/Efavirenz.html	Launched		92.0	Z8	I10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10572	10.0	mM	202.0	DMSO	315.027391	10	I	pluskal_fda_drugs_5005_I10_id
1	HY-B2234	HYCPK40897	A03	HYCPK40909	92z	84.0	4.0	B36	909.0	A18	25655-41-8	Povidone iodine	iodopovidone		Bacterial	Anti-infection	Povidone iodine (iodopovidone) displays excellent antibacterial activity which can against MRSA and MSSA strains with MICs of 31.25 mg/L and 7.82 mg/L, respectively.	Free Base		26463.0	H2O : 2.4 mg/mL (Need ultrasonic); DMSO : 15 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Infection	O=C1N(C(C)CC)CCC1.I[F,Cl,Br,I]I.[n].[n:x].[=].[10:1]	https://www.medchemexpress.com/Povidone_iodine.html	Launched		92.0	B36	I11	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2234	3.0	mM	203.0	DMSO	111.068414	11	I	pluskal_fda_drugs_5005_I11_id
24	HY-12432A	HYCPK40899	B03	HYCPK40909	92z	172.0	4.0	D28	909.0	B14	1254053-84-3	Gilteritinib hemifumarate	ASP2215 hemifumarate	610.75	FLT3; TAM Receptor	Protein Tyrosine Kinase/RTK	Gilteritinib (ASP2215) hemifumarate is a potent and ATP-competitive FLT3/AXL inhibitor with IC50 of 0.29 nM/0.73 nM,  respectively.	Fumarate	C29H44N8O3 0.5C4H4O4	146098.0	H2O : 2 mg/mL (3.27 mM; Need ultrasonic); DMSO : 1.74 mg/mL (2.85 mM; Need ultrasonic and warming); Ethanol : 2 mg/mL (3.27 mM; ultrasonic and warming and adjust pH to 3 with 1M HCl and heat to 60°C)	DMSO Solution	2mM  * 100uL	Cancer	OC(/C=C/C(O)=O)=O.NC(C1=NC(CC)=C(NC2CCOCC2)N=C1NC3=CC(OC)=C(N4CCC(N5CCN(C)CC5)CC4)C=C3)=O.[0.5]	https://www.medchemexpress.com/Gilteritinib_hemifumarate.html	Launched		92.0	D28	I11	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12432A	2.0	mM	203.0	DMSO	552.353637	11	I	pluskal_fda_drugs_5005_I11_id
1377	HY-13749A	HYCPK40906	N03	HYCPK40906	92z	1253.0	1.0	AA5	906.0	N03	654671-78-0	Sitagliptin (phosphate)	MK-0431 (phosphate)	505.31	Autophagy; Dipeptidyl Peptidase	Autophagy; Metabolic Enzyme/Protease	Sitagliptin phosphate (MK-0431 phosphate) is a potent inhibitor of DPP4 with an IC50 of 19 nM in Caco-2 cell extracts[1].	Phosphate	C16H18F6N5O5P	98879.0	H2O : 50 mg/mL (98.95 mM; Need ultrasonic); DMSO : 100 mg/mL (197.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(N1CC2=NN=C(C(F)(F)F)N2CC1)C[C@H](N)CC3=CC(F)=C(F)C=C3F.O=P(O)(O)O	https://www.medchemexpress.com/sitagliptin-phosphate.html	Launched		92.0	AA5	I11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13749A	10.0	mM	203.0	DMSO	407.118079	11	I	pluskal_fda_drugs_5005_I11_id
1662	HY-B1597	HYCPK40906	A20	HYCPK40906	92z	39.0	1.0	A39	906.0	A20	122-18-9	Cetalkonium (chloride)	Benzyldimethylhexadecylammonium (chloride)	396.09	Bacterial	Anti-infection	Cetalkonium chloride is an ammonium antiseptic agent used in many topical drugs for infections of mouth, throat and eye. Cetalkonium chloride acts as anti-inflammatory amphiphilic agent[1].	Chloride	C25H46ClN	67984.0	DMSO : 100 mg/mL (252.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	C[N+](C)(CCCCCCCCCCCCCCCC)CC1=CC=CC=C1.[Cl-]	https://www.medchemexpress.com/cetalkonium-chloride.html	Launched		92.0	A39	I11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1597	10.0	mM	203.0	DMSO	360.362477	11	I	pluskal_fda_drugs_5005_I11_id
1831	HY-10201	HYCPK40907	O10	HYCPK40907	92z	1364.0	2.0	AC20	907.0	O10	284461-73-0	Sorafenib	Bay 43-9006	464.83	Apoptosis; Autophagy; Ferroptosis; FLT3; Raf; VEGFR	Apoptosis; Autophagy; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK	Sorafenib (Bay 43-9006) is a potent and orally active Raf inhibitor with IC50s of 6 nM and 20 nM for Raf-1 and B-Raf, respectively. Sorafenib is a multikinase inhibitor with IC50s of 90 nM, 15 nM, 20 nM, 57 nM and 58 nM for VEGFR2, VEGFR3, PDGFRβ, FLT3 and c-Kit, respectively. Sorafenib induces autophagy and apoptosis. Sorafenib has anti-tumor activity. Sorafenib is a ferroptosis activator[1].	Free Base	C21H16ClF3N4O3	83807.0	DMSO : ≥ 45 mg/mL (96.81 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC(C=C1)=CC=C1OC2=CC(C(NC)=O)=NC=C2)NC3=CC=C(Cl)C(C(F)(F)F)=C3	https://www.medchemexpress.com/Sorafenib.html	Launched		92.0	AC20	I11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10201	10.0	mM	203.0	DMSO	464.086303	11	I	pluskal_fda_drugs_5005_I11_id
1842	HY-17455	HYCPK40907	J11	HYCPK40907	92z	886.0	2.0	S22	907.0	J11	68497-62-1	Pramiracetam		269.38	Others	Others	"Pramiracetam is a nootropic drug derived from piracetam, and is more potent. Pramiracetam reportedly improved cognitive deficits associated with traumatic brain injuries. 
IC50 Value: 
Target: 
in vitro: Pramiracetam sulfate did not exhibit any affinity in vitro for dopaminergic , GABAergic, serotoninergic, adrenergic, muscarinic, adenosine (IC50 > 10 uM), and benzodiazepine receptors (IC50 > 1 uM) binding sites [1].
in vivo: In a double-blind, randomized design, two groups of six subjects each received alternating placebo and single 400, 800, 1,200, and 1,600 mg oral doses of pramiracetam after an overnight fast. Mean (+/- SD) peak plasma concentrations of the four dose groups (2.71 +/- 0.54, 5.40 +/- 1.34, 6.13 +/- 0.71, 8.98 +/- 0.71 micrograms/mL) were attained between two to three hours following drug administration [2].  Two doses of pramiracetam (7.5 mg/kg and 15 mg/kg) were administered daily prior to testing for 7 weeks in a 16-arm radial maze in which nine arms were baited with food [3]."	Free Base	C14H27N3O2	11051.0	H2O : ≥ 100 mg/mL (371.22 mM); DMSO : ≥ 100 mg/mL (371.22 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NCCN(C(C)C)C(C)C)CN1C(CCC1)=O	https://www.medchemexpress.com/pramiracetam.html	Launched		92.0	S22	I11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17455	10.0	mM	203.0	DMSO	269.210327	11	I	pluskal_fda_drugs_5005_I11_id
2409	HY-B0274	HYCPK40908	E22	HYCPK40908	92z	475.0	3.0	J43	908.0	E22	113-59-7	Chlorprothixene		315.86	Bacterial; Dopamine Receptor; Histamine Receptor	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Chlorprothixene is a dopamine and histamine receptors antagonist with Kis of 18 nM, 2.96 nM, 4.56 nM, 9 nM and 3.75 nM for hD1, hD2, hD3, hD5 and hH1 receptors, respectively. Antipsychotic activity[1].	Free Base	C18H18ClNS	16505.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 33.33 mg/mL (105.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN(C)CC/C=C1C2=C(SC3=C\1C=CC=C3)C=CC(Cl)=C2	https://www.medchemexpress.com/chlorprothixene.html	Launched		92.0	J43	I11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0274	10.0	mM	203.0	DMSO	315.084848	11	I	pluskal_fda_drugs_5005_I11_id
2475	HY-B1347	HYCPK40909	G06	HYCPK40909	92z	636.0	4.0	N12	909.0	G06	6933-90-0	Clorprenaline hydrochloride		250.16	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Clorprenaline hydrochloride is a β2-adrenergic receptor agonist that is implicated in bronchial expansion. Clorprenaline has the potential for asthma research[1][2].	Hydrochloride	C11H17Cl2NO	27076.0	DMSO : 100 mg/mL (399.74 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (399.74 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	OC(CNC(C)C)C1=CC=CC=C1Cl.[H]Cl	https://www.medchemexpress.com/Clorprenaline_hydrochloride.html	Launched		92.0	N12	I11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1347	10.0	mM	203.0	DMSO	213.092042	11	I	pluskal_fda_drugs_5005_I11_id
1447	HY-14881	HYCPK40907	I14	HYCPK40907	92z	796.0	2.0	Q28	907.0	I14	843663-66-1	Bedaquiline	TMC207; R207910	555.50	Antibiotic; Bacterial	Anti-infection	Bedaquiline (TMC207) is a diarylquinoline drug and inhibits Mycobacterium tuberculosis (Mtb) F1FO-ATP synthase through targeting of both the c- and the ε-subunit[1]. Bedaquiline has uncoupler activity. Bedaquiline is used for the multi-drug resistant tuberculosis[2].	Free Base	C32H31BrN2O2	13794.0	DMSO : 12.5 mg/mL (22.50 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	BrC1=CC=C(N=C(OC)C([C@H]([C@@](C2=CC=CC3=C2C=CC=C3)(O)CCN(C)C)C4=CC=CC=C4)=C5)C5=C1	https://www.medchemexpress.com/Bedaquiline.html	Launched		92.0	Q28	I12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14881	10.0	mM	204.0	DMSO	554.15689	12	I	pluskal_fda_drugs_5005_I12_id
1514	HY-B0333	HYCPK40906	M10	HYCPK40906	92z	1171.0	1.0	Y19	906.0	M10	144-82-1	Sulfamethizole		270.33	Antibiotic; Bacterial	Anti-infection	"Sulfamethizole is a sulfathiazole antibacterial agent.
Target: Antibacterial
Sulfamethizole is a sulfathiazole antibacterial agent. Sulfamethizole is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. The inhibited reaction is necessary in these organisms for the synthesis of folic acid. Sulfamethizole, an inhibitor of dihydropteroate synthetase and the formation of folic acid, inhibited bioluminescence more than growth [1]. Treatment with sulfamethizole resulted in a significant reduction in bacterial counts in all samples from a susceptible strain (MIC, 128 micro g/ml) and a resistant strain (MIC, 512 micro g/ml). Infection with a sulII gene-positive strain (MIC, >2,048 micro g/ml) could not be treated with sulfamethizole, as no effect could be demonstrated in the urine, bladder, or kidneys [2]."	Free Base	C9H10N4O2S2	17146.0	DMSO : ≥ 100 mg/mL (369.92 mM); H2O : 0.67 mg/mL (2.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NN=C(C)S2)=O	https://www.medchemexpress.com/sulfamethizole.html	Launched		92.0	Y19	I12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0333	10.0	mM	204.0	DMSO	270.024518	12	I	pluskal_fda_drugs_5005_I12_id
1554	HY-A0007	HYCPK40906	E13	HYCPK40906	92z	409.0	1.0	I25	906.0	E13	125572-93-2	Rotigotine (Hydrochloride)	N-0923 (Hydrochloride)	351.93	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Rotigotine Hydrochloride (N-0923 Hydrochloride) is a full agonist of dopamine receptor, a partial agonist of the 5-HT1A receptor, and an antagonist of the α2B-adrenergic receptor, with Ki of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors, and dopamine D1 receptor.	Hydrochloride	C19H26ClNOS	8252.0	H2O : 4.76 mg/mL (13.53 mM; ultrasonic and warming and heat to 60°C); DMSO : ≥ 50 mg/mL (142.07 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC1=C2CC[C@@H](CC2=CC=C1)N(CCC3=CC=CS3)CCC.[H]Cl	https://www.medchemexpress.com/Rotigotine-Hydrochloride.html	Launched		92.0	I25	I12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0007	10.0	mM	204.0	DMSO	315.165685	12	I	pluskal_fda_drugs_5005_I12_id
1799	HY-17600	HYCPK40907	O08	HYCPK40907	92z	1360.0	2.0	AC16	907.0	O08	1420477-60-6	Acalabrutinib	ACP-196	465.51	Btk	Protein Tyrosine Kinase/RTK	Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor. Acalabrutinib binds covalently to Cys481 in the ATP-binding pocket of BTK. Acalabrutinib demonstrates potent on-target effects and efficacy in mouse models of chronic lymphocytic leukemia (CLL)[1][2].	Free Base	C26H23N7O2	116345.0	DMSO : 250 mg/mL (537.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=NC=CC=C1)C2=CC=C(C3=C4C(N)=NC=CN4C([C@H]5N(C(C#CC)=O)CCC5)=N3)C=C2	https://www.medchemexpress.com/Acalabrutinib.html	Launched		92.0	AC16	I12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17600	10.0	mM	204.0	DMSO	465.191323	12	I	pluskal_fda_drugs_5005_I12_id
2005	HY-B0557	HYCPK40907	I22	HYCPK40907	92z	812.0	2.0	Q44	907.0	I22	603-50-9	Bisacodyl		361.39	Dopamine Transporter; Opioid Receptor	GPCR/G Protein; Neuronal Signaling	Bisacodyl is a stimulant laxative agent that works directly on the colon to produce a bowel movement. Bisacodyl increases the secretion of PGE2 by direct activation of colon macrophages. PGE2 acts as a paracrine factor and decreases the expression of AQP3 in the colon, which inhibits water transfer from the luminal to the vascular side and leads to a laxative effect[1].	Free Base	C22H19NO4	14424.0	H2O : 0.1 mg/mL (0.28 mM; Need ultrasonic); DMSO : 50 mg/mL (138.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	CC(OC1=CC=C(C(C2=CC=C(OC(C)=O)C=C2)C3=NC=CC=C3)C=C1)=O	https://www.medchemexpress.com/Bisacodyl.html	Launched		92.0	Q44	I12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0557	10.0	mM	204.0	DMSO	361.131408	12	I	pluskal_fda_drugs_5005_I12_id
2133	HY-B1557	HYCPK40908	N10	HYCPK40908	92z	1315.0	3.0	AB19	908.0	N10	105-20-4	Betazole	Ametazole	111.15	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Betazole (Ametazole), a pyrazole analogue of histamine, is an orally active histamine H2 receptor agonist. Betazole induces gastric acid secretion and causes an immediate and significant increase in common bile duct pressure. Betazole is used as a diagnostic agent known as histalog for investigating gastric acid secretory capacity[1][2][3].		C5H9N3	89584.0	DMSO : 250 mg/mL (2249.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	NCCC1=NNC=C1	https://www.medchemexpress.com/betazole.html	Launched		92.0	AB19	I12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1557	10.0	mM	204.0	DMSO	111.079647	12	I	pluskal_fda_drugs_5005_I12_id
2271	HY-B0985	HYCPK40908	P19	HYCPK40908	92z	1525.0	3.0	AF37	908.0	P19	136-40-3	Phenazopyridine (hydrochloride)		249.70	Others	Others	Phenazopyridine hydrochloride is a chemical, which has a local analgesic effect, often used to alleviate the pain, irritation, discomfort, or urgency caused by urinary tract infections, surgery, or injury to the urinary tract.	Hydrochloride	C11H12ClN5	17276.0	DMSO : 25 mg/mL (100.12 mM; Need ultrasonic); H2O : 1 mg/mL (4.00 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Others	NC1=NC(N)=CC=C1/N=N/C2=CC=CC=C2.[H]Cl	https://www.medchemexpress.com/Phenazopyridine-hydrochloride.html	Launched		92.0	AF37	I12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0985	10.0	mM	204.0	DMSO	213.101445	12	I	pluskal_fda_drugs_5005_I12_id
2467	HY-13749	HYCPK40909	O05	HYCPK40909	92z	1402.0	4.0	AD10	909.0	O05	486460-32-6	Sitagliptin	MK-0431	407.31	Autophagy; Dipeptidyl Peptidase	Autophagy; Metabolic Enzyme/Protease	Sitagliptin (MK-0431) is a potent inhibitor of DPP4 with an IC50 of 19 nM in Caco-2 cell extracts[1].	Free Base	C16H15F6N5O	12715.0	DMSO : ≥ 50 mg/mL (122.76 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(N1CC2=NN=C(C(F)(F)F)N2CC1)C[C@H](N)CC3=CC(F)=C(F)C=C3F	https://www.medchemexpress.com/Sitagliptin.html	Launched		92.0	AD10	I12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13749	10.0	mM	204.0	DMSO	407.118079	12	I	pluskal_fda_drugs_5005_I12_id
1422	HY-B0330A	HYCPK40906	K06	HYCPK40906	92z	971.0	1.0	U11	906.0	K06	138199-71-0	Levofloxacin (hydrate)	Levofloxacin hemihydrate	370.38	Antibiotic; Bacterial; DNA/RNA Synthesis; Orthopoxvirus; Topoisomerase	Anti-infection; Cell Cycle/DNA Damage	Levofloxacin hydrate (Levofloxacin hemihydrate) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrate inhibits the DNA gyrase and topoisomerase IV.  Levofloxacin hydrate can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin hydrate shows anti-orthopoxvirus activity[1][2][3][4][5].	Free Acid	C18H20FN3O4.1/2H2O	38503.0	DMSO : 8.33 mg/mL (22.49 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (135.00 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(C1=O)=CN2[C@@H](C)COC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O.[0.5H2O]	https://www.medchemexpress.com/Levofloxacin-hydrate.html	Launched		92.0	U11	I13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0330A	10.0	mM	205.0	DMSO	361.143784	13	I	pluskal_fda_drugs_5005_I13_id
1738	HY-16973	HYCPK40907	B05	HYCPK40907	92z	106.0	2.0	C10	907.0	B05	864731-61-3	Fluralaner	A1443; AH252723	556.29	Parasite	Anti-infection	Fluralaner (INN) is a systemic insecticide and acaricide Fluralaner through potent blockage of GABA and L-glutamate gated chloride channels.	Free Base	C22H17Cl2F6N3O3	120684.0	DMSO : 200 mg/mL (359.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(NCC(NCC(F)(F)F)=O)C1=CC=C(C2=NOC(C(F)(F)F)(C3=CC(Cl)=CC(Cl)=C3)C2)C=C1C	https://www.medchemexpress.com/Fluralaner.html	Launched		92.0	C10	I13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16973	10.0	mM	205.0	DMSO	555.055116	13	I	pluskal_fda_drugs_5005_I13_id
1915	HY-B1415	HYCPK40907	K16	HYCPK40907	92z	992.0	2.0	U32	907.0	K16	882-09-7	Clofibric acid	Chlorofibrinic acid	214.65	Drug Metabolite; PPAR	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Clofibric acid (Chlorofibrinic acid), the pharmaceutically active metabolite of lipid regulators Clofibrate, Etofibrate and Etofyllinclofibrate, is a PPARα agonist which exhibits hypolipidemic effects. Clofibric acid also is an herbicide[1][2][3].	Free Acid	C10H11ClO3	17359.0	DMSO : ≥ 100 mg/mL (465.87 mM); H2O : 1 mg/mL (4.66 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Others	CC(C)(OC1=CC=C(Cl)C=C1)C(O)=O	https://www.medchemexpress.com/Clofibric-acid.html	Launched		92.0	U32	I13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1415	10.0	mM	205.0	DMSO	214.039672	13	I	pluskal_fda_drugs_5005_I13_id
1955	HY-19915	HYCPK40907	C19	HYCPK40907	92z	230.0	2.0	E38	907.0	C19	1112968-42-9	Contezolid	MRX-I	408.33	Antibiotic; Bacterial; Monoamine Oxidase	Anti-infection; Neuronal Signaling	Contezolid (MRX-I), a new and orally active oxazolidinone, is an antibiotic in study for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria. Contezolid (MRX-I) markedly reduces potential for myelosuppression and monoamine oxidase inhibition (MAOI)[1][2].		C18H15F3N4O4	119417.0	DMSO : 120 mg/mL (293.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C1CCN(C2=C(F)C=C(N3C(O[C@@H](CNC4=NOC=C4)C3)=O)C(F)=C2F)C=C1	https://www.medchemexpress.com/contezolid.html	Launched		92.0	E38	I13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19915	10.0	mM	205.0	DMSO	408.10454	13	I	pluskal_fda_drugs_5005_I13_id
2163	HY-100471	HYCPK40908	P12	HYCPK40908	92z	1511.0	3.0	AF23	908.0	P12	1632006-28-0	Esaxerenone	CS-3150; XL-550	466.47	Mineralocorticoid Receptor	Metabolic Enzyme/Protease	Esaxerenone (CS-3150) is a highly potent and selective non-steroidal mineralocorticoid receptor antagonist[1].	Free Base	C22H21F3N2O4S	27163.0	DMSO : 100 mg/mL (214.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CN(CCO)C(C2=CC=CC=C2C(F)(F)F)=C1C)NC3=CC=C(S(=O)(C)=O)C=C3	https://www.medchemexpress.com/Esaxerenone.html	Launched		92.0	AF23	I13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100471	10.0	mM	205.0	DMSO	466.117413	13	I	pluskal_fda_drugs_5005_I13_id
2175	HY-N0196	HYCPK40908	L13	HYCPK40908	92z	1129.0	3.0	X25	908.0	L13	491-67-8	Baicalein	5,6,7-Trihydroxyflavone	270.24	Ferroptosis; Influenza Virus; Xanthine Oxidase	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Baicalein (5,6,7-Trihydroxyflavone) is a xanthine oxidase inhibitor with an IC50 value of 3.12 μM.	Free Base	C15H10O5	24282.0	DMSO : 50 mg/mL (185.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C=C(C2=CC=CC=C2)OC3=CC(O)=C(O)C(O)=C13	https://www.medchemexpress.com/Baicalein.html	Launched		92.0	X25	I13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0196	10.0	mM	205.0	DMSO	270.052823	13	I	pluskal_fda_drugs_5005_I13_id
2304	HY-A0129	HYCPK40909	D07	HYCPK40909	92z	350.0	4.0	H14	909.0	D07	51-74-1	Histamine (phosphate)	Histamine diphosphate	307.14	Endogenous Metabolite; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Histamine (phosphate) diphosphate is a potent agonist of histamine receptors and vasodilator. It can activate nitric oxide synthetase.	Phosphate	C5H15N3O8P2	21502.0	DMSO : 1.43 mg/mL (4.66 mM; Need ultrasonic); H2O : 100 mg/mL (325.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology; Cancer	NCCC1=CNC=N1.O=P(O)(O)O.O=P(O)(O)O	https://www.medchemexpress.com/Histamine-phosphate.html	Launched		92.0	H14	I13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0129	10.0	mM	205.0	DMSO	111.079647	13	I	pluskal_fda_drugs_5005_I13_id
2411	HY-A0125A	HYCPK40908	G22	HYCPK40908	92z	667.0	3.0	N43	908.0	G22	59338-87-3	Alizapride (hydrochloride)		351.83	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Alizapride is a potent antiemetic, acting as a dopamine receptor antagonist. Alizapride also used in human digestive disorders[1][3].	Hydrochloride	C16H22ClN5O2	28522.0	DMSO : 33.33 mg/mL (94.73 mM; Need ultrasonic); H2O : 100 mg/mL (284.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C(C1=C(OC)C=C(NN=N2)C2=C1)NCC3N(CC=C)CCC3.Cl[H]	https://www.medchemexpress.com/Alizapride_hydrochloride.html	Launched		92.0	N43	I13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0125A	10.0	mM	205.0	DMSO	315.169525	13	I	pluskal_fda_drugs_5005_I13_id
1643	HY-B0083	HYCPK40906	N18	HYCPK40906	92z	1283.0	1.0	AA35	906.0	N18	75706-12-6	Leflunomide	HWA486; RS-34821; SU101	270.21	Bacterial; Dihydroorotate Dehydrogenase; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Leflunomide is a pyrimidine synthesis inhibitor, inhibiting dihydroorotate dehydrogenase (DHODH), and acts as a disease-modifying antirheumatic drug.	Free Base	C12H9F3N2O2	11752.0	DMSO : ≥ 50 mg/mL (185.04 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(C)ON=C1)NC2=CC=C(C(F)(F)F)C=C2	https://www.medchemexpress.com/leflunomide.html	Launched		92.0	AA35	I14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0083	10.0	mM	206.0	DMSO	270.061612	14	I	pluskal_fda_drugs_5005_I14_id
1711	HY-B1267	HYCPK40907	B03	HYCPK40907	92z	102.0	2.0	C6	907.0	B03	57-67-0	Sulfaguanidine		214.24	Antibiotic; Bacterial	Anti-infection	Sulfaguanidine is an orally active antimicrobial agent/antibiotic of sulfonamide class. Sulfaguanidine can be used for the research of enteric infections such as bacillary dysentery[1][2].	Free Base	C7H10N4O2S	17275.0	DMSO : 100 mg/mL (466.77 mM; Need ultrasonic); H2O : 3.33 mg/mL (15.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC(N)=N)=O	https://www.medchemexpress.com/Sulfaguanidine.html	Launched		92.0	C6	I14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1267	10.0	mM	206.0	DMSO	214.052447	14	I	pluskal_fda_drugs_5005_I14_id
1795	HY-17398	HYCPK40907	K08	HYCPK40907	92z	976.0	2.0	U16	907.0	K08	145525-41-3	Mitiglinide (calcium)	KAD-1229 (anhydrous); S21403 (anhydrous)	334.44	Potassium Channel	Membrane Transporter/Ion Channel	Mitiglinide Calcium (KAD-1229 anhydrous), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide Calcium is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide Calcium can be used for the research of type 2 diabetes[1][2].	Calcium	C19H24NO3.1/2Ca	9713.0	DMSO : 5 mg/mL (14.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C([O-])[C@H](CC(N1C[C@](CCCC2)([H])[C@]2([H])C1)=O)CC3=CC=CC=C3.[0.5Ca2+]	https://www.medchemexpress.com/Mitiglinide-Calcium.html	Launched		92.0	U16	I14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17398	10.0	mM	206.0	DMSO	315.183444	14	I	pluskal_fda_drugs_5005_I14_id
2003	HY-A0230A	HYCPK40907	G22	HYCPK40907	92z	620.0	2.0	M44	907.0	G22	94841-17-5	Spirapril (hydrochloride)	SCH 33844 (hydrochloride)	503.07	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Spirapril (SCH 33844) hydrochloride is a potent angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Spirapril competitively binds to ACE and prevents the conversion of angiotensin I to angiotensin II. Spirapril is an orally active prodrug of Spiraprilat and can be used for the research of hypertension, congestive heart failure[1].	Hydrochloride	C22H31ClN2O5S2	154535.0	DMSO : 100 mg/mL (198.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C([C@H](C1)N(C([C@@H](N[C@H](C(OCC)=O)CCC2=CC=CC=C2)C)=O)CC31SCCS3)O.[H]Cl	https://www.medchemexpress.com/spirapril-hydrochloride.html	Launched		92.0	M44	I14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0230A	10.0	mM	206.0	DMSO	466.159614	14	I	pluskal_fda_drugs_5005_I14_id
2016	HY-B0722	HYCPK40908	D03	HYCPK40908	92z	341.0	3.0	H5	908.0	D03	56-92-8	Histamine (dihydrochloride)		184.07	Endogenous Metabolite	Metabolic Enzyme/Protease	Histamine dihydrochloride is an endogenous metabolite.	Hydrochloride	C5H11Cl2N3	61042.0	DMSO : 100 mg/mL (543.27 mM; Need ultrasonic); H2O : 120 mg/mL (651.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	NCCC1=CN=CN1.Cl.Cl	https://www.medchemexpress.com/histamine-dihydrochloride.html	Launched		92.0	H5	I14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0722	10.0	mM	206.0	DMSO	111.079647	14	I	pluskal_fda_drugs_5005_I14_id
2038	HY-10450A	HYCPK40908	J04	HYCPK40908	92z	919.0	3.0	T7	908.0	J04	960404-48-2	Dapagliflozin ((2S)-1,2-propanediol, hydrate)	BMS-512148 (2S)-1,2-propanediol, hydrate	502.98	SGLT	Membrane Transporter/Ion Channel	"Dapagliflozin ((2S)-1,2-propanediol, hydrate)  is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. 
Dapagliflozin ((2S)-1,2-propanediol, hydrate), a new type of drug used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine[1].
Dapagliflozin ((2S)-1,2-propanediol, hydrate)  induces HIF1 expression and attenuates renal IR injury[2]."	Free Base	C24H35ClO9	14117.0	H2O : 2.38 mg/mL (4.73 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (198.82 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O.C[C@H](O)CO.O	https://www.medchemexpress.com/Dapagliflozin-_2S_-1,2-propanediol,-hydrate.html	Launched		92.0	T7	I14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10450A	10.0	mM	206.0	DMSO	408.133966	14	I	pluskal_fda_drugs_5005_I14_id
2130	HY-32721	HYCPK40908	K10	HYCPK40908	92z	1027.0	3.0	V19	908.0	K10	698387-09-6	Neratinib	HKI-272	557.04	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Neratinib (HKI-272) is an orally available, irreversible, highly selective HER2 and EGFR inhibitor with IC50s of 59 nM and 92 nM, respectively[1].	Free Base	C30H29ClN6O3	128116.0	DMSO : 13.33 mg/mL (23.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	ClC1=C(OCC2=NC=CC=C2)C=CC(NC3=C(C#N)C=NC4=CC(OCC)=C(NC(/C=C/CN(C)C)=O)C=C43)=C1	https://www.medchemexpress.com/Neratinib.html	Launched		92.0	V19	I14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-32721	10.0	mM	206.0	DMSO	556.198966	14	I	pluskal_fda_drugs_5005_I14_id
2406	HY-A0087	HYCPK40908	B22	HYCPK40908	92z	187.0	3.0	D43	908.0	B22	6197-30-4	Octocrylene		361.48	Others	Others	Octocrylene is an organic ultraviolet (UV) filter which absorbs mainly UVB radiation and short UVA wavelengths. Octocrylene has the potential for using in various cosmetic products to either provide an appropriate sun protection factor in sunscreen products or to protect cosmetic formulations from UV radiation[1].	Free Base	C24H27NO2	16467.0	DMSO : ≥ 100 mg/mL (276.64 mM); Ethanol : 50 mg/mL (138.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(OCC(CC)CCCC)/C(C#N)=C(C1=CC=CC=C1)\C2=CC=CC=C2	https://www.medchemexpress.com/Octocrylene.html	Launched		92.0	D43	I14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0087	10.0	mM	206.0	DMSO	361.204179	14	I	pluskal_fda_drugs_5005_I14_id
1405	HY-14865C	HYCPK40906	J05	HYCPK40906	92z	873.0	1.0	S9	906.0	J05	1196800-39-1	Omadacycline (hydrochloride)	PTK0796 hydrochloride; Amadacycline hydrochloride	593.11	Antibiotic; Bacterial	Anti-infection	Omadacycline (PTK 0796) hydrochloride, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline hydrochloride acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline hydrochloride possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline hydrochloride can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections[1][2][3][4].	Hydrochloride	C29H40N4O7.HCl	160563.0	H2O : ≥ 50 mg/mL (84.30 mM); DMSO : 105 mg/mL (177.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=C(O)[C@@H](N(C)C)[C@@](C[C@@]2([H])C(C(C3=C(O)C(CNCC(C)(C)C)=CC(N(C)C)=C3C2)=O)=C4O)([H])[C@@]4(O)C1=O)N.Cl	https://www.medchemexpress.com/Omadacycline__hydrochloride_.html	Launched		92.0	S9	I15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14865C	10.0	mM	207.0	DMSO	556.2897	15	I	pluskal_fda_drugs_5005_I15_id
1614	HY-17358	HYCPK40906	A17	HYCPK40906	92z	33.0	1.0	A33	906.0	A17	82034-46-6	Loteprednol Etabonate		466.95	Antibiotic; Bacterial; Glucocorticoid Receptor	Anti-infection; Immunology/Inflammation	"Loteprednol etabonate (LE) is an orally active ""soft"" steroid belonging to a unique class of glucocorticoids. Loteprednol etabonate (LE) exhibits anti-inflammatory activity and has been used in optometry and ophthalmology[1][2][3]."	Free Base	C24H31ClO7	13498.0	DMSO : 100 mg/mL (214.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Endocrinology; Inflammation/Immunology	O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])CC[C@]4(OC(OCC)=O)C(OCCl)=O)=C1	https://www.medchemexpress.com/Loteprednol-Etabonate.html	Launched		92.0	A33	I15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17358	10.0	mM	207.0	DMSO	466.175831	15	I	pluskal_fda_drugs_5005_I15_id
1848	HY-I0960	HYCPK40907	P11	HYCPK40907	92z	1462.0	2.0	AE22	907.0	P11	66-22-8	Uracil		112.09	Endogenous Metabolite	Metabolic Enzyme/Protease	Uracil is a common and naturally occurring pyrimidine derivative and one of the four nucleobases in the nucleic acid of RNA.	Free Base	C4H4N2O2	85332.0	DMSO : ≥ 25 mg/mL (223.04 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NC(C=CN1)=O	https://www.medchemexpress.com/2,4_1H,3H_-Pyrimidinedione.html	Launched		92.0	AE22	I15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-I0960	10.0	mM	207.0	DMSO	112.027277	15	I	pluskal_fda_drugs_5005_I15_id
1936	HY-B0984	HYCPK40907	P17	HYCPK40907	92z	1474.0	2.0	AE34	907.0	P17	13636-18-5	Fendiline (hydrochloride)		351.91	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Fendiline hydrochloride is a nonselective calcium channel blocker.	Hydrochloride	C23H26ClN	59878.0	DMSO : ≥ 30 mg/mL (85.25 mM); H2O : 1.82 mg/mL (5.17 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC(NCCC(C1=CC=CC=C1)C2=CC=CC=C2)C3=CC=CC=C3.[H]Cl	https://www.medchemexpress.com/Fendiline-hydrochloride.html	Launched		92.0	AE34	I15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0984	10.0	mM	207.0	DMSO	315.1987	15	I	pluskal_fda_drugs_5005_I15_id
1979	HY-30151	HYCPK40907	O20	HYCPK40907	92z	1384.0	2.0	AC40	907.0	O20	298-81-7	Methoxsalen	8-Methoxypsoralen; Xanthotoxin; 8-MOP	216.19	Cytochrome P450	Metabolic Enzyme/Protease	"Methoxsalen (8-Methoxypsoralen) is a potent tricyclic furocoumarin suicide inhibitor of CYP (cytochrome P-450), is an agent used to treat psoriasis, eczema, vitiligo and some cutaneous Lymphomas in conjunction with exposing the skin to sunlight.
Target: CYP (cytochrome P-450)
Methoxsalen is a drug used to treat psoriasis, eczema, vitiligo, and some cutaneous lymphomas in conjunction with exposing the skin to UVA light from lamps or sunlight. Methoxsalen modifies the way skin cells receive the UVA radiation, allegedly clearing up the disease. The dosage comes in 10 mg tablets, which are taken in the amount of 30 mg 75 minutes before a PUVA (psoralen + UVA) light treatment. Chemically, methoxsalen belongs to a class of organic natural molecules known asfuranocoumarins. They consist of coumarin annulated with furan.
Administration of intra peritoneal (ip) methoxsalen significantly increased nicotine's Cmax, prolonged the plasma half-life (fourfold decrease) of nicotine, and increased its area under the curve (AUC) compared with ip vehicle treatment. Methoxsalen pretreatment prolonged the duration of nicotine-induced antinociception and hypothermia (15mg/kg, po) for periods up to 6- and 24-hr postnicotine administration, respectively."	Free Base	C12H8O4	64680.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 100 mg/mL (462.56 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C1OC(C(C=C1)=C2)=C(OC)C3=C2C=CO3	https://www.medchemexpress.com/Methoxsalen.html	Launched		92.0	AC40	I15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-30151	10.0	mM	207.0	DMSO	216.042259	15	I	pluskal_fda_drugs_5005_I15_id
2256	HY-B0317	HYCPK40908	A19	HYCPK40908	92z	85.0	3.0	B37	908.0	A19	88150-42-9	Amlodipine		408.88	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Amlodipine, an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine can be used for the research of high blood pressure and cancer[1][2][3].	Free Base	C20H25ClN2O5	14122.0	DMSO : 31.25 mg/mL (76.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C(C1=C(COCCN)NC(C)=C(C(OC)=O)C1C2=CC=CC=C2Cl)OCC	https://www.medchemexpress.com/Amlodipine.html	Launched		92.0	B37	I15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0317	10.0	mM	207.0	DMSO	408.1452	15	I	pluskal_fda_drugs_5005_I15_id
2489	HY-A0034	HYCPK40909	L07	HYCPK40909	92z	1118.0	4.0	X14	909.0	L07	242478-37-1	Solifenacin	YM905 (free base)	362.46	mAChR	GPCR/G Protein; Neuronal Signaling	Solifenacin (YM905 free base) is a novel muscarinic receptor antagonist with pKis of 7.6, 6.9 and 8.0 for M1, M2 and M3 receptors, respectively.	Free Base	C23H26N2O2	27330.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 50 mg/mL (137.95 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(O[C@@]1([H])C[N@]2CC[C@@H]1CC2)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5	https://www.medchemexpress.com/Solifenacin.html	Launched		92.0	X14	I15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0034	10.0	mM	207.0	DMSO	362.199428	15	I	pluskal_fda_drugs_5005_I15_id
2550	HY-15405	HYCPK40909	I11	HYCPK40909	92z	838.0	4.0	R22	909.0	I11	163451-81-8	Teriflunomide	A77 1726	270.21	Others	Others	Teriflunomide is the active metabolite of leflunomide, an approved therapy for rheumatoid arthritis. It inhibits pyrimidine synthesis and therefore potently decreases T cell and B cell proliferation.	Free Base	C12H9F3N2O2	11527.0	DMSO : 26 mg/mL (96.22 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C/C(O)=C(C#N)/C(NC1=CC=C(C(F)(F)F)C=C1)=O.[(Z)]	https://www.medchemexpress.com/Teriflunomide.html	Launched		92.0	R22	I15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15405	10.0	mM	207.0	DMSO	270.061612	15	I	pluskal_fda_drugs_5005_I15_id
369	HY-N2079	HYCPK40899	L04	HYCPK40909	92z	1134.0	4.0	X30	909.0	L15	5610-40-2	(-)-Securinine		217.26	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	(-)-Securinine is plant-derived alkaloid and also a GABAA receptor antagonist.	Free Base	C13H15NO2	28769.0	DMSO : 2 mg/mL (9.21 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Neurological Disease; Cancer	O=C(O1)C=C2[C@@]13[C@](CCCC4)([H])N4[C@](C3)([H])C=C2	https://www.medchemexpress.com/_-_-Securinine.html	Launched		92.0	X30	I16	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N2079	2.0	mM	208.0	DMSO	217.110279	16	I	pluskal_fda_drugs_5005_I16_id
1381	HY-B0317B	HYCPK40906	B04	HYCPK40906	92z	103.0	1.0	C7	906.0	B04	111470-99-6	Amlodipine (besylate)	Amlodipine (benzenesulfonate)	567.05	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Amlodipine besylate (Amlodipine benzenesulfonate), an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine besylate can be used for the research of high blood pressure and cancer[1][2][3].	Benzenesulfonate	C26H31ClN2O8S	16986.0	DMSO : ≥ 45 mg/mL (79.36 mM); H2O : 1 mg/mL (1.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C(C1=C(COCCN)NC(C)=C(C(OC)=O)C1C2=CC=CC=C2Cl)OCC.O=S(C3=CC=CC=C3)(O)=O	https://www.medchemexpress.com/Amlodipine-besylate.html	Launched		92.0	C7	I16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0317B	10.0	mM	208.0	DMSO	408.1452	16	I	pluskal_fda_drugs_5005_I16_id
1770	HY-B0208	HYCPK40907	B07	HYCPK40907	92z	110.0	2.0	C14	907.0	B07	60-56-0	Methimazole		114.17	Others	Others	Methimazole is an antithyroid compound widely used for the research of hyperthyroidism. Methimazole has potent hepatotoxicity[1][2].	Free Base	C4H6N2S	155074.0	H2O : ≥ 50 mg/mL (437.94 mM); DMSO : ≥ 100 mg/mL (875.89 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	S=C1NC=CN1C	https://www.medchemexpress.com/methimazole.html	Launched		92.0	C14	I16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0208	10.0	mM	208.0	DMSO	114.025169	16	I	pluskal_fda_drugs_5005_I16_id
1803	HY-B0401	HYCPK40907	C09	HYCPK40907	92z	210.0	2.0	E18	907.0	C09	64-77-7	Tolbutamide		270.35	Autophagy; Potassium Channel	Autophagy; Membrane Transporter/Ion Channel	"Tolbutamide is a first generation potassium channel blocker, sulfonylurea oral hypoglycemic drug.
Target: Potassium Channel
Tolbutamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). Tolbutamide act by stimulating β cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Tolbutamide belongs to a class of medications called sulfonylureas. Tolbutamide inhibits both the basal and the cyclic AMP-stimulated protein kinase activities and the IC50 of Tolbutamide is 4 mM. Similar Tolbutamide concentrations are required for half maximal inhibition of in vitro lipolysis induced by hormones (norepinephrine and ACTH) or by dibutyryl cyclic AMP plus theophylline. Tolbutamide also inhibits both soluble and membrane-bound protein kinase from canine heart. The Tolbutamide inhibition of adipose tissue cyclic AMP-dependent protein kinase is one possible explanation for the antilipolytic effects of this drug [1]. Tolbutamide inhibits C6-glioma cell proliferation by increasing Cx43, which correlates with a reduction in pRb phosphorylation due to the up-regulation of the Cdk inhibitors p21 and p27 [2]."	Free Base	C12H18N2O3S	16823.0	DMSO : ≥ 34 mg/mL (125.76 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=S(C1=CC=C(C)C=C1)(NC(NCCCC)=O)=O	https://www.medchemexpress.com/Tolbutamide.html	Launched		92.0	E18	I16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0401	10.0	mM	208.0	DMSO	270.103813	16	I	pluskal_fda_drugs_5005_I16_id
1815	HY-75839	HYCPK40907	O09	HYCPK40907	92z	1362.0	2.0	AC18	907.0	O09	141625-93-6	Dronedarone (Hydrochloride)		593.22	Autophagy; Potassium Channel	Autophagy; Membrane Transporter/Ion Channel	Dronedarone Hydrochloride is a non-iodinated amiodarone derivative that inhibits Na+, K+ and Ca2+ currents.	Hydrochloride	C31H45ClN2O5S	6987.0	DMSO : ≥ 50 mg/mL (84.29 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CS(=O)(NC1=CC=C(OC(CCCC)=C2C(C3=CC=C(OCCCN(CCCC)CCCC)C=C3)=O)C2=C1)=O.[H]Cl	https://www.medchemexpress.com/Dronedarone-Hydrochloride.html	Launched		92.0	AC18	I16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-75839	10.0	mM	208.0	DMSO	556.297094	16	I	pluskal_fda_drugs_5005_I16_id
2261	HY-111354	HYCPK40908	F19	HYCPK40908	92z	565.0	3.0	L37	908.0	F19	25913-34-2	Tinoridine (hydrochloride)	Y-3642 (hydrochloride)	352.88	Glutathione Peroxidase	Metabolic Enzyme/Protease	Tinoridine hydrochloride is a nonsteroidal anti-inflammatory drug and also has potent radical scavenger and antiperoxidative activity.	Hydrochloride	C17H21ClN2O2S	29345.0	DMSO : 16.67 mg/mL (47.24 mM; Need ultrasonic); H2O : 2.5 mg/mL (7.08 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=C(N)SC2=C1CCN(CC3=CC=CC=C3)C2)OCC.Cl	https://www.medchemexpress.com/Tinoridine_hydrochloride.html	Launched		92.0	L37	I16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-111354	10.0	mM	208.0	DMSO	316.124549	16	I	pluskal_fda_drugs_5005_I16_id
2265	HY-B0320A	HYCPK40908	J19	HYCPK40908	92z	949.0	3.0	T37	908.0	J19	15826-37-6	Cromolyn (sodium)	Disodium Cromoglycate; FPL-670	512.33	Calcium Channel; GSK-3	Membrane Transporter/Ion Channel; Neuronal Signaling; PI3K/Akt/mTOR; Stem Cell/Wnt	Cromolyn sodium (Disodium Cromoglycate; FPL-670) is an antiallergic drug. Cromolyn sodium is a GSK-3β inhibitor with an IC50  of 2.0 μM.	Sodium	C23H14Na2O11	81390.0	H2O : 50 mg/mL (97.59 mM; Need ultrasonic); DMSO : 25 mg/mL (48.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC(COC1=C2C(C=C(C(O[Na])=O)OC2=CC=C1)=O)COC3=C4C(C=C(C(O[Na])=O)OC4=CC=C3)=O	https://www.medchemexpress.com/Cromolyn-sodium.html	Launched		92.0	T37	I16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0320A	10.0	mM	208.0	DMSO	468.069261	16	I	pluskal_fda_drugs_5005_I16_id
2284	HY-I0230	HYCPK40908	M20	HYCPK40908	92z	1239.0	3.0	Z39	908.0	M20	180468-39-7	Solifenacin (hydrochloride)	YM905 hydrochloride	398.93	mAChR	GPCR/G Protein; Neuronal Signaling	Solifenacin hydrochloride (YM905 hydrochloride) is a muscarinic receptor antagonist, with pKis of 7.6, 6.9 and 8.0 for M1, M2 and M3 receptors, respectively.	Hydrochloride	C23H27ClN2O2	2050.0	DMSO : 50 mg/mL (125.34 mM; Need ultrasonic); H2O : 50 mg/mL (125.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(O[C@H]1CN2CCC1CC2)N3[C@H](C4=C(CC3)C=CC=C4)C5=CC=CC=C5.Cl	https://www.medchemexpress.com/Solifenacin-hydrochloride.html	Launched		92.0	Z39	I16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-I0230	10.0	mM	208.0	DMSO	362.199428	16	I	pluskal_fda_drugs_5005_I16_id
367	HY-17371	HYCPK40899	J04	HYCPK40909	92z	942.0	4.0	T30	909.0	J15	61825-94-3	Oxaliplatin		397.29	Apoptosis; DNA/RNA Synthesis	Apoptosis; Cell Cycle/DNA Damage	Oxaliplatin is a DNA synthesis inhibitor. Oxaliplatin causes DNA crosslinking damage, prevents DNA replication and transcription and induces apoptosis. Oxaliplatin can be used for cancer research[1][2][3].	Free Base	C8H14N2O4Pt	96910.0	DMF : 1.67 mg/mL (4.20 mM; Need ultrasonic); H2O : 2.17 mg/mL (5.46 mM; ultrasonic and warming and heat to 60°C); DMSO : 20.83 mg/mL (52.43 mM; ultrasonic and warming and heat to 60°C); Ethanol : < 1 mg/mL (insoluble)	DMSO Solution	2mM  * 100uL	Cancer	O=C(O1)C(O[Pt]21[NH2][C@@H]3CCCC[C@H]3[NH2]2)=O	https://www.medchemexpress.com/Oxaliplatin.html	Launched		92.0	T30	I17	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17371	2.0	mM	209.0	DMSO	114.115698	17	I	pluskal_fda_drugs_5005_I17_id
1468	HY-A0016	HYCPK40908	K16	HYCPK40908	92z	1039.0	3.0	V31	908.0	K16	141626-36-0	Dronedarone	SR 33589	556.76	Adrenergic Receptor; Autophagy; Calcium Channel; Cytochrome P450; mAChR; Sodium Channel	Autophagy; GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Dronedarone (SR 33589), a derivative of amiodarone (HY-14187), is a class III antiarrhythmic agent for the study of atrial fibrillation (AF) and atrial flutter. Dronedarone is a potent blocker of multiple ion currents, including potassium current, sodium current, and L-type calcium current, and exhibits antiadrenergic effects by noncompetitive binding to β-adrenergic receptors. Dronedarone is a substrate for and a moderate inhibitor of CYP3A4[1].	Free Base	C31H44N2O5S	2206.0	DMSO : 50 mg/mL (89.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CCCCC1=C(C2=C(C=CC(NS(C)(=O)=O)=C2)O1)C(C3=CC=C(C=C3)OCCCN(CCCC)CCCC)=O	https://www.medchemexpress.com/Dronedarone.html	Launched		92.0	V31	I17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0016	10.0	mM	209.0	DMSO	556.297094	17	I	pluskal_fda_drugs_5005_I17_id
1730	HY-B0764A	HYCPK40907	E04	HYCPK40907	92z	392.0	2.0	I8	907.0	E04	938448-87-4	Bucladesine (calcium)	Dibutyryl cAMP (calcium salt); DBcAMP (calcium salt)	488.42	Apoptosis; Phosphodiesterase (PDE); PKA	Apoptosis; Metabolic Enzyme/Protease; Stem Cell/Wnt	Bucladesine calcium salt (Dibutyryl-cAMP calcium salt;DC2797 calcium salt) is a cell-permeable cyclic AMP (cAMP) analog and selectively activates cAMP dependent protein kinase (PKA) by increasing the intracellular level of cAMP. Bucladesine calcium salt acts as a phosphodiesterase (PDE) inhibitor.	Calcium	C18H23Ca0.5N5O8P	14865.0	H2O : 100 mg/mL (204.74 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (204.74 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(CCC)O[C@H]1[C@H](N2C(N=CN=C3NC(CCC)=O)=C3N=C2)O[C@@](CO4)([H])[C@@]1([H])OP4([O-])=O.[0.5Ca2+]	https://www.medchemexpress.com/Bucladesine-calcium-salt.html	Launched		92.0	I8	I17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0764A	10.0	mM	209.0	DMSO	469.136249	17	I	pluskal_fda_drugs_5005_I17_id
1987	HY-B1604	HYCPK40907	G21	HYCPK40907	92z	618.0	2.0	M42	907.0	G21	3858-89-7	Chloroprocaine (hydrochloride)	2-Chloroprocaine (hydrochloride)	307.22	Na+/K+ ATPase	Membrane Transporter/Ion Channel	Chloroprocaine hydrochloride (2-Chloroprocaine hydrochloride) is a potent inhibitor of Na,K-ATPase activity with an IC50 of 13 mM. Chloroprocaine hydrochloride blocks peripheral nerve[1].	Hydrochloride	C13H20Cl2N2O2	64226.0	DMSO : 83.33 mg/mL (271.24 mM; Need ultrasonic); H2O : 100 mg/mL (325.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCN(CC)CC)C1=CC=C(N)C=C1Cl.[H]Cl	https://www.medchemexpress.com/chloroprocaine-hydrochloride.html	Launched		92.0	M42	I17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1604	10.0	mM	209.0	DMSO	270.113506	17	I	pluskal_fda_drugs_5005_I17_id
1997	HY-18715	HYCPK40907	A22	HYCPK40907	92z	44.0	2.0	A44	907.0	A22	166734-83-4	Ornidazole (Levo-)	(S)-Ornidazole; Levornidazole	219.63	Bacterial; Parasite	Anti-infection	Ornidazole Levo- is the levo-isomer of Ornidazole. Ornidazole is a 5-nitroimidazole derivative with antiprotozoal and antibacterial properties against anaerobic bacteria. Ornidazole Levo- is the less active isomer.	Free Base	C7H10ClN3O3	17814.0	H2O : 6.67 mg/mL (30.37 mM; Need ultrasonic); DMSO : 100 mg/mL (455.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC1=NC=C([N+]([O-])=O)N1C[C@H](O)CCl	https://www.medchemexpress.com/Ornidazole-Levo-.html	Launched		92.0	A44	I17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18715	10.0	mM	209.0	DMSO	219.041069	17	I	pluskal_fda_drugs_5005_I17_id
2141	HY-17468	HYCPK40908	J11	HYCPK40908	92z	933.0	3.0	T21	908.0	J11	28395-03-1	Bumetanide	Ro 10-6338; PF 1593	364.42	NKCC	Membrane Transporter/Ion Channel	Bumetanide (Ro 10-6338; PF 1593), a highly potent loop diuretic, is a Na+-K+-Cl+ cotransporter (NKCC) blocker. Bumetanide is a selective NKCC1 inhibitor, but also inhibits NKCC2, with IC50s of 0.68 μM and 4.0 μM for hNKCC1A and hNKCC2A, respectively[1][2].	Free Acid	C17H20N2O5S	36852.0	DMSO : 100 mg/mL (274.41 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=C(O)C1=CC(NCCCC)=C(OC2=CC=CC=C2)C(S(=O)(N)=O)=C1	https://www.medchemexpress.com/bumetanide.html	Launched		92.0	T21	I17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17468	10.0	mM	209.0	DMSO	364.109293	17	I	pluskal_fda_drugs_5005_I17_id
2202	HY-B0317A	HYCPK40908	G15	HYCPK40908	92z	653.0	3.0	N29	908.0	G15	88150-47-4	Amlodipine (maleate)		524.95	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Amlodipine maleate is a dihydropyridine calcium channel blocker, acts as an orally active antianginal agent. Amlodipine maleate blocks the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium. Amlodipine maleate can be used for the research of high blood pressure and cancer[1][2][3].	Maleate	C24H29ClN2O9	15582.0	DMSO : 120 mg/mL (228.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C(C1=C(COCCN)NC(C)=C(C(OC)=O)C1C2=CC=CC=C2Cl)OCC.OC(/C=C\C(O)=O)=O	https://www.medchemexpress.com/Amlodipine-maleate.html	Launched		92.0	N29	I17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0317A	10.0	mM	209.0	DMSO	408.1452	17	I	pluskal_fda_drugs_5005_I17_id
2259	HY-17380	HYCPK40908	D19	HYCPK40908	92z	373.0	3.0	H37	908.0	D19	26921-17-5	(S)-Timolol (Maleate)	L-714,465 (Maleate); MK 950	432.49	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	(S)-Timolol Maleate (L-714,465 Maleate) is a non-cardioselective hydrophilic β-adrenoceptor blocker. (S)-Timolol Maleate is widely used as standard medication for intraocular pressure (glaucoma) by preventing the production of aqueous humor. (S)-Timolol Maleate can be used for hypertension, angina pectoris and myocardial infarction[1][2][3].	Maleate	C17H28N4O7S	14559.0	H2O : 50 mg/mL (115.61 mM; Need ultrasonic); DMSO : 100 mg/mL (231.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease	O[C@H](COC1=NSN=C1N2CCOCC2)CNC(C)(C)C.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/_S_-Timolol-Maleate.html	Launched		92.0	H37	I17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17380	10.0	mM	209.0	DMSO	316.156912	17	I	pluskal_fda_drugs_5005_I17_id
1375	HY-14744A	HYCPK40906	L03	HYCPK40906	92z	1061.0	1.0	W5	906.0	L03	150566-71-5	Levamlodipine besylate	(S)-Amlodipine besylate; Levoamlodipine besylate	567.05	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Levamlodipine besylate ((S)-Amlodipine besylate) is a powerful dihydropyridine calcium channel blocker, possessing vasodilation properties and used in the treatment of hypertension and angina[1].	Benzenesulfonate	C26H31ClN2O8S	40422.0	H2O : ≥ 3.33 mg/mL (5.87 mM); DMSO : ≥ 150 mg/mL (264.53 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(COCCN)NC(C)=C(C(OC)=O)[C@@H]1C2=CC=CC=C2Cl)OCC.OS(C3=CC=CC=C3)(=O)=O	https://www.medchemexpress.com/Levamlodipine_besylate.html	Launched		92.0	W5	I18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14744A	10.0	mM	210.0	DMSO	408.1452	18	I	pluskal_fda_drugs_5005_I18_id
1520	HY-W015883	HYCPK40906	C11	HYCPK40906	92z	213.0	1.0	E21	906.0	C11	110-17-8	Fumaric acid		116.07	Endogenous Metabolite	Metabolic Enzyme/Protease	Fumaric acid, associated with fumarase deficiency, is identified as an oncometabolite or an endogenous, cancer causing metabolite.	Free Acid	C4H4O4	65502.0	DMSO : 25 mg/mL (215.39 mM; Need ultrasonic); H2O : 11.11 mg/mL (95.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	O=C(O)/C=C/C(O)=O	https://www.medchemexpress.com/Fumaric_acid.html	Launched		92.0	E21	I18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W015883	10.0	mM	210.0	DMSO	116.010959	18	I	pluskal_fda_drugs_5005_I18_id
1608	HY-B1406	HYCPK40906	K16	HYCPK40906	92z	991.0	1.0	U31	906.0	K16	85-36-9	Acetrizoic acid		556.86	Others	Others	Acetrizoic acid is a molecule used as a contrast medium.	Free Acid	C9H6I3NO3	17540.0	DMSO : ≥ 5.6 mg/mL (10.06 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(O)C1=C(I)C=C(I)C(NC(C)=O)=C1I	https://www.medchemexpress.com/Acetrizoic-acid.html	Launched		92.0	U31	I18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1406	10.0	mM	210.0	DMSO	556.748187	18	I	pluskal_fda_drugs_5005_I18_id
1673	HY-10932	HYCPK40906	L20	HYCPK40906	92z	1095.0	1.0	W39	906.0	L20	72432-10-1	Aniracetam	Ro 13-5057	219.24	iGluR; nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Aniracetam (Ro 13-5057) is an orally active neuroprotective agent, possessing nootropics effects. Aniracetam potentiates the ionotropic quisqualate (iQA) responses in the CA1 region of rat hippocampal slices. Aniracetam also potentiates the excitatory post synaptic potentials (EPSPs) in Schaffer collateral-commissural synapses. Aniracetam can prevents the CO2-induced impairment of acquisition in hypercapnia model rats. Aniracetam can be used to research cerebral dysfunctional disorders[1][2][3][4].	Free Base	C12H13NO3	11704.0	H2O : 0.33 mg/mL (1.51 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (456.12 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N1CCCC1=O)C2=CC=C(OC)C=C2	https://www.medchemexpress.com/Aniracetam.html	Launched		92.0	W39	I18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10932	10.0	mM	210.0	DMSO	219.089543	18	I	pluskal_fda_drugs_5005_I18_id
1810	HY-B0764	HYCPK40907	J09	HYCPK40907	92z	882.0	2.0	S18	907.0	J09	16980-89-5	Bucladesine (sodium)	Dibutyryl cAMP (sodium salt); DBcAMP (sodium salt)	491.37	Phosphodiesterase (PDE); PKA	Metabolic Enzyme/Protease; Stem Cell/Wnt	Bucladesine sodium salt (Dibutyryl-cAMP sodium salt) is a stabilized cyclic AMP (cAMP) analog and a selective PKA activator. Bucladesine sodium salt raises the intracellular levels of cAMP. Bucladesine sodium salt is also a phosphodiesterase (PDE) inhibitor. Bucladesine sodium salt has anti-inflammatory activity and can be used for impaired wound healing[1][2][3][4].	Sodium	C18H23N5NaO8P	41592.0	DMSO : 170 mg/mL (345.97 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (101.76 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(CCC)O[C@H]1[C@H](N2C(N=CN=C3NC(CCC)=O)=C3N=C2)O[C@@](CO4)([H])[C@@]1([H])OP4(O[Na])=O	https://www.medchemexpress.com/Bucladesine-sodium-salt.html	Launched		92.0	S18	I18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0764	10.0	mM	210.0	DMSO	469.136249	18	I	pluskal_fda_drugs_5005_I18_id
1913	HY-15781A	HYCPK40907	I16	HYCPK40907	92z	800.0	2.0	Q32	907.0	I16	898230-59-6	(R)-Morinidazole		270.29	Bacterial	Anti-infection	(R)-Morinidazole is an orally active and 5-nitroimidazole antimicrobial agent that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation. (R)-Morinidazole can be used for bacterial infections research including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria[1].	Free Base	C11H18N4O4	17813.0	DMSO : ≥ 100 mg/mL (369.97 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@@H](CN1C([N+]([O-])=O)=CN=C1C)CN2CCOCC2	https://www.medchemexpress.com/Morinidazole-R-enantiomer.html	Launched		92.0	Q32	I18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15781A	10.0	mM	210.0	DMSO	270.132805	18	I	pluskal_fda_drugs_5005_I18_id
1989	HY-B1150	HYCPK40907	I21	HYCPK40907	92z	810.0	2.0	Q42	907.0	I21	37693-01-9	Clofoctol		365.34	Antibiotic; Bacterial; SARS-CoV	Anti-infection	Clofoctol is a bacteriostatic antibiotic. Clofoctol is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria. Clofoctol is only functional against Gram-positive bacteria and can penetrate into human lung tissue. Clofoctol is also an inhibitor of prostate cancer. Clofoctol has antiviral potency[1][2][3].	Free Base	C21H26Cl2O	119954.0	DMSO : 100 mg/mL (273.72 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Infection	OC1=CC=C(C(C)(C)CC(C)(C)C)C=C1CC2=CC=C(Cl)C=C2Cl	https://www.medchemexpress.com/Clofoctol.html	Launched		92.0	Q42	I18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1150	10.0	mM	210.0	DMSO	364.136071	18	I	pluskal_fda_drugs_5005_I18_id
2076	HY-B0151	HYCPK40908	E07	HYCPK40908	92z	445.0	3.0	J13	908.0	E07	145-13-1	Pregnenolone	3β-Hydroxy-5-pregnen-20-one	316.48	Autophagy; Cannabinoid Receptor; Endogenous Metabolite; TRP Channel	Autophagy; GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Pregnenolone (3β-Hydroxy-5-pregnen-20-one) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of tetrahydrocannabinol (THC) that are mediated by the CB1 receptors. Pregnenolone can protect the brain from cannabis intoxication[1][2]. Pregnenolone is also a TRPM3 channel activator, and also can weakly activate TRPM1 channels[3].	Free Base	C21H32O2	13391.0	DMSO : 25 mg/mL (78.99 mM; ultrasonic and warming and heat to 60°C); H2O : 0.1 mg/mL (0.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[C@@](C1=CC2)(CC[C@H](O)C1)[C@]3([H])[C@]2([H])[C@@](CC[C@@H]4C(C)=O)([H])[C@]4(C)CC3	https://www.medchemexpress.com/Pregnenolone.html	Launched		92.0	J13	I18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0151	10.0	mM	210.0	DMSO	316.24023	18	I	pluskal_fda_drugs_5005_I18_id
61	HY-W018555	HYCPK40899	O05	HYCPK40909	92z	1424.0	4.0	AD32	909.0	O16	921-01-7	D-Cysteine		121.16	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	D-Cysteine is the D-isomer of cysteine and a powerful inhibitor of Escherichia coli growth. D-cysteine is mediated by D-amino acid oxidase to produce H2S and is a neuroprotectant against cerebellar ataxias. D-Cysteine could inhibit the growth and cariogenic virulence of dual-species biofilms formed by S. mutans and S. sanguinis[1][2][3].		C3H7NO2S	179804.0	DMSO : 1 mg/mL (8.25 mM; ultrasonic and warming and heat to 60°C); H2O : 1 mg/mL (8.25 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Infection; Neurological Disease	N[C@H](CS)C(O)=O	https://www.medchemexpress.com/d-cysteine.html	Launched		92.0	AD32	I19	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W018555	2.0	mM	211.0	DMSO	121.019749	19	I	pluskal_fda_drugs_5005_I19_id
1850	HY-A0252	HYCPK40907	B12	HYCPK40907	92z	120.0	2.0	C24	907.0	B12	14556-46-8	Bupranolol		271.78	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Bupranolol is an orally active, competitive and non-selective β-adrenoceptor antagonist without intrinsic sympathomimetic activity[1].		C14H22ClNO2	113565.0	DMSO : 50 mg/mL (183.97 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	OC(CNC(C)(C)C)COC1=CC(C)=CC=C1Cl	https://www.medchemexpress.com/bupranolol.html	Launched		92.0	C24	I19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0252	10.0	mM	211.0	DMSO	271.133907	19	I	pluskal_fda_drugs_5005_I19_id
1939	HY-B0028	HYCPK40907	C18	HYCPK40907	92z	228.0	2.0	E36	907.0	C18	75607-67-9	Fludarabine (phosphate)	NSC 118218 (phosphate)	365.21	Apoptosis; Nucleoside Antimetabolite/Analog	Apoptosis; Cell Cycle/DNA Damage	Fludarabine (phosphate) is an analogue of adenosine and deoxyadenosine, which is able to compete with dATP for incorporation into DNA and inhibit DNA synthesis.	Free Acid	C10H13FN5O7P	11876.0	DMSO : ≥ 100 mg/mL (273.82 mM); H2O : 5 mg/mL (13.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	NC1=C2C(N([C@H]3[C@@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O3)C=N2)=NC(F)=N1	https://www.medchemexpress.com/Fludarabine-phosphate.html	Launched		92.0	E36	I19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0028	10.0	mM	211.0	DMSO	365.053663	19	I	pluskal_fda_drugs_5005_I19_id
2002	HY-N7101	HYCPK40907	F22	HYCPK40907	92z	524.0	2.0	K44	907.0	F22	87239-81-4	Cefpodoxime Proxetil	U-76,252; CS-807	557.60	Antibiotic; Bacterial	Anti-infection	Cefpodoxime Proxetil is a first oral and broad spectrum antibiotic that belongs to the third generation of cephalosporin. Cefpodoxime Proxetil binds to penicillin binding proteins (PBPs), which inhibits peptidoglycan synthesis, finally results in interfering bacterial cell wall biosynthesis[1].	Free Base	C21H27N5O9S2	62046.0	DMSO : 125 mg/mL (224.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(COC)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)OC(OC(OC(C)C)=O)C	https://www.medchemexpress.com/cefpodoxime-proxetil.html	Launched		92.0	K44	I19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7101	10.0	mM	211.0	DMSO	557.125019	19	I	pluskal_fda_drugs_5005_I19_id
2031	HY-13272	HYCPK40908	C04	HYCPK40908	92z	247.0	3.0	F7	908.0	C04	1110813-31-4	Dacomitinib	PF-00299804; PF-299804	469.94	Apoptosis; EGFR	Apoptosis; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively[1].	Free Base	C24H25ClFN5O2	26624.0	DMSO : 40 mg/mL (85.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(/C=C/CN1CCCCC1)NC2=CC3=C(C=C2OC)N=CN=C3NC4=CC=C(C(Cl)=C4)F	https://www.medchemexpress.com/Dacomitinib.html	Launched		92.0	F7	I19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13272	10.0	mM	211.0	DMSO	469.168081	19	I	pluskal_fda_drugs_5005_I19_id
2210	HY-N0681	HYCPK40908	O15	HYCPK40908	92z	1421.0	3.0	AD29	908.0	O15	137-08-6	D-Pantothenic acid (hemicalcium salt)	Calcium pantothenate; Calcium D-pantothenate; Vitamin B5 calcium salt	238.27	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	"D-Pantothenic acid hemicalcium salt (Vitamin B5 calcium salt), a vitamin, can reduce the patulin content of the apple juice.
IC50 value:
Target:
In vitro: In human dermal fibroblasts from three different donors, D-Pantothenic acid hemicalcium salt accelerates the wound healing process by increasing the number of migrating cells, their distance and hence their speed. In addition, cell division is increased and the protein synthesis changed [1].
In vivo:"	Calcium	C9H16NO5.1/2Ca	17067.0	H2O : 100 mg/mL (419.69 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (419.69 mM)	DMSO Solution	10mM  * 100uL	Others	O[C@@H](C(NCCC([O-])=O)=O)C(C)(C)CO.[0.5Ca2+]	https://www.medchemexpress.com/D-Pantothenic-acid-hemicalcium-salt.html	Launched		92.0	AD29	I19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0681	10.0	mM	211.0	DMSO	219.110673	19	I	pluskal_fda_drugs_5005_I19_id
2474	HY-B1540	HYCPK40909	F06	HYCPK40909	92z	540.0	4.0	L12	909.0	F06	4419-39-0	Beclometasone	Beclomethasone	408.92	Glucocorticoid Receptor	Immunology/Inflammation	Beclometasone (Beclomethasone) is a prototype glucocorticoid receptor agonist.	Free Base	C22H29ClO5	156393.0	DMSO : ≥ 32 mg/mL (78.25 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]12[C@](C(CO)=O)(O)[C@@H](C)C[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C2)=O	https://www.medchemexpress.com/Beclometasone.html	Launched		92.0	L12	I19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1540	10.0	mM	211.0	DMSO	408.170352	19	I	pluskal_fda_drugs_5005_I19_id
2545	HY-B2102	HYCPK40909	D11	HYCPK40909	92z	358.0	4.0	H22	909.0	D11	125-13-3	Oxyphenisatine	Oxyphenisatin	317.34	Others	Others	Oxyphenisatine (Oxyphenisatin) is a laxative. Oxyphenisatin acetate is the pro-drug of oxyphenisatin with anticancer activity.	Free Base	C20H15NO3	239134.0	DMSO : ≥ 100 mg/mL (315.12 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NC2=C(C=CC=C2)C1(C3=CC=C(O)C=C3)C4=CC=C(O)C=C4	https://www.medchemexpress.com/Oxyphenisatine.html	Launched		92.0	H22	I19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2102	10.0	mM	211.0	DMSO	317.105193	19	I	pluskal_fda_drugs_5005_I19_id
1372	HY-13703A	HYCPK40906	I03	HYCPK40906	92z	773.0	1.0	Q5	906.0	I03	55661-38-6	Nimustine (hydrochloride)	ACNU	309.15	Apoptosis; DNA Alkylator/Crosslinker; DNA/RNA Synthesis	Apoptosis; Cell Cycle/DNA Damage	Nimustine hydrochloride (ACNU) is a DNA cross-linking and DNA alkylating agent, which induces DNA replication blocking lesions and DNA double-strand breaks and inhibits DNA synthesis, commonly used in chemotherapy for glioblastomas[1][2][3].	Hydrochloride	C9H14Cl2N6O2	43072.0	DMSO : 62.5 mg/mL (202.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NCC1=CN=C(C)N=C1N)N(CCCl)N=O.[H]Cl	https://www.medchemexpress.com/nimustine-hydrochloride.html	Launched		92.0	Q5	I20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13703A	10.0	mM	212.0	DMSO	272.078851	20	I	pluskal_fda_drugs_5005_I20_id
1540	HY-N0324	HYCPK40906	G12	HYCPK40906	92z	599.0	1.0	M23	906.0	G12	81-25-4	Cholic acid		408.57	Endogenous Metabolite	Metabolic Enzyme/Protease	Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].	Free Acid	C24H40O5	26452.0	0.1 M NaOH : 33.33 mg/mL (81.58 mM; ultrasonic and adjust pH to 9 with NaOH); DMSO : ≥ 50 mg/mL (122.38 mM); H2O : 0.67 mg/mL (1.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	C[C@H](CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@@]21C	https://www.medchemexpress.com/Cholic_acid.html	Launched		92.0	M23	I20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0324	10.0	mM	212.0	DMSO	408.287574	20	I	pluskal_fda_drugs_5005_I20_id
1761	HY-B0422	HYCPK40907	I06	HYCPK40907	92z	780.0	2.0	Q12	907.0	I06	105816-04-4	Nateglinide	A4166; Senaglinide	317.42	Dipeptidyl Peptidase; Potassium Channel	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K+ channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus[1][2].	Free Acid	C19H27NO3	16196.0	DMSO : 100 mg/mL (315.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)[C@@H](CC1=CC=CC=C1)NC([C@H]2CC[C@H](C(C)C)CC2)=O	https://www.medchemexpress.com/Nateglinide.html	Launched		92.0	Q12	I20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0422	10.0	mM	212.0	DMSO	317.199094	20	I	pluskal_fda_drugs_5005_I20_id
1993	HY-B0209	HYCPK40907	M21	HYCPK40907	92z	1194.0	2.0	Y42	907.0	M21	17560-51-9	Metolazone	SR-720-22	365.83	Thrombin	Metabolic Enzyme/Protease	Metolazone (SR-720-22) is primarily used to treat congestive heart failure and high blood pressure.	Free Base	C16H16ClN3O3S	16558.0	DMSO : ≥ 100 mg/mL (273.35 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(C1=CC2=C(NC(C)N(C3=CC=CC=C3C)C2=O)C=C1Cl)(N)=O	https://www.medchemexpress.com/metolazone.html	Launched		92.0	Y42	I20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0209	10.0	mM	212.0	DMSO	365.06009	20	I	pluskal_fda_drugs_5005_I20_id
2014	HY-N0216	HYCPK40908	B03	HYCPK40908	92z	149.0	3.0	D5	908.0	B03	65-85-0	Benzoic acid		122.12	Bacterial; Endogenous Metabolite; Fungal	Anti-infection; Metabolic Enzyme/Protease	Benzoic acid is an aromatic alcohol existing naturally in many plants and is a common additive to food, drinks, cosmetics and other products. It acts as preservatives through inhibiting both bacteria and fungi.	Free Acid	C7H6O2	84012.0	H2O : 7.14 mg/mL (58.47 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (818.87 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)C1=CC=CC=C1	https://www.medchemexpress.com/Benzoic_acid.html	Launched		92.0	D5	I20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0216	10.0	mM	212.0	DMSO	122.036779	20	I	pluskal_fda_drugs_5005_I20_id
2120	HY-15656	HYCPK40908	A10	HYCPK40908	92z	67.0	3.0	B19	908.0	A10	1032900-25-6	Ceritinib	LDK378	558.14	Anaplastic lymphoma kinase (ALK); IGF-1R; Insulin Receptor	Protein Tyrosine Kinase/RTK	Ceritinib (LDK378) is a selective, orally bioavailable, and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib (LDK378) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib (LDK378) shows great antitumor potency[1][2].	Free Base	C28H36ClN5O3S	19216.0	DMSO : 5.6 mg/mL (10.03 mM; Need ultrasonic); Ethanol : ≥ 3.33 mg/mL (5.97 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	CC(C)OC1=CC(C2CCNCC2)=C(C)C=C1NC3=NC=C(Cl)C(NC4=CC=CC=C4S(=O)(C(C)C)=O)=N3	https://www.medchemexpress.com/LDK378.html	Launched		92.0	B19	I20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15656	10.0	mM	212.0	DMSO	557.222739	20	I	pluskal_fda_drugs_5005_I20_id
2171	HY-B0678	HYCPK40908	H13	HYCPK40908	92z	745.0	3.0	P25	908.0	H13	1665-48-1	Metaxalone	AHR438; NSC170959	221.25	Others	Others	"Metaxalone(AHR438;NSC170959) is a muscle relaxant used to relax muscles.
Target: Others
Metaxalone is a muscle relaxant used to relax muscles and relieve pain caused by strains, sprains, and other musculoskeletal conditions. Its exact mechanism of action is not known, but it may be due to general central nervous system depression. It is considered to be a moderately strong muscle relaxant, with relatively low incidence of side effects."	Free Base	C12H15NO3	15227.0	DMSO : ≥ 100 mg/mL (451.98 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1OC(COC2=CC(C)=CC(C)=C2)CN1	https://www.medchemexpress.com/Metaxalone.html	Launched		92.0	P25	I20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0678	10.0	mM	212.0	DMSO	221.105193	20	I	pluskal_fda_drugs_5005_I20_id
2499	HY-A0031	HYCPK40909	F08	HYCPK40909	92z	544.0	4.0	L16	909.0	F08	198481-32-2	Bazedoxifene	TSE-424	470.60	Estrogen Receptor/ERR	Others	Bazedoxifene (TSE-424) is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene can be used for the research of osteoporosis. Bazedoxifene also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer[1][2].	Free Base	C30H34N2O3	112207.0	DMSO : 100 mg/mL (212.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC1=C(C2=CC=C(O)C=C2)N(CC3=CC=C(OCCN4CCCCCC4)C=C3)C5=CC=C(O)C=C51	https://www.medchemexpress.com/bazedoxifene.html	Launched		92.0	L16	I20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0031	10.0	mM	212.0	DMSO	470.256943	20	I	pluskal_fda_drugs_5005_I20_id
1583	HY-B0150	HYCPK40906	B15	HYCPK40906	92z	125.0	1.0	C29	906.0	B15	98-92-0	Nicotinamide	Niacinamide; Nicotinic acid amide	122.12	Endogenous Metabolite; Sirtuin	Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease	Nicotinamide is a form of vitamin B3 or niacin that inhibits sirtuin 2 (SIRT2) activity in vitro, with an EC50 of 2 μM. Nicotinamide inhibits up to 90% melanoma cell number and increases cellular NAD+, ATP, ROS levels. Nicotinamide inhibts tumor growth in vivo and improves survival of melanoma-bearing mice, which can be used for the research of skin cancers such as melanoma[1].	Free Base	C6H6N2O	15870.0	DMSO : 50 mg/mL (409.43 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (409.43 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=CN=C1)N	https://www.medchemexpress.com/Nicotinamide.html	Launched		92.0	C29	I21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0150	10.0	mM	213.0	DMSO	122.048013	21	I	pluskal_fda_drugs_5005_I21_id
1646	HY-B0325	HYCPK40906	A19	HYCPK40906	92z	37.0	1.0	A37	906.0	A19	83-12-5	Phenindione	Rectadione	222.24	Others	Others	"Phenindione is an anticoagulant which functions as a Vitamin K antagonist.
Target: Others
Phenindione(Rectadione) is an anticoagulant which functions as a Vitamin K antagonist. A lymphocyte transformation test showed proliferation of T-cells from the hypersensitive patient, but not from four controls on exposure to phenindione in vitro. Drug-specific T-cell clones were generated and characterized in terms of their phenotype, functionality, and mechanism of antigen presentation. Forty-three human leukocyte antigen class II restricted CD4+ αβ T-cell clones were identified. T-cell activation resulted in the secretion of interferon-γ and interleukin-5 [1]."	Free Base	C15H10O2	17009.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (449.96 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C1C(C2=CC=CC=C2)C(C3=C1C=CC=C3)=O	https://www.medchemexpress.com/phenindione.html	Launched		92.0	A37	I21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0325	10.0	mM	213.0	DMSO	222.06808	21	I	pluskal_fda_drugs_5005_I21_id
1796	HY-B0395C	HYCPK40907	L08	HYCPK40907	92z	1072.0	2.0	W16	907.0	L08	163253-35-8	Sitafloxacin (hydrate)	DU6859a hydrate	436.84	Antibiotic; Bacterial	Anti-infection	Sitafloxacin (DU6859a) hydrate is a potent, orally active fluoroquinolone antibiotic with in vitro activity against a broad range of gram-positive and gram-negative bacteria, including anaerobic bacteria, as well as against atypical pathogens[1][2]. Sitafloxacin can be used for the research of respiratory tract infection and urinary tract infection[3].	Free Acid	C19H18ClF2N3O3.3/2H2O	13362.0	H2O : 1 mg/mL (2.29 mM; ultrasonic and warming and heat to 80°C); DMSO : 8.9 mg/mL (20.37 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	N[C@H]1C2(CC2)CN(C(C(Cl)=C3N([C@H]4[C@@H](F)C4)C=C(C(O)=O)C5=O)=C(C=C35)F)C1.[1.5 H2O]	https://www.medchemexpress.com/Sitafloxacin-hydrate.html	Launched		92.0	W16	I21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0395C	10.0	mM	213.0	DMSO	409.100476	21	I	pluskal_fda_drugs_5005_I21_id
1871	HY-15656A	HYCPK40907	G13	HYCPK40907	92z	602.0	2.0	M26	907.0	G13	1380575-43-8	Ceritinib dihydrochloride	LDK378 (dihydrochloride)	631.06	Anaplastic lymphoma kinase (ALK); IGF-1R; Insulin Receptor	Protein Tyrosine Kinase/RTK	Ceritinib dihydrochloride (LDK378 dihydrochloride) is a selective, orally bioavailable and ATP-competitive ALK tyrosine kinase inhibitor with an IC50 of 200 pM. Ceritinib dihydrochloride (LDK378 dihydrochloride) also inhibits IGF-1R, InsR, and STK22D with IC50 values of 8, 7, and 23 nM, respectively. Ceritinib dihydrochloride (LDK378 dihydrochloride) shows great antitumor potency[1][2].	Hydrochloride	C28H38Cl3N5O3S	13720.0	H2O : 10 mg/mL (15.85 mM; Need ultrasonic); DMSO : 100 mg/mL (158.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	CC(C)OC1=CC(C2CCNCC2)=C(C)C=C1NC3=NC=C(Cl)C(NC4=CC=CC=C4S(=O)(C(C)C)=O)=N3.[H]Cl.[H]Cl	https://www.medchemexpress.com/LDK378-dihydrochloride.html	Launched		92.0	M26	I21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15656A	10.0	mM	213.0	DMSO	557.222739	21	I	pluskal_fda_drugs_5005_I21_id
2092	HY-B0141	HYCPK40908	E08	HYCPK40908	92z	447.0	3.0	J15	908.0	E08	50-28-2	Estradiol	β-Estradiol; E2; 17β-Estradiol; 17β-Oestradiol	272.38	Bacterial; Endogenous Metabolite; Estrogen Receptor/ERR	Anti-infection; Metabolic Enzyme/Protease; Others	Estradiol (β-Estradiol) is a steroid hormone and the major female sex hormone. Estradiol can up-regulate the expression of neural markers of human endometrial stem cells (hEnSCs) and promote their neural differentiation. Estradiol can be used for the research of cancers, neurodegenerative diseases and neural tissue engineering[1][2].	Free Base	C18H24O2	67770.0	DMSO : ≥ 50 mg/mL (183.57 mM); Ethanol : 20 mg/mL (73.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@@]1([C@H]2O)[C@](CC2)([H])[C@@](CCC3=C4C=CC(O)=C3)([H])[C@]4([H])CC1	https://www.medchemexpress.com/Estradiol.html	Launched		92.0	J15	I21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0141	10.0	mM	213.0	DMSO	272.17763	21	I	pluskal_fda_drugs_5005_I21_id
2132	HY-B0259	HYCPK40908	M10	HYCPK40908	92z	1219.0	3.0	Z19	908.0	M10	26807-65-8	Indapamide		365.83	Potassium Channel	Membrane Transporter/Ion Channel	Indapamide is an orally active sulphonamide diuretic agent, that can reduce blood pressure by decreasing vascular reactivity and peripheral vascular resistance. Indapamide is also can reduce left ventricular hypertrophy[1][4].	Free Base	C16H16ClN3O3S	13761.0	H2O : 0.67 mg/mL (1.83 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (273.35 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(NN1C(C)CC2=C1C=CC=C2)C3=CC=C(Cl)C(S(=O)(N)=O)=C3	https://www.medchemexpress.com/Indapamide.html	Launched		92.0	Z19	I21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0259	10.0	mM	213.0	DMSO	365.06009	21	I	pluskal_fda_drugs_5005_I21_id
2157	HY-17396	HYCPK40908	J12	HYCPK40908	92z	935.0	3.0	T23	908.0	J12	101827-46-7	Butenafine (Hydrochloride)	KP363 (Hydrochloride)	353.93	Antibiotic; Fungal	Anti-infection	Butenafine Hydrochloride (KP363 Hydrochloride) is a synthetic benzylamine antifungal, works by inhibiting the synthesis of sterols by inhibiting squalene epoxidase.	Hydrochloride	C23H28ClN	14562.0	H2O : 1 mg/mL (2.83 mM; Need ultrasonic); DMSO : 25 mg/mL (70.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CN(CC1=CC=C(C(C)(C)C)C=C1)CC2=C3C=CC=CC3=CC=C2.[H]Cl	https://www.medchemexpress.com/Butenafine-Hydrochloride.html	Launched		92.0	T23	I21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17396	10.0	mM	213.0	DMSO	317.21435	21	I	pluskal_fda_drugs_5005_I21_id
2186	HY-A0036	HYCPK40908	G14	HYCPK40908	92z	651.0	3.0	N27	908.0	G14	198481-33-3	Bazedoxifene (acetate)	TSE-424 (acetate)	530.65	Estrogen Receptor/ERR	Others	Bazedoxifene acetate (TSE-424 acetate) is an oral, nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene acetate can be used for the research of osteoporosis. Bazedoxifene acetate also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer[1][2].	Acetate	C32H38N2O5	26740.0	DMSO : ≥ 100 mg/mL (188.45 mM); H2O : 1 mg/mL (1.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC1=C(C2=CC=C(O)C=C2)N(CC3=CC=C(OCCN4CCCCCC4)C=C3)C5=CC=C(O)C=C51.CC(O)=O	https://www.medchemexpress.com/Bazedoxifene-acetate.html	Launched		92.0	N27	I21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0036	10.0	mM	213.0	DMSO	470.256943	21	I	pluskal_fda_drugs_5005_I21_id
592	HY-17376	HYCPK40906	J07	HYCPK40906	92z	877.0	1.0	S13	906.0	J07	163222-33-1	Ezetimibe	SCH 58235	409.43	Autophagy; Keap1-Nrf2	Autophagy; NF-κB	Ezetimibe (SCH 58235) is a potent cholesterol absorption inhibitor. Ezetimibe is a Niemann-Pick C1-like1 (NPC1L1) inhibitor, and is a potent Nrf2 activator.	Free Base	C24H21F2NO3	23660.0	DMSO : ≥ 100 mg/mL (244.24 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C1N(C2=CC=C(F)C=C2)[C@H](C3=CC=C(O)C=C3)[C@H]1CC[C@@H](C4=CC=C(F)C=C4)O	https://www.medchemexpress.com/Ezetimibe.html	Launched		92.0	S13	I22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17376	10.0	mM	214.0	DMSO	409.14895	22	I	pluskal_fda_drugs_5005_I22_id
1516	HY-N0375	HYCPK40906	O10	HYCPK40906	92z	1363.0	1.0	AC19	906.0	O10	1449-05-4	18α-Glycyrrhetinic acid		470.68	Apoptosis; NF-κB; Proteasome	Apoptosis; Metabolic Enzyme/Protease; NF-κB	18α-Glycyrrhetinic acid, a diet-derived compound, is an inhibitor of NF-kB and an activator of proteasome, which serves as pro-longevity and anti-aggregation factor in a multicellular organism. 18α-Glycyrrhetinic acid induces apoptosis[1][2].	Free Acid	C30H46O4	105069.0	DMSO : 11.36 mg/mL (24.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	CC1(C)[C@@H](O)CC[C@@]2(C)[C@@]1([H])CC[C@]([C@@](CC[C@]3(C)[C@]4([H])C[C@@](C)(C(O)=O)CC3)(C)C4=C5)(C)[C@]2([H])C5=O	https://www.medchemexpress.com/18_alpha_-Glycyrrhetinic_acid.html	Launched		92.0	AC19	I22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0375	10.0	mM	214.0	DMSO	470.33961	22	I	pluskal_fda_drugs_5005_I22_id
1566	HY-13690	HYCPK40906	A14	HYCPK40906	92z	27.0	1.0	A27	906.0	A14	53-19-0	Mitotane	2,4′-DDD; o,p'-DDD	320.04	Apoptosis	Apoptosis	Mitotane (2,4′-DDD), an isomer of DDD and derivative of dichlorodiphenyltrichloroethane (DDT), is an antineoplastic agent, can be used to research adrenocortical carcinoma. Mitotane exert its adrenocorticolytic effect at least in part through lipotoxicity induced by intracellular free cholesterol (FC) accumulation. Mitotane can have direct pituitary effects on corticotroph cells. Mitotane can induce CYP3A4 gene expression via steroid and xenobiotic receptor (SXR) activation, and has drug-drug interactions[1][2][3][4].	Free Base	C14H10Cl4	9322.0	DMSO : ≥ 100 mg/mL (312.46 mM)	DMSO Solution	10mM  * 100uL	Cancer	ClC1=CC=C(C(C2=CC=CC=C2Cl)C(Cl)Cl)C=C1	https://www.medchemexpress.com/mitotane.html	Launched		92.0	A27	I22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13690	10.0	mM	214.0	DMSO	317.953661	22	I	pluskal_fda_drugs_5005_I22_id
1669	HY-B0143	HYCPK40906	H20	HYCPK40906	92z	711.0	1.0	O39	906.0	H20	59-67-6	Niacin	Nicotinic acid; Vitamin B3	123.11	Autophagy; Endogenous Metabolite	Autophagy; Metabolic Enzyme/Protease	Niacin (Vitamin B3) is an orally active water-soluble B3 vitamin that is an essential nutrient for humans. Niacin (Vitamin B3) plays a key role in energy metabolism, cell signaling cascades regulating gene expression and apoptosis. Niacin (Vitamin B3) is also used in the study of cardiovascular diseases[1][2].	Free Acid	C6H5NO2	110079.0	H2O : 10 mg/mL (81.23 mM; Need ultrasonic); DMSO : 50 mg/mL (406.14 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Cardiovascular Disease	O=C(C1=CC=CN=C1)O	https://www.medchemexpress.com/Niacin.html	Launched		92.0	O39	I22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0143	10.0	mM	214.0	DMSO	123.032028	22	I	pluskal_fda_drugs_5005_I22_id
1748	HY-B1227	HYCPK40907	L05	HYCPK40907	92z	1066.0	2.0	W10	907.0	L05	53716-49-7	Carprofen		273.71	Autophagy; COX; Endogenous Metabolite; FAAH	Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Carprofen is a nonsteroid anti-inflammatory agent, acts as a multi-target FAAH/COX inhibitor, with IC50s of 3.9 μM, 22.3 μM and 78.6 μM for COX-2, COX-1 and FAAH, respectively.	Free Acid	C15H12ClNO2	24545.0	DMSO : 100 mg/mL (365.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C(C)C1=CC(NC2=C3C=C(Cl)C=C2)=C3C=C1	https://www.medchemexpress.com/Carprofen.html	Launched		92.0	W10	I22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1227	10.0	mM	214.0	DMSO	273.055656	22	I	pluskal_fda_drugs_5005_I22_id
1905	HY-14263	HYCPK40907	A16	HYCPK40907	92z	32.0	2.0	A32	907.0	A16	2622-26-6	Pericyazine	Propericiazine; RP 8909	365.49	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Pericyazine (Propericiazine) is a first-generation antipsychotic agent that is used as an adjunct to the short-term management of severe anxiety states and psychosis[1]. Pericyazine is a selective D2-dopamine receptor antagonist[2][3]. Pericyazine has adrenolytic, anticholinergic, and extrapyramidal effects[4].	Free Base	C21H23N3OS	55760.0	DMSO : 250 mg/mL (684.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	N#CC(C=C1N2CCCN3CCC(O)CC3)=CC=C1SC4=C2C=CC=C4	https://www.medchemexpress.com/pericyazine.html	Launched		92.0	A32	I22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14263	10.0	mM	214.0	DMSO	365.156183	22	I	pluskal_fda_drugs_5005_I22_id
2091	HY-W012382	HYCPK40908	D08	HYCPK40908	92z	351.0	3.0	H15	908.0	D08	537-55-3	N-Acetyl-L-tyrosine		223.23	Endogenous Metabolite	Metabolic Enzyme/Protease	N-Acetyl-L-tyrosine originates from tyrosine through an AA acetylase, is associated with aromatic L-amino acid decarboxylase deficiency and tyrosinemia I.	Free Acid	C11H13NO4	61099.0	DMSO : 100 mg/mL (447.97 mM; Need ultrasonic); H2O : 100 mg/mL (447.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	OC1=CC=C(C=C1)C[C@@H](C(O)=O)NC(C)=O	https://www.medchemexpress.com/N-Acetyl-L-tyrosine.html	Launched		92.0	H15	I22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W012382	10.0	mM	214.0	DMSO	223.084458	22	I	pluskal_fda_drugs_5005_I22_id
2239	HY-17005	HYCPK40908	P17	HYCPK40908	92z	1521.0	3.0	AF33	908.0	P17	144689-63-4	Olmesartan medoxomil	CS 866	558.59	Angiotensin Receptor	GPCR/G Protein	Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM.	Free Base	C29H30N6O6	8104.0	DMSO : 50 mg/mL (89.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(OCC1=C(OC(O1)=O)C)C2=C(N=C(N2CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5)CCC)C(O)(C)C	https://www.medchemexpress.com/Olmesartan-medoxomil.html	Launched		92.0	AF33	I22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17005	10.0	mM	214.0	DMSO	558.222683	22	I	pluskal_fda_drugs_5005_I22_id
27	HY-B1826	HYCPK40899	E03	HYCPK40909	92z	460.0	4.0	J28	909.0	E14	106941-25-7	Adefovir	GS-0393; PMEA	273.19	HBV; Reverse Transcriptase	Anti-infection	Adefovir (GS-0393) is an adenosine monophosphate analog antiviral agent that after intracellular conversion to Adefovir diphosphate inhibits HBV DNA polymerase. Adefovir has an IC50 of 0.7 μM against HBV in the HepG2.2.15 cell line. Adefovir has good antiviral activity against several viruses, including HBV and herpesviruses[1][2][3].	Free Acid	C8H12N5O4P	152032.0	H2O : 1 mg/mL (3.66 mM; ultrasonic and warming and heat to 60°C); 0.1 M NaOH : 10 mg/mL (36.60 mM; ultrasonic and adjust pH to 10 with NaOH)	DMSO Solution	2mM  * 100uL	Infection	NC1=C2N=CN(CCOCP(O)(O)=O)C2=NC=N1	https://www.medchemexpress.com/adefovir.html	Launched		92.0	J28	J3	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1826	2.0	mM	219.0	DMSO	273.06269	3	J	pluskal_fda_drugs_5005_J3_id
1867	HY-10574	HYCPK40907	C13	HYCPK40907	92z	218.0	2.0	E26	907.0	C13	500287-72-9	Rilpivirine	R278474; TMC278; DB08864	366.42	HIV; Reverse Transcriptase	Anti-infection	Rilpivirine (R278474) is a potent and specific diarylpyrimidine (DAPY) non-nucleoside reverse transcriptase inhibitor (NNRTI). Rilpivirine has high antiviral activity against wild-type HIV (EC50=0.4 nM) and mutant viruses (EC50=0.1-2.0 nM). Rilpivirine has a high genetic barrier to resistance development of HIV[1][2].	Free Base	C22H18N6	8014.0	DMSO : 50 mg/mL (136.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC1=CC(/C=C/C#N)=CC(C)=C1NC2=CC=NC(NC3=CC=C(C=C3)C#N)=N2	https://www.medchemexpress.com/Rilpivirine.html	Launched		92.0	E26	J3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10574	10.0	mM	219.0	DMSO	366.159295	3	J	pluskal_fda_drugs_5005_J3_id
1951	HY-14247A	HYCPK40907	O18	HYCPK40907	92z	1380.0	2.0	AC36	907.0	O18	102676-47-1	Fadrozole	CGS 16949A (free base); (Rac)-FAD286	223.27	Aromatase	Others	Fadrozole (CGS 16949A free base) is a potent, selective and nonsteroidal inhibitor of aromatase with an IC50 of 6.4 nM.	Free Base	C14H13N3	26349.0	DMSO : ≥ 100 mg/mL (447.89 mM)	DMSO Solution	10mM  * 100uL	Cancer	N#CC1=CC=C(C2CCCC3=CN=CN23)C=C1	https://www.medchemexpress.com/Fadrozole.html	Launched		92.0	AC36	J3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14247A	10.0	mM	219.0	DMSO	223.110947	3	J	pluskal_fda_drugs_5005_J3_id
2267	HY-B1257	HYCPK40908	L19	HYCPK40908	92z	1141.0	3.0	X37	908.0	L19	56796-39-5	Cefmetazole (sodium)	Sodium cefmetazole	493.52	Antibiotic; Bacterial	Anti-infection	Cefmetazole sodium (Sodium cefmetazole) is a semisynthetic cephamycin antibiotic with broad-spectrum antibacterial activity, covering gram-positive, gram-negative, and anaerobic bacteria. Cefmetazole sodium binds to penicillin binding proteins (PBPs), resulting in interfering bacterial cell wall biosynthesis. Cefmetazole sodium is used for the research of gynecologic, intraabdominal, urinary tract, respiratory tract and skin and soft tissue infections[1][2][3].	Sodium	C15H16N7NaO5S3	87762.0	DMSO : 250 mg/mL (506.57 mM; Need ultrasonic); H2O : 100 mg/mL (202.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@](OC)(NC(CSCC#N)=O)C1=O)O[Na]	https://www.medchemexpress.com/Cefmetazole-sodium.html	Launched		92.0	X37	J3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1257	10.0	mM	219.0	DMSO	471.04533	3	J	pluskal_fda_drugs_5005_J3_id
2278	HY-B0293	HYCPK40908	G20	HYCPK40908	92z	663.0	3.0	N39	908.0	G20	64872-77-1	Butoconazole (nitrate)	RS 35887	474.79	Fungal	Anti-infection	Butoconazole nitrate (RS 35887), an imidazole antifungal agent, is active against Candida spp. and effective against vaginal infections due to Candida albicans. Butoconazole nitrate is presumed to function as other imidazole derivatives via inhibition of steroid synthesis[1][2].	Nitrate	C19H18Cl3N3O3S	16015.0	DMSO : ≥ 100 mg/mL (210.62 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	ClC1=C(SC(CCC2=CC=C(Cl)C=C2)CN3C=CN=C3)C(Cl)=CC=C1.O[N+]([O-])=O	https://www.medchemexpress.com/Butoconazole-nitrate.html	Launched		92.0	N39	J3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0293	10.0	mM	219.0	DMSO	410.017803	3	J	pluskal_fda_drugs_5005_J3_id
2287	HY-17379	HYCPK40908	P20	HYCPK40908	92z	1527.0	3.0	AF39	908.0	P20	134523-03-8	Atorvastatin (hemicalcium salt)	CI-981; Atorvastatin hemicalcium	577.67	Autophagy; Ferroptosis; HMG-CoA Reductase (HMGCR)	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Atorvastatin hemicalcium salt (CI-981) is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, has the ability to effectively decrease blood lipids. Atorvastatin hemicalcium salt inhibits human SV-SMC proliferation and invasion with IC50s of 0.39 μM and 2.39 μM, respectively[1][2][3].	Calcium	C33H34Ca0.5FN2O5	7406.0	DMSO : ≥ 50 mg/mL (86.55 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Inflammation/Immunology; Cancer	FC1=CC=C(C2=C(C3=CC=CC=C3)C(C(NC4=CC=CC=C4)=O)=C(C(C)C)N2CC[C@@H](O)C[C@@H](O)CC([O-])=O)C=C1.[0.5Ca2+]	https://www.medchemexpress.com/atorvastatin-hemicalcium-salt.html	Launched		92.0	AF39	J3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17379	10.0	mM	219.0	DMSO	558.253	3	J	pluskal_fda_drugs_5005_J3_id
2405	HY-B0760	HYCPK40908	A22	HYCPK40908	92z	91.0	3.0	B43	908.0	A22	42017-89-0	Fenofibric acid	FNF acid	318.75	COX; PPAR	Cell Cycle/DNA Damage; Immunology/Inflammation	Fenofibric acid, an active metabolite of fenofibrate, is a PPAR activitor, with EC50s of 22.4 μM, 1.47 μM, and 1.06 μM for PPARα, PPARγ and PPARδ, respectively; Fenofibric acid also inhibits COX-2 enzyme activity, with an IC50 of 48 nM.	Free Acid	C17H15ClO4	13706.0	DMSO : ≥ 100 mg/mL (313.73 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC(C)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C(O)=O	https://www.medchemexpress.com/Fenofibric-acid.html	Launched		92.0	B43	J3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0760	10.0	mM	219.0	DMSO	318.065887	3	J	pluskal_fda_drugs_5005_J3_id
2468	HY-B0627	HYCPK40909	P05	HYCPK40909	92z	1498.0	4.0	AF10	909.0	P05	657-24-9	Metformin	1,1-Dimethylbiguanide	129.16	AMPK; Autophagy; Mitophagy	Autophagy; Epigenetics; PI3K/Akt/mTOR	Metformin (1,1-Dimethylbiguanide) inhibits the mitochondrial respiratory chain in the liver, leading to activation of AMPK, enhancing insulin sensitivity for type 2 diabetes research. Metformin can cross the blood-brain barrier and triggers autophagy[1].	Free Base	C4H11N5	158939.0	H2O : 50 mg/mL (387.12 mM; Need ultrasonic); DMSO : 100 mg/mL (774.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Cardiovascular Disease	NC(NC(N(C)C)=N)=N	https://www.medchemexpress.com/metformin.html	Launched		92.0	AF10	J3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0627	10.0	mM	219.0	DMSO	129.101445	3	J	pluskal_fda_drugs_5005_J3_id
1443	HY-109037	HYCPK40907	N04	HYCPK40907	92z	1256.0	2.0	AA8	907.0	N04	1642288-47-8	Mavacamten	MYK461; SAR439152	273.33	Myosin	Cytoskeleton	Mavacamten (MYK461) is an orally active modulator of cardiac myosin, with IC50s of 490, 711 nM for bovine cardiac and human cardiac, respectively.	Free Base	C15H19N3O2	34449.0	DMSO : 83.33 mg/mL (304.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC(N(C1=O)C(C=C(N[C@H](C2=CC=CC=C2)C)N1)=O)C	https://www.medchemexpress.com/Mavacamten.html	Launched		92.0	AA8	J4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109037	10.0	mM	220.0	DMSO	273.147727	4	J	pluskal_fda_drugs_5005_J4_id
1654	HY-14247	HYCPK40906	I19	HYCPK40906	92z	805.0	1.0	Q37	906.0	I19	102676-31-3	Fadrozole (hydrochloride)	CGS 16949A; (Rac)-FAD286 (hydrochloride)	259.73	Aromatase	Others	Fadrozole hydrochloride (CGS 16949A) is a potent, selective and nonsteroidal inhibitor of aromatase with an IC50 of 6.4 nM.	Hydrochloride	C14H14ClN3	29209.0	H2O : 100 mg/mL (385.02 mM; Need ultrasonic); DMSO : 100 mg/mL (385.02 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	N#CC1=CC=C(C2CCCC3=CN=CN23)C=C1.Cl	https://www.medchemexpress.com/Fadrozole_hydrochloride.html	Launched		92.0	Q37	J4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14247	10.0	mM	220.0	DMSO	223.110947	4	J	pluskal_fda_drugs_5005_J4_id
1720	HY-B0698A	HYCPK40907	K03	HYCPK40907	92z	966.0	2.0	U6	907.0	K03	118081-34-8	Ceftibuten (dihydrate)	Sch-39720 (dihydrate)	446.46	Antibiotic; Bacterial	Anti-infection	Ceftibuten (Sch-39720) dihydrate, an antibiotic, is an orally active cephalosporin, possesses potent activity in vitro against a wide range of gram-negative and certain gram-positive pathogens[1][2].	Free Acid	C15H18N4O8S2	16966.0	H2O : 100 mg/mL (223.98 mM; ultrasonic and warming and heat to 80°C); DMSO : 100 mg/mL (223.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=CCS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=C\CC(O)=O)=O)C1=O)O.O.O	https://www.medchemexpress.com/Ceftibuten-dihydrate.html	Launched		92.0	U6	J4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0698A	10.0	mM	220.0	DMSO	410.035476	4	J	pluskal_fda_drugs_5005_J4_id
1782	HY-D0211	HYCPK40907	N07	HYCPK40907	92z	1262.0	2.0	AA14	907.0	N07	77-09-8	Phenolphthalein		318.32	Others	Others	Phenolphthalein is a widely applied but toxic indicator dye.	Free Base	C20H14O4	27482.0	DMSO : ≥ 50 mg/mL (157.07 mM)	DMSO Solution	10mM  * 100uL	Others	O=C1OC(C2=CC=C(O)C=C2)(C3=CC=C(O)C=C3)C4=C1C=CC=C4	https://www.medchemexpress.com/Phenolphthalein.html	Launched		92.0	AA14	J4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0211	10.0	mM	220.0	DMSO	318.089209	4	J	pluskal_fda_drugs_5005_J4_id
1992	HY-103252	HYCPK40907	L21	HYCPK40907	92z	1098.0	2.0	W42	907.0	L21	2756-87-8	Monomethyl fumarate		130.10	Drug Metabolite; GPR109A	GPCR/G Protein; Metabolic Enzyme/Protease	Monomethyl fumarate, an active metabolite of Dimethyl fumarate (DMF), is a potent GPR109A agonist. Monomethyl fumarate has the potential for multiple neuroprotective pathways and other models of retinal disease[1][2][3].		C5H6O4	97254.0	DMSO : 50 mg/mL (384.32 mM; Need ultrasonic); H2O : 10 mg/mL (76.86 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	O=C(OC)/C=C/C(O)=O	https://www.medchemexpress.com/monomethyl-fumarate.html	Launched		92.0	W42	J4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-103252	10.0	mM	220.0	DMSO	130.026609	4	J	pluskal_fda_drugs_5005_J4_id
2119	HY-13001	HYCPK40908	P09	HYCPK40908	92z	1505.0	3.0	AF17	908.0	P09	950769-58-1	Quizartinib	AC220	560.67	Apoptosis; Autophagy; FLT3; Ligands for Target Protein for PROTAC	Apoptosis; Autophagy; PROTAC; Protein Tyrosine Kinase/RTK	Quizartinib (AC220) is an orally active, highly selective and potent second-generation type II FLT3 tyrosine kinase inhibitor, with a Kd of 1.6 nM. Quizartinib inhibits wild-type FLT3 and FLT3-ITD autophosphorylation in MV4-11 cells with IC50s of 4.2 and 1.1 nM, respectively. Quizartinib can be linked to the VHL ligand via an optimized linker to form a PROTAC FLT3 degrader. Quizartinib induces apoptosis[1].	Free Base	C29H32N6O4S	20907.0	DMSO : ≥ 33 mg/mL (58.86 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=NOC(C(C)(C)C)=C1)NC2=CC=C(C=C2)C3=CN4C(SC5=CC(OCCN6CCOCC6)=CC=C45)=N3	https://www.medchemexpress.com/Quizartinib.html	Launched		92.0	AF17	J4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13001	10.0	mM	220.0	DMSO	560.220575	4	J	pluskal_fda_drugs_5005_J4_id
2273	HY-B1743A	HYCPK40908	B20	HYCPK40908	92z	183.0	3.0	D39	908.0	B20	58-58-2	Puromycin (dihydrochloride)	CL13900 (dihydrochloride)	544.43	Antibiotic; Bacterial; Parasite	Anti-infection	Puromycin dihydrochloride (CL13900 dihydrochloride), an aminonucleoside antibiotic, inhibits protein synthesis[1].	Hydrochloride	C22H31Cl2N7O5	99625.0	H2O : 50 mg/mL (91.84 mM; Need ultrasonic and warming); DMSO : 50 mg/mL (91.84 mM; Need ultrasonic); Ethanol : 5 mg/mL (9.18 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	OC[C@@H]1[C@@H](NC([C@@H](N)CC2=CC=C(OC)C=C2)=O)[C@H]([C@H](N3C=NC4=C3N=CN=C4N(C)C)O1)O.[H]Cl.[H]Cl	https://www.medchemexpress.com/Puromycin_Dihydrochloride.html	Launched		92.0	D39	J4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1743A	10.0	mM	220.0	DMSO	471.223017	4	J	pluskal_fda_drugs_5005_J4_id
2511	HY-B0198	HYCPK40909	B09	HYCPK40909	92z	162.0	4.0	D18	909.0	B09	53994-73-3	Cefaclor		367.81	Antibiotic; Bacterial	Anti-infection	Cefaclor is a well-absorbed orally active cephalosporin antibiotic.  Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3).  Cefaclor can be used for the research kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections[1][2][3].	Free Acid	C15H14ClN3O4S	16060.0	DMSO : 18.5 mg/mL (50.30 mM; Need ultrasonic and warming); H2O : 3.85 mg/mL (10.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(Cl)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=CC=C3)=O)C1=O)O	https://www.medchemexpress.com/Cefaclor.html	Launched		92.0	D18	J4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0198	10.0	mM	220.0	DMSO	367.039355	4	J	pluskal_fda_drugs_5005_J4_id
15	HY-107910	HYCPK40897	O03	HYCPK40909	92z	1428.0	4.0	AD36	909.0	O18	37326-33-3	Hyaluronidase	Hyaluronate 4-glycanohydrolase; Hyaluronoglucosaminidase		Others	Others	Hyaluronidase (Hyaluronate 4-glycanohydrolase; Hyaluronoglucosaminidase) is a naturally occurring enzyme that depolymerizes hyaluronic acid by cleavage of glycosidic bonds and has been utilized in ophthalmic surgery[1][2].			86359.0	H2O : 100 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Cancer	[Hyaluronoglucosaminidase]	https://www.medchemexpress.com/hyaluronidase.html	Launched		92.0	AD36	J5	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107910	3.0	mM	221.0	DMSO	273.172879	5	J	pluskal_fda_drugs_5005_J5_id
1495	HY-B2179	HYCPK40906	J09	HYCPK40906	92z	881.0	1.0	S17	906.0	J09	85187-37-7	Cloperastine fendizoate		648.19	Potassium Channel	Membrane Transporter/Ion Channel	Cloperastine fendizoate inhibits the hERG K+ currents in a concentration-dependent manner with an IC50 value of 27 nM.		C40H38ClNO5	26262.0	DMSO : 10 mg/mL (15.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C1=CC=CC=C1C(C2=CC(C3=CC=CC=C3)=C(O)C=C2)=O.ClC4=CC=C(C(C5=CC=CC=C5)OCCN6CCCCC6)C=C4	https://www.medchemexpress.com/Cloperastine_fendizoate.html	Launched		92.0	S17	J5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2179	10.0	mM	221.0	DMSO	318.089209	5	J	pluskal_fda_drugs_5005_J5_id
1633	HY-114277	HYCPK40906	D18	HYCPK40906	92z	323.0	1.0	G35	906.0	D18	2296729-00-3	Sotorasib	AMG-510	560.59	Ras	GPCR/G Protein	Sotorasib (AMG-510) is a first-in-class, orally bioavailable, and selective KRAS G12C covalent inhibitor. Sotorasib irreversibly inhibits KRAS G12C by locking it in an inactive GDP-bound state. Sotorasib is the first KRAS G12C inhibitor in clinical development and leads to the regression of KRAS G12C tumors[1][2].	Free Base	C30H30F2N6O3	111616.0	H2O : 33.33 mg/mL (59.46 mM; ultrasonic and adjust pH to 11 with NaOH); DMSO : 50 mg/mL (89.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C=C)N1C[C@H](C)N(C2=NC(N(C3=C(C)C=CN=C3C(C)C)C4=C2C=C(F)C(C5=C(O)C=CC=C5F)=N4)=O)CC1	https://www.medchemexpress.com/AMG-510.html	Launched		92.0	G35	J5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-114277	10.0	mM	221.0	DMSO	560.234745	5	J	pluskal_fda_drugs_5005_J5_id
1883	HY-B0906	HYCPK40907	C14	HYCPK40907	92z	220.0	2.0	E28	907.0	C14	1083-57-4	Bucetin	3-Hydroxy-p-butyrophenetidide	223.27	Others	Others	Bucetin (3-Hydroxy-p-butyrophenetidide) is an analgesic and antipyretic compound.	Free Base	C12H17NO3	17358.0	DMSO : ≥ 35 mg/mL (156.76 mM)	DMSO Solution	10mM  * 100uL	Others	CC(O)CC(NC1=CC=C(OCC)C=C1)=O	https://www.medchemexpress.com/Bucetin.html	Launched		92.0	E28	J5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0906	10.0	mM	221.0	DMSO	223.120843	5	J	pluskal_fda_drugs_5005_J5_id
1981	HY-A0158	HYCPK40907	A21	HYCPK40907	92z	42.0	2.0	A42	907.0	A21	2557-49-5	Diflorasone		410.45	Others	Others	Diflorasone act as a corticosteroid hormone receptor agonist with anti-inflammatory and immunosuppressive properties. Diflorasone enters the cell by diffusion across the cell membrane and binds to the glucocorticoid receptor (GR) in the cytoplasm. Diflorasone is used for the research of skin diseases such as?eczema?or?psoriasis[1].	Free Base	C22H28F2O5	42106.0	DMSO : 130 mg/mL (316.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(CO)=O)(O)[C@@H](C)C[C@@]1([H])[C@]3([H])C[C@H](F)C4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/Diflorasone.html	Launched		92.0	A42	J5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0158	10.0	mM	221.0	DMSO	410.19048	5	J	pluskal_fda_drugs_5005_J5_id
2087	HY-N0666C	HYCPK40908	P07	HYCPK40908	92z	1501.0	3.0	AF13	908.0	P07	3792-50-5	L-Aspartic aicd (sodium)	Sodium L-aspartate	155.08	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Aspartic aicd sodium is is an amino acid, shown to be a suitable prodrug for colon-specific drug deliverly[1][2].	Sodium	C4H6NNaO4	94050.0	H2O	DMSO Solution	10mM  * 100uL	Others	N[C@@H](CC(O)=O)C([O-])=O.[Na+]	https://www.medchemexpress.com/s-2-aminosuccinic-acid-sodium-salt.html	Launched		92.0	AF13	J5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0666C	10.0	mM	221.0	DMSO	133.037508	5	J	pluskal_fda_drugs_5005_J5_id
2280	HY-12694	HYCPK40908	I20	HYCPK40908	92z	855.0	3.0	R39	908.0	I20	179474-85-2	Prucalopride (succinate)	R-108512	485.96	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Prucalopride succinate is a selective, high affinity 5-HT4 receptor agonist with pKi of 8.6/8.1 for 5-HT4a/4b.
IC50 value:
Target: 5-HT4 agonist
in vitro: Prucalopride was a 5-HT(4) receptor agonist in the guinea-pig colon, as it induced contractions (pEC(50)=7.48+/-0.06; insensitive to a 5-HT(2A) or 5-HT(3) receptor antagonist, but inhibited by a 5-HT(4) receptor antagonist) as well as the facilitation of electrical stimulation-induced noncholinergic contractions (blocked by a 5-HT(4) receptor antagonist). Prucalopride did not cause relevant inhibition of 5-HT(2A), 5-HT(2B), or 5-HT(3), motilin or cholecystokinin (CCK(1)) receptor-mediated contractions, nor nicotinic or muscarinic acetylcholine receptor-mediated contractions, up to 10 microM [1].
in vivo: Rat microdialysis studies revealed that prucalopride maximally increased ACh and histamine levels in the prefrontal cortex at 5 and 10 mg/kg, whereas PRX-03140 significantly increased cortical histamine levels at 50 mg/kg, failing to affect ACh release at doses lower than 150 mg/kg [2]."	Succinate	C22H32ClN3O7	15249.0	DMSO : 50 mg/mL (102.89 mM; Need ultrasonic); H2O : ≥ 20 mg/mL (41.16 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CCC(O)=O.O=C(C1=C(OCC2)C2=C(N)C(Cl)=C1)NC3CCN(CCCOC)CC3	https://www.medchemexpress.com/Prucalopride-succinate.html	Launched		92.0	R39	J5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12694	10.0	mM	221.0	DMSO	367.166269	5	J	pluskal_fda_drugs_5005_J5_id
2428	HY-114778	HYCPK40909	H03	HYCPK40909	92z	726.0	4.0	P6	909.0	H03	1358715-18-0	Fluzoparib	SHR3162; Fuzuloparib	472.40	PARP	Cell Cycle/DNA Damage; Epigenetics	Fluzoparib (SHR3162) is a potent and orally active PARP1 inhibitor (IC50=1.46±0.72 nM, a cell‐free enzymatic assay) with superior antitumor activity. Fluzoparib selectively inhibits the proliferation of homologous recombination repair (HR)‐deficient cells, and sensitizes both HR‐deficient and HR‐proficient cells to cytotoxic agents. Fluzoparib exhibits good pharmacokinetic properties in vivo and can be used for BRCA1/2-mutant relapsed ovarian cancer research[1].		C22H16F4N6O2	112511.0	DMSO : 20.83 mg/mL (44.09 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NN=C(CC2=CC=C(F)C(C(N3CC4=NC(C(F)(F)F)=NN4CC3)=O)=C2)C5=C1C=CC=C5	https://www.medchemexpress.com/fluzoparib.html	Launched		92.0	P6	J5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-114778	10.0	mM	221.0	DMSO	472.127087	5	J	pluskal_fda_drugs_5005_J5_id
34	HY-114277A	HYCPK40899	L03	HYCPK40909	92z	1132.0	4.0	X28	909.0	L14	2252403-56-6	Sotorasib (racemate)	AMG-510 (racemate)	560.59	Ras	GPCR/G Protein	Sotorasib (AMG-510) racemate is the racemate of Sotorasib (AMG-510). AMG-510 is a potent, orally bioavailable, and selective KRAS G12C covalent inhibitor with anti-tumor activity.	Free Base	C30H30F2N6O3	60047.0	DMSO : 3.85 mg/mL (6.87 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Cancer	O=C1N(C2=C(C)C=CN=C2C(C)C)C3=NC(C4=C(O)C=CC=C4F)=C(F)C=C3C(N5[C@@H](C)CN(C(C=C)=O)CC5)=N1	https://www.medchemexpress.com/AMG-510_racemate.html	Launched		92.0	X28	J6	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-114277A	2.0	mM	222.0	DMSO	560.234745	6	J	pluskal_fda_drugs_5005_J6_id
1368	HY-B0724A	HYCPK40906	E03	HYCPK40906	92z	389.0	1.0	I5	906.0	E03	163680-77-1	Pazufloxacin (mesylate)	T-3762; Pazufloxacin methanesulfonate; Pazufloxacin mesilate	414.41	Antibiotic; Bacterial	Anti-infection	"Pazufloxacin (T-3761) mesylate is a fluoroquinolone antibiotic.
Target: Antibacterial
Pazufloxacin (T-3761), a new quinolone derivative, showed broad and potent antibacterial activity. T-3761 showed good efficacy in mice against systemic, pulmonary, and urinary tract infections with gram-positive and gram-negative bacteria, including quinolone-resistant Serratia marcescens and Pseudomonas aeruginosa. The in vivo activity of T-3761 was comparable to or greater than those of ofloxacin, ciprofloxacin, norfloxacin, and tosufloxacin against most infection models in mice. The activities of T-3761 were lower than those of tosufloxacin against gram-positive bacterial systemic and pulmonary infections in mice but not against infections with methicillin-resistant Staphylococcus aureus [1]. T-3761 had a broad spectrum of activity and had potent activity against gram-positive and -negative bacteria. The MICs of T-3761 against 90% of the methicillin-susceptible Staphylococcus aureus, methicillin-susceptible and -resistant Staphylococcus epidermidis, and Clostridium spp. tested were 0.39 to 6.25 micrograms/ml. The MBCs of T-3761 were either equal to or twofold greater than the MICs. The 50% inhibitory concentrations of T-3761 for DNA gyrases isolated from E. coli and P. aeruginosa were 0.88 and 1.9 micrograms/ml, respectively [2]."	Mesylate	C17H19FN2O7S	16834.0	DMSO : 100 mg/mL (241.31 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (241.31 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(C1=O)=CN2[C@@H](C)COC3=C(C4(N)CC4)C(F)=CC1=C23)O.CS(=O)(O)=O	https://www.medchemexpress.com/Pazufloxacin-mesylate.html	Launched		92.0	I5	J6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0724A	10.0	mM	222.0	DMSO	318.101585	6	J	pluskal_fda_drugs_5005_J6_id
1559	HY-B0494	HYCPK40906	J13	HYCPK40906	92z	889.0	1.0	S25	906.0	J13	2438-72-4	Bufexamac	Bufexamic acid	223.27	HDAC	Cell Cycle/DNA Damage; Epigenetics	Bufexamac is a class IIB histone deacetylases (HDAC6 and HDAC10) inhibitor used as an anti-inflammatory agent.	Free Base	C12H17NO3	18041.0	H2O : 0.67 mg/mL (3.00 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (447.89 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(NO)CC1=CC=C(OCCCC)C=C1	https://www.medchemexpress.com/bufexamac.html	Launched		92.0	S25	J6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0494	10.0	mM	222.0	DMSO	223.120843	6	J	pluskal_fda_drugs_5005_J6_id
1610	HY-14151	HYCPK40906	M16	HYCPK40906	92z	1183.0	1.0	Y31	906.0	M16	179474-81-8	Prucalopride		367.87	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Prucalopride is an orally active, selective and specific 5-HT 4 receptor agonist (high affinity), with pKis of 8.6 and 8.1 for human 5-HT4a/4b receptors, respectively. Prucalopride improves intestinal motility by promoting regeneration of the intestinal nervous system in rats. Prucalopride also shows anticancer activity by blocking of the PI3K/AKT/mTor signaling pathway. Prucalopride can be used in studies of chronic constipation, pseudo-intestinal obstruction and cancer[1][2][3].	Free Base	C18H26ClN3O3	16480.0	DMSO : ≥ 31 mg/mL (84.27 mM); H2O : 50 mg/mL (135.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	ClC1=C(N)C(CCO2)=C2C(C(NC3CCN(CCCOC)CC3)=O)=C1	https://www.medchemexpress.com/Prucalopride.html	Launched		92.0	Y31	J6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14151	10.0	mM	222.0	DMSO	367.166269	6	J	pluskal_fda_drugs_5005_J6_id
1877	HY-107329	HYCPK40907	M13	HYCPK40907	92z	1178.0	2.0	Y26	907.0	M13	33075-00-2	Cefathiamidine		472.58	Antibiotic; Bacterial	Anti-infection	Cefathiamidine is a first-generation cephalosporin antibacterial agent and is used to treat infections caused by susceptible bacteria. Cefathiamidine exhibits a wide spectrum of antimicrobial activity against bacteria. Cefathiamidine is used for the treatment of respiratory, liver, five senses, urinary tract infections, endocarditis and sepsis[1][2].	Free Acid	C19H28N4O6S2	152945.0	DMSO : 125 mg/mL (264.51 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	OC(C1=C(COC(C)=O)CS[C@@]([C@@H]2NC(CS/C(NC(C)C)=N\C(C)C)=O)([H])N1C2=O)=O	https://www.medchemexpress.com/cefathiamidine.html	Launched		92.0	Y26	J6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107329	10.0	mM	222.0	DMSO	472.145027	6	J	pluskal_fda_drugs_5005_J6_id
1984	HY-109654	HYCPK40907	D21	HYCPK40907	92z	330.0	2.0	G42	907.0	D21	27503-81-7	Ensulizole		274.30	Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Ensulizole is a sulfonated UV absorber and can intense UVB and partial UVA absorption. Ensulizole can damage the DNA through the generation of reactive oxygen species (ROS) upon UV or sunlight irradiation[1].	Free Acid	C13H10N2O3S	58090.0	DMSO : 8.33 mg/mL (30.37 mM; Need ultrasonic); 0.1 M NaOH : 10 mg/mL (36.46 mM; ultrasonic and adjust pH to 8 with NaOH)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=S(C1=CC=C2N=C(C3=CC=CC=C3)NC2=C1)(O)=O	https://www.medchemexpress.com/ensulizole.html	Launched		92.0	G42	J6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109654	10.0	mM	222.0	DMSO	274.041213	6	J	pluskal_fda_drugs_5005_J6_id
2075	HY-N0666	HYCPK40908	D07	HYCPK40908	92z	349.0	3.0	H13	908.0	D07	56-84-8	L-Aspartic acid		133.10	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Aspartic acid is is an amino acid, shown to be a suitable prodrug for colon-specific drug deliverly.	Free Acid	C4H7NO4	38998.0	H2O : 8.33 mg/mL (62.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	N[C@H](C(O)=O)CC(O)=O	https://www.medchemexpress.com/L-Aspartic_acid.html	Launched		92.0	H13	J6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0666	10.0	mM	222.0	DMSO	133.037508	6	J	pluskal_fda_drugs_5005_J6_id
2303	HY-B1080	HYCPK40909	C07	HYCPK40909	92z	254.0	4.0	F14	909.0	C07	27591-69-1	Tilorone (dihydrochloride)		483.47	HIF/HIF Prolyl-Hydroxylase; Influenza Virus	Anti-infection; Metabolic Enzyme/Protease	Tilorone dihydrochloride is the first recognized synthetic, small molecular weight compound that is an orally active interferon inducer, used as an antiviral drug.	Hydrochloride	C25H36Cl2N2O3	22620.0	H2O : 100 mg/mL (206.84 mM; Need ultrasonic); DMSO : 12.5 mg/mL (25.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1C2=C(C3=C1C=C(OCCN(CC)CC)C=C3)C=CC(OCCN(CC)CC)=C2.[H]Cl.[H]Cl	https://www.medchemexpress.com/Tilorone-dihydrochloride.html	Launched		92.0	F14	J6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1080	10.0	mM	222.0	DMSO	410.256943	6	J	pluskal_fda_drugs_5005_J6_id
1373	HY-13570C	HYCPK40906	J03	HYCPK40906	92z	869.0	1.0	S5	906.0	J03	151-73-5	Betamethasone disodium phosphate	Betamethasone 21-phosphate disodium salt; Vista-Methasone	516.40	Others	Others	Betamethasone disodium phosphate (Betamethasone 21-phosphate disodium salt) is a kind of corticosteroid, which is commonly used in the intralesional research of keloids[1].		C22H28FNa2O8P	178723.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Others	C[C@@]12[C@](C[C@@H]([C@]2(O)C(COP(O[Na])(O[Na])=O)=O)C)([H])[C@@]3([H])[C@@]([C@@]4(C(CC3)=CC(C=C4)=O)C)([C@H](C1)O)F	https://www.medchemexpress.com/betamethasone-disodium-phosphate.html	Launched		92.0	S5	J7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13570C	10.0	mM	223.0	DMSO	472.166233	7	J	pluskal_fda_drugs_5005_J7_id
1624	HY-B1206	HYCPK40906	K17	HYCPK40906	92z	993.0	1.0	U33	906.0	K17	51-60-5	Neostigmine (methyl sulfate)		334.39	Cholinesterase (ChE)	Neuronal Signaling	Neostigmine methyl sulfate is a reversible inhibitor of acetylcholinesterase, can not cross the blood-brain barrier.	Methylsulfate	C13H22N2O6S	17458.0	DMSO : ≥ 100 mg/mL (299.05 mM); H2O : 100 mg/mL (299.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	C[N+](C)(C)C1=CC=CC(OC(N(C)C)=O)=C1.O=S(OC)([O-])=O	https://www.medchemexpress.com/Neostigmine-methyl-sulfate.html	Launched		92.0	U33	J7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1206	10.0	mM	223.0	DMSO	223.144104	7	J	pluskal_fda_drugs_5005_J7_id
2010	HY-B0103A	HYCPK40907	N22	HYCPK40907	92z	1292.0	2.0	AA44	907.0	N22	61718-82-9	Fluvoxamine (maleate)	DU-23000 (maleate)	434.41	Serotonin Transporter	Neuronal Signaling	Fluvoxamine maleate (DU-23000 maleate) is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.	Maleate	C19H25F3N2O6	15627.0	DMSO : ≥ 100 mg/mL (230.20 mM); H2O : 20 mg/mL (46.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(O)/C=C\C(O)=O.FC(C1=CC=C(/C(CCCCOC)=N/OCCN)C=C1)(F)F	https://www.medchemexpress.com/Fluvoxamine-maleate.html	Launched		92.0	AA44	J7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0103A	10.0	mM	223.0	DMSO	318.155513	7	J	pluskal_fda_drugs_5005_J7_id
2176	HY-17501A	HYCPK40908	M13	HYCPK40908	92z	1225.0	3.0	Z25	908.0	M13	81732-46-9	Bambuterol hydrochloride	(±)-Bambuterol hydrochloride; KWD-2183 hydrochloride	403.90	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Bambuterol hydrochloride ((±)-Bambuterol hydrochloride; KWD-2183 hydrochloride) is a long acting beta-adrenoceptor agonist (LABA) used in the treatment of asthma; it also is a prodrug of terbutaline.	Hydrochloride	C18H30ClN3O5	16539.0	DMSO : 120 mg/mL (297.10 mM; Need ultrasonic); H2O : 2.4 mg/mL (5.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	OC(C1=CC(OC(N(C)C)=O)=CC(OC(N(C)C)=O)=C1)CNC(C)(C)C.[H]Cl	https://www.medchemexpress.com/Bambuterol-hydrochloride.html	Launched		92.0	Z25	J7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17501A	10.0	mM	223.0	DMSO	367.210721	7	J	pluskal_fda_drugs_5005_J7_id
2305	HY-A0285	HYCPK40909	E07	HYCPK40909	92z	446.0	4.0	J14	909.0	E07	3836-23-5	Norethisterone enanthate	Norigest	410.59	Progesterone Receptor	Others	Norethisterone enanthate is a long-acting parenteral progestogen. Norethisterone enanthate is orally active[1][2][3].		C27H38O3	64085.0	DMSO : 250 mg/mL (608.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	C#C[C@]1(OC(CCCCCC)=O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4([H])[C@@]3([H])CC[C@]12C)=O	https://www.medchemexpress.com/norethisterone-enanthate.html	Launched		92.0	J14	J7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0285	10.0	mM	223.0	DMSO	410.282095	7	J	pluskal_fda_drugs_5005_J7_id
2451	HY-13904	HYCPK40909	O04	HYCPK40909	92z	1400.0	4.0	AD8	909.0	O04	895519-90-1	Flumatinib	HHGV678	562.59	Bcr-Abl; c-Kit; PDGFR	Protein Tyrosine Kinase/RTK	Flumatinib (HHGV678) is an orally available, selective inhibitor of Bcr-Abl. Flumatinib inhibits c-Abl, PDGFRβ and c-Kit with IC50s of 1.2 nM, 307.6 nM and 665.5 nM, respectively[1].	Free Base	C29H29F3N8O	90063.0	DMSO : 100 mg/mL (177.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC(NC2=NC=CC(C3=CC=CN=C3)=N2)=C(C)N=C1)C4=CC=C(CN5CCN(C)CC5)C(C(F)(F)F)=C4	https://www.medchemexpress.com/Flumatinib.html	Launched		92.0	AD8	J7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13904	10.0	mM	223.0	DMSO	562.241642	7	J	pluskal_fda_drugs_5005_J7_id
2497	HY-B1062	HYCPK40909	D08	HYCPK40909	92z	352.0	4.0	H16	909.0	D08	2438-32-6	Dexchlorpheniramine (maleate)	S-(+)-Chlorpheniramine maleate salt	390.86	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Dexchlorpheniramine maleate is an antihistamine, with anticholinergic properties, used to treat allergic conditions.	Maleate	C20H23ClN2O4	23432.0	DMSO : ≥ 100 mg/mL (255.85 mM); H2O : ≥ 100 mg/mL (255.85 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(O)/C=C\C(O)=O.CN(C)CC[C@H](C1=NC=CC=C1)C2=CC=C(Cl)C=C2	https://www.medchemexpress.com/Dexchlorpheniramine-maleate.html	Launched		92.0	H16	J7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1062	10.0	mM	223.0	DMSO	274.123676	7	J	pluskal_fda_drugs_5005_J7_id
2525	HY-B1496	HYCPK40909	P09	HYCPK40909	92z	1506.0	4.0	AF18	909.0	P09	13492-01-8	Tranylcypromine (hemisulfate)	SKF 385 (hemisulfate)	182.23	Histone Demethylase; Monoamine Oxidase	Epigenetics; Neuronal Signaling	Tranylcypromine (SKF 385) hemisulfate is an irreversible, nonselective monoamine oxidase (MAO) inhibitor used in the treatment of depression. Tranylcypromine hemisulfate is also a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis. Tranylcypromine has antidepressant effects[1][2].	Sulfate	C9H12NO2S0.5	18539.0	H2O : 25 mg/mL (137.19 mM; Need ultrasonic); DMSO : 5 mg/mL (27.44 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	N[C@H]1[C@H](C2=CC=CC=C2)C1.[0.5H2SO4]	https://www.medchemexpress.com/Tranylcypromine-hemisulfate.html	Launched		92.0	AF18	J7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1496	10.0	mM	223.0	DMSO	133.089149	7	J	pluskal_fda_drugs_5005_J7_id
1592	HY-B0103	HYCPK40906	K15	HYCPK40906	92z	989.0	1.0	U29	906.0	K15	54739-18-3	Fluvoxamine	DU-23000	318.33	Serotonin Transporter	Neuronal Signaling	Fluvoxamine (DU-23000) is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor.	Free Base	C15H21F3N2O2	145135.0	DMSO : 160 mg/mL (502.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	FC(C1=CC=C(/C(CCCCOC)=N/OCCN)C=C1)(F)F	https://www.medchemexpress.com/fluvoxamine.html	Launched		92.0	U29	J8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0103	10.0	mM	224.0	DMSO	318.155513	8	J	pluskal_fda_drugs_5005_J8_id
1816	HY-B1188	HYCPK40907	P09	HYCPK40907	92z	1458.0	2.0	AE18	907.0	P09	50-34-0	Propantheline (bromide)		448.39	mAChR	GPCR/G Protein; Neuronal Signaling	Propantheline bromide is an orally active mAChR antagonist. Propantheline bromide can be used in the research of smooth muscle dysfunction, excessive sweating, cramps or spasms of the stomach, intestines or bladder, and involuntary urination[1][2][3].	Bromide	C23H30BrNO3	28021.0	H2O : 50 mg/mL (111.51 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (223.02 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC([N+](C(C)C)(C)CCOC(C1C2=C(OC3=C1C=CC=C3)C=CC=C2)=O)C.[Br-]	https://www.medchemexpress.com/Propantheline-bromide.html	Launched		92.0	AE18	J8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1188	10.0	mM	224.0	DMSO	368.22202	8	J	pluskal_fda_drugs_5005_J8_id
1838	HY-B0116	HYCPK40907	F11	HYCPK40907	92z	502.0	2.0	K22	907.0	F11	3056-17-5	Stavudine	d4T	224.21	Apoptosis; Autophagy; HIV; NOD-like Receptor (NLR); Nucleoside Antimetabolite/Analog; Reverse Transcriptase	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation	Stavudine (d4T) is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Stavudine has activity against HIV-1 and HIV-2. Stavudine also inhibits the replication of mitochondrial DNA (mtDNA). Stavudine reduces NLRP3 inflammasome activation and modulates Amyloid-β autophagy. Stavudine induces apoptosis[1][2][3][4].	Free Base	C10H12N2O4	105082.0	DMSO : 125 mg/mL (557.51 mM; Need ultrasonic); H2O : 16.67 mg/mL (74.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC[C@H]1O[C@@H](N2C=C(C)C(NC2=O)=O)C=C1	https://www.medchemexpress.com/stavudine.html	Launched		92.0	K22	J8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0116	10.0	mM	224.0	DMSO	224.079707	8	J	pluskal_fda_drugs_5005_J8_id
1887	HY-Y1311	HYCPK40907	G14	HYCPK40907	92z	604.0	2.0	M28	907.0	G14	6915-15-7	Malic acid	Hydroxybutanedioic acid; E 296	134.09	Endogenous Metabolite	Metabolic Enzyme/Protease	Malic acid (Hydroxybutanedioic acid) is a dicarboxylic acid that is naturally found in fruits such as apples and pears. It plays a role in many sour or tart foods.	Free Acid	C4H6O5	66313.0	DMSO : 100 mg/mL (745.77 mM; Need ultrasonic); H2O : 100 mg/mL (745.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(O)C(O)CC(O)=O	https://www.medchemexpress.com/Malic_acid.html	Launched		92.0	M28	J8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y1311	10.0	mM	224.0	DMSO	134.021523	8	J	pluskal_fda_drugs_5005_J8_id
1977	HY-13905	HYCPK40907	M20	HYCPK40907	92z	1192.0	2.0	Y40	907.0	M20	895519-91-2	Flumatinib (mesylate)	HHGV678 mesylate	658.69	Bcr-Abl; c-Kit; PDGFR	Protein Tyrosine Kinase/RTK	Flumatinib (HHGV678) mesylate is an orally active and selective inhibitor of Bcr-Abl. Flumatinib mesylate inhibits c-Abl, PDGFRβ and c-Kit with IC50 values of 1.2,  307.6 and 665.5 nM, respectively. Flumatinib mesylate inhibits Bcr-Abl autophosphorylation and Stat5 and Erk1/2 phosphorylation. Flumatinib mesylate inhibits tumor growth in chronic myelogenous leukemia model[1][2].	Mesylate	C30H33F3N8O4S	10475.0	DMSO : 50 mg/mL (75.91 mM; Need ultrasonic); H2O : 50 mg/mL (75.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC(NC2=NC=CC(C3=CC=CN=C3)=N2)=C(C)N=C1)C4=CC=C(CN5CCN(C)CC5)C(C(F)(F)F)=C4.CS(=O)(O)=O	https://www.medchemexpress.com/flumatinib-mesylate.html	Launched		92.0	Y40	J8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13905	10.0	mM	224.0	DMSO	562.241642	8	J	pluskal_fda_drugs_5005_J8_id
2471	HY-B0563B	HYCPK40909	C06	HYCPK40909	92z	252.0	4.0	F12	909.0	C06	98717-15-8	Ropivacaine (hydrochloride)		310.86	Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel	Ropivacaine hydrochloride is a potent?sodium channel?blocker and blocks impulse conduction via reversible inhibition of?sodium ion influx?in nerve fibrese[1][2]. Ropivacaine is also an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane[3]. Ropivacaine is widely used for neuropathic pain?management in vivo[1].	Hydrochloride	C17H27ClN2O	28196.0	DMSO : 10 mg/mL (32.17 mM; Need ultrasonic); H2O : 10 mg/mL (32.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease; Cancer	[H]Cl.O=C([C@H]1N(CCC)CCCC1)NC2=C(C)C=CC=C2C	https://www.medchemexpress.com/Ropivacaine_hydrochloride.html	Launched		92.0	F12	J8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0563B	10.0	mM	224.0	DMSO	274.204513	8	J	pluskal_fda_drugs_5005_J8_id
2494	HY-16379	HYCPK40909	A08	HYCPK40909	92z	64.0	4.0	B16	909.0	A08	937272-79-2	Pacritinib	SB1518	472.58	FLT3; JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Pacritinib (SB1518) is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V617F mutant (IC50=19 nM). Pacritinib also inhibits FLT3 (IC50=22 nM) and its mutant FLT3D835Y (IC50=6 nM).	Free Base	C28H32N4O3	26518.0	DMSO : 5 mg/mL (10.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C1(COC/C=C/COCC2=C(OCCN3CCCC3)C=CC4=C2)=CC=CC(C5=N/C(NC=C5)=N\4)=C1	https://www.medchemexpress.com/pacritinib.html	Launched		92.0	B16	J8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16379	10.0	mM	224.0	DMSO	472.247441	8	J	pluskal_fda_drugs_5005_J8_id
2540	HY-14664A	HYCPK40909	O10	HYCPK40909	92z	1412.0	4.0	AD20	909.0	O10	93957-55-2	Fluvastatin (sodium)	XU 62-320	433.45	Autophagy; Ferroptosis; HMG-CoA Reductase (HMGCR)	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Fluvastatin sodium (XU 62320) is a first fully synthetic, competitive HMG-CoA reductase inhibitor with an IC50 of 8 nM. Fluvastatin sodium protects vascular smooth muscle cells against oxidative stress through the Nrf2-dependent antioxidant pathway[1][2][3].	Sodium	C24H25FNNaO4	11788.0	H2O : 50 mg/mL (115.35 mM; Need ultrasonic); DMSO : 50 mg/mL (115.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(O[Na])C[C@H](O)C[C@H](O)/C=C/C(N1C(C)C)=C(C2=CC=C(F)C=C2)C3=C1C=CC=C3	https://www.medchemexpress.com/Fluvastatin-sodium.html	Launched		92.0	AD20	J8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14664A	10.0	mM	224.0	DMSO	411.184587	8	J	pluskal_fda_drugs_5005_J8_id
62	HY-B1247	HYCPK40899	P05	HYCPK40909	92z	1520.0	4.0	AF32	909.0	P16	553-12-8	Protoporphyrin IX		562.66	Endogenous Metabolite	Metabolic Enzyme/Protease	Protoporphyrin IX is the final intermediate in the heme biosynthetic pathway.	Free Acid	C34H34N4O4	112686.0	DMSO : 2.08 mg/mL (3.70 mM; Need ultrasonic); Ethanol : < 1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	2mM  * 100uL	Others	O=C(O)CCC1=C2/C=C3C(CCC(O)=O)=C(C)C(/C=C(N/4)/C(C)=C(C=C)C4=C\C5=N/C(C(C=C)=C5C)=C\C(N2)=C1C)=N/3	https://www.medchemexpress.com/Protoporphyrin-IX.html	Launched		92.0	AF32	J9	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1247	2.0	mM	225.0	DMSO	562.258006	9	J	pluskal_fda_drugs_5005_J9_id
1374	HY-B0908	HYCPK40906	K03	HYCPK40906	92z	965.0	1.0	U5	906.0	K03	1084-65-7	Meticrane		275.34	Chloride Channel; Sodium Channel	Membrane Transporter/Ion Channel	Meticrane is a diuretic. Meticrane inhibits the reabsorption of sodium and chloride ions in the distal convoluted tubule. Meticrane is used to treat essential hypertension.	Free Base	C10H13NO4S2	25552.0	DMSO : ≥ 50 mg/mL (181.59 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(C1=C(C)C=C(C2=C1)CCCS2(=O)=O)(N)=O	https://www.medchemexpress.com/Meticrane.html	Launched		92.0	U5	J9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0908	10.0	mM	225.0	DMSO	275.0286	9	J	pluskal_fda_drugs_5005_J9_id
1481	HY-B0152A	HYCPK40906	L08	HYCPK40906	92z	1071.0	1.0	W15	906.0	L08	2922-28-3	Adenine (hydrochloride)	6-Aminopurine (hydrochloride); Vitamin B4 (hydrochloride)	171.59	DNA/RNA Synthesis; Endogenous Metabolite	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Adenine hydrochloride (6-Aminopurine hydrochloride), a purine, is one of the four nucleobases in the nucleic acid of DNA. Adenine hydrochloride acts as a chemical component of DNA and RNA. Adenine hydrochloride also plays an important role in biochemistry involved in cellular respiration, the form of both ATP and the cofactors (NAD and FAD), and protein synthesis[1][2][3].	Hydrochloride	C5H6ClN5	231695.0	DMSO : 100 mg/mL (582.78 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	NC1=C2N=CNC2=NC=N1.Cl	https://www.medchemexpress.com/adenine-hydrochloride.html	Launched		92.0	W15	J9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0152A	10.0	mM	225.0	DMSO	135.054495	9	J	pluskal_fda_drugs_5005_J9_id
1490	HY-18204A	HYCPK40906	E09	HYCPK40906	92z	401.0	1.0	I17	906.0	E09	936623-90-4	Sacubitril/Valsartan	LCZ696	957.99	Angiotensin Receptor; Apoptosis; Neprilysin	Apoptosis; GPCR/G Protein; Metabolic Enzyme/Protease	Sacubitril/Valsartan (LCZ696), comprised Valsartan and Sacubitril (AHU377) in 1:1 molar ratio, is a first-in-class, orally bioavailable, and dual-acting angiotensin receptor-neprilysin (ARN) inhibitor for hypertension and heart failure[1][2][3]. Sacubitril/Valsartan ameliorates diabetic cardiomyopathy by inhibiting inflammation, oxidative stress and apoptosis[4].	Sodium	C48H60N6Na3O10.5	62872.0	DMSO : ≥ 100 mg/mL (104.39 mM); H2O : ≥ 50 mg/mL (52.19 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=C(CCC(O[Na])=O)N([C@H](CC(C=C1)=CC=C1C2=CC=CC=C2)C[C@@H](C)C(OCC)=O)[H].O=C(O[Na])[C@@H](N(C(CCCC)=O)CC3=CC=C(C4=CC=CC=C4C5=NN=NN5[Na])C=C3)C(C)C.[2.5H2O]	https://www.medchemexpress.com/LCZ696.html	Launched		92.0	I17	J9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18204A	10.0	mM	225.0	DMSO	411.204573	9	J	pluskal_fda_drugs_5005_J9_id
1656	HY-B1209	HYCPK40906	K19	HYCPK40906	92z	997.0	1.0	U37	906.0	K19	519-37-9	Etofylline	7-(β-Hydroxyethyl)theophylline	224.22	Others	Others	Etofylline (7-(β-Hydroxyethyl)theophylline) is a N-7-substituted derivative of Theophylline. Etofylline is a bronchodilator which can be used for the research of asthma. Etofylline is also an anticholesteremic and reduces total cholesterol level in the blood[1][2].	Free Base	C9H12N4O3	27018.0	DMSO : 25 mg/mL (111.50 mM; Need ultrasonic); H2O : 50 mg/mL (223.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(N1C)N(C)C2=C(N(CCO)C=N2)C1=O	https://www.medchemexpress.com/Etofylline.html	Launched		92.0	U37	J9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1209	10.0	mM	225.0	DMSO	224.09094	9	J	pluskal_fda_drugs_5005_J9_id
2117	HY-B1278	HYCPK40908	N09	HYCPK40908	92z	1313.0	3.0	AB17	908.0	N09	58-95-7	D-α-Tocopherol acetate	D-Vitamin E acetate	472.74	Endogenous Metabolite	Metabolic Enzyme/Protease	D-α-Tocopherol acetate (D-Vitamin E acetate) can be  hydrolyzed to d-alpha-tocopherol (VE) and absorbed in the small intestine[1].		C31H52O3	64194.0	Ethanol : 100 mg/mL (211.53 mM; Need ultrasonic); DMSO : ≥ 250 mg/mL (528.83 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(C)C(OC(C)=O)=C(C)C(C)=C2O1	https://www.medchemexpress.com/alpha-tocopherol-acetate.html	Launched		92.0	AB17	J9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1278	10.0	mM	225.0	DMSO	472.391646	9	J	pluskal_fda_drugs_5005_J9_id
2527	HY-17465	HYCPK40909	B10	HYCPK40909	92z	164.0	4.0	D20	909.0	B10	596-51-0	Glycopyrrolate	Glycopyrronium (bromide); Glycopyrrolate (bromide)	398.33	mAChR	GPCR/G Protein; Neuronal Signaling	"Glycopyrrolate (Glycopyrronium bromide) is a muscarinic competitive antagonist used as an antispasmodic.
IC50 Value:
Target: mAChR (Muscarinic acetylcholine receptor M1)
in vitro: Glycopyrrolate showed no selectivity in its binding to the M1-M3 receptors. Kinetics studies, however, showed that glycopyrrolate dissociates slowly from HASM muscarinic receptors (60% protection against [3H]-NMS binding at 30 nM) compared to ipratropium bromide [1].
in vivo: Glycopyrrolate (1 mg) tablets were then administered, starting with one tablet daily the third week and increasing the daily dose by one tablet per week until a maximum of four tablets during week six and 4 days of week seven when the daily dose was reduced to two tablets for 3 days. glycopyrrolate can be given in controlled doses provided that an adequate medical assessment has been undertaken [2]. Glycopyrrolate has a slow and erratic absorption from the gastrointestinal system, but even low plasma levels are associated with a distinct and long-lasting antisialogic effect [3]. Oral glycopyrrolate is emerging as a potential second-line treatment option, but experience with safety, efficacy, and dosing is especially limited in children [4]. phase III study, 52.3% of glycopyrrolate oral solution recipients (aged 3-18 years; n = 137) had an mTDS response (primary endpoint); the response rate was consistently above 50% at all 4-weekly timepoints, aside from the first assessment at week 4 (40.3%). In general, glycopyrrolate oral solution was well tolerated in clinical trials. The majority of adverse events were within expectations as characteristic anticholinergic outcomes [5].
Toxicity: Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. The medication also induces drowsiness or blurred vision. LD50=709 mg/kg (rat, oral)."	Bromide	C19H28BrNO3	14536.0	H2O : 100 mg/mL (251.05 mM; Need ultrasonic); DMSO : 100 mg/mL (251.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	C[N+]1(C)CC(OC(C(O)(C2CCCC2)C3=CC=CC=C3)=O)CC1.[Br-]	https://www.medchemexpress.com/Glycopyrrolate.html	Launched		92.0	D20	J9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17465	10.0	mM	225.0	DMSO	318.20637	9	J	pluskal_fda_drugs_5005_J9_id
2542	HY-B1090	HYCPK40909	A11	HYCPK40909	92z	70.0	4.0	B22	909.0	A11	298-57-7	Cinnarizine		368.51	Calcium Channel; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Membrane Transporter/Ion Channel; Neuronal Signaling	Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.	Free Base	C26H28N2	22663.0	DMSO : 7.14 mg/mL (19.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	N1(C(C2=CC=CC=C2)C3=CC=CC=C3)CCN(C/C=C/C4=CC=CC=C4)CC1	https://www.medchemexpress.com/Cinnarizine.html	Launched		92.0	B22	J9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1090	10.0	mM	225.0	DMSO	368.225249	9	J	pluskal_fda_drugs_5005_J9_id
1487	HY-B1336	HYCPK40906	B09	HYCPK40906	92z	113.0	1.0	C17	906.0	B09	67-45-8	Furazolidone		225.16	Antibiotic; Apoptosis; Bacterial; Parasite	Anti-infection; Apoptosis	"Furazolidone is a nitrofuran derivative with antiprotozoal and antibacterial activity, inhibits AML1-ETO transformed cells with IC50 value of 12.7 μM.
Target: Antibacterial 
Furazolidone is a novel therapeutic strategy in AML patients. Furazolidone can Inhibit the bone-marrow transformation mediated by a series of leukemia fusion proteins. Furazolidone significantly inhibits proliferation of AML cell lines. Furazolidone induces apoptosis of the AML leukemic cells treatment with Furazolidone induces differentiation of AML cell lines."	Free Base	C8H7N3O5	17595.0	H2O : 0.67 mg/mL (2.98 mM; Need ultrasonic); DMSO : 10 mg/mL (44.41 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1OCCN1/N=C/C2=CC=C([N+]([O-])=O)O2	https://www.medchemexpress.com/Furazolidone.html	Launched		92.0	C17	J10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1336	10.0	mM	226.0	DMSO	225.03857	10	J	pluskal_fda_drugs_5005_J10_id
1593	HY-15407	HYCPK40906	L15	HYCPK40906	92z	1085.0	1.0	W29	906.0	L15	149709-62-6	Sacubitril	AHU-377	411.49	Neprilysin	Metabolic Enzyme/Protease	Sacubitril (AHU-377) is a potent and orally active NEP (neprilysin) inhibitor with an IC50 of 5 nM. Sacubitril is a component of the heart failure medicine LCZ696. Sacubitril can be used for the research of heart failure, hypertension and COVID-19[1][2][3].	Free Acid	C24H29NO5	15592.0	DMSO : 100 mg/mL (243.02 mM; Need ultrasonic); H2O : 0.67 mg/mL (1.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cardiovascular Disease	O=C(CCC(O)=O)N[C@H](CC1=CC=C(C2=CC=CC=C2)C=C1)C[C@@H](C)C(OCC)=O	https://www.medchemexpress.com/AHU-377.html	Launched		92.0	W29	J10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15407	10.0	mM	226.0	DMSO	411.204573	10	J	pluskal_fda_drugs_5005_J10_id
1743	HY-121685A	HYCPK40907	G05	HYCPK40907	92z	586.0	2.0	M10	907.0	G05	1449686-84-3	Tipepidine (hydrochloride)		311.89	Potassium Channel	Membrane Transporter/Ion Channel	Tipepidine hydrochloride reversibly inhibits dopamine (DA) D2 receptor-mediated GIRK currents (IDA(GIRK)) with an IC50 of 7.0 μM. Tipepidine hydrochloride subsequently activates VTA dopamine neuron[1]. Tipepidine hydrochloride, a non-narcotic antitussive, exerts an antidepressant-like effect[2].	Hydrochloride	C15H18ClNS2	45894.0	DMSO : 41.67 mg/mL (133.60 mM; Need ultrasonic); H2O : 3.33 mg/mL (10.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1C/C(CCC1)=C(C2=CC=CS2)\C3=CC=CS3.[H]Cl	https://www.medchemexpress.com/tipepidine-hydrochloride.html	Launched		92.0	M10	J10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-121685A	10.0	mM	226.0	DMSO	275.080242	10	J	pluskal_fda_drugs_5005_J10_id
1769	HY-B0132	HYCPK40907	A07	HYCPK40907	92z	14.0	2.0	A14	907.0	A07	70458-96-7	Norfloxacin	MK-0366	319.33	Antibiotic; Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Norfloxacin (MK-0366) is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria, which functions by inhibiting DNA gyrase.	Free Acid	C16H18FN3O3	15700.0	DMSO : 5 mg/mL (15.66 mM; Need ultrasonic); H2O : 1 mg/mL (3.13 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCNCC3)=C2)C1=O)O	https://www.medchemexpress.com/Norfloxacin.html	Launched		92.0	A14	J10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0132	10.0	mM	226.0	DMSO	319.13322	10	J	pluskal_fda_drugs_5005_J10_id
1781	HY-18690	HYCPK40907	M07	HYCPK40907	92z	1166.0	2.0	Y14	907.0	M07	1446502-11-9	Enasidenib	AG-221	473.38	Isocitrate Dehydrogenase (IDH)	Metabolic Enzyme/Protease	Enasidenib is an oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes, with IC50s of 100 and 400 nM against IDH2R140Q and IDH2R172K, respectively.	Free Base	C19H17F6N7O	18195.0	DMSO : 50 mg/mL (105.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1	https://www.medchemexpress.com/Enasidenib.html	Launched		92.0	Y14	J10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18690	10.0	mM	226.0	DMSO	473.139877	10	J	pluskal_fda_drugs_5005_J10_id
2006	HY-B0130A	HYCPK40907	J22	HYCPK40907	92z	908.0	2.0	S44	907.0	J22	107133-36-8	Perindopril (erbumine)	Perindopril (tert-butylamine salt); S-9490 (erbumine)	441.60	Angiotensin-converting Enzyme (ACE); Apoptosis	Apoptosis; Metabolic Enzyme/Protease	"Perindopril erbumine (Perindopril tert-butylamine salt) is a potent ACE inhibitor of which is used to treat high blood pressure, heart failure or stable coronary artery disease.
Target: ACE
Perindopril is a long-acting ACE inhibitor. It is used to treat high blood pressure, heart failure or stable coronary artery disease in form of perindopril arginine (trade names include Coversyl, Coversum) or perindopril erbumine (trade name Aceon). According to the Australian government's Pharmaceutical Benefits Scheme website, based on data provided to the Australian Department of Health and Aging by the manufacturer, perindopril arginine and perindopril erbumine are therapeutically equivalent and may be interchanged without differences in clinical effect. However the dose prescribed to achieve the same effect will differ due to different molecular weights for the two forms.    
Perindopril is one of the most prescribed inhibitors of angiotensin converting enzyme, has a large evidence base, which allows to use it in patients with hypertension, diabetes mellitus type 2, coronary heart disease and chronic heart failure. In this review, the author focused on the evidence of organoprotecting properties of perindopril that lie outside lowering blood pressure."	Erbumine	C23H43N3O5	20319.0	DMSO : 10 mg/mL (22.64 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (113.22 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C([C@H]1N(C([C@@H](N[C@H](C(OCC)=O)CCC)C)=O)[C@@]2([H])CCCC[C@@]2([H])C1)O.CC(C)(C)N	https://www.medchemexpress.com/Perindopril-erbumine.html	Launched		92.0	S44	J10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0130A	10.0	mM	226.0	DMSO	368.231122	10	J	pluskal_fda_drugs_5005_J10_id
2041	HY-B0219	HYCPK40908	M04	HYCPK40908	92z	1207.0	3.0	Z7	908.0	M04	315-30-0	Allopurinol		136.11	Xanthine Oxidase	Metabolic Enzyme/Protease	Allopurinol is a potent and orally active xanthine oxidase inhibitor with an IC50 value of 0.2-50 μM. Allopurinol can be used in the treatment of hyperuricemia and gout. Allopurinol decreases the expression of HIF-1α and HIF-2α protein. Allopurinol shows anti-depressant and anti-nociception activity. Anti-leishmanial effect[1][2][3][4][5].	Free Base	C5H4N4O	16536.0	DMSO : 14 mg/mL (102.86 mM; Need ultrasonic and warming); H2O : 1 mg/mL (7.35 mM; ultrasonic and adjust pH to 11 with NaOH)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology; Neurological Disease	O=C1C2=C(NN=C2)N=CN1	https://www.medchemexpress.com/Allopurinol.html	Launched		92.0	Z7	J10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0219	10.0	mM	226.0	DMSO	136.038511	10	J	pluskal_fda_drugs_5005_J10_id
2453	HY-15287	HYCPK40909	A05	HYCPK40909	92z	58.0	4.0	B10	909.0	A05	159989-64-7	Nelfinavir	AG1341	567.78	HIV; HIV Protease	Anti-infection; Metabolic Enzyme/Protease	Nelfinavir (AG-1341) is a potent and orally bioavailable HIV-1 protease inhibitor (Ki=2 nM) for HIV infection. Nelfinavir is a broad-spectrum, anticancer agent[1][2][3].	Free Base	C32H45N3O4S	5933.0	DMSO : ≥ 100 mg/mL (176.12 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	[H][C@]12C[C@@H](C(NC(C)(C)C)=O)N(C[C@H]([C@@H](NC(C3=C(C)C(O)=CC=C3)=O)CSC4=CC=CC=C4)O)C[C@@]1([H])CCCC2	https://www.medchemexpress.com/nelfinavir.html	Launched		92.0	B10	J10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15287	10.0	mM	226.0	DMSO	567.313078	10	J	pluskal_fda_drugs_5005_J10_id
1665	HY-B1266	HYCPK40906	D20	HYCPK40906	92z	327.0	1.0	G39	906.0	D20	57-64-7	Physostigmine (salicylate)	Eserine (salicylate)	413.47	Cholinesterase (ChE)	Neuronal Signaling	Physostigmine salicylate (Eserine salicylate) is a reversible acetylcholinesterase (AChE) inhibitor. Physostigmine salicylate crosses the blood-brain barrier and stimulates central cholinergic neurotransmission. Physostigmine salicylate can reverse memory deficits in transgenic mice with Alzheimer's disease. Physostigmine salicylate is also an antidote for anticholinergic poisoning[1][2][3][4].	salicylate	C22H27N3O5	116757.0	H2O : 33.33 mg/mL (80.61 mM; Need ultrasonic); DMSO : 125 mg/mL (302.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(O)C1=CC=CC=C1O.O=C(OC2=CC3=C(N(C)[C@]4([H])[C@@]3(C)CCN4C)C=C2)NC	https://www.medchemexpress.com/physostigmine-salicylate.html	Launched		92.0	G39	J11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1266	10.0	mM	227.0	DMSO	275.163377	11	J	pluskal_fda_drugs_5005_J11_id
1784	HY-70053A	HYCPK40907	P07	HYCPK40907	92z	1454.0	2.0	AE14	907.0	P07	1206695-46-6	Fesoterodine (L-mandelate)		563.72	mAChR	GPCR/G Protein; Neuronal Signaling	Fesoterodine L-mandelate is an orally active, nonsubtype selective, competitive muscarinic receptor (mAChR) antagonist with pKi values of 8.0, 7.7, 7.4, 7.3, 7.5 for M1, M2, M3, M4, M5 receptors, respectively. Fesoterodine L-mandelate is used for the overactive bladder (OAB)[1][2].	L-Mandelate	C34H45NO6	42677.0	DMSO : 100 mg/mL (177.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	O[C@H](C(O)=O)C1=CC=CC=C1.O=C(C(C)C)OC2=CC=C(CO)C=C2[C@@H](C3=CC=CC=C3)CCN(C(C)C)C(C)C	https://www.medchemexpress.com/fesoterodine-l-mandelate.html	Launched		92.0	AE14	J11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-70053A	10.0	mM	227.0	DMSO	411.277344	11	J	pluskal_fda_drugs_5005_J11_id
1872	HY-17422	HYCPK40907	H13	HYCPK40907	92z	698.0	2.0	O26	907.0	H13	59277-89-3	Acyclovir	Aciclovir; Acycloguanosine	225.20	Antibiotic; Apoptosis; Bacterial; HSV	Anti-infection; Apoptosis	Acyclovir (Aciclovir) is a potent, orally active antiviral agent. Acyclovir has antiherpetic activity with IC50 values of 0.85 μM and 0.86 μM for HSV-1 and HSV-2, respectively. Acyclovir induces cell cycle perturbation and apoptosis. Acyclovir prevents bacterial infections during induction therapy for acute leukaemia[1][2][3][4].	Free Base	C8H11N5O3	58472.0	DMSO : ≥ 50 mg/mL (222.02 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C1NC(N)=NC2=C1N=CN2COCCO	https://www.medchemexpress.com/Acyclovir.html	Launched		92.0	O26	J11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17422	10.0	mM	227.0	DMSO	225.086189	11	J	pluskal_fda_drugs_5005_J11_id
1923	HY-B0524A	HYCPK40907	C17	HYCPK40907	92z	226.0	2.0	E34	907.0	C17	5579-84-0	Betahistine (dihydrochloride)		209.12	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Betahistine dihydrochloride is an orally active histamine H1 receptor agonist and a H3 receptor antagonist[1]. Betahistine dihydrochloride is used for the study of rheumatoid arthritis (RA)[3].	Hydrochloride	C8H14Cl2N2	15756.0	DMF : 5 mg/mL (23.91 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (239.10 mM); DMSO : 33.33 mg/mL (159.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology; Neurological Disease	CNCCC1=CC=CC=N1.Cl.Cl	https://www.medchemexpress.com/Betahistine-dihydrochloride.html	Launched		92.0	E34	J11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0524A	10.0	mM	227.0	DMSO	136.100048	11	J	pluskal_fda_drugs_5005_J11_id
2149	HY-10260	HYCPK40908	B12	HYCPK40908	92z	167.0	3.0	D23	908.0	B12	443913-73-3	Vandetanib	ZD6474	475.35	Apoptosis; Autophagy; VEGFR	Apoptosis; Autophagy; Protein Tyrosine Kinase/RTK	Vandetanib (D6474) is a potent, orally active inhibitor of VEGFR2/KDR tyrosine kinase activity (IC50=40 nM). Vandetanib also has activity versus the tyrosine kinase activity of VEGFR3/FLT4 (IC50=110 nM) and EGFR/HER1 (IC50=500 nM)[1].	Free Base	C22H24BrFN4O2	39600.0	DMSO : 20.83 mg/mL (43.82 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	FC1=CC(Br)=CC=C1NC2=NC=NC3=CC(OCC4CCN(CC4)C)=C(C=C23)OC	https://www.medchemexpress.com/Vandetanib.html	Launched		92.0	D23	J11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10260	10.0	mM	227.0	DMSO	474.106666	11	J	pluskal_fda_drugs_5005_J11_id
2172	HY-15287A	HYCPK40908	I13	HYCPK40908	92z	841.0	3.0	R25	908.0	I13	159989-65-8	Nelfinavir (Mesylate)	AG 1343 Mesylate	663.89	HIV; HIV Protease	Anti-infection; Metabolic Enzyme/Protease	Nelfinavir Mesylate (AG 1343 Mesylate) is a potent and orally bioavailable HIV-1 protease inhibitor (Ki=2 nM) for HIV infection. Nelfinavir Mesylate (AG 1343 Mesylate) is a broad-spectrum, anticancer agent[1][2][3].	Mesylate	C33H49N3O7S2	36994.0	DMSO : 100 mg/mL (150.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	[H][C@]12C[C@@H](C(NC(C)(C)C)=O)N(C[C@H]([C@@H](NC(C3=C(C)C(O)=CC=C3)=O)CSC4=CC=CC=C4)O)C[C@@]1([H])CCCC2.CS(=O)(O)=O	https://www.medchemexpress.com/Nelfinavir-Mesylate.html	Launched		92.0	R25	J11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15287A	10.0	mM	227.0	DMSO	567.313078	11	J	pluskal_fda_drugs_5005_J11_id
2211	HY-A0195	HYCPK40908	P15	HYCPK40908	92z	1517.0	3.0	AF29	908.0	P15	58551-69-2	Carboprost (tromethamine)		489.64	Prostaglandin Receptor	GPCR/G Protein	Carboprost tromethamine is the synthetic 15-methyl analogue of prostaglandin F2α. Carboprost tromethamine can effectively promote law contraction of the uterus and significantly reduce the amount of bleeding during and after delivery[1][2].	Tris	C25H47NO8	64423.0	H2O : 125 mg/mL (255.29 mM; Need ultrasonic); DMSO : 100 mg/mL (204.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	CCCCC[C@](C)(O)/C=C/[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C/C=C\CCCC(O)=O.OCC(CO)(N)CO	https://www.medchemexpress.com/carboprost-tromethamine.html	Launched		92.0	AF29	J11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0195	10.0	mM	227.0	DMSO	368.256274	11	J	pluskal_fda_drugs_5005_J11_id
2234	HY-B0662	HYCPK40908	K17	HYCPK40908	92z	1041.0	3.0	V33	908.0	K17	170105-16-5	Imidafenacin	KRP-197; ONO-8025	319.40	mAChR	GPCR/G Protein; Neuronal Signaling	"Imidafenacin(KRP-197; ONO-8025) is a potent and selective inhibitor of M3 receptors with Kb of 0.317 nM; less potent for M2 receptors(IC50=4.13 nM).
IC50 value: 0.3 nM(M3) [1]
in vitro: KRP-197 showed equipotent anti-M2 and anti-M3 activity and decreased subtype-selectivity [1]. 
in vivo: Intraduodenal administration of
 KRP-197 (0.04±0.30 mg/kg) inhibited bladder contraction dose-dependently, and the ED30 value was 0.11 mg/kg. The inhibitory action of KRP-197 on the bladder  contraction was 19 times as potent as that of oxybutynin. KRP-197 showed preventive action against
the decrease in bladder capacity induced by carbachol
(ED50 0.074 mg/kg, intragastric administration), and
the potency of the inhibitory action was 15-fold greater
than that of oxybutynin [1]. The learning-inhibitory doses of intravenous oxybutynin hydrochloride and tolterodine tartrate were 0.3 and 3 mg/kg in sham-operated rats and 0.1 and 1 mg/kg in nbM-lesioned rats, respectively. Thus, the learning impairments by those antimuscarinics were more sensitive in nbM-lesioned rats than in sham-operated rats. On the other hand, intravenous administration of imidafenacin had no influence on learning in either case of the rats. In normal rats, however, intracerebroventricular administration of imidafenacin impaired learning to the same degree as that of oxybutynin hydrochloride [2]."	Free Base	C20H21N3O	14720.0	DMSO : 31.25 mg/mL (97.84 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC(C(C1=CC=CC=C1)(C2=CC=CC=C2)CCN3C(C)=NC=C3)=O	https://www.medchemexpress.com/Imidafenacin.html	Launched		92.0	V33	J11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0662	10.0	mM	227.0	DMSO	319.168462	11	J	pluskal_fda_drugs_5005_J11_id
4	HY-N0935	HYCPK40897	D03	HYCPK40909	92z	372.0	4.0	H36	909.0	D18	76494-51-4	Ligustrazine (hydrochloride)	Chuanxiongzine (hydrochloride); Tetramethylpyrazine (hydrochloride)		Others	Others	"Ligustrazine (hydrochloride) is a natural product.
IC50 value:
Target:
In vitro: Ligustrazine hydrochloride displayed a protection effect on injured ECV304 cells, NOS and NO formation were significantly increased compared with the model group [1].
In vivo:"	Hydrochloride	C8H12N2.xHCl	29201.0	DMSO : 100 mg/mL (Need ultrasonic); H2O : 100 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Others	C1(C)=NC(C)=C(C)N=C1C.C	https://www.medchemexpress.com/Ligustrazine-hydrochloride.html	Launched		92.0	H36	J12	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0935	3.0	mM	228.0	DMSO	136.100048	12	J	pluskal_fda_drugs_5005_J12_id
12	HY-100589	HYCPK40897	L03	HYCPK40909	92z	1140.0	4.0	X36	909.0	L18	67814-76-0	Isepamicin (sulfate)	Sch 21420 (sulfate)		Antibiotic; Bacterial	Anti-infection	Isepamicin sulfate (Sch 21420 sulfate) is a broad spectrum aminoglycoside antibiotic. Isepamicin sulfate exhibits considerable antimicrobial activity against Gram-negative non-fermenters in a region with high antimicrobial resistance[1][2].	Sulfate	C22H43N5O12.xH2SO4	154188.0	H2O : 125 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Infection	O=S(O)(O)=O.O[C@@H]1[C@H]([C@@H](C[C@H](N)[C@H]1O[C@@]([C@@H]([C@@H](O)[C@@H]2O)O)([H])O[C@@H]2CN)NC([C@@H](O)CN)=O)O[C@](OC[C@](C)(O)[C@@H]3NC)([H])[C@@H]3O.[x]	https://www.medchemexpress.com/isepamicin-sulfate.html	Launched		92.0	X36	J12	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100589	3.0	mM	228.0	DMSO	569.290822	12	J	pluskal_fda_drugs_5005_J12_id
1425	HY-15025	HYCPK40906	N06	HYCPK40906	92z	1259.0	1.0	AA11	906.0	N06	139755-83-2	Sildenafil	UK-92480	474.58	Apoptosis; Autophagy; Bacterial; Phosphodiesterase (PDE)	Anti-infection; Apoptosis; Autophagy; Metabolic Enzyme/Protease	Sildenafil (UK-92480) is a potent phosphodiesterase type 5 (PDE5) inhibitor with an IC50 of 5.22 nM.	Free Base	C22H30N6O4S	39622.0	DMSO : ≥ 29 mg/mL (61.11 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C1C(N(C)N=C2CCC)=C2N=C(C3=CC(S(=O)(N4CCN(C)CC4)=O)=CC=C3OCC)N1	https://www.medchemexpress.com/Sildenafil.html	Launched		92.0	AA11	J12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15025	10.0	mM	228.0	DMSO	474.204924	12	J	pluskal_fda_drugs_5005_J12_id
1870	HY-A0030	HYCPK40907	F13	HYCPK40907	92z	506.0	2.0	K26	907.0	F13	286930-03-8	Fesoterodine (fumarate)		527.65	mAChR	GPCR/G Protein; Neuronal Signaling	Fesoterodine Fumarate is an orally active, nonsubtype selective, competitive muscarinic receptor (mAChR) antagonist with pKi values of 8.0, 7.7, 7.4, 7.3, 7.5 for M1, M2, M3, M4, M5 receptors, respectively. Fesoterodine Fumarate is used for the overactive bladder (OAB)[1][2].	Fumarate	C30H41NO7	34896.0	H2O : 100 mg/mL (189.52 mM; Need ultrasonic); DMSO : 100 mg/mL (189.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	OCC1=CC([C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(C=C1)OC(C(C)C)=O.OC(/C=C/C(O)=O)=O	https://www.medchemexpress.com/Fesoterodine-fumarate.html	Launched		92.0	K26	J12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0030	10.0	mM	228.0	DMSO	411.277344	12	J	pluskal_fda_drugs_5005_J12_id
1906	HY-B0738	HYCPK40907	B16	HYCPK40907	92z	128.0	2.0	C32	907.0	B16	1143-38-0	Dithranol	Anthralin	226.23	DNA/RNA Synthesis	Cell Cycle/DNA Damage	Dithranol (Anthralin) is an anthraquinone derivative, with potent anti-psoriatic effects. Dithranol can inhibit DNA replication and repair[1][2].	Free Base	C14H10O3	145017.0	DMSO : 10 mg/mL (44.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1C2=C(C=CC=C2O)CC3=CC=CC(O)=C13	https://www.medchemexpress.com/Dithranol.html	Launched		92.0	C32	J12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0738	10.0	mM	228.0	DMSO	226.062994	12	J	pluskal_fda_drugs_5005_J12_id
1980	HY-17589A	HYCPK40907	P20	HYCPK40907	92z	1480.0	2.0	AE40	907.0	P20	54-05-7	Chloroquine		319.87	Antibiotic; Autophagy; HIV; Parasite; SARS-CoV; Toll-like Receptor (TLR)	Anti-infection; Autophagy; Immunology/Inflammation	Chloroquine is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM)[1][2][3][4].	Free Base	C18H26ClN3	159402.0	DMSO : 50 mg/mL (156.31 mM; Need ultrasonic); Ethanol : 100 mg/mL (312.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	CC(NC1=CC=NC2=CC(Cl)=CC=C12)CCCN(CC)CC	https://www.medchemexpress.com/chloroquine.html	Launched		92.0	AE40	J12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17589A	10.0	mM	228.0	DMSO	319.181526	12	J	pluskal_fda_drugs_5005_J12_id
2229	HY-B0740	HYCPK40908	F17	HYCPK40908	92z	561.0	3.0	L33	908.0	F17	6202-23-9	Cyclobenzaprine (hydrochloride)	MK130 hydrochloride	311.85	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Cyclobenzaprine hydrochloride (MK130 hydrochloride) is a skeletal muscle relaxant and a central nervous system (CNS) depressant.
Target: 5-HT Receptor 2A
Cyclobenzaprine hydrochloride is a skeletal muscle relaxant and a central nervous system (CNS) depressant. Cyclobenzaprine hydrochloride was thought to be an alpha 2-adrenoceptor agonist that reduced muscle tone by decreasing the activity of descending noradrenergic neurons. Cyclobenzaprine hydrochloride reduced the monosynaptic reflex amplitude dose dependently and this effect was not inhibited by the alpha 2-adrenoceptor antagonists idazoxan and yohimbine. Cyclobenzaprine-induced monosynaptic reflex depression was not attenuated by noradrenergic neuronal lesions produced by 6-hydroxydopamine. Cyclobenzaprine hydrochloride is a 5-HT2 receptor antagonist and that its muscle relaxant effect is due to inhibition of serotonergic, not noradrenergic, descending systems in the spinal cord [1]. The inhibitory effects of Cyclobenzaprine hydrochloride on mono- and polysynaptic reflex potentials are due to the inhibition of descending serotonergic systems through 5-HT(2) receptors in the spinal cord [2]."	Hydrochloride	C20H22ClN	16883.0	DMSO : 50 mg/mL (160.33 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (320.67 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN(C)CC/C=C1C2=CC=CC=C2C=CC3=CC=CC=C\13.Cl	https://www.medchemexpress.com/Cyclobenzaprine-hydrochloride.html	Launched		92.0	L33	J12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0740	10.0	mM	228.0	DMSO	275.1674	12	J	pluskal_fda_drugs_5005_J12_id
2291	HY-128428	HYCPK40908	D21	HYCPK40908	92z	377.0	3.0	H41	908.0	D21	35700-23-3	Carboprost	15(S)-15-Methyl Prostaglandin F2α; 15-Methyl-PGF2α	368.51	Prostaglandin Receptor	GPCR/G Protein	Carboprost (15(S)-15-Methyl Prostaglandin F2α) is a metabolically stable synthetic analog of prostaglandin F2α. Carboprost stimulates uterine contractions and induces abortion. Carboprost is used for postpartum hemorrhage due to uterine atony and for the termination of pregnancy in the second trimester[1][2].		C21H36O5	99233.0	DMSO : 100 mg/mL (271.36 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	CCCCC[C@](C)(O)/C=C/[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C/C=C\CCCC(O)=O	https://www.medchemexpress.com/carboprost.html	Launched		92.0	H41	J12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-128428	10.0	mM	228.0	DMSO	368.256274	12	J	pluskal_fda_drugs_5005_J12_id
38	HY-B0268A	HYCPK40899	P03	HYCPK40909	92z	1516.0	4.0	AF28	909.0	P14	84294-96-2	Enoxacin (hydrate)	Enoxacin (sesquihydrate); AT-2266 (hydrate); CI-919 (hydrate)	347.34	Antibiotic; Bacterial; DNA/RNA Synthesis; MicroRNA	Anti-infection; Cell Cycle/DNA Damage; Epigenetics	Enoxacin hydrate (Enoxacin sesquihydrate), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 μg/ml) and topoisomerase IV (IC50=26.5 μg/ml). Enoxacin hydrate is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin hydrate has potent activities against gram-positive and -negative bacteria. Enoxacin hydrate is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing[1][2][3][4].	hydrate	C15H17FN4O3.3/2H2O	16206.0	DMSO : 2.78 mg/mL (8.00 mM; Need ultrasonic); 1M NaOH : 100 mg/mL (287.90 mM; ultrasonic and adjust pH to 11 with NaOH); H2O : 1 mg/mL (2.88 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	2mM  * 100uL	Infection; Cancer	O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCNCC3)=N2)C1=O)O.[1.5H2O]	https://www.medchemexpress.com/Enoxacin-hydrate.html	Launched		92.0	AF28	J13	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0268A	2.0	mM	229.0	DMSO	320.128469	13	J	pluskal_fda_drugs_5005_J13_id
1558	HY-10230	HYCPK40906	I13	HYCPK40906	92z	793.0	1.0	Q25	906.0	I13	120685-11-2	Midostaurin	PKC412; CGP 41251	570.64	Apoptosis; c-Kit; NO Synthase; PKC; VEGFR	Apoptosis; Epigenetics; Immunology/Inflammation; Protein Tyrosine Kinase/RTK; TGF-beta/Smad	Midostaurin (PKC412; CGP 41251) is an orally active, reversible multi-targeted protein kinase inhibitor. Midostaurin inhibits PKCα/β/γ, Syk, Flk-1, Akt, PKA, c-Kit, c-Fgr, c-Src, FLT3, PDFRβ and VEGFR1/2 with IC50s ranging from 22-500 nM[1][2]. Midostaurin also upregulates endothelial nitric oxide synthase (eNOS) gene expression. Midostaurin shows powerful anticancer effects[3].	Free Base	C35H30N4O4	97131.0	DMSO : 50 mg/mL (87.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=CC=C1)N(C)[C@H]2[C@@H](OC)[C@@]3(C)N(C4=C5C=CC=C4)C6=C5C7=C(C(NC7)=O)C8=C6N(C9=CC=CC=C98)[C@@](O3)([H])C2	https://www.medchemexpress.com/PKC412.html	Launched		92.0	Q25	J13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10230	10.0	mM	229.0	DMSO	570.226705	13	J	pluskal_fda_drugs_5005_J13_id
1570	HY-13662B	HYCPK40906	E14	HYCPK40906	92z	411.0	1.0	I27	906.0	E14	138530-94-6	(R)-Lansoprazole	Dexlansoprazole	369.36	Proton Pump	Membrane Transporter/Ion Channel	(R)-Lansoprazole is the R enantiomer of Lansoprazole, Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].	Free Base	C16H14F3N3O2S	15332.0	DMSO : 100 mg/mL (270.74 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=[S@@](C1=NC2=CC=CC=C2N1)CC3=NC=CC(OCC(F)(F)F)=C3C	https://www.medchemexpress.com/_R_-Lansoprazole.html	Launched		92.0	I27	J13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13662B	10.0	mM	229.0	DMSO	369.075882	13	J	pluskal_fda_drugs_5005_J13_id
1605	HY-B0960	HYCPK40906	H16	HYCPK40906	92z	703.0	1.0	O31	906.0	H16	127-71-9	Sulfabenzamide	N-Sulfanilylbenzamide	276.31	Antibiotic; Autophagy; Bacterial	Anti-infection; Autophagy	Sulfabenzamide (N-Sulfanilylbenzamide) is an antimicrobial agent and usually consumed in combination with Sulfathiazole and Sulfacetamide. Sulfabenzamide is effective against Gram-positive and negative bacterial strains[1].	Free Base	C13H12N2O3S	17474.0	DMSO : 100 mg/mL (361.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(NS(=O)(C1=CC=C(N)C=C1)=O)C2=CC=CC=C2	https://www.medchemexpress.com/Sulfabenzamide.html	Launched		92.0	O31	J13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0960	10.0	mM	229.0	DMSO	276.056863	13	J	pluskal_fda_drugs_5005_J13_id
1692	HY-B1060	HYCPK40906	O21	HYCPK40906	92z	1385.0	1.0	AC41	906.0	O21	2375-03-3	Methylprednisolone succinate (sodium)	Methylprednisolone hydrogen succinate (sodium)	496.53	Bacterial	Anti-infection	Methylprednisolone succinate (Methylprednisolone hydrogen succinate) sodium is a glucocorticoid of slightly longer half-life than that of Prednisolone. It has potential uses in antiinflammatory agents.	Sodium	C26H33NaO8	66090.0	DMSO : ≥ 25 mg/mL (50.35 mM); H2O : 50 mg/mL (100.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(COC(CCC(O[Na])=O)=O)=O)(O)CC[C@@]1([H])[C@]3([H])C[C@H](C)C4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/6_alpha_-Methylprednisolone-21-hemisuccinate-sodium-salt.html	Launched		92.0	AC41	J13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1060	10.0	mM	229.0	DMSO	474.225368	13	J	pluskal_fda_drugs_5005_J13_id
1912	HY-B0091	HYCPK40907	H16	HYCPK40907	92z	704.0	2.0	O32	907.0	H16	106685-40-9	Adapalene	CD271	412.52	Apoptosis; Autophagy; RAR/RXR	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Adapalene (CD271), a third-generation synthetic retinoid, is widely used for the research of acne. Adapalene is a potent RAR agonist, with AC50s of 2.3 nM, 9.3 nM, and 22 nM for RARβ, RARγ, RARα, respectively. Adapalene also inhibits the enzymatic activity of GOT1 in a non-competitive manner. Adapalene exhibits anti-tumor activity[1][2][3].	Free Acid	C28H28O3	11824.0	DMSO : 20 mg/mL (48.48 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	COC1=C(C23CC4CC(C3)CC(C2)C4)C=C(C5=CC6=C(C=C(C(O)=O)C=C6)C=C5)C=C1	https://www.medchemexpress.com/adapalene.html	Launched		92.0	O32	J13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0091	10.0	mM	229.0	DMSO	412.203845	13	J	pluskal_fda_drugs_5005_J13_id
2094	HY-B0311	HYCPK40908	G08	HYCPK40908	92z	639.0	3.0	N15	908.0	G08	28860-95-9	Carbidopa	(S)-(-)-Carbidopa	226.23	Aryl Hydrocarbon Receptor	Immunology/Inflammation	Carbidopa ((S)-(-)-Carbidopa), a peripheral decarboxylase inhibitor, can be used for the research of Parkinson's disease. Carbidopa is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa inhibits pancreatic cancer cell and tumor growth[1][2].	Free Acid	C10H14N2O4	16025.0	DMSO : 10 mg/mL (44.20 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	OC1=C(O)C=CC(CC(NN)(C(O)=O)C)=C1	https://www.medchemexpress.com/Carbidopa.html	Launched		92.0	N15	J13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0311	10.0	mM	229.0	DMSO	226.095357	13	J	pluskal_fda_drugs_5005_J13_id
2427	HY-D0237	HYCPK40909	G03	HYCPK40909	92z	630.0	4.0	N6	909.0	G03	54856-23-4	Betahistine (mesylate)		328.41	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Betahistine mesylate is an orally active histamine H1 receptor agonist and a H3 receptor antagonist[1]. Betahistine mesylate is used for the study of rheumatoid arthritis (RA)[3].	Mesylate	C10H20N2O6S2	78844.0	DMSO : 100 mg/mL (304.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CNCCC1=NC=CC=C1.CS(=O)(O)=O.CS(=O)(O)=O	https://www.medchemexpress.com/betahistine-mesylate.html	Launched		92.0	N6	J13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0237	10.0	mM	229.0	DMSO	136.100048	13	J	pluskal_fda_drugs_5005_J13_id
1474	HY-Z0478	HYCPK40906	E08	HYCPK40906	92z	399.0	1.0	I15	906.0	E08	5989-54-8	(-)-Limonene	(S)-(-)-Limonene	136.23	Others	Others	(-)-Limonene ((S)-(-)-Limonene) is a monoterpene found in citrus plants like lemon, orange, and grape. (-)-Limonene can induce a mild bronchoconstrictive effect[1].		C10H16	46023.0	H2O : 50 mg/mL (367.03 mM; Need ultrasonic); DMSO : 100 mg/mL (734.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC1=CC[C@@H](C(C)=C)CC1	https://www.medchemexpress.com/_S_-_-_-Limonene.html	Launched		92.0	I15	J14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Z0478	10.0	mM	230.0	DMSO	136.125201	14	J	pluskal_fda_drugs_5005_J14_id
1648	HY-B1367	HYCPK40906	C19	HYCPK40906	92z	229.0	1.0	E37	906.0	C19	7421-40-1	Carbenoxolone (disodium)		614.72	11β-HSD; Gap Junction Protein; Orthopoxvirus	Anti-infection; Cytoskeleton; Metabolic Enzyme/Protease	Carbenoxolone disodium is the active metabolite of Glycyrrhizic acid (HY-N0184) and the inhibitor of human 11β-HSD and bacterial 3α, 20β-HSD[1]. Carbenoxolone disodium is an uncoupling agent for gap junctions and a potent inhibitor of Vaccinia virus replication[2]. Carbenoxolone disodium is used for the study of peptic, esophageal and oral ulceration and inflammation. Carbenoxolone disodium inhibits Vaccinia virus replication.	Sodium	C34H48Na2O7	120700.0	DMSO : 16.67 mg/mL (27.12 mM; Need ultrasonic); H2O : 50 mg/mL (81.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	CC(C)([C@]1([H])CC[C@@]([C@@]2(CC[C@]3(CC[C@](C[C@@]3([H])C2=C4)(C)C(O[Na])=O)C)C)5C)[C@@H](OC(CCC(O[Na])=O)=O)CC[C@]1(C)[C@@]5([H])C4=O	https://www.medchemexpress.com/carbenoxolone-disodium.html	Launched		92.0	E37	J14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1367	10.0	mM	230.0	DMSO	570.355654	14	J	pluskal_fda_drugs_5005_J14_id
1723	HY-B0942	HYCPK40907	N03	HYCPK40907	92z	1254.0	2.0	AA6	907.0	N03	121-54-0	Benzethonium chloride		448.08	Bacterial; nAChR	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Benzethonium chloride inhibit human recombinant α7 and α4β2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes.	Chloride	C27H42ClNO2	17606.0	DMSO : 33.33 mg/mL (74.38 mM; Need ultrasonic); H2O : 20 mg/mL (44.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(C)(C)CC(C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1)(C)C.[Cl-]	https://www.medchemexpress.com/Benzethonium-chloride.html	Launched		92.0	AA6	J14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0942	10.0	mM	230.0	DMSO	412.321006	14	J	pluskal_fda_drugs_5005_J14_id
1862	HY-10619A	HYCPK40907	N12	HYCPK40907	92z	1272.0	2.0	AA24	907.0	N12	1038915-64-8	Niraparib (hydrochloride)	MK-4827 (hydrochloride)	356.85	Apoptosis; PARP	Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Niraparib hydrochloride (MK-4827 hydrochloride) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib hydrochloride leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity[1][2][3].	Hydrochloride	C19H21ClN4O	44579.0	H2O : 100 mg/mL (280.23 mM; Need ultrasonic); DMSO : 250 mg/mL (700.57 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	NC(C1=CC=CC2=CN(C3=CC=C([C@H]4CNCCC4)C=C3)N=C21)=O.Cl	https://www.medchemexpress.com/mk-4827-hydrochloride.html	Launched		92.0	AA24	J14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10619A	10.0	mM	230.0	DMSO	320.163711	14	J	pluskal_fda_drugs_5005_J14_id
1920	HY-B1232	HYCPK40907	P16	HYCPK40907	92z	1472.0	2.0	AE32	907.0	P16	54-36-4	Metyrapone	Su-4885	226.27	Autophagy; Cytochrome P450; Endogenous Metabolite	Autophagy; Metabolic Enzyme/Protease	Metyrapone (Su-4885) is a potent and orally active 11β-hydroxylase inhibitor and an autophagy activator, also inhibits the production of aldosterone. Metyrapone inhibits synthesis of endogenous adrenal corticosteroid, decreases glucocorticoid levels, and also affects behavior and emotion. In addition, Metyrapone increases the efficiency of autophagic process via downregulation of mTOR pathway, and interacts with Pseudomonas putida cytochrome P-450. Metyrapone can be used for researching Cushing's syndrome and depression[1][2][3][4][5].	Free Base	C14H14N2O	92015.0	H2O : ≥ 38 mg/mL (167.94 mM); DMSO : 100 mg/mL (441.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Metabolic Disease; Neurological Disease	CC(C1=CC=CN=C1)(C)C(C2=CC=CN=C2)=O	https://www.medchemexpress.com/Metyrapone.html	Launched		92.0	AE32	J14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1232	10.0	mM	230.0	DMSO	226.110613	14	J	pluskal_fda_drugs_5005_J14_id
2055	HY-16508	HYCPK40908	P05	HYCPK40908	92z	1497.0	3.0	AF9	908.0	P05	126784-99-4	Ulipristal acetate	CDB-2914	475.62	Autophagy; Progesterone Receptor	Autophagy; Others	Ulipristal acetate (CDB-2914) is an orally active, selective progesterone receptor modulator (SPRM). Ulipristal acetate stimulates the autophagic response selectively in leiomyoma cells. Ulipristal acetate has the potential for benign gynecological conditions treatment, such as uterine myoma[1][2].	Free Base	C30H37NO4	9400.0	DMSO : 33.33 mg/mL (70.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C1CCC2=C3[C@@H](C4=CC=C(N(C)C)C=C4)C[C@@]5(C)[C@](CC[C@]5(OC(C)=O)C(C)=O)([H])[C@]3([H])CCC2=C1	https://www.medchemexpress.com/ulipristal-acetate.html	Launched		92.0	AF9	J14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16508	10.0	mM	230.0	DMSO	475.272259	14	J	pluskal_fda_drugs_5005_J14_id
2242	HY-B0022	HYCPK40908	C18	HYCPK40908	92z	275.0	3.0	F35	908.0	C18	13311-84-7	Flutamide	SCH 13521	276.21	Androgen Receptor	Others	"Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor with Ki values of 55 nM, and primarily used to treat prostate cancer.
Target: androgen receptor 
in vitro: Flutamide (Eulexin) is an antiandrogen drug. Flutamide-OH, the active metabolite of flutamide, directly binds at rat anterior pituitary androgen receptor with Ki values of 55 nM [1]. lutamide does not affect the proliferation of an androgen-sensitive clone of the mouse mammary carcinoma Shionogi SC-l 15 cells in culture, shows only antiandrogenic effect, but not androgenic effect [2]. Flutamide provides treatment for prostate cancer when used along with leuprolide [3].
in vivo: Flutamide causes a markedly reduction in rat ventral prostate weight from 319 mg to 245 mg. A combination of flutamide and LHRH agonist induces an additive effect with a decrease in prostate weight to 101 mg, and an marked drop in prostatic ODC activity [4]."	Free Base	C11H11F3N2O3	13790.0	DMSO : 100 mg/mL (362.04 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.36 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC(C)C(NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1)=O	https://www.medchemexpress.com/Flutamide.html	Launched		92.0	F35	J14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0022	10.0	mM	230.0	DMSO	276.072177	14	J	pluskal_fda_drugs_5005_J14_id
2248	HY-13662	HYCPK40908	I18	HYCPK40908	92z	851.0	3.0	R35	908.0	I18	103577-45-3	Lansoprazole	AG-1749	369.36	Bacterial; Phospholipase; Proton Pump	Anti-infection; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].	Free Base	C16H14F3N3O2S	11850.0	DMSO : 100 mg/mL (270.74 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=S(C1=NC2=CC=CC=C2N1)CC3=NC=CC(OCC(F)(F)F)=C3C	https://www.medchemexpress.com/lansoprazole.html	Launched		92.0	R35	J14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13662	10.0	mM	230.0	DMSO	369.075882	14	J	pluskal_fda_drugs_5005_J14_id
1385	HY-B0329	HYCPK40906	F04	HYCPK40906	92z	487.0	1.0	K7	906.0	F04	54-85-3	Isoniazid	INH; Isonicotinic acid hydrazide; Isonicotinic hydrazide	137.14	Antibiotic; Autophagy; Bacterial; Mitophagy	Anti-infection; Autophagy	Isoniazid (INH) is a prodrug and must be activated by a bacterial catalase-peroxidase enzyme KatG. Isoniazid is bactericidal to rapidly dividing mycobacteria and has anti-tuberculostatic activity[1][2][3][4].	Free Base	C6H7N3O	14898.0	DMSO : 50 mg/mL (364.59 mM; Need ultrasonic); H2O : 33.33 mg/mL (243.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CC=NC=C1)NN	https://www.medchemexpress.com/Isoniazid.html	Launched		92.0	K7	J15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0329	10.0	mM	231.0	DMSO	137.058912	15	J	pluskal_fda_drugs_5005_J15_id
1409	HY-B1360	HYCPK40906	N05	HYCPK40906	92z	1257.0	1.0	AA9	906.0	N05	72-80-0	Chlorquinaldol	Chloquinan	228.07	Antibiotic; Bacterial; Fungal	Anti-infection	Chlorquinaldol (Chloquinan) is a mono-hydroxyquinoline, is an antifungal and antibacterial, used for topical treatment of skin conditions and vaginal infections.	Free Base	C10H7Cl2NO	17560.0	DMSO : 50 mg/mL (219.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC1=C2N=C(C)C=CC2=C(Cl)C=C1Cl	https://www.medchemexpress.com/Chlorquinaldol.html	Launched		92.0	AA9	J15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1360	10.0	mM	231.0	DMSO	226.990469	15	J	pluskal_fda_drugs_5005_J15_id
1465	HY-10619	HYCPK40908	A11	HYCPK40908	92z	69.0	3.0	B21	908.0	A11	1038915-60-4	Niraparib	MK-4827	320.39	Apoptosis; PARP	Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Niraparib (MK-4827) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity[1][2][3].	Free Base	C19H20N4O	137126.0	DMSO : 25 mg/mL (78.03 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	NC(C1=CC=CC2=CN(C3=CC=C([C@H]4CNCCC4)C=C3)N=C21)=O	https://www.medchemexpress.com/MK-4827.html	Launched		92.0	B21	J15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10619	10.0	mM	231.0	DMSO	320.163711	15	J	pluskal_fda_drugs_5005_J15_id
1621	HY-A0038	HYCPK40906	H17	HYCPK40906	92z	705.0	1.0	O33	906.0	H17	190791-29-8	Lasofoxifene (tartrate)	CP-336156 (tartrate)	563.64	Estrogen Receptor/ERR	Others	Lasofoxifene (CP-336156) tartrate is an orally active and selective estrogen receptor modulator (SERM)[1]. Lasofoxifene tartrate exhibits an anti-osteoporotic function and also inhibits primary tumor growth and metastases. Lasofoxifene tartrate can be used for the research of breast cancer and postmenopausal osteoporosis[1][2].	Tartrate	C32H37NO8	63113.0	DMSO : 83.33 mg/mL (147.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	OC1=CC=C2[C@@H](C3=CC=C(OCCN4CCCC4)C=C3)[C@@H](C5=CC=CC=C5)CCC2=C1.O=C(O)[C@@H](O)[C@H](O)C(O)=O	https://www.medchemexpress.com/Lasofoxifene-Tartrate.html	Launched		92.0	O33	J15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0038	10.0	mM	231.0	DMSO	413.235479	15	J	pluskal_fda_drugs_5005_J15_id
1653	HY-B1366	HYCPK40906	H19	HYCPK40906	92z	709.0	1.0	O37	906.0	H19	73816-42-9	Meclocycline (Sulfosalicylate Salt)		695.05	Antibiotic; Bacterial	Anti-infection	Meclocycline Sulfosalicylate Salt is a tetracycline antibiotic with broad-spectrum antibacterial activities, preventing skin bacterial infections such as acne vulgaris[1].	sulfosalicylate	C29H27ClN2O14S	64650.0	DMSO : 250 mg/mL (359.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)C1=CC(S(=O)(O)=O)=CC=C1O.O=C(C(C2=O)=C(O)[C@@H](N(C)C)[C@]3([H])[C@@H](O)[C@]4([H])C(C5=C(C(C4=C(O)[C@@]32O)=O)C(O)=CC=C5Cl)=C)N	https://www.medchemexpress.com/meclocycline-sulfosalicylate-salt.html	Launched		92.0	O37	J15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1366	10.0	mM	231.0	DMSO	476.098643	15	J	pluskal_fda_drugs_5005_J15_id
1688	HY-17361	HYCPK40906	K21	HYCPK40906	92z	1001.0	1.0	U41	906.0	K21	30544-47-9	Etofenamate		369.34	COX	Immunology/Inflammation	Etofenamate, a non-steroid anti-inflammatory drug (NSAID) and a non-selective COX inhibitor, possesses analgesic, anti-rheumatic, antipyretic and anti-inflammatory properties. Etofenamate is used in the research for osteoarthritis, arthritis and other inflammatory diseases[1][2][3].	Free Base	C18H18F3NO4	10820.0	Ethanol : 120 mg/mL (324.90 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (135.38 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCCOCCO)C1=CC=CC=C1NC2=CC=CC(C(F)(F)F)=C2	https://www.medchemexpress.com/etofenamate.html	Launched		92.0	U41	J15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17361	10.0	mM	231.0	DMSO	369.118793	15	J	pluskal_fda_drugs_5005_J15_id
1941	HY-B1303A	HYCPK40907	E18	HYCPK40907	92z	420.0	2.0	I36	907.0	E18	524-81-2	Mebhydrolin		276.38	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Mebhydrolin is a specific histamine H1 receptor antagonist.	Free Base	C19H20N2	89744.0	DMSO : 50 mg/mL (180.91 mM; Need ultrasonic); H2O : 1 mg/mL (3.62 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	CN(C1)CCC(N2CC3=CC=CC=C3)=C1C4=C2C=CC=C4	https://www.medchemexpress.com/Mebhydrolin.html	Launched		92.0	I36	J15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1303A	10.0	mM	231.0	DMSO	276.162649	15	J	pluskal_fda_drugs_5005_J15_id
2148	HY-15233	HYCPK40908	A12	HYCPK40908	92z	71.0	3.0	B23	908.0	A12	917389-32-3	Letermovir	AIC246	572.55	CMV	Anti-infection	Letermovir (AIC246) is a potent inhibitor of CMV, which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.	Free Acid	C29H28F4N4O4	10376.0	DMSO : ≥ 100 mg/mL (174.66 mM)	DMSO Solution	10mM  * 100uL	Infection	FC1=C(N=C(N2CCN(C3=CC=CC(OC)=C3)CC2)N(C4=CC(C(F)(F)F)=CC=C4OC)[C@H]5CC(O)=O)C5=CC=C1	https://www.medchemexpress.com/letermovir.html	Launched		92.0	B23	J15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15233	10.0	mM	231.0	DMSO	572.204668	15	J	pluskal_fda_drugs_5005_J15_id
59	HY-B1303	HYCPK40899	M05	HYCPK40909	92z	1232.0	4.0	Z32	909.0	M16	6153-33-9	Mebhydrolin (napadisylate)	Mebhydroline 1,5-naphthalenedisulfonate salt	841.05	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Mebhydrolin napadisylate is a specific histamine H1 receptor antagonist.	Napadisylate	C48H48N4O6S2	17523.0	DMSO : 5.56 mg/mL (6.61 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Inflammation/Immunology; Endocrinology	O=S(C1=C2C=CC=C(S(=O)(O)=O)C2=CC=C1)(O)=O.CN(C3)CCC(N4CC5=CC=CC=C5)=C3C6=C4C=CC=C6.CN(C7)CCC(N8CC9=CC=CC=C9)=C7C%10=C8C=CC=C%10	https://www.medchemexpress.com/Mebhydrolin-napadisylate.html	Launched		92.0	Z32	J16	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1303	2.0	mM	232.0	DMSO	276.162649	16	J	pluskal_fda_drugs_5005_J16_id
1435	HY-B1200	HYCPK40906	H07	HYCPK40906	92z	685.0	1.0	O13	906.0	H07	51-15-0	Pralidoxime (chloride)	2-PAM chloride	172.61	Cholinesterase (ChE)	Neuronal Signaling	Pralidoxime chloride is a potent reactivator of acetylcholinesterase (AChE). Pralidoxime chloride reactivates nerve agent-inhibited AChE via direct nucleophilic attack by the oxime moiety on the phosphorus center of the bound nerve agent. Pralidoxime chloride is an antidote for organophosphate poisoning[1][2].	Chloride	C7H9ClN2O	17719.0	DMSO : 21.67 mg/mL (125.54 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (579.34 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+]1=CC=CC=C1/C=N/O.[Cl-]	https://www.medchemexpress.com/Pralidoxime-chloride.html	Launched		92.0	O13	J16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1200	10.0	mM	232.0	DMSO	137.070939	16	J	pluskal_fda_drugs_5005_J16_id
1845	HY-B0454A	HYCPK40907	M11	HYCPK40907	92z	1174.0	2.0	Y22	907.0	M11	22832-87-7	Miconazole (nitrate)	R18134 nitrate	479.14	Antibiotic; Bacterial; Fungal	Anti-infection	Miconazole nitrate (R18134 nitrate) is an imidazole antifungal agent. Miconazole nitrate also has antibacterial effects[2].	Nitrate	C18H15Cl4N3O4	16338.0	H2O : 0.1 mg/mL (0.21 mM; Need ultrasonic); DMSO : 50 mg/mL (104.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[O-][N+](O)=O.ClC1=C(C=CC(Cl)=C1)C(OCC(C=CC(Cl)=C2)=C2Cl)CN3C=CN=C3	https://www.medchemexpress.com/miconazole-nitrate.html	Launched		92.0	Y22	J16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0454A	10.0	mM	232.0	DMSO	413.986024	16	J	pluskal_fda_drugs_5005_J16_id
1873	HY-114200	HYCPK40907	I13	HYCPK40907	92z	794.0	2.0	Q26	907.0	I13	395683-14-4	Imrecoxib	BAP-909	369.48	COX	Immunology/Inflammation	Imrecoxib (BAP-909) is a novel and selective cyclooxygenase 2 (COX-2) inhibitor with an IC50 value of 18 nM, it also inhibits COX1- activity with an IC50 value of 115 nM. Imrecoxib (BAP-909) has anti-inflammatory effect[1].	Free Base	C21H23NO3S	117011.0	DMSO : 100 mg/mL (270.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1N(CCC)CC(C2=CC=C(S(=O)(C)=O)C=C2)=C1C3=CC=C(C)C=C3	https://www.medchemexpress.com/imrecoxib.html	Launched		92.0	Q26	J16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-114200	10.0	mM	232.0	DMSO	369.139865	16	J	pluskal_fda_drugs_5005_J16_id
2106	HY-B2119	HYCPK40908	C09	HYCPK40908	92z	257.0	3.0	F17	908.0	C09	41945-48-6	Sodium tauroglycocholate	Tauroglycocholic acid sodium salt	594.74	Others	Others	Sodium tauroglycocholate is an inhibitor of the biliary acid transporting system of the hepatocyte and also a surfactant used as a chemical permeation enhancer.	Sodium	C28H47N2NaO8S	27652.0	DMSO : 30 mg/mL (50.44 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Endocrinology	O[C@H](C[C@@](C[C@H](O)CC1)([H])[C@@]1(C)[C@@]2([H])C[C@@H]3O)[C@@]2([H])[C@@](CC[C@]4([H])[C@H](C)CCC(NCC(NCCS(=O)(O[Na])=O)=O)=O)([H])[C@]34C	https://www.medchemexpress.com/Sodium_tauroglycocholate.html	Launched		92.0	F17	J16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2119	10.0	mM	232.0	DMSO	572.313137	16	J	pluskal_fda_drugs_5005_J16_id
2295	HY-17459	HYCPK40908	H21	HYCPK40908	92z	761.0	3.0	P41	908.0	H21	120202-66-6	Clopidogrel (hydrogen sulfate)	(S)-(+)-Clopidogrel bisulfate; (S)-(+)-Clopidogrel hydrogen sulfate	419.90	Cytochrome P450; P2Y Receptor	GPCR/G Protein; Metabolic Enzyme/Protease	Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively[1]. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation[2]．Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor[5].	Sulfate	C16H18ClNO6S2	11948.0	DMSO : ≥ 46.7 mg/mL (111.22 mM); H2O : 16.67 mg/mL (39.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	ClC1=C([C@@H](C(OC)=O)N2CCC3=C(C=CS3)C2)C=CC=C1.O=S(O)(O)=O	https://www.medchemexpress.com/Clopidogrel-hydrogen-sulfate.html	Launched		92.0	P41	J16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17459	10.0	mM	232.0	DMSO	321.059027	16	J	pluskal_fda_drugs_5005_J16_id
2483	HY-15232B	HYCPK40909	O06	HYCPK40909	92z	1404.0	4.0	AD12	909.0	O06	1392275-56-7	Tenofovir alafenamide hemifumarate	GS-7340 (hemifumarate)	534.50	HIV; Reverse Transcriptase	Anti-infection	Tenofovir alafenamide hemifumarate (GS-7340 hemifumarate) is an investigational oral prodrug of Tenofovir. Tenofovir is a HIV-1 nucleotide reverse transcriptase inhibitor.	Fumarate	C21H29N6O5P.1/2 C4H4O4	42424.0	DMSO : 50 mg/mL (93.55 mM; Need ultrasonic); H2O : 20 mg/mL (37.42 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	O=C(O)/C=C/C(O)=O.NC1=NC=NC2=C1N=CN2C[C@@H](C)OC[P@](OC3=CC=CC=C3)(N[C@@H](C)C(OC(C)C)=O)=O.[0.5]	https://www.medchemexpress.com/GS-7340-hemifumarate.html	Launched		92.0	AD12	J16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15232B	10.0	mM	232.0	DMSO	476.193705	16	J	pluskal_fda_drugs_5005_J16_id
2555	HY-16276	HYCPK40909	N11	HYCPK40909	92z	1318.0	4.0	AB22	909.0	N11	928134-65-0	Osilodrostat	LCI699	227.24	Mineralocorticoid Receptor	Metabolic Enzyme/Protease	Osilodrostat (LCI699) is a potent, orally active11β-hydroxylase (CYP11B1) inhibitor with an IC50 value of 35 nM. Osilodrostat is a potent, orally aldosterone synthase (CYP11B2) inhibitor with IC50 values of 0.7 nM and 160 nM for human aldosterone synthase and rat aldosterone synthase, respectively. Osilodrostat inhibits aldosterone and corticosterone synthesis. Osilodrostat has blood pressure lowering ability. Osilodrostat can be used for research of Cushing syndrome (CS)[1][2][3].	Free Base	C13H10FN3	115246.0	DMSO : 250 mg/mL (1100.16 mM; Need ultrasonic); Ethanol : 100 mg/mL (440.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	N#CC1=CC=C([C@H]2CCC3=CN=CN32)C(F)=C1	https://www.medchemexpress.com/Osilodrostat.html	Launched		92.0	AB22	J16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16276	10.0	mM	232.0	DMSO	227.085876	16	J	pluskal_fda_drugs_5005_J16_id
1369	HY-B1170	HYCPK40906	F03	HYCPK40906	92z	485.0	1.0	K5	906.0	F03	456-59-7	Cyclandelate	3,5,5-Trimethylcyclohexyl mandelate	276.37	Others	Others	Cyclandelate is a vasodilator used in the treatment of claudication, arteriosclerosis, and Raynaud's disease. It is also used to treat nighttime leg cramps, and has been investigated for its effect against migraine.	Free Base	C17H24O3	17698.0	DMSO : ≥ 44 mg/mL (159.21 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(OC1CC(C)(C)CC(C)C1)C(O)C2=CC=CC=C2	https://www.medchemexpress.com/Cyclandelate.html	Launched		92.0	K5	J17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1170	10.0	mM	233.0	DMSO	276.172545	17	J	pluskal_fda_drugs_5005_J17_id
1389	HY-15283	HYCPK40906	J04	HYCPK40906	92z	871.0	1.0	S7	906.0	J04	113665-84-2	Clopidogrel		321.82	P2Y Receptor	GPCR/G Protein	Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.	Free Base	C16H16ClNO2S	85793.0	DMSO : 50 mg/mL (155.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	ClC1=C(C=CC=C1)[C@H](N2CCC3=C(C2)C=CS3)C(OC)=O	https://www.medchemexpress.com/clopidogrel.html	Launched		92.0	S7	J17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15283	10.0	mM	233.0	DMSO	321.059027	17	J	pluskal_fda_drugs_5005_J17_id
1445	HY-15232	HYCPK40907	P04	HYCPK40907	92z	1448.0	2.0	AE8	907.0	P04	379270-37-8	Tenofovir alafenamide	GS-7340	476.47	HIV; Reverse Transcriptase	Anti-infection	Tenofovir alafenamide (GS-7340) is an investigational oral prodrug of Tenofovir. Tenofovir is a HIV-1 nucleotide reverse transcriptase inhibitor.	Free Base	C21H29N6O5P	42431.0	DMSO : ≥ 31 mg/mL (65.06 mM); H2O : 6.67 mg/mL (14.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	NC1=NC=NC2=C1N=CN2C[C@@H](C)OC[P@](OC3=CC=CC=C3)(N[C@@H](C)C(OC(C)C)=O)=O	https://www.medchemexpress.com/GS-7340.html	Launched		92.0	AE8	J17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15232	10.0	mM	233.0	DMSO	476.193705	17	J	pluskal_fda_drugs_5005_J17_id
1530	HY-13803	HYCPK40906	M11	HYCPK40906	92z	1173.0	1.0	Y21	906.0	M11	1403254-99-8	Tazemetostat	EPZ-6438; E-7438	572.74	Histone Methyltransferase	Epigenetics	Tazemetostat (EPZ-6438) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat (EPZ-6438) inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat (EPZ-6438) inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat (EPZ-6438) inhibits rat EZH2 with an IC50 of 4 nM. Tazemetostat (EPZ-6438) also inhibits EZH1 with an IC50 of 392 nM[1].	Free Base	C34H44N4O4	92235.0	DMSO : 31.25 mg/mL (54.56 mM; ultrasonic and warming and heat to 60°C); 0.1 M HCL : 14.29 mg/mL (24.95 mM; ultrasonic and adjust pH to 5 with HCl)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC(C2=CC=C(CN3CCOCC3)C=C2)=CC(N(CC)C4CCOCC4)=C1C)NCC5=C(C)C=C(C)NC5=O	https://www.medchemexpress.com/EPZ-6438.html	Launched		92.0	Y21	J17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13803	10.0	mM	233.0	DMSO	572.336256	17	J	pluskal_fda_drugs_5005_J17_id
1630	HY-B1157	HYCPK40906	A18	HYCPK40906	92z	35.0	1.0	A35	906.0	A18	3902-71-4	Trioxsalen	Trisoralen; Trioxysalen; TMP	228.24	DNA Alkylator/Crosslinker	Cell Cycle/DNA Damage	Trioxsalen (Trisoralen), a psoralen derivative, is a photochemical DNA crosslinker. Trioxsalen only works after photoactivation with near ultraviolet light. Trioxsalen is a photosensitizer that can be used for the research of vitiligo and hand eczema. Trioxsalen is used for visualization of genomic interstrand cross-links localized by laser photoactivation[1][2][3].	Free Base	C14H12O3	21696.0	DMSO : 6.6 mg/mL (28.92 mM; Need ultrasonic and warming); H2O : 1 mg/mL (4.38 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1C=C(C)C2=CC3=C(OC(C)=C3)C(C)=C2O1	https://www.medchemexpress.com/Trioxsalen.html	Launched		92.0	A35	J17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1157	10.0	mM	233.0	DMSO	228.078644	17	J	pluskal_fda_drugs_5005_J17_id
2096	HY-B1738A	HYCPK40908	I08	HYCPK40908	92z	831.0	3.0	R15	908.0	I08	94-63-3	Pralidoxime (iodide)		264.06	Cholinesterase (ChE)	Neuronal Signaling	Pralidoxime iodide is a potent reactivator of acetylcholinesterase (AChE). Pralidoxime iodide reactivates nerve agent-inhibited AChE via direct nucleophilic attack by the oxime moiety on the phosphorus center of the bound nerve agent. Pralidoxime iodide is an antidote for organophosphate poisoning[1][2].	Iodide	C7H9IN2O	64075.0	DMSO : 250 mg/mL (946.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+]1=CC=CC=C1/C=N/O.[I-]	https://www.medchemexpress.com/pralidoxime-iodide.html	Launched		92.0	R15	J17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1738A	10.0	mM	233.0	DMSO	137.070939	17	J	pluskal_fda_drugs_5005_J17_id
2118	HY-10373	HYCPK40908	O09	HYCPK40908	92z	1409.0	3.0	AD17	908.0	O09	52128-35-5	Trimetrexate	CI-898	369.42	Antibiotic; Antifolate; Bacterial; Dihydrofolate reductase (DHFR) ; DNA/RNA Synthesis; Parasite	Anti-infection; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Trimetrexate (CI-898) is an antibiotic, also a potent and orally active dihydrofolate reductase (DHFR) inhibitor, reducing the production of DNA and RNA precursors and leading to cell death, with IC50 values of 4.74 nM and 1.35 nM for human DHFR and Toxoplasma gondii DHFR. Trimetrexate can also inhibit the growth of various cancer cells. Trimetrexate can be used for researching Pneumocystis carinii pneumonia (PCP) and cancer[1][2][3][4][5].	Free Base	C19H23N5O3	28504.0	DMSO : ≥ 61.5 mg/mL (166.48 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	NC1=C(C(C)=C2CNC3=CC(OC)=C(OC)C(OC)=C3)C(C=C2)=NC(N)=N1	https://www.medchemexpress.com/Trimetrexate.html	Launched		92.0	AD17	J17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10373	10.0	mM	233.0	DMSO	369.18009	17	J	pluskal_fda_drugs_5005_J17_id
2430	HY-103370	HYCPK40909	J03	HYCPK40909	92z	918.0	4.0	T6	909.0	J03	66898-62-2	Talniflumate	BA 7602-06	414.33	Chloride Channel	Membrane Transporter/Ion Channel	Talniflumate (BA 7602-06) is the prodrug of Niflumic acid (HY-B0493), exerting its activity in the body through conversion to niflumic acid by esterase[1]. Talniflumate is an orally active Ca2+-activated Cl- channel (CaCC) blocker. Talniflumate can be used as an analgesic and anti-inflammatory agent in cystic fibrosis mouse model of distal intestinal obstructive syndrome[2].		C21H13F3N2O4	105250.0	DMSO : 83.33 mg/mL (201.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=CN=C1NC2=CC=CC(C(F)(F)F)=C2)OC3OC(C4=C3C=CC=C4)=O	https://www.medchemexpress.com/talniflumate.html	Launched		92.0	T6	J17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-103370	10.0	mM	233.0	DMSO	414.082742	17	J	pluskal_fda_drugs_5005_J17_id
1419	HY-A0004	HYCPK40906	H06	HYCPK40906	92z	683.0	1.0	O11	906.0	H06	2353-33-5	Decitabine	5-Aza-2'-deoxycytidine; 5-AZA-CdR; NSC 127716	228.21	Apoptosis; DNA Methyltransferase; Nucleoside Antimetabolite/Analog	Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Decitabine (NSC 127716) is an orally active deoxycytidine analogue antimetabolite and a DNA methyltransferase inhibitor. Decitabine incorporates into DNA in place of cytosine can covalently trap DNA methyltransferase to DNA causing irreversible inhibition of the enzyme. Decitabine induces cell G2/M arrest and cell apoptosis. Decitabine has potent anticancer activity[1][2].	Free Base	C8H12N4O4	29075.0	DMSO : ≥ 50 mg/mL (219.10 mM); H2O : 20 mg/mL (87.64 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC[C@@H]1[C@@H](O)C[C@H](N2C=NC(N)=NC2=O)O1	https://www.medchemexpress.com/Decitabine.html	Launched		92.0	O11	J18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0004	10.0	mM	234.0	DMSO	228.085855	18	J	pluskal_fda_drugs_5005_J18_id
1668	HY-15232A	HYCPK40906	G20	HYCPK40906	92z	615.0	1.0	M39	906.0	G20	379270-38-9	Tenofovir alafenamide fumarate	GS-7340 (fumarate)	592.54	HIV; Reverse Transcriptase	Anti-infection	Tenofovir alafenamide fumarate (GS-7340 fumarate) is an investigational oral prodrug of Tenofovir. Tenofovir is a HIV-1 nucleotide reverse transcriptase inhibitor.	Fumarate	C25H33N6O9P	23773.0	H2O : ≥ 25 mg/mL (42.19 mM); DMSO : ≥ 36 mg/mL (60.76 mM)	DMSO Solution	10mM  * 100uL	Infection	NC1=NC=NC2=C1N=CN2C[C@@H](C)OC[P@](OC3=CC=CC=C3)(N[C@@H](C)C(OC(C)C)=O)=O.O=C(O)/C=C/C(O)=O	https://www.medchemexpress.com/GS-7340-fumarate.html	Launched		92.0	M39	J18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15232A	10.0	mM	234.0	DMSO	476.193705	18	J	pluskal_fda_drugs_5005_J18_id
1680	HY-B0167	HYCPK40906	C21	HYCPK40906	92z	233.0	1.0	E41	906.0	C21	69-72-7	Salicylic acid	2-Hydroxybenzoic acid	138.12	Apoptosis; Autophagy; COX; Endogenous Metabolite; Mitophagy	Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease	Salicylic acid (2-Hydroxybenzoic acid) inhibits cyclo-oxygenase-2 (COX-2) activity independently of transcription factor (NF-κB) activation[1].	Free Acid	C7H6O3	15731.0	DMSO : ≥ 50 mg/mL (362.00 mM); H2O : 1 mg/mL (7.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O)C1=CC=CC=C1O	https://www.medchemexpress.com/Salicylic-acid.html	Launched		92.0	E41	J18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0167	10.0	mM	234.0	DMSO	138.031694	18	J	pluskal_fda_drugs_5005_J18_id
1828	HY-B1017	HYCPK40907	L10	HYCPK40907	92z	1076.0	2.0	W20	907.0	L10	15622-65-8	Molindone (hydrochloride)	EN-1733A	312.83	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Molindone hydrochloride (EN-1733A) is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.	Hydrochloride	C16H25ClN2O2	17527.0	H2O : 100 mg/mL (319.66 mM; Need ultrasonic); DMSO : 17.5 mg/mL (55.94 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1C2=C(NC(C)=C2CC)CCC1CN3CCOCC3.[H]Cl	https://www.medchemexpress.com/Molindone-hydrochloride.html	Launched		92.0	W20	J18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1017	10.0	mM	234.0	DMSO	276.183778	18	J	pluskal_fda_drugs_5005_J18_id
1909	HY-17464	HYCPK40907	E16	HYCPK40907	92z	416.0	2.0	I32	907.0	E16	73963-72-1	Cilostazol	OPC 13013	369.46	Autophagy; Phosphodiesterase (PDE)	Autophagy; Metabolic Enzyme/Protease	Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A, the isoform of PDE 3 in the cardiovascular system, with an IC50 of 0.2 μM[1][2].	Free Base	C20H27N5O2	11789.0	DMSO : 50 mg/mL (135.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C1NC2=C(C=C(OCCCCC3=NN=NN3C4CCCCC4)C=C2)CC1	https://www.medchemexpress.com/Cilostazol.html	Launched		92.0	I32	J18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17464	10.0	mM	234.0	DMSO	369.216475	18	J	pluskal_fda_drugs_5005_J18_id
1986	HY-B0385	HYCPK40907	F21	HYCPK40907	92z	522.0	2.0	K42	907.0	F21	56974-61-9	Gabexate (mesylate)	FOY	417.48	Factor Xa; Proteasome	Metabolic Enzyme/Protease	"Gabexate mesylate is a Factor X inhibitor; serine protease inhibitor .
Target: Factor X
Gabexate mesylate is a non-antigenic synthetic inhibitor of trypsin-like serine proteinases that is therapeutically used in the treatment of pancreatitis and disseminated intravascular coagulation and as a regional anticoagulant for hemodialysis. Values of the inhibition constant (K(i)) for gabexate mesylate binding to human and bovine tryptase were 3.4 x 10(-9) M and 1.8 x 10(-7) M (at pH 7.4 and 37.0 degrees ), respectively. Gabexate mesylate inhibited the fibrinogenolytic activity of human tryptase [1]. Gabexate Mesylate decreased the TNFalpha production of LPS-stimulated monocytes as shown by the inhibition of mRNA expression and increased the IL-10 production of LPS-stimulated monocytes. Gabexate Mesylate also suppressed the NFkappaB activity of LPS-stimulated monocytes. Inhibitory effect of Gabexate Mesylate on the TNFalpha production of activated human monocytes is mediated by the suppression of NFkappaB activation [2]. Gabexate mesylate inhibits competitively constitutive and inducible NO synthase (cNOS and iNOS, respectively), with Kivalues of 1.0×10 4M and 5.0×10 3M, respectively, at pH 7.4 and 37.0°C. gabexate mesylate increases iNOS mRNA expression in rat C6 glioma cells, as induced byE. colilipopolysaccharide plus interferon-γ. Gabexate mesylate inhibits dose-dependently nitrite production (i.e. NO release) in rat C6 glioma cells, as induced byE. colilipopolysaccharide plus interferon-γ [3]."	Mesylate	C17H27N3O7S	16243.0	H2O : 7.14 mg/mL (17.10 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (239.53 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCC)C1=CC=C(OC(CCCCCNC(N)=N)=O)C=C1.CS(=O)(O)=O	https://www.medchemexpress.com/Gabexate-mesylate.html	Launched		92.0	K42	J18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0385	10.0	mM	234.0	DMSO	321.168856	18	J	pluskal_fda_drugs_5005_J18_id
2297	HY-B0482	HYCPK40908	J21	HYCPK40908	92z	953.0	3.0	T41	908.0	J21	53164-05-9	Acemetacin	TVX 1322	415.82	COX	Immunology/Inflammation	Acemetacin (TVX 1322) is a non-steroidal anti-inflammatory drug and a glycolic acid ester of indometacin that is a cyclooxygenase inhibitor.	Free Acid	C21H18ClNO6	109323.0	DMSO : 125 mg/mL (300.61 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCC(O)=O)CC1=C(C)N(C(C2=CC=C(Cl)C=C2)=O)C3=C1C=C(OC)C=C3	https://www.medchemexpress.com/acemetacin.html	Launched		92.0	T41	J18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0482	10.0	mM	234.0	DMSO	415.082265	18	J	pluskal_fda_drugs_5005_J18_id
2435	HY-13055A	HYCPK40909	O03	HYCPK40909	92z	1398.0	4.0	AD6	909.0	O03	1033805-22-9	Telotristat ethyl	LX1032; LX1606	574.98	Tryptophan Hydroxylase	Metabolic Enzyme/Protease	Telotristat ethyl (LX1032) is a novel, orally-delivered inhibitor of tryptophan hydroxylase that reduces serotonin production.	Free Base	C27H26ClF3N6O3	31260.0	DMSO : ≥ 101.5 mg/mL (176.53 mM)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	N[C@@H](CC1=CC=C(C2=NC(N)=NC(O[C@H](C3=CC=C(Cl)C=C3N4N=C(C)C=C4)C(F)(F)F)=C2)C=C1)C(OCC)=O	https://www.medchemexpress.com/lx1606.html	Launched		92.0	AD6	J18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13055A	10.0	mM	234.0	DMSO	574.170701	18	J	pluskal_fda_drugs_5005_J18_id
51	HY-16346	HYCPK40899	E05	HYCPK40909	92z	464.0	4.0	J32	909.0	E16	290297-26-6	Netupitant	CID 6451149	578.59	Neurokinin Receptor	GPCR/G Protein; Neuronal Signaling	Netupitant (CID-6451149) is a highly potent, selective and orally active neurokinin-1 (NK1) receptor antagonist with a Ki of 0.95 nM for hNK1 in CHO cells. Netupitant has antiemetic affect[1][2][3].	Free Base	C30H32F6N4O	51581.0	DMSO : 9.09 mg/mL (15.71 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Neurological Disease; Endocrinology	CN1CCN(C2=CC(C3=C(C)C=CC=C3)=C(N(C)C(C(C4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4)(C)C)=O)C=N2)CC1	https://www.medchemexpress.com/Netupitant.html	Launched		92.0	J32	J19	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16346	2.0	mM	235.0	DMSO	578.248031	19	J	pluskal_fda_drugs_5005_J19_id
1463	HY-13026	HYCPK40908	O10	HYCPK40908	92z	1411.0	3.0	AD19	908.0	O10	870281-82-6	Idelalisib	CAL-101; GS-1101	415.42	Autophagy; PI3K	Autophagy; PI3K/Akt/mTOR	Idelalisib (CAL-101; GS-1101) is a highly selective and orally bioavailable p110δ inhibitor with an IC50 of 2.5 nM, showing 40- to 300-fold selectivity for p110δ over other PI3K class I enzymes.	Free Base	C22H18FN7O	65211.0	DMSO : ≥ 59.7 mg/mL (143.71 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1N(C2=CC=CC=C2)C([C@@H](NC3=C4N=CNC4=NC=N3)CC)=NC5=C1C(F)=CC=C5	https://www.medchemexpress.com/CAL-101.html	Launched		92.0	AD19	J19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13026	10.0	mM	235.0	DMSO	415.155686	19	J	pluskal_fda_drugs_5005_J19_id
1578	HY-13623A	HYCPK40906	M14	HYCPK40906	92z	1179.0	1.0	Y27	906.0	M14	209216-23-9	Entecavir (monohydrate)	BMS200475 (monohydrate); SQ34676 (monohydrate)	295.29	HBV	Anti-infection	Entecavir monohydrate (BMS200475 monohydrate; SQ34676 monohydrate) is a potent and selective inhibitor of HBV, with an EC50 of 3.75 nM in HepG2 cell.	Free Base	C12H17N5O4	21995.0	DMSO : ≥ 50 mg/mL (169.33 mM); H2O : 2.8 mg/mL (9.48 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection; Cancer	NC(N1)=NC(C2=C1N([C@@H](C[C@H](O)[C@H]3CO)C3=C)C=N2)=O.O	https://www.medchemexpress.com/Entecavir-monohydrate.html	Launched		92.0	Y27	J19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13623A	10.0	mM	235.0	DMSO	277.117489	19	J	pluskal_fda_drugs_5005_J19_id
1658	HY-B0418A	HYCPK40906	M19	HYCPK40906	92z	1189.0	1.0	Y37	906.0	M19	34552-83-5	Loperamide (hydrochloride)	R-18553 (hydrochloride)	513.49846	Autophagy; Opioid Receptor	Autophagy; GPCR/G Protein; Neuronal Signaling	Loperamide (hydrochloride) (R-18553 (hydrochloride)) is an opioid receptor agonist[1][2][3]. Loperamide hydrochloride is a selective and competitive human intestinal carboxylesterases (hiCE) inhibitor. Loperamide hydrochloride has anti-diarrheal effect[4].	Hydrochloride	C29H34Cl2N2O2	16110.0	DMSO : 50 mg/mL (97.37 mM; Need ultrasonic); H2O : 1 mg/mL (1.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease; Cancer	O=C(N(C)C)C(C1=CC=CC=C1)(C2=CC=CC=C2)CCN3CCC(O)(C4=CC=C(Cl)C=C4)CC3.Cl	https://www.medchemexpress.com/Loperamide-hydrochloride.html	Launched		92.0	Y37	J19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0418A	10.0	mM	235.0	DMSO	476.223056	19	J	pluskal_fda_drugs_5005_J19_id
1703	HY-B1244	HYCPK40906	J22	HYCPK40906	92z	907.0	1.0	S43	906.0	J22	551-92-8	Dimetridazole	1,2-Dimethyl-5-nitroimidazole	141.13	Antibiotic; Parasite	Anti-infection	Dmetridazole (1,2-Dimethyl-5-nitroimidazole), a nitroimidazole-based antibiotic, combats protozoan infections[1].	Free Base	C5H7N3O2	27627.0	DMSO : 50 mg/mL (354.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=[N+](C1=CN=C(C)N1C)[O-]	https://www.medchemexpress.com/Dimetridazole.html	Launched		92.0	S43	J19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1244	10.0	mM	235.0	DMSO	141.053826	19	J	pluskal_fda_drugs_5005_J19_id
2047	HY-12721	HYCPK40908	H05	HYCPK40908	92z	729.0	3.0	P9	908.0	H05	4205-90-7	Clonidine		230.09	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Clonidine is an alpha 2-adrenergic agonist[1].		C9H9Cl2N3	87335.0	DMSO : 100 mg/mL (434.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	ClC1=C(NC2=NCCN2)C(Cl)=CC=C1	https://www.medchemexpress.com/clonidine.html	Launched		92.0	P9	J19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12721	10.0	mM	235.0	DMSO	229.017353	19	J	pluskal_fda_drugs_5005_J19_id
2501	HY-17474	HYCPK40909	H08	HYCPK40909	92z	736.0	4.0	P16	909.0	H08	198470-84-7	Parecoxib	SC 69124	370.42	COX	Immunology/Inflammation	Parecoxib (SC 69124) is a highly selective?and orally active COX-2 inhibitor, the prodrug of Valdecoxib (HY-15762). Parecoxib Sodium is a nonsteroidal anti-inflammatory agent (NSAID) and inhibits prostaglandin (PG) synthesis. Parecoxib can be used for the relief of acute postoperative pain and symptoms of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis in vivo[1][2].	Free Base	C19H18N2O4S	10586.0	DMSO : ≥ 50 mg/mL (134.98 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	CCC(NS(=O)(C1=CC=C(C2=C(C)ON=C2C3=CC=CC=C3)C=C1)=O)=O	https://www.medchemexpress.com/parecoxib.html	Launched		92.0	P16	J19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17474	10.0	mM	235.0	DMSO	370.098728	19	J	pluskal_fda_drugs_5005_J19_id
2557	HY-16322	HYCPK40909	P11	HYCPK40909	92z	1510.0	4.0	AF22	909.0	P11	180064-38-4	Minodronic acid	YM-529	322.15	Apoptosis; P2X Receptor	Apoptosis; Membrane Transporter/Ion Channel	Minodronic acid (YM-529) is a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors involved in pain[1][2].	Free Acid	C9H12N2O7P2	45047.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 5 mg/mL (15.52 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer	OC(P(O)(O)=O)(P(O)(O)=O)CC1=CN=C2C=CC=CN21	https://www.medchemexpress.com/minodronic-acid.html	Launched		92.0	AF22	J19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16322	10.0	mM	235.0	DMSO	322.011974	19	J	pluskal_fda_drugs_5005_J19_id
1826	HY-107429	HYCPK40907	J10	HYCPK40907	92z	884.0	2.0	S20	907.0	J10	1622902-68-4	Abrocitinib	PF-04965842	323.41	JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Abrocitinib (PF-04965842) is a potent, orally active and selective JAK1 inhibitor, with IC50s of 29 and 803 nM for JAK1 and JAK2, respectively. Abrocitinib (PF-04965842) exhibits less active effect on TYK2 (IC50, 1.253 μM), and inhibits phosphorylation of STAT1, STAT3 and STAT5 after stimulation. Effective in autoimmune disease[1].	Free Base	C14H21N5O2S	44957.0	DMSO : 125 mg/mL (386.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CN([C@H]1C[C@@H](NS(CCC)(=O)=O)C1)C2=C3C(NC=C3)=NC=N2	https://www.medchemexpress.com/Abrocitinib.html	Launched		92.0	S20	J20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107429	10.0	mM	236.0	DMSO	323.141596	20	J	pluskal_fda_drugs_5005_J20_id
1839	HY-B0444	HYCPK40907	G11	HYCPK40907	92z	598.0	2.0	M22	907.0	G11	10347-81-6	Maprotiline (hydrochloride)		313.86	Autophagy	Autophagy	"Maprotiline hydrochloride is a selective noradrenalin re-uptake inhibitor and a tetracyclic antidepressant.
Target: Others
Maprotiline (sold as Deprilept, Ludiomil, Psymion) is a tetracyclic antidepressant (TeCA). However, Maprotiline's fourth ring is spurious, as formed by a bridge across the central tricyclic ring. It is a strong norepinephrine reuptake inhibitor with only weak effects on serotonin and dopamine reuptake. It exerts strong blocking effect at H1 receptors, moderate at 5-HT2 and alpha1 and weak blocking effect at D2 and mACh postsynaptic receptors [1, 2]."	Hydrochloride	C20H24ClN	20720.0	DMSO : 83.33 mg/mL (265.50 mM; ultrasonic and warming and heat to 60°C); H2O : 2.2 mg/mL (7.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CNCCCC1(CC2)C3=CC=CC=C3C2C4=CC=CC=C14.Cl	https://www.medchemexpress.com/maprotiline-hydrochloride.html	Launched		92.0	M22	J20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0444	10.0	mM	236.0	DMSO	277.18305	20	J	pluskal_fda_drugs_5005_J20_id
1895	HY-B0285A	HYCPK40907	G15	HYCPK40907	92z	606.0	2.0	M30	907.0	G15	2016-88-8	Amiloride (hydrochloride)	MK-870 hydrochloride	266.09	Apoptosis; Sodium Channel; TRP Channel	Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling	Amiloride hydrochloride (MK-870 hydrochloride) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]). Amiloride hydrochloride is a blocker of polycystin-2 (PC2; TRPP2[3]) channel.	Hydrochloride	C6H9Cl2N7O	14566.0	DMSO : ≥ 100 mg/mL (375.81 mM); H2O : 7.14 mg/mL (26.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=C(C1=NC(Cl)=C(N)N=C1N)NC(N)=N.Cl	https://www.medchemexpress.com/Amiloride-hydrochloride.html	Launched		92.0	M30	J20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0285A	10.0	mM	236.0	DMSO	229.047886	20	J	pluskal_fda_drugs_5005_J20_id
1907	HY-B0585	HYCPK40907	C16	HYCPK40907	92z	224.0	2.0	E32	907.0	C16	7491-74-9	Piracetam	UCB-6215	142.16	iGluR	Membrane Transporter/Ion Channel; Neuronal Signaling	Piracetam (UCB-6215) is a cyclic derivative of the neurotransmitter gamma-aminobutyric acid (GABA), used in treatment of a wide range of cognitive disorders.	Free Base	C6H10N2O2	16657.0	H2O : ≥ 50 mg/mL (351.72 mM); DMSO : ≥ 100 mg/mL (703.43 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N)CN1C(CCC1)=O	https://www.medchemexpress.com/Piracetam.html	Launched		92.0	E32	J20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0585	10.0	mM	236.0	DMSO	142.074228	20	J	pluskal_fda_drugs_5005_J20_id
1965	HY-14855	HYCPK40907	M19	HYCPK40907	92z	1190.0	2.0	Y38	907.0	M19	856866-72-3	Tedizolid	TR 700; Torezolid; DA-7157	370.34	Antibiotic; Bacterial	Anti-infection	Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome.	Free Base	C17H15FN6O3	5507.0	DMSO : 10 mg/mL (27.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1O[C@@H](CO)CN1C2=CC=C(C3=CC=C(C4=NN(C)N=N4)N=C3)C(F)=C2	https://www.medchemexpress.com/tedizolid.html	Launched		92.0	Y38	J20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14855	10.0	mM	236.0	DMSO	370.118967	20	J	pluskal_fda_drugs_5005_J20_id
2243	HY-17453	HYCPK40908	D18	HYCPK40908	92z	371.0	3.0	H35	908.0	D18	94749-08-3	Salmeterol (xinafoate)	GR 33343X xinafoate	603.75	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Salmeterol (GR 33343X) xinafoate is a potent and selective human β2 adrenoceptor agonist. Salmeterol shows potent stimulation of cAMP accumulation in CHO cells expressing human β2, β1 and β3 adrenoceptors with pEC50s of 9.6, 6.1, and 5.9, respectively[1].	Xinafoate	C36H45NO7	11611.0	DMSO : ≥ 50 mg/mL (82.82 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(C1=CC=C2C=CC=CC2=C1O)O.OC3=C(CO)C=C(C(CNCCCCCCOCCCCC4=CC=CC=C4)O)C=C3	https://www.medchemexpress.com/Salmeterol-xinafoate.html	Launched		92.0	H35	J20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17453	10.0	mM	236.0	DMSO	415.272259	20	J	pluskal_fda_drugs_5005_J20_id
2302	HY-50898A	HYCPK40908	O21	HYCPK40908	92z	1433.0	3.0	AD41	908.0	O21	388082-77-7	Lapatinib (ditosylate)	GW572016 (ditosylate); GW2016 (ditosylate)	925.46	Autophagy; EGFR; Ferroptosis	Apoptosis; Autophagy; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1].	Tosylate	C43H42ClFN4O10S3	2459.0	DMSO : 125 mg/mL (135.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=S(CCNCC1=CC=C(C2=CC=C3C(C(NC4=CC(Cl)=C(C=C4)OCC5=CC(F)=CC=C5)=NC=N3)=C2)O1)(C)=O.O=S(C6=CC=C(C)C=C6)(O)=O.O=S(C7=CC=C(C)C=C7)(O)=O	https://www.medchemexpress.com/Lapatinib-ditosylate.html	Launched		92.0	AD41	J20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50898A	10.0	mM	236.0	DMSO	580.134732	20	J	pluskal_fda_drugs_5005_J20_id
2418	HY-12745A	HYCPK40908	N22	HYCPK40908	92z	1339.0	3.0	AB43	908.0	N22	152658-17-8	Nalfurafine (hydrochloride)	TRK-820 (hydrochloride)	513.03	Opioid Receptor	GPCR/G Protein; Neuronal Signaling	Nalfurafine hydrochloride (TRK-820 hydrochloride) is a potent selective and orally active G protein-biased  kappa opioid receptor (KOR)-agonist with high translational potential[1]. Nalfurafine hydrochloride (TRK-820 hydrochloride) enhances the therapeutic potential of MOR-targeting analgesics, has the potential for uremic pruritis treatment[2].	Hydrochloride	C28H33ClN2O5	16639.0	DMSO : 33.33 mg/mL (64.97 mM; Need ultrasonic); H2O : 25 mg/mL (48.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O[C@@]1(CC[C@@H](N(C)C(/C=C/C2=COC=C2)=O)[C@]3([H])OC4=C5O)[C@]63C4=C(C=C5)C[C@@]1([H])N(CC7CC7)CC6.[H]Cl	https://www.medchemexpress.com/Nalfurafine-hydrochloride.html	Launched		92.0	AB43	J20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12745A	10.0	mM	236.0	DMSO	476.231122	20	J	pluskal_fda_drugs_5005_J20_id
1460	HY-50898	HYCPK40908	B05	HYCPK40908	92z	153.0	3.0	D9	908.0	B05	231277-92-2	Lapatinib	GW572016; GW2016	581.06	Autophagy; EGFR; Ferroptosis	Apoptosis; Autophagy; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Lapatinib (GW572016) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively[1].	Free Base	C29H26ClFN4O4S	79432.0	DMSO : 125 mg/mL (215.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=S(CCNCC1=CC=C(C2=CC=C3C(C(NC4=CC(Cl)=C(C=C4)OCC5=CC(F)=CC=C5)=NC=N3)=C2)O1)(C)=O	https://www.medchemexpress.com/Lapatinib.html	Launched		92.0	D9	J21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50898	10.0	mM	237.0	DMSO	580.134732	21	J	pluskal_fda_drugs_5005_J21_id
1532	HY-N0018	HYCPK40906	O11	HYCPK40906	92z	1365.0	1.0	AC21	906.0	O11	552-66-9	Daidzin	Daidzoside; NPI-031D; Daidzein 7-O-glucoside	416.38	Mitochondrial Metabolism; Reverse Transcriptase	Anti-infection; Metabolic Enzyme/Protease	Daidzin is an isoflavone that has anti-oxidant, anti-carcinogenic, and anti-atherosclerotic activities; directly inhibits mitochondrial aldehyde dehydrogenase 2 (IC50 = 80 nM) and is an effective anti-dipsotropic isoflavone.	Free Base	C21H20O9	25661.0	DMSO : ≥ 34 mg/mL (81.66 mM)	DMSO Solution	10mM  * 100uL	Others	OC1=CC=C(C2=COC(C=C(O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C4)=C4C2=O)C=C1	https://www.medchemexpress.com/Daidzin.html	Launched		92.0	AC21	J21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0018	10.0	mM	237.0	DMSO	416.110732	21	J	pluskal_fda_drugs_5005_J21_id
1586	HY-16503	HYCPK40906	E15	HYCPK40906	92z	413.0	1.0	I29	906.0	E15	299-75-2	Treosulfan	NSC 39069; Treosulphan	278.30	DNA Alkylator/Crosslinker	Cell Cycle/DNA Damage	Treosulfan (NSC 39069) is a bifunctional alkylating agent with activity in ovarian cancer and other solid tumor types.	Free Base	C6H14O8S2	15410.0	H2O : 50 mg/mL (179.66 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (359.32 mM)	DMSO Solution	10mM  * 100uL	Cancer	O[C@H]([C@@H](O)COS(C)(=O)=O)COS(C)(=O)=O	https://www.medchemexpress.com/Treosulfan.html	Launched		92.0	I29	J21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16503	10.0	mM	237.0	DMSO	278.013009	21	J	pluskal_fda_drugs_5005_J21_id
1627	HY-B0965	HYCPK40906	N17	HYCPK40906	92z	1281.0	1.0	AA33	906.0	N17	130-61-0	Thioridazine (hydrochloride)		407.04	5-HT Receptor; Apoptosis; Autophagy; Bacterial; Dopamine Receptor	Anti-infection; Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling	Thioridazine hydrochloride, an orally active antagonist of the dopamine receptor D2 family proteins, exhibits potent anti-psychotic and anti-anxiety activities. Thioridazine hydrochloride is also a potent inhibitor of PI3K-Akt-mTOR signaling pathways with anti-angiogenic effect. Thioridazine hydrochloride shows antiproliferative and apoptosis induction effects in various types of cancer cells, with specificity on targeting cancer stem cells (CSCs)[1][2][3][4].	Hydrochloride	C21H27ClN2S2	43341.0	DMSO : ≥ 45 mg/mL (110.55 mM); H2O : 100 mg/mL (245.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Neurological Disease	CSC(C=C1N2CCC3N(C)CCCC3)=CC=C1SC4=C2C=CC=C4.[H]Cl	https://www.medchemexpress.com/Thioridazine-hydrochloride.html	Launched		92.0	AA33	J21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0965	10.0	mM	237.0	DMSO	370.153741	21	J	pluskal_fda_drugs_5005_J21_id
1866	HY-A0092	HYCPK40907	B13	HYCPK40907	92z	122.0	2.0	C26	907.0	B13	127-48-0	Trimethadione	3,5,5,-Trimethyloxazolidine-2,4-dione	143.14	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Trimethadione (3,5,5,-Trimethyloxazolidine-2,4-dione) is an oxazolidinedione anticonvulsant agent widely used against absences seizures. Trimethadione also is a T-type calcium channel blocker which has antihyperalgesic effects[1][2].	Free Base	C6H9NO3	16757.0	DMSO : ≥ 40 mg/mL (279.45 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N1C)OC(C)(C)C1=O	https://www.medchemexpress.com/Trimethadione.html	Launched		92.0	C26	J21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0092	10.0	mM	237.0	DMSO	143.058243	21	J	pluskal_fda_drugs_5005_J21_id
2128	HY-16060	HYCPK40908	I10	HYCPK40908	92z	835.0	3.0	R19	908.0	I10	956104-40-8	Apalutamide	ARN-509	477.43	Androgen Receptor	Others	Apalutamide (ARN-509) is a potent and competitive androgen receptor (AR) antagonist, binding AR with an IC50 of 16 nM[1].	Free Base	C21H15F4N5O2S	7336.0	DMSO : 50 mg/mL (104.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC)C1=CC=C(N(C(N(C2=CC(C(F)(F)F)=C(C#N)N=C2)C3=O)=S)C43CCC4)C=C1F	https://www.medchemexpress.com/ARN-509.html	Launched		92.0	R19	J21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16060	10.0	mM	237.0	DMSO	477.088259	21	J	pluskal_fda_drugs_5005_J21_id
2170	HY-B0285B	HYCPK40908	G13	HYCPK40908	92z	649.0	3.0	N25	908.0	G13	17440-83-4	Amiloride hydrochloride dihydrate	MK-870 hydrochloride dihydrate	302.12	Apoptosis; Sodium Channel; TRP Channel	Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling	Amiloride hydrochloride dihydrate (MK-870 hydrochloride dihydrate)  is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]). Amiloride hydrochloride dihydrate is a blocker of polycystin-2 (PC2; TRPP2[3]) channel.	Hydrochloride	C6H13Cl2N7O3	27510.0	DMSO : 83.33 mg/mL (275.82 mM; ultrasonic and warming and heat to 60°C); H2O : 2 mg/mL (6.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=C(C1=NC(Cl)=C(N)N=C1N)NC(N)=N.[H]Cl.O.O	https://www.medchemexpress.com/Amiloride_hydrochloride_dihydrate.html	Launched		92.0	N25	J21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0285B	10.0	mM	237.0	DMSO	229.047886	21	J	pluskal_fda_drugs_5005_J21_id
2541	HY-10617	HYCPK40909	P10	HYCPK40909	92z	1508.0	4.0	AF20	909.0	P10	459868-92-9	Rucaparib (phosphate)	AG-014699 (phosphate); PF-01367338 (phosphate)	421.36	PARP	Cell Cycle/DNA Damage; Epigenetics	Rucaparib (AG014699) phosphate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib phosphate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib phosphate has the potential for castration-resistant prostate cancer (CRPC) research[1][2][3][4].	Phosphate	C19H21FN3O5P	31539.0	DMSO : ≥ 33 mg/mL (78.32 mM); H2O : 5 mg/mL (11.87 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=P(O)(O)O.FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1	https://www.medchemexpress.com/Rucaparib-phosphate.html	Launched		92.0	AF20	J21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10617	10.0	mM	237.0	DMSO	323.14339	21	J	pluskal_fda_drugs_5005_J21_id
1480	HY-N0145	HYCPK40906	K08	HYCPK40906	92z	975.0	1.0	U15	906.0	K08	3681-99-0	Puerarin		416.38	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Puerarin, an isoflavone extracted from Radix puerariae, is a 5-HT2C receptor antagonist.	Free Base	C21H20O9	27535.0	DMSO : 50 mg/mL (120.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C1C(C2=CC=C(O)C=C2)=COC3=C([C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)C(O)=CC=C13	https://www.medchemexpress.com/Puerarin.html	Launched		92.0	U15	J22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0145	10.0	mM	238.0	DMSO	416.110732	22	J	pluskal_fda_drugs_5005_J22_id
1591	HY-10791	HYCPK40906	J15	HYCPK40906	92z	893.0	1.0	S29	906.0	J15	87051-43-2	Ritanserin	R 55667	477.57	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Ritanserin (R 55667) is a highly potent, relatively selective, orally active, long acting antagonist of 5-HT2 receptor, with an IC50 of 0.9 nM, less active on Histamine H1, Dopamine D2, Adrenergic α1, Adrenergic α2 receptors[1].	Free Base	C27H25F2N3OS	102288.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 25 mg/mL (52.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC1=C(C(N(C=CS2)C2=N1)=O)CCN(CC/3)CCC3=C(C4=CC=C(F)C=C4)\C5=CC=C(F)C=C5	https://www.medchemexpress.com/ritanserin.html	Launched		92.0	S29	J22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10791	10.0	mM	238.0	DMSO	477.16864	22	J	pluskal_fda_drugs_5005_J22_id
1735	HY-B1231	HYCPK40907	J04	HYCPK40907	92z	872.0	2.0	S8	907.0	J04	543-15-7	Heptaminol (hydrochloride)	RP-2831 hydrochloride	181.70	Others	Others	"Heptaminol hydrochloride is a vasoconstrictor, used in the treatment of low blood pressure, particularly orthostatic hypotension.
in vivo: In the rat, Heptaminol hydrochloride prevents orthostatic hypotension, and increases the noradrenaline plasma concentration. In bovine chromaffin cells maintained in primary cultures, Heptaminol hydrochloride is found to be a competitive inhibitor of noradrenaline uptake.[1]"	Hydrochloride	C8H20ClNO	27564.0	DMSO : ≥ 100 mg/mL (550.36 mM); H2O : ≥ 100 mg/mL (550.36 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC(O)(C)CCCC(N)C.[H]Cl	https://www.medchemexpress.com/Heptaminol-hydrochloride.html	Launched		92.0	S8	J22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1231	10.0	mM	238.0	DMSO	145.146664	22	J	pluskal_fda_drugs_5005_J22_id
1766	HY-B0035	HYCPK40907	N06	HYCPK40907	92z	1260.0	2.0	AA12	907.0	N06	57-68-1	Sulfamethazine	Sulfadimidine; Sulfadimerazine	278.33	Antibiotic; Bacterial	Anti-infection	Sulfamethazine (Sulfadimidine) is an antimicrobial that is widely used to treat and prevent various animal diseases (such as gastrointestinal and respiratory tract infections). In China and the European Commission, the maximum residue level for Sulfamethazine in animal product is set at 100 μg/kg[1][2].	Free Base	C12H14N4O2S	16682.0	DMSO : 100 mg/mL (359.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC(C)=CC(C)=N2)=O	https://www.medchemexpress.com/sulfamethazine.html	Launched		92.0	AA12	J22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0035	10.0	mM	238.0	DMSO	278.083747	22	J	pluskal_fda_drugs_5005_J22_id
1854	HY-B0250	HYCPK40907	F12	HYCPK40907	92z	504.0	2.0	K24	907.0	F12	134678-17-4	Lamivudine	BCH-189	229.26	HBV; HIV; Reverse Transcriptase	Anti-infection	Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Lamivudine can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the CNS[1][2].	Free Base	C8H11N3O3S	13530.0	H2O : ≥ 50 mg/mL (218.09 mM); DMSO : 50 mg/mL (218.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	NC1=NC(N([C@H]2O[C@@H](CO)SC2)C=C1)=O	https://www.medchemexpress.com/Lamivudine.html	Launched		92.0	K24	J22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0250	10.0	mM	238.0	DMSO	229.052112	22	J	pluskal_fda_drugs_5005_J22_id
2469	HY-B0367	HYCPK40909	A06	HYCPK40909	92z	60.0	4.0	B12	909.0	A06	70374-39-9	Lornoxicam	Chlortenoxicam; Ro 13-9297	371.82	COX; Endogenous Metabolite	Immunology/Inflammation; Metabolic Enzyme/Protease	"Lornoxicam (Chlortenoxicam), a COX-1 and COX-2 inhibitor, is a new nonsteroidal anti-inflammatory drug (NSAID).
Target: COX
Lornoxicam showed a balanced inhibition of COX-1/-2 exhibiting the lowest IC50 (0.005 microM/0.008 microM) of the large panel of NSAIDs tested. lornoxicam showed a marked inhibition of IL-6 formation (IC50 54 microM) while the formation ofTNF-alpha, IL-1beta and IL-8 was only moderately affected [1]. Lornoxicam is effective in the treatment of patients with activated osteoarthritis; the analgesic and anti-inflammatory effects of lornoxicam are significantly superior to those of rofecoxib without inferiority in tolerability [2]. Lornoxicam was fully effective for prevention of hyperalgesia [3]."	Free Base	C13H10ClN3O4S2	16151.0	DMSO : 3.8 mg/mL (10.22 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=C(O)C2=C(C=C(Cl)S2)S(N1C)(=O)=O)NC3=NC=CC=C3	https://www.medchemexpress.com/Lornoxicam.html	Launched		92.0	B12	J22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0367	10.0	mM	238.0	DMSO	370.980125	22	J	pluskal_fda_drugs_5005_J22_id
2491	HY-B0962	HYCPK40909	N07	HYCPK40909	92z	1310.0	4.0	AB14	909.0	N07	129-77-1	Piperidolate (hydrochloride)		359.89	mAChR	GPCR/G Protein; Neuronal Signaling	Piperidolate hydrochloride is an antimuscarinic, inhibits intestinal cramp induced by acetylcholine (rats and dogs).	Hydrochloride	C21H26ClNO2	27944.0	DMSO : ≥ 32 mg/mL (88.92 mM); H2O : 50 mg/mL (138.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OC1CN(CC)CCC1)C(C2=CC=CC=C2)C3=CC=CC=C3.[H]Cl	https://www.medchemexpress.com/Piperidolate-hydrochloride.html	Launched		92.0	AB14	J22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0962	10.0	mM	238.0	DMSO	323.188529	22	J	pluskal_fda_drugs_5005_J22_id
2538	HY-13038A	HYCPK40909	M10	HYCPK40909	92z	1220.0	4.0	Z20	909.0	M10	901119-35-5	Fostamatinib	R788	580.46	FLT3; Syk	Protein Tyrosine Kinase/RTK	Fostamatinib (R788) is the oral prodrug of the active compound R406[1]. R406 is an orally available and competitive Syk/FLT3 inhibitor with a Ki of 30 nM and an IC50 of 41 nM[2]. R406 also inhibits Lyn (IC50=63 nM) and Lck (IC50=37 nM)[3].	Free Acid	C23H26FN6O9P	190322.0	DMSO : 62.5 mg/mL (107.67 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	COC1=CC(NC2=NC=C(C(NC3=NC(N4COP(O)(O)=O)=C(C=C3)OC(C)(C)C4=O)=N2)F)=CC(OC)=C1OC	https://www.medchemexpress.com/r788.html	Launched		92.0	Z20	J22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13038A	10.0	mM	238.0	DMSO	580.148291	22	J	pluskal_fda_drugs_5005_J22_id
8	HY-A0276	HYCPK40897	H03	HYCPK40909	92z	756.0	4.0	P36	909.0	H18	1405-41-0	Gentamicin (sulfate)		561.65 (Average)	Antibiotic; Bacterial	Anti-infection	Gentamicin sulfate, an orally active aminoglycoside antibiotic, inhibits the growth of both gram-positive and gram-negative bacteria and to inhibit several strains of mycoplasma in tissue culture. Gentamicin sulfate inhibits DNase I with an IC50 of 0.57 mM[1][2][3][4].	Sulfate	C(19-21)H(39-43)N5O7.H2SO4	24092.0	H2O : ≥ 30 mg/mL	DMSO Solution	3mg/mL  * 100uL	Infection; Cancer	O=S(O)(O)=O.O[C@]1(C)C(NC)[C@@H](O)[C@@H](O[C@H]2C(N)C[C@H](N)[C@@H](O[C@@H]3[C@H](N)CC[C@@H]([R])O3)[C@@H]2O)OC1.NC[*].C[C@H]([*])N.C[C@H]([*])NC.[R=].[or].[or]	https://www.medchemexpress.com/Gentamicin__sulfate_.html	Launched		92.0	P36	K3	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0276	3.0	mM	243.0	DMSO	477.316249	3	K	pluskal_fda_drugs_5005_K3_id
1587	HY-B0715	HYCPK40906	F15	HYCPK40906	92z	509.0	1.0	K29	906.0	F15	6493-05-6	Pentoxifylline	BL-191; PTX; Oxpentifylline	278.31	Autophagy; HIV; Phosphodiesterase (PDE)	Anti-infection; Autophagy; Metabolic Enzyme/Protease	Pentoxifylline (BL-191), a haemorheological agent, is an orally active non-selective phosphodiesterase (PDE) inhibitor, with immune modulation, anti-inflammatory, hemorheological, anti-fibrinolytic and anti-proliferation effects. Pentoxifylline can be used for the research of peripheral vascular disease, cerebrovascular disease and a number of other conditions involving a defective regional microcirculation[1][2][3].	Free Base	C13H18N4O3	16821.0	DMSO : ≥ 2.8 mg/mL (10.06 mM); H2O : 93.3 mg/mL (335.24 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(N1CCCCC(C)=O)N(C)C2=C(N(C)C=N2)C1=O	https://www.medchemexpress.com/Pentoxifylline.html	Launched		92.0	K29	K3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0715	10.0	mM	243.0	DMSO	278.13789	3	K	pluskal_fda_drugs_5005_K3_id
1638	HY-15440B	HYCPK40906	I18	HYCPK40906	92z	803.0	1.0	Q35	906.0	I18	864953-39-9	Fostemsavir Tris	BMS-663068 (Tris)	704.62	HIV	Anti-infection	Fostemsavir Tris (BMS-663068 (Tris)) is the phosphonooxymethyl prodrug of BMS-626529.  Fostemsavir Tris (BMS-663068 (Tris)) is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells.	Tris	C29H37N8O11P	58208.0	H2O : 100 mg/mL (141.92 mM; Need ultrasonic); DMSO : 125 mg/mL (177.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N1CCN(C(C2=CC=CC=C2)=O)CC1)C(C3=CN(COP(O)(O)=O)C4=C3C(OC)=CN=C4N5N=C(C)N=C5)=O.OCC(CO)(N)CO	https://www.medchemexpress.com/BMS-663068-Tris.html	Launched		92.0	Q35	K3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15440B	10.0	mM	243.0	DMSO	583.158047	3	K	pluskal_fda_drugs_5005_K3_id
1695	HY-17044	HYCPK40906	B22	HYCPK40906	92z	139.0	1.0	C43	906.0	B22	1201438-56-3	Duvelisib	IPI-145; INK1197	416.86	PI3K	PI3K/Akt/mTOR	Duvelisib (IPI-145) is a selectivite p100δ inhibitor with IC50 of 2.5 nM, 27.4 nM, 85 nM and 1602 nM for p110δ, P110γ, p110β and p110α, respectively[1][2].	Free Base	C22H17ClN6O	16252.0	DMSO : ≥ 41 mg/mL (98.35 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1N(C2=CC=CC=C2)C([C@@H](NC3=C4N=CNC4=NC=N3)C)=CC5=C1C(Cl)=CC=C5	https://www.medchemexpress.com/Duvelisib.html	Launched		92.0	C43	K3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17044	10.0	mM	243.0	DMSO	416.115237	3	K	pluskal_fda_drugs_5005_K3_id
1710	HY-15315	HYCPK40907	A03	HYCPK40907	92z	6.0	2.0	A6	907.0	A03	1187594-09-7	Baricitinib	LY3009104; INCB028050	371.42	JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Baricitinib (LY3009104; INCB028050) is a selective and orally bioavailable JAK1 and JAK2 inhibitor with IC50s of 5.9 nM and 5.7 nM, respectively.	Free Base	C16H17N7O2S	23191.0	DMSO : 25 mg/mL (67.31 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	N#CCC1(N2N=CC(C3=C4C(NC=C4)=NC=N3)=C2)CN(S(=O)(CC)=O)C1	https://www.medchemexpress.com/Baricitinib.html	Launched		92.0	A6	K3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15315	10.0	mM	243.0	DMSO	371.116444	3	K	pluskal_fda_drugs_5005_K3_id
2293	HY-B1140	HYCPK40908	F21	HYCPK40908	92z	569.0	3.0	L41	908.0	F21	364-98-7	Diazoxide	Sch-6783; SRG-95213	230.67	Autophagy; Potassium Channel	Autophagy; Membrane Transporter/Ion Channel	Diazoxide (Sch-6783) is an ATP-sensitive potassium channel activator, has the potential for hyperinsulinism treatment.	Free Base	C8H7ClN2O2S	20022.0	DMSO : ≥ 35 mg/mL (151.73 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	CC(NC1=CC=C(Cl)C=C12)=NS2(=O)=O	https://www.medchemexpress.com/Diazoxide.html	Launched		92.0	L41	K3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1140	10.0	mM	243.0	DMSO	229.991676	3	K	pluskal_fda_drugs_5005_K3_id
2478	HY-B0962A	HYCPK40909	J06	HYCPK40909	92z	924.0	4.0	T12	909.0	J06	82-98-4	Piperidolate		323.43	mAChR	GPCR/G Protein; Neuronal Signaling	Piperidolate is an antimuscarinic, inhibits intestinal cramp induced by acetylcholine (rats and dogs).	Free Base	C21H25NO2	27913.0	DMSO : ≥ 150 mg/mL (463.78 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OC1CN(CC)CCC1)C(C2=CC=CC=C2)C3=CC=CC=C3	https://www.medchemexpress.com/Piperidolate.html	Launched		92.0	T12	K3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0962A	10.0	mM	243.0	DMSO	323.188529	3	K	pluskal_fda_drugs_5005_K3_id
2480	HY-16513	HYCPK40909	L06	HYCPK40909	92z	1116.0	4.0	X12	909.0	L06	23261-20-3	VAL-083	Dianhydrodulcitol; Dianhydrogalactitol	146.14	DNA Alkylator/Crosslinker	Cell Cycle/DNA Damage	VAL-083 is an alkylating agent that creates N7 methylation on DNA, with antitumor activity.	Free Base	C6H10O4	218098.0	H2O : 50 mg/mL (342.14 mM; Need ultrasonic); DMSO : 200 mg/mL (1368.55 mM; ultrasonic and warming and heat to 60°C); DMF : ≥ 100 mg/mL (684.28 mM)	DMSO Solution	10mM  * 100uL	Cancer	O[C@H]([C@H](O)[C@]1(OC1)[H])[C@@]2([H])CO2	https://www.medchemexpress.com/val-083.html	Launched		92.0	X12	K3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16513	10.0	mM	243.0	DMSO	146.057909	3	K	pluskal_fda_drugs_5005_K3_id
50	HY-12857	HYCPK40899	D05	HYCPK40909	92z	368.0	4.0	H32	909.0	D16	1197953-54-0	Brigatinib	AP-26113	584.09	Anaplastic lymphoma kinase (ALK)	Protein Tyrosine Kinase/RTK	Brigatinib (AP-26113) is a highly potent and selective ALK inhibitor, with an IC50 of 0.6 nM[1].	Free Base	C29H39ClN7O2P	17784.0	DMSO : 2 mg/mL (3.42 mM; Need ultrasonic); Ethanol : 10 mg/mL (17.12 mM; Need ultrasonic and warming)	DMSO Solution	2mM  * 100uL	Cancer	CN1CCN(C2CCN(C3=CC=C(NC4=NC=C(Cl)C(NC5=CC=CC=C5P(C)(C)=O)=N4)C(OC)=C3)CC2)CC1	https://www.medchemexpress.com/Brigatinib.html	Launched		92.0	H32	K4	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12857	2.0	mM	244.0	DMSO	583.259138	4	K	pluskal_fda_drugs_5005_K4_id
1383	HY-13757	HYCPK40906	D04	HYCPK40906	92z	295.0	1.0	G7	906.0	D04	54965-24-1	Tamoxifen (Citrate)	ICI 46474; (Z)-Tamoxifen (Citrate); trans-Tamoxifen (Citrate)	563.64	Apoptosis; Autophagy; Estrogen Receptor/ERR; HSP	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others	Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells[1][2][3].Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen Citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively[5]. Tamoxifen Citrate activates autophagy and induces apoptosis[4].	Citrate	C32H37NO8	10538.0	DMSO : 50 mg/mL (88.71 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble); Ethanol : 10 mg/mL (17.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(C)C)C=C2)\C3=CC=CC=C3.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Tamoxifen-Citrate.html	Launched		92.0	G7	K4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13757	10.0	mM	244.0	DMSO	371.224915	4	K	pluskal_fda_drugs_5005_K4_id
1626	HY-B0566	HYCPK40906	M17	HYCPK40906	92z	1185.0	1.0	Y33	906.0	M17	23256-50-0	Guanabenz (Acetate)	BR-750; Wy8678 acetate	291.13	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Guanabenz (Acetate) (BR-750) is an alpha-2 selective adrenergic agonist used as an antihypertensive agent.	Acetate	C10H12Cl2N4O2	16020.0	DMSO : ≥ 51 mg/mL (175.18 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	ClC1=C(/C=N/NC(N)=N)C(Cl)=CC=C1.CC(O)=O	https://www.medchemexpress.com/Guanabenz-Acetate.html	Launched		92.0	Y33	K4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0566	10.0	mM	244.0	DMSO	230.012602	4	K	pluskal_fda_drugs_5005_K4_id
1851	HY-B1301	HYCPK40907	C12	HYCPK40907	92z	216.0	2.0	E24	907.0	C12	6138-79-0	Triprolidine (hydrochloride monohydrate)		332.87	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Triprolidine hydrochloride monohydrate, a first-generation antihistamine, is an oral active histamine H1 antagonist. Triprolidine hydrochloride monohydrate can be used for the research of allergic rhinitis. Triprolidine hydrochloride monohydrate exhibits spinal motor and sensory block in rats[1][2][3].	Hydrochloride	C19H25ClN2O	64381.0	H2O : 100 mg/mL (300.42 mM; Need ultrasonic); DMSO : 100 mg/mL (300.42 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	CC1=CC=C(/C(C2=NC=CC=C2)=C\CN3CCCC3)C=C1.[H]Cl.[H]O[H]	https://www.medchemexpress.com/triprolidine-hydrochloride-monohydrate.html	Launched		92.0	E24	K4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1301	10.0	mM	244.0	DMSO	278.178299	4	K	pluskal_fda_drugs_5005_K4_id
1940	HY-12515A	HYCPK40907	D18	HYCPK40907	92z	324.0	2.0	G36	907.0	D18	54527-84-3	Nicardipine (hydrochloride)	YC-93	515.99	Autophagy; Calcium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Nicardipine hydrochloride (YC-93) is a calcium channel blocker with an IC50 of 1 μM for blocking cardiac calcium channels. Nicardipine hydrochloride acts as an agent for chronic stable angina and for controlling blood pressure[1].	Hydrochloride	C26H30ClN3O6	14781.0	DMSO : ≥ 35 mg/mL (67.83 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C1=C(C)NC(C)=C(C(OCCN(C)CC2=CC=CC=C2)=O)C1C3=CC=CC([N+]([O-])=O)=C3)OC.[H]Cl	https://www.medchemexpress.com/Nicardipine-Hydrochloride.html	Launched		92.0	G36	K4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12515A	10.0	mM	244.0	DMSO	479.205636	4	K	pluskal_fda_drugs_5005_K4_id
1995	HY-B0930	HYCPK40907	O21	HYCPK40907	92z	1386.0	2.0	AC42	907.0	O21	119-41-5	Efloxate	Angorlisin	324.33	Others	Others	Efloxate is a vasodilator, used to treat chronic coronary insufficiency and Angina pectoris,	Free Base	C19H16O5	57390.0	DMSO : 130 mg/mL (400.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(OCC)COC1=CC=C2C(C=C(C3=CC=CC=C3)OC2=C1)=O	https://www.medchemexpress.com/Efloxate.html	Launched		92.0	AC42	K4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0930	10.0	mM	244.0	DMSO	324.099774	4	K	pluskal_fda_drugs_5005_K4_id
2264	HY-B0745	HYCPK40908	I19	HYCPK40908	92z	853.0	3.0	R37	908.0	I19	116649-85-5	Ramatroban	BAY u3405	416.47	Prostaglandin Receptor	GPCR/G Protein	Ramatroban is a selective thromboxane A2 (TxA2, IC50=14 nM) antagonist, which also antagonizes CRTH2 (IC50=113 nM) by inhibiting PGD2 binding.	Free Acid	C21H21FN2O4S	14525.0	DMSO : 125 mg/mL (300.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	O=C(O)CCN1C2=C(C3=C1C=CC=C3)C[C@H](NS(=O)(C4=CC=C(F)C=C4)=O)CC2	https://www.medchemexpress.com/Ramatroban.html	Launched		92.0	R37	K4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0745	10.0	mM	244.0	DMSO	416.120606	4	K	pluskal_fda_drugs_5005_K4_id
2286	HY-B0282	HYCPK40908	O20	HYCPK40908	92z	1431.0	3.0	AD39	908.0	O20	60-31-1	Acetylcholine (chloride)	ACh (chloride)	181.66	Calcium Channel; Endogenous Metabolite; nAChR	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Acetylcholine chloride (ACh chloride), a neurotransmitter, is a potent cholinergic agonist. Acetylcholine chloride is a modulator of the activity of dopaminergic (DAergic) neurons through the stimulation of nicotinic acetylcholine receptors (nAChRs)[1][2]. Acetylcholine chloride inhibits p53 mutant peptide aggregation in vitro[5].	Chloride	C7H16ClNO2	116843.0	H2O : 100 mg/mL (550.48 mM; Need ultrasonic); DMSO : 62.5 mg/mL (344.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(OCC[N+](C)(C)C)C.[Cl-]	https://www.medchemexpress.com/Acetylcholine-chloride.html	Launched		92.0	AD39	K4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0282	10.0	mM	244.0	DMSO	146.117555	4	K	pluskal_fda_drugs_5005_K4_id
1429	HY-10021	HYCPK40906	B07	HYCPK40906	92z	109.0	1.0	C13	906.0	B07	375815-87-5	Varenicline (Tartrate)	CP 526555-18	361.35	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	"Varenicline Tartrate(CP 526555;Champix) is a nicotinic receptor partial agonist; it stimulates nicotine receptors more weakly than nicotine itself does.
IC50 value:
Target: α4β2 nAChR
Varenicline(CP 526555; Champix; Chantix) is a prescription medication used to treat smoking addiction. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms Varenicline(CP 526555; Champix; Chantix)  can assist some patients to quit smoking."	Tartrate	C17H19N3O6	8277.0	H2O : 20 mg/mL (55.35 mM; ultrasonic and warming and heat to 60°C); DMSO : 14.29 mg/mL (39.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(O)[C@H](O)[C@@H](O)C(O)=O.C1(C2CC3CNC2)=C3C=C(N=CC=N4)C4=C1	https://www.medchemexpress.com/Varenicline-Tartrate.html	Launched		92.0	C13	K5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10021	10.0	mM	245.0	DMSO	150.016438	5	K	pluskal_fda_drugs_5005_K5_id
1483	HY-B0799	HYCPK40906	N08	HYCPK40906	92z	1263.0	1.0	AA15	906.0	N08	8067-24-1	Dihydroergotoxine (mesylate)	Ergoloid mesylates	2314.74	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	"Dihydroergotoxine mesylate is a complex of closely related alkaloid salts; Binds with high affinity to the GABAA receptor Cl- channel, producing an allosteric interaction with the benzodiazepine site.
IC50 value:
Target: 
Dihydroergotoxine mesylate also interacts with central dopaminergic, serotonergic and adrenergic (α1) receptors. Dihydroergotoxine mesylate displays antiproliferative activity in vitro (IC50 = 18 - 38 μM in prostate cancer cells) and exhibits cognition-enhancing, anticonvulsant and sedative activity in vivo."	Mesylate	C123H156N20O23S	99046.0	DMSO : ≥ 100 mg/mL (43.20 mM); H2O : 2 mg/mL (0.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1C[C@H](C(N[C@@]2(C)C(N([C@@H](CC(C)C)C(N3[C@@]4([H])CCC3)=O)[C@@]4(O)O2)=O)=O)CC([C@@]1([H])C5)C6=CC=CC7=C6C5=CN7.CN8C[C@H](C(N[C@@]9(C)C(N([C@@H](C(C)C)C(N%10[C@@]%11([H])CCC%10)=O)[C@@]%11(O)O9)=O)=O)CC([C@@]8([H])C%12)C%13=CC=CC%14=C%13C%12=CN%14.CN	https://www.medchemexpress.com/Dihydroergotoxine_mesylate.html	Launched		92.0	AA15	K5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0799	10.0	mM	245.0	DMSO	583.279469	5	K	pluskal_fda_drugs_5005_K5_id
1719	HY-13757A	HYCPK40907	J03	HYCPK40907	92z	870.0	2.0	S6	907.0	J03	10540-29-1	Tamoxifen	ICI 47699; (Z)-Tamoxifen; trans-Tamoxifen	371.51	Apoptosis; Autophagy; Estrogen Receptor/ERR; HSP	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Others	Tamoxifen (ICI 47699) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells[1][2][3]. Tamoxifen is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively[5]. Tamoxifen activates autophagy and induces apoptosis[4]. Tamoxifen also can induce gene knockout of CreER(T2) transgenic mouse[6].	Free Base	C26H29NO	57351.0	DMSO : 50 mg/mL (134.59 mM; Need ultrasonic); Ethanol : 50 mg/mL (134.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(C)C)C=C2)\C3=CC=CC=C3	https://www.medchemexpress.com/Tamoxifen.html	Launched		92.0	S6	K5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13757A	10.0	mM	245.0	DMSO	371.224915	5	K	pluskal_fda_drugs_5005_K5_id
1727	HY-16069	HYCPK40907	B04	HYCPK40907	92z	104.0	2.0	C8	907.0	B04	937263-43-9	Tucatinib	Irbinitinib; ARRY-380; ONT-380	480.52	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Tucatinib (Irbinitinib) is a potent, orally active and selective HER2 inhibitor with an IC50 of 8 nM.	Free Base	C26H24N8O2	145887.0	DMSO : 41.67 mg/mL (86.72 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	CC1=CC(NC2=C3C=C(NC4=NC(C)(C)CO4)C=CC3=NC=N2)=CC=C1OC5=CC6=NC=NN6C=C5	https://www.medchemexpress.com/Irbinitinib.html	Launched		92.0	C8	K5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16069	10.0	mM	245.0	DMSO	480.202222	5	K	pluskal_fda_drugs_5005_K5_id
2071	HY-16171	HYCPK40908	P06	HYCPK40908	92z	1499.0	3.0	AF11	908.0	P06	62-97-5	Diphenmanil (methylsulfate)	Diphemanil mesylate	389.51	mAChR	GPCR/G Protein; Neuronal Signaling	"Diphemanil methylsulfate is a quaternary ammonium anticholinergic. It binds muscarinic acetycholine receptors and thereby decreases secretory excretion of stomach acids as well as saliva and sweat.
IC50 value: 
Target: mAChR
Diphemanil Methylsulfate exerts its action by primarily binding the muscarinic M3 receptor. M3 receptors are located in the smooth muscles of the blood vessels, as well as in the lungs. This means they cause vasodilation and bronchoconstriction. They are also in the smooth muscles of the gastrointestinal tract (GIT), which help in increasing intestinal motility and dilating sphincters. The M3 receptors are also located in many glands which help to stimulate secretion in salivary glands and other glands of the body."	Methylsulfate	C21H27NO4S	9911.0	H2O : 16.67 mg/mL (42.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	[O-]S(=O)(OC)=O.C[N+]1(C)CC/C(CC1)=C(C2=CC=CC=C2)\C3=CC=CC=C3	https://www.medchemexpress.com/diphenmanil-methylsulfate.html	Launched		92.0	AF11	K5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16171	10.0	mM	245.0	DMSO	278.190326	5	K	pluskal_fda_drugs_5005_K5_id
2272	HY-B0561	HYCPK40908	A20	HYCPK40908	92z	87.0	3.0	B39	908.0	A20	52-01-7	Spironolactone	SC9420	416.57	Androgen Receptor; Autophagy; Mineralocorticoid Receptor	Autophagy; Metabolic Enzyme/Protease; Others	Spironolactone (SC9420) is an orally active aldosterone mineralocorticoid receptor antagonist with an IC50 of 24 nM. Spironolactone is also a potent antagonist of androgen receptor with an IC50 of 77 nM. Spironolactone promotes autophagy in podocytes[1][2][3].	Free Base	C24H32O4S	13244.0	H2O : 0.1 mg/mL (0.24 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (120.03 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	C[C@@]12[C@](OC3=O)(CC3)CC[C@@]1([H])[C@@]([C@@H](CC4=CC5=O)SC(C)=O)([H])[C@]([C@]4(CC5)C)([H])CC2	https://www.medchemexpress.com/spironolactone.html	Launched		92.0	B39	K5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0561	10.0	mM	245.0	DMSO	416.202131	5	K	pluskal_fda_drugs_5005_K5_id
2408	HY-B0881	HYCPK40908	D22	HYCPK40908	92z	379.0	3.0	H43	908.0	D22	968-81-0	Acetohexamide		324.40	Others	Others	Acetohexamide is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2; stimulate the pancreas to secrete insulin.	Free Base	C15H20N2O4S	16486.0	DMSO : 25 mg/mL (77.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=S(C1=CC=C(C(C)=O)C=C1)(NC(NC2CCCCC2)=O)=O	https://www.medchemexpress.com/Acetohexamide.html	Launched		92.0	H43	K5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0881	10.0	mM	245.0	DMSO	324.114378	5	K	pluskal_fda_drugs_5005_K5_id
2425	HY-15030	HYCPK40909	E03	HYCPK40909	92z	438.0	4.0	J6	909.0	E03	22204-53-1	Naproxen	(S)-Naproxen	230.26	Autophagy; COX	Autophagy; Immunology/Inflammation	Naproxen is a COX-1 and COX-2 inhibitor with IC50s of  8.72 and 5.15 μM, respectively in cell assay.	Free Acid	C14H14O3	120913.0	H2O : 75 mg/mL (325.72 mM; Need ultrasonic and warming); DMSO : ≥ 100 mg/mL (434.29 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	C[C@H](C(O)=O)C1=CC2=CC=C(OC)C=C2C=C1	https://www.medchemexpress.com/Naproxen.html	Launched		92.0	J6	K5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15030	10.0	mM	245.0	DMSO	230.094294	5	K	pluskal_fda_drugs_5005_K5_id
1661	HY-N0537	HYCPK40906	P19	HYCPK40906	92z	1477.0	1.0	AE37	906.0	P19	58-86-6	Xylose	D-(+)-Xylose; (+)-Xylose; Wood sugar	150.13	Endogenous Metabolite	Metabolic Enzyme/Protease	Xylose, a natural product, can be catalyzed into xylulose by xylose isomerase, and it is the key step for anaerobic ethanolic fermentation of xylose.	Free Base	C5H10O5	17451.0	DMSO : 50 mg/mL (333.04 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (333.04 mM)	DMSO Solution	10mM  * 100uL	Others	O=C[C@@H]([C@H]([C@@H](CO)O)O)O	https://www.medchemexpress.com/Xylose.html	Launched		92.0	AE37	K6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0537	10.0	mM	246.0	DMSO	150.052823	6	K	pluskal_fda_drugs_5005_K6_id
1968	HY-B0670A	HYCPK40907	P19	HYCPK40907	92z	1478.0	2.0	AE38	907.0	P19	6190-39-2	Dihydroergotamine (mesylate)		679.78	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Dihydroergotamine mesylate is an ergot alkaloid used to treat migraines.
Target: 5-HT Receptors
Dihydroergotamine is not as effective as sumatriptan or phenothiazines as a single agent for treatment of acute migraine headache; however, when administered with an antiemetic, dihydroergotamine appears to be as effective as opiates, ketorolac, or valproate. Given its nonnarcotic properties, parenteral dihydroergotamine combined with an antiemetic should be considered as effective initial therapy in clinical practice [1]. The introduction of the intranasal formulation of DHE provides both pharmacologic and patient-convenience advantages for use in migraine therapy [2, 3]."	Mesylate	C34H41N5O8S	26673.0	DMSO : 50 mg/mL (73.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O[C@@]([C@@](CCC1)([H])N1C2=O)(O[C@](NC([C@@H](CN(C)[C@]3([H])C4)C[C@]3([H])C5=C6C4=CNC6=CC=C5)=O)(C)C7=O)N7[C@H]2CC8=CC=CC=C8.CS(=O)(O)=O	https://www.medchemexpress.com/Dihydroergotamine-mesylate.html	Launched		92.0	AE38	K6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0670A	10.0	mM	246.0	DMSO	583.279469	6	K	pluskal_fda_drugs_5005_K6_id
2027	HY-B0692	HYCPK40908	O03	HYCPK40908	92z	1397.0	3.0	AD5	908.0	O03	88040-23-7	Cefepime	BMY-28142	480.56	Antibiotic; Bacterial	Anti-infection	Cefepime (BMY-28142) is a broad-spectrum and cross the blood-brain barrier cephalosporin. Cefepime shows antibacterial effects against both Gram-positive and Gram-negative aerobic bacteria. Cefepime induces neurotoxicity[1][2][3][4].		C19H24N6O5S2	126045.0	DMSO : 125 mg/mL (260.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[N+]1(CC(CS[C@]2([H])[C@@H]3NC(/C(C4=CSC(N)=N4)=N\OC)=O)=C(C([O-])=O)N2C3=O)CCCC1	https://www.medchemexpress.com/cefepime.html	Launched		92.0	AD5	K6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0692	10.0	mM	246.0	DMSO	481.132236	6	K	pluskal_fda_drugs_5005_K6_id
2194	HY-B1153	HYCPK40908	O14	HYCPK40908	92z	1419.0	3.0	AD27	908.0	O14	3820-67-5	Glafenine	Glafenin	372.80	Others	Others	Glafenine is a non-steroidal anti-inflammatory drug (NSAID), is a non-narcotic analgesic agent, widely used for the treatment of pains of various origins.	Free Base	C19H17ClN2O4	64334.0	DMSO : 100 mg/mL (268.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCC(O)CO)C1=CC=CC=C1NC2=CC=NC3=CC(Cl)=CC=C23	https://www.medchemexpress.com/Glafenine.html	Launched		92.0	AD27	K6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1153	10.0	mM	246.0	DMSO	372.087685	6	K	pluskal_fda_drugs_5005_K6_id
2197	HY-105185	HYCPK40908	B15	HYCPK40908	92z	173.0	3.0	D29	908.0	B15	136087-85-9	Fidarestat	SNK 860	279.22	Aldose Reductase	Metabolic Enzyme/Protease	Fidarestat (SNK 860) is an inhibitor of aldose reductase, with IC50s of 26 nM, 33 μM, and 1.8 μM for aldose reductase, AKR1B10 and V301L AKR1B10, respectively; Fidarestat (SNK 860) has the potential to treat diabetic disease.	Free Base	C12H10FN3O4	46194.0	DMSO : 250 mg/mL (895.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C1NC(N[C@@]12C3=C(C=CC(F)=C3)O[C@H](C(N)=O)C2)=O	https://www.medchemexpress.com/Fidarestat.html	Launched		92.0	D29	K6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-105185	10.0	mM	246.0	DMSO	279.065534	6	K	pluskal_fda_drugs_5005_K6_id
2209	HY-66010	HYCPK40908	N15	HYCPK40908	92z	1325.0	3.0	AB29	908.0	N15	26328-04-1	Cinepazide (Maleate)	MD-67350	533.5708	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Cinepazide Maleate (MD-67350) is a piperazine derivative and acts as a weak calcium channel blocker. Cinepazide Maleate is a potent vasodilator and can be used for the research of cerebrovascular diseases, including ischemic stroke, brain?infarct et. al[1].</br>	Maleate	C26H35N3O9	13645.0	DMSO : 100 mg/mL (187.42 mM; Need ultrasonic); H2O : 50 mg/mL (93.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(N1CCN(CC(N2CCCC2)=O)CC1)/C=C/C3=CC(OC)=C(OC)C(OC)=C3.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Cinepazide-Maleate.html	Launched		92.0	AB29	K6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-66010	10.0	mM	246.0	DMSO	417.226371	6	K	pluskal_fda_drugs_5005_K6_id
2473	HY-14258A	HYCPK40909	E06	HYCPK40909	92z	444.0	4.0	J12	909.0	E06	219861-08-2	Escitalopram (oxalate)	(S)-Citalopram (oxalate); (S)-(+)-Citalopram (oxalate)	414.43	Serotonin Transporter	Neuronal Signaling	Escitalopram ((S)-Citalopram) oxalate, the S-enantiomer of racemic Citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. Escitalopram oxalate has ～30 fold higher binding affinity than its R(-)-enantiomer and shows selectivity over both dopamine transporter (DAT) and norepinephrine transporter (NET). Escitalopram oxalate is an antidepressant for the research of major depression[1][2].	Oxalate	C22H23FN2O5	15396.0	H2O : ≥ 14.29 mg/mL (34.48 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	FC1=CC=C([C@@]2(CCCN(C)C)C(C=CC(C#N)=C3)=C3CO2)C=C1.O=C(O)C(O)=O	https://www.medchemexpress.com/Escitalopram-oxalate.html	Launched		92.0	J12	K6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14258A	10.0	mM	246.0	DMSO	324.163792	6	K	pluskal_fda_drugs_5005_K6_id
2552	HY-B1671	HYCPK40909	K11	HYCPK40909	92z	1030.0	4.0	V22	909.0	K11	500-64-1	(+)-Kavain		230.26	Calcium Channel; GABA Receptor; Sodium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	(+)-Kavain, a main kavalactone extracted from Piper methysticum, has anticonvulsive properties, attenuating vascular smooth muscle contraction through interactions with voltage-dependent Na+ and Ca2+ channels[1]. (+)-Kavain is shown to bind at the α4β2δ GABAA receptor and potentiate GABA efficacy[2]. (+)-Kavain is used as a treatment for inflammatory diseases, its anti-inflammatory action has been widely studied[4].	Free Base	C14H14O3	83962.0	DMSO : 50 mg/mL (217.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	O=C1C=C(OC)C[C@H](/C=C/C2=CC=CC=C2)O1	https://www.medchemexpress.com/__addition__-Kavain.html	Launched		92.0	V22	K6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1671	10.0	mM	246.0	DMSO	230.094294	6	K	pluskal_fda_drugs_5005_K6_id
366	HY-B0402	HYCPK40899	I04	HYCPK40909	92z	846.0	4.0	R30	909.0	I15	768-94-5	Amantadine	1-Adamantanamine; 1-Aminoadamantane	151.25	Apoptosis; Bcl-2 Family; CDK; Influenza Virus; Orthopoxvirus; SARS-CoV	Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Amantadine (1-Adamantanamine) is an orally avtive and potent antiviral agent with activity against influenza A viruses. Amantadine inhibits several ion channels such as NMDA and M2, and also inhibits Coronavirus ion channels. Amantadine also has anti-orthopoxvirus and anticancer activity. Amantadine can be used for Parkinson's disease, postoperative cognitive dysfunction (POCD) and COVID-19 research[1][2][3][4][5][6].		C10H17N	151369.0	DMSO : 1 mg/mL (6.61 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Cancer; Infection; Neurological Disease	NC12C[C@H]3C[C@@H](C2)C[C@@H](C1)C3	https://www.medchemexpress.com/amantadine.html	Launched		92.0	R30	K7	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0402	2.0	mM	247.0	DMSO	151.1361	7	K	pluskal_fda_drugs_5005_K7_id
1892	HY-B0433A	HYCPK40907	D15	HYCPK40907	92z	318.0	2.0	G30	907.0	D15	6119-47-7	Quinine (hydrochloride dihydrate)		396.91	Parasite; Potassium Channel	Anti-infection; Membrane Transporter/Ion Channel	Quinine hydrochloride dihydrate (Qualaquin) is an orally active and can be used in anti-malarial studies. Quinine hydrochloride dihydrate is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2].	Hydrochloride	C20H29ClN2O4	16817.0	DMSO : ≥ 100 mg/mL (251.95 mM); H2O : 20 mg/mL (50.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	COC1=CC2=C(N=CC=C2[C@H]([C@@]3([H])[N@](C[C@@H]4C=C)CC[C@@]4([H])C3)O)C=C1.Cl.O.O	https://www.medchemexpress.com/quinine-hydrochloride-dihydrate.html	Launched		92.0	G30	K7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0433A	10.0	mM	247.0	DMSO	324.183778	7	K	pluskal_fda_drugs_5005_K7_id
1967	HY-108402	HYCPK40907	O19	HYCPK40907	92z	1382.0	2.0	AC38	907.0	O19	69739-16-8	Cefodizime		584.67	Antibiotic; Bacterial	Anti-infection	Cefodizime is a third generation cephalosporin antibiotic with a broad spectrum of antibacterial activity. Cefodizime has no renal toxic effect, good tolerance and immune regulation activity, and has the potential for severe infections of the respiratory and urinary tracts[1][2].	Free Acid	C20H20N6O7S4	152455.0	DMSO : 20.83 mg/mL (35.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NC(C)=C(CC(O)=O)S3)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)O	https://www.medchemexpress.com/cefodizime.html	Launched		92.0	AC38	K7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108402	10.0	mM	247.0	DMSO	584.027631	7	K	pluskal_fda_drugs_5005_K7_id
2095	HY-15284	HYCPK40908	H08	HYCPK40908	92z	735.0	3.0	P15	908.0	H08	150322-43-3	Prasugrel	PCR 4099	373.44	P2Y Receptor	GPCR/G Protein	Prasugrel (PCR 4099), a thienopyridine and prodrug, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation[1].	Free Base	C20H20FNO3S	175852.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 100 mg/mL (267.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	FC1=CC=CC=C1C(C(C2CC2)=O)N3CCC4=C(C3)C=C(S4)OC(C)=O	https://www.medchemexpress.com/prasugrel.html	Launched		92.0	P15	K7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15284	10.0	mM	247.0	DMSO	373.114793	7	K	pluskal_fda_drugs_5005_K7_id
2127	HY-B0595	HYCPK40908	H10	HYCPK40908	92z	739.0	3.0	P19	908.0	H10	132907-72-3	Ramosetron (Hydrochloride)	YM060	315.80	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Ramosetron Hydrochloride(YM060 Hydrochloride) is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting.
Target: 5-HT3 Receptor
Ramosetron hydrochloride selectively blocks serotonin receptors (5-HT3). Serotonin plays a vital role in vomiting, serotonin-induced bradycardic reflex and peristalsis. The pharmacological action of Ramosetron hydrochloride is sustained and potent."	Hydrochloride	C17H18ClN3O	14653.0	H2O : 100 mg/mL (316.66 mM; Need ultrasonic); DMSO : 32 mg/mL (101.33 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(C1=CN(C)C2=C1C=CC=C2)[C@@H](C3)CCC4=C3NC=N4.Cl	https://www.medchemexpress.com/Ramosetron-Hydrochloride.html	Launched		92.0	P19	K7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0595	10.0	mM	247.0	DMSO	279.137162	7	K	pluskal_fda_drugs_5005_K7_id
2277	HY-B0290	HYCPK40908	F20	HYCPK40908	92z	567.0	3.0	L39	908.0	F20	103177-37-3	Pranlukast	ONO-1078	481.50	Endogenous Metabolite; Leukotriene Receptor	GPCR/G Protein; Metabolic Enzyme/Protease	Pranlukast is a highly potent, selective and competitive antagonist of peptide leukotrienes. Pranlukast inhibits [3H]LTE4, [3H]LTD4, and [3H]LTC4 bindings to lung membranes with Kis of 0.63±0.11, 0.99±0.19, and 5640±680 nM, respectively.	Free Base	C27H23N5O4	13194.0	DMSO : 33.33 mg/mL (69.22 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(NC1=C2C(C(C=C(C3=NNN=N3)O2)=O)=CC=C1)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4	https://www.medchemexpress.com/pranlukast.html	Launched		92.0	L39	K7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0290	10.0	mM	247.0	DMSO	481.175004	7	K	pluskal_fda_drugs_5005_K7_id
2283	HY-15030A	HYCPK40908	L20	HYCPK40908	92z	1143.0	3.0	X39	908.0	L20	26159-34-2	Naproxen (sodium)		252.24	Autophagy; COX	Autophagy; Immunology/Inflammation	Naproxen sodium is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively in cell assay.	Sodium	C14H13NaO3	64540.0	DMSO : 5 mg/mL (19.82 mM; Need ultrasonic); H2O : 75 mg/mL (297.34 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	C[C@H](C(O[Na])=O)C1=CC2=CC=C(OC)C=C2C=C1	https://www.medchemexpress.com/Naproxen-sodium.html	Launched		92.0	X39	K7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15030A	10.0	mM	247.0	DMSO	230.094294	7	K	pluskal_fda_drugs_5005_K7_id
2559	HY-A0043A	HYCPK40909	B12	HYCPK40909	92z	168.0	4.0	D24	909.0	B12	92077-78-6	Cilazapril (monohydrate)	Ro 31-2848 monohydrate	435.51	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	"Cilazapril Monohydrate is a angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.
Target: ACE
Cilazapril is a new nonthiol group containing angiotensin converting enzyme (ACE) inhibitor. Cilazapril has been investigated in more than 4000 patients with all degrees of hypertension, as well as in the special patient groups such as the elderly, renally impaired, and patients with concomitant diseases, such as congestive cardiac failure or chronic obstructive pulmonary disease [1]. Cilazapril is a very potent and highly effective converting enzyme inhibitor. Doses well below 5 mg/day will probably suffice for therapeutic efficacy [2]."	Free Acid	C22H33N3O6	13888.0	DMSO : ≥ 100 mg/mL (229.62 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C([C@@H]1CCCN2N1C([C@@H](N[C@H](C(OCC)=O)CCC3=CC=CC=C3)CCC2)=O)O.O	https://www.medchemexpress.com/Cilazapril-monohydrate.html	Launched		92.0	D24	K7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0043A	10.0	mM	247.0	DMSO	417.226371	7	K	pluskal_fda_drugs_5005_K7_id
1473	HY-13308	HYCPK40906	D08	HYCPK40906	92z	303.0	1.0	G15	906.0	D08	835621-07-3	Regorafenib (Hydrochloride)	BAY 73-4506 (hydrochloride)	519.28	Autophagy; PDGFR; Raf; RET; VEGFR	Autophagy; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK	Regorafenib Hydrochloride (BAY 73-4506 hydrochloride) is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1 with IC50s of 13/4.2/46, 22, 7, 1.5 and 2.5 nM, respectively[1].	Hydrochloride	C21H16Cl2F4N4O3	12512.0	DMSO : ≥ 5.6 mg/mL (10.78 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	ClC1=C(C(F)(F)F)C=C(NC(NC2=C(F)C=C(OC3=CC=NC(C(NC)=O)=C3)C=C2)=O)C=C1.Cl	https://www.medchemexpress.com/Regorafenib-Hydrochloride.html	Launched		92.0	G15	K8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13308	10.0	mM	248.0	DMSO	482.076881	8	K	pluskal_fda_drugs_5005_K8_id
1637	HY-100639	HYCPK40906	H18	HYCPK40906	92z	707.0	1.0	O35	906.0	H18	292135-78-5	Roflumilast N-oxide		419.21	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Roflumilast N-oxide is a PDE type 4 inhibitor.	Free Base	C17H14Cl2F2N2O4	27623.0	DMSO : 250 mg/mL (596.36 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(NC1=C(Cl)C=N(C=C1Cl)=O)C2=CC=C(OC(F)F)C(OCC3CC3)=C2	https://www.medchemexpress.com/Roflumilast_N-oxide.html	Launched		92.0	O35	K8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100639	10.0	mM	248.0	DMSO	418.029869	8	K	pluskal_fda_drugs_5005_K8_id
1764	HY-B0402A	HYCPK40907	L06	HYCPK40907	92z	1068.0	2.0	W12	907.0	L06	665-66-7	Amantadine (hydrochloride)	1-Adamantanamine hydrochloride; 1-Adamantylamine hydrochloride; 1-Aminoadamantane hydrochloride	187.71	Apoptosis; Bcl-2 Family; CDK; Influenza Virus; Orthopoxvirus; SARS-CoV	Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Amantadine (1-Adamantanamine) hydrochloride is an orally avtive and potent antiviral agent with activity against influenza A viruses. Amantadine hydrochloride inhibits several ion channels such as NMDA and M2, and also inhibits Coronavirus ion channels. Amantadine hydrochloride also has anti-orthopoxvirus and anticancer activity. Amantadine hydrochloride can be used for Parkinson's disease, postoperative cognitive dysfunction (POCD) and COVID-19 research[1][2][3][4][5][6].	Hydrochloride	C10H18ClN	13623.0	H2O : ≥ 50 mg/mL (266.37 mM); DMSO : 100 mg/mL (532.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Neurological Disease	NC1(C2)C[C@@H]3C[C@@H](C[C@H]2C3)C1.Cl	https://www.medchemexpress.com/Amantadine-hydrochloride.html	Launched		92.0	W12	K8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0402A	10.0	mM	248.0	DMSO	151.1361	8	K	pluskal_fda_drugs_5005_K8_id
1765	HY-108402A	HYCPK40907	M06	HYCPK40907	92z	1164.0	2.0	Y12	907.0	M06	86329-79-5	Cefodizime (sodium)		628.63	Antibiotic; Bacterial	Anti-infection	Cefodizime sodium is a third generation cephalosporin antibiotic with a broad spectrum of antibacterial activity. Cefodizime sodium  has no renal toxic effect, good tolerance and immune regulation activity, and can be used for the research of severe infections of the respiratory and urinary tracts[1][2].	Sodium	C20H18N6Na2O7S4	67184.0	DMSO : 62.5 mg/mL (99.42 mM; Need ultrasonic); H2O : 100 mg/mL (159.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NC(C)=C(CC(O[Na])=O)S3)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)O[Na]	https://www.medchemexpress.com/cefodizime-sodium.html	Launched		92.0	Y12	K8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108402A	10.0	mM	248.0	DMSO	584.027631	8	K	pluskal_fda_drugs_5005_K8_id
1935	HY-B0372A	HYCPK40907	O17	HYCPK40907	92z	1378.0	2.0	AC34	907.0	O17	611-75-6	Bromhexine (hydrochloride)		412.59	Autophagy; HIV; SARS-CoV	Anti-infection; Autophagy	Bromhexine hydrochloride is a potent and specific TMPRSS2 protease inhibitor with an IC50 of 0.75 μM. Bromhexine hydrochloride can prevent and manage SARS-CoV-2 infection. Bromhexine hydrochloride is an autophagy agonist. Bromhexine hydrochloride is a mucolytic cough suppressant and has the potential for a range of respiratory conditions[1][2][3][4].	Hydrochloride	C14H21Br2ClN2	15159.0	DMSO : 20 mg/mL (48.47 mM; Need ultrasonic); H2O : 3.33 mg/mL (8.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CN(C1CCCCC1)CC2=CC(Br)=CC(Br)=C2N.Cl	https://www.medchemexpress.com/Bromhexine-hydrochloride.html	Launched		92.0	AC34	K8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0372A	10.0	mM	248.0	DMSO	373.999323	8	K	pluskal_fda_drugs_5005_K8_id
2066	HY-A0273	HYCPK40908	K06	HYCPK40908	92z	1019.0	3.0	V11	908.0	K06	479-92-5	Propyphenazone	4-Isopropylantipyrine; Isopropylphenazone	230.31	COX	Immunology/Inflammation	"Propyphenazone is a pyrazolone derivative with anti-inflammatory, analgesic and antipyretic activity, Propyphenazone-based analogues as prodrugs and selective cyclooxygenase-2 inhibitors.
Target：COX-2
Propyphenazone is structurally related to aminophenazone it has been associated with severe blood dyscrasias. Propyphenazone is introduced for the treatment of rheumatic disorders."	Free Base	C14H18N2O	20287.0	DMSO : ≥ 2.6 mg/mL (11.29 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1N(C2=CC=CC=C2)N(C)C(C)=C1C(C)C	https://www.medchemexpress.com/Propyphenazone.html	Launched		92.0	V11	K8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0273	10.0	mM	248.0	DMSO	230.141913	8	K	pluskal_fda_drugs_5005_K8_id
2217	HY-13727A	HYCPK40908	F16	HYCPK40908	92z	559.0	3.0	L31	908.0	F16	144675-97-8	Pixantrone	BBR 2778	557.51	Topoisomerase	Cell Cycle/DNA Damage	Pixantrone (BBR 2778) dimaleate is a topoisomerase II inhibitor and DNA intercalator, with anti-tumor activity.	Maleate	C25H27N5O10	86644.0	H2O : 5 mg/mL (8.97 mM; ultrasonic and warming and heat to 80°C); DMSO : 33.33 mg/mL (59.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)/C=C\C(O)=O.O=C(O)/C=C\C(O)=O.O=C(C1=C(NCCN)C=CC(NCCN)=C12)C3=C(C=NC=C3)C2=O	https://www.medchemexpress.com/pixantrone-dimaleate.html	Launched		92.0	L31	K8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13727A	10.0	mM	248.0	DMSO	325.153875	8	K	pluskal_fda_drugs_5005_K8_id
2416	HY-B0725	HYCPK40908	L22	HYCPK40908	92z	1147.0	3.0	X43	908.0	L22	1229-29-4	Doxepin (Hydrochloride)		315.84	Cytochrome P450; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	"Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2[1][2].
Doxepin inhibits reuptake of serotonin and norepinephrine as a tricyclic antidepressant[3].</br>.
Doxepin has therapeutic effects in atopic dermatitis，chronic urticarial，can improve cognitive processes， protect central nervous system[4].</br>.
Doxepin has also been proposed as a protective factor against oxidative stress[5].</br>."	Hydrochloride	C19H22ClNO	16625.0	DMSO : ≥ 100 mg/mL (316.62 mM); H2O : ≥ 50 mg/mL (158.31 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CN(C)CC/C=C1C2=CC=CC=C2OCC3=CC=CC=C/13.Cl	https://www.medchemexpress.com/doxepin-hydrochloride.html	Launched		92.0	X43	K8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0725	10.0	mM	248.0	DMSO	279.162314	8	K	pluskal_fda_drugs_5005_K8_id
1476	HY-N0094	HYCPK40906	G08	HYCPK40906	92z	591.0	1.0	M15	906.0	G08	35212-22-7	Ipriflavone		280.32	Others	Others	Ipriflavone is a synthetic isoflavone derivative used to suppress bone resorption.	Free Base	C18H16O3	24252.0	DMSO : 33.33 mg/mL (118.90 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C1C(C2=CC=CC=C2)=COC3=CC(OC(C)C)=CC=C13	https://www.medchemexpress.com/Ipriflavone.html	Launched		92.0	M15	K9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0094	10.0	mM	249.0	DMSO	280.109944	9	K	pluskal_fda_drugs_5005_K9_id
1705	HY-13929	HYCPK40906	L22	HYCPK40906	92z	1099.0	1.0	W43	906.0	L22	59-63-2	Isocarboxazid		231.25	Monoamine Oxidase	Neuronal Signaling	Isocarboxazid is a non-selective and irreversible inhibitor of monoamine oxidase, with an IC50 of 4.8 μM for rat brain monoamine oxidase in vitro[1].	Free Base	C12H13N3O2	110777.0	DMSO : 100 mg/mL (432.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=NOC(C)=C1)NNCC2=CC=CC=C2	https://www.medchemexpress.com/Isocarboxazid.html	Launched		92.0	W43	K9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13929	10.0	mM	249.0	DMSO	231.100777	9	K	pluskal_fda_drugs_5005_K9_id
1771	HY-A0142A	HYCPK40907	C07	HYCPK40907	92z	206.0	2.0	E14	907.0	C07	72822-13-0	Dapiprazole (hydrochloride)		361.91	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Dapiprazole hydrochloride is a potent, selective and orally active alpha-1 adrenoceptor antagonist. Dapiprazole hydrochloride suppresses the opioid withdrawal symptoms. Dapiprazole hydrochloride is also used as eye drops for reversing mydriasis[1][2][3].	Hydrochloride	C19H28ClN5	21138.0	DMSO : ≥ 31 mg/mL (85.66 mM); H2O : 50 mg/mL (138.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	CC1=CC=CC=C1N2CCN(CCC3=NN=C4CCCCN43)CC2.[H]Cl	https://www.medchemexpress.com/Dapiprazole-hydrochloride.html	Launched		92.0	E14	K9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0142A	10.0	mM	249.0	DMSO	325.226646	9	K	pluskal_fda_drugs_5005_K9_id
1783	HY-12390	HYCPK40907	O07	HYCPK40907	92z	1358.0	2.0	AC14	907.0	O07	23047-25-8	Lofepramine	Lopramine	418.96	Others	Others	Lofepramine (Lopramine) is a potent tricyclic antidepressant and is extensively metabolised to Desipramine. The antidepressant activity of Lofepramine stems from the facilitation of noradrenergic neurotransmission by uptake inhibition. Lofepramine may also potentiate serotoninergic neurotransmission by inhibition of the neuronal uptake of serotonin and the enzyme tryptophan pyrrolase. Lofepramine has significant anxiolytic efficacy in addition to its antidepressant properties[1].	Free Base	C26H27ClN2O	101244.0	DMSO : 50 mg/mL (119.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN(CC(C1=CC=C(Cl)C=C1)=O)CCCN2C3=CC=CC=C3CCC4=CC=CC=C42	https://www.medchemexpress.com/lofepramine.html	Launched		92.0	AC14	K9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12390	10.0	mM	249.0	DMSO	418.181191	9	K	pluskal_fda_drugs_5005_K9_id
1884	HY-13677A	HYCPK40907	D14	HYCPK40907	92z	316.0	2.0	G28	907.0	D14	6112-76-1	6-Mercaptopurine hydrate	Mercaptopurine hydrate; 6-MP hydrate	170.19	Nucleoside Antimetabolite/Analog	Cell Cycle/DNA Damage	6-Mercaptopurine hydrate (Mercaptopurine hydrate; 6-MP hydrate) is a purine analogue which acts as an antagonist of the endogenous purines and has been widely used as antileukemic agent and immunosuppressive drug.	Free Base	C5H6N4OS	27451.0	DMSO : 50 mg/mL (293.79 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	S=C1NC=NC2=C1NC=N2.O	https://www.medchemexpress.com/6-Mercaptopurine_hydrate.html	Launched		92.0	G28	K9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13677A	10.0	mM	249.0	DMSO	152.015667	9	K	pluskal_fda_drugs_5005_K9_id
1916	HY-135815	HYCPK40907	L16	HYCPK40907	92z	1088.0	2.0	W32	907.0	L16	1847461-43-1	Mobocertinib	TAK-788; AP32788	585.70	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Mobocertinib (TAK-788) is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib potently inhibits oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib can be used in NSCLC research[1][2].		C32H39N7O4	148104.0	DMSO : 25 mg/mL (42.68 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CN=C(NC2=CC(NC(C=C)=O)=C(N(CCN(C)C)C)C=C2OC)N=C1C3=CN(C)C4=C3C=CC=C4)OC(C)C	https://www.medchemexpress.com/mobocertinib.html	Launched		92.0	W32	K9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-135815	10.0	mM	249.0	DMSO	585.306353	9	K	pluskal_fda_drugs_5005_K9_id
2054	HY-16391	HYCPK40908	O05	HYCPK40908	92z	1401.0	3.0	AD9	908.0	O05	1095173-27-5	Glasdegib	PF-04449913	374.43898	Smo	Stem Cell/Wnt	Glasdegib (PF-04449913) is a potent and orally bioavailable smoothened inhibitor. Glasdegib (PF-04449913) binds to human SMO (amino acids 181-787) with an IC50 of 4 nM[1].	Free Base	C21H22N6O	26237.0	DMSO : ≥ 83.33 mg/mL (222.55 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(C#N)C=C1)N[C@H]2C[C@H](C3=NC4=CC=CC=C4N3)N(C)CC2	https://www.medchemexpress.com/PF-04449913.html	Launched		92.0	AD9	K9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16391	10.0	mM	249.0	DMSO	374.185509	9	K	pluskal_fda_drugs_5005_K9_id
2124	HY-10331	HYCPK40908	E10	HYCPK40908	92z	451.0	3.0	J19	908.0	E10	755037-03-7	Regorafenib	BAY 73-4506	482.82	Autophagy; c-Kit; FGFR; PDGFR; Raf; RET; VEGFR	Autophagy; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK	Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].	Free Base	C21H15ClF4N4O3	29524.0	DMSO : 150 mg/mL (310.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(C(C(F)(F)F)=C1)Cl)NC2=CC=C(OC3=CC(C(NC)=O)=NC=C3)C=C2F	https://www.medchemexpress.com/Regorafenib.html	Launched		92.0	J19	K9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10331	10.0	mM	249.0	DMSO	482.076881	9	K	pluskal_fda_drugs_5005_K9_id
1472	HY-B0901	HYCPK40906	C08	HYCPK40906	92z	207.0	1.0	E15	906.0	C08	10457-90-6	Bromperidol	R-11333	420.32	Bacterial; Dopamine Receptor	Anti-infection; GPCR/G Protein; Neuronal Signaling	Bromperidol (R-11333) possesses antipsychotic activity, with a high affinity for central dopamine receptors D2. Bromperidol can kill Mycobacteria in a synergistic manner with Spectinomycin[1][2].	Free Base	C21H23BrFNO2	87863.0	DMSO : 50 mg/mL (118.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease	O=C(C1=CC=C(F)C=C1)CCCN2CCC(O)(C3=CC=C(Br)C=C3)CC2	https://www.medchemexpress.com/Bromperidol.html	Launched		92.0	E15	K10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0901	10.0	mM	250.0	DMSO	419.089619	10	K	pluskal_fda_drugs_5005_K10_id
1778	HY-B0398	HYCPK40907	J07	HYCPK40907	92z	878.0	2.0	S14	907.0	J07	389-08-2	Nalidixic acid		232.24	Antibiotic; Bacterial; Topoisomerase	Anti-infection; Cell Cycle/DNA Damage	Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria[1].	Free Acid	C12H12N2O3	26154.0	DMSO : 6 mg/mL (25.84 mM; Need ultrasonic); H2O : 5 mg/mL (21.53 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(CC)C2=C(C=CC(C)=N2)C1=O)O	https://www.medchemexpress.com/nalidixic-acid.html	Launched		92.0	S14	K10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0398	10.0	mM	250.0	DMSO	232.084792	10	K	pluskal_fda_drugs_5005_K10_id
1858	HY-14184	HYCPK40907	J12	HYCPK40907	92z	888.0	2.0	S24	907.0	J12	441798-33-0	Macitentan	ACT-064992	588.27	Apoptosis; Endothelin Receptor	Apoptosis; GPCR/G Protein	Macitentan (ACT-064992) is an orally active, non-peptide dual ETA and ETB (endothelin receptor) antagonist. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)[1].	Free Base	C19H20Br2N6O4S	65435.0	DMSO : ≥ 50 mg/mL (84.99 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	BrC1=CN=C(OCCOC2=C(C3=CC=C(Br)C=C3)C(NS(NCCC)(=O)=O)=NC=N2)N=C1	https://www.medchemexpress.com/Macitentan.html	Launched		92.0	S24	K10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14184	10.0	mM	250.0	DMSO	585.963348	10	K	pluskal_fda_drugs_5005_K10_id
2162	HY-N0098	HYCPK40908	O12	HYCPK40908	92z	1415.0	3.0	AD23	908.0	O12	121-33-5	Vanillin	p-Vanillin; m-Methoxy-p-hydroxybenzaldehyde; p-Hydroxy-m-methoxybenzaldehyde	152.15	Endogenous Metabolite	Metabolic Enzyme/Protease	Vanillin (p-Vanillin) is a single molecule extracted from vanilla beans and also a popular odor used widely in perfume, food and medicine.	Free Base	C8H8O3	55425.0	DMSO : 100 mg/mL (657.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=CC1=CC=C(O)C(OC)=C1	https://www.medchemexpress.com/Vanillin.html	Launched		92.0	AD23	K10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0098	10.0	mM	250.0	DMSO	152.047344	10	K	pluskal_fda_drugs_5005_K10_id
2222	HY-A0024	HYCPK40908	O16	HYCPK40908	92z	1423.0	3.0	AD31	908.0	O16	124937-51-5	Tolterodine	(R)-(+)-Tolterodine; (+)-Tolterodine; (R)-Tolterodine; PNU-200583	325.49	mAChR	GPCR/G Protein; Neuronal Signaling	"Tolterodine(PNU-200583) is a potent muscarinic receptor antagonists that show selectivity for the urinary bladder over salivary glands in vivo. 
IC50 Value:
Target: mAChR
in vitro: Carbachol-induced contractions of isolated guinea pig bladder were effectively inhibited by tolterodine (IC50 14 nM) and 5-HM (IC50 5.7 nM).  The IC50 values were in the microM range and the antimuscarinic potency of tolterodine was 27, 200 and 370-485 times higher, respectively, than its potency in blocking histamine receptors, alpha-adrenoceptors and calcium channels. The active metabolite, 5-HM, was >900 times less potent at these sites than at bladder muscarinic receptors [1].
in vivo: Tolterodine was extensively metabolized in vivo [2].  In the passive-avoidance test, tolterodine at 1 or 3 mg/kg had no effect on memory; the latency to cross and percentage of animals crossing were comparable to controls. In contrast, scopolamine induced a memory deficit; the latency to cross was decreased, and the number of animals crossing was increased [3]."	Free Base	C22H31NO	61393.0	DMSO : 100 mg/mL (307.23 mM; Need ultrasonic); Ethanol : 120 mg/mL (368.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(C)N(C(C)C)CC[C@H](C1=CC=CC=C1)C2=C(O)C=CC(C)=C2	https://www.medchemexpress.com/Tolterodine.html	Launched		92.0	AD31	K10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0024	10.0	mM	250.0	DMSO	325.240565	10	K	pluskal_fda_drugs_5005_K10_id
2454	HY-B0362A	HYCPK40909	B05	HYCPK40909	92z	154.0	4.0	D10	909.0	B05	65-28-1	Phentolamine (mesylate)	Phentolamine methanesulfonate	377.46	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Phentolamine mesylate (Phentolamine methanesulfonate) is a reversible, non-selective, and orally active blocker of α1 and α2 adrenergic receptor that expands blood vessels to reduce peripheral vascular resistance. Phentolamine mesylate can be used for the research of pheochromocytoma-related hypertension, heart failure and erectile dysfunction[1][2][3].	Mesylate	C18H23N3O4S	17023.0	H2O : ≥ 50 mg/mL (132.46 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	CS(O)(=O)=O.CC1=CC=C(N(C2=CC(O)=CC=C2)CC3=NCCN3)C=C1	https://www.medchemexpress.com/phentolamine-mesylate.html	Launched		92.0	D10	K10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0362A	10.0	mM	250.0	DMSO	281.152812	10	K	pluskal_fda_drugs_5005_K10_id
2465	HY-10331A	HYCPK40909	M05	HYCPK40909	92z	1210.0	4.0	Z10	909.0	M05	1019206-88-2	Regorafenib (monohydrate)	BAY 73-4506 (monohydrate)	500.83	Autophagy; c-Kit; FGFR; PDGFR; Raf; RET; VEGFR	Autophagy; MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK	Regorafenib (BAY 73-4506) monohydrate is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib monohydrate shows very robust antitumor and antiangiogenic activity[1].	Free Base	C21H17ClF4N4O4	9764.0	DMSO : 50 mg/mL (99.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(C(C(F)(F)F)=C1)Cl)NC2=CC=C(OC3=CC(C(NC)=O)=NC=C3)C=C2F.O	https://www.medchemexpress.com/Regorafenib-monohydrate.html	Launched		92.0	Z10	K10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10331A	10.0	mM	250.0	DMSO	482.076881	10	K	pluskal_fda_drugs_5005_K10_id
2514	HY-17613	HYCPK40909	E09	HYCPK40909	92z	450.0	4.0	J18	909.0	E09	870964-67-3	Evocalcet	KHK7580	374.48	CaSR	GPCR/G Protein	Evocalcet has an activating effect on calcium sensing receptor (CaSR) extracted from patent WO 2017061621 A1, compound A.	Free Acid	C24H26N2O2	27798.0	DMSO : 30 mg/mL (80.11 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)CC1=CC=C(N2C[C@@H](N[C@@H](C3=C4C=CC=CC4=CC=C3)C)CC2)C=C1	https://www.medchemexpress.com/Evocalcet.html	Launched		92.0	J18	K10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17613	10.0	mM	250.0	DMSO	374.199428	10	K	pluskal_fda_drugs_5005_K10_id
1449	HY-B0075	HYCPK40907	K14	HYCPK40907	92z	988.0	2.0	U28	907.0	K14	73-31-4	Melatonin	N-Acetyl-5-methoxytryptamine	232.28	Apoptosis; Autophagy; Endogenous Metabolite; Melatonin Receptor; Mitophagy	Apoptosis; Autophagy; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Melatonin is a hormone made by the pineal gland that can activates melatonin receptor. Melatonin plays a role in sleep and possesses important antioxidative and anti-inflammatory properties[1][2][3]. Melatonin is a novel selective ATF-6 inhibitor and induces human hepatoma cell apoptosis through COX-2 downregulation[4]. Melatonin attenuates palmitic acid-induced (HY-N0830) mouse granulosa cells apoptosis via endoplasmic reticulum stress[5].	Free Base	C13H16N2O2	38567.0	DMSO : 100 mg/mL (430.51 mM; Need ultrasonic); Ethanol : 12.5 mg/mL (53.81 mM; Need ultrasonic); H2O : 1.1 mg/mL (4.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	CC(NCCC1=CNC2=C1C=C(OC)C=C2)=O	https://www.medchemexpress.com/Melatonin.html	Launched		92.0	U28	K11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0075	10.0	mM	251.0	DMSO	232.121178	11	K	pluskal_fda_drugs_5005_K11_id
1527	HY-13238A	HYCPK40906	J11	HYCPK40906	92z	885.0	1.0	S21	906.0	J11	1051375-19-9	Dolutegravir (sodium)	S/GSK1349572 (sodium)	441.36	HIV; HIV Integrase	Anti-infection; Metabolic Enzyme/Protease	Dolutegravir sodium (S/GSK1349572 sodium) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer. Dolutegravir sodium (S/GSK1349572 sodium) inhibits HIV-1 viral replication with an IC50 of 0.51 nM in peripheral blood mononuclear cells. Dolutegravir sodium (S/GSK1349572 sodium) retains a high potency against the HIV-1 Y143R, N155H, and G140S/Q148H mutants (EC50=3.6-5.8 nM)[1][2].	Sodium	C20H18F2N3NaO5	13529.0	DMSO : ≥ 4.5 mg/mL (10.20 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2=C(O[Na])C1=O)C[C@]3([H])OCC[C@@H](C)N3C2=O)NCC4=CC=C(F)C=C4F	https://www.medchemexpress.com/Dolutegravir-sodium.html	Launched		92.0	S21	K11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13238A	10.0	mM	251.0	DMSO	419.129277	11	K	pluskal_fda_drugs_5005_K11_id
1571	HY-107431	HYCPK40906	F14	HYCPK40906	92z	507.0	1.0	K27	906.0	F14	147-20-6	Diphenylpyraline		281.39	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Diphenylpyraline is a potent histamine H1?receptor antagonist. Diphenylpyraline acts as an orally active antihistamine agent?with antimuscarinic and antiallergic effects. Diphenylpyraline can be used for the research of allergic diseases, including rhinitis and hay fever, and pruritic skin disorders et.al[1].		C19H23NO	90375.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 100 mg/mL (355.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CN(CC1)CCC1OC(C2=CC=CC=C2)C3=CC=CC=C3	https://www.medchemexpress.com/diphenylpyraline.html	Launched		92.0	K27	K11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107431	10.0	mM	251.0	DMSO	281.177964	11	K	pluskal_fda_drugs_5005_K11_id
1841	HY-16568	HYCPK40907	I11	HYCPK40907	92z	790.0	2.0	Q22	907.0	I11	136572-09-3	Irinotecan (hydrochloride trihydrate)	(+)-Irinotecan (hydrochloride trihydrate); CPT-11 (hydrochloride trihydrate)	677.18	Autophagy; Topoisomerase	Autophagy; Cell Cycle/DNA Damage	Irinotecan hydrochloride trihydrate ((+)-Irinotecan hydrochloride trihydrate) is a topoisomerase I inhibitor with antitumor activity[1].	Hydrochloride	C33H45ClN4O9	7781.0	H2O : 1.52 mg/mL (2.24 mM; Need ultrasonic and warming); DMSO : 50 mg/mL (73.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	[H]Cl.O=C(N1CCC(N2CCCCC2)CC1)OC3=CC=C4N=C5C(CN6C(C(COC([C@@]7(CC)O)=O)=C7C=C65)=O)=C(CC)C4=C3.O.O.O	https://www.medchemexpress.com/irinotecan-hydrochloride-trihydrate.html	Launched		92.0	Q22	K11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16568	10.0	mM	251.0	DMSO	586.279135	11	K	pluskal_fda_drugs_5005_K11_id
1891	HY-B0894	HYCPK40907	C15	HYCPK40907	92z	222.0	2.0	E30	907.0	C15	102-29-4	Resorcinol monoacetate	Acetylresorcinol; Resorcin monoacetate	152.15	Others	Others	Resorcinol monoacetate (Acetylresorcinol) is an antiseptic and a disinfectant, is a chemical intermediate for the production of many other pharmaceuticals, and has the potential for acne, seborrheic dermatitis, eczema, psoriasis, and other skin disorders research.	Free Base	C8H8O3	125608.0	DMSO : ≥ 43 mg/mL (282.62 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	OC1=CC(OC(C)=O)=CC=C1	https://www.medchemexpress.com/Resorcinol-monoacetate.html	Launched		92.0	E30	K11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0894	10.0	mM	251.0	DMSO	152.047344	11	K	pluskal_fda_drugs_5005_K11_id
2226	HY-90010	HYCPK40908	C17	HYCPK40908	92z	273.0	3.0	F33	908.0	C17	124937-52-6	Tolterodine (tartrate)	Kabi-2234; PNU-200583E	475.57	mAChR	GPCR/G Protein; Neuronal Signaling	Tolterodine Tartrate (Kabi-2234; PNU-200583E) is a potent muscarinic receptor antagonist and shows selectivity for the urinary bladder over salivary glands in vivo.	Tartrate	C26H37NO7	4025.0	H2O : 16.67 mg/mL (35.05 mM; Need ultrasonic); DMSO : 100 mg/mL (210.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC1=CC=C(C=C1[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2)C.O=C([C@@H]([C@H](C(O)=O)O)O)O	https://www.medchemexpress.com/Tolterodine-Tartrate.html	Launched		92.0	F33	K11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-90010	10.0	mM	251.0	DMSO	325.240565	11	K	pluskal_fda_drugs_5005_K11_id
2452	HY-13748	HYCPK40909	P04	HYCPK40909	92z	1496.0	4.0	AF8	909.0	P04	22888-70-6	Silibinin	Silibinin A; Silymarin I	482.44	Autophagy; Reactive Oxygen Species	Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Silibinin (Silibinin A), an effective anti-cancer and chemopreventive agent, has been shown to exert multiple effects on cancer cells, including inhibition of both cell proliferation and migration.	Free Base	C25H22O10	114551.0	DMSO : 250 mg/mL (518.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1[C@H](O)[C@@H](C2=CC=C(O[C@H](CO)[C@@H](C3=CC=C(O)C(OC)=C3)O4)C4=C2)OC5=CC(O)=CC(O)=C15	https://www.medchemexpress.com/silibinin.html	Launched		92.0	AF8	K11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13748	10.0	mM	251.0	DMSO	482.121297	11	K	pluskal_fda_drugs_5005_K11_id
2502	HY-B0696A	HYCPK40909	I08	HYCPK40909	92z	832.0	4.0	R16	909.0	I08	145821-59-6	Tiagabine (hydrochloride)	NO050328 hydrochloride; NO328 hydrochloride; TGB hydrochloride	412.01	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Tiagabine hydrochloride is a potent and selective GABA reuptake inhibitor, used as an anticonvulsant agent, with IC50s of 67, 446 and 182 nM for [3H]GABA uptake in Synaptosomes, Neurons and Glia, respectively[1].	Hydrochloride	C20H26ClNO2S2	40423.0	H2O : 100 mg/mL (242.71 mM; Need ultrasonic); DMSO : ≥ 53 mg/mL (128.64 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C([C@H]1CN(CC/C=C(C2=C(C)C=CS2)/C3=C(C)C=CS3)CCC1)O.[H]Cl	https://www.medchemexpress.com/Tiagabine-hydrochloride.html	Launched		92.0	R16	K11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0696A	10.0	mM	251.0	DMSO	375.132671	11	K	pluskal_fda_drugs_5005_K11_id
10	HY-N7073	HYCPK40897	J03	HYCPK40909	92z	948.0	4.0	T36	909.0	J18	65666-07-1	Silymarin			SARS-CoV	Anti-infection	Silymarin is an extract of the milk thistle (Silybum marianum). Silymarin is an effective SARS-CoV-2 main protease (Mpro) inhibitor. Silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Silymarin has the chemopreventive effect on hepatocellular carcinoma (HCC). Silymarin has the potential for COVID-19 research[1][2][4].			80758.0	DMSO : 120 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Cancer; Infection; Inflammation/Immunology; Neurological Disease	[Silymarin]	https://www.medchemexpress.com/silymarin.html	Launched		92.0	T36	K12	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7073	3.0	mM	252.0	DMSO	482.121297	12	K	pluskal_fda_drugs_5005_K12_id
1639	HY-16562A	HYCPK40906	J18	HYCPK40906	92z	899.0	1.0	S35	906.0	J18	100286-90-6	Irinotecan (hydrochloride)	(+)-Irinotecan (hydrochloride); CPT-11 (hydrochloride)	623.14	Autophagy; Topoisomerase	Autophagy; Cell Cycle/DNA Damage	Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer[1].	Hydrochloride	C33H39ClN4O6	86874.0	DMSO : 125 mg/mL (200.60 mM; Need ultrasonic); H2O : 3.33 mg/mL (5.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N1CCC(N2CCCCC2)CC1)OC3=CC=C4N=C5C(CN6C(C(COC([C@@]7(CC)O)=O)=C7C=C65)=O)=C(CC)C4=C3.[H]Cl	https://www.medchemexpress.com/Irinotecan-hydrochloride.html	Launched		92.0	S35	K12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16562A	10.0	mM	252.0	DMSO	586.279135	12	K	pluskal_fda_drugs_5005_K12_id
1657	HY-14538	HYCPK40906	L19	HYCPK40906	92z	1093.0	1.0	W37	906.0	L19	52-86-8	Haloperidol		375.86	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Haloperidol is a potent dopamine D2 receptor antagonist, widely used as an antipsychotic.	Free Base	C21H23ClFNO2	23139.0	DMSO : 16.67 mg/mL (44.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	ClC(C=C1)=CC=C1C2(O)CCN(CCCC(C3=CC=C(F)C=C3)=O)CC2	https://www.medchemexpress.com/Haloperidol.html	Launched		92.0	W37	K12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14538	10.0	mM	252.0	DMSO	375.140135	12	K	pluskal_fda_drugs_5005_K12_id
1843	HY-119972	HYCPK40907	K11	HYCPK40907	92z	982.0	2.0	U22	907.0	K11	579-38-4	Diloxanide		234.08	Parasite	Anti-infection	Diloxanide is an anti-protozoal agent and can be used for the research of asymptomatic-intestinal amebiasis caused by Entamoeba histolytica or some other protozoal infections. Diloxanide is an active luminal amebicide and hydrolyzed in the gastrointestinal tract from its prodrug Diloxanide furoate (HY-B1147)[1].	Free Base	C9H9Cl2NO2	81826.0	DMSO : 33.33 mg/mL (142.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(Cl)Cl)N(C)C1=CC=C(C=C1)O	https://www.medchemexpress.com/diloxanide.html	Launched		92.0	U22	K12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-119972	10.0	mM	252.0	DMSO	233.001034	12	K	pluskal_fda_drugs_5005_K12_id
1879	HY-B1167	HYCPK40907	O13	HYCPK40907	92z	1370.0	2.0	AC26	907.0	O13	4360-12-7	Ajmaline	Cardiorythmine; (+)-Ajmaline	326.43	Sodium Channel	Membrane Transporter/Ion Channel	Ajmaline (Cardiorythmine) is a sodium channel blocking, class 1A anti-arrhythmic agent.  Ajmaline blocks HERG currents with an IC50 of 1 μM in HEK cells and 42.3 μM in Xenopus oocytes. Ajmaline can be used for the research of the ventricular tachyarrhythmia[1][2].	Free Base	C20H26N2O2	24016.0	DMSO : ≥ 100 mg/mL (306.34 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CN1C2=CC=CC=C2[C@@]34[C@]1([H])[C@@](C[C@H]5[C@H](CC)[C@H]6O)([H])[N@]6[C@]([H])([C@H]5[C@H]4O)C3	https://www.medchemexpress.com/Ajmaline.html	Launched		92.0	AC26	K12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1167	10.0	mM	252.0	DMSO	326.199428	12	K	pluskal_fda_drugs_5005_K12_id
1990	HY-B0787	HYCPK40907	J21	HYCPK40907	92z	906.0	2.0	S42	907.0	J21	131410-48-5	Gadodiamide		573.66	Others	Others	Gadodiamide(Omniscan) is a gadolinium-based MRI contrast agent, used in MR imaging procedures to assist in the visualization of blood vessels.	Free Base	C16H26GdN5O8	33357.0	DMSO : 5.56 mg/mL (9.69 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (174.32 mM)	DMSO Solution	10mM  * 100uL	Others	CNC1=O[Gd+3]([N]2(C3)CC4)([N]5(C6)CC2)(O=C(NC)C5)([O-]C7=O)([O-]C6=O)([O-]C3=O)[N]4(C7)C1	https://www.medchemexpress.com/Gadodiamide.html	Launched		92.0	S42	K12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0787	10.0	mM	252.0	DMSO	419.201613	12	K	pluskal_fda_drugs_5005_K12_id
2145	HY-N0538	HYCPK40908	N11	HYCPK40908	92z	1317.0	3.0	AB21	908.0	N11	87-99-0	Xylitol	Xylite	152.15	Autophagy; Bacterial; Endogenous Metabolite	Anti-infection; Autophagy; Metabolic Enzyme/Protease	"Xylitol is a chemical categorized as a polyalcohol or sugar alcohol.
Target: Others
Xylitol is a chemical categorized as a polyalcohol or sugar alcohol (alditol). Xylitol has the formula (CHOH)3(CH2OH)2 and is an achiral isomer of pentane-1,2,3,4,5-pentol. Xylitol is used as a diabetic sweetener which is roughly as sweet as sucrose with 33% fewer calories. Unlike other natural or synthetic sweeteners, xylitol is actively beneficial for dental health by reducing caries to a third in regular use and helpful to remineralization. Xylitol is naturally found in low concentrations in the fibers of many fruits and vegetables, and can be extracted from various berries, oats, and mushrooms, as well as fibrous material such as corn husks and sugar cane bagasse and birch."	Free Base	C5H12O5	16414.0	H2O : 110 mg/mL (722.97 mM; Need ultrasonic); DMSO : 130 mg/mL (854.42 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC[C@@H](O)[C@H](O)[C@@H](O)CO	https://www.medchemexpress.com/xylitol.html	Launched		92.0	AB21	K12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0538	10.0	mM	252.0	DMSO	152.068473	12	K	pluskal_fda_drugs_5005_K12_id
2506	HY-B0970	HYCPK40909	M08	HYCPK40909	92z	1216.0	4.0	Z16	909.0	M08	132-18-3	Diphenylpyraline (hydrochloride)	4-Diphenylmethoxy-1-methylpiperidine hydrochloride	317.85	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Diphenylpyraline hydrochloride is a potent histamine H1?receptor antagonist. Diphenylpyraline hydrochloride acts as an orally active antihistamine agent?with antimuscarinic and antiallergic effects. Diphenylpyraline hydrochloride can be used for the relief of allergic conditions including rhinitis and hay fever, and in pruritic skin disorders in vivo.[1]	Hydrochloride	C19H24ClNO	29826.0	H2O : 100 mg/mL (314.61 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (314.61 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CN1CCC(OC(C2=CC=CC=C2)C3=CC=CC=C3)CC1.[H]Cl	https://www.medchemexpress.com/Diphenylpyraline-hydrochloride.html	Launched		92.0	Z16	K12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0970	10.0	mM	252.0	DMSO	281.177964	12	K	pluskal_fda_drugs_5005_K12_id
33	HY-10581	HYCPK40899	K03	HYCPK40909	92z	1036.0	4.0	V28	909.0	K14	112811-59-3	Gatifloxacin	AM-1155; BMS-206584; PD135432	375.39	Antibiotic; Bacterial; Topoisomerase	Anti-infection; Cell Cycle/DNA Damage	Gatifloxacin (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50=0.109 μg/ml)[1]. Gatifloxacin can be used to treat bacterial conjunctivitis?in vivo.	Free Acid	C19H22FN3O4	13023.0	H2O : 1 mg/mL (2.66 mM; Need ultrasonic); DMSO : 2 mg/mL (5.33 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection	CC1NCCN(C2=C(F)C=C3C(N(C4CC4)C=C(C(O)=O)C3=O)=C2OC)C1	https://www.medchemexpress.com/Gatifloxacin.html	Launched		92.0	V28	K13	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10581	2.0	mM	253.0	DMSO	375.159434	13	K	pluskal_fda_drugs_5005_K13_id
37	HY-13011A	HYCPK40899	O03	HYCPK40909	92z	1420.0	4.0	AD28	909.0	O14	1256589-74-8	Alectinib (Hydrochloride)	CH5424802 (Hydrochloride); RO5424802 (Hydrochloride); AF-802 (Hydrochloride)	519.08	Anaplastic lymphoma kinase (ALK)	Protein Tyrosine Kinase/RTK	Alectinib Hydrochloride (CH5424802 Hydrochloride; RO5424802 Hydrochloride; AF-802 Hydrochloride) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively[1]. Alectinib demonstrates effective central nervous system (CNS) penetration[2].	Hydrochloride	C30H35ClN4O2	13852.0	DMSO : 5 mg/mL (9.63 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	2mM  * 100uL	Cancer	[H]Cl.N#CC1=CC2=C(C3=C(N2)C(C)(C4=CC(N5CCC(CC5)N6CCOCC6)=C(C=C4C3=O)CC)C)C=C1	https://www.medchemexpress.com/CH5424802-Hydrochloride.html	Launched		92.0	AD28	K13	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13011A	2.0	mM	253.0	DMSO	482.268176	13	K	pluskal_fda_drugs_5005_K13_id
1647	HY-B0997	HYCPK40906	B19	HYCPK40906	92z	133.0	1.0	C37	906.0	B19	1435-55-8	Hydroquinidine	Dihydroquinidine; (+)-Hydroquinidine; Hydroconquinine	326.43	Others	Others	Hydroquinidine (Dihydroquinidine) is a derivative of Quinidine (an antiarrhythmic agent). Hydroquinidine prolongs the QT interval and has antiarrhythmic efficacy[1][2][3].	Free Base	C20H26N2O2	67580.0	DMSO : 20.83 mg/mL (63.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O[C@@H](C1=CC=NC2=C1C=C(OC)C=C2)[C@]3([H])[N@](C[C@@H]4CC)CC[C@H]4C3	https://www.medchemexpress.com/Hydroquinidine.html	Launched		92.0	C37	K13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0997	10.0	mM	253.0	DMSO	326.199428	13	K	pluskal_fda_drugs_5005_K13_id
1699	HY-13669	HYCPK40906	F22	HYCPK40906	92z	523.0	1.0	K43	906.0	F22	13010-47-4	Lomustine	CCNU; NSC 79037	233.70	Apoptosis; Autophagy; DNA Alkylator/Crosslinker	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Lomustine (CCNU; NSC 79037) is a DNA alkylating agent, with antitumor activity.	Free Base	C9H16ClN3O2	46208.0	DMSO : ≥ 100 mg/mL (427.90 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1CCCCC1)N(CCCl)N=O	https://www.medchemexpress.com/Lomustine.html	Launched		92.0	K43	K13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13669	10.0	mM	253.0	DMSO	233.093104	13	K	pluskal_fda_drugs_5005_K13_id
1908	HY-17480	HYCPK40907	D16	HYCPK40907	92z	320.0	2.0	G32	907.0	D16	20187-55-7	Bendazac		282.29	Others	Others	Bendazac is an oxyacetic acid with anti-inflammatory, antinecrotic, choleretic and antilipidaemic properties. Bendazac acts by preventing protein denaturation and delays the cataractogenic process[1][2].		C16H14N2O3	79163.0	DMSO : 250 mg/mL (885.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3	https://www.medchemexpress.com/bendazac.html	Launched		92.0	G32	K13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17480	10.0	mM	253.0	DMSO	282.100442	13	K	pluskal_fda_drugs_5005_K13_id
2020	HY-10440	HYCPK40908	H03	HYCPK40908	92z	725.0	3.0	P5	908.0	H03	879085-55-9	Vismodegib	GDC-0449	421.29706	Autophagy; Hedgehog	Autophagy; Stem Cell/Wnt	Vismodegib (GDC-0449) is an orally active hedgehog pathway inhibitor with an IC50 of 3 nM. Vismodegib also inhibits P-gp, ABCG2 with IC50 values of 3.0 μM and 1.4 μM, respectively[1][2].	Free Base	C19H14Cl2N2O3S	96820.0	DMSO : 50 mg/mL (118.68 mM; Need ultrasonic); Ethanol : 3.33 mg/mL (7.90 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=C(C=C1Cl)S(=O)(C)=O)NC2=CC=C(C(C3=NC=CC=C3)=C2)Cl	https://www.medchemexpress.com/Vismodegib.html	Launched		92.0	P5	K13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10440	10.0	mM	253.0	DMSO	420.010219	13	K	pluskal_fda_drugs_5005_K13_id
2112	HY-13629	HYCPK40908	I09	HYCPK40908	92z	833.0	3.0	R17	908.0	I09	33419-42-0	Etoposide	VP-16; VP-16-213	588.56	Antibiotic; Apoptosis; Autophagy; Bacterial; Mitophagy; Topoisomerase	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage	Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy[1].	Free Base	C29H32O13	113741.0	DMSO : ≥ 39 mg/mL (66.26 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C1OC[C@]2([H])[C@H](O[C@H]3[C@@H]([C@H]([C@@H]4O[C@H](C)OC[C@H]4O3)O)O)C5=C(C=C6OCOC6=C5)[C@@H](C7=CC(OC)=C(O)C(OC)=C7)[C@]21[H]	https://www.medchemexpress.com/etoposide.html	Launched		92.0	R17	K13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13629	10.0	mM	253.0	DMSO	588.184291	13	K	pluskal_fda_drugs_5005_K13_id
2177	HY-B1173	HYCPK40908	N13	HYCPK40908	92z	1321.0	3.0	AB25	908.0	N13	464-49-3	(+)-Camphor	D-(+)-Camphor; (1R)-(+)-Camphor	152.23	Bacterial	Anti-infection	(+)-Camphor is an ingredient in cooking, and as an embalming fluid for medicinal purposes,	Free Base	C10H16O	17432.0	DMSO : ≥ 50 mg/mL (328.45 mM)	DMSO Solution	10mM  * 100uL	Others	CC1(C)[C@@]2(C)CC[C@@H]1CC2=O	https://www.medchemexpress.com/__addition__-Camphor.html	Launched		92.0	AB25	K13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1173	10.0	mM	253.0	DMSO	152.120115	13	K	pluskal_fda_drugs_5005_K13_id
1560	HY-B0348	HYCPK40906	K13	HYCPK40906	92z	985.0	1.0	U25	906.0	K13	88678-31-3	Liranaftate	Piritetrate; M-732	328.43	Fungal	Anti-infection	Liranaftate (Piritetrate) is a squalene epoxidase inhibitor with anti-fungicidal activities. Liranaftate can be used for the research of dermatophytes. Liranaftate also suppresses fungal element-promoted production of IL-8 and experimental inflammation[1][2][3][4].	Free Base	C18H20N2O2S	13494.0	DMSO : 100 mg/mL (304.48 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	S=C(OC1=CC=C2CCCCC2=C1)N(C3=NC(OC)=CC=C3)C	https://www.medchemexpress.com/Liranaftate.html	Launched		92.0	U25	K14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0348	10.0	mM	254.0	DMSO	328.124549	14	K	pluskal_fda_drugs_5005_K14_id
1641	HY-15851	HYCPK40906	L18	HYCPK40906	92z	1091.0	1.0	W35	906.0	L18	864750-70-9	Revefenacin	TD-4208; GSK1160724	597.75	mAChR	GPCR/G Protein; Neuronal Signaling	Revefenacin (TD-4208; GSK1160724) is a potent mAChR antagonist; has a high affinity on M3 receptor with a Ki of 0.18 nM.	Free Base	C35H43N5O4	26324.0	DMSO : 100 mg/mL (167.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	O=C(OC1CCN(CCN(C(C2=CC=C(CN3CCC(C(N)=O)CC3)C=C2)=O)C)CC1)NC4=CC=CC=C4C5=CC=CC=C5	https://www.medchemexpress.com/Revefenacin.html	Launched		92.0	W35	K14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15851	10.0	mM	254.0	DMSO	597.331505	14	K	pluskal_fda_drugs_5005_K14_id
1864	HY-B1413	HYCPK40907	P12	HYCPK40907	92z	1464.0	2.0	AE24	907.0	P12	87940-60-1	Eprobemide	LIS 630	282.77	Monoamine Oxidase	Neuronal Signaling	Eprobemide is a non-competitive reversible inhibitor of monoamine oxidase A.	Free Base	C14H19ClN2O2	34715.0	DMSO : ≥ 125 mg/mL (442.06 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NCCCN1CCOCC1)C2=CC=C(Cl)C=C2	https://www.medchemexpress.com/Eprobemide.html	Launched		92.0	AE24	K14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1413	10.0	mM	254.0	DMSO	282.113506	14	K	pluskal_fda_drugs_5005_K14_id
1919	HY-N0808	HYCPK40907	O16	HYCPK40907	92z	1376.0	2.0	AC32	907.0	O16	76-22-2	Camphor	(±)-Camphor	152.23	Influenza Virus; TRP Channel	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Camphor ((±)-Camphor) is a topical anti-infective and anti-pruritic and internally as a stimulant and carminative. However, Camphor is poisonous when ingested. Antiviral, antitussive, and anticancer activities[1]. Camphor is a TRPV3 agonist[2].	Free Base	C10H16O	27559.0	DMSO : 100 mg/mL (656.90 mM; Need ultrasonic); H2O : 5 mg/mL (32.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=C1C(C2(C)C)(C)CCC2C1	https://www.medchemexpress.com/Camphor.html	Launched		92.0	AC32	K14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0808	10.0	mM	254.0	DMSO	152.120115	14	K	pluskal_fda_drugs_5005_K14_id
2022	HY-13768A	HYCPK40908	J03	HYCPK40908	92z	917.0	3.0	T5	908.0	J03	119413-54-6	Topotecan (Hydrochloride)	SKF 104864A (Hydrochloride); NSC 609669 (Hydrochloride)	457.91	Apoptosis; Autophagy; Topoisomerase	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.	Hydrochloride	C23H24ClN3O5	20527.0	DMSO : 100 mg/mL (218.38 mM; Need ultrasonic); H2O : 33.33 mg/mL (72.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	[H]Cl.O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=CC5=C(CN(C)C)C(O)=CC=C5N=C4C3=C2)=O	https://www.medchemexpress.com/Topotecan-Hydrochloride.html	Launched		92.0	T5	K14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13768A	10.0	mM	254.0	DMSO	421.163771	14	K	pluskal_fda_drugs_5005_K14_id
2033	HY-100703	HYCPK40908	E04	HYCPK40908	92z	439.0	3.0	J7	908.0	E04	1893-33-0	Pipamperone	Floropipamide; McN-JR 3345; R 3345	375.48	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Pipamperone (Floropipamide; McN-JR 3345; R 3345) is a high-affinity antagonist of 5-HT2A receptor (pKi=8.2) and D4 receptor (pKi=8.0) and a low-affinity antagonist of D2 receptor (pKi=6.7)[1].	Free Base	C21H30FN3O2	122995.0	DMSO : 100 mg/mL (266.33 mM; Need ultrasonic); 0.1 M HCL : 25 mg/mL (66.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1(N2CCCCC2)CCN(CCCC(C3=CC=C(F)C=C3)=O)CC1)N	https://www.medchemexpress.com/pipamperone.html	Launched		92.0	J7	K14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100703	10.0	mM	254.0	DMSO	375.232205	14	K	pluskal_fda_drugs_5005_K14_id
2529	HY-13011	HYCPK40909	D10	HYCPK40909	92z	356.0	4.0	H20	909.0	D10	1256580-46-7	Alectinib	CH5424802; RO5424802; AF802	482.62	Anaplastic lymphoma kinase (ALK)	Protein Tyrosine Kinase/RTK	Alectinib (CH5424802) is a potent, selective, and orally available ALK inhibitor with an IC50 of 1.9 nM and a Kd value of 2.4 nM (in an ATP-competitive manner), and also inhibits ALK F1174L and ALK R1275Q with IC50s of 1 nM and 3.5 nM, respectively[1]. Alectinib demonstrates effective central nervous system (CNS) penetration[2].	Free Base	C30H34N4O2	93730.0	DMSO : 6.2 mg/mL (12.85 mM; Need warming)	DMSO Solution	10mM  * 100uL	Cancer	N#CC1=CC2=C(C3=C(N2)C(C)(C4=CC(N5CCC(CC5)N6CCOCC6)=C(C=C4C3=O)CC)C)C=C1	https://www.medchemexpress.com/CH5424802.html	Launched		92.0	H20	K14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13011	10.0	mM	254.0	DMSO	482.268176	14	K	pluskal_fda_drugs_5005_K14_id
2546	HY-103392	HYCPK40909	E11	HYCPK40909	92z	454.0	4.0	J22	909.0	E11	49763-96-4	Stiripentol	BCX2600	234.29	Cytochrome P450	Metabolic Enzyme/Protease	Stiripentol (STP) is an anticonvulsant agent, which can inhibit N-demethylation of CLB to NCLB mediatated by CYP3A4 (noncompetitively) and CYP2C19 (competitively) with Ki of 1.59±0.07 and 0.516±0.065 μM and IC50 of 1.58 and 3.29 μM, respectively.	Free Base	C14H18O3	27658.0	DMSO : 150 mg/mL (640.23 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC(C)(C)C(O)/C=C/C1=CC=C(OCO2)C2=C1	https://www.medchemexpress.com/Stiripentol.html	Launched		92.0	J22	K14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-103392	10.0	mM	254.0	DMSO	234.125594	14	K	pluskal_fda_drugs_5005_K14_id
1508	HY-B0702	HYCPK40906	G10	HYCPK40906	92z	595.0	1.0	M19	906.0	G10	27848-84-6	Nicergoline		484.39	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Nicergoline, an ergoline derivative ester of bromonicotinic acid, is a potent, selective and orally active antagonist of α1A-adrenoceptor. Nicergoline has vasodilator effects. Nicergoline also has ameliorative effects on cognitive function in mouse models of Alzheimer's disease[1][2].	Free Base	C24H26BrN3O3	26989.0	DMSO : 100 mg/mL (206.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease	CO[C@@]([C@@]1([H])C2)(C[C@@H](COC(C3=CN=CC(Br)=C3)=O)CN1C)C4=C5C2=CN(C)C5=CC=C4	https://www.medchemexpress.com/nicergoline.html	Launched		92.0	M19	K15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0702	10.0	mM	255.0	DMSO	483.115754	15	K	pluskal_fda_drugs_5005_K15_id
1544	HY-N1446	HYCPK40906	K12	HYCPK40906	92z	983.0	1.0	U23	906.0	K12	112-80-1	Oleic acid	9-cis-Octadecenoic acid; 9Z-Octadecenoic acid	282.46	Apoptosis; Endogenous Metabolite; Na+/K+ ATPase	Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Oleic acid (9-cis-Octadecenoic acid) is an abundant monounsaturated fatty acid[1]. Oleic acid is a Na+/K+ ATPase activator[2].	Free Acid	C18H34O2	89337.0	DMSO : ≥ 62.5 mg/mL (221.27 mM); Ethanol : 100 mg/mL (354.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	CCCCCCCC/C=C\CCCCCCCC(O)=O	https://www.medchemexpress.com/Oleic_acid.html	Launched		92.0	U23	K15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N1446	10.0	mM	255.0	DMSO	282.25588	15	K	pluskal_fda_drugs_5005_K15_id
1812	HY-B1048	HYCPK40907	L09	HYCPK40907	92z	1074.0	2.0	W18	907.0	L09	2066-89-9	Pasiniazid	Paraniazide; Pasiniazide; Isonicotinic acid hydrazide p-aminosalicylate	290.27	Bacterial	Anti-infection	Pasiniazid is an anti-TB and anti-leprosy drug, used to treat various types of TB and leprosy.	Free Acid	C13H14N4O4	27783.0	DMSO : ≥ 160 mg/mL (551.21 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=NC=C1)NN.O=C(O)C2=CC=C(N)C=C2O	https://www.medchemexpress.com/Pasiniazid.html	Launched		92.0	W18	K15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1048	10.0	mM	255.0	DMSO	153.042593	15	K	pluskal_fda_drugs_5005_K15_id
1875	HY-17002	HYCPK40907	K13	HYCPK40907	92z	986.0	2.0	U26	907.0	K13	94055-76-2	Suplatast (Tosilate)	IPD 1151T	499.64	Interleukin Related	Immunology/Inflammation	Suplatast Tosilate (IPD 1151T) is an orally active Th2 cytokine inhibitor which can inhibit both IL-4 and IL-5 production from Th2 cells and suppress IgE synthesis. Suplatast Tosilate is an anti-allergic agent. Suplatast Tosilate has antiasthmatic, anti-inflammatory and antifibrotic activity[1][2][3][4].	Tosylate	C23H33NO7S2	20618.0	DMSO : ≥ 33 mg/mL (66.05 mM); H2O : ≥ 100 mg/mL (200.14 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[S+](C)CCC(NC1=CC=C(C=C1)OCC(COCC)O)=O.CC2=CC=C(C=C2)S(=O)([O-])=O	https://www.medchemexpress.com/Suplatast-Tosilate.html	Launched		92.0	U26	K15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17002	10.0	mM	255.0	DMSO	328.157706	15	K	pluskal_fda_drugs_5005_K15_id
2008	HY-B1135	HYCPK40907	L22	HYCPK40907	92z	1100.0	2.0	W44	907.0	L22	3562-84-3	Benzbromarone		424.08	Apoptosis; Xanthine Oxidase	Apoptosis; Metabolic Enzyme/Protease	Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout.	Free Base	C17H12Br2O3	96153.0	DMSO : ≥ 100 mg/mL (235.80 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(C1=CC(Br)=C(O)C(Br)=C1)C2=C(CC)OC3=CC=CC=C23	https://www.medchemexpress.com/Benzbromarone.html	Launched		92.0	W44	K15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1135	10.0	mM	255.0	DMSO	421.915318	15	K	pluskal_fda_drugs_5005_K15_id
2015	HY-B0185	HYCPK40908	C03	HYCPK40908	92z	245.0	3.0	F5	908.0	C03	137-58-6	Lidocaine	Lignocaine	234.34	Apoptosis; ERK; MEK; NF-κB; Sodium Channel	Apoptosis; MAPK/ERK Pathway; Membrane Transporter/Ion Channel; NF-κB; Stem Cell/Wnt	Lidocaine (Lignocaine) inhibits sodium channels involving complex voltage and using dependence[1]. Lidocaine decreases growth, migration and invasion of gastric carcinoma cells via up-regulating miR-145 expression and further inactivation of MEK/ERK and NF-κB signaling pathways. Lidocaine is an amide derivative and has potential for the research of ventricular arrhythmia[2].	Free Base	C14H22N2O	14140.0	H2O : ≥ 5 mg/mL (21.34 mM); DMSO : ≥ 100 mg/mL (426.73 mM)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C(NC1=C(C)C=CC=C1C)CN(CC)CC	https://www.medchemexpress.com/Lidocaine.html	Launched		92.0	F5	K15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0185	10.0	mM	255.0	DMSO	234.173213	15	K	pluskal_fda_drugs_5005_K15_id
2200	HY-15148	HYCPK40908	E15	HYCPK40908	92z	461.0	3.0	J29	908.0	E15	174484-41-4	Tipranavir	PNU-140690	602.66	HIV; HIV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Tipranavir (PNU-140690) inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against multi-protease inhibitor (PI)-resistant HIV-1 isolates with IC50s of 66-410 nM[1][2]. Tipranavir inhibits SARS-CoV-2 3CLpro activity[3].	Free Base	C31H33F3N2O5S	8235.0	Ethanol : ≥ 50 mg/mL (82.97 mM); DMSO : 200 mg/mL (331.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1C([C@H](CC)C2=CC=CC(NS(C3=CC=C(C(F)(F)F)C=N3)(=O)=O)=C2)=C(O)C[C@](CCC4=CC=CC=C4)(CCC)O1	https://www.medchemexpress.com/Tipranavir.html	Launched		92.0	J29	K15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15148	10.0	mM	255.0	DMSO	602.206228	15	K	pluskal_fda_drugs_5005_K15_id
2214	HY-B0456	HYCPK40908	C16	HYCPK40908	92z	271.0	3.0	F31	908.0	C16	83-88-5	Riboflavin	Vitamin B2; E101	376.36	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	"Riboflavin is an easily absorbed micronutrient with a key role in maintaining health in humans and other animals.
Target: Others
Riboflavin (vitamin B2) is the direct precursor of redox enzyme cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which are essential for multiple cell physiology [1]. Urinary excretion of riboflavin contributes to one-half of the overall removal of riboflavin from plasma. No sex differences were observed for any of the pharmacokinetic variables (P > 0.05) [2]. Riboflavin, similar to other vitamins of the B complex, presents anti-inflammatory activity but its full characterization has not yet been carried out. Riboflavin (25, 50 or 100 mg/kg, i.p.), administered immediately and 2 h after the injection of carrageenan, induced antiedema and antinociceptive effects. The antinociceptive effect was not inhibited by the pretreatment with cadmium sulfate (1 mg/kg), an inhibitor of flavokinase. Riboflavin (50 or 100 mg/kg, i.p., 0 and 2 h) also inhibited the fever induced by lipopolysaccharide (LPS) in rats. Riboflavin is a safe drug, is approved for clinical use and exacerbates the antinociceptive effect of morphine, may warrant clinical trials to assess its potential in the treatment of different painful or inflammatory conditions [3]."	Free Base	C17H20N4O6	17147.0	DMSO : 17.86 mg/mL (47.45 mM; ultrasonic and warming and heat to 60°C); H2O : 14.29 mg/mL (37.97 mM; ultrasonic and adjust pH to 8 with NaOH)	DMSO Solution	10mM  * 100uL	Cancer	O[C@H]([C@H](O)[C@H](O)CO)CN1C(C=C(C)C(C)=C2)=C2N=C(C(N3)=O)C1=NC3=O	https://www.medchemexpress.com/riboflavin.html	Launched		92.0	F31	K15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0456	10.0	mM	255.0	DMSO	376.138284	15	K	pluskal_fda_drugs_5005_K15_id
1494	HY-B2194	HYCPK40906	I09	HYCPK40906	92z	785.0	1.0	Q17	906.0	I09	11042-64-1	γ-Oryzanol		602.89	DNA Methyltransferase	Epigenetics	γ-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. γ-Oryzanol significantly inhibits the activities of DNMT1 (IC50=3.2 μM), DNMT3a (IC50=22.3 μM).	Free Base	C40H58O4	26681.0	DMSO : 62.5 mg/mL (103.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	C[C@@H]([C@@]1([H])CC[C@]2(C)[C@]1(C)CCC34C2CCC5[C@@]3(CC[C@H](OC(/C=C/C6=CC(OC)=C(O)C=C6)=O)C5(C)C)C4)CC/C=C(C)\C	https://www.medchemexpress.com/_gamma_-Oryzanol.html	Launched		92.0	Q17	K16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2194	10.0	mM	256.0	DMSO	602.43351	16	K	pluskal_fda_drugs_5005_K16_id
1903	HY-17512A	HYCPK40907	O15	HYCPK40907	92z	1374.0	2.0	AC30	907.0	O15	124750-99-8	Losartan (potassium)	DuP-753 (potassium)	461.00	Angiotensin Receptor	GPCR/G Protein	Losartan potassium (DuP-753 potassium) is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM.	Potassium	C22H22ClKN6O	12947.0	DMSO : ≥ 110 mg/mL (238.61 mM); H2O : 50 mg/mL (108.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	OCC1=C(Cl)N=C(CCCC)N1CC2=CC=C(C3=CC=CC=C3C4=N[N-]N=N4)C=C2.[K+]	https://www.medchemexpress.com/Losartan-potassium.html	Launched		92.0	AC30	K16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17512A	10.0	mM	256.0	DMSO	422.162187	16	K	pluskal_fda_drugs_5005_K16_id
2025	HY-18252	HYCPK40908	M03	HYCPK40908	92z	1205.0	3.0	Z5	908.0	M03	330784-47-9	Avanafil	TA1790	483.95	Endogenous Metabolite; NO Synthase; Phosphodiesterase (PDE)	Immunology/Inflammation; Metabolic Enzyme/Protease	Avanafil (TA-1790) is a potent and selective phosphodiesterase-5 (PDE-5) inhibitor with IC50 values of 5.2 nM, 630 nM, 5700 nM, 6200 nM, 12000 nM, 27000 nM, 51000 nM and 53000 nM for PDE-5, PDE-6, PDE-4, PDE-10, PDE-8, PDE-7, PDE-2 and PDE-1, respectively. Avanafil activates NO/cGMP/PKG signaling-pathway to decrease loss in BMD, bone atrophy, and oxidative stress. Avanafil inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels. Avanafil can be used for the research of erectile dysfunction and osteoporosis[1][2][3].	Free Base	C23H26ClN7O3	11995.0	DMSO : 50 mg/mL (103.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cardiovascular Disease	COC1=C(Cl)C=C(CNC2=C(C(NCC3=NC=CC=N3)=O)C=NC(N4[C@H](CO)CCC4)=N2)C=C1	https://www.medchemexpress.com/Avanafil.html	Launched		92.0	Z5	K16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18252	10.0	mM	256.0	DMSO	483.178565	16	K	pluskal_fda_drugs_5005_K16_id
2093	HY-W012185	HYCPK40908	F08	HYCPK40908	92z	543.0	3.0	L15	908.0	F08	90-39-1	(-)-Sparteine	(-)-Lupinidine	234.39	Others	Others	(-)-Sparteine is a natural alkaloid isolated from beans.	Free Base	C15H26N2	102152.0	DMSO : 12.5 mg/mL (53.33 mM; Need ultrasonic); H2O : 1.82 mg/mL (7.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	[H][C@]12CCCCN1C[C@H]3[C@]4([H])CCCCN4C[C@@H]2C3	https://www.medchemexpress.com/_-_-Sparteine.html	Launched		92.0	L15	K16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W012185	10.0	mM	256.0	DMSO	234.209599	16	K	pluskal_fda_drugs_5005_K16_id
2135	HY-W011522	HYCPK40908	D11	HYCPK40908	92z	357.0	3.0	H21	908.0	D11	19388-87-5	Taurolidine		284.35	Antibiotic; Apoptosis; Bacterial	Anti-infection; Apoptosis	Taurolidine is a broad-spectrum antimicrobial for the prevention of central venous catheter-related infections. Taurolidine has a direct and selective antineoplastic effect on brain tumor cells by the induction of apoptosis[1].		C7H16N4O4S2	58340.0	DMSO : 62.5 mg/mL (219.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=S1(NCN(CN(CC2)CNS2(=O)=O)CC1)=O	https://www.medchemexpress.com/taurolidine.html	Launched		92.0	H21	K16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W011522	10.0	mM	256.0	DMSO	284.061297	16	K	pluskal_fda_drugs_5005_K16_id
2213	HY-B1253	HYCPK40908	B16	HYCPK40908	92z	175.0	3.0	D31	908.0	B16	55-86-7	Chlormethine (hydrochloride)	Mechlorethamine hydrochloride	192.51	Others	Others	"Chlormethine hydrochloride is a vesicant and necrotizing irritant destructive to mucous membranes. The hydrochloride is used as an antineoplastic in Hodgkin's disease and lymphomas. 
Target: 
Chlormethine is a nitrogen mustard . It is the prototype of alkylating agents, a group of anticancer chemotherapeutic drugs. It works by binding to DNA, crosslinking two strands and preventing cell duplication. It binds to the N7 nitrogen on the DNA base guanine."	Hydrochloride	C5H12Cl3N	84002.0	DMSO : 250 mg/mL (1298.63 mM; Need ultrasonic); H2O : 100 mg/mL (519.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	ClCCN(CCCl)C.[H]Cl	https://www.medchemexpress.com/Chlormethine-hydrochloride.html	Launched		92.0	D31	K16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1253	10.0	mM	256.0	DMSO	155.026855	16	K	pluskal_fda_drugs_5005_K16_id
2270	HY-B0331A	HYCPK40908	O19	HYCPK40908	92z	1429.0	3.0	AD37	908.0	O19	76095-16-4	Enalapril (maleate)	MK-421 (maleate)	492.52	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Enalapril (maleate) (MK-421 (maleate)), the active metabolite of enalapril, is an angiotensin-converting enzyme (ACE) inhibitor.	Maleate	C24H32N2O9	14712.0	H2O : 33.33 mg/mL (67.67 mM; Need ultrasonic and warming); DMSO : ≥ 50 mg/mL (101.52 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(O)[C@H]1N(C([C@H](C)N[C@H](C(OCC)=O)CCC2=CC=CC=C2)=O)CCC1.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/enalapril-maleate.html	Launched		92.0	AD37	K16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0331A	10.0	mM	256.0	DMSO	376.199822	16	K	pluskal_fda_drugs_5005_K16_id
2482	HY-B1693	HYCPK40909	N06	HYCPK40909	92z	1308.0	4.0	AB12	909.0	N06	60-99-1	Levomepromazine	Methotrimeprazine	328.47	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Levomepromazine (Methotrimeprazine) is an orally available neuroleptic agent, which is commonly used to relieve nausea and vomiting in palliative care settings. Levomepromazine has antagonist actions at multiple neurotransmitter receptor sites, including dopaminergic, cholinergic, serotonin and histamine receptors[1].	Free Base	C19H24N2OS	152194.0	DMSO : 41.67 mg/mL (126.86 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	COC1=CC=C2SC3=C(N(C2=C1)C[C@@H](CN(C)C)C)C=CC=C3	https://www.medchemexpress.com/levomepromazine.html	Launched		92.0	AB12	K16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1693	10.0	mM	256.0	DMSO	328.160934	16	K	pluskal_fda_drugs_5005_K16_id
1413	HY-14144	HYCPK40906	B06	HYCPK40906	92z	107.0	1.0	C11	906.0	B06	320345-99-1	Aclidinium (Bromide)	LAS 34273; LAS-W 330	564.55	mAChR	GPCR/G Protein; Neuronal Signaling	Aclidinium Bromide (LAS 34273; LAS-W 330) is a long-acting, inhaled muscarinic antagonist. Aclidinium Bromide has the potential for chronic obstructive pulmonary disease (COPD) research[1][2][3][4].	Bromide	C26H30BrNO4S2	7007.0	DMSO : 33.33 mg/mL (59.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)C(C4=CC=CS4)(O)C5=CC=CS5.[Br-]	https://www.medchemexpress.com/Aclidinium-Bromide.html	Launched		92.0	C11	K17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14144	10.0	mM	257.0	DMSO	484.161077	17	K	pluskal_fda_drugs_5005_K17_id
1834	HY-B2167	HYCPK40907	B11	HYCPK40907	92z	118.0	2.0	C22	907.0	B11	6217-54-5	Docosahexaenoic acid	DHA; Cervonic acid	328.49	Endogenous Metabolite	Metabolic Enzyme/Protease	Docosahexaenoic Acid (DHA) is an omega-3 fatty acid abundantly present brain and retina. It can be obtained directly from fish oil and maternal milk.	Free Acid	C22H32O2	159167.0	DMSO : 100 mg/mL (304.42 mM; Need ultrasonic); Ethanol : 50 mg/mL (152.21 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (304.42 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(O)=O	https://www.medchemexpress.com/Docosahexaenoic-Acid.html	Launched		92.0	C22	K17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2167	10.0	mM	257.0	DMSO	328.24023	17	K	pluskal_fda_drugs_5005_K17_id
1855	HY-117287	HYCPK40907	G12	HYCPK40907	92z	600.0	2.0	M24	907.0	G12	1609392-27-9	Deucravacitinib	BMS-986165	425.46	IFNAR; Interleukin Related; JAK	Epigenetics; Immunology/Inflammation; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable allosteric TYK2 inhibitor for the treatment of autoimmune diseases, which selectively binds to TYK2 pseudokinase (JH2) domain (IC50=1.0 nM) and blocks receptor-mediated Tyk2 activation by stabilizing the regulatory JH2 domain. Deucravacitinib inhibits IL-12/23 and type I IFN pathways[1][2].	Free Base	C20H19D3N8O3	59262.0	DMSO : 37.5 mg/mL (88.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=NN=C(NC(C2CC2)=O)C=C1NC3=CC=CC(C4=NN(C)C=N4)=C3OC)NC([2H])([2H])[2H]	https://www.medchemexpress.com/BMS-986165.html	Launched		92.0	M24	K17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-117287	10.0	mM	257.0	DMSO	422.181487	17	K	pluskal_fda_drugs_5005_K17_id
1970	HY-B1551	HYCPK40907	F20	HYCPK40907	92z	520.0	2.0	K40	907.0	F20	104-31-4	Benzonatate	Benzononatine	603.74	Sodium Channel	Membrane Transporter/Ion Channel	Benzonatate (Benzononatine) is a peripheral oral antitussive that dampens the activity of cough stretch receptors. Benzonatate has sodium channel-blocking properties and local anesthetic effects on the respiratory stretch receptors due to a tetracaine-like metabolite[1][2].		C30H53NO11	142094.0	DMSO : 100 mg/mL (165.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)C1=CC=C(NCCCC)C=C1	https://www.medchemexpress.com/benzonatate.html	Launched		92.0	K40	K17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1551	10.0	mM	257.0	DMSO	603.361862	17	K	pluskal_fda_drugs_5005_K17_id
2011	HY-Y1683	HYCPK40907	O22	HYCPK40907	92z	1388.0	2.0	AC44	907.0	O22	89-78-1	DL-Menthol	Racementhol	156.27	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	DL-Menthol is a relative configuration of (-)-Menthol. DL-Menthol relates to the activation of GABAA receptor[1].	Free Base	C10H20O	27520.0	DMSO : 100 mg/mL (639.92 mM; Need ultrasonic); H2O : 1 mg/mL (6.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	C[C@H]1C[C@@H](O)[C@H](C(C)C)CC1	https://www.medchemexpress.com/dl-menthol.html	Launched		92.0	AC44	K17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y1683	10.0	mM	257.0	DMSO	156.151415	17	K	pluskal_fda_drugs_5005_K17_id
2044	HY-B0516	HYCPK40908	E05	HYCPK40908	92z	441.0	3.0	J9	908.0	E05	23964-57-0	Articaine (hydrochloride)	Hoe-045	320.84	NF-κB; NOD-like Receptor (NLR); Sodium Channel	Immunology/Inflammation; Membrane Transporter/Ion Channel; NF-κB	Articaine hydrochloride (Hoe-045) is an amide anaesthetic containing an ester group, reversibly binding to the α-subunit of the voltage-gated sodium channels within the inner cavity of the nerve, can provide effective pain relief. Articaine hydrochloride ameliorates LPS-induced acute kidney injury via inhibition of NF-?B activation and the NLRP3 inflammasome pathway[1][2][3].	Hydrochloride	C13H21ClN2O3S	15468.0	DMSO : 100 mg/mL (311.68 mM; Need ultrasonic); H2O : 100 mg/mL (311.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C(C)NCCC)NC(C(C)=CS1)=C1C(OC)=O.Cl	https://www.medchemexpress.com/Articaine-hydrochloride.html	Launched		92.0	J9	K17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0516	10.0	mM	257.0	DMSO	284.119463	17	K	pluskal_fda_drugs_5005_K17_id
2181	HY-B1893	HYCPK40908	B14	HYCPK40908	92z	171.0	3.0	D27	908.0	B14	426-13-1	Fluorometholone		376.46	Glucocorticoid Receptor	Immunology/Inflammation	Fluorometholone, a synthetic glucocorticoid, is a glucocorticoid receptor agonist with anti-inflammatory and anti-allergic properties. Fluorometholone can be used for the research of dry eye[1].		C22H29FO4	64178.0	DMSO : 50 mg/mL (132.82 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC([C@@]1(O)CC[C@@]2([H])[C@]3([H])C[C@H](C)C4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)=O)=O	https://www.medchemexpress.com/fluorometholone.html	Launched		92.0	D27	K17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1893	10.0	mM	257.0	DMSO	376.204988	17	K	pluskal_fda_drugs_5005_K17_id
2558	HY-B0012	HYCPK40909	A12	HYCPK40909	92z	72.0	4.0	B24	909.0	A12	40391-99-9	Pamidronic acid		235.07	Bacterial; Wnt; β-catenin	Anti-infection; Stem Cell/Wnt	Pamidronic acid is a drug used to treat a broad spectrum of bone absorption diseases.	Free Acid	C3H11NO7P2	83695.0	H2O : 5 mg/mL (21.27 mM; ultrasonic and warming and heat to 80°C); DMSO : < 1 mg/mL (insoluble or slightly soluble)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology	OC(P(O)(O)=O)(P(O)(O)=O)CCN	https://www.medchemexpress.com/Pamidronic_acid.html	Launched		92.0	B24	K17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0012	10.0	mM	257.0	DMSO	235.001075	17	K	pluskal_fda_drugs_5005_K17_id
1455	HY-B1359	HYCPK40907	B20	HYCPK40907	92z	136.0	2.0	C40	907.0	B20	7220-79-3	Methylene blue (trihydrate)	C.I. Basic Blue 9 trihydrate	373.90	Guanylate Cyclase; Monoamine Oxidase; NO Synthase; Parasite	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Methylene blue trihydrate (C.I. Basic Blue 9 trihydrate) is a guanylyl cyclase (sGC), monoamine oxidase A (MAO-A) and NO synthase (NOS) inhibitor. Methylene blue trihydrate is a vasopressor and is often used as a dye in several medical procedures. Methylene blue trihydrate has antinociception, antimalarial, antidepressant and anxiolytic activity effects. Methylene Blue trihydrate has the potential for methemoglobinemias, neurodegenerative disorders and ifosfamide-induced encephalopathytreatment[1][2][3].	hydrate	C16H24ClN3O3S	63900.0	DMSO : 100 mg/mL (267.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Neurological Disease	CN(C1=CC(SC2=C/C(C=CC2=N3)=[N+](C)\C)=C3C=C1)C.[3 H2O].[Cl-]	https://www.medchemexpress.com/methylene-blue-trihydrate.html	Launched		92.0	C40	K18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1359	10.0	mM	258.0	DMSO	284.121595	18	K	pluskal_fda_drugs_5005_K18_id
1461	HY-108293	HYCPK40908	C05	HYCPK40908	92z	249.0	3.0	F9	908.0	C05	39219-28-8	Promestriene		328.49	Estrogen Receptor/ERR	Others	Promestriene is a synthetic diethyl-ether of estradiol and a locally effective estrogen. Promestriene has an efficient action on vaginal atrophy while it is minimally absorbed[1][2].		C22H32O2	64028.0	DMSO : 20 mg/mL (60.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	C[C@@]12[C@@H](OC)CC[C@@]1([H])[C@]3([H])CCC4=C(C=CC(OCCC)=C4)[C@@]3([H])CC2	https://www.medchemexpress.com/promestriene.html	Launched		92.0	F9	K18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108293	10.0	mM	258.0	DMSO	328.24023	18	K	pluskal_fda_drugs_5005_K18_id
1536	HY-N0543	HYCPK40906	C12	HYCPK40906	92z	215.0	1.0	E23	906.0	C12	97-59-6	Allantoin	5-Ureidohydantoin	158.12	Endogenous Metabolite; Imidazoline Receptor	Metabolic Enzyme/Protease; Neuronal Signaling	Allantoin is a skin conditioning agent that promotes healthy skin, stimulates new and healthy tissue growth.	Free Base	C4H6N4O3	26321.0	DMSO : 50 mg/mL (316.22 mM; Need ultrasonic); H2O : 3.85 mg/mL (24.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(N)NC(C(N1)=O)NC1=O	https://www.medchemexpress.com/Allantoin.html	Launched		92.0	E23	K18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0543	10.0	mM	258.0	DMSO	158.04399	18	K	pluskal_fda_drugs_5005_K18_id
1714	HY-17570	HYCPK40907	E03	HYCPK40907	92z	390.0	2.0	I6	907.0	E03	382-67-2	Desoximetasone		376.46	Others	Others	"Desoximetasone(Topicort) is a medication belonging to the family of medications known as topical corticosteroids; is used for the relief of various skin conditions, including rashes.
IC50 value:
Target: 
When using desoximetasone, some of the medication may be absorbed through the skin and into the bloodstream. Too much absorption can lead to unwanted side effects elsewhere in the body. To keep this problem to a minimum, avoid using large amounts of desoximetasone over large areas, do not use it for extended periods of time, and do not cover it with airtight dressings such as plastic wrap or adhesive bandages unless specifically told to by your doctor.[1] Children may absorb more medication than adults do. Desoximetasone is for use only on the skin and should be kept out of the eyes."	Free Base	C22H29FO4	47110.0	DMSO : ≥ 100 mg/mL (265.63 mM); H2O : 0.14 mg/mL (0.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	F[C@@]1([C@]2(C=C3)C)[C@](CCC2=CC3=O)([H])[C@@](C[C@@H](C)[C@@H]4C(CO)=O)([H])[C@]4(C)C[C@@H]1O	https://www.medchemexpress.com/desoximetasone.html	Launched		92.0	I6	K18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17570	10.0	mM	258.0	DMSO	376.204988	18	K	pluskal_fda_drugs_5005_K18_id
1811	HY-A0084	HYCPK40907	K09	HYCPK40907	92z	978.0	2.0	U18	907.0	K09	614-39-1	Procainamide (hydrochloride)		271.79	Autophagy	Autophagy	Procainamide hydrochloride is an anti-arrhythmic agent and is used to treat cardiac arrhythmia; induces rapid block of the batrachotoxin(BTX)-activated sodium channels of the heart muscle and acts as antagonist to long gating closures.	Hydrochloride	C13H22ClN3O	16402.0	DMSO : 50 mg/mL (183.97 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (183.97 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NCCN(CC)CC)C1=CC=C(N)C=C1.[H]Cl	https://www.medchemexpress.com/Procainamide-hydrochloride.html	Launched		92.0	U18	K18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0084	10.0	mM	258.0	DMSO	235.168462	18	K	pluskal_fda_drugs_5005_K18_id
1973	HY-B0878	HYCPK40907	I20	HYCPK40907	92z	808.0	2.0	Q40	907.0	I20	66852-54-8	Halobetasol (propionate)	BMY-30056; CGP-14458; Ulobetasol propionate	484.96	Others	Others	Halobetasol propionate is a synthetic corticosteroid for topical dermatological use; exhibits anti-inflammatory, antipruritic, and vasoconstrictive properties.	Free Base	C25H31ClF2O5	16382.0	DMSO : ≥ 100 mg/mL (206.20 mM)	DMSO Solution	10mM  * 100uL	Others	C[C@@]12[C@](C(CCl)=O)(OC(CC)=O)[C@@H](C)C[C@@]1([H])[C@]3([H])C[C@H](F)C4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/Halobetasol-propionate.html	Launched		92.0	Q40	K18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0878	10.0	mM	258.0	DMSO	484.182808	18	K	pluskal_fda_drugs_5005_K18_id
2057	HY-B1268	HYCPK40908	B06	HYCPK40908	92z	155.0	3.0	D11	908.0	B06	577-11-7	Docusate (Sodium)	Dioctyl sulfosuccinate (sodium salt)	444.56	HSV	Anti-infection	Docusate Sodium (Dioctyl sulfosuccinate sodium salt) is a laxative used to for the research of constipation, for constipation due to the use of opiates it maybe used with a stimulant laxative, can be taken by mouth or rectally.	Sodium	C20H37NaO7S	17453.0	H2O : ≥ 20 mg/mL (44.99 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(OCC(CC)CCCC)C(S(=O)(O[Na])=O)CC(OCC(CC)CCCC)=O	https://www.medchemexpress.com/Docusate-Sodium.html	Launched		92.0	D11	K18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1268	10.0	mM	258.0	DMSO	422.233825	18	K	pluskal_fda_drugs_5005_K18_id
2443	HY-N6972	HYCPK40909	G04	HYCPK40909	92z	632.0	4.0	N8	909.0	G04	481-49-2	Cepharanthine		606.71	SARS-CoV	Anti-infection	Cepharanthine is a natural product isolated from the plant Stephania?cephalantha?Hayata. Cepharanthine has anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) activity. Cepharanthine has good effective in suppressing viral proliferation (half maximal (50%) inhibitory concentration (IC50) and 90% inhibitory concentration (IC90) values of 1.90 and 4.46?μM[1].	Free Base	C37H38N2O6	151679.0	DMSO : 50 mg/mL (82.41 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	[H][C@]12N(C)CCC(C1=C3)=CC(OC)=C3OC4=C5C(OCO5)=CC6=C4[C@](N(C)CC6)([H])CC(C=C7)=CC=C7OC8=C(OC)C=CC(C2)=C8	https://www.medchemexpress.com/cepharanthine.html	Launched		92.0	N8	K18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N6972	10.0	mM	258.0	DMSO	606.272987	18	K	pluskal_fda_drugs_5005_K18_id
2018	HY-13636	HYCPK40908	F03	HYCPK40908	92z	533.0	3.0	L5	908.0	F03	129453-61-8	Fulvestrant	ICI 182780; ZD 9238; ZM 182780	606.77	Apoptosis; Autophagy; Estrogen Receptor/ERR	Apoptosis; Autophagy; Others	Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant is also a GPR30 agonist. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy[1].	Free Base	C32H47F5O3S	30984.0	DMSO : 250 mg/mL (412.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@@]12[C@@H](O)CC[C@@]1([H])[C@]3([H])[C@H](CCCCCCCCCS(CCCC(F)(F)C(F)(F)F)=O)CC4=C(C=CC(O)=C4)[C@@]3([H])CC2	https://www.medchemexpress.com/Fulvestrant.html	Launched		92.0	L5	K19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13636	10.0	mM	259.0	DMSO	606.316607	19	K	pluskal_fda_drugs_5005_K19_id
2019	HY-A0153A	HYCPK40908	G03	HYCPK40908	92z	629.0	3.0	N5	908.0	G03	24356-60-3	Cephapirin (sodium)	Cefapirin (sodium)	445.45	Antibiotic; Bacterial	Anti-infection	Cephapirin sodium (Cefapirin sodium) is an ephalosporin antibiotic with broad-spectrum antimicrobial activity[1][2][3].	Sodium	C17H16N3NaO6S2	46031.0	DMSO : 33.33 mg/mL (74.82 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (224.49 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(COC(C)=O)CSC2C(NC(CSC3=CC=NC=C3)=O)C1=O)O[Na]	https://www.medchemexpress.com/cephapirin-sodium.html	Launched		92.0	N5	K19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0153A	10.0	mM	259.0	DMSO	423.055877	19	K	pluskal_fda_drugs_5005_K19_id
2080	HY-B0235	HYCPK40908	I07	HYCPK40908	92z	829.0	3.0	R13	908.0	I07	133-67-5	Trichlormethiazide		380.66	Others	Others	Trichlormethiazide is an orally active thiazide diuretic, with antihypertensive effect. Trichlormethiazide increases urine volume (UV), Na and K excretion and tends to improve the depressed creatinine clearance (CCRE) in acute renal failure rats model[1][2].	Free Base	C8H8Cl3N3O4S2	16675.0	DMSO : 150 mg/mL (394.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=S(C1=C(Cl)C=C(C2=C1)NC(C(Cl)Cl)NS2(=O)=O)(N)=O	https://www.medchemexpress.com/Trichlormethiazide.html	Launched		92.0	R13	K19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0235	10.0	mM	259.0	DMSO	378.902181	19	K	pluskal_fda_drugs_5005_K19_id
2084	HY-A0084A	HYCPK40908	M07	HYCPK40908	92z	1213.0	3.0	Z13	908.0	M07	51-06-9	Procainamide	Procaine amide; SP 100	235.33	DNA Methyltransferase	Epigenetics	Procainamide is a specific and potent inhibitor of DNA methyltransferase 1 (DNMT1). Procainamide is a Class 1A antiarrhythmic agent. Procainamide has the potential for the research of cancer and arrhythmias[1][2].		C13H21N3O	213301.0	DMSO : 100 mg/mL (424.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C(NCCN(CC)CC)C1=CC=C(N)C=C1	https://www.medchemexpress.com/procainamide.html	Launched		92.0	Z13	K19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0084A	10.0	mM	259.0	DMSO	235.168462	19	K	pluskal_fda_drugs_5005_K19_id
2260	HY-B0321	HYCPK40908	E19	HYCPK40908	92z	469.0	3.0	J37	908.0	E19	1508-75-4	Tropicamide	Ro 1-7683	284.35	mAChR	GPCR/G Protein; Neuronal Signaling	Tropicamide (Ro 1-7683) is a selective M4 muscarinic acetylcholine receptor antagonist. Tropicamide produces short acting mydriasis (dilation of the pupil) and cycloplegia when applied as eye drops[1][2].	Free Base	C17H20N2O2	16055.0	DMSO : 25 mg/mL (87.92 mM; Need ultrasonic); H2O : 0.67 mg/mL (2.36 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N(CC)CC1=CC=NC=C1)C(C2=CC=CC=C2)CO	https://www.medchemexpress.com/Tropicamide.html	Launched		92.0	J37	K19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0321	10.0	mM	259.0	DMSO	284.152478	19	K	pluskal_fda_drugs_5005_K19_id
2479	HY-10261A	HYCPK40909	K06	HYCPK40909	92z	1020.0	4.0	V12	909.0	K06	850140-73-7	Afatinib (dimaleate)	BIBW 2992MA2	718.08	Akt; Apoptosis; Autophagy; c-Met/HGFR; EGFR; p38 MAPK	Apoptosis; Autophagy; JAK/STAT Signaling; MAPK/ERK Pathway; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK	Afatinib (BIBW 2992) dimaleate is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib dimaleate can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer[1][2][3][4].	Maleate	C32H33ClFN5O11	24772.0	DMSO : ≥ 35 mg/mL (48.74 mM); H2O : 50 mg/mL (69.63 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=C(C=C2C(C(NC3=CC(Cl)=C(C=C3)F)=NC=N2)=C1)O[C@H]4CCOC4)/C=C/CN(C)C.O=C(O)/C=C\C(O)=O.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Afatinib-dimaleate.html	Launched		92.0	V12	K19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10261A	10.0	mM	259.0	DMSO	485.162996	19	K	pluskal_fda_drugs_5005_K19_id
2507	HY-A0091	HYCPK40909	N08	HYCPK40909	92z	1312.0	4.0	AB16	909.0	N08	306-07-0	Pargyline (hydrochloride)		195.69	Monoamine Oxidase	Neuronal Signaling	Pargyline hydrochloride is an irreversible monoamine oxidase (MAO) inhibitor with Kis of 13 μM and 0.5 μM for MAO-A and MAO-B, respectively. Pargyline hydrochloride has antihypertensive and anticancer activities[1][2][3].	Hydrochloride	C11H14ClN	105700.0	DMSO : ≥ 32 mg/mL (163.52 mM); H2O : 100 mg/mL (511.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	C#CCN(C)CC1=CC=CC=C1.[H]Cl	https://www.medchemexpress.com/Pargyline-hydrochloride.html	Launched		92.0	AB16	K19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0091	10.0	mM	259.0	DMSO	159.104799	19	K	pluskal_fda_drugs_5005_K19_id
2534	HY-135853	HYCPK40909	I10	HYCPK40909	92z	836.0	4.0	R20	909.0	I10	2492423-29-5	Molnupiravir	EIDD-2801; MK-4482	329.31	Influenza Virus; SARS-CoV	Anti-infection	Molnupiravir (EIDD-2801) is an orally bioavailable prodrug of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza[1][2].		C13H19N3O7	91156.0	DMSO : 50 mg/mL (151.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N([C@@]1([H])[C@H](O)[C@H](O)[C@@]([H])(COC(C(C)C)=O)O1)C=C2)NC2=NO	https://www.medchemexpress.com/eidd-2801.html	Launched		92.0	R20	K19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-135853	10.0	mM	259.0	DMSO	329.1223	19	K	pluskal_fda_drugs_5005_K19_id
595	HY-N0178	HYCPK40906	M07	HYCPK40906	92z	1165.0	1.0	Y13	906.0	M07	520-27-4	Diosmin		608.54	Aryl Hydrocarbon Receptor	Immunology/Inflammation	Diosmin is a flavonoid found in a variety of citrus fruits and also an agonist of the aryl hydrocarbon receptor (AhR).	Free Base	C28H32O15	222379.0	DMSO : 100 mg/mL (164.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C1C=C(C2=CC=C(OC)C(O)=C2)OC3=CC(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]5[C@@H]([C@@H]([C@H]([C@H](C)O5)O)O)O)O4)O)O)O)=CC(O)=C13	https://www.medchemexpress.com/Diosmin.html	Launched		92.0	Y13	K20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0178	10.0	mM	260.0	DMSO	608.17412	20	K	pluskal_fda_drugs_5005_K20_id
1437	HY-B0034	HYCPK40906	N07	HYCPK40906	92z	1261.0	1.0	AA13	906.0	N07	120011-70-3	Donepezil (Hydrochloride)	E2020	415.95	Cholinesterase (ChE)	Neuronal Signaling	Donepezil Hydrochloride (E2020) is a reversible, selective AChE inhibitor with an IC50 of 6.7 nM for AChE activity. Donepezil shows high selectivity for AChE over BuChE[1]. Donepezil exhibits neuroprotective effect on Aβ42 neurotoxicity[2].	Hydrochloride	C24H30ClNO3	22260.0	DMSO : 6.2 mg/mL (14.91 mM; Need warming); H2O : 33.33 mg/mL (80.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C1C(CC2CCN(CC3=CC=CC=C3)CC2)CC4=C1C=C(OC)C(OC)=C4.[H]Cl	https://www.medchemexpress.com/Donepezil-Hydrochloride.html	Launched		92.0	AA13	K20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0034	10.0	mM	260.0	DMSO	379.214744	20	K	pluskal_fda_drugs_5005_K20_id
1551	HY-B1256	HYCPK40906	B13	HYCPK40906	92z	121.0	1.0	C25	906.0	B13	56238-63-2	Cefuroxime (sodium)		446.37	Antibiotic; Bacterial	Anti-infection	Cefuroxime sodium is an orally active second-generation cephalosporin antibiotic with increased stability to β-lactamase. Cefuroxime sodium has a broad spectrum activity against Gram-positive and Gram-negative bacteria[1].	Sodium	C16H15N4NaO8S	29179.0	DMSO : ≥ 100 mg/mL (224.03 mM); H2O : 50 mg/mL (112.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@H](NC(/C(C3=CC=CO3)=N\OC)=O)C1=O)O[Na]	https://www.medchemexpress.com/Cefuroxime-sodium.html	Launched		92.0	C25	K20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1256	10.0	mM	260.0	DMSO	424.068884	20	K	pluskal_fda_drugs_5005_K20_id
2192	HY-16582A	HYCPK40908	M14	HYCPK40908	92z	1227.0	3.0	Z27	908.0	M14	956697-53-3	Sonidegib	Erismodegib; LDE225; NVP-LDE225	485.50	Smo	Stem Cell/Wnt	Sonidegib (Erismodegib) is a potent and selective Smo antagonist with IC50 of 1.3 nM and 2.5 nM for mouse and human Smo in binding assay, respectively[1].	Free Base	C26H26F3N3O3	16487.0	DMSO : 50 mg/mL (102.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(C)C(C(C=C2)=CC=C2OC(F)(F)F)=CC=C1)NC3=CC=C(N=C3)N4C[C@@H](C)O[C@@H](C)C4	https://www.medchemexpress.com/lde225.html	Launched		92.0	Z27	K20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16582A	10.0	mM	260.0	DMSO	485.192626	20	K	pluskal_fda_drugs_5005_K20_id
2212	HY-B2219	HYCPK40908	A16	HYCPK40908	92z	79.0	3.0	B31	908.0	A16	57-11-4	Stearic acid		284.48	Endogenous Metabolite	Metabolic Enzyme/Protease	Stearic acid is a long chain dietary saturated fatty acid which exists in many animal and vegetable fats and oils.	Free Acid	C18H36O2	33628.0	DMSO : ≥ 14.29 mg/mL (50.23 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	CCCCCCCCCCCCCCCCCC(O)=O	https://www.medchemexpress.com/Stearic_acid.html	Launched		92.0	B31	K20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2219	10.0	mM	260.0	DMSO	284.27153	20	K	pluskal_fda_drugs_5005_K20_id
2274	HY-A0066A	HYCPK40908	C20	HYCPK40908	92z	279.0	3.0	F39	908.0	C20	59-97-2	Tolazoline (hydrochloride)	Imidaline (hydrochloride); NSC35110 (hydrochloride)	196.68	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	"Tolazoline (hydrochloride)(Imidaline (hydrochloride)) Hcl is a non-selective competitive α-adrenergic receptor antagonist.
IC50 value:
Target:  α-adrenoceptor antagonist
Tolazoline can be synthesized by the heterocyclation of the ethyl ester of iminophenzylacetic acid with ethylene diamine, which forms the desired product. The structure of tolazoline is strikingly similar to α-adrenergic agonists, which are antiedema sympathomimetics."	Hydrochloride	C10H13ClN2	16408.0	DMSO : 33.33 mg/mL (169.46 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (254.22 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	[H]Cl.C1(CC2=CC=CC=C2)=NCCN1	https://www.medchemexpress.com/Tolazoline-hydrochloride.html	Launched		92.0	F39	K20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0066A	10.0	mM	260.0	DMSO	160.100048	20	K	pluskal_fda_drugs_5005_K20_id
2289	HY-B0492	HYCPK40908	B21	HYCPK40908	92z	185.0	3.0	D41	908.0	B21	78246-49-8	Paroxetine (hydrochloride)	BRL29060 hydrochloride; BRL29060A	365.83	Autophagy; Serotonin Transporter	Autophagy; Neuronal Signaling	Paroxetine hydrochloride is a potent selective serotonin-reuptake inhibitor, commonly prescribed as an GRK2 inhibitor with IC50 of 14?μM. Paroxetine hydrochloride can be used for the research of depressive disorder[1][2][3].	Hydrochloride	C19H21ClFNO3	16051.0	DMSO : 100 mg/mL (273.35 mM; Need ultrasonic); H2O : 5 mg/mL (13.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	FC1=CC=C([C@H]2[C@H](COC3=CC=C(OCO4)C4=C3)CNCC2)C=C1.Cl	https://www.medchemexpress.com/Paroxetine-hydrochloride.html	Launched		92.0	D41	K20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0492	10.0	mM	260.0	DMSO	329.142722	20	K	pluskal_fda_drugs_5005_K20_id
2415	HY-B0249	HYCPK40908	K22	HYCPK40908	92z	1051.0	3.0	V43	908.0	K22	69655-05-6	Didanosine	2',3'-Dideoxyinosine; ddI	236.23	HIV; Reverse Transcriptase	Anti-infection	Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV[1][2][3].	Free Base	C10H12N4O3	13747.0	DMSO : 62.5 mg/mL (264.57 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC[C@@H]1CC[C@H](N2C3=C(N=C2)C(O)=NC=N3)O1	https://www.medchemexpress.com/Didanosine.html	Launched		92.0	V43	K20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0249	10.0	mM	260.0	DMSO	236.09094	20	K	pluskal_fda_drugs_5005_K20_id
1371	HY-B1032	HYCPK40906	H03	HYCPK40906	92z	677.0	1.0	O5	906.0	H03	17692-31-8	Dropropizine	(±)-Dropropizine; UCB-196	236.31	Others	Others	Dropropizine ((±)-Dropropizine) is a peripheral antitussive agent that acts by inhibiting cough reflex through its action on the peripheral receptors and their afferent conductors[1].	Free Base	C13H20N2O2	17209.0	DMSO : ≥ 41 mg/mL (173.50 mM); H2O : ≥ 33.33 mg/mL (141.04 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	OCC(O)CN1CCN(C2=CC=CC=C2)CC1	https://www.medchemexpress.com/Dropropizine.html	Launched		92.0	O5	K21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1032	10.0	mM	261.0	DMSO	236.152478	21	K	pluskal_fda_drugs_5005_K21_id
1380	HY-19730	HYCPK40906	A04	HYCPK40906	92z	7.0	1.0	A7	906.0	A04	1353550-13-6	Olmutinib	HM61713, BI 1482694	486.59	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Olmutinib (HM61713; BI-1482694) is an orally active and irreversible third EGFR tyrosine kinase inhibitor that binds to a cysteine residue near the kinase domain. Olmutinib  is used for NSCLC[1][2].	Free Base	C26H26N6O2S	19637.0	DMSO : ≥ 44 mg/mL (90.43 mM)	DMSO Solution	10mM  * 100uL	Cancer	C=CC(NC1=CC=CC(OC2=C3C(C=CS3)=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=N2)=C1)=O	https://www.medchemexpress.com/Olmutinib.html	Launched		92.0	A7	K21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19730	10.0	mM	261.0	DMSO	486.183795	21	K	pluskal_fda_drugs_5005_K21_id
1790	HY-A0059	HYCPK40907	F08	HYCPK40907	92z	496.0	2.0	K16	907.0	F08	4936-47-4	Nifuratel	NF 113; SAP 113; Methylmercadone	285.28	Antibiotic; Bacterial; Parasite	Anti-infection	"Nifuratel(NF 113, SAP 113) is a broad antibacterial spectrum agent, which is used as an antibacterial, antifungal, and antiprotozoal (Trichomonas).
IC50 Value: 0.125-1 μg/mL(MIC, A. vaginae) [1]
Target: Antibacterial;  Antiprotozoal 
in vitro: In vitro, nifuratel is able to inhibit the growth of A. vaginae, with a MIC range of 0.125-1 μg/mL; it is active against G. vaginalis and does not affect lactobacilli [1].
in vivo: Patients were randomized to receive a 2-week course of bismuth subcitrate (8 mg/kg/day, q.d.s.), amoxicillin (50 mg/kg/day, q.d.s.), with either nifuratel (15 mg/kg/day, q.d.s.) or furazolidone (10 mg/kg/day, q.d.s.), plus omeprazole (0.5 mg/kg, once daily) [2].
Toxicity: There were no serious adverse reactions and were no withdrawals due to any side-effects. All of side-effects were self-limiting (dark stools, urine discoloration, blackening of the tongue, and others) [3].
Clinical trial: N/A"	Free Base	C10H11N3O5S	9645.0	DMSO : 50 mg/mL (175.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1OC(CSC)CN1/N=C/C2=CC=C([N+]([O-])=O)O2	https://www.medchemexpress.com/nifuratel.html	Launched		92.0	K16	K21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0059	10.0	mM	261.0	DMSO	285.041941	21	K	pluskal_fda_drugs_5005_K21_id
2088	HY-B0406A	HYCPK40908	A08	HYCPK40908	92z	63.0	3.0	B15	908.0	A08	590-63-6	Bethanechol (chloride)	Carbamyl-β-methylcholine chloride	196.68	mAChR	GPCR/G Protein; Neuronal Signaling	Bethanechol chloride (Carbamyl-β-methylcholine chloride), a parasympathomimetic agent, is a mAChR agonist that exerts its effects via directly stimulating the mAChR (M1, M2, M3, M4, and M5) of the parasympathetic nervous system[1].	Chloride	C7H17ClN2O2	13584.0	H2O : ≥ 50 mg/mL (254.22 mM); DMSO : 11.11 mg/mL (56.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC(OC(N)=O)C[N+](C)(C)C.[Cl-]	https://www.medchemexpress.com/Bethanechol-chloride.html	Launched		92.0	B15	K21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0406A	10.0	mM	261.0	DMSO	161.128454	21	K	pluskal_fda_drugs_5005_K21_id
2111	HY-15122	HYCPK40908	H09	HYCPK40908	92z	737.0	3.0	P17	908.0	H09	115-53-7	Sinomenine		329.39	Apoptosis; Autophagy; NF-κB; Opioid Receptor	Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling; NF-κB	Sinomenine, an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].		C19H23NO4	103256.0	DMSO : 50 mg/mL (151.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	OC(C1=C2C[C@@]3([H])[C@](C=C4OC)([H])[C@@]1(CCN3C)CC4=O)=C(C=C2)OC	https://www.medchemexpress.com/sinomenine.html	Launched		92.0	P17	K21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15122	10.0	mM	261.0	DMSO	329.162708	21	K	pluskal_fda_drugs_5005_K21_id
2215	HY-B0453	HYCPK40908	D16	HYCPK40908	92z	367.0	3.0	H31	908.0	D16	24169-02-6	Econazole (nitrate)		444.70	Antibiotic; Bacterial; Fungal	Anti-infection	Econazole nitrate is an imidazole class antifungal medication[1]. Econazole nitrate also has antibacterial activity[2].	Nitrate	C18H16Cl3N3O4	16618.0	H2O : 0.67 mg/mL (1.51 mM; Need ultrasonic); DMSO : 50 mg/mL (112.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	[O-][N+](O)=O.ClC1=C(C=CC(Cl)=C1)C(OCC2=CC=C(Cl)C=C2)CN3C=CN=C3	https://www.medchemexpress.com/econazole-nitrate.html	Launched		92.0	H31	K21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0453	10.0	mM	261.0	DMSO	380.024996	21	K	pluskal_fda_drugs_5005_K21_id
2477	HY-N0480A	HYCPK40909	I06	HYCPK40909	92z	828.0	4.0	R12	909.0	I06	16994-56-2	Reserpine (hydrochloride)		645.14	Monoamine Transporter	Membrane Transporter/Ion Channel	Reserpine hydrochloride is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).	Hydrochloride	C33H41ClN2O9	141413.0	DMSO : 50 mg/mL (77.50 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C([C@H]([C@@H](OC)[C@H](OC(C1=CC(OC)=C(OC)C(OC)=C1)=O)C[C@]2([H])CN3CC4)[C@@]2([H])C[C@]3([H])C5=C4C(C=CC(OC)=C6)=C6N5)OC.Cl	https://www.medchemexpress.com/reserpine-hydrochloride.html	Launched		92.0	R12	K21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0480A	10.0	mM	261.0	DMSO	608.273381	21	K	pluskal_fda_drugs_5005_K21_id
2539	HY-15516	HYCPK40909	N10	HYCPK40909	92z	1316.0	4.0	AB20	909.0	N10	1018899-04-1	Sotagliflozin	LX-4211; LP-802034	424.94	SGLT	Membrane Transporter/Ion Channel	Sotagliflozin (LX-4211) is a potent dual SGLT2/1 inhibitor. Antidiabetic agents.	Free Base	C21H25ClO5S	8805.0	DMSO : ≥ 100 mg/mL (235.33 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	ClC(C=CC([C@@H]1O[C@H](SC)[C@@H](O)[C@H](O)[C@H]1O)=C2)=C2CC3=CC=C(OCC)C=C3	https://www.medchemexpress.com/LX-4211.html	Launched		92.0	AB20	K21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15516	10.0	mM	261.0	DMSO	424.111123	21	K	pluskal_fda_drugs_5005_K21_id
1388	HY-15122A	HYCPK40906	I04	HYCPK40906	92z	775.0	1.0	Q7	906.0	I04	6080-33-7	Sinomenine hydrochloride	Cucoline hydrochloride	365.85	Apoptosis; Autophagy; NF-κB; Opioid Receptor	Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling; NF-κB	Sinomenine hydrochloride (Cucoline hydrochloride), an alkaloid extracted from?Sinomenium acutum, is a blocker of the NF-κB activation[1]. Sinomenine also is an activator of μ-opioid receptor[2].	Hydrochloride	C19H24ClNO4	152033.0	DMSO : 100 mg/mL (273.34 mM; Need ultrasonic and warming); H2O : 16.67 mg/mL (45.57 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	OC(C1=C2C[C@@]3([H])[C@](C=C4OC)([H])[C@@]1(CCN3C)CC4=O)=C(C=C2)OC.Cl	https://www.medchemexpress.com/Sinomenine_hydrochloride.html	Launched		92.0	Q7	K22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15122A	10.0	mM	262.0	DMSO	329.162708	22	K	pluskal_fda_drugs_5005_K22_id
1407	HY-10181A	HYCPK40906	L05	HYCPK40906	92z	1065.0	1.0	W9	906.0	L05	854001-07-3	Dasatinib (hydrochloride)	BMS-354825 (hydrochloride)	524.47	Apoptosis; Autophagy; Bcr-Abl; Src	Apoptosis; Autophagy; Protein Tyrosine Kinase/RTK	Dasatinib (BMS-354825) hydrochloride is a highly potent, ATP competitive, orally active dual Src/Bcr-Abl inhibitor with potent antitumor activity. The Kis are 16 pM and 30 pM for Src and Bcr-Abl, respectively.  Dasatinib hydrochloride inhibits Bcr-Abl and Src with IC50s of <1.0 nM and 0.5 nM, respectively[1]. Dasatinib hydrochloride also induces apoptosis and autophagy.	Hydrochloride	C22H27Cl2N7O2S	49542.0	DMSO : 15 mg/mL (28.60 mM; Need ultrasonic and warming); H2O : 10 mg/mL (19.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CN=C(S1)NC2=NC(C)=NC(N3CCN(CC3)CCO)=C2)NC4=C(C=CC=C4Cl)C.[H]Cl	https://www.medchemexpress.com/Dasatinib-hydrochloride.html	Launched		92.0	W9	K22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10181A	10.0	mM	262.0	DMSO	487.155722	22	K	pluskal_fda_drugs_5005_K22_id
1597	HY-B1742	HYCPK40906	P15	HYCPK40906	92z	1469.0	1.0	AE29	906.0	P15	603-00-9	Proxyphylline		238.24	Adenosine Receptor	GPCR/G Protein	Proxyphylline is a methylxanthine derivative used as a cardiac stimulant, vasodilator and bronchodilator[1].	Free Base	C10H14N4O3	26313.0	DMSO : ≥ 100 mg/mL (419.74 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(N1C)N(C)C2=C(N(CC(O)C)C=N2)C1=O	https://www.medchemexpress.com/Proxyphylline.html	Launched		92.0	AE29	K22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1742	10.0	mM	262.0	DMSO	238.10659	22	K	pluskal_fda_drugs_5005_K22_id
1677	HY-13599	HYCPK40906	P20	HYCPK40906	92z	1479.0	1.0	AE39	906.0	P20	4291-63-8	Cladribine	2-Chloro-2′-deoxyadenosine; CldAdo; 2CdA	285.69	Adenosine Deaminase; Apoptosis	Apoptosis; Metabolic Enzyme/Protease	Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis[1][2].	Free Base	C10H12ClN5O3	23178.0	H2O : 10 mg/mL (35.00 mM; Need ultrasonic); DMSO : ≥ 30 mg/mL (105.01 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	OC[C@@H]1[C@H](C[C@H](N2C=NC3=C2N=C(Cl)N=C3N)O1)O	https://www.medchemexpress.com/Cladribine.html	Launched		92.0	AE39	K22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13599	10.0	mM	262.0	DMSO	285.062867	22	K	pluskal_fda_drugs_5005_K22_id
1802	HY-N0714	HYCPK40907	B09	HYCPK40907	92z	114.0	2.0	C18	907.0	B09	478-61-5	Berbamine		608.72	Autophagy; NF-κB	Autophagy; NF-κB	Berbamine is a natural compound extracted from traditional Chinese medicine?Phellodendron amurense Rupr. with anti-tumor, immunomodulatory and cardiovascular effects. Berbamine?is a calcium channel blocker.	Free Base	C37H40N2O6	119117.0	DMSO : 100 mg/mL (164.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	COC1=C(OC2=CC([C@]3([H])CC(C=C4)=CC=C4O5)=C(CCN3C)C=C2OC)C([C@@]6([H])CC7=CC=C(O)C5=C7)=C(CCN6C)C=C1OC	https://www.medchemexpress.com/Berbamine.html	Launched		92.0	C18	K22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0714	10.0	mM	262.0	DMSO	608.288637	22	K	pluskal_fda_drugs_5005_K22_id
1925	HY-B0974	HYCPK40907	E17	HYCPK40907	92z	418.0	2.0	I34	907.0	E17	132-92-3	Methicillin (sodium salt)	Meticillin (sodium)	402.40	Antibiotic; Bacterial	Anti-infection	Methicillin sodium salt (Meticillin sodium) is a β-lactam, semi-synthetic antibiotic related to penicillin antibiotic. Methicillin sodium salt inhibits penicillin-binding proteins involved in the synthesis of peptidoglycan. Methicillin sodium salt inhibits S. aureus with a MIC value of 2.1 μg/mL. Methicillin sodium salt can be used for the research of inflammation[1][2].	Sodium	C17H19N2NaO6S	98633.0	DMSO : 125 mg/mL (310.64 mM; Need ultrasonic); H2O : 100 mg/mL (248.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@H](N1C2=O)C(C)(S[C@@]1([C@@H]2NC(C3=C(C=CC=C3OC)OC)=O)[H])C)O[Na]	https://www.medchemexpress.com/Methicillin-sodium-salt.html	Launched		92.0	I34	K22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0974	10.0	mM	262.0	DMSO	380.104207	22	K	pluskal_fda_drugs_5005_K22_id
2073	HY-15834A	HYCPK40908	B07	HYCPK40908	92z	157.0	3.0	D13	908.0	B07	144143-96-4	Eprosartan (mesylate)	SKF-108566J	520.62	Angiotensin Receptor	GPCR/G Protein	Eprosartan mesylate (SKF-108566J) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan mesylate binds angiotensin II receptor with IC50s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively[1].	Mesylate	C24H28N2O7S2	10966.0	DMSO : ≥ 48 mg/mL (92.20 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	OC(/C(CC1=CC=CS1)=C/C2=CN=C(CCCC)N2CC3=CC=C(C(O)=O)C=C3)=O.CS(=O)(O)=O	https://www.medchemexpress.com/Eprosartan-mesylate.html	Launched		92.0	D13	K22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15834A	10.0	mM	262.0	DMSO	424.145678	22	K	pluskal_fda_drugs_5005_K22_id
2104	HY-B0215	HYCPK40908	A09	HYCPK40908	92z	65.0	3.0	B17	908.0	A09	616-91-1	Acetylcysteine	N-Acetylcysteine; N-Acetyl-L-cysteine; NAC	163.19486	Apoptosis; Endogenous Metabolite; Ferroptosis; Influenza Virus; Reactive Oxygen Species	Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor[1]. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases[5]. Acetylcysteine induces cell apoptosis[2][3]. Acetylcysteine also has anti-influenza virus activities[7].	Free Acid	C5H9NO3S	85220.0	H2O : 163 mg/mL (998.84 mM; ultrasonic and adjust pH to 7 with NaOH); DMSO : ≥ 100 mg/mL (612.78 mM)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease; Cancer	SC[C@@H](C(O)=O)NC(C)=O	https://www.medchemexpress.com/Acetylcysteine.html	Launched		92.0	B17	K22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0215	10.0	mM	262.0	DMSO	163.030314	22	K	pluskal_fda_drugs_5005_K22_id
1386	HY-B2158	HYCPK40906	G04	HYCPK40906	92z	583.0	1.0	M7	906.0	G04	569-57-3	Chlorotrianisene		380.86	COX; Estrogen Receptor/ERR	Immunology/Inflammation; Others	Chlorotrianisene is a long-acting non-steroidal estrogen and an orally active estrogen receptor modulator. Chlorotrianisene exhibits antiestrogenic activity. Chlorotrianisene potently inhibits the enzyme COX-1 and inhibits platelet aggregation in whole blood[1][2][3].		C23H21ClO3	91093.0	DMSO : 100 mg/mL (262.56 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cardiovascular Disease	Cl/C(C1=CC=C(OC)C=C1)=C(C2=CC=C(OC)C=C2)/C3=CC=C(OC)C=C3	https://www.medchemexpress.com/chlorotrianisene.html	Launched		92.0	M7	L3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2158	10.0	mM	267.0	DMSO	380.117922	3	L	pluskal_fda_drugs_5005_L3_id
1521	HY-14929A	HYCPK40906	D11	HYCPK40906	92z	309.0	1.0	G21	906.0	D11	75172-81-5	Migalastat (hydrochloride)	GR181413A	199.63	Others	Others	Migalastat hydrochloride (GR181413A) is a potent and competitive inhibitor of α-galactosidase A (α-Gal A) with an IC50 of 0.04 μM for human α-Gal A.	Hydrochloride	C6H14ClNO4	67103.0	H2O : ≥ 200 mg/mL (1001.85 mM)	DMSO Solution	10mM  * 100uL	Others	O[C@H]1[C@@H](CO)NC[C@H](O)[C@H]1O.Cl	https://www.medchemexpress.com/Migalastat__hydrochloride_.html	Launched		92.0	G21	L3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14929A	10.0	mM	267.0	DMSO	163.084458	3	L	pluskal_fda_drugs_5005_L3_id
1577	HY-B1696	HYCPK40906	L14	HYCPK40906	92z	1083.0	1.0	W27	906.0	L14	6014-30-8	Methyldopate		239.27	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Methyldopate is an ethyl ester prodrug of α-Methyldopa (α-MD; HY-B0225). Methyldopa (L-(-)-α-Methyldopa) is an α-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopate has the potential for severe hypertension research [1].		C12H17NO4	217531.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CCOC([C@@](C)(N)CC1=CC(O)=C(C=C1)O)=O	https://www.medchemexpress.com/methyldopate.html	Launched		92.0	W27	L3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1696	10.0	mM	267.0	DMSO	239.115758	3	L	pluskal_fda_drugs_5005_L3_id
1724	HY-14281	HYCPK40907	O03	HYCPK40907	92z	1350.0	2.0	AC6	907.0	O03	13647-35-3	Trilostane	Win 24540	329.43	Others	Others	"Trilostane(Win 24540; Modrastane) is an inhibitor of 3 β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.
IC50 value:
Target: 3 β-HSD
Trilostane is an inhibitor of 3 β-hydroxysteroid dehydrogenase (3-β-HSD or delta 5-delta 4-isomerase), an essential enzyme for the biosynthesis of all classes of hormonal steroids. It has been used in the treatment of Cushing′s syndrome for stopping the production of cortisol, and is currently approved for dogs in the US, but is still a human drug in the UK and other countries. It is being investigated as a possible treatment for both breast cancer and prostate cancer to prevent the synthesis of estrogens and androgens from endogenous precursors. It has also been used to inhibit endogenous production of progesterone in research studies."	Free Base	C20H27NO3	81117.0	DMSO : ≥ 56 mg/mL (169.99 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	OC1=C(C#N)C[C@@]2(C)[C@@]3(CC[C@]4([H])[C@]2([H])CC[C@@]5(C)[C@@]4([H])CC[C@@H]5O)[C@@H]1O3	https://www.medchemexpress.com/Trilostane.html	Launched		92.0	AC6	L3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14281	10.0	mM	267.0	DMSO	329.199094	3	L	pluskal_fda_drugs_5005_L3_id
1829	HY-76260	HYCPK40907	M10	HYCPK40907	92z	1172.0	2.0	Y20	907.0	M10	122547-49-3	Faropenem sodium		307.30	Antibiotic; Bacterial	Anti-infection	Faropenem sodium is an orally bioavailable penem antibiotic which can efficiently kill Mycobacterium tuberculosis.	Sodium	C12H14NNaO5S	28914.0	H2O : 100 mg/mL (325.41 mM; Need ultrasonic); DMSO : 25 mg/mL (81.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@]([H])1[C@@H](C)O)N([C@@H]1S2)C(C(O[Na])=O)=C2[C@@H]3OCCC3	https://www.medchemexpress.com/Faropenem_sodium.html	Launched		92.0	Y20	L3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-76260	10.0	mM	267.0	DMSO	285.067094	3	L	pluskal_fda_drugs_5005_L3_id
1975	HY-117743	HYCPK40907	K20	HYCPK40907	92z	1000.0	2.0	U40	907.0	K20	133040-01-4	Eprosartan	SKF-108566J (free base)	424.51	Angiotensin Receptor	GPCR/G Protein	Eprosartan (SKF-108566J free base) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan binds angiotensin II receptor with IC50s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively [1].		C23H24N2O4S	104802.0	DMSO : 125 mg/mL (294.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CC=C(C=C1)CN2C(/C=C(CC3=CC=CS3)/C(O)=O)=CN=C2CCCC)O	https://www.medchemexpress.com/eprosartan.html	Launched		92.0	U40	L3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-117743	10.0	mM	267.0	DMSO	424.145678	3	L	pluskal_fda_drugs_5005_L3_id
1988	HY-13858A	HYCPK40907	H21	HYCPK40907	92z	714.0	2.0	O42	907.0	H21	1035979-44-2	Sarecycline (hydrochloride)		523.96	Antibiotic; Bacterial; DNA/RNA Synthesis	Anti-infection; Cell Cycle/DNA Damage	Sarecycline hydrochloride is a narrow-spectrum tetracycline-class antibiotic. Sarecycline hydrochloride possesses anti-inflammatory properties and potent activity against Gram-positive bacteria, including activity against multiple strains of Cutibacterium acnes. Sarecycline hydrochloride interferes with tRNA accommodation and tethers mRNA to the 70S ribosome[1][2][3].	Hydrochloride	C24H30ClN3O8	213723.0	DMSO : 100 mg/mL (190.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[H]Cl.O[C@]12[C@](C[C@@]3([H])C(C(C4=C(O)C=CC(CN(C)OC)=C4C3)=O)=C2O)([H])[C@@H](C(O)=C(C1=O)C(N)=O)N(C)C	https://www.medchemexpress.com/sarecycline-hydrochloride.html	Launched		92.0	O42	L3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13858A	10.0	mM	267.0	DMSO	487.195465	3	L	pluskal_fda_drugs_5005_L3_id
2444	HY-N0148	HYCPK40909	H04	HYCPK40909	92z	728.0	4.0	P8	909.0	H04	153-18-4	Rutin	Rutoside; Quercetin 3-O-rutinoside	610.52	Amyloid-β; Apoptosis; Autophagy; Endogenous Metabolite	Apoptosis; Autophagy; Metabolic Enzyme/Protease; Neuronal Signaling	Rutin (Rutoside) is a flavonoid found in many plants and shows a wide range of biological activities including anti-inflammatory, antidiabetic, antioxidant, neuroprotective, nephroprotective, hepatoprotective and reducing Aβ oligomer activities. Rutin can cross the blood brain barrier. Rutin attenuates vancomycin-induced renal tubular cell apoptosis via suppression of apoptosis, mitochondrial dysfunction, and oxidative stress[1][2][3].	Free Base	C27H30O16	20442.0	DMSO : 50 mg/mL (81.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO[C@H]3[C@@H]([C@@H]([C@H]([C@H](C)O3)O)O)O)O2)O)O)O)=C(C4=CC=C(O)C(O)=C4)OC5=CC(O)=CC(O)=C15	https://www.medchemexpress.com/Rutin.html	Launched		92.0	P8	L3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0148	10.0	mM	267.0	DMSO	610.153385	3	L	pluskal_fda_drugs_5005_L3_id
49	HY-B0180	HYCPK40899	C05	HYCPK40909	92z	272.0	4.0	F32	909.0	C16	99011-02-6	Imiquimod	R 837	240.30	Autophagy; HSV; SARS-CoV; Toll-like Receptor (TLR)	Anti-infection; Autophagy; Immunology/Inflammation	Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19[1][2].	Free Base	C14H16N4	15858.0	DMSO : 2 mg/mL (8.32 mM; ultrasonic and warming and heat to 70°C); H2O : 2.64 mg/mL (10.99 mM; ultrasonic and adjust pH to 2 with HCl)	DMSO Solution	2mM  * 100uL	Cancer; Infection; Inflammation/Immunology	NC1=NC2=CC=CC=C2C3=C1N=CN3CC(C)C	https://www.medchemexpress.com/Imiquimod.html	Launched		92.0	F32	L4	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0180	2.0	mM	268.0	DMSO	240.137497	4	L	pluskal_fda_drugs_5005_L4_id
1384	HY-B0135A	HYCPK40906	E04	HYCPK40906	92z	391.0	1.0	I7	906.0	E04	41733-55-5	Furosemide (sodium)		352.73	GABA Receptor; NKCC	Membrane Transporter/Ion Channel; Neuronal Signaling	Furosemide sodium is a potent and orally active inhibitor of Na+/K+/2Cl-?(NKCC) cotransporter, NKCC1 and NKCC2[1].?Furosemide sodium is also a GABAA?receptors antagonist and displays 100-fold selectivity for?α6-containing receptors than?α1-containing receptors. Furosemide sodium acts as a loop diuretic and used for the study of congestive heart failure, hypertension and edema[2].	Sodium	C12H10ClN2NaO5S	41001.0	DMSO : ≥ 150 mg/mL (425.25 mM); H2O : 100 mg/mL (283.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease	O=C(C1=CC(S(=O)(N)=O)=C(C=C1NCC2=CC=CO2)Cl)O[Na]	https://www.medchemexpress.com/Furosemide-sodium.html	Launched		92.0	I7	L4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0135A	10.0	mM	268.0	DMSO	330.00772	4	L	pluskal_fda_drugs_5005_L4_id
1492	HY-N0115	HYCPK40906	G09	HYCPK40906	92z	593.0	1.0	M17	906.0	G09	62499-27-8	Gastrodin	Gastrodine	286.28	Others	Others	Gastrodin, a main constituent of a Chinese herbal medicine Tianma, has been known to display anti-inflammatory effects. Gastrodin, has long been used for treating dizziness, epilepsy, stroke and dementia.	Free Base	C13H18O7	26958.0	DMSO : ≥ 100 mg/mL (349.31 mM); H2O : 100 mg/mL (349.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	O[C@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)[C@@H]1OC2=CC=C(CO)C=C2	https://www.medchemexpress.com/Gastrodin.html	Launched		92.0	M17	L4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0115	10.0	mM	268.0	DMSO	286.105253	4	L	pluskal_fda_drugs_5005_L4_id
1628	HY-16106	HYCPK40906	O17	HYCPK40906	92z	1377.0	1.0	AC33	906.0	O17	1207456-01-6	Talazoparib	BMN-673; LT-673	380.35	PARP	Cell Cycle/DNA Damage; Epigenetics	Talazoparib (BMN-673) is a highly potent, orally active PARP1/2 inhibitor.Talazoparib inhibits PARP1 and PARP2 enzyme activity with Kis of 1.2 nM and 0.87 nM, respectively. Talazoparib has antitumor activity[1].	Free Base	C19H14F2N6O	8329.0	DMSO : 25 mg/mL (65.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NN=C2C3=C1C=C(F)C=C3N[C@H](C4=CC=C(F)C=C4)[C@H]2C5=NC=NN5C	https://www.medchemexpress.com/BMN-673.html	Launched		92.0	AC33	L4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16106	10.0	mM	268.0	DMSO	380.119716	4	L	pluskal_fda_drugs_5005_L4_id
1893	HY-15337	HYCPK40907	E15	HYCPK40907	92z	414.0	2.0	I30	907.0	E15	520-26-3	Hesperidin	Hesperetin 7-rutinoside	610.56	Apoptosis; Autophagy; Endogenous Metabolite; Reactive Oxygen Species	Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Hesperidin (Hesperetin 7-rutinoside), a flavanone glycoside, is isolated from citrus fruits. Hesperidin has numerous biological properties, such as decreasing inflammatory mediators and exerting significant antioxidant effects. Hesperidin also exhibits antitumor and antiallergic activities[1][2].	Free Base	C28H34O15	21115.0	DMSO : ≥ 33 mg/mL (54.05 mM)	DMSO Solution	10mM  * 100uL	Cancer	OC1=C(OC)C=CC([C@@H]2CC(C3=C(C=C(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)C=C3O)O2)=O)=C1	https://www.medchemexpress.com/Hesperidin.html	Launched		92.0	I30	L4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15337	10.0	mM	268.0	DMSO	610.18977	4	L	pluskal_fda_drugs_5005_L4_id
2026	HY-109099	HYCPK40908	N03	HYCPK40908	92z	1301.0	3.0	AB5	908.0	N03	1513857-77-6	Pemigatinib	INCB054828	487.50	FGFR	Protein Tyrosine Kinase/RTK	Pemigatinib (INCB054828) is an orally active, selective FGFR inhibitor with IC50s of 0.4 nM, 0.5 nM, 1.2 nM, 30 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively. Pemigatinib has the potential for cholangiocarcinoma[1][2].	Free Base	C24H27F2N5O4	80338.0	DMSO : 25 mg/mL (51.28 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	CCN(C(N(C(C(F)=C(OC)C=C1OC)=C1F)C2)=O)C(C2=CN3)=C4C3=NC(CN5CCOCC5)=C4	https://www.medchemexpress.com/Pemigatinib.html	Launched		92.0	AB5	L4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109099	10.0	mM	268.0	DMSO	487.203111	4	L	pluskal_fda_drugs_5005_L4_id
2246	HY-76657A	HYCPK40908	G18	HYCPK40908	92z	659.0	3.0	N35	908.0	G18	170098-38-1	Alvimopan (dihydrate)	ADL 8-2698 dihydrate; LY 246736 dihydrate	460.56314	Opioid Receptor	GPCR/G Protein; Neuronal Signaling	Alvimopan dihydrate (ADL 8-2698 dihydrate) is a potent, selective, orally active and reversible μ-opioid receptor antagonist, with an IC50 of 1.7 nM. Alvimopan dihydrate has selectivity for μ-opioid receptor (Ki=0.47 nM) over κ- and δ-opioid receptors (Kis=100, 12 nM, respectively). Alvimopan dihydrate can be used for the research of postoperative ileus[1][2][3].	Free Acid	C25H36N2O6	9492.0	DMSO : 33.33 mg/mL (72.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	OC1=CC=CC([C@@]2(C)[C@@H](C)CN(C[C@H](CC3=CC=CC=C3)C(NCC(O)=O)=O)CC2)=C1.O.O	https://www.medchemexpress.com/alvimopan-dihydrate.html	Launched		92.0	N35	L4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-76657A	10.0	mM	268.0	DMSO	424.236208	4	L	pluskal_fda_drugs_5005_L4_id
2532	HY-B0276	HYCPK40909	G10	HYCPK40909	92z	644.0	4.0	N20	909.0	G10	536-33-4	Ethionamide	2-Ethylthioisonicotinamide	166.24	Antibiotic; Bacterial	Anti-infection	"Ethionamide(2-ethylthioisonicotinamide) is an antibiotic used in the treatment of tuberculosis.
Target: Antibacterial
Ethionamide is a second-line antitubercular agent that inhibits mycolic acid synthesis. It also may be used for treatment of leprosy. Ethionamide is a prodrug. It is activated by the enzyme EthA, a mono-oxygenase in Mycobacterium tuberculosis, and binds NAD+ to form an adduct which inhibits InhA in the same way as isoniazid. Expression of the ethA gene is controlled by EthR, a transcriptional repressor. It is understood that improving ethA expression will increase the efficacy of ethionamide and so EthR inhibitors are of great interest to co-drug developers. The action may be through disruption of mycolic acid [1, 2]."	Free Base	C8H10N2S	16401.0	DMSO : 250 mg/mL (1503.85 mM; Need ultrasonic); H2O : 0.67 mg/mL (4.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	S=C(C1=CC(CC)=NC=C1)N	https://www.medchemexpress.com/Ethionamide.html	Launched		92.0	N20	L4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0276	10.0	mM	268.0	DMSO	166.056469	4	L	pluskal_fda_drugs_5005_L4_id
1446	HY-16767	HYCPK40907	H14	HYCPK40907	92z	700.0	2.0	O28	907.0	H14	1338225-97-0	Doravirine	MK-1439	425.75	HIV; Reverse Transcriptase	Anti-infection	Doravirine (MK-1439) is a highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor with IC50s of  4.5 nM, 5.5 nM and 6.1 nM against the wild type and K103N and Y181C reverse transcriptase mutants, respectively[1].	Free Base	C17H11ClF3N5O3	22166.0	DMSO : 100 mg/mL (234.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	N#CC1=CC(OC2=C(C(F)(F)F)C=CN(CC(N3C)=NNC3=O)C2=O)=CC(Cl)=C1	https://www.medchemexpress.com/Doravirine.html	Launched		92.0	O28	L5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16767	10.0	mM	269.0	DMSO	425.050252	5	L	pluskal_fda_drugs_5005_L5_id
1525	HY-108413	HYCPK40906	H11	HYCPK40906	92z	693.0	1.0	O21	906.0	H11	1373431-65-2	Talazoparib tosylate	BMN 673ts	552.55	PARP	Cell Cycle/DNA Damage; Epigenetics	Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1.	Tosylate	C26H22F2N6O4S	29997.0	DMSO : ≥ 108 mg/mL (195.46 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NN=C2C3=C1C=C(F)C=C3N[C@H](C4=CC=C(F)C=C4)[C@H]2C5=NC=NN5C.O=S(C6=CC=C(C)C=C6)(O)=O	https://www.medchemexpress.com/Talazoparib_tosylate.html	Launched		92.0	O21	L5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108413	10.0	mM	269.0	DMSO	380.119716	5	L	pluskal_fda_drugs_5005_L5_id
1526	HY-N0159	HYCPK40906	I11	HYCPK40906	92z	789.0	1.0	Q21	906.0	I11	552-41-0	Paeonol		166.17	Autophagy; Monoamine Oxidase	Autophagy; Neuronal Signaling	Paeonol is an active extraction from the root of Paeonia suffruticosa, Paeonol inhibits MAO-A and MAO-B with IC50 of 54.6 μM and 42.5 μM, respectively.	Free Base	C9H10O3	23776.0	DMSO : ≥ 38 mg/mL (228.68 mM); H2O : 1 mg/mL (6.02 mM; Need ultrasonic); Ethanol : 50 mg/mL (300.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC(C1=CC=C(OC)C=C1O)=O	https://www.medchemexpress.com/Paeonol.html	Launched		92.0	Q21	L5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0159	10.0	mM	269.0	DMSO	166.062994	5	L	pluskal_fda_drugs_5005_L5_id
1619	HY-B0180A	HYCPK40906	F17	HYCPK40906	92z	513.0	1.0	K33	906.0	F17	99011-78-6	Imiquimod (hydrochloride)	R 837 (hydrochloride)	276.76	Autophagy; HSV; SARS-CoV; Toll-like Receptor (TLR)	Anti-infection; Autophagy; Immunology/Inflammation	Imiquimod hydrochloride (R 837 hydrochloride), an immune response modifier, is a selective toll like receptor 7 (TLR7) agonist. Imiquimod hydrochloride exhibits antiviral and antitumor effects in vivo. Imiquimod hydrochloride can be used for the research of external genital, perianal warts, cancer and COVID-19[1][2].	Hydrochloride	C14H17ClN4	92204.0	DMSO : 8 mg/mL (28.91 mM; ultrasonic and warming and heat to 50°C); Ethanol : 3.85 mg/mL (13.91 mM; Need ultrasonic); H2O : 4.8 mg/mL (17.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	NC1=NC2=CC=CC=C2C3=C1N=CN3CC(C)C.Cl	https://www.medchemexpress.com/imiquimod-hydrochloride.html	Launched		92.0	K33	L5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0180A	10.0	mM	269.0	DMSO	240.137497	5	L	pluskal_fda_drugs_5005_L5_id
1821	HY-B0253	HYCPK40907	E10	HYCPK40907	92z	404.0	2.0	I20	907.0	E10	36322-90-4	Piroxicam	CP-16171	331.35	COX	Immunology/Inflammation	Piroxicam (CP-16171) is a non-steroidal anti-inflammatory drugs, acts as a COX inhibitor, with IC50s of 47, 25 μM for human monocyte COX-1 and COX-2, respectively.	Free Base	C15H13N3O4S	14738.0	DMSO : 50 mg/mL (150.90 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(C1=C(O)C2=CC=CC=C2S(N1C)(=O)=O)NC3=NC=CC=C3	https://www.medchemexpress.com/piroxicam.html	Launched		92.0	I20	L5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0253	10.0	mM	269.0	DMSO	331.062677	5	L	pluskal_fda_drugs_5005_L5_id
2103	HY-17505	HYCPK40908	P08	HYCPK40908	92z	1503.0	3.0	AF15	908.0	P08	145040-37-5	Candesartan Cilexetil	TCV-116	610.66	Angiotensin Receptor; Apoptosis	Apoptosis; GPCR/G Protein	"Candesartan Cilexetil (TCV-116) is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Target: Type-1 angiotensin II receptor
Candesartan is generally well tolerated and significantly reduced cardiovascular deaths and hospital admissions for heart failure. Ejection fraction or treatment at baseline did not alter these effects [1]. In rats, TCV-116 inhibited the pressor responses to Ang I, Ang II, and Ang III without an effect on the bradykinin (BK)-induced depressor response. In SHR, the antihypertensive effect of TCV-116 (10 mg/kg) was larger than the maximum antihypertensive effect of enalapril and was not intensified by combination with enalapril. TCV-116 is more effective than enalapril in reducing blood pressure in SHR and 1K, 1C-HR, and that the BK- and/or prostaglandin-potentiating effect of enalapril contributes little to its antihypertensive mechanism in SHR [2]."	Free Base	C33H34N6O6	15456.0	DMSO : ≥ 50 mg/mL (81.88 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C5=NNN=N5)C=C3)=CC=C1)OC(OC(OC6CCCCC6)=O)C	https://www.medchemexpress.com/Candesartan-Cilexetil.html	Launched		92.0	AF15	L5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17505	10.0	mM	269.0	DMSO	610.253983	5	L	pluskal_fda_drugs_5005_L5_id
2463	HY-109108A	HYCPK40909	K05	HYCPK40909	92z	1018.0	4.0	V10	909.0	K05	1809336-93-3	Valemetostat (tosylate)	DS-3201 (tosylate)	660.22	Histone Methyltransferase	Epigenetics	Valemetostat tosylate (DS-3201 tosylate), a first-in-class EZH1/2 dual inhibitor. Valemetostat tosylate can be used for the research of relapsed/refractory peripheral T-cell lymphoma[1].	Tosylate	C33H42ClN3O7S	51716.0	DMSO : 100 mg/mL (151.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=S(C1=CC=C(C)C=C1)(O)=O.CC2=C(O[C@@](C)([C@]3([H])CC[C@@H](N(C)C)CC3)O4)C4=C(Cl)C=C2C(NCC(C5=O)=C(C=C(C)N5)C)=O	https://www.medchemexpress.com/valemetostat-tosylate.html	Launched		92.0	V10	L5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109108A	10.0	mM	269.0	DMSO	487.223784	5	L	pluskal_fda_drugs_5005_L5_id
2486	HY-17423A	HYCPK40909	B07	HYCPK40909	92z	158.0	4.0	D14	909.0	B07	188062-50-2	Abacavir (sulfate)	Abacavir Hemisulfate; ABC sulfate	433.45	Apoptosis; HIV; Reverse Transcriptase; Telomerase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Abacavir sulfate (Abacavir Hemisulfate) is a competitive, orally active nucleoside reverse transcriptase inhibitor. Abacavir sulfate can inhibits the replication of HIV. Abacavir sulfate shows anticancer activity in prostate cancer cell lines. Abacavir sulfate can trespass the blood-brain-barrier and suppresses telomerase activity[1][2][3].	Sulfate	C14H18N6O.1/2H2O4S	27772.0	DMSO : 50 mg/mL (115.35 mM; Need ultrasonic); H2O : 33.33 mg/mL (76.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(O)(O)=O.NC1=NC(NC2CC2)=C3N=CN([C@H]4C=C[C@@H](CO)C4)C3=N1.[1/2]	https://www.medchemexpress.com/Abacavir-sulfate.html	Launched		92.0	D14	L5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17423A	10.0	mM	269.0	DMSO	286.154209	5	L	pluskal_fda_drugs_5005_L5_id
1466	HY-B2078A	HYCPK40908	B11	HYCPK40908	92z	165.0	3.0	D21	908.0	B11	10402-53-6	Eprazinone (dihydrochloride)		453.44	Neurokinin Receptor	GPCR/G Protein; Neuronal Signaling	Eprazinone dihydrochloride is a gent with mucolytic, secretolytic, antitussive, and bronchial antispasmodic properties. Eprazinone dihydrochloride is a neurokinin 1 receptor (NK1R) ligand. Eprazinone dihydrochloride has the potential for chronic bronchitis treatment that improved pulmonary function and arterial partial pressure of oxygen[1][2].	Hydrochloride	C24H34Cl2N2O2	64004.0	H2O : ≥ 25 mg/mL (55.13 mM); DMSO : 6.25 mg/mL (13.78 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=CC=C1)C(C)CN2CCN(CC(OCC)C3=CC=CC=C3)CC2.Cl[H].Cl[H]	https://www.medchemexpress.com/eprazinone-dihydrochloride.html	Launched		92.0	D21	L6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2078A	10.0	mM	270.0	DMSO	380.246378	6	L	pluskal_fda_drugs_5005_L6_id
1549	HY-B0442	HYCPK40906	P12	HYCPK40906	92z	1463.0	1.0	AE23	906.0	P12	224785-90-4	Vardenafil		488.60	Endogenous Metabolite; Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Vardenafil is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4[1]. Vardenafil competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels[2]. Vardenafil can be used for the research of erectile dysfunction, hepatitis, diabetes[1]-[6].	Free Base	C23H32N6O4S	151821.0	DMSO : 25 mg/mL (51.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Metabolic Disease; Inflammation/Immunology	CCCC1=NC(C)=C2N1N=C(C(C=C(S(=O)(N3CCN(CC)CC3)=O)C=C4)=C4OCC)NC2=O	https://www.medchemexpress.com/Vardenafil.html	Launched		92.0	AE23	L6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0442	10.0	mM	270.0	DMSO	488.220575	6	L	pluskal_fda_drugs_5005_L6_id
1607	HY-B0612A	HYCPK40906	J16	HYCPK40906	92z	895.0	1.0	S31	906.0	J16	132866-11-6	Lercanidipine (hydrochloride)		648.19	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Lercanidipine hydrochloride is a lipophilic third-generation dihydropyridine-calcium channel blocker (DHP-CCB). Lercanidipine hydrochloride has long lasting antihypertensive action and reno-protective effect[1][2][3].	Hydrochloride	C36H42ClN3O6	16201.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 50 mg/mL (77.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OC(C)(C)CN(CCC(C3=CC=CC=C3)C4=CC=CC=C4)C.[H]Cl	https://www.medchemexpress.com/Lercanidipine-hydrochloride.html	Launched		92.0	S31	L6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0612A	10.0	mM	270.0	DMSO	611.299536	6	L	pluskal_fda_drugs_5005_L6_id
1640	HY-B0882	HYCPK40906	K18	HYCPK40906	92z	995.0	1.0	U35	906.0	K18	116-38-1	Edrophonium (chloride)		201.69	Cholinesterase (ChE)	Neuronal Signaling	Edrophonium chloride is a readily reversible acetylcholinesterase inhibitor; prevents breakdown of the neurotransmitter acetylcholine and acts by competitively inhibiting the enzyme acetylcholinesterase, mainly at the neuromuscular junction.	Chloride	C10H16ClNO	16562.0	DMSO : 62.5 mg/mL (309.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+](C)(CC)C1=CC=CC(O)=C1.[Cl-]	https://www.medchemexpress.com/Edrophonium-chloride.html	Launched		92.0	U35	L6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0882	10.0	mM	270.0	DMSO	166.122641	6	L	pluskal_fda_drugs_5005_L6_id
1684	HY-B0262	HYCPK40906	G21	HYCPK40906	92z	617.0	1.0	M41	906.0	G21	532-03-6	Methocarbamol		241.2405	Sodium Channel	Membrane Transporter/Ion Channel	Methocarbamol is an orally active central muscle relaxant and blocks muscular Nav1.4 channel. Methocarbamol reversibly affects voltage dependence of inactivation of Nav1.4 channel. Methocarbamol has the potential for muscle spasms and pain syndromes research[1][2][3].	Free Base	C11H15NO5	16036.0	DMSO : ≥ 100 mg/mL (414.52 mM); H2O : 4 mg/mL (16.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC(COC1=CC=CC=C1OC)COC(N)=O	https://www.medchemexpress.com/Methocarbamol.html	Launched		92.0	M41	L6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0262	10.0	mM	270.0	DMSO	241.095023	6	L	pluskal_fda_drugs_5005_L6_id
1957	HY-18300	HYCPK40907	E19	HYCPK40907	92z	422.0	2.0	I38	907.0	E19	1206161-97-8	Filgotinib	GLPG0634	425.50	JAK	Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Filgotinib (GLPG0634) is a selective and orally active JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.	Free Base	C21H23N5O3S	22566.0	DMSO : 25 mg/mL (58.75 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1CC1)NC2=NN3C(C4=CC=C(CN5CCS(CC5)(=O)=O)C=C4)=CC=CC3=N2	https://www.medchemexpress.com/GLPG0634.html	Launched		92.0	I38	L6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18300	10.0	mM	270.0	DMSO	425.152161	6	L	pluskal_fda_drugs_5005_L6_id
2183	HY-W040073	HYCPK40908	D14	HYCPK40908	92z	363.0	3.0	H27	908.0	D14	23256-30-6	Nifurtimox		287.30	Lactate Dehydrogenase; Parasite	Anti-infection; Metabolic Enzyme/Protease	Nifurtimox, an antiprotozoal agent, which is generally used for the treatment of infections with Trypanosoma cruzi, has been used in the therapy of neuroblastoma. Nifurtimox affects enzyme activity of lactate dehydrogenase (LDH).	Free Base	C10H13N3O5S	39695.0	DMSO : 150 mg/mL (522.10 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=S1(CC(C)N(/N=C/C2=CC=C([N+]([O-])=O)O2)CC1)=O	https://www.medchemexpress.com/Nifurtimox.html	Launched		92.0	H27	L6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W040073	10.0	mM	270.0	DMSO	287.057592	6	L	pluskal_fda_drugs_5005_L6_id
2456	HY-103093	HYCPK40909	D05	HYCPK40909	92z	346.0	4.0	H10	909.0	D05	26615-21-4	Zotepine		331.86	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM and 8 nM, respectively. Zotepine exhibits antidepressive and anxiolytic effects in vivo[1][2].		C18H18ClNOS	116841.0	DMSO : 25 mg/mL (75.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	ClC1=CC=C(SC2=CC=CC=C2C=C3OCCN(C)C)C3=C1	https://www.medchemexpress.com/zotepine.html	Launched		92.0	H10	L6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-103093	10.0	mM	270.0	DMSO	331.079763	6	L	pluskal_fda_drugs_5005_L6_id
54	HY-13910	HYCPK40899	H05	HYCPK40909	92z	752.0	4.0	P32	909.0	H16	147127-20-6	Tenofovir	GS 1278; PMPA	287.21	HBV; HIV; Reverse Transcriptase	Anti-infection	Tenofovir (GS 1278) is a nucleotide reverse transcriptase inhibitor to treat HIV and chronic Hepatitis B (HBV)[1].	Free Acid	C9H14N5O4P	11787.0	H2O : 2 mg/mL (6.96 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection	C[C@@H](OCP(O)(O)=O)CN1C=NC2=C(N)N=CN=C12	https://www.medchemexpress.com/tenofovir.html	Launched		92.0	P32	L7	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13910	2.0	mM	271.0	DMSO	287.078341	7	L	pluskal_fda_drugs_5005_L7_id
1575	HY-B0442A	HYCPK40906	J14	HYCPK40906	92z	891.0	1.0	S27	906.0	J14	224785-91-5	Vardenafil (hydrochloride)		525.06	Endogenous Metabolite; Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Vardenafil hydrochloride is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil hydrochloride shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4[1]. Vardenafil hydrochloride competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels[2]. Vardenafil hydrochloride can be used for the research of erectile dysfunction, hepatitis, diabetes[1]-[6].	Hydrochloride	C23H33ClN6O4S	11636.0	DMSO : 100 mg/mL (190.45 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (190.45 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Metabolic Disease; Inflammation/Immunology	CCCC1=NC(C)=C2N1N=C(C(C=C(S(=O)(N3CCN(CC)CC3)=O)C=C4)=C4OCC)NC2=O.Cl	https://www.medchemexpress.com/Vardenafil-hydrochloride.html	Launched		92.0	S27	L7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0442A	10.0	mM	271.0	DMSO	488.220575	7	L	pluskal_fda_drugs_5005_L7_id
1701	HY-B0411	HYCPK40906	H22	HYCPK40906	92z	715.0	1.0	O43	906.0	H22	57808-66-9	Domperidone	R33812	425.91	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Domperidone (R33812) is an orally active and selective dopamine-2 receptor antagonist. Domperidone acts as an antiemetic and a prokinetic agent through its effects on the chemoreceptor trigger zone and motor function of the stomach and small intestine[1].	Free Base	C22H24ClN5O2	11944.0	DMSO : 50 mg/mL (117.40 mM; Need ultrasonic); H2O : 0.67 mg/mL (1.57 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1NC2=CC(Cl)=CC=C2N1C3CCN(CCCN4C5=CC=CC=C5NC4=O)CC3	https://www.medchemexpress.com/domperidone.html	Launched		92.0	O43	L7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0411	10.0	mM	271.0	DMSO	425.161853	7	L	pluskal_fda_drugs_5005_L7_id
1750	HY-B1307	HYCPK40907	N05	HYCPK40907	92z	1258.0	2.0	AA10	907.0	N05	61-80-3	Zoxazolamine		168.58	Cytochrome P450	Metabolic Enzyme/Protease	Zoxazolamine is widely used for a pharmacologic test that serves as a convenient indicator of changes in cytochrome P-450 activity in rodents.	Free Base	C7H5ClN2O	29585.0	DMSO : ≥ 100 mg/mL (593.19 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC1=NC2=CC(Cl)=CC=C2O1	https://www.medchemexpress.com/Zoxazolamine.html	Launched		92.0	AA10	L7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1307	10.0	mM	271.0	DMSO	168.00904	7	L	pluskal_fda_drugs_5005_L7_id
1807	HY-D0844	HYCPK40907	G09	HYCPK40907	92z	594.0	2.0	M18	907.0	G09	27025-41-8	Glutathione oxidized	L-Glutathione oxidized; GSSG; Oxiglutatione	612.63	Endogenous Metabolite; Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Glutathione oxidized (GSSG) is produced by the oxidation of glutathione. Detoxification of reactive oxygen species is accompanied by production of glutathione oxidized. Glutathione oxidized can be used for the research of sickle cells and erythrocytes[1].	Free Acid	C20H32N6O12S2	150442.0	H2O : 250 mg/mL (408.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(NCC(O)=O)[C@H](CSSC[C@@H](C(NCC(O)=O)=O)NC(CC[C@H](N)C(O)=O)=O)NC(CC[C@H](N)C(O)=O)=O	https://www.medchemexpress.com/Glutathione_oxidized.html	Launched		92.0	M18	L7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0844	10.0	mM	271.0	DMSO	612.151962	7	L	pluskal_fda_drugs_5005_L7_id
1938	HY-B0574	HYCPK40907	B18	HYCPK40907	92z	132.0	2.0	C36	907.0	B18	61-68-7	Mefenamic acid		241.29	COX	Immunology/Inflammation	Mefenamic acid is a non-steroidal anti-inflammatory agent, acting as a competitive inhibitor of hCOX-1 and hCOX-2, with IC50s of 40 nM and 3 μM for hCOX-1 and hCOX-2, respectively.	Free Acid	C15H15NO2	16865.0	H2O : < 0.1 mg/mL (insoluble); DMSO : ≥ 100 mg/mL (414.44 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C1=CC=CC=C1NC2=CC=CC(C)=C2C	https://www.medchemexpress.com/mefenamic-acid.html	Launched		92.0	C36	L7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0574	10.0	mM	271.0	DMSO	241.110279	7	L	pluskal_fda_drugs_5005_L7_id
2180	HY-B0683	HYCPK40908	A14	HYCPK40908	92z	75.0	3.0	B27	908.0	A14	74397-12-9	Limaprost	17α,20-dimethyl-δ2-PGE1; ONO1206; OP1206	380.52	PGE synthase	Immunology/Inflammation	Limaprost (OP1206) is a PGE1 analogue and a potent and orally active vasodilator. Limaprost increases blood flow and inhibits platelet aggregation. Limaprost pain relief, has antianginal effects, and can be used for ischaemic symptoms research[1][2].	Free Acid	C22H36O5	46014.0	DMSO : ≥ 40 mg/mL (105.12 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	O=C(O)/C=C/CCCC[C@@H]1[C@@H](/C=C/[C@@H](O)C[C@@H](C)CCCC)[C@H](O)CC1=O	https://www.medchemexpress.com/Limaprost.html	Launched		92.0	B27	L7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0683	10.0	mM	271.0	DMSO	380.256274	7	L	pluskal_fda_drugs_5005_L7_id
2235	HY-B0310	HYCPK40908	L17	HYCPK40908	92z	1137.0	3.0	X33	908.0	L17	76963-41-2	Nizatidine		331.46	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Nizatidine is a potent and orally active histamine H2 receptor  antagonist, can be used for the research of stomach?and?intestines ulcers. Nizatidine works by decreasing the secretion of gastric?acid the stomach makes and prevent ulcers from coming back after they have healed in animal models[1].	Free Base	C12H21N5O2S2	15164.0	H2O : 20 mg/mL (60.34 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (150.85 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Inflammation/Immunology	CN/C(NCCSCC1=CSC(CN(C)C)=N1)=C\[N+]([O-])=O	https://www.medchemexpress.com/Nizatidine.html	Launched		92.0	X33	L7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0310	10.0	mM	271.0	DMSO	331.113667	7	L	pluskal_fda_drugs_5005_L7_id
1742	HY-17043	HYCPK40907	F05	HYCPK40907	92z	490.0	2.0	K10	907.0	F05	79794-75-5	Loratadine	Loratidine; SCH 29851	382.88	Histamine Receptor; Influenza Virus	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Loratadine (SCH-29851) is a selective inverse peripheral histamine H1-receptor agonist with an IC50 of >32 μM. Loratadine has anti-dengue-virus (DENV) activity. Loratadine can inhibit immunologic release of inflammatory mediators.	Free Base	C22H23ClN2O2	8513.0	DMSO : 50 mg/mL (130.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Endocrinology; Inflammation/Immunology; Cancer	O=C(N1CC/C(CC1)=C2C3=CC=C(Cl)C=C3CCC4=CC=CN=C4\2)OCC	https://www.medchemexpress.com/Loratadine.html	Launched		92.0	K10	L8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17043	10.0	mM	272.0	DMSO	382.144806	8	L	pluskal_fda_drugs_5005_L8_id
1789	HY-B1165	HYCPK40907	E08	HYCPK40907	92z	400.0	2.0	I16	907.0	E08	41354-29-4	Cyproheptadine (hydrochloride sesquihydrate)		350.88	5-HT Receptor; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Cyproheptadine hydrochloride sesquihydrate is an antihistamine and is an antagonist of serotonin and histamine2.	Hydrochloride	C21H21N.3/2H2O.HCl	19176.0	DMSO : 33.33 mg/mL (94.99 mM; Need ultrasonic); H2O : 0.67 mg/mL (1.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CN1CC/C(CC1)=C2C3=CC=CC=C3C=CC4=CC=CC=C/24.[H]Cl.[1.5H2O]	https://www.medchemexpress.com/Cyproheptadine-hydrochloride-sesquihydrate.html	Launched		92.0	I16	L8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1165	10.0	mM	272.0	DMSO	287.1674	8	L	pluskal_fda_drugs_5005_L8_id
1847	HY-B0926	HYCPK40907	O11	HYCPK40907	92z	1366.0	2.0	AC22	907.0	O11	117-96-4	Diatrizoic acid	Diatrizoate; Amidotrizoic acid	613.91	Apoptosis	Apoptosis	Diatrizoic acid (Diatrizoate) is an iodinated radiocontrast agent and has the potential for radiographic imaging of the airways. Diatrizoic acid induces mitochondrial turnover and oxidative stress, and activating apoptosis by dysregulating calcium[1][2].	Free Acid	C11H9I3N2O4	17261.0	DMSO : 100 mg/mL (162.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C1=C(I)C(NC(C)=O)=C(I)C(NC(C)=O)=C1I	https://www.medchemexpress.com/Diatrizoic-acid.html	Launched		92.0	AC22	L8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0926	10.0	mM	272.0	DMSO	613.769651	8	L	pluskal_fda_drugs_5005_L8_id
1865	HY-10981A	HYCPK40907	A13	HYCPK40907	92z	26.0	2.0	A26	907.0	A13	857890-39-2	Lenvatinib (mesylate)	E7080 (mesylate)	522.96	c-Kit; FGFR; PDGFR; RET; VEGFR	Protein Tyrosine Kinase/RTK	Lenvatinib mesylate (E7080 mesylate), an oral, multi-targeted tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, PDGFR, KIT, and RET, shows  potent antitumor activities[1][2].	Mesylate	C22H23ClN4O7S	90007.0	DMSO : 7.35 mg/mL (14.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(OC)C=C2N=CC=C(OC3=CC=C(NC(NC4CC4)=O)C(Cl)=C3)C2=C1)N.OS(=O)(C)=O	https://www.medchemexpress.com/lenvatinib-mesylate.html	Launched		92.0	A26	L8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10981A	10.0	mM	272.0	DMSO	426.109483	8	L	pluskal_fda_drugs_5005_L8_id
2017	HY-B0356B	HYCPK40908	E03	HYCPK40908	92z	437.0	3.0	J5	908.0	E03	86393-32-0	Ciprofloxacin (hydrochloride monohydrate)	Bay-09867 (hydrochloride monohydrate)	385.82	Antibiotic; Apoptosis; Bacterial; Mitochondrial Metabolism; Reactive Oxygen Species; Topoisomerase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Ciprofloxacin (Bay-09867) hydrochloride monohydrate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin hydrochloride monohydrate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin hydrochloride monohydrate has anti-proliferative activity and induces apoptosis. Ciprofloxacin hydrochloride monohydrate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].	Hydrochloride	C17H21ClFN3O4	130902.0	DMSO : 5 mg/mL (12.96 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	[H]O[H].[H]Cl.O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCNCC4)=C3)C1=O)O	https://www.medchemexpress.com/ciprofloxacin-hydrochloride-monohydrate.html	Launched		92.0	J5	L8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0356B	10.0	mM	272.0	DMSO	331.13322	8	L	pluskal_fda_drugs_5005_L8_id
2136	HY-B0017	HYCPK40908	E11	HYCPK40908	92z	453.0	3.0	J21	908.0	E11	3424-98-4	Telbivudine	Epavudine; L-Thymidine; NV 02B	242.23	HBV	Anti-infection	Telbivudine (Epavudine), an orally active thymidine nucleoside analog, is a potent antiviral inhibitor of hepatitis B virus (HBV) replication[1].	Free Base	C10H14N2O5	11698.0	H2O : 33.33 mg/mL (137.60 mM; Need ultrasonic); DMSO : 50 mg/mL (206.42 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC1=CN([C@@H]2C[C@@H](O)[C@H](CO)O2)C(NC1=O)=O	https://www.medchemexpress.com/telbivudine.html	Launched		92.0	J21	L8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0017	10.0	mM	272.0	DMSO	242.090272	8	L	pluskal_fda_drugs_5005_L8_id
2208	HY-12057	HYCPK40908	M15	HYCPK40908	92z	1229.0	3.0	Z29	908.0	M15	918504-65-1	Vemurafenib	PLX4032; RG7204; RO5185426	489.92	Autophagy; Raf	Autophagy; MAPK/ERK Pathway	Vemurafenib (PLX4032) is a first-in-class, selective, potent inhibitor of B-RAF kinase, with IC50s of 31 and 48 nM for RAFV600E and c-RAF-1, respectively[1][4]. Vemurafenib induces cell autophagy[5].	Free Base	C23H18ClF2N3O3S	24311.0	DMSO : 50 mg/mL (102.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	FC1=CC=C(C(F)=C1C(C2=CNC3=NC=C(C=C32)C4=CC=C(C=C4)Cl)=O)NS(CCC)(=O)=O	https://www.medchemexpress.com/Vemurafenib.html	Launched		92.0	Z29	L8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12057	10.0	mM	272.0	DMSO	489.072547	8	L	pluskal_fda_drugs_5005_L8_id
2420	HY-B1462	HYCPK40908	P22	HYCPK40908	92z	1531.0	3.0	AF43	908.0	P22	95-25-0	Chlorzoxazone		169.57	Cytochrome P450	Metabolic Enzyme/Protease	Chlorzoxazone is a centrally acting muscle relaxant used to treat muscle spasm and the resulting pain or discomfort. It acts on the spinal cord by depressing reflexes.Chlorzoxazone is currently being used as a marker substrate in vitro/vivo studies to quantify cytochrome P450 2E1 (CYP2E1) activity in humans.	Free Base	C7H4ClNO2	18571.0	DMSO : ≥ 100 mg/mL (589.73 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C1OC2=CC=C(Cl)C=C2N1	https://www.medchemexpress.com/Chlorzoxazone.html	Launched		92.0	AF43	L8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1462	10.0	mM	272.0	DMSO	168.993056	8	L	pluskal_fda_drugs_5005_L8_id
57	HY-B0356	HYCPK40899	K05	HYCPK40909	92z	1040.0	4.0	V32	909.0	K16	85721-33-1	Ciprofloxacin	Bay-09867	331.34	Antibiotic; Apoptosis; Bacterial; Mitochondrial Metabolism; Reactive Oxygen Species; Topoisomerase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity[1][2][3][4].	Free Acid	C17H18FN3O3	16121.0	H2O : < 0.1 mg/mL (insoluble); 0.1 M HCL : 16.67 mg/mL (50.31 mM; ultrasonic and warming and adjust pH to 2 with HCl and heat to 60°C)	DMSO Solution	2mM  * 100uL	Cancer; Infection	O=C(C1=CN(C2CC2)C3=C(C=C(F)C(N4CCNCC4)=C3)C1=O)O	https://www.medchemexpress.com/Ciprofloxacin.html	Launched		92.0	V32	L9	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0356	2.0	mM	273.0	DMSO	331.13322	9	L	pluskal_fda_drugs_5005_L9_id
368	HY-14763	HYCPK40899	K04	HYCPK40909	92z	1038.0	4.0	V30	909.0	K15	839712-12-8	Cariprazine	RGH-188	427.41	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Cariprazine is a novel antipsychotic drug candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).	Free Base	C21H32Cl2N4O	104732.0	DMSO : 2 mg/mL (4.68 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Neurological Disease	O=C(N[C@H]1CC[C@H](CCN2CCN(C3=CC=CC(Cl)=C3Cl)CC2)CC1)N(C)C	https://www.medchemexpress.com/Cariprazine.html	Launched		92.0	V30	L9	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14763	2.0	mM	273.0	DMSO	426.195317	9	L	pluskal_fda_drugs_5005_L9_id
1503	HY-B1456A	HYCPK40906	B10	HYCPK40906	92z	115.0	1.0	C19	906.0	B10	29679-58-1	Fenoprofen	LILLY-53858	242.27	Melanocortin Receptor	GPCR/G Protein; Neuronal Signaling	Fenoprofen (LILLY-53858) is a nonsteroidal anti-inflammatory agent (NSAID). Fenoprofen can be used to to relieve symptoms of arthritis (osteoarthritis and rheumatoid arthritis), such as inflammation, swelling, stiffness, and joint pain. Fenoprofen is an allosteric enhancer for melanocortin receptors. Fenoprofen also increases ERK1/2 activation[1][2].		C15H14O3	158402.0	DMSO : 100 mg/mL (412.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C(C)C1=CC=CC(OC2=CC=CC=C2)=C1	https://www.medchemexpress.com/fenoprofen.html	Launched		92.0	C19	L9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1456A	10.0	mM	273.0	DMSO	242.094294	9	L	pluskal_fda_drugs_5005_L9_id
1533	HY-N0682	HYCPK40906	P11	HYCPK40906	92z	1461.0	1.0	AE21	906.0	P11	58-56-0	Pyridoxine (hydrochloride)	Pyridoxol (hydrochloride); Vitamin B6 (hydrochloride)	205.64	Endogenous Metabolite; Keap1-Nrf2	Metabolic Enzyme/Protease; NF-κB	Pyridoxine hydrochloride (Pyridoxol; Vitamin B6) is a pyridine derivative. Pyridoxine (Pyridoxol; Vitamin B6) exerts antioxidant effects in cell model of Alzheimer's disease via the Nrf-2/HO-1 pathway.	Hydrochloride	C8H12ClNO3	26561.0	H2O : ≥ 50 mg/mL (243.14 mM); DMSO : ≥ 50 mg/mL (243.14 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	OCC1=C(CO)C(O)=C(C)N=C1.Cl	https://www.medchemexpress.com/Pyridoxine_hydrochloride.html	Launched		92.0	AE21	L9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0682	10.0	mM	273.0	DMSO	169.073893	9	L	pluskal_fda_drugs_5005_L9_id
1555	HY-14892A	HYCPK40906	F13	HYCPK40906	92z	505.0	1.0	K25	906.0	F13	1374639-74-3	Gemigliptin (tartrate)	LC15-0444 (tartrate)	639.45	Dipeptidyl Peptidase	Metabolic Enzyme/Protease	Gemigliptin tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC50 of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties. Gemigliptin tartrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications[1][2].	Tartrate	C22H25F8N5O8	30865.0	DMSO : 100 mg/mL (156.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(O)[C@H](O)[C@@H](O)C(O)=O.O=C1N(C[C@@H](N)CC(N2CCC3=C(C(F)(F)F)N=C(C(F)(F)F)N=C3C2)=O)CC(F)(F)CC1	https://www.medchemexpress.com/gemigliptin-tartrate.html	Launched		92.0	K25	L9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14892A	10.0	mM	273.0	DMSO	489.141101	9	L	pluskal_fda_drugs_5005_L9_id
1797	HY-B1053	HYCPK40907	M08	HYCPK40907	92z	1168.0	2.0	Y16	907.0	M08	2276-90-6	Iotalamic acid	Iothalamic acid	613.91	Others	Others	Lotalamic acid (Iothalamic acid) is a molecule used as a contrast medium.	Free Acid	C11H9I3N2O4	147675.0	DMSO : ≥ 25 mg/mL (40.72 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)C1=C(I)C(C(NC)=O)=C(I)C(NC(C)=O)=C1I	https://www.medchemexpress.com/Iotalamic-acid.html	Launched		92.0	Y16	L9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1053	10.0	mM	273.0	DMSO	613.769651	9	L	pluskal_fda_drugs_5005_L9_id
1880	HY-A0010	HYCPK40907	P13	HYCPK40907	92z	1466.0	2.0	AE26	907.0	P13	177834-92-3	Eletriptan (hydrobromide)	Eletriptan HBr; UK-116044 (hydrobromide)	463.43	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Eletriptan hydrobromide (Eletriptan HBr) is a selective 5-HT1B and 5-HT1D receptor agonist with Ki of 0.92 nM and 3.14 nM, respectively.
IC50 value: 0.82 nM/3.14 nM (5-HT1B/5-HT1D, Ki) [1]
Target: 5-HT1B/5-HT1D 
in vitro: [3H]Eletriptan has a total number of binding sites (Bmax) of 2478 fmol/mg and 1576 fmol/mg for 5-HT1B and 5-HT1D, respectively. [3H]Eletriptan has a significantly faster association rate (K(on) 0.249/min/nM) than [3H]sumatriptan (K(on) 0.024/min/nM) and a significantly slower off-rate (K(off) 0.027/min compared to 0.037/min for [3H]sumatriptan) [1]. Eletriptan induces concentration-dependent contractions of meningeal artery, coronary artery, and saphenous vein. The potency of Eletriptan is higher in meningeal artery than in coronary artery (86-fold) or saphenous vein (66-fold). The predicted contraction by Eletriptan (40 mg and 80 mg) and sumatriptan (100 mg) at free C(max) observed in clinical trials is similar in meningeal artery [2].
in vivo: Eletriptan (<1000 mg/kg, i.v.) produces a dose-dependent reduction of carotid arterial blood flow in the anaesthetised dog. Eletriptan reduces coronary artery diameter with ED50 value of 63 mg/kg in the anaesthetised dog. Eletriptan (<300 mg/kg, i.v.) administered prior to electrical stimulation of the trigeminal ganglion produces a dose-related and complete inhibition of plasma protein extravasation in the dura mater rats. Eletriptan (100 mg/kg, i.v.) produces a complete inhibition of plasma protein extravasation in rat dura mater [3]. Iontophoretic ejection (50 nA) of Eletriptan suppresses the response in 75% of cells and causes an average suppression of cell firing of 42% in cats [4]."	Hydrobromide	C22H27BrN2O2S	633.0	DMSO : 110 mg/mL (237.36 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=S(CCC1=CC2=C(NC=C2C[C@@H]3N(CCC3)C)C=C1)(C4=CC=CC=C4)=O.Br	https://www.medchemexpress.com/Eletriptan-hydrobromide.html	Launched		92.0	AE26	L9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0010	10.0	mM	273.0	DMSO	382.171499	9	L	pluskal_fda_drugs_5005_L9_id
2268	HY-B0518A	HYCPK40908	M19	HYCPK40908	92z	1237.0	3.0	Z37	908.0	M19	65473-14-5	Naftifine (hydrochloride)		323.86	Antibiotic; Fungal	Anti-infection	Naftifine hydrochloride is an antibiotic. Naftifine hydrochloride has antifungal activity against dermatophytes, aspergilli, Sporothrix schenckii, and yeasts of the genus Candida. Naftifine hydrochloride can be used for the research of superficial dermatomycoses inhibition[1].	Hydrochloride	C21H22ClN	12904.0	Ethanol : 25 mg/mL (77.19 mM; Need ultrasonic); DMSO : 100 mg/mL (308.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CN(C/C=C/C1=CC=CC=C1)CC2=CC=CC3=CC=CC=C23.Cl	https://www.medchemexpress.com/naftifine-hydrochloride.html	Launched		92.0	Z37	L9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0518A	10.0	mM	273.0	DMSO	287.1674	9	L	pluskal_fda_drugs_5005_L9_id
1412	HY-A0019	HYCPK40906	A06	HYCPK40906	92z	11.0	1.0	A11	906.0	A06	144598-75-4	Paliperidone	9-Hydroxyrisperidone	426.48	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1].	Free Base	C23H27FN4O3	61155.0	DMSO : 5 mg/mL (11.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC1=C(C(N2CCCC(C2=N1)O)=O)CCN3CCC(CC3)C4=NOC5=C4C=CC(F)=C5	https://www.medchemexpress.com/Paliperidone.html	Launched		92.0	A11	L10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0019	10.0	mM	274.0	DMSO	426.206719	10	L	pluskal_fda_drugs_5005_L10_id
1485	HY-B1465	HYCPK40906	P08	HYCPK40906	92z	1455.0	1.0	AE15	906.0	P08	36653-82-4	1-Hexadecanol		242.44	Endogenous Metabolite	Metabolic Enzyme/Protease	1-Hexadecanol is a fatty alcohol, a lipophilic substrate.	Free Base	C16H34O	45493.0	DMSO : 10 mg/mL (41.25 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Others	CCCCCCCCCCCCCCCCO	https://www.medchemexpress.com/1-hexadecanol.html	Launched		92.0	AE15	L10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1465	10.0	mM	274.0	DMSO	242.260966	10	L	pluskal_fda_drugs_5005_L10_id
1827	HY-B1596	HYCPK40907	K10	HYCPK40907	92z	980.0	2.0	U20	907.0	K10	68401-81-0	Ceftizoxime		383.40	Antibiotic; Bacterial	Anti-infection	Ceftizoxime is a bacterial inhibitor which acts by interfering with bacterial cell wall synthesis and inhibiting cross-linking of the peptidoglycan.	Free Acid	C13H13N5O5S2	36013.0	DMSO : 25 mg/mL (65.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=CCS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)O	https://www.medchemexpress.com/Ceftizoxime.html	Launched		92.0	U20	L10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1596	10.0	mM	274.0	DMSO	383.035811	10	L	pluskal_fda_drugs_5005_L10_id
1852	HY-B1328	HYCPK40907	D12	HYCPK40907	92z	312.0	2.0	G24	907.0	D12	65-23-6	Pyridoxine	Pyridoxol	169.18	Endogenous Metabolite; Keap1-Nrf2	Metabolic Enzyme/Protease; NF-κB	Pyridoxine (Pyridoxol) is a pyridine derivative. Pyridoxine exerts antioxidant effects in cell model of Alzheimer's disease via the Nrf-2/HO-1 pathway.	Free Base	C8H11NO3	143381.0	DMSO : 100 mg/mL (591.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	OCC1=C(CO)C(O)=C(C)N=C1	https://www.medchemexpress.com/Pyridoxine.html	Launched		92.0	G24	L10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1328	10.0	mM	274.0	DMSO	169.073893	10	L	pluskal_fda_drugs_5005_L10_id
1972	HY-A0060	HYCPK40907	H20	HYCPK40907	92z	712.0	2.0	O40	907.0	H20	59937-28-9	Malotilate	NKK 105	288.38	Lipoxygenase	Metabolic Enzyme/Protease	Malotilate (NKK 105), an orally active hepatotropic agent and an anti-fibrotic substance, selectively inhibits the 5-lipoxygenase (5-LOX) (IC50=4.7 μM). Malotilate prevents the development of hepatocytic injury in alcohol-pyrazole hepatitis by decreasing hepatic acetaldehyde levels and preventing the retention of transferrin in the hepatocytes[1][2].	Free Base	C12H16O4S2	16377.0	DMSO : ≥ 100 mg/mL (346.76 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(OC(C)C)/C(C(OC(C)C)=O)=C1SC=CS\1	https://www.medchemexpress.com/malotilate.html	Launched		92.0	O40	L10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0060	10.0	mM	274.0	DMSO	288.049001	10	L	pluskal_fda_drugs_5005_L10_id
2182	HY-B0104	HYCPK40908	C14	HYCPK40908	92z	267.0	3.0	F27	908.0	C14	93479-97-1	Glimepiride	Glimperide; HOE-490	490.62	Amyloid-β; Others	Neuronal Signaling; Others	Glimepiride (Glimperide) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg.	Free Base	C24H34N4O5S	11790.0	DMSO : 33.33 mg/mL (67.93 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(N1C(C(CC)=C(C)C1)=O)NCCC2=CC=C(S(=O)(NC(N[C@H]3CC[C@H](C)CC3)=O)=O)C=C2	https://www.medchemexpress.com/glimepiride.html	Launched		92.0	F27	L10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0104	10.0	mM	274.0	DMSO	490.224991	10	L	pluskal_fda_drugs_5005_L10_id
2203	HY-12137	HYCPK40908	H15	HYCPK40908	92z	749.0	3.0	P29	908.0	H15	755038-65-4	Volasertib	BI 6727	618.81	Apoptosis; Polo-like Kinase (PLK)	Apoptosis; Cell Cycle/DNA Damage	Volasertib (BI 6727) is an orally active, highly potent and ATP-competitive Polo-like kinase 1 (PLK1) inhibitor with an IC50 of 0.87 nM. Volasertib inhibits PLK2 and PLK3 with IC50s of 5 and 56 nM, respectively. Volasertib induces mitotic arrest and apoptosis. Volasertib, a dihydropteridinone derivative, shows marked antitumor activity in multiple cancer models[1][2].	Free Base	C34H50N8O3	57030.0	DMSO : 50 mg/mL (80.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=C(C(OC)=C1)NC2=NC=C(N(C3=O)C)C(N([C@@H]3CC)C(C)C)=N2)N[C@H]4CC[C@@H](CC4)N5CCN(CC5)CC6CC6	https://www.medchemexpress.com/Volasertib.html	Launched		92.0	P29	L10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12137	10.0	mM	274.0	DMSO	618.400587	10	L	pluskal_fda_drugs_5005_L10_id
2218	HY-N0052A	HYCPK40908	G16	HYCPK40908	92z	655.0	3.0	N31	908.0	G16	5578-73-4	Sanguinarine (chloride)	Sanguinarin (chloride); Sanguinarium (chloride); Pseudochelerythrine (chloride)	367.78	Apoptosis; Autophagy; Bacterial; Parasite	Anti-infection; Apoptosis; Autophagy	Sanguinarine (Sanguinarin) chloride, a benzophenanthridine alkaloid derived from the root of Sanguinaria Canadensis, can stimulate apoptosis via activating the production of reactive oxygen species (ROS). Sanguinarine-induced apoptosis is associated with the activation of JNK and NF-κB.	Chloride	C20H14ClNO4	17507.0	H2O : 6 mg/mL (16.31 mM; Need ultrasonic); DMSO : 5 mg/mL (13.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[N+]1=CC2=C3C(OCO3)=CC=C2C(C=CC4=C5)=C1C4=CC6=C5OCO6.[Cl-]	https://www.medchemexpress.com/Sanguinarine-chloride.html	Launched		92.0	N31	L10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0052A	10.0	mM	274.0	DMSO	332.091734	10	L	pluskal_fda_drugs_5005_L10_id
60	HY-A0020	HYCPK40899	N05	HYCPK40909	92z	1328.0	4.0	AB32	909.0	N16	104121-92-8	Eldecalcitol	ED-71; 2-(3-hydroxypropoxy)-1,25-dihydroxyvitamin D3	490.72	Apoptosis; VD/VDR	Apoptosis; Vitamin D Related	Eldecalcitol (ED-71) is an orally active vitamin D3 analogue, inhibits bone resorption and increases bone mineral density. Eldecalcitol (ED-71) displays anti-tumor effect and inhibits cell proliferation, migration and induces apoptosis by suppressing GPx-1[1][2][3][4].	Free Base	C30H50O5	28122.0	DMSO : 3.33 mg/mL (6.79 mM; ultrasonic and warming and heat to 60°C); Methanol : 8.33 mg/mL (16.98 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology	O[C@H]1[C@@H](OCCCO)[C@H](O)C(/C(C1)=C\C=C2[C@]3([H])CC[C@H]([C@H](C)CCCC(C)(O)C)[C@@]3(C)CCC\2)=C	https://www.medchemexpress.com/Eldecalcitol.html	Launched		92.0	AB32	L11	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0020	2.0	mM	275.0	DMSO	490.365825	11	L	pluskal_fda_drugs_5005_L11_id
1631	HY-17507B	HYCPK40906	B18	HYCPK40906	92z	131.0	1.0	C35	906.0	B18	164579-32-2	Pantoprazole (sodium hydrate)	BY1023 (sodium hydrate); SKF96022 (sodium hydrate)	432.37	Apoptosis; Autophagy; Bacterial; Proton Pump	Anti-infection; Apoptosis; Autophagy; Membrane Transporter/Ion Channel	Pantoprazole sodium hydrate (BY10232 sodium hydrate) is an orally active and potent proton pump inhibitor (PPI)[1]. Pantoprazole sodium hydrate, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole sodium hydrate improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole sodium hydrate significantly increased tumor growth delay combined with Doxorubicin (HY-15142)[3][4].	Sodium	C16H17F2N3NaO5.5S	123166.0	DMSO : 100 mg/mL (231.28 mM; Need ultrasonic); H2O : 250 mg/mL (578.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=S(C1=NC2=CC=C(OC(F)F)C=C2N1[Na])CC3=NC=CC(OC)=C3OC.[1.5H2O]	https://www.medchemexpress.com/Pantoprazole-sodium-hydrate.html	Launched		92.0	C35	L11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17507B	10.0	mM	275.0	DMSO	383.075133	11	L	pluskal_fda_drugs_5005_L11_id
1635	HY-N7142	HYCPK40906	F18	HYCPK40906	92z	515.0	1.0	K35	906.0	F18	55-27-6	DL-Norepinephrine (hydrochloride)		205.64	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	DL-Norepinephrine hydrochloride is a synthetic phenylethylamine that mimics the sympathomimetic actions of the endogenous norepinephrine．DL-Norepinephrine hydrochloride is a neurotransmitter targets α1 and β1 adrenoceptors, has an increasing effect on subendocardial oxygen tension[1].	Hydrochloride	C8H12ClNO3	119440.0	DMSO : 50 mg/mL (243.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	OC1=CC=C(C(O)CN)C=C1O.[H]Cl	https://www.medchemexpress.com/dl-norepinephrine-hydrochloride.html	Launched		92.0	K35	L11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7142	10.0	mM	275.0	DMSO	169.073893	11	L	pluskal_fda_drugs_5005_L11_id
1759	HY-17452A	HYCPK40907	G06	HYCPK40907	92z	588.0	2.0	M12	907.0	G06	117467-28-4	Cefditoren (Pivoxil)	Cefditoren pivoxyl; Cefditoren pivaloyloxymethyl ester; ME 1207	620.72	Antibiotic; Bacterial	Anti-infection	Cefditoren Pivoxil (ME 1207) is a broad-spectrum, third-generation, oral cephalosporin antibacterial with enhanced stability against many common β lactamases. Cefditoren  Pivoxil has activity against Gram-negative organisms and Gram-positive organisms. Cefditoren  Pivoxil can be used in the research of infection diseases such as acute exacerbations of chronic bronchitis, community-acquired pneumonia (CAP), streptococcal pharyngitis/tonsillitis, or uncomplicated skin and skin structure infections[1][2].	Free Base	C25H28N6O7S3	15392.0	DMSO : ≥ 100 mg/mL (161.10 mM)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(C(N12)=C(/C=C\C3=C(C)N=CS3)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)OCOC(C(C)(C)C)=O	https://www.medchemexpress.com/Cefditoren-Pivoxil.html	Launched		92.0	M12	L11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17452A	10.0	mM	275.0	DMSO	620.11816	11	L	pluskal_fda_drugs_5005_L11_id
1836	HY-13210	HYCPK40907	D11	HYCPK40907	92z	310.0	2.0	G22	907.0	D11	139110-80-8	Zanamivir		332.31	Antibiotic; Influenza Virus	Anti-infection	Zanamivir is an influenza viral neuraminidase inhibitor with IC50 values of 0.95 nM and 2.7 nM for influenza A and B, respectively.	Free Acid	C12H20N4O7	6854.0	H2O : ≥ 33.33 mg/mL (100.30 mM)	DMSO Solution	10mM  * 100uL	Infection	NC(N[C@@H]1[C@H]([C@@]([H])(OC(C(O)=O)=C1)[C@@H]([C@@H](CO)O)O)NC(C)=O)=N	https://www.medchemexpress.com/Zanamivir.html	Launched		92.0	G22	L11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13210	10.0	mM	275.0	DMSO	332.133199	11	L	pluskal_fda_drugs_5005_L11_id
2046	HY-B1305	HYCPK40908	G05	HYCPK40908	92z	633.0	3.0	N9	908.0	G05	6170-42-9	Chloropyramine hydrochloride		326.26	FAK; Histamine Receptor; VEGFR	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling; Protein Tyrosine Kinase/RTK	Chloropyramine hydrochloride is a histamine receptor H1 antagonist which can also inhibit the biochemical function of  VEGFR-3 and FAK.	Hydrochloride	C16H21Cl2N3	64158.0	DMSO : 30 mg/mL (91.95 mM; Need ultrasonic and warming); H2O : 100 mg/mL (306.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	CN(C)CCN(CC1=CC=C(Cl)C=C1)C2=NC=CC=C2.[H]Cl	https://www.medchemexpress.com/Chloropyramine_hydrochloride.html	Launched		92.0	N9	L11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1305	10.0	mM	275.0	DMSO	289.134575	11	L	pluskal_fda_drugs_5005_L11_id
2085	HY-13605A	HYCPK40908	N07	HYCPK40908	92z	1309.0	3.0	AB13	908.0	N07	69-74-9	Cytarabine (hydrochloride)	Cytosine β-D-arabinofuranoside hydrochloride; Cytosine Arabinoside hydrochloride; Ara-C hydrochloride	279.68	Autophagy; DNA/RNA Synthesis; HSV; Nucleoside Antimetabolite/Analog	Anti-infection; Autophagy; Cell Cycle/DNA Damage	Cytarabine hydrochloride, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine hydrochloride has antiviral effects against HSV.	Hydrochloride	C9H14ClN3O5	90556.0	DMSO : 50 mg/mL (178.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O[C@H]1[C@H](O)[C@H](N2C(N=C(N)C=C2)=O)O[C@@H]1CO.Cl	https://www.medchemexpress.com/cytarabine-hydrochloride.html	Launched		92.0	AB13	L11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13605A	10.0	mM	275.0	DMSO	243.085521	11	L	pluskal_fda_drugs_5005_L11_id
2275	HY-B0731A	HYCPK40908	D20	HYCPK40908	92z	375.0	3.0	H39	908.0	D20	150915-41-6	Perospirone	SM-9018 (free base)	426.57	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Perospirone (SM-9018 free base) is an orally active antagonist of 5-HT2A receptor (Ki=0.6 nM) and dopamine D2 receptor (Ki=1.4 nM), and also a partial agonist of 5-HT1A receptor (Ki=2.9 nM). Perospirone is an atypical antipsychotic agent and has the potential for schizophrenic disease research[1][2].	Free Base	C23H30N4O2S	61413.0	DMSO : 5 mg/mL (11.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C([C@@]1([H])[C@]2([H])CCCC1)N(C2=O)CCCCN3CCN(C4=NSC5=C4C=CC=C5)CC3	https://www.medchemexpress.com/perospirone.html	Launched		92.0	H39	L11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0731A	10.0	mM	275.0	DMSO	426.208947	11	L	pluskal_fda_drugs_5005_L11_id
42	HY-13764	HYCPK40899	D04	HYCPK40909	92z	366.0	4.0	H30	909.0	D15	518-34-3	Tetrandrine	NSC-77037; d-Tetrandrine	622.75	Calcium Channel; Parasite; Potassium Channel	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Tetrandrine (NSC-77037; d-Tetrandrine) is a bis-benzyl-isoquinoline alkaloid, which inhibits voltage-gated Ca2+ current (ICa) and Ca2+-activated K+ current.	Free Base	C38H42N2O6	85614.0	DMSO : 5 mg/mL (8.03 mM; Need ultrasonic and warming)	DMSO Solution	2mM  * 100uL	Cancer; Inflammation/Immunology	COC1=CC(CCN(C)[C@@]2([H])CC3=CC(O4)=C(OC)C=C3)=C2C(OC5=C(OC)C=C6C([C@]([H])(CC7=CC=C4C=C7)N(C)CC6)=C5)=C1OC	https://www.medchemexpress.com/Tetrandrine.html	Launched		92.0	H30	L12	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13764	2.0	mM	276.0	DMSO	622.304287	12	L	pluskal_fda_drugs_5005_L12_id
1632	HY-107322	HYCPK40906	C18	HYCPK40906	92z	227.0	1.0	E35	906.0	C18	104757-53-1	Barnidipine (hydrochloride)	Mepirodipine (hydrochloride); YM-09730-5	528.00	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	"Barnidipine hydrochloride (Mepirodipine hydrochloride) is an L-type calcium antagonist (CaA) with high affinity for [3H] initrendipine binding sites (Ki=0.21 nmol/l), has selective action against  CaA  receptors[1].
Barnidipine hydrochloride (Mepirodipine hydrochloride) is an antihypertensive drug and acts by the reduction of peripheral vascular resistance secondary to its vasodilatory action[2]."	Hydrochloride	C27H30ClN3O6	49949.0	DMSO : 250 mg/mL (473.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(OC)=O)[C@@H]1C2=CC([N+]([O-])=O)=CC=C2)O[C@@H]3CN(CC4=CC=CC=C4)CC3.[H]Cl	https://www.medchemexpress.com/barnidipine-hydrochloride.html	Launched		92.0	E35	L12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107322	10.0	mM	276.0	DMSO	491.205636	12	L	pluskal_fda_drugs_5005_L12_id
1959	HY-13715A	HYCPK40907	G19	HYCPK40907	92z	614.0	2.0	M38	907.0	G19	329-56-6	Norepinephrine (hydrochloride)	Levarterenol (hydrochloride); L-Noradrenaline (hydrochloride)	205.64	Adrenergic Receptor; Autophagy; Endogenous Metabolite	Autophagy; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Norepinephrine (Levarterenol; L-Noradrenaline) hydrochloride is a potent adrenergic receptor (AR) agonist. Norepinephrine activates α1, α2, β1 receptors[1][2][3][4].	Hydrochloride	C8H12ClNO3	148483.0	H2O : 250 mg/mL (1215.72 mM; Need ultrasonic); DMSO : 44 mg/mL (213.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	OC1=CC=C([C@@H](O)CN)C=C1O.Cl	https://www.medchemexpress.com/Norepinephrine-hydrochloride.html	Launched		92.0	M38	L12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13715A	10.0	mM	276.0	DMSO	169.073893	12	L	pluskal_fda_drugs_5005_L12_id
2058	HY-13605	HYCPK40908	C06	HYCPK40908	92z	251.0	3.0	F11	908.0	C06	147-94-4	Cytarabine	Cytosine β-D-arabinofuranoside; Cytosine Arabinoside; Ara-C	243.22	Apoptosis; Autophagy; DNA/RNA Synthesis; Endogenous Metabolite; HSV; Nucleoside Antimetabolite/Analog; Orthopoxvirus	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Cytarabine, a nucleoside analog, causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC50 of 16 nM. Cytarabine has antiviral effects against HSV. Cytarabine shows anti-orthopoxvirus activity.	Free Base	C9H13N3O5	149838.0	DMSO : 17.3 mg/mL (71.13 mM; Need ultrasonic and warming); H2O : 48 mg/mL (197.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C1N=C(C=CN1[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O2)N	https://www.medchemexpress.com/Cytarabine.html	Launched		92.0	F11	L12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13605	10.0	mM	276.0	DMSO	243.085521	12	L	pluskal_fda_drugs_5005_L12_id
2137	HY-22437	HYCPK40908	F11	HYCPK40908	92z	549.0	3.0	L21	908.0	F11	133033-93-9	(±)-Darifenacin	(±)-UK-88525	426.55	mAChR	GPCR/G Protein; Neuronal Signaling	(±)-Darifenacin is the racemate of Darifenacin. Darifenacin is a selective M3 muscarinic receptor antagonist[1].		C28H30N2O2	29665.0	DMSO : 100 mg/mL (234.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	NC(C(C1CN(CCC2=CC=C(OCC3)C3=C2)CC1)(C4=CC=CC=C4)C5=CC=CC=C5)=O	https://www.medchemexpress.com/racemic-darifenacin.html	Launched		92.0	L21	L12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-22437	10.0	mM	276.0	DMSO	426.230728	12	L	pluskal_fda_drugs_5005_L12_id
2152	HY-N0676	HYCPK40908	E12	HYCPK40908	92z	455.0	3.0	J23	908.0	E12	134418-28-3	Dehydroandrographolide		332.43	Influenza Virus	Anti-infection	Dehydroandrographolide can be extracted from herbal medicine Andrographis paniculata Nees. Dehydroandrographolide reduces oxidative stress in LPS-induced acute lung injury by inactivating iNOS. Dehydroandrographolide has anti-infective activity[1][2][3].	Free Base	C20H28O4	79167.0	DMSO : 250 mg/mL (752.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@@]([C@H]1C/C=C(C=CO2)/C2=O)(CC[C@H]3O)[C@@](CCC1=C)([H])[C@]3(C)CO	https://www.medchemexpress.com/Dehydroandrographolide.html	Launched		92.0	J23	L12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0676	10.0	mM	276.0	DMSO	332.198759	12	L	pluskal_fda_drugs_5005_L12_id
2288	HY-B0394	HYCPK40908	A21	HYCPK40908	92z	89.0	3.0	B41	908.0	A21	5908-99-6	Atropine (sulfate monohydrate)	Tropine tropate (sulfate monohydrate); DL-Hyoscyamine (sulfate monohydrate)	347.43	mAChR	GPCR/G Protein; Neuronal Signaling	Atropine (Tropine tropate) sulfate monohydrate is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine sulfate monohydrate inhibits ACh-induced relaxations in human pulmonary veins. Atropine sulfate monohydrate can be used for research of anti-myopia and bradycardia[1][2][3][4].	Sulfate	C17H23NO3.1/2H2O4S.1/2H2O	16822.0	DMSO : 50 mg/mL (143.91 mM; Need ultrasonic); H2O : 33.33 mg/mL (95.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease	O=[S](O)(O)=O.O=C(C(C1=CC=CC=C1)CO)O[C@H]2C[C@@H](CC3)N(C)[C@@H]3C2.[1/2].O.[1/2]	https://www.medchemexpress.com/Atropine-sulfate-monohydrate.html	Launched		92.0	B41	L12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0394	10.0	mM	276.0	DMSO	289.167794	12	L	pluskal_fda_drugs_5005_L12_id
2528	HY-17507A	HYCPK40909	C10	HYCPK40909	92z	260.0	4.0	F20	909.0	C10	138786-67-1	Pantoprazole (sodium)	BY1023 (sodium); SKF96022 (sodium)	405.35	Apoptosis; Autophagy; Bacterial; Proton Pump	Anti-infection; Apoptosis; Autophagy; Membrane Transporter/Ion Channel	Pantoprazole sodium (BY10232 sodium) is an orally active and potent proton pump inhibitor (PPI)[1]. Pantoprazole sodium, a substituted benzimidazole, is a potent H+/K+-ATPase inhibitor with an IC50 of 6.8 μM. Pantoprazole sodium improves pH stability and has anti-secretory, anti-ulcer activities. Pantoprazole sodium significantly increased tumor growth delay combined with Doxorubicin (HY-15142)[3][4].	Sodium	C16H14F2N3NaO4S	15449.0	H2O : 3.85 mg/mL (9.50 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (246.70 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=S(C1=NC2=CC=C(OC(F)F)C=C2[N-]1)CC3=NC=CC(OC)=C3OC.[Na+]	https://www.medchemexpress.com/Pantoprazole-sodium.html	Launched		92.0	F20	L12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17507A	10.0	mM	276.0	DMSO	383.075133	12	L	pluskal_fda_drugs_5005_L12_id
1557	HY-B0346	HYCPK40906	H13	HYCPK40906	92z	697.0	1.0	O25	906.0	H13	51-52-5	Propylthiouracil	6-n-Propylthiouracil; 6-Propyl-2-thiouracil; PTU	170.23	Others	Others	"Propylthiouracil(6-Propyl-2-thiouracil) is a thyroperoxidase and 5'-deiodinase inhibitor. 
Target: Thyroperoxidase (TPO)
Propylthiouracil (PTU) is a thiouracil-derived drug used to treat hyperthyroidism (including Graves' disease) by decreasing the amount of thyroid hormone produced by the thyroid gland [1]. The antithyroid drug 6-propylthiouracil (PTU) was shown to have an unexpectedly prolonged inhibitory effect on iodination in the thyroid glands of rats. Eighteen hours after injection of a relatively small dose, iodination in the thyroid remained inhibited by more than 90% [2]. PTU inhibits the enzyme thyroperoxidase, which normally acts in thyroid hormone synthesis by oxidizing the anion iodide (I-) to iodine (I0), facilitating iodine's addition to tyrosine residues on the hormone precursor thyroglobulin. This is one of the essential steps in the formation of thyroxine (T4). PTU does not inhibit the action of the sodium-dependent iodide transporter located on follicular cells' basolateral membranes. Inhibition of this step requires competitive inhibitors, such as perchlorate and thiocyanate. From Wikipedia."	Free Base	C7H10N2OS	16249.0	DMSO : ≥ 100 mg/mL (587.44 mM); H2O : 0.67 mg/mL (3.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(C=C(CCC)N1)NC1=S	https://www.medchemexpress.com/Propylthiouracil.html	Launched		92.0	O25	L13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0346	10.0	mM	277.0	DMSO	170.051384	13	L	pluskal_fda_drugs_5005_L13_id
1574	HY-B0241	HYCPK40906	I14	HYCPK40906	92z	795.0	1.0	Q27	906.0	I14	22254-24-6	Ipratropium (bromide)	Sch 1000	412.36	mAChR	GPCR/G Protein; Neuronal Signaling	Ipratropium bromide (Sch 1000) is a muscarinic receptor antagonist, with IC50s of 2.9 nM, 2 nM, and 1.7 nM for M1, M2, and M3 receptors, respectively. Ipratropium bromide relaxes smooth muscle, can be used in the research for COPD (chronic obstructive pulmonary disease) and asthma[1][2][3][4][5].	Bromide	C20H30BrNO3	19829.0	DMSO : ≥ 35 mg/mL (84.88 mM); H2O : 100 mg/mL (242.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	C[N+]1([C@H]2CC[C@H]1CC(OC(C(CO)C3=CC=CC=C3)=O)C2)C(C)C.[Br-]	https://www.medchemexpress.com/Ipratropium-bromide.html	Launched		92.0	Q27	L13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0241	10.0	mM	277.0	DMSO	332.22202	13	L	pluskal_fda_drugs_5005_L13_id
2257	HY-17404	HYCPK40908	B19	HYCPK40908	92z	181.0	3.0	D37	908.0	B19	132203-70-4	Cilnidipine	FRC-8653	492.52	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Cilnidipine is a long-acting, second-generation dihydropyridine Ca2+-channel blocker on L and N-type Ca2+ channel[1][2][3][4]. Antihypertensive effects[5].	Free Base	C27H28N2O7	11677.0	DMSO : ≥ 100 mg/mL (203.04 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(OC/C=C/C2=CC=CC=C2)=O)C1C3=CC=CC([N+]([O-])=O)=C3)OCCOC	https://www.medchemexpress.com/cilnidipine.html	Launched		92.0	D37	L13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17404	10.0	mM	277.0	DMSO	492.189651	13	L	pluskal_fda_drugs_5005_L13_id
2285	HY-B0031	HYCPK40908	N20	HYCPK40908	92z	1335.0	3.0	AB39	908.0	N20	111974-72-2	Quetiapine (hemifumarate)		441.54	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Quetiapine hemifumarate is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor. Quetiapine hemifumarate is a dopamine receptor antagonist with a pIC50 of 6.33 for human D2 receptor. Quetiapine hemifumarate has moderate to high affinity for the human D2, HT1A, 5-HT2A, 5-HT2C receptor with pKis of 7.25, 5.74, 7.54, 5.55. Antidepressant and anxiolytic effects[1].	Fumarate	C23H27N3O4S	8078.0	H2O : 1.25 mg/mL (2.83 mM; Need ultrasonic); DMSO : 50 mg/mL (113.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	OCCOCCN(CC1)CCN1C2=NC(C=CC=C3)=C3SC4=C2C=CC=C4.O=C(O)/C=C/C(O)=O.[0.5]	https://www.medchemexpress.com/Quetiapine-fumarate.html	Launched		92.0	AB39	L13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0031	10.0	mM	277.0	DMSO	383.166748	13	L	pluskal_fda_drugs_5005_L13_id
2410	HY-B0158	HYCPK40908	F22	HYCPK40908	92z	571.0	3.0	L43	908.0	F22	65-46-3	Cytidine	Cytosine β-D-riboside; Cytosine-1-β-D-ribofuranoside	243.22	Endogenous Metabolite; Nucleoside Antimetabolite/Analog	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Cytidine is a pyrimidine nucleoside and acts as a component of RNA. Cytidine is a precursor of uridine. Cytidine controls neuronal-glial glutamate cycling, affecting cerebral phospholipid metabolism, catecholamine synthesis, and mitochondrial function[1][2][3].	Free Base	C9H13N3O5	93363.0	H2O : ≥ 50 mg/mL (205.58 mM); DMSO : 50 mg/mL (205.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(N=C(N)C=C2)=O)O1	https://www.medchemexpress.com/Cytidine.html	Launched		92.0	L43	L13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0158	10.0	mM	277.0	DMSO	243.085521	13	L	pluskal_fda_drugs_5005_L13_id
2458	HY-N0471A	HYCPK40909	F05	HYCPK40909	92z	538.0	4.0	L10	909.0	F05	620-61-1	L-Hyoscyamine (sulfate)	Daturine (sulfate)	338.41	mAChR	GPCR/G Protein; Neuronal Signaling	L-Hyoscyamine sulfate (Daturine sulfate), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine sulfate is a levo-isomer to Atropine (HY-B1205)[1][2].	Sulfate	C17H24NO5S0.5	154974.0	DMSO : 25 mg/mL (73.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1[C@@H]2C[C@@H](OC([C@@H](C3=CC=CC=C3)CO)=O)C[C@H]1CC2.[0.5H2SO4]	https://www.medchemexpress.com/l-hyoscyamine-sulfate.html	Launched		92.0	L10	L13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0471A	10.0	mM	277.0	DMSO	289.167794	13	L	pluskal_fda_drugs_5005_L13_id
2517	HY-B1117	HYCPK40909	H09	HYCPK40909	92z	738.0	4.0	P18	909.0	H09	33564-30-6	Cefoxitin (sodium)	MK-306	449.43	Antibiotic; Bacterial	Anti-infection	Cefoxitin sodium (MK-306) is a cephamycin antibiotic, often grouped with the second generation cephalosporins, acts by interfering with cell wall synthesis, its activity spectrum includes a broad range of gram-negative and gram-positive bacteria.	Sodium	C16H16N3NaO7S2	18295.0	DMSO : ≥ 100 mg/mL (222.50 mM); H2O : ≥ 100 mg/mL (222.50 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@@](NC(CC3=CC=CS3)=O)(OC)C1=O)O[Na]	https://www.medchemexpress.com/Cefoxitin-sodium.html	Launched		92.0	P18	L13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1117	10.0	mM	277.0	DMSO	427.050792	13	L	pluskal_fda_drugs_5005_L13_id
2537	HY-14588	HYCPK40909	L10	HYCPK40909	92z	1124.0	4.0	X20	909.0	L10	192725-17-0	Lopinavir	ABT-378	628.80	HIV; HIV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Lopinavir (ABT-378) is a highly potent, selective peptidomimetic inhibitor of the HIV-1 protease, with Kis of 1.3 to 3.6 pM for wild-type and mutant HIV protease. Lopinavir acts by arresting maturation of HIV-1 thereby blocking its infectivity[1][2]. Lopinavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 14.2 μM[3].	Free Base	C37H48N4O5	11749.0	DMSO : 250 mg/mL (397.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	CC1=C(OCC(N[C@@H](CC2=CC=CC=C2)[C@@H](O)C[C@H](CC3=CC=CC=C3)NC([C@H](C(C)C)N4C(NCCC4)=O)=O)=O)C(C)=CC=C1	https://www.medchemexpress.com/lopinavir.html	Launched		92.0	X20	L13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14588	10.0	mM	277.0	DMSO	628.362471	13	L	pluskal_fda_drugs_5005_L13_id
28	HY-B0032	HYCPK40899	F03	HYCPK40909	92z	556.0	4.0	L28	909.0	F14	367514-88-3	Lurasidone (Hydrochloride)	SM-13496 (Hydrochloride)	529.14	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is an antagonist of both dopamine D2 and 5-HT7 with IC50s of 1.68  and 0.495 nM, respectively. Lurasidone (Hydrochloride) (SM-13496 (Hydrochloride)) is also a partial agonist of 5-HT1A receptor with an IC50 of 6.75 nM.	Hydrochloride	C28H37ClN4O2S	16422.0	DMSO : 6.67 mg/mL (12.61 mM; ultrasonic and warming and adjust pH to 3 with HCl and heat to 80°C); H2O : < 0.1 mg/mL (insoluble); Ethanol : 2 mg/mL (3.78 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Neurological Disease	O=C([C@H]([C@H]1CC[C@@H]2C1)[C@H]2C3=O)N3C[C@@H]4CCCC[C@H]4CN(CC5)CCN5C6=NSC7=CC=CC=C76.Cl	https://www.medchemexpress.com/Lurasidone-Hydrochloride.html	Launched		92.0	L28	L14	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0032	2.0	mM	278.0	DMSO	492.255897	14	L	pluskal_fda_drugs_5005_L14_id
1365	HY-B1069	HYCPK40906	B03	HYCPK40906	92z	101.0	1.0	C5	906.0	B03	25717-80-0	Molsidomine	SIN-10; Morsydomine	242.23	Drug Metabolite	Metabolic Enzyme/Protease	Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine, which is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound.	Free Base	C9H14N4O4	17377.0	DMSO : ≥ 100 mg/mL (412.83 mM); H2O : 25 mg/mL (103.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C([N-]C1=C[N+](N2CCOCC2)=NO1)OCC	https://www.medchemexpress.com/Molsidomine.html	Launched		92.0	C5	L14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1069	10.0	mM	278.0	DMSO	243.108781	14	L	pluskal_fda_drugs_5005_L14_id
1456	HY-109121	HYCPK40907	C20	HYCPK40907	92z	232.0	2.0	E40	907.0	C20	1345410-31-2	Reldesemtiv	CK-2127107	384.38	Others	Others	Reldesemtiv (CK-2127107) is a selective, orally active and next-generation fast skeletal muscle troponin activator (FSTA). Reldesemtiv selectively activates fast skeletal myofibrils with an EC50 of 3.4 μM. Reldesemtiv increases exercise performance in a heart failure model[1].	Free Base	C19H18F2N6O	80572.0	DMSO : 250 mg/mL (650.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CN(C2=CN=C(NC[C@]3(C4=NC=CC=C4F)C[C@H](F)C3)N=C2)C=C1)N	https://www.medchemexpress.com/reldesemtiv.html	Launched		92.0	E40	L14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109121	10.0	mM	278.0	DMSO	384.151016	14	L	pluskal_fda_drugs_5005_L14_id
1666	HY-10820	HYCPK40906	E20	HYCPK40906	92z	423.0	1.0	I39	906.0	E20	137281-23-3	Pemetrexed	LY231514	427.41	Antifolate; Autophagy	Autophagy; Cell Cycle/DNA Damage	Pemetrexed (LY231514) is an antifolate, the Ki values of the pentaglutamate of Pemetrexed (LY231514) are 1.3, 7.2, and 65 nM for inhibits thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), respectively[1].	Free Acid	C20H21N5O6	97513.0	DMSO : 250 mg/mL (584.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NC(N)=NC2=C1C(CCC3=CC=C(C(N[C@H](C(O)=O)CCC(O)=O)=O)C=C3)=CN2	https://www.medchemexpress.com/pemetrexed.html	Launched		92.0	I39	L14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10820	10.0	mM	278.0	DMSO	427.149183	14	L	pluskal_fda_drugs_5005_L14_id
1687	HY-B1205	HYCPK40906	J21	HYCPK40906	92z	905.0	1.0	S41	906.0	J21	51-55-8	Atropine	Tropine tropate; DL-Hyoscyamine	289.37	Endogenous Metabolite; mAChR	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Atropine (Tropine tropate) is a competitive muscarinic acetylcholine receptor (mAChR) antagonist with IC50 values of 0.39 and 0.71 nM for Human mAChR M4 and Chicken mAChR M4, respectively. Atropine inhibits ACh-induced relaxations in human pulmonary veins. Atropine can be used for research of anti-myopia and bradycardia[1][2][3][4].	Free Base	C17H23NO3	135978.0	DMSO : ≥ 96.6 mg/mL (333.83 mM); H2O : 2.9 mg/mL (10.02 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease	O=C(O[C@@H]1C[C@@H](N2C)CC[C@@H]2C1)C(CO)C3=CC=CC=C3	https://www.medchemexpress.com/Atropine.html	Launched		92.0	S41	L14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1205	10.0	mM	278.0	DMSO	289.167794	14	L	pluskal_fda_drugs_5005_L14_id
1809	HY-B0106	HYCPK40907	I09	HYCPK40907	92z	786.0	2.0	Q18	907.0	I09	102767-28-2	Levetiracetam	UCB L059	170.21	DNA Methyltransferase	Epigenetics	Levetiracetam, an antiepileptic agent, binds the synaptic vesicle protein SV2A. Levetiracetam enhances Temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Levetiracetam modulates HDAC levels ultimately silencing MGMT, thus increasing Temozolomide effectiveness. A chemosensitizer agent[1][2].	Free Base	C8H14N2O2	42234.0	H2O : ≥ 85 mg/mL (499.38 mM); DMSO : ≥ 85 mg/mL (499.38 mM)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	NC([C@@H](N(CCC1)C1=O)CC)=O	https://www.medchemexpress.com/levetiracetam.html	Launched		92.0	Q18	L14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0106	10.0	mM	278.0	DMSO	170.105528	14	L	pluskal_fda_drugs_5005_L14_id
1994	HY-12502A	HYCPK40907	N21	HYCPK40907	92z	1290.0	2.0	AA42	907.0	N21	111011-76-8	Efonidipine (hydrochloride monoethanolate)	NZ-105 hydrochloride monoethanolate	714.18	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	"Efonidipine hydrochloride monoethanolate (NZ-105 hydrochloride monoethanolate) is a dual T-type and L-type calcium channel blocker (CCB).
IC50 value: 
Target: calcium channel blocker
in vitro: Efonidipine and nifedipine, but not other examined CCBs, also increased the N(6), 2'-O-dibutyryladenosine 3',5'-cyclic monophosphate (dbcAMP)-induced StAR mRNA, which reflects the action of adrenocorticotropic hormone, and efonidipine and R(-)-efonidipine enhanced the dbcAMP-induced DHEA-S production in NCI-H295R adrenocortical carcinoma cells [1]. I(Ca(T)) was blocked mainly by a tonic manner by nifedipine, by a use-dependent manner by mibefradil, and by a combination of both manners by efonidipine. IC50s of these Ca2+ channel antagonists to I(Ca(T)) and L-type Ca2+ channel current (I(Ca(L))) were 1.2 micromol/l and 0.14 nmol/l for nifedipine; 0.87 and 1.4 micromol/l for mibefradil, and 0.35 micromol/l and 1.8 nmol/l for efonidipine, respectively [4].
in vivo: Twenty hypertensive patients on chronic hemodialysis were given efonidipine 20-60 mg twice daily and amlodipine 2.5-7.5 mg once daily for 12 weeks each in a random crossover manner. The average blood pressure was comparable between the efonidipine and amlodipine periods (151 + or - 15/77 + or - 8 versus 153 + or - 15/76 + or - 8 mmHg). The pulse rate did not change significantly during the administration periods [2].  In the UM-X7.1 group, EFO treatment significantly attenuated the decrease of LVEF without affecting blood pressure compared with the vehicle group. EFO treatment decreased heart rate (by approximately 10%) in both groups [3]."	Hydrochloride	C36H45ClN3O8P	38352.0	DMSO : 125 mg/mL (175.03 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC1=C(P2(OCC(C)(C)CO2)=O)C(C3=CC([N+]([O-])=O)=CC=C3)C(C(OCCN(C4=CC=CC=C4)CC5=CC=CC=C5)=O)=C(C)N1.[H]Cl.CCO	https://www.medchemexpress.com/Efonidipine-hydrochloride-monoethanolate.html	Launched		92.0	AA42	L14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12502A	10.0	mM	278.0	DMSO	631.244737	14	L	pluskal_fda_drugs_5005_L14_id
2440	HY-N7139B	HYCPK40909	D04	HYCPK40909	92z	344.0	4.0	H8	909.0	D04	41372-02-5	Penicillin G benzathine (tetrahydrate)	Benzathine benzylpenicillin (tetrahydrate)	981.18	Bacterial	Anti-infection	Penicillin G benzathine tetrahydrate (Benzathine benzylpenicillin tetrahydrate) is an antibiotic against many bacterial infections[1].		C48H64N6O12S2	120459.0	DMSO : ≥ 250 mg/mL (254.80 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(CC3=CC=CC=C3)=O)N1C2=O)O.O=C([C@@H](C(C)(C)S[C@]4([H])[C@@H]5NC(CC6=CC=CC=C6)=O)N4C5=O)O.C7(CNCCNCC8=CC=CC=C8)=CC=CC=C7.O.O.O.O	https://www.medchemexpress.com/penicillin-g-benzathine-tetrahydrate.html	Launched		92.0	H8	L14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7139B	10.0	mM	278.0	DMSO	334.098728	14	L	pluskal_fda_drugs_5005_L14_id
1370	HY-B0777	HYCPK40906	G03	HYCPK40906	92z	581.0	1.0	M5	906.0	G03	113507-06-5	Moxidectin	CL301423	639.82	Antibiotic; Parasite	Anti-infection	"Moxidectin(ProHeart 6; CL301423; Cydectin) is an anthelmintic drug which kills parasitic worms (helminths), and is used for the prevention and control of heartworm and intestinal worms.
IC50 value:
Target: Anti-parasitic
Moxidectin is a semisynthetic derivative of nemadectin, which is produced by fermentation by Streptomyces cyano-griseus. Moxidectin treats and controls some of the most common internal and external parasites by selectively binding to a parasite's glutamate-gated chloride ion channels. These channels are vital to the function of invertebrate nerve and muscle cells; when moxidectin binds to the channels, it disrupts neurotransmission, resulting in paralysis and death of the parasite. Studies of moxidectin show the side effects vary by animal and may be affected by the product’s formulation, application method and dosage."	Free Base	C37H53NO8	16563.0	DMSO : 100 mg/mL (156.29 mM; Need ultrasonic); H2O : 1 mg/mL (1.56 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	C/C([C@H]([C@H](/C1=N/OC)C)O[C@]2(C1)C[C@](OC([C@@](C=C(C)[C@@H](O)[C@@]3([H])OC/C4=C\C=C\[C@H](C)C5)([H])[C@@]34O)=O)([H])C[C@](C/C=C5\C)([H])O2)=C\C(C)C	https://www.medchemexpress.com/moxidectin.html	Launched		92.0	M5	L15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0777	10.0	mM	279.0	DMSO	639.377118	15	L	pluskal_fda_drugs_5005_L15_id
1505	HY-N0193	HYCPK40906	D10	HYCPK40906	92z	307.0	1.0	G19	906.0	D10	88495-63-0	Artesunate		384.42	Ferroptosis; Parasite; STAT; Virus Protease	Anti-infection; Apoptosis; JAK/STAT Signaling; Stem Cell/Wnt	Artesunate is an inhibitor of both STAT-3 and exported protein 1 (EXP1).	Free Acid	C19H28O8	40636.0	H2O : < 0.1 mg/mL (insoluble); 7.5% sodium bicarbonate : 20 mg/mL (52.03 mM; Need ultrasonic); DMSO : 83.33 mg/mL (216.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O[C@H]1[C@H](C)[C@]2([H])CC[C@@H](C)[C@]3([H])CC[C@@](O4)(C)OO[C@]32[C@]4([H])O1)CCC(O)=O	https://www.medchemexpress.com/Artesunate.html	Launched		92.0	G19	L15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0193	10.0	mM	279.0	DMSO	384.178418	15	L	pluskal_fda_drugs_5005_L15_id
1670	HY-B1658A	HYCPK40906	I20	HYCPK40906	92z	807.0	1.0	Q39	906.0	I20	158930-17-7	Frovatriptan (succinate hydrate)	(R)-Frovatriptan (succinate hydrate); SB 209509 (succinate hydrate); VML 251 (succinate hydrate)	379.41	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Frovatriptan succinate hydrate ((R)-Frovatriptan succinate hydrate) is a potent, high affinity, selective and orally active 5-HT1B (pK50 of 8.2) and 5-HT1D receptor agonist. Frovatriptan succinate hydrate exhibits >10-fold selectivity for 5-HT1B and 5-HT1D over 5-HT1A, 5-HT1F, and 5-HT7 and >1000-fold selectivity over other 5-HT, dopamine, histamine H1, and α1-adrenoceptor. Frovatriptan succinate hydrate has the potential for migraine research[1][2].	Succinate	C18H25N3O6	149696.0	DMSO : 100 mg/mL (263.57 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(O)CCC(O)=O.O=C(C1=CC2=C(NC3=C2C[C@H](NC)CC3)C=C1)N.O	https://www.medchemexpress.com/frovatriptan-succinate-hydrate.html	Launched		92.0	Q39	L15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1658A	10.0	mM	279.0	DMSO	243.137162	15	L	pluskal_fda_drugs_5005_L15_id
1740	HY-14605A	HYCPK40907	D05	HYCPK40907	92z	298.0	2.0	G10	907.0	D05	136236-51-6	Rasagiline	(R)-AGN1135; TVP1012	171.24	Monoamine Oxidase	Neuronal Signaling	Rasagiline (R-AGN1135) is a highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor with IC50s of 4.43?nM and 412?nM for rat brain MAO B and A activity, respectively[1].	Free Base	C12H13N	98718.0	DMSO : 100 mg/mL (583.98 mM; Need ultrasonic); H2O : ≥ 5.88 mg/mL (34.34 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	C#CCN[C@H]1C2=CC=CC=C2CC1	https://www.medchemexpress.com/rasagiline.html	Launched		92.0	G10	L15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14605A	10.0	mM	279.0	DMSO	171.104799	15	L	pluskal_fda_drugs_5005_L15_id
1808	HY-B1330	HYCPK40907	H09	HYCPK40907	92z	690.0	2.0	O18	907.0	H09	6620-60-6	Proglumide		334.41	Cholecystokinin Receptor	GPCR/G Protein; Neuronal Signaling	Proglumide is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide selective blocks CCK’s effects in the central nervous system (CNS). Proglumide has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide also has antiepileptic and antioxidant activities[1][2][3][4][5].	Free Acid	C18H26N2O4	58886.0	DMSO : ≥ 65 mg/mL (194.37 mM)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Neurological Disease	O=C(O)CCC(NC(C1=CC=CC=C1)=O)C(N(CCC)CCC)=O	https://www.medchemexpress.com/Proglumide.html	Launched		92.0	O18	L15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1330	10.0	mM	279.0	DMSO	334.189257	15	L	pluskal_fda_drugs_5005_L15_id
2083	HY-13781	HYCPK40908	L07	HYCPK40908	92z	1117.0	3.0	X13	908.0	L07	357166-30-4	Pemetrexed (disodium hemipenta hydrate)	LY231514 (disodium hemipenta hydrate)	516.41	Antifolate; Apoptosis; Autophagy	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Pemetrexed disodium hemipenta hydrate is a novel antifolate, the Ki values of the pentaglutamate of LY231514 are 1.3, 7.2, and 65 nM for inhibits thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), respectively.	Sodium	C20H24N5Na2O8.5	8602.0	H2O : 100 mg/mL (193.64 mM; Need ultrasonic); DMSO : 2 mg/mL (3.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O[Na])CC[C@@H](C(O[Na])=O)NC(C1=CC=C(CCC2=CNC(N=C(N)N3)=C2C3=O)C=C1)=O.[2.5H2O]	https://www.medchemexpress.com/Pemetrexed-disodium-hemipenta-hydrate_-1:2:2.5.html	Launched		92.0	X13	L15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13781	10.0	mM	279.0	DMSO	427.149183	15	L	pluskal_fda_drugs_5005_L15_id
2505	HY-N0471	HYCPK40909	L08	HYCPK40909	92z	1120.0	4.0	X16	909.0	L08	101-31-5	L-Hyoscyamine	Daturine	289.37	mAChR	GPCR/G Protein; Neuronal Signaling	L-Hyoscyamine (Daturine), a natural plant tropane alkaloid, is a potent and competitive muscarinic receptor (MR) antagonist. L-Hyoscyamine is a levo-isomer to Atropine (HY-B1205)[1][2].	Free Base	C17H23NO3	23213.0	DMSO : 100 mg/mL (345.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1[C@@H]2C[C@@H](OC([C@@H](C3=CC=CC=C3)CO)=O)C[C@H]1CC2	https://www.medchemexpress.com/L-Hyoscyamine.html	Launched		92.0	X16	L15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0471	10.0	mM	279.0	DMSO	289.167794	15	L	pluskal_fda_drugs_5005_L15_id
2523	HY-15206	HYCPK40909	N09	HYCPK40909	92z	1314.0	4.0	AB18	909.0	N09	10238-21-8	Glibenclamide	Glyburide	494.00	Autophagy; CFTR; Mitochondrial Metabolism; P-glycoprotein; Potassium Channel	Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) inhibitor and can be used for the research of diabetes and obesity[1]. Glibenclamide inhibits P-glycoprotein. Glibenclamide directly binds and blocks the SUR1 subunits of KATP and inhibits the cystic fibrosis transmembrane conductance regulator protein (CFTR)[3]. Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability[4]. Glibenclamide can induce autophagy[5].	Free Base	C23H28ClN3O5S	11855.0	DMSO : 250 mg/mL (506.07 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.20 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Metabolic Disease	ClC1=CC(C(NCCC2=CC=C(S(NC(NC3CCCCC3)=O)(=O)=O)C=C2)=O)=C(OC)C=C1	https://www.medchemexpress.com/glibenclamide.html	Launched		92.0	AB18	L15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15206	10.0	mM	279.0	DMSO	493.14382	15	L	pluskal_fda_drugs_5005_L15_id
1428	HY-14188	HYCPK40906	A07	HYCPK40906	92z	13.0	1.0	A13	906.0	A07	19774-82-4	Amiodarone (hydrochloride)		681.77	Autophagy; Potassium Channel	Autophagy; Membrane Transporter/Ion Channel	Amiodarone hydrochloride, a benzofuran-based Class III antiarrhythmic agent, inhibits WT outwardIhERG tails with an IC50 of ～45 nM[1]. Amiodarone hydrochloride induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts[2]. Amiodarone hydrochloride can be used in the research of both supraventricular and ventricular arrhythmias[1].	Hydrochloride	C25H30ClI2NO3	60800.0	DMSO : 24.5 mg/mL (35.94 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	CCCCC1=C(C(C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)=O)C3=C(O1)C=CC=C3.Cl	https://www.medchemexpress.com/Amiodarone-hydrochloride.html	Launched		92.0	A13	L16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14188	10.0	mM	280.0	DMSO	645.02369	16	L	pluskal_fda_drugs_5005_L16_id
1582	HY-12720A	HYCPK40906	A15	HYCPK40906	92z	29.0	1.0	A29	906.0	A15	73218-79-8	Apraclonidine (hydrochloride)	ALO 2145	281.57	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Apraclonidine hydrochloride (ALO 2145), a selective α2 and weak α1 receptor agonist activity, effectively lowers intraocular pressure (IOP) in human eyes. Apraclonidine hydrochloride is a topical ophthalmic solution and has the ability to elevate the eye lid[1][2].	Hydrochloride	C9H11Cl3N4	132616.0	H2O : ≥ 12.5 mg/mL (44.39 mM); DMSO : 125 mg/mL (443.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1.[H]Cl	https://www.medchemexpress.com/apraclonidine-hydrochloride.html	Launched		92.0	A29	L16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12720A	10.0	mM	280.0	DMSO	244.028252	16	L	pluskal_fda_drugs_5005_L16_id
1620	HY-B0364A	HYCPK40906	G17	HYCPK40906	92z	609.0	1.0	M33	906.0	G17	536-43-6	Dyclonine (hydrochloride)	Dyclocaine hydrochloride	325.87	Aldehyde Dehydrogenase (ALDH); Bacterial; Fungal	Anti-infection; Metabolic Enzyme/Protease	Dyclonine (Dyclocaine) hydrochloride is an orally effective ALDH covalent inhibitor (crosses blood-brain barrier), with an IC50 of 35 μM for ALDH2 and 76 μM for ALDH3A1. Dyclonine hydrochloride has sensitizing activities for targeted cancer cells and antibacterial. Dyclonine hydrochloride is also a local anesthetic that blocks the transmission of various nerve impulses or stimuli and inhibits the sensation of touch and pain[1][2][3].	Hydrochloride	C18H28ClNO2	14744.0	DMSO : ≥ 25 mg/mL (76.72 mM); H2O : 50 mg/mL (153.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(C1=CC=C(OCCCC)C=C1)CCN2CCCCC2.Cl	https://www.medchemexpress.com/dyclonine-hydrochloride.html	Launched		92.0	M33	L16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0364A	10.0	mM	280.0	DMSO	289.204179	16	L	pluskal_fda_drugs_5005_L16_id
1794	HY-10888	HYCPK40907	J08	HYCPK40907	92z	880.0	2.0	S16	907.0	J08	155270-99-8	Istradefylline	KW-6002	384.43	Adenosine Receptor	GPCR/G Protein	Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson's disease.	Free Base	C20H24N4O4	66729.0	DMSO : 25.33 mg/mL (65.89 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1C2=C(N=C(/C=C/C3=CC(OC)=C(OC)C=C3)N2C)N(CC)C(N1CC)=O	https://www.medchemexpress.com/Istradefylline.html	Launched		92.0	S16	L16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10888	10.0	mM	280.0	DMSO	384.179755	16	L	pluskal_fda_drugs_5005_L16_id
1798	HY-17490	HYCPK40907	N08	HYCPK40907	92z	1264.0	2.0	AA16	907.0	N08	33996-33-7	Oxaceprol	N-Acetyl-L-hydroxyproline	173.17	Others	Others	Oxaceprol (N-Acetyl-L-hydroxyproline), an orally active derivative of L-proline, possesses distinct anti-inflammatory activity. Oxaceprol is usually used for the research of osteoarthritis and rheumatoid arthritis[1][2].	Free Acid	C7H11NO4	20978.0	DMSO : ≥ 100 mg/mL (577.47 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O)[C@H]1N(C(C)=O)C[C@H](O)C1	https://www.medchemexpress.com/Oxaceprol.html	Launched		92.0	AA16	L16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17490	10.0	mM	280.0	DMSO	173.068808	16	L	pluskal_fda_drugs_5005_L16_id
1835	HY-50946	HYCPK40907	C11	HYCPK40907	92z	214.0	2.0	E22	907.0	C11	220127-57-1	Imatinib (Mesylate)	STI571 (Mesylate); CGP-57148B (Mesylate)	589.71	Autophagy; Bcr-Abl; c-Kit; PDGFR	Autophagy; Protein Tyrosine Kinase/RTK	Imatinib Mesylate (STI571 Mesylate) is a tyrosine kinases inhibitor that inhibits c-Kit, Bcr-Abl, and PDGFR (IC50=100 nM) tyrosine kinases.	Mesylate	C30H35N7O4S	25212.0	DMSO : 125 mg/mL (211.97 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (84.79 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=S(O)(C)=O.O=C(NC1=CC=C(C(NC2=NC=CC(C3=CC=CN=C3)=N2)=C1)C)C4=CC=C(CN5CCN(CC5)C)C=C4	https://www.medchemexpress.com/Imatinib-Mesylate.html	Launched		92.0	E22	L16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50946	10.0	mM	280.0	DMSO	493.259009	16	L	pluskal_fda_drugs_5005_L16_id
2223	HY-B1130	HYCPK40908	P16	HYCPK40908	92z	1519.0	3.0	AF31	908.0	P16	34552-84-6	Isoxicam		335.34	COX	Immunology/Inflammation	Isoxicam is an orally active, long-acting, non-steroidal anti-inflammatory agent for the research of arthritis[1]. Isoxicam is a nonselective inhibitor of COX-1 and COX-2[2].	Free Base	C14H13N3O5S	64330.0	DMSO : 5 mg/mL (14.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=C(O)C2=CC=CC=C2S(N1C)(=O)=O)NC3=NOC(C)=C3	https://www.medchemexpress.com/isoxicam.html	Launched		92.0	AF31	L16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1130	10.0	mM	280.0	DMSO	335.057592	16	L	pluskal_fda_drugs_5005_L16_id
2426	HY-123593	HYCPK40909	F03	HYCPK40909	92z	534.0	4.0	L6	909.0	F03	138470-70-9	Mozavaptan (hydrochloride)	OPC-31260 (hydrochloride)	464.00	Vasopressin Receptor	GPCR/G Protein	Mozavaptan hydrochloride (OPC-31260 hydrochloride) is a benzazepine derivative and a potent, selective, competitive and orally active vasopressin V2 receptor antagonist with an IC50 of 14 nM. Mozavaptan hydrochloride shows ~85-fold selectivity for V2 receptor over V1 receptor (IC50 of 1.2 μM), and can antagonize the antidiuretic action of arginine vasopressin (AVP) in vivo. Mozavaptan hydrochloride has the potential for hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), and congestive heart failure treatment[1][2].	Hydrochloride	C27H30ClN3O2	61997.0	DMSO : 20.83 mg/mL (44.89 mM; Need ultrasonic); H2O : 10 mg/mL (21.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Metabolic Disease	CC1=CC=CC=C1C(NC2=CC=C(C(N3C(C=CC=C4)=C4C(N(C)C)CCC3)=O)C=C2)=O.Cl	https://www.medchemexpress.com/mozavaptan-hydrochloride.html	Launched		92.0	L6	L16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-123593	10.0	mM	280.0	DMSO	427.225977	16	L	pluskal_fda_drugs_5005_L16_id
1524	HY-N0898	HYCPK40906	G11	HYCPK40906	92z	597.0	1.0	M21	906.0	G11	154-23-4	Catechin	(+)-Catechin; Cianidanol; Catechuic acid	290.27	Apoptosis; COX; Endogenous Metabolite; Influenza Virus	Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease	Catechin ((+)-Catechin) inhibits cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM.	Free Base	C15H14O6	55382.0	DMSO : ≥ 100 mg/mL (344.51 mM); H2O : 12.5 mg/mL (43.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O[C@@H]1[C@@H](C2=CC(O)=C(O)C=C2)OC3=CC(O)=CC(O)=C3C1	https://www.medchemexpress.com/Catechin.html	Launched		92.0	M21	L17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0898	10.0	mM	281.0	DMSO	290.079038	17	L	pluskal_fda_drugs_5005_L17_id
1556	HY-108880	HYCPK40906	G13	HYCPK40906	92z	601.0	1.0	M25	906.0	G13	26605-69-6	Carindacillin (sodium)	Carbenicillin indanyl sodium; CP-15464-2	516.54	Bacterial	Anti-infection	Carindacillin (Carbenicillin indanyl) sodium is an orally active and broad-spectrum antimicrobial agent. Carindacillin sodium can be hydrolyzed to Carbenicillin in vivo. Carindacillin sodium can be used for the research of urinary-tract infection[1][2].	Sodium	C26H25N2NaO6S	127053.0	DMSO : 250 mg/mL (483.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(C1=CC=CC=C1)C(OC2=CC=C3C(CCC3)=C2)=O)N[C@H]4[C@](SC(C)5C)([H])N(C4=O)[C@H]5C(O[Na])=O	https://www.medchemexpress.com/carindacillin-sodium.html	Launched		92.0	M25	L17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108880	10.0	mM	281.0	DMSO	494.151158	17	L	pluskal_fda_drugs_5005_L17_id
1675	HY-B0166	HYCPK40906	N20	HYCPK40906	92z	1287.0	1.0	AA39	906.0	N20	50-81-7	L-Ascorbic acid	L-Ascorbate; Vitamin C	176.12	Apoptosis; Calcium Channel; Endogenous Metabolite; Reactive Oxygen Species	Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB	L-Ascorbic acid (L-Ascorbate), an electron donor, is an endogenous antioxidant agent. L-Ascorbic acid inhibits selectively Cav3.2 channels with an IC50 of 6.5 μM. L-Ascorbic acid is also a collagen deposition enhancer and an elastogenesis inhibitor[1][2][3]. L-Ascorbic acid exhibits anti-cancer effects through the generation of reactive oxygen species (ROS) and selective damage to cancer cells[4].	Free Base	C6H8O6	16468.0	DMSO : 100 mg/mL (567.79 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (567.79 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Neurological Disease	OC([C@@]1([H])[C@H](CO)O)=C(O)C(O1)=O	https://www.medchemexpress.com/L-Ascorbic-acid.html	Launched		92.0	AA39	L17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0166	10.0	mM	281.0	DMSO	176.032088	17	L	pluskal_fda_drugs_5005_L17_id
1801	HY-10227	HYCPK40907	A09	HYCPK40907	92z	18.0	2.0	A18	907.0	A09	179324-69-7	Bortezomib	PS-341; LDP-341; NSC 681239	384.24	Apoptosis; Autophagy; NF-κB; Proteasome	Apoptosis; Autophagy; Metabolic Enzyme/Protease; NF-κB	Bortezomib (PS-341) is a reversible and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki=0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-κB. Bortezomib is the first proteasome inhibitor anticancer agent. Anti-cancer activity[1][2].	Free Base	C19H25BN4O4	99036.0	DMSO : 50 mg/mL (130.13 mM; Need ultrasonic); Ethanol : 66.67 mg/mL (173.51 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	OB(O)[C@H](CC(C)C)NC([C@@H](NC(C1=NC=CN=C1)=O)CC2=CC=CC=C2)=O	https://www.medchemexpress.com/Bortezomib.html	Launched		92.0	A18	L17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10227	10.0	mM	281.0	DMSO	384.196886	17	L	pluskal_fda_drugs_5005_L17_id
1914	HY-B1216	HYCPK40907	J16	HYCPK40907	92z	896.0	2.0	S32	907.0	J16	52432-72-1	Oxeladin (citrate)		527.60	Others	Others	Oxeladin citrate is a cough suppressant, is a highly potent and effective drug used to treat all types of cough of various etiologies.	Citrate	C26H41NO10	27566.0	DMSO : ≥ 100 mg/mL (189.54 mM); H2O : ≥ 50 mg/mL (94.77 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCCOCCN(CC)CC)C(CC)(CC)C1=CC=CC=C1.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Oxeladin-citrate.html	Launched		92.0	S32	L17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1216	10.0	mM	281.0	DMSO	335.246044	17	L	pluskal_fda_drugs_5005_L17_id
2204	HY-B0210A	HYCPK40908	I15	HYCPK40908	92z	845.0	3.0	R29	908.0	I15	62893-20-3	Cefoperazone (sodium salt)	CP 52640-2	667.65	Antibiotic; Bacterial	Anti-infection	Cefoperazone sodium salt (CP 52640-2), a semisynthetic cephalosporin, has a broad spectrum of antibacterial activity[1].	Sodium	C25H26N9NaO8S2	44480.0	H2O : 60 mg/mL (89.87 mM; Need ultrasonic); DMSO : 250 mg/mL (374.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@H](NC([C@H](NC(N4C(C(N(CC)CC4)=O)=O)=O)C5=CC=C(O)C=C5)=O)C1=O)O[Na]	https://www.medchemexpress.com/Cefoperazone-sodium-salt.html	Launched		92.0	R29	L17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0210A	10.0	mM	281.0	DMSO	645.142401	17	L	pluskal_fda_drugs_5005_L17_id
2247	HY-B0280	HYCPK40908	H18	HYCPK40908	92z	755.0	3.0	P35	908.0	H18	95635-55-5	Ranolazine	CVT 303; RS 43285-003	427.54	Calcium Channel; Sodium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Ranolazine (CVT 303) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50  values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP)[1][2]. Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor[3]. Antianginal agent.	Free Base	C24H33N3O4	37671.0	DMSO : 125 mg/mL (292.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(NC1=C(C)C=CC=C1C)CN2CCN(CC(O)COC3=CC=CC=C3OC)CC2	https://www.medchemexpress.com/ranolazine.html	Launched		92.0	P35	L17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0280	10.0	mM	281.0	DMSO	427.247107	17	L	pluskal_fda_drugs_5005_L17_id
2422	HY-10586	HYCPK40909	B03	HYCPK40909	92z	150.0	4.0	D6	909.0	B03	320-67-2	5-Azacytidine	Azacitidine; 5-AzaC; Ladakamycin	244.20	Antibiotic; Autophagy; Bacterial; DNA Methyltransferase; Nucleoside Antimetabolite/Analog	Anti-infection; Autophagy; Cell Cycle/DNA Damage; Epigenetics	5-Azacytidine (Azacitidine; 5-AzaC; Ladakamycin) is a nucleoside analogue of cytidine that specifically inhibits DNA methylation. 5-Azacytidine is incorporated into DNA to covalently trap DNA methyltransferases and contributes to reverse epigenetic changes[1][2]. 5-Azacytidine induces cell autophagy[4].	Free Base	C8H12N4O5	212382.0	DMSO : ≥ 31 mg/mL (126.95 mM); H2O : 33.33 mg/mL (136.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C=NC(N)=NC2=O)O1	https://www.medchemexpress.com/5-Azacytidine.html	Launched		92.0	D6	L17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10586	10.0	mM	281.0	DMSO	244.080769	17	L	pluskal_fda_drugs_5005_L17_id
9	HY-N0355	HYCPK40897	I03	HYCPK40909	92z	852.0	4.0	R36	909.0	I18	225937-10-0	(+)-Catechin hydrate			COX	Immunology/Inflammation	(+)-Catechin hydrate inhibits cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM.	hydrate	C15H14O6.xH2O	28488.0	DMSO : 50 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Cancer	OC1=CC(O)=C(C[C@H](O)[C@@H](C2=CC=C(O)C(O)=C2)O3)C3=C1.[xH2O]	https://www.medchemexpress.com/__addition__-Catechin_hydrate.html	Launched		92.0	R36	L18	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0355	3.0	mM	282.0	DMSO	290.079038	18	L	pluskal_fda_drugs_5005_L18_id
1410	HY-N0281	HYCPK40906	O05	HYCPK40906	92z	1353.0	1.0	AC9	906.0	O05	486-35-1	Daphnetin	7,8-Dihydroxycoumarin	178.14	Akt; AMPK; Apoptosis; Autophagy; Bcl-2 Family; Caspase; EGFR; mTOR; Parasite; PARP; PKA; PKC; Reactive Oxygen Species	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; Immunology/Inflammation; JAK/STAT Signaling; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; TGF-beta/Smad	Daphnetin (7,8-dihydroxycoumarin), one coumarin derivative can be found in plants of the Genus Daphne, is a potent, oral active protein kinase inhibitor, with IC50s of 7.67 μM, 9.33 μM and 25.01 μM for EGFR, PKA and PKC in vitro, respectively. Daphnetin triggers ROS-induced cell apoptosis and induces cytoprotective autophagy by modulating the AMPK/Akt/mTOR pathway. Daphnetin has anti-inflammation activitity and inhibits TNF-α, IL-1?, ROS, and MDA production. Daphnetin has schizontocidal activity against malaria parasites. Daphnetin can be used for rheumatoid arthritis , cancer and anti-malarian research[1][2][3][4].	Free Base	C9H6O4	32284.0	DMSO : 50 mg/mL (280.68 mM; Need ultrasonic); H2O : 1 mg/mL (5.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C1C=CC2=CC=C(O)C(O)=C2O1	https://www.medchemexpress.com/Daphnetin.html	Launched		92.0	AC9	L18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0281	10.0	mM	282.0	DMSO	178.026609	18	L	pluskal_fda_drugs_5005_L18_id
1539	HY-14557A	HYCPK40906	F12	HYCPK40906	92z	503.0	1.0	K23	906.0	F12	706782-28-7	Pimavanserin (hemitartrate)	ACP-103 (hemitartrate)	502.59	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Pimavanserin (ACP-103) hemitartrate is a potent 5-HT 2A receptor inverse agonist with pIC50 and pKi of 8.73 and 9.3, respectively.	Tartrate	C25H34FN3O2.1/2C4H6O6	37557.0	DMSO : ≥ 75 mg/mL (149.23 mM); H2O : 50 mg/mL (99.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(O)[C@H](O)[C@@H](O)C(O)=O.O=C(NCC1=CC=C(OCC(C)C)C=C1)N(CC2=CC=C(F)C=C2)C3CCN(C)CC3.[1/2]	https://www.medchemexpress.com/Pimavanserin_tartrate.html	Launched		92.0	K23	L18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14557A	10.0	mM	282.0	DMSO	427.263506	18	L	pluskal_fda_drugs_5005_L18_id
1611	HY-18258	HYCPK40906	N16	HYCPK40906	92z	1279.0	1.0	AA31	906.0	N16	633-65-8	Berberine (chloride)	Natural Yellow 18 (chloride)	371.81	Antibiotic; Autophagy; Bacterial; Endogenous Metabolite; Parasite; Reactive Oxygen Species; Topoisomerase	Anti-infection; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties[1].	Chloride	C20H18ClNO4	62647.0	H2O : < 0.1 mg/mL (ultrasonic) (insoluble); DMSO : 12.5 mg/mL (33.62 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	COC1=C(OC)C2=C[N+]3=C(C(C(CC3)=C4)=CC5=C4OCO5)C=C2C=C1.[Cl-]	https://www.medchemexpress.com/Berberine-chloride.html	Launched		92.0	AA31	L18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18258	10.0	mM	282.0	DMSO	336.123034	18	L	pluskal_fda_drugs_5005_L18_id
1702	HY-B0434	HYCPK40906	I22	HYCPK40906	92z	811.0	1.0	Q43	906.0	I22	36791-04-5	Ribavirin	ICN-1229	244.20	Antibiotic; HCV; Orthopoxvirus; RSV	Anti-infection	Ribavirin (ICN-1229) is an antiviral agent against a broad spectrum of viruses including HCV, HIVl, and RSV. Ribavirin also has anti-orthopoxvirus and anti-variola activities.	Free Base	C8H12N4O5	110681.0	H2O : 100 mg/mL (409.50 mM; Need ultrasonic); DMSO : 100 mg/mL (409.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O[C@H]1[C@@H](O)[C@H](N2C=NC(C(N)=O)=N2)O[C@@H]1CO	https://www.medchemexpress.com/ribavirin.html	Launched		92.0	Q43	L18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0434	10.0	mM	282.0	DMSO	244.080769	18	L	pluskal_fda_drugs_5005_L18_id
1902	HY-B0485	HYCPK40907	N15	HYCPK40907	92z	1278.0	2.0	AA30	907.0	N15	356-12-7	Fluocinonide		494.52	Glucocorticoid Receptor	Immunology/Inflammation	"Fluocinonide (Vanos) is a potent glucocorticoid steroid used topically as anti-inflammatory agent for the treatment of skin disorders.
Target: Glucocorticoid Receptor
Fluocinonide is a potent glucocorticoid steroid used topically as an anti-inflammatory agent for the treatment of skin disorders such as eczema and seborrhoeic dermatitis. Fluocinonide ranks as a ""high-potency"" topical corticosteroid. Minimal amounts should be used for a minimal length of time to avoid the occurrence of adverse effects. Fluocinonide should not be used if infection is present. Fluocinonide is used in veterinary medicine. It is a treatment for allergies in dogs. Natural systemic cortisol concentrations can be suppressed for weeks after one week of topical exposure. From Wikipedia."	Free Base	C26H32F2O7	27135.0	DMSO : 100 mg/mL (202.22 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](C[C@H](F)C3=CC4=O)([H])[C@@](F)([C@]3(C=C4)C)[C@@H](O)C5)(OC(C)(C)O1)[C@]25C)COC(C)=O	https://www.medchemexpress.com/Fluocinonide.html	Launched		92.0	AA30	L18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0485	10.0	mM	282.0	DMSO	494.21161	18	L	pluskal_fda_drugs_5005_L18_id
2131	HY-13463B	HYCPK40908	L10	HYCPK40908	92z	1123.0	3.0	X19	908.0	L10	570403-17-7	Avatrombopag (hydrochloride)	AKR-501 (hydrochloride); E5501 (hydrochloride); YM477 (hydrochloride)	686.12	Thrombopoietin Receptor	Immunology/Inflammation	Avatrombopag (AKR-501) hydrochloride is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag hydrochloride mimics the biological activities of TPO. Avatrombopag hydrochloride increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag hydrochloride is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A[1][2][3].	Hydrochloride	C29H35Cl3N6O3S2	20014.0	DMSO : 8.33 mg/mL (12.14 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(C1CCN(C2=NC=C(C(NC3=NC(C4=CC(Cl)=CS4)=C(N5CCN(C6CCCCC6)CC5)S3)=O)C=C2Cl)CC1)O.Cl	https://www.medchemexpress.com/avatrombopag-hydrochloride.html	Launched		92.0	X19	L18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13463B	10.0	mM	282.0	DMSO	648.151086	18	L	pluskal_fda_drugs_5005_L18_id
2166	HY-13676	HYCPK40908	C13	HYCPK40908	92z	265.0	3.0	F25	908.0	C13	595-33-5	Megestrol acetate		384.51	Autophagy; HIV; Progesterone Receptor	Anti-infection; Autophagy; Others	Megestrol acetate is a synthetic and orally active progesteronal agent. Megestrol acetate is effective as an appetite stimulant for wasting syndromes such as cachexia. Megestrol acetate decreases nuclear and cytosol androgen receptors human BPH tissue. Megestrol acetate has the potential for HIV study and downregulates autophagic catabolic pathway[1][2][3][4][5].<br/>	Free Base	C24H32O4	15186.0	DMSO : 20 mg/mL (52.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	CC([C@@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])C=C(C)C4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O	https://www.medchemexpress.com/Megestrol-Acetate.html	Launched		92.0	F25	L18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13676	10.0	mM	282.0	DMSO	384.23006	18	L	pluskal_fda_drugs_5005_L18_id
39	HY-A0070	HYCPK40899	A04	HYCPK40909	92z	78.0	4.0	B30	909.0	A15	55-06-1	Liothyronine (sodium)	Triiodothyronine (sodium); 3,3',5-Triiodo-L-thyronine (sodium); T3 (sodium)	672.96	Endogenous Metabolite; Thyroid Hormone Receptor	Metabolic Enzyme/Protease; Others	Liothyronine sodium is an active form of thyroid hormone.  Liothyronine sodium is a potent thyroid hormone receptors TRα and TRβ agonist with Kis of 2.33 nM for hTRα and hTRβ, respectively[1][2][3].	Sodium	C15H11I3NNaO4	15896.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); 0.1 M NaOH : 12.5 mg/mL (18.57 mM; ultrasonic and adjust pH to 11 with NaOH); DMSO : 5.56 mg/mL (8.26 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Cancer; Endocrinology	N[C@@H](CC1=CC(I)=C(C(I)=C1)OC2=CC=C(O)C(I)=C2)C(O[Na])=O	https://www.medchemexpress.com/3,3_acute_,5-Triiodo-L-thyronine-sodium.html	Launched		92.0	B30	L19	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0070	2.0	mM	283.0	DMSO	650.790052	19	L	pluskal_fda_drugs_5005_L19_id
1568	HY-107961	HYCPK40906	C14	HYCPK40906	92z	219.0	1.0	E27	906.0	C14	33564-31-7	Diflorasone diacetate		494.52	Others	Others	Diflorasone diacetate is an anti-inflammatory steroid compound used as locally or topically agent. Diflorasone diacetate is being used for skin disorders to control corticosteroid-responsive dermatoses[1].		C26H32F2O7	159087.0	DMSO : 100 mg/mL (202.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(OCC([C@]1(OC(C)=O)[C@]2(C)[C@@]([H])(C[C@@H]1C)[C@]3([C@@]([C@]4(C)C([C@H](C3)F)=CC(C=C4)=O)([C@H](C2)O)F)[H])=O)=O	https://www.medchemexpress.com/diflorasone-diacetate.html	Launched		92.0	E27	L19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107961	10.0	mM	283.0	DMSO	494.21161	19	L	pluskal_fda_drugs_5005_L19_id
1731	HY-B2245	HYCPK40907	F04	HYCPK40907	92z	488.0	2.0	K8	907.0	F04	113-38-2	Estradiol dipropionate		384.51	Estrogen Receptor/ERR; Progesterone Receptor	Others	Estradiol dipropionate is a combined estrogen-progesterone, acts as an estrogen and progesterone agonist[1].		C24H32O4	78872.0	DMSO : 62.5 mg/mL (162.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	C[C@@]12[C@@H](OC(CC)=O)CC[C@@]1([H])[C@]3([H])CCC4=C(C=CC(OC(CC)=O)=C4)[C@@]3([H])CC2	https://www.medchemexpress.com/estradiol-dipropionate.html	Launched		92.0	K8	L19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2245	10.0	mM	283.0	DMSO	384.23006	19	L	pluskal_fda_drugs_5005_L19_id
1849	HY-B1589A	HYCPK40907	A12	HYCPK40907	92z	24.0	2.0	A24	907.0	A12	3505-38-2	Carbinoxamine maleate salt		406.86	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Carbinoxamine maleate salt is a histamine H1 receptor antagonist.	Maleate	C20H23ClN2O5	27080.0	DMSO : 100 mg/mL (245.78 mM; Need ultrasonic); H2O : 50 mg/mL (122.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	ClC1=CC=C(C(C2=NC=CC=C2)OCCN(C)C)C=C1.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/Carbinoxamine_maleate_salt.html	Launched		92.0	A24	L19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1589A	10.0	mM	283.0	DMSO	290.118591	19	L	pluskal_fda_drugs_5005_L19_id
1901	HY-N0716B	HYCPK40907	M15	HYCPK40907	92z	1182.0	2.0	Y30	907.0	M15	633-66-9	Berberine (sulfate)	Natural Yellow 18 (sulfate)	433.43	Autophagy; Bacterial; Parasite; Reactive Oxygen Species; Topoisomerase	Anti-infection; Autophagy; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Berberine sulfate is an alkaloid isolated from the Chinese herbal medicine Huanglian, as an antibiotic. Berberine sulfate induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Berberine sulfate has antineoplastic properties[1].	Sulfate	C20H19NO8S	178735.0	DMSO : 5 mg/mL (11.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	COC1=C(OC)C2=C[N+]3=C(C(C(CC3)=C4)=CC5=C4OCO5)C=C2C=C1.O=S(O)([O-])=O	https://www.medchemexpress.com/berberine-sulfate.html	Launched		92.0	Y30	L19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0716B	10.0	mM	283.0	DMSO	336.123034	19	L	pluskal_fda_drugs_5005_L19_id
2142	HY-12866A	HYCPK40908	K11	HYCPK40908	92z	1029.0	3.0	V21	908.0	K11	1223405-08-0	Larotrectinib sulfate	LOXO-101 (sulfate); ARRY-470 (sulfate)	526.51	Apoptosis; Trk Receptor	Apoptosis; Neuronal Signaling; Protein Tyrosine Kinase/RTK	Larotrectinib sulfate (LOXO-101 sulfate; ARRY-470 sulfate) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).	Sulfate	C21H24F2N6O6S	26690.0	DMSO : 50 mg/mL (94.96 mM; Need ultrasonic); H2O : 2 mg/mL (3.80 mM; ultrasonic and adjust pH to 2 with 1M HCl)	DMSO Solution	10mM  * 100uL	Cancer	O=S(O)(O)=O.O=C(N1CC[C@H](O)C1)NC2=C3N=C(N4[C@@H](C5=CC(F)=CC=C5F)CCC4)C=CN3N=C2	https://www.medchemexpress.com/LOXO-101-sulfate.html	Launched		92.0	V21	L19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12866A	10.0	mM	283.0	DMSO	428.17723	19	L	pluskal_fda_drugs_5005_L19_id
2144	HY-B0511	HYCPK40908	M11	HYCPK40908	92z	1221.0	3.0	Z21	908.0	M11	58-85-5	Biotin	Vitamin B7; Vitamin H; D-Biotin	244.31	Endogenous Metabolite	Metabolic Enzyme/Protease	Biotin (Vitamin B7) is a water-soluble B vitamin and serves as a coenzyme for five carboxylases in humans, involved in the synthesis of fatty acids, isoleucine, and valine, and in gluconeogenesis. Biotin is necessary for cell growth, the production of fatty acids, and the metabolism of fats and amino acids[1][2][3].	Free Acid	C10H16N2O3S	16768.0	DMSO : 100 mg/mL (409.32 mM; Need ultrasonic); H2O : 1 mg/mL (4.09 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)CCCC[C@@H]1SC[C@]([C@]1([H])N2)([H])NC2=O	https://www.medchemexpress.com/biotin.html	Launched		92.0	Z21	L19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0511	10.0	mM	283.0	DMSO	244.088163	19	L	pluskal_fda_drugs_5005_L19_id
2296	HY-B0476	HYCPK40908	I21	HYCPK40908	92z	857.0	3.0	R41	908.0	I21	62-44-2	Phenacetin	Acetophenetidin	179.22	COX	Immunology/Inflammation	Phenacetin (Acetophenetidin) is a non-opioid analgesic/antipyretic agent. Phenacetin is a selective COX-3 inhibitor. Phenacetin is used as probe of cytochrome P450 enzymes CYP1A2 in human liver microsomes and in rats[1][2][3].	Free Base	C10H13NO2	17022.0	H2O : 0.67 mg/mL (3.74 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (557.97 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(NC1=CC=C(OCC)C=C1)=O	https://www.medchemexpress.com/phenacetin.html	Launched		92.0	R41	L19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0476	10.0	mM	283.0	DMSO	179.094629	19	L	pluskal_fda_drugs_5005_L19_id
36	HY-B0655	HYCPK40899	N03	HYCPK40909	92z	1324.0	4.0	AB28	909.0	N14	81938-43-4	Zofenopril (calcium)	SQ26991	448.58	Angiotensin-converting Enzyme (ACE); Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	"Zofenopril Calcium (SQ26991) is an antioxidant that acts as an angiotensin-converting enzyme inhibitor.
Target: ACE
Zofenopril Calcium is a pro-drug designed to undergo metabolic hydrolysis yielding the active free sulfhydryl compound zofenoprilat, which is an angiotensin converting enzyme (ACE) inhibitor [1]. Zofenopril Calcium promotes the regeneration of peripheral nerve injuries in rat models [2]. Zofenopril Calcium increases SR calcium cycling and stimulates active calcium uptake into the SR [3]."	Calcium	C22H22Ca0.5NO4S2	12359.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 2 mg/mL (4.46 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Cardiovascular Disease	O=C(N(C[C@@H](SC1=CC=CC=C1)C2)[C@@H]2C([O-])=O)[C@H](C)CSC(C3=CC=CC=C3)=O.[0.5Ca2+]	https://www.medchemexpress.com/Zofenopril-calcium.html	Launched		92.0	AB28	L20	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0655	2.0	mM	284.0	DMSO	429.10685	20	L	pluskal_fda_drugs_5005_L20_id
1478	HY-B0387	HYCPK40906	I08	HYCPK40906	92z	783.0	1.0	Q15	906.0	I08	122647-32-9	Ibutilide (fumarate)	U70226E	442.61	Potassium Channel	Membrane Transporter/Ion Channel	Ibutilide (U70226E) fumarate, an action potential-prolonging antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells[1].	Fumarate	C22H38N2O5S	16530.0	DMSO : ≥ 50 mg/mL (112.97 mM); H2O : 50 mg/mL (112.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CS(=O)(NC1=CC=C(C(O)CCCN(CC)CCCCCCC)C=C1)=O.O=C(O)/C=C/C(O)=O	https://www.medchemexpress.com/Ibutilide-fumarate.html	Launched		92.0	Q15	L20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0387	10.0	mM	284.0	DMSO	384.244664	20	L	pluskal_fda_drugs_5005_L20_id
1885	HY-B0510	HYCPK40907	E14	HYCPK40907	92z	412.0	2.0	I28	907.0	E14	738-70-5	Trimethoprim		290.32	Antibiotic; Antifolate; Bacterial; Influenza Virus	Anti-infection; Cell Cycle/DNA Damage	Trimethoprim is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim is active against a wide range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim has the potential for the research of urinary tract infections, Shigellosis and Pneumocystis pneumonia. Trimethoprim can inhibit infection of Influenza A virus in chick embryo when combinated with zinc[1][2][3][4].	Free Base	C14H18N4O3	16035.0	DMSO : 50 mg/mL (172.22 mM; Need ultrasonic); H2O : 0.67 mg/mL (2.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	NC1=NC=C(CC2=CC(OC)=C(OC)C(OC)=C2)C(N)=N1	https://www.medchemexpress.com/Trimethoprim.html	Launched		92.0	I28	L20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0510	10.0	mM	284.0	DMSO	290.13789	20	L	pluskal_fda_drugs_5005_L20_id
1904	HY-17497A	HYCPK40907	P15	HYCPK40907	92z	1470.0	2.0	AE30	907.0	P15	34381-68-5	Acebutolol (hydrochloride)		372.89	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Acebutolol hydrochloride is an orally active β1 adrenergic receptor (β1AR) antagonist. Acebutolol hydrochloride is used in the treatment of hypertension, angina pectoris and cardiac arrhythmias[1][2][3].	Hydrochloride	C18H29ClN2O4	15372.0	H2O : ≥ 50 mg/mL (134.09 mM); DMSO : 100 mg/mL (268.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	CCCC(NC1=CC=C(OCC(O)CNC(C)C)C(C(C)=O)=C1)=O.Cl	https://www.medchemexpress.com/Acebutolol-hydrochloride.html	Launched		92.0	AE30	L20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17497A	10.0	mM	284.0	DMSO	336.204907	20	L	pluskal_fda_drugs_5005_L20_id
1921	HY-B0886A	HYCPK40907	A17	HYCPK40907	92z	34.0	2.0	A34	907.0	A17	54-92-2	Iproniazid		179.22	Monoamine Oxidase	Neuronal Signaling	Iproniazid is a non-selective, irreversible monoamine oxidase (MAO) inhibitor of the hydrazine class. Iproniazid has antidepressive activity[1].		C9H13N3O	222394.0	H2O : ≥ 100 mg/mL (557.97 mM); DMSO : 100 mg/mL (557.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=NC=C1)NNC(C)C	https://www.medchemexpress.com/iproniazid.html	Launched		92.0	A34	L20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0886A	10.0	mM	284.0	DMSO	179.105862	20	L	pluskal_fda_drugs_5005_L20_id
2081	HY-15553A	HYCPK40908	J07	HYCPK40908	92z	925.0	3.0	T13	908.0	J07	116666-63-8	Mibefradil (dihydrochloride)	Ro 40-5967 (dihydrochloride)	568.55	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Mibefradil dihydrochloride (Ro 40-5967 dihydrochloride) is a calcium channel blocker with moderate selectivity for T-type Ca2+ channels (IC50s of 2.7 μM and 18.6 μM for T-type and L-type currents, respectively)[1].	Hydrochloride	C29H40Cl2FN3O3	8616.0	H2O : ≥ 125 mg/mL (219.86 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(O[C@@]1(CCN(CCCC2=NC3=CC=CC=C3N2)C)[C@@H](C(C)C)C4=C(C=C(F)C=C4)CC1)COC.[H]Cl.[H]Cl	https://www.medchemexpress.com/Mibefradil-dihydrochloride.html	Launched		92.0	T13	L20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15553A	10.0	mM	284.0	DMSO	495.28972	20	L	pluskal_fda_drugs_5005_L20_id
2196	HY-10582	HYCPK40908	A15	HYCPK40908	92z	77.0	3.0	B29	908.0	A15	5104-49-4	Flurbiprofen	dl-Flurbiprofen	244.26	Apoptosis; COX	Apoptosis; Immunology/Inflammation	Flurbiprofen (dl-Flurbiprofen) is a potent, orally active nonsteroidal anti-inflammatory agent (NSAIA/NSAID), with antipyretic and analgesic activities. Flurbiprofen is commonly used for the research of inflammatory diseases, including osteoarthritis and rheumatoid arthritis. Flurbiprofen is a non-selective cyclooxygenase (COX)  inhibitor that can be used for the research of colorectal cancer[1][2][3].	Free Acid	C15H13FO2	34956.0	DMSO : ≥ 100 mg/mL (409.40 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	FC1=C(C2=CC=CC=C2)C=CC(C(C)C(O)=O)=C1	https://www.medchemexpress.com/Flurbiprofen.html	Launched		92.0	B29	L20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10582	10.0	mM	284.0	DMSO	244.089958	20	L	pluskal_fda_drugs_5005_L20_id
2432	HY-13761	HYCPK40909	L03	HYCPK40909	92z	1110.0	4.0	X6	909.0	L03	29767-20-2	Teniposide	VM26	656.65	Topoisomerase	Cell Cycle/DNA Damage	Teniposide is a podophyllotoxin derivative, acts as a topoisomerase II inhibitor, and used as a chemotherapeutic agent.	Free Base	C32H32O13S	24543.0	DMSO : ≥ 30 mg/mL (45.69 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1OC[C@]2([H])[C@H](O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO4)O3)O[C@@H]4C5=CC=CS5)O)O)C6=C(C=C7OCOC7=C6)[C@@H](C8=CC(OC)=C(O)C(OC)=C8)[C@]21[H]	https://www.medchemexpress.com/Teniposide.html	Launched		92.0	X6	L20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13761	10.0	mM	284.0	DMSO	656.156362	20	L	pluskal_fda_drugs_5005_L20_id
41	HY-113224	HYCPK40899	C04	HYCPK40909	92z	270.0	4.0	F30	909.0	C15	313-04-2	Desmosterol		384.64	Endogenous Metabolite	Metabolic Enzyme/Protease	Desmosterol is a molecule similar to cholesterol. Desmosterol is the immediate precursor of cholesterol in the Bloch pathway of cholesterol biosynthesis. Desmosterol, as an endogenous metabolite, used to study cholesterol metabolism[1].		C27H44O	153078.0	H2O : ≥ 16.67 mg/mL (43.34 mM); DMSO : 2 mg/mL (5.20 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Metabolic Disease	C/C(C)=C\CC[C@@H](C)[C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C	https://www.medchemexpress.com/Desmosterol.html	Launched		92.0	F30	L21	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-113224	2.0	mM	285.0	DMSO	384.339216	21	L	pluskal_fda_drugs_5005_L21_id
1564	HY-B0659A	HYCPK40906	O13	HYCPK40906	92z	1369.0	1.0	AC25	906.0	O13	70359-46-5	Brimonidine (tartrate)	UK 14304 (tartrate); AGN190342 (tartrate)	442.22	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Brimonidine tartrate (UK 14304 tartrate)  is a full α2-adrenergic receptor (α2-AR) agonist.	Tartrate	C15H16BrN5O6	16838.0	DMSO : 50 mg/mL (113.07 mM; Need ultrasonic); H2O : 25 mg/mL (56.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C(O)[C@H](O)[C@@H](O)C(O)=O.BrC1=C2N=CC=NC2=CC=C1NC3=NCCN3	https://www.medchemexpress.com/UK-14,304-tartrate.html	Launched		92.0	AC25	L21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0659A	10.0	mM	285.0	DMSO	291.011957	21	L	pluskal_fda_drugs_5005_L21_id
1708	HY-18681	HYCPK40906	O22	HYCPK40906	92z	1387.0	1.0	AC43	906.0	O22	1446321-46-5	Voxelotor	GBT 440	337.37	Others	Others	Voxelotor (GBT 440) is a potent inhibitor of haemoglobin S (HbS) polymerization. Voxelotor has the potential for sickle cell disease (SCD) treatment[1].	Free Base	C19H19N3O3	44805.0	DMSO : 100 mg/mL (296.41 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	OC1=CC=CC(OCC2=C(C3=CC=NN3C(C)C)N=CC=C2)=C1C=O	https://www.medchemexpress.com/GBT-440.html	Launched		92.0	AC43	L21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18681	10.0	mM	285.0	DMSO	337.142641	21	L	pluskal_fda_drugs_5005_L21_id
1978	HY-13683	HYCPK40907	N20	HYCPK40907	92z	1288.0	2.0	AA40	907.0	N20	84371-65-3	Mifepristone	RU486; RU 38486	429.59	Autophagy; Glucocorticoid Receptor; NO Synthase; Progesterone Receptor	Autophagy; Immunology/Inflammation; Others	Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC50s of 0.2 nM and 2.6 nM in in vitro assay[1].	Free Base	C29H35NO2	12913.0	DMSO : 100 mg/mL (232.78 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@@]12[C@@](C#CC)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CCC4=C3[C@@H](C5=CC=C(N(C)C)C=C5)C2)=O	https://www.medchemexpress.com/Mifepristone.html	Launched		92.0	AA40	L21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13683	10.0	mM	285.0	DMSO	429.266779	21	L	pluskal_fda_drugs_5005_L21_id
2036	HY-B0475	HYCPK40908	H04	HYCPK40908	92z	727.0	3.0	P7	908.0	H04	1218-35-5	Xylometazoline (hydrochloride)		280.84	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Xylometazoline hydrochloride is an α-adrenergic receptor agonist (Ki=0.05-1.7 μM). Xylometazoline hydrochloride can constrict nasal blood vessels and increase nasal airflow. Xylometazoline hydrochloride can be used in nose stuffiness and runny nose research[1][2].	Hydrochloride	C16H25ClN2	16644.0	DMSO : 25 mg/mL (89.02 mM; Need ultrasonic); H2O : 50 mg/mL (178.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC1=C(CC2=NCCN2)C(C)=CC(C(C)(C)C)=C1.Cl	https://www.medchemexpress.com/xylometazoline-hydrochloride.html	Launched		92.0	P7	L21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0475	10.0	mM	285.0	DMSO	244.193949	21	L	pluskal_fda_drugs_5005_L21_id
2086	HY-108751	HYCPK40908	O07	HYCPK40908	92z	1405.0	3.0	AD13	908.0	O07	1259305-29-7	Aripiprazole Lauroxil		660.71	Others	Others	Aripiprazole lauroxil,  an N-acyloxymethyl?prodrug?of?aripiprazole, is a?Long-acting injectable (LAI)?typical antipsychotic for?schizophrenia. Aripiprazole lauroxil is cleaved by body’s enzyme esterase to N-hydroxymethyl aripiprazole (plus lauric acid) and then to aripiprazole (plus formaldehyde), no toxicity[1].		C36H51Cl2N3O4	79542.0	DMSO : 8.33 mg/mL (12.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCCCCCCCCCCC(OCN1C(CCC2=C1C=C(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)C=C2)=O)=O	https://www.medchemexpress.com/aripiprazole-lauroxil.html	Launched		92.0	AD13	L21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108751	10.0	mM	285.0	DMSO	659.325662	21	L	pluskal_fda_drugs_5005_L21_id
2201	HY-B0886	HYCPK40908	F15	HYCPK40908	92z	557.0	3.0	L29	908.0	F15	305-33-9	Iproniazid (phosphate)		277.21	Monoamine Oxidase	Neuronal Signaling	Iproniazid phosphate is a non-selective, irreversible monoamine oxidase (MAO) inhibitor of the hydrazine class. Iproniazid phosphate has antidepressive activity[1].	Phosphate	C9H16N3O5P	17206.0	DMSO : 100 mg/mL (360.74 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (180.37 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=NC=C1)NNC(C)C.O=P(O)(O)O	https://www.medchemexpress.com/Iproniazid-phosphate.html	Launched		92.0	L29	L21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0886	10.0	mM	285.0	DMSO	179.105862	21	L	pluskal_fda_drugs_5005_L21_id
2536	HY-B0218	HYCPK40909	K10	HYCPK40909	92z	1028.0	4.0	V20	909.0	K10	96829-58-2	Orlistat	Tetrahydrolipstatin; Ro-18-0647	495.73	Apoptosis; Fatty Acid Synthase (FASN)	Apoptosis; Metabolic Enzyme/Protease	Orlistat (Tetrahydrolipstatin) is a well-known irreversible inhibitor of pancreatic and gastric lipases. Orlistat is also an inhibitor of fatty acid synthase (FASN), is used orally for long-term research of obesity[1].?Anti-atherosclerotic?effect[2].	Free Base	C29H53NO5	150680.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 100 mg/mL (201.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C1[C@@H](CCCCCC)[C@H](C[C@@H](OC([C@@H](N([H])C([H])=O)CC(C)C)=O)CCCCCCCCCCC)O1	https://www.medchemexpress.com/orlistat.html	Launched		92.0	V20	L21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0218	10.0	mM	285.0	DMSO	495.392374	21	L	pluskal_fda_drugs_5005_L21_id
1563	HY-B1139	HYCPK40906	N13	HYCPK40906	92z	1273.0	1.0	AA25	906.0	N13	3644-61-9	Tolperisone (hydrochloride)		281.82	Others	Others	Tolperisone hydrochloride is a centrally acting muscle relaxant, is indicated for use in the treatment of pathologically increased tone of the cross-striated muscle caused by neurological diseases (damage of the pyramidal tract, multiple sclerosis, myelopathy, encephalomyelitis) and of spastic paralysis and other encephalopathies manifested with muscular dystonia.	Hydrochloride	C16H24ClNO	17621.0	DMSO : 100 mg/mL (354.84 mM; ultrasonic and warming and heat to 60°C); H2O : 100 mg/mL (354.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=C(C)C=C1)C(C)CN2CCCCC2.[H]Cl	https://www.medchemexpress.com/Tolperisone-hydrochloride.html	Launched		92.0	AA25	L22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1139	10.0	mM	286.0	DMSO	245.177964	22	L	pluskal_fda_drugs_5005_L22_id
1645	HY-14284	HYCPK40906	P18	HYCPK40906	92z	1475.0	1.0	AE35	906.0	P18	75530-68-6	Nilvadipine	FK235; FR34235	385.37	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Nilvadipine is a potent calcium channel antagonist, and the IC50 value is around 0.1 nM.	Free Base	C19H19N3O6	156166.0	DMSO : ≥ 50 mg/mL (129.75 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	COC(C1=C(C#N)NC(C)=C(C(OC(C)C)=O)C1C2=CC([N+]([O-])=O)=CC=C2)=O	https://www.medchemexpress.com/nilvadipine.html	Launched		92.0	AE35	L22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14284	10.0	mM	286.0	DMSO	385.127385	22	L	pluskal_fda_drugs_5005_L22_id
1744	HY-B0890	HYCPK40907	H05	HYCPK40907	92z	682.0	2.0	O10	907.0	H05	64092-48-4	Zomepirac (sodium salt)	McN-2783-21-98	313.71	PGE synthase	Immunology/Inflammation	Zomepirac sodium salt (McN-2783-21-98) is a potent prostaglandin biosynthesis inhibitor. Zomepirac sodium salt is a non-steroidal anti-inflammatory drug (NSAID). Zomepirac sodium salt can cause immune-mediated liver injury[1][2].	Sodium	C15H13ClNNaO3	21780.0	H2O : 5 mg/mL (15.94 mM; Need ultrasonic); DMSO : 100 mg/mL (318.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O[Na])CC1=CC(C)=C(C(C2=CC=C(Cl)C=C2)=O)N1C	https://www.medchemexpress.com/Zomepirac-sodium-salt.html	Launched		92.0	O10	L22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0890	10.0	mM	286.0	DMSO	291.066221	22	L	pluskal_fda_drugs_5005_L22_id
1996	HY-14654	HYCPK40907	P21	HYCPK40907	92z	1482.0	2.0	AE42	907.0	P21	50-78-2	Aspirin	Acetylsalicylic Acid; ASA	180.16	Apoptosis; Autophagy; Caspase; COX; Mitophagy; NF-κB; p38 MAPK; Virus Protease	Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation; MAPK/ERK Pathway; NF-κB	Aspirin (Acetylsalicylic Acid) is an orally active, potent and irreversible inhibitor of cyclooxygenase COX-1 and COX-2, with IC50 values of 5 and 210 μg/mL, respectively. Aspirin induces apoptosis. Aspirin inhibits the activation of NF-κB. Aspirin also inhibits platelet prostaglandin synthetase, and can prevent coronary artery and cerebrovascular thrombosis[1][2][3][4][5][6].	Free Acid	C9H8O4	16326.0	DMSO : 400 mg/mL (2220.25 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.56 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease	OC(C1=C(OC(C)=O)C=CC=C1)=O	https://www.medchemexpress.com/aspirin.html	Launched		92.0	AE42	L22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14654	10.0	mM	286.0	DMSO	180.042259	22	L	pluskal_fda_drugs_5005_L22_id
2009	HY-B0426A	HYCPK40907	M22	HYCPK40907	92z	1196.0	2.0	Y44	907.0	M22	140462-76-6	Olopatadine (hydrochloride)	ALO4943A; KW4679	373.87	Endogenous Metabolite; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	"Olopatadine hydrochloride (ALO4943A) is a histamine blocker used to treat allergic conjunctivitis.
Target: Histamine Receptor
Olopatadine hydrochloride (ALO4943A) is one of the second-generation histamine H1 receptor antagonists that are treated for allergic disorders. 
Olopatadine hydrochloride (ALO4943A) significantly inhibited the ear swelling and the increased production of IL-4, IL-1beta, IL-6, GM-CSF and NGF in the lesioned ear [1]. 
Olopatadine hydrochloride (ALO4943A) was highly and rapidly absorbed in healthy human volunteers. The urinary excretion of Olopatadine hydrochloride (ALO4943A) accounted for not less than 58% and the contribution of metabolism was considerably low in the clearance of olopatadine in humans. 
Olopatadine hydrochloride (ALO4943A) is one of the few renal clearance drugs in antiallergic drugs. 
Olopatadine hydrochloride (ALO4943A) was shown to be useful for the treatment of allergic rhinitis and chronic urticaria in double-blind clinical trials [2]. 
Olopatadine hydrochloride (ALO4943A) inhibits histamine release in a concentration-dependent fashion (IC50 = 559 microM) from human conjunctival mast cell preparations in vitro. Passive anaphylaxis in guinea pig conjunctiva was attenuated by Olopatadine hydrochloride (ALO4943A) applied 30 min prior to intravenous or topical ocular antigen challenge (ED50 values 0.0067% and 0.0170%, w/v, respectively) [3]."	Hydrochloride	C21H24ClNO3	16365.0	DMSO : 50 mg/mL (133.74 mM; Need ultrasonic); H2O : 6.67 mg/mL (17.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(O)CC1=CC=C(C/2=C1)OCC3=CC=CC=C3C2=C\CCN(C)C.Cl	https://www.medchemexpress.com/Olopatadine-hydrochloride.html	Launched		92.0	Y44	L22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0426A	10.0	mM	286.0	DMSO	337.167794	22	L	pluskal_fda_drugs_5005_L22_id
2154	HY-105019A	HYCPK40908	G12	HYCPK40908	92z	647.0	3.0	N23	908.0	G12	380449-54-7	Melflufen (hydrochloride)	Melphalan flufenamide (hydrochloride)	534.88	Apoptosis; DNA Alkylator/Crosslinker	Apoptosis; Cell Cycle/DNA Damage	Melflufen (Melphalan flufenamide) hydrochloride, a dipeptide prodrug of Melphalan, is an alkylating agent. Melflufen hydrochloride shows antitumor activity against multiple myeloma (MM) cells and inhibits angiogenesis. Melflufen hydrochloride induces irreversible DNA damage and cytotoxicity in MM cells[1][2][3].	Hydrochloride	C24H31Cl3FN3O3	84630.0	DMSO : 33.33 mg/mL (62.31 mM; Need ultrasonic); H2O : 1 mg/mL (1.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(OCC)[C@H](CC1=CC=C(F)C=C1)NC([C@H](CC2=CC=C(N(CCCl)CCCl)C=C2)N)=O.[H]Cl	https://www.medchemexpress.com/melflufen-hydrochloride.html	Launched		92.0	N23	L22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-105019A	10.0	mM	286.0	DMSO	497.164825	22	L	pluskal_fda_drugs_5005_L22_id
2438	HY-14249	HYCPK40909	B04	HYCPK40909	92z	152.0	4.0	D8	909.0	B04	90357-06-5	Bicalutamide		430.37	Androgen Receptor; Autophagy	Autophagy; Others	Bicalutamide is an orally active non-steroidal androgen receptor (AR) antagonist. Bicalutamide can be used for the research of prostate cancer[1].	Free Base	C18H14F4N2O4S	15754.0	DMSO : ≥ 50 mg/mL (116.18 mM)	DMSO Solution	10mM  * 100uL	Cancer	FC1=CC=C(S(=O)(CC(O)(C(NC2=CC=C(C#N)C(C(F)(F)F)=C2)=O)C)=O)C=C1	https://www.medchemexpress.com/Bicalutamide.html	Launched		92.0	D8	L22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14249	10.0	mM	286.0	DMSO	430.061041	22	L	pluskal_fda_drugs_5005_L22_id
2488	HY-17007	HYCPK40909	K07	HYCPK40909	92z	1022.0	4.0	V14	909.0	K07	127779-20-8	Saquinavir	Ro 31-8959	670.84	HIV; HIV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy. Saquinavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.36 μM.	Free Base	C38H50N6O5	5409.0	DMSO : 100 mg/mL (149.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C(N[C@@H](CC(N)=O)C(N[C@@H](CC1=CC=CC=C1)[C@H](O)CN2[C@H](C(NC(C)(C)C)=O)C[C@@](CCCC3)([H])[C@@]3([H])C2)=O)C4=NC5=CC=CC=C5C=C4	https://www.medchemexpress.com/Saquinavir.html	Launched		92.0	V14	L22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17007	10.0	mM	286.0	DMSO	670.384269	22	L	pluskal_fda_drugs_5005_L22_id
1541	HY-B0396	HYCPK40906	H12	HYCPK40906	92z	695.0	1.0	O23	906.0	H12	161715-24-8	Tebipenem pivoxil	L084	497.63	Antibiotic; Bacterial	Anti-infection	Tebipenem pivoxil (L084) is an orally active antibiotic against a variety of pathogenic bacteria. Tebipenem pivoxil binds penicillin-binding protein (PBP), thereby inhibiting cell wall synthesis[1].	Free Base	C22H31N3O6S2	25326.0	DMSO : ≥ 150 mg/mL (301.43 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N1C2=O)=C(SC3CN(C4=NCCS4)C3)[C@H](C)[C@]1([H])[C@@]2([H])[C@H](O)C)OCOC(C(C)(C)C)=O	https://www.medchemexpress.com/tebipenem-pivoxil.html	Launched		92.0	O23	M3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0396	10.0	mM	291.0	DMSO	497.165428	3	M	pluskal_fda_drugs_5005_M3_id
1567	HY-N0172	HYCPK40906	B14	HYCPK40906	92z	123.0	1.0	C27	906.0	B14	331-39-5	Caffeic acid		180.16	Endogenous Metabolite; Lipoxygenase; TRP Channel	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Caffeic acid is an inhibitor of both TRPV1 ion channel and 5-Lipoxygenase (5-LO).	Free Acid	C9H8O4	27665.0	DMSO : 100 mg/mL (555.06 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O)/C=C/C1=CC=C(O)C(O)=C1	https://www.medchemexpress.com/Caffeic_acid.html	Launched		92.0	C27	M3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0172	10.0	mM	291.0	DMSO	180.042259	3	M	pluskal_fda_drugs_5005_M3_id
1572	HY-B0319	HYCPK40906	G14	HYCPK40906	92z	603.0	1.0	M27	906.0	G14	65899-73-2	Tioconazole	UK-20349	387.71	Antibiotic; Fungal	Anti-infection	Tioconazole (UK-20349) is an antifungal imidazole derivative with broad spectrum activity. Tioconazole has inhibitory active aginst several dermatophytes and several yeasts with MIC50s <3.12 mg/L and <9 mg/L, respectively[1].	Free Base	C16H13Cl3N2OS	16021.0	H2O : 0.1 mg/mL (0.26 mM; Need ultrasonic); DMSO : 250 mg/mL (644.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	ClC1=CC=C(C(OCC2=C(Cl)SC=C2)CN3C=CN=C3)C(Cl)=C1	https://www.medchemexpress.com/Tioconazole.html	Launched		92.0	M27	M3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0319	10.0	mM	291.0	DMSO	385.981417	3	M	pluskal_fda_drugs_5005_M3_id
1651	HY-B0245	HYCPK40906	F19	HYCPK40906	92z	517.0	1.0	K37	906.0	F19	55-98-1	Busulfan		246.30	Apoptosis; DNA Alkylator/Crosslinker	Apoptosis; Cell Cycle/DNA Damage	Busulfan is a potent alkylator with selective immunosuppressive effect on bone marrow.	Free Base	C6H14O6S2	26314.0	DMSO : 50 mg/mL (203.00 mM; Need ultrasonic); H2O : 1 mg/mL (4.06 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	CS(=O)(OCCCCOS(C)(=O)=O)=O	https://www.medchemexpress.com/busulfan.html	Launched		92.0	K37	M3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0245	10.0	mM	291.0	DMSO	246.02318	3	M	pluskal_fda_drugs_5005_M3_id
2167	HY-N0303	HYCPK40908	D13	HYCPK40908	92z	361.0	3.0	H25	908.0	D13	58186-27-9	Idebenone		338.44	Apoptosis; Mitochondrial Metabolism	Apoptosis; Metabolic Enzyme/Protease	Idebenone, a well-appreciated mitochondrial protectant, exhibits protective efficacy against neurotoxicity and can be used for the research of Alzheimer's disease, Huntington's disease. Idebenone (oxidised form) has a dose-dependent inhibitory effect on the enzymatic metabolism of arachidonic acid in astroglial homogenates (IC50=16.65 μM)[1]. Idebenone, a coenzyme Q10 analog and an antioxidant, induces apoptotic cell death in the human dopaminergic neuroblastoma SHSY-5Y cells[2]. Idebenone quickly crosses the blood-brain barrier.	Free Base	C19H30O5	16896.0	DMSO : ≥ 100 mg/mL (295.47 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1C(CCCCCCCCCCO)=C(C)C(C(OC)=C1OC)=O	https://www.medchemexpress.com/idebenone.html	Launched		92.0	H25	M3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0303	10.0	mM	291.0	DMSO	338.209324	3	M	pluskal_fda_drugs_5005_M3_id
2225	HY-B0719	HYCPK40908	B17	HYCPK40908	92z	177.0	3.0	D33	908.0	B17	75567-37-2	Ingenol Mebutate	Ingenol 3-angelate; PEP005	430.53	PKC	Epigenetics; TGF-beta/Smad	Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-α, PKC-β, PKC-γ, PKC-δ, and PKC-ε, respectively, and has antiinflammatory and antitumor activity.	Free Base	C25H34O6	79502.0	DMSO : ≥ 100 mg/mL (232.27 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	C/C=C(C)\C(O[C@H]1C(C)=C[C@]23[C@]1(O)[C@H](O)C(CO)=C[C@@](C3=O)([H])[C@@]4([H])[C@@](C4(C)C)([H])C[C@H]2C)=O	https://www.medchemexpress.com/Ingenol-Mebutate.html	Launched		92.0	D33	M3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0719	10.0	mM	291.0	DMSO	430.235539	3	M	pluskal_fda_drugs_5005_M3_id
2434	HY-10235	HYCPK40909	N03	HYCPK40909	92z	1302.0	4.0	AB6	909.0	N03	402957-28-2	Telaprevir	VX-950	679.85	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Telaprevir (VX-950) is a highly selective, reversible, and potent peptidomimetic inhibitor of the HCV NS3-4A protease, the steady-state inhibitory constant (Ki) of Telaprevir is 7 nM against a genotype 1 (H strain) NS3 protease domain plus a NS4A cofactor peptide[1][2][3]. Telaprevir inhibits SARS-CoV-2 3CLpro activity[4].	Free Base	C36H53N7O6	8559.0	DMSO : ≥ 50 mg/mL (73.55 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(N([C@@H]1C(N[C@H](C(C(NC2CC2)=O)=O)CCC)=O)C[C@@]3(CCC[C@@]31[H])[H])[C@@H](NC([C@@H](NC(C4=NC=CN=C4)=O)C5CCCCC5)=O)C(C)(C)C	https://www.medchemexpress.com/Telaprevir.html	Launched		92.0	AB6	M3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10235	10.0	mM	291.0	DMSO	679.405732	3	M	pluskal_fda_drugs_5005_M3_id
2485	HY-Y0682A	HYCPK40909	A07	HYCPK40909	92z	62.0	4.0	B14	909.0	A07	6381-92-6	Ethylenediaminetetraacetic acid (disodium dihydrate)	EDTA (disodium dihydrate)	372.24	Others	Others	Ethylenediaminetetraacetic acid (EDTA) disodium dihydrate is a chelating agent used as a protease inhibitor and metal ion scavenger. Ethylenediaminetetraacetic acid disodium dihydrate is used extensively during protein purification. Ethylenediaminetetraacetic acid disodium dihydrate has been shown to be a noneffective molecule on cellulase activity. Ethylenediaminetetraacetic acid disodium dihydrate binds to metals including calcium and facilitates their excretion[1][2].	Sodium	C10H18N2Na2O10	158847.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)CN(CCN(CC(O)=O)CC(O[Na])=O)CC(O[Na])=O.O.O	https://www.medchemexpress.com/ethylenediaminetetraacetic-acid-disodium-dihydrate.html	Launched		92.0	B14	M3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0682A	10.0	mM	291.0	DMSO	292.090665	3	M	pluskal_fda_drugs_5005_M3_id
1512	HY-13580	HYCPK40906	K10	HYCPK40906	92z	979.0	1.0	U19	906.0	K10	51333-22-3	Budesonide		430.53	Glucocorticoid Receptor	Immunology/Inflammation	Budesonide, an inhaled glucocortical steroid, is an orally active glucocorticoid receptor agonist. Budesonide decreases the size of lung tumors, reverses DNA hypomethylation and modulates mRNA expression of genes. Budesonide is an anti-inflammatory agent used for asthma[1][2][3].	Free Base	C25H34O6	137120.0	DMSO : 215 mg/mL (499.38 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(C=C[C@@]12C)C=C1CC[C@@]([C@]2([H])[C@@H](O)C[C@@]34C)([H])[C@]3([H])C[C@]5([H])[C@@]4(C(CO)=O)OC(CCC)O5	https://www.medchemexpress.com/budesonide.html	Launched		92.0	U19	M4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13580	10.0	mM	292.0	DMSO	430.235539	4	M	pluskal_fda_drugs_5005_M4_id
1655	HY-17476	HYCPK40906	J19	HYCPK40906	92z	901.0	1.0	S37	906.0	J19	5749-67-7	Carbasalate calcium		259.24	Others	Others	Carbasalate calcium is an anti-inflammatory, antipyretic, and analgesic agent.	Calcium	C9H7O4.CH4N2O.1/2Ca	27097.0	H2O : 100 mg/mL (385.74 mM; Need ultrasonic); DMSO : 5 mg/mL (19.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C([O-])C1=CC=CC=C1OC(C)=O.NC(N)=O.[0.5Ca2+]	https://www.medchemexpress.com/Carbasalate_calcium.html	Launched		92.0	S37	M4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17476	10.0	mM	292.0	DMSO	180.042259	4	M	pluskal_fda_drugs_5005_M4_id
1878	HY-B1761	HYCPK40907	N13	HYCPK40907	92z	1274.0	2.0	AA26	907.0	N13	481-06-1	Santonin	Alpha-Santonin	246.30	Parasite	Anti-infection	Santonin is an active principle of the plant Artemisia cina, which is formely used to treat worms[1].		C15H18O3	45414.0	DMSO : 62.5 mg/mL (253.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1[C@@H](C)[C@@](CC[C@@]2(C)C=CC(C(C)=C23)=O)([H])[C@]3([H])O1	https://www.medchemexpress.com/santonin.html	Launched		92.0	AA26	M4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1761	10.0	mM	292.0	DMSO	246.125594	4	M	pluskal_fda_drugs_5005_M4_id
1881	HY-110080	HYCPK40907	A14	HYCPK40907	92z	28.0	2.0	A28	907.0	A14	19875-60-6	Lisuride (maleate)		454.52	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Lisuride (maleate) is a potent agonist of dopamine with a probably direct action on dopaminergic receptors. Lisuride (maleate) is an ergot derivative. Lisuride (maleate) releases the premenstrual mastalgia without significant side effects[1][2].	Maleate	C24H30N4O5	154089.0	DMSO : 25 mg/mL (55.00 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC(/C=C\C(O)=O)=O.CN1[C@@]2([H])C(C3=CC=CC4=C3C(C2)=CN4)=C[C@@H](C1)NC(N(CC)CC)=O	https://www.medchemexpress.com/lisuride-maleate.html	Launched		92.0	A28	M4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-110080	10.0	mM	292.0	DMSO	338.210661	4	M	pluskal_fda_drugs_5005_M4_id
1946	HY-10209	HYCPK40907	J18	HYCPK40907	92z	900.0	2.0	S36	907.0	J18	790299-79-5	Masitinib	AB1010	498.64	Apoptosis; c-Kit; FAK; FGFR; PDGFR; Src	Apoptosis; Protein Tyrosine Kinase/RTK	Masitinib (AB1010) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib (AB1010) has anti-proliferative, pro-apoptotic activity and low toxicity[1][2][4].	Free Base	C28H30N6OS	22374.0	DMSO : 100 mg/mL (200.55 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(C(NC2=NC(C3=CC=CN=C3)=CS2)=C1)C)C4=CC=C(CN5CCN(CC5)C)C=C4	https://www.medchemexpress.com/Masitinib.html	Launched		92.0	S36	M4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10209	10.0	mM	292.0	DMSO	498.220181	4	M	pluskal_fda_drugs_5005_M4_id
2238	HY-100666	HYCPK40908	O17	HYCPK40908	92z	1425.0	3.0	AD33	908.0	O17	194798-83-9	Fosfluconazole		386.25	Fungal	Anti-infection	Fosfluconazole is a prodrug of Fluconazole that is widely used as an antifungal agent.	Free Acid	C13H13F2N6O4P	89897.0	DMSO : 6.2 mg/mL (16.05 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection	FC1=CC=C(C(CN2N=CN=C2)(OP(O)(O)=O)CN3N=CN=C3)C(F)=C1	https://www.medchemexpress.com/Fosfluconazole.html	Launched		92.0	AD33	M4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100666	10.0	mM	292.0	DMSO	386.070396	4	M	pluskal_fda_drugs_5005_M4_id
2254	HY-17609	HYCPK40908	O18	HYCPK40908	92z	1427.0	3.0	AD35	908.0	O18	1024828-77-0	Difelikefalin	CR-845; FE-202845	679.85	Opioid Receptor	GPCR/G Protein; Neuronal Signaling	Difelikefalin (CR-845; FE-202845) is a peripherally restricted and selective agonist of kappa opioid receptor (KOR). Difelikefalin produces anti-inflammatory effects and has the potential in modulating pruritus in conditions such as chronic kidney disease[1][2].		C36H53N7O6	113400.0	DMSO : 100 mg/mL (147.09 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (147.09 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1(N)CCN(C([C@@H](CCCCN)NC([C@@H](CC(C)C)NC([C@@H](CC2=CC=CC=C2)NC([C@@H](CC3=CC=CC=C3)N)=O)=O)=O)=O)CC1)O	https://www.medchemexpress.com/difelikefalin.html	Launched		92.0	AD35	M4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17609	10.0	mM	292.0	DMSO	679.405732	4	M	pluskal_fda_drugs_5005_M4_id
2508	HY-B0808	HYCPK40909	O08	HYCPK40909	92z	1408.0	4.0	AD16	909.0	O08	21256-18-8	Oxaprozin	Oxaprozinum; Wy21743	293.32	Akt; Apoptosis; COX; IKK; NF-κB	Apoptosis; Immunology/Inflammation; NF-κB; PI3K/Akt/mTOR	Oxaprozin is an orally active and potent COX inhibitor, with IC50 values of 2.2 μM for human platelet COX-1 and and 36 μM for IL-1-stimulated human synovial cell COX-2, respectively. Oxaprozin also inhibits the activation of NF-κB. Oxaprozin induces cell apoptosis. Oxaprozin shows anti-inflammatory activity. Oxaprozin-mediated inhibition of the Akt/IKK/NF-κB pathway contributes to its anti-inflammatory properties[1][2].	Free Acid	C18H15NO3	26966.0	DMSO : ≥ 100 mg/mL (340.92 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O)CCC1=NC(C2=CC=CC=C2)=C(C3=CC=CC=C3)O1	https://www.medchemexpress.com/Oxaprozin.html	Launched		92.0	AD16	M4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0808	10.0	mM	292.0	DMSO	293.105193	4	M	pluskal_fda_drugs_5005_M4_id
1470	HY-A0023A	HYCPK40908	M16	HYCPK40908	92z	1231.0	3.0	Z31	908.0	M16	850649-61-5	Alogliptin	SYR-322 (free base)	339.39	Dipeptidyl Peptidase; Ferroptosis	Apoptosis; Metabolic Enzyme/Protease	Alogliptin (SYR-322 free base) is a potent, selective and orally active inhibitor of DPP-4 with an IC50 of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Alogliptin can be used for the research of type 2 diabetes[1][2][3].	Free Base	C18H21N5O2	152944.0	DMSO : 100 mg/mL (294.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Inflammation/Immunology; Cardiovascular Disease	O=C(C=C(N1C[C@H](N)CCC1)N(C2=O)CC3=C(C#N)C=CC=C3)N2C	https://www.medchemexpress.com/alogliptin.html	Launched		92.0	Z31	M5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0023A	10.0	mM	293.0	DMSO	339.169525	5	M	pluskal_fda_drugs_5005_M5_id
1528	HY-10209A	HYCPK40906	K11	HYCPK40906	92z	981.0	1.0	U21	906.0	K11	1048007-93-7	Masitinib (mesylate)	AB-1010 mesylate	594.75	Apoptosis; c-Kit; FGFR; PDGFR; Src	Apoptosis; Protein Tyrosine Kinase/RTK	Masitinib mesylate (AB-1010 mesylate) is a potent, orally bioavailable, and selective inhibitor of c-Kit (IC50=200 nM for human recombinant c-Kit). It also inhibits PDGFRα/β (IC50s=540/800 nM), Lyn (IC50= 510 nM for LynB), Lck, and, to a lesser extent, FGFR3 and FAK. Masitinib mesylate (AB-1010 mesylate) has anti-proliferative, pro-apoptotic activity and low toxicity[1][2][4].	Mesylate	C29H34N6O4S2	24576.0	DMSO : ≥ 30 mg/mL (50.44 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(C(NC2=NC(C3=CC=CN=C3)=CS2)=C1)C)C4=CC=C(CN5CCN(CC5)C)C=C4.CS(=O)(O)=O	https://www.medchemexpress.com/masitinib-mesylate.html	Launched		92.0	U21	M5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10209A	10.0	mM	293.0	DMSO	498.220181	5	M	pluskal_fda_drugs_5005_M5_id
1652	HY-B0578	HYCPK40906	G19	HYCPK40906	92z	613.0	1.0	M37	906.0	G19	68767-14-6	Loxoprofen		246.30	COX	Immunology/Inflammation	Loxoprofen is a non-steroidal, orally active anti-inflammatory agent with analgesic and anti-pyretic properties. Loxoprofen is a nonselective COX inhibitor with IC50s of 6.5 and 13.5 μM for COX-1 and COX-2, respectively. Loxoprofen can reduce atherosclerosis and shows antitumor activity[1][2][3][4].	Free Acid	C15H18O3	13146.0	DMSO : ≥ 100 mg/mL (406.01 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Cardiovascular Disease	O=C1C(CCC1)CC2=CC=C(C(C)C(O)=O)C=C2	https://www.medchemexpress.com/Loxoprofen.html	Launched		92.0	M37	M5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0578	10.0	mM	293.0	DMSO	246.125594	5	M	pluskal_fda_drugs_5005_M5_id
1966	HY-N0395	HYCPK40907	N19	HYCPK40907	92z	1286.0	2.0	AA38	907.0	N19	7660-25-5	Fructose		180.16	Others	Others	Fructose is a simple ketonic monosaccharide found in many plants, where it is often bonded to glucose to form the disaccharide sucrose.	Free Base	C6H12O6	27372.0	H2O : 100 mg/mL (555.06 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (555.06 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease; Cancer	O[C@H]1[C@@H](O)[C@H](O)[C@@](O)(CO)OC1	https://www.medchemexpress.com/Fructose.html	Launched		92.0	AA38	M5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0395	10.0	mM	293.0	DMSO	180.063388	5	M	pluskal_fda_drugs_5005_M5_id
2113	HY-B1101A	HYCPK40908	J09	HYCPK40908	92z	929.0	3.0	T17	908.0	J09	13187-06-9	Pimethixene maleate	Pimetixene maleate	409.50	5-HT Receptor; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	"Pimethixene maleate is antihistamine and antiserotonergic compound, acts as an antimigraine agent.
Pimethixene maleate is a highly potent antagonist of 5-HT1A, 5-HT2A, 5-HT2B, 5-HT2C, histamine H1, dopamine D2 and D4.4 as well as muscarinic M1 and M2 receptors, with pKis of 7.63, 10.22, 10.44, 8.42, 10.14, 8.19, 7.54, 8.61 and 9.38, respectively[1]."	Maleate	C23H23NO4S	121711.0	DMSO : 100 mg/mL (244.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CN1CC/C(CC1)=C2C3=C(SC4=C\2C=CC=C4)C=CC=C3.OC(/C=C\C(O)=O)=O	https://www.medchemexpress.com/pimethixene-maleate.html	Launched		92.0	T17	M5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1101A	10.0	mM	293.0	DMSO	293.123821	5	M	pluskal_fda_drugs_5005_M5_id
2140	HY-14737	HYCPK40908	I11	HYCPK40908	92z	837.0	3.0	R21	908.0	I11	400827-46-5	Ceftaroline fosamil	TAK-599; PPI0903	744.74	Antibiotic; Bacterial	Anti-infection	Ceftaroline fosamil (TAK-599), a cephalosporin derivative, is an N-phosphono prodrug of anti-methicillin-resistant Staphylococcus aureus (MRSA) T-91825. Ceftaroline fosamil can be used for the research of MRSA infection[1][2][3].	Acetate	C24H25N8O10PS4	109267.0	DMSO : 250 mg/mL (335.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1[C@@H](NC(/C(C2=NSC(NP(O)(O)=O)=N2)=N\OCC)=O)[C@@]3([H])SCC(SC4=NC(C5=CC=[N+](C)C=C5)=CS4)=C(C(O)=O)N13.CC([O-])=O	https://www.medchemexpress.com/Ceftaroline_fosamil.html	Launched		92.0	R21	M5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14737	10.0	mM	293.0	DMSO	685.017557	5	M	pluskal_fda_drugs_5005_M5_id
2158	HY-N0322	HYCPK40908	K12	HYCPK40908	92z	1031.0	3.0	V23	908.0	K12	57-88-5	Cholesterol		386.65	Bacterial; Endogenous Metabolite; Estrogen Receptor/ERR	Anti-infection; Metabolic Enzyme/Protease; Others	Cholesterol is the major sterol in mammals and is makes up 20-25% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3].	Free Base	C27H46O	213542.0	Ethanol : 14.29 mg/mL (36.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O[C@H](C1)CC[C@@]2(C)C1=CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@]4([H])[C@@H](CCCC(C)C)C	https://www.medchemexpress.com/Cholesterol.html	Launched		92.0	V23	M5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0322	10.0	mM	293.0	DMSO	386.354866	5	M	pluskal_fda_drugs_5005_M5_id
2311	HY-B0592	HYCPK40909	D12	HYCPK40909	92z	360.0	4.0	H24	909.0	D12	87679-37-6	Trandolapril	RU44570	430.54	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Trandolapril (RU44570) is a nonsulfhydryl prodrug that is hydrolysed to the active diacid Trandolaprilat. Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that has been used in the treatment of hypertension and congestive heart failure (CHF), and after myocardial infarction (MI)[1].	Free Acid	C24H34N2O5	27999.0	DMSO : 100 mg/mL (232.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C([C@H]1N(C([C@@H](N[C@H](C(OCC)=O)CCC2=CC=CC=C2)C)=O)[C@@]3([H])CCCC[C@]3([H])C1)O	https://www.medchemexpress.com/trandolapril.html	Launched		92.0	H24	M5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0592	10.0	mM	293.0	DMSO	430.246772	5	M	pluskal_fda_drugs_5005_M5_id
1394	HY-B0809	HYCPK40906	O04	HYCPK40906	92z	1351.0	1.0	AC7	906.0	O04	58-55-9	Theophylline	1,3-Dimethylxanthine; Theo-24	180.16	Adenosine Receptor; Apoptosis; Endogenous Metabolite; HDAC; Interleukin Related; Phosphodiesterase (PDE); TNF Receptor	Apoptosis; Cell Cycle/DNA Damage; Epigenetics; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease	Theophylline (1,3-Dimethylxanthine) is a potent phosphodiesterase (PDE) inhibitor, adenosine receptor antagonist, and histone deacetylase (HDAC) activator. Theophylline (1,3-Dimethylxanthine) inhibits PDE3 activity to relax airway smooth muscle. Theophylline (1,3-Dimethylxanthine) has anti-inflammatory activity by increase IL-10 and inhibit NF-κB into the nucleus. Theophylline (1,3-Dimethylxanthine) induces apoptosis. Theophylline (1,3-Dimethylxanthine) can be used for asthma and chronic obstructive pulmonary disease (COPD) research[1][2][3][4][5].	Free Base	C7H8N4O2	15935.0	DMSO : 11.11 mg/mL (61.67 mM; Need ultrasonic); H2O : 5 mg/mL (27.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N1C)N(C)C2=C(N=CN2)C1=O	https://www.medchemexpress.com/Theophylline.html	Launched		92.0	AC7	M6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0809	10.0	mM	294.0	DMSO	180.064725	6	M	pluskal_fda_drugs_5005_M6_id
1546	HY-W020044	HYCPK40906	M12	HYCPK40906	92z	1175.0	1.0	Y23	906.0	M12	10191-41-0	DL-alpha-Tocopherol	DL-α-Tocopherol	430.71	Ferroptosis	Apoptosis	DL-alpha-Tocopherol is a synthetic vitamin E, with antioxidation effect. DL-alpha-Tocopherol protects human skin fibroblasts against the cytotoxic effect of UVB[1].		C29H50O2	46024.0	H2O : 100 mg/mL (232.17 mM; Need ultrasonic); DMSO : 100 mg/mL (232.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CC1=C2C(CCC(CCCC(C)CCCC(C)CCCC(C)C)(C)O2)=C(C)C(O)=C1C	https://www.medchemexpress.com/dl-alpha-tocopherol.html	Launched		92.0	Y23	M6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W020044	10.0	mM	294.0	DMSO	430.381081	6	M	pluskal_fda_drugs_5005_M6_id
1650	HY-14274	HYCPK40906	E19	HYCPK40906	92z	421.0	1.0	I37	906.0	E19	120511-73-1	Anastrozole	ZD1033	293.37	Aromatase	Others	Anastrozole is a potent, highly selective aromatase inhibitor, which inhibits human placental aromatase with an IC50 of 15 nM.	Free Base	C17H19N5	25371.0	DMSO : ≥ 100 mg/mL (340.87 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC(C)(C#N)C1=CC(C(C)(C#N)C)=CC(CN2C=NC=N2)=C1	https://www.medchemexpress.com/Anastrozole.html	Launched		92.0	I37	M6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14274	10.0	mM	294.0	DMSO	293.164046	6	M	pluskal_fda_drugs_5005_M6_id
1763	HY-B0517	HYCPK40907	K06	HYCPK40907	92z	972.0	2.0	U12	907.0	K06	96-88-8	Mepivacaine		246.35	Sodium Channel	Membrane Transporter/Ion Channel	Mepivacaine is an amide-type local anesthetic agent. Mepivacaine binds to specific voltage-gated sodium ion channels in neuronal cell membranes, which inhibits both sodium influx and membrane depolarization[1][2].		C15H22N2O	78987.0	DMSO : 33.33 mg/mL (135.30 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C(CCCC1)N1C)NC(C(C)=CC=C2)=C2C	https://www.medchemexpress.com/mepivacaine.html	Launched		92.0	U12	M6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0517	10.0	mM	294.0	DMSO	246.173213	6	M	pluskal_fda_drugs_5005_M6_id
2029	HY-B0371D	HYCPK40908	A04	HYCPK40908	92z	55.0	3.0	B7	908.0	A04	109351-33-9	(S)-Terazosin		387.43	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	(S)-Terazosin is an active S-enantiomer of Terazosin. (S)-Terazosin is a potent and high-affinity α-adrenoceptor antagonist with Ki values of 3.91 nM, 0.79 nM and 1.16 nM for α1a, α1b and α1d-adrenoceptor, respectively. (S)-Terazosin also has high-affinity for α2a, α2B and α2c-adrenoceptor with Ki values of 729 nM, 3.5 nM and 46.4 nM, respectively[1].	Free Base	C19H25N5O4	61526.0	DMSO : 150 mg/mL (387.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)[C@H]4OCCC4	https://www.medchemexpress.com/s-terazosin.html	Launched		92.0	B7	M6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0371D	10.0	mM	294.0	DMSO	387.190654	6	M	pluskal_fda_drugs_5005_M6_id
2179	HY-B0378A	HYCPK40908	P13	HYCPK40908	92z	1513.0	3.0	AF25	908.0	P13	82586-52-5	Moexipril (hydrochloride)	RS-10085	535.03	Angiotensin-converting Enzyme (ACE); Apoptosis	Apoptosis; Metabolic Enzyme/Protease	Moexipril hydrochloride (RS-10085) is an orally active inhibitor of angiotensin-converting enzyme (ACE), and becomes effective by being hydrolyzed to moexiprila (hydrochloride). Moexipril hydrochloride exhibits antihypertensive and neuroprotective effects[1]-[4].	Hydrochloride	C27H35ClN2O7	16017.0	DMSO : 250 mg/mL (467.26 mM; Need ultrasonic); H2O : 100 mg/mL (186.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C([C@H]1N(C([C@@H](N[C@H](C(OCC)=O)CCC2=CC=CC=C2)C)=O)CC3=C(C=C(OC)C(OC)=C3)C1)O.Cl	https://www.medchemexpress.com/Moexipril-hydrochloride.html	Launched		92.0	AF25	M6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0378A	10.0	mM	294.0	DMSO	498.236601	6	M	pluskal_fda_drugs_5005_M6_id
2193	HY-12533	HYCPK40908	N14	HYCPK40908	92z	1323.0	3.0	AB27	908.0	N14	3737-09-5	Disopyramide	Dicorantil; SC-7031	339.47	Potassium Channel; Sodium Channel	Membrane Transporter/Ion Channel	Disopyramide (Dicorantil) is a class IA antiarrhythmic drug with efficacy in ventricular and atrial arrhythmias. Disopyramide blocks the fast inward sodium current of cardiac muscle and prolongs the duration of cardiac action potentials. Disopyramide inhibits HERG encoded potassium channels. Disopyramide also exhibits complex protein binding, and has a potent negative inotropic action[1][2][3].		C21H29N3O	64165.0	DMSO : ≥ 250 mg/mL (736.44 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	NC(C(C1=CC=CC=C1)(C2=CC=CC=N2)CCN(C(C)C)C(C)C)=O	https://www.medchemexpress.com/disopyramide.html	Launched		92.0	AB27	M6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12533	10.0	mM	294.0	DMSO	339.231063	6	M	pluskal_fda_drugs_5005_M6_id
2455	HY-14667	HYCPK40909	C05	HYCPK40909	92z	250.0	4.0	F10	909.0	C05	182431-12-5	Lomitapide	AEGR-733; BMS-201038	693.72	Others	Others	Lomitapide (AEGR-733; BMS-201038) is a potent inhibitor of microsomal triglyceride-transfer protein (MTP) with an IC50 of 8 nM in vitro.	Free Base	C39H37F6N3O2	23057.0	DMSO : ≥ 100 mg/mL (144.15 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1(CCCCN2CCC(NC(C3=CC=CC=C3C4=CC=C(C(F)(F)F)C=C4)=O)CC2)C5=C(C6=C1C=CC=C6)C=CC=C5)NCC(F)(F)F	https://www.medchemexpress.com/Lomitapide.html	Launched		92.0	F10	M6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14667	10.0	mM	294.0	DMSO	693.278997	6	M	pluskal_fda_drugs_5005_M6_id
5	HY-N7112	HYCPK40897	E03	HYCPK40909	92z	468.0	4.0	J36	909.0	E18	1392-21-8	Leucomycin	Kitasamycin		Antibiotic; Bacterial	Anti-infection	Leucomycin (kitasamycin) is a macrolide antibiotic produced by Streptomyces kitasatoensis[1][2][3][4].			59268.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 110 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Infection	[Leucomycin]	https://www.medchemexpress.com/leucomycin.html	Launched		92.0	J36	M7	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7112	3.0	mM	295.0	DMSO	701.398641	7	M	pluskal_fda_drugs_5005_M7_id
1398	HY-A0148A	HYCPK40906	C05	HYCPK40906	92z	201.0	1.0	E9	906.0	C05	36167-63-2	Halofantrine (hydrochloride)	SKF-102886; WR-171669 (hydrochloride)	536.88	Parasite	Anti-infection	Halofantrine hydrochloride (SKF-102886) is a blocker of delayed rectifier potassium current via the inhibition of  human-ether-a-go-go-related gene (HERG) channel and a potent antimalarial compound[1][2].	Hydrochloride	C26H31Cl3F3NO	222442.0	DMSO : 30 mg/mL (55.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC(CCN(CCCC)CCCC)C1=CC2=C(Cl)C=C(Cl)C=C2C3=CC(C(F)(F)F)=CC=C31.[H]Cl	https://www.medchemexpress.com/Halofantrine_hydrochloride.html	Launched		92.0	E9	M7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0148A	10.0	mM	295.0	DMSO	499.165655	7	M	pluskal_fda_drugs_5005_M7_id
1436	HY-10340A	HYCPK40906	I07	HYCPK40906	92z	781.0	1.0	Q13	906.0	I07	1038395-65-1	Tirbanibulin (dihydrochloride)	KX2-391 (dihydrochloride); KX-01 (dihydrochloride)	504.45	Microtubule/Tubulin; Src	Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK	Tirbanibulin (dihydrochloride) (KX2-391 (dihydrochloride)) is an inhibitor of Src that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines.	Hydrochloride	C26H31Cl2N3O3	4795.0	DMSO : 33.33 mg/mL (66.07 mM; Need ultrasonic); H2O : 50 mg/mL (99.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(CC1=NC=C(C2=CC=C(OCCN3CCOCC3)C=C2)C=C1)NCC4=CC=CC=C4.Cl.Cl	https://www.medchemexpress.com/KX2-391-dihydrochloride.html	Launched		92.0	Q13	M7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10340A	10.0	mM	295.0	DMSO	431.220892	7	M	pluskal_fda_drugs_5005_M7_id
1820	HY-B0140	HYCPK40907	D10	HYCPK40907	92z	308.0	2.0	G20	907.0	D10	317-34-0	Aminophylline		420.43	Adenosine Receptor; Phosphodiesterase (PDE)	GPCR/G Protein; Metabolic Enzyme/Protease	Aminophylline is a competitive and non-selective phosphodiesterase (PDE) inhibitor. Aminophylline is a competitive adenosine receptor antagonist. Aminophylline has apulmonary vasodilator action as well as a bronchodilator action and has the potential for asthma research[1][2].	Ethylenediamine	C16H24N10O4	15963.0	DMSO : 14.29 mg/mL (33.99 mM; Need ultrasonic); H2O : 6.25 mg/mL (14.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(N1C)N(C)C2=C(N=CN2)C1=O.O=C(N3C)N(C)C4=C(N=CN4)C3=O.NCCN	https://www.medchemexpress.com/Aminophylline.html	Launched		92.0	G20	M7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0140	10.0	mM	295.0	DMSO	180.064725	7	M	pluskal_fda_drugs_5005_M7_id
1999	HY-B0177	HYCPK40907	C22	HYCPK40907	92z	236.0	2.0	E44	907.0	C22	19387-91-8	Tinidazole		247.27	Antibiotic; Bacterial; Parasite	Anti-infection	Tinidazole, an orally available antibacterial agent, is a 5-nitroimidazole with selective activity against anaerobic bacteria and protozoa[1].	Free Base	C8H13N3O4S	16503.0	DMSO : ≥ 50 mg/mL (202.21 mM); H2O : 3.33 mg/mL (13.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	CC1=NC=C([N+]([O-])=O)N1CCS(=O)(CC)=O	https://www.medchemexpress.com/tinidazole.html	Launched		92.0	E44	M7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0177	10.0	mM	295.0	DMSO	247.062677	7	M	pluskal_fda_drugs_5005_M7_id
2048	HY-B0716	HYCPK40908	I05	HYCPK40908	92z	825.0	3.0	R9	908.0	I05	34661-75-1	Urapidil		387.48	5-HT Receptor; Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Urapidil is an α1 adrenoreceptor antagonist and a 5-HT1A receptor agonist.	Free Base	C20H29N5O3	28527.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 25 mg/mL (64.52 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	O=C1N(C)C(C=C(NCCCN2CCN(C3=CC=CC=C3OC)CC2)N1C)=O	https://www.medchemexpress.com/Urapidil.html	Launched		92.0	R9	M7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0716	10.0	mM	295.0	DMSO	387.22704	7	M	pluskal_fda_drugs_5005_M7_id
2056	HY-B1319	HYCPK40908	A06	HYCPK40908	92z	59.0	3.0	B11	908.0	A06	637-58-1	Pramocaine (hydrochloride)	Pramoxine hydrochloride	329.86	Others	Others	Pramocaine hydrochloride decreases the permeability of neuronal membranes to sodium ions, blocking both initiation and conduction of nerve impulses.	Hydrochloride	C17H28ClNO3	17163.0	DMSO : 100 mg/mL (303.16 mM; Need ultrasonic); H2O : 100 mg/mL (303.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1.[H]Cl	https://www.medchemexpress.com/Pramocaine-hydrochloride.html	Launched		92.0	B11	M7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1319	10.0	mM	295.0	DMSO	293.199094	7	M	pluskal_fda_drugs_5005_M7_id
2249	HY-109057	HYCPK40908	J18	HYCPK40908	92z	947.0	3.0	T35	908.0	J18	1262132-81-9	Enarodustat	JTZ-951	340.33	HIF/HIF Prolyl-Hydroxylase	Metabolic Enzyme/Protease	Enarodustat is a potent and orally active hypoxia-inducible factor prolyl hydroxylase inhibitor, with an EC50 of 0.22 μM. Enarodustat has the potential for renal anemia treatment.	Free Acid	C17H16N4O4	63028.0	DMSO : 83.33 mg/mL (244.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(C(C1=NC=NN1C(CCC2=CC=CC=C2)=C3)=C3O)NCC(O)=O	https://www.medchemexpress.com/Enarodustat.html	Launched		92.0	T35	M7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109057	10.0	mM	295.0	DMSO	340.117155	7	M	pluskal_fda_drugs_5005_M7_id
35	HY-A0128A	HYCPK40899	M03	HYCPK40909	92z	1228.0	4.0	Z28	909.0	M14	129-74-8	Buclizine (dihydrochloride)		505.95	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Buclizine dihydrochloride is an orally active antihistamine antiallergic compound. Buclizine dihydrochloride is a potent teratogen in the rat and shows anti-tumor activity[1][2][3].	Hydrochloride	C28H35Cl3N2	78875.0	DMSO : 2.5 mg/mL (4.94 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Cancer; Inflammation/Immunology	CC(C1=CC=C(CN2CCN(C(C3=CC=C(Cl)C=C3)C4=CC=CC=C4)CC2)C=C1)(C)C.[H]Cl.[H]Cl	https://www.medchemexpress.com/buclizine-dihydrochloride.html	Launched		92.0	Z28	M8	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0128A	2.0	mM	296.0	DMSO	432.233227	8	M	pluskal_fda_drugs_5005_M8_id
1391	HY-138687	HYCPK40906	L04	HYCPK40906	92z	1063.0	1.0	W7	906.0	L04	2628280-40-8	Nirmatrelvir	PF-07321332	499.53	SARS-CoV	Anti-infection	Nirmatrelvir (PF-07321332) is a potent and orally active SARS-CoV?3C-like protease (3CLPRO) inhibitor. Nirmatrelvir (PF-07321332) targets to the SARS-CoV-2 virus and can be used for COVID-19 research[1].		C23H32F3N5O4	120577.0	Ethanol : 50 mg/mL (100.09 mM; Need ultrasonic); DMSO : 140 mg/mL (280.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(NCC1)[C@@H]1C[C@@H](C#N)NC([C@@H]2[C@]3([H])[C@@](CN2C([C@H](C(C)(C)C)NC(C(F)(F)F)=O)=O)([H])C3(C)C)=O	https://www.medchemexpress.com/pf-07321332.html	Launched		92.0	W7	M8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-138687	10.0	mM	296.0	DMSO	499.240639	8	M	pluskal_fda_drugs_5005_M8_id
1427	HY-B2229	HYCPK40906	P06	HYCPK40906	92z	1451.0	1.0	AE11	906.0	P06	3286-46-2	Sulbutiamine	Bisibuthiamine	702.89	Others	Others	Sulbutiamine is a synthetic analogue of vitamin B1 used for the treatment of asthenia.	Free Base	C32H46N8O6S2	26745.0	DMSO : ≥ 75 mg/mL (106.70 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	C/C(N(C=O)CC1=CN=C(C)N=C1N)=C(CCOC(C(C)C)=O)/SS/C(CCOC(C(C)C)=O)=C(C)\N(C=O)CC2=CN=C(C)N=C2N	https://www.medchemexpress.com/Sulbutiamine.html	Launched		92.0	AE11	M8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2229	10.0	mM	296.0	DMSO	702.298173	8	M	pluskal_fda_drugs_5005_M8_id
1538	HY-17568	HYCPK40906	E12	HYCPK40906	92z	407.0	1.0	I23	906.0	E12	2444-46-4	Nonivamide	Pelargonic acid vanillylamide; Nonanoic acid vanillylamide; Pseudocapsaicin	293.40	TRP Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Nonivamide is a <b<TRPV1 agonist, which exhibits 4d-EC50 value of 5.1 mg/L in static toxicity tests.	Free Base	C17H27NO3	26888.0	DMSO : 100 mg/mL (340.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCCCCCCCC(NCC1=CC=C(O)C(OC)=C1)=O	https://www.medchemexpress.com/Nonivamide.html	Launched		92.0	I23	M8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17568	10.0	mM	296.0	DMSO	293.199094	8	M	pluskal_fda_drugs_5005_M8_id
1780	HY-12640	HYCPK40907	L07	HYCPK40907	92z	1070.0	2.0	W14	907.0	L07	22204-24-6	Pyrantel (pamoate)	Pyrantel embonate	594.68	Antibiotic; nAChR; Parasite	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Pyrantel pamoate (Pyrantel embonate) is an orally active anthelmintic and an agonist of the nicotinic acetylcholine receptor (nAChR). Pyrantel pamoate can cause spasmodic muscle paralysis in parasites. Pyrantel pamoate can be used in the study of parasitic infections such as ascariasis, hookworm infections, intestinal worms (pinworm infections), trichinosis and trichinosis[1][2].	Pamoate	C34H30N2O6S	15053.0	DMSO : 20.83 mg/mL (35.03 mM; ultrasonic and warming and heat to 70°C)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=C(O)C(CC2=C3C=CC=CC3=CC(C(O)=O)=C2O)=C4C=CC=CC4=C1)O.CN5CCCN=C5/C=C/C6=CC=CS6	https://www.medchemexpress.com/Pyrantel-pamoate.html	Launched		92.0	W14	M8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12640	10.0	mM	296.0	DMSO	388.094688	8	M	pluskal_fda_drugs_5005_M8_id
1868	HY-B1639	HYCPK40907	D13	HYCPK40907	92z	314.0	2.0	G26	907.0	D13	77671-31-9	Enoximone		248.30	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Enoximone is an inotropic vasodilating agent and a selective and orally active phosphodiesterase III (PDE3) inhibitor with an IC50 of 5.9 μM. Enoximone induces vasodilatation and increases intracellular levels of cAMP by inhibiting cGMP-inhibited PDE. Enoximone also exhibits PDE4 inhibitory effect with an IC50 of 21.1 μM for myocardial PDE4A. Enoximone has the potential for congestive heart failure research and has bronchodilatory, antiasthma and anti-inflammatory effects[1][2][3].		C12H12N2O2S	66679.0	DMSO : 8.33 mg/mL (33.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	O=C1NC(C)=C(C(C2=CC=C(SC)C=C2)=O)N1	https://www.medchemexpress.com/enoximone.html	Launched		92.0	G26	M8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1639	10.0	mM	296.0	DMSO	248.061949	8	M	pluskal_fda_drugs_5005_M8_id
1918	HY-B0306	HYCPK40907	N16	HYCPK40907	92z	1280.0	2.0	AA32	907.0	N16	14222-60-7	Prothionamide	Protionamide	180.27	Antibiotic; Bacterial	Anti-infection	"Protionamide (or prothionamide) is a drug used in the treatment of tuberculosis; has also been tested for use in the treatment of leprosy.
Target: Anti tuberculosis
Although ETH and PTH are both potent drugs against M. tuberculosis (MIC = ～0.5 μg/ml) (24), they do not affect E. coli growth, even at very high concentrations (100 μg/ml), which is primarily caused by the absence of an EthA homologue in E. coli [1]. Clinical improvement was noted in 74% of the patients treated with ethionamide and in 83% of those treated with prothionamide. Therapy was well tolerated and drug-related hepatotoxicity did not require discontinuation of therapy. The 500-mg dose of both ethionamide and prothionamide resulted in loss in Mycobacterium leprae viability more rapidly than did the 250-mg dose, and prothionamide at both dose levels was superior to the equivalent dose of ethionamide [2]."	Free Base	C9H12N2S	16716.0	DMSO : 100 mg/mL (554.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	S=C(C1=CC(CCC)=NC=C1)N	https://www.medchemexpress.com/prothionamide.html	Launched		92.0	AA32	M8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0306	10.0	mM	296.0	DMSO	180.072119	8	M	pluskal_fda_drugs_5005_M8_id
2045	HY-B2098	HYCPK40908	F05	HYCPK40908	92z	537.0	3.0	L9	908.0	F05	479-50-5	Lucanthone		340.48	Autophagy; Parasite	Anti-infection; Autophagy	Lucanthone is an endonuclease inhibitor of Apurinic endonuclease-1 (APE-1).	Free Base	C20H24N2OS	27611.0	DMSO : 25 mg/mL (73.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C2=C(SC3=C1C=CC=C3)C(C)=CC=C2NCCN(CC)CC	https://www.medchemexpress.com/Lucanthone.html	Launched		92.0	L9	M8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2098	10.0	mM	296.0	DMSO	340.160934	8	M	pluskal_fda_drugs_5005_M8_id
43	HY-17514	HYCPK40899	E04	HYCPK40909	92z	462.0	4.0	J30	909.0	E15	84625-61-6	Itraconazole	R51211	705.63	Antibiotic; Autophagy; Bacterial; Cytochrome P450; Fungal; Hedgehog	Anti-infection; Autophagy; Metabolic Enzyme/Protease; Stem Cell/Wnt	Itraconazole (R51211) is a triazole antifungal agent and a potent and orally active Hedgehog (Hh) signaling pathway antagonist with an IC50 of ~800 nM. Itraconazole potently inhibits lanosterol 14α-demethylase (cytochrome P450 enzyme), thereby inhibits the oxidative conversion of lanosterol to ergosterol. Itraconazole has anticancer and antiangiogenic effects. Itraconazole is a oxysterol-binding protein (OSBP) inhibitor[1][2][3][4].	Free Base	C35H38Cl2N8O4	15455.0	DMSO : 6.25 mg/mL (8.86 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection; Cancer	ClC1=C(C=CC(Cl)=C1)[C@@]2(O[C@@H](COC3=CC=C(N4CCN(C5=CC=C(N(C=NN6C(C)CC)C6=O)C=C5)CC4)C=C3)CO2)CN7C=NC=N7	https://www.medchemexpress.com/Itraconazole.html	Launched		92.0	J30	M9	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17514	2.0	mM	297.0	DMSO	704.239307	9	M	pluskal_fda_drugs_5005_M9_id
1440	HY-B0983	HYCPK40906	A08	HYCPK40906	92z	15.0	1.0	A15	906.0	A08	13609-67-1	Hydrocortisone 17-butyrate	Cortisol 17-butyrate; Hydrocortisone butyrate	432.55	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Hydrocortisone 17-butyrate is an adrenocortico hormone	Free Base	C25H36O6	38410.0	DMSO : 100 mg/mL (231.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]12[C@](C(CO)=O)(OC(CCC)=O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/Hydrocortisone-17-butyrate.html	Launched		92.0	A15	M9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0983	10.0	mM	297.0	DMSO	432.251189	9	M	pluskal_fda_drugs_5005_M9_id
1768	HY-B1124	HYCPK40907	P06	HYCPK40907	92z	1452.0	2.0	AE12	907.0	P06	34161-24-5	Fipexide		388.84	Adenylate Cyclase; Dopamine Transporter	GPCR/G Protein; Neuronal Signaling	Fipexide, a parachloro-phenossiacetic acid derivative, is a nootropic drug. Fipexide reduces striatal adenylate cyclase activity. Fipexide has positive effect on cognitive performance by dopaminergic neurotransmission. Fipexide is used for senile dementia research[1].	Free Base	C20H21ClN2O4	22771.0	DMSO : 50 mg/mL (128.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	ClC1=CC=C(OCC(N2CCN(CC3=CC=C(OCO4)C4=C3)CC2)=O)C=C1	https://www.medchemexpress.com/Fipexide.html	Launched		92.0	AE12	M9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1124	10.0	mM	297.0	DMSO	388.118985	9	M	pluskal_fda_drugs_5005_M9_id
1825	HY-14874	HYCPK40907	I10	HYCPK40907	92z	788.0	2.0	Q20	907.0	I10	577778-58-6	Topiroxostat	FYX-051	248.24	Cytochrome P450; Xanthine Oxidase	Metabolic Enzyme/Protease	Topiroxostat (FYX-051) is a potent and orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 5.3 nM and a Ki value of 5.7 nM. Topiroxostat exhibits weak CYP3A4-inhibitory activity (18.6%). Topiroxostat has the potential for hyperuricemia treatment[1][2].	Free Base	C13H8N6	11041.0	DMSO : 23.5 mg/mL (94.67 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Metabolic Disease	N#CC1=NC=CC(C2=NNC(C3=CC=NC=C3)=N2)=C1	https://www.medchemexpress.com/Topiroxostat.html	Launched		92.0	Q20	M9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14874	10.0	mM	297.0	DMSO	248.081044	9	M	pluskal_fda_drugs_5005_M9_id
2064	HY-100490A	HYCPK40908	I06	HYCPK40908	92z	827.0	3.0	R11	908.0	I06	207572-68-7	Rilmenidine (hemifumarate)		238.28	Adrenergic Receptor; Apoptosis; Autophagy; Imidazoline Receptor	Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling	Rilmenidine hemifumarate, an innovative antihypertensive agent, is an orally active, selective I1 imidazoline receptor agonist. Rilmenidine hemifumarate is an alpha 2-adrenoceptor agonist. Rilmenidine hemifumarate induces autophagy. Rilmenidine hemifumarate acts both centrally by reducing sympathetic overactivity and in the kidney by inhibiting the Na+/H+ antiport. Rilmenidine hemifumarate modulates proliferation and stimulates the proapoptotic protein Bax thus inducing the perturbation of the mitochondrial pathway and apoptosis in human leukemic K562 cells [1][2][3].	Fumarate	C10H16N2O.1/2C4H4O4	154544.0	H2O : 50 mg/mL (209.84 mM; Need ultrasonic); DMSO : 10 mg/mL (41.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	O=C(O)/C=C/C(O)=O.C1(NC(C2CC2)C3CC3)=NCCO1.[0.5]	https://www.medchemexpress.com/rilmenidine-hemifumarate.html	Launched		92.0	R11	M9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100490A	10.0	mM	297.0	DMSO	180.126263	9	M	pluskal_fda_drugs_5005_M9_id
2146	HY-B0361	HYCPK40908	O11	HYCPK40908	92z	1413.0	3.0	AD21	908.0	O11	22839-47-0	Aspartame	SC-18862	294.30	Others	Others	Aspartame (SC-18862) is a methyl ester of a dipeptide. Aspartame can be used as a synthetic nonnutritive sweetener. Aspartame is composed of phenylalanine (50%), aspartic acid (40%) and methanol (10%)[1][2].	Free Acid	C14H18N2O5	29551.0	DMSO : 25 mg/mL (84.95 mM; Need ultrasonic); H2O : 5 mg/mL (16.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OC)[C@@H](NC([C@@H](N)CC(O)=O)=O)CC1=CC=CC=C1	https://www.medchemexpress.com/aspartame.html	Launched		92.0	AD21	M9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0361	10.0	mM	297.0	DMSO	294.121572	9	M	pluskal_fda_drugs_5005_M9_id
2518	HY-B0537B	HYCPK40909	I09	HYCPK40909	92z	834.0	4.0	R18	909.0	I09	140-64-7	Pentamidine (isethionate)	MP-601205 (isethionate)	592.68	Antibiotic; Bacterial; Fungal; Parasite; Phosphatase	Anti-infection; Metabolic Enzyme/Protease	Pentamidine isethionate (MP-601205 isethionate) is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine isethionate inhibits parasite Leishmania infantum with an IC50 of 2.5 μM. Pentamidine isethionate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine isethionate has the potential for Gambian trypanosomiasis, antimony-resistant leishmaniasis, and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities[1][2][3][4].	Isethionate	C23H36N4O10S2	15792.0	H2O : 100 mg/mL (168.73 mM; Need ultrasonic); DMSO : 100 mg/mL (168.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	N=C(C1=CC=C(OCCCCCOC2=CC=C(C(N)=N)C=C2)C=C1)N.OCCS(=O)(O)=O.OCCS(=O)(O)=O	https://www.medchemexpress.com/Pentamidine-isethionate.html	Launched		92.0	R18	M9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0537B	10.0	mM	297.0	DMSO	340.189926	9	M	pluskal_fda_drugs_5005_M9_id
2522	HY-79077	HYCPK40909	M09	HYCPK40909	92z	1218.0	4.0	Z18	909.0	M09	2070014-82-1	Osimertinib (dimesylate)	AZD-9291 (dimesylate); Mereletinib (dimesylate)	691.82	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Osimertinib dimesylate (AZD-9291 dimesylate) is an irreversible and mutant selective EGFR inhibitor with IC50s of 12 and 1 nM against EGFRL858R and EGFRL858R/T790M, respectively.	Mesylate	C30H41N7O8S2	66549.0	DMSO : 2.63 mg/mL (3.80 mM; Need ultrasonic); H2O : 100 mg/mL (144.55 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CS(=O)(O)=O.C=CC(NC1=CC(NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O.CS(=O)(O)=O	https://www.medchemexpress.com/AZD-9291-dimesylate.html	Launched		92.0	Z18	M9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-79077	10.0	mM	297.0	DMSO	499.269573	9	M	pluskal_fda_drugs_5005_M9_id
44	HY-B0458	HYCPK40899	N04	HYCPK40909	92z	1326.0	4.0	AB30	909.0	N15	121123-17-9	Cefprozil (monohydrate)		407.44	Antibiotic; Bacterial	Anti-infection	Cefprozil monohydrate (Cefzil) is a second-generation cephalosporin type antibiotic[1].	Free Acid	C18H21N3O6S	16321.0	DMSO : 1.1 mg/mL (2.70 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection	OC(C(N1[C@@]2([H])[C@H](NC([C@@H](C3=CC=C(O)C=C3)N)=O)C1=O)=C(CS2)/C=C/C)=O.O	https://www.medchemexpress.com/Cefprozil-monohydrate.html	Launched		92.0	AB30	M10	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0458	2.0	mM	298.0	DMSO	389.104542	10	M	pluskal_fda_drugs_5005_M10_id
363	HY-N0473	HYCPK40899	F04	HYCPK40909	92z	558.0	4.0	L30	909.0	F15	60-18-4	L-Tyrosine		181.19	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Tyrosine is a non-essential amino acid which can inhibit citrate synthase activity in the posterior cortex.	Free Acid	C9H11NO3	27070.0	1M HCl : 50 mg/mL (275.95 mM; Need ultrasonic); DMSO : 1 mg/mL (5.52 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Neurological Disease	N[C@@H](CC1=CC=C(C=C1)O)C(O)=O	https://www.medchemexpress.com/L-Tyrosine.html	Launched		92.0	L30	M10	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0473	2.0	mM	298.0	DMSO	181.073893	10	M	pluskal_fda_drugs_5005_M10_id
1442	HY-B0758	HYCPK40907	M04	HYCPK40907	92z	1160.0	2.0	Y8	907.0	M04	30751-05-4	Troxipide		294.35	Others	Others	Troxipide is an orally active defensive factor-enhancing therapeutic agent for gastritis and gastric ulcer (GU). Troxipide is a non-antisecretory gastro protective agent with antiulcer, anti-inflammatory and mucus-secreting properties[1][2].	Free Base	C15H22N2O4	18795.0	DMSO : 9.09 mg/mL (30.88 mM; Need ultrasonic); H2O : 1 mg/mL (3.40 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(NC1CNCCC1)C2=CC(OC)=C(OC)C(OC)=C2	https://www.medchemexpress.com/Troxipide.html	Launched		92.0	Y8	M10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0758	10.0	mM	298.0	DMSO	294.157957	10	M	pluskal_fda_drugs_5005_M10_id
1452	HY-17367A	HYCPK40907	N14	HYCPK40907	92z	1276.0	2.0	AA28	907.0	N14	229975-97-7	Atazanavir (sulfate)	BMS-232632 sulfate	802.93	Cytochrome P450; Endogenous Metabolite; HIV; HIV Protease; P-glycoprotein; SARS-CoV	Anti-infection; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	"Atazanavir (BMS-232632) sulfate, a highly selective HIV-1 protease inhibitor, is the first protease inhibitor approved for once-daily administration[1]. Atazanavir sulfate is a substrate and inhibitor of CYP3A4, and an inhibitor and inducer of P-glycoprotein (P-gp)[2]. Atazanavir sulfate is also a SARS-CoV 3CLpro inhibitor with an IC50 of 
3.49 μM[3]."	Sulfate	C38H54N6O11S	60684.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 166 mg/mL (206.74 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(OC)N[C@@H](C(C)(C)C)C(NN(CC1=CC=C(C2=NC=CC=C2)C=C1)C[C@H](O)[C@H](CC3=CC=CC=C3)NC([C@H](C(C)(C)C)NC(OC)=O)=O)=O.O=S(O)(O)=O	https://www.medchemexpress.com/Atazanavir-sulfate.html	Launched		92.0	AA28	M10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17367A	10.0	mM	298.0	DMSO	704.389748	10	M	pluskal_fda_drugs_5005_M10_id
1749	HY-B0982	HYCPK40907	M05	HYCPK40907	92z	1162.0	2.0	Y10	907.0	M05	13523-86-9	Pindolol	LB-46	248.32	5-HT Receptor; Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Pindolol (LB-46) is a nonselective β-blocker with partial beta-adrenergic receptor agonist activity, also functions as a 5-HT1A receptor weak partial antagonist (Ki=33nM).	Free Base	C14H20N2O2	43127.0	DMSO : 50 mg/mL (201.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	OC(CNC(C)C)COC1=CC=CC2=C1C=CN2	https://www.medchemexpress.com/Pindolol.html	Launched		92.0	Y10	M10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0982	10.0	mM	298.0	DMSO	248.152478	10	M	pluskal_fda_drugs_5005_M10_id
1874	HY-19696A	HYCPK40907	J13	HYCPK40907	92z	890.0	2.0	S26	907.0	J13	35807-85-3	Tauroursodeoxycholate (sodium)	Tauroursodeoxycholic acid (sodium); TUDCA (sodium); UR 906 (sodium)	521.69	Apoptosis; Caspase; Endogenous Metabolite; ERK	Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Stem Cell/Wnt	Tauroursodeoxycholate (Tauroursodeoxycholic acid; TUDCA) sodium is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.	Sodium	C26H44NNaO6S	19325.0	H2O : 100 mg/mL (191.68 mM; Need ultrasonic); DMSO : 100 mg/mL (191.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@H](CCC(NCCS(=O)(O[Na])=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C	https://www.medchemexpress.com/Tauroursodeoxycholate-Sodium.html	Launched		92.0	S26	M10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19696A	10.0	mM	298.0	DMSO	499.296759	10	M	pluskal_fda_drugs_5005_M10_id
2185	HY-15780	HYCPK40908	F14	HYCPK40908	92z	555.0	3.0	L27	908.0	F14	913611-97-9	Brexpiprazole	OPC-34712	433.57	5-HT Receptor; Adrenergic Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Brexpiprazole (OPC-34712), an atypical orally active antipsychotic drug, is a partial agonist of human 5-HT1A and dopamine D2L receptor with Kis of 0.12 nM and 0.3 nM, respectively. Brexpiprazole is also a 5-HT2A receptor antagonist with a Ki of 0.47 nM. Brexpiprazole also shows potent antagonist activity at human noradrenergic α1B (Ki=0.17 nM) and α2C receptors (Ki=0.59 nM)[1][2].	Free Base	C25H27N3O2S	11421.0	DMSO : 25 mg/mL (57.66 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1NC2=C(C=CC(OCCCCN3CCN(C4=C(C=CS5)C5=CC=C4)CC3)=C2)C=C1	https://www.medchemexpress.com/Brexpiprazole.html	Launched		92.0	L27	M10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15780	10.0	mM	298.0	DMSO	433.182398	10	M	pluskal_fda_drugs_5005_M10_id
2221	HY-B1438	HYCPK40908	N16	HYCPK40908	92z	1327.0	3.0	AB31	908.0	N16	976-71-6	Canrenone	Aldadiene; SC9376	340.46	Endogenous Metabolite; Mineralocorticoid Receptor	Metabolic Enzyme/Protease	Canrenone (Aldadiene) is an aldosterone antagonist extensively used as a diuretic agent.	Free Base	C22H28O3	29563.0	DMSO : ≥ 100 mg/mL (293.72 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	C[C@@]12[C@]3(CCC(O3)=O)CC[C@@]1([H])[C@]4([H])C=CC5=CC(CC[C@]5(C)[C@@]4([H])CC2)=O	https://www.medchemexpress.com/Canrenone.html	Launched		92.0	AB31	M10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1438	10.0	mM	298.0	DMSO	340.203845	10	M	pluskal_fda_drugs_5005_M10_id
1396	HY-B1768	HYCPK40906	A05	HYCPK40906	92z	9.0	1.0	A9	906.0	A05	304-55-2	Succimer	Dimercaptosuccinic acid; DMSA	182.22	Others	Others	Succimer is a widely used chelating agent for the treatment of Pb poisoning.	Free Acid	C4H6O4S2	31803.0	DMSO : ≥ 100 mg/mL (548.79 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(O)[C@@H](S)[C@@H](S)C(O)=O	https://www.medchemexpress.com/Succimer.html	Launched		92.0	A9	M11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1768	10.0	mM	299.0	DMSO	181.970751	11	M	pluskal_fda_drugs_5005_M11_id
1450	HY-B1899A	HYCPK40907	L14	HYCPK40907	92z	1084.0	2.0	W28	907.0	L14	110026-03-4	Taurodeoxycholic acid (sodium hydrate)	Sodium taurodeoxycholate (monohydrate)	539.70	Endogenous Metabolite; G protein-coupled Bile Acid Receptor 1	GPCR/G Protein; Metabolic Enzyme/Protease	Taurodeoxycholic acid sodium hydrate (Sodium taurodeoxycholate monohydrate), a bile acid, is an amphiphilic surfactant molecule synthesized from cholesterol in the liver. Taurodeoxycholic acid sodium hydrate activates the S1PR2 pathway in addition to the TGR5 pathway[1].	Sodium	C26H46NNaO7S	42148.0	DMSO : 125 mg/mL (231.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	C[C@H](CCC(NCCS(=O)(O[Na])=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C.O	https://www.medchemexpress.com/taurodeoxychloic-acid-sodium-hydrate.html	Launched		92.0	W28	M11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1899A	10.0	mM	299.0	DMSO	499.296759	11	M	pluskal_fda_drugs_5005_M11_id
1489	HY-90005	HYCPK40906	D09	HYCPK40906	92z	305.0	1.0	G17	906.0	D09	269055-15-4	Etravirine	R165335; TMC125	435.28	HIV; Reverse Transcriptase	Anti-infection	Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for the treatment of HIV.	Free Base	C20H15BrN6O	3444.0	DMSO : 50 mg/mL (114.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	N#CC1=CC(C)=C(C(C)=C1)OC2=NC(NC3=CC=C(C=C3)C#N)=NC(N)=C2Br	https://www.medchemexpress.com/etravirine.html	Launched		92.0	G17	M11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-90005	10.0	mM	299.0	DMSO	434.049071	11	M	pluskal_fda_drugs_5005_M11_id
1886	HY-B0192A	HYCPK40907	F14	HYCPK40907	92z	508.0	2.0	K28	907.0	F14	81403-68-1	Alfuzosin (hydrochloride)	SL 77499-10	425.91	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Alfuzosin (SL 77499-10) hydrochloride is an orally active, selective and competitive α1-adrenoceptor antagonist. Alfuzosin hydrochloride relaxes the muscles of the prostate and bladder neck, aiding in urination. Alfuzosin hydrochloride can be used in study of benign prostatic hyperplasia (BPH)[1][2].	Hydrochloride	C19H28ClN5O4	45999.0	DMSO : 31.25 mg/mL (73.37 mM; Need ultrasonic); H2O : 50 mg/mL (117.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(C1OCCC1)NCCCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)C.Cl	https://www.medchemexpress.com/alfuzosin-hydrochloride.html	Launched		92.0	K28	M11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0192A	10.0	mM	299.0	DMSO	389.206304	11	M	pluskal_fda_drugs_5005_M11_id
2037	HY-B1710	HYCPK40908	I04	HYCPK40908	92z	823.0	3.0	R7	908.0	I04	51-98-9	Norethindrone acetate	19-Norethindrone acetate	340.46	Progesterone Receptor	Others	Norethindrone acetate is a female hormone used for the research of endometriosis[1].	Free Base	C22H28O3	26320.0	H2O : 0.67 mg/mL (1.97 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (293.72 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology; Cardiovascular Disease; Cancer	C#C[C@]1(OC(C)=O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4([H])[C@@]3([H])CC[C@]12C)=O	https://www.medchemexpress.com/Norethindrone_acetate.html	Launched		92.0	R7	M11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1710	10.0	mM	299.0	DMSO	340.203845	11	M	pluskal_fda_drugs_5005_M11_id
2276	HY-66012	HYCPK40908	E20	HYCPK40908	92z	471.0	3.0	J39	908.0	E20	5875-06-9	Proparacaine (Hydrochloride)	Proxymetacaine Hydrochloride	330.85	Apoptosis	Apoptosis	Proparacaine Hydrochloride (Proxymetacaine Hydrochloride) is a derivative of lidocaine (HY-B0185), with immunomodulatory effect and glucocorticomimetic activity[1][2].	Hydrochloride	C16H27ClN2O3	15626.0	H2O : 33.33 mg/mL (100.74 mM; Need ultrasonic); DMSO : 50 mg/mL (151.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCCN(CC)CC)C1=CC=C(OCCC)C(N)=C1.[H]Cl	https://www.medchemexpress.com/Proparacaine-Hydrochloride.html	Launched		92.0	J39	M11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-66012	10.0	mM	299.0	DMSO	294.194343	11	M	pluskal_fda_drugs_5005_M11_id
2424	HY-N0164	HYCPK40909	D03	HYCPK40909	92z	342.0	4.0	H6	909.0	D03	519-02-8	Matrine	Matridin-15-one; Vegard; α-Matrine	248.36	Apoptosis; Autophagy; Ferroptosis; Mitophagy; Opioid Receptor	Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling	Matrine (Matridin-15-one) is an alkaloid found in plants from the Sophora genus that can act as a kappa opioid receptor and u-receptor agonist. Matrine has a variety of pharmacological effects, including anti-cancer, anti-oxidative stress, anti-inflammation and anti-apoptosis effects. Matrine is potential in the research of disease like human non-small cell lung cancer, hepatoma, papillary thyroid cancer and acute kidney injury (AKI)[1][2][3][4][5].	Free Base	C15H24N2O	27619.0	H2O : 20 mg/mL (80.53 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (201.32 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C1CCC[C@]2([H])[C@@]3([H])CCCN4[C@@]3([H])[C@](CCC4)([H])CN21	https://www.medchemexpress.com/Matrine.html	Launched		92.0	H6	M11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0164	10.0	mM	299.0	DMSO	248.188863	11	M	pluskal_fda_drugs_5005_M11_id
2461	HY-10300	HYCPK40909	I05	HYCPK40909	92z	826.0	4.0	R10	909.0	I05	865466-24-6	Narlaprevir	SCH 900518	707.96	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Narlaprevir (SCH 900518) is a selective and orally bioavailable NS3 protease inhibitor with a Ki value of 6 nM and an EC90 value of 40 nM[1]. Narlaprevir also inhibits the HCV nonstructural protein 3 serine protease[2]. Narlaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.3 μM[3].	Free Base	C36H61N5O7S	107109.0	DMSO : ≥ 50 mg/mL (70.63 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(CC1(NC(N[C@H](C(N2[C@@H]([C@@]3([H])C(C)([C@]3(C2)[H])C)C(N[C@H](C(C(NC4CC4)=O)=O)CCCC)=O)=O)C(C)(C)C)=O)CCCCC1)(C(C)(C)C)=O	https://www.medchemexpress.com/Narlaprevir.html	Launched		92.0	R10	M11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10300	10.0	mM	299.0	DMSO	707.42917	11	M	pluskal_fda_drugs_5005_M11_id
1642	HY-13772	HYCPK40906	M18	HYCPK40906	92z	1187.0	1.0	Y35	906.0	M18	56124-62-0	Valrubicin	AD-32	723.64	Antibiotic; PKC	Anti-infection; Epigenetics; TGF-beta/Smad	Valrubicin is a chemotherapy agent, inhibits TPA- and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 μM, respectively, and has antitumor and antiinflammatory activity.	Free Base	C34H36F3NO13	113794.0	DMSO : 125 mg/mL (172.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	CCCCC(OCC([C@]1(O)CC2=C(C(O)=C3C(C4=C(C(C3=C2O)=O)C=CC=C4OC)=O)[C@@H](O[C@H]5C[C@H](NC(C(F)(F)F)=O)[C@H](O)[C@H](C)O5)C1)=O)=O	https://www.medchemexpress.com/Valrubicin.html	Launched		92.0	Y35	M12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13772	10.0	mM	300.0	DMSO	723.213875	12	M	pluskal_fda_drugs_5005_M12_id
1818	HY-15036A	HYCPK40907	B10	HYCPK40907	92z	116.0	2.0	C20	907.0	B10	78213-16-8	Diclofenac (diethylamine)		369.29	Apoptosis; COX	Apoptosis; Immunology/Inflammation	Diclofenac diethylamine is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells[1], and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively[2]. Diclofenac diethylamine induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade[3].	Diethylamine	C18H22Cl2N2O2	40458.0	DMSO : 150 mg/mL (406.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl.CCNCC	https://www.medchemexpress.com/diclofenac-diethylamine.html	Launched		92.0	C20	M12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15036A	10.0	mM	300.0	DMSO	295.016684	12	M	pluskal_fda_drugs_5005_M12_id
1882	HY-B0887	HYCPK40907	B14	HYCPK40907	92z	124.0	2.0	C28	907.0	B14	52645-53-1	Permethrin	NRDC-143	391.29	Parasite	Anti-infection	Permethrin (NRDC-143) is an insecticide, acaricide, and insect repellent; functions as a neurotoxin, affecting neuron membranes by prolonging sodium channel activation.	Free Base	C21H20Cl2O3	17356.0	DMSO : 50 mg/mL (127.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1C(C)(C)C1/C=C(Cl)\Cl)OCC2=CC=CC(OC3=CC=CC=C3)=C2	https://www.medchemexpress.com/Permethrin.html	Launched		92.0	C28	M12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0887	10.0	mM	300.0	DMSO	390.07895	12	M	pluskal_fda_drugs_5005_M12_id
2007	HY-B0154	HYCPK40907	K22	HYCPK40907	92z	1004.0	2.0	U44	907.0	K22	80474-14-2	Fluticasone (propionate)		500.57	Endogenous Metabolite; Enterovirus; Glucocorticoid Receptor	Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease	Fluticasone propionate, a potent topical anti-inflammatory corticosteroid, is a selective glucocorticoid receptor agonist, with an absolute affinity (KD) of 0.5 nM. Fluticasone propionate shows little or no activity at other steroid receptors. Anti-viral activity[1][2].	Free Base	C25H31F3O5S	16191.0	DMSO : 100 mg/mL (199.77 mM; Need ultrasonic); H2O : 1 mg/mL (2.00 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection; Endocrinology; Inflammation/Immunology	O=C(CC)O[C@@]([C@]([C@@]1([H])C2)(C[C@H](O)[C@](F)([C@]3(C=C4)C)[C@@]1([H])C[C@H](F)C3=CC4=O)C)([C@@H]2C)C(SCF)=O	https://www.medchemexpress.com/Fluticasone-propionate.html	Launched		92.0	U44	M12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0154	10.0	mM	300.0	DMSO	500.18443	12	M	pluskal_fda_drugs_5005_M12_id
2034	HY-B0640A	HYCPK40908	F04	HYCPK40908	92z	535.0	3.0	L7	908.0	F04	108929-04-0	Epinastine (hydrochloride)	WAL801 (hydrochloride)	285.77	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Epinastine hydrochloride (WAL801 hydrochloride) is an antihistamine and mast cell stabilizer. Epinastine hydrochloride is a potent, selective and orally-active histamine H1 receptor antagonist. Epinastine hydrochloride also inhibits IL-8 release and has an antiallergic action[1][2][3].	Hydrochloride	C16H16ClN3	79088.0	DMSO : 50 mg/mL (174.97 mM; Need ultrasonic); H2O : 100 mg/mL (349.93 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	NC1=NCC2N1C3=CC=CC=C3CC4=CC=CC=C24.[H]Cl	https://www.medchemexpress.com/epinastine-hydrochloride.html	Launched		92.0	L7	M12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0640A	10.0	mM	300.0	DMSO	249.126597	12	M	pluskal_fda_drugs_5005_M12_id
2126	HY-100562	HYCPK40908	G10	HYCPK40908	92z	643.0	3.0	N19	908.0	G10	2295-58-1	Flopropione		182.17	5-HT Receptor; COMT	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Flopropione is a 5-HT receptor antagonist and also a catechol-o-methyltransferase (COMT) inhibitor[1][2]. Flopropione also as an antispasmodic agent[3].	Free Base	C9H10O4	27618.0	DMSO : 150 mg/mL (823.41 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Neurological Disease	CCC(C1=C(O)C=C(O)C=C1O)=O	https://www.medchemexpress.com/Flopropione.html	Launched		92.0	N19	M12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100562	10.0	mM	300.0	DMSO	182.057909	12	M	pluskal_fda_drugs_5005_M12_id
2233	HY-N0510	HYCPK40908	J17	HYCPK40908	92z	945.0	3.0	T33	908.0	J17	313-67-7	Aristolochic acid A	Aristolochic acid I; TR 1736	341.27	NF-κB	NF-κB	Aristolochic acid A (Aristolochic acid I; TR 1736) is the main component of plant extract Aristolochic acids, which are found in various herbal plants of genus Aristolochia and Asarum. Aristolochic acid A significantly reduces both activator protein 1 (AP-1) and NF-κB activities. Aristolochic acid A reduces BLCAP gene expression in human cell lines[1].	Free Acid	C17H11NO7	111785.0	DMSO : 25 mg/mL (73.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC(C1=CC2=C(OCO2)C3=C4C(C(OC)=CC=C4)=CC([N+]([O-])=O)=C31)=O	https://www.medchemexpress.com/aristolochic-acid-a.html	Launched		92.0	T33	M12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0510	10.0	mM	300.0	DMSO	341.053552	12	M	pluskal_fda_drugs_5005_M12_id
2516	HY-17443B	HYCPK40909	G09	HYCPK40909	92z	642.0	4.0	N18	909.0	G09	201677-61-4	Sivelestat (sodium tetrahydrate)	EI546 (sodium tetrahydrate); LY544349 (sodium tetrahydrate); ONO5046 (sodium tetrahydrate)	528.51	Elastase; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Sivelestat (EI546) sodium tetrahydrate is a competitive inhibitor of human neutrophil elastase, with an IC50 of 44 nM and a Ki of 200 nM. Sivelestat (EI546) sodium tetrahydrate has the potential for the study of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19[1][2][3][4].	Sodium	C20H29N2NaO11S	113121.0	DMSO : 250 mg/mL (473.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC(C)(C)C(OC1=CC=C(S(=O)(NC2=CC=CC=C2C(NCC(O[Na])=O)=O)=O)C=C1)=O.O.O.O.O	https://www.medchemexpress.com/Sivelestat-sodium-tetrahydrate.html	Launched		92.0	N18	M12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17443B	10.0	mM	300.0	DMSO	434.114772	12	M	pluskal_fda_drugs_5005_M12_id
1482	HY-17443	HYCPK40906	M08	HYCPK40906	92z	1167.0	1.0	Y15	906.0	M08	127373-66-4	Sivelestat	EI546; LY544349; ONO5046	434.46	Elastase; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Sivelestat (EI546) is a competitive inhibitor of human neutrophil elastase, with an IC50 of 44 nM and a Ki of 200 nM. Sivelestat (EI546) has the potential for the study of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19[1][2][3][4].	Free Acid	C20H22N2O7S	26626.0	Ethanol : 3.03 mg/mL (6.97 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (230.17 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC(C)(C)C(OC1=CC=C(S(=O)(NC2=CC=CC=C2C(NCC(O)=O)=O)=O)C=C1)=O	https://www.medchemexpress.com/sivelestat.html	Launched		92.0	Y15	M13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17443	10.0	mM	301.0	DMSO	434.114772	13	M	pluskal_fda_drugs_5005_M13_id
1598	HY-B1172	HYCPK40906	A16	HYCPK40906	92z	31.0	1.0	A31	906.0	A16	4618-18-2	Lactulose	4-O-β-D-Galactopyranosyl-D-fructose	342.30	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Lactulose is a non-absortable sugar used in the treatment of constipation and hepatic encephalopathy. It generally begin working after eight to twelve hours but may take up to two days to improve constipation.	Free Base	C12H22O11	32017.0	H2O : ≥ 100 mg/mL (292.14 mM); DMSO : 25 mg/mL (73.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	OCC([C@H]([C@@H]([C@@H](CO)O)O[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)O)O)=O	https://www.medchemexpress.com/Lactulose.html	Launched		92.0	A31	M13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1172	10.0	mM	301.0	DMSO	342.116212	13	M	pluskal_fda_drugs_5005_M13_id
1660	HY-10465	HYCPK40906	O19	HYCPK40906	92z	1381.0	1.0	AC37	906.0	O19	1009119-65-6	Daclatasvir (dihydrochloride)	BMS-790052 (dihydrochloride); EBP 883 (dihydrochloride)	811.80	HCV	Anti-infection	Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir dihydrochloride is also an organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 μM and 3.27 μM, respectively[1][2][3].	Hydrochloride	C40H52Cl2N8O6	25987.0	DMSO : ≥ 56 mg/mL (68.98 mM); H2O : 50 mg/mL (61.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N1CCC[C@H]1C2=NC=C(C3=CC=C(C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C([C@H](C(C)C)NC(OC)=O)=O)C=C3)N2)[C@H](C(C)C)NC(OC)=O.[H]Cl.[H]Cl	https://www.medchemexpress.com/Daclatasvir-dihydrochloride.html	Launched		92.0	AC37	M13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10465	10.0	mM	301.0	DMSO	738.385331	13	M	pluskal_fda_drugs_5005_M13_id
2042	HY-B0584	HYCPK40908	N04	HYCPK40908	92z	1303.0	3.0	AB7	908.0	N04	157283-68-6	Travoprost	Fluprostenol isopropyl ester; AL6221; Flu-Ipr	500.5477096	Prostaglandin Receptor	GPCR/G Protein	Travoprost (Fluprostenol isopropyl ester), an isopropyl ester prodrug, is a high affinity, selective FP prostaglandin full receptor agonist. Travoprost has the ocular hypotensive efficacy and has the potential for glaucoma and ocular hypertension[1].	Free Base	C26H35F3O6	16965.0	Ethanol : 60 mg/mL (119.87 mM; Need ultrasonic); DMSO : ≥ 41.67 mg/mL (83.25 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C(OC(C)C)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COC2=CC=CC(C(F)(F)F)=C2)[C@H](O)C[C@@H]1O	https://www.medchemexpress.com/travoprost.html	Launched		92.0	AB7	M13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0584	10.0	mM	301.0	DMSO	500.238573	13	M	pluskal_fda_drugs_5005_M13_id
2090	HY-B0400	HYCPK40908	C08	HYCPK40908	92z	255.0	3.0	F15	908.0	C08	50-70-4	D-Sorbitol	Sorbitol; D-Glucitol	182.17	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	D-Sorbitol (Sorbitol) is a six-carbon sugar alcohol and can used as a sugar substitute. D-Sorbitol can be used as a stabilizing excipient and/or isotonicity agent, sweetener, humectant, thickener and dietary supplement[1].	Free Base	C6H14O6	17052.0	H2O : 100 mg/mL (548.94 mM; Need ultrasonic); DMSO : 100 mg/mL (548.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	OC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O	https://www.medchemexpress.com/d-sorbitol.html	Launched		92.0	F15	M13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0400	10.0	mM	301.0	DMSO	182.079038	13	M	pluskal_fda_drugs_5005_M13_id
2236	HY-B0640	HYCPK40908	M17	HYCPK40908	92z	1233.0	3.0	Z33	908.0	M17	80012-43-7	Epinastine	WAL801	249.31	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Epinastine (WAL801) is an antihistamine and mast cell stabilizer. Epinastine is a potent, selective and orally-active histamine H1 receptor antagonist. Epinastine also inhibits IL-8 release and has an antiallergic action[1][2][3][4].	Free Base	C16H15N3	14697.0	DMSO : ≥ 50 mg/mL (200.55 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	NC1=NCC2N1C3=CC=CC=C3CC4=CC=CC=C24	https://www.medchemexpress.com/epinastine.html	Launched		92.0	Z33	M13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0640	10.0	mM	301.0	DMSO	249.126597	13	M	pluskal_fda_drugs_5005_M13_id
2241	HY-15038	HYCPK40908	B18	HYCPK40908	92z	179.0	3.0	D35	908.0	B18	15307-81-0	Diclofenac (potassium)		334.24	Apoptosis; COX	Apoptosis; Immunology/Inflammation	Diclofenac potassium is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells[1], and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively[2]. Diclofenac potassium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade[3].	Potassium	C14H10Cl2KNO2	64015.0	DMSO : 100 mg/mL (299.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O[K])CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl	https://www.medchemexpress.com/diclofenac-potassium.html	Launched		92.0	D35	M13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15038	10.0	mM	301.0	DMSO	295.016684	13	M	pluskal_fda_drugs_5005_M13_id
2476	HY-109015	HYCPK40909	H06	HYCPK40909	92z	732.0	4.0	P12	909.0	H06	1616493-44-7	Tucidinostat	Chidamide; HBI-8000; CS 055	390.41	HDAC	Cell Cycle/DNA Damage; Epigenetics	Tucidinostat (Chidamide) is a potent and orally bioavailable HDAC enzymes class I (HDAC1/2/3) and class IIb (HDAC10) inhibitor, with IC50s of 95, 160, 67 and 78 nM, less active on HDAC8 and HDAC11 (IC50s, 733 nM, 432 nM, respectively), and shows no effect on HDAC4/5/6/7/9[1].	Free Base	C22H19FN4O2	179634.0	DMSO : ≥ 50 mg/mL (128.07 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=C(CNC(/C=C/C2=CN=CC=C2)=O)C=C1)NC(C=CC(F)=C3)=C3N	https://www.medchemexpress.com/Tucidinostat.html	Launched		92.0	P12	M13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109015	10.0	mM	301.0	DMSO	390.149204	13	M	pluskal_fda_drugs_5005_M13_id
3	HY-B2134	HYCPK40897	C03	HYCPK40909	92z	276.0	4.0	F36	909.0	C18	8024-48-4	Casanthranol			Others	Others	Casanthranol is a concentrated mixture of anthranol glycosides from cascara sagrada (dried bark of Rhamnus p.) and used as a laxative in constipation and various medical conditions, stimulant laxative Casanthranol encourages bowel movements by acting on the intestinal wall to increase muscle contractions[1].			27754.0	DMSO : ≥ 50 mg/mL	DMSO Solution	3mg/mL  * 100uL	Metabolic Disease	[Casanthranol]	https://www.medchemexpress.com/Casanthranol.html	Launched		92.0	F36	M14	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2134	3.0	mM	302.0	DMSO	434.121297	14	M	pluskal_fda_drugs_5005_M14_id
6	HY-B2068	HYCPK40897	F03	HYCPK40909	92z	564.0	4.0	L36	909.0	F18	8047-67-4	Iron sucrose	Iron saccharate		Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Iron sucrose (Iron saccharate) is a intravenous iron preparation and a pro-oxidant agent. Iron sucrose has the potential for iron deficiency anemia treatment[1][2][3][4].			63916.0	DMSO : 40 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Metabolic Disease; Cancer	[Iron sucrose]	https://www.medchemexpress.com/iron-sucrose.html	Launched		92.0	L36	M14	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2068	3.0	mM	302.0	DMSO	342.116212	14	M	pluskal_fda_drugs_5005_M14_id
1411	HY-B1517A	HYCPK40906	P05	HYCPK40906	92z	1449.0	1.0	AE9	906.0	P05	13707-88-5	Alprenolol (hydrochloride)	(RS)-Alprenolol hydrochloride; dl-Alprenolol hydrochloride	285.81	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Alprenolol ((RS)-Alprenolol; dl-Alprenolol) hydrochloride is an orally active non-selective β-adrenoceptor antagonist and an antagonist of 5-HT1A and 5-HT1B receptors. Alprenolol hydrochloride is used as an anti-hypertensive, anti-anginal and anti-arrhythmic agent[1][2][3].	Hydrochloride	C15H24ClNO2	44317.0	DMSO : 100 mg/mL (349.88 mM; Need ultrasonic); H2O : 50 mg/mL (174.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	OC(COC1=CC=CC=C1CC=C)CNC(C)C.[H]Cl	https://www.medchemexpress.com/Alprenolol-hydrochloride.html	Launched		92.0	AE9	M14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1517A	10.0	mM	302.0	DMSO	249.172879	14	M	pluskal_fda_drugs_5005_M14_id
1423	HY-D0711	HYCPK40906	L06	HYCPK40906	92z	1067.0	1.0	W11	906.0	L06	3599-32-4	Indocyanine green	Foxgreen; IC Green; Cardiogreen	774.96	Others	Others	Indocyanine green (Foxgreen) is a low toxicic fluorescent agent that has been widely used in medical diagnostics, such as determining cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography.	Sodium	C43H47N2NaO6S2	105987.0	H2O : 5 mg/mL (6.45 mM; ultrasonic and warming and heat to 60°C); DMSO : 33.33 mg/mL (43.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=S(CCCC[N+]1=C(/C=C/C=C/C=C/C=C2N(CCCCS(=O)(O[Na])=O)C3=C(C4=CC=CC=C4C=C3)C/2(C)C)C(C)(C)C5=C1C=CC6=CC=CC=C56)([O-])=O	https://www.medchemexpress.com/Cardiogreen.html	Launched		92.0	W11	M14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-D0711	10.0	mM	302.0	DMSO	752.295379	14	M	pluskal_fda_drugs_5005_M14_id
1486	HY-B0958	HYCPK40906	A09	HYCPK40906	92z	17.0	1.0	A17	906.0	A09	12650-69-0	Mupirocin	BRL-4910A; Pseudomonic acid	500.62	Antibiotic; Bacterial	Anti-infection	Mupirocin (BRL-4910A, Pseudomonic acid) is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2].	Free Acid	C26H44O9	16547.0	DMSO : ≥ 100 mg/mL (199.75 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@@H]1[C@@](CO[C@@H](C/C(C)=C/C(OCCCCCCCCC(O)=O)=O)[C@@H]1O)([H])C[C@H]2[C@@]([C@@H](C)[C@@H](O)C)([H])O2	https://www.medchemexpress.com/Mupirocin.html	Launched		92.0	A17	M14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0958	10.0	mM	302.0	DMSO	500.298533	14	M	pluskal_fda_drugs_5005_M14_id
1817	HY-B0121	HYCPK40907	A10	HYCPK40907	92z	20.0	2.0	A20	907.0	A10	103628-48-4	Sumatriptan (succinate)	GR 43175	413.49	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Sumatriptan succinate (GR 43175) is an orally active 5-HT1 receptor agonist with Kis of 17 nM, 27 nM and 100 nM for 5-HT1D, 5-HT1B and 5-HT1A receptors, respectively. Sumatriptan succinate can be used for migraine headache research[1][2].	Succinate	C18H27N3O6S	13900.0	DMSO : 50 mg/mL (120.92 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (241.84 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(O)CCC(O)=O.O=S(CC1=CC2=C(NC=C2CCN(C)C)C=C1)(NC)=O	https://www.medchemexpress.com/Sumatriptan-succinate.html	Launched		92.0	A20	M14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0121	10.0	mM	302.0	DMSO	295.135448	14	M	pluskal_fda_drugs_5005_M14_id
2101	HY-B0744D	HYCPK40908	N08	HYCPK40908	92z	1311.0	3.0	AB15	908.0	N08	69955-42-6	L-Eflornithine (monohydrochloride)	L-DFMO (monohydrochloride); ; L-RMI71782 (monohydrochloride); L-α-difluoromethylornithine (monohydrochloride)	218.63	Parasite	Anti-infection	L-Eflornithine monohydrochloride (L-DFMO monohydrochloride) is an enantiomer of Eflornithine. L-Eflornithine is an irreversible ornithine decarboxylase (ODC) inhibitor with a KD of 1.3±0.3 μM, and a Kinact of 0.15±0.03 min-1[1].	Hydrochloride	C6H13ClF2N2O2	81038.0	H2O : 50 mg/mL (228.70 mM; Need ultrasonic); DMSO : 200 mg/mL (914.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	N[C@](CCCN)(C(F)F)C(O)=O.Cl	https://www.medchemexpress.com/L-Eflornithine_monohydrochloride.html	Launched		92.0	AB15	M14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0744D	10.0	mM	302.0	DMSO	182.086684	14	M	pluskal_fda_drugs_5005_M14_id
2174	HY-A0095	HYCPK40908	K13	HYCPK40908	92z	1033.0	3.0	V25	908.0	K13	167933-07-5	Flibanserin	BIMT-17; BIMT-17BS	390.40	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Flibanserin (BIMT-17; BIMT-17BS) is an orally active serotonin 5-HT1A receptor agonist and 5-HT2A receptor antagonist with Ki values of 1 nM and 49 nM, respectively. Flibanserin binds to dopamine D4 receptors with an Ki value of 4-24 nM. Flibanserin shows anti-depression and anti-anxiety effect, can be used to hypoactive sexual desire disorder (HSDD) research[1]-[5].	Free Base	C20H21F3N4O	17354.0	DMSO : 50 mg/mL (128.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C1NC2=CC=CC=C2N1CCN3CCN(C4=CC=CC(C(F)(F)F)=C4)CC3	https://www.medchemexpress.com/Flibanserin.html	Launched		92.0	V25	M14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0095	10.0	mM	302.0	DMSO	390.166746	14	M	pluskal_fda_drugs_5005_M14_id
25	HY-B2235	HYCPK40899	C03	HYCPK40909	92z	268.0	4.0	F28	909.0	C14	8002-43-5	Lecithin		758.06	Endogenous Metabolite	Metabolic Enzyme/Protease	Lecithin is regarded as a safe, conventional phospholipid source. Phospholipids are reported to alter the fatty acid composition and microstructure of the membranes in animal cells.	Free Base	C42H80NO8P	26593.0	H2O : 3.33 mg/mL (4.39 mM; Need ultrasonic); DMSO : 5 mg/mL (6.60 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Others	O=P(OC[C@@H](COC(CCCCCCCCCCCCCCC)=O)OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)(OCC[N+](C)(C)C)[O-]	https://www.medchemexpress.com/Lecithin.html	Launched		92.0	F28	M15	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2235	2.0	mM	303.0	DMSO	758.569432	15	M	pluskal_fda_drugs_5005_M15_id
1400	HY-B0255	HYCPK40906	E05	HYCPK40906	92z	393.0	1.0	I9	906.0	E05	142340-99-6	Adefovir dipivoxil	GS 0840	501.47	Endogenous Metabolite; HBV; Orthopoxvirus; Reverse Transcriptase	Anti-infection; Metabolic Enzyme/Protease	Adefovir dipivoxil, an adenosine analogue, is an oral prodrug of the nucleoside reverse transcriptase inhibitor Adefovir.  Adefovir dipivoxil inhibits both the wild type and HBV Lamivudine-resistant strains[1][2]. Adefovir dipivoxil shows anti-orthopoxvirus activity.	Free Base	C20H32N5O8P	13694.0	H2O : 0.67 mg/mL (1.34 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (199.41 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	NC1=C2N=CN(CCOCP(OCOC(C(C)(C)C)=O)(OCOC(C(C)(C)C)=O)=O)C2=NC=N1	https://www.medchemexpress.com/Adefovir-dipivoxil.html	Launched		92.0	I9	M15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0255	10.0	mM	303.0	DMSO	501.19885	15	M	pluskal_fda_drugs_5005_M15_id
1420	HY-15856B	HYCPK40906	I06	HYCPK40906	92z	779.0	1.0	Q11	906.0	I06	2413-38-9	Flupentixol (dihydrochloride)	Flupenthixol (dihydrochloride)	507.44	Apoptosis; Dopamine Receptor; PI3K	Apoptosis; GPCR/G Protein; Neuronal Signaling; PI3K/Akt/mTOR	Flupentixol is an orally active D1/D2 dopamine receptor antagonist and new PI3K inhibitor (PI3Kα IC50=127 nM). Flupentixol shows anti-proliferative activity to cancer cells and induces apoptosis. Flupentixol can also be used in schizophrenia, anxiolytic and depressive research[1][2][3].	Hydrochloride	C23H27Cl2F3N2OS	60851.0	H2O : 100 mg/mL (197.07 mM; Need ultrasonic); DMSO : 33.33 mg/mL (65.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	OCCN1CCN(CC/C=C2C3=C(SC4=C/2C=CC=C4)C=CC(C(F)(F)F)=C3)CC1.[H]Cl.[H]Cl	https://www.medchemexpress.com/Flupentixol_dihydrochloride.html	Launched		92.0	Q11	M15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15856B	10.0	mM	303.0	DMSO	434.163969	15	M	pluskal_fda_drugs_5005_M15_id
1595	HY-18342	HYCPK40906	N15	HYCPK40906	92z	1277.0	1.0	AA29	906.0	N15	22494-42-4	Diflunisal	MK-647	250.20	COX	Immunology/Inflammation	Diflunisal (MK-647) is a salicylate derivative with nonsteroidal anti-inflammatory and uricosuric properties, which is used alone as an analgesic and in rheumatoid arthritis patients. The mechanism of action of diflunisal is as a Cyclooxygenase (COX) Inhibitor.	Free Acid	C13H8F2O3	29613.0	DMSO : 50 mg/mL (199.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(C1=CC(C2=CC=C(F)C=C2F)=CC=C1O)O	https://www.medchemexpress.com/Diflunisal.html	Launched		92.0	AA29	M15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18342	10.0	mM	303.0	DMSO	250.044151	15	M	pluskal_fda_drugs_5005_M15_id
1728	HY-B0552	HYCPK40907	C04	HYCPK40907	92z	200.0	2.0	E8	907.0	C04	85-79-0	Dibucaine	Cinchocaine	343.46	Sodium Channel	Membrane Transporter/Ion Channel	Dibucaine (Cinchocaine) is a sodium channel inhibitor. Dibucaine is a potent SChE inhibitor[1][2].	Free Base	C20H29N3O2	17055.0	DMSO : ≥ 36 mg/mL (104.82 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC(OCCCC)=NC2=CC=CC=C12)NCCN(CC)CC	https://www.medchemexpress.com/Dibucaine.html	Launched		92.0	E8	M15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0552	10.0	mM	303.0	DMSO	343.225977	15	M	pluskal_fda_drugs_5005_M15_id
2219	HY-B0115	HYCPK40908	H16	HYCPK40908	92z	751.0	3.0	P31	908.0	H16	15574-96-6	Pizotifen	Pizotyline; BC-105	295.44	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Pizotifen (Pizotyline) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.	Free Base	C19H21NS	15668.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 20 mg/mL (67.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1CC/C(CC1)=C2C3=CC=CC=C3CCC4=C\2C=CS4	https://www.medchemexpress.com/Pizotifen.html	Launched		92.0	P31	M15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0115	10.0	mM	303.0	DMSO	295.139471	15	M	pluskal_fda_drugs_5005_M15_id
2240	HY-100441	HYCPK40908	A18	HYCPK40908	92z	83.0	3.0	B35	908.0	A18	81846-19-7	Treprostinil	UT-15	390.51	Prostaglandin Receptor	GPCR/G Protein	Treprostinil (UT-15) is a potent DP1 and EP2 agonist with EC50 values of 0.6±0.1 and 6.2±1.2 nM, respectively.	Free Acid	C23H34O5	64030.0	DMSO : ≥ 125 mg/mL (320.09 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	OC(COC1=CC=CC2=C1C[C@](C[C@@H](O)[C@@H]3CC[C@@H](O)CCCCC)([H])[C@]3([H])C2)=O	https://www.medchemexpress.com/Treprostinil.html	Launched		92.0	B35	M15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100441	10.0	mM	303.0	DMSO	390.240624	15	M	pluskal_fda_drugs_5005_M15_id
2290	HY-B0078	HYCPK40908	C21	HYCPK40908	92z	281.0	3.0	F41	908.0	C21	4342-03-4	Dacarbazine	Imidazole Carboxamide	182.18	Apoptosis; Nucleoside Antimetabolite/Analog	Apoptosis; Cell Cycle/DNA Damage	Dacarbazine is a cell cycle nonspecific antineoplastic alkylating agent. Dacarbazine inhibits T and B lymphoblastic response, with IC50 values of 50 and 10 μg/ml, respectively. Dacarbazine can be used for the research of metastatic malignant melanoma[1][2].	Free Base	C6H10N6O	15431.0	DMSO : 5 mg/mL (27.45 mM; ultrasonic and warming and heat to 60°C); H2O : 1 mg/mL (5.49 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(/N=N/N(C)C)NC=N1)N	https://www.medchemexpress.com/Dacarbazine.html	Launched		92.0	F41	M15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0078	10.0	mM	303.0	DMSO	182.091609	15	M	pluskal_fda_drugs_5005_M15_id
11	HY-B1390B	HYCPK40897	K03	HYCPK40909	92z	1044.0	4.0	V36	909.0	K18	82385-42-0	Saccharin (sodium hydrate)			Bacterial	Anti-infection	Saccharin sodium hydrate is an orally active, non-caloric artificial sweeteners (NAS). Saccharin sodium hydrate has bacteriostatic and microbiome-modulating properties[1].	Sodium	C7H5NO3S.xH2O.Na	79105.0	H2O : 83.33 mg/mL (Need ultrasonic); DMSO : 250 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Inflammation/Immunology	O=C(C1=C2C=CC=C1)N([Na])S2(=O)=O.O.[x]	https://www.medchemexpress.com/saccharin-sodium-hydrate.html	Launched		92.0	V36	M16	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1390B	3.0	mM	304.0	DMSO	182.999014	16	M	pluskal_fda_drugs_5005_M16_id
1459	HY-B0273	HYCPK40908	A05	HYCPK40908	92z	57.0	3.0	B9	908.0	A05	68-35-9	Sulfadiazine		250.28	Antibiotic; Bacterial; Parasite	Anti-infection	Sulfadiazine is a sulfonamide?antibiotic with antimalarial activity. Sulfadiazine can be used for toxoplasmosis research[1][2].	Free Base	C10H10N4O2S	16537.0	DMSO : ≥ 50 mg/mL (199.78 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC=CC=N2)=O	https://www.medchemexpress.com/sulfadiazine.html	Launched		92.0	B9	M16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0273	10.0	mM	304.0	DMSO	250.052447	16	M	pluskal_fda_drugs_5005_M16_id
1691	HY-B0636	HYCPK40906	N21	HYCPK40906	92z	1289.0	1.0	AA41	906.0	N21	76-25-5	Triamcinolone acetonide		434.50	Glucocorticoid Receptor	Immunology/Inflammation	"Triamcinolone acetonide is a more potent type of triamcinolone, being about 8 times as effective as prednisone. 
Target: Glucocorticoid Receptor
Triamcinolone acetonide is a synthetic corticosteroid used to treat various skin conditions, to relieve the discomfort of mouth sores, and in nasal spray form, to treat allergic rhinitis. It is a more potent derivative of triamcinolone, and is about 8 times as potent as prednisone [1]."	Free Base	C24H31FO6	15207.0	H2O : 0.1 mg/mL (0.23 mM; Need ultrasonic); DMSO : 50 mg/mL (115.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	OCC([C@]12[C@@]3([C@@]([C@@]4([H])[C@]([C@H](C3)O)([C@@]5(C(CC4)=CC(C=C5)=O)C)F)([H])C[C@@]1([H])OC(C)(O2)C)C)=O	https://www.medchemexpress.com/Triamcinolone-acetonide.html	Launched		92.0	AA41	M16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0636	10.0	mM	304.0	DMSO	434.210467	16	M	pluskal_fda_drugs_5005_M16_id
2012	HY-12199B	HYCPK40907	P22	HYCPK40907	92z	1484.0	2.0	AE44	907.0	P22	903576-44-3	Pitolisant (hydrochloride)	Ciproxidine; BF 2649	332.31	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Pitolisant hydrochloride is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM).	Hydrochloride	C17H27Cl2NO	101692.0	DMSO : ≥ 43 mg/mL (129.40 mM); H2O : 100 mg/mL (300.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	ClC(C=C1)=CC=C1CCCOCCCN2CCCCC2.Cl	https://www.medchemexpress.com/Pitolisant-hydrochloride.html	Launched		92.0	AE44	M16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12199B	10.0	mM	304.0	DMSO	295.170292	16	M	pluskal_fda_drugs_5005_M16_id
2024	HY-N0783	HYCPK40908	L03	HYCPK40908	92z	1109.0	3.0	X5	908.0	L03	22368-21-4	Eupatilin		344.32	Autophagy; PPAR	Autophagy; Cell Cycle/DNA Damage	Eupatilin, a lipophilic flavonoid isolated from Artemisia argyi Lévl. et Van., is a PPARα agonist, and possesses anti-apoptotic, anti-oxidative and anti-inflammatory activities.	Free Base	C18H16O7	101898.0	DMSO : 33.33 mg/mL (96.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease; Cancer	O=C1C=C(C2=CC=C(OC)C(OC)=C2)OC3=CC(O)=C(OC)C(O)=C13	https://www.medchemexpress.com/Eupatilin.html	Launched		92.0	X5	M16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0783	10.0	mM	304.0	DMSO	344.089603	16	M	pluskal_fda_drugs_5005_M16_id
2039	HY-16504	HYCPK40908	K04	HYCPK40908	92z	1015.0	3.0	V7	908.0	K04	289480-64-4	Treprostinil (sodium)	UT-15 (sodium)	412.49	Prostaglandin Receptor	GPCR/G Protein	Treprostinil (UT-15) sodium is a potent DP1 and EP2 agonist with EC50 values of 0.6±0.1 and 6.2±1.2 nM, respectively.	Sodium	C23H33NaO5	23239.0	DMSO : ≥ 26 mg/mL (63.03 mM); H2O : 16.67 mg/mL (40.41 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(O[Na])COC1=C2C[C@@]3([H])C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]3([H])CC2=CC=C1	https://www.medchemexpress.com/Treprostinil-sodium.html	Launched		92.0	V7	M16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16504	10.0	mM	304.0	DMSO	390.240624	16	M	pluskal_fda_drugs_5005_M16_id
2082	HY-15298A	HYCPK40908	K07	HYCPK40908	92z	1021.0	3.0	V13	908.0	K07	1206524-86-8	Grazoprevir potassium salt	MK-5172 (potassium salt)	804.99	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Grazoprevir potassium salt (MK-5172 potassium salt) is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Kis of 0.01 nM (gt1b), 0.01 nM (gt1a), 0.08 nM (gt2a), 0.15 nM (gt2b), 0.90 nM (gt3a), respectively[1][2]. Grazoprevir potassium salt inhibits SARS-CoV-2 3CLpro activity[3].	Potassium	C38H49KN6O9S	9513.0	DMSO : ≥ 100 mg/mL (124.23 mM)	DMSO Solution	10mM  * 100uL	Infection	COC1=CC2=C(N=C(CCCCC[C@@H]3C[C@H]3OC4=O)C(O[C@H]5CN(C([C@H](C(C)(C)C)N4)=O)[C@H](C(N[C@@]([C@@H]6C=C)(C6)C([N-]S(C7CC7)(=O)=O)=O)=O)C5)=N2)C=C1.[K+]	https://www.medchemexpress.com/MK-5172-potassium-salt.html	Launched		92.0	V13	M16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15298A	10.0	mM	304.0	DMSO	766.335998	16	M	pluskal_fda_drugs_5005_M16_id
2509	HY-B1197	HYCPK40909	P08	HYCPK40909	92z	1504.0	4.0	AF16	909.0	P08	51022-69-6	Amcinonide	CL-34699	502.57	Glucocorticoid Receptor	Immunology/Inflammation	"Amcinonide inhibit NO release from activated microglia with IC50 3.38 nM. Amcinonide has affinity for the glucocorticoid receptor.
IC50 value: 3.38 nM  [1]
Target: NO release
in vitro: Simultaneous immunofluorescent staining for T6 and Ia antigenicity within human epidermis of Amcinonide treated skin detected reduced numbers of T6+/Ia+ cells with a concomitant increase in T6+/Ia- cells. [2]
in vivo: Amcinonide is an anti-inflammatory agent, elicites whitening of a few hairs in both pheomelanic and eumelanic mice. Amcinonide brings about a marked reduction in the numbers of DOPA-positive epidermal melanocytes inhabiting the tails of eumelanic or pheomelanic mice. Amcinonide exertes a deleterious influence on the structure and function of tail epidermis. [3]"	Free Base	C28H35FO7	65113.0	DMSO : 250 mg/mL (497.44 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]12[C@@]3(C(COC(C)=O)=O)[C@@](OC4(O3)CCCC4)([H])C[C@@]1([H])[C@]5([H])CCC6=CC(C=C[C@]6(C)[C@@]5(F)[C@@H](O)C2)=O	https://www.medchemexpress.com/Amcinonide.html	Launched		92.0	AF16	M16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1197	10.0	mM	304.0	DMSO	502.236682	16	M	pluskal_fda_drugs_5005_M16_id
1364	HY-15777A	HYCPK40906	A03	HYCPK40906	92z	5.0	1.0	A5	906.0	A03	1211443-80-9	Ribociclib hydrochloride	LEE011 (hydrochloride)	471.00	CDK	Cell Cycle/DNA Damage	Ribociclib hydrochloride (LEE011 hydrochloride) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex.	Hydrochloride	C23H31ClN8O	96930.0	H2O : 10 mg/mL (21.23 mM; Need ultrasonic); DMSO : 7.69 mg/mL (16.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N(C)C)C(N1C2CCCC2)=CC(C1=N3)=CN=C3NC(N=C4)=CC=C4N5CCNCC5.Cl	https://www.medchemexpress.com/lee011-hydrochloride.html	Launched		92.0	A5	M17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15777A	10.0	mM	305.0	DMSO	434.254258	17	M	pluskal_fda_drugs_5005_M17_id
1898	HY-B1064	HYCPK40907	J15	HYCPK40907	92z	894.0	2.0	S30	907.0	J15	24729-96-2	Clindamycin phosphate	Clindamycin 2-phosphate; U-28508	504.96	Antibiotic; Bacterial; Parasite	Anti-infection	"Clindamycin phosphate (Clindamycin 2-phosphate) is a broad-spectrum bacteriostatic lincosamide antibiotic. Clindamycin phosphate is the prodrug of <a href=""/Clindamycin.html"" class=""link-product"" target=""_blank"">Clindamycin</a> (HY-B1455) with no antimicrobial activity in vitro but can be rapidly converted in vivo to the active parent drug, Clindamycin, by phosphatase ester hydrolysis. Clindamycin phosphate can be used for researching acne and bacterial vaginosis[1][2][3]."	Free Acid	C18H34ClN2O8PS	39730.0	H2O : ≥ 320 mg/mL (633.71 mM)	DMSO Solution	10mM  * 100uL	Infection	CCC[C@H]1CN(C)[C@H](C(N[C@@]([H])([C@@]2([H])O[C@H](SC)[C@H](OP(O)(O)=O)[C@@H](O)[C@H]2O)[C@@H](Cl)C)=O)C1	https://www.medchemexpress.com/Clindamycin-phosphate.html	Launched		92.0	S30	M17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1064	10.0	mM	305.0	DMSO	504.146201	17	M	pluskal_fda_drugs_5005_M17_id
2032	HY-107212	HYCPK40908	D04	HYCPK40908	92z	343.0	3.0	H7	908.0	D04	220119-17-5	Selamectin		769.96	Bacterial; Chloride Channel; Parasite; P-glycoprotein	Anti-infection; Membrane Transporter/Ion Channel	Selamectin, a semi-synthetic macrocyclic lactone, is a potent parasiticide and anthelminthic. Selamectin activates glutamate-gated chloride channels in neurons and pharyngeal muscles to prevent heartworm, Lymphatic filariae, and nematode infection. Selamectin is also a potent P-glycoprotein substrate and a P-glycoprotein inhibitor with an IC50 of 120 nM[1][2].	Free Base	C43H63NO11	26396.0	DMSO : ≥ 100 mg/mL (129.88 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@@]12[C@@]3([H])/C(C(C)=C[C@@]1([H])C(O[C@]4([H])C[C@]5(O[C@@](C/C=C(C)/[C@@H](O[C@@]6([H])C[C@@H]([C@@H](O)[C@H](C)O6)OC)[C@@H](C)/C=C/C=C2\CO3)([H])C4)O[C@H](C7CCCCC7)[C@@H](C)CC5)=O)=N\O	https://www.medchemexpress.com/Selamectin.html	Launched		92.0	H7	M17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107212	10.0	mM	305.0	DMSO	769.440112	17	M	pluskal_fda_drugs_5005_M17_id
2105	HY-17368	HYCPK40908	B09	HYCPK40908	92z	161.0	3.0	D17	908.0	B09	123441-03-2	Rivastigmine	S-Rivastigmine	250.34	Cholinesterase (ChE)	Neuronal Signaling	Rivastigmine (S-Rivastigmine) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM , 4.15 μM, respectively. Rivastigmine can pass the blood brain barrier (BBB). Rivastigmine is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease[1][2].	Free Base	C14H22N2O2	126789.0	DMSO : ≥ 50 mg/mL (199.73 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N(C)CC)OC1=CC=CC([C@H](C)N(C)C)=C1	https://www.medchemexpress.com/Rivastigmine.html	Launched		92.0	D17	M17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17368	10.0	mM	305.0	DMSO	250.168128	17	M	pluskal_fda_drugs_5005_M17_id
2178	HY-15164	HYCPK40908	O13	HYCPK40908	92z	1417.0	3.0	AD25	908.0	O13	1204313-51-8	Icotinib (Hydrochloride)	BPI-2009H	427.88	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Icotinib Hydrochloride (BPI-2009) is a potent and specific EGFR inhibitor with an IC50 of 5 nM; also inhibits mutant EGFRL858R, EGFRL858R/T790M, EGFRT790M and EGFRL861Q.	Hydrochloride	C22H22ClN3O4	7663.0	DMSO : 25 mg/mL (58.43 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	C#CC1=CC(NC2=C(C=C(OCCOCCOCCO3)C3=C4)C4=NC=N2)=CC=C1.[H]Cl	https://www.medchemexpress.com/Icotinib-Hydrochloride.html	Launched		92.0	AD25	M17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15164	10.0	mM	305.0	DMSO	391.153206	17	M	pluskal_fda_drugs_5005_M17_id
2250	HY-10882	HYCPK40908	K18	HYCPK40908	92z	1043.0	3.0	V35	908.0	K18	23593-75-1	Clotrimazole		344.84	Antibiotic; Autophagy; Bacterial; Fungal	Anti-infection; Autophagy	Clotrimazole is an imidazole derivative, an antifungal compound and is a CYP (cytochrome P450) inhibitor. Clotrimazole has antibacterial activity.	Free Base	C22H17ClN2	15646.0	H2O : 0.1 mg/mL (0.29 mM; Need ultrasonic); DMSO : 50 mg/mL (144.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	ClC1=CC=CC=C1C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4	https://www.medchemexpress.com/Clotrimazole.html	Launched		92.0	V35	M17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10882	10.0	mM	305.0	DMSO	344.108026	17	M	pluskal_fda_drugs_5005_M17_id
2481	HY-Y0272	HYCPK40909	M06	HYCPK40909	92z	1212.0	4.0	Z12	909.0	M06	81-07-2	Saccharin		183.18	Bacterial	Anti-infection	Saccharin is an orally active, non-caloric artificial sweeteners (NAS). Saccharin has bacteriostatic and microbiome-modulating properties[1].		C7H5NO3S	27767.0	DMSO : 100 mg/mL (545.91 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=C2C=CC=C1)NS2(=O)=O	https://www.medchemexpress.com/saccharin.html	Launched		92.0	Z12	M17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0272	10.0	mM	305.0	DMSO	182.999014	17	M	pluskal_fda_drugs_5005_M17_id
2496	HY-16478	HYCPK40909	C08	HYCPK40909	92z	256.0	4.0	F16	909.0	C08	733030-01-8	Trifluridine/tipiracil hydrochloride mixture	TAS-102; FTD/TPI	435.76	Nucleoside Antimetabolite/Analog; Thymidylate Synthase	Apoptosis; Cell Cycle/DNA Damage	Trifluridine/tipiracil hydrochloride mixture (TAS-102) is a potent and orally active nucleoside antitumor agent. The composition of Trifluridine/tipiracil hydrochloride mixture (TAS-102) is a 1:0.5 mixture (on a molar basis) of alpha,alpha,alpha-tri-fluorothymidine (FTD) and thymidine phosphorylase inhibitor (TPI). Trifluridine/tipiracil hydrochloride mixture (TAS-102) shows the antitumor activity mainly via the inhibition of thymidylate synthase (TS) and incorporation into DNA[1][2].	Hydrochloride	C10H11F3N2O5.1/2C9H11ClN4O2.1/2HCl	79931.0	DMSO : 2.34 mg/mL (5.37 mM; Need ultrasonic and warming); DMF : 20 mg/mL (45.90 mM; Need ultrasonic); H2O : 100 mg/mL (229.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1N([C@H]2C[C@H](O)[C@@H](CO)O2)C=C(C(F)(F)F)C(N1)=O.O=C3N([C@H]4C[C@H](O)[C@@H](CO)O4)C=C(C(F)(F)F)C(N3)=O.O=C5NC(CN6CCCC6=N)=C(Cl)C(N5)=O.Cl	https://www.medchemexpress.com/TAS-102.html	Launched		92.0	F16	M17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16478	10.0	mM	305.0	DMSO	296.062006	17	M	pluskal_fda_drugs_5005_M17_id
1629	HY-B2122	HYCPK40906	P17	HYCPK40906	92z	1473.0	1.0	AE33	906.0	P17	585-88-6	Maltitol		344.31	Others	Others	Maltitol is a sugar alcohol used as a sugar substitute. It has 75-90% of the sweetness of sucrose (table sugar) and nearly identical properties. Maltitol may also be used as a plasticizer in gelatin capsules, as an emollient, and as a humectant[1].	Free Base	C12H24O11	27534.0	DMSO : 33.33 mg/mL (96.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O[C@H](CO)[C@H]([C@H](O)[C@H](CO)O)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1	https://www.medchemexpress.com/Maltitol.html	Launched		92.0	AE33	M18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2122	10.0	mM	306.0	DMSO	344.131862	18	M	pluskal_fda_drugs_5005_M18_id
1746	HY-B1145	HYCPK40907	J05	HYCPK40907	92z	874.0	2.0	S10	907.0	J05	3697-42-5	Chlorhexidine (dihydrochloride)		578.37	Antibiotic; Bacterial	Anti-infection	Chlorhexidine dihydrochloride is an antibacterial, used as an antiseptic and for other applications.	Hydrochloride	C22H32Cl4N10	145448.0	DMSO : 20.83 mg/mL (36.02 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection; Cancer	N=C(NC1=CC=C(Cl)C=C1)NC(NCCCCCCNC(NC(NC2=CC=C(Cl)C=C2)=N)=N)=N.[H]Cl.[H]Cl	https://www.medchemexpress.com/Chlorhexidine-dihydrochloride.html	Launched		92.0	S10	M18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1145	10.0	mM	306.0	DMSO	504.203196	18	M	pluskal_fda_drugs_5005_M18_id
1804	HY-B0924	HYCPK40907	D09	HYCPK40907	92z	306.0	2.0	G18	907.0	D09	117-37-3	Anisindione		252.26	Others	Others	Anisindione is a synthetic anticoagulant, prevents the formation of active procoagulation factors II, VII, IX, and X.	Free Base	C16H12O3	21779.0	DMSO : ≥ 50 mg/mL (198.21 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C1C(C2=CC=C(OC)C=C2)C(C3=C1C=CC=C3)=O	https://www.medchemexpress.com/Anisindione.html	Launched		92.0	G18	M18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0924	10.0	mM	306.0	DMSO	252.078644	18	M	pluskal_fda_drugs_5005_M18_id
1889	HY-108365	HYCPK40907	A15	HYCPK40907	92z	30.0	2.0	A30	907.0	A15	145435-72-9	Gamithromycin	ML-1709460	777.04	Antibiotic; Bacterial	Anti-infection	Gamithromycin is an antimicrobial agent which can inhibit the growth of MmmSC strains B237 and Tan8 with MICs of 0.00012 and 0.00006 μg/mL, respectively.	Free Base	C40H76N2O12	26568.0	DMSO : 100 mg/mL (128.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O[C@H]([C@H](C[C@@H](C)O1)N(C)C)[C@]1([H])O[C@@H]2[C@H]([C@@H]([C@H](C(O[C@@H]([C@@](C)(O)[C@H](O)[C@@H](C)CN(CCC)[C@H](C)C[C@]2(O)C)CC)=O)C)O[C@@]3([H])C[C@](C)([C@@H](O)[C@H](C)O3)OC)C	https://www.medchemexpress.com/Gamithromycin.html	Launched		92.0	A30	M18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108365	10.0	mM	306.0	DMSO	776.539826	18	M	pluskal_fda_drugs_5005_M18_id
1960	HY-107915	HYCPK40907	H19	HYCPK40907	92z	710.0	2.0	O38	907.0	H19	829-74-3	Levonordefrin	(-)-Cobefrin; (-)-α-Methylnoradrenaline; (-)-Nordefrin	183.20	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Levonordefrin, a common alternative to levoepinephrine as a vasoconstrictor in dental local anesthetic preparations, is usually used in fivefold higher concentrations. Levonordefrin is generally considered equivalent to epinephrine[1].		C9H13NO3	153040.0	H2O : 5 mg/mL (27.29 mM; ultrasonic and warming and adjust pH to 1 with HCl and heat to 60°C)	DMSO Solution	10mM  * 100uL	Others	OC1=CC=C([C@@H](O)[C@@H](N)C)C=C1O	https://www.medchemexpress.com/levonordefrin.html	Launched		92.0	O38	M18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107915	10.0	mM	306.0	DMSO	183.089543	18	M	pluskal_fda_drugs_5005_M18_id
2061	HY-A0061	HYCPK40908	F06	HYCPK40908	92z	539.0	3.0	L11	908.0	F06	70-00-8	Trifluridine	Trifluorothymidine; 5-Trifluorothymidine; TFT	296.20	HSV; Nucleoside Antimetabolite/Analog; Orthopoxvirus; Thymidylate Synthase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Trifluridine (Trifluorothymidine; 5-Trifluorothymidine; TFT) is an irreversible thymidylate synthase inhibitor, and thereby suppresses DNA synthesis. Trifluridine is an antiviral drug for herpes simplex virus (HSV) infection. Trifluorothymidine also has anti-orthopoxvirus activity[3].	Free Base	C10H11F3N2O5	9651.0	DMSO : ≥ 100 mg/mL (337.61 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C(C(F)(F)F)=CN([C@@H]2O[C@H](CO)[C@@H](O)C2)C(N1)=O	https://www.medchemexpress.com/Trifluorothymidine.html	Launched		92.0	L11	M18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0061	10.0	mM	306.0	DMSO	296.062006	18	M	pluskal_fda_drugs_5005_M18_id
2169	HY-15777B	HYCPK40908	F13	HYCPK40908	92z	553.0	3.0	L25	908.0	F13	1374639-75-4	Ribociclib succinate	LEE011 (succinate)	552.63	CDK	Cell Cycle/DNA Damage	Ribociclib succinate (LEE011 succinate) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex.	Succinate	C27H36N8O5	28239.0	DMSO : 41.67 mg/mL (75.40 mM; Need ultrasonic); H2O : 4.17 mg/mL (7.55 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N(C)C)C(N1C2CCCC2)=CC(C1=N3)=CN=C3NC(N=C4)=CC=C4N5CCNCC5.OC(CCC(O)=O)=O	https://www.medchemexpress.com/lee011-succinate.html	Launched		92.0	L25	M18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15777B	10.0	mM	306.0	DMSO	434.254258	18	M	pluskal_fda_drugs_5005_M18_id
2199	HY-15373	HYCPK40908	D15	HYCPK40908	92z	365.0	3.0	H29	908.0	D15	65646-68-6	Fenretinide	4-HPR	391.55	Autophagy; RAR/RXR	Autophagy; Metabolic Enzyme/Protease	Fenretinide (4-HPR) is a synthetic retinoid deriverative, binding to the retinoic acid receptors (RAR) at concentrations necessary to induce cell death.	Free Base	C26H33NO2	6780.0	DMSO : ≥ 130 mg/mL (332.01 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC(/C=C/C=C(/C=C/C1=C(CCCC(C)1C)C)C)=C\C(NC2=CC=C(O)C=C2)=O	https://www.medchemexpress.com/Fenretinide.html	Launched		92.0	H29	M18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15373	10.0	mM	306.0	DMSO	391.251129	18	M	pluskal_fda_drugs_5005_M18_id
58	HY-B0308	HYCPK40899	L05	HYCPK40909	92z	1136.0	4.0	X32	909.0	L16	110871-86-8	Sparfloxacin	CI-978; AT-4140	392.40	Antibiotic; Bacterial	Anti-infection	Sparfloxacin (CI-978) is a fluoroquinolone antibiotic, shows broad and potent antibacterial activity.	Free Acid	C19H22F2N4O3	16399.0	H2O : 0.67 mg/mL (1.71 mM; Need ultrasonic); 0.1 M NaOH : 50 mg/mL (127.42 mM; ultrasonic and adjust pH to 11 with NaOH); DMSO : 3.33 mg/mL (8.49 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection	O=C(C1=CN(C2CC2)C3=C(C(N)=C(F)C(N4C[C@H](C)N[C@H](C)C4)=C3F)C1=O)O	https://www.medchemexpress.com/sparfloxacin.html	Launched		92.0	X32	M19	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0308	2.0	mM	307.0	DMSO	392.165997	19	M	pluskal_fda_drugs_5005_M19_id
1430	HY-B0684	HYCPK40906	C07	HYCPK40906	92z	205.0	1.0	E13	906.0	C07	60166-93-0	Iopamidol	B-15000; SQ-13396	777.09	Others	Others	Iopamidol is a nonionic, X-Ray iodinated contrast agent (CA) for a wide variety of diagnostic applications. Iopamidol contains amide and hydroxyl functionalities that can be exploited for the generation of the chemical exchange saturation transfer (CEST) contrast[1].	Free Base	C17H22I3N3O8	14714.0	H2O : 100 mg/mL (128.69 mM; Need ultrasonic); DMSO : 50 mg/mL (64.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(I)C(NC([C@@H](O)C)=O)=C(I)C(C(NC(CO)CO)=O)=C1I)NC(CO)CO	https://www.medchemexpress.com/Iopamidol.html	Launched		92.0	E13	M19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0684	10.0	mM	307.0	DMSO	776.854109	19	M	pluskal_fda_drugs_5005_M19_id
1603	HY-B2177	HYCPK40906	F16	HYCPK40906	92z	511.0	1.0	K31	906.0	F16	528-92-7	Apronal	Allylisopropylacetylurea; Apronalide	184.24	Others	Others	Apronal (Allylisopropylacetylurea, Apronalide) can bu used for the research of neuropsychiatry disorders.	Free Base	C9H16N2O2	26307.0	DMSO : 150 mg/mL (814.16 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C=CCC(C(C)C)C(NC(N)=O)=O		Launched		92.0	K31	M19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2177	10.0	mM	307.0	DMSO	184.121178	19	M	pluskal_fda_drugs_5005_M19_id
1779	HY-B0703	HYCPK40907	K07	HYCPK40907	92z	974.0	2.0	U14	907.0	K07	236395-14-5	Eslicarbazepine acetate	BIA 2-093	296.32	Beta-secretase; Sodium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Eslicarbazepine acetate (BIA 2-093), an antiepileptic drug, is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel.	Free Base	C17H16N2O3	42017.0	DMSO : ≥ 100 mg/mL (337.47 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(N1C2=CC=CC=C2C[C@H](OC(C)=O)C3=CC=CC=C31)N	https://www.medchemexpress.com/eslicarbazepine-acetate.html	Launched		92.0	U14	M19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0703	10.0	mM	307.0	DMSO	296.116092	19	M	pluskal_fda_drugs_5005_M19_id
1974	HY-15777C	HYCPK40907	J20	HYCPK40907	92z	904.0	2.0	S40	907.0	J20	1374639-79-8	Ribociclib succinate hydrate	LEE011 (succinate hydrate)	570.64	CDK	Cell Cycle/DNA Damage	Ribociclib succinate hydrate (LEE011 succinate hydrate) is a highly specific CDK4/6 inhibitor with IC50 values of 10 nM and 39 nM, respectively, and is over 1,000-fold less potent against the cyclin B/CDK1 complex.	Succinate	C27H38N8O6	25121.0	DMSO : 100 mg/mL (175.24 mM; Need ultrasonic); H2O : 4 mg/mL (7.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(N(C)C)C(N1C2CCCC2)=CC(C1=N3)=CN=C3NC(N=C4)=CC=C4N5CCNCC5.OC(CCC(O)=O)=O.[F,Cl,Br,I].O	https://www.medchemexpress.com/LEE011-succinate-hydrate.html	Launched		92.0	S40	M19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15777C	10.0	mM	307.0	DMSO	434.254258	19	M	pluskal_fda_drugs_5005_M19_id
2164	HY-B1389	HYCPK40908	A13	HYCPK40908	92z	73.0	3.0	B25	908.0	A13	81025-04-9	Lactitol (monohydrate)	D-Lactitol (monohydrate)	362.33	Bacterial	Anti-infection	Lactitol monohydrate is a disaccharide analogue of lactulose. It has been widely used in the treatment of constipation & hepatic encephalopathy. Lactitol is sugar alcohol used as replacement sweeteners.	Free Base	C12H26O12	17565.0	H2O : 120 mg/mL (331.19 mM; Need ultrasonic); DMSO : 100 mg/mL (275.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	OC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O[C@H]1[C@@H]([C@H]([C@H]([C@@H](CO)O1)O)O)O)O)O.[H]O[H]	https://www.medchemexpress.com/Lactitol-monohydrate.html	Launched		92.0	B25	M19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1389	10.0	mM	307.0	DMSO	344.131862	19	M	pluskal_fda_drugs_5005_M19_id
2189	HY-123210	HYCPK40908	J14	HYCPK40908	92z	939.0	3.0	T27	908.0	J14	139755-85-4	Lodenafil	Hydroxyhomosildenafil	504.60	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Lodenafil is a potent phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED)[1].	Free Base	C23H32N6O5S	43860.0	DMSO : ≥ 250 mg/mL (495.44 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C1C2=C(NC(C3=CC(S(=O)(N4CCN(CC4)CCO)=O)=CC=C3OCC)=N1)C(CCC)=NN2C	https://www.medchemexpress.com/lodenafil.html	Launched		92.0	T27	M19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-123210	10.0	mM	307.0	DMSO	504.215489	19	M	pluskal_fda_drugs_5005_M19_id
2504	HY-B0114	HYCPK40909	K08	HYCPK40909	92z	1024.0	4.0	V16	909.0	K08	28721-07-5	Oxcarbazepine	GP 47680	252.27	Apoptosis; Sodium Channel	Apoptosis; Membrane Transporter/Ion Channel	Oxcarbazepine is a sodium channel blocker[1]. Oxcarbazepine significantly inhibits glioblastoma cell growth and induces apoptosis or G2/M arrest in glioblastoma cell lines[2]. Anti-cancer and anticonvulsant effects[2][3].	Free Base	C15H12N2O2	15707.0	DMSO : 50 mg/mL (198.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	O=C(N1C2=CC=CC=C2CC(C3=CC=CC=C31)=O)N	https://www.medchemexpress.com/Oxcarbazepine.html	Launched		92.0	V16	M19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0114	10.0	mM	307.0	DMSO	252.089878	19	M	pluskal_fda_drugs_5005_M19_id
1448	HY-B0914	HYCPK40907	J14	HYCPK40907	92z	892.0	2.0	S28	907.0	J14	112-38-9	10-Undecenoic acid	Undecylenic acid	184.28	Antibiotic; Endogenous Metabolite; Fungal	Anti-infection; Metabolic Enzyme/Protease	10-Undecenoic acid was used as a starting reagent in the syntheses of Pheromone (11Z)-hexadecenal.	Free Acid	C11H20O2	17212.0	DMSO : ≥ 50 mg/mL (271.33 mM)	DMSO Solution	10mM  * 100uL	Others	C=CCCCCCCCCC(O)=O	https://www.medchemexpress.com/10-Undecenoic-acid.html	Launched		92.0	S28	M20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0914	10.0	mM	308.0	DMSO	184.14633	20	M	pluskal_fda_drugs_5005_M20_id
1499	HY-B0129	HYCPK40906	N09	HYCPK40906	92z	1265.0	1.0	AA17	906.0	N09	78110-38-0	Aztreonam	SQ-26,776	435.43278	Antibiotic; Bacterial	Anti-infection	Aztreonam (SQ-26,776) is a synthetic monocyclic beta-lactam antibiotic, which has a very high affinity for penicillin-binding protein 3 (PBP-3).	Free Acid	C13H17N5O8S2	15844.0	H2O : 10 mg/mL (22.97 mM; Need ultrasonic); DMSO : 50 mg/mL (114.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	CC(C)(O/N=C(C1=CSC(N)=N1)\C(N[C@H]2[C@H](C)N(S(=O)(O)=O)C2=O)=O)C(O)=O	https://www.medchemexpress.com/Aztreonam.html	Launched		92.0	AA17	M20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0129	10.0	mM	308.0	DMSO	435.051855	20	M	pluskal_fda_drugs_5005_M20_id
1721	HY-B0448A	HYCPK40907	L03	HYCPK40907	92z	1062.0	2.0	W6	907.0	L03	630-93-3	Phenytoin (sodium)	5,5-Diphenylhydantoin (sodium salt)	274.25	Sodium Channel; Virus Protease	Anti-infection; Membrane Transporter/Ion Channel	Phenytoin sodium (5,5-Diphenylhydantoin sodium salt) is a potent Voltage-gated Na+ channels (VGSCs) blocker. Phenytoin has antiepileptic activity and reduces breast tumour growth and metastasis in mice[1][2].	Sodium	C15H11N2NaO2	17148.0	DMSO : 50 mg/mL (182.32 mM; Need ultrasonic); H2O : 1 mg/mL (3.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C1N=C(O[Na])NC1(C2=CC=CC=C2)C3=CC=CC=C3	https://www.medchemexpress.com/Phenytoin-sodium.html	Launched		92.0	W6	M20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0448A	10.0	mM	308.0	DMSO	252.089878	20	M	pluskal_fda_drugs_5005_M20_id
1830	HY-10457A	HYCPK40907	N10	HYCPK40907	92z	1268.0	2.0	AA20	907.0	N10	866933-51-9	Velusetrag (hydrochloride)	TD-5108 (hydrochloride)	541.10	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Velusetrag (TD-5108) hydrochloride is an orally active, potent and selective agonist of serotonin 5-HT4 receptor (5-HT4R), with a pKi of 7.7. Velusetrag hydrochloride exhibits no affinity (Ki>10 μM) for 5-HT2A and 5-HT2B receptors. Velusetrag hydrochloride can be used for the research of gastrointestinal diseases and Parkinson's disease[1][2][3][4][5].	Hydrochloride	C25H37ClN4O5S	114654.0	DMSO : 220 mg/mL (406.58 mM; Need ultrasonic); H2O : 10 mg/mL (18.48 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	[H]Cl.O=C(C1=CC2=C(N(C(C)C)C1=O)C=CC=C2)N[C@@H]3C[C@@H](N4C[C@@H](O)CN(C)S(=O)(C)=O)CC[C@@H]4C3	https://www.medchemexpress.com/velusetrag-hydrochloride.html	Launched		92.0	AA20	M20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10457A	10.0	mM	308.0	DMSO	504.240641	20	M	pluskal_fda_drugs_5005_M20_id
1844	HY-13570	HYCPK40907	L11	HYCPK40907	92z	1078.0	2.0	W22	907.0	L11	378-44-9	Betamethasone		392.46	Apoptosis; Glucocorticoid Receptor	Apoptosis; Immunology/Inflammation	Betamethasone is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive activities. Betamethasone accelerates fetal lung maturation and induces gene expression and apoptosis[1][2][3][4].	Free Base	C22H29FO5	11797.0	DMSO : ≥ 50 mg/mL (127.40 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]12[C@](C[C@H](C)[C@]2(O)C(CO)=O)([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C1)=O	https://www.medchemexpress.com/betamethasone.html	Launched		92.0	W22	M20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13570	10.0	mM	308.0	DMSO	392.199902	20	M	pluskal_fda_drugs_5005_M20_id
1856	HY-12053A	HYCPK40907	H12	HYCPK40907	92z	696.0	2.0	O24	907.0	H12	125317-39-7	Vinorelbine (ditartrate)	KW-2307; Nor-5'-anhydrovinblastine ditartrate	1079.11	Autophagy; Microtubule/Tubulin	Autophagy; Cell Cycle/DNA Damage; Cytoskeleton	Vinorelbine (ditartrate) is an anti-mitotic agent which inhibits the proliferation of Hela cells with IC50 of 1.25 nM.	Tartrate	C53H66N4O20	118502.0	DMSO : ≥ 100 mg/mL (92.67 mM); H2O : ≥ 100 mg/mL (92.67 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC[C@@]1(C=CCN2CC3)[C@@]2([H])[C@@]3(C(C=C([C@@](C4=C5C(C=CC=C6)=C6N4)(CC(C=C(CC)C7)([H])CN7C5)C(OC)=O)C(OC)=C8)=C8N9C)[C@]9([H])[C@](C(OC)=O)(O)[C@@H]1OC(C)=O.O=C(O)[C@H](O)[C@@H](O)C(O)=O.O=C(O)[C@H](O)[C@@H](O)C(O)=O	https://www.medchemexpress.com/Vinorelbine-ditartrate.html	Launched		92.0	O24	M20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12053A	10.0	mM	308.0	DMSO	778.394165	20	M	pluskal_fda_drugs_5005_M20_id
1860	HY-A0021	HYCPK40907	L12	HYCPK40907	92z	1080.0	2.0	W24	907.0	L12	135729-62-3	Palonosetron (hydrochloride)		332.87	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Palonosetron hydrochloride is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
IC50 Value:
Target: 5-HT Receptor
Palonosetron is the most effective of the 5-HT3 antagonists in controlling delayed CINV nausea and vomiting that appear more than 24 hours after the first dose of a course of chemotherapy."	Hydrochloride	C19H25ClN2O	20739.0	DMSO : 3.33 mg/mL (10.00 mM; Need ultrasonic); H2O : 100 mg/mL (300.42 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C1N(C[C@@]([H])(CCC2)C3=C2C=CC=C13)[C@@H]4CN5CCC4CC5.[H]Cl	https://www.medchemexpress.com/Palonosetron-Hydrochloride.html	Launched		92.0	W24	M20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0021	10.0	mM	308.0	DMSO	296.188863	20	M	pluskal_fda_drugs_5005_M20_id
1985	HY-B1076	HYCPK40907	E21	HYCPK40907	92z	426.0	2.0	I42	907.0	E21	2668-66-8	Medrysone	HMS; 6α-Methyl-11β-hydroxyprogesterone	344.49	Others	Others	Medrysone is a corticosteroid, in ophthalmology for the treatment of eye inflammations.	Free Base	C22H32O3	28294.0	DMSO : 50 mg/mL (145.14 mM; ultrasonic and warming and heat to 60°C); H2O : < 0.1 mg/mL (ultrasonic) (insoluble); Ethanol : ≥ 25 mg/mL (72.57 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC([C@H]1CC[C@@]2([H])[C@]3([H])C[C@H](C)C4=CC(CC[C@]4(C)[C@@]3([H])[C@@H](O)C[C@]12C)=O)=O	https://www.medchemexpress.com/Medrysone.html	Launched		92.0	I42	M20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1076	10.0	mM	308.0	DMSO	344.235145	20	M	pluskal_fda_drugs_5005_M20_id
1432	HY-15295	HYCPK40906	E07	HYCPK40906	92z	397.0	1.0	I13	906.0	E07	881681-01-2	Vonoprazan (Fumarate)	TAK-438	461.46	Proton Pump	Membrane Transporter/Ion Channel	Vonoprazan Fumarate (TAK-438), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan Fumarate is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease[1][2].	Fumarate	C21H20FN3O6S	7162.0	DMSO : 50 mg/mL (108.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O)/C=C/C(O)=O.O=S(N1C=C(CNC)C=C1C2=CC=CC=C2F)(C3=CC=CN=C3)=O.[(E)]	https://www.medchemexpress.com/TAK-438.html	Launched		92.0	I13	M21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15295	10.0	mM	309.0	DMSO	345.094726	21	M	pluskal_fda_drugs_5005_M21_id
1531	HY-13017	HYCPK40906	N11	HYCPK40906	92z	1269.0	1.0	AA21	906.0	N11	873054-44-5	Ivacaftor	VX-770	392.49	Autophagy; CFTR	Autophagy; Membrane Transporter/Ion Channel	Ivacaftor (VX-770) is a potent and orally bioavailable CFTR potentiator, targeting G551D-CFTR and F508del-CFTR with EC50s of 100 nM and 25 nM, respectively.	Free Base	C24H28N2O3	14874.0	DMSO : 50 mg/mL (127.39 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	CC(C)(C1=C(C=C(C(C(C)(C)C)=C1)O)NC(C2=CNC3=C(C2=O)C=CC=C3)=O)C	https://www.medchemexpress.com/Ivacaftor.html	Launched		92.0	AA21	M21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13017	10.0	mM	309.0	DMSO	392.209993	21	M	pluskal_fda_drugs_5005_M21_id
1616	HY-B0673	HYCPK40906	C17	HYCPK40906	92z	225.0	1.0	E33	906.0	C17	53179-13-8	Pirfenidone	AMR69	185.22	CCR; TGF-beta/Smad	GPCR/G Protein; Immunology/Inflammation; Stem Cell/Wnt; TGF-beta/Smad	Pirfenidone (AMR69) is an antifibrotic agent that attenuates CCL2 and CCL12 production in fibrocyte cells. Pirfenidone has growth-inhibitory effect and reduces TGF-β2 protein levels in human glioma cell lines. Pirfenidone also has anti-inflammatory activities[1][2][3].	Free Base	C12H11NO	15738.0	DMSO : ≥ 100 mg/mL (539.90 mM); H2O : 16.67 mg/mL (90.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C1C=CC(C)=CN1C2=CC=CC=C2	https://www.medchemexpress.com/Pirfenidone.html	Launched		92.0	E33	M21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0673	10.0	mM	309.0	DMSO	185.084064	21	M	pluskal_fda_drugs_5005_M21_id
1664	HY-13234	HYCPK40906	C20	HYCPK40906	92z	231.0	1.0	E39	906.0	C20	80621-81-4	Rifaximin		785.88	Antibiotic; Bacterial; DNA/RNA Synthesis	Anti-infection; Cell Cycle/DNA Damage	Rifaximin, a gastrointestinal-selective antibiotic, binds the β-subunit of bacterial DNA-dependent RNA polymerase, resulting in inhibition of bacterial RNA synthesis. Rifaximin susceptibility is higher against Gram-positive strains (MIC: 0.03-5 mg/ml) compared to Gram-negative bacteria (MIC: 8-50 mg/mL)[1][2].	Free Base	C43H51N3O11	23273.0	DMSO : ≥ 50 mg/mL (63.62 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1C2=C(O[C@@]1(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@@H](O)[C@@H](C)/C=C/C=C(C)\C3=O)C)O)C)OC(C)=O)C)OC)C)C(C)=C(O)C4=C2C5=C(C(N3)=C4O)N6C(C=C(C)C=C6)=N5	https://www.medchemexpress.com/Rifaximin.html	Launched		92.0	E39	M21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13234	10.0	mM	309.0	DMSO	785.352359	21	M	pluskal_fda_drugs_5005_M21_id
1767	HY-B0466	HYCPK40907	O06	HYCPK40907	92z	1356.0	2.0	AC12	907.0	O06	7081-44-9	Cloxacillin (sodium monohydrate)		475.88	Antibiotic; Bacterial	Anti-infection	Cloxacillin sodium monohydrate is an orally active antibacterial agent and β-lactamase inhibitor with an IC50 of 0.04 μM. Cloxacillin sodium monohydrate can suppress the S. aureus-induced inflammatory response by inhibiting the activation of MAPKs, NF-кB and NLRP3-related proteins[1][2][3].	Sodium	C19H19ClN3NaO6S	13417.0	DMSO : 100 mg/mL (210.14 mM; Need ultrasonic); H2O : 50 mg/mL (105.07 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Cancer	O=C(C(C(C(C=CC=C1)=C1Cl)=NO2)=C2C)N[C@H]3[C@](SC(C)(C)[C@@H]4C(O[Na])=O)([H])N4C3=O.O	https://www.medchemexpress.com/Cloxacillin-sodium-monohydrate.html	Launched		92.0	AC12	M21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0466	10.0	mM	309.0	DMSO	435.065569	21	M	pluskal_fda_drugs_5005_M21_id
2245	HY-B0161A	HYCPK40908	F18	HYCPK40908	92z	563.0	3.0	L35	908.0	F18	136434-34-9	Duloxetine (hydrochloride)	(S)-Duloxetine hydrochloride; LY-248686 hydrochloride	333.88	Serotonin Transporter	Neuronal Signaling	Duloxetine hydrochloride ((S)-Duloxetine hydrochloride) is a serotonin-norepinephrine reuptake inhibitor (SNRI) with a Ki of 4.6 nM, used for treatment of major depressive disorder and generalized anxiety disorder (GAD)[1][2].	Hydrochloride	C18H20ClNOS	16150.0	DMSO : ≥ 100 mg/mL (299.51 mM); H2O : 5 mg/mL (14.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C3=CC=CS3.[H]Cl	https://www.medchemexpress.com/Duloxetine-hydrochloride.html	Launched		92.0	L35	M21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0161A	10.0	mM	309.0	DMSO	297.118735	21	M	pluskal_fda_drugs_5005_M21_id
2258	HY-14289	HYCPK40908	C19	HYCPK40908	92z	277.0	3.0	F37	908.0	C19	51481-61-9	Cimetidine	SKF-92334	252.34	Bacterial; Histamine Receptor	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Cimetidine (SKF-92334) is an orally active and inverse histamine H2 receptor antagonist with a Ki of 0.6 μM. Cimetidine is a gastric acid reducer, and can be used for duodenal and gastric ulcers research. Cimetidine has anti-cancer and anti-inflammatory activity[1][2][5].	Free Base	C10H16N6S	15393.0	H2O : 2 mg/mL (7.93 mM; Need ultrasonic); DMSO : 60 mg/mL (237.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	CC1=C(CSCC/N=C(NC)/NC#N)NC=N1	https://www.medchemexpress.com/Cimetidine.html	Launched		92.0	F37	M21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14289	10.0	mM	309.0	DMSO	252.115716	21	M	pluskal_fda_drugs_5005_M21_id
2447	HY-13571	HYCPK40909	K04	HYCPK40909	92z	1016.0	4.0	V8	909.0	K04	5593-20-4	Betamethasone dipropionate	Betamethasone 17,21-dipropionate	504.59	Glucocorticoid Receptor	Immunology/Inflammation	Betamethasone dipropionate is a glucocorticoid steroid with anti-inflammatory and immunosuppressive abilities.	Free Base	C28H37FO7	25854.0	DMSO : 110 mg/mL (218.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]12[C@](C[C@H](C)[C@]2(OC(CC)=O)C(COC(CC)=O)=O)([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C1)=O	https://www.medchemexpress.com/Betamethasone_dipropionate.html	Launched		92.0	V8	M21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13571	10.0	mM	309.0	DMSO	504.252332	21	M	pluskal_fda_drugs_5005_M21_id
1414	HY-N0053	HYCPK40906	C06	HYCPK40906	92z	203.0	1.0	E11	906.0	C06	66-97-7	Psoralen	Ficusin	186.16	Apoptosis; HIV; Influenza Virus	Anti-infection; Apoptosis	Psoralen (Ficusin) is a coumarin isolated from the seeds of Fructus Psoraleae. Psoralen exhibits a wide range of biological properties, including anti-cancer, antioxidant, antidepressant, anticancer, antibacterial, and antiviral, et al[1].	Free Base	C11H6O3	116332.0	DMSO : 100 mg/mL (537.17 mM; Need ultrasonic); H2O : 1 mg/mL (5.37 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C=CC2=CC3=C(OC=C3)C=C2O1	https://www.medchemexpress.com/Psoralen.html	Launched		92.0	E11	M22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0053	10.0	mM	310.0	DMSO	186.031694	22	M	pluskal_fda_drugs_5005_M22_id
1493	HY-B0312	HYCPK40906	H09	HYCPK40906	92z	689.0	1.0	O17	906.0	H09	58-32-2	Dipyridamole		504.63	Apoptosis; Phosphodiesterase (PDE)	Apoptosis; Metabolic Enzyme/Protease	Dipyridamole is an orally active phosphodiesterase (PDE) inhibitor. Dipyridamole also is an antiplatelet agent used in secondary prophylaxis against stroke. Dipyridamole can induce cancer cell-specific apoptosis[1][2][3].	Free Base	C24H40N8O4	15979.0	DMSO : ≥ 50 mg/mL (99.08 mM); H2O : 0.67 mg/mL (1.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	OCCN(CCO)C1=NC(N2CCCCC2)=C(N=C(N(CCO)CCO)N=C3N4CCCCC4)C3=N1	https://www.medchemexpress.com/Dipyridamole.html	Launched		92.0	O17	M22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0312	10.0	mM	310.0	DMSO	504.317252	22	M	pluskal_fda_drugs_5005_M22_id
1543	HY-B0806	HYCPK40906	J12	HYCPK40906	92z	887.0	1.0	S23	906.0	J12	500-92-5	Proguanil		253.73	Antifolate; Parasite	Anti-infection; Cell Cycle/DNA Damage	Proguanil, an antimalarial prodrug, is metabolized to the active metabolite Cycloguanil (HY-12784). Proguanil is a dihydrofolate reductase (DHFR) inhibitor[1][2].	Free Base	C11H16ClN5	114092.0	DMSO : ≥ 130 mg/mL (512.36 mM)	DMSO Solution	10mM  * 100uL	Infection	N=C(NC1=CC=C(Cl)C=C1)NC(NC(C)C)=N	https://www.medchemexpress.com/Proguanil.html	Launched		92.0	S23	M22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0806	10.0	mM	310.0	DMSO	253.109423	22	M	pluskal_fda_drugs_5005_M22_id
1685	HY-B1362	HYCPK40906	H21	HYCPK40906	92z	713.0	1.0	O41	906.0	H21	73334-07-3	Iopromide		791.11	Others	Others	Iopromide is a non-ionic, monomeric, iodine-based contrast medium for intravascular administration.	Free Base	C18H24I3N3O8	28589.0	DMSO : 100 mg/mL (126.40 mM; Need ultrasonic); H2O : 100 mg/mL (126.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(I)C(NC(COC)=O)=C(I)C(C(NCC(O)CO)=O)=C1I)N(CC(O)CO)C	https://www.medchemexpress.com/Iopromide.html	Launched		92.0	O41	M22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1362	10.0	mM	310.0	DMSO	790.869759	22	M	pluskal_fda_drugs_5005_M22_id
1942	HY-14299	HYCPK40907	F18	HYCPK40907	92z	516.0	2.0	K36	907.0	F18	312753-06-3	Indacaterol		392.49	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Indacaterol is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol inhibits NF-κB activity in a β-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD (chronic obstructive pulmonary disorder). Indacaterol can also be used in cardiovascular disease research[1][2].	Free Base	C24H28N2O3	83960.0	DMSO : 62.5 mg/mL (159.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	OC1=CC=C([C@@H](O)CNC2CC(C=C(CC)C(CC)=C3)=C3C2)C4=C1NC(C=C4)=O	https://www.medchemexpress.com/indacaterol.html	Launched		92.0	K36	M22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14299	10.0	mM	310.0	DMSO	392.209993	22	M	pluskal_fda_drugs_5005_M22_id
2153	HY-18204	HYCPK40908	F12	HYCPK40908	92z	551.0	3.0	L23	908.0	F12	137862-53-4	Valsartan	CGP 48933	435.52	Angiotensin Receptor	GPCR/G Protein	Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1].	Free Acid	C24H29N5O3	104017.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : ≥ 100 mg/mL (229.61 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	CC(C)[C@@H](C(O)=O)N(C(CCCC)=O)CC1=CC=C(C2=CC=CC=C2C3=NNN=N3)C=C1	https://www.medchemexpress.com/Valsartan.html	Launched		92.0	L23	M22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18204	10.0	mM	310.0	DMSO	435.22704	22	M	pluskal_fda_drugs_5005_M22_id
2417	HY-100007	HYCPK40908	M22	HYCPK40908	92z	1243.0	3.0	Z43	908.0	M22	881681-00-1	Vonoprazan	TAK-438 (free base)	345.39	Bacterial; Proton Pump	Anti-infection; Membrane Transporter/Ion Channel	Vonoprazan (TAK-438 free base), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease. Vonoprazan can be used for eradication of Helicobacter pylori[1][2][3].	Free Base	C17H16FN3O2S	20332.0	DMSO : 100 mg/mL (289.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	O=S(N1C=C(CNC)C=C1C2=CC=CC=C2F)(C3=CC=CN=C3)=O	https://www.medchemexpress.com/TAK-438-free-base.html	Launched		92.0	Z43	M22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-100007	10.0	mM	310.0	DMSO	345.094726	22	M	pluskal_fda_drugs_5005_M22_id
2419	HY-15414A	HYCPK40908	O22	HYCPK40908	92z	1435.0	3.0	AD43	908.0	O22	960203-27-4	Vortioxetine (hydrobromide)	Lu AA21004 (hydrobromide)	379.36	5-HT Receptor; Serotonin Transporter	GPCR/G Protein; Neuronal Signaling	Vortioxetine hydrobromide is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.	Hydrobromide	C18H23BrN2S	8965.0	DMSO : 50 mg/mL (131.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(C)=C1.[H]Br	https://www.medchemexpress.com/Vortioxetine-hydrobromide.html	Launched		92.0	AD43	M22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15414A	10.0	mM	310.0	DMSO	298.15037	22	M	pluskal_fda_drugs_5005_M22_id
48	HY-16297A	HYCPK40899	B05	HYCPK40909	92z	176.0	4.0	D32	909.0	B16	1231929-97-7	Abemaciclib	LY2835219	506.59	CDK	Cell Cycle/DNA Damage	Abemaciclib (LY2835219) is a selective CDK4/6 inhibitor with IC50 values of 2 nM and 10 nM for CDK4 and CDK6, respectively.	Free Base	C27H32F2N8	63833.0	DMSO : 5 mg/mL (9.87 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Cancer	CC1=NC2=C(F)C=C(C3=NC(NC4=NC=C(CN5CCN(CC)CC5)C=C4)=NC=C3F)C=C2N1C(C)C	https://www.medchemexpress.com/LY2835219-free-base.html	Launched		92.0	D32	N3	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16297A	2.0	mM	315.0	DMSO	506.271799	3	N	pluskal_fda_drugs_5005_N3_id
1392	HY-15959	HYCPK40906	M04	HYCPK40906	92z	1159.0	1.0	Y7	906.0	M04	1313725-88-0	Savolitinib	Volitinib; HMPL-504; AZD-6094	345.36	c-Met/HGFR	Protein Tyrosine Kinase/RTK	Savolitinib (AZD-6094) is a potent, highly selective, and orally bioavailable c-Met inhibitor with IC50 s of 5 nM and 3 nM for c-Met and p-Met, respectively. Savolitinib (AZD-6094) selectively binds to and inhibits the activation of c-Met in an ATP-competitive manner, and disrupts c-Met signal transduction pathways. Antineoplastic activity[1][2].	Free Base	C17H15N9	38913.0	DMSO : ≥ 20.83 mg/mL (60.31 mM)	DMSO Solution	10mM  * 100uL	Cancer	CN1N=CC(C2=CN=C3C(N([C@H](C4=CN5C(C=C4)=NC=C5)C)N=N3)=N2)=C1	https://www.medchemexpress.com/Savolitinib.html	Launched		92.0	Y7	N3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15959	10.0	mM	315.0	DMSO	345.145041	3	N	pluskal_fda_drugs_5005_N3_id
1399	HY-90003A	HYCPK40906	D05	HYCPK40906	92z	297.0	1.0	G9	906.0	D05	30123-17-2	Tianeptine (sodium salt)		458.93	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Tianeptine sodium salt is a selective facilitator of 5-HT uptake. Tianeptine sodium salt has no affinity for a wide range of receptors, including 5-HT and dopamine (IC50>10 μM) and has no effect on noradrenalin or dopamine uptake. Tianeptine sodium salt has antidepressant, anxiolytic, analgesic and neuroprotective activities[1][2][3][4].	Sodium	C21H24ClN2NaO4S	8030.0	DMSO : 100 mg/mL (217.90 mM; Need ultrasonic); H2O : 100 mg/mL (217.90 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(CCCCCCNC(C1=CC=CC=C1N2C)C3=CC=C(C=C3S2(=O)=O)Cl)O[Na]	https://www.medchemexpress.com/tianeptine-sodium-salt.html	Launched		92.0	G9	N3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-90003A	10.0	mM	315.0	DMSO	436.122356	3	N	pluskal_fda_drugs_5005_N3_id
1406	HY-B0614A	HYCPK40906	K05	HYCPK40906	92z	969.0	1.0	U9	906.0	K05	13009-99-9	Mafenide (Acetate)		246.28	Antibiotic; Bacterial	Anti-infection	Mafenide Acetate is an effective sulfonamide-type antimicrobial agent used for burn wounds. Mafenide Acetate shows activity against both Gram-positive and Gram-negative organisms, including Pseudomonas aeruginosa, via inhibition of nucleotide synthesis[1][2].	Acetate	C9H14N2O4S	16804.0	DMSO : 100 mg/mL (406.04 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (406.04 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(CN)C=C1)(N)=O.CC(O)=O	https://www.medchemexpress.com/Mafenide-Acetate.html	Launched		92.0	U9	N3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0614A	10.0	mM	315.0	DMSO	186.046299	3	N	pluskal_fda_drugs_5005_N3_id
1682	HY-15414	HYCPK40906	E21	HYCPK40906	92z	425.0	1.0	I41	906.0	E21	508233-74-7	Vortioxetine	Lu AA 21004	298.45	5-HT Receptor; Serotonin Transporter	GPCR/G Protein; Neuronal Signaling	Vortioxetine is a inhibitor of 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT, with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.	Free Base	C18H22N2S	8966.0	DMSO : 50 mg/mL (167.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(C)=C1	https://www.medchemexpress.com/Vortioxetine.html	Launched		92.0	I41	N3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15414	10.0	mM	315.0	DMSO	298.15037	3	N	pluskal_fda_drugs_5005_N3_id
1762	HY-10852	HYCPK40907	J06	HYCPK40907	92z	876.0	2.0	S12	907.0	J06	664338-39-0	Arterolane	OZ 277; RBx 11160	392.53	Parasite	Anti-infection	Arterolane is an antimalarial agent, with IC50 of both 1.1 nM against P. falciparum Ro73 and W2, respectively.	Free Base	C22H36N2O4	43219.0	DMSO : 100 mg/mL (254.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(NCC(N)(C)C)C[C@H](CC1)CC[C@]21OO[C@]3(O2)[C@H]4C[C@@H]5C[C@H](C4)C[C@H]3C5	https://www.medchemexpress.com/Arterolane.html	Launched		92.0	S12	N3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10852	10.0	mM	315.0	DMSO	392.267508	3	N	pluskal_fda_drugs_5005_N3_id
1857	HY-13756A	HYCPK40907	I12	HYCPK40907	92z	792.0	2.0	Q24	907.0	I12	109581-93-3	Tacrolimus (monohydrate)	FK506 (monohydrate); Fujimycin (monohydrate); FR900506 (monohydrate)	822.03	Antibiotic; Autophagy; Bacterial; FKBP; Phosphatase	Anti-infection; Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease	Tacrolimus monohydrate (FK506 monohydrate), a macrocyclic lactone, binds to FK506 binding protein (FKBP) to form a complex and inhibits calcineurin phosphatase, which inhibits T-lymphocyte signal transduction and IL-2 transcription. Immunosuppressive properties[1].	Free Base	C44H71NO13	39160.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 100 mg/mL (121.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=C([C@@](CCCC1)([H])N1C(C([C@@]2(O)[C@H](C)C[C@H](OC)[C@@](O2)([H])[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H]3CC=C)=O)=O)O[C@H](/C(C)=C/[C@H]4C[C@@H](OC)[C@H](O)CC4)[C@H](C)[C@@H](O)CC3=O.O	https://www.medchemexpress.com/tacrolimus-monohydrate.html	Launched		92.0	Q24	N3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13756A	10.0	mM	315.0	DMSO	803.481977	3	N	pluskal_fda_drugs_5005_N3_id
2059	HY-B2174	HYCPK40908	D06	HYCPK40908	92z	347.0	3.0	H11	908.0	D06	1837-57-6	Ethacridine (lactate)	Acrinol	343.38	Bacterial	Anti-infection	Ethacridine lactate (Acrinol) is a widely used antiseptic and abortifacient. Ethacridine lactate is effective against Staphylococcus aureus and other gram-positive cocci. Ethacridine lactate is also a poly(ADP-ribose) glycohydrolase (PARG) inhibitor[1][2][3].	Lactic acid	C18H21N3O4	26075.0	DMSO : ≥ 100 mg/mL (291.22 mM)	DMSO Solution	10mM  * 100uL	Infection	CC(O)C(O)=O.NC1=CC2=NC3=CC=C(OCC)C=C3C(N)=C2C=C1	https://www.medchemexpress.com/Ethacridine_lactate.html	Launched		92.0	H11	N3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2174	10.0	mM	315.0	DMSO	253.121512	3	N	pluskal_fda_drugs_5005_N3_id
1454	HY-13771	HYCPK40907	A20	HYCPK40907	92z	40.0	2.0	A40	907.0	A20	128-13-2	Ursodeoxycholic acid	Ursodeoxycholate; Ursodiol; UDCA	392.57	Endogenous Metabolite; FXR; G protein-coupled Bile Acid Receptor 1	GPCR/G Protein; Metabolic Enzyme/Protease	Ursodeoxycholic acid (Ursodeoxycholate) is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. Ursodeoxycholic acid acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors, including G-protein coupled bile acid receptor 5 (TGR5, GPCR19) and the farnesoid X receptor (FXR). Ursodeoxycholic acid can be used for the research of a variety of hepatic and gastrointestinal diseases. Orally active[1][2].	Free Acid	C24H40O4	89551.0	DMSO : ≥ 100 mg/mL (254.73 mM); H2O : 1 mg/mL (2.55 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	C[C@H](CCC(O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C	https://www.medchemexpress.com/Ursodiol.html	Launched		92.0	A40	N4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13771	10.0	mM	316.0	DMSO	392.29266	4	N	pluskal_fda_drugs_5005_N4_id
1517	HY-N0402	HYCPK40906	P10	HYCPK40906	92z	1459.0	1.0	AE19	906.0	P10	71963-77-4	Artemether	Dihydroqinghaosu methyl ether; Dihydroartemisinin methyl ether; SM224	298.37	Parasite	Anti-infection	"Artemether is an antimalarial for the treatment of resistant strains of falciparum malaria.
Target: Antiparasitic
Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. Artemether exhibits the highest activity against juvenile stages of the parasites, while adult worms are significantly less susceptible. There was no indication of neurotoxicity following repeated high doses of artemether given fortnightly for up to 5 months. Artemether-integrated with other control strategies-has considerable potential for reducing the current burden of schistosomiasis in different epidemiological settings [1]. There were remarkably inhibitory effects of artmeter on brain glioma growth and angiogenesis in SD rats and the mechanism that artemether inhibited brain glioma growth might be penetrating the blood-brain barrier and inhibiting angiogenesis [2]."	Free Base	C16H26O5	16878.0	DMSO : 100 mg/mL (335.15 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@H]1[C@@H](OC)O[C@@]2([H])[C@]34[C@@]([C@H](C)CC[C@]41[H])([H])CC[C@@](O2)(C)OO3	https://www.medchemexpress.com/artemether.html	Launched		92.0	AE19	N4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0402	10.0	mM	316.0	DMSO	298.178024	4	N	pluskal_fda_drugs_5005_N4_id
1697	HY-N0019	HYCPK40906	D22	HYCPK40906	92z	331.0	1.0	G43	906.0	D22	486-66-8	Daidzein		254.24	Endogenous Metabolite; PPAR	Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Daidzein is a soy isoflavone, which acts as a PPAR activator.	Free Base	C15H10O4	92201.0	DMSO : ≥ 50 mg/mL (196.66 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C1C(C2=CC=C(O)C=C2)=COC3=CC(O)=CC=C13	https://www.medchemexpress.com/Daidzein.html	Launched		92.0	G43	N4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0019	10.0	mM	316.0	DMSO	254.057909	4	N	pluskal_fda_drugs_5005_N4_id
1950	HY-B0284	HYCPK40907	N18	HYCPK40907	92z	1284.0	2.0	AA36	907.0	N18	21829-25-4	Nifedipine	BAY-a-1040	346.33	Autophagy; Calcium Channel	Autophagy; Membrane Transporter/Ion Channel; Neuronal Signaling	Nifedipine (BAY-a-1040) is a potent calcium channel blocker and drug of choice for cardiac insufficiencies.	Free Base	C17H18N2O6	15280.0	DMSO : 100 mg/mL (288.74 mM; Need ultrasonic); H2O : 1 mg/mL (2.89 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC=C2[N+]([O-])=O)OC	https://www.medchemexpress.com/Nifedipine.html	Launched		92.0	AA36	N4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0284	10.0	mM	316.0	DMSO	346.116486	4	N	pluskal_fda_drugs_5005_N4_id
2139	HY-90003	HYCPK40908	H11	HYCPK40908	92z	741.0	3.0	P21	908.0	H11	72797-41-2	Tianeptine		436.95	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Tianeptine is a selective facilitator of 5-HT uptake. Tianeptine has no affinity for a wide range of receptors, including 5-HT and dopamine (IC50>10 μM) and has no effect on noradrenalin or dopamine uptake. Tianeptine has antidepressant, anxiolytic, analgesic and neuroprotective activities[1][2][3][4].	Free Acid	C21H25ClN2O4S	3331.0	DMSO : 10 mg/mL (22.89 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(CCCCCCNC(C1=CC=CC=C1N2C)C3=CC=C(C=C3S2(=O)=O)Cl)O	https://www.medchemexpress.com/Tianeptine.html	Launched		92.0	P21	N4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-90003	10.0	mM	316.0	DMSO	436.122356	4	N	pluskal_fda_drugs_5005_N4_id
2281	HY-10222	HYCPK40908	J20	HYCPK40908	92z	951.0	3.0	T39	908.0	J20	219989-84-1	Ixabepilone	BMS-247550; Aza-epothilone B	506.70	Apoptosis; Bacterial; Microtubule/Tubulin	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Ixabepilone (BMS-247550) is an orally bioavailable?microtubule?inhibitor, which binds to tubulin and promotes tubulin polymerization and microtubule stabilization, thereby arrests cells in the G2-M phase of the cell cycle and induces tumor cell apoptosis.	Free Base	C27H42N2O5S	41125.0	DMSO : 83.33 mg/mL (164.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@@H]([C@H]([C@H](CCC[C@]1(O[C@]1(C[C@H](N2)/C(C)=C/C3=CSC(C)=N3)[H])C)C)O)C)C(C)([C@H](CC2=O)O)C	https://www.medchemexpress.com/Ixabepilone.html	Launched		92.0	T39	N4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10222	10.0	mM	316.0	DMSO	506.281443	4	N	pluskal_fda_drugs_5005_N4_id
2300	HY-B0594	HYCPK40908	M21	HYCPK40908	92z	1241.0	3.0	Z41	908.0	M21	66108-95-0	Iohexol		821.14	Autophagy; Mitophagy	Autophagy	Iohexol is a radiographic contrast agent and can be applied for myelography, computerized tomography?(cisternography, ventriculography) and MicroCT imaging in vivo[1].	Free Base	C19H26I3N3O9	17021.0	DMSO : 50 mg/mL (60.89 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (60.89 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(I)C(N(C(C)=O)CC(O)CO)=C(I)C(C(NCC(O)CO)=O)=C1I)NCC(O)CO	https://www.medchemexpress.com/iohexol.html	Launched		92.0	Z41	N4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0594	10.0	mM	316.0	DMSO	820.880323	4	N	pluskal_fda_drugs_5005_N4_id
2413	HY-B1294	HYCPK40908	I22	HYCPK40908	92z	859.0	3.0	R43	908.0	I22	60719-84-8	Amrinone	Inamrinone	187.20	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Amrinone (Inamrinone) is a positive inotropic-vasodilator agent. Amrinone is a selective phosphodiesterase III inhibitor that increases cyclic adenosine monophosphate by preventing its breakdown. Amrinone is also an orally active, non-glycosidic and non-catecholamine cardiotonic agent[1][2][3].		C10H9N3O	63966.0	DMSO : 16.67 mg/mL (89.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C1C(N)=CC(C2=CC=NC=C2)=CN1	https://www.medchemexpress.com/amrinone.html	Launched		92.0	R43	N4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1294	10.0	mM	316.0	DMSO	187.074562	4	N	pluskal_fda_drugs_5005_N4_id
1515	HY-A0181	HYCPK40906	N10	HYCPK40906	92z	1267.0	1.0	AA19	906.0	N10	61-19-8	Adenosine monophosphate	AMP	347.22	Endogenous Metabolite	Metabolic Enzyme/Protease	Adenosine monophosphate is a key cellular metabolite regulating energy homeostasis and signal transduction.	Free Acid	C10H14N5O7P	44927.0	DMSO : 16.67 mg/mL (48.01 mM; Need ultrasonic); H2O : 1.67 mg/mL (4.81 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N2C=NC3=C2N=CN=C3N	https://www.medchemexpress.com/Adenosine_monophosphate.html	Launched		92.0	AA19	N5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0181	10.0	mM	317.0	DMSO	347.063084	5	N	pluskal_fda_drugs_5005_N5_id
1519	HY-13771A	HYCPK40906	B11	HYCPK40906	92z	117.0	1.0	C21	906.0	B11	2898-95-5	Ursodeoxycholic acid (sodium)	Ursodeoxycholate (sodium); Ursodiol (sodium); UCDA (sodium)	414.55	Endogenous Metabolite; FXR; G protein-coupled Bile Acid Receptor 1	GPCR/G Protein; Metabolic Enzyme/Protease	Ursodeoxycholic acid (Ursodeoxycholate) sodium is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors, including G-protein coupled bile acid receptor 5 (TGR5, GPCR19) and the farnesoid X receptor (FXR). Ursodeoxycholic acid sodium can be used for the research of a variety of hepatic and gastrointestinal diseases. Orally active[1][2].	Sodium	C24H39NaO4	123364.0	H2O : ≥ 100 mg/mL (241.23 mM); DMSO : 125 mg/mL (301.53 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology	C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(O[Na])=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4([C@](C[C@@H](CC4)O)([H])C[C@@H]3O)C	https://www.medchemexpress.com/ursodeoxycholic-acid-sodium.html	Launched		92.0	C21	N5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13771A	10.0	mM	317.0	DMSO	392.29266	5	N	pluskal_fda_drugs_5005_N5_id
1679	HY-119695A	HYCPK40906	B21	HYCPK40906	92z	137.0	1.0	C41	906.0	B21	139893-43-9	Simvastatin acid (ammonium)	Tenivastatin (ammonium)	453.61	HMG-CoA Reductase (HMGCR); Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Simvastatin acid (Tenivastatin) ammonium is a potent HMG-CoA reductase (HMGCR) inhibitor. Simvastatin acid ammonium reduces Indoxyl sulfate-mediated reactive oxygen species (ROS) production in human cardiomyocytes. Simvastatin acid ammonium can also modulates OATP3A1 expression in cardiomyocytes and HEK293 cells transfected with the OATP3A1 gene[1][2].	Ammonium	C25H43NO6	109383.0	DMSO : 11.11 mg/mL (24.49 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	O=C(C[C@@H](C[C@@H](CC[C@H]1[C@H](C=CC2=C[C@@H](C[C@@H]([C@]12[H])OC(C(C)(CC)C)=O)C)C)O)O)[O-].[NH4+]	https://www.medchemexpress.com/simvastatin-acid-ammonium.html	Launched		92.0	C41	N5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-119695A	10.0	mM	317.0	DMSO	436.282489	5	N	pluskal_fda_drugs_5005_N5_id
1725	HY-19447	HYCPK40907	P03	HYCPK40907	92z	1446.0	2.0	AE6	907.0	P03	441785-25-7	Besifovir	LB80331	299.22	HBV	Anti-infection	Besifovir (LB80331), a parent drug converted by LB80380, further metabolizes to its active form, LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV) [1][2].	Free Acid	C10H14N5O4P	45905.0	DMSO : 250 mg/mL (835.51 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (334.20 mM)	DMSO Solution	10mM  * 100uL	Infection	NC1=NC=C2N=CN(CC3(OCP(O)(O)=O)CC3)C2=N1	https://www.medchemexpress.com/besifovir.html	Launched		92.0	AE6	N5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19447	10.0	mM	317.0	DMSO	299.078341	5	N	pluskal_fda_drugs_5005_N5_id
1814	HY-19518	HYCPK40907	N09	HYCPK40907	92z	1266.0	2.0	AA18	907.0	N09	860005-21-6	Latanoprostene bunod	NCX116; LBN	507.62	Others	Others	Latanoprostene bunod (LBN), a nitric oxide (NO)-donating prostaglandin F2a analog, is a topical ophthalmic therapeutic for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (OHT) [1].	Free Base	C27H41NO8	84740.0	DMSO : 100 mg/mL (197.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCCCO[N+]([O-])=O)CCC/C=C\C[C@@H]1[C@@H](CC[C@@H](O)CCC2=CC=CC=C2)[C@H](O)C[C@@H]1O	https://www.medchemexpress.com/latanoprostene-bunod.html	Launched		92.0	AA18	N5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19518	10.0	mM	317.0	DMSO	507.283217	5	N	pluskal_fda_drugs_5005_N5_id
1888	HY-B0507A	HYCPK40907	P14	HYCPK40907	92z	1468.0	2.0	AE28	907.0	P14	144-74-1	Sulfathiazole (sodium)		277.30	Antibiotic; Bacterial	Anti-infection	"Sulfathiazole sodium is an organosulfur compound that has been used as a short-acting sulfa drug.
Target: Antibacterial
Sulfathiazole (20 μg/L) starts to be degraded between day 31 and day 38 in one of the two batch reactors containing different wastewater matrices. Sulfathiazole is degraded at a substantially faster rate than sulfamethoxazole or sulfamethazine in the nitrification process (S3) [1]. Recovery from spiked manure slurry samples is 64% for Sulfathiazole at pH 9. Sulfathiazole has acidity constant of pKa of 7.1and retention times (tR) of 7.8. S/N values for Sulfathiazole are above 100 at the 1 mg/kg level [2]. Sulfathiazole sorption to inorganic sorbents exhibits pronounced pH dependence consistent with sorbate speciation and sorbent charge properties. Sulfathiazole cations are most important for sorption to clay minerals, followed by neutral species [3]."	Sodium	C9H8N3NaO2S2	62204.0	DMSO : 140 mg/mL (504.87 mM; Need ultrasonic); H2O : 140 mg/mL (504.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)([N-]C2=NC=CS2)=O.[Na+]	https://www.medchemexpress.com/Sulfathiazole-sodium.html	Launched		92.0	AE28	N5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0507A	10.0	mM	317.0	DMSO	255.013619	5	N	pluskal_fda_drugs_5005_N5_id
2216	HY-B0704	HYCPK40908	E16	HYCPK40908	92z	463.0	3.0	J31	908.0	E16	123-99-9	Azelaic acid	Nonanedioic acid	188.22	Endogenous Metabolite	Metabolic Enzyme/Protease	Azelaic acid is an organic compound produced by the ozonolysis of oleic acid; component of a number of hair and skin conditioners.	Free Acid	C9H16O4	16504.0	H2O : 2 mg/mL (10.63 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (531.29 mM)	DMSO Solution	10mM  * 100uL	Others	OC(CCCCCCCC(O)=O)=O	https://www.medchemexpress.com/Azelaic-acid.html	Launched		92.0	J31	N5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0704	10.0	mM	317.0	DMSO	188.104859	5	N	pluskal_fda_drugs_5005_N5_id
2500	HY-N6804	HYCPK40909	G08	HYCPK40909	92z	640.0	4.0	N16	909.0	G08	79165-06-3	Diammonium Glycyrrhizinate		856.99	Others	Others	Diammonium Glycyrrhizinate, isolated from the licorice root, is a widely used anti-inflammatory agent[1].	Ammonium	C42H68N2O16	103812.0	DMSO : 100 mg/mL (116.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	C[C@]1(C(O)=O)CC[C@@]([C@]2(C1)[H])(CC[C@](C2=CC3=O)(C4(C)CC[C@](C(C)(C)C(O[C@@]5([H])O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]5O[C@@]6([H])[C@H](O)[C@@H](O)[C@H](O)C(C(O)=O)O6)CC7)([H])[C@@]7(C)[C@]43[H])C)C.[H]N([H])[H].[H]N([H])[H]	https://www.medchemexpress.com/diammonium-glycyrrhizinate.html	Launched		92.0	N16	N5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N6804	10.0	mM	317.0	DMSO	822.403786	5	N	pluskal_fda_drugs_5005_N5_id
1471	HY-17569	HYCPK40906	B08	HYCPK40906	92z	111.0	1.0	C15	906.0	B08	23674-86-4	Difluprednate		508.55	Phospholipase	Metabolic Enzyme/Protease	Difluprednate is a topical corticosteroid, which is thought to act by the induction of phospholipase A2 inhibitory proteins (lipocortins). Difluprednate is used for the symptomatic treatment of inflammation and pain associated with ocular surgery.	Free Base	C27H34F2O7	16988.0	DMSO : 250 mg/mL (491.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C([C@]([C@]12C)(CC[C@@]1([H])[C@@](C[C@H](F)C3=CC4=O)([H])[C@@](F)([C@]3(C=C4)C)[C@@H](O)C2)OC(CCC)=O)COC(C)=O	https://www.medchemexpress.com/Difluprednate.html	Launched		92.0	C15	N6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17569	10.0	mM	318.0	DMSO	508.22726	6	N	pluskal_fda_drugs_5005_N6_id
1548	HY-N0488	HYCPK40906	O12	HYCPK40906	92z	1367.0	1.0	AC23	906.0	O12	2068-78-2	Vincristine (sulfate)	Leurocristine (sulfate); NSC-67574 (sulfate); 22-Oxovincaleukoblastine (sulfate)	923.04	Apoptosis; Microtubule/Tubulin	Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Vincristine sulfate is an antitumor vinca alkaloid which inhibits microtubule formation in mitotic spindle, resulting in an arrest of dividing cells at the metaphase stage. It binds to microtubule with a Ki of 85 nM.	Sulfate	C46H58N4O14S	110590.0	DMSO : 83.33 mg/mL (90.28 mM; ultrasonic and warming and heat to 80°C); H2O : 50 mg/mL (54.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC[C@@]1(C=CCN2CC3)[C@@]2([H])[C@@]3(C4=CC([C@](C5=C6C7=CC=CC=C7N5)(C[C@](C[C@](CC)(O)C8)([H])C[N@@]8CC6)C(OC)=O)=C(OC)C=C4N9C=O)[C@]9([H])[C@](C(OC)=O)(O)[C@@H]1OC(C)=O.O=S(O)(O)=O	https://www.medchemexpress.com/vincristine-sulfate.html	Launched		92.0	AC23	N6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0488	10.0	mM	318.0	DMSO	824.399644	6	N	pluskal_fda_drugs_5005_N6_id
1602	HY-B0544	HYCPK40906	E16	HYCPK40906	92z	415.0	1.0	I31	906.0	E16	10040-45-6	Sodium Picosulfate	Sodium Picosulphate	481.41	Others	Others	"Sodium Picosulfate inhibits absorption of water and electrolytes, and increases their secretion.
Target: Others
Sodium Picosulfate displays cytotoxic effects on cultured liver cells. 800 and 1600 mg/mL induces dose-dependently vacuolic and fatty change as well as necrosis combined with a lowered mitotic activity and a slight increase in LDH values of the rapidly growing cultured liver cells of rabbit. Comparable but less severe effects are observed in 4-day old liver cell cultures of rat, while liver cells cultured for 6 to 11 days tolerate 1600 mg/mL Sodium Picosulfate. In human liver cultures the number of cells is slightly lowered at 800 and 1600 mg/mL and the number of nuclei in division is decreased dependent on dose [1]. Sodium Picosulphate has no major influence on ileal and colonic epithelial cell proliferation. In a 12 weeks study, 10 mg/kg Sodium Picosulphate continuously treatment does not influence the labeling index of Brdu (LI) in the ileum and induces no statistically significant increase of the LI when the treated groups are compared with the control group. The proliferative pattern along the crypts remains unchanged with sodium picosulphate treatment throughout the study [2]. Sodium Picosulphate does not induce chronic changes in colonic motility in rats under long-term treatment. 10mg/kg/day Sodium Picosulphate pretreated for 23 weeks does not induce any significant change in the duration of long spike bursts (LSB) which are associated with phasic contractions, or in LSB frequency in the fasted state or after a 3-gram meal [3]."	Sodium	C18H13NNa2O8S2	15727.0	DMSO : 100 mg/mL (207.72 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (207.72 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=S(OC1=CC=C(C=C1)C(C2=CC=CC=N2)C3=CC=C(OS(=O)(O[Na])=O)C=C3)(O[Na])=O	https://www.medchemexpress.com/Sodium-Picosulfate.html	Launched		92.0	I31	N6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0544	10.0	mM	318.0	DMSO	437.023908	6	N	pluskal_fda_drugs_5005_N6_id
1734	HY-111603	HYCPK40907	I04	HYCPK40907	92z	776.0	2.0	Q8	907.0	I04	20123-80-2	Calcium dobesilate		418.41	Apoptosis	Apoptosis	Calcium dobesilate, a vasoprotective, is widely used in chronic venous disease, diabetic retinopathy and the symptoms of haemorrhoidal attack in many countries.	Calcium	C12H10CaO10S2	38848.0	H2O : ≥ 100 mg/mL (239.00 mM); DMSO : 150 mg/mL (358.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=S(C1=CC(O)=CC=C1O)([O-])=O.O=S(C2=CC(O)=CC=C2O)([O-])=O.[Ca+2]	https://www.medchemexpress.com/Calcium_dobesilate.html	Launched		92.0	Q8	N6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-111603	10.0	mM	318.0	DMSO	189.993594	6	N	pluskal_fda_drugs_5005_N6_id
1792	HY-B1212	HYCPK40907	H08	HYCPK40907	92z	688.0	2.0	O16	907.0	H08	521-74-4	Broxyquinoline	Dibromohydroxyquinoline; 5,7-Dibromo-8-hydroxyquinoline	302.95	Parasite	Anti-infection	Broxyquinoline (Dibromohydroxyquinoline) is a potent severe fever with thrombocytopenia syndrome virus (SFTSV) inhibitor with an IC50 of 5.8 μM. Broxyquinoline is an antiprotozoal agent[1][2].	Free Base	C9H5Br2NO	17628.0	H2O : 0.67 mg/mL (2.21 mM; Need ultrasonic); DMSO : 31.25 mg/mL (103.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	OC1=C2N=CC=CC2=C(Br)C=C1Br	https://www.medchemexpress.com/Broxyquinoline.html	Launched		92.0	O16	N6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1212	10.0	mM	318.0	DMSO	300.873788	6	N	pluskal_fda_drugs_5005_N6_id
1900	HY-A0181A	HYCPK40907	L15	HYCPK40907	92z	1086.0	2.0	W30	907.0	L15	18422-05-4	Adenosine 5'-monophosphate monohydrate	5'-AMP monohydrate	365.24	Adenosine Receptor; Endogenous Metabolite; HSV	Anti-infection; GPCR/G Protein; Metabolic Enzyme/Protease	Adenosine 5'-monophosphate monohydrate is an adenosine A1 receptor agonist. Adenosine 5'-monophosphate monohydrate has significant antiviral activity against HSV-1 and HSV-2.	Free Acid	C10H16N5O8P	42361.0	H2O : 5 mg/mL (13.69 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease	O=P(O)(OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3N)O1)O)O)O.O	https://www.medchemexpress.com/Adenosine_5_acute_-monophosphate_monohydrate.html	Launched		92.0	W30	N6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0181A	10.0	mM	318.0	DMSO	347.063084	6	N	pluskal_fda_drugs_5005_N6_id
2035	HY-N0593	HYCPK40908	G04	HYCPK40908	92z	631.0	3.0	N7	908.0	G04	83-44-3	Deoxycholic acid	Cholanoic Acid; Desoxycholic acid	392.57	Endogenous Metabolite; G protein-coupled Bile Acid Receptor 1	GPCR/G Protein; Metabolic Enzyme/Protease	Deoxycholic acid (cholanoic acid), a bile acid, is a by-product of intestinal metabolism, that activates the G protein-coupled bile acid receptorTGR5[1][2].	Free Acid	C24H40O4	26040.0	DMSO : ≥ 100 mg/mL (254.73 mM); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease	C[C@@]1([C@@]2([H])[C@H](C)CCC(O)=O)[C@](CC2)([H])[C@@](CC[C@@]3([H])[C@@]4(CC[C@@H](O)C3)C)([H])[C@]4([H])C[C@@H]1O	https://www.medchemexpress.com/Deoxycholic_acid.html	Launched		92.0	N7	N6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0593	10.0	mM	318.0	DMSO	392.29266	6	N	pluskal_fda_drugs_5005_N6_id
2077	HY-17479A	HYCPK40908	F07	HYCPK40908	92z	541.0	3.0	L13	908.0	F07	61618-27-7	Amfenac (Sodium Hydrate)		295.27	COX	Immunology/Inflammation	Amfenac Sodium Hydrate is a COX-2 inhibitor.	Sodium	C15H14NNaO4	28487.0	DMSO : 150 mg/mL (508.01 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(O[Na])CC1=CC=CC(C(C2=CC=CC=C2)=O)=C1N.[H]O[H]	https://www.medchemexpress.com/Amfenac_Sodium_Hydrate.html	Launched		92.0	L13	N6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17479A	10.0	mM	318.0	DMSO	255.089543	6	N	pluskal_fda_drugs_5005_N6_id
1382	HY-16560	HYCPK40906	C04	HYCPK40906	92z	199.0	1.0	E7	906.0	C04	7689-03-4	Camptothecin	Campathecin; (S)-(+)-Camptothecin; CPT	348.35	ADC Cytotoxin; Antibiotic; Apoptosis; Fungal; Influenza Virus; MicroRNA; Topoisomerase	Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics	Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM[1]. Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells[2][3].	Free Base	C20H16N2O4	65791.0	DMSO : 6.25 mg/mL (17.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C1C2=C([C@@](O)(CC)C(OC2)=O)C=C(N1C3)C(C3=C4)=NC5=C4C=CC=C5	https://www.medchemexpress.com/Campathecin.html	Launched		92.0	E7	N7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16560	10.0	mM	319.0	DMSO	348.111007	7	N	pluskal_fda_drugs_5005_N7_id
1390	HY-B0336	HYCPK40906	K04	HYCPK40906	92z	967.0	1.0	U7	906.0	K04	52549-17-4	Pranoprofen		255.27	Apoptosis; COX; PGE synthase	Apoptosis; Immunology/Inflammation	Pranoprofen is a non-steroidal anti-inflammatory agent (NSAID) for the research of keratitis or other ophthalmology diseases.?Pranoprofen inhibit COX-1 and COX-2 enzymes, thus blocking arachidonic acid converted to eicosanoids and reducing prostaglandins synthesis[1][2].	Free Acid	C15H13NO3	15958.0	DMSO : ≥ 100 mg/mL (391.74 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	CC(C(O)=O)C1=CC2=C(C=C1)OC3=NC=CC=C3C2	https://www.medchemexpress.com/Pranoprofen.html	Launched		92.0	U7	N7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0336	10.0	mM	319.0	DMSO	255.089543	7	N	pluskal_fda_drugs_5005_N7_id
1617	HY-B0647	HYCPK40906	D17	HYCPK40906	92z	321.0	1.0	G33	906.0	D17	6066-49-5	Butylphthalide	3-n-Butylphthalide; 3-Butylphthalide	190.24	Others	Others	"Butylphthalide(3-n-Butylphthalide) is an anti-cerebral-ischemia drug; first isolated from the seeds of celery, showed efficacy in animal models of stroke.
IC50 value:
Target:
3-n-butylphthalide alleviates oxidative stress caused by chronic cerebral ischemia, improves cholinergic function, and inhibits amyloid beta accumulation, thereby improving cerebral neuronal injury and cognitive deficits [2].  Intragastric NBP administration to 4-month-old SAMP8 mice for 2 months significantly improved spatial learning and memory ability. Moreover, the loss of choline acetyltransferase (ChAT)-positive neurons in the medial septal nucleus and the vertical limb of the diagonal band in SAMP8 mice was slowed down, as was the decline in the protein and mRNA expression of ChAT in the hippocampus, cerebral cortex, and forebrain [4]."	Free Base	C12H14O2	62852.0	DMSO : 250 mg/mL (1314.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1OC(CCCC)C2=C1C=CC=C2	https://www.medchemexpress.com/Butylphthalide.html	Launched		92.0	G33	N7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0647	10.0	mM	319.0	DMSO	190.09938	7	N	pluskal_fda_drugs_5005_N7_id
1861	HY-B1270	HYCPK40907	M12	HYCPK40907	92z	1176.0	2.0	Y24	907.0	M12	579-56-6	Isoxsuprine hydrochloride		337.84	Adrenergic Receptor; iGluR	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Isoxsuprine hydrochloride is a beta-adrenergic receptor agonist with Kis of 13.65 μΜ and 3.48 μΜ for myometrial and placcntal beta-adrenergic receptor, respectively. Isoxsuprine hydrochloride is also a NMDA receptor antagonist.	Hydrochloride	C18H24ClNO3	27695.0	DMSO : 140 mg/mL (414.40 mM; Need ultrasonic); H2O : 15.56 mg/mL (46.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	OC(C(NC(C)COC1=CC=CC=C1)C)C2=CC=C(O)C=C2.[H]Cl	https://www.medchemexpress.com/Isoxsuprine_hydrochloride.html	Launched		92.0	Y24	N7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1270	10.0	mM	319.0	DMSO	301.167794	7	N	pluskal_fda_drugs_5005_N7_id
2023	HY-N7074	HYCPK40908	K03	HYCPK40908	92z	1013.0	3.0	V5	908.0	K03	8006-54-0	Lanolin		1293.34	Bacterial	Anti-infection	Lanolin is a yellow fat obtained from sheep's wool. Lanolin is used topically for sore, cracked nipples during breastfeeding[1].		C54H84N16O21	46115.0	DMSO : 100 mg/mL (77.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	[Lanolin]	https://www.medchemexpress.com/lanolin.html	Launched		92.0	V5	N7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7074	10.0	mM	319.0	DMSO	508.521931	7	N	pluskal_fda_drugs_5005_N7_id
2060	HY-B0435	HYCPK40908	E06	HYCPK40908	92z	443.0	3.0	J11	908.0	E06	80214-83-1	Roxithromycin	RU-28965	837.05	Antibiotic; Bacterial	Anti-infection	Roxithromycin (RU-28965) is a semi-synthetic macrolide antibiotic.	Free Base	C41H76N2O15	17059.0	DMSO : ≥ 100 mg/mL (119.47 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	C[C@H]([C@H]([C@](O)(C[C@H](/C1=N\OCOCCOC)C)C)O[C@@](O[C@H](C)C[C@@H]2N(C)C)([H])[C@@H]2O)[C@]([C@H](C(O[C@@H]([C@@](O)([C@H](O)[C@H]1C)C)CC)=O)C)([H])O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC	https://www.medchemexpress.com/roxithromycin.html	Launched		92.0	J11	N7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0435	10.0	mM	319.0	DMSO	836.52457	7	N	pluskal_fda_drugs_5005_N7_id
2255	HY-14273	HYCPK40908	P18	HYCPK40908	92z	1523.0	3.0	AF35	908.0	P18	241479-67-4	Isavuconazole	BAL-4815; RO-0094815	437.47	Antibiotic; Cytochrome P450; Fungal	Anti-infection; Metabolic Enzyme/Protease	Isavuconazole (BAL-4815) is a triazole prodrug with antifungal activity against yeasts, molds, and dimorphic fungi.  Isavuconazole inhibits ergosterol biosynthesis and results in the disruption of fungal membrane structure and function. Isavuconazole is a moderate inhibitor of CYP3A4.	Free Base	C22H17F2N5OS	15134.0	DMSO : ≥ 50 mg/mL (114.29 mM)	DMSO Solution	10mM  * 100uL	Infection	FC1=CC=C(F)C=C1[C@](CN2C=NC=N2)(O)[C@@H](C)C3=NC(C4=CC=C(C#N)C=C4)=CS3	https://www.medchemexpress.com/Isavuconazole.html	Launched		92.0	AF35	N7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14273	10.0	mM	319.0	DMSO	437.112188	7	N	pluskal_fda_drugs_5005_N7_id
2262	HY-13551	HYCPK40908	G19	HYCPK40908	92z	661.0	3.0	N37	908.0	G19	51264-14-3	Amsacrine	m-AMSA; acridinyl anisidide	393.46	Autophagy; Topoisomerase	Autophagy; Cell Cycle/DNA Damage	Amsacrine (m-AMSA; acridinyl anisidide) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.	Free Base	C21H19N3O3S	14152.0	DMSO : 9.3 mg/mL (23.64 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer	CS(=O)(NC1=CC=C(NC2=C(C=CC=C3)C3=NC4=CC=CC=C42)C(OC)=C1)=O	https://www.medchemexpress.com/Amsacrine.html	Launched		92.0	N37	N7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13551	10.0	mM	319.0	DMSO	393.114712	7	N	pluskal_fda_drugs_5005_N7_id
1426	HY-19912	HYCPK40906	O06	HYCPK40906	92z	1355.0	1.0	AC11	906.0	O06	1194506-26-7	Fruquintinib	HMPL-013	393.39	VEGFR	Protein Tyrosine Kinase/RTK	Fruquintinib (HMPL-013) is a highly potent and selective VEGFR 1/2/3 inhibitor with IC50s of 33, 0.35, and 35 nM, respectively.	Free Base	C21H19N3O5	95759.0	DMSO : 5.88 mg/mL (14.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(C)OC2=CC(OC3=C4C=C(OC)C(OC)=CC4=NC=N3)=CC=C12)NC	https://www.medchemexpress.com/Fruquintinib.html	Launched		92.0	AC11	N8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19912	10.0	mM	320.0	DMSO	393.132471	8	N	pluskal_fda_drugs_5005_N8_id
1475	HY-B1640	HYCPK40906	F08	HYCPK40906	92z	495.0	1.0	K15	906.0	F08	58-54-8	Ethacrynic acid	Etacrynic acid	303.14	Calcium Channel; Gutathione S-transferase; NF-κB	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB	Ethacrynic acid (Etacrynic acid) is a diuretic. Ethacrynic acid is an inhibitor of glutathione S-transferases (GSTs). Ethacrynic acid is a potent inhibitor of NF-kB-signaling pathway, and also modulates leukotriene formation. Ethacrynic acid also inhibits L-type voltage-dependent and store-operated calcium channel, leading to relaxation of airway smooth muscle (ASM) cells. Ethacrynic acid has anti-inflammatory properties that reduces the retinoid-induced ear edema in mice[1][2][3][4].		C13H12Cl2O4	106665.0	H2O : 27.5 mg/mL (90.72 mM; Need ultrasonic); DMSO : 100 mg/mL (329.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(O)COC1=CC=C(C(C(CC)=C)=O)C(Cl)=C1Cl	https://www.medchemexpress.com/ethacrynic-acid.html	Launched		92.0	K15	N8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1640	10.0	mM	320.0	DMSO	302.011264	8	N	pluskal_fda_drugs_5005_N8_id
1542	HY-N0175	HYCPK40906	I12	HYCPK40906	92z	791.0	1.0	Q23	906.0	I12	485-35-8	Cytisinicline	Cytisine; Sophorine; Baptitoxine	190.24	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Cytisinicline (Cytisine) is an alkaloid. Cytisinicline (Cytisine) is a partial agonist of α4β2 nAChRs[1], and partial to full agonist at β4 containing receptors and α7 receptors[2]. Has been used medically to help with smoking cessation[3].	Free Base	C11H14N2O	36972.0	H2O : ≥ 100 mg/mL (525.65 mM); DMSO : 125 mg/mL (657.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C1N(C[C@@]2([H])C[C@]3([H])CNC2)C3=CC=C1	https://www.medchemexpress.com/Cytisine.html	Launched		92.0	Q23	N8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0175	10.0	mM	320.0	DMSO	190.110613	8	N	pluskal_fda_drugs_5005_N8_id
1576	HY-B0247	HYCPK40906	K14	HYCPK40906	92z	987.0	1.0	U27	906.0	K14	56211-40-6	Torsemide	Torasemide	348.42	Others	Others	Torsemide (Torasemide) is an orally active loop diuretic. Torsemide has anti-aldosterone and vasodilatory effects. Torsemide also can be used for the research of heart failure, renal disease and hepatic cirrhosis[1][1][3].	Free Base	C16H20N4O3S	16023.0	DMSO : ≥ 3.5 mg/mL (10.05 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=S(C1=C(NC2=CC=CC(C)=C2)C=CN=C1)(NC(NC(C)C)=O)=O	https://www.medchemexpress.com/Torsemide.html	Launched		92.0	U27	N8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0247	10.0	mM	320.0	DMSO	348.125611	8	N	pluskal_fda_drugs_5005_N8_id
1636	HY-12009	HYCPK40906	G18	HYCPK40906	92z	611.0	1.0	M35	906.0	G18	635702-64-6	Pazopanib (Hydrochloride)	GW786034 (Hydrochloride)	473.98	Autophagy; c-Fms; c-Kit; FGFR; PDGFR; VEGFR	Autophagy; Protein Tyrosine Kinase/RTK	Pazopanib Hydrochloride (GW786034 Hydrochloride) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with an IC50 of 10, 30, 47, 84, 74, 140 and 146 nM, respectively.	Hydrochloride	C21H24ClN7O2S	23720.0	DMSO : 10 mg/mL (21.10 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	CC1=CC=C(C=C1S(N)(=O)=O)NC2=NC=CC(N(C3=CC4=NN(C(C)=C4C=C3)C)C)=N2.Cl	https://www.medchemexpress.com/Pazopanib-Hydrochloride.html	Launched		92.0	M35	N8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12009	10.0	mM	320.0	DMSO	437.163394	8	N	pluskal_fda_drugs_5005_N8_id
1931	HY-17634	HYCPK40907	K17	HYCPK40907	92z	994.0	2.0	U34	907.0	K17	1365970-03-1	Glecaprevir	ABT-493	838.87	HCV; HCV Protease; SARS-CoV	Anti-infection; Metabolic Enzyme/Protease	Glecaprevir is a novel HCV NS3/4A protease inhibitor, with IC50 values ranging from 3.5 to 11.3 nM. Glecaprevir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 4.09 μM[2].	Free Base	C38H46F4N6O9S	41899.0	DMSO : ≥ 83.3 mg/mL (99.30 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@H]1N(C([C@@H](NC(O[C@@]2([H])[C@@]3([H])CCC2)=O)C(C)(C)C)=O)C[C@@](OC4=NC5=CC=CC=C5N=C4C(F)(/C=C/CO3)F)([H])C1)N[C@]6([C@H](C(F)F)C6)C(NS(=O)(C7(CC7)C)=O)=O	https://www.medchemexpress.com/Glecaprevir.html	Launched		92.0	U34	N8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17634	10.0	mM	320.0	DMSO	838.298311	8	N	pluskal_fda_drugs_5005_N8_id
2173	HY-13637	HYCPK40908	J13	HYCPK40908	92z	937.0	3.0	T25	908.0	J13	82410-32-0	Ganciclovir	BW 759; 2'-Nor-2'-deoxyguanosine	255.23	Antibiotic; CMV; HSV; Nucleoside Antimetabolite/Analog	Anti-infection; Cell Cycle/DNA Damage	Ganciclovir (BW 759), a nucleoside analogue, is an orally active antiviral agent with activity against CMV. Ganciclovir also has activity in vitro against members of the herpes group and some other DNA viruses. Ganciclovir inhibits the in vitro replication of human herpes viruses (HSV 1 and 2, CMV) and adenovirus serotypes 1, 2, 4, 6, 8, 10, 19, 22 and 28. Ganciclovir has an IC50 of 5.2 μM for feline herpesvirus type-1 (FHV-1) and can diffuse into the brain[1][2][3].	Free Base	C9H13N5O4	35795.0	H2O : 1.67 mg/mL (6.54 mM; Need ultrasonic); DMSO : 60 mg/mL (235.08 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1NC(N)=NC2=C1N=CN2COC(CO)CO	https://www.medchemexpress.com/ganciclovir.html	Launched		92.0	T25	N8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13637	10.0	mM	320.0	DMSO	255.096754	8	N	pluskal_fda_drugs_5005_N8_id
2531	HY-112306	HYCPK40909	F10	HYCPK40909	92z	548.0	4.0	L20	909.0	F10	1442472-39-0	Ripretinib	DCC-2618	510.36	Apoptosis; c-Kit; FLT3; PDGFR; VEGFR	Apoptosis; Protein Tyrosine Kinase/RTK	Ripretinib (DCC-2618) is an orally bioavailable, selective KIT and PDGFRA switch-control inhibitor. Ripretinib (DCC-2618) targets and binds to both wild-type and mutant forms of KIT and PDGFRA specifically at their switch pocket binding sites, thereby preventing the switch from inactive to active conformations of these kinases and inactivating their wild-type and mutant forms. Ripretinib (DCC-2618) also inhibits multiple other kinase targets, such as FLT3 and KDR (or VEGFR-2)[1][2]. DCC-2618 exerts antineoplastic effect and induces apoptosis[3].	Free Base	C24H21BrFN5O2	43392.0	DMSO : 25 mg/mL (48.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC(C2=CC3=C(C=C(NC)N=C3)N(CC)C2=O)=C(Br)C=C1F)NC4=CC=CC=C4	https://www.medchemexpress.com/DCC-2618.html	Launched		92.0	L20	N8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-112306	10.0	mM	320.0	DMSO	509.086265	8	N	pluskal_fda_drugs_5005_N8_id
1417	HY-17608	HYCPK40906	F06	HYCPK40906	92z	491.0	1.0	K11	906.0	F06	960539-70-2	Daprodustat	GSK1278863	393.43	HIF/HIF Prolyl-Hydroxylase	Metabolic Enzyme/Protease	Daprodustat (GSK1278863) is an orally active hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor being developed for the treatment of anemia associated with chronic kidney disease.	Free Acid	C19H27N3O6	19964.0	DMSO : 19.5 mg/mL (49.56 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O)CNC(C(C(N1C2CCCCC2)=O)C(N(C3CCCCC3)C1=O)=O)=O	https://www.medchemexpress.com/Daprodustat.html	Launched		92.0	K11	N9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17608	10.0	mM	321.0	DMSO	393.189986	9	N	pluskal_fda_drugs_5005_N9_id
1488	HY-B1510	HYCPK40906	C09	HYCPK40906	92z	209.0	1.0	E17	906.0	C09	87848-99-5	Acrivastine	BW825C	348.44	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.	Free Acid	C22H24N2O2	24466.0	DMSO : 50 mg/mL (143.50 mM; Need ultrasonic); H2O : 1 mg/mL (2.87 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C(O)/C=C/C1=NC(/C(C2=CC=C(C)C=C2)=C/CN3CCCC3)=CC=C1	https://www.medchemexpress.com/Acrivastine.html	Launched		92.0	E17	N9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1510	10.0	mM	321.0	DMSO	348.183778	9	N	pluskal_fda_drugs_5005_N9_id
1732	HY-17385	HYCPK40907	G04	HYCPK40907	92z	584.0	2.0	M8	907.0	G04	82248-59-7	Atomoxetine (hydrochloride)	Tomoxetine (hydrochloride); (R)-Tomoxetine (hydrochloride); LY 139603	291.82	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	"Atomoxetine hydrochloride is a potent and selective noradrenalin re-uptake inhibitor (Ki values are 5, 77 and 1451 nM for inhibition of radioligand binding to human NET, SERT and DAT respectively). IC50 value: 5 nM (Ki for human NET)
Target: NET
Atomoxetine displays minimal affinity for a range of other neurotransmitter receptors and transporters (Ki > 1 μM). Atomoxetine is antidepressant and a commonly used non-stimulant treatment for Attention deficit hyperactivity disorder (ADHD)."	Hydrochloride	C17H22ClNO	40115.0	DMSO : ≥ 100 mg/mL (342.68 mM); H2O : 50 mg/mL (171.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC1=CC=CC=C1O[C@@H](C2=CC=CC=C2)CCNC.[H]Cl	https://www.medchemexpress.com/Atomoxetine-hydrochloride.html	Launched		92.0	M8	N9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17385	10.0	mM	321.0	DMSO	255.162314	9	N	pluskal_fda_drugs_5005_N9_id
1924	HY-B0642	HYCPK40907	D17	HYCPK40907	92z	322.0	2.0	G34	907.0	D17	16051-77-7	Isosorbide mononitrate	Isosorbide-5-mononitrate	191.14	Autophagy; Endogenous Metabolite	Autophagy; Metabolic Enzyme/Protease	Isosorbide mononitrate(Isosorbide-5-mononitrate) is a nitrate-class compound used for angina pectoris; acts by dilating the blood vessels so as to reduce the blood pressure.	Free Base	C6H9NO6	13929.0	H2O : 50 mg/mL (261.59 mM; Need ultrasonic); DMSO : 100 mg/mL (523.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=[N+]([O-])O[C@H]1[C@](OC[C@@H]2O)([H])[C@]2([H])OC1	https://www.medchemexpress.com/Isosorbide-mononitrate.html	Launched		92.0	G34	N9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0642	10.0	mM	321.0	DMSO	191.042987	9	N	pluskal_fda_drugs_5005_N9_id
1956	HY-111613	HYCPK40907	D19	HYCPK40907	92z	326.0	2.0	G38	907.0	D19	53251-94-8	Pinaverium bromide		591.42	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Pinaverium bromide is an L-type calcium channel blocker with selectivity for the gastrointestinal tract, effectively relieves pain, diarrhea and intestinal discomfort, provides good therapeutic efficacies without significant adverse effects on Irritable bowel syndrome (IBS) patients[1].	Bromide	C26H41Br2NO4	39768.0	DMSO : 50 mg/mL (84.54 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC1(C)C2CCC(CCOCC[N+]3(CC4=CC(OC)=C(OC)C=C4Br)CCOCC3)C1C2.[Br-]	https://www.medchemexpress.com/Pinaverium_bromide.html	Launched		92.0	G38	N9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-111613	10.0	mM	321.0	DMSO	510.221347	9	N	pluskal_fda_drugs_5005_N9_id
2108	HY-15202	HYCPK40908	E09	HYCPK40908	92z	449.0	3.0	J17	908.0	E09	606143-89-9	Binimetinib	MEK162; ARRY-162; ARRY-438162	441.23	Autophagy; MEK	Autophagy; MAPK/ERK Pathway	Binimetinib (MEK162) is an oral and selective MEK1/2 inhibitor. Binimetinib (MEK162) inhibits MEK with an IC50 of 12 nM.	Free Base	C17H15BrF2N4O3	6247.0	DMSO : 50 mg/mL (113.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	BrC1=CC=C(C(F)=C1)NC2=C(C3=C(C=C2C(NOCCO)=O)N(C=N3)C)F	https://www.medchemexpress.com/MEK162.html	Launched		92.0	J17	N9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15202	10.0	mM	321.0	DMSO	440.029559	9	N	pluskal_fda_drugs_5005_N9_id
2484	HY-70057	HYCPK40909	P06	HYCPK40909	92z	1500.0	4.0	AF12	909.0	P06	133865-89-1	Safinamide	FCE 26743; EMD 1195686	302.34	Monoamine Oxidase	Neuronal Signaling	Safinamide is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 μM) over MAO-A (IC50=580 μM)[1]. Safinamide also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8?μM) than at resting (IC50=262?μM) potentials. Safinamide has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke etc.al[2][3].	Free Base	C17H19FN2O2	2077.0	DMSO : ≥ 100 mg/mL (330.75 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C([C@@H](NCC1=CC=C(OCC2=CC(F)=CC=C2)C=C1)C)N	https://www.medchemexpress.com/Safinamide.html	Launched		92.0	AF12	N9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-70057	10.0	mM	321.0	DMSO	302.143056	9	N	pluskal_fda_drugs_5005_N9_id
2526	HY-B0015	HYCPK40909	A10	HYCPK40909	92z	68.0	4.0	B20	909.0	A10	33069-62-4	Paclitaxel		853.91	ADC Cytotoxin; Apoptosis; Autophagy; Microtubule/Tubulin	Antibody-drug Conjugate/ADC Related; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton	Paclitaxel is a naturally occurring antineoplastic agent and stabilizes tubulin polymerization. Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy[1][2].	Free Base	C47H51NO14	112766.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 100 mg/mL (117.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=CC=C1)N[C@@H](C2=CC=CC=C2)[C@H](C(O[C@@H]3C(C)=C([C@@H](OC(C)=O)C([C@@]4(C)[C@]([C@@](CO5)(OC(C)=O)[C@@]5([H])C[C@@H]4O)([H])[C@@H]6OC(C7=CC=CC=C7)=O)=O)C(C)(C)[C@@]6(O)C3)=O)O	https://www.medchemexpress.com/Paclitaxel.html	Launched		92.0	B20	N9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0015	10.0	mM	321.0	DMSO	853.330955	9	N	pluskal_fda_drugs_5005_N9_id
26	HY-17599	HYCPK40899	D03	HYCPK40909	92z	364.0	4.0	H28	909.0	D14	144-29-6	Piperazine (citrate)	1,4-Diazacyclohexane (citrate)	321.33	GABA Receptor; Parasite	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	Piperazine (1,4-Diazacyclohexane) citrate is a gamma-aminobutyric acid (GABA) agonist[1]. Piperazine citrate is a vital building block and is an essential core in numerous marketed drugs with diverse pharmacological activities[2].	Citrate	C6H8O7.3/2C4H10N2	146596.0	DMSO : 2.17 mg/mL (6.75 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Infection	O=C(CC(C(O)=O)(O)CC(O)=O)O.O=C(CC(C(O)=O)(O)CC(O)=O)O.N1CCNCC1.N2CCNCC2.N3CCNCC3	https://www.medchemexpress.com/Piperazine-citrate.html	Launched		92.0	H28	N10	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17599	2.0	mM	322.0	DMSO	192.027003	10	N	pluskal_fda_drugs_5005_N10_id
593	HY-B0404A	HYCPK40906	K07	HYCPK40906	92z	973.0	1.0	U13	906.0	K07	14919-77-8	Benserazide (hydrochloride)	Serazide; Ro 4-4602	293.70	Others	Others	Benserazide hydrochloride (Serazide) is commonly used in Parkinson's disease and is an inhibitor of peripheral aromatic L-amino acid decarboxylase (AADC)[1].	Hydrochloride	C10H16ClN3O5	103618.0	H2O : ≥ 50 mg/mL (170.24 mM); DMSO : 100 mg/mL (340.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC(CO)C(NNCC1=CC=C(O)C(O)=C1O)=O.Cl	https://www.medchemexpress.com/Benserazide-hydrochloride.html	Launched		92.0	U13	N10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0404A	10.0	mM	322.0	DMSO	257.101171	10	N	pluskal_fda_drugs_5005_N10_id
1562	HY-14814A	HYCPK40906	M13	HYCPK40906	92z	1177.0	1.0	Y25	906.0	M13	352458-37-8	Delafloxacin (meglumine)	ABT492 meglumine; RX-3341 meglumine; WQ-3034 meglumine	635.97	Antibiotic; Bacterial	Anti-infection	Delafloxacin meglumine (ABT492 meglumine; RX-3341 meglumine; WQ-3034 meglumine) is a broad-spectrum fluoroquinolone antibiotic. Delafloxacin has a broad spectrum of activity that includes drug-resistant Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumonia[1].	Meglumine	C25H29ClF3N5O9	9287.0	H2O : 50 mg/mL (78.62 mM; Need ultrasonic); DMSO : ≥ 6.4 mg/mL (10.06 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C(C1=CN(C2=NC(N)=C(F)C=C2F)C3=C(C=C(F)C(N4CC(O)C4)=C3Cl)C1=O)O.O[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)CNC	https://www.medchemexpress.com/Delafloxacin_meglumine.html	Launched		92.0	Y25	N10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14814A	10.0	mM	322.0	DMSO	440.049917	10	N	pluskal_fda_drugs_5005_N10_id
1899	HY-B0305A	HYCPK40907	K15	HYCPK40907	92z	990.0	2.0	U30	907.0	K15	93793-83-0	Roxatidine (Acetate Hydrochloride)	HOE 760	384.90	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Roxatidine Acetate Hydrochloride is a potent, selective, competitive and orally active histamine H2-receptor antagonist. Roxatidine Acetate Hydrochloride has antisecretory potency against gastric acid secretion. Roxatidine Acetate Hydrochloride can also suppress inflammatory responses and can be used for gastric and duodenal ulcers research. Roxatidine Acetate Hydrochloride has antitumor activity[1][2][3].	Hydrochloride	C19H29ClN2O4	16016.0	DMSO : 50 mg/mL (129.90 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (129.90 mM)	DMSO Solution	10mM  * 100uL	Cancer; Metabolic Disease; Inflammation/Immunology	O=C(NCCCOC1=CC=CC(CN2CCCCC2)=C1)COC(C)=O.Cl	https://www.medchemexpress.com/Roxatidine-Acetate-Hydrochloride.html	Launched		92.0	U30	N10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0305A	10.0	mM	322.0	DMSO	348.204907	10	N	pluskal_fda_drugs_5005_N10_id
1910	HY-15310	HYCPK40907	F16	HYCPK40907	92z	512.0	2.0	K32	907.0	F16	70288-86-7	Ivermectin	MK-933	875.09	Antibiotic; Autophagy; Bacterial; HIV; HSV; Mitophagy; Parasite; SARS-CoV	Anti-infection; Autophagy	Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. Ivermectin (MK-933) is a specific inhibitor of Impα/β1-mediated nuclear import and has potent antiviral activity towards both HIV-1 and dengue virus. It is a positive allosteric effector of P2X4 and the α7 neuronal nicotinic acetylcholine receptor (nAChRs). Ivermectin also inhibits bovine herpesvirus1 (BoHV-1) replication and inhibits BoHV-1 DNA polymerase nuclear import[1][2][3][4]. Ivermectin is a candidate therapeutic against SARS-CoV-2/COVID-19[5].	Free Base	C48H74O14	58743.0	DMSO : 250 mg/mL (285.68 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Infection; Cancer	CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@H](/C(C)=C/C[C@@H]3C[C@H]4C[C@@]5(O[C@]([H])(C(C)C)[C@@H](C)CC5)O3)[C@@H](C)/C=C/C=C6CO[C@@]7([H])[C@]\6(O)[C@H](C(O4)=O)C=C(C)[C@H]7O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O.CO[C@H]8C[C@H](O[C@H]9[C@H](C)O[C@@H](O[C@H](/C(	https://www.medchemexpress.com/Ivermectin.html	Launched		92.0	K32	N10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15310	10.0	mM	322.0	DMSO	860.492207	10	N	pluskal_fda_drugs_5005_N10_id
1911	HY-19733	HYCPK40907	G16	HYCPK40907	92z	608.0	2.0	M32	907.0	G16	1187020-80-9	Lumateperone (tosylate)	ITI-007 (tosylate)	565.70	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Lumateperone (ITI-007) tosylate is a 5-HT2A receptor antagonist (Ki = 0.54 nM), a partial agonist of presynaptic D2 receptors and an antagonist of postsynaptic D2 receptors (Ki = 32 nM), and a dopamine D1 receptor modulator. Lumateperone  tosylate has anticancer activity and can also be used in studies of psychiatric disorders such as schizophrenia[1][2][3].	Tosylate	C31H36FN3O4S	26645.0	DMSO : 100 mg/mL (176.77 mM; Need ultrasonic); H2O : 1 mg/mL (1.77 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=C(F)C=C1)CCCN2CC[C@@](N3CCN(C)C4=C3C5=CC=C4)([H])[C@@]5([H])C2.O=S(C6=CC=C(C)C=C6)(O)=O	https://www.medchemexpress.com/lumateperone-Tosylate.html	Launched		92.0	M32	N10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19733	10.0	mM	322.0	DMSO	393.221641	10	N	pluskal_fda_drugs_5005_N10_id
1930	HY-70057A	HYCPK40907	J17	HYCPK40907	92z	898.0	2.0	S34	907.0	J17	202825-46-5	Safinamide (mesylate)	FCE 26743 (mesylate); EMD 1195686 (mesylate)	398.45	Monoamine Oxidase	Neuronal Signaling	Safinamide (FCE 26743; EMD 1195686) mesylate is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 μM) over MAO-A (IC50=580 nM)[1]. Safinamide mesylate also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8?μM) than at resting (IC50=262?μM) potentials. Safinamide mesylate has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke et.al[2][3].	Mesylate	C18H23FN2O5S	79206.0	DMSO : 250 mg/mL (627.43 mM; Need ultrasonic); H2O : ≥ 20 mg/mL (50.19 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease	C[C@H](NCC1=CC=C(OCC2=CC=CC(F)=C2)C=C1)C(N)=O.CS(=O)(O)=O	https://www.medchemexpress.com/safinamide-mesylate.html	Launched		92.0	S34	N10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-70057A	10.0	mM	322.0	DMSO	302.143056	10	N	pluskal_fda_drugs_5005_N10_id
2224	HY-15403A	HYCPK40908	A17	HYCPK40908	92z	81.0	3.0	B33	908.0	A17	195733-43-8	Atrasentan (hydrochloride)	ABT-627 (hydrochloride); (+)-A 127722 (hydrochloride); A-147627 (hydrochloride)	547.08	Endothelin Receptor	GPCR/G Protein	Atrasentan hydrochloride (ABT-627 hydrochloride) is a selective endothelin A receptor antagonist with an IC50 of 0.0551 nM for ETA[1].	Hydrochloride	C29H39ClN2O6	9251.0	DMSO : ≥ 100 mg/mL (182.79 mM); H2O : 0.5 mg/mL (0.91 mM; ultrasonic and warming and adjust pH to 4 with HCl and heat to 60°C); 0.1 M HCL : < 1 mg/mL (ultrasonic;warming;adjust pH to 1 with HCl;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology; Cardiovascular Disease	O=C([C@H]1[C@H](C2=CC=C(OC)C=C2)N(CC(N(CCCC)CCCC)=O)C[C@@H]1C3=CC=C(OCO4)C4=C3)O.Cl	https://www.medchemexpress.com/Atrasentan-hydrochloride.html	Launched		92.0	B33	N10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15403A	10.0	mM	322.0	DMSO	510.272987	10	N	pluskal_fda_drugs_5005_N10_id
1462	HY-B0205	HYCPK40908	D05	HYCPK40908	92z	345.0	3.0	H9	908.0	D05	139481-59-7	Candesartan	CV 11974	440.45	Angiotensin Receptor; PPAR	Cell Cycle/DNA Damage; GPCR/G Protein	Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3].	Free Acid	C24H20N6O3	20057.0	DMSO : ≥ 100 mg/mL (227.04 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=C(C1=C2C(N=C(OCC)N2CC3=CC=C(C4=CC=CC=C4C5=NNN=N5)C=C3)=CC=C1)O	https://www.medchemexpress.com/candesartan.html	Launched		92.0	H9	N11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0205	10.0	mM	323.0	DMSO	440.159689	11	N	pluskal_fda_drugs_5005_N11_id
1579	HY-B1156	HYCPK40906	N14	HYCPK40906	92z	1275.0	1.0	AA27	906.0	N14	38821-53-3	Cephradine	Cefradine; SQ-11436	349.40	Antibiotic; Bacterial; TOPK	Anti-infection; Cell Cycle/DNA Damage	Cephradine (Cefradine) is a broad-spectrum and orally active cephalosporin. Cephradine is active against both gram-positive and gram-negative pathogens. Cephradine is effective in eradicating most penicillinase-producing organisms. Cephradine has been used in the research of genitourinary, gastrointestinal and respiratory tract infections, and in infections of the skin and soft tissues. Cephradine blocks solar-ultraviolet induced skin inflammation through direct inhibition of TOPK[1][2][3].	Free Acid	C16H19N3O4S	31682.0	DMSO : ≥ 3.6 mg/mL (10.30 mM); H2O : 8.33 mg/mL (23.84 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CCC=CC3)=O)C1=O)O	https://www.medchemexpress.com/Cefradine.html	Launched		92.0	AA27	N11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1156	10.0	mM	323.0	DMSO	349.109627	11	N	pluskal_fda_drugs_5005_N11_id
1722	HY-10562A	HYCPK40907	M03	HYCPK40907	92z	1158.0	2.0	Y6	907.0	M03	83846-83-7	Ketanserin (tartrate)	R41468 tartrate	545.51	5-HT Receptor; Autophagy; Potassium Channel	Autophagy; GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Ketanserin (R41468) tartrate is a selective 5-HT2 receptor antagonist. Ketanserin tartrate also blocks hERG current (IhERG) in a concentration-dependent manner (IC50=0.11 μM).	Tartrate	C26H28FN3O9	34510.0	DMSO : 150 mg/mL (274.97 mM; Need ultrasonic); H2O : 6 mg/mL (11.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=CC=C1N2)N(CCN3CCC(C(C4=CC=C(F)C=C4)=O)CC3)C2=O.O=C(O)[C@H](O)[C@@H](O)C(O)=O	https://www.medchemexpress.com/Ketanserin-tartrate.html	Launched		92.0	Y6	N11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10562A	10.0	mM	323.0	DMSO	395.16452	11	N	pluskal_fda_drugs_5005_N11_id
1944	HY-B1799	HYCPK40907	H18	HYCPK40907	92z	708.0	2.0	O36	907.0	H18	26171-23-3	Tolmetin		257.28	COX	Immunology/Inflammation	Tolmetin is an orally active and potent COX inhibitor with IC50s of 0.35 μM and 0.82 μM human COX-1 and COX-2, respectively. Tolmetin is a non-steroidal anti-inflammatory drug (NSAID)[1][2].		C15H15NO3	78775.0	DMSO : 100 mg/mL (388.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(O)CC1=CC=C(C(C2=CC=C(C)C=C2)=O)N1C	https://www.medchemexpress.com/tolmetin.html	Launched		92.0	O36	N11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1799	10.0	mM	323.0	DMSO	257.105193	11	N	pluskal_fda_drugs_5005_N11_id
2070	HY-B1127	HYCPK40908	O06	HYCPK40908	92z	1403.0	3.0	AD11	908.0	O06	3440-28-6	Betamipron	N-Benzoyl-β-alanine	193.20	Antibiotic; Bacterial	Anti-infection	Betamipron is a chemical compound which is used together with Panipenem to inhibit Panipenem uptake into the renal tubule and prevent nephrotoxicity.	Free Acid	C10H11NO3	17262.0	DMSO : 100 mg/mL (517.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(O)CCNC(C1=CC=CC=C1)=O	https://www.medchemexpress.com/Betamipron.html	Launched		92.0	AD11	N11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1127	10.0	mM	323.0	DMSO	193.073893	11	N	pluskal_fda_drugs_5005_N11_id
2207	HY-N0198	HYCPK40908	L15	HYCPK40908	92z	1133.0	3.0	X29	908.0	L15	500-38-9	Nordihydroguaiaretic acid	NDGA	302.36	Autophagy; Ferroptosis; Lipoxygenase	Apoptosis; Autophagy; Metabolic Enzyme/Protease	Nordihydroguaiaretic acid is a 5-lipoxygenase (5LOX) (IC50=8 μM) and tyrosine kinase inhibitor.	Free Base	C18H22O4	88926.0	DMSO : 250 mg/mL (826.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	CC(CC1=CC=C(O)C(O)=C1)C(C)CC2=CC=C(O)C(O)=C2	https://www.medchemexpress.com/nordihydroguaiaretic-acid.html	Launched		92.0	X29	N11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0198	10.0	mM	323.0	DMSO	302.151809	11	N	pluskal_fda_drugs_5005_N11_id
2503	HY-B1246	HYCPK40909	J08	HYCPK40909	92z	928.0	4.0	T16	909.0	J08	553-08-2	Thonzonium (bromide)		591.71	Bacterial; Proton Pump	Anti-infection; Membrane Transporter/Ion Channel	Thonzonium bromide is an antibacterial agent that is structurally similar to Farnesol (HY-Y0248A). Thonzonium bromide is also a monocationic surface-active agent, which inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo. Thonzonium bromide inhibits proton transport in a dose-dependent manner (EC50=69 μM)[1][2][3].	Bromide	C32H55BrN4O	62988.0	DMSO : ≥ 30 mg/mL (50.70 mM)	DMSO Solution	10mM  * 100uL	Infection	CCCCCCCCCCCCCCCC[N+](C)(CCN(CC1=CC=C(OC)C=C1)C2=NC=CC=N2)C.[Br-]	https://www.medchemexpress.com/Thonzonium-bromide.html	Launched		92.0	T16	N11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1246	10.0	mM	323.0	DMSO	511.437039	11	N	pluskal_fda_drugs_5005_N11_id
2535	HY-15531	HYCPK40909	J10	HYCPK40909	92z	932.0	4.0	T20	909.0	J10	1257044-40-8	Venetoclax	ABT-199; GDC-0199	868.44	Autophagy; Bcl-2 Family	Apoptosis; Autophagy	Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0.01 nM. Venetoclax induces autophagy[1][2][3].	Free Base	C45H50ClN7O7S	153095.0	DMSO : 77.5 mg/mL (89.24 mM; Need ultrasonic); Ethanol : < 1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NS(=O)(C1=CC=C(NCC2CCOCC2)C([N+]([O-])=O)=C1)=O)C3=CC=C(N4CCN(CC5=C(C6=CC=C(Cl)C=C6)CC(C)(C)CC5)CC4)C=C3OC7=CN=C(NC=C8)C8=C7	https://www.medchemexpress.com/ABT-199.html	Launched		92.0	T20	N11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15531	10.0	mM	323.0	DMSO	867.318096	11	N	pluskal_fda_drugs_5005_N11_id
1484	HY-B1052	HYCPK40906	O08	HYCPK40906	92z	1359.0	1.0	AC15	906.0	O08	21498-08-8	Lofexidine (hydrochloride)	Baq-168; MDL-14042	295.59	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Lofexidine (hydrochloride) is a selective α2-receptor agonist, commonly used to alleviate the physical symptoms of heroin and other types of opioid withdrawal[1][2].	Hydrochloride	C11H13Cl3N2O	85600.0	H2O : ≥ 100 mg/mL (338.31 mM); DMSO : 100 mg/mL (338.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CC(C1=NCCN1)OC2=C(Cl)C=CC=C2Cl.[H]Cl	https://www.medchemexpress.com/Lofexidine-hydrochloride.html	Launched		92.0	AC15	N12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1052	10.0	mM	324.0	DMSO	258.032668	12	N	pluskal_fda_drugs_5005_N12_id
1739	HY-19840	HYCPK40907	C05	HYCPK40907	92z	202.0	2.0	E10	907.0	C05	1535212-07-7	Voxilaprevir	GS-9857	868.93	HCV Protease	Anti-infection; Metabolic Enzyme/Protease	Voxilaprevir (GS-9857) is a noncovalent, reversible inhibitor of HCV NS3/4A protease inhibitor (PI) with pangenotypic antiviral activity[1]. Voxilaprevir inhibits genotype 1b and 3a wild-type NS3 proteases with Ki values of 0.038 nM and 0.066 nM, respectively[1]. Voxilaprevir is an orally active direct-acting antiviral agent (DAA) and can be used for HCV infection research[2].	Free Base	C40H52F4N6O9S	113486.0	DMSO : ≥ 100 mg/mL (115.08 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@H]1N(C([C@@H](NC(O[C@H]2[C@H]3C2)=O)C(C)(C)C)=O)C[C@@](OC4=NC5=CC(OC)=CC=C5N=C4C(F)(CCCC3)F)([H])[C@H]1CC)N[C@]6([C@H](C(F)F)C6)C(NS(=O)(C7(CC7)C)=O)=O	https://www.medchemexpress.com/voxilaprevir.html	Launched		92.0	E10	N12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19840	10.0	mM	324.0	DMSO	868.345261	12	N	pluskal_fda_drugs_5005_N12_id
1833	HY-A0005	HYCPK40907	A11	HYCPK40907	92z	22.0	2.0	A22	907.0	A11	123318-82-1	Clofarabine		303.68	Apoptosis; Autophagy; Nucleoside Antimetabolite/Analog	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Clofarabine, a nucleoside analogue for research of cancer, is a potent inhibitor of ribonucleotide reductase (IC50=65 nM) by binding to the allosteric site on the regulatory subunit[1].	Free Base	C10H11ClFN5O3	11534.0	DMSO : ≥ 50 mg/mL (164.65 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	F[C@H]([C@H](N1C2=C(C(N)=NC(Cl)=N2)N=C1)O[C@@H]3CO)[C@@H]3O	https://www.medchemexpress.com/clofarabine.html	Launched		92.0	A22	N12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0005	10.0	mM	324.0	DMSO	303.053445	12	N	pluskal_fda_drugs_5005_N12_id
1896	HY-10452	HYCPK40907	H15	HYCPK40907	92z	702.0	2.0	O30	907.0	H15	1239908-20-3	Ixazomib citrate	MLN9708	517.12	Autophagy; Proteasome	Autophagy; Metabolic Enzyme/Protease	Ixazomib citrate (MLN9708) is a reversible inhibitor of the chymotrypsin-like proteolytic β5 site of the 20S proteasome with an IC50 of 3.4 nM and a Ki of 0.93 nM.	Free Acid	C20H23BCl2N2O9	65684.0	DMSO : 250 mg/mL (483.45 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CC1(CC(O)=O)OB([C@@H](NC(CNC(C2=CC(Cl)=CC=C2Cl)=O)=O)CC(C)C)OC1=O	https://www.medchemexpress.com/MLN9708.html	Launched		92.0	O30	N12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10452	10.0	mM	324.0	DMSO	516.087366	12	N	pluskal_fda_drugs_5005_N12_id
1922	HY-17369	HYCPK40907	B17	HYCPK40907	92z	130.0	2.0	C34	907.0	B17	150915-40-5	Tirofiban (hydrochloride monohydrate)	L700462 (hydrochloride monohydrate); MK383 (hydrochloride monohydrate)	495.07	Integrin	Cytoskeleton	Tirofiban (L700462) hydrochloride monohydrate is a selective and reversible platelet integrin receptor (Gp IIb/IIIa) antagonist that inhibits fibrinogen binding to this receptor and has antithrombotic activity. Tirofiban hydrochloride monohydrate induces proliferation and migration on endothelial cell by inducing production of VEGF. Tirofiban hydrochloride monohydrate can significantly reduces myocardial no-reflow and ischemia-reperfusion injury by alleviating myocardial microvascular structural and endothelial dysfunction in the ischemic area[1][2][3].	Hydrochloride	C22H39ClN2O6S	99128.0	DMSO : 100 mg/mL (201.99 mM; Need ultrasonic); H2O : 1 mg/mL (2.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=S(N[C@H](C(O)=O)CC1=CC=C(OCCCCC2CCNCC2)C=C1)(CCCC)=O.[H]Cl.[H]O[H]	https://www.medchemexpress.com/Tirofiban-hydrochloride-monohydrate.html	Launched		92.0	C34	N12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17369	10.0	mM	324.0	DMSO	440.234493	12	N	pluskal_fda_drugs_5005_N12_id
2110	HY-15297	HYCPK40908	G09	HYCPK40908	92z	641.0	3.0	N17	908.0	G09	81840-15-5	Vesnarinone	OPC-8212	395.45	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Vesnarinone (OPC-8212) is an orally active phosphodiesterase 3 (PDE3) inhibitor. Vesnarinone can increase in calcium flux and decrease in potassium flux. Vesnarinone shows dose-dependent positive inotropic activity. Vesnarinone can be used in heart failure research[1][2][3][4].	Free Base	C22H25N3O4	19423.0	DMSO : 16.67 mg/mL (42.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cardiovascular Disease	O=C1NC2=C(C=C(N3CCN(C(C4=CC=C(OC)C(OC)=C4)=O)CC3)C=C2)CC1	https://www.medchemexpress.com/Vesnarinone.html	Launched		92.0	N17	N12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15297	10.0	mM	324.0	DMSO	395.184506	12	N	pluskal_fda_drugs_5005_N12_id
2151	HY-66004	HYCPK40908	D12	HYCPK40908	92z	359.0	3.0	H23	908.0	D12	2623-33-8	4-Acetamidophenyl acetate		193.20	Bacterial; Parasite	Anti-infection	4-Acetamidophenyl acetate is an impurity of Acetaminophen (paracetamol). Acetaminophen, an analgesic drug, is a selective COX-2 inhibitor (IC50=25.8 μM), and is a potent hepatic N-acetyltransferase 2 (NAT2) inhibitor[1][2].		C10H11NO3	146011.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(C)NC1=CC=C(OC(C)=O)C=C1	https://www.medchemexpress.com/4-acetamidophenyl-acetate.html	Launched		92.0	H23	N12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-66004	10.0	mM	324.0	DMSO	193.073893	12	N	pluskal_fda_drugs_5005_N12_id
2493	HY-B0522A	HYCPK40909	P07	HYCPK40909	92z	1502.0	4.0	AF14	909.0	P07	69-52-3	Ampicillin (sodium)	D-(-)-α-Aminobenzylpenicillin (sodium salt)	371.38	Antibiotic; Bacterial	Anti-infection	Ampicillin sodium (D-(-)-α-Aminobenzylpenicillin sodium salt) is a broad-spectrum beta-lactam antibiotic against a variety of gram-positive and gram-negative bacteria[1].	Sodium	C16H18N3NaO4S	13365.0	H2O : ≥ 200 mg/mL (538.53 mM); DMSO : 200 mg/mL (538.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H]1N(C2=O)[C@]([C@@H]2NC([C@@H](C3=CC=CC=C3)N)=O)([H])SC1(C)C)O[Na]	https://www.medchemexpress.com/Ampicillin-sodium.html	Launched		92.0	AF14	N12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0522A	10.0	mM	324.0	DMSO	349.109627	12	N	pluskal_fda_drugs_5005_N12_id
1403	HY-B0522B	HYCPK40906	H05	HYCPK40906	92z	681.0	1.0	O9	906.0	H05	7177-48-2	Ampicillin (trihydrate)	D-(-)-α-Aminobenzylpenicillin (trihydrate)	403.45	Antibiotic; Bacterial	Anti-infection	Ampicillin trihydrate (D-(-)-α-Aminobenzylpenicillin trihydrate) is a broad-spectrum beta-lactam antibiotic against a variety of gram-positive and gram-negative bacteria.	hydrate	C16H25N3O7S	230072.0	H2O : 5 mg/mL (12.39 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Infection	OC([C@@H]1N(C2=O)[C@]([C@@H]2NC([C@@H](C3=CC=CC=C3)N)=O)([H])SC1(C)C)=O.[3H2O]	https://www.medchemexpress.com/ampicillin-trihydrate.html	Launched		92.0	O9	N13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0522B	10.0	mM	325.0	DMSO	349.109627	13	N	pluskal_fda_drugs_5005_N13_id
1404	HY-B1052A	HYCPK40906	I05	HYCPK40906	92z	777.0	1.0	Q9	906.0	I05	31036-80-3	Lofexidine		259.13	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Lofexidine is a selective α2-receptor agonist, commonly used to alleviate the physical symptoms of heroin and other types of opioid withdrawal[1][2].	Free Base	C11H12Cl2N2O	97405.0	DMSO : 62.5 mg/mL (241.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CC(C1=NCCN1)OC2=C(Cl)C=CC=C2Cl	https://www.medchemexpress.com/Lofexidine.html	Launched		92.0	Q9	N13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1052A	10.0	mM	325.0	DMSO	258.032668	13	N	pluskal_fda_drugs_5005_N13_id
1458	HY-B1371	HYCPK40908	P04	HYCPK40908	92z	1495.0	3.0	AF7	908.0	P04	749-02-0	Spiperone	Spiroperidol	395.47	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Spiperone is a potent dopamine D2, serotonin 5-HT1A, and serotonin 5-HT2A antagonist. Spiperone is a widely used pharmacological tool. Spiperone has the potential for the research of neurology diseases[1].		C23H26FN3O2	150954.0	DMSO : 33.33 mg/mL (84.28 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1NCN(C2=CC=CC=C2)C13CCN(CCCC(C4=CC=C(F)C=C4)=O)CC3	https://www.medchemexpress.com/spiperone.html	Launched		92.0	AF7	N13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1371	10.0	mM	325.0	DMSO	395.200905	13	N	pluskal_fda_drugs_5005_N13_id
1671	HY-N0060A	HYCPK40906	J20	HYCPK40906	92z	903.0	1.0	S39	906.0	J20	24276-84-4	Ferulic acid (sodium)	Coniferic acid (sodium)	216.17	Endogenous Metabolite; FGFR; Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Protein Tyrosine Kinase/RTK	Ferulic acid sodium is a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 μM for FGFR1 and FGFR2, respectively.	Sodium	C10H9NaO4	18863.0	H2O : 100 mg/mL (462.60 mM; Need ultrasonic); DMSO : 33.33 mg/mL (154.18 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(O[Na])/C=C/C1=CC=C(O)C(OC)=C1	https://www.medchemexpress.com/Ferulic-acid-sodium.html	Launched		92.0	S39	N13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0060A	10.0	mM	325.0	DMSO	194.057909	13	N	pluskal_fda_drugs_5005_N13_id
1823	HY-B0009	HYCPK40907	G10	HYCPK40907	92z	596.0	2.0	M20	907.0	G10	78755-81-4	Flumazenil	Ro 15-1788	303.29	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Flumazenil is a competitive GABAA receptor antagonist, used in the treatment of benzodiazepine overdoses.	Free Base	C15H14FN3O3	102166.0	DMSO : 20 mg/mL (65.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=C2CN(C(C3=CC(F)=CC=C3N2C=N1)=O)C)OCC	https://www.medchemexpress.com/Flumazenil.html	Launched		92.0	M20	N13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0009	10.0	mM	325.0	DMSO	303.10192	13	N	pluskal_fda_drugs_5005_N13_id
1962	HY-B0232	HYCPK40907	J19	HYCPK40907	92z	902.0	2.0	S38	907.0	J19	115256-11-6	Dofetilide	UK 68789	441.56	Potassium Channel	Membrane Transporter/Ion Channel	Dofetilide (UK 68789), as a class III antiarrhythmic agent, is an orally active, potent and specific IKr blocker. Dofetilide can be used for the research of cardiovascular disease[1][2].	Free Base	C19H27N3O5S2	15898.0	DMSO : ≥ 100 mg/mL (226.47 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CS(=O)(NC1=CC=C(CCN(C)CCOC2=CC=C(NS(=O)(C)=O)C=C2)C=C1)=O	https://www.medchemexpress.com/Dofetilide.html	Launched		92.0	S38	N13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0232	10.0	mM	325.0	DMSO	441.139213	13	N	pluskal_fda_drugs_5005_N13_id
2063	HY-B0388	HYCPK40908	H06	HYCPK40908	92z	731.0	3.0	P11	908.0	H06	23288-49-5	Probucol	DH-581	516.84	Virus Protease	Anti-infection	Probucol (DH-581) is an anti-hyperlipidemic drug by lowering the level of cholesterol in the bloodstream by increasing the rate of LDL catabolism.	Free Base	C31H48O2S2	16835.0	DMSO : ≥ 100 mg/mL (193.48 mM); H2O : 0.67 mg/mL (1.30 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC(SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1)(SC2=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C2)C	https://www.medchemexpress.com/probucol.html	Launched		92.0	P11	N13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0388	10.0	mM	325.0	DMSO	516.309573	13	N	pluskal_fda_drugs_5005_N13_id
2512	HY-B1102	HYCPK40909	C09	HYCPK40909	92z	258.0	4.0	F18	909.0	C09	314-13-6	Evans Blue	Direct Blue 53; C.I. 23860	960.81	EAAT2	Membrane Transporter/Ion Channel	"Evans Blue is a potent inhibitor of L-glutamate uptake via the membrane bound excitatory amino acid transporter (EAAT). Able to antagonize AMPA and kainate receptor mediated currents (IC50 values are 220 and 150 nM, respectively). 
IC50 value: 220/150 nM
Target: L-glutamate uptake receptor
Evans blue is a biological dye, for detection of cell survival. Evans Blue can not penetrate  healthy cell membrane, but can penetrate into death cell. Binds with high affinity to serum albumin."	Sodium	C34H24N6Na4O14S4	23169.0	DMSO : ≥ 25 mg/mL (26.02 mM); H2O : 33.33 mg/mL (34.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CC1=CC(C2=CC=C(/N=N/C3=C(O)C4=C(N)C(S(=O)(O[Na])=O)=CC(S(=O)(O[Na])=O)=C4C=C3)C(C)=C2)=CC=C1/N=N/C5=C(O)C6=C(N)C(S(=O)(O[Na])=O)=CC(S(=O)(O[Na])=O)=C6C=C5	https://www.medchemexpress.com/Evans-Blue.html	Launched		92.0	F18	N13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1102	10.0	mM	325.0	DMSO	872.054634	13	N	pluskal_fda_drugs_5005_N13_id
56	HY-13736A	HYCPK40899	J05	HYCPK40909	92z	944.0	4.0	T32	909.0	J16	94424-50-7	Quinagolide (hydrochloride)	CV205-502 hydrochloride	432.02	Akt; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling; PI3K/Akt/mTOR	Quinagolide hydrochloride (CV205-502 hydrochloride) is a selective and orally active dopamine D2 receptor agonist. Quinagolide hydrochloride is an inhibitor of prolactin. Quinagolide hydrochloride down-regulates AKT levels and its phosphorylation. Quinagolide hydrochloride shows antitumor effects, it can be used for the research of cancer[1][2].	Hydrochloride	C20H34ClN3O3S	18386.0	DMSO : 3.85 mg/mL (8.91 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Cancer; Neurological Disease	OC1=C2C(C[C@](N(CCC)C[C@@H](NS(N(CC)CC)(=O)=O)C3)([H])[C@@]3([H])C2)=CC=C1.Cl	https://www.medchemexpress.com/Quinagolide-hydrochloride.html	Launched		92.0	T32	N14	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13736A	2.0	mM	326.0	DMSO	395.224263	14	N	pluskal_fda_drugs_5005_N14_id
1612	HY-B1350	HYCPK40906	O16	HYCPK40906	92z	1375.0	1.0	AC31	906.0	O16	6990-06-3	Fusidic acid	Fusidate; SQ-16603	516.71	Antibiotic; Bacterial	Anti-infection	Fusidic acid (Fusidate) a bacteriostatic antibiotic produced from the Fusidium coccineum fungus, belongs to the class of steroids. Fusidic acid has no corticosteroid effects. Fusidic acid inhibits the growth of bacteria by preventing the release of translation elongation factor G (EF-G) from the ribosome[1][2].	Free Acid	C31H48O6	124891.0	DMSO : 100 mg/mL (193.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@@H]([C@]1([H])CC[C@]([C@@](C[C@@H]/2OC(C)=O)3C)4C)[C@H](O)CC[C@]1(C)[C@]4([H])[C@H](O)C[C@@]3([H])C2=C(C(O)=O)/CC/C=C(C)\C	https://www.medchemexpress.com/fusidic-acid.html	Launched		92.0	AC31	N14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1350	10.0	mM	326.0	DMSO	516.345089	14	N	pluskal_fda_drugs_5005_N14_id
1897	HY-B1245	HYCPK40907	I15	HYCPK40907	92z	798.0	2.0	Q30	907.0	I15	552-94-3	Salsalate	Salicylsalicylic acid; Disalicylic acid	258.23	Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Salsalate, a non-acetylated salicylate, is an effective antirheumatic drug that bypasses gastric absorption and also avoids cyclooxygenase inhibition. Salsalate has anti-inflammatory activity and reduces glucose levels, insulin resistance, and cytokine expression. Salsalate can be used in the research of type 2 diabetes[1][2].	Free Acid	C14H10O5	17604.0	H2O : 0.67 mg/mL (2.59 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (387.25 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OC1=CC=CC=C1C(O)=O)C2=CC=CC=C2O	https://www.medchemexpress.com/Salsalate.html	Launched		92.0	Q30	N14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1245	10.0	mM	326.0	DMSO	258.052823	14	N	pluskal_fda_drugs_5005_N14_id
1952	HY-15789	HYCPK40907	P18	HYCPK40907	92z	1476.0	2.0	AE36	907.0	P18	1370468-36-2	Elbasvir	MK-8742	882.02	HCV	Anti-infection	Elbasvir (MK-8742) is a hepatitis C virus nonstructural protein 5A (HCV NS5A) inhibitor with EC50s of 4, 3 and 3 nM against genotype 1a, 1b, and 2a, respectively.	Free Base	C49H55N9O7	59694.0	DMSO : ≥ 50 mg/mL (56.69 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@H](C(C)C)NC(OC)=O)N(CCC1)[C@@H]1C(N2)=NC=C2C(C=C3)=CC4=C3C5=CC6=CC(C7=CN=C([C@H]8N(C([C@H](C(C)C)NC(OC)=O)=O)CCC8)N7)=CC=C6N5[C@H](C9=CC=CC=C9)O4	https://www.medchemexpress.com/Elbasvir.html	Launched		92.0	AE36	N14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15789	10.0	mM	326.0	DMSO	881.422445	14	N	pluskal_fda_drugs_5005_N14_id
2067	HY-B0976A	HYCPK40908	L06	HYCPK40908	92z	1115.0	3.0	X11	908.0	L06	1944-12-3	Fenoterol (hydrobromide)	Th-1165a; Phenoterol (hydrobromide)	384.26	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research[1][2].	Bromide	C17H22BrNO4	28105.0	DMSO : ≥ 100 mg/mL (260.24 mM); H2O : 25 mg/mL (65.06 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	[H]Br.OC1=CC(C(O)CNC(C)CC2=CC=C(O)C=C2)=CC(O)=C1	https://www.medchemexpress.com/Fenoterol-hydrobromide.html	Launched		92.0	X11	N14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0976A	10.0	mM	326.0	DMSO	303.147058	14	N	pluskal_fda_drugs_5005_N14_id
2407	HY-B1306	HYCPK40908	C22	HYCPK40908	92z	283.0	3.0	F43	908.0	C22	61-78-9	4-Aminohippuric acid	p-Aminohippuric acid	194.19	Endogenous Metabolite	Metabolic Enzyme/Protease	4-Aminohippuric acid is a diagnostic agent, useful in medical tests involving the kidney, used in the measurement of renal plasma flow.	Free Acid	C9H10N2O3	17477.0	H2O : ≥ 1.7 mg/mL (8.75 mM); DMSO : 50 mg/mL (257.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(O)CNC(C1=CC=C(N)C=C1)=O	https://www.medchemexpress.com/4-Aminohippuric-acid.html	Launched		92.0	F43	N14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1306	10.0	mM	326.0	DMSO	194.069142	14	N	pluskal_fda_drugs_5005_N14_id
2421	HY-10224	HYCPK40909	A03	HYCPK40909	92z	54.0	4.0	B6	909.0	A03	404950-80-7	Panobinostat	LBH589; NVP-LBH589	349.43	Apoptosis; Autophagy; HDAC; HIV	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics	Panobinostat (LBH589; NVP-LBH589) is a potent and orally active non-selective HDAC inhibitor, and has antineoplastic activities[1][2]. Panobinostat induces HIV-1 virus production even at low concentration range 8-31 nM, stimulates HIV-1 expression in latently infected cells[4]. Panobinostat induces cell apoptosis and autophagy. Panobinostat can be used for the study of refractory or relapsed multiple myeloma[3].	Free Base	C21H23N3O2	231753.0	DMSO : ≥ 100 mg/mL (286.18 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(/C=C/C1=CC=C(CNCCC2=C(NC3=C2C=CC=C3)C)C=C1)NO	https://www.medchemexpress.com/Panobinostat.html	Launched		92.0	B6	N14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10224	10.0	mM	326.0	DMSO	349.179027	14	N	pluskal_fda_drugs_5005_N14_id
2464	HY-15244	HYCPK40909	L05	HYCPK40909	92z	1114.0	4.0	X10	909.0	L05	1217486-61-7	Alpelisib	BYL-719	441.47	PI3K	PI3K/Akt/mTOR	Alpelisib (BYL-719) is a potent, selective, and orally active PI3Kα inhibitor. Alpelisib (BYL-719) shows efficacy in targeting PIK3CA-mutated cancer. Alpelisib (BYL-719) also inhibits p110α/p110γ/p110δ/p110β with IC50s of 5/250/290/1200 nM, respectively. Antineoplastic activity[1][2][3].		C19H22F3N5O2S	218124.0	DMSO : 83.33 mg/mL (188.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC(N=C(S1)NC(N2CCC[C@H]2C(N)=O)=O)=C1C3=CC(C(C)(C(F)(F)F)C)=NC=C3	https://www.medchemexpress.com/BYL-719.html	Launched		92.0	X10	N14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15244	10.0	mM	326.0	DMSO	441.144631	14	N	pluskal_fda_drugs_5005_N14_id
1395	HY-B1350A	HYCPK40906	P04	HYCPK40906	92z	1447.0	1.0	AE7	906.0	P04	751-94-0	Fusidic acid (sodium salt)	Sodium fusidate; SQ-16360	538.69	Antibiotic; Bacterial	Anti-infection	Fusidic acid sodium salt (Sodium fusidate), a bacteriostatic antibiotic produced from the Fusidium coccineum fungus, belongs to the class of steroids. Fusidic acid sodium salt has no corticosteroid effects. Fusidic acid sodium salt inhibits the growth of bacteria by preventing the release of translation elongation factor G (EF-G) from the ribosome[1][2].	Sodium	C31H47NaO6	16991.0	H2O : ≥ 100 mg/mL (185.64 mM); DMSO : ≥ 100 mg/mL (185.64 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	C[C@@H]([C@]1([H])CC[C@]([C@@](C[C@@H]/2OC(C)=O)3C)4C)[C@H](O)CC[C@]1(C)[C@]4([H])[C@H](O)C[C@@]3([H])C2=C(C(O[Na])=O)/CC/C=C(C)\C	https://www.medchemexpress.com/Fusidic-acid-sodium-salt.html	Launched		92.0	AE7	N15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1350A	10.0	mM	327.0	DMSO	516.345089	15	N	pluskal_fda_drugs_5005_N15_id
1433	HY-17001	HYCPK40906	F07	HYCPK40906	92z	493.0	1.0	K13	906.0	F07	75507-68-5	Flupirtine (Maleate)		420.39	iGluR; Potassium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Flupirtine Maleate is a?brain?penetrant, and orally bioavailable, non-opioid and centrally acting analgesic agent. Flupirtine Maleate is an indirect N-methyl-D-aspartate receptor (NMDAR) antagonist. Neuroprotective properties[1][2].	Maleate	C19H21FN4O6	6797.0	DMSO : 100 mg/mL (237.87 mM; Need ultrasonic); H2O : 1.43 mg/mL (3.40 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(NC1=CC=C(N=C1N)NCC2=CC=C(C=C2)F)OCC.O=C(/C=C\C(O)=O)O	https://www.medchemexpress.com/Flupirtine-Maleate.html	Launched		92.0	K13	N15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17001	10.0	mM	327.0	DMSO	304.133554	15	N	pluskal_fda_drugs_5005_N15_id
1510	HY-14183	HYCPK40906	I10	HYCPK40906	92z	787.0	1.0	Q19	906.0	I10	748810-28-8	Vernakalant (Hydrochloride)	RSD1235 hydrochloride	385.93	Potassium Channel	Membrane Transporter/Ion Channel	Vernakalant hydrochloride is a mixed voltage- and frequency-dependent Na+ and atria-preferred K+ channel blocker. IC50 for block by Vernakalant of wild-type and mutant Kv1.5 channels Fractional block is 13.35±0.93 μM, 0.61±0.03 μM, and 1.63±0.09 μM for Kv1.5 channelwt, Kv1.5 channelI508F, Kv1.5 channelT479A, respectively.	Hydrochloride	C20H32ClNO4	4880.0	DMSO : 50 mg/mL (129.56 mM; Need ultrasonic); H2O : 50 mg/mL (129.56 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	COC1=C(OC)C=C(CCO[C@H]2[C@H](N3CC[C@@H](O)C3)CCCC2)C=C1.Cl	https://www.medchemexpress.com/Vernakalant-Hydrochloride.html	Launched		92.0	Q19	N15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14183	10.0	mM	327.0	DMSO	349.225308	15	N	pluskal_fda_drugs_5005_N15_id
1869	HY-B1916	HYCPK40907	E13	HYCPK40907	92z	410.0	2.0	I26	907.0	E13	24916-51-6	Acetylspiramycin	Spiramycin B; Spiramycin II; Foromacidin B	885.09	Antibiotic; Bacterial; Parasite	Anti-infection	Acetylspiramycin (Spiramycin B; Spiramycin II; Foromacidin B) is a potent and orally active macrolide antibiotic produced by various Streptomyces species, an acetylated derivative of Spiramycin (HY-100593). Acetylspiramycin is an antimicrobial agent with activity against gram-positive organisms, including?Streptococcus pyogenes, S. viridans, Corynebacterium diphtheriae?and methicillin-sensitive?Staphylococcus aureus. Acetylspiramycin is also a potent antiprotozoal agent that against parasitic infection caused by?Cryptosporidium?spp[1][2].	Free Base	C45H76N2O15	27625.0	DMSO : ≥ 50 mg/mL (56.49 mM)	DMSO Solution	10mM  * 100uL	Infection	O[C@H]1[C@](O[C@H](C)[C@@H](O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@]2(O)C)[C@@H]1N(C)C)([H])O[C@@H]([C@H](C[C@H]([C@H](/C=C/C=C/C3)O[C@](CC[C@@H]4N(C)C)([H])O[C@@H]4C)C)CC=O)[C@H]([C@](CC(O[C@@H]3C)=O)([H])OC(C)=O)OC	https://www.medchemexpress.com/Acetylspiramycin.html	Launched		92.0	I26	N15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1916	10.0	mM	327.0	DMSO	884.52457	15	N	pluskal_fda_drugs_5005_N15_id
1928	HY-B1460	HYCPK40907	H17	HYCPK40907	92z	706.0	2.0	O34	907.0	H17	61318-91-0	Sulconazole (mononitrate)	(±)-Sulconazole (mononitrate)	460.76	Bacterial; Fungal	Anti-infection	Sulconazole mononitrate ((±)-Sulconazole mononitrate), an imidazole derivative, is a broad-spectrum fungicide. Sulconazole mononitrate can be used for the research of dermatomycoses, pityriasis versicolor, and cutaneous candidiasis[1][2].	Nitrate	C18H16Cl3N3O3S	158850.0	DMSO : 125 mg/mL (271.29 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[O-][N+](O)=O.ClC1=CC=C(C(SCC2=CC=C(Cl)C=C2)CN3C=CN=C3)C(Cl)=C1	https://www.medchemexpress.com/sulconazole-mononitrate.html	Launched		92.0	O34	N15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1460	10.0	mM	327.0	DMSO	396.002153	15	N	pluskal_fda_drugs_5005_N15_id
2100	HY-A0080	HYCPK40908	M08	HYCPK40908	92z	1215.0	3.0	Z15	908.0	M08	94-16-6	Aminohippurate (sodium)	Sodium p-aminohippurate; p-Aminohippuric acid sodium salt	216.17	Others	Others	Aminohippurate sodium is a diagnostic agent useful in medical tests involving the kidney used in the measurement of renal plasma flow.	Sodium	C9H9N2NaO3	16360.0	DMSO : ≥ 46 mg/mL (212.80 mM); H2O : 100 mg/mL (462.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(O[Na])CNC(C1=CC=C(N)C=C1)=O	https://www.medchemexpress.com/Aminohippurate-sodium.html	Launched		92.0	Z15	N15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0080	10.0	mM	327.0	DMSO	194.069142	15	N	pluskal_fda_drugs_5005_N15_id
2165	HY-50935	HYCPK40908	B13	HYCPK40908	92z	169.0	3.0	D25	908.0	B13	97322-87-7	Troglitazone	CS-045	441.54	Apoptosis; Autophagy; Ferroptosis; PPAR	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Troglitazone is a PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine?PPARγ receptor, respectively.	Free Base	C24H27NO5S	37691.0	DMSO : 160 mg/mL (362.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(SC1CC(C=C2)=CC=C2OCC3(C)OC(C(CC3)=C4C)=C(C)C(C)=C4O)NC1=O	https://www.medchemexpress.com/troglitazone.html	Launched		92.0	D25	N15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50935	10.0	mM	327.0	DMSO	441.160994	15	N	pluskal_fda_drugs_5005_N15_id
2470	HY-14658	HYCPK40909	B06	HYCPK40909	92z	156.0	4.0	D12	909.0	B06	50-35-1	Thalidomide		258.23	Apoptosis; Autophagy; Bacterial; Ligands for E3 Ligase; Molecular Glues	Anti-infection; Apoptosis; Autophagy; PROTAC	Thalidomide inhibits cereblon (CRBN), a part of the cullin-4 E3 ubiquitin ligase complex CUL4-RBX1-DDB1, with a Kd of ～250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties. Thalidomide can work as molecular glue to potentiate substrate.	Free Base	C13H10N2O4	150452.0	DMSO : 150 mg/mL (580.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C1N(C2CCC(NC2=O)=O)C(C3=CC=CC=C31)=O		Launched		92.0	D12	N15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14658	10.0	mM	327.0	DMSO	258.064057	15	N	pluskal_fda_drugs_5005_N15_id
594	HY-14261	HYCPK40906	L07	HYCPK40906	92z	1069.0	1.0	W13	906.0	L07	163521-08-2	Vilazodone (Hydrochloride)	EMD 68843 (Hydrochloride); SB659746A (Hydrochloride)	477.99	5-HT Receptor; Serotonin Transporter	GPCR/G Protein; Neuronal Signaling	Vilazodone Hydrochloride (EMD 68843 Hydrochloride) is a serotonin transporter (SER) inhibitor and 5-HT1A receptor partial agonist.	Hydrochloride	C26H28ClN5O2	5320.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : 25 mg/mL (52.30 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	NC(C1=CC2=C(C=CC(N3CCN(CCCCC4=CNC5=CC=C(C=C54)C#N)CC3)=C2)O1)=O.[H]Cl	https://www.medchemexpress.com/Vilazodone-Hydrochloride.html	Launched		92.0	W13	N16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14261	10.0	mM	328.0	DMSO	441.216475	16	N	pluskal_fda_drugs_5005_N16_id
1507	HY-70013	HYCPK40906	F10	HYCPK40906	92z	499.0	1.0	K19	906.0	F10	154229-19-3	Abiraterone	CB-7598	349.51	Cytochrome P450	Metabolic Enzyme/Protease	Abiraterone is a potent and irreversible CYP17A1 inhibitor with antiandrogen activity, which inhibits both the 17α-hydroxylase and 17,20-lyase activity of the cytochrome p450 enzyme CYP17 with IC50s of 2.5 nM and 15 nM, respectively.	Free Base	C24H31NO	3368.0	Ethanol : 5.4 mg/mL (15.45 mM; Need ultrasonic); DMSO : 5 mg/mL (14.31 mM; Need ultrasonic); DMF : 8.75 mg/mL (25.04 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer	C[C@@]12C(C3=CN=CC=C3)=CC[C@]1([C@@]4(CC=C5[C@@](C)([C@]4(CC2)[H])CC[C@@H](C5)O)[H])[H]	https://www.medchemexpress.com/Abiraterone.html	Launched		92.0	K19	N16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-70013	10.0	mM	328.0	DMSO	349.240565	16	N	pluskal_fda_drugs_5005_N16_id
1523	HY-15602A	HYCPK40906	F11	HYCPK40906	92z	501.0	1.0	K21	906.0	F11	1441674-54-9	Ledipasvir (acetone)	GS-5885 acetone	947.0790064	HCV	Anti-infection	Ledipasvir acetone (GS-5885 acetone) is the active ingredient of Ledipasvir. Ledipasvir is an inhibitor of the hepatitis C virus NS5A, with EC50 values of 34 pM against GT1a and 4 pM against GT1b replicon.	Free Base	C52H60F2N8O7	16976.0	DMSO : 110 mg/mL (116.15 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(OC)N[C@H](C(N([C@H](C1=NC=C(C2=CC(C(F)(F)C3=C4C=CC(C5=CC=C6N=C([C@H]7N(C([C@@H](NC(OC)=O)C(C)C)=O)[C@]8([H])CC[C@@]7([H])C8)NC6=C5)=C3)=C4C=C2)N1)C9)CC%109CC%10)=O)C(C)C.CC(C)=O	https://www.medchemexpress.com/Ledipasvir-acetone.html	Launched		92.0	K21	N16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15602A	10.0	mM	328.0	DMSO	888.413438	16	N	pluskal_fda_drugs_5005_N16_id
1733	HY-112076	HYCPK40907	H04	HYCPK40907	92z	680.0	2.0	O8	907.0	H04	2870-71-5	Atropine methyl (bromide)	Methylatropine (bromide)	384.31	mAChR	GPCR/G Protein; Neuronal Signaling	Atropine methyl bromide, a muscarinic receptor (mAChR) antagonist, is a quaternary ammonium salt of atropine and a mydriatic for dilation of the pupil during ophthalmic examination. It is introduced for relieving pyloric spasm in infants for its highly polar nature. It penetrates less readily into the central nervous system than atropine[1][2].	Bromide	C18H26BrNO3	39609.0	DMSO : 150 mg/mL (390.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+]1([C@H]2C[C@H](OC(C(C3=CC=CC=C3)CO)=O)C[C@@H]1CC2)C.[Br-]	https://www.medchemexpress.com/Atropine_methyl_bromide.html	Launched		92.0	O8	N16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-112076	10.0	mM	328.0	DMSO	304.19072	16	N	pluskal_fda_drugs_5005_N16_id
1772	HY-B1286	HYCPK40907	D07	HYCPK40907	92z	302.0	2.0	G14	907.0	D07	59703-84-3	Piperacillin (sodium)	Sodium piperacillin	539.54	Antibiotic; Bacterial	Anti-infection	Piperacillin sodium is a broad-spectrum β-lactam antibiotic.	Sodium	C23H26N5NaO7S	24196.0	DMSO : 100 mg/mL (185.34 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (185.34 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC([C@H](NC(N3C(C(N(CC)CC3)=O)=O)=O)C4=CC=CC=C4)=O)N1C2=O)O[Na]	https://www.medchemexpress.com/Piperacillin-sodium.html	Launched		92.0	G14	N16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1286	10.0	mM	328.0	DMSO	517.163119	16	N	pluskal_fda_drugs_5005_N16_id
1846	HY-B1275	HYCPK40907	N11	HYCPK40907	92z	1270.0	2.0	AA22	907.0	N11	58-71-9	Cephalothin (sodium)	Cefalotin sodium	418.42	Antibiotic; Bacterial	Anti-infection	Cephalothin sodium is a first generation cephem antibiotic with a wide range antibacterial activity, is active against gram-positive and gram-negative bacteria.	Sodium	C16H15N2NaO6S2	29291.0	H2O : 50 mg/mL (119.50 mM; Need ultrasonic); DMSO : 50 mg/mL (119.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(COC(C)=O)CS[C@]2([H])[C@H](NC(CC3=CC=CS3)=O)C1=O)O[Na]	https://www.medchemexpress.com/Cephalothin-sodium.html	Launched		92.0	AA22	N16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1275	10.0	mM	328.0	DMSO	396.044978	16	N	pluskal_fda_drugs_5005_N16_id
2068	HY-B0570	HYCPK40908	M06	HYCPK40908	92z	1211.0	3.0	Z11	908.0	M06	541-22-0	Decamethonium (Bromide)		418.29	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	"Decamethonium Bromide is a nicotinic AChR partial agonist and neuromuscular blocking agent.
Target: nAChR
Decamethonium (Syncurine) is a depolarizing muscle relaxant or neuromuscular blocking agent, and is used in anesthesia to induce paralysis. Decamethonium, which has a short action time, is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor. In the motor endplate, it causes depolarization, preventing further effects to the normal release of acetylcholine from the presynaptic terminal, and therefore preventing the neural stimulus from affecting the muscle. In the process of binding, decamethonium actually activates (depolarizes) the motor endplate, but since the decamethonium itself is not degraded, the membrane remains depolarized and unresponsive to normal acetylcholine release [1]."	Bromide	C16H38Br2N2	16724.0	H2O : ≥ 50 mg/mL (119.53 mM); DMSO : 83.33 mg/mL (199.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-]	https://www.medchemexpress.com/decamethonium-bromide.html	Launched		92.0	Z11	N16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0570	10.0	mM	328.0	DMSO	258.302402	16	N	pluskal_fda_drugs_5005_N16_id
2495	HY-Y0569C	HYCPK40909	B08	HYCPK40909	92z	160.0	4.0	D16	909.0	B08	299-27-4	Potassium Gluconate	Potassium D-gluconate	234.25	Endogenous Metabolite; Fungal	Anti-infection; Metabolic Enzyme/Protease	Potassium Gluconate (Potassium D-gluconate) is an orally active carboxylic acid by the oxidation with antiseptic and chelating properties[1].	Potassium	C6H11KO7	178624.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Infection; Cancer	O[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)C(O[K])=O	https://www.medchemexpress.com/potassium-gluconate.html	Launched		92.0	D16	N16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0569C	10.0	mM	328.0	DMSO	196.058303	16	N	pluskal_fda_drugs_5005_N16_id
1376	HY-B1297	HYCPK40906	M03	HYCPK40906	92z	1157.0	1.0	Y5	906.0	M03	60925-61-3	Ceforanide		519.55	Antibiotic; Bacterial	Anti-infection	Ceforanide is a second generation cephalosporin administered intravenously or intramuscularly. Ceforanide has a spectrum of in vitro antibacterial activity[1].		C20H21N7O6S2	64767.0	DMSO : 125 mg/mL (240.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3CC(O)=O)CS[C@]2([H])[C@H](NC(CC4=CC=CC=C4CN)=O)C1=O)O	https://www.medchemexpress.com/ceforanide.html	Launched		92.0	Y5	N17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1297	10.0	mM	329.0	DMSO	519.099473	17	N	pluskal_fda_drugs_5005_N17_id
1457	HY-15306A	HYCPK40907	D20	HYCPK40907	92z	328.0	2.0	G40	907.0	D20	496775-62-3	Eltrombopag (Olamine)	Eltrombopag diethanolamine salt; SB-497115GR	564.63	Apoptosis; Bacterial; Thrombopoietin Receptor	Anti-infection; Apoptosis; Immunology/Inflammation	Eltrombopag Olamine (Eltrombopag diethanolamine salt) is an orally active thrombopoietin receptor nonpeptide agonist. Eltrombopag Olamine owns thrombopoietic activity, and has been used to research low blood platelet counts with chronic immune thrombocytopenia. Eltrombopag Olamine can be used for the research of cardiovascular. Eltrombopag Olamine also has highly inhibitory effects against multidrug resistant Staphylococcus aureus. Eltrombopag Olamine can induce apoptosis in hepatocellular carcinomab (HCC) as well[1][2][3][4][5].	Olamine	C29H36N6O6	9854.0	DMSO : ≥ 50 mg/mL (88.55 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Cardiovascular Disease	O=C(C1=CC(C2=CC=CC(N/N=C3C(C)=NN(C4=CC=C(C)C(C)=C4)C/3=O)=C2O)=CC=C1)O.NCCO.NCCO	https://www.medchemexpress.com/Eltrombopag-Olamine.html	Launched		92.0	G40	N17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15306A	10.0	mM	329.0	DMSO	442.164105	17	N	pluskal_fda_drugs_5005_N17_id
2079	HY-B1092	HYCPK40908	H07	HYCPK40908	92z	733.0	3.0	P13	908.0	H07	299-28-5	Gluconate (Calcium)	Calcium D-gluconate; Gluconic acid hemicalcium salt	216.20	Endogenous Metabolite	Metabolic Enzyme/Protease	Gluconate Calcium (Calcium D-gluconate) is a mineral supplement, manufactured by the neutralization of gluconic acid with lime or calcium carbonate.	Calcium	C6H12O7.1/2Ca	17210.0	H2O : 20 mg/mL (92.51 mM; Need ultrasonic); DMSO : 1 mg/mL (4.63 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Others	O[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)C(O)=O.[1/2Ca]	https://www.medchemexpress.com/Gluconate-Calcium.html	Launched		92.0	P13	N17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1092	10.0	mM	329.0	DMSO	196.058303	17	N	pluskal_fda_drugs_5005_N17_id
2115	HY-P0205B	HYCPK40908	L09	HYCPK40908	92z	1121.0	3.0	X17	908.0	L09		Saralasin (TFA)	[Sar1,Ala8] Angiotensin II (TFA)	1026.07	Angiotensin Receptor	GPCR/G Protein	Saralasin ([Sar1,Ala8] Angiotensin II) TFA is an octapeptide analog of angiotensin II. Saralasin TFA is a competitive angiotensin II receptor antagonist with a Ki value of 0.32 nM for 74% of the binding sites, and has partial agonist activity as well. Saralasin TFA can be used for the research of renovascular hypertension, renin-dependent (angiotensinogenic) hypertension[1][3][6].	Trifluoroacetate	C44H66F3N13O12	178881.0	H2O : 100 mg/mL (97.46 mM; Need ultrasonic); DMSO : 50 mg/mL (48.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	C[C@@H](C(O)=O)NC([C@H]1N(C([C@H](CC2=CNC=N2)NC([C@H](C(C)C)NC([C@H](CC3=CC=C(C=C3)O)NC([C@H](C(C)C)NC([C@H](CCCNC(N)=N)NC(CNC)=O)=O)=O)=O)=O)=O)CCC1)=O.OC(C(F)(F)F)=O	https://www.medchemexpress.com/saralasin-tfa.html	Launched		92.0	X17	N17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P0205B	10.0	mM	329.0	DMSO	911.497735	17	N	pluskal_fda_drugs_5005_N17_id
2155	HY-B0735A	HYCPK40908	H12	HYCPK40908	92z	743.0	3.0	P23	908.0	H12	67227-57-0	Fenoldopam (mesylate)	Fenoldopam methanesulfonate; SKF-82526 mesylate	401.86	Apoptosis; Dopamine Receptor	Apoptosis; GPCR/G Protein; Neuronal Signaling	Fenoldopam mesylate (SKF-82526) is a D1 receptor agonist and a novel lysine-specific demethylase 1 (LSD1) inhibitor (IC50=0.8974 μM). Fenoldopam mesylate shows anti-hypertensive effects, anti-cancer cell proliferation activity and can induce cells apoptosis[1][2][3].	Mesylate	C17H20ClNO6S	16146.0	DMSO : ≥ 36 mg/mL (89.58 mM); H2O : 10 mg/mL (24.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Cardiovascular Disease	OC1=C(O)C=C2C(C3=CC=C(O)C=C3)CNCCC2=C1Cl.CS(=O)(O)=O	https://www.medchemexpress.com/Fenoldopam-mesylate.html	Launched		92.0	P23	N17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0735A	10.0	mM	329.0	DMSO	305.081871	17	N	pluskal_fda_drugs_5005_N17_id
2161	HY-A0003	HYCPK40908	N12	HYCPK40908	92z	1319.0	3.0	AB23	908.0	N12	191732-72-6	Lenalidomide	CC-5013	259.26062	Apoptosis; Ligands for E3 Ligase; Molecular Glues	Apoptosis; PROTAC	Lenalidomide (CC-5013), a derivative of Thalidomide, acts as molecular glue. Lenalidomide is an orally active immunomodulator. Lenalidomide (CC-5013) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide (CC-5013) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells[1][2].	Free Base	C13H13N3O3	20918.0	DMSO : 100 mg/mL (385.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C1C2=CC=CC(N)=C2CN1C(C(N3)=O)CCC3=O	https://www.medchemexpress.com/Lenalidomide.html	Launched		92.0	AB23	N17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0003	10.0	mM	329.0	DMSO	259.095691	17	N	pluskal_fda_drugs_5005_N17_id
2433	HY-14773	HYCPK40909	M03	HYCPK40909	92z	1206.0	4.0	Z6	909.0	M03	223673-61-8	Mirabegron	YM178	396.51	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Mirabegron is a selective β3-adrenoceptor agonist with EC50 of 22.4 nM.	Free Base	C21H24N4O2S	9281.0	DMSO : 100 mg/mL (252.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	O=C(NC1=CC=C(CCNC[C@H](O)C2=CC=CC=C2)C=C1)CC3=CSC(N)=N3	https://www.medchemexpress.com/mirabegron.html	Launched		92.0	Z6	N17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14773	10.0	mM	329.0	DMSO	396.161997	17	N	pluskal_fda_drugs_5005_N17_id
2510	HY-18716	HYCPK40909	A09	HYCPK40909	92z	66.0	4.0	B18	909.0	A09	1124347-33-6	Dextrorotation nimorazole phosphate ester		350.26	Bacterial; Parasite	Anti-infection	"Dextrorotation nimorazole phosphate ester is an anti-anaerobic and anti-parasitic agent.
Target: Antibacterial, Antiparasitic
Dextrorotary morpholine ornidazole organic phosphate is a newly developed, highly efficient, good tolerated, fourth-generation nitroimidazole derivative."	Free Acid	C11H19N4O7P	18680.0	DMSO : ≥ 32 mg/mL (91.36 mM)	DMSO Solution	10mM  * 100uL	Infection	CC1=NC=C([N+]([O-])=O)N1C[C@H](OP(O)(O)=O)CN2CCOCC2	https://www.medchemexpress.com/Dextrorotation-nimorazole-phosphate-ester.html	Launched		92.0	B18	N17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-18716	10.0	mM	329.0	DMSO	350.099136	17	N	pluskal_fda_drugs_5005_N17_id
1753	HY-N2064	HYCPK40907	A06	HYCPK40907	92z	12.0	2.0	A12	907.0	A06	17659-49-3	Racanisodamine		305.37	mAChR	GPCR/G Protein; Neuronal Signaling	Racanisodamine is one of the racemic isomers of anisodamine, resembles anisodamine in pharmacological effect. Racanisodamine is a non-selective muscarinic antagonist, used as a component of eye drops for myopic control[1].	Free Base	C17H23NO4	28945.0	H2O : 8.33 mg/mL (27.28 mM; ultrasonic and warming and heat to 60°C); DMSO : ≥ 125 mg/mL (409.34 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OC1CC(N2C)CC(O)C2C1)C(CO)C3=CC=CC=C3	https://www.medchemexpress.com/racanisodamine.html	Launched		92.0	A12	N18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N2064	10.0	mM	330.0	DMSO	305.162708	18	N	pluskal_fda_drugs_5005_N18_id
1929	HY-113293B	HYCPK40907	I17	HYCPK40907	92z	802.0	2.0	Q34	907.0	I17	438-67-5	Estrone sulfate (sodium)		372.41	Endogenous Metabolite; Estrogen Receptor/ERR	Metabolic Enzyme/Protease; Others	Estrone sulfate, a biologically inactive form of estrogen, is a major circulating plasma estrogen that is converted into the biologically active estrogen, estrone (E1) by steroid sulfatase (STS). strone sulfate can be used for the research of breast cancer[1][2].	Sodium	C18H21NaO5S	153087.0	DMSO : 33.33 mg/mL (89.50 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	C[C@]1([C@](CC2)([H])[C@]3([H])CCC4=C(C=CC(OS(=O)(O[Na])=O)=C4)[C@@]3([H])CC1)C2=O	https://www.medchemexpress.com/estrone-sulfate-sodium.html	Launched		92.0	Q34	N18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-113293B	10.0	mM	330.0	DMSO	350.118795	18	N	pluskal_fda_drugs_5005_N18_id
1953	HY-B0292A	HYCPK40907	A19	HYCPK40907	92z	38.0	2.0	A38	907.0	A19	64228-81-5	Atracurium (besylate)	BW-33A	1243.48	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Atracurium (BW-33A) besylate is a potent, competitive and non-depolarizing neuromuscular blocking agent. Atracurium besylate also is an AChR receptor antagonist. Atracurium besylate induces bronchoconstriction and neuromuscular blockade. Atracurium besylate promotes astroglial differentiation[1][2][3][4][5].	Benzenesulfonate	C65H82N2O18S2	16207.0	DMSO : 100 mg/mL (80.42 mM; Need ultrasonic); H2O : 33.33 mg/mL (26.80 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	O=S(C1=CC=CC=C1)([O-])=O.O=C(OCCCCCOC(CC[N+]2(C)C(CC3=CC=C(OC)C(OC)=C3)C4=C(C=C(OC)C(OC)=C4)CC2)=O)CC[N+]5(C)C(CC6=CC=C(OC)C(OC)=C6)C7=C(C=C(OC)C(OC)=C7)CC5.O=S(C8=CC=CC=C8)([O-])=O	https://www.medchemexpress.com/Atracurium-besylate.html	Launched		92.0	A38	N18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0292A	10.0	mM	330.0	DMSO	928.507429	18	N	pluskal_fda_drugs_5005_N18_id
2114	HY-I0177	HYCPK40908	K09	HYCPK40908	92z	1025.0	3.0	V17	908.0	K09	163521-19-5	Vilazodone carboxylic acid		442.51	Others	Others	Vilazodone carboxylic acid is a vilazodone metabolite observed in both urine (major) and plasma (minor)[1].		C26H26N4O3	8725.0	DMSO : 4 mg/mL (9.04 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Others	O=C(C1=CC2=CC(N3CCN(CCCCC4=CNC5=C4C=C(C#N)C=C5)CC3)=CC=C2O1)O	https://www.medchemexpress.com/vilazodone-carboxylic-acid.html	Launched		92.0	V17	N18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-I0177	10.0	mM	330.0	DMSO	442.200491	18	N	pluskal_fda_drugs_5005_N18_id
2125	HY-12164	HYCPK40908	F10	HYCPK40908	92z	547.0	3.0	L19	908.0	F10	726169-73-9	Mocetinostat	MGCD0103	396.44	Apoptosis; Autophagy; HDAC	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics	Mocetinostat (MGCD0103) is a potent, orally active and isotype-selective HDAC (Class I/IV) inhibitor with IC50s of 0.15, 0.29, 1.66 and 0.59 μM for HDAC1, HDAC2, HDAC3 and HDAC11, respectively. Mocetinostat shows no inhibition on HDAC4, HDAC5, HDAC6, HDAC7, or HDAC8.	Free Base	C23H20N6O	186017.0	DMSO : 50 mg/mL (126.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=C(C=C1)CNC2=NC=CC(C3=CC=CN=C3)=N2)NC4=CC=CC=C4N	https://www.medchemexpress.com/Mocetinostat.html	Launched		92.0	L19	N18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12164	10.0	mM	330.0	DMSO	396.169859	18	N	pluskal_fda_drugs_5005_N18_id
2230	HY-A0003B	HYCPK40908	G17	HYCPK40908	92z	657.0	3.0	N33	908.0	G17	847871-99-2	Lenalidomide (hemihydrate)	CC-5013 hemihydrate	268.27	Apoptosis; Ligands for E3 Ligase; Molecular Glues	Apoptosis; PROTAC	Lenalidomide hemihydrate (CC-5013 hemihydrate), a derivative of Thalidomide, acts as molecular glue. Lenalidomide hemihydrate is an orally active immunomodulator. Lenalidomide hemihydrate (CC-5013 hemihydrate) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide hemihydrate (CC-5013 hemihydrate) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells[1][2].	Free Base	C13H14N3O3.5	11054.0	H2O : 0.1 mg/mL (0.37 mM; Need ultrasonic); DMSO : 50 mg/mL (186.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1N(C2C(NC(CC2)=O)=O)CC3=C(N)C=CC=C31.[0.5 H2O]	https://www.medchemexpress.com/Lenalidomide-hemihydrate.html	Launched		92.0	N33	N18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0003B	10.0	mM	330.0	DMSO	259.095691	18	N	pluskal_fda_drugs_5005_N18_id
2279	HY-B0264	HYCPK40908	H20	HYCPK40908	92z	759.0	3.0	P39	908.0	H20	93-14-1	Guaifenesin	Guaiacol glyceryl ether; Guaiphenesin; Glycerol guaiacolate	198.22	Others	Others	Guaifenesin (Guaiacol glyceryl ether), a constituent of guaiac resin from the wood of Guajacum officinale Linné, is an expectorant. Guaifenesin can alleviate cough discomfortby increasing sputum volume and decreasing its viscosity, thereby promoting effective cough[1][2].	Free Base	C10H14O4	16057.0	DMSO : 100 mg/mL (504.49 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	OCC(O)COC1=CC=CC=C1OC	https://www.medchemexpress.com/Guaifenesin.html	Launched		92.0	P39	N18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0264	10.0	mM	330.0	DMSO	198.089209	18	N	pluskal_fda_drugs_5005_N18_id
2492	HY-14660A	HYCPK40909	O07	HYCPK40909	92z	1406.0	4.0	AD14	909.0	O07	1195768-06-9	Dabrafenib (Mesylate)	GSK2118436 Mesylate; GSK 2118436B	615.67	Raf	MAPK/ERK Pathway	Dabrafenib Mesylate is a potent and selective Raf kinase inhibitor with IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively.	Mesylate	C24H24F3N5O5S3	63330.0	DMSO : ≥ 36 mg/mL (58.47 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC(C)(C)C1=NC(C2=C(F)C(NS(C3=C(F)C=CC=C3F)(=O)=O)=CC=C2)=C(C4=CC=NC(N)=N4)S1.CS(=O)(O)=O	https://www.medchemexpress.com/Dabrafenib-Mesylate.html	Launched		92.0	AD14	N18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14660A	10.0	mM	330.0	DMSO	519.101052	18	N	pluskal_fda_drugs_5005_N18_id
40	HY-10330A	HYCPK40899	B04	HYCPK40909	92z	174.0	4.0	D30	909.0	B15	874819-74-6	Toceranib (phosphate)	SU11654 (phosphate); PHA 291639E (phosphate)	494.45	c-Kit; PDGFR; VEGFR	Protein Tyrosine Kinase/RTK	Toceranib phosphate (SU11654 phosphate) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. Toceranib phosphate (SU11654 phosphate) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors[1] [2].	Phosphate	C22H28FN4O6P	8982.0	DMSO : 2.46 mg/mL (4.98 mM; Need ultrasonic and warming); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	2mM  * 100uL	Cancer	O=C(NCCN1CCCC1)C2=C(NC(/C=C3C(NC4=C\3C=C(C=C4)F)=O)=C2C)C.O=P(O)(O)O	https://www.medchemexpress.com/Toceranib-phosphate.html	Launched		92.0	D30	N19	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10330A	2.0	mM	331.0	DMSO	396.196154	19	N	pluskal_fda_drugs_5005_N19_id
1667	HY-A0014	HYCPK40906	F20	HYCPK40906	92z	519.0	1.0	K39	906.0	F20	196597-26-9	Ramelteon	TAK-375	259.34	Melatonin Receptor	GPCR/G Protein; Neuronal Signaling	Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation[1][2].	Free Base	C16H21NO2	12056.0	DMSO : ≥ 50 mg/mL (192.80 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology; Cancer	O=C(NCC[C@H]1C2=C(C=CC3=C2CCO3)CC1)CC	https://www.medchemexpress.com/ramelteon.html	Launched		92.0	K39	N19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0014	10.0	mM	331.0	DMSO	259.157229	19	N	pluskal_fda_drugs_5005_N19_id
1964	HY-108324	HYCPK40907	L19	HYCPK40907	92z	1094.0	2.0	W38	907.0	L19	3313-26-6	(Z)-Thiothixene		443.63	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	(Z)-Thiothixene is an antagonist of serotonergic receptor extracted from patent US 20150141345 A1.	Free Base	C23H29N3O2S2	123705.0	DMSO : 10 mg/mL (22.54 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=S(C1=CC(/C2=C\CCN3CCN(C)CC3)=C(SC4=C2C=CC=C4)C=C1)(N(C)C)=O	https://www.medchemexpress.com/_Z_-Thiothixene.html	Launched		92.0	W38	N19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108324	10.0	mM	331.0	DMSO	443.170119	19	N	pluskal_fda_drugs_5005_N19_id
2001	HY-A0154	HYCPK40907	E22	HYCPK40907	92z	428.0	2.0	I44	907.0	E22	17598-65-1	Deslanoside	Deacetyllanatoside C; Desacetyllanatoside C	943.08	Drug Metabolite; Na+/K+ ATPase	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease	Deslanoside (Desacetyllanatoside C) is a rapidly acting cardiac glycoside used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. Deslanoside inhibits the Na-K-ATPase membrane pump, resulting in an increase in intracellular sodium and calcium concentrations [1][2][3].	Free Base	C47H74O19	124744.0	DMSO : 100 mg/mL (106.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O[C@]([C@@](CC[C@@]1([H])[C@@]2(CC[C@H](O[C@@](O[C@H](C)[C@H]3O[C@@](O[C@H](C)[C@H]4O[C@@](O[C@H](C)[C@H]5O[C@]([C@@H]([C@@H](O)[C@@H]6O)O)([H])O[C@@H]6CO)([H])C[C@@H]5O)([H])C[C@@H]4O)([H])C[C@@H]3O)C1)C)([H])[C@]2([H])C[C@H]7O)(CC[C@@H]8C(CO9)=CC9=O)[C@	https://www.medchemexpress.com/deslanoside.html	Launched		92.0	I44	N19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0154	10.0	mM	331.0	DMSO	942.48243	19	N	pluskal_fda_drugs_5005_N19_id
2043	HY-14660	HYCPK40908	O04	HYCPK40908	92z	1399.0	3.0	AD7	908.0	O04	1195765-45-7	Dabrafenib	GSK2118436A; GSK2118436	519.56	Raf	MAPK/ERK Pathway	Dabrafenib (GSK2118436A) is an ATP-competitive inhibitor of Raf with IC50s of 5 nM and 0.6 nM for C-Raf and B-RafV600E, respectively[4].	Free Base	C23H20F3N5O2S2	102718.0	DMSO : ≥ 33 mg/mL (63.52 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC(C)(C)C1=NC(C2=C(F)C(NS(C3=C(F)C=CC=C3F)(=O)=O)=CC=C2)=C(C4=CC=NC(N)=N4)S1	https://www.medchemexpress.com/Dabrafenib.html	Launched		92.0	AD7	N19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14660	10.0	mM	331.0	DMSO	519.101052	19	N	pluskal_fda_drugs_5005_N19_id
2050	HY-N0584A	HYCPK40908	K05	HYCPK40908	92z	1017.0	3.0	V9	908.0	K05	55449-49-5	Anisodamine (hydrobromide)	6-Hydroxyhyoscyamine (hydrobromide)	386.28	mAChR	GPCR/G Protein; Neuronal Signaling	Anisodamine hydrobromide (6-Hydroxyhyoscyamine hydrobromide), a belladonna alkaloid, is a non-subtype-selective muscarinic and a nicotinic cholinoceptor antagonist. Anisodamine hydrobromide shows antioxidant, anti-inflammatory properties[1][2].	Hydrobromide	C17H24BrNO4	213685.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CN1[C@H]2[C@@H](O)C[C@@H]1C[C@H](OC([C@@H](C3=CC=CC=C3)CO)=O)C2.Br	https://www.medchemexpress.com/anisodamine-hydrobromide.html	Launched		92.0	V9	N19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0584A	10.0	mM	331.0	DMSO	305.162708	19	N	pluskal_fda_drugs_5005_N19_id
2065	HY-13295	HYCPK40908	J06	HYCPK40908	92z	923.0	3.0	T11	908.0	J06	42971-09-5	Vinpocetine	Ethyl apovincaminate	350.45	IKK; Phosphodiesterase (PDE); Sodium Channel	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; NF-κB	Vinpocetine (Ethyl apovincaminate) is a derivative of the alkaloid Vincamine that blocks voltage-gated Na+ channels. The IC50 value of Vinpocetine on direct IKK inhibition in the cell-free system is 17.17 μM. Vinpocetine is a phosphodiesterase (PDE) inhibitor and inhibits NF-κB-dependent inflammatory responses by directly targeting IκB kinase complex (IKK), and has been widely used for the treatment of cerebrovascular disorders[1][2][3].	Free Base	C22H26N2O2	9401.0	DMSO : 6.25 mg/mL (17.83 mM; Need ultrasonic); Ethanol : 7.14 mg/mL (20.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease; Cardiovascular Disease; Cancer	CCOC(C1=C[C@]2(CC)CCCN3CCC(C4=C(C=CC=C4)N51)=C5[C@]23[H])=O	https://www.medchemexpress.com/Vinpocetine.html	Launched		92.0	T11	N19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13295	10.0	mM	331.0	DMSO	350.199428	19	N	pluskal_fda_drugs_5005_N19_id
2441	HY-N6951	HYCPK40909	E04	HYCPK40909	92z	440.0	4.0	J8	909.0	E04	489-84-9	Guaiazulene		198.30	Endogenous Metabolite	Metabolic Enzyme/Protease	Guaiazulene is present in several essential oils of medicinal and aromatic plants, with antioxidant activity. Guaiazulene has in vitro cytotoxic activity against neuron and N2a neuroblastom (N2a-NB) cells[1][2].	Free Base	C15H18	112021.0	DMSO : 50 mg/mL (252.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	CC(C1=CC2=C(C)C=CC2=C(C)C=C1)C	https://www.medchemexpress.com/guaiazulene.html	Launched		92.0	J8	N19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N6951	10.0	mM	331.0	DMSO	198.140851	19	N	pluskal_fda_drugs_5005_N19_id
370	HY-10330	HYCPK40899	M04	HYCPK40909	92z	1230.0	4.0	Z30	909.0	M15	356068-94-5	Toceranib	SU11654; PHA 291639E	396.46	c-Kit; PDGFR; VEGFR	Protein Tyrosine Kinase/RTK	Toceranib phosphate (SU11654 phosphate) is an orally active receptor tyrosine kinase (RTK) inhibitor, and it potently inhibits PDGFR, VEGFR, and Kit with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. Toceranib phosphate (SU11654 phosphate) has antitumor and antiangiogenic activity, and used in the treatment of canine mast cell tumors[1][2].	Free Base	C22H25FN4O2	4008.0	DMSO : 2.5 mg/mL (6.31 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	2mM  * 100uL	Cancer	O=C(NCCN1CCCC1)C2=C(NC(/C=C3C(NC4=C\3C=C(C=C4)F)=O)=C2C)C	https://www.medchemexpress.com/Toceranib.html	Launched		92.0	Z30	N20	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10330	2.0	mM	332.0	DMSO	396.196154	20	N	pluskal_fda_drugs_5005_N20_id
1416	HY-N0697	HYCPK40906	E06	HYCPK40906	92z	395.0	1.0	I11	906.0	E06	42553-65-1	Crocin	Crocin I	976.96	Endogenous Metabolite	Metabolic Enzyme/Protease	Crocin (Crocin I) is a nutraceutical and the main constituent isolated from the stigmas of Crocus sativus with immense pharmacological properties as anti-inflammatory, anticancer, antidepressant and anticonvulsant[1].	Free Base	C44H64O24	64399.0	DMSO : 125 mg/mL (127.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	O[C@@H]([C@H](O)[C@H]1O)[C@H](O[C@H]1OC(/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C(O[C@@H]([C@@H]([C@@H](O)[C@@H]2O)O)O[C@@H]2CO[C@@H]([C@@H]([C@@H](O)[C@@H]3O)O)O[C@@H]3CO)=O)=O)CO[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4CO	https://www.medchemexpress.com/crocin.html	Launched		92.0	I11	N20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0697	10.0	mM	332.0	DMSO	976.378753	20	N	pluskal_fda_drugs_5005_N20_id
1498	HY-Y0055	HYCPK40906	M09	HYCPK40906	92z	1169.0	1.0	Y17	906.0	M09	92-84-2	Phenothiazine		199.27	Antibiotic; Bacterial; Fungal; Parasite	Anti-infection	Phenothiazine is an antibiotic which has insecticidal, fungicidal, antibacterial and anthelmintic activities. Phenothiazine also can be used for the research of neurological diseases[1][2].		C12H9NS	27511.0	DMSO : 150 mg/mL (752.75 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease	C12=CC=CC=C1NC3=C(C=CC=C3)S2	https://www.medchemexpress.com/phenothiazine.html	Launched		92.0	Y17	N20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-Y0055	10.0	mM	332.0	DMSO	199.04557	20	N	pluskal_fda_drugs_5005_N20_id
1943	HY-13571A	HYCPK40907	G18	HYCPK40907	92z	612.0	2.0	M36	907.0	G18	5534-09-8	Beclometasone dipropionate		521.04	Glucocorticoid Receptor; NO Synthase; Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Beclometasone dipropionate, the prodrug of Beclometasone, is an orally active and potent glucocorticoid recepter agonist. Beclometasone dipropionate acts via a glucocorticoid receptor and suppresses inflammation and hyperproliferation. Beclometasone dipropionate can be used for asthma [1][2].	Free Base	C28H37ClO7	26339.0	DMSO : ≥ 100 mg/mL (191.92 mM); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]12[C@](C[C@H](C)[C@]2(OC(CC)=O)C(COC(CC)=O)=O)([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C1)=O	https://www.medchemexpress.com/Beclometasone-dipropionate.html	Launched		92.0	M36	N20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13571A	10.0	mM	332.0	DMSO	520.222781	20	N	pluskal_fda_drugs_5005_N20_id
2121	HY-15388	HYCPK40908	B10	HYCPK40908	92z	163.0	3.0	D19	908.0	B10	118292-40-3	Tazarotene	AGN 190168	351.46	Autophagy; RAR/RXR	Autophagy; Metabolic Enzyme/Protease	Tazarotene (AGN 190168) is a selective retinoic acid receptor (RAR) agonist for the treatment of plaque psoriasis and acne vulgaris.	Free Base	C21H21NO2S	16319.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 50 mg/mL (142.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(C1=CC=C(C#CC2=CC=C3C(C(C)(C)CCS3)=C2)N=C1)OCC	https://www.medchemexpress.com/Tazarotene.html	Launched		92.0	D19	N20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15388	10.0	mM	332.0	DMSO	351.1293	20	N	pluskal_fda_drugs_5005_N20_id
2156	HY-B0573	HYCPK40908	I12	HYCPK40908	92z	839.0	3.0	R23	908.0	I12	318-98-9	Propranolol (hydrochloride)		295.80	Adrenergic Receptor; Bacterial	Anti-infection; GPCR/G Protein; Neuronal Signaling	Propranolol hydrochloride is a nonselective β-adrenergic receptor (βAR) antagonist, has high affinity for the β1AR and β2AR with Ki values of 1.8 nM and 0.8 nM, respectively[1]. Propranolol hydrochloride inhibits [3H]-DHA binding to rat brain membrane preparation with an IC50 of 12 nM[2]. Propranolol hydrochloride is used for study of hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy[3].	Hydrochloride	C16H22ClNO2	26496.0	DMSO : ≥ 150 mg/mL (507.10 mM); H2O : 33.33 mg/mL (112.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology; Cancer	OC(CNC(C)C)COC1=CC=CC2=CC=CC=C12.Cl	https://www.medchemexpress.com/Propranolol-hydrochloride.html	Launched		92.0	R23	N20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0573	10.0	mM	332.0	DMSO	259.157229	20	N	pluskal_fda_drugs_5005_N20_id
2251	HY-B0304A	HYCPK40908	L18	HYCPK40908	92z	1139.0	3.0	X35	908.0	L18	129938-20-1	Dapoxetine (hydrochloride)	LY-210448 hydrochloride	341.87	Serotonin Transporter	Neuronal Signaling	Dapoxetine (LY-210448) hydrochloride is an orally active and selective serotonin reuptake inhibitor (SSRI). Dapoxetine hydrochloride can be used for the research of premature ejaculation (PE)[1].	Hydrochloride	C21H24ClNO	15163.0	DMSO : ≥ 32 mg/mL (93.60 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN(C)[C@H](C1=CC=CC=C1)CCOC2=C3C(C=CC=C3)=CC=C2.Cl	https://www.medchemexpress.com/Dapoxetine-hydrochloride.html	Launched		92.0	X35	N20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0304A	10.0	mM	332.0	DMSO	305.177964	20	N	pluskal_fda_drugs_5005_N20_id
2437	HY-10451	HYCPK40909	A04	HYCPK40909	92z	56.0	4.0	B8	909.0	A04	842133-18-0	Canagliflozin	JNJ 28431754	444.52	SGLT	Membrane Transporter/Ion Channel	Canagliflozin (JNJ 28431754) is a selective SGLT2 inhibitor with IC50s of 2 nM, 3.7 nM, and 4.4 nM for mSGLT2, rSGLT2, and hSGLT2 in CHOK cells, respectively[1].	Free Base	C24H25FO5S	19549.0	DMSO : ≥ 50 mg/mL (112.48 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	FC1=CC=C(C2=CC=C(CC3=C(C=CC([C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4O)O)O)CO)=C3)C)S2)C=C1	https://www.medchemexpress.com/Canagliflozin.html	Launched		92.0	B8	N20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10451	10.0	mM	332.0	DMSO	444.140673	20	N	pluskal_fda_drugs_5005_N20_id
1550	HY-10064	HYCPK40906	A13	HYCPK40906	92z	25.0	1.0	A25	906.0	A13	274693-27-5	Ticagrelor	AZD6140; AR-C 126532XX	522.57	P2Y Receptor	GPCR/G Protein	Ticagrelor (AZD6140) is a reversible oral P2Y12 receptor antagonist for the treatment of platelet aggregation.	Free Base	C23H28F2N6O4S	11346.0	DMSO : ≥ 50 mg/mL (95.68 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O[C@H]1[C@@H](O)[C@H](N2N=NC3=C(N[C@H]4[C@H](C5=CC=C(F)C(F)=C5)C4)N=C(SCCC)N=C32)C[C@@H]1OCCO	https://www.medchemexpress.com/Ticagrelor.html	Launched		92.0	A25	N21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10064	10.0	mM	333.0	DMSO	522.186081	21	N	pluskal_fda_drugs_5005_N21_id
1596	HY-13502	HYCPK40906	O15	HYCPK40906	92z	1373.0	1.0	AC29	906.0	O15	65271-80-9	Mitoxantrone	Mitozantrone; NSC 301739	444.48	Apoptosis; Endogenous Metabolite; Orthopoxvirus; PKC; Topoisomerase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease; TGF-beta/Smad	Mitoxantrone is a potent topoisomerase II inhibitor. Mitoxantrone also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone shows antitumor activity[1][2][3][4]. Mitoxantrone also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively[5].	Free Base	C22H28N4O6	113119.0	DMSO : 62.5 mg/mL (140.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C1C2=C(C(NCCNCCO)=CC=C2NCCNCCO)C(C3=C(O)C=CC(O)=C13)=O	https://www.medchemexpress.com/mitoxantrone.html	Launched		92.0	AC29	N21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13502	10.0	mM	333.0	DMSO	444.200885	21	N	pluskal_fda_drugs_5005_N21_id
1726	HY-A0256B	HYCPK40907	A04	HYCPK40907	92z	8.0	2.0	A8	907.0	A04	61177-44-4	Clavulanate (lithium)		205.09	Antibiotic; Bacterial	Anti-infection	Clavulanate lithium is a potent β-lactamase inhibitor and acts as an antibiotic[1][2].	Lithium	C8H8LiNO5	58767.0	H2O : 50 mg/mL (243.80 mM; Need ultrasonic); DMSO : 5 mg/mL (24.38 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](/C(O[C@]1([H])C2)=C/CO)N1C2=O)O[Li]	https://www.medchemexpress.com/clavulanate-lithium.html	Launched		92.0	A8	N21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0256B	10.0	mM	333.0	DMSO	199.048072	21	N	pluskal_fda_drugs_5005_N21_id
1837	HY-13859	HYCPK40907	E11	HYCPK40907	92z	406.0	2.0	I22	907.0	E11	163252-36-6	Clevudine	L-FMAU	260.22	DNA/RNA Synthesis; HBV; Orthopoxvirus	Anti-infection; Cell Cycle/DNA Damage	Clevudine (L-FMAU), a nucleoside analog of the unnatural L-configuration, has potent anti-HBV activity with long half-life, low toxicity. Clevudine is a non-competitive inhibitor that is not incorporated into the viral DNA but rather binds to the polymerase. Clevudine is active against cowpox virus respiratory infection in mice[1][2][3].	Free Base	C10H13FN2O5	145048.0	DMSO : 100 mg/mL (384.29 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (192.15 mM)	DMSO Solution	10mM  * 100uL	Infection	OC[C@H]1[C@H](O)[C@@H](F)[C@@H](N2C(NC(C(C)=C2)=O)=O)O1	https://www.medchemexpress.com/Clevudine.html	Launched		92.0	I22	N21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13859	10.0	mM	333.0	DMSO	260.08085	21	N	pluskal_fda_drugs_5005_N21_id
1971	HY-17573A	HYCPK40907	G20	HYCPK40907	92z	616.0	2.0	M40	907.0	G20	1631754-28-3	Carbetocin (acetate)		1048.21	Oxytocin Receptor	GPCR/G Protein	Carbetocin acetate, an oxytocin (OT) analogue, is an oxytocin receptor agonist with a Ki of 7.1 nM. Carbetocin acetate has high affinity to chimeric N-terminus (E1) of the oxytocin receptor (Ki=1.17 μM). Carbetocin acetate has the potential for postpartum hemorrhage research. Carbetocin acetate can crosse the blood-brain barrier and produces antidepressant-like activity via activation of oxytocin receptors in the CNS[1][2][3].	Acetate	C47H73N11O14S	121292.0	H2O : 10 mg/mL (9.54 mM; ultrasonic and warming and heat to 60°C); DMSO : 125 mg/mL (119.25 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Endocrinology; Neurological Disease	O=C([C@H](CSCCCC(N[C@H](C1=O)CC2=CC=C(OC)C=C2)=O)NC([C@@H](NC([C@](NC([C@](N1)([H])[C@@H](C)CC)=O)([H])CCC(N)=O)=O)CC(N)=O)=O)N(CCC3)[C@@H]3C(N[C@@H](CC(C)C)C(NCC(N)=O)=O)=O.CC(O)=O	https://www.medchemexpress.com/carbetocin-acetate.html	Launched		92.0	M40	N21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17573A	10.0	mM	333.0	DMSO	987.484788	21	N	pluskal_fda_drugs_5005_N21_id
2306	HY-B1739	HYCPK40909	F07	HYCPK40909	92z	542.0	4.0	L14	909.0	F07	1247-64-9	Pregnenolone monosulfate	3β-Hydroxy-5-pregnen-20-one monosulfate	396.54	Autophagy; Cannabinoid Receptor; Endogenous Metabolite; TRP Channel	Autophagy; GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Pregnenolone monosulfate (3β-Hydroxy-5-pregnen-20-one monosulfate) is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone monosulfate acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of tetrahydrocannabinol (THC) that are mediated by the CB1 receptors. Pregnenolone monosulfate can protect the brain from cannabis intoxication[1][2]. Pregnenolone monosulfate is also a TRPM3 channel activator, and also can weakly activate TRPM1 channels[3].	Free Acid	C21H32O5S	58141.0	DMSO : 62.5 mg/mL (157.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC([C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](OS(=O)(O)=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O	https://www.medchemexpress.com/Pregnenolone_monosulfate.html	Launched		92.0	L14	N21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1739	10.0	mM	333.0	DMSO	396.197045	21	N	pluskal_fda_drugs_5005_N21_id
2450	HY-13426	HYCPK40909	N04	HYCPK40909	92z	1304.0	4.0	AB8	909.0	N04	808118-40-3	Roxadustat	FG-4592	352.34	Ferroptosis; HIF/HIF Prolyl-Hydroxylase	Apoptosis; Metabolic Enzyme/Protease	Roxadustat is an orally active hypoxia-inducible factor (HIF) prolyl-hydroxylase (PHD) inhibitor (HIF-PHI) that promotes erythropoiesis through increasing endogenous erythropoietin, improving iron regulation, and reducing hepcidin[1].	Free Acid	C19H16N2O5	57672.0	H2O : < 0.1 mg/mL (ultrasonic) (insoluble); DMSO : ≥ 100 mg/mL (283.82 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CNC(C1=C(O)C2=C(C(C)=N1)C=C(OC3=CC=CC=C3)C=C2)=O	https://www.medchemexpress.com/FG-4592.html	Launched		92.0	AB8	N21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13426	10.0	mM	333.0	DMSO	352.105922	21	N	pluskal_fda_drugs_5005_N21_id
2553	HY-10448A	HYCPK40909	L11	HYCPK40909	92z	1126.0	4.0	X22	909.0	L11	404-86-4	Capsaicinoid		305.41	Apoptosis; Autophagy; Endogenous Metabolite; TRP Channel	Apoptosis; Autophagy; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Capsaicinoid is a mixture of Capsaicin and Dihydrocapsaicin. Capsaicinoid is an capsaicin receptor (TRPV1) agonist[1][2].		C18H27NO3	115913.0	DMSO : 100 mg/mL (327.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	CC(C)/C=C/CCCCC(NCC1=CC=C(O)C(OC)=C1)=O	https://www.medchemexpress.com/capsaicin-purity-99.html	Launched		92.0	X22	N21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10448A	10.0	mM	333.0	DMSO	305.199094	21	N	pluskal_fda_drugs_5005_N21_id
1408	HY-B2156	HYCPK40906	M05	HYCPK40906	92z	1161.0	1.0	Y9	906.0	M05	863-61-6	Menaquinone-4	Vitamin K2(MK-4); Menaquinone K4	444.65	Endogenous Metabolite	Metabolic Enzyme/Protease	Menaquinone-4 is a vitamin K, used as a hemostatic agent, and also a adjunctive therapy for the pain of osteoporosis.	Free Base	C31H40O2	40387.0	DMSO : 20 mg/mL (44.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C(C)=C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)\C)C(C2=C1C=CC=C2)=O	https://www.medchemexpress.com/Menaquinone-4.html	Launched		92.0	Y9	N22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2156	10.0	mM	334.0	DMSO	444.302831	22	N	pluskal_fda_drugs_5005_N22_id
1773	HY-17400	HYCPK40907	E07	HYCPK40907	92z	398.0	2.0	I14	907.0	E07	17902-23-7	Tegafur	FT 207; NSC 148958	200.17	Nucleoside Antimetabolite/Analog	Cell Cycle/DNA Damage	Tegafur (FT 207; NSC 148958) is a chemotherapeutic 5-FU prodrug used in the treatment of cancers; is a component of tegafur-uracil.	Free Base	C8H9FN2O3	15247.0	DMSO : ≥ 48 mg/mL (239.80 mM); H2O : ≥ 20 mg/mL (99.92 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NC(C(F)=CN1C2OCCC2)=O	https://www.medchemexpress.com/Tegafur.html	Launched		92.0	I14	N22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17400	10.0	mM	334.0	DMSO	200.05972	22	N	pluskal_fda_drugs_5005_N22_id
1775	HY-B1100	HYCPK40907	G07	HYCPK40907	92z	590.0	2.0	M14	907.0	G07	313-06-4	Estradiol (cypionate)		396.56	Estrogen Receptor/ERR	Others	"Estradiol cypionate is a 17 β-cyclopentylpropinate ester of estradiol, inhibits ET-1 synthesis via estrogen receptor
IC50 value:
Target: estrogen receptor
Estradiol cypionate is a synthetic ester, is a estrogen. Compared to other commonly used estradiol esters, via the intramuscular route, Estradiol cypionate is found to have the longest duration of action with a duration of ~11 days,"	Free Base	C26H36O3	37035.0	DMSO : ≥ 30 mg/mL (75.65 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C[C@@]12[C@@H](OC(CCC3CCCC3)=O)CC[C@@]1([H])[C@]4([H])CCC5=C(C=CC(O)=C5)[C@@]4([H])CC2	https://www.medchemexpress.com/Estradiol-cypionate.html	Launched		92.0	M14	N22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1100	10.0	mM	334.0	DMSO	396.266445	22	N	pluskal_fda_drugs_5005_N22_id
1787	HY-101952	HYCPK40907	C08	HYCPK40907	92z	208.0	2.0	E16	907.0	C08	363-24-6	Prostaglandin E2	PGE2; Dinoprostone	352.47	Endogenous Metabolite; Prostaglandin Receptor	GPCR/G Protein; Metabolic Enzyme/Protease	Prostaglandin E2 (PGE2) is a hormone-like substance that participate in a wide range of body functions such as the contraction and relaxation of smooth muscle, the dilation and constriction of blood vessels, control of blood pressure, and modulation of inflammation.	Free Acid	C20H32O5	119146.0	DMSO : 100 mg/mL (283.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C(C[C@H]1O)=O)C/C=C\CCCC(O)=O	https://www.medchemexpress.com/Prostaglandin_E2.html	Launched		92.0	E16	N22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101952	10.0	mM	334.0	DMSO	352.224974	22	N	pluskal_fda_drugs_5005_N22_id
1961	HY-B1548	HYCPK40907	I19	HYCPK40907	92z	806.0	2.0	Q38	907.0	I19	22994-85-0	Benznidazol	Ro 07-1051; Ro 71051	260.25	Antibiotic; Parasite	Anti-infection	Benznidazol (Ro 07-1051) is an antiparasitic medication, with an IC50 of 20.35 μM for Colombian T. cruzi strains, and has been used in the treatment of Chagas disease[1][2].	Free Base	C12H12N4O3	79780.0	DMSO : 50 mg/mL (192.12 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(NCC1=CC=CC=C1)CN2C=CN=C2[N+]([O-])=O	https://www.medchemexpress.com/Benznidazol.html	Launched		92.0	Q38	N22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1548	10.0	mM	334.0	DMSO	260.09094	22	N	pluskal_fda_drugs_5005_N22_id
2423	HY-10409	HYCPK40909	C03	HYCPK40909	92z	246.0	4.0	F6	909.0	C03	936091-26-8	Fedratinib	TG-101348; SAR 302503	524.68	Apoptosis; JAK	Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Fedratinib (TG-101348) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib induces cancer cell apoptosis and has the potential for myeloproliferative disorders research[1][2].	Free Base	C27H36N6O3S	130269.0	DMSO : 125 mg/mL (238.24 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=S(C1=CC=CC(NC2=NC(NC3=CC=C(C=C3)OCCN4CCCC4)=NC=C2C)=C1)(NC(C)(C)C)=O	https://www.medchemexpress.com/TG-101348.html	Launched		92.0	F6	N22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10409	10.0	mM	334.0	DMSO	524.25696	22	N	pluskal_fda_drugs_5005_N22_id
2513	HY-17572A	HYCPK40909	D09	HYCPK40909	92z	354.0	4.0	H18	909.0	D09	914453-95-5	Atosiban (acetate)	RW22164 (acetate); RWJ22164 (acetate)	1054.24	Oxytocin Receptor; Vasopressin Receptor	GPCR/G Protein	Atosiban acetate (RW22164 acetate;RWJ22164 acetate) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research[1].	Acetate	C45H71N11O14S2	64855.0	H2O : 50 mg/mL (47.43 mM; Need ultrasonic); DMSO : 100 mg/mL (94.86 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	O=C([C@H](CSSCCC(N[C@@H](C1=O)CC2=CC=C(OCC)C=C2)=O)NC([C@@H](NC(C(NC([C@](N1)([H])[C@@H](C)CC)=O)[C@H](O)C)=O)CC(N)=O)=O)N(CCC3)[C@@H]3C(N[C@@H](CCCN)C(NCC(N)=O)=O)=O.OC(C)=O	https://www.medchemexpress.com/atosiban-acetate.html	Launched		92.0	H18	N22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17572A	10.0	mM	334.0	DMSO	993.441209	22	N	pluskal_fda_drugs_5005_N22_id
2533	HY-50856	HYCPK40909	H10	HYCPK40909	92z	740.0	4.0	P20	909.0	H10	941678-49-5	Ruxolitinib	INCB18424	306.37	Apoptosis; Autophagy; JAK; Mitophagy	Apoptosis; Autophagy; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Ruxolitinib (INCB18424) is a potent and selective JAK1/2 inhibitor with IC50s of 3.3 nM and 2.8 nM in cell-free assays, and has 130-fold selectivity for JAK1/2 over JAK3[1]. Ruxolitinib induces autophagy and kills tumor cells through toxic mitophagy[3].	Free Base	C17H18N6	136926.0	H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble); DMSO : ≥ 100 mg/mL (326.40 mM)	DMSO Solution	10mM  * 100uL	Cancer	N#CC[C@H](C1CCCC1)N2N=CC(C3=C4C=CNC4=NC=N3)=C2	https://www.medchemexpress.com/Ruxolitinib.html	Launched		92.0	P20	N22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50856	10.0	mM	334.0	DMSO	306.159295	22	N	pluskal_fda_drugs_5005_N22_id
1511	HY-14852A	HYCPK40906	J10	HYCPK40906	92z	883.0	1.0	S19	906.0	J10	951395-08-7	Tafamidis meglumine	Fx-1006A	503.33	Transthyretin (TTR)	Neuronal Signaling	Tafamidis meglumine (Fx-1006A) is a potent and selective transthyretin (TTR) stabilizer, shows comparable potency and efficacy to the mutumant homotetramers V30M-TTR, V122I-TTR and wild type WT-TTR, with EC50s of 2.7-3.2 μM. Tafamidis meglumine inhibits amyloidogenesis[1].	Meglumine	C21H24Cl2N2O8	38672.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 12.5 mg/mL (24.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1=CC=C2N=C(C3=CC(Cl)=CC(Cl)=C3)OC2=C1)O.O[C@@H]([C@@H]([C@@H](CO)O)O)[C@@H](O)CNC	https://www.medchemexpress.com/Tafamidis_meglumine.html	Launched		92.0	S19	O3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14852A	10.0	mM	339.0	DMSO	306.980298	3	O	pluskal_fda_drugs_5005_O3_id
1561	HY-10409A	HYCPK40906	L13	HYCPK40906	92z	1081.0	1.0	W25	906.0	L13	1374744-69-0	Fedratinib (hydrochloride hydrate)	TG-101348 (hydrochloride hydrate); SAR 302503 (hydrochloride hydrate)	615.62	Apoptosis; JAK	Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Fedratinib hydrochloride hydrate (TG-101348 hydrochloride hydrate) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. Fedratinib hydrochloride hydrate shows 35- and 334-fold selectivity over JAK1 and JAK3, respectively. Fedratinib hydrochloride hydrate induces cancer cell apoptosis and has the potential for myeloproliferative disorders research[1][2].	Hydrochloride	C27H40Cl2N6O4S	86195.0	H2O : 100 mg/mL (162.44 mM; Need ultrasonic); DMSO : 125 mg/mL (203.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	[H]Cl.[H]O[H].[H]Cl.O=S(C1=CC=CC(NC2=NC(NC3=CC=C(C=C3)OCCN4CCCC4)=NC=C2C)=C1)(NC(C)(C)C)=O	https://www.medchemexpress.com/fedratinib-hydrochloride-hydrate.html	Launched		92.0	W25	O3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10409A	10.0	mM	339.0	DMSO	524.25696	3	O	pluskal_fda_drugs_5005_O3_id
1569	HY-17509	HYCPK40906	D14	HYCPK40906	92z	315.0	1.0	G27	906.0	D14	169590-41-4	Deracoxib	SC 046; SC 46; SC 59046	397.37	Apoptosis; COX	Apoptosis; Immunology/Inflammation	"Deracoxib, a selective cyclooxygenase-2 inhibitor, is a non-narcotic, non-steroidal anti-inflammatory drug (NSAID). 
IC50 Value: 70 to 150 uM(inhibition of 3 osteosarcoma cell lines) [1]
Target: COX
in vitro: Concentration of deracoxib required for 50% inhibition of cell viability (IC50) was reached in all 3 osteosarcoma cell lines and ranged from 70 to 150 microM, whereas the IC50 for piroxicam was only reached in the POS cell line at 500 microM. Neither deracoxib nor piroxicam induced sufficient toxicity in fibroblasts to reach an IC50. Exposure of osteosarcoma cells to cytotoxic concentrations of deracoxib and piroxicam did not result in DNA fragmentation [1]. Concomitant treatment of cells with piroxicam and deracoxib resulted in significant induction of apoptosis at lower concentrations and accumulation of cells in the G /G  phase. Significant cytotoxic effects exhibited by the combination of piroxicam and deracoxib against canine mammary carcinoma cells in vitro suggest an attractive approach for the treatment of canine mammary carcinoma [2].
in vivo: Perioperative administration of deracoxib to dogs at 1-2 mg/kg/day for 3 days significantly improves analgesia in the postoperative surgical period after soft tissue surgery [3]. Dogs were treated PO with deracoxib at a dosage of 3 mg/kg/d (1.36 mg/lb/d) as a single-agent treatment for TCC. Tumor response was assessed via radiography, abdominal ultrasonography, and ultrasonographic mapping of urinary bladder masses. Toxic effects of deracoxib administration in dogs were assessed through clinical observations and hematologic and biochemical analyses. 24 dogs for which tumor response was assessed, 4 (17%) had partial remission, 17 (71%) had stable disease, and 3 (13%) had progressive disease; initial response could not be assessed in 2 of 26 dogs. The median survival time was 323 days. Median time to progressive disease was 133 days. Renal, hepatic, and gastrointestinal abnormalities attributed to deracoxib administration were noted in 4% (1/26), 4% (1/26), and 19% (5/26) of dogs, respectively [4]."	Free Base	C17H14F3N3O3S	12448.0	DMSO : 50 mg/mL (125.83 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=S(C1=CC=C(N2N=C(C(F)F)C=C2C3=CC=C(OC)C(F)=C3)C=C1)(N)=O	https://www.medchemexpress.com/deracoxib.html	Launched		92.0	G27	O3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17509	10.0	mM	339.0	DMSO	397.070797	3	O	pluskal_fda_drugs_5005_O3_id
1674	HY-14283	HYCPK40906	M20	HYCPK40906	92z	1191.0	1.0	Y39	906.0	M20	187164-19-8	Luliconazole	NND 502	354.28	Antibiotic; Fungal	Anti-infection	Luliconazole (NND 502)?is a topical antifungal imidazole antibiotic with broad-spectrum and potent antifungal activity. Luliconazole can be used for the research of skin infection, including?dermatophytosis, tinea corporis, tinea pedis?et al[1].	Free Base	C14H9Cl2N3S2	20605.0	DMSO : 50 mg/mL (141.13 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	ClC1=CC(Cl)=CC=C1[C@@H]2CS/C(S2)=C(C#N)\N3C=CN=C3	https://www.medchemexpress.com/Luliconazole.html	Launched		92.0	Y39	O3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14283	10.0	mM	339.0	DMSO	352.961495	3	O	pluskal_fda_drugs_5005_O3_id
1686	HY-17004	HYCPK40906	I21	HYCPK40906	92z	809.0	1.0	Q41	906.0	I21	144689-24-7	Olmesartan	RNH-6270	446.50	Angiotensin Receptor	GPCR/G Protein	Olmesartan (RNH-6270) is an angiotensin II receptor (AT1R) antagonist used to treat high blood pressure[1][2].	Free Acid	C24H26N6O3	25283.0	DMSO : 20.83 mg/mL (46.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O)C1=C(N=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4)CCC)C(O)(C)C	https://www.medchemexpress.com/Olmesartan.html	Launched		92.0	Q41	O3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17004	10.0	mM	339.0	DMSO	446.206639	3	O	pluskal_fda_drugs_5005_O3_id
1954	HY-17034	HYCPK40907	B19	HYCPK40907	92z	134.0	2.0	C38	907.0	B19	86347-14-0	Medetomidine		200.28	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	"Medetomidine(Domtor) is a potent, highly selective α2-adrenoceptor agonist (Ki values are 1.08 and 1750 nM for α2- and α1-adrenoceptors respectively). 
IC50 value:
Target:  α2-adrenoceptor
Medetomidine displays greater selectivity over α1-adrenoceptors than clonidine and UK 14,304 (1620-, 220- and 300-fold respectively). Medetomidine inhibits twitch response in electrically stimulated mouse vas deferens (pD2 = 9.0). Active in vivo; displays hypotensive, bradycardic, anxiolytic, hypothermic and analgesic effects."	Free Base	C13H16N2	78937.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 250 mg/mL (1248.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CC(C1=CN=CN1)C2=CC=CC(C)=C2C	https://www.medchemexpress.com/medetomidine.html	Launched		92.0	C38	O3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17034	10.0	mM	339.0	DMSO	200.131349	3	O	pluskal_fda_drugs_5005_O3_id
2309	HY-17571A	HYCPK40909	I07	HYCPK40909	92z	830.0	4.0	R14	909.0	I07	6233-83-6	Oxytocin (acetate)	α-Hypophamine (acetate); Oxytocic hormone (acetate)	1067.24	Endogenous Metabolite; Oxytocin Receptor	GPCR/G Protein; Metabolic Enzyme/Protease	Oxytocin (α-Hypophamine) acetate is a pleiotropic, hypothalamic peptide known for facilitating parturition, lactation, and prosocial behaviors. Oxytocin acetate can function as a stress-coping molecule with anti-inflammatory, antioxidant, and protective effects especially in the face of adversity or trauma[1][2].	Acetate	C45H70N12O14S2	16893.0	DMSO : ≥ 44 mg/mL (41.23 mM); H2O : 50 mg/mL (46.85 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C([C@H](CSSC[C@@H](C(N[C@H](C1=O)CC2=CC=C(O)C=C2)=O)N)NC([C@@H](NC([C@@H](NC(C(N1)[C@@H](C)CC)=O)CCC(N)=O)=O)CC(N)=O)=O)N(CCC3)[C@@H]3C(N[C@@H](CC(C)C)C(NCC(N)=O)=O)=O.CC(O)=O	https://www.medchemexpress.com/Oxytocin-acetate.html	Launched		92.0	R14	O3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17571A	10.0	mM	339.0	DMSO	1006.436458	3	O	pluskal_fda_drugs_5005_O3_id
2520	HY-A0027	HYCPK40909	K09	HYCPK40909	92z	1026.0	4.0	V18	909.0	K09	5053-08-7	Fenspiride (hydrochloride)		296.79	Histamine Receptor; Phosphodiesterase (PDE)	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Fenspiride, an orally active non-steroidal antiinflammatory agent, is an antagonist of H1-histamine receptor. Fenspiride inhibites phosphodiesterase 3 (PDE3), phosphodiesterase 4 (PDE4) and phosphodiesterase 5 (PDE5) activities with -log IC50 values of 3.44, 4.16 and approximately 3.8, respectively. Fenspiride can be used for the research of respiratory diseases[1][2][3].	Hydrochloride	C15H21ClN2O2	6691.0	H2O : 50 mg/mL (168.47 mM; Need ultrasonic); DMSO : 33.33 mg/mL (112.30 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C1OC2(CCN(CCC3=CC=CC=C3)CC2)CN1.[H]Cl	https://www.medchemexpress.com/Fenspiride-Hydrochloride.html	Launched		92.0	V18	O3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0027	10.0	mM	339.0	DMSO	260.152478	3	O	pluskal_fda_drugs_5005_O3_id
1534	HY-B1014	HYCPK40906	A12	HYCPK40906	92z	23.0	1.0	A23	906.0	A12	152-72-7	Acenocoumarol		353.33	Others	Others	Acenocoumarol is an anticoagulant that functions as a Vitamin K antagonist.	Free Base	C19H15NO6	145329.0	DMSO : 100 mg/mL (283.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C1C(C(C2=CC=C([N+]([O-])=O)C=C2)CC(C)=O)=C(O)C3=CC=CC=C3O1	https://www.medchemexpress.com/Acenocoumarol.html	Launched		92.0	A23	O4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1014	10.0	mM	340.0	DMSO	353.089937	4	O	pluskal_fda_drugs_5005_O4_id
2028	HY-14655	HYCPK40908	P03	HYCPK40908	92z	1493.0	3.0	AF5	908.0	P03	599-79-1	Sulfasalazine	NSC 667219	398.39	Antibiotic; Apoptosis; Autophagy; Bacterial; Ferroptosis; NF-κB	Anti-infection; Apoptosis; Autophagy; NF-κB	Sulfasalazine (NSC 667219) is an anti-rheumatic agent for the research of rheumatoid arthritis and ulcerative colitis. Sulfasalazine can suppress NF-κB activity. Sulfasalazine is a type 1 ferroptosis inducer[1][2][3][4].	Free Acid	C18H14N4O5S	14146.0	NH4OH : 150 mg/mL (376.52 mM; ultrasonic and adjust pH to 9 with NH4OH); DMSO : 80 mg/mL (200.81 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	OC(C1=C(O)C=CC(/N=N/C2=CC=C(S(=O)(NC3=NC=CC=C3)=O)C=C2)=C1)=O	https://www.medchemexpress.com/Sulfasalazine.html	Launched		92.0	AF5	O4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14655	10.0	mM	340.0	DMSO	398.068491	4	O	pluskal_fda_drugs_5005_O4_id
2134	HY-112823A	HYCPK40908	C11	HYCPK40908	92z	261.0	3.0	F21	908.0	C11	2134096-06-1	Almonertinib (mesylate)	HS-10296 (mesylate)	621.75	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Almonertinib (HS-10296) mesylate is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM). Almonertinib mesylate is used for the research of the non-small cell lung cancer[1][2].	Mesylate	C31H39N7O5S	154448.0	DMSO : 31.25 mg/mL (50.26 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	COC(C=C(N(C)CCN(C)C)C(NC(C=C)=O)=C1)=C1NC2=NC(C3=CN(C4CC4)C5=C3C=CC=C5)=CC=N2.CS(=O)(O)=O	https://www.medchemexpress.com/almonertinib-mesylate.html	Launched		92.0	F21	O4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-112823A	10.0	mM	340.0	DMSO	525.285223	4	O	pluskal_fda_drugs_5005_O4_id
2150	HY-50910	HYCPK40908	C12	HYCPK40908	92z	263.0	3.0	F23	908.0	C12	162635-04-3	Temsirolimus	CCI-779	1030.29	Apoptosis; Autophagy; Bacterial; mTOR	Anti-infection; Apoptosis; Autophagy; PI3K/Akt/mTOR	Temsirolimus is an inhibitor of mTOR with an IC50 of 1.76 μM. Temsirolimus activates autophagy and prevents deterioration of cardiac function in animal model[8].	Free Base	C56H87NO16	151972.0	Ethanol : 200 mg/mL (194.12 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble); DMSO : 250 mg/mL (242.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@@]1(O)[C@@H](CC[C@@H](C[C@@H](/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C([C@@H]([C@@H](/C(C)=C/[C@H]2C)O)OC)=O)C)OC)O1)C)C(N3CCCC[C@H]3C(O[C@@H](CC2=O)[C@@H](C[C@H]4C[C@H]([C@H](OC(C(C)(CO)CO)=O)CC4)OC)C)=O)=O	https://www.medchemexpress.com/Temsirolimus.html	Launched		92.0	F23	O4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50910	10.0	mM	340.0	DMSO	1029.602486	4	O	pluskal_fda_drugs_5005_O4_id
2228	HY-B0623A	HYCPK40908	E17	HYCPK40908	92z	465.0	3.0	J33	908.0	E17	91374-20-8	Ropinirole (hydrochloride)	SKF 101468 (hydrochloride)	296.84	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Ropinirole (SKF 101468) hydrochloride is an orally active, potent D3/D2 receptor agonist with a Ki of 29 nM for D2 receptor. Ropinirole hydrochloride has pEC50s of 7.4, 8.4 and 6.8 for hD2, hD3 and hD4 receptors, respectively. Ropinirole hydrochloride has no affinity for the D1 receptors. Ropinirole hydrochloride has the potential for Parkinson's disease[1][2].	Hydrochloride	C16H25ClN2O	15248.0	DMSO : 16.67 mg/mL (56.16 mM; Need ultrasonic); H2O : 100 mg/mL (336.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C1NC2=C(C(CCN(CCC)CCC)=CC=C2)C1.Cl	https://www.medchemexpress.com/Ropinirole-hydrochloride.html	Launched		92.0	J33	O4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0623A	10.0	mM	340.0	DMSO	260.188863	4	O	pluskal_fda_drugs_5005_O4_id
2266	HY-17034B	HYCPK40908	K19	HYCPK40908	92z	1045.0	3.0	V37	908.0	K19	86347-15-1	Medetomidine (hydrochloride)	MPV785	236.74	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Medetomidine (hydrochloride) is a potent, selective, and specific α2-adrenoceptor agonist in both the peripheral and central nervous systems. Medetomidine hydrochloride can induce sedation, analgesia, anxiolysis, and muscle relaxation in a variety of species[1].	Hydrochloride	C13H17ClN2	13196.0	DMSO : 100 mg/mL (422.40 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (211.20 mM); Ethanol : 100 mg/mL (422.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CC(C1=CN=CN1)C2=CC=CC(C)=C2C.Cl	https://www.medchemexpress.com/Medetomidine-hydrochloride.html	Launched		92.0	V37	O4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17034B	10.0	mM	340.0	DMSO	200.131349	4	O	pluskal_fda_drugs_5005_O4_id
2459	HY-13911	HYCPK40909	G05	HYCPK40909	92z	634.0	4.0	N10	909.0	G05	105628-72-6	Hydroxyfasudil	HA-1100	307.37	ROCK	Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad	Hydroxyfasudil is a ROCK inhibitor, with IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively.	Free Base	C14H17N3O3S	22813.0	DMSO : ≥ 31 mg/mL (100.86 mM)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Cardiovascular Disease	O=C1NC=CC2=C1C=CC=C2S(=O)(N3CCNCCC3)=O	https://www.medchemexpress.com/Hydroxyfasudil.html	Launched		92.0	N10	O4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13911	10.0	mM	340.0	DMSO	307.099062	4	O	pluskal_fda_drugs_5005_O4_id
2530	HY-101467A	HYCPK40909	E10	HYCPK40909	92z	452.0	4.0	J20	909.0	E10	1977495-97-8	Trilaciclib (hydrochloride)	G1T28 (hydrochloride)	519.47	CDK	Cell Cycle/DNA Damage	Trilaciclib hydrochloride (G1T28 hydrochloride) is a CDK4/6 inhibitor with IC50s of 1 nM and 4 nM for CDK4 and CDK6, respectively[1].	Hydrochloride	C24H32Cl2N8O	33075.0	DMSO : 1.1 mg/mL (2.12 mM; Need ultrasonic); H2O : 25.64 mg/mL (49.36 mM; ultrasonic and adjust pH to 2 with HCl)	DMSO Solution	10mM  * 100uL	Cancer	O=C1C2=CC3=CN=C(NC4=CC=C(N5CCN(C)CC5)C=N4)N=C3N2C6(CCCCC6)CN1.[H]Cl.[H]Cl	https://www.medchemexpress.com/Trilaciclib_hydrochloride.html	Launched		92.0	J20	O4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101467A	10.0	mM	340.0	DMSO	446.254258	4	O	pluskal_fda_drugs_5005_O4_id
45	HY-B0803	HYCPK40899	O04	HYCPK40909	92z	1422.0	4.0	AD30	909.0	O15	82186-77-4	Lumefantrine	Benflumetol	528.94	Autophagy; Parasite	Anti-infection; Autophagy	Lumefantrine is an antimalarial drug, used in combination with Artemether. The artemether-lumefantrine (AL) as the first- and second-line anti-malarial drugs.	Free Base	C30H32Cl3NO	18510.0	DMF : 25 mg/mL (47.26 mM; ultrasonic and warming and heat to 60°C); DMSO : 2 mg/mL (3.78 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection	OC(CN(CCCC)CCCC)C1=CC(Cl)=CC(/C2=C\C3=CC=C(Cl)C=C3)=C1C4=C2C=C(Cl)C=C4	https://www.medchemexpress.com/Lumefantrine.html	Launched		92.0	AD30	O5	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0803	2.0	mM	341.0	DMSO	527.154948	5	O	pluskal_fda_drugs_5005_O5_id
1393	HY-14546	HYCPK40906	N04	HYCPK40906	92z	1255.0	1.0	AA7	906.0	N04	129722-12-9	Aripiprazole	OPC-14597	448.39	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Aripiprazole (OPC-14597), an atypical antipsychotic, is a potent and high-affinity dopamine D2 receptor partial agonist. Aripiprazole is an inverse agonist at 5-HT2B and 5-HT2A receptors and displays partial agonist actions at 5-HT1A, 5-HT2C, D3, and D4 receptors. Aripiprazole can be used for the research of schizophrenia and COVID19[1][2][3][4].	Free Base	C23H27Cl2N3O2	32655.0	DMF : 50 mg/mL (111.51 mM; Need ultrasonic); DMSO : 100 mg/mL (223.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Neurological Disease	O=C1NC2=C(C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=C2)CC1	https://www.medchemexpress.com/Aripiprazole.html	Launched		92.0	AA7	O5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14546	10.0	mM	341.0	DMSO	447.148032	5	O	pluskal_fda_drugs_5005_O5_id
1709	HY-32329A	HYCPK40906	P22	HYCPK40906	92z	1483.0	1.0	AE43	906.0	P22	85650-57-3	Setiptiline (maleate)	MO-8282	377.43	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Setiptiline maleate (MO-8282 maleate) is a serotonin receptor antagonist. Setiptiline maleate is a tetracyclic antidepressant (TeCA) which acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). Setiptiline maleate acts as a norepinephrine reuptake inhibitor, α2-adrenergic receptor antagonist, and serotonin receptor antagonist, likely at the 5-HT2A, 5-HT2C, and/or 5-HT3 subtypes, as well as an H1 receptor inverse agonist/antihistamine[1][2][3][4].	Maleate	C23H23NO4	574.0	DMSO : 100 mg/mL (264.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1CC(C(C=CC=C2)=C2C3)=C(CC1)C4=C3C=CC=C4.O=C(O)/C=C\C(O)=O	https://www.medchemexpress.com/setiptiline-maleate.html	Launched		92.0	AE43	O5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-32329A	10.0	mM	341.0	DMSO	261.15175	5	O	pluskal_fda_drugs_5005_O5_id
1785	HY-16985	HYCPK40907	A08	HYCPK40907	92z	16.0	2.0	A16	907.0	A08	1297538-32-9	Darolutamide	ODM-201; BAY-1841788	398.85	Androgen Receptor	Others	Darolutamide (ODM-201;BAY-1841788) is a potent androgen receptor (AR) antagonist with an IC50 of 26 nM in in vitro assay.	Free Base	C19H19ClN6O2	18661.0	DMSO : 125 mg/mL (313.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	ClC1=C(C#N)C=CC(C2=NN(C[C@H](C)NC(C3=NNC(C(O)C)=C3)=O)C=C2)=C1	https://www.medchemexpress.com/ODM-201.html	Launched		92.0	A16	O5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16985	10.0	mM	341.0	DMSO	398.125802	5	O	pluskal_fda_drugs_5005_O5_id
1791	HY-A0182	HYCPK40907	G08	HYCPK40907	92z	592.0	2.0	M16	907.0	G08	56-59-7	Felypressin	PLV-2	1040.22	Vasopressin Receptor	GPCR/G Protein	Felypressin (PLV-2) is a non-catecholamine vasoconstrictor and a vasopressin 1 agonist. Felypressin is widely used in dental procedures[1][2].	Free Base	C46H65N13O11S2	41278.0	DMSO : ≥ 10.4 mg/mL (10.00 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C([C@H](CSSC[C@@H](C(N[C@H](C1=O)CC2=CC=CC=C2)=O)N)NC([C@@H](NC([C@@H](NC([C@](N1)([H])CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)N(CCC4)[C@@H]4C(N[C@@H](CCCCN)C(NCC(N)=O)=O)=O	https://www.medchemexpress.com/Felypressin.html	Launched		92.0	M16	O5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0182	10.0	mM	341.0	DMSO	1039.436792	5	O	pluskal_fda_drugs_5005_O5_id
1840	HY-101588	HYCPK40907	H11	HYCPK40907	92z	694.0	2.0	O22	907.0	H11	1015787-98-0	Gefapixant	MK-7264; AF-219	353.40	P2X Receptor	Membrane Transporter/Ion Channel	Gefapixant is an orally active and potent purinergic P2X3 receptor (P2X3R) antagonist, with IC50 values of ~30 nM versus recombinant hP2X3 homotrimers and 100-250 nM at hP2X2/3 heterotrimeric receptors. Gefapixant can be used for the research of chronic cough and knee osteoarthritis[1][2][3].	Free Base	C14H19N5O4S	35084.0	DMSO : 5 mg/mL (14.15 mM; ultrasonic and adjust pH to 5-6 with HCl)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=S(C1=CC(OC2=CN=C(N)N=C2N)=C(C(C)C)C=C1OC)(N)=O	https://www.medchemexpress.com/Gefapixant.html	Launched		92.0	O22	O5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101588	10.0	mM	341.0	DMSO	353.115775	5	O	pluskal_fda_drugs_5005_O5_id
2107	HY-17039	HYCPK40908	D09	HYCPK40908	92z	353.0	3.0	H17	908.0	D09	147084-10-4	Alcaftadine	R89674	307.39	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Alcaftadine (R89674) is a histamine H1 receptor antagonist, which is used to prevent eye irritation brought on by allergic conjunctivitis. Alcaftadine is a broad-spectrum antihistamine displaying a high affinity for histamine H1 and H2 receptors and a lower affinity for H4 receptors. Alcaftadine also exhibits modulatory action on immune cell recruitment and mast cell stabilizing effects[1][2].	Free Base	C19H21N3O	16203.0	DMSO : ≥ 40 mg/mL (130.13 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=CC1=CN=C2N1CCC3=CC=CC=C3/C2=C4CCN(C)CC\4	https://www.medchemexpress.com/Alcaftadine.html	Launched		92.0	H17	O5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17039	10.0	mM	341.0	DMSO	307.168462	5	O	pluskal_fda_drugs_5005_O5_id
2191	HY-B0556A	HYCPK40908	L14	HYCPK40908	92z	1131.0	3.0	X27	908.0	L14	522-48-5	Tetrahydrozoline (hydrochloride)	Tetryzoline (hydrochloride)	236.74	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Tetrahydrozoline hydrochloride (Tetryzoline hydrochloride), a derivative of imidazoline, is an α-adrenergic agonist that causes vasoconstriction. Tetrahydrozoline hydrochloride is widely used for the research of nasal congestion and conjunctival congestion[1][2].	Hydrochloride	C13H17ClN2	16656.0	DMSO : 16.67 mg/mL (70.41 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (211.20 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	C1(C2CCCC3=C2C=CC=C3)=NCCN1.Cl	https://www.medchemexpress.com/Tetrahydrozoline-hydrochloride.html	Launched		92.0	X27	O5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0556A	10.0	mM	341.0	DMSO	200.131349	5	O	pluskal_fda_drugs_5005_O5_id
1367	HY-B1667	HYCPK40906	D03	HYCPK40906	92z	293.0	1.0	G5	906.0	D03	71-81-8	Isopropamide (iodide)		480.43	Others	Others	Isopropamide iodide is a long-acting quaternary anticholinergic agent. Isopropamide iodide is used in peptic ulcer and other gastrointestinal disorders marked by hyperacidity and hypermotility[1][2].	Iodide	C23H33IN2O	64022.0	DMSO : 250 mg/mL (520.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC([N+](CCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(N)=O)(C(C)C)C)C.[I-]	https://www.medchemexpress.com/isopropamide-iodide.html	Launched		92.0	G5	O6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1667	10.0	mM	342.0	DMSO	353.25874	6	O	pluskal_fda_drugs_5005_O6_id
1464	HY-B0381B	HYCPK40908	P10	HYCPK40908	92z	1507.0	3.0	AF19	908.0	P10	116209-55-3	Levobetaxolol (hydrochloride)	(S)-Betaxolol hydrochloride; AL-1577A	343.89	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Levobetaxolol hydrochloride is a beta-adrenergic receptor inhibitor (beta blocker) that can lower the pressure in the eye. Levobetaxolol hydrochloride can be used for the research of glaucoma.	Hydrochloride	C18H30ClNO3	18505.0	DMSO : ≥ 100 mg/mL (290.79 mM); H2O : 25 mg/mL (72.70 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	O[C@@H](CNC(C)C)COC1=CC=C(CCOCC2CC2)C=C1.[H]Cl	https://www.medchemexpress.com/Levobetaxolol-hydrochloride.html	Launched		92.0	AF19	O6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0381B	10.0	mM	342.0	DMSO	307.214744	6	O	pluskal_fda_drugs_5005_O6_id
1518	HY-B0989	HYCPK40906	A11	HYCPK40906	92z	21.0	1.0	A21	906.0	A11	138-41-0	Carzenide	4-Sulfamoylbenzoic acid	201.20	Others	Others	Carzenide is an organic synthesis intermediate, for synthetic drug.	Free Acid	C7H7NO4S	17360.0	DMSO : 100 mg/mL (497.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(O)C1=CC=C(S(=O)(N)=O)C=C1	https://www.medchemexpress.com/Carzenide.html	Launched		92.0	A21	O6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0989	10.0	mM	342.0	DMSO	201.009579	6	O	pluskal_fda_drugs_5005_O6_id
1599	HY-B1114	HYCPK40906	B16	HYCPK40906	92z	127.0	1.0	C31	906.0	B16	33342-05-1	Gliquidone	AR-DF 26	527.63	Others	Others	Gliquidone (AR-DF 26) is an anti-diabetic drug in the sulfonylurea class, used in the treatment of diabetes mellitus type 2.	Free Base	C27H33N3O6S	17157.0	DMSO : 50 mg/mL (94.76 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=S(C1=CC=C(CCN(C(C(C)(C)C2=C3C=C(OC)C=C2)=O)C3=O)C=C1)(NC(NC4CCCCC4)=O)=O	https://www.medchemexpress.com/Gliquidone.html	Launched		92.0	C31	O6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1114	10.0	mM	342.0	DMSO	527.209007	6	O	pluskal_fda_drugs_5005_O6_id
1712	HY-A0065	HYCPK40907	C03	HYCPK40907	92z	198.0	2.0	E6	907.0	C03	827022-33-3	Palbociclib (isethionate)	PD 0332991 isethionate	573.66	CDK	Cell Cycle/DNA Damage	Palbociclib (PD 0332991) isethionate is an orally active selective CDK4 and CDK6 inhibitor with IC50 values of 11 and 16 nM, respectively. Palbociclib isethionate has potent anti-proliferative activity and induces cell cycle arrest in cancer cells, which can be used in the research of HR-positive and HER2-negative breast cancer and hepatocellular carcinoma[1][3][4].	Isethionate	C26H35N7O6S	14498.0	H2O : 50 mg/mL (87.16 mM; Need ultrasonic); DMSO : 10 mg/mL (17.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	CC(C1=C(N2C3CCCC3)N=C(NC4=NC=C(N5CCNCC5)C=C4)N=C1)=C(C(C)=O)C2=O.OCCS(O)(=O)=O	https://www.medchemexpress.com/Palbociclib-isethionate.html	Launched		92.0	E6	O6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0065	10.0	mM	342.0	DMSO	447.238273	6	O	pluskal_fda_drugs_5005_O6_id
1747	HY-W017770	HYCPK40907	K05	HYCPK40907	92z	970.0	2.0	U10	907.0	K05	97540-22-2	S-Adenosyl-L-methionine (disulfate tosylate)	Ademetionine (disulfate tosylate); S-Adenosyl methionine (disulfate tosylate); AdoMet (disulfate tosylate)	766.80	Endogenous Metabolite	Metabolic Enzyme/Protease	S-Adenosyl-L-methionine disulfate tosylate (Ademetionine disulfate tosylate) is the principal biological methyl donor synthesized in all mammalian cells but most abundantly in the liver.	Sulfate	C22H34N6O16S4	17102.0	H2O : 33.33 mg/mL (43.47 mM; Need ultrasonic); DMSO : ≥ 50 mg/mL (65.21 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	N[C@@H](CC[S+](C[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3N)O1)O)O)C)C(O)=O.O=S(O)([O-])=O.O=S(O)(O)=O.OS(=O)(C4=CC=C(C)C=C4)=O	https://www.medchemexpress.com/S-Adenosyl-L-methionine_disulfate_tosylate.html	Launched		92.0	U10	O6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W017770	10.0	mM	342.0	DMSO	399.144515	6	O	pluskal_fda_drugs_5005_O6_id
1758	HY-32329	HYCPK40907	F06	HYCPK40907	92z	492.0	2.0	K12	907.0	F06	57262-94-9	Setiptiline	Org-8282	261.36	5-HT Receptor; Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Setiptiline (Org-8282) is a serotonin receptor antagonist. Setiptiline is a tetracyclic antidepressant (TeCA) which acts as a noradrenergic and specific serotonergic antidepressant (NaSSA). Setiptiline acts as a norepinephrine reuptake inhibitor, α2-adrenergic receptor antagonist, and serotonin receptor antagonist, likely at the 5-HT2A, 5-HT2C, and/or 5-HT3 subtypes, as well as an H1 receptor inverse agonist/antihistamine.	Free Base	C19H19N	1116.0	DMSO : 25 mg/mL (95.65 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1CC2=C(CC1)C3=CC=CC=C3CC4=C2C=CC=C4	https://www.medchemexpress.com/Setiptiline.html	Launched		92.0	K12	O6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-32329	10.0	mM	342.0	DMSO	261.15175	6	O	pluskal_fda_drugs_5005_O6_id
2472	HY-13948	HYCPK40909	D06	HYCPK40909	92z	348.0	4.0	H12	909.0	D06	4474-91-3	Angiotensin II human	Angiotensin II; Ang II; DRVYIHPF	1046.18	Angiotensin Receptor; Apoptosis	Apoptosis; GPCR/G Protein	Angiotensin II (Angiotensin II) is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system. Angiotensin II human plays a central role in regulating human blood pressure, which is mainly mediated by interactions between Angiotensin II and the G-protein-coupled receptors (GPCRs) Angiotensin II type 1 receptor (AT1R) and Angiotensin II type 2 receptor (AT2R). Angiotensin II human stimulates sympathetic nervous stimulation, increases aldosterone biosynthesis and renal actions. Angiotensin II human induces growth of vascular smooth muscle cells, increases collagen type I and III synthesis in fibroblasts, leading to thickening of the vascular wall and myocardium, and fibrosis. Angiotensin II human also induces apoptosis. Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway[1][2][3][4].	Free Acid	C50H71N13O12	160168.0	H2O : 50 mg/mL (47.79 mM; Need ultrasonic); DMSO : 100 mg/mL (95.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology; Cancer	O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC2=CNC=N2)C(N3[C@@H](CCC3)C(N[C@@H](CC4=CC=CC=C4)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(O)=O)N	https://www.medchemexpress.com/Angiotensin-II-human.html	Launched		92.0	H12	O6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13948	10.0	mM	342.0	DMSO	1045.534515	6	O	pluskal_fda_drugs_5005_O6_id
1502	HY-16569	HYCPK40906	A10	HYCPK40906	92z	19.0	1.0	A19	906.0	A10	64-86-8	Colchicine		399.44	Apoptosis; Autophagy; Microtubule/Tubulin	Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton	Colchicine is a tubulin inhibitor and a microtubule disrupting agent. Colchicine inhibits microtubule polymerization with an IC50 of 3 nM[1][2][3]. Colchicine is also a competitive antagonist of the α3 glycine receptors (GlyRs)[4].	Free Base	C22H25NO6	113972.0	DMSO : ≥ 48 mg/mL (120.17 mM); H2O : ≥ 33.33 mg/mL (83.44 mM)	DMSO Solution	10mM  * 100uL	Cancer	CC(N[C@H](C1=C2)CCC3=CC(OC)=C(OC)C(OC)=C3C1=CC=C(OC)C2=O)=O	https://www.medchemexpress.com/Colchicine.html	Launched		92.0	A19	O7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16569	10.0	mM	343.0	DMSO	399.168188	7	O	pluskal_fda_drugs_5005_O7_id
1672	HY-50878	HYCPK40906	K20	HYCPK40906	92z	999.0	1.0	U39	906.0	K20	877399-52-5	Crizotinib	PF-02341066	450.34	Anaplastic lymphoma kinase (ALK); Autophagy; c-Met/HGFR; ROS Kinase	Autophagy; Protein Tyrosine Kinase/RTK	Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib is also a ROS1 inhibitor. Crizotinib has effective tumor growth inhibition[1][2][3].	Free Base	C21H22Cl2FN5O	6049.0	DMSO : 33.33 mg/mL (74.01 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	ClC1=C(F)C=CC(Cl)=C1[C@H](OC2=CC(C3=CN(N=C3)C4CCNCC4)=CN=C2N)C	https://www.medchemexpress.com/Crizotinib.html	Launched		92.0	U39	O7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50878	10.0	mM	343.0	DMSO	449.118544	7	O	pluskal_fda_drugs_5005_O7_id
1927	HY-B0381	HYCPK40907	G17	HYCPK40907	92z	610.0	2.0	M34	907.0	G17	63659-18-7	Betaxolol		307.43	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Betaxolol is a selective beta1 adrenergic receptor blocker that can be used for the research of hypertension and glaucoma.	Free Base	C18H29NO3	15993.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 100 mg/mL (325.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	OC(CNC(C)C)COC1=CC=C(CCOCC2CC2)C=C1	https://www.medchemexpress.com/Betaxolol.html	Launched		92.0	M34	O7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0381	10.0	mM	343.0	DMSO	307.214744	7	O	pluskal_fda_drugs_5005_O7_id
1991	HY-13553	HYCPK40907	K21	HYCPK40907	92z	1002.0	2.0	U42	907.0	K21	166663-25-8	Anidulafungin	LY303366	1140.24	Antibiotic; Fungal	Anti-infection	Anidulafungin is a new semisynthetic echinocandin with antifungal potency.	Free Base	C58H73N7O17	19239.0	DMSO : ≥ 30 mg/mL (26.31 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O[C@@H]1C[C@H](N2C1)C(N[C@@H]([C@H](O)[C@@H](O)C3=CC=C(O)C=C3)C(N[C@@H]([C@@H](C)O)C(N4[C@@H]([C@@H](O)[C@@H](C)C4)C(N[C@H](O)[C@H](O)C[C@H](NC(C5=CC=C(C6=CC=C(C7=CC=C(OCCCCC)C=C7)C=C6)C=C5)=O)C(N[C@@H]([C@H](O)C)C2=O)=O)=O)=O)=O)=O	https://www.medchemexpress.com/Anidulafungin.html	Launched		92.0	U42	O7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13553	10.0	mM	343.0	DMSO	1139.506294	7	O	pluskal_fda_drugs_5005_O7_id
2021	HY-B0928	HYCPK40908	I03	HYCPK40908	92z	821.0	3.0	R5	908.0	I03	118-56-9	Homosalate	Homomenthyl salicylate	262.34	Others	Others	Homosalate is an organic compound used in some sunscreens, it is used as a chemical UV filter, protecting the skin from sun damage.	Free Base	C16H22O3	17351.0	DMSO : 100 mg/mL (381.18 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Others	O=C(OC1CC(C)(C)CC(C)C1)C2=CC=CC=C2O	https://www.medchemexpress.com/Homosalate.html	Launched		92.0	R5	O7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0928	10.0	mM	343.0	DMSO	262.156895	7	O	pluskal_fda_drugs_5005_O7_id
2160	HY-A0133	HYCPK40908	M12	HYCPK40908	92z	1223.0	3.0	Z23	908.0	M12	104-29-0	Chlorphenesin		202.63	Bacterial; Fungal	Anti-infection	Chlorphenesin is a reversible antigen-associated immunosuppressant. Chlorphenesin is an antibacterial and antifungal agent used in numerous eye care cosmetics[1].		C9H11ClO3	78649.0	H2O : ≥ 6.67 mg/mL (32.92 mM); DMSO : 100 mg/mL (493.51 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	OCC(O)COC1=CC=C(Cl)C=C1	https://www.medchemexpress.com/chlorphenesin.html	Launched		92.0	Z23	O7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0133	10.0	mM	343.0	DMSO	202.039672	7	O	pluskal_fda_drugs_5005_O7_id
2232	HY-17592	HYCPK40908	I17	HYCPK40908	92z	849.0	3.0	R33	908.0	I17	97-18-7	Bithionol		356.05	Bacterial; Parasite	Anti-infection	Bithionol is an antibacterial, anthelmintic, and algaecide agent. Bithionol is also a potent inhibitor of soluble adenylyl cyclase through binding to the allosteric activator site (IC50: 4 μM)[1][2].	Free Base	C12H6Cl4O2S	15038.0	DMSO : ≥ 33 mg/mL (92.68 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	OC1=C(Cl)C=C(Cl)C=C1SC2=CC(Cl)=CC(Cl)=C2O		Launched		92.0	R33	O7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17592	10.0	mM	343.0	DMSO	353.884261	7	O	pluskal_fda_drugs_5005_O7_id
2310	HY-13538	HYCPK40909	C12	HYCPK40909	92z	264.0	4.0	F24	909.0	C12	210829-30-4	Gemcitabine elaidate	CP-4126; CO-101; Gemcitabine 5'-elaidate	527.64	Apoptosis; Autophagy; Nucleoside Antimetabolite/Analog	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Gemcitabine elaidate (CP-4126) is lipophilic pro-drug of Gemcitabine. Gemcitabine elaidate is converted to Gemcitabine by esterases in order to be phosphorylated.  Gemcitabine elaidate exhibits anti-tumor activity[1][2].	Free Base	C27H43F2N3O5	21381.0	DMSO : ≥ 26 mg/mL (49.28 mM)	DMSO Solution	10mM  * 100uL	Cancer	O[C@@H](C(F)(F)[C@H](N1C(N=C(C=C1)N)=O)O2)[C@H]2COC(CCCCCCC/C=C/CCCCCCCC)=O	https://www.medchemexpress.com/Gemcitabine-elaidate.html	Launched		92.0	F24	O7	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13538	10.0	mM	343.0	DMSO	527.317078	7	O	pluskal_fda_drugs_5005_O7_id
1590	HY-B1292	HYCPK40906	I15	HYCPK40906	92z	797.0	1.0	Q29	906.0	I15	606-17-7	Iodipamide	Adipiodone	1139.76	Others	Others	Iodipamide is a tri-iodinated benzoate derivative and ionic dimeric contrast agent used in diagnostic imaging.	Free Acid	C20H14I6N2O6	33479.0	DMSO : 125 mg/mL (109.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(NC1=C(I)C(C(O)=O)=C(I)C=C1I)CCCCC(NC2=C(I)C(C(O)=O)=C(I)C=C2I)=O	https://www.medchemexpress.com/Iodipamide.html	Launched		92.0	Q29	O8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1292	10.0	mM	344.0	DMSO	1139.512024	8	O	pluskal_fda_drugs_5005_O8_id
1613	HY-12005	HYCPK40906	P16	HYCPK40906	92z	1471.0	1.0	AE31	906.0	P16	162359-56-0	Fingolimod (hydrochloride)	FTY720	343.93	LPL Receptor; PAK	Cell Cycle/DNA Damage; Cytoskeleton; GPCR/G Protein	Fingolimod hydrochloride (FTY720), an analog of sphingosine, is a potent sphingosine 1-phosphate (S1P) receptors modulator. Fingolimod hydrochloride is phosphorylated  by sphingosine kinases, particularly by SK2, and then binds S1PR1, 3, 4, and 5. Fingolimod hydrochloride induces the internalization of S1P1, and consequently, inhibits S1P activity. Fingolimod hydrochloride also is a pak1 activator[1][4].	Hydrochloride	C19H34ClNO2	26663.0	DMSO : ≥ 100 mg/mL (290.76 mM); H2O : 50 mg/mL (145.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	OCC(N)(CO)CCC1=CC=C(C=C1)CCCCCCCC.[H]Cl	https://www.medchemexpress.com/Fingolimod-hydrochloride.html	Launched		92.0	AE31	O8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12005	10.0	mM	344.0	DMSO	307.251129	8	O	pluskal_fda_drugs_5005_O8_id
1693	HY-107385	HYCPK40906	P21	HYCPK40906	92z	1481.0	1.0	AE41	906.0	P21	119169-78-7	Epristeride	ONO-9302; SKF105657	399.57	5 alpha Reductase	Metabolic Enzyme/Protease	Epristeride (ONO-9302) is a selective, specific and orally active uncompetitive inhibitor of human steroid 5 alpha-reductase isoform 2. Epristeride has inhibitory effects for SR isoenzymes types 2 with Ki value of 0.7-2 nM. Epristeride can be used for the research of prostatic hyperplasia and acne[1].	Free Acid	C25H37NO3	110604.0	DMSO : 100 mg/mL (250.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@@]12[C@](CC[C@@H]2C(NC(C)(C)C)=O)([H])[C@@]3([H])[C@]([C@@]4(C(C=C(C(O)=O)CC4)=CC3)C)([H])CC1	https://www.medchemexpress.com/Epristeride.html	Launched		92.0	AE41	O8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107385	10.0	mM	344.0	DMSO	399.277344	8	O	pluskal_fda_drugs_5005_O8_id
1754	HY-15409	HYCPK40907	B06	HYCPK40907	92z	108.0	2.0	C12	907.0	B06	864070-44-0	Empagliflozin	BI 10773	450.91	SGLT	Membrane Transporter/Ion Channel	Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2[1].	Free Base	C23H27ClO7	152451.0	DMSO : 50 mg/mL (110.89 mM; Need ultrasonic); H2O : 0.11 mg/mL (0.24 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Metabolic Disease	ClC(C=CC([C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)=C2)=C2CC(C=C3)=CC=C3O[C@H]4CCOC4	https://www.medchemexpress.com/Empagliflozin.html	Launched		92.0	C12	O8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15409	10.0	mM	344.0	DMSO	450.144531	8	O	pluskal_fda_drugs_5005_O8_id
1760	HY-A0275	HYCPK40907	H06	HYCPK40907	92z	684.0	2.0	O12	907.0	H06	30578-37-1	Amezinium (methylsulfate)	Amezinium metilsulfate; Lu-1631	313.33	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	"Amezinium metilsulfate has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition ofnoradrenaline and tyramine uptake. 
Target: alpha and beta-1 receptors
Amezinium metilsulfate is a sympathomimetic drug used for the treatment of low blood pressure. Cardiovascular effects of the new sympathomimetic Amezinium metilsulphate are investigated in 25 patients compared with a control group (n = 25). During spinal/epidural anaesthesia 5 mg amezinium is given i.v. if blood pressure dropped greater than 20 mmHg. from starting-point. A significant recovery of blood pressure (epidural anaesthesia: syst 21%, diast 9%; spinal anaesthesia: syst 13%, diast 6.6%) and a decrease in heart rate (6.8% resp. 4,5%) are thought due to peripheral vasoconstriction. Amezinium proves a stimulating drug for alpha- and beta 1-receptors by stabilising the systemic blood pressure in spinal/epidural anaesthesia."	Methylsulfate	C12H15N3O5S	20337.0	DMSO : ≥ 34 mg/mL (108.51 mM); H2O : 50 mg/mL (159.58 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	COC1=CC(N)=CN=[N+]1C2=CC=CC=C2.O=S(OC)([O-])=O	https://www.medchemexpress.com/Amezinium-methylsulfate.html	Launched		92.0	O12	O8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0275	10.0	mM	344.0	DMSO	202.097488	8	O	pluskal_fda_drugs_5005_O8_id
1947	HY-B0307	HYCPK40907	K18	HYCPK40907	92z	996.0	2.0	U36	907.0	K18	54-42-2	Idoxuridine	5-Iodo-2′-deoxyuridine; 5-IUdR; IdUrd	354.10	Orthopoxvirus; Phosphatase	Anti-infection; Metabolic Enzyme/Protease	Idoxuridine (5-Iodo-2′-deoxyuridine, 5-IUdR, IdUrd) is an iodinated thymidine analogue that competitively inhibits  phosphorylases. Idoxuridine can inhibit viral activity, particularly viral eye infections, including herpes simplex keratitis, by inhibiting DNA polymerase and affecting viral replication. Idoxuridine against feline herpesvirus has the IC50 value of 4.3 μM[1]. Idoxuridine shows anti-orthopoxvirus activity.	Free Base	C9H11IN2O5	33898.0	DMSO : 125 mg/mL (353.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	OC[C@@H]1[C@H](C[C@H](N2C(NC(C(I)=C2)=O)=O)O1)O	https://www.medchemexpress.com/Idoxuridine.html	Launched		92.0	U36	O8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0307	10.0	mM	344.0	DMSO	353.971269	8	O	pluskal_fda_drugs_5005_O8_id
1948	HY-15005	HYCPK40907	L18	HYCPK40907	92z	1092.0	2.0	W36	907.0	L18	1190307-88-0	Sofosbuvir	GS-7977; PSI-7977	529.45	HCV	Anti-infection	Sofosbuvir (GS-7977) is an HCV RNA replication inhibitor with an EC50 of 92 nM[1].	Free Base	C22H29FN3O9P	17016.0	H2O : 25 mg/mL (47.22 mM; ultrasonic and warming and heat to 50°C); DMSO : 100 mg/mL (188.88 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C1N([C@H]2[C@]([C@H](O)[C@@H](CO[P@](OC3=CC=CC=C3)(N[C@@H](C)C(OC(C)C)=O)=O)O2)(C)F)C=CC(N1)=O	https://www.medchemexpress.com/PSI-7977.html	Launched		92.0	W36	O8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15005	10.0	mM	344.0	DMSO	529.162544	8	O	pluskal_fda_drugs_5005_O8_id
2168	HY-B0003	HYCPK40908	E13	HYCPK40908	92z	457.0	3.0	J25	908.0	E13	122111-03-9	Gemcitabine (hydrochloride)	LY 188011 (hydrochloride)	299.66	Apoptosis; Autophagy; DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Gemcitabine Hydrochloride (LY 188011 Hydrochloride) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine Hydrochloride inhibits DNA synthesis and repair, resulting in autophagyand apoptosis[1][2].	Hydrochloride	C9H12ClF2N3O4	51697.0	DMF : 2.5 mg/mL (8.34 mM; Need ultrasonic); H2O : ≥ 66.66 mg/mL (222.45 mM); DMSO : 25 mg/mL (83.43 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O[C@H]1C(F)(F)[C@H](N2C(N=C(N)C=C2)=O)O[C@@H]1CO.Cl	https://www.medchemexpress.com/Gemcitabine-Hydrochloride.html	Launched		92.0	J25	O8	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0003	10.0	mM	344.0	DMSO	263.071762	8	O	pluskal_fda_drugs_5005_O8_id
1713	HY-B1177	HYCPK40907	D03	HYCPK40907	92z	294.0	2.0	G6	907.0	D03	483-63-6	Crotamiton		203.28	Parasite	Anti-infection	Crotamiton is a drug that is used both as a scabicidal (for treating scabies) and as a general antipruritic. It is a prescription lotion based medicine that is applied to the whole body to get rid of the scabies parasite.	Free Base	C13H17NO	17410.0	DMSO : 140 mg/mL (688.71 mM; Need ultrasonic); H2O : 140 mg/mL (688.71 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	C/C=C/C(N(CC)C1=CC=CC=C1C)=O	https://www.medchemexpress.com/Crotamiton.html	Launched		92.0	G6	O9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1177	10.0	mM	345.0	DMSO	203.131014	9	O	pluskal_fda_drugs_5005_O9_id
1755	HY-A0163	HYCPK40907	C06	HYCPK40907	92z	204.0	2.0	E12	907.0	C06	53772-83-1	Zuclopenthixol	(Z)-Clopenthixol	400.96	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Zuclopenthixol is a thioxanthene derivative which acts as a mixed dopamine D1/D2 receptor antagonist.	Free Base	C22H25ClN2OS	32316.0	DMSO : ≥ 150 mg/mL (374.10 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	OCCN1CCN(CC/C=C2C3=C(SC4=C\2C=CC=C4)C=CC(Cl)=C3)CC1	https://www.medchemexpress.com/Zuclopenthixol.html	Launched		92.0	E12	O9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0163	10.0	mM	345.0	DMSO	400.137612	9	O	pluskal_fda_drugs_5005_O9_id
1822	HY-B0363	HYCPK40907	F10	HYCPK40907	92z	500.0	2.0	K20	907.0	F10	51803-78-2	Nimesulide	R805	308.31	COX	Immunology/Inflammation	Nimesulide is a selective COX-2 inhibitor, with IC50s of 70 nM-70 μM in a time-dependent manner, but it shows no effect on COX-1 (IC50 >100 μM). Nimesulide has potent anti-inflammatory, analgesic and antipyretic properties.	Free Base	C13H12N2O5S	16281.0	DMSO : ≥ 100 mg/mL (324.35 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CS(=O)(NC1=CC=C([N+]([O-])=O)C=C1OC2=CC=CC=C2)=O	https://www.medchemexpress.com/nimesulide.html	Launched		92.0	K20	O9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0363	10.0	mM	345.0	DMSO	308.046692	9	O	pluskal_fda_drugs_5005_O9_id
1832	HY-15991	HYCPK40907	P10	HYCPK40907	92z	1460.0	2.0	AE20	907.0	P10	1234423-95-0	Tenapanor	AZD1722; RDX5791	1145.05	Na+/H+ Exchanger (NHE)	Membrane Transporter/Ion Channel	Tenapanor (AZD1722) is a potent and orally active sodium/hydrogen exchanger isoform 3 (NHE3) inhibitor. Tenapanor  reduces intestinal phosphate absorption predominantly through reduction of passive paracellular phosphate flux. Tenapanor has the potential for the research of hyperphosphatemia[1][2].	Free Base	C50H66Cl4N8O10S2	25038.0	DMSO : 50 mg/mL (43.67 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(NCCOCCOCCNS(=O)(C1=CC=CC([C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)=C1)=O)NCCCCNC(NCCOCCOCCNS(=O)(C4=CC=CC([C@@H]5CN(C)CC6=C5C=C(Cl)C=C6Cl)=C4)=O)=O	https://www.medchemexpress.com/Tenapanor.html	Launched		92.0	AE20	O9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15991	10.0	mM	345.0	DMSO	1142.309743	9	O	pluskal_fda_drugs_5005_O9_id
2097	HY-17440	HYCPK40908	J08	HYCPK40908	92z	927.0	3.0	T15	908.0	J08	119302-91-9	Rocuronium (Bromide)	ORG 9426 (Bromide)	609.68	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Rocuronium Bromide (ORG 9426 Bromide) is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal musclerelaxation during surgery or mechanical ventilation.	Bromide	C32H53BrN2O4	9169.0	DMSO : 100 mg/mL (164.02 mM; Need ultrasonic); H2O : 100 mg/mL (164.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	C[C@@]12[C@](C[C@H]([N+]3(CC=C)CCCC3)[C@@H]2OC(C)=O)([H])[C@]([C@]4([H])CC1)([H])CC[C@@]([C@]4(C)C5)([H])C[C@H](O)[C@H]5N6CCOCC6.[Br-]	https://www.medchemexpress.com/rocuronium-bromide.html	Launched		92.0	T15	O9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17440	10.0	mM	345.0	DMSO	529.399985	9	O	pluskal_fda_drugs_5005_O9_id
2116	HY-17026	HYCPK40908	M09	HYCPK40908	92z	1217.0	3.0	Z17	908.0	M09	95058-81-4	Gemcitabine	LY 188011	263.20	Apoptosis; Autophagy; DNA/RNA Synthesis; Nucleoside Antimetabolite/Analog	Apoptosis; Autophagy; Cell Cycle/DNA Damage	Gemcitabine (LY 188011) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine inhibits DNA synthesis and repair, resulting in autophagyand apoptosis[1][2].	Free Base	C9H11F2N3O4	109382.0	DMSO : 250 mg/mL (949.85 mM; Need ultrasonic); Ethanol : 12.5 mg/mL (47.49 mM; Need ultrasonic); H2O : 6.25 mg/mL (23.75 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	NC(C=CN1[C@H]2C(F)(F)[C@H](O)[C@@H](CO)O2)=NC1=O	https://www.medchemexpress.com/Gemcitabine.html	Launched		92.0	Z17	O9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17026	10.0	mM	345.0	DMSO	263.071762	9	O	pluskal_fda_drugs_5005_O9_id
2187	HY-W042301	HYCPK40908	H14	HYCPK40908	92z	747.0	3.0	P27	908.0	H14	14293-44-8	Xipamide		354.81	Others	Others	Xipamide is a sulfonamide-based diuretic. Xipamide is an antihypertensive agent able to selectively inhibit the anion exchanger (AE)[1].		C15H15ClN2O4S	57799.0	DMSO : 250 mg/mL (704.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(NC1=C(C)C=CC=C1C)C2=CC(S(=O)(N)=O)=C(Cl)C=C2O	https://www.medchemexpress.com/xipamide.html	Launched		92.0	P27	O9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-W042301	10.0	mM	345.0	DMSO	354.044106	9	O	pluskal_fda_drugs_5005_O9_id
2253	HY-12689	HYCPK40908	N18	HYCPK40908	92z	1331.0	3.0	AB35	908.0	N18	1260075-17-9	Mitapivat	AG-348	450.55	Pyruvate Kinase	Metabolic Enzyme/Protease	Mitapivat (AG-348) is an orally active pyruvate kinase allosteric activator. Mitapivat increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes, shows the potential to restore the activity of PK (pyruvate kinase)-deficient glycolytic pathways. Mitapivat can be used in study of PK deficiency[1][2][3].	Free Base	C24H26N4O3S	26982.0	DMSO : 20.83 mg/mL (46.23 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=S(C1=C2N=CC=CC2=CC=C1)(NC3=CC=C(C(N4CCN(CC5CC5)CC4)=O)C=C3)=O	https://www.medchemexpress.com/PKR-IN-1.html	Launched		92.0	AB35	O9	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12689	10.0	mM	345.0	DMSO	450.172562	9	O	pluskal_fda_drugs_5005_O9_id
7	HY-B2172	HYCPK40897	G03	HYCPK40909	92z	660.0	4.0	N36	909.0	G18	12001-79-5	Vitamin K			Endogenous Metabolite	Metabolic Enzyme/Protease	Vitamin K, the blood-clotting vitamin, is important for the function of numerous proteins within the body, such as the coagulation factors, osteocalcin and matrix-Gla protein.	Free Base		152631.0	DMSO : 100 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Cardiovascular Disease; Cancer	[Vitamin K]	https://www.medchemexpress.com/Vitamin_K.html	Launched		92.0	N36	O10	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2172	3.0	mM	346.0	DMSO	450.349781	10	O	pluskal_fda_drugs_5005_O10_id
1415	HY-107789	HYCPK40906	D06	HYCPK40906	92z	299.0	1.0	G11	906.0	D06	1847-58-1	Sodium lauryl sulfoacetate		330.42	Others	Others	Sodium lauryl sulfoacetate is a solid anionic surfactant of vegetable origin[1]. Sodium lauryl sulfoacetate is an immunoadjuvant. Anti-immunosuppressive effect[2].	Sodium	C14H27NaO5S	142909.0	DMSO : 15.62 mg/mL (47.27 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(OCCCCCCCCCCCC)CS(=O)(O[Na])=O	https://www.medchemexpress.com/sodium-lauryl-sulfoacetate.html	Launched		92.0	G11	O10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107789	10.0	mM	346.0	DMSO	308.165745	10	O	pluskal_fda_drugs_5005_O10_id
1431	HY-B0579	HYCPK40906	D07	HYCPK40906	92z	301.0	1.0	G13	906.0	D07	59865-13-3	Cyclosporin A	Cyclosporine A; Ciclosporin A; CsA	1202.61	Antibiotic; Complement System; Phosphatase	Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease	Cyclosporin A (Cyclosporine A) is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of calcineurin with an IC50 of 5 nM[3]. Cyclosporin A also inhibits CD11a/CD18 adhesion[8].	Free Base	C62H111N11O12	34526.0	Ethanol : 50 mg/mL (41.58 mM; Need ultrasonic); DMSO : 62.5 mg/mL (51.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	C/C=C/C[C@H]([C@@H](O)[C@@]1(N(C)C([C@]([H])(C(C)C)N(C)C([C@H](CC(C)C)N(C)C([C@]([H])(CC(C)C)N(C)C([C@@H](C)NC([C@H](C)NC([C@@H](N(C([C@@]([H])(NC([C@@H](N(C(CN(C([C@@H](NC1=O)CC)=O)C)=O)C)CC(C)C)=O)C(C)C)=O)C)CC(C)C)=O)=O)=O)=O)=O)=O)[H])C	https://www.medchemexpress.com/cyclosporin-a.html	Launched		92.0	G13	O10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0579	10.0	mM	346.0	DMSO	1201.841368	10	O	pluskal_fda_drugs_5005_O10_id
1736	HY-101184	HYCPK40907	K04	HYCPK40907	92z	968.0	2.0	U8	907.0	K04	1415379-56-4	T807	AV-1451	263.27	Tau Protein	Neuronal Signaling	T807 a novel tau positron emission tomography (PET) tracer.	Free Base	C16H10FN3	24997.0	DMSO : ≥ 16.6 mg/mL (63.05 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	FC1=CC=C(C2=CC3=C(C=C2)C(C=NC=C4)=C4N3)C=N1	https://www.medchemexpress.com/T807.html	Launched		92.0	U8	O10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-101184	10.0	mM	346.0	DMSO	263.085876	10	O	pluskal_fda_drugs_5005_O10_id
1813	HY-B0105B	HYCPK40907	M09	HYCPK40907	92z	1170.0	2.0	Y18	907.0	M09	142128-57-2	(-)-Ketoconazole	(-)-Ketoconazol; (-)-R 41400	531.43	Fungal	Anti-infection	(-)-Ketoconazole ((-)-R 41400) is one of the enantiomer of Ketoconazole. Ketoconazole is a racemic mixture of two enantiomers, levoketoconazole ((2S,4R)-(?)-ketoconazole) and dextroketoconazole ((2R,4S)-(+)-ketoconazole).	Free Base	C26H28Cl2N4O4	31884.0	DMSO : 33.33 mg/mL (62.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	CC(N1CCN(C2=CC=C(OC[C@H]3O[C@](CN4C=CN=C4)(C5=CC=C(Cl)C=C5Cl)OC3)C=C2)CC1)=O	https://www.medchemexpress.com/_-_-Ketoconazole.html	Launched		92.0	Y18	O10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0105B	10.0	mM	346.0	DMSO	530.148761	10	O	pluskal_fda_drugs_5005_O10_id
1983	HY-13666	HYCPK40907	C21	HYCPK40907	92z	234.0	2.0	E42	907.0	C21	16595-80-5	Levamisole (hydrochloride)	(-)-Tetramisole hydrochloride	240.75	HSV; Parasite	Anti-infection	Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV.	Hydrochloride	C11H13ClN2S	15278.0	DMSO : 15.5 mg/mL (64.38 mM; Need ultrasonic and warming); Ethanol : 12.5 mg/mL (51.92 mM; Need ultrasonic); H2O : 50 mg/mL (207.68 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Neurological Disease	[H]Cl.C12=N[C@@H](C3=CC=CC=C3)CN1CCS2	https://www.medchemexpress.com/Levamisole-hydrochloride.html	Launched		92.0	E42	O10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13666	10.0	mM	346.0	DMSO	204.072119	10	O	pluskal_fda_drugs_5005_O10_id
2231	HY-B1832	HYCPK40908	H17	HYCPK40908	92z	753.0	3.0	P33	908.0	H17	125-10-0	Prednisone acetate	Prednisone 21-acetate	400.46	Glucocorticoid Receptor	Immunology/Inflammation	Prednisone acetate (Prednisone 21-acetate), the acetate salt form of prednisolone, is a glucocorticoid receptor agonist with anti-inflammatory and immunomodulating properties[1].	Free Base	C23H28O6	101239.0	DMSO : 25 mg/mL (62.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	C[C@@]1(C2)[C@](C(COC(C)=O)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])C2=O)=O	https://www.medchemexpress.com/prednisone-acetate.html	Launched		92.0	P33	O10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1832	10.0	mM	346.0	DMSO	400.188589	10	O	pluskal_fda_drugs_5005_O10_id
2282	HY-A0032A	HYCPK40908	K20	HYCPK40908	92z	1047.0	3.0	V39	908.0	K20	175865-59-5	Valganciclovir (hydrochloride)		390.82	CMV	Anti-infection	"Valganciclovir (hydrochloride), the L-valyl ester of ganciclovir, is actually a prodrug for ganciclovir. Valganciclovir is an antiviral medication used to treat cytomegalovirus infections.
IC50 Value: 
Target: CMV
in vitro: In cell culture model systems using Caco-2 cells for PEPT1 and SKPT cells for PEPT2, valganciclovir inhibited glycylsarcosine transport mediated by PEPT1 and PEPT2 with K(i) values (inhibition constant) of 1.68+/-0.30 and 0.043+/- 0.005 mM, respectively. The inhibition by valganciclovir was competitive in both cases [1].
in vivo: 37 patients were enrolled; 19 patients received treatment with VGV and 18 patients received treatment with GCV. The VGV was not inferior in efficacy to GCV as pre-emptive therapy, with rates of viral clearance at 28 days of 89.5% and 83%, respectively (P-value for non-inferiority = 0.030). Toxicities were similar between the 2 arms. No patients developed CMV disease [2]. Patients being treated with an alemtuzumab-containing regimen received prophylaxis with either valaciclovir 500 mg orally daily orvalganciclovir 450 mg orally twice daily. None of the 20 patients randomized to valganciclovir experienced CMV reactivation (P = .004) [3]."	Hydrochloride	C14H23ClN6O5	12948.0	H2O : ≥ 50 mg/mL (127.94 mM); DMSO : 50 mg/mL (127.94 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	N[C@@H](C(C)C)C(OCC(OCN1C=NC2=C1N=C(N)NC2=O)CO)=O.[H]Cl	https://www.medchemexpress.com/valganciclovir-hydrochloride.html	Launched		92.0	V39	O10	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0032A	10.0	mM	346.0	DMSO	354.165168	10	O	pluskal_fda_drugs_5005_O10_id
14	HY-A0248	HYCPK40897	N03	HYCPK40909	92z	1332.0	4.0	AB36	909.0	N18	1405-20-5	Polymyxin B (Sulfate)		1287.53 (PolymyxinB2Sulfate)	Antibiotic; Bacterial	Anti-infection	Polymyxin B Sulfate is a potent antibacterial agent and a relatively toxic antibiotic. Polymyxin B Sulfate also is a antiendotoxin agent. Polymyxin B Sulfate shows endotoxin-neutralizing properties can be used as adjunctive therapy in gram-negative sepsis. Polymyxin B Sulfate shows antibacterial activities in vitro and in vivo[1][2][3].	Sulfate	C55H96N16O13.H2SO4 (Polymyxin B2 Sulfate)	63047.0	H2O : ≥ 25 mg/mL	DMSO Solution	3mg/mL  * 100uL	Infection	O=S(O)(O)=O.O=C(N[C@H](C(N[C@@](C(N[C@H](C(N[C@@]1([H])[C@H](O)C)=O)CCN)=O)([H])CCN)=O)CC(C)C)[C@H](NC([C@@H](NC([C@@](CCNC1=O)([H])NC([C@H](CCN)NC([C@H]([C@H](O)C)NC([C@H](CCN)NC(CCCCC(C)C)=O)=O)=O)=O)=O)CCN)=O)CC2=CC=CC=C2.O=C(N[C@H](C(N[C@@](C(N[C@H](C	https://www.medchemexpress.com/Polymyxin-B-Sulfate.html	Launched		92.0	AB36	O11	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0248	3.0	mM	347.0	DMSO	1202.749927	11	O	pluskal_fda_drugs_5005_O11_id
1467	HY-B0774	HYCPK40908	J16	HYCPK40908	92z	943.0	3.0	T31	908.0	J16	112665-43-7	Seratrodast	AA 2414	354.44	Prostaglandin Receptor	GPCR/G Protein	Seratrodast(AA 2414) is an anti-asthmatic agent and a potent and selective thromboxane A2 receptor (TP) antagonist.	Free Acid	C22H26O4	16529.0	DMSO : ≥ 100 mg/mL (282.14 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	CC(C1=O)=C(C(C(C)=C1C)=O)C(C2=CC=CC=C2)CCCCCC(O)=O	https://www.medchemexpress.com/seratrodast.html	Launched		92.0	T31	O11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0774	10.0	mM	347.0	DMSO	354.183109	11	O	pluskal_fda_drugs_5005_O11_id
1659	HY-10268	HYCPK40906	N19	HYCPK40906	92z	1285.0	1.0	AA37	906.0	N19	330942-05-7	Betrixaban	PRT054021	451.91	Factor Xa	Metabolic Enzyme/Protease	Betrixaban (PRT054021) is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban shows antithrombotic effect[1][3].	Free Base	C23H22ClN5O3	25848.0	DMSO : 25 mg/mL (55.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	N=C(N(C)C)C(C=C1)=CC=C1C(NC2=CC=C(OC)C=C2C(NC(C=C3)=NC=C3Cl)=O)=O	https://www.medchemexpress.com/Betrixaban.html	Launched		92.0	AA37	O11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10268	10.0	mM	347.0	DMSO	451.141117	11	O	pluskal_fda_drugs_5005_O11_id
1859	HY-118620	HYCPK40907	K12	HYCPK40907	92z	984.0	2.0	U24	907.0	K12	72-69-5	Nortriptyline	Desmethylamitriptyline; Desitriptilina	263.38	Autophagy; Drug Metabolite	Autophagy; Metabolic Enzyme/Protease	Nortriptyline (Desmethylamitriptyline), the main active metabolite of Amitriptyline, is a tricyclic antidepressant used to relieve the symptoms of depression. Nortriptyline is a potent autophagy inhibitor[1][2].		C19H21N	228380.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Cancer; Neurological Disease	CNCC/C=C1C2=CC=CC=C2CCC3=CC=CC=C\13	https://www.medchemexpress.com/nortriptyline.html	Launched		92.0	U24	O11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-118620	10.0	mM	347.0	DMSO	263.1674	11	O	pluskal_fda_drugs_5005_O11_id
1963	HY-U00190	HYCPK40907	K19	HYCPK40907	92z	998.0	2.0	U38	907.0	K19	20424-00-4	Deprodone propionate	RD20000	400.51	Bacterial	Anti-infection	Deprodone propionate (RD20000) is a corticosteroid which is obtained by esterifying with propionic acid the 17-position of the prednisolone skeleton and deoxidating its 21-position.	Free Base	C24H32O5	58298.0	DMSO : 250 mg/mL (624.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@@](C(C)=O)(CC[C@@]1([H])[C@@]3([H])[C@]([C@@]4(C(CC3)=CC(C=C4)=O)C)([H])[C@@H](O)C2)OC(CC)=O	https://www.medchemexpress.com/RD20000.html	Launched		92.0	U38	O11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-U00190	10.0	mM	347.0	DMSO	400.224974	11	O	pluskal_fda_drugs_5005_O11_id
1976	HY-B0134A	HYCPK40907	L20	HYCPK40907	92z	1096.0	2.0	W40	907.0	L20	65391-42-6	Bestatin (hydrochloride)	Ubenimex hydrochloride	344.83	Aminopeptidase; Antibiotic; Bacterial	Anti-infection; Metabolic Enzyme/Protease	Bestatin hydrochloride is an inhibitor of CD13 (Aminopeptidase N)/APN and leukotriene A4 hydrolase, used for cancer research.	Hydrochloride	C16H25ClN2O4	81763.0	H2O : 100 mg/mL (290.00 mM; Need ultrasonic); DMSO : 250 mg/mL (724.99 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	CC(C)C[C@@H](C(O)=O)NC([C@@H](O)[C@H](N)CC1=CC=CC=C1)=O.Cl	https://www.medchemexpress.com/Bestatin-hydrochloride.html	Launched		92.0	W40	O11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0134A	10.0	mM	347.0	DMSO	308.173607	11	O	pluskal_fda_drugs_5005_O11_id
2109	HY-A0106	HYCPK40908	F09	HYCPK40908	92z	545.0	3.0	L17	908.0	F09	14769-73-4	(S)-(-)-Levamisole	Levamisole; L-Tetramisole; Levamisol	204.29	nAChR; Parasite	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	(S)-(-)-Levamisole (Levamisole), an anthelmintic agent with immunomodulatory properties. (S)-(-)-Levamisole acts as a positive allosteric modulator (PAM) for the α3β2 (EC50=300 μM) and α3β4 (EC50=100 μM) subtype of nAChRs. Orally active[1][2].		C11H12N2S	135071.0	10 mM in DMSO	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Cancer	C12=N[C@@H](C3=CC=CC=C3)CN1CCS2	https://www.medchemexpress.com/s-minus-levamisole.html	Launched		92.0	L17	O11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0106	10.0	mM	347.0	DMSO	204.072119	11	O	pluskal_fda_drugs_5005_O11_id
2244	HY-N0862	HYCPK40908	E18	HYCPK40908	92z	467.0	3.0	J35	908.0	E18	26833-85-2	Harringtonine		531.59	Influenza Virus	Anti-infection	Harringtonine is a natural Cephalotaxus alkaloid that inhibits protein synthesis. Harringtonine has anti-chikungunya virus (CHIKV) activities with an EC50 of 0.24 μM.	Free Base	C28H37NO9	87126.0	DMSO : 100 mg/mL (188.11 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C([C@@](CC(OC)=O)(O)CCC(C)(O)C)O[C@H]1[C@](C2=CC(OCO3)=C3C=C2CCN4CCC5)([H])[C@]45C=C1OC	https://www.medchemexpress.com/Harringtonine.html	Launched		92.0	J35	O11	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0862	10.0	mM	347.0	DMSO	531.246832	11	O	pluskal_fda_drugs_5005_O11_id
1434	HY-B1194	HYCPK40906	G07	HYCPK40906	92z	589.0	1.0	M13	906.0	G07	5086-74-8	Tetramisole (hydrochloride)	(±)-Tetramisole hydrochloride; DL-Tetramisole hydrochloride; R-829	240.75	Antibiotic; Parasite; Phosphatase	Anti-infection; Metabolic Enzyme/Protease	Tetramisole hydrochloride is an inhibitor of alkaline phosphatases, is a high purity antiparasitic.	Hydrochloride	C11H13ClN2S	17531.0	DMSO : 10 mg/mL (41.54 mM; Need ultrasonic); H2O : 100 mg/mL (415.37 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[H]Cl.C12=NC(C3=CC=CC=C3)CN1CCS2	https://www.medchemexpress.com/Tetramisole-hydrochloride.html	Launched		92.0	M13	O12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1194	10.0	mM	348.0	DMSO	204.072119	12	O	pluskal_fda_drugs_5005_O12_id
1441	HY-B2206	HYCPK40907	L04	HYCPK40907	92z	1064.0	2.0	W8	907.0	L04	51-77-4	Gefarnate		400.64	Others	Others	Gefarnate is a drug used for the treatment of gastritis and gastric ulcer, and has been proposed for use in the treatment of dry eye syndrome.	Free Base	C27H44O2	57377.0	DMSO : 31.25 mg/mL (78.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C/C(C)=C\CC/C(C)=C/CC/C(C)=C/CCC(OC/C=C(C)/CC/C=C(C)/C)=O	https://www.medchemexpress.com/Gefarnate.html	Launched		92.0	W8	O12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2206	10.0	mM	348.0	DMSO	400.334131	12	O	pluskal_fda_drugs_5005_O12_id
1545	HY-77036	HYCPK40906	L12	HYCPK40906	92z	1079.0	1.0	W23	906.0	L12	1672-88-4	Furagin	Furazidine; Furazidin	264.19	Bacterial	Anti-infection	"Furagin, nitrofurantoin analog, is an anti-bacterial agent. Furagin is 2-substituted 5-nitrofuran, chemically and structurally similar to well-known antibacterial compound nitrofurantoin.
IC50 Value: 
Target: Antibacterial
in vitro: The furagin concentrations in serum remain several hours above the MIC concentrations of many pathogenic bacteria. Despite the high concentrations in serum, the urine levels of furagin were generally lower than those of nitrofurantoin. The 24 hr recoveries in urine were 8--13% for furagin and about 36% for nitrofurantoin [1].
in vivo: A time-independent increase in SCE frequency was found in lymphocytes of children treated with furagin. Total CA frequency did not differ significantly between groups of children with various duration of furagin treatment [2]. Women were randomised into two groups receiving either ciprofloxacin 250mg twice a day for 3 days (n=13) or furagin 100mg three times a day for 7 days (n=14). Median lengths of follow-up were 4 days and 5 days in the ciprofloxacin and furagin groups, respectively [3]."	Free Base	C10H8N4O5	5314.0	DMSO : 25 mg/mL (94.63 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Infection	O=C1NC(CN1/N=C/C=C/C2=CC=C(O2)[N+]([O-])=O)=O	https://www.medchemexpress.com/Furagin.html	Launched		92.0	W23	O12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-77036	10.0	mM	348.0	DMSO	264.049469	12	O	pluskal_fda_drugs_5005_O12_id
1676	HY-106638	HYCPK40906	O20	HYCPK40906	92z	1383.0	1.0	AC39	906.0	O20	515814-01-4	Voclosporin	ISAtx-247	1214.62	Phosphatase	Metabolic Enzyme/Protease	Voclosporin (ISAtx-247) is a calcineurin (PP2B) (CN) inhibitor[1].	Free Base	C63H111N11O12	33311.0	DMSO : ≥ 50 mg/mL (41.17 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C=C/C=C/C[C@@H](C)[C@H]([C@]1([H])N(C([C@](N(C([C@@H](N(C([C@](N(C([C@H](NC([C@@H](NC([C@H](CC(C)C)N(C)C([C@@](C(C)C)([H])NC([C@H](CC(C)C)N(C)C(CN(C)C([C@H](CC)NC1=O)=O)=O)=O)=O)=O)C)=O)C)=O)C)([H])CC(C)C)=O)C)CC(C)C)=O)C)([H])C(C)C)=O)C)O	https://www.medchemexpress.com/Voclosporin.html	Launched		92.0	AC39	O12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-106638	10.0	mM	348.0	DMSO	1213.841368	12	O	pluskal_fda_drugs_5005_O12_id
1737	HY-N0127	HYCPK40907	A05	HYCPK40907	92z	10.0	2.0	A10	907.0	A05	65-19-0	Yohimbine (Hydrochloride)		390.90	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Yohimbine Hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.	Hydrochloride	C21H27ClN2O3	18735.0	H2O : 3.33 mg/mL (8.52 mM; Need ultrasonic); DMSO : 33.33 mg/mL (85.26 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	[H][C@]12C(NC3=C4C=CC=C3)=C4CCN1C[C@@]5(CC[C@H](O)[C@H](C(OC)=O)[C@]5(C2)[H])[H].[H]Cl	https://www.medchemexpress.com/Yohimbine-Hydrochloride.html	Launched		92.0	A10	O12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0127	10.0	mM	348.0	DMSO	354.194343	12	O	pluskal_fda_drugs_5005_O12_id
1917	HY-14930A	HYCPK40907	M16	HYCPK40907	92z	1184.0	2.0	Y32	907.0	M16	862189-96-6	Mirodenafil (dihydrochloride)	SK-3530 dihydrochloride	604.59	Apoptosis; Glucocorticoid Receptor; Phosphodiesterase (PDE); Wnt; β-catenin	Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; Stem Cell/Wnt	Mirodenafil (SK3530) dihydrochloride is an orally active, potent, reversible, and selective phosphodiesterase 5 (PDE5) inhibitor. Mirodenafil dihydrochloride is a glucocorticoid receptor (GR) modulator Mirodenafil dihydrochloride activates the Wnt/β-catenin signaling pathway by downregulating Dkk1 expression. Mirodenafil dihydrochloride can be used for the research of erectile dysfunction (ED), Alzheimer’s disease (AD) and systemic sclerosis (SSc)[1][2][3].	Hydrochloride	C26H39Cl2N5O5S	12263.0	DMSO : ≥ 100 mg/mL (165.40 mM)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology; Neurological Disease	[H]Cl.[H]Cl.O=C1C(N(CC)C=C2CCC)=C2N=C(C3=CC(S(=O)(N4CCN(CCO)CC4)=O)=CC=C3OCCC)N1	https://www.medchemexpress.com/Mirodenafil-dihydrochloride.html	Launched		92.0	Y32	O12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14930A	10.0	mM	348.0	DMSO	531.25154	12	O	pluskal_fda_drugs_5005_O12_id
2227	HY-B1288	HYCPK40908	D17	HYCPK40908	92z	369.0	3.0	H33	908.0	D17	5987-82-6	Oxybuprocaine hydrochloride	Benoxinate hydrochloride	344.88	Sodium Channel	Membrane Transporter/Ion Channel	Oxybuprocaine hydrochloride (Benoxinate hydrochloride) reversibly blocks sodium channels and prevents propagation of painful nerve impulses in the cornea, conjunctiva, and sclera. Oxybuprocaine hydrochloride is used especially in ophthalmology and otolaryngology[1][2][3].	Hydrochloride	C17H29ClN2O3	63898.0	H2O : ≥ 100 mg/mL (289.96 mM); DMSO : 100 mg/mL (289.96 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCN(CC)CC)C1=CC=C(N)C(OCCCC)=C1.[H]Cl	https://www.medchemexpress.com/oxybuprocaine-hydrochloride.html	Launched		92.0	H33	O12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1288	10.0	mM	348.0	DMSO	308.209993	12	O	pluskal_fda_drugs_5005_O12_id
2544	HY-15296	HYCPK40909	C11	HYCPK40909	92z	262.0	4.0	F22	909.0	C11	81409-90-7	Cabergoline	FCE-21336	451.60	Autophagy; Dopamine Receptor	Autophagy; GPCR/G Protein; Neuronal Signaling	Cabergoline is an ergot derived-dopamine D2-like receptor agonist that has high affinity for D2, D3, and 5-HT2B receptors (Ki=0.7, 1.5, and 1.2, respectively).	Free Base	C26H37N5O2	151968.0	DMSO : 250 mg/mL (553.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C=CCN1[C@@]2([H])[C@@](C[C@H](C1)C(N(CCCN(C)C)C(NCC)=O)=O)([H])C3=CC=CC4=C3C(C2)=CN4	https://www.medchemexpress.com/Cabergoline.html	Launched		92.0	F22	O12	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15296	10.0	mM	348.0	DMSO	451.294725	12	O	pluskal_fda_drugs_5005_O12_id
1535	HY-N0623	HYCPK40906	B12	HYCPK40906	92z	119.0	1.0	C23	906.0	B12	73-22-3	L-Tryptophan	Tryptophan; Tryptophane	204.23	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Tryptophan (Tryptophan) is an essential amino acid that is the precursor of serotonin, melatonin, and vitamin B3[1].	Free Acid	C11H12N2O2	26056.0	DMSO : 7.69 mg/mL (37.65 mM; Need ultrasonic); H2O : 12.5 mg/mL (61.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	N[C@@H](CC1=CNC2=CC=CC=C12)C(O)=O	https://www.medchemexpress.com/L-Tryptophan.html	Launched		92.0	C23	O13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0623	10.0	mM	349.0	DMSO	204.089878	13	O	pluskal_fda_drugs_5005_O13_id
1552	HY-B0925	HYCPK40906	C13	HYCPK40906	92z	217.0	1.0	E25	906.0	C13	1173-88-2	Oxacillin (sodium salt)		423.42	Antibiotic; Bacterial	Anti-infection	Oxacillin sodium salt is an orally active synthetic penicillin with good bactericidal activity against staphylococci and other gram-positive pathogens[1].	Sodium	C19H18N3NaO5S	115861.0	DMSO : 125 mg/mL (295.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(O[Na])[C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C3=C(C)ON=C3C4=CC=CC=C4)=O)N1C2=O	https://www.medchemexpress.com/Oxacillin-sodium-salt.html	Launched		92.0	E25	O13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0925	10.0	mM	349.0	DMSO	401.104542	13	O	pluskal_fda_drugs_5005_O13_id
1752	HY-B0512	HYCPK40907	P05	HYCPK40907	92z	1450.0	2.0	AE10	907.0	P05	127-79-7	Sulfamerazine	RP2632	264.30	Antibiotic; Bacterial	Anti-infection	Sulfamerazine (RP-2632) is a sulfonamide antibacterial. Sulfamerazine, the monomethyl derivative of sulfadiazine, is 2-sulfanilamido-4-methylpyrimidine. Sulfamerazine is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthesizes[1].	Free Base	C11H12N4O2S	13317.0	H2O : 0.1 mg/mL (0.38 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (378.36 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(C1=CC=C(N)C=C1)(NC2=NC=CC(C)=N2)=O	https://www.medchemexpress.com/sulfamerazine.html	Launched		92.0	AE10	O13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0512	10.0	mM	349.0	DMSO	264.068097	13	O	pluskal_fda_drugs_5005_O13_id
1890	HY-15666A	HYCPK40907	B15	HYCPK40907	92z	126.0	2.0	C30	907.0	B15	1421783-64-3	Olverembatinib (dimesylate)	GZD824 (dimesylate); HQP1351 (dimesylate)	724.77	Bcr-Abl	Protein Tyrosine Kinase/RTK	Olverembatinib (GZD824) dimesylate is a potent and orally active pan-Bcr-Abl inhibitor. Olverembatinib dimesylate potently inhibits a broad spectrum of Bcr-Abl mutants. Olverembatinib dimesylate strongly inhibits native Bcr-Abl and Bcr-AblT315I with IC50s of 0.34 nM and 0.68 nM, respectively. Olverembatinib dimesylate has antitumor activity[1].	Mesylate	C31H35F3N6O7S2	78863.0	H2O : ≥ 50 mg/mL (68.99 mM); DMSO : 125 mg/mL (172.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(NC1=CC=C(CN2CCN(C)CC2)C(C(F)(F)F)=C1)C3=CC=C(C)C(C#CC4=CN=C(NN=C5)C5=C4)=C3.CS(=O)(O)=O.CS(=O)(O)=O	https://www.medchemexpress.com/gzd824-dimesylate.html	Launched		92.0	C30	O13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15666A	10.0	mM	349.0	DMSO	532.219844	13	O	pluskal_fda_drugs_5005_O13_id
2004	HY-12710A	HYCPK40907	H22	HYCPK40907	92z	716.0	2.0	O44	907.0	H22	6211-32-1	Rauwolscine (hydrochloride)	α-Yohimbine hydrochloride; Corynanthidine hydrochloride; Isoyohimbine hydrochloride	390.90	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Rauwolscine hydrochloride is a potent and specific α2 adrenergic receptor antagonist with a Ki of 12 nM.	Hydrochloride	C21H27ClN2O3	222153.0	DMSO : 6 mg/mL (15.35 mM; Need ultrasonic); H2O : 5 mg/mL (12.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	[H]Cl.[H][C@]12C(NC3=C4C=CC=C3)=C4CCN1C[C@@]5([H])CC[C@H](O)[C@@H](C(OC)=O)[C@]5(C2)[H]	https://www.medchemexpress.com/Rauwolscine_hydrochloride.html	Launched		92.0	O44	O13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12710A	10.0	mM	349.0	DMSO	354.194343	13	O	pluskal_fda_drugs_5005_O13_id
2013	HY-B0415	HYCPK40908	A03	HYCPK40908	92z	53.0	3.0	B5	908.0	A03	67-73-2	Fluocinolone (Acetonide)		452.49	Glucocorticoid Receptor	Immunology/Inflammation	"Fluocinolone Acetonide is a glucocorticoid derivative used topically in the treatment of various skin disorders.
Target: Glucocorticoid Receptor
Fluocinolone acetonide is a corticosteroid primarily used in dermatology to reduce skin inflammation and relieve itching. It is a synthetic hydrocortisone derivative. The fluorine substitution at position 9 in the steroid nucleus greatly enhances its activity. A typical dosage strength used in dermatology is 0.01-0.025%. One such cream is sold under the brand name Flucort-N and includes the antibiotic neomycin. The Glucocorticoid Receptor(GR) binding affinity (IC50) for Fluocinolone Acetonide(FA) was 2.0 nM, respectively. The values is similar to the GR transactivation EC50 of 0.7 nM for FA, respectively [1, 2]."	Free Base	C24H30F2O6	46442.0	DMSO : ≥ 31 mg/mL (68.51 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](C[C@H](F)C3=CC4=O)([H])[C@@](F)([C@]3(C=C4)C)[C@@H](O)C5)(OC(C)(C)O1)[C@]25C)CO	https://www.medchemexpress.com/Fluocinolone-Acetonide.html	Launched		92.0	B5	O13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0415	10.0	mM	349.0	DMSO	452.201045	13	O	pluskal_fda_drugs_5005_O13_id
2294	HY-12554A	HYCPK40908	G21	HYCPK40908	92z	665.0	3.0	N41	908.0	G21	1884420-36-3	Terlipressin (acetate)		1347.48	Vasopressin Receptor	GPCR/G Protein	Terlipressin acetate is a vasopressin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research[1][2][3][4][5].	Acetate	C56H82N16O19S2	65259.0	H2O : 100 mg/mL (74.21 mM; Need ultrasonic); DMSO : 100 mg/mL (74.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology; Cardiovascular Disease	O=C([C@H](CSSC[C@@H](C(N[C@H](C1=O)CC2=CC=C(O)C=C2)=O)NC(CNC(CNC(CN)=O)=O)=O)NC([C@@H](NC([C@@H](NC([C@](N1)([H])CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)N(CCC4)[C@@H]4C(N[C@@H](CCCCN)C(NCC(N)=O)=O)=O.CC(O)=O.CC(O)=O	https://www.medchemexpress.com/terlipressin-acetate.html	Launched		92.0	N41	O13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12554A	10.0	mM	349.0	DMSO	1226.496098	13	O	pluskal_fda_drugs_5005_O13_id
2429	HY-120081A	HYCPK40909	I03	HYCPK40909	92z	822.0	4.0	R6	909.0	I03	7081-40-5	Metixene (hydrochloride hydrate)		363.94	Others	Others	Metixene (Piperidine) hydrochloride hydrate is an anticholinergic and antiparkinsonian agent. Metixene hydrochloride hydrate potently inhibits binding of quinuclidinyl benzilate (QNB) with the muscarinic receptor, IC50 and Ki values of 55 nM and 15 nM, respectively. Metixene hydrochloride hydrate can be used for the research of parkinsonian[1][2][3].	Hydrochloride	C20H26ClNOS	41324.0	DMSO : 77.5 mg/mL (212.95 mM; Need ultrasonic); H2O : 10 mg/mL (27.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CN1CC(CCC1)CC2C3=C(C=CC=C3)SC4=C2C=CC=C4.Cl.O	https://www.medchemexpress.com/Metixene_hydrochloride_hydrate.html	Launched		92.0	R6	O13	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-120081A	10.0	mM	349.0	DMSO	309.155121	13	O	pluskal_fda_drugs_5005_O13_id
1387	HY-B0465	HYCPK40906	H04	HYCPK40906	92z	679.0	1.0	O7	906.0	H04	7240-38-2	Oxacillin (sodium monohydrate)		441.43	Antibiotic; Bacterial	Anti-infection	Oxacillin sodium monohydrate is an antibiotic similar to Flucloxacillin used in resistant staphylococci infections study[1].	Sodium	C19H20N3NaO6S	18264.0	H2O : ≥ 100 mg/mL (226.54 mM); DMSO : 50 mg/mL (113.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(O[Na])[C@@H]1N(C2=O)[C@]([C@@H]2NC(C(C(C3=CC=CC=C3)=NO4)=C4C)=O)([H])SC1(C)C.O	https://www.medchemexpress.com/Oxacillin-sodium-monohydrate.html	Launched		92.0	O7	O14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0465	10.0	mM	350.0	DMSO	401.104542	14	O	pluskal_fda_drugs_5005_O14_id
1451	HY-B1021	HYCPK40907	M14	HYCPK40907	92z	1180.0	2.0	Y28	907.0	M14	1617-90-9	Vincamine		354.44	Free Fatty Acid Receptor	GPCR/G Protein	Vincamine?is a monoterpenoid indole alkaloid extracted from the?Madagascar periwinkle. Vincamine?is a peripheral?vasodilator?and exerts a selective vasoregulator action on the brain microcapilar circulation[1]. Vincamine?is a?GPR40?agonist and acts as a β-cell protector by ameliorating β-cell dysfunction and promoting glucose-stimulated insulin secretion (GSIS).?Vincamine?improves glucose homeostasis?in vivo, and has the potential for the type 2 diabetes mellitus (T2DM) research[2].	Free Base	C21H26N2O3	17266.0	DMSO : 25 mg/mL (70.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	O=C(OC)[C@@]1(O)C[C@@]2(CC)[C@@]3([H])C(N1C4=CC=CC=C54)=C5CCN3CCC2	https://www.medchemexpress.com/Vincamine.html	Launched		92.0	Y28	O14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1021	10.0	mM	350.0	DMSO	354.194343	14	O	pluskal_fda_drugs_5005_O14_id
1589	HY-108766	HYCPK40906	H15	HYCPK40906	92z	701.0	1.0	O29	906.0	H15	1114544-31-8	Ponatinib (hydrochloride)	AP24534 (hydrochloride)	569.02	Autophagy; Bcr-Abl; FGFR; PDGFR; Src; VEGFR	Autophagy; Protein Tyrosine Kinase/RTK	Ponatinib (AP24534) hydrochloride is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively[1].	Hydrochloride	C29H28ClF3N6O	152346.0	DMSO : 25 mg/mL (43.94 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=CC=C(C)C(C#CC2=CN=C3C=CC=NN23)=C1)NC4=CC=C(CN5CCN(CC5)C)C(C(F)(F)F)=C4.Cl	https://www.medchemexpress.com/ponatinib-hydrochloride.html	Launched		92.0	O29	O14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108766	10.0	mM	350.0	DMSO	532.219844	14	O	pluskal_fda_drugs_5005_O14_id
1757	HY-B0600	HYCPK40907	E06	HYCPK40907	92z	396.0	2.0	I12	907.0	E06	209860-87-7	Tafluprost	AFP-168; MK2452	452.53	Others	Others	"Tafluprost(AFP-168) is an anti-glaucoma prostaglandin (PG) analog.
Target:Others
Tafluprost showed significant IOP-lowering effects without any safety concerns in patients with various types of glaucoma and OH in daily clinical practice and tafluprost is highly effective in any therapeutic patterns [1]. Tafluprost with reduced BAK has potential as a superior antiglaucoma drug, not only for its IOP-lowering effect, but also for its good corneal safety profile [2]. Tafluprost single-use vials treatment was effective in reducing IOP over the 3 years of this study, but visual field performance worsened by 10.3%-13.8% in patients with normal-tension glaucoma. Safety was satisfactory [3]."	Free Base	C25H34F2O5	56285.0	DMSO : ≥ 270 mg/mL (596.65 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(OC(C)C)CCC/C=C\C[C@@H]1[C@@H](/C=C/C(F)(F)COC2=CC=CC=C2)[C@H](O)C[C@@H]1O	https://www.medchemexpress.com/tafluprost.html	Launched		92.0	I12	O14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0600	10.0	mM	350.0	DMSO	452.237431	14	O	pluskal_fda_drugs_5005_O14_id
1958	HY-30235A	HYCPK40907	F19	HYCPK40907	92z	518.0	2.0	K38	907.0	F19	132-69-4	Benzydamine (hydrochloride)		345.87	Bacterial; PGE synthase	Anti-infection; Immunology/Inflammation	Benzydamine hydrochloride is a locally-acting nonsteroidal anti-inflammatory drug with local anaesthetic and analgesic properties; selectively binds to prostaglandin synthetase and has notable in vitro antibacterial activity.	Hydrochloride	C19H24ClN3O	17500.0	H2O : ≥ 41 mg/mL (118.54 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3.[H]Cl	https://www.medchemexpress.com/Benzydamine-hydrochloride.html	Launched		92.0	K38	O14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-30235A	10.0	mM	350.0	DMSO	309.184112	14	O	pluskal_fda_drugs_5005_O14_id
1982	HY-13673A	HYCPK40907	B21	HYCPK40907	92z	138.0	2.0	C42	907.0	B21	145781-92-6	Goserelin (acetate)	ICI-118630 (acetate)	1329.46	Apoptosis; GnRH Receptor	Apoptosis; GPCR/G Protein	Goserelin acetate (ICI-118630 acetate), a decapeptide analogue of gonadotropin-releasing hormone (GnRH/LHRH), functions as a GnRH agonist. Goserelin acetate can be used for the research of breast cancer, epithelial ovarian cancer and prostate cancer[1][2].	Acetate	C61H88N18O16	179361.0	DMSO : ≥ 28 mg/mL (21.06 mM); H2O : 100 mg/mL (75.22 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	O=C(N[C@H](C(N[C@@H](CC1=CC=C(O)C=C1)C(N[C@H](COC(C)(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCCNC(N)=N)C(N2CCC[C@H]2C(NNC(N)=O)=O)=O)=O)=O)=O)=O)CO)[C@@H](NC([C@H](CC3=CN=CN3)NC([C@@H](N4)CCC4=O)=O)=O)CC5=CNC6=C5C=CC=C6.CC(O)=O	https://www.medchemexpress.com/Goserelin-acetate.html	Launched		92.0	C42	O14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13673A	10.0	mM	350.0	DMSO	1268.641439	14	O	pluskal_fda_drugs_5005_O14_id
2206	HY-10221	HYCPK40908	K15	HYCPK40908	92z	1037.0	3.0	V29	908.0	K15	149647-78-9	Vorinostat	SAHA; Suberoylanilide hydroxamic acid	264.32	Apoptosis; Autophagy; Filovirus; HDAC; HPV; Mitophagy	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics	Vorinostat (SAHA) is a potent and orally active pan-inhibitor of HDAC1, HDAC2 and HDAC3 (Class I), HDAC6 and HDAC7 (Class II) and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis[1][4]. Vorinostat is also an effective inhibitor of human papillomaviruse (HPV)-18 DNA amplification[7].	Free Base	C14H20N2O3	97213.0	DMSO : ≥ 100 mg/mL (378.33 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(NC1=CC=CC=C1)CCCCCCC(NO)=O	https://www.medchemexpress.com/Vorinostat.html	Launched		92.0	V29	O14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10221	10.0	mM	350.0	DMSO	264.147393	14	O	pluskal_fda_drugs_5005_O14_id
2252	HY-B0535A	HYCPK40908	M18	HYCPK40908	92z	1235.0	3.0	Z35	908.0	M18	1070-11-7	Ethambutol (dihydrochloride)	Emb dihydrochloride	277.23	Antibiotic; Bacterial	Anti-infection	"Ethambutol dihydrochloride (Emb dihydrochloride) is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases.
Target: Antibacterial
Ethambutol dihydrochloride (Emb dihydrochloride) directly affects two polymers, arabinogalactan (AG) and lipoarabinomannan (LAM) in Mycobacterium smegmatis. In M. smegmatis, Ethambutol inhibits synthesis of arabinan completely and inhibits AG synthesis most likely as a consequence of this; more than 50% of the cell arabinan is released from the bacteria following Ethambutol treatment, whereas no galactan is released. Ethambutol main targets against embB gene product in M. avium. Ethambutol induces 60% changes in the embB gene in M. tuberculosis resistant mutants [1]. 
Ethambutol dihydrochloride (Emb dihydrochloride) is effective against actively growing microorganisms of the genus Mycobacterium, including M. tuberculosis. Nearly all strains of M. tuberculosis and M. kansasii as well as a number of strains of the M. aviumcomplex (MAC) are sensitive to Ethambutol. [1] 
Ethambutol dihydrochloride (Emb dihydrochloride) is potency against M. tuberculosis (H37Rv) with MIC of 0.5 μg/mL in vitro [2]. Ethambutol is efficient on treatment of mycobacterial-infected macrophages. When M. tuberculosis infected macrophages are treated with 6 μg/mL Ethambutol, the log CFUs following treatment for 3 days is 4.17, while value in control group is 4.8. The MICs for M. avium (MTCC 1723) and M. smegmatis (MTCC 6) are 15 μg/mL and 0.18 μg/mL, respectively. Ethambutol is efficient in animal model. 100 mg/kg Ethambutol given orally 15 days post i.v. infection 1 ×/week for 5 weeks, induces a lower log CFU compared with untreatment (4.59 vs 5.07) [3]."	Hydrochloride	C10H26Cl2N2O2	13585.0	DMSO : 100 mg/mL (360.71 mM; Need ultrasonic); H2O : ≥ 50 mg/mL (180.36 mM)	DMSO Solution	10mM  * 100uL	Infection	CC[C@H](NCCN[C@@H](CC)CO)CO.Cl.Cl	https://www.medchemexpress.com/Ethambutol-dihydrochloride.html	Launched		92.0	Z35	O14	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0535A	10.0	mM	350.0	DMSO	204.183778	14	O	pluskal_fda_drugs_5005_O14_id
1438	HY-N0677	HYCPK40906	O07	HYCPK40906	92z	1357.0	1.0	AC13	906.0	O07	786593-06-4	Dehydroandrographolide succinate		532.58	Influenza Virus	Anti-infection	Dehydroandrographolide succinate, extracted from herbal medicine Andrographis paniculata (Burm f) Nees, is widely used for the treatment of viral pneumonia and viral upper respiratory tract infections because of its immunostimulatory, anti-infective and anti-inflammatory effect[1].	Free Acid	C28H36O10	146330.0	DMSO : 100 mg/mL (187.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Cancer	O=C(OC[C@]1(C)[C@H](OC(CCC(O)=O)=O)CC[C@@]2(C)[C@H](/C=C/C3=CCOC3=O)C(CC[C@]12[H])=C)CCC(O)=O	https://www.medchemexpress.com/dehydroandrographolide-succinate.html	Launched		92.0	AC13	O15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0677	10.0	mM	351.0	DMSO	532.230847	15	O	pluskal_fda_drugs_5005_O15_id
1683	HY-A0246A	HYCPK40906	F21	HYCPK40906	92z	521.0	1.0	K41	906.0	F21	1847-24-1	Flucloxacillin sodium		475.85	Antibiotic; Bacterial	Anti-infection	Flucloxacillin sodium is an active antibiotic against gram-positive and gram-negative bacteria[1][2].	Sodium	C19H16ClFN3NaO5S	28148.0	H2O : 100 mg/mL (210.15 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (210.15 mM)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H]1N(C2=O)[C@]([C@@H]2NC(C(C(C(C(F)=CC=C3)=C3Cl)=NO4)=C4C)=O)([H])SC1(C)C)O[Na]	https://www.medchemexpress.com/Flucloxacillin_sodium.html	Launched		92.0	K41	O15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0246A	10.0	mM	351.0	DMSO	453.056148	15	O	pluskal_fda_drugs_5005_O15_id
1933	HY-B1024	HYCPK40907	M17	HYCPK40907	92z	1186.0	2.0	Y34	907.0	M17	16485-10-2	DL-Panthenol	DL-Pantothenol; DL-Pantothenyl alcohol	205.25	Others	Others	DL-Panthenol (DL-Pantothenol) is an alcohol derivative of pantothenyl acid. DL-Panthenol exerts eyelash protection effect. DL-Panthenol is widely used in the Skin and hair conditioner research[1][2].	Free Base	C9H19NO4	17394.0	DMSO : ≥ 46 mg/mL (224.12 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(NCCCO)C(O)C(C)(C)CO	https://www.medchemexpress.com/DL-Panthenol.html	Launched		92.0	Y34	O15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1024	10.0	mM	351.0	DMSO	205.131408	15	O	pluskal_fda_drugs_5005_O15_id
2069	HY-16316	HYCPK40908	N06	HYCPK40908	92z	1307.0	3.0	AB11	908.0	N06	36592-77-5	Metipranolol hydrochloride		345.86	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Metipranolol hydrochloride is a non-selective β adrenergic receptor blocking agent.	Hydrochloride	C17H28ClNO4	29573.0	DMSO : 100 mg/mL (289.13 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (289.13 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	CC1=C(OC(C)=O)C(C)=C(C)C(OCC(O)CNC(C)C)=C1.[H]Cl	https://www.medchemexpress.com/Metipranolol_hydrochloride.html	Launched		92.0	AB11	O15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16316	10.0	mM	351.0	DMSO	309.194008	15	O	pluskal_fda_drugs_5005_O15_id
2147	HY-B0797	HYCPK40908	P11	HYCPK40908	92z	1509.0	3.0	AF21	908.0	P11	54350-48-0	Etretinate	Ro 10-9359	354.48	Apoptosis	Apoptosis	Etretinate(Ro 10-9359) is a second-generation retinoid that has the potential for severe psoriasis treatment.	Free Base	C23H30O3	15320.0	DMSO : 25 mg/mL (70.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	O=C(OCC)/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C=C(OC)C(C)=C1C	https://www.medchemexpress.com/Etretinate.html	Launched		92.0	AF21	O15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0797	10.0	mM	351.0	DMSO	354.219495	15	O	pluskal_fda_drugs_5005_O15_id
2263	HY-13604	HYCPK40908	H19	HYCPK40908	92z	757.0	3.0	P37	908.0	H19	427-51-0	Cyproterone acetate		402.91	Androgen Receptor	Others	Cyproterone acetate is an anti-androgen (IC50=7.1 nM) and progestogen synthetic steroid. Cyproterone acetate has affinity with progesteron and with glucocorticoidal receptors[1][2].	Free Base	C23H27ClO4	13789.0	Ethanol : 20 mg/mL (49.64 mM; Need ultrasonic); DMSO : 33.33 mg/mL (82.72 mM; Need ultrasonic); H2O : 0.1 mg/mL (0.25 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Endocrinology	C[C@@]12C(C(Cl)=C[C@]3([H])[C@]2([H])C[C@@]4(C)[C@@]3([H])CC[C@@]4(C(C)=O)OC(C)=O)=CC([C@H]5[C@@H]1C5)=O	https://www.medchemexpress.com/Cyproterone-acetate.html	Launched		92.0	P37	O15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13604	10.0	mM	351.0	DMSO	402.159787	15	O	pluskal_fda_drugs_5005_O15_id
2445	HY-B2209A	HYCPK40909	I04	HYCPK40909	92z	824.0	4.0	R8	909.0	I04	59461-30-2	Hydroxocobalamin (monohydrochloride)	Vitamin B12a (monohydrochloride)	1382.82	Endogenous Metabolite	Metabolic Enzyme/Protease	Hydroxocobalamin monohydrochloride (Vitamin B12a monohydrochloride) is an injectable naturally occurring form of vitamin B12 with a favorable adverse effect profile, used as a dietary supplement in the treatment of vitamin B12 deficiency including pernicious anemia[1][2].	Hydrochloride	C62H90ClCoN13O15P	118501.0	H2O : 25 mg/mL (18.08 mM; Need ultrasonic); DMSO : 100 mg/mL (72.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC12[N]([Co+3]34([N]5=CN(C(OC(CO)C6OP7([O-])=O)C6O)C8=C5C=C(C)C(C)=C8)([OH-])[N-]9C2C(CC(N)=O)C(C)(CCC(NCC(C)O7)=O)C9=C(C)C(C(CCC(N)=O)C%10(C)C)=[N]3C%10=CC%11=[N]4C(C(CC(N)=O)(C)C%11CCC(N)=O)=C%12C)=C%12C(CCC(N)=O)C1(C)CC(N)=O.Cl[H]	https://www.medchemexpress.com/Hydroxocobalamin_hydrochloride.html	Launched		92.0	R8	O15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2209A	10.0	mM	351.0	DMSO	1271.646781	15	O	pluskal_fda_drugs_5005_O15_id
2448	HY-N0158	HYCPK40909	L04	HYCPK40909	92z	1112.0	4.0	X8	909.0	L04	16837-52-8	Oxymatrine		264.36	Apoptosis; TGF-beta/Smad	Apoptosis; Stem Cell/Wnt; TGF-beta/Smad	Oxymatrine, an alkaloid from Sophora flavescens Alt. with anti-inflammatory, antifibrosis, and antitumor effects, inhibits the iNOS expression and TGF-β/Smad pathway. Oxymatrine inhibits bocavirus minute virus of canines (MVC) replication, reduces viral gene expression and decreases apoptosis induced by viral infection.	Free Base	C15H24N2O2	25568.0	DMSO : 100 mg/mL (378.27 mM; Need ultrasonic); H2O : 100 mg/mL (378.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=C1CCC[C@]2([H])[C@@]3([H])CCC[N@@+]4([O-])[C@@]3([H])[C@](CCC4)([H])CN21	https://www.medchemexpress.com/Oxymatrine.html	Launched		92.0	X8	O15	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0158	10.0	mM	351.0	DMSO	264.183778	15	O	pluskal_fda_drugs_5005_O15_id
53	HY-N0677A	HYCPK40899	G05	HYCPK40909	92z	656.0	4.0	N32	909.0	G16	76958-99-1	Kalii Dehydrographolidi Succinas	Potassium dehydroandrographolide succinate	570.67	Others	Others	Kalii Dehydrographolidi Succinas (Potassium dehydroandrographolide succinate), extracted from herbal medicine Andrographis paniculata (Burm f) Nees, is widely used for the treatment of viral pneumonia and viral upper respiratory tract infections because of its immunostimulatory, anti-infective and anti-inflammatory effect[1][2].	Potassium	C28H35KO10	64103.0	DMSO : 5 mg/mL (8.76 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection; Inflammation/Immunology; Cancer	O=C(OC[C@]1(C)[C@H](OC(CCC(O)=O)=O)CC[C@@]2(C)[C@H](/C=C/C3=CCOC3=O)C(CC[C@]12[H])=C)CCC(O[K])=O	https://www.medchemexpress.com/kalii-dehydrographolidi-succinas.html	Launched		92.0	N32	O16	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0677A	2.0	mM	352.0	DMSO	532.230847	16	O	pluskal_fda_drugs_5005_O16_id
1469	HY-N0492	HYCPK40908	L16	HYCPK40908	92z	1135.0	3.0	X31	908.0	L16	1077-28-7	α-Lipoic Acid	Thioctic acid; (±)-α-Lipoic acid; DL-α-Lipoic acid	206.33	Apoptosis; Endogenous Metabolite; HIV; Mitochondrial Metabolism; NF-κB	Anti-infection; Apoptosis; Metabolic Enzyme/Protease; NF-κB	"α-Lipoic Acid (Thioctic acid) is an antioxidant, which is an essential cofactor of mitochondrial enzyme complexes. α-Lipoic Acid inhibits NF-κB-dependent HIV-1 LTR activation[1][2][3]. α-Lipoic Acid induces endoplasmic reticulum (ER) stress-mediated apoptosis in hepatoma cells[4]. α-Lipoic Acid can be used with <a href=""/CPUL1.html"" class=""link-product"" target=""_blank"">CPUL1</a> (HY-151802) to construct the self-assembled nanoaggregate CPUL1-LA NA, which has improved antitumor efficacy than CPUL1[5]."	Free Acid	C8H14O2S2	17258.0	H2O : 0.1 mg/mL (0.48 mM; Need ultrasonic); DMSO : ≥ 100 mg/mL (484.66 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=C(O)CCCCC1SSCC1	https://www.medchemexpress.com/_alpha_-Lipoic-Acid.html	Launched		92.0	X31	O16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0492	10.0	mM	352.0	DMSO	206.043522	16	O	pluskal_fda_drugs_5005_O16_id
1479	HY-B2209B	HYCPK40906	J08	HYCPK40906	92z	879.0	1.0	S15	906.0	J08	22465-48-1	Hydroxocobalamin (acetate)		1388.39	Endogenous Metabolite	Metabolic Enzyme/Protease	Hydroxocobalamin acetate is an injectable naturally occurring form of vitamin B12 with a favorable adverse effect profile, used as a dietary supplement in the research of vitamin B12 deficiency including pernicious anemia[1][2].	Acetate	C64H91CoN13O16P	105011.0	DMSO : 100 mg/mL (72.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC12[N]([Co+3]34([N-]5C2C(CC(N)=O)C(C)(CCC(NCC(C)O6)=O)C5=C(C)C(C(CCC(N)=O)C7(C)C)=[N]3C7=CC8=[N]4C(C(CC(N)=O)(C)C8CCC(N)=O)=C9C)([N]%10=CN(C(OC(CO)C%11OP6([O-])=O)C%11O)C%12=C%10C=C(C)C(C)=C%12)[O-]C(C)=O)=C9C(CCC(N)=O)C1(C)CC(N)=O	https://www.medchemexpress.com/hydroxocobalamin-acetate.html	Launched		92.0	S15	O16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2209B	10.0	mM	352.0	DMSO	1271.646781	16	O	pluskal_fda_drugs_5005_O16_id
1689	HY-121567	HYCPK40906	L21	HYCPK40906	92z	1097.0	1.0	W41	906.0	L21	22664-55-7	Metipranolol		309.40	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Metipranolol is a nonselective and orally active β-adrenergic receptor antagonist. Metipranolol can be used for hypertension and glaucoma research[1][2].		C17H27NO4	99044.0	DMSO : 250 mg/mL (808.02 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC(OC1=C(C=C(C(C)=C1C)OCC(CNC(C)C)O)C)=O	https://www.medchemexpress.com/metipranolol.html	Launched		92.0	W41	O16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-121567	10.0	mM	352.0	DMSO	309.194008	16	O	pluskal_fda_drugs_5005_O16_id
2053	HY-11103	HYCPK40908	N05	HYCPK40908	92z	1305.0	3.0	AB9	908.0	N05	210421-74-2	Sitaxsentan (sodium)	IPI 1040 (sodium); TBC11251 (sodium)	476.89	Endothelin Receptor	GPCR/G Protein	Sitaxsentan sodium (IPI 1040 sodium; TBC11251 sodium) is an orally active, highly selective antagonist of endothelin A receptors.	Sodium	C18H14ClN2NaO6S2	3562.0	H2O : 100 mg/mL (209.69 mM; Need ultrasonic); DMSO : 100 mg/mL (209.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	O=S(C1=C(SC=C1)C(CC2=C(C=C3OCOC3=C2)C)=O)(N([Na])C4=C(C(C)=NO4)Cl)=O	https://www.medchemexpress.com/Sitaxsentan-sodium.html	Launched		92.0	AB9	O16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-11103	10.0	mM	352.0	DMSO	454.006006	16	O	pluskal_fda_drugs_5005_O16_id
2078	HY-B1214	HYCPK40908	G07	HYCPK40908	92z	637.0	3.0	N13	908.0	G07	52-21-1	Prednisolone acetate	Prednisolone 21-acetate	402.48	Glucocorticoid Receptor	Immunology/Inflammation	Prednisolone acetate (Prednisolone 21-acetate) is an adrenal cortico hormones, with anti-inflammatory, anti-allergic and immune suppressive effects.	Free Base	C23H30O6	17160.0	DMSO : 50 mg/mL (124.23 mM; Need ultrasonic); H2O : 0.67 mg/mL (1.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(COC(C)=O)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O	https://www.medchemexpress.com/Prednisolone-21-acetate.html	Launched		92.0	N13	O16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1214	10.0	mM	352.0	DMSO	402.204239	16	O	pluskal_fda_drugs_5005_O16_id
2547	HY-14879A	HYCPK40909	F11	HYCPK40909	92z	550.0	4.0	L22	909.0	F11	1192491-61-4	Avibactam (sodium)	NXL-104	287.23	Antibiotic; Bacterial	Anti-infection	Avibactam sodium (NXL-104)  is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively[1].	Sodium	C7H10N3NaO6S	149342.0	H2O : 50 mg/mL (174.08 mM; Need ultrasonic); DMSO : ≥ 30 mg/mL (104.45 mM)	DMSO Solution	10mM  * 100uL	Infection	O=S(ON1[C@]2([H])CC[C@@H](C(N)=O)[N@@](C2)C1=O)(O[Na])=O	https://www.medchemexpress.com/Avibactam-sodium.html	Launched		92.0	L22	O16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14879A	10.0	mM	352.0	DMSO	265.036856	16	O	pluskal_fda_drugs_5005_O16_id
2556	HY-12956	HYCPK40909	O11	HYCPK40909	92z	1414.0	4.0	AD22	909.0	O11	551-11-1	Dinoprost	Prostaglandin F2α; PGF2α	354.48	Apoptosis; Autophagy; Endogenous Metabolite; Prostaglandin Receptor	Apoptosis; Autophagy; GPCR/G Protein; Metabolic Enzyme/Protease	Dinoprost (Prostaglandin F2α) is an orally active, potent prostaglandin F (PGF) receptor (FP receptor) agonist. Dinoprost is a luteolytic hormone produced locally in the endometrial luminal epithelium and corpus luteum (CL). Dinoprost plays a key role in the onset and progression of labour[1][2].	Free Acid	C20H34O5	118500.0	H2O : 100 mg/mL (282.10 mM; Need ultrasonic); DMSO : 100 mg/mL (282.10 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(O)=O	https://www.medchemexpress.com/Dinoprost.html	Launched		92.0	AD22	O16	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12956	10.0	mM	352.0	DMSO	354.240624	16	O	pluskal_fda_drugs_5005_O16_id
2	HY-B1068	HYCPK40897	B03	HYCPK40909	92z	180.0	4.0	D36	909.0	B18	25301-02-4	Tyloxapol	Triton WR1339	261.38 (monomer)	Others	Others	Tyloxapol (Triton WR1339) is a nonionic liquid polymer of the alkyl aryl polyether alcohol type, used as a surface active stabilizer. Tyloxapol (Triton WR1339) is used to induce hyperlipidemia in animals[1][2].	Free Base	(C15H21O(C2H4O)m)n	92462.0	H2O : 120 mg/mL (Need ultrasonic); DMSO : ≥ 38 mg/mL; Ethanol : 100 mg/mL (Need ultrasonic)	DMSO Solution	3mg/mL  * 100uL	Metabolic Disease	[H]OCCOC1=C(CC)C=C(C(CC(C)(C)C)(C)C)C=C1C.[6].[=].[<].[5].[8].[n].[m].[_].[=].[m].[n]	https://www.medchemexpress.com/Tyloxapol.html	Launched		92.0	D36	O17	233.3333333	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1068	3.0	mM	353.0	DMSO	206.167065	17	O	pluskal_fda_drugs_5005_O17_id
1504	HY-B0479	HYCPK40906	C10	HYCPK40906	92z	211.0	1.0	E19	906.0	C10	15318-45-3	Thiamphenicol	Thiophenicol; Dextrosulphenidol	356.22	Antibiotic; Bacterial	Anti-infection	Thiamphenicol (Thiophenicol), a methyl-sulfonyl derivative of Chloramphenicol, is a broad-spectrum antimicrobial antibiotic. Thiamphenicol acts by binding to the 50S ribosomal subunit, leading to inhibition of protein synthesis and bacteriostatic effect (against Gram-negative, Gram-positive aerobic and anaerobic bacteria)[1][2].	Free Base	C12H15Cl2NO5S	16280.0	DMSO : 100 mg/mL (280.73 mM; Need ultrasonic); H2O : 2 mg/mL (5.61 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N[C@H](CO)[C@H](O)C1=CC=C(S(=O)(C)=O)C=C1)C(Cl)Cl	https://www.medchemexpress.com/Thiamphenicol.html	Launched		92.0	E19	O17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0479	10.0	mM	353.0	DMSO	355.004799	17	O	pluskal_fda_drugs_5005_O17_id
1609	HY-17461A	HYCPK40906	L16	HYCPK40906	92z	1087.0	1.0	W31	906.0	L16	50-04-4	Cortisone acetate	Cortisone 21-acetate	402.48	Endogenous Metabolite; Glucocorticoid Receptor	Immunology/Inflammation; Metabolic Enzyme/Protease	Cortisone acetate (Cortisone 21-acetate), an oxidized metabolite of Cortisol (a Glucocorticoid). Cortisone acetate acts as an immunosuppressant and anti-inflammatory agent. Cortisone acetate can partially intervene in binding of Glucocorticoid to Glucocorticoid-receptor at high concentrations[1][3][4].	Free Base	C23H30O6	10209.0	DMSO : 6.8 mg/mL (16.90 mM; Need ultrasonic and warming); H2O : 1 mg/mL (2.48 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	C[C@@]1(C2)[C@](C(COC(C)=O)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])C2=O)=O	https://www.medchemexpress.com/Cortisone-acetate.html	Launched		92.0	W31	O17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17461A	10.0	mM	353.0	DMSO	402.204239	17	O	pluskal_fda_drugs_5005_O17_id
1678	HY-B1078	HYCPK40906	A21	HYCPK40906	92z	41.0	1.0	A41	906.0	A21	27164-46-1	Cefazolin (sodium)	Cephazolin (sodium)	476.49	Antibiotic; Bacterial	Anti-infection	Cefazolin sodium is a first-generation cephalosporin antibiotic and can be used in varieties of bacterial infections research[1]. Cefazolin sodium has anti-inflammatory effect and can attenuate post-operative cognitive dysfunction (POCD)[2].	Sodium	C14H13N8NaO4S3	17764.0	H2O : ≥ 100 mg/mL (209.87 mM); DMSO : 100 mg/mL (209.87 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Neurological Disease	O=C(C(N12)=C(CSC3=NN=C(C)S3)CS[C@]2([H])[C@H](NC(CN4N=NN=C4)=O)C1=O)O[Na]	https://www.medchemexpress.com/Cefazolin-sodium.html	Launched		92.0	A41	O17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1078	10.0	mM	353.0	DMSO	454.030014	17	O	pluskal_fda_drugs_5005_O17_id
1698	HY-A0082	HYCPK40906	E22	HYCPK40906	92z	427.0	1.0	I43	906.0	E22	3254-89-5	Diphenidol (hydrochloride)	Difenidol hydrochloride	345.91	mAChR; Sodium Channel	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Diphenidol hydrochloride (Difenidol hydrochloride) is a non-selective muscarinic M1-M4 receptor antagonist, has anti-arrhythmic activity. Diphenidol hydrochloride is also a potent non-specific blocker of voltage-gated ion channels (Na+, K+, and Ca2+) in neuronal cells[1][2].	Hydrochloride	C21H28ClNO	16363.0	DMSO : ≥ 46 mg/mL (132.98 mM); H2O : 16.67 mg/mL (48.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	OC(C1=CC=CC=C1)(C2=CC=CC=C2)CCCN3CCCCC3.[H]Cl	https://www.medchemexpress.com/Diphenidol-hydrochloride.html	Launched		92.0	I43	O17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0082	10.0	mM	353.0	DMSO	309.209264	17	O	pluskal_fda_drugs_5005_O17_id
2292	HY-B0879A	HYCPK40908	E21	HYCPK40908	92z	473.0	3.0	J41	908.0	E21	129-46-4	Suramin (sodium salt)	Suramin (hexasodium salt)	1429.17	Apoptosis; Parasite; Phosphatase; Reverse Transcriptase; SARS-CoV; Sirtuin; Topoisomerase	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease	"Suramin sodium salt	(Suramin hexasodium salt) is a reversible and competitive protein-tyrosine phosphatases (PTPases) inhibitor[1]. Suramin sodium salt is a potent inhibitor of sirtuins: SirT1 (IC50=297 nM), SirT2 (IC50=1.15 μM), and SirT5 (IC50=22 μM)[2]. Suramin sodium salt is a competitive inhibitor of reverse transcriptase (DNA topoisomerase II: IC50=5 μM)[3][4]. Suramin sodium salt is a potent SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitor[5]. Suramin sodium salt efficiently inhibits IP5K and is an antiparasitic, anti-neoplastic and anti-angiogenic agent[6][7][8]."	Sodium	C51H34N6Na6O23S6	152201.0	DMSO : 83.33 mg/mL (58.31 mM; Need ultrasonic); H2O : ≥ 200 mg/mL (139.94 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Cardiovascular Disease	O=C(NC1=CC(C(NC2=CC(C(NC3=CC=C(S(=O)(O[Na])=O)C4=CC(S(=O)(O[Na])=O)=CC(S(=O)(O[Na])=O)=C34)=O)=CC=C2C)=O)=CC=C1)NC5=CC(C(NC6=CC(C(NC7=CC=C(S(=O)(O[Na])=O)C8=CC(S(=O)(O[Na])=O)=CC(S(=O)(O[Na])=O)=C78)=O)=CC=C6C)=O)=CC=C5	https://www.medchemexpress.com/Suramin-sodium-salt.html	Launched		92.0	J41	O17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0879A	10.0	mM	353.0	DMSO	1296.046908	17	O	pluskal_fda_drugs_5005_O17_id
2404	HY-U00103	HYCPK40908	P21	HYCPK40908	92z	1529.0	3.0	AF41	908.0	P21	5611-51-8	Triamcinolone hexacetonide		532.64	Others	Others	Triamcinolone hexacetonide is a commonly used long-acting steroids in treatment of subacute and chronic inflammatory joint diseases.	Free Base	C30H41FO7	34699.0	DMSO : 41.67 mg/mL (78.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C([C@]([C@@]1([H])C[C@@]2([H])[C@@](CCC3=CC4=O)([H])[C@@](F)([C@]3(C=C4)C)[C@@H](O)C5)(OC(C)(C)O1)[C@]25C)COC(CC(C)(C)C)=O	https://www.medchemexpress.com/Triamcinolone_hexacetonide.html	Launched		92.0	AF41	O17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-U00103	10.0	mM	353.0	DMSO	532.283632	17	O	pluskal_fda_drugs_5005_O17_id
2519	HY-B0223	HYCPK40909	J09	HYCPK40909	92z	930.0	4.0	T18	909.0	J09	54965-21-8	Albendazole	SKF-62979	265.33	Antibiotic; Apoptosis; Autophagy; Bacterial; HIF/HIF Prolyl-Hydroxylase; Microtubule/Tubulin; Parasite; Reactive Oxygen Species; VEGFR	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Cytoskeleton; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Protein Tyrosine Kinase/RTK	Albendazole (SKF-62979) is an orally active and broad-spectrum parasiticide with high effectiveness and low host toxicity, is used for the research of gastrointestinal parasites in humans and animals. Albendazole induces apoptosis and autophagy in cancer cells. Albendazole also inhibits tubulin polymerization and HIF-1α, VEGF expression, has antioxidant activity, and inhibits the glycolytic process in cancer cells[1][2][3][4][5].	Free Base	C12H15N3O2S	15040.0	H2O : 0.67 mg/mL (2.53 mM; Need ultrasonic); DMSO : 20 mg/mL (75.38 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C(OC)NC1=NC2=CC=C(SCCC)C=C2N1	https://www.medchemexpress.com/Albendazole.html	Launched		92.0	T18	O17	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0223	10.0	mM	353.0	DMSO	265.088498	17	O	pluskal_fda_drugs_5005_O17_id
1378	HY-B1322	HYCPK40906	O03	HYCPK40906	92z	1349.0	1.0	AC5	906.0	O03	6398-98-7	Amodiaquine (dihydrochloride dihydrate)	Amodiaquin (dihydrochloride dihydrate)	464.81	Histone Methyltransferase; Parasite	Anti-infection; Epigenetics	Amodiaquine dihydrochloride dihydrate (Amodiaquin dihydrochloride dihydrate), a 4-aminoquinoline class of antimalarial agent, is a potent and orally active histamine N-methyltransferase inhibitor. Amodiaquine dihydrochloride dihydrate is also a Nurr1 agonist and specifically binds to Nurr1-LBD (ligand binding domain) with an EC50 of ~20 μM. Anti-inflammatory effect[1][2][3][4].	Hydrochloride	C20H22ClN3O.2H2O.2HCl	29754.0	DMSO : 100 mg/mL (215.14 mM; Need ultrasonic); H2O : 20 mg/mL (43.03 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Neurological Disease	OC1=CC=C(NC2=CC=NC3=CC(Cl)=CC=C23)C=C1CN(CC)CC.Cl.Cl.O.O	https://www.medchemexpress.com/Amodiaquin-dihydrochloride-dihydrate.html	Launched		92.0	AC5	O18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1322	10.0	mM	354.0	DMSO	355.14514	18	O	pluskal_fda_drugs_5005_O18_id
1506	HY-13331	HYCPK40906	E10	HYCPK40906	92z	403.0	1.0	I19	906.0	E10	19608-29-8	Clascoterone	Cortexolone 17 alpha-propionate; Cortexolone 17α-propionate; CB-03-01	402.52	Androgen Receptor	Others	Clascoterone (Cortexolone 17 alpha-propionate;Cortexolone 17α-propionate;CB-03-01) is a new topical and peripherally selective androgen antagonist.	Free Base	C24H34O5	26925.0	DMSO : ≥ 100 mg/mL (248.43 mM)	DMSO Solution	10mM  * 100uL	Endocrinology	O=C1CC[C@@]2(C)C(CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])CC[C@@]4(C(CO)=O)OC(CC)=O)=C1	https://www.medchemexpress.com/Cortexolone-17-alpha-propionate.html	Launched		92.0	I19	O18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13331	10.0	mM	354.0	DMSO	402.240624	18	O	pluskal_fda_drugs_5005_O18_id
1584	HY-B1892	HYCPK40906	C15	HYCPK40906	92z	221.0	1.0	E29	906.0	C15	25953-19-9	Cefazolin	Cephazolin	454.51	Antibiotic; Bacterial	Anti-infection	Cefazolin (Cephazolin) is a first-generation cephalosporin antibiotic and can be used in varieties of bacterial infections research[1]. Cefazolin has anti-inflammatory effect and can attenuate post-operative cognitive dysfunction (POCD)[2].		C14H14N8O4S3	79609.0	DMSO : 250 mg/mL (550.04 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology; Neurological Disease	O=C(C(N12)=C(CSC3=NN=C(C)S3)CS[C@]2([H])[C@H](NC(CN4N=NN=C4)=O)C1=O)O	https://www.medchemexpress.com/cefazolin.html	Launched		92.0	E29	O18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1892	10.0	mM	354.0	DMSO	454.030014	18	O	pluskal_fda_drugs_5005_O18_id
1788	HY-108896	HYCPK40907	D08	HYCPK40907	92z	304.0	2.0	G16	907.0	D08	138614-30-9	Icatibant (acetate)	HOE 140 (acetate)	1364.57	Bradykinin Receptor	GPCR/G Protein	Icatibant acetate (HOE-140 acetate) is a potent and specific peptide antagonist of bradykinin B2 receptor with an IC50 and Ki of 1.07 nM and 0.798 nM respectively[1][2][3].	Acetate	C61H93N19O15S	81711.0	DMSO : 100 mg/mL (73.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	CC(O)=O.O=C([C@@H]1N(CC2=CC=CC=C2C1)C([C@H](CO)NC([C@@H](NC(CNC([C@H]3N(C[C@H](O)C3)C([C@H]4N(CCC4)C([C@H](CCCNC(N)=N)NC([C@H](N)CCCNC(N)=N)=O)=O)=O)=O)=O)CC5=CC=CS5)=O)=O)N6[C@]7([H])[C@](CCCC7)([H])C[C@H]6C(N[C@H](C(O)=O)CCCNC(N)=N)=O	https://www.medchemexpress.com/icatibant-acetate.html	Launched		92.0	G16	O18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-108896	10.0	mM	354.0	DMSO	1303.660795	18	O	pluskal_fda_drugs_5005_O18_id
2000	HY-14196	HYCPK40907	D22	HYCPK40907	92z	332.0	2.0	G44	907.0	D22	29218-27-7	Toloxatone	MD 69276	207.23	Monoamine Oxidase	Neuronal Signaling	Toloxatone (MD 69276) is a reversible monoamine oxidase A (MAOA) inhibitor[1]. Antidepressant[1].	Free Base	C11H13NO3	40213.0	DMSO : 125 mg/mL (603.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC1=CC(N2C(OC(CO)C2)=O)=CC=C1	https://www.medchemexpress.com/toloxatone.html	Launched		92.0	G44	O18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14196	10.0	mM	354.0	DMSO	207.089543	18	O	pluskal_fda_drugs_5005_O18_id
2102	HY-112301	HYCPK40908	O08	HYCPK40908	92z	1407.0	3.0	AD15	908.0	O08	2097132-94-8	Pralsetinib	BLU-667	533.60	RET	Protein Tyrosine Kinase/RTK	Pralsetinib (BLU-667) is a highly potent, selective RET inhibitor. Pralsetinib (BLU-667) inhibits WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion with IC50s of 0.4, 0.3, 0.4, 0.4, and 0.4 nM, respectively[1].	Free Base	C27H32FN9O2	60892.0	DMSO : ≥ 100 mg/mL (187.41 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C([C@@]1(OC)CC[C@H](C2=NC(NC3=NNC(C)=C3)=CC(C)=N2)CC1)N[C@H](C4=CC=C(N5N=CC(F)=C5)N=C4)C	https://www.medchemexpress.com/Blu667.html	Launched		92.0	AD15	O18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-112301	10.0	mM	354.0	DMSO	533.266299	18	O	pluskal_fda_drugs_5005_O18_id
2205	HY-B1339	HYCPK40908	J15	HYCPK40908	92z	941.0	3.0	T29	908.0	J15	67-92-5	Dicyclomine (hydrochloride)	Dicycloverine (hydrochloride)	345.95	mAChR	GPCR/G Protein; Neuronal Signaling	Dicyclomine hydrochloride is a potent and orally active muscarinic cholinergic receptors antagonist. Dicyclomine hydrochloride shows high affinity for muscarinic M1 receptor subtype (Ki=5.1 nM) and M2 receptor subtype (Ki=54.6 nM) in brush-border membrane and basal plasma membranes, respectively[1]. Dicyclomine is an antispasmodic agent and relieves smooth muscle spasm of the gastrointestinal tract in vivo[2].	Hydrochloride	C19H36ClNO2	64389.0	H2O : 100 mg/mL (289.06 mM; Need ultrasonic); DMSO : 33.33 mg/mL (96.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(C1(C2CCCCC2)CCCCC1)OCCN(CC)CC.[H]Cl	https://www.medchemexpress.com/dicyclomine-hydrochloride.html	Launched		92.0	T29	O18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1339	10.0	mM	354.0	DMSO	309.266779	18	O	pluskal_fda_drugs_5005_O18_id
2543	HY-N0680	HYCPK40909	B11	HYCPK40909	92z	166.0	4.0	D22	909.0	B11	67-03-8	Thiamine (hydrochloride)	Thiamine chloride (hydrochloride); Vitamin B1 (hydrochloride)	337.27	Apoptosis; Bacterial; Endogenous Metabolite; HBV	Anti-infection; Apoptosis; Metabolic Enzyme/Protease	Thiamine hydrochloride (Thiamine chloride hydrochloride) is an essential micronutrient needed as a cofactor for many central metabolic enzymes.	Hydrochloride	C12H18Cl2N4OS	114349.0	DMSO : 6.67 mg/mL (19.78 mM; Need ultrasonic); H2O : 100 mg/mL (296.50 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N.[Cl-].Cl	https://www.medchemexpress.com/Thiamine_hydrochloride.html	Launched		92.0	D22	O18	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0680	10.0	mM	354.0	DMSO	265.111759	18	O	pluskal_fda_drugs_5005_O18_id
46	HY-106033	HYCPK40899	P04	HYCPK40909	92z	1518.0	4.0	AF30	909.0	P15	204318-14-9	Edotreotide	DOTATOC; SDZ-SMT 487; SMT 487	1421.64	Others	Others	Edotreotide is a somatostatin analogue. Edotreotide bound to various radionuclides, has the potential for the research and diagnosis of certain types of cancer[1].		C65H92N14O18S2	146945.0	H2O : 5 mg/mL (3.52 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	2mM  * 100uL	Cancer	O=C([C@@H](NC([C@@](CSSC[C@@H](C(N[C@H](CO)[C@H](O)C)=O)NC([C@@]([C@H](O)C)([H])NC([C@@](CCCCN)([H])NC1=O)=O)=O)([H])NC([C@H](NC(CN2CCN(CCN(CC(O)=O)CCN(CC(O)=O)CC2)CC(O)=O)=O)CC3=CC=CC=C3)=O)=O)CC4=CC=C(O)C=C4)N[C@@H]1CC5=CNC6=C5C=CC=C6	https://www.medchemexpress.com/edotreotide.html	Launched		92.0	AF30	O19	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-106033	2.0	mM	355.0	DMSO	1420.615544	19	O	pluskal_fda_drugs_5005_O19_id
47	HY-B1383	HYCPK40899	A05	HYCPK40909	92z	80.0	4.0	B32	909.0	A16	79-61-8	Dichlorisone acetate		455.37	Endogenous Metabolite	Metabolic Enzyme/Protease	Dichlorisone acetate is a synthetic glucocorticoid corticosteroid used as an anti-inflammatory agent.	Free Base	C23H28Cl2O5	26570.0	H2O : < 0.1 mg/mL (insoluble); DMSO : 4.35 mg/mL (9.55 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Inflammation/Immunology	C[C@@]12[C@](C(COC(C)=O)=O)(O)CC[C@@]1([H])[C@]3([H])CCC4=CC(C=C[C@]4(C)[C@@]3(Cl)[C@@H](Cl)C2)=O	https://www.medchemexpress.com/Dichlorisone_acetate.html	Launched		92.0	B32	O19	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1383	2.0	mM	355.0	DMSO	454.131379	19	O	pluskal_fda_drugs_5005_O19_id
1439	HY-15258A	HYCPK40906	P07	HYCPK40906	92z	1453.0	1.0	AE13	906.0	P07	1151516-14-1	Lesinurad (sodium)	RDEA-594 sodium	426.26	URAT1	Membrane Transporter/Ion Channel	Lesinurad sodium is a URAT1 and OAT inhibitor, is determined to be a substrate for the kidney transporters OAT1 and OAT3 with Km values of 0.85 and 2 μM, respectively.	Sodium	C17H13BrN3NaO2S	18688.0	DMSO : ≥ 26 mg/mL (61.00 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(O[Na])CSC1=NN=C(Br)N1C2=C3C=CC=CC3=C(C4CC4)C=C2	https://www.medchemexpress.com/Lesinurad-sodium.html	Launched		92.0	AE13	O19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15258A	10.0	mM	355.0	DMSO	402.99901	19	O	pluskal_fda_drugs_5005_O19_id
1580	HY-10052	HYCPK40906	O14	HYCPK40906	92z	1371.0	1.0	AC27	906.0	O14	170729-80-3	Aprepitant	MK-0869; MK-869; L-754030	534.43	Antibiotic; Bacterial; HIV; Neurokinin Receptor	Anti-infection; GPCR/G Protein; Neuronal Signaling	Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.	Free Base	C23H21F7N4O3	31982.0	DMSO : ≥ 100 mg/mL (187.12 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology; Cancer	O=C1NC(CN2[C@H]([C@@H](O[C@@H](C3=CC(C(F)(F)F)=CC(C(F)(F)F)=C3)C)OCC2)C4=CC=C(F)C=C4)=NN1	https://www.medchemexpress.com/Aprepitant.html	Launched		92.0	AC27	O19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10052	10.0	mM	355.0	DMSO	534.150188	19	O	pluskal_fda_drugs_5005_O19_id
1622	HY-B0316	HYCPK40906	I17	HYCPK40906	92z	801.0	1.0	Q33	906.0	I17	70356-09-1	Avobenzone		310.39	Apoptosis; Estrogen Receptor/ERR	Apoptosis; Others	Avobenzone, a dibenzoylmethane compound, is one of the most widely used filters in sunscreens for skin photoprotection in the UVA band. Avobenzone is an endocrine disruptor that directly binds to estrogen receptor β and acts as an estrogen agonist[1][2].	Free Base	C20H22O3	16026.0	DMSO : ≥ 50 mg/mL (161.09 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Others	O=C(C1=CC=C(C(C)(C)C)C=C1)CC(C2=CC=C(OC)C=C2)=O	https://www.medchemexpress.com/Avobenzone.html	Launched		92.0	Q33	O19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0316	10.0	mM	355.0	DMSO	310.156895	19	O	pluskal_fda_drugs_5005_O19_id
1634	HY-B2223	HYCPK40906	E18	HYCPK40906	92z	419.0	1.0	I35	906.0	E18	532-43-4	Thiamine nitrate	Vitamin B1 nitrate	327.36	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Thiamine nitrate is an essential vitamin which can enhance normal neuronal actives.	Nitrate	C12H17N5O4S	26199.0	DMSO : 15 mg/mL (45.82 mM; Need ultrasonic and warming)	DMSO Solution	10mM  * 100uL	Metabolic Disease	CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N.[O-][N+]([O-])=O	https://www.medchemexpress.com/Thiamine_nitrate.html	Launched		92.0	I35	O19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2223	10.0	mM	355.0	DMSO	265.111759	19	O	pluskal_fda_drugs_5005_O19_id
2184	HY-B0450	HYCPK40908	E14	HYCPK40908	92z	459.0	3.0	J27	908.0	E14	29342-05-0	Ciclopirox	HOE296b	207.27	Autophagy; Bacterial; Ferroptosis; Fungal	Anti-infection; Apoptosis; Autophagy	Ciclopirox (HOE296b) is a synthetic antifungal agent that can be used for superficial mycoses reseaech. Ciclopirox olamine has a very broad spectrum of activity and inhibits dermatophytes, yeasts, molds, and many Gram-positive and Gram-negative species pathogenic[1].	Free Base	C12H17NO2	14821.0	DMSO : 100 mg/mL (482.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	CC(C=C(C1CCCCC1)N2O)=CC2=O	https://www.medchemexpress.com/Ciclopirox.html	Launched		92.0	J27	O19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0450	10.0	mM	355.0	DMSO	207.125929	19	O	pluskal_fda_drugs_5005_O19_id
2237	HY-N0096	HYCPK40908	N17	HYCPK40908	92z	1329.0	3.0	AB33	908.0	N17	483-14-7	Rotundine	(-)-Tetrahydropalmatine; L-Tetrahydropalmatine	355.43	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Rotundine is an antagonist of dopamine D1, D2 and D3 receptors with  IC50s of 166 nM, 1.4 μM and 3.3 μM, respectively. Rotundine is also an antagonist of 5-HT1A with an IC50 of 370 nM.	Free Base	C21H25NO4	27283.0	DMSO : ≥ 100 mg/mL (281.35 mM); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Neurological Disease	COC1=CC=C2C(CN3CCC4=CC(OC)=C(OC)C=C4[C@]3([H])C2)=C1OC	https://www.medchemexpress.com/Rotundine.html	Launched		92.0	AB33	O19	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0096	10.0	mM	355.0	DMSO	355.178358	19	O	pluskal_fda_drugs_5005_O19_id
1444	HY-10846	HYCPK40907	O04	HYCPK40907	92z	1352.0	2.0	AC8	907.0	O04	681492-22-8	Delamanid	OPC-67683	534.48	Antibiotic; Bacterial	Anti-infection	Delamanid, a newer mycobacterial cell wall synthesis inhibitor, inhibits the synthesisi of mucolic acids[1].	Free Base	C25H25F3N4O6	78643.0	DMSO : ≥ 50 mg/mL (93.55 mM); Ethanol : 2 mg/mL (3.74 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	FC(F)(F)OC1=CC=C(OC2CCN(C3=CC=C(OC[C@@]4(C)CN5C(O4)=NC([N+]([O-])=O)=C5)C=C3)CC2)C=C1	https://www.medchemexpress.com/Delamanid.html	Launched		92.0	AC8	O20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10846	10.0	mM	356.0	DMSO	534.172619	20	O	pluskal_fda_drugs_5005_O20_id
1491	HY-N0300A	HYCPK40906	F09	HYCPK40906	92z	497.0	1.0	K17	906.0	F09	6024-85-7	Tetrahydropalmatine (hydrochloride)	DL-Tetrahydropalmatine (hydrochloride)	391.89	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Tetrahydropalmatine (DL-Tetrahydropalmatine) hydrochloride possesses analgesic effects. Tetrahydropalmatine hydrochloride acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1].	Hydrochloride	C21H26ClNO4	105549.0	H2O : 4 mg/mL (10.21 mM; ultrasonic and warming and heat to 60°C); DMSO : 25 mg/mL (63.79 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	COC1=CC=C2C(CN3CCC4=CC(OC)=C(OC)C=C4C3C2)=C1OC.[H]Cl	https://www.medchemexpress.com/tetrahydropalmatine-hydrochloride.html	Launched		92.0	K17	O20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0300A	10.0	mM	356.0	DMSO	355.178358	20	O	pluskal_fda_drugs_5005_O20_id
1644	HY-12516	HYCPK40906	O18	HYCPK40906	92z	1379.0	1.0	AC35	906.0	O18	54024-22-5	Desogestrel	Org-2969	310.47	Progesterone Receptor	Others	Desogestrel(Org-2969) is a third-generation 19-nortestosterone derivative progestogen; is contained in many oral contraceptive preparations, both combined (COCs) to ethinyl-estradiol (EE) or alone in a progestin-only pill (POP).	Free Base	C22H30O	14745.0	DMSO : 16.67 mg/mL (53.69 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Others	[H][C@@]12C(CC[C@]([C@@](CC[C@@]3(O)C#C)([H])[C@]3(CC)C4)([H])[C@]2([H])C4=C)=CCCC1	https://www.medchemexpress.com/Desogestrel.html	Launched		92.0	AC35	O20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12516	10.0	mM	356.0	DMSO	310.229666	20	O	pluskal_fda_drugs_5005_O20_id
1696	HY-15258	HYCPK40906	C22	HYCPK40906	92z	235.0	1.0	E43	906.0	C22	878672-00-5	Lesinurad	RDEA594	404.28	URAT1	Membrane Transporter/Ion Channel	Lesinurad is a URAT1 and OAT inhibitor, is determined to be a substrate for the kidney transporters OAT1 and OAT3 with Km values of 0.85 and 2 μM, respectively.	Free Acid	C17H14BrN3O2S	19815.0	DMSO : 100 mg/mL (247.35 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	BrC1=NN=C(SCC(O)=O)N1C2=C3C(C=CC=C3)=C(C4CC4)C=C2	https://www.medchemexpress.com/Lesinurad.html	Launched		92.0	E43	O20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15258	10.0	mM	356.0	DMSO	402.99901	20	O	pluskal_fda_drugs_5005_O20_id
2040	HY-B2141	HYCPK40908	L04	HYCPK40908	92z	1111.0	3.0	X7	908.0	L04	621-72-7	Bendazol		208.26	NO Synthase	Immunology/Inflammation	Bendazol is a hypotensive drug which can also enhance NO synthase activity in renal glomeruli and collecting tubules.	Free Base	C14H12N2	27067.0	DMSO : 100 mg/mL (480.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	C1(CC2=CC=CC=C2)=NC3=CC=CC=C3N1	https://www.medchemexpress.com/Bendazol.html	Launched		92.0	X7	O20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2141	10.0	mM	356.0	DMSO	208.100048	20	O	pluskal_fda_drugs_5005_O20_id
2099	HY-B1486	HYCPK40908	L08	HYCPK40908	92z	1119.0	3.0	X15	908.0	L08	6452-73-9	Oxprenolol (hydrochloride)	Ba 39089	301.81	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Oxprenolol hydrochloride (Ba 39089) is an orally bioavailable β-adrenergic receptor (β-AR) antagonist with a Ki of 7.10 nM in a radioligand binding assay using rat heart muscle[1].	Hydrochloride	C15H24ClNO3	64567.0	DMSO : 250 mg/mL (828.34 mM; Need ultrasonic); H2O : 100 mg/mL (331.33 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	OC(COC1=CC=CC=C1OCC=C)CNC(C)C.[H]Cl	https://www.medchemexpress.com/oxprenolol-hydrochloride.html	Launched		92.0	X15	O20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1486	10.0	mM	356.0	DMSO	265.167794	20	O	pluskal_fda_drugs_5005_O20_id
2269	HY-P0009A	HYCPK40908	N19	HYCPK40908	92z	1333.0	3.0	AB37	908.0	N19	145672-81-7	Cetrorelix (Acetate)	SB-75 (acetate)	1491.09	GnRH Receptor	GPCR/G Protein	Cetrorelix Acetate (SB-75 acetate) is a potent gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM[1].	Acetate	C72H96ClN17O16	66810.0	DMSO : 50 mg/mL (33.53 mM; Need ultrasonic); H2O : 2 mg/mL (1.34 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Endocrinology	CC(O)=O.O=C(N(CCC1)[C@@H]1C(N[C@H](C)C(N)=O)=O)[C@H](CCCNC(N)=N)NC([C@H](CC(C)C)NC([C@@H](CCCNC(N)=O)NC([C@@H](NC([C@H](CO)NC([C@H](NC([C@H](NC([C@H](NC(C)=O)CC2=CC3=CC=CC=C3C=C2)=O)CC4=CC=C(Cl)C=C4)=O)CC5=CN=CC=C5)=O)=O)CC6=CC=C(O)C=C6)=O)=O)=O	https://www.medchemexpress.com/Cetrorelix-Acetate.html	Launched		92.0	AB37	O20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P0009A	10.0	mM	356.0	DMSO	1429.669818	20	O	pluskal_fda_drugs_5005_O20_id
2487	HY-14519A	HYCPK40909	J07	HYCPK40909	92z	926.0	4.0	T14	909.0	J07	7413-34-5	Methotrexate (disodium)	Amethopterin (disodium); CL14377 (disodium); WR19039 (disodium)	498.40	ADC Cytotoxin; Antifolate; Apoptosis; Bacterial; DNA/RNA Synthesis	Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Cell Cycle/DNA Damage	Methotrexate (Amethopterin) disodium, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis. Methotrexate disodium, also an immunosuppressant and antineoplastic agent, is used for the research of rheumatoid arthritis and a number of different cancers (such as acute lymphoblastic leukemia)[1][2][3].	Sodium	C20H20N8Na2O5	81188.0	H2O : 50 mg/mL (100.32 mM; Need ultrasonic); DMSO : 5 mg/mL (10.03 mM; ultrasonic and warming and adjust pH to 5 with HCl and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	NC1=NC(N)=C2C(N=CC(CN(C)C3=CC=C(C(N[C@@H](CCC(O[Na])=O)C(O[Na])=O)=O)C=C3)=N2)=N1	https://www.medchemexpress.com/methotrexate-disodium.html	Launched		92.0	T14	O20	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14519A	10.0	mM	356.0	DMSO	454.171316	20	O	pluskal_fda_drugs_5005_O20_id
30	HY-107833	HYCPK40899	H03	HYCPK40909	92z	748.0	4.0	P28	909.0	H14	102961-72-8	A40926		1716.53	Bacterial	Anti-infection	A40926, the precursor of Dalbavancin, is a second-generation glycopeptide antibiotic. A40926 inhibits gram-positive bacteria, and is very active against Neisseria gonorrhoeae[1].		C83H88Cl2N8O28	108778.0	DMSO : 5.88 mg/mL (3.43 mM; ultrasonic and warming and heat to 20°C)	DMSO Solution	2mM  * 100uL	Infection	ClC1=CC(C(O)C(C(NC(C(O)=O)C(C=CC=C2O[C@@H]3[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)=C2C4=C(O)C=CC(C5NC(C6NC(C(C7=C(Cl)C(O)=CC(O8)=C7)NC(C9NC(C(C%10=CC8=C(O)C=C%10)NC)=O)=O)=O)=O)=C4)=O)NC5=O)=CC=C1OC%11=CC6=CC(OC%12=CC=C(C9)C=C%12)=C%11O[C@@H]%13O[C@H](C(O	https://www.medchemexpress.com/a40926.html	Launched		92.0	P28	O21	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107833	2.0	mM	357.0	DMSO	1714.50851	21	O	pluskal_fda_drugs_5005_O21_id
365	HY-B1896B	HYCPK40899	H04	HYCPK40909	92z	750.0	4.0	P30	909.0	H15	915967-82-7	Piperaquine (tetraphosphate tetrahydrate)		999.60	Parasite	Anti-infection	Piperaquine tetraphosphate tetrahydrate is a bisquinoline antimalarial agent. Piperaquine tetraphosphate tetrahydrate can be used in antimalarial research in combination with Artemisinin[1][2].	Phosphate	C29H32Cl2N6.4H3O4P.4H2O	40049.0	DMSO : 5 mg/mL (5.00 mM; Need ultrasonic and warming); H2O : 6 mg/mL (6.00 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection	ClC1=CC=C2C(N3CCN(CCCN4CCN(C5=CC=NC6=CC(Cl)=CC=C56)CC4)CC3)=CC=NC2=C1.OP(O)(O)=O.[4].[4 H2O]	https://www.medchemexpress.com/piperaquine-tetraphosphate-tetrahydrate.html	Launched		92.0	P30	O21	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1896B	2.0	mM	357.0	DMSO	534.20655	21	O	pluskal_fda_drugs_5005_O21_id
1496	HY-10570	HYCPK40906	K09	HYCPK40906	92z	977.0	1.0	U17	906.0	K09	129618-40-2	Nevirapine	BI-RG 587; NSC 641530; NVP	266.30	HIV; Parasite; Reverse Transcriptase	Anti-infection	Nevirapine is a non-nucleoside inhibitor of HIV-1 reverse transcriptase used to treat and prevent HIV/AIDS; with a Ki of 270 μM[1].	Free Base	C15H14N4O	14244.0	DMSO : 14.29 mg/mL (53.66 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	O=C1C2=C(N=CC=C2)N(C3CC3)C4=NC=CC(C)=C4N1	https://www.medchemexpress.com/Nevirapine.html	Launched		92.0	U17	O21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10570	10.0	mM	357.0	DMSO	266.116761	21	O	pluskal_fda_drugs_5005_O21_id
1501	HY-14275	HYCPK40906	P09	HYCPK40906	92z	1457.0	1.0	AE17	906.0	P09	52-53-9	Verapamil	(±)-Verapamil; CP-16533-1	454.60	Calcium Channel; Cytochrome P450; P-glycoprotein	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research[1][2][3].		C27H38N2O4	123209.0	DMSO : 100 mg/mL (219.97 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	COC1=CC=C(C(C#N)(C(C)C)CCCN(CCC2=CC=C(OC)C(OC)=C2)C)C=C1OC	https://www.medchemexpress.com/verapamil.html	Launched		92.0	AE17	O21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14275	10.0	mM	357.0	DMSO	454.283158	21	O	pluskal_fda_drugs_5005_O21_id
1553	HY-B0379A	HYCPK40906	D13	HYCPK40906	92z	313.0	1.0	G25	906.0	D13	50-42-0	Adiphenine (hydrochloride)		347.88	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Adiphenine hydrochloride is a non-competitive inhibitor of nicotinic acetylcholine receptor (nAChR), with an IC50s of 1.9, 1.8, 3.7, and 6.3 μM for α1, α3β4, α4β2, and α4β4, respectively. Adiphenine hydrochloride has anticonvulsant effects[1][2][3].	Hydrochloride	C20H26ClNO2	16162.0	DMSO : ≥ 100 mg/mL (287.46 mM); H2O : ≥ 50 mg/mL (143.73 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCCN(CC)CC)C(C1=CC=CC=C1)C2=CC=CC=C2.Cl	https://www.medchemexpress.com/Adiphenine-hydrochloride.html	Launched		92.0	G25	O21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0379A	10.0	mM	357.0	DMSO	311.188529	21	O	pluskal_fda_drugs_5005_O21_id
2052	HY-N0700	HYCPK40908	M05	HYCPK40908	92z	1209.0	3.0	Z9	908.0	M05	2883-98-9	alpha-Asarone	α-Asarone; trans-Asarone	208.25	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	alpha-Asarone (α-Asarone) is one of the main psychoactive compounds, and possesses an antidepressant-like activity in mice.	Free Base	C12H16O3	20205.0	H2O : 0.67 mg/mL (3.22 mM; Need ultrasonic); DMSO : 100 mg/mL (480.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	C/C=C/C1=C(OC)C=C(OC)C(OC)=C1	https://www.medchemexpress.com/alpha-Asarone.html	Launched		92.0	Z9	O21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0700	10.0	mM	357.0	DMSO	208.109944	21	O	pluskal_fda_drugs_5005_O21_id
2442	HY-N0300	HYCPK40909	F04	HYCPK40909	92z	536.0	4.0	L8	909.0	F04	2934-97-6	Tetrahydropalmatine	DL-Tetrahydropalmatine	355.43	Apoptosis; Dopamine Receptor	Apoptosis; GPCR/G Protein; Neuronal Signaling	Tetrahydropalmatine possesses analgesic effects. Tetrahydropalmatine acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1].	Free Base	C21H25NO4	91178.0	DMSO : 6.67 mg/mL (18.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	COC1=CC=C2C(CN3CCC4=CC(OC)=C(OC)C=C4C3C2)=C1OC	https://www.medchemexpress.com/Tetrahydropalmatine.html	Launched		92.0	L8	O21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0300	10.0	mM	357.0	DMSO	355.178358	21	O	pluskal_fda_drugs_5005_O21_id
2524	HY-B1033	HYCPK40909	O09	HYCPK40909	92z	1410.0	4.0	AD18	909.0	O09	17692-51-2	Metergoline		403.52	5-HT Receptor; Dopamine Receptor; Sodium Channel	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Metergoline is a serotonin (5-HT) receptor and dopamine receptors antagonist, with pKis of 8.64, 8.75 and 8.75 for 5-HT2A, 5-HT2B and 5-HT2C, respectively. Metergoline is a high-affinity ligand for the h5-HT7 receptor, with a Ki of 16 nM. Metergoline is also a reversible neural Na+ channels inhibitor. Metergoline is commonly used for the research of seasonal affective disorder, prolactin hormone regulation[1][2][3].	Free Base	C25H29N3O2	61839.0	DMSO : 125 mg/mL (309.77 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	O=C(OCC1=CC=CC=C1)NC[C@H](C[C@@]23[H])CN(C)[C@]2([H])CC4=CN(C)C5=CC=CC3=C54	https://www.medchemexpress.com/Metergoline.html	Launched		92.0	AD18	O21	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1033	10.0	mM	357.0	DMSO	403.225977	21	O	pluskal_fda_drugs_5005_O21_id
29	HY-P0052	HYCPK40899	G03	HYCPK40909	92z	652.0	4.0	N28	909.0	G14	159519-65-0	Enfuvirtide	T20; DP178	4491.88	HIV	Anti-infection	Enfuvirtide (T20;DP178) is an anti-HIV-1 fusion inhibitor peptide.		C204H301N51O64	117132.0	H2O : 0.67 mg/mL (0.15 mM; Need ultrasonic); DMSO : 20 mg/mL (4.45 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection	[Ac-YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF-NH2]	https://www.medchemexpress.com/Enfuvirtide.html	Launched		92.0	N28	O22	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P0052	2.0	mM	358.0	DMSO	4489.186644	22	O	pluskal_fda_drugs_5005_O22_id
1509	HY-A0064	HYCPK40906	H10	HYCPK40906	92z	691.0	1.0	O19	906.0	H10	152-11-4	Verapamil (hydrochloride)	(±)-Verapamil (hydrochloride); CP-16533-1 (hydrochloride)	491.06	Calcium Channel; Cytochrome P450; P-glycoprotein	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil hydrochloride also inhibits CYP3A4. Verapamil hydrochloride has the potential for high blood pressure, heart arrhythmias and angina research[1][2][3].	Hydrochloride	C27H39ClN2O4	45931.0	H2O : 50 mg/mL (101.82 mM; Need ultrasonic); DMSO : ≥ 31 mg/mL (63.13 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	[H]Cl.COC1=CC=C(C(C#N)(C(C)C)CCCN(CCC2=CC=C(OC)C(OC)=C2)C)C=C1OC	https://www.medchemexpress.com/Verapamil-hydrochloride.html	Launched		92.0	O19	O22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0064	10.0	mM	358.0	DMSO	454.283158	22	O	pluskal_fda_drugs_5005_O22_id
1565	HY-14894	HYCPK40906	P13	HYCPK40906	92z	1465.0	1.0	AE25	906.0	P13	761423-87-4	Ipragliflozin	ASP1941	404.45	SGLT	Membrane Transporter/Ion Channel	Ipragliflozin (ASP1941) is an orally active and selective SGLT2 inhibitor with IC50s of 7.38  and 1876  nM, 6.73 and 1166 nM, 5.64 and 1380 nM for human SGLT2 and SGLT1, rat SGLT2 and SGLT1, mouse SGLT2 and SGLT1, respectively. Antidiabetic agent[1].	Free Base	C21H21FO5S	12161.0	H2O : ≥ 0.1 mg/mL (0.25 mM); DMSO : ≥ 100 mg/mL (247.25 mM)	DMSO Solution	10mM  * 100uL	Metabolic Disease	FC1=CC=C([C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)C=C1CC3=CC(C=CC=C4)=C4S3	https://www.medchemexpress.com/ipragliflozin.html	Launched		92.0	AE25	O22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14894	10.0	mM	358.0	DMSO	404.109373	22	O	pluskal_fda_drugs_5005_O22_id
1601	HY-B1466	HYCPK40906	D16	HYCPK40906	92z	319.0	1.0	G31	906.0	D16	42057-22-7	Mezlocillin (sodium)	BAY-f 1353 (sodium)	561.56	Antibiotic; Bacterial	Anti-infection	Mezlocillin (BAY-f 1353) sodium is a β-lactam antibiotic, a semisynthetic and extended-spectrum antibiotic. Mezlocillin sodium is active against both gram-negative and gram-positive bacteria. Mezlocillin sodium can be used in bacterial infection research[1][2].	Sodium	C21H24N5NaO8S2	115859.0	DMSO : 250 mg/mL (445.19 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC([C@H](NC(N3CCN(S(=O)(C)=O)C3=O)=O)C4=CC=CC=C4)=O)N1C2=O)O[Na]	https://www.medchemexpress.com/Mezlocillin-sodium.html	Launched		92.0	G31	O22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1466	10.0	mM	358.0	DMSO	539.114455	22	O	pluskal_fda_drugs_5005_O22_id
1945	HY-B0084	HYCPK40907	I18	HYCPK40907	92z	804.0	2.0	Q36	907.0	I18	65928-58-7	Dienogest	STS 557	311.42	Progesterone Receptor	Others	Dienogest (STS-557) is an orally active and selective progesterone receptor agonist that effectively reduces the gene expression of COX-2, mPGES-1 and aromatase. Dienogest also inhibits the mRNA and protein expression of PGE2 synthase and the activation of NF-κB. Dienogest can be used in studies of endometriosis, menopause and menorrhagia[1][2].	Free Base	C20H25NO2	15429.0	DMSO : 25 mg/mL (80.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology	C[C@@]12[C@](O)(CC#N)CC[C@@]1([H])[C@]3([H])CCC4=CC(CCC4=C3CC2)=O	https://www.medchemexpress.com/Dienogest.html	Launched		92.0	Q36	O22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0084	10.0	mM	358.0	DMSO	311.188529	22	O	pluskal_fda_drugs_5005_O22_id
1998	HY-B0883	HYCPK40907	B22	HYCPK40907	92z	140.0	2.0	C44	907.0	B22	1811-28-5	Proflavine (hemisulfate)	Proflavin hemisulfate; 3,6-Diaminoacridine hemisulfate	258.29	Autophagy; Bacterial; Potassium Channel	Anti-infection; Autophagy; Membrane Transporter/Ion Channel	Proflavine hemisulfate, an acridine dye, is a known DNA intercalating agent. Anti-microbial agent[1]. Proflavine hemisulfate behaves as a pore blocker for Kir3.2. Proflavine hemisulfate is a potential lead compound for Kir3.2-associated neurological diseases[2].	Sulfate	C13H11N3.1/2 H2SO4	17216.0	H2O : ≥ 5 mg/mL (19.36 mM)	DMSO Solution	10mM  * 100uL	Infection; Cancer	NC1=CC2=NC3=CC(N)=CC=C3C=C2C=C1.[0.5H2SO4]	https://www.medchemexpress.com/Proflavine-hemisulfate.html	Launched		92.0	C44	O22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0883	10.0	mM	358.0	DMSO	209.095297	22	O	pluskal_fda_drugs_5005_O22_id
2072	HY-B1403	HYCPK40908	A07	HYCPK40908	92z	61.0	3.0	B13	908.0	A07	84-17-3	Dienestrol		266.33	Estrogen Receptor/ERR	Others	Dienestrol is a synthetic, non-steroidal estrogen, is an estrogen receptor agonist, for the treatment of menopausal and postmenopausal symptoms.	Free Base	C18H18O2	17594.0	DMSO : 155 mg/mL (581.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	C/C=C(C1=CC=C(O)C=C1)/C(C2=CC=C(O)C=C2)=C/C	https://www.medchemexpress.com/Dienestrol.html	Launched		92.0	B13	O22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1403	10.0	mM	358.0	DMSO	266.13068	22	O	pluskal_fda_drugs_5005_O22_id
2143	HY-B0008	HYCPK40908	L11	HYCPK40908	92z	1125.0	3.0	X21	908.0	L11	38194-50-2	Sulindac	MK-231	356.41	NF-κB; PD-1/PD-L1	Immunology/Inflammation; NF-κB	Sulindac (MK-231) is an orally active nonsteroidal anti-inflammatory agent. Sulindac also is an immunomodulatory agent. Sulindac can be used for the research of arthritis of the spine, gouty arthritis and kinds of cancer including colorectal cancer (CRC) and lung cancer[1][2].	Free Acid	C20H17FO3S	5165.0	DMSO : 100 mg/mL (280.58 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(CC(C1=C2C=CC(F)=C1)=C(/C2=C/C3=CC=C(C=C3)S(C)=O)C)O	https://www.medchemexpress.com/Sulindac.html	Launched		92.0	X21	O22	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0008	10.0	mM	358.0	DMSO	356.088244	22	O	pluskal_fda_drugs_5005_O22_id
31	HY-P0035	HYCPK40899	I03	HYCPK40909	92z	844.0	4.0	R28	909.0	I14	11061-68-0	Insulin (human)		5807.57	Insulin Receptor	Protein Tyrosine Kinase/RTK	Insulin (human) is a polypeptide hormone that regulates the level of glucose.		C257H383N65O77S6	99149.0	H2O : 13.33 mg/mL (2.30 mM; ultrasonic and adjust pH to 4 with HCl)	DMSO Solution	2mM  * 100uL	Metabolic Disease; Endocrinology	[Insulin (human)]	https://www.medchemexpress.com/Insulin_human_.html	Launched		92.0	R28	P3	350.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P0035	2.0	mM	363.0	DMSO	5803.637649	3	P	pluskal_fda_drugs_5005_P3_id
1366	HY-13010	HYCPK40906	C03	HYCPK40906	92z	197.0	1.0	E5	906.0	C03	248281-84-7	Laquinimod	ABR-215062	356.80	Apoptosis; NF-κB	Apoptosis; NF-κB	Laquinimod (ABR-215062), an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system. Laquinimod reduces astrocytic NF-κB activation to protect from Cuprizone-induced demyelination. Laquinimod has?the?potential?for relapsing remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS; RRMS or CPMS) as well as neurodegenerative diseases?research[1][2][3][4].	Free Base	C19H17ClN2O3	6537.0	DMSO : 100 mg/mL (280.27 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=C(O)C2=C(N(C)C1=O)C=CC=C2Cl)N(CC)C3=CC=CC=C3	https://www.medchemexpress.com/Laquinimod.html	Launched		92.0	E5	P3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-13010	10.0	mM	363.0	DMSO	356.09277	3	P	pluskal_fda_drugs_5005_P3_id
1606	HY-135336A	HYCPK40906	I16	HYCPK40906	92z	799.0	1.0	Q31	906.0	I16	36622-28-3	(S)-Verapamil (hydrochloride)	(S)-(-)-Verapamil (hydrochloride)	491.06	Apoptosis; Calcium Channel; Leukotriene Receptor	Apoptosis; GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	(S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) inhibits leukotriene C4 (LTC4) and calcein transport by MRP1. (S)-Verapamil hydrochloride leads to the death of potentially resistant tumor cells[1][2].	Hydrochloride	C27H39ClN2O4	81504.0	H2O : 100 mg/mL (203.64 mM; Need ultrasonic); DMSO : 200 mg/mL (407.28 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	COC1=C(OC)C=CC(CCN(C)CCC[C@@](C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)=C1.Cl	https://www.medchemexpress.com/s-verapamil-hydrochloride.html	Launched		92.0	Q31	P3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-135336A	10.0	mM	363.0	DMSO	454.283158	3	P	pluskal_fda_drugs_5005_P3_id
1745	HY-B1802A	HYCPK40907	I05	HYCPK40907	92z	778.0	2.0	Q10	907.0	I05	1400591-39-0	Tosufloxacin (tosylate hydrate)	A-61827 (tosylate hydrate); T-3262	594.56	Antibiotic; Bacterial	Anti-infection	Tosufloxacin tosylate hydrate (A-61827) is an orally active fluoroquinolone antibiotic. Tosufloxacin shows a broad spectrum of antibacterial activity against gram-positive and gram-negative bacteria[1][2].	Tosylate	C26H25F3N4O7S	21113.0	DMSO : 12.5 mg/mL (21.02 mM; Need ultrasonic); H2O : 1 mg/mL (1.68 mM; ultrasonic and warming and heat to 80°C)	DMSO Solution	10mM  * 100uL	Infection	CC1=CC=C(S(=O)(O)=O)C=C1.O=C(C2=CN(C3=CC=C(F)C=C3F)C4=C(C=C(F)C(N5CC(N)CC5)=N4)C2=O)O.O	https://www.medchemexpress.com/Tosufloxacin-tosylate-hydrate.html	Launched		92.0	Q10	P3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1802A	10.0	mM	363.0	DMSO	404.109625	3	P	pluskal_fda_drugs_5005_P3_id
1926	HY-14541	HYCPK40907	F17	HYCPK40907	92z	514.0	2.0	K34	907.0	F17	132539-06-1	Olanzapine	LY170053	312.43	5-HT Receptor; Adrenergic Receptor; Apoptosis; Autophagy; Dopamine Receptor; mAChR; Mitophagy	Apoptosis; Autophagy; GPCR/G Protein; Neuronal Signaling	Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic  α1 receptor (Ki=19  nM). Olanzapine is an atypical antipsychotic[1][2].	Free Base	C17H20N4S	8959.0	DMSO : 20 mg/mL (64.01 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CC1=CC(C(N2CCN(C)CC2)=N3)=C(S1)NC4=C3C=CC=C4	https://www.medchemexpress.com/Olanzapine.html	Launched		92.0	K34	P3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14541	10.0	mM	363.0	DMSO	312.140868	3	P	pluskal_fda_drugs_5005_P3_id
2220	HY-N0163	HYCPK40908	I16	HYCPK40908	92z	847.0	3.0	R31	908.0	I16	528-43-8	Magnolol		266.33	Autophagy; Bacterial; PPAR; RAR/RXR	Anti-infection; Autophagy; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Magnolol, a natural lignan isolated from the stem bark of Magnolia officinalis, is a dual agonist of both RXRα and PPARγ, with EC50 values of 10.4 μM and 17.7 μM, respectively.	Free Base	C18H18O2	18215.0	DMSO : 100 mg/mL (375.47 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease	OC1=CC=C(CC=C)C=C1C2=CC(CC=C)=CC=C2O	https://www.medchemexpress.com/Magnolol.html	Launched		92.0	R31	P3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0163	10.0	mM	363.0	DMSO	266.13068	3	P	pluskal_fda_drugs_5005_P3_id
2457	HY-15605	HYCPK40909	E05	HYCPK40909	92z	442.0	4.0	J10	909.0	E05	1269440-17-6	Encorafenib	LGX818	540.01	Raf	MAPK/ERK Pathway	Encorafenib (LGX818) is a highly potent BRAF inhibitor with selective anti-proliferative and apoptotic activity in cells expressing BRAFV600E (EC50=4 nM).	Free Base	C22H27ClFN7O4S	228439.0	DMSO : 50 mg/mL (92.59 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(OC)N[C@@H](C)CNC1=NC=CC(C2=CN(C(C)C)N=C2C3=CC(Cl)=CC(NS(=O)(C)=O)=C3F)=N1	https://www.medchemexpress.com/LGX818.html	Launched		92.0	J10	P3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15605	10.0	mM	363.0	DMSO	539.151779	3	P	pluskal_fda_drugs_5005_P3_id
2466	HY-14252	HYCPK40909	N05	HYCPK40909	92z	1306.0	4.0	AB10	909.0	N05	78415-72-2	Milrinone	Win 47203	211.22	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Milrinone is a PDE3 inhibitor, and also an inotrope and vasodilator.	Free Base	C12H9N3O	12250.0	DMSO : 50 mg/mL (236.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	CC(N1)=C(C2=CC=NC=C2)C=C(C#N)C1=O	https://www.medchemexpress.com/Milrinone.html	Launched		92.0	AB10	P3	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-14252	10.0	mM	363.0	DMSO	211.074562	3	P	pluskal_fda_drugs_5005_P3_id
1522	HY-50904	HYCPK40906	E11	HYCPK40906	92z	405.0	1.0	I21	906.0	E11	656247-17-5	Nintedanib	BIBF 1120	539.62	FGFR; PDGFR; VEGFR	Protein Tyrosine Kinase/RTK	Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively.	Free Base	C31H33N5O4	39446.0	DMSO : 11.5 mg/mL (21.31 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C1NC2=CC(C(OC)=O)=CC=C2/C1=C(NC3=CC=C(N(C(CN4CCN(C)CC4)=O)C)C=C3)\C5=CC=CC=C5	https://www.medchemexpress.com/BIBF-1120.html	Launched		92.0	I21	P4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50904	10.0	mM	364.0	DMSO	539.253255	4	P	pluskal_fda_drugs_5005_P4_id
1585	HY-40354A	HYCPK40906	D15	HYCPK40906	92z	317.0	1.0	G29	906.0	D15	540737-29-9	Tofacitinib (citrate)	Tasocitinib (citrate); CP-690550 (citrate)	504.49	Apoptosis; Bacterial; Fungal; Influenza Virus; JAK	Anti-infection; Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Tofacitinib citrate is an orally available JAK1/2/3 inhibitor with IC50s of 1, 20, and 112 nM, respectively. Tofacitinib citrate has antibacterial, antifungal and antiviral activities.	Citrate	C22H28N6O8	62010.0	DMSO : 28.57 mg/mL (56.63 mM; Need ultrasonic); H2O : 3.33 mg/mL (6.60 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=C(CC#N)N1C[C@H](N(C2=C3C(NC=C3)=NC=N2)C)[C@H](C)CC1.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Tofacitinib-citrate.html	Launched		92.0	G29	P4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-40354A	10.0	mM	364.0	DMSO	312.169859	4	P	pluskal_fda_drugs_5005_P4_id
1717	HY-B0968A	HYCPK40907	H03	HYCPK40907	92z	678.0	2.0	O6	907.0	H03	5011-34-7	Trimetazidine		266.34	Autophagy	Autophagy	Trimetazidine is a selective long chain 3-ketoyl coenzyme A thiolase inhibitor with an IC50 of 75 nM, which can inhibit β-oxidation of free fatty acid (FFA). Trimetazidine is an effective antianginal agent and a cytoprotective drug, has anti-oxidant, anti-inflammatory, antinociceptive and gastroprotective properties. Trimetazidine triggers autophagy. Trimetazidine is also a 3-hydroxyacyl-CoA dehydrogenase (HADHA) inhibitor[1][2][3][4].		C14H22N2O3	153748.0	DMSO : ≥ 125 mg/mL (469.32 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	COC1=CC=C(CN2CCNCC2)C(OC)=C1OC	https://www.medchemexpress.com/trimetazidine.html	Launched		92.0	O6	P4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0968A	10.0	mM	364.0	DMSO	266.163043	4	P	pluskal_fda_drugs_5005_P4_id
1729	HY-B1271	HYCPK40907	D04	HYCPK40907	92z	296.0	2.0	G8	907.0	D04	57-96-5	Sulfinpyrazone	G-28315	404.48	Endogenous Metabolite	Metabolic Enzyme/Protease	Sulfinpyrazone (G-28315) is an orally active and potent uricosuric agent for chronic and intermittent gouty arthritis. Sulfinpyrazone has antithrombotic and platelet inhibitory effects[1][2].		C23H20N2O3S	89025.0	DMSO : 33.33 mg/mL (82.40 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1CCS(C2=CC=CC=C2)=O)N(C3=CC=CC=C3)N(C4=CC=CC=C4)C1=O	https://www.medchemexpress.com/sulfinpyrazone.html	Launched		92.0	G8	P4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1271	10.0	mM	364.0	DMSO	404.119463	4	P	pluskal_fda_drugs_5005_P4_id
1863	HY-B0225B	HYCPK40907	O12	HYCPK40907	92z	1368.0	2.0	AC24	907.0	O12	41372-08-1	Methyldopa (hydrate)	L-(-)-α-Methyldopa (hydrate); MK-351 (hydrate)	238.24	Adrenergic Receptor; Endogenous Metabolite	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	Methyldopa hydrate (L-(-)-α-Methyldopa hydrate), a potent antihyoertensive agent, is an alpha-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopa hydrate is a prodrug and is metabolized (α-Methylepinephrine) in the central nervous system[1][2].	Free Acid	C10H16NO5.5	16471.0	DMSO : 33.33 mg/mL (139.90 mM; Need ultrasonic); H2O : 1 mg/mL (4.20 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Endocrinology	OC1=C(O)C=CC(C[C@@](C)(C(O)=O)N)=C1.[1.5H2O]	https://www.medchemexpress.com/L-_-_-_alpha_-Methyldopa-hydrate.html	Launched		92.0	AC24	P4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0225B	10.0	mM	364.0	DMSO	211.084458	4	P	pluskal_fda_drugs_5005_P4_id
1934	HY-109031	HYCPK40907	N17	HYCPK40907	92z	1282.0	2.0	AA34	907.0	N17	1285572-51-1	Dotinurad		358.20	URAT1	Membrane Transporter/Ion Channel	Dotinurad is a potent and selective urate reabsorption inhibitor. Dotinurad inhibits urate transporter 1 (URAT1) with an IC50 value of 37.2 nM. Dotinurad acts as a uricosuric agent[1].	Free Base	C14H9Cl2NO4S	105114.0	DMSO : 65 mg/mL (181.46 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	O=C(C1=CC(Cl)=C(O)C(Cl)=C1)N(C2)C3=CC=CC=C3S2(=O)=O	https://www.medchemexpress.com/dotinurad.html	Launched		92.0	AA34	P4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-109031	10.0	mM	364.0	DMSO	356.962934	4	P	pluskal_fda_drugs_5005_P4_id
2195	HY-B0347	HYCPK40908	P14	HYCPK40908	92z	1515.0	3.0	AF27	908.0	P14	103890-78-4	Lacidipine		455.54	Apoptosis; Calcium Channel; Caspase; Reactive Oxygen Species	Apoptosis; Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κB	Lacidipine is an orally active and highly selective L-type calcium channel blocker that acts on smooth muscle calcium channels, primarily dilates peripheral arteries, reduces peripheral resistance, and has long-lasting anti-hypertensive activity. Lacidipine protects HKCs from apoptosis induced by ATP depletion and recovery by modulating the caspase-3 pathway. Lacidipine can be used in studies of hypertension, atherosclerosis and acute kidney injury (AKI)[1][2].	Free Base	C26H33NO6	16248.0	DMSO : ≥ 50 mg/mL (109.76 mM)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=C(C)NC(C)=C(C(OCC)=O)C1C2=CC=CC=C2/C=C/C(OC(C)(C)C)=O)OCC	https://www.medchemexpress.com/Lacidipine.html	Launched		92.0	AF27	P4	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0347	10.0	mM	364.0	DMSO	455.230788	4	P	pluskal_fda_drugs_5005_P4_id
1707	HY-50706	HYCPK40906	N22	HYCPK40906	92z	1291.0	1.0	AA43	906.0	N22	606143-52-6	Selumetinib	AZD6244; ARRY-142886	457.68	Apoptosis; MEK	Apoptosis; MAPK/ERK Pathway	Selumetinib (AZD6244) is selective, non-ATP-competitive oral MEK1/2 inhibitor, with an IC50 of 14 nM for MEK1. Selumetinib (AZD6244) inhibits ERK1/2 phosphorylation.	Free Base	C17H15BrClFN4O3	87644.0	DMSO : 10 mg/mL (21.85 mM; Need ultrasonic); H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	DMSO Solution	10mM  * 100uL	Cancer	O=C(C1=C(C(F)=C2N=CN(C2=C1)C)NC3=CC=C(C=C3Cl)Br)NOCCO	https://www.medchemexpress.com/Selumetinib.html	Launched		92.0	AA43	P5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-50706	10.0	mM	365.0	DMSO	456.000008	5	P	pluskal_fda_drugs_5005_P5_id
1715	HY-B1374	HYCPK40907	F03	HYCPK40907	92z	486.0	2.0	K6	907.0	F03	73231-34-2	Florfenicol	(-)-Florfenicol; SCH-25298	358.21	Antibiotic; Bacterial	Anti-infection	Florfenicol, a commonly used veterinary antibiotic, is currently indicated for the treatment of bovine respiratory disease, and also used in aquaculture for the control of enteric septicemia in catfish. Florfenicol can induce early embryonic death in eggs, with an LC50 of 1.07 μg/g.	Free Base	C12H14Cl2FNO4S	17598.0	DMSO : 100 mg/mL (279.17 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(N[C@H](CF)[C@H](O)C1=CC=C(S(=O)(C)=O)C=C1)C(Cl)Cl	https://www.medchemexpress.com/Florfenicol.html	Launched		92.0	K6	P5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1374	10.0	mM	365.0	DMSO	357.000463	5	P	pluskal_fda_drugs_5005_P5_id
1718	HY-B2111	HYCPK40907	I03	HYCPK40907	92z	774.0	2.0	Q6	907.0	I03	56715-13-0	(R)-(+)-Atenolol		266.34	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	(R)-(+)-Atenolol is the less active enantiomer of the (R,S)-atenolol. (R,S)-atenolol is a β-adrenergic receptor antagonist[1][2].	Free Base	C14H22N2O3	55612.0	DMSO : ≥ 100 mg/mL (375.46 mM)	DMSO Solution	10mM  * 100uL	Others	O=C(N)CC1=CC=C(OC[C@H](O)CNC(C)C)C=C1	https://www.medchemexpress.com/r-atenolol.html	Launched		92.0	Q6	P5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2111	10.0	mM	365.0	DMSO	266.163043	5	P	pluskal_fda_drugs_5005_P5_id
1793	HY-17392	HYCPK40907	I08	HYCPK40907	92z	784.0	2.0	Q16	907.0	I08	7481-89-2	Zalcitabine	2',3'-Dideoxycytidine; ddC; Dideoxycytidine	211.22	HIV; Reverse Transcriptase	Anti-infection	Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection.	Free Base	C9H13N3O3	152328.0	DMSO : 62.5 mg/mL (295.90 mM; Need ultrasonic); H2O : ≥ 25 mg/mL (118.36 mM)	DMSO Solution	10mM  * 100uL	Infection	OC[C@@H]1CC[C@H](N2C(N=C(C=C2)N)=O)O1	https://www.medchemexpress.com/Zalcitabine.html	Launched		92.0	Q16	P5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17392	10.0	mM	365.0	DMSO	211.095691	5	P	pluskal_fda_drugs_5005_P5_id
2074	HY-B1300	HYCPK40908	C07	HYCPK40908	92z	253.0	3.0	F13	908.0	C07	61270-78-8	Cefonicid (sodium)		586.53	Antibiotic; Bacterial	Anti-infection	"Cefonicid sodium is a broadspectrum cephalosporin antibiotic which inhibits the formation of the bacterial cell wall. 
Target: Antibacterial
Cefonicid sodium can inhibit the carnitine/carnitine antiport when it is added internally and externally to proteoliposomes. It is known that the molecule contains various electroactive groups that can be detected using adsorptive square-wave stripping voltammetry. In addition, the compound can be detected in solution using UV spectroscopy at 265 nm. Cefonicid sodium is effective against Escherichia coli, Klebsiella, Citrobacter, Enterobacter, indole-negative Proteus, and Providencia."	Sodium	C18H16N6Na2O8S3	19173.0	DMSO : 33.33 mg/mL (56.83 mM; Need ultrasonic); H2O : 100 mg/mL (170.49 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3CS(=O)(O[Na])=O)CS[C@]2([H])[C@H](NC([C@H](O)C4=CC=CC=C4)=O)C1=O)O[Na]	https://www.medchemexpress.com/Cefonicid-sodium.html	Launched		92.0	F13	P5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1300	10.0	mM	365.0	DMSO	542.034825	5	P	pluskal_fda_drugs_5005_P5_id
2123	HY-40354	HYCPK40908	D10	HYCPK40908	92z	355.0	3.0	H19	908.0	D10	477600-75-2	Tofacitinib	Tasocitinib; CP-690550	312.37	Apoptosis; JAK	Apoptosis; Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt	Tofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively.	Free Base	C16H20N6O	110600.0	DMSO : 125 mg/mL (400.17 mM; Need ultrasonic); H2O : 0.15 mg/mL (0.48 mM; Need ultrasonic and warming); Ethanol : 2.5 mg/mL (8.00 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(CC#N)N1C[C@H](N(C2=C3C(NC=C3)=NC=N2)C)[C@H](C)CC1	https://www.medchemexpress.com/Tofacitinib.html	Launched		92.0	H19	P5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-40354	10.0	mM	365.0	DMSO	312.169859	5	P	pluskal_fda_drugs_5005_P5_id
2299	HY-12288	HYCPK40908	L21	HYCPK40908	92z	1145.0	3.0	X41	908.0	L21	1306760-87-1	Ozanimod	RPC-1063	404.46	LPL Receptor	GPCR/G Protein	Ozanimod (RPC-1063), a sphingosine 1-phosphate (S1P) receptor modulator that binds with high affinity selectively to S1P receptor subtypes 1 (S1P1) and 5 (S1P5). Ozanimod has modulate effect for hS1P1 and hS1P5 receptor with EC50s of 1.03 nM and 8.6 nM, respectively. Ozanimod can be used for the research of relapsing multiple sclerosis (MS)[1].	Free Base	C23H24N4O3	19150.0	DMSO : ≥ 29 mg/mL (71.70 mM)	DMSO Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	N#CC1=CC(C2=NC(C3=CC=CC4=C3CC[C@@H]4NCCO)=NO2)=CC=C1OC(C)C	https://www.medchemexpress.com/Ozanimod.html	Launched		92.0	X41	P5	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-12288	10.0	mM	365.0	DMSO	404.184841	5	P	pluskal_fda_drugs_5005_P5_id
1649	HY-N0156	HYCPK40906	D19	HYCPK40906	92z	325.0	1.0	G37	906.0	D19	508-02-1	Oleanolic Acid	Oleanic acid; Caryophyllin	456.70	Autophagy; Endogenous Metabolite; HIV	Anti-infection; Autophagy; Metabolic Enzyme/Protease	Oleanolic acid (Caryophyllin) is a natural compound from plants with anti-tumor activities.	Free Acid	C30H48O3	132669.0	DMSO : 5 mg/mL (10.95 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@]([C@@]1([H])[C@]2(CC[C@@H]3O)C)(CC[C@@]2([H])C3(C)C)[C@@](C4=CC1)(CC[C@]5(C(O)=O)[C@@]4([H])CC(C)(C)CC5)C	https://www.medchemexpress.com/Oleanolic-Acid.html	Launched		92.0	G37	P6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0156	10.0	mM	366.0	DMSO	456.360345	6	P	pluskal_fda_drugs_5005_P6_id
1800	HY-N7137	HYCPK40907	P08	HYCPK40907	92z	1456.0	2.0	AE16	907.0	P08	6533-00-2	Norgestrel		312.45	Reactive Oxygen Species	Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Norgestrel is a synthetic analog of progesterone, a compound commonly found in oral contraceptive pill, and a powerful neuroprotective antioxidant, preventing light-induced ROS in photoreceptor cells, and cell death[1][2].	Free Base	C21H28O2	64313.0	DMSO : 100 mg/mL (320.05 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	C#C[C@@]1(O)CC[C@@]2([H])[C@]3([H])CCC4=CC(CC[C@]4([H])[C@@]3([H])CC[C@]12CC)=O	https://www.medchemexpress.com/norgestrel.html	Launched		92.0	AE16	P6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7137	10.0	mM	366.0	DMSO	312.20893	6	P	pluskal_fda_drugs_5005_P6_id
1969	HY-B1272	HYCPK40907	E20	HYCPK40907	92z	424.0	2.0	I40	907.0	E20	58-28-6	Desipramine (hydrochloride)		302.84	Dopamine Transporter; Serotonin Transporter	Neuronal Signaling	Desipramine hydrochloride is an inhibitor of norepinephrine transporter (NET), 5-HT transporter (SERT) and dopamine transporter (DAT) with Kis of 4, 61 and 78,720 nM, respectively.	Hydrochloride	C18H23ClN2	27657.0	DMSO : ≥ 100 mg/mL (330.21 mM); H2O : 100 mg/mL (330.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31.[H]Cl	https://www.medchemexpress.com/Desipramine_hydrochloride.html	Launched		92.0	I40	P6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1272	10.0	mM	366.0	DMSO	266.178299	6	P	pluskal_fda_drugs_5005_P6_id
2051	HY-B0358A	HYCPK40908	L05	HYCPK40908	92z	1113.0	3.0	X9	908.0	L05	30484-77-6	Flunarizine (dihydrochloride)		477.42	Calcium Channel; Dopamine Receptor; Sodium Channel	GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling	Flunarizine dihydrochloride is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine dihydrochloride is a D2 dopamine receptor antagonist. Flunarizine dihydrochloride shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].	Hydrochloride	C26H28Cl2F2N2	16246.0	H2O : 1 mg/mL (2.09 mM; Need ultrasonic); DMSO : 50 mg/mL (104.73 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	FC1=CC=C(C(N2CCN(C/C=C/C3=CC=CC=C3)CC2)C4=CC=C(F)C=C4)C=C1.Cl.Cl	https://www.medchemexpress.com/Flunarizine-dihydrochloride.html	Launched		92.0	X9	P6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0358A	10.0	mM	366.0	DMSO	404.206405	6	P	pluskal_fda_drugs_5005_P6_id
2138	HY-15142	HYCPK40908	G11	HYCPK40908	92z	645.0	3.0	N21	908.0	G11	25316-40-9	Doxorubicin (hydrochloride)	Hydroxydaunorubicin (hydrochloride)	579.98	ADC Cytotoxin; AMPK; Antibiotic; Apoptosis; Autophagy; Bacterial; HBV; HIV; Mitophagy; Topoisomerase	Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage; Epigenetics; PI3K/Akt/mTOR	Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy[1][2][3].	Hydrochloride	C27H30ClNO11	97451.0	DMSO : 35.71 mg/mL (61.57 mM; ultrasonic and warming and heat to 60°C); H2O : 20 mg/mL (34.48 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Infection	COC1=C2C(C(C(C(O)=C(C[C@](C(CO)=O)(O)C[C@@H]3O[C@@]4([H])C[C@H](N)[C@H](O)[C@H](C)O4)C3=C5O)=C5C2=O)=O)=CC=C1.[H]Cl	https://www.medchemexpress.com/Doxorubicin-hydrochloride.html	Launched		92.0	N21	P6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-15142	10.0	mM	366.0	DMSO	543.174061	6	P	pluskal_fda_drugs_5005_P6_id
2188	HY-16500	HYCPK40908	I14	HYCPK40908	92z	843.0	3.0	R27	908.0	I14	82964-04-3	Tolrestat	AY-27773	357.35	Aldose Reductase	Metabolic Enzyme/Protease	Tolrestat is a potent, orally active aldose reductase inhibitor with IC50 of 35 nM.	Free Acid	C16H14F3NO3S	10782.0	DMSO : 50 mg/mL (139.92 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	O=C(O)CN(C(C1=C2C=CC(OC)=C(C(F)(F)F)C2=CC=C1)=S)C	https://www.medchemexpress.com/Tolrestat.html	Launched		92.0	R27	P6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-16500	10.0	mM	366.0	DMSO	357.064649	6	P	pluskal_fda_drugs_5005_P6_id
2431	HY-10020	HYCPK40909	K03	HYCPK40909	92z	1014.0	4.0	V6	909.0	K03	230615-23-3	Varenicline (Hydrochloride)	CP 526555 hydrochloride	247.72	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Varenicline Hydrochloride (CP 526555 hydrochloride) is a high affinity, selective α4β2 nicotine acetylcholine receptor (nAChR) partial agonist and full α7 nAChR agonist[1][2][3]. Varenicline Hydrochloride is also a potent partial agonist of α6β2 nAChR in striatum of rats with a Ki value of 0.12 nM[4].	Hydrochloride	C13H14ClN3	23798.0	H2O : 50 mg/mL (201.84 mM; Need ultrasonic); DMSO : ≥ 2.5 mg/mL (10.09 mM)	DMSO Solution	10mM  * 100uL	Neurological Disease; Cancer	C1(C2CC3CNC2)=C3C=C(N=CC=N4)C4=C1.Cl	https://www.medchemexpress.com/Varenicline-Hydrochloride.html	Launched		92.0	V6	P6	70.0	nl	5005	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-10020	10.0	mM	366.0	DMSO	211.110947	6	P	pluskal_fda_drugs_5005_P6_id
19	HY-17567B	HYCPK40898	D03	HYCPK40910					910.0	D19	9045-22-1	Heparin (Lithium salt)			Autophagy; Bacterial; Thrombin	Anti-infection; Autophagy; Metabolic Enzyme/Protease	Heparin Lithium salt is an anticoagulant which binds reversibly to antithrombin III (ATIII). Heparin Lithium salt significantly inhibits exosome-cell interactions.	Lithium	(C14H25NO20S3)n.xLi	109896.0	H2O : 100 mg/mL (Need ultrasonic)	Water Solution	3mg/mL  * 100uL	Cardiovascular Disease; Cancer	O[C@H]1[C@H](O[C@H]2[C@H](OS(O)(=O)=O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O2)[C@@H](COS(O)(=O)=O)O[C@H](OC)[C@@H]1NS(O)(=O)=O.[n].[.xLi]	https://www.medchemexpress.com/Heparin_Lithium_salt.html	Launched		910.0	D19	A3	233.3333333	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17567B	3.0	mM	3.0	DMSO	623.013205	3	A	pluskal_fda_drugs_5006_A3_id
2562	HY-A0124A	HYCPK40910	E03	HYCPK40910					910.0	E03	69056-38-8	Sapropterin (dihydrochloride)	(6R)-BH4 (dihydrochloride); (6R)-Tetrahydro-L-biopterin (dihydrochloride)	314.17	Others	Others	Sapropterin ((6R)-BH4) dihydrochloride is an orally active phenylalanine hydroxylase (PAH) cofactor, which is effective in reducing blood phenylalanine concentrations. Sapropterin dihydrochloride can be used in study of phenylketonuria (PKU)[1].	Hydrochloride	C9H17Cl2N5O3	66707.0	H2O : 100 mg/mL (318.30 mM; Need ultrasonic); DMSO : ≥ 200 mg/mL (636.60 mM)	Water Solution	10mM  * 100uL	Cardiovascular Disease	O=C1N=C(N)NC2=C1N[C@@H]([C@@H](O)[C@@H](O)C)CN2.[H]Cl.[H]Cl	https://www.medchemexpress.com/Sapropterin-dihydrochloride.html	Launched		910.0	E3	A3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0124A	10.0	mM	3.0	DMSO	241.117489	3	A	pluskal_fda_drugs_5006_A3_id
2564	HY-Y0966	HYCPK40910	G03	HYCPK40910					910.0	G03	56-40-6	Glycine		75.07	Endogenous Metabolite; iGluR	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Glycine is an inhibitory neurotransmitter in the CNS and also acts as a co-agonist along with glutamate, facilitating an excitatory potential at the glutaminergic N-methyl-D-aspartic acid (NMDA) receptors.	Free Acid	C2H5NO2	44104.0	H2O : 130 mg/mL (1731.72 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	NCC(O)=O	https://www.medchemexpress.com/2-Aminoacetic_acid.html	Launched		910.0	G3	A3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-Y0966	10.0	mM	3.0	DMSO	75.032028	3	A	pluskal_fda_drugs_5006_A3_id
2575	HY-A0022A	HYCPK40910	B04	HYCPK40910					910.0	B04	63302-99-8	Azaphen (dihydrochloride monohydrate)	Azafen dihydrochloride monohydrate; Pipofezin dihydrochloride monohydrate; Pipofezine dihydrochloride monohydrate; Azaphenonxazine dihydrochloride monohydrate	388.29212	Serotonin Transporter	Neuronal Signaling	"Pipofezine(Azafen or Azaphen) is a potent inhibitor of the reuptake of serotonin. 
IC50 Value: 
Target: SSRIs
Pipofezine is a tricyclic antidepressant (TCA) approved in Russia for the treatment ofdepression."	Hydrochloride	C16H23Cl2N5O2	5796.0	H2O : ≥ 100 mg/mL (257.54 mM); DMSO : 1 mg/mL (2.58 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	[H]Cl.[H]Cl.CN1C2=CC=CC=C2OC3=C1C=C(N4CCN(C)CC4)N=N3.O	https://www.medchemexpress.com/Azaphen-dihydrochloride-monohydrate.html	Launched		910.0	B4	A3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0022A	10.0	mM	3.0	DMSO	297.15896	3	A	pluskal_fda_drugs_5006_A3_id
2630	HY-14781	HYCPK40910	I07	HYCPK40910					910.0	I07	31690-09-2	Levomefolic acid	5-MTHF	459.46	DNA/RNA Synthesis; Endogenous Metabolite; Reactive Oxygen Species	Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Levomefolic acid (5-MTHF) is an orally active, brain-penetrant natural active form of folic acid and is one of the most widely used folic acid food supplements[1][2].	Free Acid	C20H25N7O6	25387.0	DMSO : 1 mg/mL (2.18 mM; Need ultrasonic); H2O : 5 mg/mL (10.88 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Infection	O=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(NC[C@@H]2N(C)C3=C(NC(N)=NC3=O)NC2)C=C1)=O	https://www.medchemexpress.com/Levomefolic-acid.html	Launched		910.0	I7	A3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14781	10.0	mM	3.0	DMSO	459.186632	3	A	pluskal_fda_drugs_5006_A3_id
2659	HY-B1346	HYCPK40910	J09	HYCPK40910					910.0	J09	6899-04-3	DL-Glutamine	(±)-Glutamine; DL-Gl	146.14	Endogenous Metabolite; Ferroptosis	Apoptosis; Metabolic Enzyme/Protease	DL-Glutamine is used for biochemical research and drug synthesis.	Free Acid	C5H10N2O3	62168.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 33.33 mg/mL (228.07 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	NC(CCC(N)=O)C(O)=O	https://www.medchemexpress.com/DL-Glutamine.html	Launched		910.0	J9	A3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1346	10.0	mM	3.0	DMSO	146.069142	3	A	pluskal_fda_drugs_5006_A3_id
2678	HY-N0378	HYCPK40910	M10	HYCPK40910					910.0	M10	69-65-8	D-Mannitol	Mannitol; Mannite	182.17	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	"D-Mannitol is an osmotic diuretic agent and a weak renal vasodilator.
Target: Others
D(-)Mannitol is a sugar alcohol that can be used as an inert osmotic control substance. The uptake and phosphorylation of d-mannitol is catalyzed by the mannitol-specific phosphoenolpyruvate-dependent phosphotransferase systems (PTS). Mannitol can interact with neutrophils and monocytes. Experiments have shown that it is able to decrease neutrophil apoptosis in vitro. The compound has been used in studies as a stimulator of cecal microbial growth and cellulolytic activity in rabbits. It has been observed that mannitol can lower the fat digestibility and body fat accumulation in both normal and cecectomized rats, as well as upregulate monocyte HLA-DR, monocyte and neutrophil CD11b. Studies show that the mannitol operon is repressed by the transcription factor, mannitol operon repressor (MtlR) in Escherichia coli [1-3]."	Free Base	C6H14O6	23898.0	H2O : ≥ 36 mg/mL (197.62 mM)	Water Solution	10mM  * 100uL	Metabolic Disease; Cancer	OC[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O	https://www.medchemexpress.com/D-Mannitol.html	Launched		910.0	M10	A3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0378	10.0	mM	3.0	DMSO	182.079038	3	A	pluskal_fda_drugs_5006_A3_id
2725	HY-B1657A	HYCPK40910	L13	HYCPK40910					910.0	L13	92134-98-0	Fosphenytoin (disodium)		406.24	Sodium Channel	Membrane Transporter/Ion Channel	Fosphenytoin sodium is a phenytoin prodrug with similar anticonvulsant properties. Its main mechanism is to block frequency-dependent, use-dependent and voltage-dependent neuronal sodium channels, and therefore limit repetitive firing of action potentials.	Sodium	C16H13N2Na2O6P	25210.0	H2O : ≥ 100 mg/mL (246.16 mM)	Water Solution	10mM  * 100uL	Neurological Disease	O=C1N(COP(O[Na])(O[Na])=O)C(C(C2=CC=CC=C2)(C3=CC=CC=C3)N1)=O	https://www.medchemexpress.com/Fosphenytoin_disodium.html	Launched		910.0	L13	A3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1657A	10.0	mM	3.0	DMSO	362.066773	3	A	pluskal_fda_drugs_5006_A3_id
18	HY-B2162	HYCPK40898	C03	HYCPK40910					910.0	C19	9007-28-7	Chondroitin (sulfate)	Chondroitin polysulfate		Endogenous Metabolite; MMP; NO Synthase	Immunology/Inflammation; Metabolic Enzyme/Protease	Chondroitin sulfate, one of five classes of glycosaminoglycans, has been widely used in the treatment of osteoarthritis. Chondroitin sulfate reduces inflammation mediators and the apoptotic process and is able to reduce protein production of inflammatory cytokines, iNOS and MMPs.	Free Acid	(C14H21NO14S)n	26462.0	H2O : ≥ 50 mg/mL	Water Solution	3mg/mL  * 100uL	Inflammation/Immunology	O=S(O)=O.O=S(O)=O.OC([C@@H]1[C@@H](OC)[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H](NC(C)=O)[C@H](OC)O[C@H](CO[R])[C@@H]2O[R])O1)=O.[R].[R].[=].[=].[R2=].[R1=].[n].[or]	https://www.medchemexpress.com/Chondroitin__sulfate_.html	Launched		910.0	C19	A4	233.3333333	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B2162	3.0	mM	4.0	DMSO	463.06319	4	A	pluskal_fda_drugs_5006_A4_id
64	HY-A0063A	HYCPK40900	B03	HYCPK40910					910.0	B17	183204-74-2	Tipiracil		242.66	Nucleoside Antimetabolite/Analog; Thymidylate Synthase	Apoptosis; Cell Cycle/DNA Damage	Tipiracil is a thymidine phosphorylase (TPase) inhibitor.	Free Base	C9H11ClN4O2	21973.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 1 mg/mL (4.12 mM; Need ultrasonic)	Water Solution	2mM  * 100uL	Cancer	O=C1NC(C(Cl)=C(CN2C(CCC2)=N)N1)=O	https://www.medchemexpress.com/Tipiracil.html	Launched		910.0	B17	A4	350.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0063A	2.0	mM	4.0	DMSO	242.057053	4	A	pluskal_fda_drugs_5006_A4_id
2323	HY-P0002A	HYCPK40910	C14	HYCPK40910					910.0	C14	120876-23-5	Protirelin (acetate)	Thyrotropin-releasing-hormone (acetate); TRH (acetate)	452.46	Thyroid Hormone Receptor	Others	Protirelin Acetate is a highly conserved neuropeptide that exerts the hormonal control of thyroid-stimulating hormone (TSH) levels as well as neuromodulatory functions.	Acetate	C16H22N6O4.3/2C2H4O2	117233.0	DMSO : 250 mg/mL (552.54 mM; Need ultrasonic); H2O : 50 mg/mL (110.51 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	O=C(N)[C@H]1N(C([C@H](CC2=CNC=N2)NC([C@H](CC3)NC3=O)=O)=O)CCC1.[1.5 CH3COOH]	https://www.medchemexpress.com/Protirelin-Acetate.html	Launched		910.0	C14	A4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-P0002A	10.0	mM	4.0	DMSO	362.170253	4	A	pluskal_fda_drugs_5006_A4_id
2639	HY-B1836	HYCPK40910	B08	HYCPK40910					910.0	B08	76144-81-5	Mildronate	Meldonium; MET-88; Quaterin	146.19	Others	Others	Mildronate (Meldonium) functions as a cardioprotective drug by cpmpetetively inhibiting BBOX1 and OCTN2. Mildronate (Meldonium) exhibits IC50 values of 34-62 μM for human recombinant BBOX and an EC50 of 21 μM for human OCTN2. Mildronate (Meldonium) treatment-induced redirection of long-chain FA metabolism from mitochondria to peroxisomes[1].	Free Base	C6H14N2O2	58005.0	H2O : 50 mg/mL (342.02 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	C[N+](C)(C)NCCC([O-])=O	https://www.medchemexpress.com/mildronate.html	Launched		910.0	B8	A4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1836	10.0	mM	4.0	DMSO	146.105528	4	A	pluskal_fda_drugs_5006_A4_id
2691	HY-14291	HYCPK40910	J11	HYCPK40910					910.0	J11	274901-16-5	Vildagliptin	LAF237; NVP-LAF 237	303.40	Apoptosis; Dipeptidyl Peptidase; Ferroptosis	Apoptosis; Metabolic Enzyme/Protease	Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC50 of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity[1].	Free Base	C17H25N3O2	9286.0	H2O : 50 mg/mL (164.80 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	O[C@@]1(C2)C[C@H]3C[C@H](C[C@]2(NCC(N4[C@H](C#N)CCC4)=O)C3)C1	https://www.medchemexpress.com/Vildagliptin.html	Launched		910.0	J11	A4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14291	10.0	mM	4.0	DMSO	303.194677	4	A	pluskal_fda_drugs_5006_A4_id
2709	HY-B0993	HYCPK40910	L12	HYCPK40910					910.0	L12	140678-14-4	Mangafodipir (trisodium)	MnDPDP	757.32	Others	Others	Mangafodipir trisodium (MnDPDP), hepatocellular-specific contrast agent, is an efficacious inhibitor of CIPN (chemotherapy-induced peripheral neuropath) and other conditions caused by cellular oxidative stress. Mangafodipir trisodium shows no negative interference with the tumoricidal activity of chemotherapy[1][2].	Sodium	C22H27MnN4Na3O14P2	80580.0	H2O : 33.33 mg/mL (44.01 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C1[O-][Mn+2]([N]2(C3)CC4=C5COP(O)(O)=O)([O-]C6=C(N=C7)C)([O-]C4=C(N=C5)C)([O-]C3=O)[N](CC6=C7COP([O-])(O)=O)(CC2)C1.[Na+].[Na+].[Na+]	https://www.medchemexpress.com/Mangafodipir-trisodium.html	Launched		910.0	L12	A4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0993	10.0	mM	4.0	DMSO	638.139025	4	A	pluskal_fda_drugs_5006_A4_id
2721	HY-B0030	HYCPK40910	H13	HYCPK40910					910.0	H13	68-41-7	D-Cycloserine		102.09	Antibiotic; Bacterial; iGluR	Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling	D-Cycloserine is an antibiotic which targets sequential bacterial cell wall peptidoglycan biosynthesis enzymes. D-Cycloserine is a partial NMDA agonist that can improve cognitive functions. D-Cycloserine can be used for multidrug-resistant tuberculosis research[1][2].	Free Base	C3H6N2O2	83530.0	DMSO : 1 mg/mL (9.80 mM; Need warming); H2O : 25 mg/mL (244.88 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection; Neurological Disease; Cancer	O=C1[C@H](N)CON1	https://www.medchemexpress.com/D-Cycloserine.html	Launched		910.0	H13	A4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0030	10.0	mM	4.0	DMSO	102.042927	4	A	pluskal_fda_drugs_5006_A4_id
2737	HY-B1718	HYCPK40910	A15	HYCPK40910					910.0	A15	4499-40-5	Choline theophyllinate	Oxtriphylline	283.33	Endogenous Metabolite	Metabolic Enzyme/Protease	Choline theophyllinate (Oxtriphylline) is a choline salt of theophylline with anti-asthmatic activity[1][2].	Free Base	C12H21N5O3	65310.0	H2O : 250 mg/mL (882.36 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology	C[N+](C)(CCO)C.CN1C2=C(C(N(C1=O)C)=O)N=C[N-]2	https://www.medchemexpress.com/choline-theophyllinate.html	Launched		910.0	A15	A4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1718	10.0	mM	4.0	DMSO	182.080376	4	A	pluskal_fda_drugs_5006_A4_id
2326	HY-100808	HYCPK40910	F14	HYCPK40910					910.0	F14	312-84-5	D-Serine	(R)-Serine	105.09	Endogenous Metabolite; iGluR	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	D-Serine ((R)-Serine), an endogenous amino acid involved in glia-synapse interactions that has unique neurotransmitter characteristics, is a potent co-agonist at the NMDA glutamate receptor. D-Serinee has a cardinal modulatory role in major NMDAR-dependent processes including NMDAR-mediated neurotransmission, neurotoxicity, synaptic plasticity, and cell migration[1][2].	Free Acid	C3H7NO3	111781.0	H2O : ≥ 50 mg/mL (475.78 mM)	Water Solution	10mM  * 100uL	Neurological Disease	N[C@H](CO)C(O)=O	https://www.medchemexpress.com/_R_-Serine.html	Launched		910.0	F14	A5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-100808	10.0	mM	5.0	DMSO	105.042593	5	A	pluskal_fda_drugs_5006_A5_id
2606	HY-B0089	HYCPK40910	A06	HYCPK40910					910.0	A06	56180-94-0	Acarbose	BAY g 5421	645.60	Glucosidase	Metabolic Enzyme/Protease	Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active alpha-glucosidase inhibitor (IC50=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin[1][2][3].	Free Base	C25H43NO18	48557.0	H2O : 125 mg/mL (193.62 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	OC[C@H]([C@]1(O[C@@H]2[C@H](O)[C@@H](O)[C@@H]([C@H](O2)C)N[C@]3(C=C(CO)[C@H]([C@@H]([C@H]3O)O)O)[H])[H])O[C@@H]([C@@H]([C@H]1O)O)O[C@@]([H])([C@@H]([C@H](C=O)O)O)[C@@H](CO)O	https://www.medchemexpress.com/Acarbose.html	Launched		910.0	A6	A5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0089	10.0	mM	5.0	DMSO	645.248014	5	A	pluskal_fda_drugs_5006_A5_id
2651	HY-B1815	HYCPK40910	B09	HYCPK40910					910.0	B09	437-74-1	Xanthinol Nicotinate	Xanthinol Niacinate	434.45	Others	Others	Xanthinol Nicotinate (Xanthinol Niacinate), a vasodilator, can act directly on the smooth muscle of small arteries and capillaries. Xanthinol Nicotinate expands blood vessels, improves blood rheology and reduces peripheral vascular resistance[1][2].		C19H26N6O6	63943.0	H2O : 250 mg/mL (575.44 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cardiovascular Disease	O=C(C1=CC=CN=C1)O.O=C(N2C)N(C)C3=C(N(CC(O)CN(CCO)C)C=N3)C2=O	https://www.medchemexpress.com/xanthinol-nicotinate.html	Launched		910.0	B9	A5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1815	10.0	mM	5.0	DMSO	311.159354	5	A	pluskal_fda_drugs_5006_A5_id
2669	HY-N0470	HYCPK40910	D10	HYCPK40910					910.0	D10	657-27-2	L-Lysine hydrochloride		182.65	Endogenous Metabolite; Virus Protease	Anti-infection; Metabolic Enzyme/Protease	L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health.	Hydrochloride	C6H15ClN2O2	26622.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 100 mg/mL (547.50 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection; Endocrinology; Inflammation/Immunology; Cardiovascular Disease; Cancer	N[C@@H](CCCCN)C(O)=O.[H]Cl	https://www.medchemexpress.com/L-Lysine_hydrochloride.html	Launched		910.0	D10	A5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0470	10.0	mM	5.0	DMSO	146.105528	5	A	pluskal_fda_drugs_5006_A5_id
2701	HY-B0441	HYCPK40910	D12	HYCPK40910					910.0	D12	32986-56-4	Tobramycin	Nebramycin Factor 6; Deoxykanamycin B	467.51	Antibiotic; Bacterial	Anti-infection	Tobramycin (Nebramycin Factor 6) is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms[1].	Free Base	C18H37N5O9	16244.0	H2O : ≥ 100 mg/mL (213.90 mM); DMSO : 2 mg/mL (4.28 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection; Cancer	O[C@@H]([C@@H]1O[C@@]([C@@H](C[C@@H]2O)N)([H])O[C@@H]2CN)[C@H]([C@@H](C[C@@H]1N)N)O[C@@]([C@@H]([C@@H](N)[C@@H]3O)O)([H])O[C@@H]3CO	https://www.medchemexpress.com/Tobramycin.html	Launched		910.0	D12	A5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0441	10.0	mM	5.0	DMSO	467.259128	5	A	pluskal_fda_drugs_5006_A5_id
2715	HY-B1190	HYCPK40910	B13	HYCPK40910					910.0	B13	50370-12-2	Cefadroxil	BL-S 578	363.39	Antibiotic; Bacterial	Anti-infection	Cefadroxil is a broad-spectrum antibiotic of the cephalosporin type, effective in Gram-positive and Gram-negative bacterial infections.	Free Acid	C16H17N3O5S	41302.0	H2O : 9.17 mg/mL (25.23 mM; ultrasonic and adjust pH to 3 with HCl)	Water Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=C(O)C=C3)=O)C1=O)O	https://www.medchemexpress.com/Cefadroxil.html	Launched		910.0	B13	A5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1190	10.0	mM	5.0	DMSO	363.088892	5	A	pluskal_fda_drugs_5006_A5_id
2728	HY-A0063	HYCPK40910	H14	HYCPK40910					910.0	H14	183204-72-0	Tipiracil (hydrochloride)		279.12	Nucleoside Antimetabolite/Analog	Cell Cycle/DNA Damage	Tipiracil (hydrochloride) is a thymidine phosphorylase inhibitor (TPI), used for cancer research.	Hydrochloride	C9H12Cl2N4O2	20037.0	H2O : 50 mg/mL (179.13 mM; Need ultrasonic); DMF : < 1 mg/mL (insoluble); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Cancer	[H]Cl.O=C1C(Cl)=C(CN2C(CCC2)=N)NC(N1)=O	https://www.medchemexpress.com/Tipiracil-hydrochloride.html	Launched		910.0	H14	A5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0063	10.0	mM	5.0	DMSO	242.057053	5	A	pluskal_fda_drugs_5006_A5_id
2743	HY-B0744B	HYCPK40910	G15	HYCPK40910					910.0	G15	96020-91-6	Eflornithine (hydrochloride hydrate)	DFMO hydrochloride hydrate; MDL-71782 hydrochloride hydrate; RMI-71782 hydrochloride hydrate; α-difluoromethylornithine hydrochloride hydrate	236.64	Parasite	Anti-infection	Eflornithine hydrochloride hydrate (DFMO hydrochloride hydrate) is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase. Eflornithine hydrochloride hydrate is a medication for the treatment of African trypanosomiasis and excessive facial hair growth in women[1].	Hydrochloride	C6H15ClF2N2O3	14571.0	H2O : 83.33 mg/mL (352.14 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	NC(CCCN)(C(F)F)C(O)=O.[H]Cl.O	https://www.medchemexpress.com/Eflornithine-hydrochloride,-hydrate.html	Launched		910.0	G15	A5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0744B	10.0	mM	5.0	DMSO	182.086684	5	A	pluskal_fda_drugs_5006_A5_id
68	HY-B0902A	HYCPK40900	F03	HYCPK40910					910.0	F17	106017-08-7	Rufloxacin hydrochloride	MF-934 hydrochloride	399.87	Antibiotic; Bacterial	Anti-infection	Rufloxacin hydrochloride (MF-934 hydrochloride) is a fluoroquinolone antibacterial, inhibits B-cell differentiation in human mononuclear cells, inhibits Topo.	Hydrochloride	C17H19ClFN3O3S	19143.0	DMSO : 0.0852 mg/mL (0.21 mM; Need ultrasonic and warming); H2O : 2 mg/mL (5.00 mM; Need ultrasonic)	Water Solution	2mM  * 100uL	Infection	O=C(C(C1=O)=CN2CCSC3=C(N4CCN(C)CC4)C(F)=CC1=C23)O.[H]Cl	https://www.medchemexpress.com/Rufloxacin-hydrochloride.html	Launched		910.0	F17	A6	350.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0902A	2.0	mM	6.0	DMSO	363.105291	6	A	pluskal_fda_drugs_5006_A6_id
2314	HY-B0274A	HYCPK40910	M08	HYCPK40910					910.0	M08	6469-93-8	Chlorprothixene (hydrochloride)		352.32	Bacterial; Dopamine Receptor; Histamine Receptor	Anti-infection; GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Chlorprothixene hydrochloride is a dopamine and histamine receptors antagonist with Kis of 18 nM, 2.96 nM, 4.56 nM, 9 nM and 3.75 nM for hD1, hD2, hD3, hD5 and hH1 receptors, respectively. Antipsychotic activity[1].	Hydrochloride	C18H19Cl2NS	81189.0	H2O : 50 mg/mL (141.92 mM; Need ultrasonic); Ethanol : 25 mg/mL (70.96 mM; Need ultrasonic); DMSO : 2.5 mg/mL (7.10 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	CN(C)CC/C=C1C2=C(SC3=C\1C=CC=C3)C=CC(Cl)=C2.[H]Cl	https://www.medchemexpress.com/chlorprothixene-hydrochloride.html	Launched		910.0	M8	A6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0274A	10.0	mM	6.0	DMSO	315.084848	6	A	pluskal_fda_drugs_5006_A6_id
2561	HY-13630	HYCPK40910	D03	HYCPK40910					910.0	D03	117091-64-2	Etoposide phosphate	BMY-40481	668.54	Apoptosis; Autophagy; Bacterial; Topoisomerase	Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage	Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor?to prevent re-ligation of DNA strands. Etoposide phosphate is the phosphate ester prodrug of etoposide and is considered as?active?equivalent to Etoposide. Etoposide phosphate induces cell cycle arrest,?apoptosis, and?autophagy[1][2].		C29H33O16P	84347.0	H2O : 125 mg/mL (186.97 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Infection; Neurological Disease	O=C1OC[C@]2([H])[C@H](O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO4)O3)O[C@@H]4C)O)O)C5=C(C=C6OCOC6=C5)[C@@H](C7=CC(OC)=C(OP(O)(O)=O)C(OC)=C7)[C@]21[H]	https://www.medchemexpress.com/etoposide-phosphate.html	Launched		910.0	D3	A6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13630	10.0	mM	6.0	DMSO	668.150622	6	A	pluskal_fda_drugs_5006_A6_id
2563	HY-N0469	HYCPK40910	F03	HYCPK40910					910.0	F03	56-87-1	L-Lysine		146.19	Endogenous Metabolite; Virus Protease	Anti-infection; Metabolic Enzyme/Protease	L-lysine is an essential amino acid[1][2] with important roles in connective tissues and carnitine synthesis, energy production, growth in children, and maintenance of immune functions[2].	Free Acid	C6H14N2O2	57782.0	DMSO : < 1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble or slightly soluble); H2O : 100 mg/mL (684.04 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	N[C@@H](CCCCN)C(O)=O	https://www.medchemexpress.com/L-Lysine.html	Launched		910.0	F3	A6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0469	10.0	mM	6.0	DMSO	146.105528	6	A	pluskal_fda_drugs_5006_A6_id
2599	HY-107794	HYCPK40910	J05	HYCPK40910					910.0	J05	88416-50-6	Clodronate (disodium tetrahydrate)	Disodium clodronate tetrahydrate	362.93	Others	Others	Clodronate disodium tetrahydrate (Disodium clodronate tetrahydrate) is first-generation bisphosphonate, with anti-osteoporotic, anti-inflammatory and analgesic effects. Clodronate disodium tetrahydrate is a selective, potent, reversible and Cl- competitive vesicular nucleotide transporter (VNUT) inhibitor, with an IC50 of 15.6 nM. Clodronate disodium tetrahydrate inhibits vesicular ATP release from neurons and reduces chronic neuropathic and inflammatory pain[1][2].	Sodium	CH12Cl2Na2O10P2	64034.0	H2O : 125 mg/mL (344.42 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease; Cancer	O=P(C(Cl)(Cl)P(O)(O[Na])=O)(O)O[Na].O.[4]	https://www.medchemexpress.com/clodronate-disodium-tetrahydrate.html	Launched		910.0	J5	A6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-107794	10.0	mM	6.0	DMSO	243.886016	6	A	pluskal_fda_drugs_5006_A6_id
2625	HY-B1204	HYCPK40910	D07	HYCPK40910					910.0	D07	51-45-6	Histamine	Ergamine	111.15	Endogenous Metabolite; Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; Neuronal Signaling	Histamine is an organic nitrogenous compound involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.	Free Base	C5H9N3	118371.0	H2O : ≥ 34 mg/mL (305.89 mM)	Water Solution	10mM  * 100uL	Neurological Disease; Endocrinology; Cancer	NCCC1=CN=CN1	https://www.medchemexpress.com/Histamine.html	Launched		910.0	D7	A6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1204	10.0	mM	6.0	DMSO	111.079647	6	A	pluskal_fda_drugs_5006_A6_id
2627	HY-B1829A	HYCPK40910	F07	HYCPK40910					910.0	F07	2392-39-4	Dexamethasone phosphate disodium	Dexamethasone 21-phosphate disodium salt	516.40	Glucocorticoid Receptor	Immunology/Inflammation	Dexamethasone phosphate disodium is a glucocorticoid receptor agonist.	Sodium	C22H28FNa2O8P	28604.0	H2O : ≥ 100 mg/mL (193.65 mM); DMSO : 1 mg/mL (1.94 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@]4(O)C(COP(O[Na])(O[Na])=O)=O)=C1	https://www.medchemexpress.com/Dexamethasone_phosphate_disodium.html	Launched		910.0	F7	A6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1829A	10.0	mM	6.0	DMSO	472.166233	6	A	pluskal_fda_drugs_5006_A6_id
2684	HY-W009156	HYCPK40910	C11	HYCPK40910					910.0	C11	6100-05-6	Hydroxycitric acid (tripotassium hydrate)	Potassium citrate (monohydrate)	324.41	ATP Citrate Lyase; Bacterial; Endogenous Metabolite; HIF/HIF Prolyl-Hydroxylase	Anti-infection; Metabolic Enzyme/Protease	Hydroxycitric acid tripotassium hydrate (Potassium citrate monohydrate) is the major active ingredient of Garcinia cambogia. Hydroxycitric acid tripotassium hydrate competitively inhibits ATP citrate lyase with weight loss benefits. Hydroxycitric acid tripotassium hydrate effective inhibits stones formation and also inhibits HIF, and has antioxidation, anti-inflammation and anti-tumor effects[1][2][3][4].	Potassium	C6H7K3O8	130591.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 120 mg/mL (369.90 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease; Inflammation/Immunology	O=C(O[K])CC(C(O[K])=O)(O)CC(O[K])=O.O	https://www.medchemexpress.com/hydroxycitric-acid-tripotassium-hydrate.html	Launched		910.0	C11	A6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-W009156	10.0	mM	6.0	DMSO	192.027003	6	A	pluskal_fda_drugs_5006_A6_id
63	HY-100595	HYCPK40900	A03	HYCPK40910					910.0	A17	16037-91-5	Sodium stibogluconate	Stibogluconate (trisodium nonahydrate)	910.90	Parasite; Phosphatase; SHP2	Anti-infection; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK	Sodium stibogluconate (Stibogluconate trisodium nonahydrate) is a potent inhibitor of protein tyrosine phosphatase. Sodium stibogluconate inhibits 99% of SHP-1, SHP-2 and PTP1B activity at 10, 100, 100 μg/mL, respectively.	Sodium	C12H38Na3O26Sb2	21887.0	DMSO : 1 mg/mL (1.10 mM; Need ultrasonic and warming); H2O : 3 mg/mL (3.29 mM; ultrasonic and warming and heat to 60°C)	Water Solution	2mM  * 100uL	Cancer	O=[Sb](O[C@]1([H])[C@H](O)CO)(O[C@@H](C(O)=O)[C@H]1O)O[Sb](O[C@]2([H])[C@H](O)CO)(O[C@@H](C(O)=O)[C@H]2O)=O.[9H2O].[3Na]	https://www.medchemexpress.com/Stibogluconate-sodium.html	Launched		910.0	A17	A7	350.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-100595	2.0	mM	7.0	DMSO	677.877681	7	A	pluskal_fda_drugs_5006_A7_id
2571	HY-Y0252	HYCPK40910	N03	HYCPK40910					910.0	N03	147-85-3	L-Proline		115.13	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins.	Free Acid	C5H9NO2	90176.0	H2O : 50 mg/mL (434.29 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	O=C(O)[C@H]1NCCC1	https://www.medchemexpress.com/L-Pyrrolidine-2-carboxylic_acid.html	Launched		910.0	N3	A7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-Y0252	10.0	mM	7.0	DMSO	115.063329	7	A	pluskal_fda_drugs_5006_A7_id
2602	HY-B0657A	HYCPK40910	M05	HYCPK40910					910.0	M05	22560-50-5	Clodronic acid (disodium salt)	Clodronate (disodium salt)	288.86	Others	Others	Clodronic acid (Clodronate) disodium salt, a first-generation bisphosphonate, is orally active osteoclastic bone resorption inhibitor. Clodronic acid disodium salt can be used in high bone turnover states, Paget’s disease and osteolytic bone metastases[1][2][3].	Sodium	CH2Cl2Na2O6P2	115604.0	H2O : 100 mg/mL (346.19 mM; Need ultrasonic); DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=P(C(Cl)(Cl)P(O)(O[Na])=O)(O)O[Na]	https://www.medchemexpress.com/clodronic-acid-disodium-salt.html	Launched		910.0	M5	A7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0657A	10.0	mM	7.0	DMSO	243.886016	7	A	pluskal_fda_drugs_5006_A7_id
2615	HY-A0213A	HYCPK40910	J06	HYCPK40910					910.0	J06	149845-07-8	Tiludronate (disodium)	Tiludronic acid (disodium)	362.57	Proton Pump	Membrane Transporter/Ion Channel	Tiludronate (Tiludronic Acid) disodium, an orally active bisphosphonate, can act an osteoregulator. Tiludronate is used for the research of the metabolic bone disorders. Tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. Antiresorptive and anti-inflammatory properties[1][2][3][4].	Sodium	C7H7ClNa2O6P2S	112299.0	H2O : 62.5 mg/mL (172.38 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology	O=P(O)(O[Na])C(P(O)(O[Na])=O)SC1=CC=C(Cl)C=C1	https://www.medchemexpress.com/tiludronate-disodium.html	Launched		910.0	J6	A7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0213A	10.0	mM	7.0	DMSO	317.92836	7	A	pluskal_fda_drugs_5006_A7_id
2646	HY-13667	HYCPK40910	I08	HYCPK40910					910.0	I08	80433-71-2	Levoleucovorin (Calcium)	Calcium levofolinate; CL307782	511.50	Antifolate	Cell Cycle/DNA Damage	"Levoleucovorin Calcium (Calcium levofolinate), a levo isoform of <a href=""/Leucovorin Calcium.html"" class=""link-product"" target=""_blank"">Leucovorin Calcium</a> (HY-13664), possesses antineoplastic effects. Levoleucovorin Calcium is also an augmentor of <a href=""/5-fluorouracil.html"" class=""link-product"" target=""_blank"">5-fluorouracil</a> (HY-90006) cytotoxicity against cancer[1][2]."	Calcium	C20H21CaN7O7	15281.0	H2O : 10 mg/mL (19.55 mM; Need ultrasonic); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Cancer	O=C1C2=C(NC[C@H](CNC3=CC=C(C(N[C@H](C([O-])=O)CCC([O-])=O)=O)C=C3)N2C=O)NC(N)=N1.[Ca+2]	https://www.medchemexpress.com/Levoleucovorin-Calcium.html	Launched		910.0	I8	A7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13667	10.0	mM	7.0	DMSO	473.165896	7	A	pluskal_fda_drugs_5006_A7_id
2711	HY-B1836A	HYCPK40910	N12	HYCPK40910					910.0	N12	86426-17-7	Mildronate (dihydrate)	Meldonium (dihydrate); MET-88 (dihydrate); Quaterin (dihydrate)	182.22	Others	Others	Mildronate dihydrate (Meldonium dihydrate) functions as a cardioprotective drug by cpmpetetively inhibiting BBOX1 and OCTN2. Mildronate (Meldonium) exhibits IC50 values of 34-62 μM for human recombinant BBOX and an EC50 of 21 μM for human OCTN2. Mildronate (Meldonium) treatment-induced redirection of long-chain FA metabolism from mitochondria to peroxisomes[1].	Free Base	C6H18N2O4	230099.0	DMSO : 4.85 mg/mL (26.62 mM; ultrasonic and warming and adjust pH to 4 with HCl and heat to 60°C)	Water Solution	10mM  * 100uL	Metabolic Disease; Cardiovascular Disease	C[N+](C)(C)NCCC([O-])=O.O.O	https://www.medchemexpress.com/mildronate-dihydrate.html	Launched		910.0	N12	A7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1836A	10.0	mM	7.0	DMSO	146.105528	7	A	pluskal_fda_drugs_5006_A7_id
2739	HY-B0910A	HYCPK40910	C15	HYCPK40910					910.0	C15	10049-83-9	Pyrithioxin (dihydrochloride)	Pyritinol dihydrochloride; Pyridoxine disulfide dihydrochloride; Vitamin B6 disulfide dihydrochloride	441.39	Endogenous Metabolite; Others	Metabolic Enzyme/Protease; Others	Pyrithioxin dihydrochloride is a neurodynamic compound, combined with a short period of hyperventilation (HV) was applied in cerebral infarct patients with Hemiplegia.	Hydrochloride	C16H22Cl2N2O4S2	17129.0	H2O : ≥ 41 mg/mL (92.89 mM)	Water Solution	10mM  * 100uL	Neurological Disease	OCC1=C(CSSCC2=C(CO)C(O)=C(C)N=C2)C=NC(C)=C1O.[H]Cl.[H]Cl	https://www.medchemexpress.com/Pyrithioxin-dihydrochloride.html	Launched		910.0	C15	A7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0910A	10.0	mM	7.0	DMSO	368.086449	7	A	pluskal_fda_drugs_5006_A7_id
2742	HY-B0796	HYCPK40910	F15	HYCPK40910					910.0	F15	57644-54-9	Gastrodenol	Bismuth tripotassium dicitrate; Bismuth subcitrate	704.47	Others	Others	Gastrodenol(Bismuth tripotassium dicitrate; De-Noltab)is a mineral that is used in treating ulcers and upset stomach.	Potassium	C12H10BiK3O14	233487.0	H2O : 100 mg/mL (141.95 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	O=C(CC(C([O-])=O)(O)CC([O-])=O)[O-].O=C(CC(C([O-])=O)(O)CC([O-])=O)[O-].[K+].[K+].[K+].[Bi+3]	https://www.medchemexpress.com/Gastrodenol.html	Launched		910.0	F15	A7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0796	10.0	mM	7.0	DMSO	192.027003	7	A	pluskal_fda_drugs_5006_A7_id
65	HY-14608	HYCPK40900	C03	HYCPK40910					910.0	C17	56-86-0	L-Glutamic acid		147.13	Apoptosis; Endogenous Metabolite; Ferroptosis; iGluR	Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	L-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). L-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.	Free Acid	C5H9NO4	113179.0	H2O : 6.25 mg/mL (42.48 mM; Need ultrasonic); DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble or slightly soluble)	Water Solution	2mM  * 100uL	Neurological Disease	OC(CC[C@H](N)C(O)=O)=O	https://www.medchemexpress.com/_S_-Glutamic_acid.html	Launched		910.0	C17	A8	350.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14608	2.0	mM	8.0	DMSO	147.053158	8	A	pluskal_fda_drugs_5006_A8_id
2626	HY-B0548A	HYCPK40910	E07	HYCPK40910					910.0	E07	2192-20-3	Hydroxyzine (dihydrochloride)		447.83	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	Hydroxyzine dihydrochloride, a benzodiazepine antihistamine agent, acts as a orally active histamine?H1-receptor and serotonin antagonist. Hydroxyzine dihydrochloride has anxiolytic effect and can be used forthe research of generalised anxiety disorder[1][2].	Hydrochloride	C21H29Cl3N2O2	16009.0	H2O : ≥ 150 mg/mL (334.95 mM)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	ClC1=CC=C(C=C1)C(C2=CC=CC=C2)N3CCN(CCOCCO)CC3.Cl.Cl	https://www.medchemexpress.com/Hydroxyzine-dihydrochloride.html	Launched		910.0	E7	A8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0548A	10.0	mM	8.0	DMSO	374.176106	8	A	pluskal_fda_drugs_5006_A8_id
2671	HY-B0168B	HYCPK40910	F10	HYCPK40910					910.0	F10	175131-60-9	Milnacipran ((1S-cis) hydrochloride)	Levomilnacipran hydrochloride; F-2695 hydrochloride	282.81	Serotonin Transporter	Neuronal Signaling	Milnacipran (1S-cis) hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI), used in the clinical treatment of fibromyalgia.	Hydrochloride	C15H23ClN2O	20360.0	H2O : ≥ 50 mg/mL (176.80 mM)	Water Solution	10mM  * 100uL	Neurological Disease	O=C([C@]1(C2=CC=CC=C2)[C@H](CN)C1)N(CC)CC.[H]Cl	https://www.medchemexpress.com/Milnacipran-_1S-cis_-hydrochloride.html	Launched		910.0	F10	A8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0168B	10.0	mM	8.0	DMSO	246.173213	8	A	pluskal_fda_drugs_5006_A8_id
2688	HY-B0961	HYCPK40910	G11	HYCPK40910					910.0	G11	129-16-8	Merbromin	Mercury dibromofluorescein (disodium salt); ZP1	752.67	Bacterial	Anti-infection	Merbromin acts as a topical antiseptic for minor cuts and scrapes and as a biological dye.  Merbromin is a potent inhibitor against Zika virus (ZIKV) replication. Merbromin  shows anti-ZIKV potency through ZIKVpro inhibition[1].	Sodium	C20H10Br2HgNa2O6	40871.0	DMSO : 6.67 mg/mL (8.86 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	O[Hg]C1=C(O[Na])C(Br)=CC(C2C3=C(C=CC=C3)C(O[Na])=O)=C1OC4=C2C=C(Br)C(O)=C4	https://www.medchemexpress.com/Merbromin.html	Launched		910.0	G11	A8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0961	10.0	mM	8.0	DMSO	688.852316	8	A	pluskal_fda_drugs_5006_A8_id
2712	HY-13625	HYCPK40910	O12	HYCPK40910					910.0	O12	153773-82-1	Ertapenem sodium	L-749345; MK-826	497.50	Antibiotic; Bacterial	Anti-infection	Ertapenem sodium (L-749345) is a broad spectrum and long acting β-lactam antibiotic. Ertapenem sodium has a broad-spectrum anti-anaerobic activity against a variety of anaerobes with a mode MIC of 0.12 μg/mL. Ertapenem sodium can be used for the research of severe infections caused by bacteria in the skin, lungs, stomach, pelvis, and urinary tract[1][2].	Sodium	C22H24N3NaO7S	66084.0	H2O : 50 mg/mL (100.50 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection; Cancer	O=C([C@H]1NC[C@@H](SC2=C(C(O)=O)N3[C@]([C@]([C@@H](C)O)([H])C3=O)([H])[C@H]2C)C1)NC4=CC=CC(C(O[Na])=O)=C4	https://www.medchemexpress.com/Ertapenem_sodium.html	Launched		910.0	O12	A8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13625	10.0	mM	8.0	DMSO	475.141321	8	A	pluskal_fda_drugs_5006_A8_id
2713	HY-B0515	HYCPK40910	P12	HYCPK40910					910.0	P12	138926-19-9	Ibandronate (Sodium Monohydrate)	BM-210955; RPR-102289A	359.23	Apoptosis	Apoptosis	"Ibandronate Sodium Monohydrate is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
Target: Others
Ibandronate (1.25-2 μM) significantly reduces endothelial cell growth, while ibandronate (2 μM) also significantly reduces capillary-like tube formation and increases apoptosis of endothelial cells. Ibandronate (< 100 μM) dose-dependently increases VEGF expression in endothelial cells [1]. Ibandronate (< 100 μM) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner [2].
Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly reduces the risk of new morphometric vertebral fractures by 62% and 50% (p = 0.0006), respectively, in osteoporotic women after 3 years' treatment. Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly and progressively increases BMD of lumbar spine by 6.5% and 5.7%, respectively, in osteoporotic women after 3 years' treatment [3]. Ibandronate (< 125 mg/kg s.c.) results in a dose dependent increase in bone mineral density (BMD), trabecular bone volume and trabecular number, load to failure (Fmax), and yield load in long bones and vertebrae in ovariectomized rats, and increased trabecular separation in ovariectomized rats is fully prevented by all doses [4]."	Sodium	C9H24NNaO8P2	129647.0	H2O : 25 mg/mL (69.59 mM; Need ultrasonic); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Cancer	OC(P(O)(O)=O)(P(O)(O[Na])=O)CCN(C)CCCCC.O	https://www.medchemexpress.com/Ibandronate-Sodium-Monohydrate.html	Launched		910.0	P12	A8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0515	10.0	mM	8.0	DMSO	319.094975	8	A	pluskal_fda_drugs_5006_A8_id
2720	HY-N0717	HYCPK40910	G13	HYCPK40910					910.0	G13	72-18-4	L-Valine	Valine	117.15	Others	Others	L-Valine (Valine) is a new nonlinear semiorganic material[1].	Free Acid	C5H11NO2	43652.0	H2O : 25 mg/mL (213.40 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	N[C@@H](C(C)C)C(O)=O	https://www.medchemexpress.com/L-Valine.html	Launched		910.0	G13	A8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0717	10.0	mM	8.0	DMSO	117.078979	8	A	pluskal_fda_drugs_5006_A8_id
2744	HY-B1295	HYCPK40910	H15	HYCPK40910					910.0	H15	6080-58-6	Lithium citrate (tetrahydrate)	Litarex (tetrahydrate)	281.98	ATP Citrate Lyase; Bacterial; Endogenous Metabolite; HIF/HIF Prolyl-Hydroxylase	Anti-infection; Metabolic Enzyme/Protease	Lithium citrate (Litarex) tetrahydrate is the major active ingredient of Garcinia cambogia. Lithium citrate tetrahydrate competitively inhibits ATP citrate lyase with weight loss benefits. Lithium citrate tetrahydrate effective inhibits stones formation and also inhibits HIF, and has antioxidation, anti-inflammation and anti-tumor effects[1][2][3][4].	Lithium	C6H13Li3O11	17501.0	H2O : ≥ 100 mg/mL (354.64 mM)	Water Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease; Inflammation/Immunology	O=C(CC(C(O[Li])=O)(O)CC(O[Li])=O)O[Li].O.O.O.O	https://www.medchemexpress.com/Citric-acid-trilithium-salt-tetrahydrate.html	Launched		910.0	H15	A8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1295	10.0	mM	8.0	DMSO	192.027003	8	A	pluskal_fda_drugs_5006_A8_id
2574	HY-W015410	HYCPK40910	A04	HYCPK40910					910.0	A04	150-90-3	Disodium succinate		162.05	Endogenous Metabolite	Metabolic Enzyme/Protease	Disodium succinate is the?disodium?salt of?Succinic acid. Succinic acid is an intermediate product of the tricarboxylic acid cycle, as well as one of fermentation products of anaerobic metabolism[1].	Sodium	C4H4Na2O4	45497.0	H2O : 100 mg/mL (617.09 mM; Need ultrasonic); DMSO : 1 mg/mL (6.17 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	O=C(O[Na])CCC(O[Na])=O	https://www.medchemexpress.com/disodium-succinate.html	Launched		910.0	A4	A9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-W015410	10.0	mM	9.0	DMSO	118.026609	9	A	pluskal_fda_drugs_5006_A9_id
2584	HY-B0517A	HYCPK40910	K04	HYCPK40910					910.0	K04	1722-62-9	Mepivacaine (hydrochloride)		282.81	Sodium Channel	Membrane Transporter/Ion Channel	Mepivacaine hydrochloride binds to specific voltage-gated sodium ion channels in neuronal cell membranes, which inhibits both sodium influx and membrane depolarization[1][2].	Hydrochloride	C15H23ClN2O	16247.0	H2O : 100 mg/mL (353.59 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C(C(CCCC1)N1C)NC(C(C)=CC=C2)=C2C.Cl	https://www.medchemexpress.com/mepivacaine-hydrochloride.html	Launched		910.0	K4	A9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0517A	10.0	mM	9.0	DMSO	246.173213	9	A	pluskal_fda_drugs_5006_A9_id
2634	HY-N1428C	HYCPK40910	M07	HYCPK40910					910.0	M07	3522-50-7	Ferric citrate	Iron(III) citrate; Zerenex	244.94	Antibiotic; Reactive Oxygen Species	Anti-infection; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Ferric citrate (Iron(III) citrate), an orally active iron supplement, is an efficacious phosphate binder. Ferric citratee can be used for iron deficiency anemia and chronic kidney disease (CKD) research[1][2].	Citrate	C6H5FeO7	104700.0	H2O : 5 mg/mL (20.41 mM; ultrasonic and warming and heat to 60°C)	Water Solution	10mM  * 100uL	Metabolic Disease	O=C(CC(C([O-])=O)(O)CC([O-])=O)[O-].[Fe+3]	https://www.medchemexpress.com/ferric-citrate.html	Launched		910.0	M7	A9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N1428C	10.0	mM	9.0	DMSO	192.027003	9	A	pluskal_fda_drugs_5006_A9_id
2664	HY-B1039A	HYCPK40910	O09	HYCPK40910					910.0	O09	23828-92-4	Ambroxol (hydrochloride)	NA-872 (hydrochloride)	414.56	Autophagy; Glucosidase	Autophagy; Metabolic Enzyme/Protease	Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the prodrug Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research[1][2].	Hydrochloride	C13H19Br2ClN2O	78624.0	H2O : 8.33 mg/mL (20.09 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	O[C@H]1CC[C@H](NCC2=CC(Br)=CC(Br)=C2N)CC1.[H]Cl	https://www.medchemexpress.com/ambroxol-hydrochloride.html	Launched		910.0	O9	A9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1039A	10.0	mM	9.0	DMSO	375.978587	9	A	pluskal_fda_drugs_5006_A9_id
2668	HY-17589	HYCPK40910	C10	HYCPK40910					910.0	C10	50-63-5	Chloroquine (phosphate)		515.86	Antibiotic; Autophagy; HIV; Parasite; SARS-CoV; Toll-like Receptor (TLR)	Anti-infection; Autophagy; Immunology/Inflammation	Chloroquine phosphate is an antimalarial and anti-inflammatory agent widely used to treat malaria and rheumatoid arthritis. Chloroquine phosphate is an autophagy and toll-like receptors (TLRs) inhibitor. Chloroquine phosphate is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC50=1.13 μM)[1][2][3][4].	Phosphate	C18H32ClN3O8P2	45552.0	H2O : ≥ 33 mg/mL (63.97 mM); DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Cancer; Infection; Inflammation/Immunology	O=P(O)(O)O.O=P(O)(O)O.CC(NC1=CC=NC2=CC(Cl)=CC=C12)CCCN(CC)CC	https://www.medchemexpress.com/Chloroquine-diphosphate.html	Launched		910.0	C10	A9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17589	10.0	mM	9.0	DMSO	319.181526	9	A	pluskal_fda_drugs_5006_A9_id
2681	HY-16477	HYCPK40910	P10	HYCPK40910					910.0	P10	220201-34-3	Talaporfin (sodium)	ME2906; Mono-L-aspartyl chlorin e6; NPe6	799.69	Others	Others	Talaporfin (ME2906) sodium is a chlorin based photosensitizer. Talaporfin sodium can be used for the research of various cancers by using photodynamic therapy (PDT)[1].	Sodium	C38H37N5Na4O9	119993.0	DMSO : 2 mg/mL (2.50 mM; Need ultrasonic); H2O : 25 mg/mL (31.26 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	O=C(O[Na])C[C@@H](C(O[Na])=O)NC(C/C1=C2[C@@H](CCC(O[Na])=O)[C@H](C)C(/C=C3C(C)=C(C=C)/C(N/3)=C/C(C(C)=C/4CC)=NC4=C/C5=C(C)C(C(O[Na])=O)=C1N5)=N\2)=O	https://www.medchemexpress.com/talaporfin-sodium.html	Launched		910.0	P10	A9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-16477	10.0	mM	9.0	DMSO	711.290428	9	A	pluskal_fda_drugs_5006_A9_id
2706	HY-14608A	HYCPK40910	I12	HYCPK40910					910.0	I12	142-47-2	L-Glutamic acid (monosodium salt)		169.11	Apoptosis; Endogenous Metabolite; Ferroptosis; iGluR	Apoptosis; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	L-Glutamic acid monosodium salt acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). (S)-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.	Sodium	C5H8NNaO4	26427.0	H2O : 7.14 mg/mL (42.22 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C(O[Na])CC[C@H](N)C(O)=O	https://www.medchemexpress.com/L-Glutamic_acid_monosodium_salt.html	Launched		910.0	I12	A9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14608A	10.0	mM	9.0	DMSO	147.053158	9	A	pluskal_fda_drugs_5006_A9_id
2738	HY-A0086	HYCPK40910	B15	HYCPK40910					910.0	B15	56391-57-2	Netilmicin (sulfate)	SCH-20569 (sulfate)	720.78	Antibiotic; Bacterial	Anti-infection	Netilmicin (sulfate) (SCH-20569 (sulfate)) is an active aminoglycoside antibiotic against most Gram-negative and some Gram-positive bacteria, including certain strains resistant to gentamicin.	Sulfate	C21H41N5O7.5/2H2SO4	16415.0	H2O : 100 mg/mL (138.74 mM; Need ultrasonic); DMSO : 1 mg/mL (1.39 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Infection	NCC1=CC[C@@H](N)[C@](O[C@@H]2[C@@H](N)C[C@@H](NCC)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)([H])O1.[2.5H2SO4]	https://www.medchemexpress.com/Netilmicin-sulfate.html	Launched		910.0	B15	A9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0086	10.0	mM	9.0	DMSO	475.300599	9	A	pluskal_fda_drugs_5006_A9_id
2568	HY-19638A	HYCPK40910	K03	HYCPK40910					910.0	K03	163706-36-3	Cangrelor (tetrasodium)	AR-C69931MX (tetrasodium)	864.29	P2Y Receptor	GPCR/G Protein	Cangrelor tetrasodium, an adenosine triphosphate analogue, is a reversible and selective platelet P2Y12 antagonist, with prompt and potent antiplatelet effects. Cangrelor tetrasodium directly blocks adenosine diphosphate (ADP)-induced activation and aggregation of platelets. Cangrelor tetrasodium is also a nonspecific GPR17 antagonist[1][2].	Sodium	C17H21Cl2F3N5Na4O12P3S2	80705.0	H2O : 125 mg/mL (144.63 mM; Need ultrasonic); DMSO : 12.5 mg/mL (14.46 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Cardiovascular Disease	O[C@H]1[C@@H](O)[C@H](N2C3=NC(SCCC(F)(F)F)=NC(NCCSC)=C3N=C2)O[C@@H]1COP(OP(C(Cl)(P(O[Na])(O[Na])=O)Cl)(O[Na])=O)(O[Na])=O	https://www.medchemexpress.com/cangrelor-tetrasodium.html	Launched		910.0	K3	A10	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-19638A	10.0	mM	10.0	DMSO	774.948313	10	A	pluskal_fda_drugs_5006_A10_id
2598	HY-B1864B	HYCPK40910	I05	HYCPK40910					910.0	I05	200132-83-8	Kasugamycin (hydrochloride hydrate)	Ksg (hydrochloride hydrate)	433.84	Antibiotic; Bacterial	Anti-infection	Kasugamycin hydrochloride hydrate (Ksg hydrochloride hydrate) is an antibiotic which binds both the 30S and 70S ribosome but not isolated 50S subunits. Kasugamycin hydrochloride hydrate (Ksg hydrochloride hydrate) mimics mRNA nucleotides to destabilize tRNA binding and inhibit canonical translation initiation[1][2].	Hydrochloride	C14H28ClN3O10	18875.0	DMSO : 1.67 mg/mL (3.85 mM; ultrasonic and warming and heat to 80°C); H2O : 25 mg/mL (57.62 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	OC(C(N[C@@H](C[C@@H]1N)[C@@H](C)O[C@]1([H])O[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]2O)=N)=O.[H]Cl.O	https://www.medchemexpress.com/Kasugamycin-hydrochloride-hydrate.html	Launched		910.0	I5	A10	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1864B	10.0	mM	10.0	DMSO	379.159079	10	A	pluskal_fda_drugs_5006_A10_id
2608	HY-Y0337	HYCPK40910	C06	HYCPK40910					910.0	C06	52-90-4	L-Cysteine		121.16	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Cysteine is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine suppresses ghrelin and reduces appetite in rodents and humans[1].	Free Acid	C3H7NO2S	34601.0	H2O : 33.33 mg/mL (275.09 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	N[C@@H](CS)C(O)=O	https://www.medchemexpress.com/L-Cysteine.html	Launched		910.0	C6	A10	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-Y0337	10.0	mM	10.0	DMSO	121.019749	10	A	pluskal_fda_drugs_5006_A10_id
2631	HY-B1327	HYCPK40910	J07	HYCPK40910					910.0	J07	64-72-2	Chlortetracycline (hydrochloride)	7-Chlorotetracycline (hydrochloride)	515.34	Antibiotic; Bacterial; Parasite	Anti-infection	Chlortetracycline hydrochloride (7-Chlorotetracycline hydrochloride) is a specific and potent calcium ionophore antibiotic, inhibits binding of aminoacyl-tRNA to ribosomes.	Hydrochloride	C22H24Cl2N2O8	17765.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 6.66 mg/mL (12.92 mM; Need ultrasonic and warming)	Water Solution	10mM  * 100uL	Infection	O=C(C(C1=O)=C(O)[C@@H](N(C)C)[C@]2([H])C[C@]3([H])[C@](C)(O)C4=C(C(C3=C(O)[C@@]21O)=O)C(O)=CC=C4Cl)N.[H]Cl	https://www.medchemexpress.com/Chlortetracycline-hydrochloride.html	Launched		910.0	J7	A10	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1327	10.0	mM	10.0	DMSO	478.114293	10	A	pluskal_fda_drugs_5006_A10_id
2645	HY-B1744	HYCPK40910	H08	HYCPK40910					910.0	H08	54-47-7	Pyridoxal phosphate	Pyridoxal 5′-phosphate; Pyridoxyl phosphate	247.14	Endogenous Metabolite; Reverse Transcriptase	Anti-infection; Metabolic Enzyme/Protease	Pyridoxal phosphate is the active form of vitamin B6, acts as an inhibitor of reverse transcriptases, and is used for the treatment of tardive dyskinesia.	Free Acid	C8H10NO6P	26379.0	H2O : 5 mg/mL (20.23 mM; Need ultrasonic); DMSO : 1 mg/mL (4.05 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=CC1=C(O)C(C)=NC=C1COP(O)(O)=O	https://www.medchemexpress.com/Pyridoxal_phosphate.html	Launched		910.0	H8	A10	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1744	10.0	mM	10.0	DMSO	247.024574	10	A	pluskal_fda_drugs_5006_A10_id
2679	HY-B1092A	HYCPK40910	N10	HYCPK40910					910.0	N10	527-07-1	Gluconate (sodium)	D-Gluconic acid sodium salt; Sodium D-gluconate; D-Gluconate sodium salt	218.14	Endogenous Metabolite	Metabolic Enzyme/Protease	Gluconate sodium (D-Gluconic acid sodium salt) is a corrosion and scale inhibitor of ordinary steel in simulated cooling water.	Sodium	C6H11NaO7	17429.0	DMSO : 1 mg/mL (4.58 mM; ultrasonic and warming and heat to 60°C); H2O : ≥ 100 mg/mL (458.42 mM)	Water Solution	10mM  * 100uL	Others	O[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)C(O[Na])=O	https://www.medchemexpress.com/Gluconate-sodium.html	Launched		910.0	N10	A10	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1092A	10.0	mM	10.0	DMSO	196.058303	10	A	pluskal_fda_drugs_5006_A10_id
2702	HY-N0326	HYCPK40910	E12	HYCPK40910					910.0	E12	63-68-3	L-Methionine		149.21	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Methionine is the L-isomer of Methionine, an essential amino acid for human development. Methionine acts as a hepatoprotectant.	Free Acid	C5H11NO2S	39424.0	H2O : 16.67 mg/mL (111.72 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	N[C@@H](CCSC)C(O)=O	https://www.medchemexpress.com/L-Methionin.html	Launched		910.0	E12	A10	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0326	10.0	mM	10.0	DMSO	149.05105	10	A	pluskal_fda_drugs_5006_A10_id
2717	HY-15685	HYCPK40910	D13	HYCPK40910					910.0	D13	887375-67-9	Ripasudil	K-115	395.88	ROCK	Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad	Ripasudil (K-115) is a specific inhibitor of ROCK, with IC50s of 19 and 51 nM for ROCK2 and ROCK1, respectively.	Hydrochloride	C15H23ClFN3O4S	13835.0	H2O : ≥ 50 mg/mL (126.30 mM); DMSO : 25 mg/mL (63.15 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	FC1=CN=CC2=C1C(S(N3CCCNC[C@@H]3C)(=O)=O)=CC=C2.[H]Cl.O.O	https://www.medchemexpress.com/K-115.html	Launched		910.0	D13	A10	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-15685	10.0	mM	10.0	DMSO	323.110376	10	A	pluskal_fda_drugs_5006_A10_id
2312	HY-N0184A	HYCPK40910	A03	HYCPK40910					910.0	A03	68797-35-3	Dipotassium glycyrrhizinate	Glycyrrhizic acid (dipotassium); Dipotassium glycyrrhizate	899.11	Virus Protease	Anti-infection	Dipotassium glycyrrhizinate is a natural compound, inhibits atopic dermatitis-related gene expression with anti-anti-inflammatory activity[1].	Potassium	C42H60K2O16	59731.0	H2O : 50 mg/mL (55.61 mM; Need ultrasonic); DMSO : 5 mg/mL (5.56 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology	C[C@]12[C@@](C(C=C3[C@]2(CC[C@]4(C)[C@@]3([H])C[C@](C(O[K])=O)(C)CC4)C)=O)([H])[C@@]5([C@@](C(C)([C@@H](O[C@]6([H])[C@@H]([C@H]([C@H](O)[C@@H](C(O)=O)O6)O)O[C@]7([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(O[K])=O)CC5)C)([H])CC1)C	https://www.medchemexpress.com/dipotassium-glycyrrhizinate.html	Launched		910.0	A3	A11	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0184A	10.0	mM	11.0	DMSO	822.403786	11	A	pluskal_fda_drugs_5006_A11_id
2595	HY-B0061	HYCPK40910	F05	HYCPK40910					910.0	F05	112457-95-1	Tandospirone (citrate)	SM-3997 citrate	575.61	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	"Tandospirone citrate is a potent and selective 5-HT1A receptor partial agonist (Ki = 27 nM) that displays selectivity over SR-2, SR-1C, α1, α2, D1 and D2 receptors (Ki values ranging from 1300-41000 nM). 
IC50 Value: 27±5 nM(Ki) [1]
Target: 5-HT1A
in vitro: Tandospirone is most potent at the 5-HT1A receptor, displaying a Ki value of 27 +/- 5 nM. The agent is approximately two to three orders of magnitude less potent at 5-HT2, 5-HT1C, alpha 1-adrenergic, alpha 2-adrenergic, and dopamine D1 and D2 receptors (Ki values ranging from 1300 to 41000 nM). Tandospirone is essentially inactive at 5-HT1B receptors; 5-HT uptake sites; beta-adrenergic, muscarinic cholinergic, and benzodiazepine receptors [1].  3H-SM-3997 bound rapidly, reversibly and in a saturable manner with high affinity to rat brain hippocampal membranes (Kd = 9.4 nM, Bmax = 213 fmol/mg protein) [2]. 
in vivo: Chronic treatment with tandospirone, at 0.2 and 1.0mg/kg/day, but not 2.0mg/kg/day, attenuated footshock stress-induced eLAC elevation in the mPFC [3]. Rats were acutely administered tandospirone (0, 0.1, and 1 mg/kg, i.p.). Tandospirone decreased the number of premature responses, an index of impulsive action, in a dose-dependent manner [4].
Toxicity: It is not believed to be addictive but it is known to produce mild withdrawal effects (e.g. anorexia) after abrupt discontinuation."	Citrate	C27H37N5O9	228136.0	H2O : 10.4 mg/mL (18.07 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C1N(CCCCN2CCN(C3=NC=CC=N3)CC2)C([C@@]4([H])[C@](C5)([H])CC[C@]5([H])[C@@]14[H])=O.O=C(CC(C(O)=O)(O)CC(O)=O)O	https://www.medchemexpress.com/Tandospirone-citrate.html	Launched		910.0	F5	A11	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0061	10.0	mM	11.0	DMSO	383.232125	11	A	pluskal_fda_drugs_5006_A11_id
2642	HY-B1174	HYCPK40910	E08	HYCPK40910					910.0	E08	4696-76-8	Bekanamycin	Kanamycin B	483.51	Antibiotic; Bacterial	Anti-infection	Bekanamycin (Kanamycin B) is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus, against an array of Gram-positive and Gram-negative bacterial strain[1][2].	Free Base	C18H37N5O10	18914.0	H2O : ≥ 100 mg/mL (206.82 mM); DMSO : 1 mg/mL (2.07 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Infection	O[C@H]1[C@](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@@]3([H])O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)([H])O[C@H](CO)[C@@H](O)[C@@H]1N	https://www.medchemexpress.com/Bekanamycin.html	Launched		910.0	E8	A11	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1174	10.0	mM	11.0	DMSO	483.254042	11	A	pluskal_fda_drugs_5006_A11_id
2656	HY-Y0337A	HYCPK40910	G09	HYCPK40910					910.0	G09	52-89-1	L-Cysteine (hydrochloride)		157.62	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Cysteine hydrochloride is a conditionally essential amino acid, which acts as a precursor for biologically active molecules such as hydrogen sulphide (H2S), glutathione and taurine. L-Cysteine hydrochloride suppresses ghrelin and reduces appetite in rodents and humans[1].	Hydrochloride	C3H8ClNO2S	61064.0	H2O : 100 mg/mL (634.44 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	N[C@@H](CS)C(O)=O.[H]Cl	https://www.medchemexpress.com/l-cysteine-hydrochloride.html	Launched		910.0	G9	A11	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-Y0337A	10.0	mM	11.0	DMSO	121.019749	11	A	pluskal_fda_drugs_5006_A11_id
2662	HY-17390A	HYCPK40910	M09	HYCPK40910					910.0	M09	27833-64-3	Loxapine (succinate)		445.90	5-HT Receptor; Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Loxapine succinate is an orally active dopamine inhibitor, 5-HT receptor antagonist and also a dibenzoxazepine anti-psychotic agent. Loxapine can also suppresses bacterial efflux pump activity and inhibit intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages[1][4][6].	Succinate	C22H24ClN3O5	16417.0	DMSO : 100 mg/mL (224.27 mM; Need ultrasonic); H2O : 2.5 mg/mL (5.61 mM; ultrasonic and warming and heat to 60°C)	Water Solution	10mM  * 100uL	Infection; Neurological Disease	O=C(O)CCC(O)=O.CN1CCN(C2=NC3=CC=CC=C3OC4=CC=C(Cl)C=C24)CC1	https://www.medchemexpress.com/Loxapine-succinate.html	Launched		910.0	M9	A11	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17390A	10.0	mM	11.0	DMSO	327.11384	11	A	pluskal_fda_drugs_5006_A11_id
2663	HY-11101	HYCPK40910	N09	HYCPK40910					910.0	N09	121268-17-5	Alendronate (sodium hydrate)	Alendronate; MK 217; G-704650 Adronat	325.12	Others	Others	Alendronate (sodium hydrate) is a farnesyl diphosphate synthase inhibitor with IC50 of 460 nM.	Sodium	C4H18NNaO10P2	3301.0	H2O : ≥ 28.57 mg/mL (87.88 mM)	Water Solution	10mM  * 100uL	Cancer	OP(C(O)(CCCN)P(O)(O[Na])=O)(O)=O.[3H2O]	https://www.medchemexpress.com/Alendronate-sodium-hydrate.html	Launched		910.0	N9	A11	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-11101	10.0	mM	11.0	DMSO	249.016725	11	A	pluskal_fda_drugs_5006_A11_id
2716	HY-B1000	HYCPK40910	C13	HYCPK40910					910.0	C13	1464-42-2	Selenomethionine	Seleno-DL-methionine; DL-Selenomethionine	196.11	Autophagy; Endogenous Metabolite	Autophagy; Metabolic Enzyme/Protease	Selenomethionine is a naturally occurring amino acid containing selenium, is a common natural food source of selenium.	Free Acid	C5H11NO2Se	61585.0	H2O : 12.5 mg/mL (63.74 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	O=C(O)C(N)CC[Se]C	https://www.medchemexpress.com/Selenomethionine.html	Launched		910.0	C13	A11	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1000	10.0	mM	11.0	DMSO	196.9955	11	A	pluskal_fda_drugs_5006_A11_id
2731	HY-N0325	HYCPK40910	K14	HYCPK40910					910.0	K14	59-51-8	DL-Methionine		149.21	Parasite	Anti-infection	DL-Methionine is an essential amino acid containing sulfur with oxidative stress defense effects. DL-Methionine can be used for animal natural feed. DL-Methionine also kills H. rostochiensis on potato plants[1][2][3].		C5H11NO2S	93475.0	1M HCl : 100 mg/mL (670.20 mM; ultrasonic and adjust pH to 1 with HCl); DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble or slightly soluble); H2O : 33.33 mg/mL (223.38 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection; Inflammation/Immunology	NC(CCSC)C(O)=O	https://www.medchemexpress.com/dl-methionine.html	Launched		910.0	K14	A11	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0325	10.0	mM	11.0	DMSO	149.05105	11	A	pluskal_fda_drugs_5006_A11_id
2319	HY-B0300	HYCPK40910	O13	HYCPK40910					910.0	O13	52-67-5	Penicillamine	D-(-)-Penicillamine	149.21	Drug Metabolite	Metabolic Enzyme/Protease	Penicillamine (D-(-)-Penicillamine) is a penicillin metabolic degradation product, can be used as a heavy metal chelator. Penicillamine increases free copper and enhances oxidative stress. Penicillamine has effect of seizures through nitric oxide/NMDA pathways. Penicillamine is a potential immune modulator. Penicillamine can be used for the research of Wilson disease, rheumatoid arthritis, and cystinuria[1][2][3][4].	Free Acid	C5H11NO2S	15180.0	H2O : 125 mg/mL (837.75 mM; ultrasonic and warming and heat to 60°C); DMSO : 1.43 mg/mL (9.58 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	N[C@H](C(C)(S)C)C(O)=O	https://www.medchemexpress.com/Penicillamine.html	Launched		910.0	O13	A12	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0300	10.0	mM	12.0	DMSO	149.05105	12	A	pluskal_fda_drugs_5006_A12_id
2569	HY-17015	HYCPK40910	L03	HYCPK40910					910.0	L03	1041434-82-5	Peramivir (trihydrate)	RWJ 270201 trihydrate; BCX 1812 trihydrate	382.45	Influenza Virus	Anti-infection	Peramivir trihydrate (RWJ-270201 trihydrate;BCX-1812 trihydrate) is a highly potent, selective and orally active influenza virus neuraminidase (NA) inhibitor, with IC50 values ranging from 0.9 to 4.3 nM for nine NA subtypes[1][2].	Free Acid	C15H34N4O7	5702.0	H2O : 5 mg/mL (13.07 mM; Need ultrasonic); DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Infection	O[C@H]1[C@]([C@H](C(CC)CC)NC(C)=O)([H])[C@H](NC(N)=N)C[C@@H]1C(O)=O.[H]O.[H]O.[H]O	https://www.medchemexpress.com/Peramivir-trihydrate.html	Launched		910.0	L3	A12	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17015	10.0	mM	12.0	DMSO	328.211055	12	A	pluskal_fda_drugs_5006_A12_id
2570	HY-B1285	HYCPK40910	M03	HYCPK40910					910.0	M03	59-52-9	Dimercaprol	2,3-Dimercapto-1-propanol; Dithioglycerol	124.23	HIV	Anti-infection	Dimercaprol (2,3-Dimercapto-1-propanol) is an anti-heavy metal-poisoning drug, which exhibits anti-HIV activity[1].	Free Base	C3H8OS2	116112.0	H2O : 41.67 mg/mL (335.43 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	OCC(S)CS	https://www.medchemexpress.com/dimercaprol.html	Launched		910.0	M3	A12	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1285	10.0	mM	12.0	DMSO	124.001657	12	A	pluskal_fda_drugs_5006_A12_id
2597	HY-D0214	HYCPK40910	H05	HYCPK40910					910.0	H05	632-69-9	Rose Bengal (sodium)		1017.64	Influenza Virus	Anti-infection	Rose Bengal sodium, a synthetic fluorescein derivative, and is a crimson-coloured dye with the principal component being 4,5,6,7-tetrachloro-2,4,5,7-tetraiodo fluorescein. Rose Bengal sodium has been widely used as an ophthalmic diagnostic agents, and can detect desiccated or damaged cells on the ocular surface. Rose Bengal sodium exhibits antiviral activities[1][2].	Sodium	C20H2Cl4I4Na2O5	105730.0	H2O : 31.25 mg/mL (30.71 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	O=C1OC2(C3=C(OC4=C2C=C(I)C(O[Na])=C4I)C(I)=C(O[Na])C(I)=C3)C5=C1C(Cl)=C(Cl)C(Cl)=C5Cl	https://www.medchemexpress.com/rose-bengal-sodium.html	Launched		910.0	H5	A12	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-D0214	10.0	mM	12.0	DMSO	971.499176	12	A	pluskal_fda_drugs_5006_A12_id
2607	HY-14301	HYCPK40910	B06	HYCPK40910					910.0	B06	868049-49-4	Olodaterol	BI1744	386.44	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Olodaterol (BI1744) is a selective, long acting β2-adrenoceptor (β2-AR) agonist (EC50=0.1 nM and pKi= 9.14 for human β2-adrenoceptor, respectively). Olodaterol can be used for chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis[1][2][3].	Free Base	C21H26N2O5	23792.0	H2O : 6.2 mg/mL (16.04 mM; Need ultrasonic and warming)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C1NC2=CC(O)=CC([C@@H](O)CNC(C)(C)CC3=CC=C(OC)C=C3)=C2OC1	https://www.medchemexpress.com/Olodaterol.html	Launched		910.0	B6	A12	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14301	10.0	mM	12.0	DMSO	386.184172	12	A	pluskal_fda_drugs_5006_A12_id
2680	HY-16566A	HYCPK40910	O10	HYCPK40910					910.0	O10	25389-94-0	Kanamycin (sulfate)	Kanamycin A (sulfate)	582.58	Antibiotic; Bacterial	Anti-infection	Kanamycin (Kanamycin A) sulfate is an orally active antibacterial (gram-negative/positive bacteria) agent, inhibits translocation and causes misencoding by binding to the 70 S ribosomal subunit. Kanamycin sulfate shows good inhibitory activity to both M. tuberculosis (sensitive and drug-resistant ) and K. pneumonia, which can be used in studies of tuberculosis and pneumonia[1][2][3][4].	Sulfate	C18H38N4O15S	39680.0	H2O : ≥ 25 mg/mL (42.91 mM); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Infection	OS(O)(=O)=O.O[C@H]1[C@](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)([H])O[C@H](CN)[C@@H](O)[C@@H]1O	https://www.medchemexpress.com/Kanamycin-sulfate.html	Launched		910.0	O10	A12	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-16566A	10.0	mM	12.0	DMSO	484.238058	12	A	pluskal_fda_drugs_5006_A12_id
2696	HY-B0631	HYCPK40910	O11	HYCPK40910					910.0	O11	66376-36-1	Alendronic acid		249.10	Others	Others	Alendronic acid, a bisphosphonate, is a farnesyl diphosphate synthase (FDPS) inhibitor. Alendronic acid inhibits osteoclast-mediated bone resorption. Alendronic acid shows efficacy in postmenopausal osteoporosis, malignant hypercalcemia and Paget’s disease[1].	Free Acid	C4H13NO7P2	63383.0	H2O : 8.33 mg/mL (33.44 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	OC(P(O)(O)=O)(CCCN)P(O)(O)=O	https://www.medchemexpress.com/alendronic-acid.html	Launched		910.0	O11	A12	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0631	10.0	mM	12.0	DMSO	249.016725	12	A	pluskal_fda_drugs_5006_A12_id
2719	HY-B1000A	HYCPK40910	F13	HYCPK40910					910.0	F13	3211-76-5	L-SelenoMethionine		196.11	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	L-SelenoMethionine, an L-isomer of Selenomethionine, is a major natural food-form of selenium. L-SelenoMethionin is a cancer chemopreventive agent that can reduce cancer incidence by dietary supplementation and induce apoptosis of cancer cells. L-SelenoMethionine also can increase expression of glutathione peroxidase[1][2][3].	Free Acid	C5H11NO2Se	18572.0	H2O : 14.29 mg/mL (72.87 mM; Need ultrasonic); DMSO : 1 mg/mL (5.10 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	O=C(O)[C@@H](N)CC[Se]C	https://www.medchemexpress.com/L-SelenoMethionine.html	Launched		910.0	F13	A12	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1000A	10.0	mM	12.0	DMSO	196.9955	12	A	pluskal_fda_drugs_5006_A12_id
2318	HY-B1258	HYCPK40910	N13	HYCPK40910					910.0	N13	56-91-7	4-(Aminomethyl)benzoic acid	Aminomethylbenzoic acid; α-Amino-p-toluic acid	151.16	Others	Others	4-(Aminomethyl)benzoic acid is an unnatural amino acid derivative, is an antifibrinolytic.	Free Acid	C8H9NO2	17607.0	H2O : 9.09 mg/mL (60.13 mM; Need ultrasonic); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Others	O=C(O)C1=CC=C(CN)C=C1	https://www.medchemexpress.com/4-_Aminomethyl_benzoic-acid.html	Launched		910.0	N13	A13	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1258	10.0	mM	13.0	DMSO	151.063329	13	A	pluskal_fda_drugs_5006_A13_id
2586	HY-D0208	HYCPK40910	M04	HYCPK40910					910.0	M04	518-47-8	Fluorescein (sodium)	Uranine (sodium)	376.27	Others	Others	Fluorescein (Uranine) sodium is widely used as a fluorescent tracer in medicinal and biological applications and tumor infected tissues tracer. Fluorescein (Uranine) sodium is a representative green fluorophore that has been widely used as a scaffold of practically useful green fluorescent probes[1][2].	Sodium	C20H10Na2O5	212342.0	H2O : 20.83 mg/mL (55.36 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Cancer	O=C1OC2(C3=C(OC4=C2C=CC(O[Na])=C4)C=C(O[Na])C=C3)C5=C1C=CC=C5	https://www.medchemexpress.com/fluorescein-sodium.html	Launched		910.0	M4	A13	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-D0208	10.0	mM	13.0	DMSO	332.068473	13	A	pluskal_fda_drugs_5006_A13_id
2603	HY-14254	HYCPK40910	N05	HYCPK40910					910.0	N05	119615-63-3	Olprinone (Hydrochloride)	Loprinone (Hydrochloride)	286.72	Phosphodiesterase (PDE)	Metabolic Enzyme/Protease	Olprinone (Loprinone) Hydrochloride is a potent phosphodiesterase (PDE) 3 inhibitor, with IC50s of 150, 100, 0.35 and 14 μM for PDE1, PDE2, PDE3 and PDE4, respectively. Olprinone Hydrochloride is used for the research of heart failure due to its positive inotropic and vasodilative effects. Anti-inflammatory activity[1][2].	Hydrochloride	C14H11ClN4O	8032.0	H2O : ≥ 7.69 mg/mL (26.82 mM)	Water Solution	10mM  * 100uL	Cardiovascular Disease	CC(N1)=C(C=C(C#N)C1=O)C2=CN3C(C=C2)=NC=C3.[H]Cl	https://www.medchemexpress.com/Olprinone-Hydrochloride.html	Launched		910.0	N5	A13	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14254	10.0	mM	13.0	DMSO	250.085461	13	A	pluskal_fda_drugs_5006_A13_id
2610	HY-B1488	HYCPK40910	E06	HYCPK40910					910.0	E06	1684-40-8	Tacrine (hydrochloride)		234.72	Cholinesterase (ChE); iGluR	Membrane Transporter/Ion Channel; Neuronal Signaling	Tacrine hydrochloride is a potent inhibitor of both AChE and BChE, with IC50s of 31 nM and 25.6 nM, respectively. Tacrine hydrochloride is also a NMDAR inhibitor, with an IC50 of 26 μM. Tacrine hydrochloride can be used for the research of Alzheimer’s disease[1][2].	Hydrochloride	C13H15ClN2	78798.0	H2O : 83.33 mg/mL (355.02 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	NC1=C(CCCC2)C2=NC3=CC=CC=C31.[H]Cl	https://www.medchemexpress.com/tacrine-hydrochloride.html	Launched		910.0	E6	A13	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1488	10.0	mM	13.0	DMSO	198.115698	13	A	pluskal_fda_drugs_5006_A13_id
2667	HY-B0351	HYCPK40910	B10	HYCPK40910					910.0	B10	107-35-7	Taurine	2-Aminoethanesulfonic acid	125.15	Autophagy; Endogenous Metabolite	Autophagy; Metabolic Enzyme/Protease	Taurine, a sulphur-containing amino acid and an organic osmolyte involved in cell volume regulation, provides a substrate for the formation of bile salts, and plays a role in the modulation of intracellular free calcium concentration. Taurine has the ability to activate autophagy in adipocytes[1][2][3].	Free Acid	C2H7NO3S	16418.0	H2O : 25 mg/mL (199.76 mM; Need ultrasonic); DMSO : 1 mg/mL (7.99 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease; Cancer	NCCS(=O)(O)=O	https://www.medchemexpress.com/taurine.html	Launched		910.0	B10	A13	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0351	10.0	mM	13.0	DMSO	125.014664	13	A	pluskal_fda_drugs_5006_A13_id
2675	HY-P0083	HYCPK40910	J10	HYCPK40910					910.0	J10	3397-23-7	Ornipressin	POR-8	1042.19	Others	Others	Ornipressin is a potent vasoconstrictor, hemostatic and renal agent.	Free Base	C45H63N13O12S2	96386.0	H2O : ≥ 100 mg/mL (95.95 mM)	Water Solution	10mM  * 100uL	Cardiovascular Disease	O=C([C@H](CSSC[C@@H](C(N[C@H](C1=O)CC2=CC=C(O)C=C2)=O)N)NC([C@@H](NC([C@@H](NC([C@](N1)([H])CC3=CC=CC=C3)=O)CCC(N)=O)=O)CC(N)=O)=O)N(CCC4)[C@@H]4C(N[C@@H](CCCN)C(NCC(N)=O)=O)=O	https://www.medchemexpress.com/Ornipressin.html	Launched		910.0	J10	A13	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-P0083	10.0	mM	13.0	DMSO	1041.416056	13	A	pluskal_fda_drugs_5006_A13_id
2687	HY-14301A	HYCPK40910	F11	HYCPK40910					910.0	F11	869477-96-3	Olodaterol (hydrochloride)	BI1744 (hydrochloride)	422.90	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Olodaterol (BI1744) hydrochloride is a selective, long acting β2-adrenoceptor (β2-AR) agonist (EC50=0.1 nM and pKi= 9.14 for human β2-adrenoceptor, respectively). Olodaterol can be used for chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis[1][2][3].	Hydrochloride	C21H27ClN2O5	109501.0	H2O : 250 mg/mL (591.16 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Endocrinology; Inflammation/Immunology	O=C1NC2=CC(O)=CC([C@@H](O)CNC(C)(C)CC3=CC=C(OC)C=C3)=C2OC1.[H]Cl	https://www.medchemexpress.com/olodaterol-hydrochloride.html	Launched		910.0	F11	A13	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14301A	10.0	mM	13.0	DMSO	386.184172	13	A	pluskal_fda_drugs_5006_A13_id
2703	HY-B0739A	HYCPK40910	F12	HYCPK40910					910.0	F12	33818-15-4	Citicoline (sodium)	Cytidine diphosphate-choline (sodium); CDP-Choline (sodium); Cytidine 5'-diphosphocholine (sodium)	510.31	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	Citicoline sodium salt is an intermediate in the synthesis of phosphatidylcholine which is a component of cell membranes and also exerts neuroprotective effects.	Sodium	C14H25N4NaO11P2	28642.0	H2O : ≥ 100 mg/mL (195.96 mM); DMSO : 1 mg/mL (1.96 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Neurological Disease	O[C@H]1[C@H](N(C=CC(N)=N2)C2=O)O[C@H](COP(OP(OCC[N+](C)(C)C)([O-])=O)(O[Na])=O)[C@H]1O	https://www.medchemexpress.com/Cytidoline_sodium_salt.html	Launched		910.0	F12	A13	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0739A	10.0	mM	13.0	DMSO	489.114607	13	A	pluskal_fda_drugs_5006_A13_id
2317	HY-B0739	HYCPK40910	P08	HYCPK40910					910.0	P08	987-78-0	Citicoline	Cytidine diphosphate-choline; CDP-Choline; Cytidine 5'-diphosphocholine	488.32	Apoptosis; Endogenous Metabolite	Apoptosis; Metabolic Enzyme/Protease	Citicoline (Cytidine diphosphate-choline) is an intermediate in the synthesis of phosphatidylcholine, a component of cell membranes. Citicoline exerts neuroprotective effects.	Free Acid	C14H26N4O11P2	28643.0	H2O : 50 mg/mL (102.39 mM; Need ultrasonic); DMSO : 1 mg/mL (2.05 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Neurological Disease	O[C@@H]([C@H]([C@H](N1C(N=C(C=C1)N)=O)O2)O)[C@H]2COP(OCC[N+](C)(C)C)(OP([O-])(O)=O)=O	https://www.medchemexpress.com/Citicoline.html	Launched		910.0	P8	A14	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0739	10.0	mM	14.0	DMSO	489.114607	14	A	pluskal_fda_drugs_5006_A14_id
2324	HY-B1318	HYCPK40910	D14	HYCPK40910					910.0	D14	63585-09-1	Foscarnet (sodium)	Trisodium phosphonoformate; Phosphonoformic acid trisodium salt	191.95	DNA/RNA Synthesis	Cell Cycle/DNA Damage	Foscarnet sodium (Trisodium phosphonoformate) is a viral DNA polymerase activity inhibitor, leading to reversible suppression of viral replication. Foscarnet sodium is an antiherpesvirus agent used in cytomegalovirus retinitis[1][2][3].	Sodium	CNa3O5P	65215.0	H2O : 60 mg/mL (312.58 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=P(O[Na])(O[Na])C(O[Na])=O	https://www.medchemexpress.com/foscarnet-sodium.html	Launched		910.0	D14	A14	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1318	10.0	mM	14.0	DMSO	125.97181	14	A	pluskal_fda_drugs_5006_A14_id
2601	HY-N0832	HYCPK40910	L05	HYCPK40910					910.0	L05	71-00-1	L-Histidine		155.15	Endogenous Metabolite; Mitochondrial Metabolism	Metabolic Enzyme/Protease	L-Histidine is an essential amino acid for infants. L-Histidine is an inhibitor of mitochondrial glutamine transport.	Free Acid	C6H9N3O2	113559.0	H2O : 20.83 mg/mL (134.26 mM; ultrasonic and warming and heat to 80°C); DMSO : 1 mg/mL (6.45 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Metabolic Disease; Inflammation/Immunology; Neurological Disease	N[C@@H](CC1=CNC=N1)C(O)=O	https://www.medchemexpress.com/L-Hisidine.html	Launched		910.0	L5	A14	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0832	10.0	mM	14.0	DMSO	155.069477	14	A	pluskal_fda_drugs_5006_A14_id
2617	HY-B0800	HYCPK40910	L06	HYCPK40910					910.0	L06	645-43-2	Guanethidine (sulfate)	Guanethidine monosulfate	296.39	Others	Others	Guanethidine sulfate (Guanethidine monosulfate) ia an antihypertensive agents. Guanethidine is also an adrenergic neurone blocking drug, enters noradrenergic nerve terminals by the neuronal amine carrier[1][2].	Sulfate	C10H24N4O4S	22448.0	H2O : 100 mg/mL (337.39 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	NC(NCCN1CCCCCCC1)=N.O=S(O)(O)=O	https://www.medchemexpress.com/Guanethidine-sulfate.html	Launched		910.0	L6	A14	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0800	10.0	mM	14.0	DMSO	198.184447	14	A	pluskal_fda_drugs_5006_A14_id
2652	HY-13948A	HYCPK40910	C09	HYCPK40910					910.0	C09	68521-88-0	Angiotensin II human (acetate)	Angiotensin II (acetate); Ang II (acetate); DRVYIHPF (acetate)	1106.23	Angiotensin Receptor; Apoptosis	Apoptosis; GPCR/G Protein	Angiotensin II human (Angiotensin II) acetate is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system. Angiotensin II human acetate plays a central role in regulating human blood pressure, which is mainly mediated by interactions between Angiotensin II and the G-protein-coupled receptors (GPCRs) Angiotensin II type 1 receptor (AT1R) and Angiotensin II type 2 receptor (AT2R). Angiotensin II human acetate stimulates sympathetic nervous stimulation, increases aldosterone biosynthesis and renal actions. Angiotensin II human acetate induces growth of vascular smooth muscle cells, increases collagen type I and III synthesis in fibroblasts, leading to thickening of the vascular wall and myocardium, and fibrosis. Angiotensin II human acetate also induces apoptosis. Angiotensin II human acetate induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway[1][2][3][4].	Acetate	C52H75N13O14	79611.0	H2O : 25 mg/mL (22.60 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Endocrinology; Cardiovascular Disease	O=C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC2=CNC=N2)C(N3[C@@H](CCC3)C(N[C@@H](CC4=CC=CC=C4)C(O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(O)=O)N.CC(O)=O	https://www.medchemexpress.com/angiotensin-ii-human-acetate.html	Launched		910.0	C9	A14	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13948A	10.0	mM	14.0	DMSO	1045.534515	14	A	pluskal_fda_drugs_5006_A14_id
2654	HY-B0438	HYCPK40910	E09	HYCPK40910					910.0	E09	21736-83-4	Spectinomycin (dihydrochloride)		405.27	Antibiotic; Bacterial	Anti-infection	Spectinomycin dihydrochloride is a broad-spectrum antibiotic and inhibits the growth of a variety of gram-positive and gram-negative organisms. Spectinomycin dihydrochloride acts by selectively targeting to the bacterial ribosome and interrupting protein synthesis. Spectinomycin dihydrochloride is also a noncompetitive inhibitor of td intron RNA with an Ki value of 7.2 mM[1]-[5].	Hydrochloride	C14H26Cl2N2O7	17151.0	H2O : ≥ 100 mg/mL (246.75 mM)	Water Solution	10mM  * 100uL	Infection	CN[C@@H]([C@H]([C@@H](NC)[C@@H]1O)O)[C@]2([H])[C@]1([H])O[C@@](O[C@H](C)C3)([H])[C@](O)(C3=O)O2.Cl.Cl	https://www.medchemexpress.com/spectinomycin-dihydrochloride.html	Launched		910.0	E9	A14	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0438	10.0	mM	14.0	DMSO	332.158351	14	A	pluskal_fda_drugs_5006_A14_id
2657	HY-B0549A	HYCPK40910	H09	HYCPK40910					910.0	H09	3717-88-2	Flavoxate (hydrochloride)	Rec-7-0040; DW61	427.92	Calcium Channel; mAChR; Phosphodiesterase (PDE)	GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	Flavoxate hydrochloride is a potent and competitive phosphodiesterase (PDE) inhibitor. Flavoxate hydrochloride is an antispasmodic agent and muscarinic mAChR antagonist. Flavoxate hydrochloride shows moderate calcium antagonistic activity and local anesthetic effect. Flavoxate hydrochloride can be used for the research of overactive bladder (OAB) and lower urinary tract infections[1].	Hydrochloride	C24H26ClNO4	16641.0	DMSO : 3.33 mg/mL (7.78 mM; Need ultrasonic); H2O : 5 mg/mL (11.68 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C(C1=C2C(C(C(C)=C(C3=CC=CC=C3)O2)=O)=CC=C1)OCCN4CCCCC4.Cl	https://www.medchemexpress.com/Flavoxate-hydrochloride.html	Launched		910.0	H9	A14	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0549A	10.0	mM	14.0	DMSO	391.178358	14	A	pluskal_fda_drugs_5006_A14_id
2729	HY-11017	HYCPK40910	I14	HYCPK40910					910.0	I14	129101-54-8	Rivastigmine (tartrate)	ENA 713; SDZ-ENA 713	400.42	Cholinesterase (ChE)	Neuronal Signaling	Rivastigmine tartrate (ENA 713; SDZ-ENA 713) is an orally active and potent cholinesterase (ChE) inhibitor and inhibits butyrylcholinesterase (BChE) and acetylcholinesteras (AChE) with IC50s of 0.037 μM, 4.15 μM, respectively. Rivastigmine tartrate can pass the blood brain barrier (BBB). Rivastigmine tartrate is a parasympathomimetic or cholinergic agent used for the research of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease[1][2].	Tartrate	C18H28N2O8	7194.0	H2O : 50 mg/mL (124.87 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C(OC1=CC=CC([C@@H](N(C)C)C)=C1)N(CC)C.O=C(O)[C@H](O)[C@@H](O)C(O)=O	https://www.medchemexpress.com/Rivastigmine-tartrate.html	Launched		910.0	I14	A14	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-11017	10.0	mM	14.0	DMSO	250.168128	14	A	pluskal_fda_drugs_5006_A14_id
2605	HY-B0706A	HYCPK40910	P05	HYCPK40910					910.0	P05	92823-03-5	Flomoxef (sodium)		518.45	Bacterial	Anti-infection	Flomoxef sodium is a oxacephem group antibiotic, with excellent activity against various Gram-positive bacteria[1][2].	Sodium	C15H17F2N6NaO7S2	150392.0	H2O : 250 mg/mL (482.21 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=NN3CCO)CO[C@]2([H])[C@](OC)(NC(CSC(F)F)=O)C1=O)O[Na]	https://www.medchemexpress.com/flomoxef-sodium.html	Launched		910.0	P5	A15	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0706A	10.0	mM	15.0	DMSO	496.064645	15	A	pluskal_fda_drugs_5006_A15_id
2618	HY-P0049	HYCPK40910	M06	HYCPK40910					910.0	M06	113-79-1	Argipressin	Arg8-vasopressin; AVP	1084.23	Vasopressin Receptor	GPCR/G Protein	Argipressin (Arg8-vasopressin) binds to the V1, V2, V3-vascular arginine vasopressin receptor, with a Kd value of 1.31 nM in A7r5 rat aortic smooth muscle cells for V1.	Free Base	C46H65N15O12S2	112776.0	H2O : ≥ 100 mg/mL (92.23 mM)	Water Solution	10mM  * 100uL	Neurological Disease; Cancer	[CYFQNCPRG-NH2(Disulfide bridge: Cys1-Cys6)]	https://www.medchemexpress.com/Argipressin.html	Launched		910.0	M6	A15	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-P0049	10.0	mM	15.0	DMSO	1083.437855	15	A	pluskal_fda_drugs_5006_A15_id
2686	HY-B1828A	HYCPK40910	E11	HYCPK40910					910.0	E11	22189-32-8	Spectinomycin (dihydrochloride pentahydrate)	Spectinomycin (hydrochloride hydrate)	495.35	Antibiotic; Bacterial	Anti-infection	Spectinomycin dihydrochloride pentahydrate is a broad-spectrum antibiotic and inhibits the growth of a variety of gram-positive and gram-negative organisms. Spectinomycin dihydrochloride pentahydrate acts by selectively targeting to the bacterial ribosome and interrupting protein synthesis. Spectinomycin dihydrochloride pentahydrate is also a noncompetitive inhibitor of td intron RNA with an Ki value of 7.2 mM[1]-[5].	Hydrochloride	C14H36Cl2N2O12	114371.0	H2O : 62.5 mg/mL (126.17 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=C1C[C@@H](C)O[C@@]2([H])O[C@@]3([H])[C@]([C@@H](NC)[C@@H](O)[C@@H](NC)[C@@H]3O)([H])O[C@]21O.[H]Cl.[H]Cl.[5H2O]	https://www.medchemexpress.com/Spectinomycin_dihydrochloride_pentahydrate.html	Launched		910.0	E11	A15	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1828A	10.0	mM	15.0	DMSO	332.158351	15	A	pluskal_fda_drugs_5006_A15_id
2689	HY-70020B	HYCPK40910	H11	HYCPK40910					910.0	H11	107220-28-0	Cevimeline (hydrochloride)	AF102B (hydrochloride)	235.77	mAChR	GPCR/G Protein; Neuronal Signaling	Cevimeline hydrochloride (AF102B hydrochloride) is a quinuclidine derivative of acetylcholine and a selective and orally active muscarinic M1 and M3 receptor agonist. Cevimeline hydrochloride stimulates secretion by the salivary glands and can be used as a sialogogue for xerostomia[1][2][3][4]. Cevimeline hydrochloride can cross the blood-brain barrier (BBB)[5].	Hydrochloride	C10H18ClNOS	28200.0	H2O : ≥ 50 mg/mL (212.07 mM)	Water Solution	10mM  * 100uL	Neurological Disease; Cancer	C[C@H]1SC[C@@]2(CN3CCC2CC3)O1.Cl	https://www.medchemexpress.com/Cevimeline-hydrochloride.html	Launched		910.0	H11	A15	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-70020B	10.0	mM	15.0	DMSO	199.103085	15	A	pluskal_fda_drugs_5006_A15_id
2692	HY-B0194A	HYCPK40910	K11	HYCPK40910					910.0	K11	64461-82-1	Tizanidine (hydrochloride)		290.17	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	"Tizanidine hydrochloride is an α2-adrenergic receptor agonist and inhibits neurotransmitter release from CNS noradrenergic neurons.
Target: α2-adrenergic receptor
Tizanidine is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.
Tizanidine has been found to be as effective as other antispasmodic drugs and has superior tolerability to that of baclofen and diazepam. Tizanidine can be very strong even at the 2 mg dose and may cause hypotension, so caution is advised when it is used in patients who have a history of orthostatic hypotension, or when switching from gel cap to tablet form and vice versa. Tizanidine can occasionally cause liver damage, generally the hepatocellular type. Clinical trials show that up to 5% of patients treated with tizanidine had elevated liver function test values, though symptoms disappeared upon withdrawal of the drug. Care should be used when first beginning treatment with tizanidine with regular liver tests for the first 6 months of treatment."	Hydrochloride	C9H9Cl2N5S	15976.0	H2O : 20 mg/mL (68.93 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Neurological Disease; Endocrinology	ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1.Cl	https://www.medchemexpress.com/Tizanidine-hydrochloride.html	Launched		910.0	K11	A15	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0194A	10.0	mM	15.0	DMSO	253.018894	15	A	pluskal_fda_drugs_5006_A15_id
2699	HY-B1898	HYCPK40910	B12	HYCPK40910					910.0	B12	74536-44-0	Metadoxine		298.29	PKA	Stem Cell/Wnt	Metadoxine blocks adipocyte differentiation in association with inhibition of the protein kinase A-cAMP response element binding protein (PKA-CREB) pathway.	Free Acid	C13H18N2O6	34492.0	H2O : ≥ 155 mg/mL (519.63 mM)	Water Solution	10mM  * 100uL	Metabolic Disease	O=C(O)[C@H](CC1)NC1=O.OCC2=C(CO)C(O)=C(C)N=C2	https://www.medchemexpress.com/Metadoxine.html	Launched		910.0	B12	A15	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1898	10.0	mM	15.0	DMSO	129.042593	15	A	pluskal_fda_drugs_5006_A15_id
2724	HY-B0149	HYCPK40910	K13	HYCPK40910					910.0	K13	1197-18-8	Tranexamic acid		157.21	Others	Others	"Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM. 
Target: Others
Tranexamic acid is a synthetic derivative of the amino acid lysine. Tranexamic acid is frequently used in surgeries with high risk of blood loss such as cardiac, liver, vascular and large orthopedic procedures. Its oral form is now being evaluated for use in outpatient conditions involving heavy bleeding.
Toxicity/Adverse event: Rare in general, including gastrointestinal effects, dizziness, fatigue, headache, and hypersensitivity reactions. Use of tranexamic acid has a potential risk of thrombosis."	Free Acid	C8H15NO2	16337.0	H2O : 50 mg/mL (318.05 mM; Need ultrasonic); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C([C@H]1CC[C@H](CN)CC1)O	https://www.medchemexpress.com/Tranexamic-acid.html	Launched		910.0	K13	A15	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0149	10.0	mM	15.0	DMSO	157.110279	15	A	pluskal_fda_drugs_5006_A15_id
2736	HY-B0617A	HYCPK40910	P14	HYCPK40910					910.0	P14	52248-03-0	S-Adenosyl-L-methionine (tosylate)	S-Adenosyl methionine (tosylate); Ademetionine (tosylate); AdoMet (tosylate)	570.64	Endogenous Metabolite	Metabolic Enzyme/Protease	S-Adenosyl-L-methionine tosylate (S-Adenosyl methionine tosylate) is produced endogenously from methionine and ATP by action of the enzyme methionine adenosyltransferase and is an important orally active methyl group donor. S-Adenosyl-L-methionine tosylate is a dietary supplement with potent antidepressant and analgesic effects, and has the potential for liver disease and osteoarthritis research[1][2][3].	Tosylate	C22H30N6O8S2	79928.0	H2O : 250 mg/mL (438.10 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Inflammation/Immunology; Neurological Disease	O[C@@H]([C@H]([C@H](N1C=NC2=C(N=CN=C21)N)O3)O)[C@H]3C[S+](CC[C@H](N)C(O)=O)C.O=S(C4=CC=C(C)C=C4)([O-])=O	https://www.medchemexpress.com/s-adenosyl-l-methionine-tosylate.html	Launched		910.0	P14	A15	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0617A	10.0	mM	15.0	DMSO	399.144515	15	A	pluskal_fda_drugs_5006_A15_id
2576	HY-12749A	HYCPK40910	C04	HYCPK40910					910.0	C04	43218-56-0	Midodrine (hydrochloride)	(±)-Midodrine (hydrochloride)	290.74	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Midodrine hydrochloride ((±)-Midodrine hydrochloride) is an α1-receptor agonist,  for the treatment of dysautonomia and orthostatic hypotension.	Hydrochloride	C12H19ClN2O4	56313.0	H2O : 100 mg/mL (343.95 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C(NCC(C1=CC(OC)=CC=C1OC)O)CN.[H]Cl	https://www.medchemexpress.com/Midodrine-hydrochloride.html	Launched		910.0	C4	A16	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-12749A	10.0	mM	16.0	DMSO	254.126657	16	A	pluskal_fda_drugs_5006_A16_id
2585	HY-15399	HYCPK40910	L04	HYCPK40910					910.0	L04	68506-86-5	Vigabatrin	γ-Vinyl-GABA	129.16	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	Vigabatrin (γ-Vinyl-GABA), an inhibitory neurotransmitter GABA vinyl-derivative, is an orally active and irreversible GABA transaminase inhibitor. Vigabatrin is an antiepileptic agent, which acts by increasing GABA levels in the brain by inhibiting the catabolism of GABA by GABA transaminase[1][2][3].	Free Acid	C6H11NO2	12518.0	H2O : 50 mg/mL (387.12 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	C=CC(N)CCC(O)=O	https://www.medchemexpress.com/vigabatrin.html	Launched		910.0	L4	A16	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-15399	10.0	mM	16.0	DMSO	129.078979	16	A	pluskal_fda_drugs_5006_A16_id
2616	HY-76772	HYCPK40910	K06	HYCPK40910					910.0	K06	153504-70-2	Cevimeline (hydrochloride hemihydrate)	SNI-2011; AF102B (hydrochloride hemihydrate)	244.78	mAChR	GPCR/G Protein; Neuronal Signaling	Cevimeline hydrochloride hemihydrate (SNI-2011) is a quinuclidine derivative of acetylcholine and a selective and orally active muscarinic M1 and M3 receptor agonist. Cevimeline hydrochloride hemihydrate stimulates secretion by the salivary glands and can be used as a sialogogue for xerostomia[1][2][3][4]. Cevimeline hydrochloride hemihydrate can cross the blood-brain barrier (BBB)[5].	Hydrochloride	C10H17NOS.HCl.1/2H2O	15569.0	H2O : ≥ 50 mg/mL (204.27 mM)	Water Solution	10mM  * 100uL	Neurological Disease; Cancer	C[C@H]1SC[C@@]2(CN3CCC2CC3)O1.[H]Cl.[Relative Stereochemistry].[0.5 H2O]	https://www.medchemexpress.com/Cevimeline-hydrochloride-hemihydrate.html	Launched		910.0	K6	A16	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-76772	10.0	mM	16.0	DMSO	199.103085	16	A	pluskal_fda_drugs_5006_A16_id
2635	HY-103354	HYCPK40910	N07	HYCPK40910					910.0	N07	99247-33-3	Proglumide (sodium)		356.39	Cholecystokinin Receptor	GPCR/G Protein; Neuronal Signaling	Proglumide sodium is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide sodium selective blocks CCK’s effects in the central nervous system (CNS). Proglumide sodium has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide sodium also has antiepileptic and antioxidant activities[1][2][3][4][5].	Sodium	C18H25N2NaO4	59182.0	H2O : 100 mg/mL (280.59 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Endocrinology; Neurological Disease	O=C(O[Na])CCC(NC(C1=CC=CC=C1)=O)C(N(CCC)CCC)=O	https://www.medchemexpress.com/proglumide-sodium.html	Launched		910.0	N7	A16	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-103354	10.0	mM	16.0	DMSO	334.189257	16	A	pluskal_fda_drugs_5006_A16_id
2661	HY-B0464	HYCPK40910	L09	HYCPK40910					910.0	L09	304-20-1	Hydralazine (hydrochloride)		196.64	HIF/HIF Prolyl-Hydroxylase	Metabolic Enzyme/Protease	Hydralazine hydrochloride is a orally active antihypertensive agent, reduces peripheral resistance directly by relaxing the smooth muscle cell layer in arterial vessel. Hydralazine hydrochloride has antioxidant activity, as well as inhibits ROS release and O2·- generation with an IC50 value of 9.53 mM and 1.19 mM, respectively[1][2].	Hydrochloride	C8H9ClN4	17031.0	H2O : 25 mg/mL (127.14 mM; Need ultrasonic); DMSO : 25 mg/mL (127.14 mM; ultrasonic and adjust pH to 11 with NaOH)	Water Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	NNC1=NN=CC2=C1C=CC=C2.Cl	https://www.medchemexpress.com/Hydralazine-hydrochloride.html	Launched		910.0	L9	A16	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0464	10.0	mM	16.0	DMSO	160.074896	16	A	pluskal_fda_drugs_5006_A16_id
2666	HY-B0933	HYCPK40910	A10	HYCPK40910					910.0	A10	120066-54-8	Gadoteridol	SQ-32692; Gd-HP-DO3A	557.68	Others	Others	Gadoteridol is a gadolinium-based magnetic resonance imaging (MRI) contrast agent, used in the imaging of the central nervous system[1].	Free Base	C17H28GdN4O7	99272.0	H2O : ≥ 280 mg/mL (502.08 mM); DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Neurological Disease	CC1O[Gd+3]2([N]3(CC4)CC5=O)([N]6(CC7)CC([O-]2)=O)([N]47CC8=O)([O-]8)([O-]5)[N](CC6)(CC3)C1	https://www.medchemexpress.com/Gadoteridol.html	Launched		910.0	A10	A16	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0933	10.0	mM	16.0	DMSO	404.227099	16	A	pluskal_fda_drugs_5006_A16_id
2677	HY-P0061	HYCPK40910	L10	HYCPK40910					910.0	L10	103222-11-3	Vapreotide	RC160; BMY 41606	1131.37	Neurokinin Receptor	GPCR/G Protein; Neuronal Signaling	Vapreotide is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM.	Free Base	C57H70N12O9S2	22149.0	H2O : 100 mg/mL (88.39 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	[FCYWKVCW-NH2(Disulfide bridge: Cys2-Cys7)]	https://www.medchemexpress.com/Vapreotide.html	Launched		910.0	L10	A16	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-P0061	10.0	mM	16.0	DMSO	1130.483014	16	A	pluskal_fda_drugs_5006_A16_id
2682	HY-19696	HYCPK40910	A11	HYCPK40910					910.0	A11	14605-22-2	Tauroursodeoxycholate	Tauroursodeoxycholic acid; TUDCA; UR 906	499.70	Apoptosis; Caspase; Endogenous Metabolite; ERK	Apoptosis; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Stem Cell/Wnt	Tauroursodeoxycholate (Tauroursodeoxycholic acid)  is an endoplasmic reticulum (ER) stress inhibitor. Tauroursodeoxycholate significantly reduces expression of apoptosis molecules, such as caspase-3 and caspase-12. Tauroursodeoxycholate also inhibits ERK.	Free Acid	C26H45NO6S	98815.0	DMSO : 50 mg/mL (100.06 mM; Need ultrasonic); H2O : 12.5 mg/mL (25.02 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	C[C@H](CCC(NCCS(=O)(O)=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C	https://www.medchemexpress.com/Tauroursodeoxycholate.html	Launched		910.0	A11	A16	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-19696	10.0	mM	16.0	DMSO	499.296759	16	A	pluskal_fda_drugs_5006_A16_id
16	HY-W010735	HYCPK40898	A03	HYCPK40910					910.0	A19	34369-07-8	ATP (disodium salt hydrate)	Adenosine 5'-triphosphate (disodium salt hydrate)		Endogenous Metabolite	Metabolic Enzyme/Protease	ATP disodium salt hydrate (Adenosine 5'-triphosphatedisodium salt hydrate) is a central component of energy storage and metabolism in vivo, provides the metabolic energy to drive metabolic pumps and serves as a coenzyme in cells. ATP disodium salt hydrate is an important endogenous signaling molecule in immunity and inflammation[1][2].	Sodium	C10H16N5O13Na2P3.xH2O	114689.0	H2O : 100 mg/mL (Need ultrasonic)	Water Solution	3mg/mL  * 100uL	Metabolic Disease; Inflammation/Immunology; Cancer	OP(OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=NC=NC(N)=C3N=C2)O1)(OP(OP(O)(O[Na])=O)(O[Na])=O)=O.[H]O[H].[x]	https://www.medchemexpress.com/atp-disodium-salt-hydrate.html	Launched		910.0	A19	A17	233.3333333	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-W010735	3.0	mM	17.0	DMSO	506.995745	17	A	pluskal_fda_drugs_5006_A17_id
67	HY-W031727	HYCPK40900	E03	HYCPK40910					910.0	E17	118-42-3	Hydroxychloroquine		335.87	Autophagy; Parasite; SARS-CoV; Toll-like Receptor (TLR)	Anti-infection; Autophagy; Immunology/Inflammation	Hydroxychloroquine is a synthetic antimalarial agent which can also inhibit Toll-like receptor 7/9 (TLR7/9) signaling. Hydroxychloroquine is efficiently inhibits SARS-CoV-2 infection in vitro[1][2][3].		C18H26ClN3O	109789.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 1.67 mg/mL (4.97 mM; ultrasonic and warming and heat to 60°C); 1M HCl : 100 mg/mL (297.73 mM; adjust pH to 2 with HCl)	Water Solution	2mM  * 100uL	Cancer; Infection	ClC1=CC=C2C(NC(CCCN(CCO)CC)C)=CC=NC2=C1	https://www.medchemexpress.com/hydroxychloroquine.html	Launched		910.0	E17	A17	350.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-W031727	2.0	mM	17.0	DMSO	335.17644	17	A	pluskal_fda_drugs_5006_A17_id
2588	HY-W010388	HYCPK40910	O04	HYCPK40910					910.0	O04	57-00-1	Creatine		131.14	Endogenous Metabolite	Metabolic Enzyme/Protease	Creatine, an endogenous amino acid derivative, plays an important role in cellular energy, especially in muscle and brain.	Free Acid	C4H9N3O2	57838.0	H2O : 6.25 mg/mL (47.66 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease; Cancer	O=C(O)CN(C)C(N)=N	https://www.medchemexpress.com/2-_1-Methylguanidino_acetic_acid.html	Launched		910.0	O4	A17	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-W010388	10.0	mM	17.0	DMSO	131.069477	17	A	pluskal_fda_drugs_5006_A17_id
2609	HY-B2215	HYCPK40910	D06	HYCPK40910					910.0	D06	36304-84-4	Dimemorfan (phosphate)		353.39	Sigma Receptor	Neuronal Signaling	Dimemorfan phosphate is a sigma 1 receptor agonist, used as a potent antitussive.	Phosphate	C18H28NO4P	64580.0	H2O : 10 mg/mL (28.30 mM; ultrasonic and warming and heat to 60°C); DMSO : 1 mg/mL (2.83 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	O=P(O)(O)O.CN1[C@](CC2=CC=C(C)C=C32)([H])[C@](CCCC4)([H])[C@]34CC1	https://www.medchemexpress.com/Dimemorfan_phosphate.html	Launched		910.0	D6	A17	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B2215	10.0	mM	17.0	DMSO	255.1987	17	A	pluskal_fda_drugs_5006_A17_id
2640	HY-107798	HYCPK40910	C08	HYCPK40910					910.0	C08	78247-49-1	Potassium guaiacolsulfonate (hemihydrate)		251.31	Bacterial	Anti-infection	Potassium guaiacolsulfonate hemihydrate is an orally active expectorant used for acute respiratory tract infections. Potassium guaiacolsulfonate hemihydrate helps loosen mucus and used for a cough caused by the common cold, infections or allergies in combination with other drugs[1][2].	Potassium	C7H8O5S.1/2H2O.K	64676.0	H2O : 62.5 mg/mL (248.70 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	COC1=CC(S(=O)(O[K])=O)=CC=C1O.COC2=C(C=CC=C2O)S(=O)(O[K])=O.[H]O[H]	https://www.medchemexpress.com/potassium-guaiacolsulfonate-hemihydrate.html	Launched		910.0	C8	A17	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-107798	10.0	mM	17.0	DMSO	204.009244	17	A	pluskal_fda_drugs_5006_A17_id
2672	HY-B2246	HYCPK40910	G10	HYCPK40910					910.0	G10	6645-46-1	L-Carnitine (hydrochloride)	(R)-Carnitine (hydrochloride); Levocarnitine (hydrochloride)	197.66	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Carnitine hydrochloride ((R)-Carnitine hydrochloride), a highly polar, small zwitterion, is an essential co-factor for the mitochondrial β-oxidation pathway. L-Carnitine hydrochloride functions to transport long chain fatty acyl-CoAs into the mitochondria for degradation by β-oxidation. L-Carnitine hydrochloride is an antioxidant. L-Carnitine hydrochloride can ameliorate metabolic imbalances in many inborn errors of metabolism[1][2][3].	Hydrochloride	C7H16ClNO3	58682.0	H2O : 250 mg/mL (1264.80 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease; Cancer	C[N+](C)(C)C[C@H](O)CC(O)=O.[Cl-]	https://www.medchemexpress.com/l-carnitine-hydrochloride-1.html	Launched		910.0	G10	A17	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B2246	10.0	mM	17.0	DMSO	162.11247	17	A	pluskal_fda_drugs_5006_A17_id
2693	HY-P0061A	HYCPK40910	L11	HYCPK40910					910.0	L11	849479-74-9	Vapreotide (acetate)	RC-160 acetate; BMY-41606 acetate	1191.39	Neurokinin Receptor	GPCR/G Protein; Neuronal Signaling	Vapreotide acetate (RC-160 acetate; BMY-41606 acetate) is a neurokinin-1 (NK1) receptor antagonist, with an IC50 of 330 nM.	Acetate	C57H70N12O9S2.xC2H4O2	30850.0	H2O : 14.29 mg/mL (11.99 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	OC(C)=O.[FCYWKVCW-NH2(Disulfide bridge: Cys2-Cys7)]	https://www.medchemexpress.com/Vapreotide__acetate_.html	Launched		910.0	L11	A17	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-P0061A	10.0	mM	17.0	DMSO	1130.483014	17	A	pluskal_fda_drugs_5006_A17_id
2694	HY-18206A	HYCPK40910	M11	HYCPK40910					910.0	M11	83915-83-7	Lisinopril (dihydrate)	MK-521 (dihydrate)	441.52	Angiotensin-converting Enzyme (ACE)	Metabolic Enzyme/Protease	Lisinopri dihydrate (MK-521 dihydrate) is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.	Free Acid	C21H35N3O7	16492.0	DMSO : 1 mg/mL (2.26 mM; Need ultrasonic); H2O : 33.33 mg/mL (75.49 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O=C(O)[C@H]1N(C([C@H](CCCCN)N[C@H](C(O)=O)CCC2=CC=CC=C2)=O)CCC1.O.O	https://www.medchemexpress.com/Lisinopril-dihydrate.html	Launched		910.0	M11	A17	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-18206A	10.0	mM	17.0	DMSO	405.226371	17	A	pluskal_fda_drugs_5006_A17_id
2325	HY-12651	HYCPK40910	E14	HYCPK40910					910.0	E14	63-45-6	Primaquine (diphosphate)	Primaquine (phosphate); Primaquine (bisphosphate)	455.34	Parasite	Anti-infection	Primaquine Diphosphate (Primaquine phosphate), an 8-aminoquinoline, exerts a broad spectrum of activities against various stages of parasitic malaria. Primaquine Diphosphate remains as the only agent that destroys late hepatic stages and latent tissue forms of Plasmodium vivax and Plasmodium ovale[1][2].	Phosphate	C15H27N3O9P2	29726.0	DMSO : 250 mg/mL (549.04 mM; Need ultrasonic); H2O : 25 mg/mL (54.90 mM; ultrasonic and warming and heat to 60°C)	Water Solution	10mM  * 100uL	Infection	CC(NC1=C2N=CC=CC2=CC(OC)=C1)CCCN.O=P(O)(O)O.O=P(O)(O)O	https://www.medchemexpress.com/Primaquine-Diphosphate.html	Launched		910.0	E14	A18	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-12651	10.0	mM	18.0	DMSO	259.168462	18	A	pluskal_fda_drugs_5006_A18_id
2590	HY-13749B	HYCPK40910	A05	HYCPK40910					910.0	A05	654671-77-9	Sitagliptin (phosphate monohydrate)	MK-0431 (phosphate monohydrate)	523.32	Autophagy; Dipeptidyl Peptidase	Autophagy; Metabolic Enzyme/Protease	Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP4 with an IC50 of 19 nM in Caco-2 cell extracts[1].	Phosphate	C16H20F6N5O6P	19523.0	H2O : ≥ 33 mg/mL (63.06 mM)	Water Solution	10mM  * 100uL	Metabolic Disease	[H]O[H].O=C(N1CC2=NN=C(C(F)(F)F)N2CC1)C[C@H](N)CC3=CC(F)=C(F)C=C3F.O=P(O)(O)O	https://www.medchemexpress.com/Sitagliptin-phosphate-monohydrate.html	Launched		910.0	A5	A18	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13749B	10.0	mM	18.0	DMSO	407.118079	18	A	pluskal_fda_drugs_5006_A18_id
2622	HY-B0236	HYCPK40910	A07	HYCPK40910					910.0	A07	60-32-2	6-Aminocaproic acid	EACA; Epsilon-Amino-n-caproic Acid; 6-Aminohexanoic acid	131.17	Others	Others	6-Aminocaproic acid (EACA), a monoamino carboxylic acid, is a potent and orally active inhibitor of plasmin and plasminogen. 6-Aminocaproic acid is a potent antifibrinolytic agent. 6-Aminocaproic acid prevents clot lysis through the competitive binding of lysine residues on plasminogen, inhibiting plasmin formation and reducing fibrinolysis. 6-Aminocaproic acid can be used for the research of bleeding disorders[1][2].	Free Acid	C6H13NO2	16721.0	H2O : ≥ 50 mg/mL (381.18 mM); DMSO : 1 mg/mL (7.62 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Metabolic Disease	O=C(O)CCCCCN	https://www.medchemexpress.com/6-aminocaproic-acid.html	Launched		910.0	A7	A18	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0236	10.0	mM	18.0	DMSO	131.094629	18	A	pluskal_fda_drugs_5006_A18_id
2695	HY-B2176A	HYCPK40910	N11	HYCPK40910					910.0	N11	51963-61-2	ATP (disodium trihydrate)	Adenosine-5'-triphosphate (disodium trihydrate)	605.19	Endogenous Metabolite	Metabolic Enzyme/Protease	ATP disodium trihydrate (Adenosine 5'-triphosphate disodium trihydrate) is a central component of energy storage and metabolism in vivo. ATP disodium trihydrate provides the metabolic energy to drive metabolic pumps and serves as a coenzyme in cells. ATP disodium trihydrate is an important endogenous signaling molecule in immunity and inflammation[1][2].	Sodium	C10H20N5Na2O16P3	86069.0	H2O : 250 mg/mL (413.09 mM; Need ultrasonic); DMSO : 1 mg/mL (1.65 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Metabolic Disease; Inflammation/Immunology; Cancer	O=P(O[Na])(O[Na])OP(OP(OC[C@H]1O[C@@H](N2C3=NC=NC(N)=C3N=C2)[C@H](O)[C@@H]1O)(O)=O)(O)=O.O.O.O	https://www.medchemexpress.com/atp-disodium-trihydrate.html	Launched		910.0	N11	A18	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B2176A	10.0	mM	18.0	DMSO	506.995745	18	A	pluskal_fda_drugs_5006_A18_id
2708	HY-A0089	HYCPK40910	K12	HYCPK40910					910.0	K12	1264-72-8	Colistin (sulfate)	Polymyxin E (sulfate)	1400.64	Antibiotic; Autophagy; Bacterial	Anti-infection; Autophagy	Colistin sulfate is a polypeptide antibiotic which inhibits gram-negative bacteria by binding to lipopolysaccharides and phospholipids in the outer cell membrane of gram-negative bacteria.	Sulfate	C52H98N16O13.2.5H2O4S	62961.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 50 mg/mL (35.70 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	CCC(C)CCCC(N[C@@H](CCN)C(N[C@H](C(N[C@H](C(N[C@@H](CCNC([C@H]([C@H](O)C)N1)=O)C(N[C@@H](CCN)C(N[C@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CCN)C(N[C@@H](CCN)C1=O)=O)=O)=O)=O)=O)=O)CCN)=O)[C@H](O)C)=O)=O.O=S(O)(O)=O.[2.5]	https://www.medchemexpress.com/Colistin-sulfate.html	Launched		910.0	K12	A18	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0089	10.0	mM	18.0	DMSO	1154.749927	18	A	pluskal_fda_drugs_5006_A18_id
2726	HY-B1016	HYCPK40910	M13	HYCPK40910					910.0	M13	15421-84-8	Trapidil	AR-12008	205.26	PDGFR	Protein Tyrosine Kinase/RTK	Trapidil is a vasodilator, is an antiplatelet drug with specific platelet-derived growth factor.	Free Base	C10H15N5	22656.0	H2O : ≥ 105 mg/mL (511.55 mM); DMSO : 100 mg/mL (487.19 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	CC1=NC2=NC=NN2C(N(CC)CC)=C1	https://www.medchemexpress.com/Trapidil.html	Launched		910.0	M13	A18	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1016	10.0	mM	18.0	DMSO	205.132745	18	A	pluskal_fda_drugs_5006_A18_id
2734	HY-B0399	HYCPK40910	N14	HYCPK40910					910.0	N14	541-15-1	L-Carnitine	(R)-Carnitine; Levocarnitine	161.20	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Carnitine ((R)-Carnitine), a highly polar, small zwitterion, is an essential co-factor for the mitochondrial β-oxidation pathway. L-Carnitine functions to transport long chain fatty acyl-CoAs into the mitochondria for degradation by β-oxidation. L-Carnitine is an antioxidant. L-Carnitine hydrochloride can ameliorate metabolic imbalances in many inborn errors of metabolism[1][2][3].	Free Base	C7H15NO3	16619.0	H2O : ≥ 50 mg/mL (310.17 mM)	Water Solution	10mM  * 100uL	Neurological Disease; Cancer	C[N+](C)(C)C[C@H](O)CC([O-])=O	https://www.medchemexpress.com/l-carnitine.html	Launched		910.0	N14	A18	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0399	10.0	mM	18.0	DMSO	162.11247	18	A	pluskal_fda_drugs_5006_A18_id
2745	HY-B1370	HYCPK40910	I15	HYCPK40910					910.0	I15	747-36-4	Hydroxychloroquine (sulfate)	HCQ (sulfate)	433.95	Autophagy; Parasite; SARS-CoV; Toll-like Receptor (TLR)	Anti-infection; Autophagy; Immunology/Inflammation	Hydroxychloroquine sulfate (HCQ sulfate) is a synthetic antimalarial agent which can also inhibit Toll-like receptor 7/9 (TLR7/9) signaling. Hydroxychloroquine sulfate is efficiently inhibits SARS-CoV-2 infection in vitro[1][2][3].	Sulfate	C18H28ClN3O5S	62136.0	H2O : 110 mg/mL (253.49 mM; Need ultrasonic and warming); DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble); DMF : 1.4 mg/mL (3.23 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Infection	CCN(CCO)CCCC(NC1=CC=NC2=CC(Cl)=CC=C12)C.O=S(O)(O)=O	https://www.medchemexpress.com/Hydroxychloroquine_sulfate.html	Launched		910.0	I15	A18	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1370	10.0	mM	18.0	DMSO	335.17644	18	A	pluskal_fda_drugs_5006_A18_id
2322	HY-N7097	HYCPK40910	B14	HYCPK40910					910.0	B14	28002-18-8	Sulbenicillin (disodium)		458.42	Antibiotic; Bacterial	Anti-infection	Sulbenicillin disodium is the disodium salt of Sulbenicillin. Sulbenicillin is a Penicillin antibiotic with antibacterial activity against a number of mucoid and non-mucoid strains of Pseudomonas aeruginosa[1].	Sodium	C16H16N2Na2O7S2	107212.0	H2O : 250 mg/mL (545.35 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(C(C3=CC=CC=C3)S(=O)(O[Na])=O)=O)N1C2=O)O[Na]	https://www.medchemexpress.com/sulbenicillin-disodium.html	Launched		910.0	B14	A19	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N7097	10.0	mM	19.0	DMSO	414.055543	19	A	pluskal_fda_drugs_5006_A19_id
2577	HY-N0486	HYCPK40910	D04	HYCPK40910					910.0	D04	61-90-5	L-Leucine		131.17	Endogenous Metabolite; mTOR	Metabolic Enzyme/Protease; PI3K/Akt/mTOR	L-Leucine is an essential branched-chain amino acid (BCAA), which activates the mTOR signaling pathway[1].	Free Acid	C6H13NO2	39087.0	H2O : 8.33 mg/mL (63.51 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	N[C@@H](CC(C)C)C(O)=O	https://www.medchemexpress.com/L-Leucine.html	Launched		910.0	D4	A19	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0486	10.0	mM	19.0	DMSO	131.094629	19	A	pluskal_fda_drugs_5006_A19_id
2578	HY-14879B	HYCPK40910	E04	HYCPK40910					910.0	E04		Avibactam (sodium hydrate)	NXL-104 (hydrate)	305.24	Antibiotic; Bacterial	Anti-infection	Avibactam sodium (NXL-104) hydrate is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively[1].	Sodium	C7H12N3NaO7S	18017.0	H2O : ≥ 200 mg/mL (655.22 mM)	Water Solution	10mM  * 100uL	Infection	O=S(ON1[C@]2([H])CC[C@@H](C(N)=O)[N@@](C2)C1=O)(O[Na])=O.O	https://www.medchemexpress.com/Avibactam-sodium-hydrate.html	Launched		910.0	E4	A19	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14879B	10.0	mM	19.0	DMSO	265.036856	19	A	pluskal_fda_drugs_5006_A19_id
2592	HY-N6655	HYCPK40910	C05	HYCPK40910					910.0	C05	3493-12-7	DL-Methionine methylsulfonium (chloride)		199.70	Others	Others	DL-methionine methylsulfonium chloride is a naturally occurring methionine derivative. DL-methionine methylsulfonium chloride protects gastric mucosal from ethanol-induced damage[1].	Chloride	C6H14ClNO2S	64131.0	H2O : 250 mg/mL (1251.88 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology	C[S+](CCC(N)C(O)=O)C.[Cl-]	https://www.medchemexpress.com/dl-methionine-methylsulfonium-chloride.html	Launched		910.0	C5	A19	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N6655	10.0	mM	19.0	DMSO	164.073976	19	A	pluskal_fda_drugs_5006_A19_id
2636	HY-B0597	HYCPK40910	O07	HYCPK40910					910.0	O07	114870-03-0	Fondaparinux (sodium)	Fondaparin sodium; SR-90107A	1728.08	Factor Xa	Metabolic Enzyme/Protease	Fondaparinux sodium is an antithrombin-dependent factor Xa inhibitor.	Sodium	C31H43N3Na10O49S8	111746.0	H2O : 125 mg/mL (72.33 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O[C@H]([C@@H](O)[C@@H]1O[C@](O[C@H](COS(=O)(O[Na])=O)[C@@H](O)[C@@H]2O)([H])[C@@H]2NS(=O)(O[Na])=O)[C@](O[C@@H]1C(O[Na])=O)([H])O[C@H]([C@H](O[C@@H]3O[C@]([C@@H]4O)([H])[C@@H](O[C@@H](O[C@]([C@@H]5O)([H])[C@H](O[C@H](OC)[C@@H]5NS(=O)(O[Na])=O)COS(=O)(O[Na	https://www.medchemexpress.com/Fondaparinux-sodium.html	Launched		910.0	O7	A19	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0597	10.0	mM	19.0	DMSO	1506.951333	19	A	pluskal_fda_drugs_5006_A19_id
2650	HY-B0481	HYCPK40910	A09	HYCPK40910					910.0	A09	72432-03-2	Miglitol	BAY1099; BAY-m1099	207.22	Others	Others	"Miglitol is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to breakdown complex carbohydrates into glucose.
Target: Others
Miglitol is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to breakdown complex carbohydrates into glucose. It is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body. Miglitol inhibits glycoside hydrolase enzymes called alpha-glucosidases. Since miglitol works by preventing digestion of carbohydrates, it lowers the degree of postprandial hyperglycemia. It must be taken at the start of main meals to have maximal effect. Its effect will depend on the amount of non-monosaccharide carbohydrates in a person's diet. Dietary supplementation with miglitol from pre-onset stage in OLETF rats delays the onset and development of diabetes and preserves the insulin secretory function of pancreatic islets [1]. Miglitol was orally administered at 40 mg/100 g of high-fat diet containing 45% kcal as fat to 12-week-old rats for 29 days, and age-matched rats without the agent were used as the respective controls [2]."	Free Base	C8H17NO5	16118.0	H2O : ≥ 200 mg/mL (965.16 mM)	Water Solution	10mM  * 100uL	Metabolic Disease	O[C@@H]1[C@@H](CO)N(CCO)C[C@H](O)[C@H]1O	https://www.medchemexpress.com/Miglitol.html	Launched		910.0	A9	A19	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0481	10.0	mM	19.0	DMSO	207.110673	19	A	pluskal_fda_drugs_5006_A19_id
2653	HY-13627	HYCPK40910	D09	HYCPK40910					910.0	D09	52205-73-9	Estramustine (phosphate sodium)		564.35	Apoptosis; Microtubule/Tubulin	Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton	Estramustine phosphate sodium, an estradiol analog, is an orally active antimicrotubule chemotherapy agent. Estramustine phosphate sodium depolymerises microtubules by binding to microtubule associated proteins (MAPs) and/or to tubulin. Estramustine phosphate sodium can interfere mitosis, trigger cell death and induce apoptosis, which can be used for the research of cancer like prostate cancer[1][2][3].	Sodium	C23H30Cl2NNa2O6P	45444.0	DMSO : 5 mg/mL (8.86 mM; Need ultrasonic); H2O : 62.5 mg/mL (110.75 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Endocrinology; Inflammation/Immunology	O=C(N(CCCl)CCCl)OC1=CC2=C(C=C1)[C@@]3([H])CC[C@@]4(C)[C@](CC[C@@H]4OP(O[Na])(O[Na])=O)([H])[C@]3([H])CC2	https://www.medchemexpress.com/Estramustine-phosphate-sodium.html	Launched		910.0	D9	A19	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13627	10.0	mM	19.0	DMSO	519.13443	19	A	pluskal_fda_drugs_5006_A19_id
2718	HY-B0979	HYCPK40910	E13	HYCPK40910					910.0	E13	134-63-4	Lobeline (hydrochloride)	α-Lobeline (hydrochloride); L-Lobeline (hydrochloride)	373.92	nAChR	Membrane Transporter/Ion Channel; Neuronal Signaling	Lobeline hydrochloride, a nicotinic receptor agonist, acting as a potent antagonist at both α3β2 and α4β2 neuronal nicotinic receptor subtypes.	Hydrochloride	C22H28ClNO2	60765.0	H2O : 6 mg/mL (16.05 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	CN1[C@@H](CC(C2=CC=CC=C2)=O)CCC[C@H]1C[C@H](O)C3=CC=CC=C3.[H]Cl	https://www.medchemexpress.com/Lobeline-hydrochloride.html	Launched		910.0	E13	A19	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0979	10.0	mM	19.0	DMSO	337.204179	19	A	pluskal_fda_drugs_5006_A19_id
70	HY-16168A	HYCPK40900	H03	HYCPK40910					910.0	H17	214766-78-6	Degarelix		1632.26	Apoptosis; GnRH Receptor	Apoptosis; GPCR/G Protein	Degarelix is a competitive and reversible gonadotropin-releasing hormone receptor (GnRHR/LHRHR) antagonist. Degarelix can be used for prostate cancer research[1].	Free Base	C82H103ClN18O16	90806.0	H2O : 5 mg/mL (3.06 mM; ultrasonic and warming and heat to 60°C); DMSO : 10 mg/mL (6.13 mM; Need ultrasonic)	Water Solution	2mM  * 100uL	Cancer; Endocrinology	C[C@H](C(N)=O)NC([C@H]1N(C([C@H](CCCCNC(C)C)NC([C@H](CC(C)C)NC([C@@H](CC2=CC=C(NC(N)=O)C=C2)NC([C@H](CC3=CC=C(NC([C@H](CC(N4)=O)NC4=O)=O)C=C3)NC([C@H](CO)NC([C@@H](CC5=CC=CN=C5)NC([C@@H](CC6=CC=C(Cl)C=C6)NC([C@@H](CC7=CC=C8C=CC=CC8=C7)NC(C)=O)=O)=O)=O)=O)	https://www.medchemexpress.com/Degarelix.html	Launched		910.0	H17	A20	350.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-16168A	2.0	mM	20.0	DMSO	1630.748797	20	A	pluskal_fda_drugs_5006_A20_id
2315	HY-14656	HYCPK40910	N08	HYCPK40910					910.0	N08	33286-22-5	Diltiazem (hydrochloride)	CRD-401	450.98	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Diltiazem hydrochloride is a Ca2+ influx inhibitor (slow channel blocker or calcium antagonist).	Hydrochloride	C22H27ClN2O4S	13070.0	H2O : 33.33 mg/mL (73.91 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	CN(C)CCN1C2=CC=CC=C2S[C@@H](C3=CC=C(OC)C=C3)[C@@H](OC(C)=O)C1=O.Cl	https://www.medchemexpress.com/diltiazem-hydrochloride.html	Launched		910.0	N8	A20	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14656	10.0	mM	20.0	DMSO	414.161328	20	A	pluskal_fda_drugs_5006_A20_id
2620	HY-12650	HYCPK40910	O06	HYCPK40910					910.0	O06	1138245-13-2	Mirogabalin	DS5565	209.28	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Mirogabalin (DS-5565) is a novel, preferentially selective α2δ-1 ligand characterized by high potency and selectivity to the α2δ-1 subunit of voltage-sensitive calcium channel complexes in the CNS.	Free Acid	C12H19NO2	24838.0	H2O : 7.71 mg/mL (36.84 mM; Need ultrasonic); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Neurological Disease	O=C(O)C[C@]1(CN)[C@]2([H])C=C(CC)C[C@]2([H])C1	https://www.medchemexpress.com/Mirogabalin.html	Launched		910.0	O6	A20	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-12650	10.0	mM	20.0	DMSO	209.141579	20	A	pluskal_fda_drugs_5006_A20_id
2643	HY-B2170A	HYCPK40910	F08	HYCPK40910					910.0	F08	70775-75-6	Octenidine (dihydrochloride)		623.83	Bacterial	Anti-infection	Octenidine dihydrochloride is an effective antiseptic compound for skin mucous membranes and wounds.	Hydrochloride	C36H64Cl2N4	59880.0	H2O : 33.33 mg/mL (53.43 mM; Need ultrasonic); DMSO : 5 mg/mL (8.02 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	CCCCCCCC/N=C1C=CN(CCCCCCCCCCN(C=C/2)C=CC2=N/CCCCCCCC)C=C/1.Cl.Cl	https://www.medchemexpress.com/Octenidine-dihydrochloride.html	Launched		910.0	F8	A20	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B2170A	10.0	mM	20.0	DMSO	550.497448	20	A	pluskal_fda_drugs_5006_A20_id
2644	HY-N0771	HYCPK40910	G08	HYCPK40910					910.0	G08	73-32-5	L-Isoleucine		131.17	Endogenous Metabolite	Metabolic Enzyme/Protease	L-isoleucine is a nonpolar hydrophobic amino acid[1]. L-Isoleucine is an essential amino acid.	Free Acid	C6H13NO2	27512.0	H2O : 25 mg/mL (190.59 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	N[C@@H]([C@@H](C)CC)C(O)=O	https://www.medchemexpress.com/L-Isoleucine.html	Launched		910.0	G8	A20	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0771	10.0	mM	20.0	DMSO	131.094629	20	A	pluskal_fda_drugs_5006_A20_id
2655	HY-128742	HYCPK40910	F09	HYCPK40910					910.0	F09	273724-21-3	Thiamine monophosphate (chloride) (dihydrate)		416.82	Endogenous Metabolite	Metabolic Enzyme/Protease	Thiamine monophosphate chloride (dihydrate) is an endogenous metabolite.	Chloride	C12H22ClN4O6PS	114367.0	H2O : 125 mg/mL (299.89 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	O=P(OCCC1=C(C)[N+](CC2=CN=C(C)N=C2N)=CS1)(O)O.[Cl-].[2H2O]	https://www.medchemexpress.com/thiamine-monophosphate-chloride-dihydrate.html	Launched		910.0	F9	A20	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-128742	10.0	mM	20.0	DMSO	345.078089	20	A	pluskal_fda_drugs_5006_A20_id
2683	HY-A0100	HYCPK40910	B11	HYCPK40910					910.0	B11	59-43-8	Thiamine monochloride	Vitamin B1	300.81	Bacterial; Endogenous Metabolite	Anti-infection; Metabolic Enzyme/Protease	Thiamine monochloride (Vitamin B1) is an essential vitamin that plays an important role in cellular production of energy from ingested food and enhances normal neuronal actives.	Chloride	C12H17ClN4OS	26453.0	DMSO : 1 mg/mL (3.32 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (332.44 mM)	Water Solution	10mM  * 100uL	Metabolic Disease; Neurological Disease	CC1=C(CCO)SC=[N+]1CC2=CN=C(C)N=C2N.[Cl-]	https://www.medchemexpress.com/Thiamine_monochloride.html	Launched		910.0	B11	A20	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0100	10.0	mM	20.0	DMSO	265.111759	20	A	pluskal_fda_drugs_5006_A20_id
2727	HY-N0215	HYCPK40910	G14	HYCPK40910					910.0	G14	63-91-2	L-Phenylalanine	(S)-2-Amino-3-phenylpropionic acid	165.19	Calcium Channel; Endogenous Metabolite; iGluR	Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling	L-Phenylalanine ((S)-2-Amino-3-phenylpropionic acid) is an essential amino acid isolated from Escherichia coli. L-Phenylalanine is a α2δ subunit of voltage-dependent Ca+ channels antagonist with a Ki of 980 nM. L-phenylalanine is a competitive antagonist for the glycine- and glutamate-binding sites of N-methyl-D-aspartate receptors (NMDARs) (KB of 573 μM ) and non-NMDARs, respectively. L-Phenylalanine is widely used in the production of food flavors and pharmaceuticals[1][2][3][4].	Free Acid	C9H11NO2	16033.0	H2O : 6.67 mg/mL (40.38 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	N[C@@H](CC1=CC=CC=C1)C(O)=O	https://www.medchemexpress.com/L-Phenylalanine.html	Launched		910.0	G14	A20	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0215	10.0	mM	20.0	DMSO	165.078979	20	A	pluskal_fda_drugs_5006_A20_id
17	HY-A0214	HYCPK40898	B03	HYCPK40910					910.0	B19	8068-28-8	Colistin methanesulfonate (sodium salt)			Antibiotic; Bacterial	Anti-infection	Colistin methanesulfonate sodium salt exhibits MIC values ranged from 4 to 16 mg/liter against susceptible strains (P. aeruginosa)[1].	Sodium		111974.0	H2O : 100 mg/mL (Need ultrasonic)	Water Solution	3mg/mL  * 100uL	Infection	[Colistin methanesulfonate (sodium salt)]	https://www.medchemexpress.com/colistin-methanesulfonate-sodium-salt.html	Launched		910.0	B19	A21	233.3333333	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0214	3.0	mM	21.0	DMSO	1638.627902	21	A	pluskal_fda_drugs_5006_A21_id
2321	HY-N0667	HYCPK40910	A14	HYCPK40910					910.0	A14	70-47-3	L-Asparagine	(-)-Asparagine; Asn; Asparamide	132.12	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Asparagine ((-)-Asparagine) is a non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue.	Free Acid	C4H8N2O3	34190.0	H2O : 6.67 mg/mL (50.48 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	N[C@H](C(O)=O)CC(N)=O	https://www.medchemexpress.com/L-Asparagine.html	Launched		910.0	A14	A21	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0667	10.0	mM	21.0	DMSO	132.053492	21	A	pluskal_fda_drugs_5006_A21_id
2567	HY-B1044	HYCPK40910	J03	HYCPK40910					910.0	J03	20098-14-0	Idramantone	Kemantane; 5-Hydroxy-2-adamantanone	166.22	Others	Others	Idramantone (Kemantane), an Adamantane derivative, is an immunostimulant[1].	Free Base	C10H14O2	17395.0	H2O : 20 mg/mL (120.32 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C1C(C2)CC3CC2(O)CC1C3	https://www.medchemexpress.com/Idramantone.html	Launched		910.0	J3	A21	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1044	10.0	mM	21.0	DMSO	166.09938	21	A	pluskal_fda_drugs_5006_A21_id
2593	HY-14818	HYCPK40910	D05	HYCPK40910					910.0	D05	203120-17-6	Laninamivir	R 125489	346.34	Influenza Virus	Anti-infection	Laninamivir (R 125489) is a potent influenza neuraminidase (NA) inhibitor with IC50s of 0.90 nM, 1.83 nM and 3.12 nM for avian H12N5 NA (N5), pH1N1 N1 NA (p09N1) and A/RI/5+/1957 H2N2 N2 (p57N2), respectively[1].	Free Acid	C13H22N4O7	89483.0	H2O : 5 mg/mL (14.44 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	OC[C@@H](O)[C@H]([C@@]1([H])[C@@H]([C@H](C=C(C(O)=O)O1)NC(N)=N)NC(C)=O)OC	https://www.medchemexpress.com/laninamivir.html	Launched		910.0	D5	A21	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14818	10.0	mM	21.0	DMSO	346.148849	21	A	pluskal_fda_drugs_5006_A21_id
2604	HY-119443	HYCPK40910	O05	HYCPK40910					910.0	O05	79778-41-9	Neridronate		277.15	Others	Others	Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfecta (OI) and Paget’s disease of bone (PDB). Neridronate is effective also in other skeletal diseases such as osteoporosis, algodystrophy, hypercalcemia of malignancy, and bone metastases[1][2].	Free Acid	C6H17NO7P2	145058.0	H2O : 5 mg/mL (18.04 mM; ultrasonic and warming and adjust pH to 8 with NaOH and heat to 60°C)	Water Solution	10mM  * 100uL	Cancer	OC(P(O)(O)=O)(CCCCCN)P(O)(O)=O	https://www.medchemexpress.com/neridronate.html	Launched		910.0	O5	A21	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-119443	10.0	mM	21.0	DMSO	277.048025	21	A	pluskal_fda_drugs_5006_A21_id
2674	HY-17355	HYCPK40910	I10	HYCPK40910					910.0	I10	104632-25-9	Pramipexole (dihydrochloride)		284.25	Dopamine Receptor	GPCR/G Protein; Neuronal Signaling	Pramipexole dihydrochloride is a selective and blood-brain barrier (BBB) penetrant dopamine D2-type receptor agonist, with Kis of 2.2 nM, 3.9 nM, 0.5 nM and 1.3 nM for D2-type receptor, D2, D3 and D4 receptors, respectively. Pramipexole dihydrochloride can be used for the research of Parkinson's disease (PD) and restless legs syndrome (RLS)[1][2][3].	Hydrochloride	C10H19Cl2N3S	11904.0	H2O : ≥ 50 mg/mL (175.90 mM)	Water Solution	10mM  * 100uL	Neurological Disease	NC(S1)=NC2=C1C[C@@H](NCCC)CC2.[H]Cl.[H]Cl	https://www.medchemexpress.com/pramipexole-dihydrochloride.html	Launched		910.0	I10	A21	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17355	10.0	mM	21.0	DMSO	211.114319	21	A	pluskal_fda_drugs_5006_A21_id
2714	HY-14865B	HYCPK40910	A13	HYCPK40910					910.0	A13	1075240-43-5	Omadacycline (tosylate)	PTK 0796 (tosylate); Amadacycline (tosylate)	728.85	Antibiotic; Bacterial	Anti-infection	Omadacycline (PTK 0796) tosylate, a first-in-class orally active aminomethylcycline antibacterial, is a member of the tetracycline class of antibiotics. Omadacycline tosylate acts through the inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit. Omadacycline tosylate possesses broad-spectrum antibacterial activity against aerobic and anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria. Omadacycline tosylate can be used for the research of acute bacterial skin and skin-structure infections, community-acquired pneumonia, and urinary tract infections[1][2][3][4].	Tosylate	C36H48N4O10S	94776.0	H2O : 12.5 mg/mL (17.15 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=C(C1=C(O)[C@@H](N(C)C)[C@@](C[C@@]2([H])C(C(C3=C(O)C(CNCC(C)(C)C)=CC(N(C)C)=C3C2)=O)=C4O)([H])[C@@]4(O)C1=O)N.OS(=O)(C5=CC=C(C)C=C5)=O	https://www.medchemexpress.com/omadacycline-tosylate.html	Launched		910.0	A13	A21	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14865B	10.0	mM	21.0	DMSO	556.2897	21	A	pluskal_fda_drugs_5006_A21_id
2722	HY-W040226	HYCPK40910	I13	HYCPK40910					910.0	I13	860-22-0	Indigo carmine	Indigotindisulfonate (sodium); C.I.Acid Blue 74	466.35	Others	Others	Indigo carmine is an efficient reagent for the determination of ozone by chemlluminescence (CL)[1].	Sodium	C16H8N2Na2O8S2	68422.0	H2O : 18.52 mg/mL (39.71 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	O=S(C1=CC2=C(N/C(C2=O)=C3NC4=C(C=C(S(=O)(O[Na])=O)C=C4)C\3=O)C=C1)(O[Na])=O	https://www.medchemexpress.com/indigo-carmine.html	Launched		910.0	I13	A21	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-W040226	10.0	mM	21.0	DMSO	421.987857	21	A	pluskal_fda_drugs_5006_A21_id
2583	HY-B1352	HYCPK40910	J04	HYCPK40910					910.0	J04	70-26-8	L-Ornithine	(S)-2,5-Diaminopentanoic acid	132.16	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Ornithine ((S)-2,5-Diaminopentanoic acid) is a non-proteinogenic amino acid, is mainly used in urea cycle removing excess nitrogen in vivo. L-Ornithine shows nephroprotective[1][2].	Free Acid	C5H12N2O2	17437.0	DMSO : 1.3 mg/mL (9.84 mM; Need ultrasonic); H2O : 50 mg/mL (378.33 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	N[C@@H](CCCN)C(O)=O	https://www.medchemexpress.com/L-Ornithine.html	Launched		910.0	J4	A22	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1352	10.0	mM	22.0	DMSO	132.089878	22	A	pluskal_fda_drugs_5006_A22_id
2629	HY-B0200	HYCPK40910	H07	HYCPK40910					910.0	H07	15686-71-2	Cephalexin	Cefalexin; Cephacillin	347.39	Antibiotic; Bacterial	Anti-infection	Cephalexin (Cefalexin) is a potent, orally active semisynthetic cephalosporin antibiotic with a broad antibacterial spectrum. Cephalexin has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria. Cephalexin targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall assembly. Cephalexin is used for the research of pneumonia, strep throat, and bacterial endocarditis, et al[1][2].	Free Acid	C16H17N3O4S	16063.0	H2O : 10 mg/mL (28.79 mM; Need ultrasonic and warming)	Water Solution	10mM  * 100uL	Infection; Cancer	O=C(C(N12)=C(C)CS[C@]2([H])[C@H](NC([C@H](N)C3=CC=CC=C3)=O)C1=O)O	https://www.medchemexpress.com/Cephalexin.html	Launched		910.0	H7	A22	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0200	10.0	mM	22.0	DMSO	347.093977	22	A	pluskal_fda_drugs_5006_A22_id
2685	HY-14605	HYCPK40910	D11	HYCPK40910					910.0	D11	161735-79-1	Rasagiline (mesylate)	(R)-AGN1135 (mesylate); TVP1012 (mesylate)	267.34	Apoptosis; Autophagy; Monoamine Oxidase	Apoptosis; Autophagy; Neuronal Signaling	Rasagiline (R-AGN1135) mesylate is a highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor with IC50s of 4.43?nM and 412?nM for rat brain MAO B and A activity, respectively[1].	Mesylate	C13H17NO3S	63590.0	H2O : 25 mg/mL (93.51 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	CS(=O)(O)=O.C#CCN[C@H]1C2=CC=CC=C2CC1	https://www.medchemexpress.com/rasagiline-mesylate.html	Launched		910.0	D11	A22	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-14605	10.0	mM	22.0	DMSO	171.104799	22	A	pluskal_fda_drugs_5006_A22_id
2700	HY-B0079	HYCPK40910	C12	HYCPK40910					910.0	C12	343306-79-6	Sugammadex (sodium)	Org25969	2178.01	Others	Others	Sugammadex sodium is a synthetic γ-cyclodextrin derivative, and acts as a reversal agent for neuromuscular block. Sugammadex sodium shows nephroprotective effect in ischemia-reperfusion injury[1][2].	Sodium	C72H104Na8O48S8	22594.0	H2O : ≥ 34 mg/mL (15.61 mM)	Water Solution	10mM  * 100uL	Neurological Disease; Cardiovascular Disease; Cancer	O=C(O[Na])CCSC[C@@H]1OC(O[C@@H]2[C@H]([C@H](O)C(O[C@H]3[C@H](CSCCC(O[Na])=O)OC(O[C@H]4[C@H](CSCCC(O[Na])=O)OC5[C@@H](O)[C@@H]4O)[C@@H](O)[C@@H]3O)O[C@H]2CSCCC(O[Na])=O)O)[C@@H](O)[C@H](O)[C@H]1OC(O[C@@H](CSCCC(O[Na])=O)[C@H](OC6[C@@H](O)[C@H](O)[C@@H](OC7	https://www.medchemexpress.com/Sugammadex-sodium.html	Launched		910.0	C12	A22	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0079	10.0	mM	22.0	DMSO	2000.408873	22	A	pluskal_fda_drugs_5006_A22_id
2705	HY-17438	HYCPK40910	H12	HYCPK40910					910.0	H12	113852-37-2	Cidofovir	GS 0504; HPMPC; (S)-HPMPC	279.19	Apoptosis; CMV; DNA/RNA Synthesis; Endogenous Metabolite; Orthopoxvirus	Anti-infection; Apoptosis; Cell Cycle/DNA Damage; Metabolic Enzyme/Protease	Cidofovir (GS 0504) is an acyclic monophosphate nucleotide analogue and CMV inhibitor with antiviral activity. Cidofovir inhibits cytomegalovirus (CMV) replication by selectively inhibiting viral DNA polymerase. Cidofovir induces apoptosis and can be used in studies of AIDS cytomegalovirus retinitis, herpes, and cancer[1][3]. Cidofovir also has anti-orthopoxvirus and anti-variola activities[4].	Free Acid	C8H14N3O6P	10174.0	H2O : 3.33 mg/mL (11.93 mM; Need ultrasonic); DMSO : < 1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Infection; Cancer	OC[C@@H](OCP(O)(O)=O)CN1C=CC(N)=NC1=O	https://www.medchemexpress.com/Cidofovir.html	Launched		910.0	H12	A22	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17438	10.0	mM	22.0	DMSO	279.062022	22	A	pluskal_fda_drugs_5006_A22_id
2710	HY-B0988	HYCPK40910	M12	HYCPK40910					910.0	M12	138-14-7	Deferoxamine (mesylate)	Desferrioxamine B mesylate; DFOM	656.79	Akt; Apoptosis; Autophagy; HIF/HIF Prolyl-Hydroxylase; Reactive Oxygen Species	Apoptosis; Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR	Deferoxamine mesylate (Deferoxamine B mesylate) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine mesylate upregulates HIF-1α levels with good antioxidant activity. Deferoxamine mesylate also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells. Deferoxamine mesylate can be used in studies of diabetes, neurodegenerative diseases as well as anti-cancer and anti-COVID-19[1][2][3][4][5].	Mesylate	C26H52N6O11S	65070.0	H2O : 250 mg/mL (380.64 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Infection; Metabolic Disease; Inflammation/Immunology; Neurological Disease	O=C(N(CCCCCN)O)CCC(NCCCCCN(C(CCC(NCCCCCN(C(C)=O)O)=O)=O)O)=O.CS(=O)(O)=O	https://www.medchemexpress.com/Deferoxamine-mesylate.html	Launched		910.0	M12	A22	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0988	10.0	mM	22.0	DMSO	560.353362	22	A	pluskal_fda_drugs_5006_A22_id
2730	HY-113076	HYCPK40910	J14	HYCPK40910					910.0	J14	154-87-0	Thiamine pyrophosphate		460.77	Endogenous Metabolite	Metabolic Enzyme/Protease	Thiamine pyrophosphate is the coenzyme form of Vitamin B1 and is a required intermediate in the pyruvate dehydrogenase complex and the ketoglutarate dehydrogenase complex.	Chloride	C12H19ClN4O7P2S	46050.0	DMSO : < 1 mg/mL (insoluble or slightly soluble); H2O : 41.67 mg/mL (90.44 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	OP(OP(OCCC1=C(C)[N+](CC2=CN=C(C)N=C2N)=CS1)(O)=O)(O)=O.[Cl-]	https://www.medchemexpress.com/Thiamine_pyrophosphate.html	Launched		910.0	J14	A22	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-113076	10.0	mM	22.0	DMSO	425.04442	22	A	pluskal_fda_drugs_5006_A22_id
2740	HY-17354	HYCPK40910	D15	HYCPK40910					910.0	D15	69308-37-8	(R)-Baclofen	Arbaclofen; STX209	213.66	GABA Receptor	Membrane Transporter/Ion Channel; Neuronal Signaling	(R)-Baclofen (Arbaclofen) is a selective GABAB receptor agonist[1].	Free Acid	C10H12ClNO2	212673.0	H2O : 5 mg/mL (23.40 mM; Need ultrasonic); DMSO : 1 mg/mL (4.68 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Neurological Disease	ClC1=CC=C([C@](CC(O)=O)([H])CN)C=C1	https://www.medchemexpress.com/_R_-Baclofen.html	Launched		910.0	D15	A22	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17354	10.0	mM	22.0	DMSO	213.055656	22	A	pluskal_fda_drugs_5006_A22_id
2572	HY-P2273	HYCPK40910	O03	HYCPK40910					910.0	O03	21215-62-3	Calcitonin (human)		3417.87	CGRP Receptor	GPCR/G Protein; Neuronal Signaling	Calcitonin (human) is a hypocalcemic hormone. Calcitonin can lower blood calcium levels and inhibit bone resorption. Calcitonin can be used in hypercalcemia or osteoporosis research[1][2][3].		C151H226N40O45S3	97433.0	H2O	Water Solution	10mM  * 100uL	Metabolic Disease	[CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP-NH2 (Disulfide bridge:Cys1-Cys7)]	https://www.medchemexpress.com/calcitonin-human.html	Launched		910.0	O3	B3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-P2273	10.0	mM	27.0	DMSO	3415.578788	3	B	pluskal_fda_drugs_5006_B3_id
2573	HY-W017018	HYCPK40910	P03	HYCPK40910					910.0	P03	3184-13-2	L-Ornithine (hydrochloride)		168.62	Endogenous Metabolite	Metabolic Enzyme/Protease	L-Ornithine hydrochloride is a non-proteinogenic amino acid, is mainly used in urea cycle removing excess nitrogen in vivo. L-Ornithine hydrochloride shows nephroprotective[1][2].	Hydrochloride	C5H13ClN2O2	127420.0	DMSO : < 1 mg/mL (ultrasonic) (insoluble or slightly soluble); H2O : 50 mg/mL (296.52 mM; ultrasonic and warming and heat to 60°C)	Water Solution	10mM  * 100uL	Metabolic Disease	NCCC[C@@](N)([H])C(O)=O.Cl	https://www.medchemexpress.com/H-Orn-OH.HCl.html	Launched		910.0	P3	B3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-W017018	10.0	mM	27.0	DMSO	132.089878	3	B	pluskal_fda_drugs_5006_B3_id
2581	HY-N7138	HYCPK40910	H04	HYCPK40910					910.0	H04	6064-83-1	2-(Phosphonooxy)benzoic acid		218.10	Others	Others	2-(Phosphonooxy)benzoic acid is a non-acetylated salicylic acid derivative which has the potential for inflammatory disease as well as in analgesic therapy[1].		C7H7O6P	64651.0	H2O : 250 mg/mL (1146.26 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	O=C(O)C1=CC=CC=C1OP(O)(O)=O	https://www.medchemexpress.com/2-phosphonooxy-benzoic-acid.html	Launched		910.0	H4	B3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N7138	10.0	mM	27.0	DMSO	217.998025	3	B	pluskal_fda_drugs_5006_B3_id
2587	HY-16752	HYCPK40910	N04	HYCPK40910					910.0	N04	1174018-99-5	Relebactam	MK-7655	348.38	Bacterial	Anti-infection	Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases and KPC) and class C (AmpC) enzymes. Relebactam shows antibacterial activity[1].	Free Acid	C12H20N4O6S	114223.0	H2O : 50 mg/mL (143.52 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=S(ON1[C@]2([H])CC[C@@H](C(NC3CCNCC3)=O)[N@@](C2)C1=O)(O)=O	https://www.medchemexpress.com/Relebactam.html	Launched		910.0	N4	B3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-16752	10.0	mM	27.0	DMSO	348.110355	3	B	pluskal_fda_drugs_5006_B3_id
2612	HY-N7096	HYCPK40910	G06	HYCPK40910					910.0	G06	41136-22-5	Ceftezole (sodium)	CTZ (sodium)	462.46	Antibiotic; Bacterial	Anti-infection	Ceftezole sodium (CTZ sodium) is a broad-spectrum cephem antibiotic against many species of gram-positive and gram-negative bacteria. Ceftezole sodium (CTZ sodium) is an alpha-glucosidase inhibitor with in vivo anti-diabetic activity[1][2].	Sodium	C13H11N8NaO4S3	64642.0	H2O : 250 mg/mL (540.59 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=C(C(N12)=C(CSC3=NN=CS3)CS[C@]2([H])[C@H](NC(CN4N=NN=C4)=O)C1=O)O[Na]	https://www.medchemexpress.com/ceftezole-sodium.html	Launched		910.0	G6	B3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N7096	10.0	mM	27.0	DMSO	440.014364	3	B	pluskal_fda_drugs_5006_B3_id
2619	HY-A0057A	HYCPK40910	N06	HYCPK40910					910.0	N06	60142-95-2	Gabapentin (hydrochloride)		207.70	Calcium Channel	Membrane Transporter/Ion Channel; Neuronal Signaling	Gabapentin hydrochloride is a potent, orally active P/Q type Ca2+ channel blocker. Gabapentin hydrochloride inhibits neuronal Ca2+ influx and reduction of neurotransmitter release. Gabapentin hydrochloride is a GABA analog that can be used to relieve neuropathic pain[1][2][3].	Hydrochloride	C9H18ClNO2	9484.0	H2O : 50 mg/mL (240.73 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease; Cancer	O=C(O)CC1(CN)CCCCC1.[H]Cl	https://www.medchemexpress.com/Gabapentin-hydrochloride.html	Launched		910.0	N6	B3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-A0057A	10.0	mM	27.0	DMSO	171.125929	3	B	pluskal_fda_drugs_5006_B3_id
2707	HY-B2165	HYCPK40910	J12	HYCPK40910					910.0	J12	81919-14-4	Bendazac L-Lysine		428.48	Others	Others	Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention.	L-lysine	C22H28N4O5	27114.0	H2O : 25 mg/mL (58.35 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	O=C(O)COC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3.N[C@@H](CCCCN)C(O)=O	https://www.medchemexpress.com/Bendazac_L-Lysine.html	Launched		910.0	J12	B3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B2165	10.0	mM	27.0	DMSO	282.100442	3	B	pluskal_fda_drugs_5006_B3_id
2733	HY-B0382	HYCPK40910	M14	HYCPK40910					910.0	M14	88889-14-9	Fosinopril (sodium)	SQ28555	585.64	Angiotensin-converting Enzyme (ACE); Apoptosis	Apoptosis; Metabolic Enzyme/Protease	Fosinopril Sodium is the ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor, used for the treatment of hypertension and some types of chronic heart failure.	Sodium	C30H45NNaO7P	13287.0	H2O : 33.33 mg/mL (56.91 mM; Need ultrasonic); DMSO : 1.43 mg/mL (2.44 mM; Need ultrasonic); Ethanol : 16.67 mg/mL (28.46 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cardiovascular Disease	O=C(O[Na])[C@H]1N(C(C[P@@](CCCCC2=CC=CC=C2)(O[C@H](OC(CC)=O)C(C)C)=O)=O)C[C@H](C3CCCCC3)C1	https://www.medchemexpress.com/Fosinopril-sodium.html	Launched		910.0	M14	B3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0382	10.0	mM	27.0	DMSO	563.301189	3	B	pluskal_fda_drugs_5006_B3_id
21	HY-17567C	HYCPK40898	F03	HYCPK40910					910.0	F19	9041-08-1	Heparin (sodium salt) (MW 15kDa)	Sodium heparin (MW 15kDa); Sodium heparinate (MW 15kDa)	15000(Average)	Autophagy; Factor Xa; Thrombin	Autophagy; Metabolic Enzyme/Protease	Heparin sodium salt (MW 15kDa) (Sodium heparin (MW 15kDa)) is a polymer of Heparin with the molecular weight of 15kDa. Heparin sodium salt is an anticoagulant which binds reversibly to antithrombin III (ATIII) and greatly accelerates the rate at which ATIII inactivates coagulation enzymes thrombin factor IIa and factor Xa[1].	Sodium	(C14H25NO20S3)n.xNa	61423.0	DMSO : < 1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble or slightly soluble); H2O : 20 mg/mL (Need ultrasonic)	Water Solution	3mg/mL  * 100uL	Cardiovascular Disease	O[C@H]1[C@H](O[C@H]2[C@H](OS(O)(=O)=O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O2)[C@@H](COS(O)(=O)=O)O[C@H](OC)[C@@H]1NS(O)(=O)=O.[n].[.xNa].[MW 15kDa]	https://www.medchemexpress.com/heparin-sodium-salt-mw-15kda.html	Launched		910.0	F19	B4	233.3333333	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17567C	3.0	mM	28.0	DMSO	219.158292	4	B	pluskal_fda_drugs_5006_B4_id
2560	HY-N0666B	HYCPK40910	C03	HYCPK40910					910.0	C03	10389-09-0	Aspartic acid (calcium)	Calcium L-aspartate	171.16	Endogenous Metabolite	Metabolic Enzyme/Protease	Aspartic acid calcium (Calcium L-aspartate) is a chelate where calcium is attached to an amino acid naming L-Aspartic acid. L-Aspartic acid is an amino acid and serves as a building block for proteins in the body.	Calcium	C4H5CaNO4	26117.0	H2O : ≥ 100 mg/mL (584.25 mM)	Water Solution	10mM  * 100uL	Cardiovascular Disease	N[C@@H](CC([O-])=O)C([O-])=O.[Ca+2]	https://www.medchemexpress.com/Aspartic_acid_calcium.html	Launched		910.0	C3	B4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0666B	10.0	mM	28.0	DMSO	133.037508	4	B	pluskal_fda_drugs_5006_B4_id
2582	HY-B0472	HYCPK40910	I04	HYCPK40910					910.0	I04	3810-74-0	Streptomycin (sulfate)		728.69	Antibiotic; Bacterial	Anti-infection	Streptomycin sulfate is an aminoglycoside antibiotic, that inhibits protein synthesis.	Sulfate	C21H42N7O18S1.5	22472.0	H2O : ≥ 100 mg/mL (137.23 mM); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Infection	O[C@@]1(C=O)[C@H]([C@@H](O[C@H]1C)O[C@]([C@@H]([C@@H](O)[C@@H]2NC(N)=N)O)([H])[C@H]([C@@H]2O)NC(N)=N)O[C@@](O[C@@H](CO)[C@H](O)[C@H]3O)([H])[C@H]3NC.[1.5H2SO4]	https://www.medchemexpress.com/Streptomycin-sulfate.html	Launched		910.0	I4	B4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0472	10.0	mM	28.0	DMSO	581.26567	4	B	pluskal_fda_drugs_5006_B4_id
2594	HY-P0059	HYCPK40910	E05	HYCPK40910					910.0	E05	52232-67-4	Teriparatide	Human parathyroid hormone-(1-34); hPTH (1-34)	4117.72	Others	Others	Teriparatide (Human parathyroid hormone-(1-34)) is a PHT agonist. Teriparatide (Human parathyroid hormone-(1-34))  can be used for osteoporosis research[1].	Free Acid	C181H291N55O51S2	154973.0	H2O : 100 mg/mL (24.29 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	[SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF]	https://www.medchemexpress.com/Teriparatide.html	Launched		910.0	E5	B4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-P0059	10.0	mM	28.0	DMSO	4115.130942	4	B	pluskal_fda_drugs_5006_B4_id
2614	HY-N1446B	HYCPK40910	I06	HYCPK40910					910.0	I06	143-19-1	Sodium oleate	Oleic acid (sodium); 9-cis-Octadecenoic acid (sodium); 9Z-Octadecenoic acid (sodium)	304.44	Apoptosis; Na+/K+ ATPase	Apoptosis; Membrane Transporter/Ion Channel	Sodium oleate (Oleic acid sodium) is an abundant monounsaturated fatty acid sodium[1]. Sodium oleate is a Na+/K+ ATPase activator[2].	Sodium	C18H33NaO2	96463.0	DMSO : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble or slightly soluble); H2O : 25 mg/mL (82.12 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer; Metabolic Disease	CCCCCCCC/C=C\CCCCCCCC(O[Na])=O	https://www.medchemexpress.com/sodium-oleate.html	Launched		910.0	I6	B4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N1446B	10.0	mM	28.0	DMSO	282.25588	4	B	pluskal_fda_drugs_5006_B4_id
2621	HY-B0522	HYCPK40910	P06	HYCPK40910					910.0	P06	69-53-4	Ampicillin	D-(-)-α-Aminobenzylpenicillin	349.40476	Antibiotic; Bacterial	Anti-infection	Ampicillin is a broad-spectrum beta-lactam antibiotic against a variety of gram-positive and gram-negative bacteria.	Free Acid	C16H19N3O4S	100807.0	H2O : 5 mg/mL (14.31 mM; ultrasonic and warming and heat to 60°C); 0.1 M NaOH : 25 mg/mL (71.55 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	OC([C@@H]1N(C2=O)[C@]([C@@H]2NC([C@@H](C3=CC=CC=C3)N)=O)([H])SC1(C)C)=O	https://www.medchemexpress.com/Ampicillin.html	Launched		910.0	P6	B4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0522	10.0	mM	28.0	DMSO	349.109627	4	B	pluskal_fda_drugs_5006_B4_id
2632	HY-N0455	HYCPK40910	K07	HYCPK40910					910.0	K07	74-79-3	L-Arginine	(S)-(+)-Arginine	174.20	Endogenous Metabolite; NO Synthase	Immunology/Inflammation; Metabolic Enzyme/Protease	L-Arginine ((S)-(+)-Arginine) is the substrate for the endothelial nitric oxide synthase (eNOS) to generate NO. L-Arginine is transported into vascular smooth muscle cells by the cationic amino acid transporter family of proteins where it is metabolized to nitric oxide (NO), polyamines, or L-proline[1][2].	Free Acid	C6H14N4O2	38768.0	H2O : 50 mg/mL (287.03 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	N[C@@H](CCCNC(N)=N)C(O)=O	https://www.medchemexpress.com/l-arginine.html	Launched		910.0	K7	B4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0455	10.0	mM	28.0	DMSO	174.111676	4	B	pluskal_fda_drugs_5006_B4_id
2648	HY-B0645	HYCPK40910	K08	HYCPK40910					910.0	K08	125-02-0	Prednisolone (disodium phosphate)	Prednisolone 21-phosphate disodium	484.39	Glucocorticoid Receptor	Immunology/Inflammation	"Prednisolone disodium phosphate is a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.
Target: Glucocorticoid Receptor
Prednisolone irreversibly binds with glucocorticoid receptors (GR) alpha and beta for which they have a high affinity. Prednisolone can activate and influence biochemical behaviour of most cells. The steroid/receptor complexes dimerise and interact with cellular DNA in the nucleus, binding to steroid-response elements and modifying gene transcription. They induce synthesis of some proteins, and inhibit synthesis of others. Prednisolone exerted a delayed biphasic effect on the resistant CCRF-CEM leukemic cell line, necrotic at low doses and apoptotic at higher doses. At low doses, prednisolone exerted a pre-dominant mitogenic effect despite its induction on total cell death, while at higher doses, prednisolone's mitogenic and cell death effects were counterbalanced [1, 2]."	Sodium	C21H27Na2O8P	28556.0	H2O : 50 mg/mL (103.22 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	C[C@@]1([C@@]2(O)C(COP(O[Na])(O[Na])=O)=O)[C@](CC2)([H])[C@@](CCC3=CC4=O)([H])[C@]([C@]3(C=C4)C)([H])[C@@H](O)C1	https://www.medchemexpress.com/prednisolone-disodium-phosphate.html	Launched		910.0	K8	B4	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0645	10.0	mM	28.0	DMSO	440.160005	4	B	pluskal_fda_drugs_5006_B4_id
22	HY-B2106	HYCPK40898	G03	HYCPK40910					910.0	G19	9002-92-0	Polidocanol	Polyoxyethylene lauryl ether; Polyoxyethyleneglycol Dodecyl Ether		Others	Others	Polidocanol is a sclerosing agent used successfully to treat extremity and esophageal varices and telangiectasias.		(C2H4O)nC12H26O	130889.0	H2O : 50 mg/mL (Need ultrasonic); DMSO : 50 mg/mL (Need ultrasonic)	Water Solution	3mg/mL  * 100uL	Cardiovascular Disease	OCCCOCCCCCCCCCCCCC.[n]	https://www.medchemexpress.com/Polidocanol.html	Launched		910.0	G19	B5	233.3333333	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B2106	3.0	mM	29.0	DMSO	582.434298	5	B	pluskal_fda_drugs_5006_B5_id
66	HY-13443	HYCPK40900	D03	HYCPK40910					910.0	D17	141758-74-9	Exendin-4	Exenatide	4186.57	GCGR	GPCR/G Protein	Exendin-4 (Exenatide), a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM.	Free Acid	C184H282N50O60S	80935.0	DMSO : ≥ 32 mg/mL (7.64 mM); H2O : 33.33 mg/mL (7.96 mM; Need ultrasonic); Ethanol : < 1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)	Water Solution	2mM  * 100uL	Metabolic Disease	[HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS-NH2]	https://www.medchemexpress.com/Exendin-4.html	Launched		910.0	D17	B5	350.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13443	2.0	mM	29.0	DMSO	4184.027307	5	B	pluskal_fda_drugs_5006_B5_id
2313	HY-B0119	HYCPK40910	B03	HYCPK40910					910.0	B03	115436-72-1	Risedronic acid (sodium)	Risedronate (sodium)	305.09	Others	Others	"Risedronic acid sodium is a pyridinyl biphosphonate which inhibits osteoclast-mediated bone resorption.
Target: 
Risedronic acid sodium, which was promoted in Croatia a few months ago, is the latest (III) generation of bisphosphonates, the most efficient anti-resorption drugs that inhibit osteoclast-mediated bone resorption and change the bone metabolism. Risedronic acid sodium is hence the first line of bisphosphonates for the reduction of vertebral and non-vertebral fracture risks in postmenopausal women with osteoporosis or those with a high risk of osteoporosis. It also efficiently prevents bone loss or improves bone density in men and women on a long-term corticosteroid therapy [1].
The administration of 20 and 25 mg/kg Risedronic acid sodium for 4 days led to decreases of parasitemia of 68.9% and 83.6%, respectively. On the seventh day of treatment the inhibitions were 63% and 88.9% with 20 and 25 mg/kg, respectively. After recovering the parasitemia, a dose-response curve was obtained for estimating the ID50 (dose causing 50% inhibition), equivalent to 17 ± 1.8 mg/kg after 7 days of treatment. Four days after the interruption of treatment (11 days postinfection), the parasitemias of the groups treated with 10, 15, 20, and 25 mg/kg/day were 15.3%, 15.9%, 15.2%, and 5.7%, respectively. Conversely, the group that received PBS presented parasitemia of 25.6%. Among the groups treated with Risedronic acid sodium, only the animals that received 25 mg/kg had a significant inhibition of 77.8% (see Table S1 in the supplemental material), demonstrating that even after treatment discontinuation, the parasitemia of the animals remained low in relation to that of the controls [2].
Clinical indications: Bone resorption; Male osteoporosis; Osteogenesis imperfecta; Osteoporosis; Pagets bone disease     
Toxicity: abdominal pain; anxiety, back pain; belching, bladder irritation; bone disorders and pain; bronchitis; bursitis; cataracts; chest pain; colitis; constipation; depression; diarrhea; difficulty breathing"	Sodium	C7H10NNaO7P2	15728.0	H2O : 8.33 mg/mL (27.30 mM; Need ultrasonic); DMSO : 1 mg/mL (3.28 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Others	OC(P(O)(O[Na])=O)(P(O)(O)=O)CC1=CN=CC=C1	https://www.medchemexpress.com/Risedronate-sodium.html	Launched		910.0	B3	B5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0119	10.0	mM	29.0	DMSO	283.001075	5	B	pluskal_fda_drugs_5006_B5_id
2600	HY-N0122	HYCPK40910	K05	HYCPK40910					910.0	K05	56-69-9	5-Hydroxytryptophan	5-HTP; DL-5-Hydroxytryptophan	220.22	Endogenous Metabolite	Metabolic Enzyme/Protease	5-Hydroxytryptophan, a tryptophan metabolite, is a direct 5-hydroxytryptamine (5-HT) precursor and an L-aromatic amino acid decarboxylase substrate. [1][2][3].	Free Acid	C11H12N2O3	46035.0	H2O : 12.5 mg/mL (56.76 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Metabolic Disease	NC(CC1=CNC2=CC=C(O)C=C12)C(O)=O	https://www.medchemexpress.com/5-hydroxytryptophan.html	Launched		910.0	K5	B5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0122	10.0	mM	29.0	DMSO	220.084792	5	B	pluskal_fda_drugs_5006_B5_id
2611	HY-B0068	HYCPK40910	F06	HYCPK40910					910.0	F06	123040-16-4	Azasetron (hydrochloride)	Y-25130 hydrochloride	386.27	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Azasetron (Y-25130) hydrochloride, a benzamide derivative, is a potent and selective 5-HT3 receptor antagonist. Azasetron is used in the study for Chemotherapy-induced nausea and vomiting (CINV)[1].	Hydrochloride	C17H21Cl2N3O3	13932.0	H2O : 20 mg/mL (51.78 mM; Need ultrasonic); DMSO : 2.22 mg/mL (5.75 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C(C1=C(OCC(N2C)=O)C2=CC(Cl)=C1)NC3CN4CCC3CC4.[H]Cl	https://www.medchemexpress.com/Azasetron-hydrochloride.html	Launched		910.0	F6	B5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0068	10.0	mM	29.0	DMSO	349.119319	5	B	pluskal_fda_drugs_5006_B5_id
2660	HY-B1695	HYCPK40910	K09	HYCPK40910					910.0	K09	93-60-7	Methyl nicotinate		137.14	Others	Others	Methyl nicotinate, the methyl ester of Niacin found in alcoholic beverages, that is used as an active ingredient as a rubefacient in over-the-counter topical preparations indicated for muscle and joint pain[1].	Free Base	C7H7NO2	60970.0	H2O : 100 mg/mL (729.18 mM; Need ultrasonic); DMSO : 100 mg/mL (729.18 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology	O=C(C1=CC=CN=C1)OC	https://www.medchemexpress.com/methyl-nicotinate.html	Launched		910.0	K9	B5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1695	10.0	mM	29.0	DMSO	137.047678	5	B	pluskal_fda_drugs_5006_B5_id
2670	HY-50895A	HYCPK40910	E10	HYCPK40910					910.0	E10	184475-55-6	Gefitinib (hydrochloride)	ZD-1839 hydrochloride	483.36	EGFR	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK	Gefitinib hydrochloride (ZD1839 hydrochloride) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib hydrochloride selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib hydrochloride also induces autophagy. Gefitinib hydrochloride has antitumour activity[1][2].	Hydrochloride	C22H25Cl2FN4O3	16374.0	H2O : 6.25 mg/mL (12.93 mM; Need ultrasonic); DMSO : 0.227 mg/mL (0.47 mM; Need ultrasonic and warming)	Water Solution	10mM  * 100uL	Cancer	ClC1=C(C=CC(NC2=NC=NC3=C2C=C(C(OC)=C3)OCCCN4CCOCC4)=C1)F.[H]Cl	https://www.medchemexpress.com/Gefitinib-hydrochloride.html	Launched		910.0	E10	B5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-50895A	10.0	mM	29.0	DMSO	446.152097	5	B	pluskal_fda_drugs_5006_B5_id
2735	HY-N0455A	HYCPK40910	O14	HYCPK40910					910.0	O14	1119-34-2	L-Arginine (hydrochloride)	(S)-(+)-Arginine hydrochloride	210.66	Endogenous Metabolite; NO Synthase	Immunology/Inflammation; Metabolic Enzyme/Protease	L-Arginine hydrochloride ((S)-(+)-Arginine hydrochloride) is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis.	Hydrochloride	C6H15ClN4O2	16032.0	H2O : 100 mg/mL (474.70 mM; Need ultrasonic); DMSO : < 1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Cancer	N[C@@H](CCCNC(N)=N)C(O)=O.[H]Cl	https://www.medchemexpress.com/L-Arginine-hydrochloride.html	Launched		910.0	O14	B5	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0455A	10.0	mM	29.0	DMSO	174.111676	5	B	pluskal_fda_drugs_5006_B5_id
2320	HY-N0454	HYCPK40910	P13	HYCPK40910					910.0	P13	7200-25-1	DL-Arginine		174.20	Others	Others	DL-Arginine is used in physicochemical analysis of amino acid complexation dynamics and crystal structure formations.	Free Acid	C6H14N4O2	29892.0	H2O : ≥ 150 mg/mL (861.08 mM)	Water Solution	10mM  * 100uL	Cardiovascular Disease	NC(CCCNC(N)=N)C(O)=O	https://www.medchemexpress.com/DL-Arginine.html	Launched		910.0	P13	B6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0454	10.0	mM	30.0	DMSO	174.111676	6	B	pluskal_fda_drugs_5006_B6_id
2591	HY-B0509B	HYCPK40910	B05	HYCPK40910					910.0	B05	39831-55-5	Amikacin (disulfate)	BAY 41-6551 (disulfate)	781.76	Antibiotic; Bacterial	Anti-infection	Amikacin disulfate (BAY 41-6551 dissulfate) is an aminoglycoside antibiotic and a semisynthetic analog of kanamycin. Amikacin disulfate is bactericidal, acting directly on the 30S and 50S bacerial ribosomal subunits to inhibit protein synthesis. Amikacin disulfate is very active against most Gram-negative bacteria including gentamicin- and tobramycin-resistant strains. Amikacin disulfate also inhibits the infections caused by susceptible Nocardia and nontuberculous mycobacteria[1][2].	Sulfate	C22H47N5O21S2	16283.0	H2O : 100 mg/mL (127.92 mM; Need ultrasonic); DMSO : 1 mg/mL (1.28 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Infection; Cancer	OS(O)(=O)=O.OS(O)(=O)=O.O[C@@H]1[C@H]([C@@H](C[C@H](N)[C@H]1O[C@@]([C@@H]([C@@H](O)[C@@H]2O)O)([H])O[C@@H]2CN)NC([C@@H](O)CCN)=O)O[C@@]([C@@H]([C@@H](N)[C@@H]3O)O)([H])O[C@@H]3CO	https://www.medchemexpress.com/Amikacin-sulfate.html	Launched		910.0	B5	B6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0509B	10.0	mM	30.0	DMSO	585.285736	6	B	pluskal_fda_drugs_5006_B6_id
2596	HY-B1075	HYCPK40910	G05	HYCPK40910					910.0	G05	26016-98-8	Fosfomycin (calcium)	MK-​0955 (calcium)	176.12	Antibiotic; Bacterial	Anti-infection	Fosfomycin (MK-0955) calcium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis. Fosfomycin calcium shows both in vivo and in vitro activity against a wide range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria[1][2].	Calcium	C3H5CaO4P	18454.0	H2O : 50 mg/mL (283.90 mM; ultrasonic and adjust pH to 2 with HCl); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Infection; Cancer	C[C@H]1[C@@H](P([O-])([O-])=O)O1.[Ca+2]	https://www.medchemexpress.com/Fosfomycin-calcium.html	Launched		910.0	G5	B6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1075	10.0	mM	30.0	DMSO	138.008195	6	B	pluskal_fda_drugs_5006_B6_id
2628	HY-P0017	HYCPK40910	G07	HYCPK40910					910.0	G07	9087-70-1	Aprotinin		6511.44	Influenza Virus; Ser/Thr Protease	Anti-infection; Metabolic Enzyme/Protease	Aprotinin is a bovine pancreatic trypsin inhibitor (BPTI) inhibitor which inhibits trypsin and chymotrypsin with Kis of 0.06 pM and 9 nM, respectively.	Free Base	C284H432N84O79S7	91760.0	H2O : 100 mg/mL (15.36 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	[RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA(Disulfide bridge: Cys5-Cys55,Cys14-Cys38,Cys30-Cys51)]	https://www.medchemexpress.com/Aprotinin.html	Launched		910.0	G7	B6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-P0017	10.0	mM	30.0	DMSO	6507.041382	6	B	pluskal_fda_drugs_5006_B6_id
2633	HY-B1009	HYCPK40910	L07	HYCPK40910					910.0	L07	150-38-9	Ethylenediaminetetraacetic acid (trisodium salt)	EDTA (trisodium salt); Trisodium EDTA	358.19	Ferroptosis	Apoptosis	Ethylenediaminetetraacetic acid trisodium salt (EDTA trisodium salt) is used to bind metal ions in the practice of chelation therapy, for treating mercury and lead poisoning, used in a similar manner to remove excess iron from the body, for treating the complication of repeated blood transfusions, as would be applied to treat thalassaemia.	Sodium	C10H13N2Na3O8	25406.0	H2O : 50 mg/mL (139.59 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	O=C(O)CN(CCN(CC(O[Na])=O)CC(O[Na])=O)CC(O[Na])=O	https://www.medchemexpress.com/Ethylenediaminetetraacetic-acid-trisodium-salt.html	Launched		910.0	L7	B6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1009	10.0	mM	30.0	DMSO	292.090665	6	B	pluskal_fda_drugs_5006_B6_id
2676	HY-B1222	HYCPK40910	K10	HYCPK40910					910.0	K10	53179-09-2	Sisomicin (sulfate)		692.72	Antibiotic; Bacterial	Anti-infection	Sisomicin is a broad-spectrum aminoglycoside antibiotic produced by Micromonospora inyoensis. sisomicin has great activity against gram-positive bacteria[1][2].	Sulfate	C19H37N5O7.5/2H2SO4	24538.0	H2O : 20 mg/mL (28.87 mM; Need ultrasonic and warming)	Water Solution	10mM  * 100uL	Infection	N[C@H]1[C@](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@@](O)(C)[C@H](NC)[C@H]3O)[C@H]2O)([H])OC(CN)=CC1.[2.5H2SO4]	https://www.medchemexpress.com/Sisomicin-sulfate.html	Launched		910.0	K10	B6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1222	10.0	mM	30.0	DMSO	447.269299	6	B	pluskal_fda_drugs_5006_B6_id
2690	HY-13573	HYCPK40910	I11	HYCPK40910					910.0	I11	120410-24-4	Biapenem	CLI 86815; L 627; LJC 10627	350.39	Antibiotic; Bacterial	Anti-infection	Biapenem (CLI 86815; L 627; LJC 10627) a parenteral carbapenem antibacterial agent with a broad spectrum.	Free Base	C15H18N4O4S	13320.0	H2O : 10 mg/mL (28.54 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=C1N2C(C([O-])=O)=C(SC(C3)CN4[N+]3=CN=C4)[C@H](C)[C@]2([H])[C@@]1([H])[C@H](O)C	https://www.medchemexpress.com/biapenem.html	Launched		910.0	I11	B6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13573	10.0	mM	30.0	DMSO	351.112153	6	B	pluskal_fda_drugs_5006_B6_id
2698	HY-B0538A	HYCPK40910	A12	HYCPK40910					910.0	A12	100299-08-9	Pemirolast (potassium)	TWT-8152; BMY 26517	266.30	Histamine Receptor	GPCR/G Protein; Immunology/Inflammation; Neuronal Signaling	"Pemirolast potassium (TWT-8152) is a histamine H1 antagonist and mast cell stabilizer that acts as an antiallergic agent.
Target: Histamine H1 Receptor
Pemirolast potassium (TWT-8152) is a new oral, nonbronchodilator antiallergy medication that is being evaluated for the therapy of asthma [1]. 
Pemirolast potassium (TWT-8152) inhibits chemical mediator release from tissue mast cells and is also shown to inhibit the release of peptides including substance P, Pemirolast potassium (TWT-8152) reduces kaolin intake by inhibition of substance P release in rats [2]. 
Pemirolast potassium (TWT-8152) potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats [3]. 
Pemirolast potassium (TWT-8152) potassium is used for the treatment of allergic conjunctivitis and prophylaxis for pulmonary hypersensitivity reactions to drugs such as paclitaxel [4]."	Potassium	C10H7KN6O	16037.0	H2O : 50 mg/mL (187.76 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology	O=C1C(C2=N[N-]N=N2)=CN=C3N1C=CC=C3C.[K+]	https://www.medchemexpress.com/Pemirolast-potassium.html	Launched		910.0	A12	B6	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0538A	10.0	mM	30.0	DMSO	228.075959	6	B	pluskal_fda_drugs_5006_B6_id
2566	HY-W016420	HYCPK40910	I03	HYCPK40910					910.0	I03	26016-99-9	Fosfomycin (sodium)	MK-0955 (sodium)	182.02	Antibiotic; Bacterial	Anti-infection	Fosfomycin (MK-0955) sodium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis. Fosfomycin sodium shows both in vivo and in vitro activity against a wide range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria[1][2].	Sodium	C3H5Na2O4P	85741.0	H2O : 125 mg/mL (686.74 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection; Cancer	C[C@@H]1O[C@@H]1P(O[Na])(O[Na])=O	https://www.medchemexpress.com/fosfomycin-sodium.html	Launched		910.0	I3	B7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-W016420	10.0	mM	31.0	DMSO	138.008195	7	B	pluskal_fda_drugs_5006_B7_id
2580	HY-B1228	HYCPK40910	G04	HYCPK40910					910.0	G04	53797-35-6	Ribostamycin (sulfate)	Vistamycin (sulfate)	552.55	Antibiotic; Bacterial	Anti-infection	Ribostamycin sulfate (Vistamycin sulfate) is a broad-spectrum antimicrobial, inhibits bacterial protein synthesis at the level of 30S and 50S ribosomal subunit binding, also inhibits the chaperone activity of protein disulfide isomerase (PDI), used in pharmacokinetic and nephrotoxicity studies	Sulfate	C17H36N4O14S	17573.0	H2O : 130 mg/mL (235.27 mM; Need ultrasonic); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Infection	O=S(O)(O)=O.O[C@@H]([C@H](O)[C@@H](CN)O1)[C@@H](N)[C@@]1([H])O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@@]2([H])O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O	https://www.medchemexpress.com/Ribostamycin-sulfate.html	Launched		910.0	G4	B7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1228	10.0	mM	31.0	DMSO	454.227493	7	B	pluskal_fda_drugs_5006_B7_id
2623	HY-B0730	HYCPK40910	B07	HYCPK40910					910.0	B07	109552-15-0	Pamidronate (disodium pentahydrate)		369.11	Bacterial	Anti-infection	Pamidronate disodium pentahydrate is a nitrogen-containing bisphosphonate, used to prevent osteoporosis.	Sodium	C3H19NNa2O12P2	16285.0	H2O : 7.14 mg/mL (19.34 mM; Need ultrasonic); DMSO : 1 mg/mL (2.71 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Cancer	OC(P(O)(O[Na])=O)(CCN)P(O)(O[Na])=O.O.O.O.O.O	https://www.medchemexpress.com/Pamidronate-disodium-pentahydrate.html	Launched		910.0	B7	B7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0730	10.0	mM	31.0	DMSO	235.001075	7	B	pluskal_fda_drugs_5006_B7_id
2624	HY-B0393	HYCPK40910	C07	HYCPK40910					910.0	C07	13189-98-5	Fudosteine		179.23732	Others	Others	Fudosteine is a cysteine derivative and a mucoactive agent. Fudosteine inhibits MUC5AC mucin hypersecretion by reducing MUC5AC gene expression[1][2].	Free Acid	C6H13NO3S	145006.0	H2O : ≥ 100 mg/mL (557.91 mM)	Water Solution	10mM  * 100uL	Inflammation/Immunology	N[C@@H](CSCCCO)C(O)=O	https://www.medchemexpress.com/fudosteine.html	Launched		910.0	C7	B7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0393	10.0	mM	31.0	DMSO	179.061614	7	B	pluskal_fda_drugs_5006_B7_id
2649	HY-70050C	HYCPK40910	L08	HYCPK40910					910.0	L08	122852-69-1	Alosetron (Hydrochloride)	GR 68755C; GR 68755 (Hydrochloride); GR 68755X (Hydrochloride)	330.81	5-HT Receptor	GPCR/G Protein; Neuronal Signaling	Alosetron Hydrochloride (GR 68755C) is a potent and highly selective serotonin 5-HT3 receptor antagonist. Alosetron Hydrochloride is used for the research of irritable bowel syndrome (IBS). Alosetron blocks the fast 5HT3-mediated depolarisation of guinea-pig myenteric and submucosal neurons, with IC50 at ~55 nM. Alosetron Hydrochloride attenuates the visceral nociceptive effect of rectal distension in conscious or anaesthetised dogs. Anti-inflammatory effects[1][2].	Hydrochloride	C17H19ClN4O	8636.0	H2O : 33.33 mg/mL (100.75 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Neurological Disease	O=C(C(C1=C2C=CC=C1)=C(N2C)CC3)N3CC4=C(NC=N4)C.[H]Cl	https://www.medchemexpress.com/alosetron-hydrochloride.html	Launched		910.0	L8	B7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-70050C	10.0	mM	31.0	DMSO	294.148061	7	B	pluskal_fda_drugs_5006_B7_id
2673	HY-B0455	HYCPK40910	H10	HYCPK40910					910.0	H10	98079-52-8	Lomefloxacin (hydrochloride)	SC47111A (hydrochloride)	387.81	Antibiotic; Bacterial	Anti-infection	Lomefloxacin (SC47111A) hydrochloride is a broad-spectrum quinolone antibiotic, with antimicrobial activity. Lomefloxacin hydrochloride is used for the research of respiratory tract infections, genitourinary infections, gastrointestinal infections, ENT infections, etc.[1][2].	Hydrochloride	C17H20ClF2N3O3	11942.0	H2O : 10 mg/mL (25.79 mM; Need ultrasonic and warming)	Water Solution	10mM  * 100uL	Infection	CCN(C=C(C(O)=O)C1=O)C(C1=CC(F)=C2N(CCN3)CC3C)=C2F.Cl	https://www.medchemexpress.com/lomefloxacin-hydrochloride.html	Launched		910.0	H10	B7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0455	10.0	mM	31.0	DMSO	351.139448	7	B	pluskal_fda_drugs_5006_B7_id
2723	HY-17624A	HYCPK40910	J13	HYCPK40910					910.0	J13	4146-30-9	Framycetin (sulfate)	Neomycin B (sulfate); Fradiomycin B (sulfate)	908.88	Antibiotic; Bacterial	Anti-infection	Framycetin sulfate (Neomycin B sulfate), an aminoglycoside antibiotic, is a potent RNase P cleavage activity inhibitor with a Ki of 35 μM. Framycetin sulfate competes for specific divalent metal ion binding sites in RNase P RNA. Framycetin sulfate inhibits hammerhead ribozyme with a Ki of 13.5 μM. Framycetin sulfate, a 5″-azido neomycin B precursor, binds the Drosha site in miR-525 and is used for hepatic encephalopathy and enteropathogenic E. coli infections[1][2].	Sulfate	C23H52N6O25S3	152377.0	H2O : 250 mg/mL (275.06 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=S(O)(O)=O.O=S(O)(O)=O.O=S(O)(O)=O.N[C@@H](C[C@H]1N)[C@@]([C@@H]([C@H]1O)O[C@@](O[C@H](CO)[C@H]2O[C@@]([C@@H]([C@@H](O)[C@@H]3O)N)([H])O[C@H]3CN)([H])[C@@H]2O)([H])O[C@H]([C@@H]([C@@H](O)[C@@H]4O)N)O[C@@H]4CN	https://www.medchemexpress.com/framycetin-sulfate.html	Launched		910.0	J13	B7	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17624A	10.0	mM	31.0	DMSO	614.312286	7	B	pluskal_fda_drugs_5006_B7_id
2316	HY-13679	HYCPK40910	O08	HYCPK40910					910.0	O08	19767-45-4	Sodium 2-mercaptoethanesulfonate	Sodium 2-mercaptoethanesulfonate; Mesnum	164.18	Others	Others	Mesna (Sodium 2-mercaptoethanesulfonate) is an antioxidant which has cytoprotective effects. Mesna is widely used as a systemic protective agent against chemotherapy toxicity. Mesna is also used to reduce hemorrhagic cystitis induced by cyclophosphamide[1][2].	Sodium	C2H5NaO3S2	8629.0	H2O : ≥ 50 mg/mL (304.54 mM)	Water Solution	10mM  * 100uL	Cancer	SCCS(=O)(O[Na])=O	https://www.medchemexpress.com/mesna.html	Launched		910.0	O8	B8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-13679	10.0	mM	32.0	DMSO	141.975836	8	B	pluskal_fda_drugs_5006_B8_id
2579	HY-N0487	HYCPK40910	F04	HYCPK40910					910.0	F04	29031-19-4	Glucosamine (sulfate)	D-Glucosamine (sulfate)	277.25	Autophagy; Endogenous Metabolite; HIF/HIF Prolyl-Hydroxylase; Reactive Oxygen Species	Autophagy; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB	Glucosamine sulfate (D-Glucosamine sulfate) is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids, is used as a dietary supplement. Glucosamine sulfate also is a natural constituent of glycosaminoglycans in the cartilage matrix and synovial fluid, which when administered exogenously, exerts pharmacological effects on osteoarthritic cartilage and chondrocytes[1].	Sulfate	C6H15NO9S	110601.0	H2O : 125 mg/mL (450.86 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C[C@H](N)[C@H]([C@@H]([C@@H](CO)O)O)O.O=S(O)(O)=O	https://www.medchemexpress.com/glucosamine-sulfate.html	Launched		910.0	F4	B8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0487	10.0	mM	32.0	DMSO	179.079373	8	B	pluskal_fda_drugs_5006_B8_id
2638	HY-B1587	HYCPK40910	A08	HYCPK40910					910.0	A08	69-81-8	Carbazochrome		236.23	Adrenergic Receptor	GPCR/G Protein; Neuronal Signaling	Carbazochrome is a capillary stabiliser and used for the research of haemorrhage. Carbazochrome is an antihemorrhagic agent[1].		C10H12N4O3	80416.0	H2O : 5 mg/mL (21.17 mM; ultrasonic and adjust pH to 12 with NaOH); DMSO : < 1 mg/mL (insoluble or slightly soluble)	Water Solution	10mM  * 100uL	Cardiovascular Disease	O=C1/C(C=C2C(O)CN(C)C2=C1)=N\NC(N)=O	https://www.medchemexpress.com/carbazochrome.html	Launched		910.0	A8	B8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1587	10.0	mM	32.0	DMSO	236.09094	8	B	pluskal_fda_drugs_5006_B8_id
2658	HY-15037	HYCPK40910	I09	HYCPK40910					910.0	I09	15307-79-6	Diclofenac (Sodium)	GP 45840	318.13	Apoptosis; COX	Apoptosis; Immunology/Inflammation	Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells[1], and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively[2]. Diclofenac Sodium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade[3].	Sodium	C14H10Cl2NNaO2	13286.0	H2O : 10 mg/mL (31.43 mM; ultrasonic and warming and heat to 60°C)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Cancer	O=C(O[Na])CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl	https://www.medchemexpress.com/Diclofenac-Sodium.html	Launched		910.0	I9	B8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-15037	10.0	mM	32.0	DMSO	295.016684	8	B	pluskal_fda_drugs_5006_B8_id
2665	HY-B0470	HYCPK40910	P09	HYCPK40910					910.0	P09	1405-10-3	Neomycin (sulfate)		908.88	Antibiotic; Bacterial; Phospholipase	Anti-infection; Metabolic Enzyme/Protease	Neomycin sulfate, an aminoglycoside antibiotic, exerts antibacterial activity through irreversible binding of the nuclear 30S ribosomal subunit, thereby blocking bacterial protein synthesis. Neomycin sulfate is a known phospholipase C (PLC) inhibitor. Neomycin sulfate potently inhibits both nuclear translocation of angiogenin and angiogenin-induced cell proliferation and angiogenesis[1][2].	Sulfate	C23H52N6O25S3	21914.0	H2O : 250 mg/mL (275.06 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O[C@H]1[C@H](O)[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]3O[C@H](CO)[C@@H](O[C@H]4O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]4N)[C@H]3O)O[C@@H]1CN.[3H2SO4]	https://www.medchemexpress.com/Neomycin-sulfate.html	Launched		910.0	P9	B8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0470	10.0	mM	32.0	DMSO	614.312286	8	B	pluskal_fda_drugs_5006_B8_id
2697	HY-U00106	HYCPK40910	P11	HYCPK40910					910.0	P11	51598-60-8	Cimetropium (Bromide)	DA-3177	438.36	mAChR	GPCR/G Protein; Neuronal Signaling	Cimetropium Bromide (DA-3177) is a mAChR antagonist for long-term treatment of irritable bowel syndrome.	Bromide	C21H28BrNO4	79634.0	H2O : 50 mg/mL (114.06 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Neurological Disease	C[N+]1([C@H]2[C@@H](O3)[C@@H]3[C@@H]1C[C@H](OC([C@@H](C4=CC=CC=C4)CO)=O)C2)CC5CC5.[Br-]	https://www.medchemexpress.com/Cimetropium_Bromide.html	Launched		910.0	P11	B8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-U00106	10.0	mM	32.0	DMSO	358.201285	8	B	pluskal_fda_drugs_5006_B8_id
2741	HY-B0964	HYCPK40910	E15	HYCPK40910					910.0	E15	130-40-5	Riboflavin (phosphate sodium)	FMN-Na; Riboflavin 5'-phosphate sodium; Vitamin B2 Phosphate Sodium Salt	478.33	Endogenous Metabolite	Metabolic Enzyme/Protease	Riboflavin phosphate sodium (FMN-Na) is a derivative of Riboflavin (vitamin B2) which is an essential nutrient for animals. Riboflavin phosphate sodium can be used for the research of progressive keratoconus, corneal ectasia and irregular astigmatism[1][2]. Riboflavine phosphate sodium is a very effective NAD+-recycling agent[3].	Sodium	C17H20N4NaO9P	17695.0	H2O : 20.83 mg/mL (43.55 mM; ultrasonic and warming and heat to 60°C); DMSO : 1 mg/mL (2.09 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Others	CC1=CC2=C(C=C1C)N=C(C(N2C[C@H](O)[C@H](O)[C@H](O)COP(O)(O[Na])=O)=N3)C(NC3=O)=O	https://www.medchemexpress.com/Riboflavin-phosphate-sodium.html	Launched		910.0	E15	B8	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0964	10.0	mM	32.0	DMSO	456.104615	8	B	pluskal_fda_drugs_5006_B8_id
69	HY-17383	HYCPK40900	G03	HYCPK40910					910.0	G17	151533-22-1	Levomefolate (calcium)		497.52	Antifolate	Cell Cycle/DNA Damage	"Levomefolate calcium is an artificial form of folate.
IC50 Value:
Target: Antifolate
The calcium salt of L-5-methyltetrahydrofolic acid which belongs to the group of folate vitamins (Vitamin B9, Folacin). It is a coenzymated form of folic acid and a more bioavailable alternative in dietary supplements."	Calcium	C20H23CaN7O6	91105.0	H2O : 4.4 mg/mL (8.84 mM; Need ultrasonic and warming)	Water Solution	2mM  * 100uL	Cancer	O=C([O-])CC[C@@H](C([O-])=O)NC(C1=CC=C(NC[C@@H]2N(C)C3=C(N=C(N)NC3=O)NC2)C=C1)=O.[Ca+2]	https://www.medchemexpress.com/Levomefolate-calcium.html	Launched		910.0	G17	B9	350.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-17383	2.0	mM	33.0	DMSO	459.186632	9	B	pluskal_fda_drugs_5006_B9_id
2565	HY-19930	HYCPK40910	H03	HYCPK40910					910.0	H03	1360457-46-0	Vaborbactam	RPX7009	297.14	Bacterial	Anti-infection	Vaborbactam (RPX7009) is a cyclic boronic acid pharmacophore β-lactamase inhibitor.	Free Acid	C12H16BNO5S	25000.0	H2O : 5.26 mg/mL (17.70 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Infection	O=C(O)C[C@@H]1CC[C@H](NC(CC2=CC=CS2)=O)B(O)O1	https://www.medchemexpress.com/Vaborbactam.html	Launched		910.0	H3	B9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-19930	10.0	mM	33.0	DMSO	297.084224	9	B	pluskal_fda_drugs_5006_B9_id
2589	HY-B0956	HYCPK40910	P04	HYCPK40910					910.0	P04	1263-89-4	Paromomycin (sulfate)	Aminosidine (sulfate)	713.71	Antibiotic; Bacterial; Parasite	Anti-infection	Paromomycin (Aminosidine) sulfate, a neomycin (HY-B0470) derivative, is a broad spectrum aminoglycoside antibiotic with amebicidal and bactericidal effects. Paromomycin sulfate prematures termination of translation of mRNA and inhibits protein synthesis?by specifically binds to the RNA oligonucleotide at the A site of bacterial 30S ribosomes. Paromomycin sulfate can be used for the research of bacterial and parasitic infections[1][2][3].	Sulfate	C23H47N5O18S	17763.0	Ethanol : 1 mg/mL (1.40 mM; Need ultrasonic); H2O : 100 mg/mL (140.11 mM; ultrasonic and warming and heat to 80°C); DMSO : 1 mg/mL (1.40 mM; ultrasonic and warming and heat to 80°C)	Water Solution	10mM  * 100uL	Infection	N[C@@H](C[C@H]1N)[C@@]([C@@H]([C@H]1O)O[C@@](O[C@H](CO)[C@H]2O[C@@]([C@@H]([C@@H](O)[C@@H]3O)N)([H])O[C@H]3CN)([H])[C@@H]2O)([H])O[C@H]([C@@H]([C@@H](O)[C@@H]4O)N)O[C@@H]4CO.O=S(O)(O)=O	https://www.medchemexpress.com/Paromomycin-sulfate.html	Launched		910.0	P4	B9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0956	10.0	mM	33.0	DMSO	615.296301	9	B	pluskal_fda_drugs_5006_B9_id
2613	HY-N6618	HYCPK40910	H06	HYCPK40910					910.0	H06	87-78-5	DL-Mannitol		182.17	Others	Others	DL-Mannitol is obtained by combining D-mannitol with a sample of Lmannitol obtained by reduction of L-mannono-1, Clactone[1].		C6H14O6	143378.0	H2O : 62.5 mg/mL (343.09 mM; ultrasonic and warming and heat to 60°C)	Water Solution	10mM  * 100uL	Others	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Relative stereochemistry]	https://www.medchemexpress.com/dl-mannitol.html	Launched		910.0	H6	B9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N6618	10.0	mM	33.0	DMSO	182.079038	9	B	pluskal_fda_drugs_5006_B9_id
2641	HY-B0436	HYCPK40910	D08	HYCPK40910					910.0	D08	51022-70-9	Salbutamol (hemisulfate)	Albuterol (hemisulfate); AH-3365 (hemisulfate)	288.14	Adrenergic Receptor; Autophagy	Autophagy; GPCR/G Protein; Neuronal Signaling	"Salbutamol Hemisulfate (Albuterol hemisulfate) is a short-acting β2 adrenergic receptor agonist
Target: β2 Adrenergic Receptor
Salbutamol Hemisulfate (Albuterol hemisulfate) is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. All the effects of R,S-salbutamol on guinea-pig skeletal muscles are due to the activity of the R-enantiomer. Thus there is a common enantiomeric profile for the skeletal muscle and bronchorelaxant activity of the compound [1]. Short-term Salbutamol intake did appear to improve performance during intense submaximal exercise with concomitant increase in substrate availability and utilization, but the exact mechanisms involved need further investigation [2]. Short-term administration of salbutamol increases voluntary muscle strength in man. However, the magnitude and duration of this effect vary between muscle groups. This study implies that the beta 2-adrenoceptor agonists may be of therapeutic potential in altering skeletal muscle function in humans [3]."	Sulfate	C13H22NO5S0.5	16192.0	H2O : 100 mg/mL (347.05 mM; Need ultrasonic); DMSO : 2 mg/mL (6.94 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Inflammation/Immunology; Endocrinology; Cancer	OC(C1=CC(CO)=C(O)C=C1)CNC(C)(C)C.[0.5H2SO4]	https://www.medchemexpress.com/Salbutamol-hemisulfate.html	Launched		910.0	D8	B9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0436	10.0	mM	33.0	DMSO	239.152144	9	B	pluskal_fda_drugs_5006_B9_id
2647	HY-B1582A	HYCPK40910	J08	HYCPK40910					910.0	J08	2181-04-6	Canrenoate (potassium)	Aldadiene (potassium); SC-14266	396.56	Mineralocorticoid Receptor	Metabolic Enzyme/Protease	Canrenoate (Aldadiene) potassium, a prodrug that releases canrenone, is a potent, competitive mineralocorticoid receptor (aldosterone receptor)  antagonist. Potassium canrenoate, as a diuretic, is used for the research of hypertension[1][2][3].	Potassium	C22H29KO4	104803.0	H2O : 100 mg/mL (252.17 mM; ultrasonic and warming and heat to 60°C)	Water Solution	10mM  * 100uL	Cardiovascular Disease	C[C@@]12[C@@](CCC(O[K])=O)(O)CC[C@@]1([H])[C@]3([H])C=CC4=CC(CC[C@]4(C)[C@@]3([H])CC2)=O	https://www.medchemexpress.com/canrenoate-potassium.html	Launched		910.0	J8	B9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B1582A	10.0	mM	33.0	DMSO	358.214409	9	B	pluskal_fda_drugs_5006_B9_id
2704	HY-N0390	HYCPK40910	G12	HYCPK40910					910.0	G12	56-85-9	L-Glutamine	L-Glutamic acid 5-amide	146.14	Endogenous Metabolite; Ferroptosis; mGluR	Apoptosis; GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling	L-Glutamine (L-Glutamic acid 5-amide) is a non-essential amino acid present abundantly throughout the body and involved in many metabolic processes. L-Glutamine provides a source of carbons for oxidation in some cells[1][2].	Free Acid	C5H10N2O3	113485.0	H2O : 33.33 mg/mL (228.07 mM; ultrasonic and adjust pH to 1 with HCl)	Water Solution	10mM  * 100uL	Metabolic Disease; Cancer	N[C@@H](CCC(N)=O)C(O)=O	https://www.medchemexpress.com/L-Glutamine.html	Launched		910.0	G12	B9	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-N0390	10.0	mM	33.0	DMSO	146.069142	9	B	pluskal_fda_drugs_5006_B9_id
20	HY-107911	HYCPK40898	E03	HYCPK40910					910.0	E19	9009-65-8	Protamine sulfate			Thrombin	Metabolic Enzyme/Protease	Protamine sulfate, polycationic peptide and a antiheparin agent, could neutralize the anticoagulant action of heparin and enhances lipid-mediated gene transfer[1][2][3].			153399.0	H2O : 50 mg/mL (Need ultrasonic)	Water Solution	3mg/mL  * 100uL	Metabolic Disease	[Protamine sulfate]	https://www.medchemexpress.com/protamine-sulfate.html	Launched		910.0	E19	C3	233.3333333	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-107911	3.0	mM	51.0	DMSO	10.0	3	C	pluskal_fda_drugs_5006_C3_id
2637	HY-16217	HYCPK40910	P07	HYCPK40910					910.0	P07	770691-21-9	Gadobutrol	ZK 135079	604.71	Others	Others	Gadobutrol (Gd-DO3A-butrol; ZK 135079) is a nonionic paramagnetic macrocyclic gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI)[1].	Free Base	C18H31GdN4O9	11120.0	H2O : 20 mg/mL (33.07 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	OC[C@H]1[N]23[Gd+3]([N]4(C5)CC3)([N]6(C7)CC4)([OH][C@@H]1CO)([O-]C5=O)([O-]C8=O)([O-]C7=O)[N](CC6)(C8)CC2	https://www.medchemexpress.com/Gadobutrol.html	Launched		910.0	P7	C3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-16217	10.0	mM	51.0	DMSO	30.0	3	C	pluskal_fda_drugs_5006_C3_id
2732	HY-B0911	HYCPK40910	L14	HYCPK40910					910.0	L14	11006-34-1	Chlorophyllin sodium copper salt		724.15	Others	Others	Sodium copper chlorophyllin A is a semi-synthetic mixture of sodium copper salts derived from chlorophyll, primarily used as a food additive and in alternative medicine.	Sodium	C34H31CuN4Na3O6	17297.0	H2O : ≥ 66.66 mg/mL (92.05 mM); DMSO : 1.2 mg/mL (1.66 mM; Need ultrasonic)	Water Solution	10mM  * 100uL	Cancer	O=C(O[Na])CC1=C(C(C(O[Na])=O)=C(C)C2=CC(C(CC)=C3C)=[N]4C3=CC5=C(C=C)C(C)=C6[N-]75)[N-]2[Cu+2]47[N](C8=C6)=C1C(C8C)CCC(O[Na])=O	https://www.medchemexpress.com/Chlorophyllin-sodium-copper-salt.html	Launched		910.0	L14	C3	70.0	nl	5006	384LDV_AQ_B2	GN	384PP_Corina	HY-B0911	10.0	mM	51.0	DMSO	20.0	3	C	pluskal_fda_drugs_5006_C3_id
92	HY-17565	HYCPK40902	B05	HYCPK40902	91z	105.0	1.0	C9	902.0	B05	9041-93-4	Bleomycin (sulfate)		1512.62	Antibiotic; DNA/RNA Synthesis	Anti-infection; Cell Cycle/DNA Damage	Bleomycin sulfate is a DNA synthesis inhibitor. Bleomycin hydrochloride is a DNA damaging agent. Bleomycin sulfate is an antitumor antibiotic[1].	Sulfate	C55H85N17O25S4	145395.0	H2O : 255 mg/mL (168.58 mM; Need ultrasonic and warming); DMSO : 62.5 mg/mL (41.32 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	NC(C[C@H](NC[C@@H](N)C(N)=O)C1=NC(N)=C(C)C(C(N[C@H](C(N[C@@H](C)[C@@H]([C@@H](C)C(N[C@@H](C(NCCC2=NC(C3=NC(C(NCCC[S+](C)C)=O)=CS3)=CS2)=O)[C@H](O)C)=O)O)=O)C(C4=CNC=N4)O[C@@H]5[C@]([H])(O[C@@H]6[C@@H](O)[C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](O	https://www.medchemexpress.com/Bleomycin-sulfate.html	Launched		91.0	C9	C4	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17565	10.0	mM	52.0	DMSO	10.0	4	C	pluskal_fda_drugs_5006_C4_id
254	HY-B2136	HYCPK40902	L15	HYCPK40902	91z	1085.0	1.0	W29	902.0	L15	1401-55-4	Tannic acid		1701.20	Potassium Channel	Membrane Transporter/Ion Channel	Tannic acid is a novel hERG channel blocker with IC50 of 3.4  μM.	Free Acid	C76H52O46	26432.0	H2O : ≥ 100 mg/mL (58.78 mM); DMSO : 100 mg/mL (58.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	O=C(C1=CC(OC(C2=CC(O)=C(O)C(O)=C2)=O)=C(O)C(O)=C1)OC3[C@H](OC(C4=CC(OC(C5=CC(O)=C(O)C(O)=C5)=O)=C(O)C(O)=C4)=O)[C@@H](OC(C6=CC(OC(C7=CC(O)=C(O)C(O)=C7)=O)=C(O)C(O)=C6)=O)[C@H](OC(C8=CC(OC(C9=CC(O)=C(O)C(O)=C9)=O)=C(O)C(O)=C8)=O)[C@@H](COC(C%10=CC(OC(C%11=	https://www.medchemexpress.com/Tannic_acid.html	Launched		91.0	W29	C4	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2136	10.0	mM	52.0	DMSO	60.0	4	C	pluskal_fda_drugs_5006_C4_id
390	HY-N0124	HYCPK40902	K09	HYCPK40902	91z	977.0	1.0	U17	902.0	K09	19057-60-4	Dioscin	Collettiside III; CCRIS 4123	869.04	Apoptosis; Autophagy	Apoptosis; Autophagy	"Dioscin(CCRIS 4123; Collettiside III) is a natural steroid saponin derived from several plants, showing potent anti-cancer effect against a variety of tumor cell lines. 
IC50 value:
Target: Anticancer agent
in vitro: dioscin (1, 2 and 4 μmol/L) could significantly inhibit the viability of LNCaP cells in a time- and concentration-dependent manner. Flow cytometry revealed that the apoptosis rate was increased after treatment of LNCaP cells with dioscin for 24 h, indicating that apoptosis was an important mechanism by which dioscin inhibited cancer [1]. dioscin abrogated AKT phosphorylation, which subsequently impaired RANKL-induced nuclear factor-kappaB (NF-κB) signaling pathway and inhibited NFATc1 transcriptional activity. Moreover, in vivo studies further verified the bone protection activity of dioscin in osteolytic animal model [2]. Dioscin reduced cell death and lactate dehydrogenase (LDH) release in cells subjected to I/R. I/R induced apoptosis and cytochrome c release from mitochondria to the cytosol and this was prevented by dioscin. In support, dioscin decreased Bax but increased Bcl-2 mRNA expression. Dioscin prevented I/R induced dissipation of ΔΨm [3]."	Free Base	C45H72O16	46174.0	DMSO : ≥ 100 mg/mL (115.07 mM)	DMSO Solution	10mM  * 100uL	Cancer	O[C@@H]1[C@@H](O)[C@H](C)O[C@@]([H])(O[C@H]2[C@H](O)[C@@H](O[C@]3([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@](O[C@@H]4CC5=CC[C@]([C@]([H])(C[C@@]6([H])[C@]7([H])[C@H](C)[C@]8(OC[C@H](C)CC8)O6)[C@]7(C)CC9)([H])[C@@]9([H])[C@@]5(C)CC4)([H])O[C@@H]2CO)[C@@H	https://www.medchemexpress.com/Dioscin.html	Launched		91.0	U17	C4	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N0124	10.0	mM	52.0	DMSO	50.0	4	C	pluskal_fda_drugs_5006_C4_id
403	HY-B1811	HYCPK40902	C21	HYCPK40902	91z	233.0	1.0	E41	902.0	C21	11000-17-2	Vasopressin		1084.24	Endogenous Metabolite	Metabolic Enzyme/Protease	Vasopressin is a cyclic nonapeptide that is synthesized centrally in the hypothalamus. Vasopressin participates in the hypothalamic-pituitary-adrenal axis, and regulates pituitary corticotropin secretion by potentiating the stimulatory effects of corticotropin releasing factor. Vasopressin also can act as a neurotransmitter, exerting its action by binding to specific G protein-coupled receptors[1][2][3].		C46H65N15O12S2	153861.0	H2O : 100 mg/mL (92.23 mM; Need ultrasonic); DMSO : 100 mg/mL (92.23 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Neurological Disease	[CYFQNCPR-NH2 (Disulfide Bridge: Cys1-Cys6)]	https://www.medchemexpress.com/ADH.html	Launched		91.0	E41	C4	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1811	10.0	mM	52.0	DMSO	20.0	4	C	pluskal_fda_drugs_5006_C4_id
809	HY-B1030	HYCPK40904	N07	HYCPK40904	91z	1309.0	3.0	AB13	904.0	N07	17575-22-3	Lanatoside C		985.12	Autophagy; Enterovirus	Anti-infection; Autophagy	Lanatoside C is a cardiac glycoside, can be used in the treatment of congestive heart failure and cardiac arrhythmia.Lanatoside C has an IC50 of 0.19 μM for dengue virus infection in HuH-7 cells. Lanatoside C can effectively inhibit all four serotypes of dengue virus, flavivirus Kunjin, alphavirus Chikungunya, Sindbis virus and the human enterovirus 71[1][2].	Free Base	C49H76O20	91692.0	Ethanol : 2 mg/mL (2.03 mM; Need ultrasonic); DMSO : 50 mg/mL (50.76 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease; Cancer	O[C@]([C@@](CC[C@@]1([H])[C@@]2(CC[C@H](O[C@@](O[C@H](C)[C@H]3O[C@@](O[C@H](C)[C@H]4O[C@@](O[C@H](C)[C@H]5O[C@]([C@@H]([C@@H](O)[C@@H]6O)O)([H])O[C@@H]6CO)([H])C[C@@H]5OC(C)=O)([H])C[C@@H]4O)([H])C[C@@H]3O)C1)C)([H])[C@]2([H])C[C@H]7O)(CC[C@@H]8C(CO9)=CC9	https://www.medchemexpress.com/Lanatoside-C.html	Launched		91.0	AB13	C4	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1030	10.0	mM	52.0	DMSO	70.0	4	C	pluskal_fda_drugs_5006_C4_id
857	HY-19424	HYCPK40904	N10	HYCPK40904	91z	1315.0	3.0	AB19	904.0	N10	16009-13-5	Hemin	Hemin chloride	651.94	Autophagy; Ferroptosis; Mitophagy	Apoptosis; Autophagy	Hemin is an iron-containing porphyrin. Hemin is an Heme oxygenase (HO)-1 inducer.	Free Acid	C34H32ClFeN4O4	31350.0	1M NaOH : 6.67 mg/mL (10.23 mM; ultrasonic and adjust pH to 12 with NaOH)	DMSO Solution	10mM  * 100uL	Cardiovascular Disease	[Cl-][Fe+3]123[N-]4C5=C(CCC([O-])=O)C(C)=C4C=C(C(C=C)=C6C)[N]1=C6C=C(C(C=C)=C7C)[N-]2C7=CC(C(C)=C8CCC([O-])=O)=[N]3C8=C5.[H+].[H+]	https://www.medchemexpress.com/Hemin.html	Launched		91.0	AB19	C4	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-19424	10.0	mM	52.0	DMSO	80.0	4	C	pluskal_fda_drugs_5006_C4_id
1040	HY-A0122	HYCPK40904	I22	HYCPK40904	91z	859.0	3.0	R43	904.0	I22	18378-89-7	Plicamycin	Mithramycin A	1085.15	Antibiotic; Bacterial; DNA/RNA Synthesis	Anti-infection; Cell Cycle/DNA Damage	Plicamycin is a selective specificity protein 1 (Sp1) inhibitor. Plicamycin inhibits the growth of various cancers by decreasing Sp1 protein.	Free Base	C52H76O24	179162.0	DMSO : ≥ 100 mg/mL (92.15 mM)	DMSO Solution	10mM  * 100uL	Cancer; Infection	O=C([C@H]([C@@]([C@H](OC)C([C@@H](O)[C@H](O)C)=O)([H])C1)O[C@@](O[C@H](C)[C@H]2O)([H])C[C@H]2O[C@@](O[C@H](C)[C@@H]3O)([H])C[C@H]3O[C@@](O[C@H](C)[C@H]4O)([H])C[C@@]4(O)C)C(C1=CC5=CC(O[C@H](O[C@H](C)[C@H]6O)C[C@H]6O[C@@](O[C@H](C)[C@H]7O)([H])C[C@H]7O)=C(	https://www.medchemexpress.com/Plicamycin.html	Launched		91.0	R43	C4	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0122	10.0	mM	52.0	DMSO	40.0	4	C	pluskal_fda_drugs_5006_C4_id
1066	HY-B1446	HYCPK40905	C04	HYCPK40905	91z	248.0	4.0	F8	905.0	C04	161973-10-0	Esomeprazole magnesium	(S)-Omeprazole magnesium; (-)-Omeprazole magnesium	713.12	Proton Pump	Membrane Transporter/Ion Channel	Esomeprazole magnesium ((S)-Omeprazole magnesium) is a potent and orally active H+, K+-ATPase inhibitor. Esomeprazole magnesium has the potential for upper intestinal disorders and gastroesophageal reflux disease research[1][2]. Esomeprazole magnesium acts as an exosome inhibitor by blocking the exosome release via the inhibition of V-H+-ATPases[4].	Magnesium	C34H36MgN6O6S2	33563.0	DMSO : ≥ 125 mg/mL (175.29 mM); H2O : 3 mg/mL (4.21 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Endocrinology; Cancer	CC1=C(N=CC(C)=C1OC)CS2=O[Mg+2]3([N](C4=CC=C(OC)C=C4[N-]5)=C5S(CC(N=CC(C)=C6OC)=C6C)=O3)[N]7=C2[N-]C8=CC(OC)=CC=C78	https://www.medchemexpress.com/Esomeprazole_magnesium.html	Launched		91.0	F8	C4	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1446	10.0	mM	52.0	DMSO	30.0	4	C	pluskal_fda_drugs_5006_C4_id
13	HY-N7075	HYCPK40897	M03	HYCPK40909	92z	1236.0	4.0	Z36	909.0	M18	9005-80-5	Inulin			Endogenous Metabolite	Metabolic Enzyme/Protease	Inulin is a storage polysaccharide and belongs to a group of non-digestible carbohydrates, fructan. Inulin is from  plants of the Compositae and Lilialiaceaes families, often used as a prebiotic, fat replacer, sugar replacer, texture modifier, plays beneficial role in gastric [1].			92332.0	DMSO : 100 mg/mL (Need ultrasonic); H2O : ≥ 50 mg/mL	DMSO Solution	3mg/mL  * 100uL	Metabolic Disease; Cancer	[Inulin]	https://www.medchemexpress.com/inulin.html	Launched		92.0	Z36	C5	233.3333333	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-N7075	3.0	mM	53.0	DMSO	170.0	5	C	pluskal_fda_drugs_5006_C5_id
1418	HY-B2114	HYCPK40906	G06	HYCPK40906	92z	587.0	1.0	M11	906.0	G06	6805-41-0	Escin		1131.26	Apoptosis	Apoptosis	Escin, a natural compound of triterpenoid saponins isolated from horse chestnut (Aesculus hippocastanum) seeds, can be used as a vasoprotective anti-inflammatory, anti-edematous and anti-nociceptive agent[1].	Free Acid	C55H86O24	42693.0	DMSO : 100 mg/mL (88.40 mM; Need ultrasonic); H2O : < 0.1 mg/mL (insoluble)	DMSO Solution	10mM  * 100uL	Cancer; Inflammation/Immunology	CC1(C)[C@@H](OC(/C(C)=C/C)=O)[C@H](OC(C)=O)[C@@]([C@H](O)C[C@]2(C)C3=CC[C@@]4([H])[C@@]2(C)CC[C@]5([H])[C@]4(C)CC[C@H](O[C@@H]6O[C@H](C(O)=O)[C@@H](O[C@@H]7[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O7)[C@H](O)[C@H]6O[C@@H]8OC(CO)[C@@H](O)[C@H](O)[C@H]8O)[C@@]5(C	https://www.medchemexpress.com/escin.html	Launched		92.0	M11	C5	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B2114	10.0	mM	53.0	DMSO	130.0	5	C	pluskal_fda_drugs_5006_C5_id
1700	HY-B0315	HYCPK40906	G22	HYCPK40906	92z	619.0	1.0	M43	906.0	G22	68-19-9	Vitamin B12	Cyanocobalamin	1355.37	Endogenous Metabolite	Metabolic Enzyme/Protease	Vitamin B12 is a vitamin. Vitamin B12 plays a key role in the normal functioning of the brain and nervous system, and for the formation of blood[1][2].	Free Base	C63H88CoN14O14P	96809.0	DMSO : 25 mg/mL (18.45 mM; Need ultrasonic); H2O : 6.25 mg/mL (4.61 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Metabolic Disease; Cancer	N#[C-][Co+3]123([N]4=CN(C(OC(CO)C5OP6([O-])=O)C5O)C7=C4C=C(C)C(C)=C7)[N]8=C9C(CCC(N)=O)C(CC(N)=O)(C)C8(C)C(C(CC(N)=O)C%10(CCC(NCC(C)O6)=O)C)[N-]1C%10=C(C)C(C(CCC(N)=O)C%11(C)C)=[N]2C%11=CC%12=[N]3C(C(CC(N)=O)(C)C%12CCC(N)=O)=C9C	https://www.medchemexpress.com/Vitamin-B12.html	Launched		92.0	M43	C5	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0315	10.0	mM	53.0	DMSO	210.0	5	C	pluskal_fda_drugs_5006_C5_id
1706	HY-17586	HYCPK40906	M22	HYCPK40906	92z	1195.0	1.0	Y43	906.0	M22	2227366-51-8	Dalbavancin (hydrochloride)	MDL-63397 (hydrochloride); BI-397 (hydrochloride)	1853.15	Antibiotic; Bacterial	Anti-infection	Dalbavancin hydrochloride (MDL-63397 hydrochloride) is a semisynthetic lipoglycopeptide antibiotic with potent bactericidal activity against Gram-positive bacteria. Dalbavancin hydrochloride inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively[1][2].	Hydrochloride	C88H101Cl3N10O28	114727.0	DMSO : 250 mg/mL (134.91 mM; Need ultrasonic); H2O : 50 mg/mL (26.98 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	O[C@@H]([C@@H](O)[C@@H]1O)[C@H](O[C@@H]1CO)OC2=C(C3=CC([C@@](C4=O)([H])NC([C@@](NC([C@](NC([C@@](NC5=O)([H])C6)=O)([H])C(C=C7OC(C=C8[C@H]5NC)=C(C=C8)O)=C(C(O)=C7)Cl)=O)([H])C9=CC%10=C(O[C@H](O[C@H](C(O)=O)[C@@H](O)[C@@H]%11O)[C@@H]%11NC(CCCCCCCCC(C)C)=O)C	https://www.medchemexpress.com/Dalbavancin.html	Launched		92.0	Y43	C5	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17586	10.0	mM	53.0	DMSO	190.0	5	C	pluskal_fda_drugs_5006_C5_id
1786	HY-B1831A	HYCPK40907	B08	HYCPK40907	92z	112.0	2.0	C16	907.0	B08	192564-14-0	Oritavancin (diphosphate)	LY333328 diphosphate	1989.09	Antibiotic; Bacterial	Anti-infection	Oritavancin diphosphate (LY333328 diphosphate) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin diphosphate inhibits cell wall synthesis and disrupts the membrane potential[1][2].	Phosphate	C86H103Cl3N10O34P2	18159.0	DMSO : 41.67 mg/mL (20.95 mM; Need ultrasonic); H2O : 50 mg/mL (25.14 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	O[C@@H]1[C@@H](O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@]2(C)NCC3=CC=C(C4=CC=C(Cl)C=C4)C=C3)[C@@H](O[C@H](CO)[C@H]1O)OC5=C(OC6=CC=C([C@H]([C@H]7NC([C@H](NC)CC(C)C)=O)O)C=C6Cl)C=C([C@](NC([C@@H](NC7=O)CC(N)=O)=O)([H])C(N[C@](C8=O)([H])C9=CC%10=C(O)C=C9)=O)C=C5OC	https://www.medchemexpress.com/Oritavancin-diphosphate.html	Launched		92.0	C16	C5	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B1831A	10.0	mM	53.0	DMSO	90.0	5	C	pluskal_fda_drugs_5006_C5_id
1806	HY-A0167	HYCPK40907	F09	HYCPK40907	92z	498.0	2.0	K18	907.0	F09	86050-77-3	Gadopentetate (dimeglumine)	SH-L-451A; Gadopentetic acid dimeglumine salt	938.00	Others	Others	Gadopentetate dimeglumine (SH-L-451A) is used in combination with magnetic resonance imaging (MRI) to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on the MRI.	Meglumine	C28H54GdN5O20	25825.0	DMSO : 100 mg/mL (106.61 mM; Need ultrasonic); H2O : ≥ 100 mg/mL (106.61 mM)	DMSO Solution	10mM  * 100uL	Cancer	O=C1[O-][Gd+3]([N]2(C3)CC4=O)([N]5(C6)CC7=O)([O-]C6=O)([O-]7)([O-]C3=O)([O-]4)[N](CC5)(CC2)C1.O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO.O[C@H]([C@@H](O)CNC)[C@H](O)[C@H](O)CO.[2H+]	https://www.medchemexpress.com/Gadopentetate_dimeglumine.html	Launched		92.0	K18	C5	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-A0167	10.0	mM	53.0	DMSO	110.0	5	C	pluskal_fda_drugs_5006_C5_id
2554	HY-17565A	HYCPK40909	M11	HYCPK40909	92z	1222.0	4.0	Z22	909.0	M11	67763-87-5	Bleomycin (hydrochloride)		1451.00	Antibiotic; DNA/RNA Synthesis	Anti-infection; Cell Cycle/DNA Damage	Bleomycin hydrochloride is a DNA synthesis inhibitor. Bleomycin hydrochloride is a DNA damaging agent. Bleomycin hydrochloride is an antitumor antibiotic[1].	Hydrochloride	C55H84ClN17O21S3	146400.0	H2O : 100 mg/mL (68.92 mM; Need ultrasonic); DMSO : 50 mg/mL (34.46 mM; ultrasonic and warming and heat to 60°C)	DMSO Solution	10mM  * 100uL	Cancer	NC(C[C@H](NC[C@@H](N)C(N)=O)C1=NC(N)=C(C)C(C(N[C@H](C(N[C@@H](C)[C@@H]([C@@H](C)C(N[C@@H](C(NCCC2=NC(C3=NC(C(NCCC[S+](C)C)=O)=CS3)=CS2)=O)[C@H](O)C)=O)O)=O)C(C4=CNC=N4)O[C@@H]5[C@]([H])(O[C@@H]6[C@@H](O)[C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](O	https://www.medchemexpress.com/bleomycin-hydrochloride.html	Launched		92.0	Z22	C5	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17565A	10.0	mM	53.0	DMSO	150.0	5	C	pluskal_fda_drugs_5006_C5_id
32	HY-112624	HYCPK40899	J03	HYCPK40909	92z	940.0	4.0	T28	909.0	J14	9004-54-0	Dextran	Dextran 40	40000.00	Bacterial	Anti-infection	Dextran (Dextran 40) has an inhibitory effect on thrombocyte aggregation and coagulation factors and is used as a plasma volume expander.			47072.0	10 mM in DMSO	DMSO Solution	2mM  * 100uL	Cardiovascular Disease; Cancer	[Dextran]	https://www.medchemexpress.com/dextran.html	Launched		92.0	T28	C6	350.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-112624	2.0	mM	54.0	DMSO	180.0	6	C	pluskal_fda_drugs_5006_C6_id
55	HY-107193	HYCPK40899	I05	HYCPK40909	92z	848.0	4.0	R32	909.0	I16	1405-87-4	Bacitracin		1422.69	Antibiotic; Bacterial	Anti-infection	Bacitracin is a polypeptide antibiotic used for staphylococcal infections. Bacitracin functions as an inhibitor of cell wall biosynthesis through its binding to the undecaprenyl pyrophosphate. The combination of bacitracin with other antibiotics has been efficient to be used as a topical agent[1].		C66H103N17O16S	78802.0	H2O : 6.67 mg/mL (4.69 mM; Need ultrasonic)	DMSO Solution	2mM  * 100uL	Infection; Cancer	[Bacitracin]	https://www.medchemexpress.com/bacitracin.html	Launched		92.0	R32	C6	350.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-107193	2.0	mM	54.0	DMSO	160.0	6	C	pluskal_fda_drugs_5006_C6_id
1704	HY-P0012A	HYCPK40906	K22	HYCPK40906	92z	1003.0	1.0	U43	906.0	K22	1444827-29-5	Aviptadil (acetate)	Vasoactive Intestinal Peptide acetate salt (human, rat, mouse, rabbit, canine, porcine)	3385.90	SARS-CoV	Anti-infection	Aviptadil acetate is an analog vasoactive intestinal polypeptide (VIP) with potent vasodilatory effects. Aviptadil acetate induces pulmonary vasodilation and inhibits vascular SMCs proliferation, platelet aggregation. Aviptadil acetate can be used for the research of pulmonary fibrosis, pulmonary arterial hypertension (PAH) and SARS-CoV-2 caused respiratory failure, et al[1].	Acetate	C147H238N44O42S.C2H4O2	84773.0	H2O : 100 mg/mL (29.53 mM; Need ultrasonic); DMSO : 100 mg/mL (29.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Inflammation/Immunology	[HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH2 (acetate salt)]	https://www.medchemexpress.com/aviptadil-acetate.html	Launched		92.0	U43	C6	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P0012A	10.0	mM	54.0	DMSO	200.0	6	C	pluskal_fda_drugs_5006_C6_id
1894	HY-17362	HYCPK40907	F15	HYCPK40907	92z	510.0	2.0	K30	907.0	F15	1404-93-9	Vancomycin (hydrochloride)		1485.71	Antibiotic; Autophagy; Bacterial	Anti-infection; Autophagy	Vancomycin hydrochloride is an antibiotic for the treatment of bacterial infections. It acts by inhibiting the second stage of cell wall synthesis of susceptible bacteria. Vancomycin also alters the permeability of the cell membrane and selectively inhibits ribonucleic acid synthesis.	Hydrochloride	C66H76Cl3N9O24	33883.0	DMSO : 24 mg/mL (16.15 mM; Need ultrasonic and warming); H2O : 33.33 mg/mL (22.43 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection; Cancer	ClC1=CC([C@H]([C@@H](NC([C@H](NC)CC(C)C)=O)C(N[C@@H](CC(N)=O)C(N[C@@]2([H])C(N[C@]3([H])C4=CC(C5=C(C=C(O)C=C5O)[C@](C(O)=O)([H])NC([C@](NC3=O)([H])[C@H](O)C6=CC=C7C(Cl)=C6)=O)=C(O)C=C4)=O)=O)=O)O)=CC=C1OC8=C(C(O7)=CC2=C8)O[C@H]9[C@@H]([C@H]([C@H](O)[C@@H]	https://www.medchemexpress.com/Vancomycin-hydrochloride.html	Launched		92.0	K30	C6	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-17362	10.0	mM	54.0	DMSO	120.0	6	C	pluskal_fda_drugs_5006_C6_id
2308	HY-B0146	HYCPK40909	H07	HYCPK40909	92z	734.0	4.0	P14	909.0	H07	129497-78-5	Verteporfin	CL 318952	718.79	Apoptosis; Autophagy; YAP	Apoptosis; Autophagy; Stem Cell/Wnt	Verteporfin (CL 318952) is a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as age-related macular degeneration. Verteporfin is a YAP inhibitor which disrupts YAP-TEAD interactions. Verteporfin induces cell apoptosis[1]. Verteporfinis an autophagy inhibitor that blocks?autophagy?at an early stage by inhibiting autophagosome formation[3].	Free Acid	C41H42N4O8	178492.0	DMSO : ≥ 200 mg/mL (278.25 mM); DMF : 25 mg/mL (34.78 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Cancer	C[C@]1(/C2=C/C(N3)=C4C)C(C(/C=C(C(C)=C/5C=C)\NC5=C/C6=N/C(C(CCC(OC)=O)=C6C)=C\C3=C4CCC(O)=O)=N2)=CC=C(C(OC)=O)[C@H]1C(OC)=O.C[C@]7(/C8=C/C(N9)=C%10C)C(C(/C=C(C(C)=C/%11C=C)\NC%11=C/C%12=N/C(C(CCC(O)=O)=C%12C)=C\C9=C%10CCC(OC)=O)=N8)=CC=C(C(OC)=O)[C@H]7C(O	https://www.medchemexpress.com/Verteporfin.html	Launched		92.0	P14	C6	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0146	10.0	mM	54.0	DMSO	140.0	6	C	pluskal_fda_drugs_5006_C6_id
2436	HY-P0163	HYCPK40909	P03	HYCPK40909	92z	1494.0	4.0	AF6	909.0	P03	1405-97-6	Gramicidin		1882.30	Antibiotic; Bacterial	Anti-infection	Gramicidin is an antimicrobial peptide assembling as channels in membranes and increasing their permeability towards cations.		C99H140N20O17	160319.0	DMSO : 100 mg/mL (53.13 mM; Need ultrasonic); H2O : 1 mg/mL (0.53 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Infection	[Gramicidin]	https://www.medchemexpress.com/Gramicidin.html	Launched		92.0	AF6	C6	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-P0163	10.0	mM	54.0	DMSO	220.0	6	C	pluskal_fda_drugs_5006_C6_id
2498	HY-B0586	HYCPK40909	E08	HYCPK40909	92z	448.0	4.0	J16	909.0	E08	13422-55-4	Methylcobalamin	CH3-B12	1344.38	Endogenous Metabolite	Metabolic Enzyme/Protease	Methylcobalamin (CH3-B12), a cobalamin, is a form of vitamin B12.	Free Base	C63H91CoN13O14P	13443.0	DMSO : ≥ 100 mg/mL (74.38 mM); H2O : 5 mg/mL (3.72 mM; Need ultrasonic)	DMSO Solution	10mM  * 100uL	Metabolic Disease	NC(C[C@H]1[C@@]2([H])[C@]3(C)[N]4=C([C@@H](CCC(N)=O)[C@]3(C)CC(N)=O)C(C)=C([C@](CC(N)=O)(C)[C@@H]5CCC(N)=O)[N]6=C5C=C(C(C)(C)[C@@H]7CCC(N)=O)[N]8=C7C(C)=C([C@@]1(CCC(NC[C@@H](C)O9)=O)C)[N-]2[Co+3]486([CH3-])[N](C%10=CC(C)=C(C)C=C%11%10)=CN%11[C@@H](O[C@@H	https://www.medchemexpress.com/Methylcobalamin.html	Launched		92.0	J16	C6	70.0	nl	5006	1536LDV_DMSO	GN1536MDX	384PP_Corina	HY-B0586	10.0	mM	54.0	DMSO	100.0	6	C	pluskal_fda_drugs_5006_C6_id
